PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wegert, J; Zauter, L; Appenzeller, S; Otto, C; Bausenwein, S; Vokuhl, C; Ernestus, K; Furtwangler, R; Graf, N; Gessler, M				Wegert, Jenny; Zauter, Lisa; Appenzeller, Silke; Otto, Christoph; Bausenwein, Sabrina; Vokuhl, Christian; Ernestus, Karen; Furtwaengler, Rhoikos; Graf, Norbert; Gessler, Manfred			High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro	ONCOGENE			English	Article							STEM-CELLS; MUTATIONS; CANCER; PROGENITORS; MARKERS; KIDNEY; GENES; MOUSE; LINE	In vitro models represent a critical tool in cancer research to study tumor biology and to evaluate new treatment options. Unfortunately, there are no effective preclinical models available that represent Wilms tumor (WT) - the most common pediatric renal tumor. Especially the high-risk blastemal WT subtype is not represented by the few primary cell lines established until now. Here, we describe a new 3D approach for in vitro cultivation of blastemal WT cells, where primary cultures grown in suspension as spheroids could be propagated long-term. Besides blastemal cultures, we could generate spheroids representing epithelial and stromal WT. Spheroid cultures were analyzed by immunohistochemistry in comparison to corresponding tumor sections and were further characterized by RNA sequencing. Histological appearance of spheroids resembled the original tumor and they expressed marker genes characteristic of early renal development and blastemal WT elements. The cultures were amenable to genetic manipulation and they formed xenograft tumors, which resemble the primary human tumor. This collection of WT spheroids that carry different genetic drivers forms a long-sought tool for drug testing and in vitro modeling.	[Wegert, Jenny; Zauter, Lisa; Bausenwein, Sabrina; Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, Dev Biochem, Bioctr, Wurzburg, Germany; [Appenzeller, Silke; Gessler, Manfred] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Otto, Christoph] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Pediat Surg, Expt Surg, Wurzburg, Germany; [Vokuhl, Christian] Univ Hosp Kiel, Dept Pathol, Sect Pediat Pathol, Kiel Pediat Tumor Registry, Kiel, Germany; [Ernestus, Karen] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Furtwaengler, Rhoikos; Graf, Norbert] Saarland Univ, Childrens Hosp, Pediat Oncol & Hematol, Homburg, Germany; [Furtwaengler, Rhoikos; Graf, Norbert] Saarland Univ, Med Ctr, Homburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Kiel; Schleswig Holstein University Hospital; University of Wurzburg; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Gessler, M (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dev Biochem, Bioctr, Wurzburg, Germany.; Gessler, M (corresponding author), Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany.	gessler@biozentrum.uni-wuerzburg.de	Vokuhl, Christian/M-1511-2017; Furtwängler, Rhoikos/V-3519-2018; Graf, Norbert/H-1328-2011	Furtwängler, Rhoikos/0000-0002-1967-8343; Graf, Norbert/0000-0002-2248-323X; Gessler, Manfred/0000-0002-7915-6045; Appenzeller, Silke/0000-0002-5472-8692	Deutsche Forschungsgemeinschaft [DFG Ge539/13]; Wilhelm-Sander-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung	We thank patients for participating in our research and the members of the GPOH WT study group for their efforts in collecting precious samples and data. This study was supported by the Deutsche Forschungsgemeinschaft (DFG Ge539/13) and the Wilhelm-Sander-Stiftung.	Alami J, 2003, INT J CANCER, V107, P365, DOI 10.1002/ijc.11429; Bhakta N, 2017, LANCET, V390, P2569, DOI 10.1016/S0140-6736(17)31610-0; BRESLOW N, 1993, MED PEDIATR ONCOL, V21, P172, DOI 10.1002/mpo.2950210305; Chagtai T, 2016, J CLIN ONCOL, V34, P3195, DOI 10.1200/JCO.2015.66.0001; Dome JS, 2015, J CLIN ONCOL, V33, P2999, DOI 10.1200/JCO.2015.62.1888; Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6; Faussilion M, 2008, CANCER GENET CYTOGEN, V184, P22, DOI 10.1016/j.cancergencyto.2008.02.018; Gadd S, 2017, NAT GENET, V49, P1487, DOI 10.1038/ng.3940; GARVIN AJ, 1987, AM J PATHOL, V129, P353; Hochane M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000152; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Hu QH, 2011, J CLIN INVEST, V121, P174, DOI 10.1172/JCI43772; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Kumar SV, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172361; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Lindstrom NO, 2018, DEV CELL, V45, P651, DOI 10.1016/j.devcel.2018.05.010; Magella B, 2018, DEV BIOL, V434, P36, DOI 10.1016/j.ydbio.2017.11.006; Pode-Shakked N, 2013, EMBO MOL MED, V5, P18, DOI 10.1002/emmm.201201516; Royer-Pokora B, 2010, HUM MOL GENET, V19, P1651, DOI 10.1093/hmg/ddq042; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sadak KT, 2013, NAT REV UROL, V10, P15, DOI 10.1038/nrurol.2012.218; Schutgens F, 2019, NAT BIOTECHNOL, V37, P303, DOI 10.1038/s41587-019-0048-8; Shukrun R, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.013; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Vujanic GM, 2018, NAT REV UROL, V15, P693, DOI 10.1038/s41585-018-0100-3; Walz AL, 2015, CANCER CELL, V27, P286, DOI 10.1016/j.ccell.2015.01.003; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Wegert J, 2012, GENE CHROMOSOME CANC, V51, P92, DOI 10.1002/gcc.20936; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544; Zweigerdt R, 2003, CYTOTHERAPY, V5, P399, DOI 10.1080/14653240310003062	31	9	10	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					849	861		10.1038/s41388-019-1027-8	http://dx.doi.org/10.1038/s41388-019-1027-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31562394	Green Published, hybrid			2022-12-26	WOS:000509197200008
J	Kutin, Y; Kositzki, R; Branca, RMM; Srinivas, V; Lundin, D; Haumann, M; Hogbom, M; Cox, N; Griese, JJ				Kutin, Yury; Kositzki, Ramona; Branca, Rui M. M.; Srinivas, Vivek; Lundin, Daniel; Haumann, Michael; Hogbom, Martin; Cox, Nicholas; Griese, Julia J.			Chemical flexibility of heterobimetallic Mn/Fe cofactors: R2lox and R2c proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; metalloprotein; ribonucleotide reductase; electron paramagnetic resonance (EPR); mass spectrometry (MS); X-ray crystallography; X-ray absorption spectroscopy; binuclear metal cofactor; R2-like ligand-binding oxidase; redox chemistry	TRACHOMATIS RIBONUCLEOTIDE REDUCTASE; RAY-ABSORPTION SPECTROSCOPY; MANGANESE(IV)/IRON(III) COFACTOR; ELECTRONIC-STRUCTURE; DIMANGANESE CATALASE; MANGANESE COMPLEX; RADICAL COFACTOR; STRUCTURAL BASIS; PHOTOSYSTEM-II; MN-55 ENDOR	A heterobimetallic Mn/Fe cofactor is present in the R2 subunit of class Ic ribonucleotide reductases (R2c) and in R2-like ligand-binding oxidases (R2lox). Although the protein-derived metal ligands are the same in both groups of proteins, the connectivity of the two metal ions and the chemistry each cofactor performs are different: in R2c, a one-electron oxidant, the Mn/Fe dimer is linked by two oxygen bridges (?-oxo/?-hydroxo), whereas in R2lox, a two-electron oxidant, it is linked by a single oxygen bridge (?-hydroxo) and a fatty acid ligand. Here, we identified a second coordination sphere residue that directs the divergent reactivity of the protein scaffold. We found that the residue that directly precedes the N-terminal carboxylate metal ligand is conserved as a glycine within the R2lox group but not in R2c. Substitution of the glycine with leucine converted the resting-state R2lox cofactor to an R2c-like cofactor, a ?-oxo/?-hydroxo?bridged Mn-III/Fe-III dimer. This species has recently been observed as an intermediate of the oxygen activation reaction in WT R2lox, indicating that it is physiologically relevant. Cofactor maturation in R2c and R2lox therefore follows the same pathway, with structural and functional divergence of the two cofactor forms following oxygen activation. We also show that the leucine-substituted variant no longer functions as a two-electron oxidant. Our results reveal that the residue preceding the N-terminal metal ligand directs the cofactor's reactivity toward one- or two-electron redox chemistry, presumably by setting the protonation state of the bridging oxygens and thereby perturbing the redox potential of the Mn ion.	[Kutin, Yury] Max Planck Inst Chem Energiekonvers, Stiftstr 34-36, D-45470 Mulheim, Germany; [Kositzki, Ramona; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Branca, Rui M. M.] Karolinska Inst, Canc Prote Mass Spectrometry, Dept Oncol Pathol, Sci Life Lab, Box 1031, SE-17121 Solna, Sweden; [Srinivas, Vivek; Lundin, Daniel; Hogbom, Martin; Griese, Julia J.] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Cox, Nicholas] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Griese, Julia J.] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Kutin, Yury] TU Dortmund Univ, Dept Chem & Chem Biol, D-44227 Dortmund, Germany	Max Planck Society; Free University of Berlin; Karolinska Institutet; Stockholm University; Australian National University; Uppsala University; Dortmund University of Technology	Cox, N (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.; Griese, JJ (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden.	nick.cox@anu.edu.au; julia.griese@icm.uu.se	MIchael, Haumann/A-7087-2013; Kutin, Yuri/P-1629-2017; Cox, Nicholas/J-8047-2014; Griese, Julia Johanna/GQB-0023-2022	Kutin, Yuri/0000-0001-9613-0771; Cox, Nicholas/0000-0002-7815-6115; Griese, Julia Johanna/0000-0003-3686-3062; Hogbom, Martin/0000-0001-5574-9383	Deutsche Forschungsgemeinschaft [Ha3265/6-1]; German Bundesministerium fur Bildung und Forschung within the Rontgen-Angstrom Cluster [05K14KE1]; Swedish Research Council [2016-03770, 2017-04018]; European Research Council [HIGH-GEAR 724394]; Knut and Alice Wallenberg Foundation [2017.0275]; European Community [283570]; Australian Research Council Future Fellowship [FT140100834]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Bundesministerium fur Bildung und Forschung within the Rontgen-Angstrom Cluster(Federal Ministry of Education & Research (BMBF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Community(European Commission); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by Deutsche Forschungsgemeinschaft Grant Ha3265/6-1 and a Heisenberg Fellowship, German Bundesministerium fur Bildung und Forschung Grant 05K14KE1 within the Rontgen-Angstrom Cluster (to M. Haumann), Swedish Research Council Grants 2016-03770 (to J. J. G.) and 2017-04018 (to M. Hogbom), European Research Council Grant HIGH-GEAR 724394, Knut and Alice Wallenberg Foundation Grant 2017.0275, the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 283570 (for BioStruct-X) (to M. Hogbom), and Australian Research Council Future Fellowship FT140100834 (to N. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersson CS, 2012, J AM CHEM SOC, V134, P123, DOI 10.1021/ja209678x; Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Berggren G, 2014, J BIOL CHEM, V289, P31940, DOI 10.1074/jbc.M114.592535; Blaesi EJ, 2018, P NATL ACAD SCI USA, V115, P10022, DOI 10.1073/pnas.1811993115; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2011, INORG CHEM, V50, P8238, DOI 10.1021/ic200767e; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Dassama LMK, 2013, BIOCHEMISTRY-US, V52, P6424, DOI 10.1021/bi400819x; Dassama LMK, 2012, J AM CHEM SOC, V134, P2520, DOI 10.1021/ja211314p; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Griese JJ, 2019, ACTA CRYSTALLOGR D, V75, P764, DOI 10.1107/S2059798319009926; Griese JJ, 2019, J BIOL INORG CHEM, V24, P211, DOI 10.1007/s00775-019-01639-4; Griese JJ, 2018, J BIOL INORG CHEM, V23, P879, DOI 10.1007/s00775-018-1583-3; Griese JJ, 2015, J BIOL CHEM, V290, P25254, DOI 10.1074/jbc.M115.675223; Griese JJ, 2014, J BIOL INORG CHEM, V19, P759, DOI 10.1007/s00775-014-1140-7; Griese JJ, 2013, P NATL ACAD SCI USA, V110, P17189, DOI 10.1073/pnas.1304368110; Griese JJ, 2012, METALLOMICS, V4, P894, DOI 10.1039/c2mt20080e; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Hofbauer W, 2000, J MAGN RESON, V147, P226, DOI 10.1006/jmre.2000.2202; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jiang W, 2007, BIOCHEMISTRY-US, V46, P8709, DOI 10.1021/bi700906g; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Klockenkamper R., 1997, TOTAL REFLECTION XRA; Kositzki R, 2016, INORG CHEM, V55, P9869, DOI 10.1021/acs.inorgchem.6b01752; Kutin Y, 2016, J INORG BIOCHEM, V162, P164, DOI 10.1016/j.jinorgbio.2016.04.019; Kwak Y, 2013, J AM CHEM SOC, V135, P17573, DOI 10.1021/ja409510d; Leidel N, 2012, BBA-BIOENERGETICS, V1817, P430, DOI 10.1016/j.bbabio.2011.12.008; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; Martinie RJ, 2017, J AM CHEM SOC, V139, P1950, DOI 10.1021/jacs.6b11563; Miller EK, 2017, BIOCHEMISTRY-US, V56, P3369, DOI 10.1021/acs.biochem.7b00403; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Randall DW, 1998, MOL PHYS, V95, P1283, DOI 10.1080/00268979809483259; RANDALL DW, 1995, J AM CHEM SOC, V117, P11780, DOI 10.1021/ja00152a021; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Roos K, 2011, J BIOL INORG CHEM, V16, P553, DOI 10.1007/s00775-011-0755-1; Rose HR, 2018, BIOCHEMISTRY-US, V57, P2679, DOI 10.1021/acs.biochem.8b00247; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Schafer KO, 2003, J PHYS CHEM B, V107, P1242, DOI 10.1021/jp0259768; Schafer KO, 1998, J AM CHEM SOC, V120, P13104, DOI 10.1021/ja9827548; Shafaat HS, 2014, J AM CHEM SOC, V136, P13399, DOI 10.1021/ja507435t; Sigfridsson KGV, 2013, J BIOL CHEM, V288, P9648, DOI 10.1074/jbc.M112.438796; Srinivas V., 2018, METAL INDEPENDENT RI, DOI [10.1101/348268, DOI 10.1101/348268]; Srinivas V, 2018, NATURE, V563, P416, DOI 10.1038/s41586-018-0653-6; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stolle P, 2010, FEBS J, V277, P4849, DOI 10.1111/j.1742-4658.2010.07885.x; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; Teutloff C, 2005, MAGN RESON CHEM, V43, pS51, DOI 10.1002/mrc.1685; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Voevodskaya N, 2009, J BIOL CHEM, V284, P4555, DOI 10.1074/jbc.M807190200; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; WIEGHARDT K, 1988, J AM CHEM SOC, V110, P7398, DOI 10.1021/ja00230a021; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	70	4	4	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18372	18386		10.1074/jbc.RA119.010570	http://dx.doi.org/10.1074/jbc.RA119.010570			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31591267	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000505547900031
J	Vera, CD; Johnson, CA; Walklate, J; Adhikari, A; Svicevic, M; Mijailovich, SM; Combs, AC; Langer, SJ; Ruppel, KM; Spudich, JA; Geeves, MA; Leinwand, LA				Vera, Carlos D.; Johnson, Chloe A.; Walklate, Jonathan; Adhikari, Arjun; Svicevic, Marina; Mijailovich, Srboljub M.; Combs, Ariana C.; Langer, Stephen J.; Ruppel, Kathleen M.; Spudich, James A.; Geeves, Michael A.; Leinwand, Leslie A.			Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; kinetics; molecular motor; structure-function; mathematical modeling; actin-myosin; hypertrophic cardiomyopathy	BETA-CARDIAC MYOSIN; CROSS-BRIDGE CYCLE; MUSCLE-CONTRACTION; SKELETAL-MUSCLE; MOLECULAR-BASIS; GENE; ACTIN; FORCE; PHOSPHORYLATION; PREVALENCE	Hypertrophic cardiomyopathy (HCM) is a common genetic disorder characterized by left ventricular hypertrophy and cardiac hyper-contractility. Mutations in the beta-cardiac myosin heavy chain gene (beta-MyHC) are a major cause of HCM, but the specific mechanistic changes to myosin function that lead to this disease remain incompletely understood. Predicting the severity of any beta-MyHC mutation is hindered by a lack of detailed examinations at the molecular level. Moreover, because HCM can take >= 20 years to develop, the severity of the mutations must be somewhat subtle. We hypothesized that mutations that result in early onset disease would have more severe changes in function than do later onset mutations. Here, we performed steady-state and transient kinetic analyses of myosins carrying one of seven missense mutations in the motor domain. Of these seven, four were previously identified in early onset cardiomyopathy screens. We used the parameters derived from these analyses to model the ATP-driven cross-bridge cycle. Contrary to our hypothesis, the results indicated no clear differences between early and late onset HCM mutations. Despite the lack of distinction between early and late onset HCM, the predicted occupancy of the force-holding actin.myosin.ADP complex at [Actin] = 3 K-app along with the closely related duty ratio (the fraction of myosin in strongly attached force-holding states), and the measured ATPases all changed in parallel (in both sign and degree of change) compared with wildtype (WT) values. Six of the seven HCM mutations were clearly distinct from a set of previously characterized DCM mutations.	[Vera, Carlos D.; Combs, Ariana C.; Langer, Stephen J.; Leinwand, Leslie A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vera, Carlos D.; Combs, Ariana C.; Langer, Stephen J.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Johnson, Chloe A.; Walklate, Jonathan; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Svicevic, Marina] Univ Kagujevac, Fac Sci, Kragujevac, Serbia; [Mijailovich, Srboljub M.] IIT, Dept Biol, Chicago, IL 60616 USA; [Adhikari, Arjun; Ruppel, Kathleen M.; Spudich, James A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Kent; Illinois Institute of Technology; Stanford University	Leinwand, LA (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.; Geeves, MA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	m.a.geeves@kent.ac.uk; leslie.leinwand@colorado.edu		Johnson, Chloe/0000-0003-0856-5041; Geeves, Michael/0000-0002-9364-8898; Vera, Carlos/0000-0003-1207-4878; COMBS, ARIANA/0000-0001-8327-5074; Svicevic, Marina/0000-0003-2791-3849	Children's Cardiomyopathy Foundation; National Institutes of Health [2R01GM029090, 3R01GM029090-31S1, 1F31GM111058-01A1, 2R01HL117138-05]; European Union [777204 SILICOFCM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090, F31GM111058] Funding Source: NIH RePORTER	Children's Cardiomyopathy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Children's Cardiomyopathy Foundation (to L. A. L), National Institutes of Health Grants 2R01GM029090 (to M. A. G., L. A. L., C. D. V), 3R01GM029090-31S1 and 1F31GM111058-01A1 (to C. D. V.), and 2R01HL117138-05 (to L. A. L., J. A. S., and C. D. V.), and European Union's Horizon 2020 Research and Innovation Programme Grant 777204 SILICOFCM (to M. A. G., S. M. M., M. S., and J. W.). J. A. S. is a co-founder of Cytokinetics and MyoKardia. L. A. L. is a co-founder of MyoKardia. J. A. S., L. A. L., and K. M. R. are members of the scientific advisory board for MyoKardia. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari AS, 2016, CELL REP, V17, P2857, DOI 10.1016/j.celrep.2016.11.040; Alamo L, 2017, ELIFE, V6, DOI 10.7554/eLife.24634; Anderson RL, 2018, P NATL ACAD SCI USA, V115, pEB143, DOI 10.1073/pnas.1809540115; Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Bell KM, 2019, J PHYSIOL-LONDON, V597, P2403, DOI 10.1113/JP277333; Bloemink M, 2014, J BIOL CHEM, V289, P5158, DOI 10.1074/jbc.M113.511204; Colegrave M, 2014, ANAT REC, V297, P1670, DOI 10.1002/ar.22973; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; FANANAPAZIR L, 1993, P NATL ACAD SCI USA, V90, P3993, DOI 10.1073/pnas.90.9.3993; Fenn WO, 1923, J PHYSIOL-LONDON, V58, P0175; Garcia-Giustiniani D, 2015, HEART, V101, P1047, DOI 10.1136/heartjnl-2014-307205; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Greenberg MJ, 2014, BIOPHYS J, V107, pL41, DOI 10.1016/j.bpj.2014.11.005; Hamady M, 2010, INT J CARDIOL, V144, P124, DOI 10.1016/j.ijcard.2008.12.199; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; Kawana M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601959; Kindel SJ, 2012, J CARD FAIL, V18, P396, DOI 10.1016/j.cardfail.2012.01.017; Kohler J, 2002, P NATL ACAD SCI USA, V99, P3557, DOI 10.1073/pnas.062415899; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Linari M, 2015, NATURE, V528, P276, DOI 10.1038/nature15727; Liu C, 2018, NAT STRUCT MOL BIOL, V25, P505, DOI 10.1038/s41594-018-0069-x; Marston S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072020; Mijailovich SM, 2010, COMPUT BIOL CHEM, V34, P19, DOI 10.1016/j.compbiolchem.2009.11.002; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Mohiddin SA, 2003, GENET TEST, V7, P21, DOI 10.1089/109065703321560895; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Newhard CS, 2019, AM J PHYSIOL-CELL PH, V316, pC844, DOI 10.1152/ajpcell.00494.2018; Perkins MJ, 2005, EUR HEART J, V26, P2457, DOI 10.1093/eurheartj/ehi438; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Robert-Paganin J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06191-4; Sabater-Molina M, 2018, CLIN GENET, V93, P3, DOI 10.1111/cge.13027; Seebohm B, 2009, BIOPHYS J, V97, P806, DOI 10.1016/j.bpj.2009.05.023; SMITH DA, 1995, BIOPHYS J, V69, P538, DOI 10.1016/S0006-3495(95)79927-1; Smith DA, 2014, J MUSCLE RES CELL M, V35, P295, DOI 10.1007/s10974-014-9391-z; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Spudich JA, 2019, PFLUG ARCH EUR J PHY, V471, P701, DOI 10.1007/s00424-019-02259-2; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; STEWART S, 1968, CIRCULATION, V37, P8, DOI 10.1161/01.CIR.37.1.8; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444; Trivedi Darshan V, 2018, Biophys Rev, V10, P27, DOI 10.1007/s12551-017-0274-6; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Ujfalusi Z, 2018, J BIOL CHEM, V293, P9017, DOI 10.1074/jbc.RA118.001938; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; ZOT HG, 1981, PREP BIOCHEM, V11, P381, DOI 10.1080/00327488108065530	59	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17451	17462		10.1074/jbc.RA119.010563	http://dx.doi.org/10.1074/jbc.RA119.010563			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31582565	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000503173500023
J	Xu, ZL; Wang, PC; Wang, HB; Yu, ZH; Au-Yeung, HY; Hirayama, T; Sun, HZ; Yan, AX				Xu, Zeling; Wang, Pengchao; Wang, Haibo; Yu, Zuo Hang; Au-Yeung, Ho Yu; Hirayama, Tasuku; Sun, Hongzhe; Yan, Aixin			Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; E; coli; metal homeostasis; copper transport; bacterial signal transduction; stress response; metal intoxication; metal sequestration; mismetallation; transition metals; Zn excess; metal homeostatic pathways; bacterial physiology; nutritional immunity; metallobiology	ANAEROBIC RESPIRATION; 2-COMPONENT SYSTEM; OXIDATIVE STRESS; SULFUR CLUSTERS; METAL-IONS; EFFLUX; HOMEOSTASIS; GROWTH; RESISTANCE; ENZYMES	Transition metals serve as an important class of micronutrients that are indispensable for bacterial physiology but are cytotoxic when they are in excess. Bacteria have developed exquisite homeostatic systems to control the uptake, storage, and efflux of each of biological metals and maintain a thermodynamically balanced metal quota. However, whether the pathways that control the homeostasis of different biological metals cross-talk and render cross-resistance or sensitivity in the host-pathogen interface remains largely unknown. Here, we report that zinc (Zn) excess perturbs iron (Fe) and copper (Cu) homeostasis in Escherichia coli, resulting in increased Fe and decreased Cu levels in the cell. Gene expression analysis revealed that Zn excess transiently up-regulates Fe-uptake genes and down-regulates Fe-storage genes and thereby increases the cellular Fe quota. In vitro and in vivo protein-DNA binding assays revealed that the elevated intracellular Fe poisons the primary Cu detoxification transcription regulator CueR, resulting in dysregulation of its target genes copA and cueO and activation of the secondary Cu detoxification system CusSR-cusCFBA. Supplementation with the Fe chelator 2,2?-dipyridyl (DIP) or with the reducing agent GSH abolished the induction of cusCFBA during Zn excess. Consistent with the importance of this metal homeostatic network in cell physiology, combined metal treatment, including simultaneously overloading cells with both Zn (0.25 mm) and Cu (0.25 mm) and sequestering Fe with DIP (50 ?m), substantially inhibited E. coli growth. These results advance our understanding of bacterial metallobiology and may inform the development of metal-based antimicrobial regimens to manage infectious diseases.	[Xu, Zeling; Wang, Pengchao; Yan, Aixin] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China; [Wang, Haibo; Yu, Zuo Hang; Au-Yeung, Ho Yu; Sun, Hongzhe] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China; [Hirayama, Tasuku] Gifu Pharmaceut Univ, Lab Pharmaceut & Med Chem, 1-25-4 Dairaku Nishi, Gifu 5011196, Japan	University of Hong Kong; University of Hong Kong; Gifu Pharmaceutical University	Yan, AX (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China.	ayan8@hku.hk	/D-3123-2009	/0000-0001-6697-6899	Seed Funding for Strategic Interdisciplinary Research Scheme HKU 2017; Health and Medical Research Fund (HMRF) [18171042]	Seed Funding for Strategic Interdisciplinary Research Scheme HKU 2017; Health and Medical Research Fund (HMRF)	This study was supported by Seed Funding for Strategic Interdisciplinary Research Scheme HKU 2017 (to A. Y.) and Health and Medical Research Fund (HMRF) Grant 18171042 (to A. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bird LJ, 2013, APPL ENVIRON MICROB, V79, P3619, DOI 10.1128/AEM.03944-12; Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; BOYLAN SA, 1981, J BIOL CHEM, V256, P1809; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chandrangsu P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006515; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Deng ZQ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00194; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Dudev T, 2014, CHEM REV, V114, P538, DOI 10.1021/cr4004665; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; Graham AI, 2012, MICROBIOL-SGM, V158, P284, DOI 10.1099/mic.0.053843-0; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; Gudipaty SA, 2012, FEMS MICROBIOL LETT, V330, P30, DOI 10.1111/j.1574-6968.2012.02529.x; HARMON HJ, 1974, BIOCHIM BIOPHYS ACTA, V368, P125, DOI 10.1016/0005-2728(74)90102-9; Hassan KA, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0965-y; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Imlay JA, 2014, J BIOL CHEM, V289, P28121, DOI 10.1074/jbc.R114.588814; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kapetanovic R, 2016, FASEB J, V30, P1901, DOI 10.1096/fj.201500061; Kristiansen KA, 2009, PHYSIOL PLANTARUM, V136, P369, DOI 10.1111/j.1399-3054.2009.01243.x; Lai Y, 2017, ENVIRON MICROBIOL, V19, P598, DOI 10.1111/1462-2920.13527; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Moore CM, 2005, MOL MICROBIOL, V57, P27, DOI 10.1111/j.1365-2958.2005.04642.x; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Osman D, 2019, NAT CHEM BIOL, V15, P241, DOI 10.1038/s41589-018-0211-4; Osman D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02085-z; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; POSTLE K, 1990, J BACTERIOL, V172, P2287, DOI 10.1128/jb.172.5.2287-2293.1990; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Taki M, 2010, J AM CHEM SOC, V132, P5938, DOI 10.1021/ja100714p; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Tsugawa H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/734548; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Xu ZL, 2015, ANTIBIOTICS-BASEL, V4, P379, DOI 10.3390/antibiotics4030379; Zhang YL, 2011, J BIOL CHEM, V286, P26576, DOI 10.1074/jbc.M111.243261	66	29	29	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16978	16991		10.1074/jbc.RA119.010023	http://dx.doi.org/10.1074/jbc.RA119.010023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31586033	Green Published, hybrid			2022-12-26	WOS:000501801900041
J	Ishida, JH; Wong, PO; Cohen, BE; Vali, M; Steigerwald, S; Keyhani, S				Ishida, Julie H.; Wong, Peggy O.; Cohen, Beth E.; Vali, Marzieh; Steigerwald, Stacey; Keyhani, Salomeh			Substitution of marijuana for opioids in a national survey of US adults	PLOS ONE			English	Article							CANNABIS USE; SUBSTANCES; ALCOHOL; DRUGS	Opioid prescriptions for chronic pain and subsequent opioid-related complications have risen dramatically in the US. Recent data suggest that medical marijuana laws have been associated with lower state-level opioid overdose mortality. In a national survey, we examined the prevalence of substitution of marijuana for opioids among US adults taking opioids for pain.Using GfK's KnowledgePanel, we conducted an Internet-based survey of a nationally representative sample of 16,280 adults in 2017 about individual perceptions and use of marijuana. We developed questions designed to assess the extent and reasons for substitution of marijuana for opioids. We examined opioid substitution among respondents with a history of ever using marijuana who used opioids in the past 12 months. There were 9,003 respondents, corresponding to a 55.3% response rate. The mean age was 48 years. Among the 5% (n = 486) who reported ever using marijuana and using opioids in the past year, 43% used opioids daily, and 23% reported current (past 30 day) marijuana use. Forty-one percent reported a decrease or cessation of opioid use due to marijuana use; 46% reported no change in opioid use; and 8% reported an increase in opioid use. We found that a substantial number of US adults reported that they substituted marijuana for opioids.	[Ishida, Julie H.] San Francisco VA Med Ctr, Dept Med, Div Nephrol, San Francisco, CA USA; [Wong, Peggy O.; Cohen, Beth E.; Vali, Marzieh; Steigerwald, Stacey; Keyhani, Salomeh] San Francisco VA Med Ctr, Dept Gen Internal Med, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Keyhani, S (corresponding author), San Francisco VA Med Ctr, Dept Gen Internal Med, San Francisco, CA 94121 USA.	Salomeh.Keyhani@ucsf.edu			National Heart, Lung, and Blood Institute [1R01HL130484]; National Institute of Diabetes and Digestive and Kidney Diseases [K23DK103963]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK103963] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung, and Blood Institute [grant number 1R01HL130484 (Dr. Keyhani)]; National Institute of Diabetes and Digestive and Kidney Diseases [grant number K23DK103963 (Dr. Ishida)].	Abraham A, 2018, J GEN INTERN MED, V33, P1438, DOI 10.1007/s11606-018-4492-9; [Anonymous], 2017, KNOWLEDGEPANEL; [Anonymous], 2018, STATE MED MARIJUANA; [Anonymous], 2018, 2017 NATL SURVEY DRU; Boehnke KF, 2016, J PAIN, V17, P739, DOI 10.1016/j.jpain.2016.03.002; Campbell G, 2018, LANCET PUBLIC HEALTH, V3, pE341, DOI 10.1016/S2468-2667(18)30110-5; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Fowler FJ, 2013, JAMA INTERN MED, V173, P1215, DOI 10.1001/jamainternmed.2013.6172; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Hanauer DA, 2014, JAMA INTERN MED, P7; Keyhani S, 2018, ANN INTERN MED, V169, P282, DOI 10.7326/M18-0810; Lucas P, 2017, INT J DRUG POLICY, V42, P30, DOI 10.1016/j.drugpo.2017.01.011; Lucas P, 2016, DRUG ALCOHOL REV, V35, P326, DOI 10.1111/dar.12323; Lucas P, 2013, ADDICT RES THEORY, V21, P435, DOI 10.3109/16066359.2012.733465; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; Patel A, 2014, POSITION STATEMENT U; Powell D, 2018, J HEALTH ECON, V58, P29, DOI 10.1016/j.jhealeco.2017.12.007; Reiman A, 2007, J EVID-BASED INTEGR, V12, P31, DOI 10.1177/1533210107301834; Research A.A.F.P.O, 2016, STAND DEF FIN DISP C; Reuben DB, 2015, ANN INTERN MED, V162, P295, DOI 10.7326/M14-2775; Steigerwald S, 2018, ANN INTERN MED, V169, P890, DOI 10.7326/M18-1681; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363; Vyas MB, 2018, NURS OUTLOOK, V66, P56, DOI 10.1016/j.outlook.2017.08.012	24	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0222577	10.1371/journal.pone.0222577	http://dx.doi.org/10.1371/journal.pone.0222577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584957	Green Published, gold			2022-12-26	WOS:000532407600009
J	Duan, MJ; Yang, HY; Wang, SP; Liu, Y				Duan, Meijun; Yang, Hongyu; Wang, Shangping; Liu, Yu			Self-adaptive dual-strategy differential evolution algorithm	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; GLOBAL OPTIMIZATION; CROSSOVER; ENSEMBLE; PARAMETERS	Exploration and exploitation are contradictory in differential evolution (DE) algorithm. In order to balance the search behavior between exploitation and exploration better, a novel self-adaptive dual-strategy differential evolution algorithm (SaDSDE) is proposed. Firstly, a dual-strategy mutation operator is presented based on the "DE/best/2" mutation operator with better global exploration ability and "DE/rand/2" mutation operator with stronger local exploitation ability. Secondly, the scaling factor self-adaption strategy is proposed in an individual-dependent and fitness-dependent way without extra parameters. Thirdly, the exploration ability control factor is introduced to adjust the global exploration ability dynamically in the evolution process. In order to verify and analyze the performance of SaDSDE, we compare SaDSDE with 7 state-of-art DE variants and 3 non-DE based algorithms by using 30 Benchmark test functions of 30-dimensions and 100-dimensions, respectively. The experiments results demonstrate that SaDSDE could improve global optimization performance remarkably. Moreover, the performance superiority of SaDSDE becomes more significant with the increase of the problems' dimension.	[Duan, Meijun; Yang, Hongyu] Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Peoples R China; [Yang, Hongyu; Liu, Yu] Sichuan Univ, Coll Comp Sci, Chengdu, Peoples R China; [Wang, Shangping] Sci & Technol Elect Informat Control Lab, Chengdu, Peoples R China	Sichuan University; Sichuan University	Duan, MJ (corresponding author), Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Peoples R China.	dmj23@163.com			NSFC [U1833115]; CAAC [U1833115]	NSFC(National Natural Science Foundation of China (NSFC)); CAAC	This work is supported by the NSFC and CAAC Joint Fund Project (NO. U1833115). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboamera NM, 2019, MECH ADV MATER STRUC, V26, P765, DOI 10.1080/15376494.2017.1410914; Arce F, 2018, APPL SOFT COMPUT, V68, P303, DOI 10.1016/j.asoc.2018.03.033; Awad NH, 2018, SWARM EVOL COMPUT, V39, P141, DOI 10.1016/j.swevo.2017.09.009; Awad NH, 2016, IEEE C EVOL COMPUTAT, P2958, DOI 10.1109/CEC.2016.7744163; Bui Ngoc Tam, 2015, International Journal of Machine Learning and Computing, V5, P1, DOI 10.7763/IJMLC.2015.V5.473; Cai YQ, 2018, INFORM SCIENCES, V433, P464, DOI 10.1016/j.ins.2016.10.003; Cai YQ, 2017, APPL SOFT COMPUT, V59, P659, DOI 10.1016/j.asoc.2017.06.002; Cai YQ, 2015, INFORM SCIENCES, V320, P244, DOI 10.1016/j.ins.2015.05.026; Chen L, 2014, ARAB J SCI ENG, V39, P821, DOI 10.1007/s13369-013-0803-y; Chen Q, 2015, PROBLEM DEFINITIONS; Cheng R, 2015, INFORM SCIENCES, V291, P43, DOI 10.1016/j.ins.2014.08.039; Crepinsek M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2480741.2480752; Cui LZ, 2018, INFORM SCIENCES, V422, P122, DOI 10.1016/j.ins.2017.09.002; Das S, 2008, IEEE T SYST MAN CY A, V38, P218, DOI 10.1109/TSMCA.2007.909595; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; ElQuliti SAH., 2016, J COMPUTATIONAL THEO, V13, P7909, DOI DOI 10.1166/JCTN.2016.5791; Elsayed SM, 2014, APPL MATH COMPUT, V241, P267, DOI 10.1016/j.amc.2014.05.018; Ghosh A, 2017, APPL SOFT COMPUT, V57, P329, DOI 10.1016/j.asoc.2017.03.003; Gong WY, 2014, APPL SOFT COMPUT, V15, P149, DOI 10.1016/j.asoc.2013.11.005; Gu XP, 2015, INT J ELEC POWER, V64, P664, DOI 10.1016/j.ijepes.2014.07.070; Guo SM, 2015, IEEE T EVOLUT COMPUT, V19, P31, DOI 10.1109/TEVC.2013.2297160; He XY, 2018, APPL SOFT COMPUT, V64, P227, DOI 10.1016/j.asoc.2017.11.050; Luong LD, 2013, PROCEEDINGS OF THE 2013 IEEE 7TH INTERNATIONAL POWER ENGINEERING AND OPTIMIZATION CONFERENCE (PEOCO2013), P238; Leu, 2017, P 2016 INT C MACH LE, P7; Li X, 2012, IET MICROW ANTENNA P, V6, P1573, DOI 10.1049/iet-map.2011.0611; Lin QZ, 2018, INFORM SCIENCES, V430, P46, DOI 10.1016/j.ins.2017.11.030; Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mohamed AW, 2018, SOFT COMPUT, V22, P3215, DOI 10.1007/s00500-017-2777-2; Nenavath H, 2018, APPL SOFT COMPUT, V62, P1019, DOI 10.1016/j.asoc.2017.09.039; Ponsich A, 2013, APPL SOFT COMPUT, V13, P462, DOI 10.1016/j.asoc.2012.07.034; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Qiu X, 2017, IEEE T CYBERNETICS, V47, P995, DOI 10.1109/TCYB.2016.2536167; Storn R, 2010, HOME PAGE DIFFERENTI; Storn R.M., 1995, DIFFERENTIAL EVOLUTI, V23; Suganthan PN, 2005, 2005005 KANGAL, V2005005, P2005; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Tang RL, 2017, APPL INTELL, V47, P1208, DOI 10.1007/s10489-017-0953-9; Vaisakh K, 2013, LECT NOTES COMPUT SC, V8298, P583, DOI 10.1007/978-3-319-03756-1_52; Wang SH, 2017, APPL INTELL, V47, P644, DOI 10.1007/s10489-017-0914-3; Wang X, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/419372; Wang Y, 2014, APPL SOFT COMPUT, V18, P232, DOI 10.1016/j.asoc.2014.01.038; Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271; Wu G., 2016, PROBLEM DEFINITIONS; Wu GH, 2018, INFORM SCIENCES, V423, P172, DOI 10.1016/j.ins.2017.09.053; Wu GH, 2016, INFORM SCIENCES, V329, P329, DOI 10.1016/j.ins.2015.09.009; Xu YL, 2015, COMPUT OPTIM APPL, V61, P243, DOI 10.1007/s10589-014-9701-9; Zhai SJ, 2015, NEUROCOMPUTING, V149, P573, DOI 10.1016/j.neucom.2014.08.017; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Zhu QL, 2016, INFORM SCIENCES, V345, P177, DOI 10.1016/j.ins.2016.01.046; Zhu W, 2013, INFORM SCIENCES, V223, P164, DOI 10.1016/j.ins.2012.09.019	53	7	7	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222706	10.1371/journal.pone.0222706	http://dx.doi.org/10.1371/journal.pone.0222706			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581225	Green Published, gold			2022-12-26	WOS:000532398600015
J	Kraft, C; Hennies, R; Dreckmann, K; Noguera, M; Rathkjen, PH; Gassel, M; Gereke, M				Kraft, Christian; Hennies, Rimma; Dreckmann, Karla; Noguera, Marta; Rathkjen, Poul Henning; Gassel, Michael; Gereke, Marcus			Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; CELL-MEDIATED-IMMUNITY; PROTECTION; INFECTION; DISEASE; COLOSTRUM; CYTOKINES; GENOTYPE; EFFICACY; IMPACT	In this study, we analyzed PRRS virus (PRRSv) specific lymphocyte function in piglets vaccinated with Ingelvac PRRSFLEX EU (R) at two and three weeks of age in the presence of homologous maternal immunity. Complete analysis of maternal immunity to PRRSv was evaluated postpartum, as well as passive transfer of antibodies and T cells to the piglet through colostrum intake and before and after challenge with a heterologous PRRSv at ten weeks of age. Maternal-derived antibodies were detected in piglets but declined quickly after weaning. However, vaccinated animals restored PRRSv-specific antibody levels by anamnestic response to vaccination. Cell analysis in colostrum and milk revealed presence of PRRSv-specific immune cells at suckling with higher concentrations found in colostrum than in milk. In addition, colostrum and milk contained PRRSv-specific IgA and IgG that may contribute to protection of newborn piglets. Despite the presence of PRRSv-specific Peripheral Blood Mononuclear cells (PBMCs) in colostrum and milk, no PRRSv-specific cells could be detected from blood of the piglets at one or two weeks of life. Nevertheless, cellular immunity was detectable in pre-challenged piglets up to 7 weeks after vaccination while the non-vaccinated control group showed no interferon (IFN). response to PRRSv stimulation. After challenge, all piglets developed a PRRSv-specific IFN gamma-response, which was more robust at significantly higher levels in vaccinated animals compared to the primary response to PRRSv in non-vaccinated animals. Cytokine analysis in the lung lumen showed a reduction of pro-inflammatory responses to PRRSv challenge in vaccinated animals, especially reduced interferon (IFN) a levels. In conclusion, vaccination of maternally positive piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX EU induced a humoral and cellular immune response to PRRSv and provided protection against virulent, heterologous PRRSv challenge.	[Kraft, Christian; Hennies, Rimma; Dreckmann, Karla; Noguera, Marta; Gereke, Marcus] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany; [Rathkjen, Poul Henning; Gassel, Michael] Boehringer Ingelheim Vetmed GmbH, Ingelheim, Germany	Boehringer Ingelheim; Boehringer Ingelheim	Kraft, C (corresponding author), Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany.	christian.kraft@boehringer-ingelheim.com		Kraft, Christian/0000-0002-6483-4296	Boehringer Ingelheim Vetmedica GmbH	Boehringer Ingelheim Vetmedica GmbH(Boehringer Ingelheim)	Boehringer Ingelheim Vetmedica GmbH funded the study. The funder provided support in the form of salaries for authors [all], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Balasch M, 2018, PORCINE HEALTH MANAG, V4, DOI 10.1186/s40813-018-0101-x; Balka G, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0037-y; Bandrick M, 2008, CLIN VACCINE IMMUNOL, V15, P540, DOI 10.1128/CVI.00466-07; Bandrick M, 2014, DEV COMP IMMUNOL, V43, P114, DOI 10.1016/j.dci.2013.11.005; Brockmeier SL, 2017, VET MICROBIOL, V203, P6, DOI 10.1016/j.vetmic.2017.02.003; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; CHRISTIANSON WT, 1992, AM J VET RES, V53, P44; Declerck I, 2016, J ANIM SCI, V94, P1633, DOI 10.2527/jas.2015-9564; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Diaz I, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-30; Dvorak CMT, 2018, VIRAL IMMUNOL, V31, P40, DOI 10.1089/vim.2017.0058; Fablet C, 2016, VET MICROBIOL, V192, P175, DOI 10.1016/j.vetmic.2016.07.014; FRIESS AE, 1980, ANAT EMBRYOL, V158, P179, DOI 10.1007/BF00315905; Geldhof MF, 2013, VET MICROBIOL, V167, P260, DOI 10.1016/j.vetmic.2013.08.017; HALBUR PG, 1995, VET PATHOL, V32, P648, DOI 10.1177/030098589503200606; Han K, 2013, VET J, V195, P313, DOI 10.1016/j.tvjl.2012.06.035; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Labarque G, 2004, VACCINE, V22, P4183, DOI 10.1016/j.vaccine.2004.05.008; Lauritsen KT, 2017, VET IMMUNOL IMMUNOP, V183, P22, DOI 10.1016/j.vetimm.2016.12.002; Lee JA, 2016, VET IMMUNOL IMMUNOP, V177, P48, DOI 10.1016/j.vetimm.2016.06.008; Liu YG, 2010, CLIN VACCINE IMMUNOL, V17, P1439, DOI 10.1128/CVI.00517-09; Martelli P, 2009, VACCINE, V27, P3788, DOI 10.1016/j.vaccine.2009.03.028; Morgan SB, 2016, TRANSBOUND EMERG DIS, V63, P285, DOI 10.1111/tbed.12272; Nechvatalova K, 2011, VET IMMUNOL IMMUNOP, V142, P95, DOI 10.1016/j.vetimm.2011.03.022; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Ogawa S, 2016, ANIM SCI J, V87, P1511, DOI 10.1111/asj.12573; Pileri E, 2015, VET MICROBIOL, V175, P7, DOI 10.1016/j.vetmic.2014.11.007; Piontkowski M, 2016, CAN J VET RES, V80, P124; Renson P, 2019, VACCINE, V37, P4318, DOI 10.1016/j.vaccine.2019.06.045; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Sandbulte MR, 2014, VIROLOGY, V464, P45, DOI 10.1016/j.virol.2014.06.027; Scortti M, 2006, VET J, V172, P506, DOI 10.1016/j.tvjl.2005.07.015; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; TIELEN MJM, 1981, TIJDSCHR DIERGENEESK, V106, P739; Tuboly S, 2002, ADV EXP MED BIOL, V503, P107; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223060	10.1371/journal.pone.0223060	http://dx.doi.org/10.1371/journal.pone.0223060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577832	Green Published, gold			2022-12-26	WOS:000532388000021
J	Demoz, GT; Berha, AB; Woldu, MA; Yifter, H; Shibeshi, W; Engidawork, E				Demoz, Gebre Teklemariam; Berha, Alemseged Beyene; Woldu, Minyahil Alebachew; Yifter, Helen; Shibeshi, Workineh; Engidawork, Ephrem			Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							GLYCEMIC CONTROL; MELLITUS; OUTPATIENTS	Background Patients with diabetes are at high risk of drug therapy problems (DTPs), as they are receiving multiple medications. To date, studies regarding DTPs in patients with diabetes in Ethiopia are limited. The aim of this study was to assess prevalence of DTPs, medication adherence and treatment satisfaction of patients with diabetes at Tikur Anbessa Specialized Hospital (TASH). Method A cross-sectional study was conducted on randomly selected 418 participants who fulfilled the inclusion criteria. Data were collected using structured questionnaire and patients' chart review. Cipolle's classification system was used to determine DTPs. Modified Morisky's Adherence Scale (MMAS-8) was used to measure patients' adherence to their medication. Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) patient satisfaction assessment questionnaire was used to assess patients' treatment satisfaction. Results A total of 207 DTPs in 177 (42.3%) of participants were identified. Commonly identified DTPs were dosage too low (58, 28.0%), ineffective drug therapy (54, 26.1%), and need additional drug therapy (52, 25.1%). Factors associated with DTPs were female gender (Adjusted Odds Ratio [AOR] = 2.31,95% CI:1.30-4.12); >= 3comorbidities (AOR = 3.61, 95% CI:1.19-10.96); ever married (AOR = 2.58,95% CI:1.23-5.48); type 2 diabetes (AOR = 5.62, 95% CI:1.21-26.04); non-adherence (AOR = 5.26,95% CI:2.51-11.04) and residence out of Addis Ababa (AOR = 0.30, 95% CI:0.12-0.73). Twenty four percent of participants were non-adherent to their drug therapies. Factors associated with non-adherence were diabetes complications (AOR = 2.00, 95% CI: 1.2-3.32), the female gender (AOR = 1.67, 95%CI: 1.01-2.8) and level of education (AOR = 0.42, 95%CI: 0.18-0.96). Eighty one percent of participants were satisfied with the current treatment. Conclusion A significant proportion of patients were satisfied with their treatment and a quarter of the study participants were non-adherent to their medications at TASH diabetic clinic. However, DTPs were considerably higher among the study participants. Hence, future interventions targeting prevention and resolution of DTPs deemed to be necessary.	[Demoz, Gebre Teklemariam] Aksum Univ, Coll Hlth Sci, Sch Pharm, Dept Clin Pharm, Aksum, Ethiopia; [Berha, Alemseged Beyene; Woldu, Minyahil Alebachew; Shibeshi, Workineh; Engidawork, Ephrem] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia; [Yifter, Helen] Sci Addis Ababa Univ, Coll Hlth, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia	Addis Ababa University	Engidawork, E (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia.	ephrem.engidawork@aau.edu.et	Demoz, Gebre Teklemariam/K-6986-2019; Woldu, Minyahil/ABD-9452-2020; Engidawork, Ephrem/K-7551-2019; Yifter, Helen/AIC-7732-2022	Demoz, Gebre Teklemariam/0000-0002-2534-821X; Woldu, Minyahil/0000-0002-3163-0326; Engidawork, Ephrem/0000-0002-9931-6421; Bitew, Helen Yifter/0000-0001-9241-7628; Berha, Alemseged/0000-0003-3825-2863	Medication Therapy Management thematic research project (AAU-MTM Project); Office of the Graduate Programs, Addis Ababa University	Medication Therapy Management thematic research project (AAU-MTM Project); Office of the Graduate Programs, Addis Ababa University	We would like to thank the Medication Therapy Management thematic research project (AAU-MTM Project 2017) as well as Office of the Graduate Programs, Addis Ababa University, for funding the study.	Abebaw Mastewal, 2016, ADV NURSING 2016; Abebe SM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-195; ADA Association, 2017, DIABETES CARE J CLIN, V40; Adepu R, 2013, VALUE HEALTH, P16; Al Hamid A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050479; Al-Taani GM, 2017, DRUG HEALTHC PATIENT, V9, P65, DOI 10.2147/DHPS.S125114; Ali Muhammed, 2017, BMC Res Notes, V10, P676, DOI 10.1186/s13104-017-3025-7; Asfaw AA, 2014, ARCH PHARM PRACT, V5, P113, DOI 10.4103/2045-080X.137542; Bagonza J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0820-5; Biderman A, 2009, FAM PRACT, V26, P102, DOI 10.1093/fampra/cmp007; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cipolle R, 2013, DIABETES COMORBIDITI, P1; Cipolle RJ, 2012, PHARM CARE PRACTICE, P156; Claydon-Platt K, 2012, DIABETES RES CLIN PR, V97, P223, DOI 10.1016/j.diabres.2012.03.003; Dahal PR, 2013, ASIAN J PHARM CLIN R, V6, P258; David P, 2015, EFFECTIVENESS ED MET; Europe PCN, 2017, PCNE CLASS DRUG REL; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Fugate AR, 2015, INDIAN J PHARM PRACT, V8, P79; Gebel E, 2011, DIABETES FORCAST MEG; Gelaw BK, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/617041; Haugbolle LS, 2006, PHARM WORLD SCI, V28, P239, DOI 10.1007/s11096-006-9023-9; Huri HZ, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-2; HURI HZ, 2013, BMC PUBLIC HEALTH, V13, P4346, DOI DOI 10.1186/1472-6823-13-2; IDF, 2017, IDF WDD WORLD DIAB D; IDF, 2017, IDF CLIN PRACT REC M; International Diabetes Federation (IDF), 2017, IDF DIABETES ATLAS; Jemal A, 2017, J DIABETES METAB, V8, DOI 10.4172/2155-6156.1000721; Kassahun A, 2016, J PHARM BIOALLIED SC, V8, P124, DOI 10.4103/0975-7406.171696; Kautzky-Willer A, 2015, DIABETES OBES METAB, V17, P533, DOI 10.1111/dom.12449; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; KOYRA HC, 2017, AM J PHARM SCI, V5, P40, DOI DOI 10.12691/AJPS-5-2-415; LESTER FT, 1984, DIABETES CARE, V7, P6, DOI 10.2337/diacare.7.1.6; Mamunuwa N, 2016, INT POSTGR RES C 201, P16; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Odili V, 2011, NIGERIAN J PHARM RES, V9; Ogbonna B, 2014, INT J INNOVATIVE RES; Organization WH., 2016, GLOBAL REPORT DIABET; Price D, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0075-y; Rejas J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-142; Rejas J, 2013, VALUE HEALTH, V16, P88, DOI 10.1016/j.jval.2012.08.2224; Sajith M., 2014, YOUNG, V18, P7; Shamkuwar CA, 2016, J YOUNG PHARM, V8, P39, DOI 10.5530/jyp.2016.1.9; Shareef J, 2016, DIABETES METAB SYND, V10, P82, DOI 10.1016/j.dsx.2015.09.017; Tadele K, 2017, ASSESSMENT ADHERENCE; Teklay G., 2013, J MED SCI, V13, P578, DOI [DOI 10.3923/JMS.2013.578.584, 10.3923/jms.2013.578.584]; Tooke JE, 2000, J DIABETES COMPLICAT, V14, P197, DOI 10.1016/S1056-8727(00)00083-0; Tsehay Tessema, 2014, ASSESSMENT ANTIDIABE; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Wabe NT, 2011, N AM J MED SCI, V3, P418, DOI 10.4297/najms.2011.3418; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; who.int, 2009, WHO GLOB HLTH RISKS; Wong I, 2017, HONG KONG MED J; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization (WHO), 2006, DEFINITION DIAGNOSIS; World Health Organization (WHO), 2016, WHO DIAB COUNTR PROF; Yigazu Daniel Miteku, 2017, BMC Res Notes, V10, P597, DOI 10.1186/s13104-017-2924-y	58	18	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222985	10.1371/journal.pone.0222985	http://dx.doi.org/10.1371/journal.pone.0222985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574113	Green Published, gold			2022-12-26	WOS:000532376700021
J	Detampel, P; Ganguly, A; Tehranian, S; Green, F; Singha, S; Santamaria, P; Jeje, AA; Cho, CS; Petri, B; Amrein, MW				Detampel, Pascal; Ganguly, Anutosh; Tehranian, Sara; Green, Francis; Singha, Santiswarup; Santamaria, Pere; Jeje, Ayodeji A.; Cho, Clifford S.; Petri, Bjorn; Amrein, Matthias W.			In vivo clearance of nanoparticles by transcytosis across alveolar epithelial cells	PLOS ONE			English	Article							PULMONARY; NANO; INHALATION; PARTICLES; DELIVERY	Nanoparticles in polluted air or aerosolized drug nanoparticles predominantly settle in the alveolar lung. Here, we describe a novel, highly effective pathway for the particles to cross the alveolar epithelium and reach the lymph and bloodstream. Amorphous silica nanoparticles, suspended in perfluorocarbon, were instilled into the lungs of mice for intravital microscopy. Particles formed agglomerates that settled on the alveolar wall, half of which were removed from the lung within 30 minutes. TEM histology showed agglomerates in stages of crossing the alveolar epithelium, in large compartments inside the epithelial cells and crossing the basal membrane into the interstitium. This pathway is consistent with published kinetic studies in rats and mice, using a host of (negatively) charged and polar nanoparticles.	[Detampel, Pascal; Amrein, Matthias W.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Ganguly, Anutosh; Singha, Santiswarup; Santamaria, Pere; Petri, Bjorn] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Ganguly, Anutosh; Cho, Clifford S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Tehranian, Sara; Jeje, Ayodeji A.] Univ Calgary, Dept Chem & Petr Engn, Calgary, AB, Canada; [Green, Francis] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Singha, Santiswarup; Santamaria, Pere; Petri, Bjorn] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Detampel, Pascal] Univ Basel, Dept Pharmaceut Sci, Div Pharmaceut Technol, Basel, Switzerland	University of Calgary; University of Calgary; University of Michigan System; University of Michigan; University of Calgary; University of Calgary; University of Calgary; University of Basel	Amrein, MW (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada.; Ganguly, A (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Ganguly, A (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	ganutosh@med.umich.edu; mamrein@ucalgary.ca	Santamaria, Pere/ABF-6823-2021	Ganguly, Anutosh/0000-0002-7228-7827	Canadian Institute for Health Research (CIHR); Alberta Ingenuity (Alberta Innovates); Swiss National Science Foundation (SNSF) [PBBSP3-146963]; Snyder Mouse Phenomics Resources Laboratory; Live Cell Imaging Facility - Snyder Institute for Chronic Diseases at the University of Calgary	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Ingenuity (Alberta Innovates); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Snyder Mouse Phenomics Resources Laboratory; Live Cell Imaging Facility - Snyder Institute for Chronic Diseases at the University of Calgary	This work was supported by grants from Canadian Institute for Health Research (CIHR) to MA, Nanotechnology scholarship from Alberta Ingenuity (now part of Alberta Innovates) to ST and the Swiss National Science Foundation (SNSF, PBBSP3-146963) to PD. This work was also supported by the Snyder Mouse Phenomics Resources Laboratory and Live Cell Imaging Facility, funded by the Snyder Institute for Chronic Diseases at the University of Calgary.	Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007; Anselmo AC, 2019, NAT REV DRUG DISCOV, V18, P19, DOI 10.1038/nrd.2018.183; Choi HS, 2010, NAT BIOTECHNOL, V28, P1300, DOI 10.1038/nbt.1696; de Kruijf W, 2017, CURR OPIN PHARMACOL, V36, P52, DOI 10.1016/j.coph.2017.07.015; Donaldson K, 2002, J AEROSOL MED, V15, P213, DOI 10.1089/089426802320282338; Fernandes DA, 2016, LANGMUIR, V32, P10870, DOI 10.1021/acs.langmuir.6b01867; Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001; Gehr P., 2000, PARTICLE LUNG INTERA; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Husain M, 2015, NANOTOXICOLOGY, V9, P1013, DOI 10.3109/17435390.2014.996192; Johnston CJ, 2000, TOXICOL APPL PHARM, V168, P208, DOI 10.1006/taap.2000.9037; Konduru NV, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0044-6; Kreyling WG, 2013, ACCOUNTS CHEM RES, V46, P714, DOI 10.1021/ar300043r; Kuempel ED, 2009, AM J RESP CRIT CARE, V180, P257, DOI 10.1164/rccm.200806-840OC; Lehmler HJ, 2007, EXPERT OPIN DRUG DEL, V4, P247, DOI 10.1517/17425247.4.3.247; LEHNERT BE, 1992, ENVIRON HEALTH PERSP, V97, P17, DOI 10.2307/3431327; Liu HH, 2011, ENVIRON SCI TECHNOL, V45, P9284, DOI 10.1021/es202134p; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park HG, 2014, MOL CELL TOXICOL, V10, P293, DOI 10.1007/s13273-014-0033-8; Roursgaard M, 2010, HUM EXP TOXICOL, V29, P915, DOI 10.1177/0960327110363329; Sarkar Suman, 2014, Anesth Essays Res, V8, P277, DOI 10.4103/0259-1162.143109; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; Tegen I, 2006, ATMOS CHEM PHYS, V6, P4345, DOI 10.5194/acp-6-4345-2006; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; U.S. EPA, 2000, HLTH EFF INH CRYST A; Weis CM, 1997, ANN MED, V29, P509, DOI 10.3109/07853899709007475	30	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223339	10.1371/journal.pone.0223339	http://dx.doi.org/10.1371/journal.pone.0223339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568513	Green Published, gold			2022-12-26	WOS:000532364900038
J	Freire, I; Gutner-Hoch, E; Muras, A; Benayahu, Y; Otero, A				Freire, Isabel; Gutner-Hoch, Eldad; Muras, Andrea; Benayahu, Yehuda; Otero, Ana			The effect of bacteria on planula-larvae settlement and metamorphosis in the octocoral Rhytisma fulvum fulvum	PLOS ONE			English	Article							ACYL HOMOSERINE LACTONE; SEA SOFT CORAL; RED-SEA; ANTIMICROBIAL ACTIVITY; COMMUNITIES; DIVERSITY; MICROBIOME; ZOOSPORES; DYNAMICS; SYSTEMS	While increasing evidence supports a key role of bacteria in coral larvae settlement and development, the relative importance of environmentally-acquired versus vertically-transferred bacterial population is not clear. Here we have attempted to elucidate the role of post-brooding-acquired bacteria on the development of planula-larvae of the octocoral Rhytisma f. fulvum, in an in vitro cultivation system employing different types of filtered (FSW) and autoclaved (ASW) seawater and with the addition of native bacteria. A good development of larvae was obtained in polystyrene 6-well cell culture plates in the absence of natural reef substrata, achieving a 60-80% of larvae entering metamorphosis after 32 days, even in bacteria-free seawater, indicating that the bacteria acquired during the brooding period are sufficient to support planulae development. No significant difference in planulae attachment and development was observed when using 0.45 mu m or 0.22 mu m FSW, although autoclaving the 0.45 mu m FSW negatively affected larval development, indicating the presence of beneficial bacteria. Autoclaving the different FSW homogenized the development of the larvae among the different treatments. The addition of bacterial strains isolated from the different FSW did not cause any significant effect on planulae development, although some specific strains of the genus Alteromonas seem to be beneficial for larvae development. Light was beneficial for planulae development after day 20, although no Symbiodinium cells could be observed, indicating either that light acts as a positive cue for larval development or the presence of beneficial phototrophic bacteria in the coral microbiome. The feasibility of obtaining advanced metamorphosed larvae in sterilized water provides an invaluable tool for studying the physiological role of the bacterial symbionts in the coral holobiont and the specificity of bacteria-coral interactions.	[Freire, Isabel; Muras, Andrea; Otero, Ana] Univ Santiago de Compostela, Fac Biol, Inst Acuicultura, Edificio CIBUS, Santiago De Compostela, Spain; [Freire, Isabel; Muras, Andrea; Otero, Ana] Univ Santiago de Compostela, Fac Biol, Dept Microbiol, Edificio CIBUS, Santiago De Compostela, Spain; [Gutner-Hoch, Eldad] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Zool, Tel Aviv, Israel; [Benayahu, Yehuda] Interuniv Inst Marine Sci, Elat, Israel; [Gutner-Hoch, Eldad] Marine Biol Lab, Eugene Bell Ctr, Woods Hole, MA 02543 USA	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Tel Aviv University; Marine Biological Laboratory - Woods Hole	Otero, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Inst Acuicultura, Edificio CIBUS, Santiago De Compostela, Spain.; Otero, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Microbiol, Edificio CIBUS, Santiago De Compostela, Spain.	anamaria.otero@usc.es	Otero, Ana/AAH-1623-2020; Otero, Ana/S-1882-2018	Otero, Ana/0000-0002-3315-5709; Otero, Ana/0000-0002-3315-5709; Muras, Andrea/0000-0003-1603-9762	EU FP7-Research Infrastructure Initiative Assemble (Association of European marine biological laboratories); EU FP7 Project Byefouling [612717]; Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria [ED431D 2017/22]	EU FP7-Research Infrastructure Initiative Assemble (Association of European marine biological laboratories); EU FP7 Project Byefouling; Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria(Xunta de Galicia)	This work was supported by: EU FP7-Research Infrastructure Initiative Assemble (Association of European marine biological laboratories); EU FP7 Project Byefouling (grant agreement no 612717); Xunta de Galicia, Conselleria de Cultura, Educacion e Ordenacion Universitaria (grant number ED431D 2017/22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Ben-David-Zaslow R, 1998, MAR ECOL PROG SER, V163, P235, DOI 10.3354/meps163235; BENAYAHU Y, 1984, J EXP MAR BIOL ECOL, V83, P249, DOI 10.1016/S0022-0981(84)80004-0; BENAYAHU Y, 1983, BIOL BULL, V165, P353, DOI 10.2307/1541201; Blackall LL, 2015, MOL ECOL, V24, P5330, DOI 10.1111/mec.13400; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Bryant D., 1998, REEFS RISK MAP BASED; Tran C, 2011, MAR ECOL PROG SER, V433, P85, DOI 10.3354/meps09192; Ceh J, 2013, MICROB ECOL, V65, P227, DOI 10.1007/s00248-012-0105-z; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Dobretsov S, 2015, INT BIODETER BIODEGR, V98, P53, DOI 10.1016/j.ibiod.2014.10.019; Freckelton ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep42557; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hadfield MG, 2001, CRC MAR SCI, P431; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hernandez-Agreda A, 2017, TRENDS MICROBIOL, V25, P125, DOI 10.1016/j.tim.2016.11.003; Hester ER, 2016, ISME J, V10, P1157, DOI 10.1038/ismej.2015.190; Huang YL, 2009, ISME J, V3, P296, DOI 10.1038/ismej.2008.105; Kelman D, 1998, MAR ECOL PROG SER, V169, P87, DOI 10.3354/meps169087; Kitamura M, 2007, J EXP MAR BIOL ECOL, V340, P96, DOI 10.1016/j.jembe.2006.08.012; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004; Leite DCA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00176; LEMOS ML, 1991, J APPL BACTERIOL, V71, P228, DOI 10.1111/j.1365-2672.1991.tb04452.x; Mayer AMS, 2013, MAR DRUGS, V11, P2510, DOI 10.3390/md11072510; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Peixoto RS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00341; Perkol-Finkel S, 2004, CORAL REEFS, V23, P195, DOI 10.1007/s00338-004-0384-z; Radecker N, 2015, TRENDS MICROBIOL, V23, P490, DOI 10.1016/j.tim.2015.03.008; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Rocha J, 2011, MAR DRUGS, V9, P1860, DOI 10.3390/md9101860; Rohwer F, 2001, CORAL REEFS, V20, P85; Rosenberg E, 2009, ISME J, V3, P139, DOI 10.1038/ismej.2008.104; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Slattery M, 1999, CORAL REEFS, V18, P75, DOI 10.1007/s003380050158; Sneed JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3086; Sweet MJ, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00009; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Tait K, 2013, MOL ECOL, V22, P2588, DOI 10.1111/mec.12273; Tebben J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10803; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Teplitski M, 2016, CNIDARIA PRESENT FUT, P331; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Tinh NTN, 2007, FEMS MICROBIOL ECOL, V62, P45, DOI 10.1111/j.1574-6941.2007.00378.x; Twigg MS, 2014, ENVIRON MICROBIOL, V16, P445, DOI 10.1111/1462-2920.12203; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VANDEWATER JAJM, 2018, MICROBIOME, V6, P3274, DOI DOI 10.1186/S40168-018-14; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Weber A, 2012, HAPTIC SYSTEMS ARCHITECTURE MODELING, P119, DOI 10.1007/978-3-7091-0755-3_7; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Wilkinson CR, 1996, GLOB CHANGE BIOL, V2, P547, DOI 10.1111/j.1365-2486.1996.tb00066.x; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Zeileis A, 2008, J STAT SOFTW, P28, DOI [10.18637/jss.v028.i07, DOI 10.18637/JSS.V028.I07]	60	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223214	10.1371/journal.pone.0223214	http://dx.doi.org/10.1371/journal.pone.0223214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568517	Green Published, gold			2022-12-26	WOS:000532364900028
J	Liu, YM; Song, CY; Shen, FP; Zhang, J; Song, SW				Liu, Yunmian; Song, Chunyan; Shen, Faping; Zhang, Jing; Song, Sonya Wei			IGFBP2 promotes immunosuppression associated with its mesenchymal induction and Fc gamma RIIB phosphorylation in glioblastoma	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; LONG-TERM; GROWTH; DIFFERENTIATION; ANGIOGENESIS; PROGRESSION; TRANSITION; EXPRESSION; RECEPTORS; PHENOTYPE	Immunotherapy shows a promise for treating glioblastoma (GBM), the most malignant and immunosuppressive glioma. The mesenchymal phenotype of cancer cells was frequently reported to be associated with their induction of immunosuppression within the cancer microenvironment. Overexpressed insulin-like growth factor binding protein 2 (IGFBP2) promotes GBM cell migration and invasion, and contributes to glioma progression and cancer recurrence and poor survival in GBM. However, whether IGFBP2 can induce immunosuppression in GBM was not reported yet. Thus, the study applied a syngeneic mouse GBM model, human GBM samples, and cancer-immune cell co-culture experiments to investigate the effect of IGFBP2 on GBM exposed immune cells and its association with the mesenchymal induction. We found that IGFBP2 promoted the mesenchymal feature of GBM cells. The inhibition of IGFBP2 relieved immunosuppression by increasing CD8(+) T and CD19(+) B cells and decreasing CD163(+) M2 macrophages. Further, the IGFBP2-promoted immunosuppression was associated with its induction of the mesenchymal feature of GBM cells and the inhibitory phosphorylated Fc gamma RIIB of GBM exposed immune cells. Blocking IGFBP2 suppressed tumor growth and improved survival of tumor bearing mice in the mouse GBM model. These findings support the notion that targeting the IGFBP2 may present an effective immunotherapeutic strategy for mesenchymal GBMs.	[Liu, Yunmian; Song, Chunyan; Shen, Faping; Song, Sonya Wei] Capital Med Univ, Ctr Brain Disorders Res, Beijing Inst Brain Disorders, Beijing Neurosurg Inst, Beijing, Peoples R China; [Zhang, Jing] Columbia Univ, Irving Canc Res Ctr, Inst Canc Genet, New York, NY USA	Capital Medical University; Columbia University	Song, SW (corresponding author), Capital Med Univ, Ctr Brain Disorders Res, Beijing Inst Brain Disorders, Beijing Neurosurg Inst, Beijing, Peoples R China.	sonyasong@ccmu.edu.cn		Song, Sonya Wei/0000-0002-0808-1656	National Natural Science Foundation of China [81272411, 81472754]; Beijing Natural Science Foundation [7131004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (grant No. 81272411 and 81472754, Sonya Wei Song: Funding) and Beijing Natural Science Foundation (grant No. 7131004, Sonya Wei Song: Funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Cecil DL, 2014, CANCER RES, V74, P2710, DOI 10.1158/0008-5472.CAN-13-3286; Chua CY, 2016, ONCOGENE, V35, P738, DOI 10.1038/onc.2015.131; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Dongre A, 2017, CANCER RES, V77, P3982, DOI 10.1158/0008-5472.CAN-16-3292; Donson AM, 2012, J IMMUNOL, V189, P1920, DOI 10.4049/jimmunol.1103373; Doucette T, 2013, CANCER IMMUNOL RES, V1, P112, DOI 10.1158/2326-6066.CIR-13-0028; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Gao S, 2016, CANCER RES, V76, P6543, DOI 10.1158/0008-5472.CAN-16-0438; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hennequin A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1054598; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishiura N, 2010, EUR J IMMUNOL, V40, P1192, DOI 10.1002/eji.200939848; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Kalli KR, 2008, CANCER RES, V68, P4893, DOI 10.1158/0008-5472.CAN-07-6726; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Ladanyi A, 2011, CANCER IMMUNOL IMMUN, V60, P1729, DOI 10.1007/s00262-011-1071-x; LaFrance-Corey RG, 2011, JOVE-J VIS EXP, DOI 10.3791/2747; Nduom EK, 2015, NEURO-ONCOLOGY, V17, P9, DOI 10.1093/neuonc/nov151; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Park KH, 2008, CANCER RES, V68, P8400, DOI 10.1158/0008-5472.CAN-07-5891; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Phillips LM, 2016, J PATHOL, V239, P355, DOI 10.1002/path.4734; Preza GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122723; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Shen FP, 2019, BRAIN RES, V1704, P174, DOI 10.1016/j.brainres.2018.10.018; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Yan J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv137; Yang I, 2010, J CLIN NEUROSCI, V17, P1381, DOI 10.1016/j.jocn.2010.03.031; Zhang CB, 2016, ONCOTARGET, V7, P73971, DOI 10.18632/oncotarget.12605	38	14	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222999	10.1371/journal.pone.0222999	http://dx.doi.org/10.1371/journal.pone.0222999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560714	Green Published, gold			2022-12-26	WOS:000532353700029
J	Kenawi, M; Rouger, E; Island, ML; Leroyer, P; Robin, F; Remy, S; Tesson, L; Anegon, I; Nay, K; Derbre, F; Brissot, P; Ropert, M; Cavey, T; Loreal, O				Kenawi, Moussa; Rouger, Emmanuel; Island, Marie-Laure; Leroyer, Patricia; Robin, Francois; Remy, Severine; Tesson, Laurent; Anegon, Ignacio; Nay, Kevin; Derbre, Frederic; Brissot, Pierre; Ropert, Martine; Cavey, Thibault; Loreal, Olivier			Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia	FASEB JOURNAL			English	Article						hepcidin; CRISPR/Cas9; genetic disease; metals; hepatocyte	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; MESSENGER-RNA EXPRESSION; TRANSFERRIN RECEPTOR 2; BRAIN IRON; FERROXIDASE ACTIVITY; COPPER INCORPORATION; SERUM CERULOPLASMIN; HEPCIDIN; METABOLISM; HFE	Hereditary aceruloplasminemia (HA), related to mutations in the ceruloplasmin (Cp) gene, leads to iron accumulation. Ceruloplasmin ferroxidase activity being considered essential for macrophage iron release, macrophage iron overload is expected, but it is not found in hepatic and splenic macrophages in humans. Our objective was to get a better understanding of the mechanisms leading to iron excess in HA. A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) knockout of the Cp gene was performed on Sprague-Dawley rats. We evaluated the iron status in plasma, the expression of iron metabolism genes, and the status of other metals whose interactions with iron are increasingly recognized. In Cp-/- rats, plasma ceruloplasmin and ferroxidase activity were absent, together with decreased iron concentration and transferrin saturation. Similarly as in humans, the hepatocytes were iron overloaded conversely to hepatic and splenic macrophages. Despite a relative hepcidin deficiency in Cp-/- rats and the loss of ferroxidase activity, potentially expected to limit the interaction of iron with transferrin, no increase of plasma non-transferrin-bound iron level was found. Copper was decreased in the spleen, whereas manganese was increased in the plasma. These data suggest that the reported role of ceruloplasmin cannot fully explain the iron hepatosplenic phenotype in HA, encouraging the search for additional mechanisms.	[Kenawi, Moussa; Rouger, Emmanuel; Island, Marie-Laure; Leroyer, Patricia; Robin, Francois; Brissot, Pierre; Ropert, Martine; Cavey, Thibault; Loreal, Olivier] Univ Rennes, Ctr Hosp Univ CHU Pontchaillou, Inst NuMeCan Nutr Metab & Canc,UMR 1241, INSERM,INRA,Platform Anal Elementaire & Metab Met, Rennes, France; [Remy, Severine; Tesson, Laurent; Anegon, Ignacio] INSERM, UMR 1064, CRTI, Transgen Rats ImmunoPhen Facil, Nantes, France; [Nay, Kevin; Derbre, Frederic] Univ Rennes 2, Ecole Normale Super ENS Rennes, Lab Movement Sport & Hlth Sci M2S EA7470, Bruz, France	CHU Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Rennes 2	Loreal, O (corresponding author), H op Pontchaillou, Inst NuMeCan, INSERM, UMR 1241, F-35033 Rennes, France.	olivier.loreal@univ-rennes1.fr	Anegon, Ignacio/I-7760-2018; ROBIN, François/AAH-1986-2021; Loreal, Olivier/G-3366-2013; Derbre, Frederic/R-8776-2017	Loreal, Olivier/0000-0002-7428-3766; Nay, Kevin/0000-0003-0859-992X; Derbre, Frederic/0000-0002-1531-6425; Martine, Ropert/0000-0003-1227-9427	Fondation Maladies Rares; Region Bretagne; INSERM; Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS); Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project - Investissements d'Avenir French Government Program [ANRII-INSB-0014]; Labex Immunotherapy Grand Ouest (IGO) project part of the Investissements d'Avenir French Government Program [ANR-11-LABX-0016-01]; Institut Hospitalo Universitaire (IHU-Cesti) project part of the Investissements d'Avenir French Government Program [ANR-10-IBHU-005]; Nantes Metropole; Region Pays de la Loire; UMR7196 TacGene [U1154]	Fondation Maladies Rares; Region Bretagne(Region Bretagne); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS); Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project - Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Labex Immunotherapy Grand Ouest (IGO) project part of the Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Institut Hospitalo Universitaire (IHU-Cesti) project part of the Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Nantes Metropole(Region Pays de la Loire); Region Pays de la Loire(Region Pays de la Loire); UMR7196 TacGene	This work was supported by the Fondation Maladies Rares, Region Bretagne (to M.K.), INSERM, and Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS). This work was partially supported by the Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project funded by the Investissements d'Avenir French Government Program (ANRII-INSB-0014) and also a member of Celphedia infrastructure. This work was realized in the context of the Labex Immunotherapy Grand Ouest (IGO) project (ANR-11-LABX-0016-01) and the Institut Hospitalo Universitaire (IHU-Cesti) project (ANR-10-IBHU-005), both of which are part of the Investissements d'Avenir French Government Program. The IHU-Cesti Project is also supported by Nantes Metropole and Region Pays de la Loire. The authors thank the U1154-UMR7196 TacGene for design and production of the single guide RNA4.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787; Bosio S, 2002, BLOOD, V100, P2246, DOI 10.1182/blood-2002-02-0584; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Brissot P, 2016, J HEPATOL, V64, P505, DOI 10.1016/j.jhep.2015.11.009; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brower Marcia, 2015, Lab Anim Res, V31, P166, DOI 10.5625/lar.2015.31.4.166; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; CARTWRIGHT GE, 1964, AM J CLIN NUTR, V14, P224, DOI 10.1093/ajcn/14.4.224; Cavey T, 2017, EXP PHYSIOL, V102, P291, DOI 10.1113/EP086188; Cavey T, 2015, BIOMETALS, V28, P733, DOI 10.1007/s10534-015-9862-8; Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Cherukuri S, 2004, BLOOD CELL MOL DIS, V33, P346, DOI 10.1016/j.bcmd.2004.07.003; Cornejo P, 2005, NITRIC OXIDE-BIOL CH, V13, P54, DOI 10.1016/j.niox.2005.04.009; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Finkenstedt A, 2010, J HEPATOL, V53, P1101, DOI 10.1016/j.jhep.2010.04.039; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fuqua BK, 2018, CELL MOL GASTROENTER, V6, P405, DOI 10.1016/j.jcmgh.2018.06.006; Gouya L, 2007, GASTROENTEROLOGY, V132, P679, DOI 10.1053/j.gastro.2006.11.024; Guo P, 2009, PEPTIDES, V30, P262, DOI 10.1016/j.peptides.2008.09.017; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kono S, 2006, GASTROENTEROLOGY, V131, P240, DOI 10.1053/j.gastro.2006.04.017; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Laine F, 2002, J HEPATOL, V36, P60, DOI 10.1016/S0168-8278(01)00254-9; Li YQ, 2013, BIOMED ENVIRON SCI, V26, P808, DOI 10.3967/bes2013.004; Loreal O, 2002, J HEPATOL, V36, P851, DOI 10.1016/S0168-8278(02)00042-9; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Marques L, 2012, BLOOD CELL MOL DIS, V48, P110, DOI 10.1016/j.bcmd.2011.11.005; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Miyajima H, 2015, NEUROPATHOLOGY, V35, P83, DOI 10.1111/neup.12149; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ogimoto M, 2011, INTERNAL MED, V50, P1415, DOI 10.2169/internalmedicine.50.5108; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Piperno A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00903; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Remy S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16328-y; Salaun E, 2016, J APPL PHYSIOL, V120, P178, DOI 10.1152/japplphysiol.00720.2015; SATO M, 1991, J BIOL CHEM, V266, P5128; Skidmore FM, 2008, J NEUROL NEUROSUR PS, V79, P467, DOI 10.1136/jnnp.2007.120568; SMITH AG, 1990, HEPATOLOGY, V12, P1399, DOI 10.1002/hep.1840120622; Tangudu NK, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020070; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yamamoto K, 2002, BBA-MOL BASIS DIS, V1588, P195, DOI 10.1016/S0925-4439(02)00165-5; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang Y, 2014, FOOD FUNCT, V5, P1381, DOI 10.1039/c4fo00006d	66	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13492	13502		10.1096/fj.201901106R	http://dx.doi.org/10.1096/fj.201901106R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560858	Green Submitted, Bronze			2022-12-26	WOS:000507466100036
J	Shamshoum, H; Medak, KD; Townsend, LK; Ashworth, KE; Bush, ND; Hahn, MK; Kemp, BE; Wright, DC				Shamshoum, Hesham; Medak, Kyle D.; Townsend, Logan K.; Ashworth, Kristen E.; Bush, Natasha D.; Hahn, Margaret K.; Kemp, Bruce E.; Wright, David C.			AMPK beta 1 activation suppresses antipsychotic-induced hyperglycemia in mice	FASEB JOURNAL			English	Article						olanzapine; A769662; liver; glucose; lipids	PROTEIN-KINASE; INSULIN-RESISTANCE; LOADING CONTROL; 2ND-GENERATION ANTIPSYCHOTICS; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; OLANZAPINE; METABOLISM; WEIGHT; ACTIN	Olanzapine (OLZ) is a second-generation antipsychotic that is used to treat schizophrenia but also causes acute hyperglycemia. This study aimed to determine if the ablation of AMPK beta 1-containing complexes potentiates acute OLZ-induced metabolic dysfunction and if the activation of AMPK beta 1 suppresses these effects. Female AMPK beta 1(-/-) or wild-type (WT) control mice were treated with OLZ, and changes in blood glucose, serum and liver metabolites, whole-body fuel oxidation, and pyruvate-induced increases in blood glucose were measured. Additionally, WT mice were cotreated with OLZ and A769662, a specific AMPK beta 1 activator, and we determined if cotreatment protected against acute, OLZ-induced metabolic dysfunction. OLZ-induced increases in blood glucose were exacerbated in AMPK beta 1 mice compared with WT mice, and this was paralleled by greater OLZ-induced increases in markers of liver glucose production, such as pyruvate tolerance, serum glucagon, and glucagon responsiveness. Cotreatment with A769662 attenuated OLZ-induced increases in blood glucose, serum nonesterified fatty acid, and glycerol. Furthermore, this effect was absent in AMPK beta 1(-/-) mice, consistent with A769662's specificity for the AMPK beta 1 subunit. Reductions in AMPK activity potentiate the effects of acute OLZ treatment on blood glucose, whereas specifically targeting AMPK beta 1-containing complexes is sufficient to protect against OLZ-induced hyperglycemia.	[Shamshoum, Hesham; Medak, Kyle D.; Townsend, Logan K.; Ashworth, Kristen E.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Bush, Natasha D.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hahn, Margaret K.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Dept Med, Melbourne, Vic, Australia; [Kemp, Bruce E.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic, Australia	University of Guelph; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca	Kemp, Bruce/G-9602-2019	Kemp, Bruce/0000-0001-6735-5082; Hahn, Margaret/0000-0001-8884-9946; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research (CIHR); Ontario Graduate Scholarship; Dairy Farmers of Ontario Doctoral Research Assistantship; Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship; Australian Research Council [DP170101196]; NHMRC [APP1085460]; University of Guelph	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dairy Farmers of Ontario Doctoral Research Assistantship; Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Guelph	This work was funded by a Canadian Institutes of Health Research (CIHR) grant to D.C.W., who is a Tier II Canada Research Chair in Lipids, Metabolism, and Health. H.S. was supported by an Ontario Graduate Scholarship. L.K.T. was supported by a Dairy Farmers of Ontario Doctoral Research Assistantship and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship. B.E.K. is a National Health and Medical Research Council of Australia Fellow supported by the Australian Research Council (DP170101196 and NHMRC, APP1085460). K.E.A. was supported by the University of Guelph President's Scholarship. The authors declare no conflicts of interest.	Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Bush ND, 2018, J PHARMACOL EXP THER, V365, P526, DOI 10.1124/jpet.118.248393; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; CARLING D, 1994, J BIOL CHEM, V269, P11442; Castellani LN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19260-x; Castellani LN, 2017, PSYCHONEUROENDOCRINO, V82, P38, DOI 10.1016/j.psyneuen.2017.05.005; Chintoh AF, 2009, SCHIZOPHR RES, V108, P127, DOI 10.1016/j.schres.2008.12.012; Coccurello R, 2009, J CLIN PSYCHOPHARM, V29, P576, DOI 10.1097/JCP.0b013e3181bfe13e; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Divac N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/656370; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Graff-Guerrero A, 2015, JAMA PSYCHIAT, V72, P927, DOI 10.1001/jamapsychiatry.2015.0891; Hahn MK, 2013, J CLIN PSYCHOPHARM, V33, P740, DOI 10.1097/JCP.0b013e31829e8333; Han YM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08585-4; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Ikegami M, 2013, DIABETES OBES METAB, V15, P1128, DOI 10.1111/dom.12148; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Klingerman CM, 2014, SCHIZOPHRENIA BULL, V40, P327, DOI 10.1093/schbul/sbs196; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson REK, 2014, AM J PHYSIOL-ENDOC M, V307, pE563, DOI 10.1152/ajpendo.00287.2014; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Mattiuz E, 1997, DRUG METAB DISPOS, V25, P573; Miller Del D, 2004, Prim Care Companion J Clin Psychiatry, V6, P3; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Navari RM, 2016, NEW ENGL J MED, V375, P134, DOI 10.1056/NEJMoa1515725; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Peppler WT, 2018, AM J PHYSIOL-ENDOC M, V314, pE66, DOI 10.1152/ajpendo.00226.2017; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Pringsheim Tamara, 2014, CMAJ Open, V2, pE225, DOI 10.9778/cmajo.20140009; Procyshyn RM, 2010, J CLIN PSYCHIAT, V71, P566, DOI 10.4088/JCP.08m04912gre; Remington GJ, 2015, J ENDOCRINOL, V227, P71, DOI 10.1530/JOE-15-0074; Rojo LE, 2015, PHARMACOL RES, V101, P74, DOI 10.1016/j.phrs.2015.07.022; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sharpley AL, 2005, J CLIN PSYCHIAT, V66, P450, DOI 10.4088/JCP.v66n0407; Smith BK, 2017, CURR OPIN CLIN NUTR, V20, P248, DOI 10.1097/MCO.0000000000000380; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Souza RP, 2012, J PSYCHIATR RES, V46, P462, DOI 10.1016/j.jpsychires.2012.01.010; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STEELE R, 1971, AM J PHYSIOL, V221, P883, DOI 10.1152/ajplegacy.1971.221.3.883; Takeuchi Y, 2015, DRUG SAFETY, V38, P641, DOI 10.1007/s40264-015-0298-4; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Townsend LK, 2018, PSYCHONEUROENDOCRINO, V88, P121, DOI 10.1016/j.psyneuen.2017.12.004; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Wirshing DA, 1999, J CLIN PSYCHIAT, V60, P358, DOI 10.4088/JCP.v60n0602	62	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14010	14021		10.1096/fj.201901820R	http://dx.doi.org/10.1096/fj.201901820R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31581839				2022-12-26	WOS:000507466100073
J	De Blasio, C; Zonfrilli, A; Franchitto, M; Mariano, G; Cialfi, S; Verma, N; Checquolo, S; Bellavia, D; Palermo, R; Benelli, D; Screpanti, I; Talora, C				De Blasio, Carlo; Zonfrilli, Azzurra; Franchitto, Matteo; Mariano, Germano; Cialfi, Samantha; Verma, Nagendra; Checquolo, Saula; Bellavia, Diana; Palermo, Rocco; Benelli, Dario; Screpanti, Isabella; Talora, Claudio			PLK1 targets NOTCH1 during DNA damage and mitotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch pathway; DNA damage response; cell cycle; cancer biology; stress response; Arsenic; cell transformation; DNA damage; Notch; PLK1	TUMOR-SUPPRESSOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; MUTATIONS; RELEASE; PATHWAY; ARREST; HEAD	Notch signaling plays a complex role in carcinogenesis, and its signaling pathway has both tumor suppressor and oncogenic components. To identify regulators that might control this dual activity of NOTCH1, we screened a chemical library targeting kinases and identified Polo-like kinase 1 (PLK1) as one of the kinases involved in arsenite-induced NOTCH1 down-modulation. As PLK1 activity drives mitotic entry but also is inhibited after DNA damage, we investigated the PLK1-NOTCH1 interplay in the G(2) phase of the cell cycle and in response to DNA damage. Here, we found that PLK1 regulates NOTCH1 expression at G(2)/M transition. However, when cells in G(2) phase are challenged with DNA damage, PLK1 is inhibited to prevent entry into mitosis. Interestingly, we found that the interaction between NOTCH1 and PLK1 is functionally important during the DNA damage response, as we found that whereas PLK1 activity is inhibited, NOTCH1 expression is maintained during DNA damage response. During genotoxic stress, cellular transformation requires that promitotic activity must override DNA damage checkpoint signaling to drive proliferation. Interestingly, we found that arsenite-induced genotoxic stress causes a PLK1-dependent signaling response that antagonizes the involvement of NOTCH1 in the DNA damage checkpoint. Taken together, our data provide evidence that Notch signaling is altered but not abolished in SCC cells. Thus, it is also important to recognize that Notch plasticity might be modulated and could represent a key determinant to switch on/off either the oncogenic or tumor suppressor function of Notch signaling in a single type of tumor.	[De Blasio, Carlo; Zonfrilli, Azzurra; Franchitto, Matteo; Mariano, Germano; Cialfi, Samantha; Verma, Nagendra; Bellavia, Diana; Palermo, Rocco; Benelli, Dario; Screpanti, Isabella; Talora, Claudio] Sapienza Univ Rome, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy; [Checquolo, Saula] Sapienza Univ, Dept Med Surg Sci & Biotechnol, I-04100 Latina, Italy; [Zonfrilli, Azzurra] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, I-00161 Rome, Italy; [De Blasio, Carlo] INSERM, Montpellier Canc Ctr, F-34298 Montpellier 5, France	Sapienza University Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Institut National de la Sante et de la Recherche Medicale (Inserm)	Talora, C (corresponding author), Sapienza Univ Rome, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy.	claudio.talora@uniroma1.it	Bellavia, Diana/AAO-6348-2021; Verma, Nagendra/AAX-6944-2021; Talora, Claduio/AIC-4932-2022; Benelli, Dario/D-3492-2012	Talora, Claduio/0000-0002-6973-2184; Bellavia, Diana/0000-0001-5728-2537; Verma, Nagendra/0000-0002-3149-7764; CHECQUOLO, Saula/0000-0001-5109-8392	Italian Association for Cancer Research (AIRC) [IG-15218]; Ministero dell'Istruzione, dell'Universita e della Ricerca Grant [PRIN-2017XCXAFZ]; Sapienza-Progetti Ateneo 2017	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca Grant(Ministry of Education, Universities and Research (MIUR)); Sapienza-Progetti Ateneo 2017	This work was supported by Italian Association for Cancer Research (AIRC) Grant IG-15218, Ministero dell'Istruzione, dell'Universita e della Ricerca Grant PRIN-2017XCXAFZ, and Sapienza-Progetti Ateneo 2017 (to C. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Archambault V, 2015, ONCOGENE, V34, P4799, DOI 10.1038/onc.2014.451; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beatus P, 1999, DEVELOPMENT, V126, P3925; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bruinsma W, 2014, J CELL SCI, V127, P801, DOI 10.1242/jcs.137216; Cialfi S, 2013, LEUKEMIA, V27, P485, DOI 10.1038/leu.2012.192; Cialfi S, 2014, CELL CYCLE, V13, P2046, DOI 10.4161/cc.29079; Colombo M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01823; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Palermo R, 2014, CURR MOL MED, V14, P34, DOI 10.2174/1566524013666131118105216; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Romero PV, 2015, LEUKEMIA, V29, P2442, DOI 10.1038/leu.2015.117; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Verma N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051073; Wakida T, 2017, ELIFE, V6, DOI 10.7554/eLife.29953; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	31	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17941	17950		10.1074/jbc.RA119.009881	http://dx.doi.org/10.1074/jbc.RA119.009881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31597699	Green Published, hybrid			2022-12-26	WOS:000504206800020
J	Zhang, WQ; Meyfeldt, J; Wang, HB; Kulkarni, S; Lu, J; Mandel, JA; Marburger, B; Liu, Y; Gorka, JE; Ranganathan, S; Prochownik, EV				Zhang, Weiqi; Meyfeldt, Jennifer; Wang, Huabo; Kulkarni, Sucheta; Lu, Jie; Mandel, Jordan A.; Marburger, Brady; Liu, Ying; Gorka, Joanna E.; Ranganathan, Sarangarajan; Prochownik, Edward V.			beta-Catenin mutations as determinants of hepatoblastoma phenotypes in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; MYC proto-oncogene BHLH transcription factor (c-Myc); pyruvate dehydrogenase complex (PDC); Warburg effect; Wnt pathway; yes-associated protein (YAP); beta-catenin (B-catenin); glutaminolysis; hepatoblastoma (HB); oxidative phosphorylation; pediatric cancer; yes-associated protein (YAP); catenin beta1 (CTNNB1)	YES-ASSOCIATED PROTEIN; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; WNT/BETA-CATENIN; GENE-EXPRESSION; SOMATIC MUTATIONS; SIGNALING PATHWAYS; PROGNOSTIC-FACTORS; LIVER; LANDSCAPE	Hepatoblastoma (HB) is the most common pediatric liver cancer. Although long-term survival of HB is generally favorable, it depends on clinical stage, tumor histology, and a variety of biochemical and molecular features. HB appears almost exclusively before the age of 3 years, is represented by seven histological subtypes, and is usually associated with highly heterogeneous somatic mutations in the catenin beta 1 (CTNNB1) gene, which encodes beta-catenin, a Wnt ligand-responsive transcriptional co-factor. Numerous recurring beta-catenin mutations, not previously documented in HB, have also been identified in various other pediatric and adult cancer types. Little is known about the underlying factors that determine the above HB features and behaviors or whether non-HB-associated beta-catenin mutations are tumorigenic when expressed in hepatocytes. Here, we investigated the oncogenic properties of 14 different HB- and non-HB-associated beta-catenin mutants encoded by Sleeping Beauty vectors following their delivery into the mouse liver by hydrodynamic tail-vein injection. We show that all beta-catenin mutations, as well as WT beta-catenin, are tumorigenic when co-expressed with a mutant form of yes-associated protein (YAP). However, tumor growth rates, histologies, nuclear-to-cytoplasmic partitioning, and metabolic and transcriptional landscapes were strongly influenced by the identities of the beta-catenin mutations. These findings provide a context for understanding at the molecular level the notable biological diversity of HB.	[Zhang, Weiqi; Meyfeldt, Jennifer; Wang, Huabo; Kulkarni, Sucheta; Lu, Jie; Mandel, Jordan A.; Marburger, Brady; Liu, Ying; Gorka, Joanna E.; Prochownik, Edward V.] UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Ranganathan, Sarangarajan] UPMC Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15224 USA; [Zhang, Weiqi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ranganathan, Sarangarajan; Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Hillman Canc Ctr, Pittsburgh, PA 15232 USA; [Marburger, Brady; Liu, Ying; Ranganathan, Sarangarajan] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA; [Meyfeldt, Jennifer] Lankenau Med Ctr, Dept Internal Med, Wynnewood, PA 19096 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lankenau Medical Center	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Rangos Res Ctr, Rm 5124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Ranganathan, Sarangarajan/0000-0001-6214-9167	Hyundai Hope on Wheels Scholar Grant; NCI, National Institutes of Health [RO1CA174713]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER	Hyundai Hope on Wheels Scholar Grant; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Hyundai Hope on Wheels Scholar Grant (to E.V.P.) and NCI, National Institutes of Health, Grant RO1CA174713 (to E.V.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Arcila ME, 2015, CLIN CANCER RES, V21, P1935, DOI 10.1158/1078-0432.CCR-14-2124; Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; Aronson DC, 2016, SEMIN PEDIATR SURG, V25, P265, DOI 10.1053/j.sempedsurg.2016.09.002; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Bell Danielle, 2017, Gene Expression, V17, P141, DOI 10.3727/105221616X693639; Bera G, 2017, PEDIATR SURG INT, V33, P961, DOI 10.1007/s00383-017-4115-2; Blaker H, 1999, GENE CHROMOSOME CANC, V25, P399; Burczynski ME, 2005, CURR MOL MED, V5, P83, DOI 10.2174/1566524053152933; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cairo Stefano, 2012, Front Biosci (Elite Ed), V4, P480; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Cherkaoui-Malki M, 2012, CURR DRUG METAB, V13, P1412, DOI 10.2174/138920012803762765; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Czauderna P, 2014, CURR OPIN PEDIATR, V26, P19, DOI 10.1097/MOP.0000000000000046; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dolezal JM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4178-z; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunach M, 2017, CRIT REV BIOCHEM MOL, V52, P327, DOI 10.1080/10409238.2017.1295920; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichenmuller M, 2014, J HEPATOL, V61, P1312, DOI [10.1016/j.jhep.2014.09.016, 10.1016/j.jhep.2014.08.009]; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gadd S, 2012, NEOPLASIA, V14, P742, DOI 10.1593/neo.12714; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Hooks KB, 2018, HEPATOLOGY, V68, P89, DOI 10.1002/hep.29672; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jeng YM, 2000, CANCER LETT, V152, P45, DOI 10.1016/S0304-3835(99)00433-4; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kabeer Farhia, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top069948; Khalaf AM, 2018, J HEPATOCELL CARCINO, V5, P61, DOI 10.2147/JHC.S156701; Kim M, 2014, BMB REP, V47, P540, DOI 10.5483/BMBRep.2014.47.10.177; Koch A, 2004, J PATHOL, V204, P546, DOI 10.1002/path.1662; Koch A, 1999, CANCER RES, V59, P269; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8; Levens D, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014233; Linch M, 2017, ANN ONCOL, V28, P2472, DOI 10.1093/annonc/mdx355; Lopez-Terrada D, 2014, MODERN PATHOL, V27, P472, DOI 10.1038/modpathol.2013.80; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Mandel J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5851-6; Meyers RL, 2017, LANCET ONCOL, V18, P122, DOI 10.1016/S1470-2045(16)30598-8; Meyers RL, 2009, PEDIATR BLOOD CANCER, V53, P1016, DOI 10.1002/pbc.22088; Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ohnishi H, 1996, GENE CHROMOSOME CANC, V15, P187, DOI 10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z; Park WS, 2001, J PATHOL, V193, P483; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Pinarbasi ES, 2018, CELL REP, V23, P2844, DOI 10.1016/j.celrep.2018.05.003; Purcell R, 2012, EUR J CANCER, V48, P1853, DOI 10.1016/j.ejca.2011.10.019; Qiao GL, 2016, J GASTROEN HEPATOL, V31, P621, DOI 10.1111/jgh.13165; Qiao Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4870-z; Rampetsreiter Paulina, 2011, Drug Discov Today Dis Models, V8, P67; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Shi Z, 2012, PROTEINS, V80, P61, DOI 10.1002/prot.23159; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Sumazin P, 2017, HEPATOLOGY, V65, P104, DOI 10.1002/hep.28888; Takayasu H, 2001, CLIN CANCER RES, V7, P901; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Towbin AJ, 2018, PEDIATR RADIOL, V48, P536, DOI 10.1007/s00247-018-4078-z; Trobaugh-Lotrario AD, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27103; Venkatramani R, 2014, AM J MED GENET A, V164, P2250, DOI 10.1002/ajmg.a.36638; von Schweinitz D, 1997, INT J CANCER, V74, P593, DOI 10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Wallmen B, 2012, NUCLEIC ACIDS RES, V40, P9455, DOI 10.1093/nar/gks690; Waltzer L, 1999, CANCER METAST REV, V18, P231, DOI 10.1023/A:1006321324190; Wang HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218186; Wang HB, 2018, J BIOL CHEM, V293, P14740, DOI 10.1074/jbc.RA118.004099; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang Y, 2013, TUMOR BIOL, V34, P2169, DOI 10.1007/s13277-013-0751-x; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; Winder T, 2009, ONCOL REP, V21, P1283, DOI 10.3892/or_00000352; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yang A, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26892; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	90	21	21	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17524	17542		10.1074/jbc.RA119.009979	http://dx.doi.org/10.1074/jbc.RA119.009979			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31597698	Green Published, hybrid			2022-12-26	WOS:000503173500029
J	Fu, HL; Lei, PZ; Tao, HW; Zhao, L; Yang, J				Fu, Hongliang; Lei, Peizhi; Tao, Huawei; Zhao, Li; Yang, Jing			Improved semi-supervised autoencoder for deception detection	PLOS ONE			English	Article							NETWORK	Existing algorithms of speech-based deception detection are severely restricted by the lack of sufficient number of labelled data. However, a large amount of easily available unlabelled data has not been utilized in reality. To solve this problem, this paper proposes a semi-supervised additive noise autoencoder model for deception detection. This model updates and optimizes the semi-supervised autoencoder and it consists of two layers of encoder and decoder, and a classifier. Firstly, it changes the activation function of the hidden layer in network according to the characteristics of the deception speech. Secondly, in order to prevent over-fitting during training, the specific ratio dropout is added at each layer cautiously. Finally, we directly connected the supervised classification task in the output of encoder to make the network more concise and efficient. Using the feature set specified by the INTER-SPEECH 2009 Emotion Challenge, the experimental results on Columbia-SRI-Colorado (CSC) corpus and our own deception corpus show that the proposed model can achieve more advanced performance than other alternative methods with only a small amount of labelled data.	[Fu, Hongliang; Lei, Peizhi; Tao, Huawei; Yang, Jing] Henan Univ Technol, Sch Informat Sci & Engn, Zhengzhou, Henan, Peoples R China; [Tao, Huawei; Zhao, Li] Southeast Univ, Minist Educ, Key Lab Underwater Acoust Signal Proc, Nanjing, Jiangsu, Peoples R China	Henan University of Technology; Southeast University - China	Tao, HW (corresponding author), Henan Univ Technol, Sch Informat Sci & Engn, Zhengzhou, Henan, Peoples R China.; Tao, HW (corresponding author), Southeast Univ, Minist Educ, Key Lab Underwater Acoust Signal Proc, Nanjing, Jiangsu, Peoples R China.	thw@haut.edu.cn			National Natural Science Foundation of China [61673108, 61601170]; Henan Provincial Science and Technology Research Project [192102210101]; Natural Science Project of Henan Education Department [19A510009]; Start-up Fund for High-level Talents of Henan University of Technology [31401148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Provincial Science and Technology Research Project; Natural Science Project of Henan Education Department; Start-up Fund for High-level Talents of Henan University of Technology	This work was supported by: 1.National Natural Science Foundation of China (No.61673108 and 61601170) 2.Henan Provincial Science and Technology Research Project (No.192102210101) 3.Natural Science Project of Henan Education Department (No.19A510009) 4.Start-up Fund for High-level Talents of Henan University of Technology (No.31401148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasnejad ME, 2017, PROC CVPR IEEE, P781, DOI 10.1109/CVPR.2017.90; Deng J, 2018, IEEE-ACM T AUDIO SPE, V26, P31, DOI 10.1109/TASLP.2017.2759338; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; Enos F, 2007, INTERSPEECH 2007: 8TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION, VOLS 1-4, P2432; Enos F, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P813; Goodfellow G, 2013, PROCEEDINGS OF THE 9TH INTERNATIONAL PIPELINE CONFERENCE - 2012, VOL 4, P541; Gopalan K, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P619, DOI 10.1109/ICDSP.2007.4288658; Han K, 2014, INTERSPEECH, P223; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G.E., 1994, ADV NEURAL INFORM PR; Hung Hayley, 2010, PROC ACMMM, DOI [10.1145/1873951.1874102, DOI 10.1145/1873951.1874102]; Jia XW, 2014, IEEE INT C BIOINF BI, P30, DOI 10.1109/BIBE.2014.26; Kirchhuebel C., 2013, ACOUSTIC TEMPORAL CH; Mohamed AR, 2012, INT CONF ACOUST SPEE, P4273, DOI 10.1109/ICASSP.2012.6288863; Pudur R, 2018, 2018 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS, MATERIALS ENGINEERING & NANO-TECHNOLOGY (IEMENTECH), P205; Rasmus A., 2015, 29 C NE INF PROC SYS, V2, P3546; Schuller B, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P336; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Weston Jason, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P639, DOI 10.1007/978-3-642-35289-8_34; Yan Zhou, 2015, Intelligent Computing Theories and Methodologies. 11th International Conference, ICIC 2015. Proceedings: LNCS 9225, P189, DOI 10.1007/978-3-319-22180-9_19; Zhou Y, 2015, NEUROCOMPUTING, V151, P1042, DOI 10.1016/j.neucom.2014.04.083	21	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0223361	10.1371/journal.pone.0223361	http://dx.doi.org/10.1371/journal.pone.0223361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP3JS	31593570	gold, Green Published			2022-12-26	WOS:000498164300001
J	Batt, RD; Eason, T; Garmestani, A				Batt, Ryan D.; Eason, Tarsha; Garmestani, Ahjond			Time scale of resilience loss: Implications for managing critical transitions in water quality	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; ECOLOGICAL RESILIENCE; TROPHIC CASCADES; TIPPING POINT; GROWTH-RATES; INDICATORS; EUTROPHICATION; PHYTOPLANKTON; VEGETATION; PATTERNS	Regime shifts involving critical transitions are a type of rapid ecological change that are difficult to predict, but may be preceded by decreases in resilience. Time series statistics like lag-1 autocorrelation may be useful for anticipating resilience declines; however, more study is needed to determine whether the dynamics of autocorrelation depend on the resolution of the time series being analyzed, i.e., whether they are time-scale dependent. Here, we examined timeseries simulated from a lake eutrophication model and gathered from field measurements. The field study involved collecting high frequency chlorophyll fluorescence data from an unmanipulated reference lake and a second lake undergoing experimental fertilization to induce a critical transition in the form of an algal bloom. As part of the experiment, the fertilization was halted in response to detected early warnings of the algal bloom identified by increased autocorrelation. We tested these datasets for time-scale dependence in the dynamics of lag-1 autocorrelation and found that in both the simulation and field experiment, the dynamics of autocorrelation were similar across time scales. In the simulated time series, autocorrelation increased exponentially approaching algal bloom development, and in the field experiment, the difference in autocorrelation between the manipulated and reference lakes increased sharply. These results suggest that, as an early warning indicator, autocorrelation may be robust to the time scale of the analysis. Given that a time scale can be shortened by increasing sampling frequency, or lengthened by aggregating data during analysis, these results have important implications for management as they demonstrate the potential for detecting early warning signals over a wide range of monitoring frequencies and without requiring analysts to make situation-specific decisions regarding aggregation. Such an outcome provides promise that data collection procedures, especially by automated sensors, may be used to monitor and manage ecosystem resilience without the need for strict attention to time scale.	[Batt, Ryan D.] US EPA, Natl Res Council, Cincinnati, OH 45268 USA; [Batt, Ryan D.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY USA; [Batt, Ryan D.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Eason, Tarsha] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Garmestani, Ahjond] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Garmestani, Ahjond] Univ Utrecht, Sch Law, Utrecht Ctr Water Oceans & Sustainabil Law, Utrecht, Netherlands	National Academies of Sciences, Engineering & Medicine; United States Environmental Protection Agency; Rensselaer Polytechnic Institute; Rutgers State University New Brunswick; United States Environmental Protection Agency; United States Environmental Protection Agency; Utrecht University	Eason, T (corresponding author), US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	eason.tarsha@epa.gov	Garmestani, Ahjond/AAJ-3695-2020	Garmestani, Ahjond/0000-0001-5678-7293; Eason, Tarsha/0000-0001-9881-3293	National Academy of Sciences	National Academy of Sciences	RDB is supported by a fellowship from the National Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Batt RD, 2013, P NATL ACAD SCI USA, V110, P17398, DOI 10.1073/pnas.1316721110; Batt RD, 2013, THEOR ECOL-NETH, V6, P285, DOI 10.1007/s12080-013-0190-8; Beckage B, 2008, COMPLEX SYST, V18, P159; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Boettiger C, 2012, P ROY SOC B-BIOL SCI, V279, P4734, DOI 10.1098/rspb.2012.2085; BOTSFORD LW, 1981, AM NAT, V117, P38, DOI 10.1086/283685; Brock WA, 2012, PLOS ONE, V7; Brock WA, 2006, ECOL SOC, V11; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter S R, 2003, REGIME SHIFTS LAKE E; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Cline TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00059.1; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; DAKOS V, 2012, PLOS ONE, V7; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2018, ECOL INDIC, V94, P494, DOI 10.1016/j.ecolind.2017.10.024; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Eason T, 2016, J APPL ECOL, V53, P656, DOI 10.1111/1365-2664.12597; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Frossard V, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00112; FURNAS MJ, 1990, J PLANKTON RES, V12, P1117, DOI 10.1093/plankt/12.6.1117; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gillooly JF, 2000, J PLANKTON RES, V22, P241, DOI 10.1093/plankt/22.2.241; Green OO, 2015, FRONT ECOL ENVIRON, V13, P332, DOI 10.1890/140294; Gsell AS, 2016, P NATL ACAD SCI USA, V113, pE8089, DOI 10.1073/pnas.1608242113; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Holmes EE, 2012, R J, V4, P11; JOHNSON WE, 1954, J WILDLIFE MANAGE, V18, P113, DOI 10.2307/3797621; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092097; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Litzow MA, 2013, ECOL APPL, V23, P1475, DOI 10.1890/12-0670.1; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Pace ML, 2017, P NATL ACAD SCI USA, V114, P352, DOI 10.1073/pnas.1612424114; Porter J, 2005, BIOSCIENCE, V55, P561, DOI 10.1641/0006-3568(2005)055[0561:WSNFE]2.0.CO;2; Porter JH, 2009, BIOSCIENCE, V59, P385, DOI 10.1525/bio.2009.59.5.6; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Serizawa H, 2008, ECOL RES, V23, P841, DOI 10.1007/s11284-007-0447-z; Spanbauer TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108936; Spears BM, 2017, NAT ECOL EVOL, V1, P1616, DOI 10.1038/s41559-017-0333-1; Spencer PD, 1997, CAN J FISH AQUAT SCI, V54, P2920, DOI 10.1139/cjfas-54-12-2920; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x; Wilkinson GM, 2018, ECOL MONOGR, V88, P188, DOI 10.1002/ecm.1286; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	55	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223366	10.1371/journal.pone.0223366	http://dx.doi.org/10.1371/journal.pone.0223366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589630	Green Published, gold			2022-12-26	WOS:000532427300020
J	Li, GT; Kakuda, S; Suresh, P; Canals, D; Salamone, S; London, E				Li, Guangtao; Kakuda, Shinako; Suresh, Pavana; Canals, Daniel; Salamone, Silvia; London, Erwin			Replacing plasma membrane outer leaflet lipids with exogenous lipid without damaging membrane integrity	PLOS ONE			English	Article							ASYMMETRIC VESICLES; RAFT DOMAINS; CELLS; PHOSPHOLIPIDS; SPHINGOMYELIN; SPHINGOLIPIDS; CHOLESTEROL; DEPENDENCE; INHIBITORS	We recently introduced a M alpha CD-based method to efficiently replace virtually the entire population of plasma membrane outer leaflet phospholipids and sphingolipids of cultured mammalian cells with exogenous lipids (Li et al, (2016) Proc. Natl. Acad. Sci USA 113:14025-14030). Here, we show if the lipid-to-M alpha CD ratio is too high or low, cells can round up and develop membrane leakiness. We found that this cell damage can be reversed/prevented if cells are allowed to recover from the exchange step by incubation in complete growth medium. After exchange and transfer to complete growth medium cell growth was similar to that of untreated cells. In some cases, cell damage was also prevented by carrying out exchange at close to room temperature (rather than at 37 degrees C). Exchange with lipids that do (sphingomyelin) or do not (unsaturated phosphatidylcholine) support a high level of membrane order in lipid vesicles had the analogous effect on plasma membrane order, confirming exogenous lipid localization in the plasma membrane. Importantly, changes in lipid composition and plasma membrane properties after exchange and recovery persisted for several hours. Thus, it should be possible to use lipid exchange to investigate the effect of plasma membrane lipid composition upon several aspects of membrane structure and function.	[Li, Guangtao; Kakuda, Shinako; Suresh, Pavana; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Canals, Daniel; Salamone, Silvia] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Canals, Daniel; Salamone, Silvia] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; Suresh, Pavana/0000-0003-1597-6818	National Institutes of Health [R35 GM122493]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institutes of Health R35 GM122493 to Erwin London. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adada M, 2016, CHEM PHYS LIPIDS, V197, P45, DOI 10.1016/j.chemphyslip.2015.07.008; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Cheng HT, 2011, BIOPHYS J, V100, P2671, DOI 10.1016/j.bpj.2011.04.048; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; IRIE T, 1992, J PHARM SCI, V81, P521, DOI 10.1002/jps.2600810609; Jay AG, 2017, J FLUORESC, V27, P243, DOI 10.1007/s10895-016-1951-8; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kainu V, 2010, J LIPID RES, V51, P3533, DOI 10.1194/jlr.D009373; Keller H, 2009, CHEMPHYSCHEM, V10, P2805, DOI 10.1002/cphc.200900598; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Li GT, 2016, P NATL ACAD SCI USA, V113, P14025, DOI 10.1073/pnas.1610705113; Lin QQ, 2015, BIOPHYS J, V108, P2212, DOI 10.1016/j.bpj.2015.03.056; Lin QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087903; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; Oglecka K, 2014, ELIFE, V3, DOI 10.7554/eLife.03695; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; SCOTT RE, 1979, J CELL SCI, V35, P229; SCOTT RE, 1976, ANTIMICROB AGENTS CH, V10, P646, DOI 10.1128/AAC.10.4.646; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Somogyi G, 2006, PHARMAZIE, V61, P154; Son M, 2013, J LIPID RES, V54, P3385, DOI 10.1194/jlr.M041749; Son M, 2013, J LIPID RES, V54, P223, DOI 10.1194/jlr.M032722; Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223572	10.1371/journal.pone.0223572	http://dx.doi.org/10.1371/journal.pone.0223572			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589646	Green Published, gold			2022-12-26	WOS:000532427300029
J	Huang, S; Goplen, NP; Zhu, BB; Cheon, IS; Son, YM; Wang, Z; Li, CF; Dai, QG; Jiang, L; Xiang, M; Carmona, EM; Vassallo, R; Limper, AH; Sun, J				Huang, Su; Goplen, Nick P.; Zhu, Bibo; Cheon, In Su; Son, Youngmin; Wang, Zheng; Li, Chaofan; Dai, Qigang; Jiang, Li; Xiang, Min; Carmona, Eva M.; Vassallo, Robert; Limper, Andrew H.; Sun, Jie			Macrophage PPAR-gamma suppresses long-term lung fibrotic sequelae following acute influenza infection	PLOS ONE			English	Article							T-CELL MEMORY; DENDRITIC CELLS; VIRUS-INFECTION; PULMONARY-FIBROSIS; IMMUNE-RESPONSE; STEM-CELLS; INDUCTION; BLEOMYCIN; DIFFERENTIATION; INFLAMMATION	Influenza virus causes a heterogeneous respiratory infectious disease ranging from self-limiting symptoms to non-resolving pathology in the lungs. Worldwide, seasonal influenza infections claim similar to 500,000 lives annually. Recent reports describe pathologic pulmonary sequelae that result in remodeling the architecture of lung parenchyma following respiratory infections. These dysfunctional recovery processes that disproportionately impact the elderly have been understudied. Macrophages are involved in tissue remodeling and are critical for survival of severe influenza infection. Here, we found intrinsic deficiency of the nuclear receptor PPAR-gamma in myeloid cells delayed the resolution of pulmonary inflammation following influenza infection. Mice with myeloid cell-specific PPAR-gamma deficiency subsequently presented with increased influenza-induced deposition of pulmonary collagen compared to control mice. This dysfunctional lung remodeling was progressive and sustained for at least 3 months following infection of mice with myeloid PPAR-gamma deficiency. These progressive changes were accompanied by a pro-fibrotic gene signature from lung macrophages and preceded by deficiencies in activation of genes involved with damage repair. Importantly similar aberrant gene expression patterns were also found in a secondary analysis of a study where macrophages were isolated from patients with fibrotic interstitial lung disease. Quite unexpectedly, mice with PPAR-gamma deficient macrophages were more resistant to bleomycin-induced weight loss whereas extracellular matrix deposition was unaffected compared to controls. Therefore PPAR-gamma expression in macrophages may be a pathogen-specific limiter of organ recovery rather than a ubiquitous effector pathway in response to generic damage.	[Huang, Su; Goplen, Nick P.; Zhu, Bibo; Cheon, In Su; Son, Youngmin; Wang, Zheng; Li, Chaofan; Dai, Qigang; Jiang, Li; Xiang, Min; Carmona, Eva M.; Vassallo, Robert; Limper, Andrew H.; Sun, Jie] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Thorac Dis Res Unit,Coll Med & Sci, Rochester, MN 55905 USA; [Carmona, Eva M.; Vassallo, Robert; Sun, Jie] Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sun, J (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Thorac Dis Res Unit,Coll Med & Sci, Rochester, MN 55905 USA.; Sun, J (corresponding author), Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA.	sun.jie@mayo.edu	Li, Chaofan/GMX-4943-2022	Li, Chaofan/0000-0002-5426-1498	US National Institutes of Health [RO1 AI112844, RO1 AG047156, RO1 HL126647, T32AG049672, R01 HL62150]; NHLBI [268201600004I-0-26800001-1]; Mayo Clinic Kogod Aging Center Pilot grant; Mayo Clinic Center for Biomedical Discovery discretionary fund; Huvis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062150, R01HL126647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047156, T32AG049672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mayo Clinic Kogod Aging Center Pilot grant; Mayo Clinic Center for Biomedical Discovery discretionary fund; Huvis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by the US National Institutes of Health RO1s AI112844, AG047156 and HL126647 (J.S.), T32AG049672 (N. P. G.), R01 HL62150 and NHLBI Contract 268201600004I-0-26800001-1 (A.H.L.), Mayo Clinic Kogod Aging Center Pilot grant and Mayo Clinic Center for Biomedical Discovery discretionary fund (J.S.) and Huvis Foundation grant (R.V.).	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Cheon IS, 2018, J ALLERGY CLIN IMMUN, V142, P1100, DOI 10.1016/j.jaci.2017.11.025; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Desai O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00043; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Faz-Lopez B, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8634603; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gopal R, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060505; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Guo XZJ, 2017, SEMIN IMMUNOPATHOL, V39, P541, DOI 10.1007/s00281-017-0636-y; HAMILTON RF, 1995, AM J PHYSIOL-LUNG C, V269, pL318, DOI 10.1152/ajplung.1995.269.3.L318; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Huang S, 2019, VIRAL IMMUNOL, V32, P161, DOI 10.1089/vim.2019.0016; Huang S, 2019, J VIROL, V93, DOI 10.1128/JVI.00030-19; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Italiani P, 2015, IMMUNE NETW, V15, P167, DOI 10.4110/in.2015.15.4.167; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jiang L, 2016, EUR J IMMUNOL, V46, P2778, DOI 10.1002/eji.201646548; Juarez MM, 2015, J THORAC DIS, V7, P499, DOI 10.3978/j.issn.2072-1439.2015.01.17; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kanegai CM, 2016, AM J RESP CELL MOL, V55, P613, DOI 10.1165/rcmb.2015-0387LE; Keeler SP, 2018, J IMMUNOL, V201, P2354, DOI 10.4049/jimmunol.1800671; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Li P, 2012, BRIT J RADIOL, V85, P729, DOI 10.1259/bjr/85580974; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mineo G, 2012, RADIOL MED, V117, P185, DOI 10.1007/s11547-011-0740-3; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Molyneaux PL, 2013, EUR RESPIR REV, V22, P376, DOI 10.1183/09059180.00000713; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Pebody RG, 2010, EUROSURVEILLANCE, V15; Pociask DA, 2017, AM J PATHOL, V187, P851, DOI 10.1016/j.ajpath.2016.12.012; Qiao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-107; Rawlins EL, 2015, NATURE, V517, P556, DOI 10.1038/517556a; Ruf BR, 2014, EUR J PEDIATR, V173, P265, DOI 10.1007/s00431-013-2023-6; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Shi YY, 2013, AM J RESP CRIT CARE, V188, P831, DOI 10.1164/rccm.201303-0434OC; Singh V, 2012, LUNG INDIA, V29, P277, DOI 10.4103/0970-2113.99118; Solleti SK, 2015, AM J PHYSIOL-LUNG C, V309, pL293, DOI 10.1152/ajplung.00287.2014; Sueblinvong V, 2012, AM J MED SCI, V344, P41, DOI 10.1097/MAJ.0b013e318234c132; Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wang Z, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1217; Wong SS, 2018, J INFECT DIS, V217, P245, DOI 10.1093/infdis/jix571; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yao S, 2015, MUCOSAL IMMUNOL, V8, P746, DOI 10.1038/mi.2014.106; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zhang L, 2004, TRENDS ENDOCRIN MET, V15, P500, DOI 10.1016/j.tem.2004.10.006; Zhang Y, 2019, J IMMUNOL, V202, P2332, DOI 10.4049/jimmunol.1801491; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	62	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223430	10.1371/journal.pone.0223430	http://dx.doi.org/10.1371/journal.pone.0223430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584978	gold, Green Published			2022-12-26	WOS:000532407600033
J	Nyathi, S; Dlodlo, RA; Satyanarayana, S; Takarinda, KC; Tweya, H; Hove, S; Matambo, R; Mandewo, W; Nyathi, K; Sibanda, E; Harries, AD				Nyathi, Saziso; Dlodlo, Riitta A.; Satyanarayana, Srinath; Takarinda, Kudakwashe C.; Tweya, Hannock; Hove, Sithokozile; Matambo, Ronnie; Mandewo, Winnie; Nyathi, Khulamuzi; Sibanda, Edwin; Harries, Anthony D.			Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe	PLOS ONE			English	Article							EPIDEMIOLOGY STROBE STATEMENT; ANTIRETROVIRAL THERAPY; COMPLETION; GUIDELINES; BARRIERS; ADULTS; RISK	Setting Four primary health care clinics providing tuberculosis (TB) and Human Immunodeficiency Virus care services in Bulawayo, Zimbabwe. Objectives To assess isoniazid preventive therapy (IPT) initiation and completion, factors associated with IPT uptake and incidence of TB, and TB and antiretroviral treatment (ART) outcomes among people living with HIV (PLHIV). Design This was a cohort study using routine data in the records for PLHIV initiated on ART from October 2013 to March 2014 with 31 December 2017 as the end of the follow-up period. Results A total of 408 PLHIV were eligible for IPT, 214 (52%) were initiated on IPT and 201 (94%) completed IPT. No person in the IPT-initiated group developed Tuberculosis (TB). Six persons with TB were reported among the non-IPT-initiated group leading to an incidence of 9 cases/1,000 person -years of follow-up. About 70% of those who developed and were treated for TB had a successful TB treatment outcome. The survival on ART at four years of follow-up was 88% among the IPT-initiated PLHIV that was significantly higher than the 75% survival in the group not-initiated on IPT. Conclusion The study revealed low IPT initiation among eligible PLHIV who, if started on IPT, completed the six month regimen. TB was reported only among the PLHIV not-initiated on IPT and the four year ART survival was higher in the IPT-initiated group than in the non-initiated group. These findings reinforce the need to strengthen IPT uptake among PLHIV in Bulawayo.	[Nyathi, Saziso; Hove, Sithokozile; Nyathi, Khulamuzi; Sibanda, Edwin] Hlth Serv Dept, Bulawayo, Zimbabwe; [Dlodlo, Riitta A.; Satyanarayana, Srinath; Takarinda, Kudakwashe C.; Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Dlodlo, Riitta A.; Takarinda, Kudakwashe C.; Matambo, Ronnie] Int Union TB & Lung Dis Union, Harare, Zimbabwe; [Takarinda, Kudakwashe C.] Minist Hlth & Child Care, AIDS&TB Directorate, Harare, Zimbabwe; [Tweya, Hannock] Light House Trust, Lilongwe, Malawi; [Tweya, Hannock; Harries, Anthony D.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Mandewo, Winnie] Elizabeth Glaser Peadiatr AIDS Fdn, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine	Nyathi, S (corresponding author), Hlth Serv Dept, Bulawayo, Zimbabwe.	mangethesaziso75@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551; Nyathi, Saziso/0000-0003-1916-7313	United Kingdom's Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch; The Union; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	United Kingdom's Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch; The Union; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The program was funded by the United Kingdom's Department for International Development (DFID), UK, The Union and La Fondation Veuve Emile Metz-Tesch (Luxembourg). La Fondation Veuve Emile Metz-Tesch supported open access publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-281; [Anonymous], 2017, UNAIDS DAT 2017; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Harries AD, 2019, INT J TUBERC LUNG D, V23, P241, DOI 10.5588/ijtld.18.0207; Health Services Department-City of Bulawayo, 2017, HLTH SERV DEP CIT BU; Jacobson KB, 2017, AIDS CARE, V29, P936, DOI 10.1080/09540121.2017.1283390; Lai J, 2019, INT J TUBERC LUNG D, V23, P371, DOI 10.5588/ijtld.18.0378; Lewis JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081376; Maharaj B, 2017, INT J TUBERC LUNG D, V21, P537, DOI 10.5588/ijtld.16.0775; Makoni Annamercy, 2015, BMC Res Notes, V8, P476, DOI 10.1186/s13104-015-1451-y; Ministry of Health and Child Care, 2017, NAT TB LEPR GUID; National Medicines and Therapeutics Policy Advisory Committee And Ministry of Health and Child Care, 2016, GUID ANT THER PREV T; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Takarinda KC, 2017, PUBLIC HEALTH ACTION, V7, P55, DOI 10.5588/pha.16.0102; Takarinda KC, 2012, PUBLIC HEALTH ACTION, V2, P50, DOI 10.5588/pha.12.0011; Teklay G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3525-8; Thindwa D, 2018, INT J TUBERC LUNG D, V22, P273, DOI 10.5588/ijtld.17.0370; Thindwa D, 2018, INT J TUBERC LUNG DI; UNAIDS, 2020, GLOB HIV AIDS STAT F; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weldegebreal F, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.32.12554; World Health Organisation, 2012, WHO GUID INT TUB CAS; World Health Organisation, 2018, GLOB HLTH TB REP; World Health Organisation, 2015, ADV EV ASS US IS PRE; World Health Organization, 2017, GLOB TB REP; Zimbabwe National Statistical Agency, 2014, ZIMB NAT POP CENS RE	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223076	10.1371/journal.pone.0223076	http://dx.doi.org/10.1371/journal.pone.0223076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581271	gold, Green Published			2022-12-26	WOS:000532398600028
J	Wabner, D; Overhagebock, T; Nordmann, D; Kronenberg, J; Kramer, F; Schmitz, HP				Wabner, Dario; Overhageboeck, Tom; Nordmann, Doris; Kronenberg, Julia; Kramer, Florian; Schmitz, Hans-Peter			Analysis of the protein composition of the spindle pole body during sporulation in Ashbya gossypii	PLOS ONE			English	Article							PROSPORE MEMBRANE; ACTIN; YEAST; ORGANIZATION; MEIOSIS	The spores of fungi come in a wide variety of forms and sizes, highly adapted to the route of dispersal and to survival under specific environmental conditions. The ascomycete Ashbya gossypii produces needle shaped spores with a length of 30 pm and a diameter of 1 pm. Formation of these spores relies on actin and actin regulatory proteins and is, therefore, distinct from the minor role that actin plays for spore formation in Saccharomyces cerevisiae. Using in vivo FRET-measurements of proteins labeled with fluorescent proteins, we investigate how the formin AgBnr2, a protein that promotes actin polymerization, integrates into the structure of the spindle pole body during sporulation. We also investigate the role of the A. gossypii homologs to the S. cerevisiae meiotic outer plaque proteins Spo74, Mpc54 and Ady4 for sporulation in A. gossypii. We found highest FRET of AgBnr2 with AgSpo74. Further experiments indicated that AgSpo74 is a main factor for targeting AgBnr2 to the spindle pole body. In agreement with these results, the Agspo74 deletion mutant produces no detectable spores, whereas deletion of Agmpc54 only has an effect on spore length and deletion of Agady4 has no detectable sporulation phenotype. Based on this study and in relation to previous results we suggest a model where AgBnr2 resides within an analogous structure to the meiotic outer plaque of S. cerevisiae. There it promotes formation of actin cables important for shaping the needle shaped spore structure.	[Wabner, Dario; Overhageboeck, Tom; Nordmann, Doris; Kronenberg, Julia; Kramer, Florian; Schmitz, Hans-Peter] Univ Osnabruck, Dept Genet, Osnabruck, Germany	University Osnabruck	Schmitz, HP (corresponding author), Univ Osnabruck, Dept Genet, Osnabruck, Germany.	hans-peter.schmitz@biologie.uni-osnabrueck.de		Schmitz, Hans-Peter/0000-0001-5449-4593	Deutsche Forschungsgemeinschaft (DFG) [SCHM 2388/2-1]; Osnabruck University [SCHM 2388/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Osnabruck University	This work was supported by grant SCHM 2388/2-1 from the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Osnabruck University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant SCHM 2388/2-1 from the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Osnabruck University. We thank Sandra Bartels and Bernadette Sander-Turgut for excellent technical support, Lucille Schmieding for help with editing the manuscript and Jurgen J. Heinisch for constant support.	Anderson CA, 2015, MOL BIOL CELL, V26, P1129, DOI 10.1091/mbc.E14-09-1375; Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611; Bonomi M, 2014, MOL CELL PROTEOMICS, V13, P2812, DOI 10.1074/mcp.M114.040824; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Doyle A, 2009, J CELL SCI, V122, P4330, DOI 10.1242/jcs.055202; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002; Kemper M, 2011, MOL MICROBIOL, V80, P1276, DOI 10.1111/j.1365-2958.2011.07644.x; Kimura S, 2008, J GEN PLANT PATHOL, V74, P390, DOI 10.1007/s10327-008-0113-5; Knop M, 2000, EMBO J, V19, P3657, DOI 10.1093/emboj/19.14.3657; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Lickfeld M, 2012, MOL MICROBIOL, V85, P574, DOI 10.1111/j.1365-2958.2012.08128.x; Mathieson EM, 2010, MOL BIOL CELL, V21, P3693, DOI 10.1091/mbc.E10-07-0563; Mathieson EM, 2010, J CELL SCI, V123, P2481, DOI 10.1242/jcs.062794; MOENS PB, 1971, J CELL SCI, V9, P665; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nickas ME, 2003, EUKARYOT CELL, V2, P431, DOI 10.1128/EC.2.3.431-445.2003; Ohtaka A, 2007, EUKARYOT CELL, V6, P971, DOI 10.1128/EC.00016-07; R Core Team, 2018, R LANG ENV STAT COMP; R Core Team, 2016, RSTUD INT DEV R R FD; Sambrook J., 2001, MOL CLONING LAB MANU; Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Suda Y, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/fox095; Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x; Wasserstrom L, 2013, GENETICS, V195, P87, DOI 10.1534/genetics.113.151019; Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z; Yan HY, 2012, J CELL SCI, V125, P1429, DOI 10.1242/jcs.091561	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223374	10.1371/journal.pone.0223374	http://dx.doi.org/10.1371/journal.pone.0223374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581259	gold, Green Published, Green Submitted			2022-12-26	WOS:000532398600057
J	Zhao, Y; Zhang, Y; Mehdiabad, MV; Zhou, K; Chen, YY; Li, L; Guo, J; Xu, CR				Zhao, Ying; Zhang, Yu; Mehdiabad, Milad Vazirinejad; Zhou, Ke; Chen, Yuyuan; Li, Lei; Guo, Jun; Xu, Chuanrui			Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo	PLOS ONE			English	Article							KINASE INHIBITOR FASUDIL; DRUG; PHYSIOLOGY; THERAPY	Hepatocellular carcinoma (HCC) is one of the most malignant cancers and the treatment options for this disease are limited and generally not effective. ROCK has been reported to be highly expressed in many cancer types and its inhibitor Fasudil has shown anti-cancer potential. However, its high toxicity and low solubility restrict its clinical application. Here, we report that Fasudil is effective against HCC and that a liposomal formulation (Lip-Fasudil) can enhance the anti-tumor effects of this drug both in vitro and in vivo. In vitro, Fasudil inhibited HCC cell growth with IC50 values of 0.025-0.04 mu g/mu L, with Lip-Fasudil showing slightly improved cytotoxicity with IC50 values of 0.02-0.025 mu g/mu L. Cellular mechanistic analysis indicated that Fasudil induced cell cycle arrest at the G2/M phase and that Lip-Fasudil enhanced this effect. Intriguingly, no apoptosis was detected in Fasudil- or Lip-Fasudiltreated HCC cells. In vivo, Fasudil inhibited the growth of HCC xenografts by 23% in nude mice. However, Lip-fasudil exerted anti-tumor effects (57% tumor inhibition) that were superior to those of Fasudil and similar to those of Topotecan (66%). In addition, Lip-fasudil resulted in an increased distribution of Fasudil in tumor tissues but a reduced distribution in normal organs. In conclusion, our results proved that Fasudil has the potential to be used for HCC treatment and that a liposomal formulation (Lip-Fasudil) could enhance anti -tumor efficacy and reduce systemic toxicity.	[Zhao, Ying] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pharm, Wuhan, Peoples R China; [Zhang, Yu; Mehdiabad, Milad Vazirinejad; Zhou, Ke; Chen, Yuyuan; Li, Lei; Guo, Jun; Xu, Chuanrui] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guo, J; Xu, CR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan, Hubei, Peoples R China.	1270079810@qq.com; xcr@hust.edu.cn			National Science Foundation of China [81370058, 81572723, 81872253]; Natural Science Foundation of Hubei Province of China [2015CFB611]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was financially supported by the National Science Foundation of China (81370058 and 81572723 to Chuanrui Xu, and 81872253 to Lei Li) and Natural Science Foundation of Hubei Province of China (2015CFB611 to Ying Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hu LJ, 2016, FRONT MED-PRC, V10, P61, DOI 10.1007/s11684-016-0436-0; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Llovet JM, 2008, NEW ENGL J MED, V359, P4; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Nakashima S, 1998, NEUROL MED-CHIR, V38, P805, DOI 10.2176/nmc.38.805; Pan XQ, 2002, BLOOD, V100, P594, DOI 10.1182/blood.V100.2.594; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Peng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080145; SAKO K, 1991, EUR J PHARMACOL, V209, P39, DOI 10.1016/0014-2999(91)90008-E; Shi JJ, 2013, J CARDIOVASC PHARM, V62, P341, DOI 10.1097/FJC.0b013e3182a3718f; Spangenberg HC, 2009, NAT REV GASTRO HEPAT, V6, P423, DOI 10.1038/nrgastro.2009.86; Takanashi Y, 2001, J CLIN NEUROSCI, V8, P557, DOI 10.1054/jocn.2001.0998; TAKAYASU M, 1990, ACTA NEUROCHIR, V103, P67, DOI 10.1007/BF01420194; Takeba Y, 2012, CANCER CHEMOTH PHARM, V69, P1545, DOI 10.1007/s00280-012-1862-6; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Yang XY, 2010, BIOMED PHARMACOTHER, V64, P58, DOI 10.1016/j.biopha.2009.08.006; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223232	10.1371/journal.pone.0223232	http://dx.doi.org/10.1371/journal.pone.0223232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581236	Green Published, gold			2022-12-26	WOS:000532398600041
J	Han, SH; Kim, CO; Kim, KJ; Jeon, J; Chang, H; Kim, ES; Park, H				Han, Seung Hwan; Kim, Chang Oh; Kim, Kwang Joon; Jeon, Jeanhong; Chang, Hsienhao; Kim, Eun Seo; Park, Hoon			Quantitative analysis of the bilateral coordination and gait asymmetry using inertial measurement unit-based gait analysis	PLOS ONE			English	Article							WALKING SPEED; PARKINSONS-DISEASE; TREADMILL; YOUNG; VARIABILITY; RELIABILITY; FRACTURES; DYNAMICS	Inertial measurement unit (IMU)-based gait analysis can be used to quantitatively analyze the bilateral coordination and gait asymmetry (GA). The purpose of this study was to investigate changes in bilateral coordination and GA due to gait speed using an IMU based gait analysis and identify spatiotemporal factors affecting bilateral coordination and GA. Eighty healthy adults (40 men and 40 women) participated in the study. The mean age was 26.2 years, and the mean body mass index was 22.8 kg/m(2). Three different walking speeds (80%, 100%, and 120% of preferred walking speed) on a treadmill were applied for 1 min of continuous level walking using a shoe-type IMU-based gait analysis system. The phase coordination index (PCI) and GA were calculated on three different walking speeds. Several variables (gait speed, height, body mass index, cadence, and step length) were analyzed as possible factors affecting the PCI and GA. Bilateral coordination and GA improved during fast walking (p = 0.005 and p = 0.019, respectively) and deteriorated during slow walking (p<0.001 and p = 0.008, respectively), compared with the participants' preferred walking speeds. The correlation analysis revealed that PCI was negatively correlated with step length at each walking condition and lower gait speed was negatively correlated with PCI and GA during slow walking. Both bilateral coordination and GA had a negative linear relationship with gait speed, showing an improvement in the fast walking condition and deterioration in the slow walking condition. Step length was the factor associated with the change in the bilateral coordination.	[Han, Seung Hwan; Jeon, Jeanhong; Chang, Hsienhao; Kim, Eun Seo; Park, Hoon] Yonsei Univ, Dept Orthopaed Surg, Gangnam Severance Hosp, Coll Med, Seoul, South Korea; [Kim, Chang Oh; Kim, Kwang Joon] Yonsei Univ, Coll Med, Severance Hosp, Div Geriatr,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, H (corresponding author), Yonsei Univ, Dept Orthopaed Surg, Gangnam Severance Hosp, Coll Med, Seoul, South Korea.	hoondeng@yuhs.ac	PARK, HOON/O-8387-2018	PARK, HOON/0000-0002-8063-3742; CHANG, HSIENHAO/0000-0003-1858-5863; Kim, Chang Oh/0000-0002-0773-5443	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1934]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C1934). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; Almarwani M, 2016, ARCH GERONTOL GERIAT, V66, P54, DOI 10.1016/j.archger.2016.05.001; Anwary AR, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020676; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; Chiu SL, 2015, GAIT POSTURE, V41, P316, DOI 10.1016/j.gaitpost.2014.09.015; Choi JS, 2015, J BIOMECH, V48, P1336, DOI 10.1016/j.jbiomech.2015.02.047; Chung MJ, 2010, GAIT POSTURE, V31, P131, DOI 10.1016/j.gaitpost.2009.09.013; Elsoe R, 2017, INJURY, V48, P1657, DOI 10.1016/j.injury.2017.04.045; Esser P, 2012, J NEUROSCI METH, V205, P177, DOI 10.1016/j.jneumeth.2012.01.005; Gimmon Y, 2018, J AGING PHYS ACTIV, V26, P382, DOI 10.1123/japa.2017-0120; Gimmon Y, 2017, EXP BRAIN RES, V235, P3345, DOI 10.1007/s00221-017-5061-x; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Heredia-Jimenez J, 2016, GAIT POSTURE, V45, P41, DOI 10.1016/j.gaitpost.2016.01.008; Kodesh E, 2012, GAIT POSTURE, V35, P66, DOI 10.1016/j.gaitpost.2011.08.008; Kribus-Shmiel L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192049; Larsen P, 2017, GAIT POSTURE, V51, P47, DOI 10.1016/j.gaitpost.2016.09.027; Lee M, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0384-9; Malatesta D, 2017, EUR J APPL PHYSIOL, V117, P1833, DOI 10.1007/s00421-017-3672-3; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Mazza C, 2012, GAIT POSTURE, V35, P138, DOI 10.1016/j.gaitpost.2011.08.024; Murray M P, 1967, Am J Phys Med, V46, P290; Panebianco GP, 2018, GAIT POSTURE, V66, P76, DOI 10.1016/j.gaitpost.2018.08.025; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Plotnik M, 2013, GAIT POSTURE, V38, P864, DOI 10.1016/j.gaitpost.2013.04.011; Plotnik M, 2011, EXP BRAIN RES, V208, P169, DOI 10.1007/s00221-010-2469-y; Roche B, 2018, GAIT POSTURE, V66, P45, DOI 10.1016/j.gaitpost.2018.08.017; Taborri J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010066; Trojaniello D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-152; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Werner C, 2019, CLIN REHABIL, DOI [10.1177/0269215519852143:269215519852143, DOI 10.1177/0269215519852143:269215519852143]; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yoneyama M, 2013, IEEE T NEUR SYS REH, V21, P999, DOI 10.1109/TNSRE.2013.2268251	38	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222913	10.1371/journal.pone.0222913	http://dx.doi.org/10.1371/journal.pone.0222913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574130	Green Published, gold			2022-12-26	WOS:000532376700018
J	Lecarpentier, Y; Kindler, V; Bochaton-Piallat, ML; Sakic, A; Claes, V; Hebert, JL; Vallee, A; Schussler, O				Lecarpentier, Yves; Kindler, Vincent; Bochaton-Piallat, Marie-Luce; Sakic, Antonija; Claes, Victor; Hebert, Jean-Louis; Vallee, Alexandre; Schussler, Olivier			Tripeptide Arg-Gly-Asp (RGD) modifies the molecular mechanical properties of the non-muscle myosin IIA in human bone marrow-derived myofibroblasts seeded in a collagen scaffold	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GRANULATION-TISSUE; CONTRACTILE PROPERTIES; CROSS-BRIDGES; ADHESION; INTEGRINS; PEPTIDES; TENSION	Mesenchymal stem cells (MSCs) were obtained from human bone marrow and amplified in cultures supplemented with human platelet lysate in order to generate myofibroblasts. When MSCs were seeded in solid collagen scaffolds, they differentiated into myofibroblasts that were observed to strongly bind to the substrate, forming a 3D cell scaffold network that developed tension and shortening after KCI stimulation. Moreover, MSC-laden scaffolds recapitulated the Frank-Starling mechanism so that active tension increased in response to increases in the initial length of the contractile system. This constituted a bioengineering tissue that exhibited the contractile properties observed in both striated and smooth muscles. By using the A. F. Huxley formalism, we determined the myosin cross bridge (CB) kinetics of attachment (f1) and detachment (g1 and g2), maximum myosin ATPase activity, molar myosin concentration, unitary CB force and maximum CB efficiency. CB kinetics were dramatically slow, characterizing the non-muscle myosin type IIA (NMMIIA) present in myofibroblasts. When MSCs were seeded in solid collagen scaffolds functionalized with Arg-Gly-Asp (RGD), contractility increased and CB kinetics were modified, whereas the unitary NMMIIA-CB force and maximum CB efficiency did not change. In conclusion, we provided a non-muscle bioengineering tissue whose molecular mechanical characteristics of NMMIIA were very close to those of a non-muscle contractile tissue such as the human placenta.	[Lecarpentier, Yves] Grand Hop Est Francilien, Ctr Rech Clin, Meaux, France; [Kindler, Vincent] Geneva Univ Hosp, Switzerland Fac Med, Dept Specialties Med, Hematol Serv, Geneva, Switzerland; [Bochaton-Piallat, Marie-Luce; Sakic, Antonija] Ctr Med Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Claes, Victor] Univ Antwerp, Dept Pharmaceut Sci, Antwerp, Belgium; [Hebert, Jean-Louis] Hop La Pitie Salpetriere, Inst Cardiol, Paris, France; [Vallee, Alexandre] Paris Descartes Univ, Diag & Therapeut Ctr, Hotel Dieu Hosp, Hypertens & Cardiovasc Prevent Unit, Paris, France; [Vallee, Alexandre] Hop Foch, DRCI Delegat Rech Clin & Ind, Suresnes, France; [Schussler, Olivier] Geneva Univ Hosp, Dept Cardiovasc Surg, Res Lab, Geneva, Switzerland	University of Geneva; University of Geneva; University of Antwerp; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; University of Geneva	Lecarpentier, Y (corresponding author), Grand Hop Est Francilien, Ctr Rech Clin, Meaux, France.	yves.c.lecarpentier@gmail.com		Bochaton-Piallat, Marie-Luce/0000-0001-8408-8932; Kindler, Vincent/0000-0002-5349-1857				BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; BEER JH, 1992, BLOOD, V79, P117; Bharadwaj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14348; Conti M, 2014, EJNMMI PHYS, V1, DOI 10.1186/2197-7364-1-11; CRAIG WS, 1995, BIOPOLYMERS, V37, P157, DOI 10.1002/bip.360370209; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Farley AE, 2004, AM J PHYSIOL-REG I, V287, pR680, DOI 10.1152/ajpregu.00222.2004; FELLER AC, 1985, PLACENTA, V6, P405, DOI 10.1016/S0143-4004(85)80017-5; Frank O., 1895, Z BIOL-MUNICH, V32, P273; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HILL AV, 1951, NATURE, V167, P377, DOI 10.1038/167377a0; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, J PHYSIOL-LONDON, V218, pP59; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRANTZ KE, 1963, CLIN OBSTET GYNECOL, V6, P26, DOI 10.1097/00003081-196303000-00003; Lecarpentier E, 2013, PLACENTA, V34, P1163, DOI 10.1016/j.placenta.2013.10.007; Lecarpentier Y, 2005, J THEOR BIOL, V235, P381, DOI 10.1016/j.jtbi.2005.01.018; Lecarpentier Y, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/6134787; Lecarpentier Y, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19100558; Lecarpentier Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108814; Matsumura S, 2011, PLACENTA, V32, P347, DOI 10.1016/j.placenta.2011.02.008; Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schussler O, 2009, NAT CLIN PRACT CARD, V6, P240, DOI 10.1038/ncpcardio1451; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sheterline P, 1996, PROTEIN PROFILE; Starling E., 1897, LANCET, V149, P569; Starling E. H., 1918, LINACRE LECT LAW HEA; Tomasek JJ, 2006, WOUND REPAIR REGEN, V14, P313, DOI 10.1111/j.1743-6109.2006.00126.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VALLEE A, 2017, FRONT PHYSIOL, V8, P4346, DOI DOI 10.11131/2017/101299; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; VEECH RL, 1979, J BIOL CHEM, V254, P6538	46	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222683	10.1371/journal.pone.0222683	http://dx.doi.org/10.1371/journal.pone.0222683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574082	Green Published, gold			2022-12-26	WOS:000532376700010
J	Senger, RS; Kavuru, V; Sullivan, M; Gouldin, A; Lundgren, S; Merrifield, K; Steen, C; Baker, E; Vu, T; Agnor, B; Martinez, G; Coogan, H; Carswell, W; Karageorge, L; Dev, D; Du, P; Sklar, A; Orlando, G; Pirkle, J; Robertson, JL				Senger, Ryan S.; Kavuru, Varun; Sullivan, Meaghan; Gouldin, Austin; Lundgren, Stephanie; Merrifield, Kristen; Steen, Caitlin; Baker, Emily; Vu, Tommy; Agnor, Ben; Martinez, Gabrielle; Coogan, Hana; Carswell, William; Karageorge, Lampros; Dev, Devasmita; Du, Pang; Sklar, Allan; Orlando, Giuseppe; Pirkle, James, Jr.; Robertson, John L.			Spectral characteristics of urine specimens from healthy human volunteers analyzed using Raman chemometric urinalysis (Rametrix)	PLOS ONE			English	Article							ESCHERICHIA-COLI	Raman chemometric urinalysis (Rametrix (TM)) was used to analyze 235 urine specimens from healthy individuals. The purpose of this study was to establish the "range of normal" for Raman spectra of urine specimens from healthy individuals. Ultimately, spectra falling outside of this range will be correlated with kidney and urinary tract disease. Rametrix (TM) analysis includes direct comparisons of Raman spectra but also principal component analysis (PCA), discriminant analysis of principal components (DAPC) models, multivariate statistics, and it is available through GitHub as the Rametrix (TM) LITE Toolbox for MATLAB (R). Results showed consistently overlapping Raman spectra of urine specimens with significantly larger variances in Raman shifts, found by PCA, corresponding to urea, creatinine, and glucose concentrations. A 2-way ANOVA test found that age of the urine specimen donor was statistically significant (p < 0.001) and donor sex (female or male identification) was less so (p = 0.0526). With DAPC models and blind leave-one-out build/test routines using the Rametrix (TM) PRO Toolbox (also available through GitHub), an accuracy of 71% (sensitivity = 72%; specificity = 70%) was obtained when predicting whether a urine specimen from a healthy unknown individual was from a female or male donor. Finally, from female and male donors (n = 4) who contributed first morning void urine specimens each day for 30 days, the co-occurrence of menstruation was found statistically insignificant to Rametrix (TM) results (p = 0.695). In addition, Rametrix (TM) PRO was able to link urine specimens with the individual donor with an average of 78% accuracy. Taken together, this study established the range of Raman spectra that could be expected when obtaining urine specimens from healthy individuals and analyzed by RametrixT and provides the methodology for linking results with donor characteristics.	[Senger, Ryan S.; Sullivan, Meaghan; Gouldin, Austin; Lundgren, Stephanie; Merrifield, Kristen; Steen, Caitlin; Baker, Emily; Agnor, Ben; Martinez, Gabrielle; Coogan, Hana; Carswell, William] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Senger, Ryan S.; Vu, Tommy] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA; [Senger, Ryan S.; Robertson, John L.] DialySenors Inc, Blacksburg, VA 24060 USA; [Kavuru, Varun; Karageorge, Lampros; Dev, Devasmita; Robertson, John L.] Vet Affairs Med Ctr, Salem, VA USA; [Du, Pang] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Sklar, Allan] Lewis Gale Med Ctr, Salem, VA USA; [Orlando, Giuseppe] Wake Forest Univ, Baptist Med Ctr, Dept Surg Sci Transplant, Winston Salem, NC 27101 USA; [Pirkle, James, Jr.] Wake Forest Univ, Baptist Med Ctr, Dept Internal Med Nephrol, Winston Salem, NC 27101 USA; [Robertson, John L.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Robertson, John L.] Virginia Tech Carilion Sch Med, Blacksburg, VA USA; [Robertson, John L.] Res Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Salem Veterans Affairs Medical Center; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University	Senger, RS (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.; Senger, RS (corresponding author), Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA.; Senger, RS (corresponding author), DialySenors Inc, Blacksburg, VA 24060 USA.	senger@vt.edu		Martinez, Gabrielle/0000-0001-7538-318X; Kavuru, Varun/0000-0001-8792-8044	Center for Innovative Technology [CP15015-LS]; Virginia Tech Foundation; HATCH [VA-160057]	Center for Innovative Technology; Virginia Tech Foundation; HATCH(United States Department of Agriculture (USDA))	This research was funded in part by the Center for Innovative Technology (award CP15015-LS), the Virginia Tech Foundation, and HATCH (project VA-160057). These funders provided support in salaries for authors (RSS) and materials. They had no role in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. RSS and JLR are unsalaried co-founders of DialySensors, Inc., which was involved with study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Athamneh AIM, 2014, ANTIMICROB AGENTS CH, V58, P1302, DOI 10.1128/AAC.02098-13; Athamneh AIM, 2012, APPL ENVIRON MICROB, V78, P7805, DOI 10.1128/AEM.02000-12; Bennett MR, 2017, BIOMARKERS OF KIDNEY DISEASE, 2ND EDITION, P1, DOI 10.1016/B978-0-12-803014-1.00001-7; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Christians U, 2011, BIOMARKERS OF KIDNEY DISEASE, P101, DOI 10.1016/B978-0-12-375672-5.10004-0; Edelstein C., 2017, BIOMARKERS KIDNEY DI; Fisher AK, 2018, J RAMAN SPECTROSC, V49, P885, DOI 10.1002/jrs.5348; Gardiner D., 1989, PRACTICAL RAMAN SPEC; Liu JT, 2015, APPL SPECTROSC, V69, P834, DOI 10.1366/14-07798; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Prakoura N, 2017, CELL MOL LIFE SCI, V74, P4315, DOI 10.1007/s00018-017-2650-6; Reichel RR, 2014, OCHSNER J, V14, P359; Senger R, 2019, PEER J; Shardlow A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002400; Zu TNK, 2015, J RAMAN SPECTROSC, V46, P551, DOI 10.1002/jrs.4688; Zu TNK, 2014, J BACTERIOL, V196, P3983, DOI 10.1128/JB.01590-14	16	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222115	10.1371/journal.pone.0222115	http://dx.doi.org/10.1371/journal.pone.0222115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560690	gold, Green Published			2022-12-26	WOS:000532353700007
J	Chen, JJ; Nathaniel, DL; Raghavan, P; Nelson, M; Tian, RL; Tse, E; Hong, JY; See, SK; Mok, SA; Hein, MY; Southworth, DR; Grinberg, LT; Gestwicki, JE; Leonetti, MD; Kampmann, M				Chen, John J.; Nathaniel, Diane L.; Raghavan, Preethi; Nelson, Maxine; Tian, Ruilin; Tse, Eric; Hong, Jason Y.; See, Stephanie K.; Mok, Sue-Ann; Hein, Marco Y.; Southworth, Daniel R.; Grinberg, Lea T.; Gestwicki, Jason E.; Leonetti, Manuel D.; Kampmann, Martin			Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEUROPATHOLOGIC CRITERIA; FRONTOTEMPORAL DEMENTIA; NATIONAL INSTITUTE; PLATFORM; PROTEIN; CHMP2B; TRAFFICKING; DIAGNOSIS; CONSENSUS	Intercellular propagation of protein aggregation is emerging as a key mechanism in the progression of several neurodegenerative diseases, including Alzheimer's disease and frontotemporal dementia ( FTD). However, we lack a systematic understanding of the cellular pathways controlling prion- like propagation of aggregation. To uncover such pathways, here we performed CRISPR interference (CRISPRi) screens in a human cell- based model of propagation of tau aggregation monitored by FRET. Our screens uncovered that knockdown of several components of the endosomal sorting complexes required for transport (ESCRT) machinery, including charged multivesicular body protein 6 (CHMP6), or CHMP2A in combination with CHMP2B (whose gene is linked to familial FTD), promote propagation of tau aggregation. We found that knocking down the genes encoding these proteins also causes damage to endolysosomal membranes, consistent with a role for the ESCRT pathway in endolysosomal membrane repair. Leakiness of the endolysosomal compartment significantly enhanced prion-like propagation of tau aggregation, likely by making tau seeds more available to pools of cytoplasmic tau. Together, these findings suggest that endolysosomal escape is a critical step in tau propagation in neurodegenerative diseases.	[Chen, John J.; Nathaniel, Diane L.; Nelson, Maxine; Tian, Ruilin; Tse, Eric; Hong, Jason Y.; See, Stephanie K.; Mok, Sue-Ann; Hein, Marco Y.; Southworth, Daniel R.; Gestwicki, Jason E.; Kampmann, Martin] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA; [Nelson, Maxine] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Tian, Ruilin] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94158 USA; [See, Stephanie K.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Hein, Marco Y.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hein, Marco Y.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Southworth, Daniel R.; Kampmann, Martin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Raghavan, Preethi; Leonetti, Manuel D.; Kampmann, Martin] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Mok, Sue-Ann] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Alberta	Kampmann, M (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	martin.kampmann@ucsf.edu	Hein, Marco/C-2994-2014; chen, JJ/HGB-6029-2022	Hein, Marco/0000-0002-9490-2261; Tian, Ruilin/0000-0001-7680-6682; Mok, Sue-Ann/0000-0003-4593-3368; Nelson, Maxine/0000-0003-1990-5099; Raghavan, Preethi/0000-0003-4340-3777	National Institutes of Health New Innovator Award [DP2 GM119139, R01 AG062359, R56 AG057528, U54 NS100717, S10 OD021741, R01 NS059690, P30 CA082103, P01AG019724, P50AG023501]; Paul G. Allen Distinguished Investigator Award; Tau Consortium; Chan Zuckerberg Biohub Investigator Award; Consortium for Frontotemporal Dementia Research (UCSF Neurodegenerative Disease Brain Bank); QB3/Calico Longevity Postdoctoral Fellowship; Alzheimer's Association Postdoctoral Fellowship; National Defense Science& Engineering Graduate Fellowship; EMBO long-term postdoctoral fellowship [ALTF 1193-2015]; NATIONAL INSTITUTE ON AGING [R01AG062359] Funding Source: NIH RePORTER	National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Distinguished Investigator Award; Tau Consortium; Chan Zuckerberg Biohub Investigator Award; Consortium for Frontotemporal Dementia Research (UCSF Neurodegenerative Disease Brain Bank); QB3/Calico Longevity Postdoctoral Fellowship; Alzheimer's Association Postdoctoral Fellowship; National Defense Science& Engineering Graduate Fellowship; EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health New Innovator Award Grant DP2 GM119139 (to M. K.), R01 AG062359 (to M. K.), R56 AG057528 (to M. K. and L. T. G.), U54 NS100717 (to M. K.), S10 OD021741 (supporting electron microscopy), R01 NS059690 (to J. E. G.), P30 CA082103 (supporting the UCSF Laboratory for Cell Analysis), P01AG019724 and P50AG023501 (supporting the UCSF Neurodegenerative Disease Brain Bank), a Paul G. Allen Distinguished Investigator Award (to M. K.), a Chan Zuckerberg Biohub Investigator Award (to M. K.), the Tau Consortium (to M. K., L. T. G., J. E. G. and the UCSF Neurodegenerative Disease Brain Bank), the Consortium for Frontotemporal Dementia Research (UCSF Neurodegenerative Disease Brain Bank), a QB3/Calico Longevity Postdoctoral Fellowship (to J. J. C.), an Alzheimer's Association Postdoctoral Fellowship (to J. J. C.), a National Defense Science& Engineering Graduate Fellowship (to S. K. S.), and anEMBO long-term postdoctoral fellowship ALTF 1193-2015 (to M. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Baughman HER, 2018, J BIOL CHEM, V293, P2687, DOI 10.1074/jbc.M117.803411; Bejanin A, 2017, BRAIN, V140, P3286, DOI 10.1093/brain/awx243; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Clayton EL, 2015, ACTA NEUROPATHOL, V130, P511, DOI 10.1007/s00401-015-1475-3; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hu YB, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0041-1; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Kampmann M, 2018, ACS CHEM BIOL, V13, P406, DOI 10.1021/acschembio.7b00657; Kampmann M, 2017, TRENDS MOL MED, V23, P483, DOI 10.1016/j.molmed.2017.04.003; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kumar N, 2018, J CELL BIOL, V217, P3625, DOI 10.1083/jcb.201807019; Kundel F, 2018, ACS CHEM BIOL, V13, P636, DOI 10.1021/acschembio.7b01039; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Mastop M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12212-x; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Muller-Kuller U, 2015, NUCLEIC ACIDS RES, V43, P1577, DOI 10.1093/nar/gkv019; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schreij AMA, 2016, CELL MOL LIFE SCI, V73, P1529, DOI 10.1007/s00018-015-2105-x; Seong E, 2018, ANN NEUROL, V83, P1075, DOI 10.1002/ana.25220; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Skowyra ML, 2018, SCIENCE, V360, P49, DOI 10.1126/science.aar5078; Small SA, 2017, TRENDS NEUROSCI, V40, P592, DOI 10.1016/j.tins.2017.08.003; Stohr J, 2017, NAT CHEM, V9, P874, DOI [10.1038/NCHEM.2754, 10.1038/nchem.2754]; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Tartaglia MC, 2010, ACTA NEUROPATHOL, V119, P365, DOI 10.1007/s00401-009-0605-1; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Tian RL, 2019, NEURON, V104, P239, DOI 10.1016/j.neuron.2019.07.014; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; Vaquer-Alicea J, 2019, ANNU REV BIOCHEM, V88, P785, DOI 10.1146/annurev-biochem-061516-045049; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Yan X, 2018, CELL DEV BIOL, V2018; Yeshaw WM, 2019, ELIFE, V8, DOI 10.7554/eLife.43561; Young ZT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024612; ZHOU XH, 1994, BBA-BIOMEMBRANES, V1189, P195, DOI 10.1016/0005-2736(94)90066-3	70	50	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					18952	18966		10.1074/jbc.RA119.009432	http://dx.doi.org/10.1074/jbc.RA119.009432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31578281	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000516527800001
J	Charsar, BA; Brinton, MA; Locke, K; Chen, AY; Ghosh, B; Urban, MW; Komaravolu, S; Krishnamurthy, K; Smit, R; Pasinelli, P; Wright, MC; Smith, GM; Lepore, AC				Charsar, Brittany A.; Brinton, Michael A.; Locke, Katherine; Chen, Anna Y.; Ghosh, Biswarup; Urban, Mark W.; Komaravolu, Sreeya; Krishnamurthy, Karthik; Smit, Rupert; Pasinelli, Piera; Wright, Megan C.; Smith, George M.; Lepore, Angelo C.			AAV2-BDNF promotes respiratory axon plasticity and recovery of diaphragm function following spinal cord injury	FASEB JOURNAL			English	Article						SCI; cervical; phrenic; sprouting	PHRENIC MOTONEURONS; NEUROTROPHIC FACTOR; SYNAPTIC-TRANSMISSION; BDNF; DEGENERATION; INTERNEURONS; REGENERATION; FACILITATION; MODULATION; INHIBITORS	More than half of spinal cord injury (SCI) cases occur in the cervical region, leading to respiratory dysfunction due to damaged neural circuitry that controls critically important muscles such as the diaphragm. The C3-C5 spinal cord is the location of phrenic motor neurons (PhMNs) that are responsible for diaphragm activation; PhMNs receive bulbospinal excitatory drive predominately from supraspinal neurons of the rostral ventral respiratory group (rVRG). Cervical SCI results in rVRG axon damage, PhMN denervation, and consequent partial-to-complete paralysis of hemidiaphragm. In a rat model of C2 hemisection SCI, we expressed the axon guidance molecule, brain-derived neurotrophic factor (BDNF), selectively at the location of PhMNs (ipsilateral to lesion) to promote directed growth of rVRG axons toward PhMN targets by performing intraspinal injections of adeno-associated virus serotype 2 (AAV2)-BDNF vector. AAV2-BDNF promoted significant functional diaphragm recovery, as assessed by in vivo electromyography. Within the PhMN pool ipsilateral to injury, AAV2-BDNF robustly increased sprouting of both spared contralateral-originating rVRG axons and serotonergic fibers. Furthermore, AAV2-BDNF significantly increased numbers of putative monosynaptic connections between PhMNs and these sprouting rVRG and serotonergic axons. These findings show that targeting circuit plasticity mechanisms involving the enhancement of synaptic inputs from spared axon populations is a powerful strategy for restoring respiratory function post-SCI.	[Charsar, Brittany A.; Brinton, Michael A.; Locke, Katherine; Chen, Anna Y.; Ghosh, Biswarup; Urban, Mark W.; Komaravolu, Sreeya; Lepore, Angelo C.] Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Vickie & Jack Farber Inst Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA; [Krishnamurthy, Karthik; Pasinelli, Piera] Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Jefferson Weinberg Amyotrophic Late, Philadelphia, PA 19107 USA; [Smit, Rupert; Smith, George M.] Temple Univ, Lewis Katz Sch Med, Shriners Hosp Pediat Res Ctr, Dept Anat & Cell Biol,Dept Neurosci, Philadelphia, PA 19122 USA; [Wright, Megan C.] Arcadia Univ, Dept Biol, Philadelphia, PA USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Lepore, AC (corresponding author), Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Vickie & Jack Farber Inst Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA.	angelo.lepore@jefferson.edu	Krishnamurthy, Karthik/W-2306-2017	Krishnamurthy, Karthik/0000-0003-2552-8912; Pasinelli, Piera/0000-0002-3385-2707	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) [2R01NS079702, 1F30NS103436]; Craig H. Neilsen Foundation [476686]; Shriners Hospitals for Children Viral Core Grant [SHC 84051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS103436, R01NS079702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS); Craig H. Neilsen Foundation; Shriners Hospitals for Children Viral Core Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Rich Smeyne (Thomas Jefferson University) for sharing his expertise in 2-dimensional stereology counting techniques, and for his help with implementing these methods, and Dr. Robert Sterling (Thomas Jefferson University) for his patience and assistance with statistical analysis. This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS; 2R01NS079702 to A.C.L. and 1F30NS103436 to B.A.C.), the Craig H. Neilsen Foundation (476686 to A.C.L.), and the Shriners Hospitals for Children Viral Core Grant SHC 84051 (to G.M.S.). The authors declare no conflicts of interest.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; CastroMoure F, 1997, EXP NEUROL, V147, P299, DOI 10.1006/exnr.1997.6615; Ciesielska A, 2011, MOL THER, V19, P922, DOI 10.1038/mt.2010.248; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Desai NS, 1999, LEARN MEMORY, V6, P284; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; DiPasquale E, 1997, NEUROSCI LETT, V230, P29, DOI 10.1016/S0304-3940(97)00469-2; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; ELLENBERGER HH, 1990, J COMP NEUROL, V302, P707, DOI 10.1002/cne.903020403; ELLENBERGER HH, 1988, J COMP NEUROL, V269, P47, DOI 10.1002/cne.902690104; Ghosh B, 2018, J NEUROSCI, V38, P5982, DOI 10.1523/JNEUROSCI.3084-17.2018; Gill LC, 2016, RESP PHYSIOL NEUROBI, V226, P128, DOI 10.1016/j.resp.2015.10.009; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; GOSHGARIAN HG, 1991, EXP NEUROL, V111, P135, DOI 10.1016/0014-4886(91)90061-G; Gransee HM, 2015, J NEUROTRAUM, V32, P185, DOI 10.1089/neu.2014.3464; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hernandez-Torres V, 2017, J NEUROPHYSIOL, V117, P537, DOI 10.1152/jn.00654.2016; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Lane MA, 2008, TRENDS NEUROSCI, V31, P538, DOI 10.1016/j.tins.2008.07.002; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; LEWIS LJ, 1951, AM J PHYSIOL, V166, P241, DOI 10.1152/ajplegacy.1951.166.2.241; Li K, 2015, EXP NEUROL, V271, P479, DOI 10.1016/j.expneurol.2015.07.020; Li K, 2015, MOL THER, V23, P533, DOI 10.1038/mt.2014.236; LINDSAY AD, 1993, J PHYSIOL-LONDON, V461, P213, DOI 10.1113/jphysiol.1993.sp019510; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095043, 10.1371/journal.pone.0086026]; Luo XT, 2012, INT REV NEUROBIOL, V105, P141, DOI 10.1016/B978-0-12-398309-1.00008-1; MacFarlane PM, 2009, J PHYSIOL-LONDON, V587, P5469, DOI 10.1113/jphysiol.2009.176982; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; Mantilla CB, 2009, J NEUROSCI METH, V182, P244, DOI 10.1016/j.jneumeth.2009.06.016; Martin M., 2015, JOVE-J VIS EXP, V99; Miletic G, 2002, NEUROSCI LETT, V319, P137, DOI 10.1016/S0304-3940(01)02576-9; MORENO DE, 1992, EXP NEUROL, V116, P219, DOI 10.1016/0014-4886(92)90001-7; Nicaise C, 2013, J NEUROTRAUM, V30, P1092, DOI 10.1089/neu.2012.2728; Nicaise C, 2012, J NEUROTRAUM, V29, P2748, DOI 10.1089/neu.2012.2467; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pezet S, 2002, MOL CELL NEUROSCI, V21, P51, DOI 10.1006/mcne.2002.1166; Porter W T, 1895, J Physiol, V17, P455; Quraishe S, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2952386; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Satkunendrarajah K, 2018, NATURE, V562, P419, DOI 10.1038/s41586-018-0595-z; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schizas N, 2018, CELL TISSUE RES, V372, P493, DOI 10.1007/s00441-018-2808-z; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Takeuchi T, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/7514681; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tosolini AP, 2012, NEUROSCIENCE, V200, P19, DOI 10.1016/j.neuroscience.2011.10.054; Urban MW, 2018, EXP NEUROL, V303, P108, DOI 10.1016/j.expneurol.2018.02.007; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zholudeva LV, 2017, J NEUROTRAUM, V34, P3058, DOI 10.1089/neu.2017.5045; Zimmer MB, 2007, J SPINAL CORD MED, V30, P319, DOI 10.1080/10790268.2007.11753947	65	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13775	13793		10.1096/fj.201901730R	http://dx.doi.org/10.1096/fj.201901730R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31577916	Bronze, Green Published			2022-12-26	WOS:000507466100057
J	Royal, JM; Oh, YJ; Grey, MJ; Lencer, WI; Ronquillo, N; Galandiuk, S; Matoba, N				Royal, Joshua M.; Oh, Young Jun; Grey, Michael J.; Lencer, Wayne I.; Ronquillo, Nemencio; Galandiuk, Susan; Matoba, Nobuyuki			A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response	FASEB JOURNAL			English	Article						TGF-beta; epithelial restitution; wound healing; IBD	ENDOPLASMIC-RETICULUM STRESS; INFLAMMATORY-BOWEL-DISEASE; QUALITY-CONTROL; MESENCHYMAL TRANSITION; CLINICAL-IMPLICATIONS; GASTRIC-MUCOSA; COLITIS; RESTITUTION; BINDING; SPECIFICITY	Cholera toxin B subunit (CTB) exhibits broad-spectrum biologic activity upon mucosal administration. Here, we found that a recombinant CTB containing an endoplasmic reticulum (ER) retention motif (CTB-KDEL) induces colon epithelial wound healing in colitis via the activation of an unfolded protein response (UPR) in colon epithelial cells. In a Caco2 cell wound healing model, CTB-KDEL, but not CTB or CTB-KDE, facilitated cell migration via interaction with the KDEL receptor, localization in the ER, UPR activation, and subsequent TGF-beta signaling. Inhibition of the inositol-requiring enzyme 1/X-box binding protein 1 arm of UPR abolished the cell migration effect of CTB-KDEL, indicating that the pathway is indispensable for the activity. CTB-KDEL's capacity to induce UPR and epithelial restitution or wound healing was corroborated in a dextran sodium sulfate-induced acute colitis mouse model. Furthermore, CTB-KDEL induced a UPR, up-regulated wound healing pathways, and maintained viable crypts in colon explants from patients with inflammatory bowel disease (IBD). In summary, CTB-KDEL exhibits unique wound healing effects in the colon that are mediated by its localization to the ER and subsequent activation of UPR in epithelial cells. The results provide implications for a novel therapeutic approach for mucosal healing, a significant unmet need in IBD treatment.	[Royal, Joshua M.; Oh, Young Jun; Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr,Ctr Predict Med, Louisville, KY 40292 USA; [Ronquillo, Nemencio] Univ Louisville, Sch Med, Dept Pathol & Lab Med, Div Anat Pathol, Louisville, KY 40292 USA; [Grey, Michael J.; Lencer, Wayne I.] Boston Childrens Hosp, Div Gastroenterol Nutr & Hepatol, Boston, MA USA; [Grey, Michael J.; Lencer, Wayne I.] Harvard Med Sch, Harvard Digest Dis Ctr, Dept Pediat, Boston, MA 02115 USA; [Galandiuk, Susan] Univ Louisville, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Louisville	Matoba, N (corresponding author), Univ Louisville, Sch Med, 505 S Hancock St,Room 615, Louisville, KY 40202 USA.	n.matoba@louisville.edu		Matoba, Nobuyuki/0000-0001-7231-3004; Lencer, Wayne/0000-0001-7346-2730	Helmsley Charitable Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048106] Funding Source: NIH RePORTER	Helmsley Charitable Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Chi Li (University Louisville) for technical advice on KDELR and endoplasmic reticulum immunofluorescence staining. The authors are also grateful to Dr. Brian Ceresa and Jamie Rush (University of Louisville) for technical expertise on the proximity ligation assay. This work was supported by the Helmsley Charitable Trust Fund. J.M.R. and N.M. filed a patent application pertinent to the findings in this manuscript (PCT/US2016/040041). The remaining authors declare no conflicts of interest.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Bagchi S, 2015, METHODS MOL BIOL, V1318, P149, DOI 10.1007/978-1-4939-2742-5_15; Baldauf KJ, 2017, MUCOSAL IMMUNOL, V10, P887, DOI 10.1038/mi.2016.95; Becker B, 2016, SCI REP-UK, V6, DOI 10.1038/srep28940; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boirivant M, 2001, J IMMUNOL, V166, P3522, DOI 10.4049/jimmunol.166.5.3522; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Chusri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22487; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174; Coccia EM, 2005, GUT, V54, P1558, DOI 10.1136/gut.2004.062174; CUATRECASAS P, 1973, BIOCHEMISTRY-US, V12, P3547, DOI 10.1021/bi00742a031; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; Dawson RM, 2005, J APPL TOXICOL, V25, P30, DOI 10.1002/jat.1015; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dionne S, 1998, CLIN EXP IMMUNOL, V112, P435; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Ferrari L, 2016, WORLD J GASTRO SURG, V8, P363, DOI 10.4240/wjgs.v8.i5.363; Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031; Geiger R, 2013, TRAFFIC, V14, P36, DOI 10.1111/tra.12018; Hamorsky K, 2016, METHODS MOL BIOL, V1404, P511, DOI 10.1007/978-1-4939-3389-1_33; Hamorsky KT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08003; Hamorsky KT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002046; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; LACY ER, 1984, LAB INVEST, V51, P573; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Matsuzaki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123578; McCaffrey K, 2016, ESSAYS BIOCHEM, V60, P227, DOI 10.1042/EBC20160003; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moore L, 2016, METHODS MOL BIOL, V1385, P129, DOI 10.1007/978-1-4939-3289-4_9; Okamoto R, 2016, J GASTROENTEROL, V51, P11, DOI 10.1007/s00535-015-1098-4; Orlando A, 2013, DIGEST LIVER DIS, V45, P986, DOI 10.1016/j.dld.2013.07.005; Park HJ, 2015, TISSUE ENG PT A, V21, P1982, DOI [10.1089/ten.tea.2014.0687, 10.1089/ten.TEA.2014.0687]; Randall KJ, 2011, CELL BIOL TOXICOL, V27, P267, DOI 10.1007/s10565-011-9187-5; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Royal JM, 2017, TOXINS, V9, DOI 10.3390/toxins9120379; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Siyan S, 2012, INFLAMM BOWEL DIS, V18, P1735, DOI 10.1002/ibd.22878; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Tarnawski AS, 2018, WORLD J GASTROENTERO, V24, P4721, DOI 10.3748/wjg.v24.i42.4721; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Vaughn Byron P, 2014, Curr Treat Options Gastroenterol, V12, P103, DOI 10.1007/s11938-013-0008-1; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang JM, 2017, DIABETES, V66, P177, DOI 10.2337/db16-0052; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhang LL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-29; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]	70	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13527	13545		10.1096/fj.201901255R	http://dx.doi.org/10.1096/fj.201901255R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560862	Green Published, hybrid			2022-12-26	WOS:000507466100039
J	Merriman, C; Fu, D				Merriman, Chengfeng; Fu, Dax			Down-regulation of the islet-specific zinc transporter-8 (ZnT8) protects human insulinoma cells against inflammatory stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; Type 1 diabetes; Type 2 diabetes; unfolded protein response (UPR); insulin; inflammation; endoplasmic reticulum stress (ER stress); cytokine; transport; transport metal; pancreatic beta-cells; solute carrier family 30 member 8; ZnT8; transporter	PANCREATIC BETA-CELLS; GLUCOSE-HOMEOSTASIS; FATTY-ACIDS; TYPE-1; RISK; GLUCOLIPOTOXICITY; AUTOANTIGEN; EXPRESSION; SLC30A8; SURFACE	Zinc transporter-8 (ZnT8) primarily functions as a zinc-sequestrating transporter in the insulin-secretory granules (ISGs) of pancreatic ?-cells. Loss-of-function mutations in ZnT8 are associated with protection against type-2 diabetes (T2D), but the protective mechanism is unclear. Here, we developed an in-cell ZnT8 assay to track endogenous ZnT8 responses to metabolic and inflammatory stresses applied to human insulinoma EndoC-?H1 cells. Unexpectedly, high glucose and free fatty acids did not alter cellular ZnT8 levels, but proinflammatory cytokines acutely, reversibly, and gradually down-regulated ZnT8. Approximately 50% of the cellular ZnT8 was localized to the endoplasmic reticulum (ER), which was the primary target of the cytokine-mediated ZnT8 down-regulation. Transcriptome profiling of cytokine-exposed ?-cells revealed an adaptive unfolded protein response (UPR) including a marked immunoproteasome activation that coordinately degraded ZnT8 and insulin over a 1,000-fold cytokine concentration range. RNAi-mediated ZnT8 knockdown protected cells against cytokine cytotoxicity, whereas inhibiting immunoproteasomes blocked cytokine-induced ZnT8 degradation and triggered a transition of the adaptive UPR to cell apoptosis. Hence, cytokine-induced down-regulation of the ER ZnT8 level promotes adaptive UPR, acting as a protective mechanism that decongests the ER burden of ZnT8 to protect ?-cells from proapoptotic UPR during chronic low-grade inflammation.	[Merriman, Chengfeng; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu		Fu, Dax/0000-0002-2663-1316	National Institutes of Health Shared Instrumentation Grant [S10OD016374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Barbara Smith (microscopy facility of the Johns Hopkins University School of Medicine) for assistance in cell imaging and processing, David Mohr and Jinshui Fan (Genetic Resources Core Facility of the Johns Hopkins Institute of Genetic Medicine) for RNA-Seq library preparation and Illumina sequencing, and Liliana Florea and Corina Antonescu (Computational Biology Consulting Core of the Johns Hopkins School of Medicine) for RNA-Seq data analysis and GEO-NCBI submission. The Zeiss confocal microscope was funded through National Institutes of Health Shared Instrumentation Grant S10OD016374.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Barlow J, 2013, BIOCHEM J, V456, P417, DOI 10.1042/BJ20131002; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Chabosseau P, 2016, ARCH BIOCHEM BIOPHYS, V611, P79, DOI 10.1016/j.abb.2016.05.022; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Cheng LQ, 2016, EXP THER MED, V12, P1509, DOI 10.3892/etm.2016.3457; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Egefjord L, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-7; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; El Muayed M, 2010, J ENDOCRINOL, V206, P159, DOI 10.1677/JOE-09-0420; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Farino ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148684; Flannick J, 2019, NATURE, V570, P71, DOI 10.1038/s41586-019-1231-2; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Fred RG, 2015, MOL CELL ENDOCRINOL, V414, P53, DOI 10.1016/j.mce.2015.07.015; Gurgul-Convey E, 2016, DIABETOLOGIA, V59, P2125, DOI 10.1007/s00125-016-4060-y; Hakonen E, 2018, DIABETOLOGIA, V61, P2202, DOI 10.1007/s00125-018-4687-y; Homma K, 2013, MOL CELL, V52, P75, DOI 10.1016/j.molcel.2013.08.038; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Huang LP, 2014, VITAM HORM, V95, P365, DOI 10.1016/B978-0-12-800174-5.00014-4; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; KAY TWH, 1991, DIABETOLOGIA, V34, P779, DOI 10.1007/BF00408350; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li SF, 2013, VACCINE, V31, P1610, DOI 10.1016/j.vaccine.2012.12.008; Li ZH, 2018, MOL CELL PROTEOMICS, V17, P2119, DOI 10.1074/mcp.RA118.000698; Liston A, 2017, TRENDS MOL MED, V23, P181, DOI 10.1016/j.molmed.2016.12.005; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu Y, 2015, J BIOL CHEM, V290, P18757, DOI 10.1074/jbc.M115.640524; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merriman C, 2018, J BIOL CHEM, V293, P16206, DOI 10.1074/jbc.RA118.005136; Merriman C, 2018, J BIOL CHEM, V293, P579, DOI 10.1074/jbc.RA117.000195; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Murata S, 2018, NAT IMMUNOL, V19, P923, DOI 10.1038/s41590-018-0186-z; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ohashi W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006349; Parsons DS, 2018, FEBS J, V285, P1237, DOI 10.1111/febs.14402; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rojas J, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9601801; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Scotto M, 2012, DIABETOLOGIA, V55, P2026, DOI 10.1007/s00125-012-2543-z; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsai S, 2015, DIABETES, V64, P1886, DOI 10.2337/db14-1488; Tuncay E, 2017, DIABETES, V66, P1346, DOI 10.2337/db16-1099; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wan H, 2017, P NATL ACAD SCI USA, V114, P10196, DOI 10.1073/pnas.1711169114; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wenzlau JM, 2013, CURR DIABETES REP, V13, P608, DOI 10.1007/s11892-013-0405-9; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wong WP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00394-3; Woodruff G, 2018, MOL PHARMACOL, V94, P1092, DOI 10.1124/mol.118.112557; Yu C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9083103; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	83	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16992	17006		10.1074/jbc.RA119.010937	http://dx.doi.org/10.1074/jbc.RA119.010937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31591269	Green Published, hybrid			2022-12-26	WOS:000501801900042
J	Kishi, K; Kaji, N; Kurosawa, T; Aikiyo, S; Hori, M				Kishi, Kazuhisa; Kaji, Noriyuki; Kurosawa, Tamaki; Aikiyo, Satoshi; Hori, Masatoshi			Hyperglycemia in the early stages of type 1 diabetes accelerates gastric emptying through increased networks of interstitial cells of Cajal	PLOS ONE			English	Article							ACID BREATH TEST; GASTROINTESTINAL MOTILITY; POSTOPERATIVE ILEUS; UP-REGULATION; ETV1; KIT; MECHANISMS; INOS; ICC	Gastric emptying (GE) can be either delayed or accelerated in diabetes mellitus (DM). However, most research has focused on delayed GE mediated by a chronic hyperglycemic condition in DM. As such, the function of GE in the early stages of DM is not well understood. Interstitial cells of Cajal (ICC) are pacemaker cells in the gastrointestinal tract. In the present study, we investigated changes in GE and ICC networks in the early stages of DM using a streptozotocin-induced type 1 diabetic mouse model. The changes in GE were measured by the C-13-octanoic acid breath test. ICC networks were immunohistochemically detected by an antibody for c-Kit, a specific marker for ICC. Our results showed that GE in type 1 DM was significantly accelerated in the early stages of DM (2-4 weeks after onset). In addition, acute normalization of blood glucose levels by a single administration of insulin did not recover normal GE. ICC networks of the gastric antrum were significantly increased in DM and were not affected by the acute normalization of blood glucose. In conclusion, our results suggest that GE is accelerated in the early stages of DM, and it is associated with increased ICC networks. This mechanism may help to clarify a link between the onset of DM and GE disorders.	[Kishi, Kazuhisa; Kaji, Noriyuki; Kurosawa, Tamaki; Aikiyo, Satoshi; Hori, Masatoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan	University of Tokyo	Hori, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	ahori@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24248050, 18K14604]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (24248050 to M.H. and 18K14604 to N.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Camilleri M, 2011, CLIN GASTROENTEROL H, V9, P5, DOI 10.1016/j.cgh.2010.09.022; Chedid V, 2019, AM J GASTROENTEROL, V114, P143, DOI 10.1038/s41395-018-0234-1; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Cipriani G, 2018, GASTROENTEROLOGY, V154, P2122, DOI 10.1053/j.gastro.2018.02.027; Creedon CT, 2013, JOVE-J VIS EXP, DOI 10.3791/50301; Endo M, 2014, J GASTROENTEROL, V49, P1026, DOI 10.1007/s00535-013-0854-6; Grover M, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13018; Hayashi Y, 2017, GASTROENTEROLOGY, V153, P521, DOI 10.1053/j.gastro.2017.04.020; He XD, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00001; Hori M, 2001, AM J PHYSIOL-GASTR L, V280, pG930, DOI 10.1152/ajpgi.2001.280.5.G930; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Kwon JG, 2009, GASTROENTEROLOGY, V136, P630, DOI 10.1053/j.gastro.2008.10.031; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Matsumoto K, 2008, BIOL PHARM BULL, V31, P1917, DOI 10.1248/bpb.31.1917; Mihara T, 2017, INFLAMMATION, V40, P1331, DOI 10.1007/s10753-017-0576-7; Muangchan N, 2017, BIOL PHARM BULL, V40, P1506, DOI 10.1248/bpb.b17-00320; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Vowinkel T, 2007, AM J PHYSIOL-GASTR L, V293, pG1054, DOI 10.1152/ajpgi.00350.2007; Yamamoto T, 2008, J GASTROEN HEPATOL, V23, P660, DOI 10.1111/j.1440-1746.2008.05326.x; Zhang CM, 2016, MOL CELL ENDOCRINOL, V423, P77, DOI 10.1016/j.mce.2016.01.002	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222961	10.1371/journal.pone.0222961	http://dx.doi.org/10.1371/journal.pone.0222961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596858	Green Published, gold			2022-12-26	WOS:000532444100015
J	Li, F; Zhang, CD; Fu, LJ				Li, Fangfang; Zhang, Chundong; Fu, Lijuan			PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway	PLOS ONE			English	Article							NUCLEAR LAMINA; FILOPODIA; HETEROCHROMATIN; RECOGNITION; ADHESION	Background PRR14 (Proline rich protein 14) was firstly identified for its ability to specify and localize heterochromatin during cell cycle progression. Aberrant expression of PRR14 is associated with the tumorigenesis and progression of lung cancer. However, its involvement in colon cancer remains unknown. Herein, we report the role of PRR14 in colon cancer. Methods Colon cancer tissue microarray was used to analyze and compare the expression of PRR14 among some clinicopathological characteristics of colon cancer. HCT116 and RKO cells were transfected with siRNA to downregulate PRR14 expression. The roles of PRR14 in proliferation, migration and invasion of the cell lines were determined using cell counting kit-8, colony formation assay, wound healing assay and transwell assays respectively. The expression of PRR14 was measured using immunofluorescence, qRT-PCR and western blot. Epithelial-mesenchymal transition (EMT) markers were determined by western blot. Results PRR14 was highly expressed in colon cancer tissues, and the expression level was correlated with tumor size, distant metastasis and Tumor Node Metastasis stages. Functional study revealed that downregulation of PRR14 inhibited colon cancer cells growth, migration and invasion. Furthermore, knockdown of PRR14 inhibited epithelial-mesenchymal transition (EMT) process, cell cycle-associated proteins expression and p-AKT level. Conclusion PRR14 may promote the progression and metastasis of colon cancer, and may be a novel prognostic and therapeutic marker for the disease.	[Li, Fangfang; Fu, Lijuan] Chongqing Med Univ, Dept Reprod Biol, Minist Educ, Joint Int Res Lab Reprod & Dev, Chongqing, Peoples R China; [Li, Fangfang] Army Med Univ, Southwest Hosp, Med Res Ctr, Third Mil Med Univ, Chongqing, Peoples R China; [Zhang, Chundong] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Fu, Lijuan] Chongqing Med Univ, Dept Tradit Chinese Med, Chongqing, Peoples R China	Chongqing Medical University; Army Medical University; Chongqing Medical University; Chongqing Medical University	Fu, LJ (corresponding author), Chongqing Med Univ, Dept Reprod Biol, Minist Educ, Joint Int Res Lab Reprod & Dev, Chongqing, Peoples R China.; Fu, LJ (corresponding author), Chongqing Med Univ, Dept Tradit Chinese Med, Chongqing, Peoples R China.	fulijuan@cqmu.edu.cn			Basic application general project of Southwest Hospital of Third Military Medical University [SWH2016JCYB-52]; Chongqing Natural Science Foundation [cstc2016jcyj0247]	Basic application general project of Southwest Hospital of Third Military Medical University; Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was supported by the Basic application general project of Southwest Hospital of Third Military Medical University (SWH2016JCYB-52) and Chongqing Natural Science Foundation (cstc2016jcyj0247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Del Piccolo N, 2017, BIOPHYS J, V113, P1353, DOI 10.1016/j.bpj.2017.06.029; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Kar S, 2016, CELL SYST, V2, P8, DOI 10.1016/j.cels.2016.01.007; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Moiseeva TN, 2018, DNA REPAIR, V72, P99, DOI 10.1016/j.dnarep.2018.09.003; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Poleshko A, 2014, NUCLEUS-PHILA, V5, P32, DOI 10.4161/nucl.28167; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Xiao SW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.401; Yang M, 2016, ONCOGENE, V35, P5527, DOI 10.1038/onc.2016.93; Yang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.103; Yang M, 2017, CANC RES, V77; Yang Y, 2017, INT J ONCOL, V51, P515, DOI 10.3892/ijo.2017.4044; Yu H, 2017, INT J CLIN EXP PATHO, V10, P6735	27	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0218839	10.1371/journal.pone.0218839	http://dx.doi.org/10.1371/journal.pone.0218839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596887	Green Published, Green Submitted, gold			2022-12-26	WOS:000532444100005
J	Verkissen, MN; Hjermstad, MJ; Van Belle, S; Kaasa, S; Deliens, L; Pardon, K				Verkissen, Mariette N.; Hjermstad, Marianne J.; Van Belle, Simon; Kaasa, Stein; Deliens, Luc; Pardon, Koen			Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study	PLOS ONE			English	Article							PREVALENCE; EXPERIENCE; DISTRESS; FATIGUE; DISEASE	Background People with advanced cancer experience multiple symptoms during their illness trajectory, which can fluctuate in intensity. Aim To describe the course of self-reported quality of life, emotional functioning, physical functioning and symptom intensity over time in cancer patients receiving palliative care. Design Longitudinal study with monthly assessments, using the EORTC QLQ-C15-PAL. Data were analysed (1) prospectively, from baseline to >= 8-month follow-up; and (2) retrospectively, by taking death as index date and comparing results from three cross-sectional subsamples at different stages of illness (time to death >= 6, 5-3 and 2-0 months). Linear mixed models were calculated. Setting/participants A total of 1739 patients (mean age 66, 50% male) from 30 palliative care centers in 12 countries were included. Results In prospective analyses, quality of life, functioning and symptoms-except nausea/vomiting-remained generally stable over time. In retrospective analyses, patients 2-0 months before death reported significantly lower quality of life and physical functioning scores than those 5-3 months before death, who in turn scored lower than those >= 6 months before death, suggesting progressive decline. Emotional functioning remained initially unchanged, but decreased in the last months. Pain, fatigue and appetite loss showed a stable increase in intensity towards death. Dyspnea, insomnia and constipation increased from 5-3 to 2-0 months before death. Nausea/vomiting only increased when comparing those >= 6 months before death with those 2-0 months before death. Conclusion While the prospective approach showed predominantly stable patterns for quality of life, functioning and symptom severity throughout study duration, retrospective analyses indicated that deterioration was already apparent before the terminal phase and accelerated close to death. Our findings support the importance of early symptom identification and treatment in this population, and highlight the need for further studies to explore what characterizes those with either lower or higher symptom burden at different time points towards death.	[Verkissen, Mariette N.; Van Belle, Simon; Deliens, Luc; Pardon, Koen] Vrije Univ Brussel VUB, Dept Family Med & Chron Care, End Life Care Res Grp, Brussels, Belgium; [Verkissen, Mariette N.; Van Belle, Simon; Deliens, Luc; Pardon, Koen] Univ Ghent, Brussels, Belgium; [Hjermstad, Marianne J.] Univ Oslo, Oslo Univ Hosp, European Palliat Care Res Ctr PRC, Dept Oncol, Oslo, Norway; [Hjermstad, Marianne J.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Van Belle, Simon] Ghent Univ Hosp, Dept Med Oncol, Ghent, Belgium; [Kaasa, Stein] Norwegian Univ Sci & Technol NTNU, Fac Med, European Palliat Care Res Ctr PRC, Dept Canc Res & Mol Med, Trondheim, Norway; [Kaasa, Stein] Trondheim Reg & Univ Hosp, St Olavs Hosp, Canc Clin, Trondheim, Norway; [Deliens, Luc] Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; University of Oslo; University of Oslo; Ghent University; Ghent University Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Ghent University; Ghent University Hospital	Verkissen, MN (corresponding author), Vrije Univ Brussel VUB, Dept Family Med & Chron Care, End Life Care Res Grp, Brussels, Belgium.; Verkissen, MN (corresponding author), Univ Ghent, Brussels, Belgium.	mariette.verkissen@vub.be		Pardon, Koen/0000-0002-0571-709X	Norwegian University of Science and Technology (NTNU) [6070]; St. Olavs Hospital-Trondheim University Hospital [6070]; European Union's Seventh Framework Programme FP7/2007-2013 [602541]	Norwegian University of Science and Technology (NTNU); St. Olavs Hospital-Trondheim University Hospital; European Union's Seventh Framework Programme FP7/2007-2013	The European Palliative Care Cancer Symptom (EPCCS) study is a collaborative effort between the European Palliative Care Research Centre (PRC) and the European Association for Palliative Care -Research Network (EAPCS-RN). The study was partially funded by grant no. 6070 from the joint Research Council at Norwegian University of Science and Technology (NTNU) and St. Olavs Hospital-Trondheim University Hospital. The first author has received funding from the European Union's Seventh Framework Programme FP7/2007-2013 [grant no. 602541]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ahmedzai SH, 2004, EUR J CANCER, V40, P2192, DOI 10.1016/j.ejca.2004.06.009; Barnes EA, 2002, INT J GYNECOL CANCER, V12, P424, DOI 10.1046/j.1525-1438.2002.t01-1-01147.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Davis MP, 2004, J CLIN ONCOL, V22, P1510, DOI 10.1200/JCO.2004.03.103; Delgado-Guay MO, 2009, CANCER-AM CANCER SOC, V115, P437, DOI 10.1002/cncr.24017; Deshields T, 2014, SUPPORT CARE CANCER, V22, P1089, DOI 10.1007/s00520-013-2049-3; Deshields Teresa L, 2011, J Support Oncol, V9, P216, DOI 10.1016/j.suponc.2011.06.003; Elmqvist MA, 2009, SUPPORT CARE CANCER, V17, P191, DOI 10.1007/s00520-008-0477-2; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Fayers P, 2001, EORTC QLQ C30 SCORIN; Giesinger JM, 2011, J PALLIAT MED, V14, P904, DOI 10.1089/jpm.2011.0086; Glare P, 2011, CLIN INTERV AGING, V6, P243, DOI 10.2147/CIA.S13109; Groenvold M, 2006, EUR J CANCER, V42, P55, DOI 10.1016/j.ejca.2005.06.022; Groenvold M, 2001, ADDENDUM EORTC QLQ C; Hagelin CL, 2006, SUPPORT CARE CANCER, V14, P320, DOI 10.1007/s00520-005-0886-4; Hjermstad MJ, 2018, BMJ SUPPORT PALLIAT, V8, P456, DOI 10.1136/bmjspcare-2015-000997; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; Hwang SS, 2003, J PAIN SYMPTOM MANAG, V25, P225, DOI 10.1016/S0885-3924(02)00641-3; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Luckett T, 2009, PSYCHO-ONCOLOGY, V18, P1129, DOI 10.1002/pon.1545; Lynn J, 2003, RAND HLTH, P1; McCarter K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008277; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Nekolaichuk CL, 1999, PALLIATIVE MED, V13, P311, DOI 10.1191/026921699675854885; Raijmakers NJH, 2018, SUPPORT CARE CANCER, V26, P3397, DOI 10.1007/s00520-018-4181-6; Rome RB, 2011, OCHSNER J, V11, P348; Seow H, 2011, J CLIN ONCOL, V29, P1151, DOI 10.1200/JCO.2010.30.7173; Sigurdardottir Katrin Ruth, 2008, BMC Palliat Care, V7, P16, DOI 10.1186/1472-684X-7-16; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Stromgren AS, 2006, J PAIN SYMPTOM MANAG, V31, P199, DOI 10.1016/j.jpainsymman.2005.07.007; Tanaka K, 2002, J PAIN SYMPTOM MANAG, V23, P417, DOI 10.1016/S0885-3924(02)00376-7; Tang ST, 2014, J PAIN SYMPTOM MANAG, V48, P863, DOI 10.1016/j.jpainsymman.2014.01.011; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; Tishelman C, 2007, J CLIN ONCOL, V25, P5381, DOI 10.1200/JCO.2006.08.7874	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222988	10.1371/journal.pone.0222988	http://dx.doi.org/10.1371/journal.pone.0222988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596849	Green Published, gold			2022-12-26	WOS:000532444100016
J	Hollis-Etter, KM; Montgomery, RA; Etter, DR; Anchor, CL; Chelsvig, JE; Warner, RE; Grimstad, PR; Lovin, DD; Godsey, MS				Hollis-Etter, Karmen M.; Montgomery, Robert A.; Etter, Dwayne R.; Anchor, Christopher L.; Chelsvig, James E.; Warner, Richard E.; Grimstad, Paul R.; Lovin, Diane D.; Godsey, Marvin S., Jr.			Environmental conditions for Jamestown Canyon virus correlated with population-level resource selection by white-tailed deer in a suburban landscape	PLOS ONE			English	Article							WEST-NILE-VIRUS; ODOCOILEUS-VIRGINIANUS; URBAN; MOSQUITO; HABITATS; BEHAVIOR; SEROPREVALENCE; MOVEMENTS; PATTERNS; SURVIVAL	Suburban landscapes can alter spatial patterns by white-tailed deer (Odocoileus virginianus) and increase animal contact with vectors, pathogens, and humans. Close-contact relationships at a landscape level can have broad implications for disease epidemiology. From 1995-1999, we captured and radio-collared 41 deer in two suburban forest preserves in Chicago, Illinois. We collected blood to determine if animals were seronegative or seropositive for Jamestown Canyon virus and tracked deer movements within suburban habitats. We developed utilization distributions at the population-level and evaluated resource selection for seronegative and seropositive deer. We used maximum likelihood estimation for model selection via Akaike information criterion and then restricted maximum likelihood estimation to attain unbiased estimates of the parameters in the top-ranking models. The top-ranking model describing the resource selection of seronegative deer received almost the full weight of evidence (Akaike information criterion omega(i)=0.93), and included the proportion of wetlands, precipitation in year t, and an interaction of the proportion of wetlands and precipitation in year t. The top-ranking model describing resource selection of seropositive deer received the full weight of evidence (Akaike information criterion omega(i)=1.00). The model included distance to nearest populated place, distance to nearest river, length of road in each grid cell, precipitation in year t, and an interaction of the length of road in each grid cell and precipitation in year t. These results are valuable for mapping the spatial configuration of hotspots for Jamestown Canyon virus and could be used to educate local residents and recreationalists to reduce human exposure.	[Hollis-Etter, Karmen M.] Univ Michigan, Biol Dept, Flint, MI 48503 USA; [Montgomery, Robert A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Etter, Dwayne R.] Wildlife Div Michigan Dept Nat Resources, Lansing, MI USA; [Anchor, Christopher L.; Chelsvig, James E.] Forest Preserve Dist Cook Cty, River Forest, IL USA; [Warner, Richard E.] Univ Illinois Champaign Urbana, Nat Resources & Environm Sci, Urbana, IL USA; [Grimstad, Paul R.; Lovin, Diane D.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Godsey, Marvin S., Jr.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	University of Michigan System; University of Michigan; University of Michigan Flint; Michigan State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame; Centers for Disease Control & Prevention - USA	Hollis-Etter, KM (corresponding author), Univ Michigan, Biol Dept, Flint, MI 48503 USA.	kahollis@umflint.edu	Montgomery, Robert A./C-5541-2019	Montgomery, Robert A./0000-0001-5894-0589	Cook County Animal Control	Cook County Animal Control	Direct funding for the research was provided by Cook County Animal Control awarded to KHE, CLA, and REW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.cookcountyil.gov/agency/animal-andrabies-control-0.	Andreadis TG, 2008, VECTOR-BORNE ZOONOT, V8, P175, DOI 10.1089/vbz.2007.0169; BERTRAM D. S., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P135, DOI 10.1016/0035-9203(58)90035-X; Bonnot TW, 2011, J APPL ICHTHYOL, V27, P291, DOI 10.1111/j.1439-0426.2010.01637.x; BOROMISA RD, 1987, J WILDLIFE DIS, V23, P23, DOI 10.7589/0090-3558-23.1.23; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Butzler SJ, 2011, CARTOGR GEOGR INF SC, V38, P100, DOI 10.1559/15230406382100; Calhoun LM, 2007, AM J TROP MED HYG, V77, P478, DOI 10.4269/ajtmh.2007.77.478; CARBAUGH B, 1975, J WILDLIFE MANAGE, V39, P570, DOI 10.2307/3800400; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; DeNicola AJ, 1997, WILDLIFE SOC B, V25, P496; Duquette JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100841; Etter DR, 2002, J WILDLIFE MANAGE, V66, P500, DOI 10.2307/3803183; Ganser C, 2013, J VECTOR ECOL, V38, P229, DOI 10.1111/j.1948-7134.2013.12035.x; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; GRIMSTAD PR, 1987, J WILDLIFE DIS, V23, P12, DOI 10.7589/0090-3558-23.1.12; Grund MD, 2002, J WILDLIFE MANAGE, V66, P123, DOI 10.2307/3802878; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012; Illinois Department of Agriculture, LAND COV ILL 1991 19; Illinois Natural History Survey, ILL GAP AN PROJ; Illinois State Geological Survey, ILL GEOSP DAT CLEAR; Illinois State Water Survey, COOK COUNT PREC NETW; ISSEL CJ, 1972, AM J TROP MED HYG, V21, P979, DOI 10.4269/ajtmh.1972.21.979; Johnson BJ, 2012, URBAN ECOSYST, V15, P513, DOI 10.1007/s11252-012-0248-1; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Junge RE, 2007, J ZOO WILDLIFE MED, V38, P18, DOI 10.1638/05-123.1; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kilpatrick HJ, 1999, WILDLIFE SOC B, V27, P566; Kilpatrick HJ, 1997, WILDLIFE SOC B, V25, P542; Kilpatrick HJ, 2000, WILDLIFE SOC B, V28, P1023; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Mangudo C, 2018, B ENTOMOL RES, V108, P203, DOI 10.1017/S0007485317000700; Mapes DR, 1979, SOIL SURVEY DUPAGE P, P108; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Mayo D, 2001, EMERG INFECT DIS, V7, P911; Millspaugh JJ, 2015, J ZOOL, V296, P124, DOI 10.1111/jzo.12224; Millspaugh JJ, 2019, POPULATION ECOLOGY P; Montgomery RA, 2007, MAR ECOL PROG SER, V341, P257, DOI 10.3354/meps341257; Montgomery RA, 2014, WILDLIFE BIOL, V20, P145, DOI 10.2981/wlb.13108; MORSE SS, 1991, PERSPECT BIOL MED, V34, P387; Morse Stephen S., 1993, P10; MURPHY RK, 1989, J WILDLIFE DIS, V25, P300, DOI 10.7589/0090-3558-25.2.300; NEITZEL DF, 1991, J WILDLIFE DIS, V27, P230, DOI 10.7589/0090-3558-27.2.230; Nelson R, 2002, CONNECTICUT EPIDEMIO, V22, P5; Nielson RM, 2013, ECOL EVOL, V3, P2233, DOI 10.1002/ece3.617; NIXON CM, 1995, AM MIDL NAT, V133, P290, DOI 10.2307/2426393; Nixon CM, 1991, WILDL MONOGRAPHS, V118; OMEARA GF, 1992, J AM MOSQUITO CONTR, V8, P1; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P1, DOI 10.2307/3808402; Patriquin G, 2018, EMERG INFECT DIS, V24, P118, DOI 10.3201/eid2401.170484; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Petrunenko YK, 2016, OIKOS, V125, P66, DOI 10.1111/oik.01803; Piccolo BP, 2010, CAN J ZOOL, V88, P487, DOI 10.1139/Z10-026; RAMSEY CW, 1968, J WILDLIFE MANAGE, V32, P187, DOI 10.2307/3798257; Rota CT, 2019, POPULATION ECOLOGY P; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Skovmand O, 2011, J MED ENTOMOL, V48, P813, DOI 10.1603/ME10041; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023; United States Geological Survey, 1999, GEOGR NAM INF SYST G; Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024; Ver Hoef JM, 2001, SPATIAL UNCERTAINTY; Walter WD, 2011, INT J GEOGR INF SCI, V25, P379, DOI 10.1080/13658816.2010.524163; Wang HH, 2014, AM J AGR ECON, V96, P1257, DOI 10.1093/ajae/aau036; WARING GH, 1991, APPL ANIM BEHAV SCI, V29, P215, DOI 10.1016/0168-1591(91)90249-W; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2	70	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223582	10.1371/journal.pone.0223582	http://dx.doi.org/10.1371/journal.pone.0223582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589661	gold, Green Published			2022-12-26	WOS:000532427300030
J	Chen, PC; Tsai, SH; Wang, JC; Tzeng, YS; Wang, YC; Chu, CM; Chu, SJ; Liao, WI				Chen, Po-Chuan; Tsai, Shih-Hung; Wang, Jen-Chun; Tzeng, Yuan-Sheng; Wang, Yung-Chih; Chu, Chi-Ming; Chu, Shi-Jye; Liao, Wen-, I			An elevated glycemic gap predicts adverse outcomes in diabetic patients with necrotizing fasciitis	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; STRESS-HYPERGLYCEMIA; RISK-FACTORS; MORTALITY; SEPSIS; ASSOCIATION; PNEUMONIA; VARIABLES; RESPONSES; MELLITUS	Background Diabetes is the most common comorbidity of necrotizing fasciitis (NF), but the effect of stress-induced hyperglycemia (SIH) on diabetic patients with NF has never been investigated. The aim of this study was to assess whether SIH, as determined by the glycemic gap between admission glucose levels and A(1C)-derived average glucose levels, predicts adverse outcomes in diabetic patients hospitalized with NF. Methods We retrospectively reviewed the glycemic gap and clinical outcomes in 252 diabetic patients hospitalized due to NF from 2011 to 2018 in a single medical center in Taiwan. A receiver operating characteristic (ROC) curve was used to analyze the optimal cutoff values for predicting adverse outcomes. Univariate and multivariate logistic regression analyses were employed to identify significant predictors of adverse outcomes. Results In total, 194 diabetic NF patients were enrolled. Compared with patients without adverse outcomes, patients with adverse outcomes had significantly higher glycemic gaps, Acute Physiology and Chronic Health Evaluation (APACHE) II scores and C-reactive protein (CRP) levels; lower albumin and hemoglobin levels; greater incidence of limb loss; and longer hospital and intensive care unit stays. The glycemic gap positively correlates with the laboratory risk indicator for NF scores, APACHE II scores and CRP levels. A glycemic gap of 146 mg/dL was the optimal cutoff value for predicting adverse outcomes using the ROC curve. Compared with patients with glycemic gaps <146 mg/dL, those with glycemic gaps >146 mg/dL had higher APACHE II scores and incidence rates of adverse outcomes, especially bacteremia and acute kidney injury. Multivariate analysis revealed that a glycemic gap >146 mg/dL and APACHE II score >15 were independent predictors of adverse outcomes, while the presence of hyperglycemia at admission was not. Conclusions An elevated glycemic gap was significantly independently associated with adverse outcomes in diabetic NF patients. Further prospective studies are warranted to validate the role of the glycemic gap in NF patients with diabetes.	[Chen, Po-Chuan; Tsai, Shih-Hung; Wang, Jen-Chun; Liao, Wen-, I] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan; [Tzeng, Yuan-Sheng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Plast & Reconstruct Surg, Taipei, Taiwan; [Wang, Yung-Chih] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chu, Shi-Jye] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Liao, WI (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan.	qqww0139@yahoo.com.tw	Chu, Shi-Jye/AFS-7472-2022; Wang, Yung-Chih/ABE-9069-2020	Chu, Shi-Jye/0000-0002-2723-9375; Wang, Yung-Chih/0000-0002-8491-8972	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan [TSGH-C107-044, TSGH-C108-065]; National Defense Medical Center, Taipei, Taiwan [MAB-106-066, MAB-107-012]; Ministry of Science and Technology, Taiwan [MOST 107-2314-B-016-043, MOST 107-2314-B-016-071]	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; National Defense Medical Center, Taipei, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (TSGH-C107-044, TSGH-C108-065); the National Defense Medical Center, Taipei, Taiwan (MAB-106-066, MAB-107-012); and the Ministry of Science and Technology, Taiwan (MOST 107-2314-B-016-043, MOST 107-2314-B-016-071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2017, J CLIN ENDOCR METAB, V102, P2905, DOI 10.1210/jc.2017-00191; Beauchamp LC, 2019, SURG INFECT, V20, P305, DOI 10.1089/sur.2018.182; Bernal NP, 2012, BURNS, V38, P252, DOI 10.1016/j.burns.2011.07.008; Boyer A, 2009, INTENS CARE MED, V35, P847, DOI 10.1007/s00134-008-1373-4; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Chen PC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001456; Cheng NC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1144-0; Egi M, 2011, CRIT CARE MED, V39, P105, DOI 10.1097/CCM.0b013e3181feb5ea; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; Goh T, 2014, BRIT J SURG, V101, pE119, DOI 10.1002/bjs.9371; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; Graham BB, 2010, CRIT CARE MED, V38, P16, DOI 10.1097/CCM.0b013e3181b9eaa5; Hua C, 2015, J AM ACAD DERMATOL, V73, P1006, DOI 10.1016/j.jaad.2015.08.054; Huang KF, 2011, J TRAUMA, V71, P467, DOI 10.1097/TA.0b013e318220d7fa; Jabbour G, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0097-y; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Liao WI, 2016, SCI REP-UK, V6, DOI 10.1038/srep27770; Liao WI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064476; Liu X, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0212-3; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Oncul O, 2008, DIABETES RES CLIN PR, V80, P218, DOI 10.1016/j.diabres.2007.12.001; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121527; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Roberts GW, 2015, J CLIN ENDOCR METAB, V100, P4490, DOI 10.1210/jc.2015-2660; Schuetz P, 2014, DIABETOLOGIA, V57, P275, DOI 10.1007/s00125-013-3112-9; Schuetz P, 2012, AM J MED, V125, P670, DOI 10.1016/j.amjmed.2012.03.001; Schuetz P, 2011, DIABETES CARE, V34, P771, DOI 10.2337/dc10-1185; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stegenga ME, 2010, CRIT CARE MED, V38, P539, DOI 10.1097/CCM.0b013e3181c02726; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Tan JH, 2016, BONE JOINT J, V98B, P1563, DOI 10.1302/0301-620X.98B11.37526; Thomsen RW, 2005, CLIN INFECT DIS, V40, P628, DOI 10.1086/427699; Uehara K, 2014, BONE JOINT J, V96B, P1530, DOI 10.1302/0301-620X.96B11.34888; van Vught LA, 2017, CRIT CARE MED, V45, pE1026, DOI 10.1097/CCM.0000000000002590; Wang CH, 2018, RESUSCITATION, V133, P18, DOI 10.1016/j.resuscitation.2018.09.017; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Yang CJ, 2017, AM J EMERG MED, V35, P1240, DOI 10.1016/j.ajem.2017.03.049; Yang CJ, 2017, INT J CHRONIC OBSTR, V12, P1923, DOI 10.2147/COPD.S131232; Zitkus Bruce S, 2014, Nurse Pract, V39, P22, DOI 10.1097/01.NPR.0000451880.48790.50	41	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223126	10.1371/journal.pone.0223126	http://dx.doi.org/10.1371/journal.pone.0223126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581199	Green Published, gold			2022-12-26	WOS:000532398600033
J	Kojima, T; Oishi, K; Matsubara, Y; Uchiyama, Y; Fukushima, Y; Aoki, N; Sato, S; Masuda, T; Ueda, J; Hirooka, H; Kino, K				Kojima, Tomoki; Oishi, Kazato; Matsubara, Yasushi; Uchiyama, Yuki; Fukushima, Yoshihiko; Aoki, Naoto; Sato, Say; Masuda, Tatsuaki; Ueda, Junichi; Hirooka, Hiroyuki; Kino, Katsutoshi			Cows painted with zebra-like striping can avoid biting fly attack	PLOS ONE			English	Article							STABLE FLIES DIPTERA; STOMOXYS-CALCITRANS; BEHAVIORAL-RESPONSES; HORN FLY; MUSCIDAE; CATTLE; TABANIDAE; TSETSE; COLOR; HORSEFLIES	Experimental and comparative studies suggest that the striped coats of zebras can prevent biting fly attacks. Biting flies are serious pests of livestock that cause economic losses in animal production. We hypothesized that cows painted with black and white stripes on their body could avoid biting fly attacks and show fewer fly-repelling behaviors. Six Japanese Black cows were assigned to treatments using a 3 x 3 Latin-square design. The treatments were black-and-white painted stripes, black painted stripes, and no stripes (all-black body surface). Recorded fly-repelling behaviors were head throw, ear beat, leg stamp, skin twitch, and tail flick. Photo images of the right side of each cow were taken using a commercial digital camera after every observation and biting flies on the body and each leg were counted from the photo images. Here we show that the numbers of biting flies on Japanese Black cows painted with black-and-white stripes were significantly lower than those on non-painted cows and cows painted only with black stripes. The frequencies of fly-repelling behaviors in cows painted with black-and-white stripes were also lower than those in the non-painted and black-striped cows. These results thus suggest that painting black-and-white stripes on livestock such as cattle can prevent biting fly attacks and provide an alternative method of defending livestock against biting flies without using pesticides in animal production, thereby proposing a solution for the problem of pesticide resistance in the environment.	[Kojima, Tomoki; Matsubara, Yasushi; Uchiyama, Yuki; Fukushima, Yoshihiko; Aoki, Naoto; Sato, Say; Masuda, Tatsuaki; Ueda, Junichi; Kino, Katsutoshi] Aichi Agr Res Ctr, Anim Husb Div, Nagakute, Aichi, Japan; [Oishi, Kazato; Hirooka, Hiroyuki] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto, Japan; [Ueda, Junichi] Aichi Vet Assoc, Nagoya, Aichi, Japan	Kyoto University	Kojima, T (corresponding author), Aichi Agr Res Ctr, Anim Husb Div, Nagakute, Aichi, Japan.	tomoki_kojima@pref.aichi.lg.jp	Li, Mengqi/AAG-6804-2021	Oishi, Kazato/0000-0001-9311-7432				ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Blaho M, 2013, PHYSIOL BEHAV, V119, P168, DOI 10.1016/j.physbeh.2013.06.013; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; BRADY J, 1988, B ENTOMOL RES, V78, P301, DOI 10.1017/S0007485300013067; BYFORD RL, 1992, J ANIM SCI, V70, P597, DOI 10.2527/1992.702597x; Caja G., 2004, ICAR Technical Series, P21; Campbell JB, 2001, J ECON ENTOMOL, V94, P780, DOI 10.1603/0022-0493-94.3.780; Caro T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210831; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro Tim, 2016, ZEBRA STRIPES; Egri A, 2013, INT J PARASITOL, V43, P555, DOI 10.1016/j.ijpara.2013.02.002; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; Eicher SD, 2001, J DAIRY SCI, V84, P1822, DOI [10.3168/jds.S0022-0302(01)74621-8, 10.3168/jds.S0022-0302(01)70192-0]; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; Hayashi K., 1967, Japanese Journal Zootechnical Science, V38, P376; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hogan BG, 2016, BEHAV ECOL, V27, P1547, DOI 10.1093/beheco/arw081; HOGSETTE JA, 1991, J ECON ENTOMOL, V84, P1270, DOI 10.1093/jee/84.4.1270; HOOVEN NW, 1978, J DAIRY SCI, V61, P1167, DOI 10.3168/jds.S0022-0302(78)83702-3; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181325; Horvath G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27637-1; Horvath G, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170735; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; How MJ, 2014, ZOOLOGY, V117, P163, DOI 10.1016/j.zool.2013.10.004; HRIBAR LJ, 1992, J MED ENTOMOL, V29, P346, DOI 10.1093/jmedent/29.2.346; Kaps M., 2009, BIOSTATISTICS ANIMAL, V2nd; Kondo S, 1993, RES B LIVESTOCK FARM, V15, P37; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Larison B, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140452; LYSYK TJ, 1995, J MED ENTOMOL, V32, P508, DOI 10.1093/jmedent/32.4.508; Manda M, 1982, B EXP FARM FAC AGR K, V7, P1; Melin AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145679; Moore TR, 1996, SOUTHWEST ENTOMOL, V21, P1; Mullens BA, 2006, MED VET ENTOMOL, V20, P122, DOI 10.1111/j.1365-2915.2006.00608.x; OKUMURA T, 1977, JPN J APPL ENTOMOL Z, V21, P119, DOI 10.1303/jjaez.21.119; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; ROBERTS RH, 1977, MOSQ NEWS, V37, P169; Sasaki H, 2001, APPL ENTOMOL ZOOL, V36, P515, DOI 10.1303/aez.2001.515; Schofield S, 2002, MED VET ENTOMOL, V16, P177, DOI 10.1046/j.1365-2915.2002.00361.x; Silvy Nova J., 2005, P339; Taylor DB, 2012, J MED ENTOMOL, V49, P198, DOI 10.1603/ME10050; THOMPSON PH, 1969, ANN ENTOMOL SOC AM, V62, P50, DOI 10.1093/aesa/62.1.50; Thorsteinson A. J., 1958, Entomologia Experimentalis et Applicata, V1, P191, DOI 10.1007/BF00291062; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351; WILSON B. H., 1966, J MED ENTOMOL, V3, P148, DOI 10.1093/jmedent/3.2.148	49	10	10	8	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223447	10.1371/journal.pone.0223447	http://dx.doi.org/10.1371/journal.pone.0223447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY8PI	31581218	Green Published, gold			2022-12-26	WOS:000504670000001
J	Paravisini, L; Soldavini, A; Peterson, J; Simons, CT; Peterson, DG				Paravisini, Laurianne; Soldavini, Ashley; Peterson, Julie; Simons, Christopher T.; Peterson, Devin G.			Impact of bitter tastant sub-qualities on retronasal coffee aroma perception	PLOS ONE			English	Article							CROSS-ADAPTATION; FLAVOR; DIKETOPIPERAZINES; ENHANCEMENT; SUPPRESSION; ORTHONASAL; CAPSAICIN; NICOTINE; STIMULI	The impact of different bitter taste compounds on the retronasal perception of coffee aroma was investigated. A sorted napping experiment was carried out on thirteen compounds at iso-intense bitter concentrations. Differences in perceptual bitter sub-qualities among the compounds were reported by Multidimensional Scaling (MDS) and Multiple Factor Analysis (MFA) analyses. Seven exemplar compounds were further selected to investigate the impact of taste sub-qualities on cross-modal flavor interactions. In general, the different bitter compounds, when paired with a coffee aroma isolate, significantly modified the perception of the retronasal coffee aroma profile. Interestingly, the three bitter compounds endogenous to coffee had the most similar impact on the coffee aroma profile. Further sensory analysis of these sample sets indicated no significant effect of the bitter compounds on the orthonasal perception. Gas Chromatography/Mass Spectrometry (GC/MS) analysis of the volatile composition of the samples headspace also indicated negligible impact of the bitter compounds on aroma release. Altogether evidence of cross-modal interactions occurring at a higher cognitive level were demonstrated in a complex food sample, supporting the importance of multi-modal sensory integration on flavor perception.	[Paravisini, Laurianne; Soldavini, Ashley; Peterson, Julie; Simons, Christopher T.; Peterson, Devin G.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Peterson, DG (corresponding author), Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA.	peterson.892@osu.edu	Paravisini, Laurianne/AAE-2378-2019	Paravisini, Laurianne/0000-0002-4034-7207	Flavor Research and Education Center at The Ohio State University	Flavor Research and Education Center at The Ohio State University	The authors would like to acknowledge the financial support provided by the Flavor Research and Education Center at The Ohio State University and its supporting members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Borg I., 2005, SPRINGER SERIES STAT, V2; Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Coupland JN, 2014, PHARM RES-DORDR, V31, P2921, DOI 10.1007/s11095-014-1480-6; Dehlholm C, 2012, FOOD QUAL PREFER, V26, P267, DOI 10.1016/j.foodqual.2012.02.012; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436; Dessirier JM, 1998, NEUROSCI LETT, V240, P65, DOI 10.1016/S0304-3940(97)00930-0; Drewnowski A, 2001, NUTR REV, V59, P163, DOI 10.1111/j.1753-4887.2001.tb07007.x; Engel W, 1999, DTSCH FORSCHUNGSANST, P70; Escofier B., 1983, REV STATISTIQUE APPL, V31, P43; Gautschi M, 1997, J AGR FOOD CHEM, V45, P3183, DOI 10.1021/jf9700992; Ginz M, 2000, J AGR FOOD CHEM, V48, P3528, DOI 10.1021/jf991256v; Green BG, 2012, CHEM SENSES, V37, P77, DOI 10.1093/chemse/bjr068; Green BG, 2003, CHEM SENSES, V28, P45, DOI 10.1093/chemse/28.1.45; Hanger LY, 1996, J FOOD SCI, V61, P456, DOI 10.1111/j.1365-2621.1996.tb14216.x; Hort J, 2004, J AGR FOOD CHEM, V52, P4834, DOI 10.1021/jf049681y; Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123; Lawless HT, 2003, FOOD QUAL PREFER, V14, P319, DOI 10.1016/S0950-3293(02)00128-3; LEACH EJ, 1986, CHEM SENSES, V11, P339, DOI 10.1093/chemse/11.3.339; Linscott TD, 2016, FOOD QUAL PREFER, V48, P1, DOI 10.1016/j.foodqual.2015.08.004; Malik B, CHEM SENSES, DOI [10.1093/chemse/bjz019/5470701, DOI 10.1093/CHEMSE/BJZ019/5470701]; MCBURNEY DH, 1972, PERCEPT PSYCHOPHYS, V11, P225, DOI 10.3758/BF03206254; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Nestrud MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1266, DOI 10.3758/s13414-011-0091-0; Noble AC, 1996, TRENDS FOOD SCI TECH, V7, P439, DOI 10.1016/S0924-2244(96)10044-3; Pages J, 2005, FOOD QUAL PREFER, V16, P642, DOI 10.1016/j.foodqual.2005.01.006; Paravisini L, 2017, FOOD RES INT, V100, P209, DOI 10.1016/j.foodres.2017.07.003; Shepherd GM, 2012, NEUROGASTRONOMY BRAI, DOI [10.7312/shep15910, DOI 10.7312/SHEP15910]; Simons CT, 2006, J NEUROPHYSIOL, V96, P1877, DOI 10.1152/jn.00345.2006; Simons CT, 2003, J NEUROSCI, V23, P978; Small D.M., 2012, NEURAL BASEMULTISE; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Spence C., 2012, Food oral processing: fundamentals of eating and sensory perception, P203; Spence C, 2015, CELL, V161, P24, DOI 10.1016/j.cell.2015.03.007; Thomas-Danguin T, 2016, WOODHEAD PUBL FOOD S, V299, P121, DOI 10.1016/B978-0-08-100295-7.00006-2; Wang G, 2018, BEVERAGES, V4, DOI 10.3390/beverages4040073; Welge-Lussen A, 2009, NEUROSCI LETT, V454, P124, DOI 10.1016/j.neulet.2009.03.002; World Coffee Research, 2017, SENS LEX	43	7	7	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223280	10.1371/journal.pone.0223280	http://dx.doi.org/10.1371/journal.pone.0223280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581213	Green Published, gold			2022-12-26	WOS:000532398600047
J	Doidy, J; Vidal, U; Lemoine, R				Doidy, Joan; Vidal, Ugo; Lemoine, Remi			Sugar transporters in Fabaceae, featuring SUT MST and SWEET families of the model plant Medicago truncatula and the agricultural crop Pisum sativum	PLOS ONE			English	Article							GENE-EXPRESSION ATLAS; SUCROSE TRANSPORTER; FUNCTIONAL EXPRESSION; MYCORRHIZAL ROOTS; PROVIDES INSIGHT; ARABIDOPSIS; LEGUME; EVOLUTION; CARRIER; IDENTIFICATION	Sugar transporters play a crucial role for plant productivity, as they coordinate sugar fluxes from source leaf towards sink organs (seed, fruit, root) and regulate the supply of carbon resources towards the microorganisms of the rhizosphere (bacteria and fungi). Thus, sugar fluxes mediated by SUT (sucrose transporters), MST (monosaccharide transporters) and SWEET (sugar will eventually be exported transporters) families are key determinants of crop yield and shape the microbial communities living in the soil. In this work, we performed a systematic search for sugar transporters in Fabaceae genomes, focusing on model and agronomical plants. Here, we update the inventory of sugar transporter families mining the latest version of the Medicago truncatula genome and identify for the first time SUT MST and SWEET families of the agricultural crop Pisum sativum. The sugar transporter families of these Fabaceae species comprise respectively 7 MtSUT 7 PsSUT, 72 MtMST 59 PsMST and 26 MtSWEET 22 PsSWEET. Our comprehensive phylogenetic analysis sets a milestone for the scientific community, as we propose a new and simple nomenclature to correctly name SUT MST and SWEET families. Then, we searched for transcriptomic data available for our gene repertoire. We show that several clusters of homologous genes are co-expressed in different organs, suggesting that orthologous sugar transporters may have a conserved function. We focused our analysis on gene candidates that may be involved in remobilizing resources during flowering, grain filling and in allocating carbon towards roots colonized by arbuscular mycorrhizal fungi and Rhizobia. Our findings open new perspectives for agroecological applications in legume crops, as for instance improving the yield and quality of seed productions and promoting the use of symbiotic microorganisms.	[Doidy, Joan; Vidal, Ugo; Lemoine, Remi] Univ Poitiers, EBI Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Doidy, J (corresponding author), Univ Poitiers, EBI Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France.	joan.doidy@univ-poitiers.fr	Doidy, Joan/AAO-9129-2020	Doidy, Joan/0000-0003-3966-3218	University of Poitiers; Centre National de la Recherche Scientifique (CNRS); NouvelleAquitaine Region; European Regional Development Fund (FEDER)	University of Poitiers; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); NouvelleAquitaine Region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the University of Poitiers, the Centre National de la Recherche Scientifique (CNRS), the NouvelleAquitaine Region with the 2015-2020 State-Region Planning Contracts (CPER) and the European Regional Development Fund (FEDER).	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Aldape MJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P243, DOI 10.1016/S0003-9861(02)00631-8; Aluri S, 2007, P NATL ACAD SCI USA, V104, P2537, DOI 10.1073/pnas.0610278104; Alves-Carvalho S, 2015, PLANT J, V84, P1, DOI 10.1111/tpj.12967; An J, 2019, NEW PHYTOLOGIST; Barker L, 2000, PLANT CELL, V12, P1153, DOI 10.1105/tpc.12.7.1153; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bitterlich M, 2014, PLANT J, V78, P877, DOI 10.1111/tpj.12515; Bruneau A, 2013, LEGUME PHYLOGENY CLA, P217; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Chaintreuil C, 2016, DNA RES, V23, P365, DOI 10.1093/dnares/dsw020; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Dash S, 2016, NUCLEIC ACIDS RES, V44, pD1181, DOI 10.1093/nar/gkv1159; De Ron A.M., 2015, GRAIN LEGUMES, VVolume 10; Dhandapani P, 2016, ANN BOT, V119, P841; Doidy J, 2012, MOL PLANT, V5, P1346, DOI 10.1093/mp/sss079; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; Duchene O, 2017, AGR ECOSYST ENVIRON, V240, P148, DOI 10.1016/j.agee.2017.02.019; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Flemetakis E, 2003, J EXP BOT, V54, P1789, DOI 10.1093/jxb/erg179; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Guo WJ, 2014, PLANT PHYSIOL, V164, P777, DOI 10.1104/pp.113.232751; Hackel A, 2006, PLANT J, V45, P180, DOI 10.1111/j.1365-313X.2005.02572.x; Hall TA, BIOEDIT USER FRIENDL; Harrison MJ, 1996, PLANT J, V9, P491, DOI 10.1046/j.1365-313X.1996.09040491.x; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hennion N, 2018, PHYSL PLANTARUM; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Jeena GS, 2019, PLANT MOL BIOL; Johnson DA, 2007, MOL BIOL EVOL, V24, P2412, DOI 10.1093/molbev/msm184; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kafle A, 2019, PLANT CELL ENVIRON, V42, P270, DOI 10.1111/pce.13359; Kalliampakou KI, 2011, MOL MEMBR BIOL, V28, P1, DOI 10.3109/09687688.2010.500626; Klemens PAW, 2013, PLANT PHYSIOL, V163, P1338, DOI 10.1104/pp.113.224972; Komarova NY, 2012, TRAFFIC, DOI [10.1111/j.600-0854.2012.01370.x, DOI 10.1111/J.600-0854.2012.01370.X]; Kreplak J, 2019, NAT GENET, V51, P1411, DOI 10.1038/s41588-019-0480-1; Krishnakumar V, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu179; Kryvoruchko IS, 2016, PLANT PHYSIOL, V171, P554, DOI 10.1104/pp.15.01910; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lalonde S, 2012, FRONT PLANT SCI, P3, DOI [10.3389/fpls.2012.00003, DOI 10.3389/FPLS.2012.00003]; Lemonnier P, 2014, PLANT MOL BIOL, V85, P473, DOI 10.1007/s11103-014-0198-5; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Ma QJ, 2019, PLANT CELL ENVIRON, V42, P918, DOI 10.1111/pce.13349; Manck-Gotzenberger J, 2016, FRONT PLANT SCI, P7; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Overvoorde P, 1996, SOYBEAN SUCROSE BIND; Patil G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1730-y; Patzke K, 2019, PLANT PHYSIOL, V179, P569, DOI 10.1104/pp.18.01036; Peng D, 2014, FRONT PLANT SCI, P5, DOI [10.3389/fpls.2014.00005, DOI 10.3389/FPLS.2014.00005]; Reinders A, 2008, PLANT MOL BIOL, V68, P289, DOI 10.1007/s11103-008-9370-0; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; Ruffel S, 2008, PLANT PHYSIOL, V146, P2020, DOI 10.1104/pp.107.115667; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneider S, 2012, PLANT BIOLOGY, V14, P325, DOI 10.1111/j.1438-8677.2011.00506.x; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Stagnari F, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-016-0085-1; Sugiyama A, 2017, PLANT CELL PHYSIOL, V58, P298, DOI 10.1093/pcp/pcw190; Sun MX, 2013, PLANT REPROD, V26, P83, DOI 10.1007/s00497-012-0208-1; Tegeder M, 1999, PLANT J, V18, P151, DOI 10.1046/j.1365-313X.1999.00439.x; Wang L, 2018, MOL PLANT, V11, P1, DOI 10.1016/j.molp.2017.12.012; Wang SD, 2019, PLANT PHYSIOL, V180, P2133, DOI 10.1104/pp.19.00641; Weber H, 1997, PLANT CELL, V9, P895, DOI 10.1105/tpc.9.6.895; Wezel A, 2014, AGRON SUSTAIN DEV, V34, P1, DOI 10.1007/s13593-013-0180-7; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yamada K, 2016, SCIENCE, V354, P1427, DOI 10.1126/science.aah5692; Yang JL, 2018, NEW PHYTOL, V218, P604, DOI 10.1111/nph.15004; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang CK, 2009, P NATL ACAD SCI USA, V106, P18849, DOI 10.1073/pnas.0904189106; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x; Zhou YC, 2009, J EXP BOT, V60, P71, DOI 10.1093/jxb/ern254	81	27	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223173	10.1371/journal.pone.0223173	http://dx.doi.org/10.1371/journal.pone.0223173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568488	Green Published, gold, Green Submitted			2022-12-26	WOS:000532364900026
J	Houessou, SO; Dossa, LH; Diogo, RVC; Ahozonlin, MC; Dahouda, M; Schlecht, E				Houessou, Sandrine O.; Dossa, Luc Hippolyte; Diogo, Rodrigue Vivien Cao; Ahozonlin, Maurice Cossi; Dahouda, Mahamadou; Schlecht, Eva			Confronting pastoralists' knowledge of cattle breeds raised in the extensive production systems of Benin with multivariate analyses of morphological traits	PLOS ONE			English	Article							GENETIC DIVERSITY; AFRICAN; CONSERVATION; RESOURCES; ADMIXTURE; FULANI; ZONE	Cross-border seasonal livestock movements in West Africa bring into close contact several cattle breeds. In the coastal countries hosting migrating herders from the Sahel, it often affects the genetic variability and geographical distribution of traditional cattle breeds, through their indiscriminate but also intended crossbreeding with larger-framed Sahelian cattle breeds. The need to secure and effectively manage this genetic variability, in order to respond to changing production and market conditions, is widely recognized by the scientific community, livestock herders and policy-makers. This however requires a comprehensive knowledge of the breeds' characteristics. The indigenous criteria used by pastoralists to characterize and distinguish cattle breeds remain unclear and further validation is required. This study was therefore designed to document and validate herders' knowledge on cattle breeds. From June 2015 to June 2016, 803 cattle herders participated in a phenotypic breed description in seven pastoral communities across the country. Each cattle herder was asked to name and describe morphologically the different cattle breeds in his herd. Subsequently, fifteen body measurements taken on a total of 1401 adult cattle (964 cows and 439 bulls) were submitted to multivariate analyses. Participants distinguished ten different cattle breeds kept in traditional herds according to six primary morphological traits and clearly separated zebuine from taurine breeds. These results were consistent with those of the multivariate analyses of the measured traits. However, herders' classification approach proved to be more accurate in distinguishing breeds within the zebuine subspecies. Hence, while metric measurements and molecular genetic analyses are promising approaches to fill the knowledge gap on the diversity of local farm animal genetic resources, they should integrate livestock herders' traditional knowledge for more precision.	[Houessou, Sandrine O.; Dossa, Luc Hippolyte; Ahozonlin, Maurice Cossi; Dahouda, Mahamadou] Univ Abomey Calavi, Ecole Sci & Tech Prod Anim, Fac Sci Agron, Cotonou, Benin; [Diogo, Rodrigue Vivien Cao] Univ Parakou, Fac Agron, Dept Sci & Tech Prod Anim & Halieut, Parakou, Benin; [Schlecht, Eva] Univ Kassel, Anim Husb Trop & Subtrop, Kassel, Germany; [Schlecht, Eva] Univ Gottingen, Gottingen, Germany	University of Abomey Calavi; Universitat Kassel; University of Gottingen	Dossa, LH (corresponding author), Univ Abomey Calavi, Ecole Sci & Tech Prod Anim, Fac Sci Agron, Cotonou, Benin.	hippolyte.dossa@fsa.uac.bj	Dossa, Luc Hippolyte/AAA-8931-2021; Diogo, Rodrigue Vivien Cao/ABB-5282-2021	Dossa, Luc Hippolyte/0000-0003-1436-0667; Diogo, Rodrigue Vivien Cao/0000-0002-5348-5588	Volkswagen Foundation, Germany (DE) [Az 89 367]	Volkswagen Foundation, Germany (DE)	This work was supported by Volkswagen Foundation, Germany (DE) to LHD, Grant number: Az 89 367, URL: https://www.volkswagenstiftung.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye G. S., 1994, World Animal Review (Multilingual Edition), V78, P22; Alphonsus C., 2012, WORLD J LIFE SCI MED, V2, P134; Alvarez I, 2017, J ANIM BREED GENET, V134, P393, DOI 10.1111/jbg.12278; Alvarez I, 2014, MOL BIOL REP, V41, P3745, DOI 10.1007/s11033-014-3239-x; [Anonymous], [No title captured]; Ayantunde AA, 2018, ANIMAL, V12, pS199, DOI 10.1017/S175173111800174X; Belemsaga DMA, 2005, Applications of Gene-Based Technologies for Improving Animal Production and Health in Developing Countries, P167, DOI 10.1007/1-4020-3312-5_15; Belli P, 2008, REV ELEV MED VET PAY, V61, P51, DOI DOI 10.19182/remvt.10013; Birteeb PT, 2012, TROP ANIM HEALTH PRO, V45, P267, DOI 10.1007/s11250-012-0211-4; Blench R., 1999, TRADITIONAL LIVESTOC, V67; Boutrais E, 2007, AFRICA, V77, P18; Boutrais J., 1992, TERRAINS DEV APPROCH, P235; Brown T, 2015, OUTLOOK AGR, V44, P173, DOI 10.5367/oa.2015.0210; Bruford MW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00314; DAGRIS (Domestic Animal Genetic Resources Information System), 2018, BREEDS BEN; Delgado JV, 2001, ANIM GENET RESOUR IN, V29, P7, DOI [DOI 10.1017/S1014233900005162, 10.1017/S1014233900005162]; Desta TT, 2011, TROP ANIM HEALTH PRO, V43, P851, DOI 10.1007/s11250-010-9772-2; Djedjebi TS, 2009, THESIS; Dossa LH, 2007, SMALL RUMINANT RES, V73, P150, DOI 10.1016/j.smallrumres.2007.01.003; Dossa LH, 2016, TROP ANIM HEALTH PRO, V48, P349, DOI 10.1007/s11250-015-0958-5; Dueppen SA, 2012, J ARCHAEOL SCI, V39, P92, DOI 10.1016/j.jas.2011.09.005; Eruola AO, 2013, WORLD J AGR SCI, V1, P318; Flori L, 2014, MOL ECOL, V23, P3241, DOI 10.1111/mec.12816; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Grema M, 2017, ARCH ANIM BREED, V60, P399, DOI 10.5194/aab-60-399-2017; Hall S. J. G., 1995, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V48, P77; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2010, SCIENCE, V328, P1640, DOI 10.1126/science.1186254; Hoffmann I, 2010, ANIM GENET, V41, P32, DOI 10.1111/j.1365-2052.2010.02043.x; Holloway L, 2011, AGR HUM VALUES, V28, P533, DOI 10.1007/s10460-010-9298-2; Jabbar MA, 1999, OUTLOOK AGR, V28, P239, DOI 10.1177/003072709902800407; Kefena E., 2012, Animal Genetic Resources, P1; Kim SJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3742-2; Kratli S, 2008, NOMAD PEOPLES, V12, P11, DOI 10.3167/np.2008.120102; Kugonza DR, 2012, TROP ANIM HEALTH PRO, V44, P557, DOI 10.1007/s11250-011-9935-9; Lanari MR, 2003, ARCH TIERZUCHT, V46, P347, DOI 10.5194/aab-46-347-2003; Moazami-Goudarzi K., 2001, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V54, P129; Mwai O, 2015, ASIAN AUSTRAL J ANIM, V28, P911, DOI 10.5713/ajas.15.0002R; N'goran K. E., 2008, Archivos de Zootecnia, V57, P415; Ndiaye NP, 2015, VET WORLD, V8, P994, DOI 10.14202/vetworld.2015.994-1005; Ogunsanmi AO, 2000, ISR J VET MED, V55, P1; Okpeku M., 2011, Acta Agriculturae Slovenica, V98, P101, DOI 10.2478/v10014-011-0026-4; Pelican M., 2012, AFRICAN STUDY MONOGR, V33, P165, DOI [DOI 10.14989/159427, 10.18632/oncotarget.11780, DOI 10.18632/oncotarget.11780]; Porter V., 2016, MASONS WORLD ENCY LI; Porter V., 2002, WORLD DICT LIVESTOCK; Rege JEO, 2011, LIVEST SCI, V136, P15, DOI 10.1016/j.livsci.2010.09.003; Sunderland TCH, 2011, INT FOREST REV, V13, P265, DOI 10.1505/146554811798293908; Talabi A. O., 2012, Bulletin of Animal Health and Production in Africa, V60, P187; Tamou C, 2018, LIVEST SCI, V210, P129, DOI 10.1016/j.livsci.2018.02.013; Traore A, 2008, SMALL RUMINANT RES, V80, P62, DOI 10.1016/j.smallrumres.2008.09.011; Traore A, 2015, TROP ANIM HEALTH PRO, V47, P1505, DOI 10.1007/s11250-015-0891-7; Traore A, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-35; Van Driel A., 2002, 64 LEIDEN U LEIDEN; Yakubu A., 2010, Acta Agriculturae Slovenica, V96, P75, DOI 10.2478/v10014-010-0018-9; Yakubu A, 2010, ACTA AGR SCAND A-AN, V60, P74, DOI 10.1080/09064702.2010.502242; Yakubu A., 2009, Trakia Journal of Sciences, V7, P67; Youssao AKI., 2000, ANIMAL GENETIC RESOU, V27, P17, DOI [10.1017/S1014233900001255, DOI 10.1017/S1014233900001255]	57	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222756	10.1371/journal.pone.0222756	http://dx.doi.org/10.1371/journal.pone.0222756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8DO	31557214	Green Published, gold			2022-12-26	WOS:000515075400001
J	Xu, R; Liu, SH				Xu, Rui; Liu, Shihe			Level Set method-based two-dimensional numerical model for simulation of nonuniform open-channel flow	PLOS ONE			English	Article							FREE-SURFACE FLOW; EFFICIENT IMPLEMENTATION; VOLUME; MASS	The capture precision of the free surface of an open-channel with a water-air interface directly affects the calculation precision of flow field characteristics and general characteristics of the flow. Significant research effort has been devoted to Level Set since its creation, although the relevant research is mainly limited to bubble or droplet movement. In this paper, Level Set method is applied to a two-dimensional numerical simulation of open-channel turbulence, while a new numerical model is proposed and multispot synchronized experimental data are applied to the validation of numerical model. In addition, the model is used to study the flow field characteristics and general characteristics of open-channel flow, which have a water-level lowering curve. The study shows that (1) a semilogarithm zone of vertical distribution of longitudinal velocity is still present amid the transition of flow from nonuniform to uniform, and the depth-averaged velocity and wall shear stress increase along the flowing path. (2) both the energy loss coefficient and roughness coefficient of the flow at nonuniform flow region are greater than the respective values at uniform flow region, and the magnitude of the deviation is relevant to the magnitude of the flow deviation from uniform flow stage.	[Xu, Rui; Liu, Shihe] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Peoples R China; [Xu, Rui; Liu, Shihe] Wuhan Univ, Sch Water Resources & Hydropower Engn, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Liu, SH (corresponding author), Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Peoples R China.; Liu, SH (corresponding author), Wuhan Univ, Sch Water Resources & Hydropower Engn, Wuhan, Hubei, Peoples R China.	shiheliu@tom.com			National Key Technology Research and Development Program of China [2018YFC0407603]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China)	This work has been supported by the National Key Technology Research and Development Program of China (2018YFC0407603). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albadawi A, 2012, J PHYS C SERIES, V395; Bilger C, 2017, J COMPUT PHYS, V345, P665, DOI 10.1016/j.jcp.2017.05.044; Bu L, 2012, INT J THERM SCI, V59, P1, DOI 10.1016/j.ijthermalsci.2012.04.011; CARDOSO AH, 1991, J HYDRAUL RES, V29, P525, DOI 10.1080/00221689109498972; Castro-Orgaz O, 2011, J HYDRAUL RES, V49, P55, DOI 10.1080/00221686.2010.526758; Chandran K, 2019, SADHANA-ACAD P ENG S, V44, DOI 10.1007/s12046-018-1000-1; Dey S, 2002, FLOW MEAS INSTRUM, V13, P247, DOI 10.1016/S0955-5986(02)00055-9; HAYASE T, 1992, J COMPUT PHYS, V98, P108, DOI 10.1016/0021-9991(92)90177-Z; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Jiang GS, 1996, J COMPUT PHYS, V126, P202, DOI 10.1006/jcph.1996.0130; Kamath A, 2019, WATER-SUI, V11, DOI 10.3390/w11030456; Kang M, 2008, COMPUT FLUIDS, V37, P524, DOI 10.1016/j.compfluid.2007.07.002; Kelecy FJ, 1997, J COMPUT PHYS, V138, P939, DOI 10.1006/jcph.1997.5847; Khosronejad A, 2019, J HYDRAUL ENG, V145, DOI 10.1061/(ASCE)HY.1943-7900.0001546; Liu Q, 2017, WATER SCI ENG, V10, P43, DOI 10.1016/j.wse.2017.03.008; McSherry RJ, 2017, J HYDRODYN, V29, P1, DOI 10.1016/S1001-6058(16)60712-6; NEZU I, 1995, FLOW MEAS INSTRUM, V6, P49, DOI 10.1016/0955-5986(95)93458-7; Nezu I, 2011, J HYDRO-ENVIRON RES, V5, P215, DOI 10.1016/j.jher.2011.05.004; Nikitin K, 2008, RUSS J NUMER ANAL M, V23, P469, DOI 10.1515/RJNAMM.2008.027; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Pan D, 2000, INT J NUMER METH FL, V33, P203, DOI 10.1002/(SICI)1097-0363(20000530)33:2<203::AID-FLD9>3.0.CO;2-F; Pantankar SV., 1980, NUMERICAL HEAT TRANS; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; PATEL VC, 1985, AIAA J, V23, P1308, DOI 10.2514/3.9086; Qian L, 2012, P ROY SOC A-MATH PHY, V468, P305, DOI 10.1098/rspa.2011.0379; Ramamurthy AS, 2006, J IRRIG DRAIN ENG, V132, P425, DOI 10.1061/(ASCE)0733-9437(2006)132:4(425); Sennes G, 2007, J COASTAL RES, P1086; SHIONO K, 1991, J FLUID MECH, V222, P617, DOI 10.1017/S0022112091001246; Shirani E, 2011, J APPL FLUID MECH, V4, P43; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; Song T, 2001, J ENG MECH-ASCE, V127, P219, DOI 10.1061/(ASCE)0733-9399(2001)127:3(219); Sussman M, 1999, J COMPUT PHYS, V148, P81, DOI 10.1006/jcph.1998.6106; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Ubbink O, 1999, J COMPUT PHYS, V153, P26, DOI 10.1006/jcph.1999.6276; Versteeg H.K., 2007, INTRO COMPUTATIONAL; Violeau D, 2007, INT J NUMER METH FL, V53, P277, DOI 10.1002/fld.1292; Zhang YL, 2010, INT J NUMER METH FL, V63, P651, DOI 10.1002/fld.2090	37	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223167	10.1371/journal.pone.0223167	http://dx.doi.org/10.1371/journal.pone.0223167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KW4WS	31557255	gold, Green Published			2022-12-26	WOS:000521167300001
J	Yu, X; Chao, L; Zhang, WD; Chen, LC; Yang, QP; Zhang, GJ; Wang, SL				Yu, Xin; Chao, Lin; Zhang, Weidong; Chen, Longchi; Yang, Qingpeng; Zhang, Guangjie; Wang, Silong			Effects of inorganic nitrogen and litters of Masson Pine on soil organic carbon decomposition	PLOS ONE			English	Article							MICROBIAL COMMUNITY; LEAF-LITTER; FOLIAR LITTER; MATTER; FOREST; MECHANISMS; DEPOSITION; GROWTH; ADDITIONS; ECOSYSTEM	Soil organic matter (SOM) mineralization represents one of the largest fluxes in the global carbon cycle. Numerous studies have shown that soil organic carbon decomposition was largely changed owing to the addition of litter, however very few studies have focused on the role of plant organs in the priming effects (PEs). Here, we studied the effects of different Pinus massoniana organs (fresh leaf, leaf litter, twigs, absorptive fine roots, and transport fine roots) on C-4 soil respiration by applying the C-13 isotopic natural abundance method. Results showed that the effects of plant organs on PEs were significantly different at the end of 210 days incubation, which can be ascribed to contrasting organs traits especially nonstructural carbohydrates and water-soluble compounds. Transport fine roots and fresh leaf induced positive PE, whereas absorptive fine roots induced negative PE. Leaf litter did not change the native SOC decomposition. Plant organ addition can change the microbial community and result in the reduction of bacteria-to-fungi ratio. Our results suggest that with regard to determining the PE of the entire ecosystem, using fresh leaf to represent leaf litter and aboveground to represent underground is implausible.	[Yu, Xin; Chao, Lin; Zhang, Weidong; Chen, Longchi; Yang, Qingpeng; Zhang, Guangjie; Wang, Silong] Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China; [Yu, Xin; Chao, Lin; Zhang, Guangjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Weidong; Chen, Longchi; Yang, Qingpeng; Wang, Silong] Chinese Acad Sci, Huitong Expt Stn Forest Ecol, Huitong, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Zhang, WD; Wang, SL (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China.; Zhang, WD; Wang, SL (corresponding author), Chinese Acad Sci, Huitong Expt Stn Forest Ecol, Huitong, Peoples R China.	wdzhang@iae.ac.cn; slwang@iae.ac.cn			National Natural Science Foundation of China [U1805243]; key research program of Frontier Sciences of the Chinese Academy of Sciences,Key Laboratory of Drug Research (CN) [QYZDBSSW-DQC002-03]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2017239]; National Key Research and Development Program of China [2016YFA060080203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key research program of Frontier Sciences of the Chinese Academy of Sciences,Key Laboratory of Drug Research (CN); Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Key Research and Development Program of China	This work received support from: National Natural Science Foundation of China U1805243; key research program of Frontier Sciences of the Chinese Academy of Sciences,Key Laboratory of Drug Research (CN) QYZDBSSW-DQC002-03; Youth Innovation Promotion Association of the Chinese Academy of Sciences 2017239 Weidong Zhang; National Key Research and Development Program of China 2016YFA060080203 Weidong Zhang.; We thank Tang haichuan, Lei shiqi, Xu rui and Wang li for assistance in collecting samples in the field, and two anonymous reviewers for helpful comments on revision of this manuscript. This work was financially supported by the National Natural Science Foundation of China (U1805243).	Aerts R, 1999, J EXP BOT, V50, P29, DOI 10.1093/jexbot/50.330.29; Aye NS, 2018, SOIL BIOL BIOCHEM, V123, P33, DOI 10.1016/j.soilbio.2018.04.027; Bamminger C, 2014, BIOL FERT SOILS, V50, P1189, DOI 10.1007/s00374-014-0968-x; Berg B, 2013, DECOMPOSITION HUMUS, DOI 10.1007/978-3-030-59631-6; Berg B, 2017, FOREST ECOL MANAG, V403, P137, DOI 10.1016/j.foreco.2017.08.022; Berg B, 2014, SOIL BIOL BIOCHEM, V78, P222, DOI 10.1016/j.soilbio.2014.08.005; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya EV, 2007, APPL SOIL ECOL, V37, P95, DOI 10.1016/j.apsoil.2007.05.002; Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; David A., 2004, SCIENCE, V304; Di Lonardo DP, 2018, SOIL BIOL BIOCHEM, V126, P49, DOI 10.1016/j.soilbio.2018.07.025; Di Lonardo DP, 2017, SOIL BIOL BIOCHEM, V108, P41, DOI 10.1016/j.soilbio.2017.01.017; Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4; Finzi AC, 2015, GLOBAL CHANGE BIOL, V21, P2082, DOI 10.1111/gcb.12816; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2011, SOIL BIOL BIOCHEM, V43, P86, DOI 10.1016/j.soilbio.2010.09.017; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Freschet GT, 2013, J ECOL, V101, P943, DOI 10.1111/1365-2745.12092; Freschet GT, 2012, FUNCT ECOL, V26, P56, DOI 10.1111/j.1365-2435.2011.01913.x; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; Gul S, 2012, APPL SOIL ECOL, V60, P84, DOI 10.1016/j.apsoil.2012.03.006; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hicks LC, 2019, SOIL BIOL BIOCHEM, V129, P212, DOI 10.1016/j.soilbio.2018.10.015; Kirschbaum MUF, 2000, TREE PHYSIOL, V20, P309; Klotzbucher T, 2011, ECOLOGY, V92, P1052, DOI 10.1890/i0012-9658-92-5-1052; Kou XC, 2018, PLANT SOIL, V432, P129, DOI 10.1007/s11104-018-3782-7; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Liu WX, 2018, GEODERMA, V332, P37, DOI 10.1016/j.geoderma.2018.07.008; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; McCormack ML, 2015, NEW PHYTOL, V207, P505, DOI 10.1111/nph.13363; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Qiao N, 2016, SCI REPORTS, V6, DOI [10.1038/s41598-016-0015-2, DOI 10.1038/S41598-016-0015-2]; Rinkes ZL, 2014, BIOGEOCHEMISTRY, V117, P153, DOI 10.1007/s10533-013-9872-y; Schlesinger WH, 2016, GLOBAL CHANGE BIOL, V22, P2318, DOI 10.1111/gcb.13105; Sun T, 2018, P NATL ACAD SCI USA, V115, P10392, DOI 10.1073/pnas.1716595115; Tao DY, 2016, J FORESTRY RES, V27, P707, DOI 10.1007/s11676-015-0192-z; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; Varma V, 2018, ECOL EVOL, V8, P8467, DOI 10.1002/ece3.4289; Wang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10102; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wu JJ, 2017, APPL SOIL ECOL, V113, P45, DOI 10.1016/j.apsoil.2017.01.013; Yang Hui-xia, 2010, Shengtaixue Zazhi, V29, P2334; Yao HY, 2012, SOIL BIOL BIOCHEM, V53, P72, DOI 10.1016/j.soilbio.2012.05.006; Zeng LX, 2018, SCI TOTAL ENVIRON, V639, P679, DOI 10.1016/j.scitotenv.2018.05.208; Zhang WD, 2016, ECOLOGY, V97, P2834, DOI 10.1002/ecy.1515; Zhang WD, 2012, SOIL BIOL BIOCHEM, V47, P116, DOI 10.1016/j.soilbio.2011.12.004; Zhang XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184978	51	0	0	11	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222973	10.1371/journal.pone.0222973	http://dx.doi.org/10.1371/journal.pone.0222973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557199	Green Published, gold			2022-12-26	WOS:000532345500052
J	Ma, J; Li, JH; Qian, MR; He, N; Cao, Y; Liu, YP; Wu, KC; He, SX				Ma, Jing; Li, Jianhui; Qian, Meirui; He, Nan; Cao, Ying; Liu, Yaping; Wu, Kaichun; He, Shuixiang			The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity	FASEB JOURNAL			English	Article						intestinal permeability; CUMS; fecal microbiota transplantation	IRRITABLE-BOWEL-SYNDROME; FECAL MICROBIOTA TRANSPLANTATION; IMPAIRED STRESS-RESPONSE; GUT MICROBIOTA; ANXIETY; EXPRESSION; SYSTEM; ACTIVATION; MECHANISMS; MUCOSAL	So far, a comprehensive animal model that can mimic both the central and peripheral pathophysiological changes of irritable bowel syndrome (IBS) is lacking. Here, we developed a novel IBS rat model combining trinitro-benzene-sulfonic acid (TNBS) and chronic unpredictable mild stress (CUMS) (designated as TC-IBS) and compared it with the TNBS-induced and CUMS-induced models. TC-IBS showed a pronounced depression phenotype with increased corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 expression at the frontal cortex and increased serum ACTH concentration. Visceral hypersensitivity (VH), as evidenced by colorectal distention (CRD) test, was highest in TC-IBS, accompanied by increased serum 5-hydroxytryptamine (5-HT) level and colonic 5-HT receptor 3A (5-HT3AR)/5-HT receptor 2B expression, impaired tight junction protein expression including occludin, zonula occludens-1, and phosphorylated myosin light chain. Palonosetron, a second generation of 5-HT3AR antagonist, alleviated VH significantly in TC-IBS. 16S rRNA sequencing showed that TNBS plus CUMS induced a significant disturbance of the gut microbiota. Cytokine profile analysis of TC-IBS model indicated an innate immune activation both in serum and colonic mucosa. Further, fecal microbiota transplantation improved VH and some pathophysiological changes in TC-IBS. In summary, we established a postinflammatory IBS model covering multifactorial pathophysiological changes, which may help to develop therapies that target specific IBS subtype.	[Ma, Jing; Liu, Yaping; He, Shuixiang] Xi An Jiao Tong Univ, Dept Digest Dis, Affiliated Hosp 1, Xian, Peoples R China; [Ma, Jing; Qian, Meirui; He, Nan; Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian, Peoples R China; [Ma, Jing; Qian, Meirui; He, Nan; Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian, Peoples R China; [Li, Jianhui] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian, Peoples R China; [Cao, Ying] Northwest Univ, Sch Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an	Wu, KC (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China.; Wu, KC (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China.; He, SX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp, Dept Gastroenterol, Xian 710032, Peoples R China.	kaicwu@fmmu.edu.cn; dyyyjxk@mail.xjtu.edu.cn			State Key Laboratory of Cancer Biology	State Key Laboratory of Cancer Biology	The authors thank Prof. Huang Niu and Dr. Zhou Yu (both from National Institute of Biological Sciences, Beijing, China) for developing the animal model. This study was funded by State Key Laboratory of Cancer Biology. The authors declare no conflicts of interest.	Bale TL, 2002, J NEUROSCI, V22, P193, DOI 10.1523/JNEUROSCI.22-01-00193.2002; Barbara G., 2016, GASTROENTEROLOGY, DOI [10.1053/j.gas-tro.2016.02.028, DOI 10.1053/J.GAS-TRO.2016.02.028]; Bashashati M, 2014, NEUROGASTROENT MOTIL, V26, P1036, DOI 10.1111/nmo.12358; Bennet SMP, 2015, GUT LIVER, V9, P318, DOI 10.5009/gnl14344; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Bhattarai Y, 2017, AM J PHYSIOL-GASTR L, V312, pG52, DOI 10.1152/ajpgi.00338.2016; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Ford AC, 2009, AM J GASTROENTEROL, V104, P1831, DOI 10.1038/ajg.2009.223; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Halkjaer SI, 2018, GUT, V67, P2107, DOI 10.1136/gutjnl-2018-316434; Halkjaer SI, 2017, WORLD J GASTROENTERO, V23, P4112, DOI 10.3748/wjg.v23.i22.4112; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Johnsen PH, 2018, LANCET GASTROENTEROL, V3, P17, DOI 10.1016/S2468-1253(17)30338-2; Jones MP, 2017, CLIN GASTROENTEROL H, V15, P1014, DOI 10.1016/j.cgh.2016.12.032; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Martinez C, 2013, GUT, V62, P1160, DOI 10.1136/gutjnl-2012-302093; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935; Qin HY, 2012, WORLD J GASTROENTERO, V18, P2481, DOI 10.3748/wjg.v18.i20.2481; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Shao Y, 2015, CAN J PHYSIOL PHARM, V93, P633, DOI 10.1139/cjpp-2015-0039; Simpson J, 2008, NEUROGASTROENT MOTIL, V20, P392, DOI 10.1111/j.1365-2982.2007.01037.x; Simren M, 2018, GUT, V67, P255, DOI 10.1136/gutjnl-2016-312361; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spiller R, 2007, LANCET, V369, P1586, DOI 10.1016/S0140-6736(07)60726-0; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Traini C, 2017, J CELL MOL MED, V21, P735, DOI 10.1111/jcmm.13016; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; WILLIAMS CL, 1988, GASTROENTEROLOGY, V94, P611, DOI 10.1016/0016-5085(88)90231-4; Wu J, 2017, WORLD J GASTROENTERO, V23, P6339, DOI 10.3748/wjg.v23.i34.6339	42	4	5	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13560	13571		10.1096/fj.201901489R	http://dx.doi.org/10.1096/fj.201901489R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570003	Bronze			2022-12-26	WOS:000507466100041
J	Zheng, F; Jia, BW; Dong, FF; Liu, L; Rasul, F; He, JJ; Fu, CH				Zheng, Fan; Jia, Bowen; Dong, Fenfen; Liu, Ling; Rasul, Faiz; He, Jiajia; Fu, Chuanhai			Glucose starvation induces mitochondrial fragmentation depending on the dynamin GTPase Dnm1/Drp1 in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; stress; glucose; dynamin; fungi	PROTEIN-KINASE; DRP1; PHOSPHORYLATION; DIVISION; ACTIVATION; TRANSLOCATION; DEGRADATION; MORPHOLOGY; PATHWAY; CYCLASE	Mitochondria undergo morphological and dynamic changes in response to environmental stresses. Few studies have focused on addressing mitochondrial remodeling under stress. Using the fission yeast Schizosaccharomyces pombe as a model organism, here we investigated mitochondrial remodeling under glucose starvation. We employed live-cell microscopy to monitor mitochondrial morphology and dynamics of cells in profusion chambers under glucose starvation. Our results revealed that mitochondria fragment within minutes after glucose starvation and that the dynamin GTPase Dnm1 is required for promoting mitochondrial fragmentation. Moreover, we found that glucose starvation enhances Dnm1 localization to mitochondria and increases the frequency of mitochondrial fission but decreases PKA activity. We further demonstrate that low PKA activity enhances glucose starvation?induced mitochondrial fragmentation, whereas high PKA activity confers resistance to glucose starvation?induced mitochondrial fragmentation. Moreover, we observed that AMP-activated protein kinase is not involved in regulating mitochondrial fragmentation under glucose starvation. Of note, glucose starvation?induced mitochondrial fragmentation was associated with enhanced reactive oxygen species production. Our work provides detailed mechanistic insights into mitochondrial remodeling in response to glucose starvation.	[Zheng, Fan; Dong, Fenfen; Liu, Ling; Rasul, Faiz; He, Jiajia; Fu, Chuanhai] Univ Sci & Technol China, CAS Ctr Excellence Mol Cell Sci, Hefei Natl Sci Ctr Phys Sci Microscale, MOE Key Lab Cellular Dynam, Hefei 230027, Anhui, Peoples R China; [Zheng, Fan; Dong, Fenfen; Liu, Ling; Rasul, Faiz; He, Jiajia; Fu, Chuanhai] Univ Sci & Technol China, CAS Ctr Excellence Mol Cell Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Anhui Key Lab Chem Biol, Hefei 230027, Anhui, Peoples R China; [Zheng, Fan; Jia, Bowen; Dong, Fenfen; Liu, Ling; Rasul, Faiz; He, Jiajia; Fu, Chuanhai] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Jia, Bowen] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Hong Kong University of Science & Technology	Fu, CH (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Mol Cell Sci, Hefei Natl Sci Ctr Phys Sci Microscale, MOE Key Lab Cellular Dynam, Hefei 230027, Anhui, Peoples R China.; Fu, CH (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Mol Cell Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Anhui Key Lab Chem Biol, Hefei 230027, Anhui, Peoples R China.; Fu, CH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	cchuanhai@ustc.edu.cn	Dong, Fenfen/ABG-9400-2021; Fu, Chuanhai/G-8303-2016; Zheng, Fan/GNM-9399-2022	Fu, Chuanhai/0000-0003-4354-3796; Zheng, Fan/0000-0001-7005-0941; Rasul, Faiz/0000-0002-8386-5020	National Key Research and Development Program of China [2018YFC1004700]; National Natural Science Foundation of China [91754106, 31871350, 31671406, 31601095, 31621002]; Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDB19040101]; Major/Innovative Program of Development Foundation of the Hefei Center for Physical Science and Technology [2017FXCX008]; China's 1000 Young Talents Recruitment Program	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences Grant; Major/Innovative Program of Development Foundation of the Hefei Center for Physical Science and Technology; China's 1000 Young Talents Recruitment Program	This work was supported by National Key Research and Development Program of China Grant 2018YFC1004700; National Natural Science Foundation of China Grants 91754106, 31871350, 31671406, 31601095, and 31621002; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19040101; Major/Innovative Program of Development Foundation of the Hefei Center for Physical Science and Technology Grant 2017FXCX008; and China's 1000 Young Talents Recruitment Program. The authors declare that they have no conflicts of interest with the contents of this article.	Ahamad N, 2016, GENETICS, V204, P1397, DOI 10.1534/genetics.116.193896; Alaamery MA, 2008, GENETICS, V178, P1927, DOI 10.1534/genetics.107.086165; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BYRNE SM, 1993, J CELL SCI, V105, P1095; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Fu CH, 2011, CURR BIOL, V21, P1431, DOI 10.1016/j.cub.2011.07.013; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; HOFFMAN CS, 1991, GENE DEV, V5, P561, DOI 10.1101/gad.5.4.561; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; KAWAMUKAI M, 1991, CELL REGUL, V2, P155, DOI 10.1091/mbc.2.2.155; Lee H, 2014, MOL CELLS, V37, P89, DOI 10.14348/molcells.2014.2329; Liu WY, 2019, J MOL CELL BIOL, V11, P944, DOI 10.1093/jmcb/mjz038; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Prudent J, 2016, CURR BIOL, V26, pR207, DOI 10.1016/j.cub.2016.01.009; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Saitoh S, 2015, MOL BIOL CELL, V26, P373, DOI 10.1091/mbc.E14-11-1503; Saitoh S, 2014, FEBS LETT, V588, P2373, DOI 10.1016/j.febslet.2014.04.047; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Takeda K, 2015, MITOCHONDRION, V22, P91, DOI 10.1016/j.mito.2015.04.003; THEVELEIN JM, 1984, ARCH MICROBIOL, V138, P64, DOI 10.1007/BF00425409; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zheng F, 2014, MOL BIOL CELL, V25, P2750, DOI 10.1091/mbc.E14-03-0786	42	9	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17725	17734		10.1074/jbc.RA119.010185	http://dx.doi.org/10.1074/jbc.RA119.010185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31562247	hybrid, Green Published			2022-12-26	WOS:000504206800003
J	Su, ZL; Kuscu, C; Malik, A; Shibata, E; Dutta, A				Su, Zhangli; Kuscu, Canan; Malik, Asrar; Shibata, Etsuko; Dutta, Anindya			Angiogenin generates specific stress-induced tRNA halves and is not involved in tRF-3?mediated gene silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA metabolism; RNA processing; transfer RNA (tRNA); ribonuclease; stress; angiogenin; gene regulation; noncoding RNA; small RNA; tRNA fragment	CANCER PROGRESSION; FRAGMENTS; CELLS; CLEAVAGE; RIBONUCLEASE; TRANSLATION; BIOGENESIS; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION	tRNA fragments (tRFs) and tRNA halves have been implicated in various cellular processes, including gene silencing, translation, stress granule assembly, cell differentiation, retrotransposon activity, symbiosis, apoptosis, and more. Overexpressed angiogenin (ANG) cleaves tRNA anticodons and produces tRNA halves similar to those produced in response to stress. However, it is not clear whether endogenous ANG is essential for producing the stress-induced tRNA halves. It is also not clear whether smaller tRFs are generated from the tRNA halves. Here, using global short RNA-Seq approach, we found that ANG overexpression selectively cleaves a subset of tRNAs, including tRNA(Glu), tRNA(Gly), tRNA(Lys), tRNA(Val), tRNA(His), tRNA(Asp), and tRNA(SeC) to produce tRNA halves and tRF-5s that are 26?30 bases long. Surprisingly, ANG knockout revealed that the majority of stress-induced tRNA halves, except for the 5? half from tRNA(HisGTG) and the 3? half from tRNA(AspGTC), are ANG independent, suggesting there are other RNases that produce tRNA halves. We also found that the 17?25 bases?long tRF-3s and tRF-5s that could enter into Argonaute complexes are not induced by ANG overexpression, suggesting that they are generated independently from tRNA halves. Consistent with this, ANG knockout did not decrease tRF-3 levels or gene-silencing activity. We conclude that ANG cleaves specific tRNAs and is not the only RNase that creates tRNA halves and that the shorter tRFs are not generated from the tRNA halves or from independent tRNA cleavage by ANG.	[Su, Zhangli; Kuscu, Canan; Malik, Asrar; Shibata, Etsuko; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA; [Kuscu, Canan] Univ Tennessee, Transplant Res Inst, Dept Surg, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Virginia; University of Tennessee System; University of Tennessee Health Science Center	Dutta, A (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA.	ad8q@virginia.edu		Malik, Asrar Ahmad/0000-0003-1950-8747; Kuscu, Canan/0000-0002-8043-7960; Dutta, Anindya/0000-0002-4319-0073; Su, Zhangli/0000-0001-6495-3351	National Institutes of Health [R01 AR067712]; University of Virginia Brain Institute; University of Virginia Supporting Transformative Autism Research (STAR) Pilot Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Brain Institute; University of Virginia Supporting Transformative Autism Research (STAR) Pilot Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 AR067712, University of Virginia Brain Institute Seed Funding and University of Virginia Supporting Transformative Autism Research (STAR) Pilot Award (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bakowska-Zywicka K, 2016, FEBS OPEN BIO, V6, P1186, DOI 10.1002/2211-5463.12127; Balatti V, 2017, P NATL ACAD SCI USA, V114, P8071, DOI 10.1073/pnas.1706908114; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen ZJ, 2019, NUCLEIC ACIDS RES, V47, P2533, DOI 10.1093/nar/gky1250; Cognat V, 2017, NUCLEIC ACIDS RES, V45, P3460, DOI 10.1093/nar/gkw1122; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Czech A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003767; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Dhahbi JM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00074; Donovan J, 2017, RNA, V23, P1660, DOI 10.1261/rna.062000.117; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Faridani OR, 2016, NAT BIOTECHNOL, V34, P1264, DOI 10.1038/nbt.3701; Ferrero G, 2018, ONCOTARGET, V9, P3097, DOI 10.18632/oncotarget.23203; Fricker R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07949-6; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gebert D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4031-9; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Godoy PM, 2018, CELL REP, V25, P1346, DOI 10.1016/j.celrep.2018.10.014; Goncalves KA, 2016, CELL, V166, P894, DOI 10.1016/j.cell.2016.06.042; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Guzzi N, 2018, CELL, V173, P1204, DOI 10.1016/j.cell.2018.03.008; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Honda S, 2017, NUCLEIC ACIDS RES, V45, P9108, DOI 10.1093/nar/gkx537; Honda S, 2015, P NATL ACAD SCI USA, V112, pE3816, DOI 10.1073/pnas.1510077112; Huang Hsiao-Yun, 2016, Life-Basel, V6, P16, DOI 10.3390/life6020016; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Keam SP, 2017, J PROTEOME RES, V16, P413, DOI 10.1021/acs.jproteome.6b00267; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kim HK, 2017, NATURE, V552, P57, DOI 10.1038/nature25005; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Krishna S, 2019, EMBO REP, V20, DOI 10.15252/embr.201947789; Kumar P, 2015, NUCLEIC ACIDS RES, V43, pD141, DOI 10.1093/nar/gku1138; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Kuscu C, 2018, RNA, V24, P1093, DOI 10.1261/rna.066126.118; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Loher P, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep41184; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo SQ, 2018, NUCLEIC ACIDS RES, V46, P5250, DOI 10.1093/nar/gky189; Lyons SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01278-w; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Megel C, 2019, NUCLEIC ACIDS RES, V47, P941, DOI 10.1093/nar/gky1156; Mesitov MV, 2017, SCI REP-UK, V7, DOI 10.1038/srep46080; MOENNER M, 1994, EUR J BIOCHEM, V226, P483, DOI 10.1111/j.1432-1033.1994.tb20073.x; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Pekarsky Y, 2016, P NATL ACAD SCI USA, V113, P5071, DOI 10.1073/pnas.1604266113; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Ren B, 2019, SCIENCE, V365, P919, DOI 10.1126/science.aav8907; RUSSO N, 1994, P NATL ACAD SCI USA, V91, P2920, DOI 10.1073/pnas.91.8.2920; RYBAK SM, 1988, BIOCHEMISTRY-US, V27, P2288, DOI 10.1021/bi00407a007; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Selitsky SR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07675; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sheng JH, 2016, ACTA BIOCH BIOPH SIN, V48, P399, DOI 10.1093/abbs/gmv131; Sheng JH, 2014, J CELL PHYSIOL, V229, P521, DOI 10.1002/jcp.24477; Shurtleff MJ, 2017, P NATL ACAD SCI USA, V114, pE8987, DOI 10.1073/pnas.1712108114; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Soares AR, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0050-8; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Srinivasan S, 2019, CELL, V177, P446, DOI 10.1016/j.cell.2019.03.024; Thomas SP, 2018, RNA, V24, P1018, DOI 10.1261/rna.065516.117; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tosar JP, 2018, NUCLEIC ACIDS RES, V46, P9081, DOI 10.1093/nar/gky495; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; Wang XY, 2018, RNA, V24, P1305, DOI 10.1261/rna.067033.118; Wei ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01196-x; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x; Zhang X, 2016, J IMMUNOL, V196, P1591, DOI 10.4049/jimmunol.1500805; Zhang YF, 2018, NAT CELL BIOL, V20, P535, DOI 10.1038/s41556-018-0087-2	90	60	62	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16930	16941		10.1074/jbc.RA119.009272	http://dx.doi.org/10.1074/jbc.RA119.009272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31582561	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000501801900037
J	Yamada, T; Ashida, Y; Tatebayashi, D; Himori, K				Yamada, Takashi; Ashida, Yuki; Tatebayashi, Daisuke; Himori, Koichi			Myofibrillar function differs markedly between denervated and dexamethasone-treated rat skeletal muscles: Role of mechanical load	PLOS ONE			English	Article							MYOSIN LOSS; PROTEIN; ATROPHY; DEGRADATION; DYSFUNCTION; CALPAIN; FORCE; ACTIVATION; EXPRESSION; PATTERNS	Although there is good evidence to indicate a major role of intrinsic impairment of the contractile apparatus in muscle weakness seen in several pathophysiological conditions, the factors responsible for control of myofibrillar function are not fully understood. To investigate the role of mechanical load in myofibrillar function, we compared the skinned fiber force between denervated (DEN) and dexamethasone-treated (DEX) rat skeletal muscles with or without neuromuscular electrical stimulation (ES) training. DEN and DEX were induced by cutting the sciatic nerve and daily injection of dexamethasone (5 mg/kg/day) for 7 days, respectively. For ES training, plantarflexor muscles were electrically stimulated to produce four sets of five isometric contractions each day. In situ maximum torque was markedly depressed in the DEN muscles compared to the DEX muscles (-74% vs. -10%), whereas there was not much difference in the degree of atrophy in gastrocnemius muscles between DEN and DEX groups (-24% vs. -17%). Similar results were obtained in the skinned fiber preparation, with a greater reduction in maximum Ca2+- activated force in the DEN than in the DEX group (-53% vs. -16%). Moreover, there was a parallel decline in myosin heavy chain (MyHC) and actin content per muscle volume in DEN muscles, but not in DEX muscles, which was associated with upregulation of NADPH oxidase (NOX) 2, neuronal nitric oxide synthase (nNOS), and endothelial NOS expression, translocation of nNOS from the membrane to the cytosol, and augmentation of mRNA levels of muscle RING finger protein 1 (MuRF-1) and atrogin-1. Importantly, mechanical load evoked by ES protects against DEN- and DEX-induced myofibrillar dysfunction and these molecular alterations. Our findings provide novel insights regarding the difference in intrinsic contractile properties between DEN and DEX and suggest an important role of mechanical load in preserving myofibrillar function in skeletal muscle.	[Yamada, Takashi; Ashida, Yuki; Tatebayashi, Daisuke; Himori, Koichi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Ashida, Yuki; Himori, Koichi] Japan Soc Promot Sci, Tokyo, Japan	Sapporo Medical University; Japan Society for the Promotion of Science	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880	Japan Society for the Promotion of Science [JP17H02123, JP19J22784, JP18J13103]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grants No. JP17H02123 to TY; No. JP19J22784 to YA and No. JP18J13103 to KH (https://www.jsps.go.jp/english/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Alamdari N, 2012, AM J PHYSIOL-REG I, V303, pR1090, DOI 10.1152/ajpregu.00636.2011; ALLEN DG, 1982, J PHYSIOL-LONDON, V327, P79, DOI 10.1113/jphysiol.1982.sp014221; Argadine HM, 2009, J APPL PHYSIOL, V107, P438, DOI 10.1152/japplphysiol.91247.2008; Bhattacharya AK, 2016, IEEE C EVOL COMPUTAT, P3003, DOI 10.1109/CEC.2016.7744169; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bowen TS, 2017, FASEB J, V31, P60, DOI 10.1096/fj.201600672R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; DODD SL, 1995, MUSCLE NERVE, V18, P190, DOI 10.1002/mus.880180207; Eason JM, 2000, PHYS THER, V80, P160, DOI 10.1093/ptj/80.2.160; Friedrich O, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12885; Friedrich O, 2015, PHYSIOL REV, V95, P1025, DOI 10.1152/physrev.00028.2014; Furlow JD, 2013, PHYSIOL GENOMICS, V45, P1168, DOI 10.1152/physiolgenomics.00022.2013; Geiger PC, 2001, J APPL PHYSIOL, V90, P1196, DOI 10.1152/jappl.2001.90.4.1196; Germinario E, 2002, J APPL PHYSIOL, V92, P2045, DOI 10.1152/japplphysiol.00673.2001; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Kalamgi RC, 2016, J PHYSIOL-LONDON, V594, P4371, DOI 10.1113/JP271973; Kanzaki K, 2014, J MUSCLE RES CELL M, V35, P179, DOI 10.1007/s10974-014-9378-9; Konno S, 2005, NEUROCHEM RES, V30, P669, DOI 10.1007/s11064-005-2755-4; Kuczmarski JM, 2018, EXP PHYSIOL, V103, P545, DOI 10.1113/EP086649; LASZEWSKI B, 1985, AM J PHYSIOL, V248, pE363, DOI 10.1152/ajpendo.1985.248.3.E363; Lawler JM, 2014, AM J PHYSIOL-REG I, V306, pR470, DOI 10.1152/ajpregu.00371.2013; Terradas ALI, 2018, J PATHOL, V246, P433, DOI 10.1002/path.5149; Minetto MA, 2015, MUSCLE NERVE, V52, P631, DOI 10.1002/mus.24572; MOISESCU DG, 1978, J PHYSIOL-LONDON, V275, P241, DOI 10.1113/jphysiol.1978.sp012188; Mozaffar T, 2007, MUSCLE NERVE, V35, P55, DOI 10.1002/mus.20647; Ochala J, 2008, EXP PHYSIOL, V93, P486, DOI 10.1113/expphysiol.2007.041798; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Ottenheijm CAC, 2005, AM J RESP CRIT CARE, V172, P200, DOI 10.1164/rccm.200502-262OC; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Renaud G, 2013, J PHYSIOL-LONDON, V591, P1385, DOI 10.1113/jphysiol.2012.248724; Rudnick J, 2004, FASEB J, V18, P1228, DOI 10.1096/fj.03-0792fje; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Supinski GS, 2007, J APPL PHYSIOL, V102, P2056, DOI 10.1152/japplphysiol.01138.2006; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tiago T, 2006, BIOCHEMISTRY-US, V45, P3794, DOI 10.1021/bi0518500; Tiago T, 2006, BIOCHEM BIOPH RES CO, V342, P44, DOI 10.1016/j.bbrc.2006.01.112; Watanabe D, 2016, AM J PHYSIOL-REG I, V311, pR919, DOI 10.1152/ajpregu.00046.2016; Yamada T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01111; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907	50	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223551	10.1371/journal.pone.0223551	http://dx.doi.org/10.1371/journal.pone.0223551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596883	Green Submitted, Green Published, gold			2022-12-26	WOS:000532444100042
J	Rout, SK; Gabhale, YR; Dutta, A; Balakrishnan, S; Lala, MM; Setia, MS; Bhuyan, K; Manglani, MV				Rout, Sarit Kumar; Gabhale, Yashwant R.; Dutta, Ambarish; Balakrishnan, Sudha; Lala, Mamatha M.; Setia, Maninder Singh; Bhuyan, Khanindra; Manglani, Mamta, V			Can telemedicine initiative be an effective intervention strategy for improving treatment compliance for pediatric HIV patients: Evidences on costs and improvement in treatment compliance from Maharashtra, India	PLOS ONE			English	Article							HIV/AIDS PREVENTION; CARE; HEALTH	Background India has recently introduced telemedicine initiatives to enhance access to specialized care at a low cost for the pediatric HIV patients, who face multiple challenges due to growing disease burden and limited preparedness of the health system to address it. There are limited evidences on the cost-effectiveness of these interventions. This study was undertaken in Maharashtra, a province, located in the western region of the country, to inform policy regarding the effectiveness of this programme. The objective was to estimate the unit cost of ART services for pediatric HIV patients and examine the efficiency in the use of resource and treatment compliance resulting from telemedicine initiatives in pediatric HIV compared to usual ART services. Methods We selected 6 ART centers (3 from linked centers linked to Pediatric HIV Centre of Excellence (PCoE) and 3 from non-linked centers) randomly from three high, middle and low ART centers, categorized on the basis of case load in each arm. A bottom up costing methodology was adopted to understand the unit cost of services. Loss to follow up and timeliness of the visits were compared between the two arms and were linked to the cost. Results The average cost per-visit was INR 1803 in the linked centers and that for the non-linked centers was INR 3412. There has been 5 percentage point improvement in lost to follow-up in the linked centers compared to non-linked centers against a back-drop of a reduction in per-pediatric patient cost of INR 557. The linkage has resulted in increase in timeliness of the visits in linked centers compared to non-linked centers. Discussion and conclusion The telemedicine linkage led to an increase in the case load leading to a decrease in cost. The evidence on efficiency in the use of resource and improvement in treatment compliance as suggested by this study could be used to scale up this initiative.	[Rout, Sarit Kumar; Dutta, Ambarish] Indian Inst Publ Hlth, Bhubaneswar, Odisha, India; [Gabhale, Yashwant R.; Lala, Mamatha M.; Manglani, Mamta, V] LTM Med Coll & Gen Hosp, Pediat Ctr Excellence HIV Care, Dept Pediat, Mumbai, Maharashtra, India; [Balakrishnan, Sudha] UNICEF India, New Delhi, India; [Setia, Maninder Singh] Karanam Consultancy, Mumbai, Maharashtra, India; [Bhuyan, Khanindra] UNICEF State Off, Mumbai, Maharashtra, India		Rout, SK (corresponding author), Indian Inst Publ Hlth, Bhubaneswar, Odisha, India.	sarit.kumar@phfi.org	Setia, Maninder/AAH-8123-2021	Rout, Sarit/0000-0003-0831-789X; Dutta, Ambarish/0000-0002-4019-7472; Setia, Maninder Singh/0000-0003-1291-9033	UNICEF India and its state counterpart in Maharashtra; LTMGH, Sion, Mumbai	UNICEF India and its state counterpart in Maharashtra; LTMGH, Sion, Mumbai	UNICEF India and its state counterpart in Maharashtra provided financial support to LTMGH, Sion, Mumbai for conducting this study. We received a small funding from LTMGH, Sion, Mumbai to undertake this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript has been developed as a part of the evaluation of telemedicine initiative implemented by the Department of Pediatrics, LTMMC & LTMGH, Sion, Mumbai, India, for improving pediatric health outcomes in the state of Maharashtra. Many organizations and experts were involved in this process and, we take this opportunity to thank everyone, who, contributed in this process. Our sincere thanks are due to the dean of medical college hospital for approving this study. We sincerely thank NACO, MSACS, MDACS & Department of Pediatrics, LTMMC & LTMGH, Sion, Mumbai, for providing necessary permission as well as facilitating data collection process from different ART centers to make relevant analysis for this study. UNICEF India and its state counterpart in Maharashtra provided technical as well financial support for conducting this study and we sincerely acknowledge their valuable contribution in the whole process. Our tanks are due to field investigators, nurses, midwives, supervisors, laboratory staff, and department staff members, who made significant contribution for this study. We also provide our thanks to the mothers, and children who participated in this study. Our sincere thanks are due to Sudipta Samal, who worked as a research associate and helped in the data analysis in this project.	Acharya Rajesh V, 2016, J Family Med Prim Care, V5, P798, DOI 10.4103/2249-4863.201174; Bhat R., 2006, COSTING HIV AIDS INT; Burns F., 1998, INFORM HLTH INFORM S; Dandona L, 2008, AIDS, V22, pS43, DOI 10.1097/01.aids.0000327622.24232.aa; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Freedberg KA, CLIN IMPACT COST EFF; Ghia CJ, 2013, INDIAN MED GAZETTE, V146, P1; Guinness L, 2005, B WORLD HEALTH ORGAN, V83, P747; Haacker M, 2009, DIR DEV, P75; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; Lala MM, 2014, INDIAN J MED RES, V140, P704; Le Doare K, 2015, ARCH DIS CHILD, V100, P527, DOI 10.1136/archdischild-2014-307019; Marseille E, 2014, LANCET GLOB HEALTH, V2, pE493, DOI 10.1016/S2214-109X(14)70295-5; Marshall DA, 2009, MED CARE, V47, pS14, DOI 10.1097/MLR.0b013e3181a31971; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; Pandve HT, 2015, N AM J MED SCI, V7, P575, DOI 10.4103/1947-2714.172853; Perednia DA, 2003, JAMA-J AM MED ASSOC, V273, P483; PFI, COST AN SCAL IN; Saifu HN, 2012, AM J MANAG CARE, V18, P207; Shepard D. S., 1999, J MENT HEALTH POLICY, V2, P91, DOI DOI 10.1002/(SICI)1099-176X(199906)2:23.0.CO;2-I; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2018, UNAIDS DAT 2018; Waldura JF, 2013, J GEN INTERN MED, V28, P793, DOI 10.1007/s11606-013-2332-5; Walker D, 2003, HEALTH POLICY PLANN, V18, P4, DOI 10.1093/heapol/18.1.4; Whitten PS, SYSTEMATIC REV COST, DOI [10.1136/bmj.324.7351.1434, DOI 10.1136/BMJ.324.7351.1434]; WHO, 1998, HLTH TEL POL; Wootton R., J ROYAL SOC MED; World Health Organization, 2013, CONGUID UANT DRU; Young JD, 2014, CLIN INFECT DIS, V59, P123, DOI 10.1093/cid/ciu222; Zolfo M, 2015, J TELEMED TELECARE, P65	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0223303	10.1371/journal.pone.0223303	http://dx.doi.org/10.1371/journal.pone.0223303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593580	gold, Green Published			2022-12-26	WOS:000532431700005
J	Biteye, B; Fall, AG; Seck, MT; Ciss, M; Diop, M; Gimonneau, G				Biteye, Biram; Fall, Assane Gueye; Seck, Momar Talla; Ciss, Mamadou; Diop, Mariame; Gimonneau, Geoffrey			Host-feeding patterns of Aedes (Aedimorphus) vexans arabiensis, a Rift Valley Fever virus vector in the Ferlo pastoral ecosystem of Senegal	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WEST-NILE-VIRUS; MITOCHONDRIAL-DNA; REACTION PCR; BLOOD MEALS; IDENTIFICATION; DIPTERA; BARKEDJI; AMPLIFICATION; TRANSMISSION	Background Host-vector contact is a key factor in vectorial capacity assessment and thus the transmission of mosquito-borne viruses such as Rift Valley Fever (RVF), an emerging zoonotic disease of interest in West Africa. The knowledge of the host-feeding patterns of vector species constitutes a key element in the assessment of their epidemiological importance in a given environment. The aim of this work was to identify the blood meal origins of the mosquito Aedes vexans arabiensis, the main vector of RVF virus in the Ferlo pastoral ecosystem of Senegal. Methodology/principal findings Engorged female mosquitoes were collected in Younoufe ' re ' in the pastoral ecosystem in the Ferlo region during the 2014 rainy season. CO2-baited CDC light traps were set at six points for two consecutive nights every month from July to November. Domestic animals present around traps were identified and counted for each trapping session. Blood meal sources of engorged mosquitoes were identified using a vertebrate-specific multiplexed primer set based on cytochrome b. Blood meal sources were successfully identified for 319 out of 416 blood-fed females (76.68%), of which 163 (51.1%) were single meals, 146 (45.77%) mixed meals from two different hosts and 10 (3.13%) mixed meals from three different hosts. Aedes vexans arabiensis fed preferentially on mammals especially on horse compared to other hosts (FR = 46.83). Proportions of single and mixed meals showed significant temporal and spatial variations according to the availability of the hosts. Conclusion Aedes vexans arabiensis shows an opportunistic feeding behavior depending on the host availability. This species fed preferentially on mammals especially on horses (primary hosts) and ruminants (secondary hosts).	[Biteye, Biram; Fall, Assane Gueye; Seck, Momar Talla; Ciss, Mamadou; Diop, Mariame] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, BP 2057, Dakar, Senegal; [Gimonneau, Geoffrey] CIRAD, UMR INTERTRYP, Montpellier, France; [Gimonneau, Geoffrey] Ctr Int Rech Dev Elevage Zone Subhumide, Bobo Dioulasso 01, Burkina Faso; [Gimonneau, Geoffrey] Univ Montpellier, CIRAD, INTERTRYP, IRD, Montpellier, France	CIRAD; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Biteye, B (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, BP 2057, Dakar, Senegal.	biteye88@yahoo.fr		BITEYE, Biram/0000-0003-3474-7578	M T S FP7-613996 Vmerge European Union	M T S FP7-613996 Vmerge European Union	Funded by M T S FP7-613996 Vmerge European Union. http://www.vmerge.eu.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; AKANE A, 1994, J FORENSIC SCI, V39, P362; Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1; Ba Y, 2006, B SOC PATHOL EXOT, V99; Bakhoum MT, 2016, ACTA TROP, V157, P59, DOI 10.1016/j.actatropica.2016.01.023; Bakhoum MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084316; Bataille M, 1999, FORENSIC SCI INT, V99, P165, DOI 10.1016/S0379-0738(98)00185-6; BEIER JC, 1987, J MED ENTOMOL, V24, P28, DOI 10.1093/jmedent/24.1.28; Biteye B, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2591-9; Brunhers J, 1999, CULICIDAE AFRIQUE ME; Chevalier V, 2009, TRANSBOUND EMERG DIS, V56, P372, DOI 10.1111/j.1865-1682.2009.01083.x; Chevalier V, 2005, EMERG INFECT DIS, V11, P1693, DOI DOI 10.3201/EID1111.050193; de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x; DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267; Diallo D, 2008, Bull Soc Pathol Exot, V101, P410; Diallo D, 2011, J VECTOR ECOL, V36, P426, DOI 10.1111/j.1948-7134.2011.00184.x; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Fall AG, 2012, MED VET ENTOMOL, V26, P106, DOI 10.1111/j.1365-2915.2011.00974.x; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gingrich JB, 2005, J AM MOSQUITO CONTR, V21, P194, DOI 10.2987/8756-971X(2005)21[194:HPOSWN]2.0.CO;2; Guillaud M, 1988, ANN I PASTEUR VIROLO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hervy JP, 1998, CALE LOGICIEL IDENTI; HESS AD, 1968, MOSQ NEWS, V28, P386; Humair PF, 2007, J MED ENTOMOL, V44, P869, DOI 10.1603/0022-2585(2007)44[869:MIOBSI]2.0.CO;2; JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7; Kawada H, 2012, PARASITE VECTOR, V5, P8; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lancelot R, 2011, PARASIT VECTORS, V4; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Lujan DA, 2014, J MED ENTOMOL, V51, P264, DOI 10.1603/ME13163; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Matsunaga T, 1999, MEAT SCI, V51, P143, DOI 10.1016/S0309-1740(98)00112-0; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Nabeth P, 2001, EMERG INFECT DIS, V7, P1052, DOI 10.3201/eid0706.010627; NDIONE JA, 2003, ENVIRON RISQUE SANTE, V2, P176; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; OIE, 2014, RIFT VALL FEV SEN DK; OIE, 2013, 20130924 OIE; Peyre M, 2015, ZOONOSES PUBLIC HLTH, V62, P309, DOI 10.1111/zph.12153; Pitzer JB, 2011, J MED ENTOMOL, V48, P53, DOI 10.1603/ME10123; Poche RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0883-0; R Core Team, 2021, R LANGUAGE ENV STAT; Reeves LE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190633; RURANGIRWA FR, 1986, ACTA TROP, V43, P379; Schaffner F, 2001, MOUTIQUES EUROPE PRO; Solano P, 1997, ACTA TROP, V65, P175, DOI 10.1016/S0001-706X(97)00663-3; Sow A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw149; Stephenson E, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3405-z; TOBOLEWSKI J, 1992, J MED ENTOMOL, V29, P1049, DOI 10.1093/jmedent/29.6.1049; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	56	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0215194	10.1371/journal.pone.0215194	http://dx.doi.org/10.1371/journal.pone.0215194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584948	Green Published, Green Submitted, gold			2022-12-26	WOS:000532407600002
J	Elmer, J; Fogliato, R; Setia, N; Mui, W; Lynch, M; Hulsey, E; Nagin, D				Elmer, Jonathan; Fogliato, Riccardo; Setia, Nikita; Mui, Wilson; Lynch, Michael; Hulsey, Eric; Nagin, Daniel			Trajectories of prescription opioids filled over time	PLOS ONE			English	Article							UNITED-STATES; PRESCRIBING PATTERNS; IDENTIFY PATIENTS; RISK; OVERDOSES; ABUSE	We performed a retrospective cohort study that aimed to identify one or more groups that followed a pattern of chronic, high prescription use and quantify individuals' time-dependent probabilities of belonging to a high-utilizer group. We analyzed data from 52,456 adults age 18-45 who enrolled in Medicaid from 2009-2017 in Allegheny County, Pennsylvania who filled at least one prescription for an opioid analgesic. We used group-based trajectory modeling to identify groups of individuals with distinct patterns of prescription opioid use over time. We found the population to be comprised of three distinct trajectory groups. The first group comprised 83% of the population and filled few, if any, opioid prescriptions after their index prescription. The second group (12%) initially filled an average of one prescription per month, but declined over two years to near-zero. The third group (6%) demonstrated sustained high opioid prescriptions utilization. Using individual patients' posterior probability of membership in the high utilization group, which can be updated iteratively over time as new information become available, we defined a sensitive threshold predictive of sustained future opioid utilization. We conclude that individuals at risk of sustained opioid utilization can be identified early in their clinical course from limited observational data.	[Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15260 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Fogliato, Riccardo; Nagin, Daniel] Carnegie Mellon Univ, Dept Stat & Data Sci, Pittsburgh, PA 15213 USA; [Setia, Nikita; Mui, Wilson] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Lynch, Michael] Univ Pittsburgh, Sch Med, Dept Emergency Med, Div Med Toxicol, Pittsburgh, PA USA; [Hulsey, Eric] Allegheny Cty Dept Human Serv, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elmer, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15260 USA.; Elmer, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Elmer, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	elmerjp@upmc.edu			National Institutes of Health [5K23NS097629]; Deloitte Consulting, LLP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS097629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deloitte Consulting, LLP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research time is supported by the National Institutes of Health through grant 5K23NS097629 to JE. This work was supported by a grant by Deloitte Consulting, LLP, to Carnegie Mellon University (no grant number) to all. The funders played no role in the design of the study, or any aspects of the study conduct or decision to publish.	[Anonymous], 2017, PAIN MAN OP EP BAL S; Belgrade MJ, 2006, J PAIN, V7, P671, DOI 10.1016/j.jpain.2006.03.001; Blendon RJ, 2018, NEW ENGL J MED, V378, P407, DOI 10.1056/NEJMp1714529; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Butler SF, 2008, J PAIN, V9, P360, DOI 10.1016/j.jpain.2007.11.014; Compton PA, 2008, J PAIN SYMPTOM MANAG, V36, P383, DOI 10.1016/j.jpainsymman.2007.11.006; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kitzmiller EM, 2013, IDS CASE STUDY ALLEG; Klijn SL, 2017, STAT METHODS MED RES, V26, P2424, DOI 10.1177/0962280215598665; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Nagin D., 2005, GROUP BASED MODELING, Vx; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Passik Steven D, 2005, J Opioid Manag, V1, P257; Paulozzi LJ, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6409a1; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Rice JB, 2012, PAIN MED, V13, P1162, DOI 10.1111/j.1526-4637.2012.01450.x; Ringwalt C, 2015, PAIN MED, V16, P633, DOI 10.1111/pme.12555; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Serdarevic M, 2017, CURR OPIN PSYCHIATR, V30, P238, DOI 10.1097/YCO.0000000000000337; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Soelberg CD, 2017, ANESTH ANALG, V125, P1675, DOI 10.1213/ANE.0000000000002403; VanHouten JP, 2019, MMWR-MORBID MORTAL W, V68, P1, DOI 10.15585/mmwr.mm6801a1; Vivolo-Kantor AM, 2018, MMWR-MORBID MORTAL W, V67, P279, DOI 10.15585/mmwr.mm6709e1; White AG, 2009, AM J MANAG CARE, V15, P897	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0222677	10.1371/journal.pone.0222677	http://dx.doi.org/10.1371/journal.pone.0222677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584961	Green Published, gold			2022-12-26	WOS:000532407600010
J	Furfaro, LL; Chang, BJ; Kahler, CM; Payne, MS				Furfaro, Lucy L.; Chang, Barbara J.; Kahler, Charlene M.; Payne, Matthew S.			Genomic characterisation of perinatal Western Australian Streptococcus agalactiae isolates	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; MULTIPLEX PCR ASSAY; SEROTYPE IV; ANTIBIOTIC-RESISTANCE; INVASIVE DISEASE; ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; MATERNAL COLONIZATION; POPULATION-STRUCTURE; VIRULENCE FACTORS	As a leading cause of neonatal sepsis, Streptococcus agalactiae, commonly known as Group B Streptococcus, is a major neonatal pathogen. Current global screening practices employ risk- or culture-based protocols for detection of these organisms. In Western Australia (WA), universal culture-based screening is provided, with subsequent intrapartum antibiotic prophylaxis for all S. agalactiae-positive women during labour. Widespread antibiotic exposure is not ideal and this is one of the factors driving development of vaccines against S. agalactiae. Vaccine candidates have focused on the capsule, surface proteins and pilus types, however, capsule serotypes are known to vary geographically. The aim of this study was to use genome sequencing to gain an understanding of the circulating genotypes in WA, and to assess variations in the associated gene pools. We sequenced 141 antenatal carriage (vaginal/rectal) isolates and 10 neonatal invasive disease isolates from WA. Based on the global PubMLST database, the 151 strains were characterised into 30 sequence types, with clustering of these mainly into clonal complexes 1, 12, 17, 19 and 23. Of the genes encoding eleven surface proteins that were analysed, the most prevalent were fbp, lmb and scpB which were present in >= 98% of isolates. A cluster of non-haemolytic isolates, one of which was a neonatal invasive disease isolate, appeared to lack the entire cyl locus. Admixture analysis of population structure revealed evidence of genetic transfer among the WA isolates across structural groups. When compared against the PubMLST S. agalactiae data, WA isolates showed high levels of strain diversity with minimal apparent clustering. This is the first whole genome sequence study of WA S. agalactiae isolates and also represents the first addition of Australian isolate data to PubMLST. This report provides insight into the distribution and diversity of vaccine targets of S. agalactiae within Western Australia, indicating that the most appropriate capsular vaccine for this population would be the proposed pentavalent (Cps Ia, Ib, II, III and V) preparation, whilst vaccines targeting surface proteins should ideally utilise Fbp, Lmb and/or ScpB.	[Furfaro, Lucy L.; Payne, Matthew S.] Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Perth, WA, Australia; [Chang, Barbara J.; Kahler, Charlene M.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Biomed Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia	Furfaro, LL (corresponding author), Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Perth, WA, Australia.	lucy.furfaro@uwa.edu.au	; Furfaro, Lucy/H-5569-2018	Chang, Barbara/0000-0002-6077-1646; Furfaro, Lucy/0000-0001-7652-0713	Wesfarmers Centre of Vaccines and Infectious Diseases; Australian Government; Women and Infants Research Foundation (WIRF); NHMRC [1144040]	Wesfarmers Centre of Vaccines and Infectious Diseases; Australian Government(Australian GovernmentCGIAR); Women and Infants Research Foundation (WIRF); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a Wesfarmers Centre of Vaccines and Infectious Diseases Seed Funding Grant received by all authors. LLF is supported by the Australian Government Research Training Program Scholarship and the Professor Gordon King Postgraduate Scholarship provided by the Women and Infants Research Foundation (WIRF). MSP is supported by an NHMRC Project Grant [1144040]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Campisi E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29799; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Creti R, 2004, J CLIN MICROBIOL, V42, P1326, DOI 10.1128/JCM.42.3.1326-1329.2004; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Dangor Z, 2015, EXPERT REV VACCINES, V14, P1651, DOI 10.1586/14760584.2015.1085307; Diedrick MJ, 2010, J CLIN MICROBIOL, V48, P3100, DOI 10.1128/JCM.00277-10; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; Eskandarian N, 2015, EUR J CLIN MICROBIOL, V34, P579, DOI 10.1007/s10096-014-2265-x; Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572; Flores AR, 2015, P NATL ACAD SCI USA, V112, P6431, DOI 10.1073/pnas.1504725112; Florindo C, 2014, EURO SURVEILL, V19; Furfaro LL, 2019, J MED MICROBIOLOGY; Furfaro LL, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00049-18; Furfaro LL, 2017, DIAGN MICR INFEC DIS, V89, P7, DOI 10.1016/j.diagmicrobio.2017.06.003; Gendrin C, 2017, J INFECT DIS; Gherardi G, 2007, J CLIN MICROBIOL, V45, P2909, DOI 10.1128/JCM.00999-07; Granlund M, 1998, J INFECT DIS, V177, P967, DOI 10.1086/515233; Gudjonsdottir MJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1266-4; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Heath PT, 2016, VACCINE, V34, P2876, DOI 10.1016/j.vaccine.2015.12.072; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kapatai G, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3820-5; Ko DW, 2015, J PAEDIAT CHILD HLTH; Kong F, 2008, J CLIN MICROBIOL, V46, P2745, DOI 10.1128/JCM.00189-08; Kong FR, 2002, J CLIN MICROBIOL, V40, P620, DOI 10.1128/JCM.40.2.620-626.2002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lachenauer CS, 1999, J INFECT DIS, V179, P1030, DOI 10.1086/314666; Larsson C, 2006, ARCH DIS CHILD-FETAL, V91, pF403, DOI 10.1136/adc.2005.090472; Lartigue MF, 2009, J CLIN MICROBIOL, V47, P2284, DOI 10.1128/JCM.00175-09; Lazzarin M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1057-8; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lin SM, 2018, CLIN EXP VACCINE RES, V7, P76, DOI 10.7774/cevr.2018.7.1.76; Liu GYH, 2004, FRONT BIOSCI-LANDMRK, V9, P1794, DOI 10.2741/1296; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Lyhs U, 2016, EMERG INFECT DIS, V22, P2097, DOI 10.3201/eid2212.151447; Madrid L, 2017, CLIN INFECT DIS, V65, pS160, DOI 10.1093/cid/cix656; Martins ER, 2010, J BACTERIOL, V192, P1361, DOI 10.1128/JB.01130-09; Meehan M, 2014, EUR J CLIN MICROBIOL, V33, P1155, DOI 10.1007/s10096-014-2055-5; Mehershahi KS, 2015, GENOME ANNOUNC, V3; MILLIGAN TW, 1978, INFECT IMMUN, V21, P738, DOI 10.1128/IAI.21.3.738-746.1978; Neemuchwala A, 2016, EMERG INFECT DIS, V22, P1941, DOI 10.3201//eid2211.152064; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rodriguez-Granger J, 2015, PATHOGENS DIS; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Seale AC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.67, 10.1038/NMICROBIOL.2016.67]; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Singh P, 2012, J BACTERIOL, V194, P6005, DOI 10.1128/JB.01378-12; Six A, 2016, J CLIN MICROBIOL, V54, P75, DOI 10.1128/JCM.02177-15; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Springman AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-159; Suhaimi MES, 2017, J INFECT PUBLIC HEAL, V10, P14, DOI 10.1016/j.jiph.2016.01.009; Taylor K, 2006, THESIS; Teatero S, 2015, EMERG INFECT DIS, V21, P585, DOI 10.3201/eid2014.140759; Teatero S, 2014, J CLIN MICROBIOL, V52, P1441, DOI 10.1128/JCM.03554-13; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zeng XY, 2006, ANTIMICROB AGENTS CH, V50, P204, DOI 10.1128/AAC.50.1.204-209.2006; Zhao Z, 2008, CLIN MICROBIOL INFEC, V14, P260, DOI 10.1111/j.1469-0691.2007.01914.x	69	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223256	10.1371/journal.pone.0223256	http://dx.doi.org/10.1371/journal.pone.0223256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577825	Green Published, gold			2022-12-26	WOS:000532388000026
J	Li, Y; Giorgi, EE; Beckman, KB; Caberto, C; Kazma, R; Lum-Jones, A; Haiman, CA; Le Marchand, L; Stram, DO; Saxena, R; Cheng, I				Li, Yuqing; Giorgi, Elena E.; Beckman, Kenneth B.; Caberto, Christian; Kazma, Remi; Lum-Jones, Annette; Haiman, Christopher A.; Le Marchand, Loic; Stram, Daniel O.; Saxena, Richa; Cheng, Iona			Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DNA MUTATIONS; VARIANT; DAMAGE; CELLS; TWINS; GWAS; RARE	Background The mitochondrial genome encodes for thirty-seven proteins, among them thirteen are essential for the oxidative phosphorylation (OXPHOS) system. Inherited variation in mitochondrial genes may influence cancer development through changes in mitochondrial proteins, altering the OXPHOS process and promoting the production of reactive oxidative species. Methods To investigate the association between mitochondrial genetic variation and breast cancer risk, we tested 314 mitochondrial SNPs (mtSNPs), capturing four complexes of the mitochondrial OXPHOS pathway and mtSNP groupings for rRNA and tRNA, in 2,723 breast cancer cases and 3,260 controls from the Multiethnic Cohort Study. Results We examined the collective set of 314 mtSNPs as well as subsets of mtSNPs grouped by mitochondrial OXPHOS pathway, complexes, and genes, using the sequence kernel association test and adjusting for age, sex, and principal components of global ancestry. We also tested haplogroup associations using unconditional logistic regression and adjusting for the same covariates. Stratified analyses were conducted by self-reported maternal race/ethnicity. No significant mitochondrial OXPHOS pathway, gene, and haplogroup associations were observed in African Americans, Asian Americans, Latinos, and Native Hawaiians. In European Americans, a global test of all genetic variants of the mitochondrial genome identified an association with breast cancer risk (P = 0.017, q = 0.102). In mtSNP-subset analysis, the gene MT-CO2 (P = 0.001, q = 0.09) in Complex IV (cytochrome c oxidase) and MT-ND2 (P = 0.004, q = 0.19) in Complex I (NADH dehydrogenase (ubiquinone)) were significantly associated with breast cancer risk. Conclusions In summary, our findings suggest that collective mitochondrial genetic variation and particularly in the MT-CO2 and MT-ND2 may play a role in breast cancer risk among European Americans. Further replication is warranted in larger populations and future studies should evaluate the contribution of mitochondrial proteins encoded by both the nuclear and mitochondrial genomes to breast cancer risk.	[Li, Yuqing; Cheng, Iona] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Giorgi, Elena E.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA; [Beckman, Kenneth B.] Univ Minnesota, Genom Ctr, Minneapolis, MN USA; [Caberto, Christian; Lum-Jones, Annette; Le Marchand, Loic] Univ Hawaii, Epidemiol Program, Canc Ctr, Honolulu, HI 96822 USA; [Kazma, Remi] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Haiman, Christopher A.; Stram, Daniel O.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Saxena, Richa] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Saxena, Richa] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System; Roche Holding; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Cheng, I (corresponding author), Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA.	Iona.Cheng@ucsf.edu		Saxena, Richa/0000-0003-2233-1065	NCI [R01 CA140636, R03 CA173782, R01 CA63464, CA98758, U01 CA164973]; National Human Genome Research Institute [U01HG004802]; NATIONAL CANCER INSTITUTE [U01CA164973, P30CA071789] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded through NCI (R01 CA140636 to IC, R03 CA173782 to IC, R01 CA63464, CA98758, and U01 CA164973 to LLM) and through the National Human Genome Research Institute, U01HG004802 to LLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2014, CANCER EPIDEM BIOMAR, V23, P658, DOI 10.1158/1055-9965.EPI-13-0340; Ali AT, 2019, ELIFE, V8, DOI 10.7554/eLife.41927; American Cancer Society, 2019, CANC FACTS FIGURES 2; ANDERSON L, 1981, P NATL ACAD SCI-BIOL, V78, P2407, DOI 10.1073/pnas.78.4.2407; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Blein S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0567-2; Bonilla C, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0171-8; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Cohen T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006407; Covarrubias D, 2008, J HUM GENET, V53, P924, DOI 10.1007/s10038-008-0331-x; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fachal L, 2015, CURR OPIN GENET DEV, V30, P32, DOI 10.1016/j.gde.2015.01.004; Fejerman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6260; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Francis A, 2013, MITOCHONDRION, V13, P559, DOI 10.1016/j.mito.2013.08.004; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kujoth GC, 2008, EXP GERONTOL, V43, P20, DOI 10.1016/j.exger.2007.09.010; Lamb R, 2015, ONCOTARGET, V6, P21892, DOI 10.18632/oncotarget.5260; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Leigh-Brown S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-215; Li YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136796; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Low SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076463; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Setiawan VW, 2008, CANCER GENET CYTOGEN, V181, P16, DOI 10.1016/j.cancergencyto.2007.10.019; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Singh R, 2016, MOL CANCER RES, V14, P78, DOI 10.1158/1541-7786.MCR-15-0151; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222284	10.1371/journal.pone.0222284	http://dx.doi.org/10.1371/journal.pone.0222284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577800	gold, Green Published			2022-12-26	WOS:000532388000008
J	Zhong, W; Guo, XM; Wang, GL				Zhong, Wei; Guo, Xuemei; Wang, Guoli			QRStree: A prefix tree-based model to fetal QRS complexes detection	PLOS ONE			English	Article							ECG EXTRACTION; SIGNAL; TRIE	Non-invasive fetal electrocardiography (NI-FECG) plays an important role in fetal heart rate (FHR) measurement during the pregnancy. However, despite the large number of methods that have been proposed for adult ECG signal processing, the analysis of NI-FECG remains challenging and largely unexplored. In this study, we propose a prefix tree-based framework, called QRStree, for FHR measurement directly from the abdominal ECG (AECG). The procedure is composed of three stages: Firstly, a preprocessing stage is employed for noise elimination. Secondly, the proposed prefix tree-based method is used for fetal QRS complexes (FQRS) detection. Finally, a correction stage is applied for false positive and false negative correction. The novelty of the framework relies on using the range of FHR to establish the connections between the FQRS. The consecutive FQRS can be considered as strings composed of alphabet items, thus we can use the prefix tree to store them. A vertex of the tree contains an alphabet, thus a path of the tree gives a string. Such that, by storing the connections of the FQRS into the prefix tree structure, the problem of FQRS detection converts to a problem of optimal path selection. Specifically, after selecting the optimal path of the tree, the nodes in the optimal path are collected as detected FQRS. Since the prefix tree can cover every possible combination of the FQRS candidates, it has the potential to reduce the occurrence of miss detections. Results on two different databases show that the proposed method is effective in FHR measurement from single-channel AECG. The focus on single-channel FHR measurement facilitates the long-term monitoring for healthcare at home.	[Zhong, Wei; Guo, Xuemei; Wang, Guoli] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Peoples R China; [Zhong, Wei; Guo, Xuemei; Wang, Guoli] Minist Educ, Key Lab Machine Intelligence & Adv Comp, Guangzhou, Peoples R China	Sun Yat Sen University	Wang, GL (corresponding author), Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Peoples R China.; Wang, GL (corresponding author), Minist Educ, Key Lab Machine Intelligence & Adv Comp, Guangzhou, Peoples R China.	isswgl@mail.sysu.edu.cn	Wang, Guo Li/Q-1225-2019	Wang, Guo Li/0000-0003-4031-7996	National Natural Science Foundation of P.R. China [61772574, 61375080, U1811462]; Key Program of the National Social Science Fund of China [18ZDA308]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Key Program of the National Social Science Fund of China	This work was supported in part by the National Natural Science Foundation of P.R. China under Grant Nos. 61772574, 61375080 and U1811462 and in part by the Key Program of the National Social Science Fund of China with Grant No 18ZDA308.	Andreotti F, 2017, IEEE T BIO-MED ENG, V64, P2793, DOI 10.1109/TBME.2017.2675543; Andreotti F, 2016, PHYSIOL MEAS, V37, P627, DOI 10.1088/0967-3334/37/5/627; Andreotti F, 2014, PHYSIOL MEAS, V35, P1551, DOI 10.1088/0967-3334/35/8/1551; Assaleh K, 2007, IEEE T BIO-MED ENG, V54, P59, DOI 10.1109/TBME.2006.883728; Behar J, 2016, PHYSIOL MEAS, V37, pR1, DOI 10.1088/0967-3334/37/5/R1; Behar J, 2013, COMPUT CARDIOL CONF, V40, P297, DOI 10.1049/iet-tv.41.18108; Behar J, 2014, PHYSIOL MEAS, V35, P1569, DOI 10.1088/0967-3334/35/8/1569; Behar J, 2014, ANN BIOMED ENG, V42, P1340, DOI 10.1007/s10439-014-0993-9; Behar J, 2013, IEEE T BIO-MED ENG, V60, P1660, DOI 10.1109/TBME.2013.2240452; Bodon F, 2003, MATH COMPUT MODEL, V38, P739, DOI [10.1016/0895-7177(03)90058-6, 10.1016/S0895-7177(03)00275-9]; Castillo E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199308; Cerutti S., 2009, J PERINATAL MED OFFI, V14, P445, DOI DOI 10.1515/jpme.1986.14.6.445; Clifford GD, 2014, PHYSIOL MEAS, V35, P1521, DOI 10.1088/0967-3334/35/8/1521; Clifford GD, 2006, ADV METHODS TOOLS EC, V35; Dessi A, 2014, PHYSIOL MEAS, V35, P1621, DOI 10.1088/0967-3334/35/8/1621; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hamilton PS, 1996, IEEE T BIO-MED ENG, V43, P105, DOI 10.1109/10.477707; Hasan MA, 2009, BIOL PROCED ONLINE, V11, P263, DOI 10.1007/s12575-009-9006-z; Johnson AEW, 2015, PHYSIOL MEAS, V36, P1665, DOI 10.1088/0967-3334/36/8/1665; Kanjilal PP, 1997, IEEE T BIO-MED ENG, V44, P51, DOI 10.1109/10.553712; Lewis MJ, 2003, MED ENG PHYS, V25, P801, DOI 10.1016/S1350-4533(03)00121-8; Liu CY, 2014, PHYSIOL MEAS, V35, P1665, DOI 10.1088/0967-3334/35/8/1665; Najafabadi FS, 2006, COMPUT BIOL MED, V36, P241, DOI 10.1016/j.compbiomed.2004.11.004; Oudijk MA, 2004, BJOG-INT J OBSTET GY, V111, P656, DOI 10.1111/j.1471-0528.2004.00178.x; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Peters M, 2001, J PERINAT MED, V29, P408, DOI 10.1515/JPM.2001.057; Pyun G, 2014, KNOWL-BASED SYST, V55, P125, DOI 10.1016/j.knosys.2013.10.013; Sameni R., 2008, THESIS; Sameni Reza, 2010, Open Pacing Electrophysiol Ther J, V3, P4; Silva I, 2013, COMPUT CARDIOL CONF, V40, P149; Pham TT, 2014, ENG APPL ARTIF INTEL, V32, P88, DOI 10.1016/j.engappai.2014.02.019; Van TT, 2011, STUD COMPUT INTELL, V351, P147; Uno T., 2005, P 1 INT WORKSH OP SO; Vahidi A, 2005, VEHICLE SYST DYN, V43, P31, DOI 10.1080/00423110412331290446; von Steinburg SP, 2013, PEERJ, V1, DOI 10.7717/peerj.82; Vullings R, 2009, PHYSIOL MEAS, V30, P291, DOI 10.1088/0967-3334/30/3/005; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Zhang NN, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030457; Zhong W, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aab297	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223057	10.1371/journal.pone.0223057	http://dx.doi.org/10.1371/journal.pone.0223057			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574123	gold, Green Published			2022-12-26	WOS:000532376700028
J	Gonzalez-Pabon, MJ; Figueredo, F; Martinez-Casillas, DC; Corton, E				Jesus Gonzalez-Pabon, Maria; Figueredo, Federico; Martinez-Casillas, Diana C.; Corton, Eduardo			Characterization of a new composite membrane for point of need paper-based micro-scale microbial fuel cell analytical devices	PLOS ONE			English	Article							POLYMER ELECTROLYTE MEMBRANES; PROTON-EXCHANGE MEMBRANE; POWER-GENERATION; BIOELECTROCHEMICAL SYSTEMS; ELECTRICITY-GENERATION; CHITOSAN MEMBRANES; ETHER KETONE; AIR-CATHODE; PERFORMANCE; SEPARATORS	Microbial fuel cells (MFCs) can evolve in a viable technology if environmentally sound materials are developed and became available at low cost for these devices. This is especially important not only for the designing of large wastewater treatment systems, but also for the fabrication of low-cost, single-use devices. In this work we synthesized membranes by a simple procedure involving easily-biodegradable and economic materials such as poly (vinyl alcohol) (PVA), chitosan (CS) and the composite PVA:CS. Membranes were chemical and physically characterized and compared to Nafion (R). Performance was studied using the membrane as separator in a typical H-Type MFCs showing that PVA:CS membrane outperform Nafion (R) 4 times (power production) while being 75 times more economic. We found that performance in MFC depends over interactions among several membrane characteristics such as oxygen permeability and ion conductivity. Moreover, we design a paper-based micro-scale MFC, which was used as a toxicity assay using 16 mu L samples containing formaldehyde as a model toxicant. The PVA:CS membrane presented here can offer low environmental impact and become a very interesting option for point of need single-use analytical devices, especially in low-income countries where burning is used as disposal method, and toxic fluoride fumes (from Nafion (R)) can be released to the environment.	[Jesus Gonzalez-Pabon, Maria; Figueredo, Federico; Martinez-Casillas, Diana C.; Corton, Eduardo] Univ Buenos Aires, Lab Biosensors & Bioanal LABB, Dept Quim Biol, Buenos Aires, DF, Argentina; [Jesus Gonzalez-Pabon, Maria; Figueredo, Federico; Martinez-Casillas, Diana C.; Corton, Eduardo] Univ Buenos Aires, IQUIBICEN, CONICET, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Jesus Gonzalez-Pabon, Maria; Figueredo, Federico; Martinez-Casillas, Diana C.; Corton, Eduardo] CONACYT TecNM ITD, Durango, Dgo, Mexico	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Corton, E (corresponding author), Univ Buenos Aires, Lab Biosensors & Bioanal LABB, Dept Quim Biol, Buenos Aires, DF, Argentina.	eduardo@qb.fcen.uba.ar		Corton, Eduardo/0000-0003-1897-4666; Martinez-Casillas, Diana/0000-0002-0128-3335; Gonzalez-Pabon, Maria J/0000-0001-9641-0167	National Agency of Scientific and Technological Promotion (ANPCyT) [BID-PICT 2013-0033, BID-PICT 2014-0402]; CONICET [PIP 2015 2017 GI]	National Agency of Scientific and Technological Promotion (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work presented here was funded by the National Agency of Scientific and Technological Promotion (ANPCyT), by the grants `BID-PICT 2013-0033' and 'BID-PICT 2014-0402'. The authors also appreciate the grant provided by the CONICET, award No. PIP 2015 2017 GI. Author E. Corto ' n received all the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P591, DOI 10.1016/j.bios.2014.04.053; Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P580, DOI 10.1016/j.bios.2014.04.034; Angioni S, 2017, J POWER SOURCES, V348, P57, DOI 10.1016/j.jpowsour.2017.02.084; Antolini E, 2015, BIOSENS BIOELECTRON, V69, P54, DOI 10.1016/j.bios.2015.02.013; Ayyaru S, 2011, BIORESOURCE TECHNOL, V102, P11167, DOI 10.1016/j.biortech.2011.09.021; Bakonyi P, 2018, J MEMBRANE SCI, V564, P508, DOI 10.1016/j.memsci.2018.07.051; Batista MKS, 2006, CARBOHYD POLYM, V64, P299, DOI 10.1016/j.carbpol.2005.11.040; Bollella P, 2018, CURR OPIN ELECTROCHE, V10, P157, DOI 10.1016/j.coelec.2018.06.003; Chae KJ, 2008, ENERG FUEL, V22, P169, DOI 10.1021/ef700308u; Chae KJ, 2010, INT J HYDROGEN ENERG, V35, P13379, DOI 10.1016/j.ijhydene.2009.11.114; Chatterjee P, 2018, ENVIRON ENG MANAG J, V17, P1531, DOI 10.30638/eemj.2018.152; Chen G, 2012, ACS APPL MATER INTER, V4, P6454, DOI 10.1021/am302301t; Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1; Choi G, 2015, ANALYST, V140, P4277, DOI 10.1039/c5an00492f; Choi S, 2015, BIOSENS BIOELECTRON, V69, P8, DOI 10.1016/j.bios.2015.02.021; Chouler J, 2018, BIOSENS BIOELECTRON, V102, P49, DOI 10.1016/j.bios.2017.11.018; Chouler J, 2017, ELECTROCHIM ACTA, V231, P319, DOI 10.1016/j.electacta.2017.01.195; Christgen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136108; Darbari ZM, 2016, DESALIN WATER TREAT, V57, P1634, DOI 10.1080/19443994.2014.978390; Das S, 2018, POLYM REV, V58, P610, DOI 10.1080/15583724.2017.1418377; Dashtimoghadam E, 2010, POLYM ADVAN TECHNOL, V21, P726, DOI 10.1002/pat.1496; Daud SM, 2015, BIORESOURCE TECHNOL, V195, P170, DOI 10.1016/j.biortech.2015.06.105; Desmet C, 2016, BIOSENS BIOELECTRON, V76, P145, DOI 10.1016/j.bios.2015.06.052; Figueredo F, 2018, ELECTROANAL, V30, P497, DOI 10.1002/elan.201700782; Figueredo F, 2015, ASTROBIOLOGY, V15, P717, DOI 10.1089/ast.2015.1288; Goswami R, 2018, BIOFUELS-UK, V9, P203, DOI 10.1080/17597269.2017.1302682; Habiba U, 2017, J HAZARD MATER, V322, P182, DOI 10.1016/j.jhazmat.2016.06.028; Harewood AJT, 2017, INT J ENVIRON SCI TE, V14, P1535, DOI 10.1007/s13762-017-1258-6; Hernandez-Flores G, 2016, INT J HYDROGEN ENERG, V41, P23354, DOI 10.1016/j.ijhydene.2016.08.206; Hernandez-Flores G, 2015, INT J HYDROGEN ENERG, V40, P17380, DOI 10.1016/j.ijhydene.2015.10.024; Hernandez-Flores G, 2015, INT J HYDROGEN ENERG, V40, P17323, DOI 10.1016/j.ijhydene.2015.06.057; Holder SL, 2016, CARBOHYD POLYM, V149, P251, DOI 10.1016/j.carbpol.2016.04.118; Ji E, 2011, BIOSENS BIOELECTRON, V26, P3266, DOI 10.1016/j.bios.2010.12.039; Jia H, 2016, BIORESOURCE TECHNOL, V218, P286, DOI 10.1016/j.biortech.2016.06.064; Kadier A, 2016, ALEX ENG J, V55, P427, DOI 10.1016/j.aej.2015.10.008; Kalaiselvimary J, 2018, IONICS, V24, P3555, DOI 10.1007/s11581-018-2485-7; Kim Y, 2014, J MEMBRANE SCI, V463, P205, DOI 10.1016/j.memsci.2014.03.061; Lee CH, 2005, IND ENG CHEM RES, V44, P7617, DOI 10.1021/ie0501172; Lefebvre O, 2011, BIORESOURCE TECHNOL, V102, P6291, DOI 10.1016/j.biortech.2011.02.003; Lehmani A, 1997, J ELECTROANAL CHEM, V428, P81, DOI 10.1016/S0022-0728(96)05060-7; Li XY, 2018, ENERG CONVERS MANAGE, V165, P488, DOI 10.1016/j.enconman.2018.03.074; Lv CC, 2019, ELECTROCHIM ACTA, V304, P360, DOI 10.1016/j.electacta.2019.02.094; Ma J, 2012, ECS ELECTROCHEM LETT, V1, pF41, DOI 10.1149/2.005206eel; Ma J, 2011, J POWER SOURCES, V196, P8257, DOI 10.1016/j.jpowsour.2011.06.009; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martins JG, 2018, CARBOHYD POLYM, V188, P136, DOI 10.1016/j.carbpol.2018.01.112; Mathuriya AS, 2018, APPL MICROBIOL BIOT, V102, P9419, DOI 10.1007/s00253-018-9339-0; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Modi A, 2017, INT J HYDROGEN ENERG, V42, P3271, DOI 10.1016/j.ijhydene.2016.10.041; Mohammadifar M, 2018, RENEW ENERG, V118, P695, DOI 10.1016/j.renene.2017.11.059; Mukoma P, 2004, J MEMBRANE SCI, V243, P293, DOI 10.1016/j.memsci.2004.06.032; Mukoma P, 2004, J POWER SOURCES, V136, P16, DOI 10.1016/j.jpowsour.2004.05.027; Pant D, 2012, RSC ADV, V2, P1248, DOI 10.1039/c1ra00839k; Pasini Cabello SD, 2017, CARBOHYD POLYM, V157, P1759, DOI [10.1016/j.carbpol.2016.11.061, DOI 10.1016/J.CARBPOL.2016.11.061]; Rhim JW, 2004, J MEMBRANE SCI, V238, P143, DOI 10.1016/j.memsci.2004.03.030; Rudra R, 2015, RSC ADV, V5, P83436, DOI 10.1039/c5ra16068e; Sahebjamee N, 2019, CARBOHYD POLYM, V210, P264, DOI 10.1016/j.carbpol.2019.01.074; Sivasankaran A, 2016, CHEM ENG J, V289, P442, DOI 10.1016/j.cej.2015.12.095; Smitha B, 2005, J APPL POLYM SCI, V95, P1154, DOI 10.1002/app.20982; Srinophakun P, 2017, J CLEAN PROD, V142, P1274, DOI 10.1016/j.jclepro.2016.06.153; Stenina IA, 2004, DESALINATION, V170, P49, DOI 10.1016/j.desal.2004.02.092; Tiwari BR, 2016, MATER CHEM PHYS, V182, P86, DOI 10.1016/j.matchemphys.2016.07.008; Unnikrishnan EK, 1997, J MEMBRANE SCI, V137, P133, DOI 10.1016/S0376-7388(97)00193-2; Veerubhotla R, 2017, BIOSENS BIOELECTRON, V94, P464, DOI 10.1016/j.bios.2017.03.020; Veerubhotla R, 2015, LAB CHIP, V15, P2580, DOI 10.1039/c5lc00211g; Venkatesan PN, 2015, J MATER SCI, V50, P6302, DOI 10.1007/s10853-015-9167-x; Witt MA, 2010, J BRAZIL CHEM SOC, V21, P1692, DOI 10.1590/S0103-50532010000900014; Wu H, 2018, BIORESOURCE TECHNOL, V260, P130, DOI 10.1016/j.biortech.2018.03.133; Xia YY, 2016, BIOSENS BIOELECTRON, V77, P774, DOI 10.1016/j.bios.2015.10.032; Xu D, 2008, MATER SCI TECH-LOND, V24, P1076, DOI 10.1179/174328408X341762; Xu GH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06779; Ye YS, 2012, POLYMERS-BASEL, V4, P913, DOI 10.3390/polym4020913; Yee RSL, 2012, CHEM ENG RES DES, V90, P950, DOI 10.1016/j.cherd.2011.10.015; ZAWODZINSKI TA, 1991, J PHYS CHEM-US, V95, P6040, DOI 10.1021/j100168a060; Zinadini S, 2017, ENERGY, V125, P427, DOI 10.1016/j.energy.2017.02.146	75	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222538	10.1371/journal.pone.0222538	http://dx.doi.org/10.1371/journal.pone.0222538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568487	Green Published, gold			2022-12-26	WOS:000532364900004
J	Paraskevopoulou, S; Dennis, AB; Weithoff, G; Hartmann, S; Tiedemann, R				Paraskevopoulou, Sofia; Dennis, Alice B.; Weithoff, Guntram; Hartmann, Stefanie; Tiedemann, Ralph			Within species expressed genetic variability and gene expression response to different temperatures in the rotifer Brachionus calyciflorus sensu stricto	PLOS ONE			English	Article							TRANSCRIPTOME RESPONSE; THERMAL-STRESS; PACIFIC OYSTER; COMPLEX; SALINITY; COPEPOD; MODEL; RNA; IDENTIFICATION; REPRODUCTION	Genetic divergence is impacted by many factors, including phylogenetic history, gene flow, genetic drift, and divergent selection. Rotifers are an important component of aquatic ecosystems, and genetic variation is essential to their ongoing adaptive diversification and local adaptation. In addition to coding sequence divergence, variation in gene expression may relate to variable heat tolerance, and can impose ecological barriers within species. Temperature plays a significant role in aquatic ecosystems by affecting species abundance, spatio-temporal distribution, and habitat colonization. Recently described (formerly cryptic) species of the Brachionus calyciflorus complex exhibit different temperature tolerance both in natural and in laboratory studies, and show that B. calyciflorus sensu stricto (s.s.) is a thermotolerant species. Even within B. calyciflorus s.s., there is a tendency for further temperature specializations. Comparison of expressed genes allows us to assess the impact of stressors on both expression and sequence divergence among disparate populations within a single species. Here, we have used RNA-seq to explore expressed genetic diversity in B. calyciflorus s.s. in two mitochondrial DNA lineages with different phylogenetic histories and differences in thermotolerance. We identify a suite of candidate genes that may underlie local adaptation, with a particular focus on the response to sustained high or low temperatures. We do not find adaptive divergence in established candidate genes for thermal adaptation. Rather, we detect divergent selection among our two lineages in genes related to metabolism (lipid metabolism, metabolism of xenobiotics).	[Paraskevopoulou, Sofia; Dennis, Alice B.; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Paraskevopoulou, Sofia; Weithoff, Guntram] Univ Potsdam, Inst Biochem & Biol, Unit Ecol & Ecosyst Modelling, Potsdam, Germany; [Weithoff, Guntram] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Hartmann, Stefanie] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Adapt Gen, Potsdam, Germany	University of Potsdam; University of Potsdam; University of Potsdam	Paraskevopoulou, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany.; Paraskevopoulou, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Ecol & Ecosyst Modelling, Potsdam, Germany.	paraskevopou@uni-potsdam.de	Paraskevopoulou, Sofia/GSO-3859-2022; Paraskevopoulou, Sofia/GSO-3013-2022	Paraskevopoulou, Sofia/0000-0003-4274-0579	University of Potsdam; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Potsdam	University of Potsdam; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam	The study was supported by University of Potsdam. We also acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Andrews S., 2010, FASTQC QUALITY CONTR; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Campillo S, 2011, EVOL ECOL, V25, P933, DOI 10.1007/s10682-010-9447-5; Chen G, 2008, MOL ECOL, V17, P1451, DOI 10.1111/j.1365-294X.2007.03657.x; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cui MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187105; Davidson NM, 2017, GENOME BIOL, V18, P1, DOI [10.5281/zenodo.830594, DOI 10.5281/ZENODO.830594]; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Des Marteaux LE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3711-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Franch-Gras L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34188-y; Franch-Gras L, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0427; Gabaldon C, 2017, HYDROBIOLOGIA, V796, P7, DOI 10.1007/s10750-016-2723-9; Geerts AN, 2014, EVOL ECOL RES, V16, P517; Gismondi A, 2014, NUCLEIC ACIDS RES, V42, P12668, DOI 10.1093/nar/gku996; Gomez A, 1997, OECOLOGIA, V111, P350, DOI 10.1007/s004420050245; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gribble KE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3540-x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hales NR, 2017, MOL ECOL, V26, P5003, DOI 10.1111/mec.14213; Han J, 2018, COMP BIOCHEM PHYS D, V25, P26, DOI 10.1016/j.cbd.2017.10.003; Hanson SJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-412; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Jenkins DG, 1998, ECOL MONOGR, V68, P421, DOI 10.1890/0012-9615(1998)068[0421:DSCDIS]2.0.CO;2; KADLUBAR FF, 1994, DRUG METAB REV, V26, P37, DOI 10.3109/03602539409029783; Kaneko G, 2002, FISHERIES SCI, V68, P1317, DOI 10.1046/j.1444-2906.2002.00570.x; Kauler P, 2011, J FRESHWATER ECOL, V26, P399, DOI 10.1080/02705060.2011.563998; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kenney Justin W., 2014, Advances in Biological Regulation, V55, P15, DOI 10.1016/j.jbior.2014.04.003; Khang TF, 2015, PEERJ, V3, DOI 10.7717/peerj.1360; Kim BM, 2017, MOL CELL TOXICOL, V13, P105, DOI 10.1007/s13273-017-0011-z; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee MC, 2019, COMP BIOCHEM PHYS D, V30, P179, DOI 10.1016/j.cbd.2019.03.001; Lee MC, 2017, COMP BIOCHEM PHYS A, V214, P79, DOI 10.1016/j.cbpa.2017.09.014; Lee SH, 2017, FISHERIES SCI, V83, P725, DOI 10.1007/s12562-017-1104-2; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li L, 2010, J PLANKTON RES, V32, P951, DOI 10.1093/plankt/fbq014; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; LUBZENS E, 1993, HYDROBIOLOGIA, V255, P127, DOI 10.1007/BF00025830; LUBZENS E, 1985, AQUACULTURE, V47, P27, DOI 10.1016/0044-8486(85)90005-5; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Monroig O, 2018, FISHERIES SCI, V84, P911, DOI 10.1007/s12562-018-1254-x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mou ZL, 2000, PLANT CELL, V12, P405, DOI 10.1105/tpc.12.3.405; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orsini L, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.30; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Papakostas S, 2016, SYST BIOL, V65, P508, DOI 10.1093/sysbio/syw016; Paraskevopoulou S, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0498; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; R Core Team, 2021, R LANGUAGE ENV STAT; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Smith HA, 2012, J EXP MAR BIOL ECOL, V413, P1, DOI 10.1016/j.jembe.2011.11.027; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Smolina I, 2015, MAR ECOL PROG SER, V534, P79, DOI 10.3354/meps11398; SNELL TW, 1986, MAR BIOL, V92, P157, DOI 10.1007/BF00392832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang WC, 2018, ECOTOX ENVIRON SAFE, V153, P127, DOI 10.1016/j.ecoenv.2018.01.028; Tsai YC, J NUCL ACIDS; Wallace RL, 2009, ENCY INLAND WATERS; Wallace RL, 2015, FRESHWATER INVERTEBR; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Xiang XL, 2011, MOL PHYLOGENET EVOL, V59, P386, DOI 10.1016/j.ympev.2011.02.011; Xiang XL, 2010, HYDROBIOLOGIA, V638, P67, DOI 10.1007/s10750-009-0010-8; Xu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179922; Yampolsky LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-859; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yin XW, 2008, AQUAT ECOL, V42, P165, DOI 10.1007/s10452-007-9092-4; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021; Zhang XX, 2008, BIOTECHNOL LETT, V30, P1289, DOI 10.1007/s10529-008-9685-6; Zhang Y, 2018, HYDROBIOLOGIA, V807, P313, DOI 10.1007/s10750-017-3407-9; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	86	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223134	10.1371/journal.pone.0223134	http://dx.doi.org/10.1371/journal.pone.0223134			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KU7LF	31568501	Green Published, gold			2022-12-26	WOS:000519893900001
J	Calvez, J; Weber, M; Ecochard, C; Kleim, L; Flanagan, J; Biourge, V; German, AJ				Calvez, Juliane; Weber, Mickael; Ecochard, Claude; Kleim, Louise; Flanagan, John; Biourge, Vincent; German, Alexander J.			Metabolisable energy content in canine and feline foods is best predicted by the NRC2006 equation	PLOS ONE			English	Article							DOG	Although animal trials are the most accurate approach to determine the metabolisable energy (ME) content of pet food, these are expensive and labour-intensive. Instead, various equations have been proposed to predict ME content, but no single method is universally recommended. Data from canine and feline feeding studies, conducted according to Association of American Feed Control Officials recommendations, over a 6-year period at a single research site, were utilised to determine the performance of different predictive equations. Predictive equations tested included the modified At water (MA equation), NRC 2006 equations using both crude fibre (NRC 2006(cf)) and total dietary fibre (NRC 2006(tdf)), and new equations reported in the most recent study assessing ME predictive equations (Hall equations; PLoS ONE 8(1): e54405). Where appropriate, equations were tested using both predicted gross energy (GE) and GE measured by bomb calorimetry. Associations between measured and predicted ME were compared with Deming regression, whilst agreement was assessed with Bland-Altman plots. 335 feeding trials were included, comprising 207 canine (182 dry food; 25 wet food) and 128 feline trials (104 dry food, 24 wet food). Predicted ME was positively associated with measured ME whatever the equation used (P<0.001 for all). Agreement between predicted and actual ME was worst for the MA equation, for all food types, with evidence of both a systematic bias and proportional errors evident for all food types. The NRC 2006(cf) and Hall equations were intermediate in performance, whilst the NRC 2006(tdf) equations performed best especially when using measured rather than predicted GE, with the narrowest 95% limits of agreement, minimal bias and proportional error. In conclusion, when predicting ME content of pet food, veterinarians, nutritionists, pet food manufacturers and regulatory bodies are strongly advised to use the NRC 2006(tdf) equations and using measured rather than predicted GE.	[Calvez, Juliane; Weber, Mickael; Ecochard, Claude; Kleim, Louise; Flanagan, John; Biourge, Vincent] Royal Canin Res Ctr, Aimargues, France; [German, Alexander J.] Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England; [German, Alexander J.] Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England; [Calvez, Juliane] Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France	University of Liverpool; University of Liverpool; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	German, AJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England.; German, AJ (corresponding author), Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England.	ajgerman@liverpool.ac.uk	Calvez, Juliane/AAG-3963-2022; Calvez, Juliane/AFK-5464-2022	Calvez, Juliane/0000-0003-1181-9786; Calvez, Juliane/0000-0003-1181-9786	Royal Canin; University of Liverpool	Royal Canin; University of Liverpool	This work was funded by Royal Canin. The funder provided support in the form of salaries for authors (JC, MW, CE, LK, JF, VB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, whilst AJG is an employee of the University of Liverpool, his academic position is financially supported by the funder. The specific roles of these authors are articulated in the `competing interests' section.; The authors wish to thank all caregivers for participating in the study. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Conflicts of interest are as follows: At the time the study all authors were either employees Royal Canin, except JC (who was undertaking an internship at the Royal Canin research campus) and AJG (whose academic post at the University of Liverpool is supported by Royal Canin). AJG has also received financial remuneration for providing educational material, speaking at conferences, and consultancy work from this company; all such remuneration has been for projects unrelated to the work reported in this manuscript. Authors were involved in the study design, data collection, data analysis, or data interpretation, and also in both the writing of the manuscript and in the decision to submit it for publication.	Association of American Feed Control Officials, 2018, OFFICIAL PUBLICATION; Atwater WO, 1902, USDA FARMERS B, V142, P1; Bermingham EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109681; Bermingham EN, 2010, BRIT J NUTR, V103, P1083, DOI 10.1017/S000711450999290X; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Budd JR., 2013, MEASUREMENT PROCEDUR, V33; Castrillo C, 2009, REV BRAS ZOOTECN, V38, P1, DOI 10.1590/S1516-35982009001300001; European Pet Food Federation (FEDIAF), NUTR REQ; German AJ, 2011, J ANIM PHYSIOL AN N, V95, P368, DOI 10.1111/j.1439-0396.2010.01063.x; German AJ, 2007, J VET INTERN MED, V21, P1174, DOI 10.1892/06-280.1; Giancristofaro R.A., 2003, STATISTICA, V63, P375; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jensen AL, 2006, VET CLIN PATH, V35, P276, DOI 10.1111/j.1939-165X.2006.tb00131.x; KENDALL PT, 1985, FELINE PRACT, V15, P38; KENDALL PT, 1982, J SCI FOOD AGR, V33, P823, DOI 10.1002/jsfa.2740330903; Kienzle E, 2002, J NUTR, V132, p1796S, DOI 10.1093/jn/132.6.1796S; Kienzle E, 1998, J ANIM PHYSIOL AN N, V79, P69, DOI 10.1111/j.1439-0396.1998.tb00630.x; Kienzle E, 2006, J NUTR, V136, p2041S, DOI 10.1093/jn/136.7.2041S; KUHLMAN G, 1993, FELINE PRACT, V21, P16; Laflamme DP, 2001, J ANIM PHYSIOL AN N, V85, P222, DOI 10.1046/j.1439-0396.2001.00330.x; Martin RF, 2000, CLIN CHEM, V46, P100; National Research Council, 1985, NUTR REQ DOGS CATS; NAUMANN C, 1997, METHODENBUCH, V3; Nutritional Research Council, 2006, NUTR REQ DOGS CATS; PROSKY L, 1985, J ASSOC OFF ANA CHEM, V68, P677; Thatcher CD., 2010, SMALL ANIMAL CLIN NU, V5th ed., P3; Yamka RM, 2007, J ANIM SCI, V85, P204, DOI 10.2527/jas.2005-336	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223099	10.1371/journal.pone.0223099	http://dx.doi.org/10.1371/journal.pone.0223099			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560713	Green Published, gold			2022-12-26	WOS:000532353700036
J	Sah, BR; Veit-Haibach, P; Strobel, K; Banyai, M; Huellner, MW				Sah, Bert-Ram; Veit-Haibach, Patrick; Strobel, Klaus; Banyai, Martin; Huellner, Martin W.			CT-perfusion in peripheral arterial disease - Correlation with angiographic and hemodynamic parameters	PLOS ONE			English	Article							MOTION CORRECTION; MUSCLE PERFUSION; TISSUE PERFUSION; FOOT; REPRODUCIBILITY; AGREEMENT; ALBUMIN	Objective The purpose of this study was the assessment of volumetric CT-perfusion (CTP) of the lower leg musculature in patients with symptomatic peripheral arterial disease (PAD) of the lower extremities, comparing it with established angiographic and hemodynamic parameters. Materials and methods Thirty-five consecutive patients with symptomatic PAD of the lower extremities requiring interventional revascularization were assessed prospectively. All patients underwent a CTP scan of the lower leg, and hemodynamic and angiographic assessment. Hemodynamic parameters, specifically ankle-brachial pressure index (ABI), ankle blood pressure (ABP), peak systolic velocity (PSV), and segmental pulse oscillography (SPO) level, were determined. Lesion length and degree of collateralization were assessed by interventional angiography. CTP parameters were calculated with a perfusion software, acting on a no outflow assumption. A sequential two-compartment model was used. Differences in CTP parameters and correlations between CTP, hemodynamic and angiographic parameters were assessed with non-parametric tests. Results The cohort consisted of 27 subjects with an occlusion, and eight with a high-grade stenosis. The mean blood flow (BF) was 7.71 +/- 2.96 ml/100ml*min(-1), mean blood volume (BV) 0.71 +/- 0.33 ml/100ml, and mean mean transit time (MTT) 7.22 +/- 2.66 s. BF and BV were higher in subjects with longer lesions, and BV was higher in subjects with lower ABI. Significant correlations were found between lesion length and BV (r = 0.65) and BF (r = 0.52). Significant inverse correlations were found between BV and ABI and between BV and ABP (r = -0.56, for both correlations). Conclusions In our study, we have shown the feasibility of CTP for the assessment of PAD. In the future, this quantitative method might serve as a non-invasive method, possibly complementing the diagnostic workup of patients with peripheral arterial disease.	[Sah, Bert-Ram] Univ Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Sah, Bert-Ram] Kings Coll London, Dept Canc Imaging, London, England; [Veit-Haibach, Patrick; Huellner, Martin W.] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Veit-Haibach, Patrick] Univ Hosp Zurich, Dept Radiol, Zurich, Switzerland; [Veit-Haibach, Patrick; Huellner, Martin W.] Univ Zurich, Zurich, Switzerland; [Veit-Haibach, Patrick] Univ Toronto, Joint Dept Med Imaging, Toronto, ON, Canada; [Veit-Haibach, Patrick; Strobel, Klaus; Huellner, Martin W.] Lucerne Cantonal Hosp, Dept Radiol & Nucl Med, Luzern, Switzerland; [Banyai, Martin] Lucerne Cantonal Hosp, Dept Internal Med, Subdiv Angiol, Luzern, Switzerland; [Banyai, Martin] Univ Hosp Zurich, Clin Angiol, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of London; King's College London; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Toronto; Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Zurich; University Zurich Hospital	Sah, BR (corresponding author), Univ Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland.; Sah, BR (corresponding author), Kings Coll London, Dept Canc Imaging, London, England.	BR.SAH.pub@gmail.com			Bayer Healthcare; Siemens Healthcare; GE Healthcare; Swiss National Science Foundation	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Siemens Healthcare(Siemens AG); GE Healthcare(General ElectricGE Healthcare); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors received no specific funding for this work. The authors of this manuscript state that this work has not received any funding. P. V.H. received ISS grants from Bayer Healthcare and Siemens Healthcare for CTP-studies. M.H.: Institutional grants from GE Healthcare. B.S. received a research grant from Swiss National Science Foundation. All other authors declare that they have no conflict of interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraogu UO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207456; Alexandrescu V, 2011, DIABET METAB SYND OB, V4, P327, DOI 10.2147/DMSO.S23471; Alexandrescu V, 2011, J ENDOVASC THER, V18, P376, DOI 10.1583/10-3260.1; Amarteifio E, 2013, EUR J RADIOL, V82, P640, DOI 10.1016/j.ejrad.2012.11.022; Barfett J, 2012, INT J CARDIOVAS IMAG, V28, P2073, DOI 10.1007/s10554-011-9978-z; Barfett J, 2010, J COMPUT ASSIST TOMO, V34, P626, DOI 10.1097/RCT.0b013e3181d53258; Buschmann EE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199374; Chandler A, 2012, BRIT J RADIOL, V85, pE514, DOI 10.1259/bjr/31999821; Chandler A, 2011, ACAD RADIOL, V18, P286, DOI 10.1016/j.acra.2010.10.008; Chu LL, 2018, EUR RADIOL, V28, P5069, DOI 10.1007/s00330-018-5492-1; Cooke JP, 2015, CIRC RES, V116, P1561, DOI 10.1161/CIRCRESAHA.115.303565; Cornejo Del Rio V, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0186220; Dawson P, 2006, EUR J RADIOL, V60, P331, DOI 10.1016/j.ejrad.2006.06.023; Diekmann S, 2010, AM J NEURORADIOL, V31, P1003, DOI 10.3174/ajnr.A1971; DWARS BJ, 1989, EUR J NUCL MED, V15, P38, DOI 10.1007/BF00253597; Fok PW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205599; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Ippolito D, 2016, J COMPUT ASSIST TOMO, V40, P152, DOI 10.1097/RCT.0000000000000331; Jiji RS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-14; Kumar VA, 2016, BIOMATERIALS, V98, P113, DOI 10.1016/j.biomaterials.2016.04.032; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lenga L, 2017, J THORAC IMAG, V32, P151, DOI 10.1097/RTI.0000000000000259; Lin Eugene, 2009, J Cardiovasc Comput Tomogr, V3, P403, DOI 10.1016/j.jcct.2009.07.003; LIN WY, 1995, CLIN NUCL MED, V20, P449, DOI 10.1097/00003072-199505000-00016; Mather R., 2013, CURRENT RADIOLOGY RE, V1, P64, DOI [10.1007/s40134-012-0004-6, DOI 10.1007/S40134-012-0004-6]; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; MORIARTY KT, 1994, DIABETIC MED, V11, P22, DOI 10.1111/j.1464-5491.1994.tb00224.x; Neville RF, 2009, ANN VASC SURG, V23, P367, DOI 10.1016/j.avsg.2008.08.022; Ng CS, 2011, AM J ROENTGENOL, V197, P113, DOI 10.2214/AJR.10.5404; Penuelas I, 2007, J NUCL MED, V48, P1216, DOI 10.2967/jnumed.106.039180; Pollak AW, 2012, JACC-CARDIOVASC IMAG, V5, P1224, DOI 10.1016/j.jcmg.2012.03.022; Prezzi D, 2015, EUR J RADIOL, V84, P2380, DOI 10.1016/j.ejrad.2015.03.022; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Bretas EAS, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170214; Scremin OU, 2010, AM J PHYS MED REHAB, V89, P473, DOI 10.1097/PHM.0b013e3181d89b08; STURROCK NDC, 1995, DIABETIC MED, V12, P445, DOI 10.1111/j.1464-5491.1995.tb00512.x; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Wang QL, 2017, THORAC CANCER, V8, P427, DOI 10.1111/1759-7714.12458	40	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223066	10.1371/journal.pone.0223066	http://dx.doi.org/10.1371/journal.pone.0223066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560706	Green Accepted, gold, Green Published			2022-12-26	WOS:000532353700033
J	Diez, JLG; Galindo, JG; Pena, AS				Garcia Diez, Jose Luis; Gonzalez Galindo, Jesus; Soriano Pena, Antonio		Univ Politecnica Madrid	Adjustment of a numerical model for pore pressure generation during an earthquake	PLOS ONE			English	Article							DETERMINISTIC ASSESSMENT; LIQUEFACTION; SAND	This article proposes methodology for evaluating the accuracy of the pore pressure generation model devised by Byrne, as implemented in a commercial software program using a Mohr-Coulomb-type failure criterion and a Finn constitutive model. The different empirical formulas of liquefaction developed by Seed and Idriss are reviewed, as well as various constitutive models specified in the literature, emphasizing the selection of the Finn model for the liquefaction study. In the analysis a comparison is carried out using the factors of safety against liquefaction (FSLs) devised by Seed and Idriss and the adapted formula by Boulanger and Idriss. The analysis assumes a hypothesis to verify whether a soil element is liquefied. The results are then compared with those of a numerical model that simulates a soil column, the base of which is subjected to the same seismic inputs of varying magnitudes, M-w, and peak ground accelerations, Pga, to which the empirical model was subjected. Adjusted equations are provided on the based on that comparison to allow for the calibration of the Byrne equation using the (N-1)(60) value obtained via a standard penetration test (SPT), for the study of liquefaction problems in situations in which there are earthquakes of varying magnitudes.	[Garcia Diez, Jose Luis; Gonzalez Galindo, Jesus; Soriano Pena, Antonio; Univ Politecnica Madrid] Univ Politecn Madrid UPM, Dept Engn & Soil Morphol, ETS Ingenieros Caminos, C&P, Madrid, Spain	Universidad Politecnica de Madrid	Diez, JLG (corresponding author), Univ Politecn Madrid UPM, Dept Engn & Soil Morphol, ETS Ingenieros Caminos, C&P, Madrid, Spain.	joseluis.garcia.diez@alumnos.upm.es		Garcia Diez, Jose Luis/0000-0002-1554-4575; GONZALEZ GALINDO, JESUS/0000-0003-3371-5865				Andrianopoulos KI, 2010, SOIL DYN EARTHQ ENG, V30, P895, DOI 10.1016/j.soildyn.2010.04.001; Boulanger R.W., 2014, UCDCGM1401 DEP CIV E; Boulanger RW, 2012, J GEOTECH GEOENVIRON, V138, P898, DOI 10.1061/(ASCE)GT.1943-5606.0000668; Boulanger RW, 2004, SOIL DYN EARTHQ ENG, V1, P32, DOI DOI 10.1016/J.SOILDYN.2004.11.023; Byrne P.M., 1995, STATIC DYNAMIC PROPE; Byrne P.M., 1991, P 2 INT C REC ADV GE, V1, P47; Cetin K. O., 2000, UCBGT200009 GEOT ENG; Cetin K. O., 2016, 081601 METUGTENG SOI; Cetin KO, 2018, SOIL DYN EARTHQ ENG, V115, P698, DOI 10.1016/j.soildyn.2018.09.012; Cetin KO, 2004, J GEOTECH GEOENVIRON, V130, P1314, DOI 10.1061/(ASCE)1090-0241(2004)130:12(1314); Galindo R., 2010, THESIS; Golesorkhi R., 1989, THESIS; Idriss I. M., 2010, UCDCGM102 DEP CIV EN; Idriss IM, 1999, PUBL NO FHW, VFHWA-RD-99-165; Idriss IM, 2008, MONOGRAPH EARTHQ ENG, VMNO-12; Imai T., 1982, P 2 EUR S PEN TEST A, P57; Ishihara K., 1977, SOILS FOUND, V17, P1, DOI [10.3208/sandf1972.17.3_1, DOI 10.3208/SANDF1972.17.3_1]; Itasca, 2012, FLAC3D FAST LAGR AN; JEFFERIES MG, 1993, GEOTECHNIQUE, V43, P91, DOI 10.1680/geot.1993.43.1.91; Martin GR, 1975, J GEOTECHNICAL ENG D, V101, P423, DOI [10.1061/AJGEB6.0000164, DOI 10.1061/AJGEB6.0000164]; Mogami T., 1953, P 3 INT C SOIL MECH, V1, P152; Patino H, 2009, THESIS; Rauch AF, 2000, J GEOTECH GEOENVIRON, V126, P360, DOI 10.1061/(ASCE)1090-0241(2000)126:4(360); Rostami H, 2018, GEOTECH SP, P493; Seed H.B., 1984, UCBEERC8415; Seed H.B., 1971, ASCE J SOIL MECH FDN, V97, P1249, DOI [10.1061/jsfeaq.0001662, DOI 10.1061/JSFEAQ.0001662, 10.1061/JSFEAQ.0001662]; SEED HB, 1985, J GEOTECH ENG-ASCE, V111, P1425; Shibata T, 1981, P 16 ANN CONV JAP SO, P621; Soriano A., 2015, THESIS; Tokimatsu K., 1983, SOILS FOUND, V23, P56, DOI [10.3208/sandf1972.23.4_56, DOI 10.3208/SANDF1972.23.4_56]; WANG ZL, 1990, J ENG MECH-ASCE, V116, P983, DOI 10.1061/(ASCE)0733-9399(1990)116:5(983); Yang Y, 2017, ENG GEOL, V221, P41, DOI 10.1016/j.enggeo.2017.02.032; Youd T.L., 1998, ASCE J GEOTECH GEOEN, V127, P817	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222834	10.1371/journal.pone.0222834	http://dx.doi.org/10.1371/journal.pone.0222834			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557203	gold, Green Published, Green Submitted			2022-12-26	WOS:000532345500038
J	Mellouk, N; Rame, C; Naquin, D; Jaszczyszyn, Y; Touze, JL; Briant, E; Guillaume, D; Ntallaris, T; Humblot, P; Dupont, J				Mellouk, Namya; Rame, Christelle; Naquin, Delphine; Jaszczyszyn, Yan; Touze, Jean-Luc; Briant, Eric; Guillaume, Daniel; Ntallaris, Theodoros; Humblot, Patrice; Dupont, Joelle			Impact of the severity of negative energy balance on gene expression in the subcutaneous adipose tissue of periparturient primiparous Holstein dairy cows: Identification of potential novel metabolic signals for the reproductive system	PLOS ONE			English	Article							BOVINE GRANULOSA-CELLS; LIPID-METABOLISM; NETWORK EXPRESSION; IN-VITRO; RNA-SEQ; LACTATION; INSULIN; INFLAMMATION; PERFORMANCE; PERIOD	The severity of negative energy balance (NEB) in high-producing dairy cows has a high incidence among health diseases. The cow's energy status during early lactation critically affects metabolic and reproductive parameters. The first objective of this study was to investigate by RNA-seq analysis and RT-qPCR the gene expression profile in white adipose tissue and by gene ontology and upstream regulation tools the relationships with energy metabolism and reproduction in two groups of primiparous dairy cows with extreme NEB statuses (NEB < -9 Mcal/day vs. NEB > -9 Mcal/day) around parturition. The second objective was to determine the potential involvement of a new adipokine identified as a candidate for the regulation of ovarian function in our RNA-seq analysis by using bovine primary granulosa culture, thymidine incorporation to determine cell proliferation and ELISA assays to measure progesterone secretion. The RNA-seq analysis revealed that 514 genes were over-expressed and 695 were under-expressed in the adipose tissue of cows with severe NEB (SNEB) and cows with moderate NEB (MNEB) during the -4 and 16 wkpp period. In addition, 491 genes were over-expressed and 705 genes were under-expressed in the adipose tissue of SNEB cows compared to MNEB cows. Among these differently expressed genes (DEGs), 298 were related to metabolic functions and 264 to reproductive traits. A set of 19 DEGs were validated by RT-qPCR, including CCL21 (C-C motif chemokine ligand 21). Moreover, CCL21, a gene known to be secreted by adipose tissue, was chosen for further analysis in plasma and ovaries. The use of next-generation sequencing technologies allowed us to characterise the transcriptome of white adipose tissue from primiparous cows with different levels of NEB during lactation. This study highlighted the alteration of the expression of genes related to lipid metabolism, including CCL21, which is released in the bloodstream and associated with the in vitro regulation of ovarian functions.	[Mellouk, Namya; Rame, Christelle; Touze, Jean-Luc; Guillaume, Daniel; Dupont, Joelle] INRA UMR85 Physiol Reprod & Comportements, Nouzilly, France; [Mellouk, Namya; Rame, Christelle; Touze, Jean-Luc; Guillaume, Daniel; Dupont, Joelle] CNRS UMR7247 Physiol Reprod & Comportements, Nouzilly, France; [Mellouk, Namya; Rame, Christelle; Touze, Jean-Luc; Guillaume, Daniel; Dupont, Joelle] Univ Francois Rabelais Tours, F-37041 Nouzilly, France; [Naquin, Delphine; Jaszczyszyn, Yan] Univ Paris Sud, Inst Integrat Biol Cell I2BC, CNRS, CEA, Gif Sur Yvette, France; [Briant, Eric] INRA, UEPAO 1297, Nouzilly, France; [Ntallaris, Theodoros; Humblot, Patrice] SLU, Div Reprod, Dept Clin Sci, Uppsala, Sweden	INRAE; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Swedish University of Agricultural Sciences	Dupont, J (corresponding author), INRA UMR85 Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), CNRS UMR7247 Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), Univ Francois Rabelais Tours, F-37041 Nouzilly, France.	joelle.dupont@inra.fr	Ntalalris, Theodoros/B-7739-2016; Mellouk, Namya/AAL-7583-2021	Ntalalris, Theodoros/0000-0003-3588-091X; Naquin, Delphine/0000-0001-9174-4686	European Union Seventh Framework Programs (FP7:2007-2013) [311776]; Ministere de la Recherche (Ministry of Research)	European Union Seventh Framework Programs (FP7:2007-2013); Ministere de la Recherche (Ministry of Research)	All experimental procedures were supported from a funding program named European Union Seventh Framework Programs (FP7:2007-2013) under the grant agreement no. 311776, to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mickael Dupont, Mickael Delanoue, Ludovic Me ' tivier, and Christophe Mouaze of the Experimental Unit UEPAO for animal management and involvement in the experiment. N. Mellouk is a PhD student supported by the Ministere de la Recherche (Ministry of Research). We thank also ProofReading Service Company for the English editing of this manuscript.	Abdelli A, 2017, THERIOGENOLOGY, V93, P99, DOI 10.1016/j.theriogenology.2017.01.030; Alharthi A, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-017-0221-1; BUTLER WR, 1989, J DAIRY SCI, V72, P767, DOI 10.3168/jds.S0022-0302(89)79169-4; Canepa S., 2008, CAH TECHN INRA, V64, P19; De Koster J, 2017, DOMEST ANIM ENDOCRIN, V59, P100, DOI 10.1016/j.domaniend.2016.12.004; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Ferguson J., 2001, P 2001 INT NUTR C SA, V169, P65; Gaidatzis D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/nbt.3269; Gillund P, 2001, J DAIRY SCI, V84, P1390, DOI 10.3168/jds.S0022-0302(01)70170-1; Girard A, 2015, THERIOGENOLOGY, V84, P1350, DOI 10.1016/j.theriogenology.2015.07.015; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Golini VE, 2014, THERIOGENOLOGY, V82, P580, DOI 10.1016/j.theriogenology.2014.05.019; Huang WL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05702-5; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Ji P, 2014, J DAIRY SCI, V97, P3441, DOI 10.3168/jds.2013-7296; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Ji P., 2009, J DAIRY SCI S1, V92, P709; Jorritsma R, 2003, VET RES, V34, P11, DOI 10.1051/vetres:2002054; Khan MJ, 2013, J DAIRY SCI, V96, P2171, DOI 10.3168/jds.2012-5794; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuhla B, 2016, DOMEST ANIM ENDOCRIN, V56, pS2, DOI 10.1016/j.domaniend.2015.12.002; LeBlanc SJ, 2005, J DAIRY SCI, V88, P159, DOI 10.3168/jds.S0022-0302(05)72674-6; LUCY MC, 1992, REPROD NUTR DEV, V32, P331, DOI 10.1051/rnd:19920403; Maillard V, 2011, REPRODUCTION, V141, P467, DOI 10.1530/REP-10-0419; Maillard V, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-23; Mann S, 2016, J DAIRY SCI, V99, P6737, DOI 10.3168/jds.2016-10969; MCNAMARA JP, 1986, J LIPID RES, V27, P150; MCNAMARA JP, 1989, J DAIRY SCI, V72, P407, DOI 10.3168/jds.S0022-0302(89)79122-0; MCNAMARA JP, 1994, J NUTR, V124, pS1383, DOI 10.1093/jn/124.suppl_8.1383S; Mellouk N, 2017, J DAIRY SCI, V100, P8518, DOI 10.3168/jds.2017-12657; Mellouk N, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0467-x; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Moore SG, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.132951; REMOND B, 1988, REPROD NUTR DEV, V28, P109, DOI 10.1051/rnd:19880117; Reverchon M, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134650; Reverchon M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117044; Reverchon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093198; Rocco SM, 2013, J DAIRY SCI, V96, P3108, DOI 10.3168/jds.2012-6097; RUTANEN EM, 1993, ANN MED, V25, P343, DOI 10.3109/07853899309147295; Salazar-Ortiz J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-130; Salin S, 2017, J DAIRY SCI, V100, P5266, DOI 10.3168/jds.2016-11871; Saremi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086211; Selim S, 2014, PHYSIOL GENOMICS, V46, P328, DOI 10.1152/physiolgenomics.00115.2013; Sheldon IM, 2014, REPRODUCTION, V148, pR41, DOI 10.1530/REP-14-0163; SHIRLEY JE, 1973, J DAIRY SCI, V56, P569, DOI 10.3168/jds.S0022-0302(73)85220-8; Singh SP, 2014, J DAIRY SCI, V97, P1535, DOI 10.3168/jds.2013-7598; SIROIS J, 1988, BIOL REPROD, V39, P308, DOI 10.1095/biolreprod39.2.308; Sordillo LM, 2013, VET CLIN N AM-FOOD A, V29, P267, DOI 10.1016/j.cvfa.2013.03.002; SPICER LJ, 1994, DOMEST ANIM ENDOCRIN, V11, P25, DOI 10.1016/0739-7240(94)90034-5; Sumner JM, 2007, J DAIRY SCI, V90, P5237, DOI 10.3168/jds.2007-0307; Sumner-Thomson JM, 2011, J DAIRY SCI, V94, P361, DOI 10.3168/jds.2010-3447; Townson DH, 2002, J ANIM SCI, V80, P1053; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Tribulo P, 2018, J DAIRY SCI, V101, P690, DOI 10.3168/jds.2017-13221; van der Kolk JH, 2017, VET QUART, V37, P262, DOI 10.1080/01652176.2017.1354561; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Leesen R, 2014, J DAIRY SCI, V97, P1128, DOI 10.3168/jds.2013-7185; Waerp HKL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201284; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wathes DC, 2013, REPROD FERT DEVELOP, V25, P48, DOI 10.1071/RD12272	60	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222954	10.1371/journal.pone.0222954	http://dx.doi.org/10.1371/journal.pone.0222954			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557215	gold, Green Published			2022-12-26	WOS:000532345500050
J	Levinsky, NC; Mallela, J; Opoka, AM; Harmon, K; Lewis, HV; Zingarelli, B; Wong, HR; Alder, MN				Levinsky, Nick C.; Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Lewis, Hannah V.; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.			The olfactomedin-4 positive neutrophil has a role in murine intestinal ischemia/reperfusion injury	FASEB JOURNAL			English	Article						neutrophil subsets; neutrophil heterogeneity; OLFM4; iNos	STAPHYLOCOCCUS-AUREUS; INNATE IMMUNITY; SUBSET; INHIBITION; MICE	Olfactomedin-4 (OLFM4) identifies a subset of neutrophils conserved in both mouse and man, associated with worse outcomes in several inflammatory conditions. We investigated the role of OLFM4-positive neutrophils in murine intestinal ischemia/reperfusion (IR) injury. Wild-type (WT) C57B1/6 and OLFM4 null mice were subjected to intestinal IR injury and then monitored for survival or tissues harvested for further analyses. In vivo intestinal barrier function was determined via functional assay of permeability to FITC-dextran. OLFM4 null mice had a significant 7-d survival benefit and less intestinal barrier dysfunction compared with WT. Early after IR, WT mice had worse mucosal damage on histologic examination. Experiments involving adoptive transfer of bone marrow demonstrated that the mortality phenotype associated with OLFM4-positive neutrophils was transferrable to OLFM4 null mice. After IR injury, WT mice also had increased intestinal tissue activation of NF kappa B and expression of iNOS, 2 signaling pathways previously demonstrated to be involved in intestinal IR injury. In combination, these experiments show that OLFM4-positive neutrophils are centrally involved in the pathologic pathway leading to intestinal damage and mortality after IR injury. This may provide a therapeutic target for mitigation of intestinal IR injury in a variety of common clinical situations.	[Levinsky, Nick C.; Lewis, Hannah V.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Alder, MN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Crit Care Med, 3333 Burnet Ave MLC 7006, Cincinnati, OH 45229 USA.	matthew.alder@cchmc.org	, Basilia/AAV-7582-2021; Mallela, Jaya/AAJ-9875-2021		U.S. National Institutes of Health, National Institute of General Medical Sciences [R35 GM126943, K08 GM124298, T32 GM008478-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, K08GM124298, R35GM126943] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Cincinnati Children's Hospital Medical Center Animal Bone Marrow Transplantation Core and Flow Cytometry Core facilities for assistance with this work. This work was funded by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R35 GM126943, K08 GM124298, and T32 GM008478-25. The authors declare no conflicts of interest.	Alder MN, 2019, INNATE IMMUN-LONDON, V25, P22, DOI 10.1177/1753425918817611; Alder MN, 2017, CRIT CARE MED, V45, pE426, DOI 10.1097/CCM.0000000000002102; Barocelli E, 2006, NITRIC OXIDE-BIOL CH, V14, P212, DOI 10.1016/j.niox.2005.11.006; Brand HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131927; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Grootjans J, 2016, WORLD J GASTROENTERO, V22, P2760, DOI 10.3748/wjg.v22.i9.2760; Gubernatorova E. O., 2016, JOVE-J VIS EXP, V2016, P111; Guette C, 2015, PROTEOM CLIN APPL, V9, P58, DOI 10.1002/prca.201400083; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kangelaris KN, 2015, AM J PHYSIOL-LUNG C, V308, pL1102, DOI 10.1152/ajplung.00380.2014; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Liu W, 2016, ONCOGENE, V35, P5237, DOI 10.1038/onc.2016.58; Liu WL, 2018, AM J PHYSIOL-CELL PH, V315, pC494, DOI 10.1152/ajpcell.00336.2017; Liu WL, 2016, CANCER METAST REV, V35, P201, DOI 10.1007/s10555-016-9624-2; Liu WL, 2013, J CLIN INVEST, V123, P3751, DOI 10.1172/JCI68453; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Ode Y, 2018, J LEUKOCYTE BIOL, V103, P693, DOI 10.1002/JLB.3A0817-327RR; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Rosenbauer F, 2004, BLOOD, V103, P4294, DOI 10.1182/blood-2003-08-2688; SCHOENBERG MH, 1991, GUT, V32, P905, DOI 10.1136/gut.32.8.905; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Souza DG, 2005, BRIT J PHARMACOL, V145, P246, DOI 10.1038/sj.bjp.0706190; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; Tak T, 2017, BLOOD, V129, P3476, DOI 10.1182/blood-2016-07-727669; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wu ZP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006067; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	33	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13660	13668		10.1096/fj.201901231R	http://dx.doi.org/10.1096/fj.201901231R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31593636	Green Published, Bronze			2022-12-26	WOS:000507466100048
J	Milano-Foster, J; Ray, S; Home, P; Ganguly, A; Bhattacharya, B; Bajpai, S; Pal, A; Mason, CW; Paul, S				Milano-Foster, Jessica; Ray, Soma; Home, Pratik; Ganguly, Avishek; Bhattacharya, Bhaswati; Bajpai, Shilpika; Pal, Aratrika; Mason, Clifford W.; Paul, Soumen			Regulation of human trophoblast syncytialization by histone demethylase LSD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						placenta; trophoblast; transcription regulation; histone demethylase; human; cytotrophoblast; LSD1; syncytiotrophoblast	HUMAN CHORIONIC-GONADOTROPIN; TRANSCRIPTION FACTOR; ANDROGEN-RECEPTOR; CELL-LINE; SIGNALING PATHWAYS; GENE-EXPRESSION; GATA FACTORS; STEM-CELLS; DIFFERENTIATION; PLACENTA	A successful pregnancy is critically dependent upon proper placental development and function. During human placentation, villous cytotrophoblast (CTB) progenitors differentiate to form syncytiotrophoblasts (SynTBs), which provide the exchange surface between the mother and fetus and secrete hormones to ensure proper progression of pregnancy. However, epigenetic mechanisms that regulate SynTB differentiation from CTB progenitors are incompletely understood. Here, we show that lysine-specific demethylase 1 (LSD1; also known as KDM1A), a histone demethylase, is essential to this process. LSD1 is expressed both in CTB progenitors and differentiated SynTBs in first-trimester placental villi; accordingly, expression in SynTBs is maintained throughout gestation. Impairment of LSD1 function in trophoblast progenitors inhibits induction of endogenous retrovirally encoded genes SYNCYTIN1/endogenous retrovirus group W member 1, envelope (ERVW1) and SYNCYTIN2/endogenous retrovirus group FRD member 1, envelope (ERVFRD1), encoding fusogenic proteins critical to human trophoblast syncytialization. Loss of LSD1 also impairs induction of chorionic gonadotropin alpha (CGA) and chorionic gonadotropin beta (CGB) genes, which encode alpha and beta subunits of human chorionic gonadotrophin (hCG), a hormone essential to modulate maternal physiology during pregnancy. Mechanistic analyses at the endogenous ERVW1, CGA, and CGB loci revealed a regulatory axis in which LSD1 induces demethylation of repressive histone H3 lysine 9 dimethylation (H3K9Me2) and interacts with transcription factor GATA2 to promote RNA polymerase II (RNA-POL-II) recruitment and activate gene transcription. Our study reveals a novel LSD1-GATA2 axis, which regulates human trophoblast syncytialization.	[Milano-Foster, Jessica; Ray, Soma; Home, Pratik; Ganguly, Avishek; Bhattacharya, Bhaswati; Bajpai, Shilpika; Pal, Aratrika; Mason, Clifford W.; Paul, Soumen] Univ Kansas, Med Ctr, Inst Reprod Hlth & Perinatal Res, Kansas City, KS 66160 USA; [Milano-Foster, Jessica; Ray, Soma; Home, Pratik; Ganguly, Avishek; Bhattacharya, Bhaswati; Bajpai, Shilpika; Pal, Aratrika; Mason, Clifford W.; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Mason, Clifford W.; Paul, Soumen] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, MS 3050, Kansas City, KS 66160 USA.	spaul2@kumc.edu		Mason, Clifford/0000-0001-5969-4279	National Institutes of Health [HD062546, HD098880, HD079363]; Kansas Idea Network Of Biomedical Research Excellence (K-IBRE) [P20GM103418]; University of Kansas Biomedical Research Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062546, R21HD098880, P01HD079363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Idea Network Of Biomedical Research Excellence (K-IBRE); University of Kansas Biomedical Research Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HD062546, HD098880, and HD079363 and Bridging Grant P20GM103418 under the Kansas Idea Network Of Biomedical Research Excellence (K-IBRE) (to S.P.) and a University of Kansas Biomedical Research Training Program grant (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Ahmed M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160325; Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Ancelin K, 2016, ELIFE, V5, DOI 10.7554/eLife.08851; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baird DD, 2003, BIOL REPROD, V68, P448, DOI 10.1095/biolreprod.102.008425; BEER AE, 1982, BIOL REPROD, V26, P15, DOI 10.1095/biolreprod26.1.15; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; BO M, 1992, J BIOL CHEM, V267, P3179; Boss AL, 2018, HUM REPROD UPDATE, V24, P750, DOI 10.1093/humupd/dmy030; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Castex J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.48; Chamley LW, 2014, PLACENTA, V35, pS74, DOI 10.1016/j.placenta.2013.10.014; Chang CW, 2018, J ENDOCRINOL, V236, pR43, DOI 10.1530/JOE-17-0402; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005; Di Stefano B, 2016, NAT CELL BIOL, V18, P371, DOI 10.1038/ncb3326; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; FIDDES JC, 1984, RECENT PROG HORM RES, V40, P43; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Guo YD, 2016, AM J TRANSL RES, V8, P2265; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Harris LK, 2007, HUM REPROD, V22, P2834, DOI 10.1093/humrep/dem303; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Home P, 2017, DEVELOPMENT, V144, P876, DOI 10.1242/dev.145318; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; James JL, 2012, PLACENTA, V33, P327, DOI 10.1016/j.placenta.2012.01.020; Jindal P, 2007, HUM REPROD, V22, P313, DOI 10.1093/humrep/del128; Kim HS, 2007, PLACENTA, V28, P77, DOI 10.1016/j.placenta.2006.01.025; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knofler M, 2019, CELL MOL LIFE SCI, V76, P3479, DOI 10.1007/s00018-019-03104-6; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Knott JG, 2014, REPRODUCTION, V148, pR121, DOI 10.1530/REP-14-0072; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kozub Meghan M, 2017, F1000Res, V6, P2016, DOI 10.12688/f1000research.12169.1; Kroener L, 2016, SEMIN REPROD MED, V34, P27, DOI 10.1055/s-0035-1570029; Kwak YT, 2019, ENDOCRINOLOGY, V160, P2189, DOI 10.1210/en.2019-00144; Latos PA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8776; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liu F, 1997, AM J PHYSIOL-CELL PH, V273, pC1596, DOI 10.1152/ajpcell.1997.273.5.C1596; Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Martowicz ML, 2006, J BIOL CHEM, V281, P37345, DOI 10.1074/jbc.M605774200; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Nair SS, 2013, MOL CELL, V49, P704, DOI 10.1016/j.molcel.2012.12.016; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; PATTILLO RA, 1968, CANCER RES, V28, P1231; Paul S, 2017, PLACENTA, V60, pS61, DOI 10.1016/j.placenta.2017.05.005; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Petroff MG, 2006, METH MOLEC MED, V121, P203; POLICASTRO PF, 1986, J BIOL CHEM, V261, P5907; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Quinn J, 2006, METH MOLEC MED, V121, P125; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Robertson W B, 1985, Obstet Gynecol Annu, V14, P411; Saha B, 2013, MOL CELL BIOL, V33, P2691, DOI 10.1128/MCB.00069-13; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schmidt A, 2015, J REPROD IMMUNOL, V108, P65, DOI 10.1016/j.jri.2015.03.001; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; Takeuchi M, 2015, P NATL ACAD SCI USA, V112, P13922, DOI 10.1073/pnas.1517326112; TALMADGE K, 1984, NATURE, V307, P37, DOI 10.1038/307037a0; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thambyrajah R, 2016, NAT CELL BIOL, V18, P21, DOI 10.1038/ncb3276; Tosic M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02740-5; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang JM, 2013, BIOCHEM BIOPH RES CO, V434, P460, DOI 10.1016/j.bbrc.2013.04.004; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wu D, 2019, MOL THER-NUCL ACIDS, V16, P605, DOI 10.1016/j.omtn.2019.04.009; Wu D, 2018, MOL THER-NUCL ACIDS, V12, P381, DOI 10.1016/j.omtn.2018.05.020; Xu YT, 2018, MOL THER-NUCL ACIDS, V12, P195, DOI 10.1016/j.omtn.2018.05.007; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922; Zhu DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4174; Zimmermann G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092429	97	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17301	17313		10.1074/jbc.RA119.010518	http://dx.doi.org/10.1074/jbc.RA119.010518			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31591264	Green Published, hybrid			2022-12-26	WOS:000503173500012
J	Subburaj, S; Lee, K; Jeon, Y; Tu, LH; Son, G; Choi, S; Lim, YP; McGregor, C; Lee, GJ				Subburaj, Saminathan; Lee, Kayoun; Jeon, Yongsam; Tu, Luhua; Son, Gilwoo; Choi, SuBok; Lim, Yong-Pyo; McGregor, Cecilia; Lee, Geung-Joo			Whole genome resequencing of watermelons to identify single nucleotide polymorphisms related to flesh color and lycopene content	PLOS ONE			English	Article							LANATUS THUNB. MATSUM.; GENETIC-LINKAGE MAP; CITRULLUS-LANATUS; MICROSATELLITE MARKERS; CANARY YELLOW; RIND PATTERN; QTL ANALYSIS; CAPS MARKER; DIVERSITY; SNP	Cultivated watermelon (Citrullus lanatus) is one of the most important food crops in the Cucurbitaceae family. Diversification after domestication has led cultivated watermelons to exhibit diverse fruit flesh colors, including red, yellow, and orange. Recently, there has been increased interest in red-fleshed watermelons because they contain the antioxidant cis-isomeric lycopene. We performed whole genome resequencing (WGRS) of 24 watermelons with different flesh colors to identify single-nucleotide polymorphisms (SNPs) related to high lycopene content. The resequencing data revealed 203,894-279,412 SNPs from read mapping between inbred lines and the 97103 reference genome. In total, 295,065 filtered SNPs were identified, which had an average polymorphism information content of 0.297. Most of these SNPs were intergenic (90.1%) and possessed a transversion (Tv) rate of 31.64%. Overall, 2,369 SNPs were chosen at 0.5 Mb physical intervals to analyze genetic diversity across the 24 inbred lines. A neighbor-joining dendrogram and principal coordinate analysis (PCA) based on the 2,369 SNPs revealed that the 24 inbred lines could be grouped into high and low lycopene-type watermelons. In addition, we analyzed SNPs that could discriminate high lycopene content, red-fleshed watermelon from low lycopene, yellow or orange watermelon inbred lines. For validation, 19 SNPs (designated as WMHL1-19) were chosen randomly, and cleavage amplified polymorphic sequence (CAPS) markers were designed. Genotyping of the above 24 lines and 12 additional commercial cultivars using WMHL1-19 CAPS markers resulted in match rates of over 0.92 for most validated markers in correlation with the flesh color phenotypes. Our results provide valuable genomic information regarding the high lycopene content phenotype of red-fleshed cultivated watermelons, and the identified SNPs will be useful for the development of molecular markers in the marker-assisted breeding of watermelons with high lycopene content.	[Subburaj, Saminathan; Lee, Kayoun; Jeon, Yongsam; Tu, Luhua; Lim, Yong-Pyo; Lee, Geung-Joo] Chungnam Natl Univ, Dept Hort, Daejeon, South Korea; [Son, Gilwoo] Hyundai Seed Co Ltd, Breeding Inst, Yeoju, Gyeonggi, South Korea; [Choi, SuBok] Asia Seed Co Ltd, Seoul, South Korea; [McGregor, Cecilia] Univ Georgia, Dept Hort, Athens, GA 30602 USA	Chungnam National University; University System of Georgia; University of Georgia	Lee, GJ (corresponding author), Chungnam Natl Univ, Dept Hort, Daejeon, South Korea.	gjlee@cnu.ac.kr		SUBBURAJ, SAMINATHAN/0000-0002-9660-7661; Lee, Geung-Joo/0000-0002-3774-1860; McGregor, Cecilia/0000-0001-8189-1092	Golden Seed Project (Center for Vegetable Seed Development), Ministry of Agriculture, Food and Rural Affairs (MAFRA) of Korea [213003-05-1-SBW30]; Ministry of Agriculture, Food, and Rural Affairs of Korea	Golden Seed Project (Center for Vegetable Seed Development), Ministry of Agriculture, Food and Rural Affairs (MAFRA) of Korea; Ministry of Agriculture, Food, and Rural Affairs of Korea	This study was supported by the Golden Seed Project (Center for Vegetable Seed Development, No. 213003-05-1-SBW30), Ministry of Agriculture, Food and Rural Affairs (MAFRA) of Korea. The Ministry of Agriculture, Food, and Rural Affairs of Korea provided support in the form of research costs and salaries for authors SS, KL, YJ, LT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hyundai Seed and Asia Seed provided research materials, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Alquezar B, 2008, PHYTOCHEMISTRY, V69, P1997, DOI 10.1016/j.phytochem.2008.04.020; Bang H, 2007, MOL BREEDING, V20, P63, DOI 10.1007/s11032-006-9076-4; Bang H, 2014, EUPHYTICA, V200, P363, DOI 10.1007/s10681-014-1158-5; Bang H, 2010, J AM SOC HORTIC SCI, V135, P362, DOI 10.21273/JASHS.135.4.362; BECKMANN JS, 1986, EUPHYTICA, V35, P111, DOI 10.1007/BF00028548; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Branham S, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0747-0; Carrillo-Lopez A, 2014, J FOOD SCI TECH MYS, V51, P2720, DOI 10.1007/s13197-012-0782-0; Cheng Y, 2016, SCI HORTIC-AMSTERDAM, V202, P25, DOI 10.1016/j.scienta.2016.01.004; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dia M, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.66; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Feng D, 2010, INFLAMM RES, V59, P115, DOI 10.1007/s00011-009-0077-8; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Gusmini G, 2006, J HERED, V97, P177, DOI 10.1093/jhered/esj023; Hashizume T, 2003, THEOR APPL GENET, V106, P779, DOI 10.1007/s00122-002-1030-1; Henderson W. R., 1989, Report - Cucurbit Genetics Cooperative, P59; Henderson WR, 1998, J HERED, V89, P50, DOI 10.1093/jhered/89.1.50; Hildebrand C.E., 1992, LOS ALAMOS SCI, V20, P100; Kim KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145665; Kumar R, 2011, J HERED, V102, P489, DOI 10.1093/jhered/esr025; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Levi A, 2004, J AM SOC HORTIC SCI, V129, P553, DOI 10.21273/JASHS.129.4.0553; Levi A, 2001, GENET RESOUR CROP EV, V48, P559, DOI 10.1023/A:1013888418442; Levi A, 2001, HORTSCIENCE, V36, P1096, DOI 10.21273/HORTSCI.36.6.1096; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu S, 2016, BREEDING SCI, V66, P244, DOI 10.1270/jsbbs.66.244; Liu S, 2015, EUPHYTICA, V202, P411, DOI 10.1007/s10681-014-1308-9; Mohanty NK, 2005, UROL ONCOL-SEMIN ORI, V23, P383, DOI 10.1016/j.urolonc.2005.05.012; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nimmakayala P, 2014, MOL BREEDING, V34, P537, DOI 10.1007/s11032-014-0056-9; Paris HS, 2015, ANN BOT-LONDON, V116, P133, DOI 10.1093/aob/mcv077; Park G, 2018, HORTIC SCI TECHNOL, V36, P280, DOI 10.12972/kjhst.20180028; Perkins-Veazie P, 2006, J AGR FOOD CHEM, V54, P2593, DOI 10.1021/jf052066p; Poole CF, 1944, J HERED, V35, P122, DOI 10.1093/oxfordjournals.jhered.a105364; Poole Charles F., 1945, JOUR AGRIC RES, V71, P533; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Reddy UK, 2015, J HERED, V106, P166, DOI 10.1093/jhered/esu077; Reddy UK, 2014, G3-GENES GENOM GENET, V4, P2219, DOI 10.1534/g3.114.012815; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Sandhu KS, 2012, THEOR APPL GENET, V125, P1403, DOI 10.1007/s00122-012-1921-8; Tadmor Y, 2005, FOOD RES INT, V38, P837, DOI 10.1016/j.foodres.2004.07.011; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; UPOV (International union for the protection of new varieties of plants), 2013, WAT GUID COND TESTS, V142, P1; Yang HB, 2015, KOREAN J HORTIC SCI, V33, P559, DOI 10.7235/hort.2015.14070; Yang XP, 2016, PLANT GENET RESOUR-C, V14, P226, DOI 10.1017/S1479262115000659; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhu QL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3442-3	51	6	8	8	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223441	10.1371/journal.pone.0223441	http://dx.doi.org/10.1371/journal.pone.0223441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596903	Green Published, Green Submitted, gold			2022-12-26	WOS:000532444100033
J	Vilela, DS; Koroiva, R; Cordero-Rivera, A; Guillermo-Ferreira, R				Vilela, Diogo Silva; Koroiva, Ricardo; Cordero-Rivera, Adolfo; Guillermo-Ferreira, Rhainer			A further study on Franciscobasis Machado & Bede, 2016 (Odonata: Coenagrionidae), a newly described genus from Minas Gerais, Brazil	PLOS ONE			English	Article							DAMSELFLY ISCHNURA-GRAELLSII; COLOR POLYMORPHISM; DNA; INHERITANCE; LARVAE	The genus Franciscobasis Machado & Bede, 2016 is endemic to the Serra da Canastra National Park in Minas Gerais state, Brazil. Two species of Franciscobasis were described simultaneously with the genus description: F. franciscoi and F. sonia, the latter described only from females. Through morphological and molecular analysis, we investigated if F. sonia may represent the young female of F. franciscoi. Resulting data did not present adequate differences between females to characterize them as different species. Therefore, we suggest that F. sonia is a junior synonym of F. franciscoi, and the female of F. franciscoi goes through a complex ontogenetic color change.	[Vilela, Diogo Silva] Univ Sao Paulo, Dept Biol, Grad Program Entomol, Ribeirao Preto, Brazil; [Vilela, Diogo Silva; Guillermo-Ferreira, Rhainer] Univ Fed Sao Carlos, Dept Hydrobiol, Lab Ecol Studies Ethol & Evolut LESTES, Sao Carlos, Brazil; [Koroiva, Ricardo] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Cordero-Rivera, Adolfo] Univ Vigo, Dept Ecol & Biol Anim, ECOEVO Lab, Pontevedra, Spain	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Institute Nacional de Pesquisas da Amazonia; Universidade de Vigo	Vilela, DS (corresponding author), Univ Sao Paulo, Dept Biol, Grad Program Entomol, Ribeirao Preto, Brazil.; Vilela, DS (corresponding author), Univ Fed Sao Carlos, Dept Hydrobiol, Lab Ecol Studies Ethol & Evolut LESTES, Sao Carlos, Brazil.	deeogoo@gmail.com	Koroiva, Ricardo/F-5767-2015; Vilela, Diogo/AHC-3051-2022; Ferreira, Rhainer Guillermo/ABH-2294-2021	Koroiva, Ricardo/0000-0002-6658-0824; Vilela, Diogo/0000-0001-6510-7018; Ferreira, Rhainer Guillermo/0000-0001-7774-5252	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140732/2016-0]; Rufford Foundation [RSG 25133-2]; FEDER funds [PGC2018-096656-B-I00]; Spanish Ministry with competencies in Science; PNPD/CAPES; FAPEAM (FIXAM I/FAPEAM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rufford Foundation; FEDER funds(European Commission); Spanish Ministry with competencies in Science; PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEAM (FIXAM I/FAPEAM)	This study was funded by grants/scholarships by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Proc.140732/2016-0) to DSV, PNPD/CAPES, FAPEAM (FIXAM I/FAPEAM) and Rufford Foundation (RSG 25133-2) to RK, and a grant from the Spanish Ministry with competencies in Science, including FEDER funds (PGC2018-096656-B-I00) to ACR.	Andres JA, 1999, HEREDITY, V82, P328, DOI 10.1038/sj.hdy.6884930; [Anonymous], 2011, CCDB PRIMER SETS SEQ; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1990, HEREDITY, V64, P341, DOI 10.1038/hdy.1990.42; Cordero A., 1996, Journal of the British Dragonfly Society, V12, P50; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dijkstra KDB, 2014, SYST ENTOMOL, V39, P68, DOI 10.1111/syen.12035; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fincke Ola M., 2005, International Journal of Odonatology, V8, P183; FINCKE OM, 1994, EVOL ECOL, V8, P328, DOI 10.1007/BF01238282; Garrison R.W., 2010, DAMSELFLY GENERA NEW; HIGASHI T, 1993, ECOL RES, V8, P103, DOI 10.1007/BF02348613; Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; JOHNSON C, 1973, Odonatologica, V2, P69; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim MJ, 2014, ENTOMOL RES, V44, P65, DOI 10.1111/1748-5967.12051; Koroiva R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182283; Koroiva R, 2018, J MED ENTOMOL, V55, P1055, DOI 10.1093/jme/tjy045; Koroiva R, 2018, MITOCHONDRIAL DNA A, V29, P765, DOI 10.1080/24701394.2017.1357709; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lencioni FAA, 2006, DAMSELFLIES BRAZIL I, V2; Machado ABM, 2015, INT J ODONATOL, V18, P269, DOI 10.1080/13887890.2015.1072113; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Orr AG, 2015, ZOOTAXA, V4040, P384, DOI 10.11646/zootaxa.4040.3.9; Orr AG, 2015, ZOOTAXA, V3985, P565, DOI 10.11646/zootaxa.3985.4.5; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PAULSON D R, 1983, Odonatologica, V12, P59; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Robinson J. V., 1996, Odonatologica, V25, P83; Sanchez-Guillen RA, 2020, J EVOLUTION BIOL, V33, P551, DOI 10.1111/jeb.13289; Sanmartin-Villar I, 2016, PEERJ, V4, DOI 10.7717/peerj.2380; Sanmartin-Villar I, 2016, ODONATOLOGICA, V45, P77, DOI 10.5281/zenodo.50850; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Telfer AC, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6313; Vilela DS, 2017, INT J ODONATOL, V20, P191, DOI 10.1080/13887890.2017.1373152; Von Ellenrieder N, 2008, ZOOTAXA, P1; Von Ellenrieder Natalia, 2008, Rev. Soc. Entomol. Argent., V67, P81; VONELLENRIEDER N, 2008, ZOOTAXA 0618, P1; WAAGE J K, 1980, Odonatologica, V9, P217; WATANABE M, 1987, ZOOL SCI, V4, P575; Westfall M.J., 2006, DAMSELFLIES N AM; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0223241	10.1371/journal.pone.0223241	http://dx.doi.org/10.1371/journal.pone.0223241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV3VK	31593578	gold, Green Published			2022-12-26	WOS:000520411100001
J	Jensen, RE; Enkegaard, A; Steenberg, T				Jensen, Rasmus Emil; Enkegaard, Annie; Steenberg, Tove			Increased fecundity of Aphis fabae on Vicia faba plants following seed or leaf inoculation with the entomopathogenic fungus Beauveria bassiana	PLOS ONE			English	Article							COLONIZATION; ASCOMYCOTA; ENDOPHYTES; HORMESIS; GROWTH	Since the discovery that entomopathogenic fungi can live inside plants as endophytes, researchers have been trying to understand how this affects mainly plants and herbivores. We studied how inoculation of Vicia faba L. (Fabales: Fabaceae) plants with Beauveria bassiana (Balsamo-Crivelli) Vuillemin (Ascomycota: Hypocreales) (strain GHA) either via the seeds or leaves influenced the nymph production of two successive generations of Aphis fabae Scopoli (Hemiptera: Aphididae). While we did not find any difference in nymph production for the first generation of aphids, second-generation aphids on both seed- and spray inoculated plants produced significantly higher numbers of nymphs than aphids on uninoculated plants. This emphasizes the importance of two (or multi-) generational experimentation. Beauveria bassiana was recovered from 26.0, 68.8 and 6.3% of respectively seed-, spray inoculated and control plants, thus, demonstrating its ability to live as an endophyte in V. faba. The confirmation that plants inoculated with entomopathogenic fungi can have a positive effect on pest insects makes careful consideration of these multi-trophic interactions imperative.	[Jensen, Rasmus Emil; Enkegaard, Annie; Steenberg, Tove] Aarhus Univ, Dept Agroecol, Sect Plant Pathol & Entomol, Flakkebjerg, Denmark	Aarhus University	Jensen, RE (corresponding author), Aarhus Univ, Dept Agroecol, Sect Plant Pathol & Entomol, Flakkebjerg, Denmark.	rasmusej@agro.au.dk		Jensen, Rasmus Emil/0000-0002-1808-1318	Graduate School of Science and Technology at Aarhus University	Graduate School of Science and Technology at Aarhus University	This work was supported by the Graduate School of Science and Technology at Aarhus University. The author(s) received no additional external funding for this study.	Afandhi A, 2019, CHEM BIOL TECHNOL AG, V6, DOI 10.1186/s40538-019-0148-1; Allegrucci Natalia, 2017, Journal of Plant Protection Research, V57, P331, DOI 10.1515/jppr-2017-0045; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P30; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Barribeau SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-251; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Berns AE, 2008, EUR J SOIL SCI, V59, P540, DOI 10.1111/j.1365-2389.2008.01016.x; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Cameron DD, 2013, TRENDS PLANT SCI, V18, P539, DOI 10.1016/j.tplants.2013.06.004; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Clifton EH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194815; Cutler GC, 2017, ACS SYM SER, V1249, P101; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Dara S. K., 2017, American Journal of Plant Sciences, V8, P1224, DOI 10.4236/ajps.2017.86081; Fox J., 2018, R COMPANION APPL REG, VThird; Gange AC, 2019, NEW PHYTOL; Garcia JE, 2011, ADV BIOL RES; Greenfield M, 2016, BIOL CONTROL, V95, P40, DOI 10.1016/j.biocontrol.2016.01.002; Guesmi-Jouini J, 2014, J INVERTEBR PATHOL, V119, P1, DOI 10.1016/j.jip.2014.03.004; Haney CH, 2018, MOL ECOL, V27, P1833, DOI 10.1111/mec.14400; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jaber LR, 2018, BIOL CONTROL, V116, P36, DOI 10.1016/j.biocontrol.2017.01.018; Jaber LR, 2016, BIOL CONTROL, V103, P187, DOI 10.1016/j.biocontrol.2016.09.008; Jaber LR, 2018, BIOL CONTROL, DOI [10.1016/j.biocontrol.2016.09.001, DOI 10.1016/J.BIOCONTROL.2016.09.001]; Khan AL, 2012, WORLD J MICROB BIOT, V28, P1483, DOI 10.1007/s11274-011-0950-9; Klieber J, 2016, J APPL ENTOMOL, V140, P580, DOI 10.1111/jen.12287; Krell V, 2018, FUNGAL ECOL, V34, P43, DOI 10.1016/j.funeco.2018.04.002; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Martinez AFR, 2018, ENTOMOL EXP APPL, V166, P53, DOI 10.1111/eea.12637; McKinnon AC, 2017, INTERACTIONS ISOLATE; McKinnon AC, 2017, BIOCONTROL, V62, P1, DOI 10.1007/s10526-016-9769-5; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pineda A, 2012, PLANT BIOLOGY, V14, P83, DOI 10.1111/j.1438-8677.2011.00549.x; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; R_Core_Team, R LANG ENV STAT COMP; Rondot Y, 2018, BIOL CONTROL, V116, P82, DOI 10.1016/j.biocontrol.2016.10.006; Russo ML, 2019, J KING SAUD UNIV SCI, V31, P728, DOI 10.1016/j.jksus.2018.04.008; Russo ML, 2015, BIOCONTROL SCI TECHN, V25, P475, DOI 10.1080/09583157.2014.982511; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sanchez-Rodriguez AR, 2018, BIOL CONTROL, V116, P90, DOI 10.1016/j.biocontrol.2017.01.012; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Tall S, 2018, MICROB ECOL, V76, P1002, DOI 10.1007/s00248-018-1180-6; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2018, MYCOLOGIA, V110, P4, DOI 10.1080/00275514.2017.1418578; Vidal S, 2015, CURRENT SCI, V109; Wang JB, 2016, ADV GENET, V94, P67, DOI 10.1016/bs.adgen.2016.01.002; Wang SY, 2017, J PEST SCI, V90, P389, DOI 10.1007/s10340-016-0770-7; Wei Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9413; Wickham H, 2016, ELEGANT GRAPHICS DAT, VSecond; Zitlalpopoca-Hernandez G, 2017, APPL SOIL ECOL, V115, P38, DOI 10.1016/j.apsoil.2017.03.014	55	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223616	10.1371/journal.pone.0223616	http://dx.doi.org/10.1371/journal.pone.0223616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589639	Green Published, gold			2022-12-26	WOS:000532427300032
J	Gjessing, MC; Steinum, T; Olsen, AB; Lie, KI; Tavornpanich, S; Colquhoun, DJ; Gjevre, AG				Gjessing, Mona C.; Steinum, Terje; Olsen, Anne Berit; Lie, Kai Inge; Tavornpanich, Saraya; Colquhoun, Duncan J.; Gjevre, Anne-Gerd			Histopathological investigation of complex gill disease in sea farmed Atlantic salmon	PLOS ONE			English	Article							SALAR L.; NEOPARAMOEBA-PERURANS; INFECTION; PATHOLOGY; POXVIRUS; EPITHELIOCYSTIS; CHLAMYDIALES; INFLAMMATION; LESIONS; AGENT	Various agents including Ca. Piscichlamydia salmonis, Ca. Branchiomonas cysticola, Des-mozoon lepeophtherii, Paramoeba perurans and salmon gill poxvirus may be associated with complex gill disease in Atlantic salmon. Co-infections involving two or more of these agents are common and histopathological interpretation of lesions is therefore challenging. In this study, we developed a semi-quantitative scoring system for examination of histopathological gill lesions in sea-farmed Atlantic salmon suffering from gill disease. Following qPCR analysis of gills sampled for Ca. P. salmonis, Ca. B. cysticola, D. lepeophtherii and P. perurans from 22 geographically spread outbreaks, five cases representing different infectious loads and combinations of agents were chosen for histopathological scoring. Twenty-eight histological features were evaluated and potential associations between individual pathological changes and the occurrence of individual agents studied. The inter-observer agreement in interpretation of histological parameters between the three pathologists involved, was calculated to validate robustness of the scoring scheme. Seventeen histological parameters met the criteria for inter-observer agreement analysis and were included in the calculation. The three most frequent findings were identification of subepithelial leukocytes, epithelial cell hyperplasia and mucus cell hyperplasia. While few findings could be specifically related to particular agents, necrosis in hyperplastic lesions, pustules and necrosis of subepithelial cells appeared to be associated with the presence of Ca. B. cysticola. Further, lesion profiles clearly support the previously identified association between P. perurans and pathological changes associated with AGD. Very few pathological changes were observed in the single case in which Ca. P. salmonis was the dominating agent. Some lesions were only very rarely observed e.g. chloride cell necrosis, epithelial cell apoptosis, lamellar deposition of melanin and haemophagocytosis. The scoring scheme developed and applied was robust and sensitive. A less extensive scheme for routine diagnostic use is proposed.	[Gjessing, Mona C.; Steinum, Terje; Lie, Kai Inge; Tavornpanich, Saraya; Colquhoun, Duncan J.; Gjevre, Anne-Gerd] Norwegian Vet Inst, Oslo, Norway; [Olsen, Anne Berit] Norwegian Vet Inst, Bergen, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute	Gjessing, MC (corresponding author), Norwegian Vet Inst, Oslo, Norway.	mona.gjessing@vetinst.no	Steinum, Terje Marken/AAE-1179-2020; Thompson, Kimberly/O-7707-2015; Thompson, Kim/GLU-8547-2022; Tavornpanich, Saraya/ABG-7643-2020	Thompson, Kimberly/0000-0003-3550-4842; tavornpanich, saraya/0000-0002-9713-6881; Steinum, Terje Marken/0000-0001-5377-9765	Norwegian Seafood Research Fund project [900800]; Norwegian research council [233858]	Norwegian Seafood Research Fund project; Norwegian research council(Research Council of NorwayEuropean Commission)	This work was supported by: MCG, Norwegian Seafood Research Fund project 900800: https://www.fhf.no/; Norwegian research council 233858: https://www.forskningsradet.no/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Adams MB, 2001, J FISH DIS, V24, P535, DOI 10.1046/j.1365-2761.2001.00330.x; [Anonymous], 2019, R LANG ENV STAT COMP; Apablaza P, 2017, J AQUAT ANIM HEALTH, V29, P143, DOI 10.1080/08997659.2017.1339643; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Freeman MA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-231; Freeman MA, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-58; Fringuelli E, 2012, J FISH DIS, V35, P711, DOI 10.1111/j.1365-2761.2012.01395.x; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Gjessing MC, 2018, J FISH DIS, V41, P1103, DOI 10.1111/jfd.12802; Gjessing MC, 2017, J FISH DIS, V40, P1253, DOI 10.1111/jfd.12608; Gjessing MC, 2017, J FISH DIS; Gjessing MC, 2015, J VIROL, V89, P9348, DOI 10.1128/JVI.01174-15; Gunnarsson GS, 2017, AQUACULTURE, V468, P126, DOI 10.1016/j.aquaculture.2016.10.011; Herrero A, 2018, J COMP PATHOL, V163, P23, DOI 10.1016/j.jcpa.2018.07.004; Hou SP, 2018, EUR J DERMATOL, V28, P628, DOI 10.1684/ejd.2018.3399; KENT ML, 1995, DIS AQUAT ORGAN, V22, P77, DOI 10.3354/dao022077; Koppang EO, 2015, MUCOSAL HLTH AQUACUL, P385; Kvellestad A, 2005, DIS AQUAT ORGAN, V67, P47, DOI 10.3354/dao067047; Lovy J, 2011, DIS AQUAT ORGAN, V94, P125, DOI 10.3354/dao02322; Matthews CGG, 2013, J FISH DIS, V36, P861, DOI 10.1111/jfd.12084; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Mitchell SO, 2013, DIS AQUAT ORGAN, V103, P35, DOI 10.3354/dao02563; Mitchell SO, 2012, AQUACULT INT, V20, P813, DOI 10.1007/s10499-012-9504-x; Munday BL, 2001, J FISH DIS, V24, P497, DOI 10.1046/j.1365-2761.2001.00329.x; Nylund A, 2008, ARCH VIROL, V153, P1299, DOI 10.1007/s00705-008-0117-7; Nylund S, 2015, ARCH MICROBIOL, V197, P17, DOI 10.1007/s00203-014-1038-3; Rodger HD, 2013, B EUR ASSOC FISH PAT, V33, P35; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; ROUBAL FR, 1989, J FISH DIS, V12, P481, DOI 10.1111/j.1365-2761.1989.tb00559.x; Rutgers M, 2010, OSTEOARTHR CARTILAGE, V18, P12, DOI 10.1016/j.joca.2009.08.009; Sanchez JG, 1997, J FISH DIS, V20, P375, DOI 10.1046/j.1365-2761.1997.00312.x; Savykoski T, 2004, RESPIRATION, V71, P120, DOI 10.1159/000076671; Steinum T, 2008, J FISH DIS, V31, P205, DOI 10.1111/j.1365-2761.2007.00893.x; Steinum T, 2010, DIS AQUAT ORGAN, V91, P201, DOI 10.3354/dao02266; Steinum T, 2009, AQUACULTURE, V293, P172, DOI 10.1016/j.aquaculture.2009.05.006; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Weli SC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2303-5; Young ND, 2007, INT J PARASITOL, V37, P1469, DOI 10.1016/j.ijpara.2007.04.018; [No title captured]	42	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222926	10.1371/journal.pone.0222926	http://dx.doi.org/10.1371/journal.pone.0222926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581255	Green Published, gold			2022-12-26	WOS:000532398600022
J	Juarez-Sanchez, D; Blake, JG; Hellgren, EC				Juarez-Sanchez, Diego; Blake, John G.; Hellgren, Eric C.			Variation in Neotropical river otter (Lontra longicaudis) diet: Effects of an invasive prey species	PLOS ONE			English	Article							CATFISH LORICARIIDAE PTERYGOPLICHTHYS; STABLE-ISOTOPE ANALYSIS; AMAZON SAILFIN CATFISH; SILURIFORMES LORICARIIDAE; PARDALIS CASTELNAU; TROPHIC-POSITION; NATIVE PREDATOR; LUTRA-LUTRA; NICHE WIDTH; FISH	Predation is one of the main barriers that exotic species may face in newly colonized areas and may help stop or control the potential negative impacts of invasive species in the environment. We evaluated if the consumption of an invasive prey (armored catfish: Pterygoplichtys sp.) affects the dietary niche breadth and trophic level of a native predator (Neotropical river otter: Lontra longicaudis) in northern Guatemala. We examined otter scats from three rivers: two where the invasive armored catfish occurred and one without the invasive fish. Samples were collected two and seven years after the first report of the catfish in the area. We performed gross scat analysis and stable isotope analyses of nitrogen and carbon of fecal matter. Where the invasive armored catfish occurred, it was the main prey item for L. longicaudis. Particularly in the river outside of protected areas seven years after the first report of the catfish, where it accounted for 49% of the otter diet. Concordance was found between the two techniques to estimate dietary niche breadth and trophic level. The dietary niche breath of otters was narrower seven years after the invasion in comparison to two years after the invasion in both invaded rivers, but the extent of the reduction was lesser inside the protected area. Finally, the trophic level of otters also showed a reduction related to the occurrence of the armored catfish in their diet.	[Juarez-Sanchez, Diego; Blake, John G.; Hellgren, Eric C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Juarez-Sanchez, D (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	adjuarez@ufl.edu	Juarez-Sanchez, Diego/GYU-9238-2022	Juarez-Sanchez, Diego/0000-0001-7045-2035				ANGERBJORN A, 1994, OECOLOGIA, V99, P226, DOI 10.1007/BF00627734; Aranda-Sanchez JM, 2012, MANUAL RASTREO MAMIF; Aurioles-Gamboa D, 2009, J MAMMAL, V90, P1410, DOI 10.1644/08-MAMM-A-209R2.1; BALTZ DM, 1993, ECOL APPL, V3, P246, DOI 10.2307/1941827; Barrientos C., 2000, BIOL ASSESSMENT LAGU, P41; Barrientos C, 2018, REV MEX BIODIVERS, V89, P118, DOI 10.22201/ib.20078706e.2018.4.2180; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Bunkley-Williams Lucy, 1994, Caribbean Journal of Science, V30, P90; Burress ED, 2013, ECOL FRESHW FISH, V22, P66, DOI 10.1111/eff.12002; Cameron EK, 2012, DIVERS DISTRIB, V18, P1190, DOI 10.1111/j.1472-4642.2012.00912.x; Capps KA, 2015, FRESHW SCI, V34, P784, DOI 10.1086/681527; Capps KA, 2015, BIOL INVASIONS, V17, P1253, DOI 10.1007/s10530-014-0793-z; Capps KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054093; Capps KA, 2011, AQUAT CONSERV, V21, P528, DOI 10.1002/aqc.1210; Casariego-Madorell A, REV MEX MASTOZOO, V44, DOI [10.1590/S1984-46702011000100006, DOI 10.1590/S1984-46702011000100006]; Cattau CE, 2017, NAT ECOL EVOL, P1, DOI [10.1038/8415590160001, DOI 10.1038/8415590160001]; Cattau CE, 2016, ECOL APPL, V26, P1952, DOI 10.1890/15-1020.1; Chaichana Ratcha, 2013, Kasetsart Journal Natural Science, V47, P581; Chemes Silvina B., 2010, Mastozool. neotrop., V17, P19; Codron D, 2005, S AFR J WILDL RES, V35, P43; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Corcuera Zabarburu CA, 2015, EVALUACION TEMPERATU; Crait JR, 2007, ECOLOGY, V88, P1040, DOI 10.1890/06-0078; Crowley S, 2013, ECOSCIENCE, V20, P28, DOI 10.2980/20-1-3509; da Cruz AL, 2013, FISH PHYSIOL BIOCHEM, V39, P243, DOI 10.1007/s10695-012-9695-0; da Silva Fabiano Aguiar, 2012, Acta Scientiarum Biological Sciences, V34, P407, DOI 10.4025/actascibiolsci.v34i4.10332; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; de Oliveira C, 2001, CYTOBIOS, V105, P153; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; Fricke R, 2018, CATALOG FISHES, DOI [10.11646/zootaxa.3882.1.1, DOI 10.11646/ZOOTAXA.3882.1.1]; Fry B, 2006, STABLE ISOTOPE ECOLO, DOI 10.1007/0-387-33745-8; Gibbs MA, 2008, J FISH BIOL, V73, P1562, DOI 10.1111/j.1095-8649.2008.02031.x; Gibbs M, 2010, SOUTHEAST NAT, V9, P635, DOI 10.1656/058.009.0401; Gibbs MA, 2013, AQUAT INVASIONS, V8, P207, DOI 10.3391/ai.2013.8.2.08; Granados-Dieseldorff Pablo, 2012, Check List, V8, P95; Greendfield D.W., 1997, FISHES CONTINENTAL W, V1st; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; Hatch KA, 2011, URSUS, V22, P133, DOI 10.2192/URSUS-D-10-00034.1; Holdridge L.R., 1971, FOREST ENV TROPICAL; Hubbs C., 2008, ANNOTATED CHECKLIST; Hubilla M., 2007, J ENVIRON SCI MANAG, V10, P10; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Juarez-Sanchez D, 2010, GUIA ILUSTRADA PELOS; Juarez-Sanchez D., 2017, SCALE GUIDE IDENTIFY; Kasper Carlos Benhur, 2004, Rev. Bras. Zool., V21, P499, DOI 10.1590/S0101-81752004000300012; Kasper CB, 2008, IHERINGIA SER ZOOL, V98, P469, DOI 10.1590/S0073-47212008000400009; Kasper Carlos Benhur, 2004, Rev. Bras. Zool., V21, P65, DOI 10.1590/S0101-81752004000100012; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; King RB, 2006, CAN J ZOOL, V84, P108, DOI 10.1139/Z05-182; Krebs CJ, 1999, ECOLOGICAL METHODOLO, DOI [10.1037/023990, DOI 10.1037/023990]; KRUUK H, 1994, PHYSIOL ZOOL, V67, P1174, DOI 10.1086/physzool.67.5.30163888; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; LEVINS RICHARD, 1968; Lienart GDH, 2013, SOUTHWEST NAT, V58, P238, DOI 10.1894/0038-4909-58.2.238; Lopes CA, 2015, ENVIRON BIOL FISH, V98, P1081, DOI 10.1007/s10641-014-0343-7; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Mayor-Victoria Rosemary, 2010, Acta biol.Colomb., V15, P237; Monroy-Vilchis O, 2009, REV MEX BIODIVERS, V80, P801; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Newsome SD, 2004, J ARCHAEOL SCI, V31, P1101, DOI 10.1016/j.jas.2004.02.001; Nico LG, 2010, NEOTROP ICHTHYOL, V8, P893, DOI 10.1590/S1679-62252010005000014; Nico Leo G., 2009, Aquatic Invasions, V4, P511; Nico LG, 2009, ANSRP B, V9, P1; Noonburg EG, 2005, ECOLOGY, V86, P2555, DOI 10.1890/05-0143; Novakowski GC, 2008, NEOTROP ICHTHYOL, V6, P567, DOI 10.1590/S1679-62252008000400004; Orfinger AB, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-07; Pardini R, 1998, J ZOOL, V245, P385, DOI 10.1111/j.1469-7998.1998.tb00113.x; Peer N, 2015, WATER SA, V41, P549, DOI [10.4314/wsa.v41i4.15, 10.4314/WSA.V41I4.15]; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pfeiffer P, 1998, J COMP PHYSIOL B, V168, P143, DOI 10.1007/s003600050130; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quintela Fernando Marques, 2008, Neotropical Biology and Conservation, V3, P119, DOI 10.4013/nbc.20083.03; R Core Team, 2018, R LANG ENV STAT COMP; Rheingantz ML, 2011, ZOOLOGIA-CURITIBA, V28, P37, DOI 10.1590/S1984-46702011000100006; Rheingantz Marcelo Lopes, 2012, IUCN Otter Specialist Group Bulletin, V29, P80; Ríos-Muñoz César A., 2015, Huitzil, V16, P62; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; Skewes O, 2012, REV CHIL HIST NAT, V85, P227, DOI 10.4067/S0716-078X2012000200009; Sousa KS, 2013, MAMM STUDY, V38, P155, DOI 10.3106/041.038.0304; Stevens PW, 2006, ESTUARIES COASTS, V29, P997, DOI 10.1007/BF02798661; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Toro-Ramirez A, 2014, J APPL ICHTHYOL, V30, P532, DOI 10.1111/jai.12391; Wakida-Kusunoki AT, 2007, SOUTHWEST NAT, V52, P141, DOI 10.1894/0038-4909(2007)52[141:ASCPPC]2.0.CO;2; Wakida-Kusunoki AT, 2008, HIDROBIOLOGICA, V18, P251; Wanger TC, 2011, P ROY SOC B-BIOL SCI, V278, P690, DOI 10.1098/rspb.2010.1512; Ward-Fear G, 2010, J APPL ECOL, V47, P273, DOI 10.1111/j.1365-2664.2010.01773.x; Wengeler WR, 2010, BIOL CONSERV, V143, P1144, DOI 10.1016/j.biocon.2010.02.012; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wu LW, 2011, ZOOL STUD, V50, P235; Yirga G, 2015, WILDLIFE RES, V42, P563, DOI 10.1071/WR14228	97	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0217727	10.1371/journal.pone.0217727	http://dx.doi.org/10.1371/journal.pone.0217727			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581191	Green Submitted, Green Published, gold			2022-12-26	WOS:000532398600002
J	Ballo, O; Stratmann, J; Serve, H; Steffen, B; Finkelmeier, F; Brandts, C				Ballo, Olivier; Stratmann, Jan; Serve, Hubert; Steffen, Bjoern; Finkelmeier, Fabian; Brandts, Christian			Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; COMPLETE REMISSION; ELDERLY-PATIENTS; GENE-MUTATIONS; ACHIEVEMENT; EXPRESSION; MORPHOLOGY	Introduction Vacuolization is a frequently found morphological feature in acute myeloid leukemia (AML) blasts. Subcellular origin and biological function as well as prognostic impact are currently unknown. The aim of this study was to evaluate whether vacuolization correlates with clinically relevant AML features. Materials & methods Bone marrow smears of patients diagnosed with AML at the University Hospital Frankfurt between January 2011 and August 2013 were analyzed for blast vacuolization and correlated with clinically relevant AML features. Patients undergoing standard induction chemotherapy were further analyzed for molecular and cytogenetic features as well as treatment response and survival. Results 14 of 100 patients diagnosed with AML receiving standard induction chemotherapy had evidence of blast vacuolization. Positivity for vacuolization correlated with a CD15 positive immunophenotype and with a higher incidence of high-risk AML according to the European LeukemiaNet risk stratification. AML patients with blast vacuolization had a poor blast clearance after standard induction chemotherapy and poor survival. Discussion In conclusion, our findings demonstrate that vacuolization can easily be determined in myeloid leukemia blasts and may be a useful biomarker to predict AML risk groups as well as early treatment response rates and survival.	[Ballo, Olivier; Stratmann, Jan; Serve, Hubert; Steffen, Bjoern; Brandts, Christian] Goethe Univ, Dept Med Hematol Oncol, Frankfurt, Germany; [Serve, Hubert; Brandts, Christian] German Canc Consortium DKTK, Heidelberg, Germany; [Serve, Hubert; Brandts, Christian] German Canc Res Ctr, Heidelberg, Germany; [Finkelmeier, Fabian] Goethe Univ, Dept Med Gastroenterol Hepatol & Endocrinol, Frankfurt, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt	Ballo, O; Brandts, C (corresponding author), Goethe Univ, Dept Med Hematol Oncol, Frankfurt, Germany.; Brandts, C (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Brandts, C (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	oliver.ballo@kgu.de; christian.brandts@kgu.de						BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; CAMPOS L, 1989, BRIT J HAEMATOL, V72, P161, DOI 10.1111/j.1365-2141.1989.tb07677.x; Chen WN, 2006, BLOOD, V108, P1783, DOI 10.1182/blood-2006-03-014340; Chen YJ, 2016, ONCOTARGETS THER, V9, P4453, DOI 10.2147/OTT.S105664; Chisini M, 2017, HEMATOL ONCOL, V35, P804, DOI 10.1002/hon.2331; Dang H, 2013, HUM PATHOL, V44, P55, DOI 10.1016/j.humpath.2012.04.008; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; FENAUX P, 1993, BLOOD, V82, P3241; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Gervais C, 2008, LEUKEMIA, V22, P1567, DOI 10.1038/leu.2008.128; HIDDEMANN W, 1987, BLOOD, V69, P744; Hoelzer D, 2016, ANN ONCOL, V27, pv69, DOI 10.1093/annonc/mdw025; Hoelzer D, 2014, BLOOD, V124, P3870, DOI 10.1182/blood-2014-03-563627; Huang LS, 2017, LEUKEMIA RES, V53, P20, DOI 10.1016/j.leukres.2016.11.016; Kern W, 2003, BLOOD, V101, P64, DOI 10.1182/blood-2002-02-0532; KERR MA, 1992, HISTOCHEM J, V24, P811, DOI 10.1007/BF01046353; Kroschinsky FP, 2008, HAEMATOLOGICA, V93, P283, DOI 10.3324/haematol.11669; Krug U, 2011, DTSCH ARZTEBL INT, V108, P863, DOI 10.3238/arztebl.2011.0863; Kussick SJ, 2004, LEUKEMIA, V18, P1591, DOI 10.1038/sj.leu.2403458; LARSON RA, 1986, BLOOD, V68, P1242; Pang C, 2015, J AM MED INFORM ASSN, V22, P65, DOI 10.1136/amiajnl-2013-002577; Pappenheim A., 1912, FOLIA HAEMATOL, P339; Tang GL, 2015, HUM PATHOL, V46, P65, DOI 10.1016/j.humpath.2014.09.008; Tien HF, 1995, CANCER GENET CYTOGEN, V84, P60, DOI 10.1016/0165-4608(95)00084-4; Virchow R., 1845, WEISSES BLUT FRORIEP, P151	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223013	10.1371/journal.pone.0223013	http://dx.doi.org/10.1371/journal.pone.0223013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568521	gold, Green Published			2022-12-26	WOS:000532364900019
J	Morinaga, Y; Take, Y; Sasaki, D; Ota, K; Kaku, N; Uno, N; Sakamoto, K; Kosai, K; Miyazaki, T; Hasegawa, H; Izumikawa, K; Mukae, H; Yanagihara, K				Morinaga, Yoshitomo; Take, Yuki; Sasaki, Daisuke; Ota, Kenji; Kaku, Norihito; Uno, Naoki; Sakamoto, Kei; Kosai, Kosuke; Miyazaki, Taiga; Hasegawa, Hiroo; Izumikawa, Koichi; Mukae, Hiroshi; Yanagihara, Katsunori			Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; ASSOCIATION	The alteration of the microbial community in the upper respiratory tract (URT) can contribute to the colonization and invasion of respiratory pathogens. However, there are no studies regarding whether the characteristics of the URT microbiota can be affected by infections in lower respiratory tract (LRT). To elucidate the microbial profiles of the URT during pneumonia, the oral, nasal, and lung microbiota was evaluated at the early phase in a murine pneumonia model by direct intratracheal inoculation of Klebsiella pneumoniae. The meta 16S rRNA sequencing of bronchoalveolar lavage fluid after K. pneumoniae inoculation presented alterations in the beta diversity of the microbes, but not in the alpha diversity. At this point, a significant increase in microbial alpha diversity was observed in the oral cavity, but not in the nasal cavity. The significant increase was observed in the family Carnobacteriaceae and family Enterococcaceae. These results suggest that characterizing the microbial community of the respiratory tract may not just involve a simple downstream relationship from the URT to the LRT. The health status of the LRT may influence the oral microbiota. Thus, evaluation of the oral microbiota may contribute towards monitoring lung health; the oral microbiota may act as a diagnostic marker of pneumonia.	[Morinaga, Yoshitomo; Take, Yuki; Sasaki, Daisuke; Ota, Kenji; Kaku, Norihito; Uno, Naoki; Sakamoto, Kei; Kosai, Kosuke; Hasegawa, Hiroo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Morinaga, Yoshitomo; Ota, Kenji; Uno, Naoki; Kosai, Kosuke; Miyazaki, Taiga; Izumikawa, Koichi; Mukae, Hiroshi] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan; [Miyazaki, Taiga; Izumikawa, Koichi] Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Morinaga, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan.; Morinaga, Y (corresponding author), Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan.	y-morina@nagasaki-u.ac.jp	Ota, Kenji/AAK-2675-2021; Kaku, Norihito/N-4488-2015	Kaku, Norihito/0000-0002-4086-4853	Ministry of Health, Labour, and Welfare in Japan [15K09572]	Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Grant-in-Aid for Scientific Research (C) from the Ministry of Health, Labour, and Welfare in Japan (15K09572).	Abe K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198757; Abusleme L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2655; Akata K, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0235-z; Alberti MO, 2016, ANTIMICROB AGENTS CH, V60, P1411, DOI 10.1128/AAC.02645-15; Asakawa M, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00332-18; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Boaden E, 2017, GERODONTOLOGY, V34, P343, DOI 10.1111/ger.12271; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cho SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035114; Cookson WOCM, 2018, NAT REV MICROBIOL, V16, P111, DOI 10.1038/nrmicro.2017.122; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Harada Y, 2014, CLIN MICROBIOL INFEC, V20, pO831, DOI 10.1111/1469-0691.12677; Kageyama S, 2018, J GERONTOL A-BIOL, V73, P1097, DOI 10.1093/gerona/glx205; Kato H, 2007, ORAL MICROBIOL IMMUN, V22, P131, DOI 10.1111/j.1399-302X.2007.00328.x; LaClaire L, 2000, ANTIMICROB AGENTS CH, V44, P2001, DOI 10.1128/AAC.44.7.2001-2003.2000; Lu HF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.101; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004; RUOFF KL, 1991, CLIN MICROBIOL REV, V4, P184, DOI 10.1128/CMR.4.2.184-190.1991; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sedgley CM, 2004, ORAL MICROBIOL IMMUN, V19, P95, DOI 10.1111/j.0902-0055.2004.00122.x; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222589	10.1371/journal.pone.0222589	http://dx.doi.org/10.1371/journal.pone.0222589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560693	Green Published, gold			2022-12-26	WOS:000532353700016
J	Shah, SI; Paine, JG; Perez, C; Ullah, G				Shah, Syed, I; Paine, Johanna G.; Perez, Carlos; Ullah, Ghanim			Mitochondrial fragmentation and network architecture in degenerative diseases	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; ALZHEIMERS-DISEASE; AMYLOID-BETA; CYTOSOLIC CALCIUM; DYNAMICS; FUSION; FISSION; OPA1; MITONEET; MORPHOLOGY	Fragmentation of mitochondrial network has been implicated in many neurodegenerative, renal, and metabolic diseases. However, a quantitative measure of the microscopic parameters resulting in the impaired balance between fission and fusion of mitochondria and consequently the fragmented networks in a wide range of pathological conditions does not exist. Here we present a comprehensive analysis of mitochondrial networks in cells with Alzheimer's disease (AD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), optic neuropathy (OPA), diabetes/cancer, acute kidney injury, Ca2+ overload, and Down Syndrome (DS) pathologies that indicates significant network fragmentation in all these conditions. Furthermore, we found key differences in the way the microscopic rates of fission and fusion are affected in different conditions. The observed fragmentation in cells with AD, HD, DS, kidney injury, Ca2+ overload, and diabetes/cancer pathologies results from the imbalance between the fission and fusion through lateral interactions, whereas that in OPA, PD, and ALS results from impaired balance between fission and fusion arising from longitudinal interactions of mitochondria. Such microscopic difference leads to major disparities in the fine structure and topology of the network that could have significant implications for the way fragmentation affects various cell functions in different diseases.	[Shah, Syed, I; Paine, Johanna G.; Perez, Carlos; Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Ullah, G (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	gullah@usf.edu		Paine, Johanna/0000-0003-2449-1257; Ullah, Ghanim/0000-0002-3716-8742	National Institute of Health [R01 AG053988]; NATIONAL INSTITUTE ON AGING [R01AG053988] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This works was supported by National Institute of Health through grant R01 AG053988 (to GU). URL of funder website: https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C, 2017, J VET SCI, V18, P261, DOI 10.4142/jvs.2017.18.3.261; Ahn C, 2015, MOL CELL ENDOCRINOL, V412, P302, DOI 10.1016/j.mce.2015.05.017; AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Aon MA, 2009, INT J BIOCHEM CELL B, V41, P1940, DOI 10.1016/j.biocel.2009.02.016; Area-Gomez E, 2017, FASEB J, V31, P864, DOI 10.1096/fj.201601309; Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003; Bach D, 2003, J BIOL CHEM; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Berridge M.J., 2012, CALCIUM SIGNALLING R; Berridge MJ, 2017, BIOCHEM BIOPH RES CO, V485, P5, DOI 10.1016/j.bbrc.2017.01.098; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006; Carafoli E., 2007, SUBCELLULAR BIOCH, V45, P481; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Collins TJ, 2002, J PHYSIOL-LONDON, V539, p98P; Coskun PE, 2012, CURRENT GERONTOLOGY; Costa RO, 2010, J ALZHEIMERS DIS, V20, P625, DOI 10.3233/JAD-2010-091369; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Debattisti V, 2017, CELL REP, V21, P1667, DOI 10.1016/j.celrep.2017.10.060; Deheshi S, 2015, J NEUROCHEM, V133, P684, DOI 10.1111/jnc.13090; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dirnberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15669; Eisner V, 2018, NATURE CELL BIOL, P1, DOI [10.1038/s41556-017-0025-8, DOI 10.1038/S41556-017-0025-8]; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Frieden M, 2004, J BIOL CHEM; Geldenhuys WJ, 2014, DRUG DISCOV TODAY, V19, P1601, DOI 10.1016/j.drudis.2014.05.001; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Guardia-Laguarta C, 2015, MOVEMENT DISORD, V30, P1026, DOI 10.1002/mds.26239; Hartmann B, 2016, ELIFE, V5, DOI 10.7554/eLife.16078; HEATH H, 1979, J CLIN ENDOCR METAB, V49, P462, DOI 10.1210/jcem-49-3-462; Hedskog L, 2013, P NATL ACAD SCI USA; Helguera P, 2013, CELL METAB, V17, P132, DOI 10.1016/j.cmet.2012.12.005; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Izzo A, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0004-y; Izzo A, 2017, HUM MOL GENET, V26, P1056, DOI 10.1093/hmg/ddx016; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; Josephs KA, 2015, ANN NEUROL, V78, P697, DOI 10.1002/ana.24493; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lajdova I, 2009, NEPHROL DIAL TRANSPL, V24, P3376, DOI 10.1093/ndt/gfp292; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liao PC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178105; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Massry SG, 1997, MINER ELECTROL METAB, V23, P253; MASSRY SG, 1993, AM J KIDNEY DIS, V21, P81, DOI 10.1016/S0272-6386(12)80727-X; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; MOLINA AJ, 2009, DIABETES; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Penttila S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319; Perez MJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00553; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rainbolt TK, 2016, CELL REP, V14, P2041, DOI 10.1016/j.celrep.2016.02.011; Reis Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028694; Rivera A, 1996, HYPERTENSION, V28, P213, DOI 10.1161/01.HYP.28.2.213; Santel A, 2006, BBA-MOL CELL RES, V1763, P490, DOI 10.1016/j.bbamcr.2006.02.004; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Smith E. F., 2017, NEUROSCIENCE LETT; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Sukhorukov VM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002745; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Szabadkai G, 2003, J BIOL CHEM, V278, P15153, DOI 10.1074/jbc.M300180200; Tan AR, 2011, CELL CALCIUM, V49, P108, DOI 10.1016/j.ceca.2010.12.002; Teves JMY, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00737; Tronstad KJ, 2014, CURR PHARM DESIGN, V20, P5634, DOI 10.2174/1381612820666140305230546; Vernay A, 2017, P NATL ACAD SCI USA, V114, P8277, DOI 10.1073/pnas.1706643114; Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Woo JAA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15558; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yang JS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01403; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zamponi E, 2018, AGING CELL, V17, DOI 10.1111/acel.12812; Zamponi N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18351-5; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	121	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223014	10.1371/journal.pone.0223014	http://dx.doi.org/10.1371/journal.pone.0223014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557225	Green Published, gold			2022-12-26	WOS:000532345500059
J	Jung, JH; Lee, H; Cao, B; Liao, P; Zeng, SX; Lu, H				Jung, Ji Hoon; Lee, Hyemin; Cao, Bo; Liao, Peng; Zeng, Shelya X.; Lu, Hua			RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53	ONCOGENE			English	Article							C-MYC; DEGRADATION; PATHWAY; LOOP; MDM2	RNA-binding motif protein 10 (RBM10) is an RNA-binding protein frequently deleted or mutated in lung cancer cells. Recent reports showed that the knockdown of RBM10 in human cancer cells enhances the growth of mouse tumor xenografts, suggesting that RBM10 acts as a tumor suppressor. RBM10 also regulates alternative splicing and controls cancer cell proliferation. However, the underlying molecular mechanisms for its tumor suppression role remain largely unclear. Here, we for the first time report that RBM10 can induce apoptosis and inhibit cancer cell proliferation by activating p53. Our analysis of cancer genomic databases showed that patients with wild-type RBM10 and p53 survive longer than do those with mutated p53 or less RBM10. RBM10 overexpression markedly inhibited mitochondrial respiration, cell migration and proliferation of various cancer cells that harbor wild-type p53. Also, RBM10 overexpression elongated p53's half-life by disrupting MDM2-p53 interaction and subsequently repressing p53 ubiquitination, whereas knockdown of RBM10 decreased p53 stability. Altogether, our results demonstrate that RBM10 inhibits cancer cell proliferation and induces apoptosis in part by blocking the MDM2-p53 feedback loop.	[Jung, Ji Hoon; Lee, Hyemin; Cao, Bo; Liao, Peng; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Dept Biochem & Mol Biol, Sch Med, New Orleans, LA 70112 USA; [Jung, Ji Hoon; Lee, Hyemin; Cao, Bo; Liao, Peng; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Tulane Canc Ctr, Sch Med, New Orleans, LA 70112 USA; [Jung, Ji Hoon] Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea	Tulane University; Tulane University; Kyung Hee University	Lu, H (corresponding author), Tulane Univ, Dept Biochem & Mol Biol, Sch Med, New Orleans, LA 70112 USA.; Lu, H (corresponding author), Tulane Univ, Tulane Canc Ctr, Sch Med, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Liao, Peng/Y-1896-2019; Jung, Jihoon/HHY-7803-2022; CAO, BO/F-6682-2015	Liao, Peng/0000-0002-8409-5574; CAO, BO/0000-0002-4933-6424	National Institutes of Health (NIH)-National Cancer Institute (NCI) [R01CA095441, R01CA172468, R01CA127724]	National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Juan Valcarcel for providing us with RBM10 plasmid, Yongbo Wang for providing us with GFP-RBM10, and Xiang Zhou as well as other members of the Lu laboratory for active discussion. This work was supported in part by National Institutes of Health (NIH)-National Cancer Institute (NCI) grants (R01CA095441, R01CA172468, and R01CA127724) to HL and SXZ.	Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Cao B, 2017, ONCOTARGET, V8, P90651, DOI 10.18632/oncotarget.21544; Collins KM, 2017, NUCLEIC ACIDS RES, V45, P6761, DOI 10.1093/nar/gkx225; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Guan GF, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691740; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Jung JH, 2015, CANCER BIOL THER, V16, P412, DOI 10.1080/15384047.2014.1002698; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Liao JM, 2014, ONCOGENE, V33, P4916, DOI 10.1038/onc.2013.430; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Sharma N, 2010, DIFFERENTIATION, V79, P218, DOI 10.1016/j.diff.2010.02.001; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang MX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0646-0; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	24	19	20	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1031	1040		10.1038/s41388-019-1034-9	http://dx.doi.org/10.1038/s41388-019-1034-9			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591476	Green Accepted			2022-12-26	WOS:000511209700006
J	Zhou, Y; Liu, HY; Wang, J; Wang, XL; Qian, LL; Xu, F; Song, WG; Wu, DB; Shen, Z; Feng, DQ; Ling, B; Xiao, WH; Shan, G; Chen, L				Zhou, Ying; Liu, Hanyuan; Wang, Juan; Wang, Xiaolin; Qian, Lili; Xu, Fei; Song, Weiguo; Wu, Dabao; Shen, Zhen; Feng, Dingqing; Ling, Bin; Xiao, Weihua; Shan, Ge; Chen, Liang			Delta Np63 alpha exerts antitumor functions in cervical squamous cell carcinoma	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGENERATIVE PROLIFERATION; BREAST-CANCER; DNA-BINDING; P63; EXPRESSION; CISPLATIN; PROTEIN; ACTIVATION; TARGET	The molecular basis underlying the aggressive nature and excessive proliferation of cervical squamous cancer cell remains unclear. Delta Np63 alpha is the predominant isotype of p63 expressed in the epithelia and regulates epithelial cell differentiation. The pro-/anti-tumor role of Delta Np63 alpha in different kinds of solid tumors remains controversial and the precise molecular mechanisms are still elusive. In this study, we uncovered the molecular functions of Delta Np63 alpha in cervical squamous cell carcinoma to clarify its roles as a tumor suppressor. We demonstrated that Delta Np63 alpha suppressed cell migration, invasiveness, and tumor growth in SiHa and ME-180 cells with both in vivo and in vitro assays. Mechanistic investigation via RNA-sequencing and chromatin immunoprecipitation-sequencing revealed that Delta Np63 alpha exerted its antitumor capacity via regulating the expression of a cohort of cell junction genes. Further, we showed that ZNF385B and CLDN1 were two direct Delta Np63 alpha targets with significant relevance to cervical squamous cell carcinoma examined in cell cultures, tumor xenografts, and clinic tumors. We also demonstrated that Delta Np63 alpha downregulated NFATC1 to reduce cisplatin resistance. These findings shed new lights on functions of Delta Np63 alpha in tumors and providing novel insights in targeted therapy of cervical cancers.	[Zhou, Ying; Qian, Lili; Wu, Dabao; Shen, Zhen; Chen, Liang] Univ Sci & Technol China, Anhui Prov Hosp, Affiliated Hosp 1, Dept Obstet & Gynecol, Hefei 230001, Anhui, Peoples R China; [Liu, Hanyuan; Wang, Juan; Xu, Fei; Song, Weiguo] Anhui Med Univ, Hefei 230001, Anhui, Peoples R China; [Wang, Xiaolin; Xiao, Weihua; Shan, Ge; Chen, Liang] Univ Sci & Technol China, Sch Life Sci, Div Mol Med, CAS Key Lab Innate Immun & Chron Dis,Hefei Natl L, Hefei 230027, Peoples R China; [Feng, Dingqing; Ling, Bin] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China; [Shan, Ge] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, L (corresponding author), Univ Sci & Technol China, Anhui Prov Hosp, Affiliated Hosp 1, Dept Obstet & Gynecol, Hefei 230001, Anhui, Peoples R China.; Shan, G; Chen, L (corresponding author), Univ Sci & Technol China, Sch Life Sci, Div Mol Med, CAS Key Lab Innate Immun & Chron Dis,Hefei Natl L, Hefei 230027, Peoples R China.; Shan, G (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	shange@ustc.edu.cn; anqingcl@ustc.edu.cn	钱, 钱丽丽/GWV-8162-2022	Zhou, Ying/0000-0001-8992-7897	National Natural Science Foundation of China [81872110, 31600657, 81272881, 8137277"9, 81372777, 31725016, 81902632]; National Key Research and Development Program [2018YFC1003903]; Anhui Provincial Key Research and Development Projects [1704a0802151]; Strategic Priority Research Program (Pilot study): "Biological basis of aging and therapeutic strategies" of the Chinese Academy of Sciences [XDPB10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Anhui Provincial Key Research and Development Projects; Strategic Priority Research Program (Pilot study): "Biological basis of aging and therapeutic strategies" of the Chinese Academy of Sciences	We would like to thank Yuhui Miao, Huimin Liu, Lu Qi, Xu Liu, Shuai Wei, Jingxin Li in University of Science and Technology of China for their valuable comments during the preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (No. 81872110, 31600657, 81272881, 8137277"9, 81372777, 31725016, and 81902632); National Key Research and Development Program (2018YFC1003903); Anhui Provincial Key Research and Development Projects (1704a0802151); the Strategic Priority Research Program (Pilot study): "Biological basis of aging and therapeutic strategies" of the Chinese Academy of Sciences (grant XDPB10).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen L, 2015, P NATL ACAD SCI USA, V112, P10002, DOI 10.1073/pnas.1502159112; Chen YL, 2018, CELL MOL LIFE SCI, V75, P965, DOI 10.1007/s00018-017-2666-y; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Crotti TN, 2006, GENE, V372, P92, DOI 10.1016/j.gene.2005.12.012; Dang TT, 2015, CANCER RES, V75, P3925, DOI 10.1158/0008-5472.CAN-14-3363; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Eftang LL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-586; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Gerald RC, 2002, CELL, V109, P67; Hoevel T, 2002, J CELL PHYSIOL, V191, P60, DOI 10.1002/jcp.10076; Hu SS, 2016, NAT STRUCT MOL BIOL, V23, P1011, DOI 10.1038/nsmb.3302; Im JY, 2016, BBA-MOL CELL RES, V1863, P40, DOI 10.1016/j.bbamcr.2015.10.011; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katayama A, 2017, PATHOL INT, V67, P404, DOI 10.1111/pin.12560; Ko E, 2013, CLIN CANCER RES, V19, P1204, DOI 10.1158/1078-0432.CCR-12-2848; Koster MI, 2004, DIFFERENTIATION, V72, P364, DOI 10.1111/j.1432-0436.2004.07208002.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Lee M, 2006, MOL CELLS, V22, P1; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Lv J, 2017, MOL CELL BIOCHEM, V432, P91, DOI 10.1007/s11010-017-3000-6; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Mills AA, 2006, CURR OPIN GENET DEV, V16, P38, DOI 10.1016/j.gde.2005.12.001; Minion LE, 2018, GYNECOL ONCOL, V148, P609, DOI 10.1016/j.ygyno.2018.01.009; National Research Council, 2011, GUIDE CARE USE LAB A; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Qian LL, 2017, CYTOKINE, V96, P114, DOI 10.1016/j.cyto.2017.04.001; Qian X, 2015, CRIT REV ONCOL HEMAT, V95, P337, DOI 10.1016/j.critrevonc.2015.03.009; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ratovitski EA, 2013, FEBS LETT, V587, P3581, DOI 10.1016/j.febslet.2013.09.023; Rizzo JM, 2016, CELL DEATH DIFFER, V23, P1073, DOI 10.1038/cdd.2015.162; Rodriguez-Carunchio L, 2015, BJOG-INT J OBSTET GY, V122, P119, DOI 10.1111/1471-0528.13071; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Rusan M, 2015, CLIN CANCER RES, V21, P2009, DOI 10.1158/1078-0432.CCR-14-1101; Saladi SV, 2017, CANCER CELL, V31, P35, DOI 10.1016/j.ccell.2016.12.001; Salah Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.6; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Si H, 2016, ONCOGENE, V35, P5781, DOI 10.1038/onc.2016.112; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sol ES, 2009, J GYNECOL ONCOL, V20, P28, DOI 10.3802/jgo.2009.20.1.28; Szymborska A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029223; Tran MN, 2013, J BIOL CHEM, V288, P3275, DOI 10.1074/jbc.M112.408104; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005; Zhou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022065; Zhou Y, 2011, CLIN INVEST MED, V34, pE184; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	57	8	8	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					905	921		10.1038/s41388-019-1033-x	http://dx.doi.org/10.1038/s41388-019-1033-x			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31576015				2022-12-26	WOS:000509197200012
J	Birkl, D; O'Leary, MN; Quiros, M; Azcutia, V; Schaller, M; Reed, M; Nishio, H; Keeney, J; Neish, AS; Lukacs, NW; Parkos, CA; Nusrat, A				Birkl, Dorothee; O'Leary, Monique N.; Quiros, Miguel; Azcutia, Veronica; Schaller, Matthew; Reed, Michelle; Nishio, Hikaru; Keeney, Justin; Neish, Andrew S.; Lukacs, Nicholas W.; Parkos, Charles A.; Nusrat, Asma			Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair	FASEB JOURNAL			English	Article						epithelium; GPCRs; FPR2; inflammation; inflammatory bowel disease	INFLAMMATORY PROTEIN 3-ALPHA; DENDRITIC CELLS; CROSS-DESENSITIZATION; INTERNATIONAL UNION; CHEMOKINE RECEPTORS; EPITHELIAL-CELLS; ACTIVATION; RESOLUTION; RESPONSES; MACROPHAGES	Mucosal wound repair is coordinated by dynamic crosstalk between endogenous and exogenous mediators and specific receptors on epithelial cells and infiltrating immune cells. One class of such receptor-ligand pairs involves formyl peptide receptors (FPRs) that have been shown to influence inflammatory response and repair. Here we explored the role of murine Fpr2/3, an ortholog of human FPR2/receptor for lipoxin A4 (ALX), in orchestrating intestinal mucosal repair. Compared with wild-type (WT) mice, Fpr2/3(-/-) mice exhibited delayed recovery from acute experimental colitis and perturbed repair after biopsy-induced colonic mucosal injury. Decreased numbers of infiltrating monocytes were observed in healing wounds from Fpr2/3(-/-) mice compared with WT animals. Bone marrow transplant experiments revealed that Fpr2/3(-/-) monocytes showed a competitive disadvantage when infiltrating colonic wounds. Moreover, Fpr2/3(-/-) monocytes were defective in chemotactic responses to the chemokine CC chemokine ligand (CCL)20, which is up-regulated during early phases of inflammation. Analysis of Fpr2/3(-/-) monocytes revealed altered expression of the CCL20 receptor CC chemokine receptor (CCR)6, suggesting that Fpr2/3 regulates CCL20-CCR6-mediated monocyte chemotaxis to sites of mucosal injury in the gut. These findings demonstrate an important contribution of Fpr2/3 in facilitating monocyte recruitment to sites of mucosal injury to influence wound repair.	[Birkl, Dorothee; O'Leary, Monique N.; Quiros, Miguel; Azcutia, Veronica; Schaller, Matthew; Reed, Michelle; Keeney, Justin; Lukacs, Nicholas W.; Parkos, Charles A.; Nusrat, Asma] Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Nishio, Hikaru; Neish, Andrew S.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Emory University	Nusrat, A (corresponding author), Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	anusrat@umich.edu	Schaller, Matthew/AAL-7640-2020; Azcutia, Veronica/AAW-2443-2020	Azcutia, Veronica/0000-0003-2160-5175; Quiros, Miguel/0000-0002-0089-3502; Keeney, Justin/0000-0003-1748-0971	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK055679, DK089763, DK059888, DK072564, DK079392, DK061379]; German Research Foundation (DFG) Research Fellowship [SI 2282/1-1]; Crohn's and Colitis Foundation Career Development Award [544599]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061379] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation (DFG) Research Fellowship(German Research Foundation (DFG)); Crohn's and Colitis Foundation Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Prof. Mauro Perretti (Queen Mary University of London London, United Kingdom) for providing the Fpr2/3<SUP>-/-</SUP> mice, and Madeline R. Barron and Darius Feier (University of Michigan) for experimental help during their experimental rotation in the researchers' laboratory. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK055679, DK089763, and DK059888 (to A.N.) and DK072564, DK079392, and DK061379 (to C.A.P.); German Research Foundation (DFG) Research Fellowship SI 2282/1-1 (to D.B.); and Crohn's and Colitis Foundation Career Development Award 544599 (to M.Q.). The authors declare no conflicts of interest.	Alam A, 2014, MUCOSAL IMMUNOL, V7, P645, DOI 10.1038/mi.2013.84; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bednar F, 2014, J IMMUNOL, V192, P5305, DOI 10.4049/jimmunol.1302983; Birkl D, 2019, MUCOSAL IMMUNOL, V12, P909, DOI 10.1038/s41385-019-0150-8; Blackwood RA, 1996, J LEUKOCYTE BIOL, V60, P88, DOI 10.1002/jlb.60.1.88; Bradford EM, 2017, J IMMUNOL, V199, P1886, DOI 10.4049/jimmunol.1601066; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Giebeler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100522; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466; Kagnoff MF, 2014, J CLIN INVEST, V124, P2841, DOI 10.1172/JCI75225; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Kwon YW, 2015, WOUND REPAIR REGEN, V23, P575, DOI 10.1111/wrr.12315; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Li BQ, 2001, BLOOD, V97, P2941, DOI 10.1182/blood.V97.10.2941; Liu MX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084408, 10.1371/journal.pone.0108012, 10.1371/journal.pone.0102344]; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; McArthur S, 2015, J IMMUNOL, V195, P1139, DOI 10.4049/jimmunol.1500733; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Murphy PM, 2000, PHARMACOL REV, V52, P145; Muto Y, 2015, J MOL EVOL, V80, P130, DOI 10.1007/s00239-015-9666-z; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Petri MH, 2015, CARDIOVASC RES, V105, P65, DOI 10.1093/cvr/cvu224; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shen WP, 2000, BLOOD, V96, P2887, DOI 10.1182/blood.V96.8.2887.h8002887_2887_2894; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Starner TD, 2003, AM J RESP CELL MOL, V29, P627, DOI 10.1165/rcmb.2002-0272OC; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Trivedi PJ, 2018, J CROHNS COLITIS, V12, pS641, DOI 10.1093/ecco-jcc/jjx145; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	63	15	15	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13632	13643		10.1096/fj.201901163R	http://dx.doi.org/10.1096/fj.201901163R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585047	Green Submitted, Green Published, Bronze			2022-12-26	WOS:000507466100046
J	Hobbs, JK; Meier, EPW; Pluvinage, B; Mey, MA; Boraston, AB				Hobbs, Joanne K.; Meier, Edward P. W.; Pluvinage, Benjamin; Mey, Mackenzie A.; Boraston, Alisdair B.			Molecular analysis of an enigmatic Streptococcus pneumoniae virulence factor: The raffinose-family oligosaccharide utilization system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; host-pathogen interaction; Streptococcus; structure-function; X-ray crystallography; virulence factor; galactosidase; pneumococcus; raffinose-family oligosaccharide (RFO)	SOLUTE-BINDING PROTEIN; ALPHA-GALACTOSIDASE; IDENTIFICATION; TRANSPORT; RECOGNITION; METABOLISM; DIVERSITY; BIFIDOBACTERIUM; BIOSYNTHESIS; COLONIZATION	Streptococcus pneumoniae is an opportunistic respiratory pathogen that can spread to other body sites, including the ears, brain, and blood. The ability of this bacterium to break down, import, and metabolize a wide range of glycans is key to its virulence. Intriguingly, S. pneumoniae can utilize several plant oligosaccharides for growth in vitro, including raffinose-family oligosaccharides (RFOs, which are alpha-(1 -> 6)-galactosyl extensions of sucrose). An RFO utilization locus has been identified in the pneumococcal genome; however, none of the proteins encoded by this locus have been biochemically characterized. The enigmatic ability of S. pneumoniae to utilize RFOs has recently received attention because mutations in two of the RFO locus genes have been linked to the tissue tropism of clinical pneumococcal isolates. Here, we use functional studies combined with X-ray crystallography to show that although the pneumococcal RFO locus encodes for all the machinery required for uptake and degradation of RFOs, the individual pathway components are biochemically inefficient. We also demonstrate that the initiating enzyme in this pathway, the alpha-galactosidase Aga (a family 36 glycoside hydrolase), can cleave alpha-(1 -> 3)-linked galactose units from a linear blood group antigen. We propose that the pneumococcal RFO pathway is an evolutionary relic that is not utilized in this streptococcal species and, as such, is under no selection pressure to maintain binding affinity and/or catalytic efficiency. We speculate that the apparent contribution of RFO utilization to pneumococcal tissue tropism may, in fact, be due to the essential role the ATPase RafK plays in the transport of other carbohydrates.	[Hobbs, Joanne K.; Meier, Edward P. W.; Pluvinage, Benjamin; Mey, Mackenzie A.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada.	boraston@uvic.ca		Hobbs, Joanne/0000-0001-5239-8039; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research Operating Grant [PJT 159786]	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grant PJT 159786. The authors declare that they have no conflicts of interest with the contents of this article.	Abboft DW, 2007, J MOL BIOL, V369, P759, DOI 10.1016/j.jmb.2007.03.045; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Culurgioni S, 2017, STRUCTURE, V25, P79, DOI 10.1016/j.str.2016.11.008; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Ejby M, 2016, J BIOL CHEM, V291, P20220, DOI 10.1074/jbc.M116.746529; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hardy GG, 2000, J BACTERIOL, V182, P1854, DOI 10.1128/JB.182.7.1854-1863.2000; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hobbs JK, 2019, J BIOL CHEM, V294, P12670, DOI 10.1074/jbc.RA119.009368; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Jarvis GN, 2001, FEMS MICROBIOL ECOL, V35, P49; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACKS S, 1968, GENETICS, V60, P685; LIEBANA J, 1993, MICROBIOS, V76, P7; Linke CM, 2013, J BACTERIOL, V195, P1031, DOI 10.1128/JB.01560-12; Mao BY, 2018, FOOD FUNCT, V9, P5824, DOI 10.1039/c8fo01687a; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Merceron R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394114; Minhas V, 2019, MBIO, V10, DOI 10.1128/mBio.02596-18; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Paterson NG, 2006, ACTA CRYSTALLOGR F, V62, P676, DOI 10.1107/S1744309106021695; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Robb M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006090; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Schnaar Ronald L., 2017, ESSENTIALS GLYCOBIOL; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Siegel SJ, 2015, ANNU REV MICROBIOL, V69, P425, DOI 10.1146/annurev-micro-091014-104209; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tyx RE, 2011, J BACTERIOL, V193, P3512, DOI 10.1128/JB.01410-10; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; Willenborg J, 2016, FEBS LETT, V590, P3905, DOI 10.1002/1873-3468.12317; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Yu WL, 2013, J BIOL CHEM, V288, P14949, DOI 10.1074/jbc.M113.454751	65	4	4	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17197	17208		10.1074/jbc.RA119.010280	http://dx.doi.org/10.1074/jbc.RA119.010280			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31591266	hybrid, Green Published			2022-12-26	WOS:000503173500004
J	Boehr, AK; Arnold, JJ; Oh, HS; Cameron, CE; Boehr, DD				Boehr, Alyson K.; Arnold, Jamie J.; Oh, Hyung S.; Cameron, Craig E.; Boehr, David D.			2?-C-methylated nucleotides terminate virus RNA synthesis by preventing active site closure of the viral RNA-dependent RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; hepatitis C virus (HCV); NMR; nucleoside; nucleotide analogue; plus-stranded RNA virus; poliovirus; RNA polymerase; viral polymerase; 2?-C-methyl ribonucleoside; positive-strand RNA virus	HEPATITIS-C; STRUCTURAL BASIS; MOTIF D; REPLICATION; FIDELITY; INHIBITION; 3D(POL); ANALOGS; TRANSLOCATION; DETERMINES	The 2?-C-methyl ribonucleosides are nucleoside analogs representing an important class of antiviral agents, especially against positive-strand RNA viruses. Their value is highlighted by the highly successful anti-hepatitis C drug sofosbuvir. When appropriately phosphorylated, these nucleotides are successfully incorporated into RNA by the virally encoded RNA-dependent RNA polymerase (RdRp). This activity prevents further RNA extension, but the mechanism is poorly characterized. Previously, we had identified NMR signatures characteristic of formation of RdRp?RNA binary and RdRp?RNA?NTP ternary complexes for the poliovirus RdRp, including an open-to-closed conformational change necessary to prepare the active site for catalysis of phosphoryl transfer. Here we used these observations as a framework for interpreting the effects of 2?-C-methyl adenosine analogs on RNA chain extension in solution-state NMR spectroscopy experiments, enabling us to gain additional mechanistic insights into 2?-C-methyl ribonucleoside-mediated RNA chain termination. Contrary to what has been proposed previously, poliovirus RdRp that was bound to RNA with an incorporated 2?-C-methyl nucleotide could still bind to the next incoming NTP. Our results also indicated that incorporation of the 2?-C-methyl nucleotide does not disrupt RdRp?RNA interactions and does not prevent translocation. Instead, incorporation of the 2?-C-methyl nucleotide blocked closure of the RdRp active site upon binding of the next correct incoming NTP, which prevented further nucleotide addition. We propose that other nucleotide analogs that act as nonobligate chain terminators may operate through a similar mechanism.	[Boehr, Alyson K.; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Arnold, Jamie J.; Oh, Hyung S.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	ddb12@psu.edu		Oh, Hyung Suk/0000-0002-1739-0389	NIAID, National Institutes of Health [AI104878, AI45818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104878, R01AI045818] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants AI104878 (to D. D. B.) and AI45818 (to C. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Arnold JJ, 2006, ANAL BIOCHEM, V350, P214, DOI 10.1016/j.ab.2005.11.001; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Bandyopadhyay AS, 2015, FUTURE MICROBIOL, V10, P791, DOI [10.2217/FMB.15.19, 10.2217/fmb.15.19]; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001; D'Ambrosio R, 2017, CURR OPIN VIROL, V24, P31, DOI 10.1016/j.coviro.2017.03.017; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Deval J, 2014, CURR OPIN VIROL, V9, P1, DOI 10.1016/j.coviro.2014.08.004; Dulin D, 2017, CELL REP, V21, P1063, DOI 10.1016/j.celrep.2017.10.005; Dutartre H, 2006, ANTIMICROB AGENTS CH, V50, P4161, DOI 10.1128/AAC.00433-06; Eyer L, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02093-18, 10.1128/aac.02093-18]; Ferrero D, 2018, SUBCELL BIOCHEM, V88, P39, DOI 10.1007/978-981-10-8456-0_3; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Fung A, 2014, ANTIMICROB AGENTS CH, V58, P3636, DOI 10.1128/AAC.02666-14; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Harki DA, 2006, J MED CHEM, V49, P6166, DOI 10.1021/jm060872x; Hedskog C, 2015, J CLIN MICROBIOL, V53, P2049, DOI 10.1128/JCM.02624-14; Jin ZN, 2015, ANTIMICROB AGENTS CH, V59, P7504, DOI 10.1128/AAC.01391-15; Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Liu XR, 2015, VIRUSES-BASEL, V7, P5571, DOI 10.3390/v7102894; Liu XR, 2013, J BIOL CHEM, V288, P32753, DOI 10.1074/jbc.M113.484428; McKinlay MA, 2014, J INFECT DIS, V210, pS447, DOI 10.1093/infdis/jiu043; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Rosenzweig R, 2014, ANNU REV BIOCHEM, V83, P291, DOI 10.1146/annurev-biochem-060713-035829; Sholders AJ, 2014, J MOL BIOL, V426, P1407, DOI 10.1016/j.jmb.2013.12.031; Shu B, 2017, RNA BIOL, V14, P1314, DOI 10.1080/15476286.2017.1300221; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Sun J., 2019, VIRUSES, V11, pE490; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Van Dycke J, 2018, J INFECT DIS, V218, P1753, DOI 10.1093/infdis/jiy398; Wang LS, 2016, J MED VIROL, V88, P1844, DOI 10.1002/jmv.24554; Yang XR, 2017, J BIOL CHEM, V292, P3810, DOI 10.1074/jbc.M116.750638; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Zajac M, 2019, EUR J MED CHEM, V165, P225, DOI 10.1016/j.ejmech.2019.01.025	51	1	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16897	16907		10.1074/jbc.RA119.010214	http://dx.doi.org/10.1074/jbc.RA119.010214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31575662	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000501801900034
J	Cipriani, D; Rodriguez, B; Hani, L; Zimmermann, R; Fichtner, J; Ulrich, CT; Raabe, A; Beck, J; Z'Graggen, WJ				Cipriani, Debora; Rodriguez, Belen; Haeni, Levin; Zimmermann, Raya; Fichtner, Jens; Ulrich, Christian T.; Raabe, Andreas; Beck, Juergen; Z'Graggen, Werner J.			Postural changes in optic nerve and optic nerve sheath diameters in postural orthostatic tachycardia syndrome and spontaneous intracranial hypotension: A cohort study	PLOS ONE			English	Article							SONOGRAPHIC ASSESSMENT; RELIABILITY; MANAGEMENT; HEADACHE; SYNCOPE	Background Postural orthostatic tachycardia syndrome is a disorder of the autonomic nervous system. Approximately 30% of patients experience orthostatic headaches. Orthostatic headaches also are a hallmark symptom in spontaneous intracranial hypotension. While the cause of orthostatic headaches in spontaneous intracranial hypotension can be linked to the cerebrospinal fluid loss at the spinal level and consecutively reduced intracranial pressure in the upright position, the cause of orthostatic headaches in postural orthostatic tachycardia syndrome still remains unknown. The present study examined orthostatic changes of intracranial pressure using dynamic ultrasound of the optic nerve and optic nerve sheath diameter in postural orthostatic tachycardia syndrome, spontaneous intracranial hypotension and healthy subjects. Methods Data was obtained from postural orthostatic tachycardia syndrome patients with (n = 7) and without orthostatic headaches (n = 7), spontaneous intracranial hypotension patients (n = 5) and healthy subjects (n = 8). All participants underwent high-resolution transorbital ultrasound in the supine and upright position to assess optic nerve and optic nerve sheath diameter. Results Group differences were found in percentage deviations when changing position of optic nerve sheath diameter (p < 0.01), but not regarding the optic nerve diameter. Pairwise comparisons indicated differences in optic nerve sheath diameter only between spontaneous intracranial hypotension and the other groups. No differences were found between postural orthostatic tachycardia syndrome patients with and without orthostatic headaches. Conclusion This study shows that the size of the optic nerve sheath diameter dynamically decreases during orthostatic stress in spontaneous intracranial hypotension, but not in postural orthostatic tachycardia syndrome with or without orthostatic headaches, which indicates different underlying causes.	[Cipriani, Debora; Rodriguez, Belen; Haeni, Levin; Zimmermann, Raya; Fichtner, Jens; Ulrich, Christian T.; Raabe, Andreas; Z'Graggen, Werner J.] Bern Univ Hosp, Dept Neurosurg, Inselspital, Bern, Switzerland; [Cipriani, Debora; Beck, Juergen] Med Ctr Univ Freiburg, Dept Neurosurg, Freiburg, Germany; [Z'Graggen, Werner J.] Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Z'Graggen, WJ (corresponding author), Bern Univ Hosp, Dept Neurosurg, Inselspital, Bern, Switzerland.; Z'Graggen, WJ (corresponding author), Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland.	werner.zgraggen@insel.ch		Rodriguez, Belen/0000-0003-2426-0045; Hani, Levin/0000-0001-7892-7138; Z'Graggen, Werner/0000-0002-5684-4419				Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Beck J, 2016, NEUROLOGY, V87, P1220, DOI 10.1212/WNL.0000000000003122; Benarroch EE, 2012, MAYO CLIN PROC, V87, P1214, DOI 10.1016/j.mayocp.2012.08.013; Merlicco AC, 2018, ACTA NEUROL SCAND, V138, P388, DOI 10.1111/ane.12976; Deb A., 2014, BAYLOR U MED CTR P, V28, P157; Diaz JH, 2001, REGION ANESTH PAIN M, V26, P582, DOI 10.1053/rapm.2001.28275; Dubost C, 2011, BRIT J ANAESTH, V107, P627, DOI 10.1093/bja/aer186; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Ertl M, 2017, EUR J NEUROL, V24, P461, DOI 10.1111/ene.13225; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; Fichtner J., 2018, CEPHALALGIA; Fichtner J, 2016, J NEUROL NEUROSUR PS, V87, P650, DOI 10.1136/jnnp-2015-310853; Freeman R, 2011, AUTON NEUROSCI-BASIC, V161, P46, DOI 10.1016/j.autneu.2011.02.004; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Garland EM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0583-8; Graf N., 2018, CEPHALALGIA; Khurana RK, 2011, CEPHALALGIA, V31, P409, DOI 10.1177/0333102410382792; Lambert E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00280; Lochner P, 2019, ULTRASCHALL MED, V40, P247, DOI 10.1055/a-0719-4903; Lochner P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0594-3; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Mathias CJ, 2012, NAT REV NEUROL, V8, P22, DOI 10.1038/nrneurol.2011.187; Mokri B, 2003, NEUROLOGY, V61, P980, DOI 10.1212/01.WNL.0000085868.37963.7D; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 1996, J NEUROSURG, V84, P151; Schondorf R, 1999, J AUTONOM NERV SYST, V75, P192, DOI 10.1016/S0165-1838(98)00177-5; Spears RC, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0425-4; Steinborn M, 2015, ULTRASCHALL MED, V36, P54, DOI 10.1055/s-0034-1385012; Takeuchi N, 2012, J NEUROSURG, V117, P372, DOI 10.3171/2012.5.JNS1271; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Watanabe A, 2008, AM J NEURORADIOL, V29, P863, DOI 10.3174/ajnr.A1027	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223484	10.1371/journal.pone.0223484	http://dx.doi.org/10.1371/journal.pone.0223484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596889	Green Published, gold			2022-12-26	WOS:000532444100038
J	Ibragimov, U; Beane, S; Friedman, SR; Komro, K; Adimora, AA; Edwards, JK; Williams, LD; Tempalski, B; Livingston, MD; Stall, RD; Wingood, GM; Cooper, HLF				Ibragimov, Umedjon; Beane, Stephanie; Friedman, Samuel R.; Komro, Kelli; Adimora, Adaora A.; Edwards, Jessie K.; Williams, Leslie D.; Tempalski, Barbara; Livingston, Melvin D.; Stall, Ronald D.; Wingood, Gina M.; Cooper, Hannah L. F.			States with higher minimum wages have lower STI rates among women: Results of an ecological study of 66 US metropolitan areas, 2003-2015	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; INJECT DRUGS; RESIDENTIAL SEGREGATION; SYPHILIS INFECTION; INCOME INEQUALITY; GONORRHEA RATES; HEALTH OUTCOMES; UNITED-STATES; YOUNG-ADULTS; PREVALENCE	Prior research has found that places and people that are more economically disadvantaged have higher rates and risks, respectively, of sexually transmitted infections (STIs). Economic disadvantages at the level of places and people, however, are themselves influenced by economic policies. To enhance the policy relevance of STI research, we explore, for the first time, the relationship between state-level minimum wage policies and STI rates among women in a cohort of 66 large metropolitan statistical areas (MSAs) in the US spanning 2003-2015. Our annual state-level minimum wage measure was adjusted for inflation and cost of living. STI outcomes (rates of primary and secondary syphilis, gonorrhea and chlamydia per 100,000 women) were obtained from the CDC. We used multivariable hierarchical linear models to test the hypothesis that higher minimum wages would be associated with lower STI rates. We preliminarily explored possible socioeconomic mediators of the minimum wage/STI relationship (e.g., MSA-level rates of poverty, employment, and incarceration). We found that a $1 increase in the price-adjusted minimum wage over time was associated with a 19.7% decrease in syphilis rates among women and with an 8.5% drop in gonorrhea rates among women. The association between minimum wage and chlamydia rates did not meet our cutpoint for substantive significance. Preliminary mediation analyses suggest that MSA-level employment among women may mediate the relationship between minimum wage and gonorrhea. Consistent with an emerging body of research on minimum wage and health, our findings suggest that increasing the minimum wage may have a protective effect on STI rates among women. If other studies support this finding, public health strategies to reduce STIs among women should include advocating for a higher minimum wage.	[Ibragimov, Umedjon; Beane, Stephanie; Komro, Kelli; Livingston, Melvin D.; Cooper, Hannah L. F.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Friedman, Samuel R.; Tempalski, Barbara] Natl Dev & Res Inst Inc, New York, NY USA; [Adimora, Adaora A.; Edwards, Jessie K.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Adimora, Adaora A.] Univ N Carolina, Div Infect Dis, Sch Med, Chapel Hill, NC 27515 USA; [Williams, Leslie D.] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL USA; [Stall, Ronald D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Stall, Ronald D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Wingood, Gina M.] Columbia Univ, Dept Sociomed Sci, New York, NY USA	Emory University; Rollins School Public Health; National Development & Research Institutes, Inc; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Ibragimov, U (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA.	ubragi@emory.edu		Ibragimov, Umedjon/0000-0001-7111-2139; Friedman, Sam/0000-0003-2083-1226	National Institute on Drug Abuse, National Institutes of Health [DA037568]; Center for AIDS Research at Emory University [P30AI050409]; Center for Drug Use and HIV Research [P30 DA11041]; National Institute on Minority Health and Health Disparities, National Institutes of Health [R01MD010241]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, R01DA037568] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD010241] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for AIDS Research at Emory University; Center for Drug Use and HIV Research; National Institute on Minority Health and Health Disparities, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The following grants supported this project: National Institute on Drug Abuse, National Institutes of Health (DA037568; PIs: Cooper, Friedman, and Stall); Center for AIDS Research at Emory University (P30AI050409; PI: Del Rio); and Center for Drug Use and HIV Research (P30 DA11041; PI Sherry Deren); National Institute on Minority Health and Health Disparities, National Institutes of Health (R01MD010241; PIs: Komro, Wagenaar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora A. A., 2013, NEW PUB LIC HLTH STD, P13, DOI [10.1007/978-1-4614-4526-5, DOI 10.1007/978-1-4614-4526-5]; Adimora AA, 2002, EPIDEMIOLOGY, V13, P707, DOI 10.1097/00001648-200211000-00016; American Public Health Association, 2016, IMPR HLTH INCR MIN W; Biello KB, 2012, AM J PUBLIC HEALTH, V102, P1370, DOI 10.2105/AJPH.2011.300516; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; *CDCP, 2006, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2016, HIGH BURD STDS THREA; Centers for Disease Control and Prevention, 2018, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2011, 10 WAYS STDS IMP WOM; Chen J, 2014, HEALTH SERV RES, V49, P705, DOI 10.1111/1475-6773.12113; Chesson HW, 2010, SEX TRANSM INFECT, V86, P52, DOI 10.1136/sti.2009.040873; Congressional Budget Office, 2014, EFF MIN WAG INCR EMP; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; Cooper D., 2013, RAISING FEDERAL MINI; Cooper HLF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150410; Cooper HLF, 2016, AM J PUBLIC HEALTH, V106, P517, DOI 10.2105/AJPH.2015.302911; Crofton SO, 2009, AM J ECON SOCIOL, V68, P445, DOI 10.1111/j.1536-7150.2009.00632.x; Crotton SO, 2009, AM J ECON SOCIOL, V68, P445; Dunkle KL, 2010, PUBLIC HEALTH REP, V125, P90, DOI 10.1177/00333549101250S413; Executive Office of President of the United States, 2016, EC PERSP INC CRIM JU; Figueiredo Filho Dalson Britto, 2013, Bras. political sci. rev., V7, P31; Ford JL, 2011, AM J PUBLIC HEALTH, V101, P1696, DOI 10.2105/AJPH.2011.300213; Friedman SR, 2016, INT J DRUG POLICY, V32, P11, DOI 10.1016/j.drugpo.2016.03.003; Friedman SR, 2014, ANN EPIDEMIOL, V24, P304, DOI 10.1016/j.annepidem.2014.01.008; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Geisler WM, 2006, SEX TRANSM DIS, V33, P389, DOI 10.1097/01.olq.0000194584.80513.4a; German D, 2012, AIDS BEHAV, V16, P168, DOI 10.1007/s10461-011-9882-5; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guo G, 2007, ANN M AM SOC ASS NEW; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hernan MA, 2002, STAT MED, V21, P1689, DOI 10.1002/sim.1144; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Ibragimov U, 2018, J URBAN HEALTH, P1; Jardim E., 2017, MINIMUM WAGE INCREAS; Kilmarx PH, 1997, AM J PUBLIC HEALTH, V87, P1937, DOI 10.2105/AJPH.87.12.1937; Komro KA, 2016, AM J PUBLIC HEALTH, V106, P1514, DOI 10.2105/AJPH.2016.303268; Kreider B, 2012, J AM STAT ASSOC, V107, P958, DOI 10.1080/01621459.2012.682828; Lee PH, 2014, J EPIDEMIOL, V24, P161, DOI 10.2188/jea.JE20130062; Leichliter JS, 2016, SEX TRANSM DIS, V43, pS113, DOI 10.1097/OLQ.0000000000000289; Lenhart O, 2017, EUR J HEALTH ECON, V18, P1031, DOI 10.1007/s10198-016-0847-5; Loza O, 2010, ADDICTION, V105, P1448, DOI 10.1111/j.1360-0443.2010.02985.x; Marshall BDL, 2009, HEALTH PLACE, V15, P783, DOI 10.1016/j.healthplace.2008.12.005; Meer J, 2015, J HUMAN RESOURCES; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Misra J, 2007, GENDER SOC, V21, P804, DOI 10.1177/0891243207308445; Moller S, 2003, AM SOCIOL REV, V68, P22, DOI 10.2307/3088901; National Low Income Housing Coalition, 2018, OUT REACH HIGH COST; Office of Management and Budget, 2000, STAND DEF METR MICR; Osypuk Theresa L, 2014, Curr Epidemiol Rep, V1, P149; Pines HA, 2015, INT J STD AIDS, V26, P1022, DOI 10.1177/0956462414568394; Pouget ER, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0323; Pugsley RA, 2013, SEX TRANSM DIS, V40, P439, DOI 10.1097/OLQ.0b013e31828c6416; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rupasingha Anil, 2007, J SOCIO-ECON, V36, P650, DOI [DOI 10.1016/J.SOCEC.2006.12.021, 10.1016/j.socec.2006.12.021]; SAS Institute I, 2010, SAS STAT R 9 2 US CO; Sharpe TT, 2012, J WOMENS HEALTH, V21, P249, DOI 10.1089/jwh.2011.3350; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Strully KW, 2010, AM SOCIOL REV, V75, P534, DOI 10.1177/0003122410374086; Su L., 2018, HETEROGENEOUS EFFECT; The Seattle Minimum Wage Study Team, 2016, REP IMP SEATRL MIN W; Thomas JC, 2008, AM J PUBLIC HEALTH, V98, pS181, DOI 10.2105/AJPH.98.Supplement_1.S181; Thomas JC, 2003, ETHNIC DIS, V13, P362; Thomas JC, 1999, SOC SCI MED, V49, P1075, DOI 10.1016/S0277-9536(99)00197-5; Tsao TY, 2016, AM J PUBLIC HEALTH, V106, P1036, DOI 10.2105/AJPH.2016.303188; US Bureau of Labor Statistics, 2013, CHAR MIN WAG WORK 20; Van der Meer T, 2010, AM SOCIOL REV, V75, P173, DOI 10.1177/0003122409359166; Volscho Jr, 2005, RES SOCIAL STRATIFIC, V23, P343, DOI DOI 10.1016/S0276-5624(05)23011-1; Weir BW, 2007, AIDS BEHAV, V11, pS31, DOI 10.1007/s10461-007-9284-x; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Yang J., 2012, CORNELL STAT CONSULT, VVolume 83, P3; Zack M, 2010, COLLINEARITY DIAGNOS	73	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223579	10.1371/journal.pone.0223579	http://dx.doi.org/10.1371/journal.pone.0223579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596890	Green Published, gold			2022-12-26	WOS:000532444100045
J	Li, Q; Jia, RR; Dou, WF; Qi, JJ; Qin, XJ; Fu, YY; He, YR; Chen, SC				Li, Qiang; Jia, Ruirui; Dou, Wanfu; Qi, Jingjing; Qin, Xiujuan; Fu, Yongyao; He, Yongrui; Chen, Shanchun			CsBZIP40, a BZIP transcription factor in sweet orange, plays a positive regulatory role in citrus bacterial canker response and tolerance	PLOS ONE			English	Article							GENE-EXPRESSION; ENHANCED RESISTANCE; DEFENSE; GENOME; FAMILY; NPR1; PREDICTION; PROTEIN	Citrus bacterial canker (CBC) caused by Xanthomonas citri subsp. citri (Xcc) is a systemic bacterial disease that affects citrus plantations globally. Biotic stress in plants has been linked to a group of important transcription factors known as Basic Leucine Zippers (BZIPs). In this study, CsBZIP40 was functionally characterized by expression analysis, including induction by Xcc and hormones, subcellular localization, over-expression and RNAi silencing. CsBZIP40 belongs to group D of the CsBZIP family of transcription factors and localizes in the nucleus, potentially serving as a transcriptional regulator. In wild type (WT) plants CsBZIP40 can be induced by plant hormones in addition to infection by Xcc which has given insight into its involvement in CBC. In the present study, over-expression of CsBZIP40 conferred resistance to Xcc while its silencing led to Xcc susceptibility. Both over-expression and RNAi affected salicylic acid (SA) production and expression of the genes involved in the SA synthesis and signaling pathway, in addition to interaction of CsBZIP40 with CsNPR1, as detected by a GST pull-down assay. Taken together, the results of this study confirmed the important role of CsBZIP40 in improving resistance to citrus canker through the SA signaling pathway by the presence of NPR1 to activate PR genes. Our findings are of potential value in the breeding of tolerance to CBC in citrus fruits.	[Li, Qiang; Dou, Wanfu; Qi, Jingjing; Qin, Xiujuan; He, Yongrui; Chen, Shanchun] Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Chongqing, Peoples R China; [Jia, Ruirui] Chongqing Univ, Sch Life Sci, Key Lab Plant Hormones & Dev Regulat Chongqing, Chongqing, Peoples R China; [Fu, Yongyao] Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China	Chinese Academy of Agricultural Sciences; Southwest University - China; Chongqing University; Yangtze Normal University	He, YR; Chen, SC (corresponding author), Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Chongqing, Peoples R China.	heyongrui@cric.cn; chenshanchun@cric.cn			National Key Research and Development Program of China [2018YFD1000306]; Earmarked Funds for China Agriculture Research System [CARS-26]; Guangxi Science and Technology Key Project [GuiKeAA18118046-6]; Natural Science Foundation of China [31701935, 31500245]; Opening Project of Key Laboratory of Horticulture Science for Southern Mountainous Regions	National Key Research and Development Program of China; Earmarked Funds for China Agriculture Research System; Guangxi Science and Technology Key Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Project of Key Laboratory of Horticulture Science for Southern Mountainous Regions	This study was funded by the National Key Research and Development Program of China (2018YFD1000306), Earmarked Funds for China Agriculture Research System (CARS-26), Guangxi Science and Technology Key Project (GuiKeAA18118046-6), Natural Science Foundation of China (31701935, 31500245), Opening Project of Key Laboratory of Horticulture Science for Southern Mountainous Regions.	Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Amorim LLB, 2017, CURR PROTEIN PEPT SC, V18, P335, DOI 10.2174/1389203717666160619185308; Bai YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158966; Baloglu MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096014; Barah P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00532; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; da Silva AEA, 2005, GENET MOL RES, V4, P525; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Donmez D, 2013, SCI WORLD J, DOI 10.1155/2013/491207; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fan QR, 2013, PROCEEDINGS OF THE 2013 ASIA-PACIFIC COMPUTATIONAL INTELLIGENCE AND INFORMATION TECHNOLOGY CONFERENCE, P299; Fawal N, 2014, TRENDS GENET, V30, P323, DOI 10.1016/j.tig.2014.06.004; Fobert PR, 2005, CURR OPIN PLANT BIOL, V8, P378, DOI 10.1016/j.pbi.2005.05.003; Gamboa-Melendez H, 2013, EUKARYOT CELL, V12, P1403, DOI 10.1128/EC.00141-13; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gottwald TR, 2002, PHYTOPATHOLOGY, V92, P361, DOI 10.1094/PHYTO.2002.92.4.361; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee SC, 2006, PLANTA, V224, P1209, DOI 10.1007/s00425-006-0302-4; Li Q, 2015, GENOME BIOL EVOL, V7, P1068, DOI 10.1093/gbe/evv048; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; NG DWK, 2018, INT J MOL SCI, V19, P13265, DOI DOI 10.3390/0145213; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Sendin LN, 2017, PLANT MOL BIOL, V93, P607, DOI 10.1007/s11103-017-0586-8; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pourabed E, 2015, MOL BIOTECHNOL, V57, P12, DOI 10.1007/s12033-014-9797-2; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Sato F, 1996, PLANT CELL PHYSIOL, V37, P249, DOI 10.1093/oxfordjournals.pcp.a028939; Schutze K, 2008, TRENDS PLANT SCI, V13, P247, DOI 10.1016/j.tplants.2008.03.002; Singh Sandeepa, 2009, Physiology and Molecular Biology of Plants, V15, P3, DOI 10.1007/s12298-009-0001-2; Song W, 2014, INT J DATA WAREHOUS, V10, P1, DOI 10.4018/ijdwm.2014010101; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087723; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	51	14	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223498	10.1371/journal.pone.0223498	http://dx.doi.org/10.1371/journal.pone.0223498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584990	gold, Green Published			2022-12-26	WOS:000532407600043
J	Reader, AT; Ehrsson, HH				Reader, Arran T.; Ehrsson, H. Henrik			Weakening the subjective sensation of own hand ownership does not interfere with rapid finger movements	PLOS ONE			English	Article							RUBBER HAND; CORTICOSPINAL EXCITABILITY; PREMOTOR CORTEX; VISUAL CAPTURE; LIMB OWNERSHIP; POSITION SENSE; SPATIAL LIMITS; WILLED ACTION; REACTION-TIME; BODILY SELF	When we perform a movement we generally have a clear distinction between which parts of the world constitute our body and which parts do not. However, how the sense of ownership over our body supports movement is not yet fully understood. We aimed to see whether a sense of ownership over the hand supports the performance of rapid hand movements. In three experiments (n = 48, n = 30, n = 24), we presented participants with congruent and incongruent visuotactile and visuoproprioceptive information regarding their own hand. In keeping with previous experiments, multisensory disintegration resulted in a reduction in the subjective sensation of ownership over the hand, as reflected in questionnaire responses. Following sensory stimulation, participants were required to rapidly abduct their index finger whilst the movement was tracked. We examined the hypothesis that, should a sense of ownership over the limb be necessary for generating rapid movements with that limb, reaction time would increase when hand ownership was reduced, whilst the acceleration and velocity of the movement would decrease. We observed that reductions in own hand ownership did not interfere with rapid index finger abduction, suggesting that the motor system may not be reliant on a subjective sense of ownership over the body in order to generate movement.	[Reader, Arran T.; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Reader, AT (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	arran.reader@ki.se	Reader, Arran T./N-6214-2014	Reader, Arran T./0000-0002-0273-6367; Ehrsson, Henrik/0000-0003-2333-345X	Swedish Research Council; Torsten Soderbergs Stiftelse; Goran Gustafssons Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderbergs Stiftelse; Goran Gustafssons Stiftelse	This work was supported by The Swedish Research Council, Torsten Soderbergs Stiftelse, and Goran Gustafssons Stiftelse (to HHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim Z, 2018, EXP BRAIN RES, V236, P551, DOI 10.1007/s00221-017-5137-7; Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergouignan L, 2014, P NATL ACAD SCI USA, V111, P4421, DOI 10.1073/pnas.1318801111; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brugger P, 2014, CURR OPIN NEUROL, V27, P644, DOI 10.1097/WCO.0000000000000151; Burin D, 2018, CONSCIOUS COGN, V58, P186, DOI 10.1016/j.concog.2017.12.005; Burin D, 2017, NEUROPSYCHOLOGIA, V107, P41, DOI 10.1016/j.neuropsychologia.2017.11.004; Burin D, 2017, COGNITION, V166, P164, DOI 10.1016/j.cognition.2017.05.035; Burin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117155; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Collins KL, 2017, P NATL ACAD SCI USA, V114, P166, DOI 10.1073/pnas.1616305114; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Davey N J, 1998, Motor Control, V2, P241; Davies AMA, 2013, CONSCIOUS COGN, V22, P613, DOI 10.1016/j.concog.2013.03.006; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; della Gatta F, 2016, ELIFE, V5, DOI 10.7554/eLife.14972; Duque J, 2017, TRENDS NEUROSCI, V40, P219, DOI 10.1016/j.tins.2017.02.006; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Fossataro C, 2016, SCI REP, V6, P1; Fossataro C, 2018, EUR J NEUROSCI, V48, P2272, DOI 10.1111/ejn.14116; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Graham KT, 2015, ATTEN PERCEPT PSYCHO, V77, P207, DOI 10.3758/s13414-014-0748-6; Guterstam A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09831; Haggard P, 2017, NAT REV NEUROSCI, V18, P197, DOI 10.1038/nrn.2017.14; Heed T, 2011, ACTA PSYCHOL, V138, P263, DOI [10.1016/j.actpsy.2011.07.003, 10.1016/j.actpsy2011.07.003]; Isayama R, 2019, J NEUROPHYSIOL, V121, P563, DOI 10.1152/jn.00345.2018; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; JASP Team, 2018, JASP VERS 0 9; Jenkinson PM, 2018, CORTEX, V101, P300, DOI 10.1016/j.cortex.2018.02.001; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2010, EXP BRAIN RES, V202, P203, DOI 10.1007/s00221-009-2124-7; Kannape OA, 2019, NEUROPSYCHOLOGIA, V124, P161, DOI 10.1016/j.neuropsychologia.2018.12.014; Karabanov AN, 2017, EUR J NEUROSCI, V45, P964, DOI 10.1111/ejn.13538; Kilteni K, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2010.00145, 10.3389/fnhum.2016.00145]; Kilteni K, 2017, P NATL ACAD SCI USA, V114, P8426, DOI 10.1073/pnas.1703347114; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Lane T, 2017, COGN RES, V2, DOI 10.1186/s41235-016-0041-4; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Lesur MR, 2019, ACHRONOPRESENCE TEMP, DOI [10.1101/596858, DOI 10.1101/596858]; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, ACTA PSYCHOL, V132, P166, DOI 10.1016/j.actpsy.2009.02.003; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; Martinaud O, 2017, CORTEX, V87, P174, DOI 10.1016/j.cortex.2016.09.025; Naito E, 2016, NEUROSCI RES, V104, P16, DOI 10.1016/j.neures.2015.10.013; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Newport R, 2011, COGN NEUROSCI-UK, V2, P179, DOI 10.1080/17588928.2011.565120; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Osumi M, 2018, HUM MOVEMENT SCI, V57, P251, DOI 10.1016/j.humov.2017.09.003; Perepelkina O, 2018, CONSCIOUS COGN, V65, P216, DOI 10.1016/j.concog.2018.09.005; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Pyasik M, 2019, PSYCHOL RES-PSYCH FO, V83, P185, DOI 10.1007/s00426-018-1137-x; Ronchi Roberta, 2018, Handb Clin Neurol, V151, P313, DOI 10.1016/B978-0-444-63622-5.00015-2; ROSSINI PM, 1988, BRAIN RES, V458, P20, DOI 10.1016/0006-8993(88)90491-X; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Scandola M, 2017, CONSCIOUS COGN, V49, P278, DOI 10.1016/j.concog.2017.01.010; Schmalzl L, 2014, NEUROCASE, V20, P407, DOI 10.1080/13554794.2013.791861; Smit M, 2019, J NEUROPSYCHOL, V13, P603, DOI 10.1111/jnp.12153; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; Tidoni E, 2014, RESTOR NEUROL NEUROS, V32, P611, DOI 10.3233/RNN-130385; Tieri G, 2018, EXPERT REV MED DEVIC, V15, P107, DOI 10.1080/17434440.2018.1425613; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; van den Berg B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37718; van den Heiligenberg FMZ, 2018, BRAIN, V141, P1422, DOI 10.1093/brain/awy054; van der Hoort B, 2014, ATTEN PERCEPT PSYCHO, V76, P1414, DOI 10.3758/s13414-014-0664-9; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; van Doorn J, 2018, AM STAT, V72, P303, DOI 10.1080/00031305.2016.1264998; van Stralen HE, 2013, PERCEPTION, V42, P991, DOI 10.1068/p7583; Weiss C, 2014, NEUROPSYCHOLOGIA, V52, P82, DOI 10.1016/j.neuropsychologia.2013.09.034; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	84	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223580	10.1371/journal.pone.0223580	http://dx.doi.org/10.1371/journal.pone.0223580			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31585001	gold, Green Published, Green Submitted			2022-12-26	WOS:000532407600045
J	Snyder, A; Link, R; Dorheim, K; Ben Kravitz; Ben Bond-Lamberty; Hartin, C				Snyder, Abigail; Link, Robert; Dorheim, Kalyn; Ben Kravitz; Ben Bond-Lamberty; Hartin, Corinne			Joint emulation of Earth System Model temperature-precipitation realizations with internal variability and space-time and cross-variable correlation: fldgen v2.0 software description	PLOS ONE			English	Article							CLIMATE-CHANGE; 21ST-CENTURY	Earth System Models (ESMs) are excellent tools for quantifying many aspects of future climate dynamics but are too computationally expensive to produce large collections of scenarios for downstream users of ESM data. In particular, many researchers focused on the impacts of climate change require large collections of ESM runs to rigorously study the impacts to both human and natural systems of low-frequency high-importance events, such as multi-year droughts. Climate model emulators provide an effective mechanism for filling this gap, reproducing many aspects of ESMs rapidly but with lower precision. The fldgen v1.0 R package quickly generates thousands of realizations of gridded temperature fields by randomizing the residuals of pattern scaling temperature output from any single ESM, retaining the spatial and temporal variance and covariance structures of the input data at a low computational cost. The fldgen v2.0 R package described here extends this capability to produce joint realizations of multiple variables, with a focus on temperature and precipitation in an open source software package available for community use (https://github.com/jgcri/fldgen). This substantially improves the fldgen package by removing the requirement that the ESM variables be normally distributed, and will enable researchers to quickly generate covarying temperature and precipitation data that are synthetic but faithful to the characteristics of the original ESM.	[Snyder, Abigail; Link, Robert; Dorheim, Kalyn; Ben Bond-Lamberty; Hartin, Corinne] Pacific Northwest Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Ben Kravitz] Indiana Univ, Dept Earth & Atmospher Sci, Bloomington, IN USA; [Ben Kravitz] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Snyder, A (corresponding author), Pacific Northwest Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA.	abigail.snyder@pnnl.gov	Dorheim, Kalyn/AAB-4518-2020	Dorheim, Kalyn/0000-0001-8093-8397; Link, Robert/0000-0002-7071-248X; Snyder, Abigail/0000-0002-9034-9948	Pacific Northwest National Laboratory through the Laboratory Directed Research and Development program; U.S. Department of Energy, Office of Science, as part of research in Multi-Sector Dynamics, Earth and Environmental System Modeling Program; Indiana University Environmental Resilience Institute; Prepared for Environmental Change grand challenge initiative	Pacific Northwest National Laboratory through the Laboratory Directed Research and Development program; U.S. Department of Energy, Office of Science, as part of research in Multi-Sector Dynamics, Earth and Environmental System Modeling Program(United States Department of Energy (DOE)); Indiana University Environmental Resilience Institute; Prepared for Environmental Change grand challenge initiative	Primary funding was provided by Pacific Northwest National Laboratory through the Laboratory Directed Research and Development program (supported AS, RL, KD, BK, BBL, CH). Research was additionally funded with support provided by the U.S. Department of Energy, Office of Science, as part of research in Multi-Sector Dynamics, Earth and Environmental System Modeling Program (AS, RL, KD, BK, BBL, CH). Research was also supported in part by the Indiana University Environmental Resilience Institute and the Prepared for Environmental Change grand challenge initiative (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeff SE, 2016, CLIM CHANG; Calvin K, 2019, GEOSCI MODEL DEV, V12, P677, DOI 10.5194/gmd-12-677-2019; Castruccio S, 2013, ANN APPL STAT, V7, P1593, DOI 10.1214/13-AOAS656; Champeney DC, 1973, FOURIER TRANSFORMS T; Cui RY, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aad8f7; Diffenbaugh NS, 2017, P NATL ACAD SCI USA, V114, P4881, DOI 10.1073/pnas.1618082114; Hejazi MI, 2014, HYDROL EARTH SYST SC, V18, P2859, DOI 10.5194/hess-18-2859-2014; Kilsby CG, 2007, ENVIRON MODELL SOFTW, V22, P1705, DOI 10.1016/j.envsoft.2007.02.005; Link R, 2018, FLDGEN V1 0 EMULATOR; Osborn TJ, 2016, CLIMATIC CHANGE, V134, P353, DOI 10.1007/s10584-015-1509-9; Pfahl S, 2017, NAT CLIM CHANGE, V7, P423, DOI [10.1038/nclimate3287, 10.1038/NCLIMATE3287]; Rosenzweig Cynthia, 2014, Proc Natl Acad Sci U S A, V111, P3268, DOI 10.1073/pnas.1222463110; SNYDER L, 2019, RESP RES, V20, DOI DOI 10.5281/ZENODO.3372579; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabef2; Trenberth KE, 2015, NAT CLIM CHANGE, V5, P725, DOI 10.1038/NCLIMATE2657; Wakeel M, 2016, APPL ENERG, V178, P868, DOI 10.1016/j.apenergy.2016.06.114; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114; Zscheischler J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700263	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223542	10.1371/journal.pone.0223542	http://dx.doi.org/10.1371/journal.pone.0223542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584973	Green Published, gold, Green Submitted			2022-12-26	WOS:000532407600044
J	Khan, AR; Reichmann, LG; Ibal, JC; Shin, JH; Liu, Y; Collins, H; LePage, B; Terry, N				Khan, Abdur Rahim; Reichmann, L. G.; Ibal, J. C.; Shin, J. H.; Liu, Y.; Collins, H.; LePage, B.; Terry, N.			Variation in pickleweed root-associated microbial communities at different locations of a saline solid waste management unit contaminated with petroleum hydrocarbons	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SOIL; OIL; BIOREMEDIATION; RHIZOSPHERE; PHYTOREMEDIATION; DEGRADATION; DYNAMICS; SALT	The main purpose of this study was to explore the potential influences of pickleweed vegetation on the abundance, diversity and metabolic activities of microbial communities in four distinct areas of a petroleum-contaminated solid waste management unit (SWMU) located in Contra Costa County, northern California. The four areas sampled include two central areas, one of which is central vegetated (CV) and one unvegetated (UV), and two peripheral vegetated areas, one of which is located to the west side of the SWMU (V-West) and one located to the east side (V-East). Measurements were made of total petroleum hydrocarbons (TPH), polyaromatic hydrocarbons (PAH), soil physicochemical properties, and various aspects of microbial communities including metabolic activities, microbial abundances (PLFAs), diversity and composition based on amplicon sequencing. The peripheral V-East and V-West sites had 10-times lower electrical conductivity (EC) than that of the CV and UV sites. The high salinity levels of the CV and UV sites were associated with significant reductions in bacterial and fungal abundances (PLFA) when compared to V-East but not when compared to V-West. TPH levels of CV and UV were not significantly different from those of V-West but were substantially lower than V-East TPH (19,311 mg/kg of dry soil), the high value of which may have been associated with a pipeline that ran through the area. Microbial activities (in terms of soil respiration and the activities of three soil enzymes, i.e., urease, lipase, and phosphatase) were greatest in the vegetated sites compared to the UV site. The prokaryotic community was not diverse as revealed by the Shannon index with no significant variation among the four groups of samples. However, the fungal community of the peripheral sites, V-East and V-West had significantly higher OTU richness and Shannon index. Structure of prokaryotic communities inhabiting the rhizosphere of pickleweed plants at the three sites differed significantly and were also different from those found in the UV region of the central site according to pairwise, global PERMANOVA and ANOSIM analyses. The differences in OTU-based rhizosphere-associated bacterial and fungal communities' composition were explained mainly by the changes in soil EC and pH. The results suggest that saline TPH-contaminated areas that are vegetated with pickleweed are likely to have increased abundances, diversity and metabolic activities in the rhizosphere compared to unvegetated areas, even in the presence of high salinity.	[Khan, Abdur Rahim; Reichmann, L. G.; Liu, Y.; Terry, N.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ibal, J. C.; Shin, J. H.] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea; [Collins, H.] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [LePage, B.] Pacific Gas & Elect Co, San Ramon, CA USA; [LePage, B.] Acad Nat Sci, Philadelphia, PA USA; [Khan, Abdur Rahim] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Berkeley; Kyungpook National University; United States Department of Agriculture (USDA); University of California System; University of California Davis	Khan, AR; Terry, N (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Khan, AR (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	rahim_kust84@yahoo.com; nterry@berkeley.edu	Khan, Abdur Rahim/N-5836-2015	Khan, Abdur Rahim/0000-0001-5370-6216; Reichmann, Lara/0000-0002-9737-7300	UC Berkeley [51719]	UC Berkeley	This work was supported by UC Berkeley Grant #51719. The University of California, Berkeley, provided support in the form of salaries for authors [ARK, LR, NT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. PG&E has provided logistic support, granted access to the property, and showed us the different areas within the site. Author BLP is employed by PG&E.	Abed RMM, 2015, MICROB ECOL, V69, P95, DOI 10.1007/s00248-014-0475-5; Allen JP, 2007, APPL ENVIRON MICROB, V73, P2860, DOI 10.1128/AEM.01752-06; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Ben-David EA, 2011, FEMS MICROBIOL ECOL, V76, P492, DOI 10.1111/j.1574-6941.2011.01075.x; BERGMAN B, 2007, ASS ENDOPHYTIC NITRO, P257; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourceret A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142851; Brassington KJ, 2007, CRIT REV ENV SCI TEC, V37, P199, DOI 10.1080/10643380600819625; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Cai B, 2016, BIOCHEM ENG J, V112, P170, DOI 10.1016/j.bej.2016.04.018; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaudhary DR, 2017, INT J PHYTOREMEDIAT, V19, P478, DOI 10.1080/15226514.2016.1244168; Chen L, 2014, ENVIRON SCI POLLUT R, V21, P7538, DOI 10.1007/s11356-014-2670-9; Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067353; Cocarta DM, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081365; Correa-Garcia S, 2018, MICROB BIOTECHNOL, V11, P819, DOI 10.1111/1751-7915.13303; Cundy AB, 2016, J ENVIRON MANAGE, V184, P67, DOI 10.1016/j.jenvman.2016.03.028; Dendooven L, 2010, SOIL BIOL BIOCHEM, V42, P865, DOI 10.1016/j.soilbio.2010.02.014; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; dos Santos JJ, 2018, J ENVIRON MANAGE, V210, P104, DOI 10.1016/j.jenvman.2018.01.015; Ebadi A, 2018, J ENVIRON MANAGE, V219, P260, DOI 10.1016/j.jenvman.2018.04.115; Ebadi A, 2017, J ADV RES, V8, P627, DOI 10.1016/j.jare.2017.06.008; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; Ferrari BC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00217; Fountoulakis MS, 2009, ECOL ENG, V35, P1702, DOI 10.1016/j.ecoleng.2009.06.011; Gkorezis P, 2016, FRONTIERS MICROBIOLO, P7, DOI [10.3389/fmicb.2016.00007, DOI 10.3389/FMICB.2016.00007]; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Harper D, 2008, PALAEONTOL ELECTRON, V4, P9; Jarrell WM, 1999, LT EC RES NETWK SER, V2, P55; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Margesin R, 2002, BIOTECHNOL LETT, V24, P27, DOI 10.1023/A:1013801131553; MILLE G, 1991, FRESEN J ANAL CHEM, V339, P788, DOI 10.1007/BF00321746; Mishra S, 2001, APPL ENVIRON MICROB, V67, P1675, DOI 10.1128/AEM.67.4.1675-1681.2001; Mitter EK, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00849, 10.3389/fmicb.2017.00011]; Mukherjee S, 2015, MOL ECOL, V24, P628, DOI 10.1111/mec.13053; Oliveira V, 2014, FEMS MICROBIOL ECOL, V90, P647, DOI 10.1111/1574-6941.12425; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Puglisi E, 2006, SOIL BIOL BIOCHEM, V38, P1673, DOI 10.1016/j.soilbio.2005.11.021; Qin X, 2012, LETT APPL MICROBIOL, V55, P210, DOI 10.1111/j.1472-765X.2012.03280.x; Ren G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00022; RHYKERD RL, 1995, ENVIRON POLLUT, V90, P127, DOI 10.1016/0269-7491(94)00087-T; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shahi A, 2016, CHEM ENG J, V306, P60, DOI 10.1016/j.cej.2016.07.016; Sousa AI, 2008, CHEMOSPHERE, V70, P850, DOI 10.1016/j.chemosphere.2007.07.012; Tardif S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01363; Thion C, 2012, FEMS MICROBIOL ECOL, V82, P169, DOI 10.1111/j.1574-6941.2012.01414.x; Ulrich AC, 2009, BIODEGRADATION, V20, P27, DOI 10.1007/s10532-008-9196-0; Vancov T, 2009, FEMS MICROBIOL LETT, V296, P91, DOI 10.1111/j.1574-6968.2009.01621.x; Varjani SJ, 2017, BIORESOURCE TECHNOL, V223, P277, DOI 10.1016/j.biortech.2016.10.037; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Xia J, 2017, INT J SYST EVOL MICR, V67, P1281, DOI 10.1099/ijsem.0.001806; Xia MQ, 2017, INT BIODETER BIODEGR, V123, P70, DOI 10.1016/j.ibiod.2017.06.003; Yang YR, 2017, FORESTS, V8, DOI 10.3390/f8110430; Yergeau E, 2018, ISME J, V12, P869, DOI 10.1038/s41396-017-0018-4; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163	57	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222901	10.1371/journal.pone.0222901	http://dx.doi.org/10.1371/journal.pone.0222901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581244	Green Published, gold			2022-12-26	WOS:000532398600020
J	Murphy, GR; Dunstan, RH; Macdonald, MM; Borges, N; Radford, Z; Sparkes, DL; Dascombe, BJ; Roberts, TK				Murphy, Grace R.; Dunstan, R. Hugh; Macdonald, Margaret M.; Borges, Nattai; Radford, Zoe; Sparkes, Diane L.; Dascombe, Benjamin J.; Roberts, Timothy K.			Relationships between electrolyte and amino acid compositions in sweat during exercise suggest a role for amino acids and K+ in reabsorption of Na+ and Cl- from sweat	PLOS ONE			English	Article							ECCRINE SWEAT	Concentrations of free amino acids and [K+] in human sweat can be many times higher than in plasma. Conversely, [Na+] and [Cl-] in sweat are hypotonic to plasma. It was hypothesised that the amino acids and K+ were directly or indirectly associated with the resorption of Na+ and Cl- in the sweat duct. The implication would be that, as resources of these components became limiting during prolonged exercise then the capacity to resorb [Na+] and [Cl-] would diminish, resulting in progressively higher levels in sweat. If this were the case, then [Na+] and [Cl-] in sweat would have inverse relationships with [K+] and the amino acids during exercise. Forearm sweat was collected from 11 recreational athletes at regular intervals during a prolonged period of cycling exercise after 15, 25, 35, 45, 55 and 65 minutes. The subjects also provided passive sweat samples via 15 minutes of thermal stimulation. The sweat samples were analysed for concentrations of amino acids, Na+, Cl-, K+, Mg2+ and Ca2+. The exercise sweat had a total amino acid concentration of 6.4 +/- 1.2mM after 15 minutes which was lower than the passive sweat concentration at 11.6 +/- 0.8mM (p<0.05) and showed an altered array of electrolytes, indicating that exercise stimulated a change in sweat composition. During the exercise period, [Na+] in sweat increased from 23.3 +/- 3.0mM to 34.6 +/- 2.4mM (p<0.01) over 65 minutes whilst the total concentrations of amino acids in sweat decreased from 6.4 +/- 1.2mM to 3.6 +/- 0.5mM. [Na+] showed significant negative correlations with the concentrations of total amino acids (r = -0.97, p<0.05), K+(r = -0.93, p<0.05) and Ca2+ (r = -0.83, p<0.05) in sweat. The results supported the hypothesis that amino acids and K+, as well as Ca2+, were associated with resorption of Na+ and Cl-.	[Murphy, Grace R.; Dunstan, R. Hugh; Macdonald, Margaret M.; Borges, Nattai; Radford, Zoe; Sparkes, Diane L.; Dascombe, Benjamin J.; Roberts, Timothy K.] Univ Newcastle, Callaghan, NSW, Australia	University of Newcastle	Dunstan, RH (corresponding author), Univ Newcastle, Callaghan, NSW, Australia.	hugh.dunstan@newcastle.edu.au		Borges, Nattai/0000-0002-4182-8088; Dascombe, Ben/0000-0003-3374-3575	Gideon Lang Research Foundation [G1701109]	Gideon Lang Research Foundation	This work was supported by the Gideon Lang Research Foundation grant number G1701109 to RHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG MD, 1973, METABOLISM, V22, P561, DOI 10.1016/0026-0495(73)90069-3; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Beekley MD, 2004, RES Q EXERCISE SPORT, V75, P337, DOI 10.1080/02701367.2004.10609165; Bovell D, 2002, J PHYSL LONDON; BRUSILOW SAUL W., 1963, JOUR CLIN INVET, V42, P920; CHRISTENSEN HN, 1967, J BIOL CHEM, V242, P5237; Cui CY, 2016, J DERMATOL SCI, V81, P129, DOI 10.1016/j.jdermsci.2015.11.001; Cui CY, 2015, EXP DERMATOL, V24, P644, DOI 10.1111/exd.12773; Dunstan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167844; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Fukuba Y, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13456; GITLITZ PH, 1974, CLIN CHEM, V20, P1305; Golding LA., 1982, YS WAY PHYS FITNESS, VRev. ed; Hew-Butler T, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00021; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LIAPPIS N, 1972, AM J CLIN NUTR, V25, P661; LICHTON IJ, 1957, J APPL PHYSIOL, V11, P422, DOI 10.1152/jappl.1957.11.3.422; Nigro N, 2015, J AM GERIATR SOC, V63, P470, DOI 10.1111/jgs.13325; O'Connor Robert E, 2006, Cleve Clin J Med, V73 Suppl 3, pS13; Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1017/S0958067000020583; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; REDDY MM, 1994, J MEMBRANE BIOL, V140, P57; SATO K, 1973, AM J PHYSIOL, V225, P1147, DOI 10.1152/ajplegacy.1973.225.5.1147; Sato K., 1993, PERSPECTIVES EXERCIS, V6, P85; Sato K., REV PHYSL BIOCH PHAR, V79; Sato K, 1970, J INVEST DERMATOL, P55; Sato K, 1989, J AM ACAD DERMATOL, P20; Schazmann B, 2010, ANAL METHODS-UK, V2, P342, DOI 10.1039/b9ay00184k; Schwartz IL, 1956, J CLIN INVEST, P35; Sonner Z, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4921039; SZABO G, 1967, PHILOS T ROY SOC B, V252, P447, DOI 10.1098/rstb.1967.0029; Taylor NAS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-4; WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306; WILKERSON JE, 1982, J APPL PHYSIOL, V53, P1529, DOI 10.1152/jappl.1982.53.6.1529; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	36	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223381	10.1371/journal.pone.0223381	http://dx.doi.org/10.1371/journal.pone.0223381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581276	Green Published, gold			2022-12-26	WOS:000532398600060
J	Blystad, MH; Andersen, D; Johansen, EB				Blystad, Magnus H.; Andersen, Danielle; Johansen, Espen B.			Female rats release a trapped cagemate following shaping of the door opening response: Opening latency when the restrainer was baited with food, was empty, or contained a cagemate	PLOS ONE			English	Article							OPEN-FIELD BEHAVIOR; EMPATHY; ILLUMINATION; SEX; COMMUNICATION; ADOLESCENTS; STARTLE; AUTISM; BRAIN; PAIN	Research on pro-social rat behaviour is growing within the fields of comparative psychology and social neuroscience. However, much work remains on mapping important variables influencing this behaviour, and there is even disagreement on whether this behaviour is empathetically motivated and correctly labelled pro-social, or whether the behaviour is motivated by social contact. The present study used the helping behaviour paradigm where a rat can release a familiar cagemate from a restrainer. Prior to testing with a trapped cagemate, restrainer door opening was trained and baseline opening latencies when the restrainer was empty or baited with food were established. The findings show that the first-time release occurred sooner than in previous research and that rats used a previously demonstrated response to release the trapped cagemate. Further, rats opened the restrainer door more often and with shorter latencies when the restrainer contained a cagemate than when the restrainer was empty, but less often and with longer latencies than when the restrainer contained food. The test of whether illumination levels affect door-opening included in the study showed no effects.	[Blystad, Magnus H.; Andersen, Danielle; Johansen, Espen B.] OsloMet Oslo Metropolitan Univ, Dept Behav Sci, Oslo, Norway	Oslo Metropolitan University (OsloMet)	Blystad, MH (corresponding author), OsloMet Oslo Metropolitan Univ, Dept Behav Sci, Oslo, Norway.	mblyst@oslomet.no	Blystad, Magnus Helgheim/ABE-5832-2021	Blystad, Magnus Helgheim/0000-0003-1579-3907				ADERMAN D, 1970, J PERS SOC PSYCHOL, V14, P141, DOI 10.1037/h0028770; Ali F, 2009, PERS INDIV DIFFER, V47, P758, DOI 10.1016/j.paid.2009.06.016; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett ST, 2012, BEHAV PHARMACOL, V23, P781, DOI 10.1097/FBP.0b013e32835a38d9; Bartal IB, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00850; Bartal IB, 2014, ELIFE, V3, DOI 10.7554/eLife.01385; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Baumans V., 2016, IMPACT LIGHT NOISE C, P311; Blair RJR, 2007, EMPATHY IN MENTAL ILLNESS, P3; BRELAND K, 1961, AM PSYCHOL, V16, P681, DOI 10.1037/h0040090; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; Carrillo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136979; Catania C. A, 1992, LEARNING; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Cuff BMP, 2016, EMOT REV, V8, P144, DOI 10.1177/1754073914558466; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; de Waal FBM, 2012, SO NEUROSCI SER, P87; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Decety J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0077; Gini G, 2007, AGGRESSIVE BEHAV, V33, P467, DOI 10.1002/ab.20204; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; GREENE JT, 1969, PSYCHON SCI, V14, P47, DOI 10.3758/BF03336420; Hachiga Y, 2018, J EXP ANAL BEHAV, V110, P267, DOI 10.1002/jeab.464; Hernandez-Lallement Julen, 2014, Front Neurosci, V8, P443, DOI 10.3389/fnins.2014.00443; Hiura LC, 2018, BEHAV PROCESS, V152, P37, DOI 10.1016/j.beproc.2018.03.014; IGARASHI E, 1995, PHYSIOL BEHAV, V57, P699, DOI 10.1016/0031-9384(94)00317-3; Keysers C, 2017, CURR TOP BEHAV NEURO, V30, P179, DOI 10.1007/7854_2016_439; Killeen PR, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0097-9; Klejbor I, 2013, FOLIA MORPHOL, V72, P300, DOI 10.5603/FM.2013.0050; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Marquez C, 2015, CURR BIOL, V25, P1736, DOI 10.1016/j.cub.2015.05.018; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Perez-Manrique A, 2018, BIOL REV, V93, P248, DOI 10.1111/brv.12342; QUADAGNO DM, 1972, ANIM BEHAV, V20, P732, DOI 10.1016/S0003-3472(72)80145-3; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Roberts W, 1996, CHILD DEV, V67, P449, DOI 10.2307/1131826; Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGY, V21, P431, DOI 10.1037/0894-4105.21.4.431; Siebenaler J. B., 1956, Journal of Mammalogy, V37, P126, DOI 10.2307/1375558; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Sivaselvachandran S, 2018, NEUROSCI BIOBEHAV R, V91, P130, DOI 10.1016/j.neubiorev.2016.06.007; Smith A, 2009, PSYCHOL REC, V59, P273, DOI 10.1007/BF03395663; Stavrinides P, 2010, EDUC PSYCHOL-UK, V30, P793, DOI 10.1080/01443410.2010.506004; Stotland E, 1969, ADV EXP SOC PSYCHOL, V4, P271, DOI DOI 10.1016/S0065-2601(08)60080-5; Titchener EB, 2014, DIALOGUES PHILOS MEN, V7, P25; Tomek SE, 2019, ADDICT BIOL, V24, P676, DOI 10.1111/adb.12633; VALLE FP, 1970, AM J PSYCHOL, V83, P103, DOI 10.2307/1420860; van Noorden THJ, 2015, J YOUTH ADOLESCENCE, V44, P637, DOI 10.1007/s10964-014-0135-6; VANDERSCHUREN LJMJ, 1995, PHYSIOL BEHAV, V58, P119, DOI 10.1016/0031-9384(94)00385-I; Vasconcelos M, 2012, BIOL LETTERS, V8, P910, DOI 10.1098/rsbl.2012.0554; Walker DL, 1997, BIOL PSYCHIAT, V42, P461, DOI 10.1016/S0006-3223(96)00441-6; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Willadsen M, 2014, J COMP PSYCHOL, V128, P56, DOI 10.1037/a0034778; Williams A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00425; WILLIAMS DI, 1971, ANIM BEHAV, V19, P365, DOI 10.1016/S0003-3472(71)80018-0	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223039	10.1371/journal.pone.0223039	http://dx.doi.org/10.1371/journal.pone.0223039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574116	Green Published, gold			2022-12-26	WOS:000532376700025
J	Liu, YJ; Keane, A; Simms, KT; Lew, JB; Shi, JF; Mazariego, C; Yuill, S; Jeronimo, J; Qiao, YL; Canfell, K				Liu, Yi-Jun; Keane, Adam; Simms, Kate T.; Lew, Jie-Bin; Shi, Ju-Fang; Mazariego, Carolyn; Yuill, Susan; Jeronimo, Jose; Qiao, You-Lin; Canfell, Karen			Development and application of a framework to estimate health care costs in China: The cervical cancer example	PLOS ONE			English	Article							VACCINATION	Objectives Information on healthcare costs in low-and-middle-income countries is limited. This study presents a framework to perform healthcare cost estimates for each province in China. Methods This study has two aims. Using cervical cancer as an example, the first aim is to use data (including micro-costing data) from one province to derive estimates for other provinces in China. This used provincial and national Chinese-language statistical reports and considered levels of service delivery, hospital-seeking behaviour, and the urban/rural population distribution. The second aim is to characterise the relationship between the reference costs estimated using the method mentioned above and two sets of cost estimates derived using simplified cost-scaling method with per capita Gross Domestic Product (GDP), and the Human Development Index (HDI). For simplified methods, regression modelling characterised the relationship between province-specific healthcare costs and macro-economic indicators, then we used the exponential fit to extrapolate costs. Results Using the reference method, the estimated costs were found to vary substantially by urban/rural regions and between provinces; the ratios of highest to lowest provincial costs were 3.5 for visual inspection with acetic acid (VIA), 4.4 for cold knife conisation (CKC) and 4.6 for stage II cancer treatment. The HDI-based scaling method generally resulted in a better fit to reference costs than the GDP method. Conclusions These reference costs for cervical cancer can inform cost-effectiveness evaluation of cervical screening and HPV vaccination in China. HDI-based methods for cost-scaling-based on social, as well as purely economic, factors-have potential to provide more accurate estimates.	[Liu, Yi-Jun] Zunyi Med Univ, Sch Publ Hlth, Zunyi, Guizhou, Peoples R China; [Liu, Yi-Jun; Keane, Adam; Simms, Kate T.; Lew, Jie-Bin; Mazariego, Carolyn; Yuill, Susan; Canfell, Karen] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Shi, Ju-Fang; Qiao, You-Lin] Chinese Acad Med Sci & Peking Union Med Coll, Canc Inst & Hosp, Dept Epidemiol, Beijing, Peoples R China; [Jeronimo, Jose] Global Coalit Cerv Canc, Arlington, VA USA; [Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Canfell, Karen] UNSW, Prince Wales Clin Sch, Fac Med, Sydney, NSW, Australia	Zunyi Medical University; Cancer Council New South Wales; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; University of New South Wales Sydney	Canfell, K (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.; Canfell, K (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia.; Canfell, K (corresponding author), UNSW, Prince Wales Clin Sch, Fac Med, Sydney, NSW, Australia.	karen.canfell@nswcc.org.au	Qiao, You-Lin/B-4139-2012	Qiao, You-Lin/0000-0001-6380-0871; Yuill, Susan/0000-0001-7609-972X; Keane, Adam/0000-0001-7496-6746; Lew, Jie-Bin/0000-0003-2837-3565; Canfell, Karen/0000-0002-6443-6618; Mazariego, Carolyn/0000-0003-3965-4960; Liu, Yi jun/0000-0001-5169-1188; Simms, Kate/0000-0003-2568-7956	National Health and Medical Research Council China [APP1080314]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-1-019]	National Health and Medical Research Council China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This study was supported by the National Health and Medical Research Council APP1080314_China and Chinese Academy of Medical Sciences Initiative for Innovative Medicine 2016-I2M-1-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, HLTH SYSTEMS TRANSIT; Bank of China, EXCH RAT; Beijing Statistics Bureau, 2018, BEIJ STAT YB 2018; Campos NG, 2015, INT J CANCER, V137, P2208, DOI 10.1002/ijc.29594; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Canfell K, 2011, VACCINE, V29, P2487, DOI 10.1016/j.vaccine.2010.12.085; Center for Health Statistics and Information National Health and Family Planning Commission, 2015, AN REP NAT HLTH SERV; Deb S., 2015, IARIW OECD SPEC C PA; Fang Hai, CHINESE HLTH CARE SY; Fuchs VR, 2013, NEW ENGL J MED, V369, P107, DOI 10.1056/NEJMp1305298; Gao L, 2016, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-016-0091-z; Global Data Lab, SUBN HUM DEV IND SD; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Guangdong Statistics Bureau, STAT B EC SOC DEV GU; Ke X, 2011, DETERMINANTS HLTH EX, V26, P1; Levin CE, 2015, VACCINE, V33, P2830, DOI 10.1016/j.vaccine.2015.02.052; Liu YJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2207-3; Meng Kai LD, 2016, CHIN J HOSP ADM, V32, P84; Mo XT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2592-5; National Bureau of Statistics of China, CONS PRIC IND; National Bureau of Statistics of China, 2018, CHIN STAT YB 2018; National Health and Family Planning Commission, 2018, CHIN HLTH STAT YB 20; Piabuo SM, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0159-1; Shenzhen Statistics Bureau, 2018, SHENZH STAT YB 2018; Shi J F, 2016, Zhonghua Zhong Liu Za Zhi, V38, P929, DOI 10.3760/cma.j.issn.0253-3766.2016.12.010; Shi JF, 2009, COST EFFECTIVENESS V; Shi JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-123; Shi JF, 2011, BMC CANCER, V11, DOI [10.1186/1471-2407-11-239, 10.1186/1472-6750-11-77]; The Central People's Government of China, OUTL CHIN ADM DIV 20; The Central People's Government of China, ADM DIV PEOPL REP CH; Toy M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139876; University of Colorado, CON LEEP TREATM; World Health Organization, MAK CHOIC HLTH WHO G; Xu He, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P399; Xu X, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-47; Zhang Q, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2893-x; Zhao Fang-hui, 2012, Zhonghua Zhong Liu Za Zhi, V34, P632, DOI 10.3760/cma.j.issn.0253-3766.2012.08.017	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222760	10.1371/journal.pone.0222760	http://dx.doi.org/10.1371/journal.pone.0222760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ1YF	31574103	gold, Green Submitted, Green Published			2022-12-26	WOS:000529966900001
J	Toms, R; Mayne, DJ; Feng, XQ; Bonney, A				Toms, Renin; Mayne, Darren J.; Feng, Xiaoqi; Bonney, Andrew			Geographic variation in cardiometabolic risk distribution: A cross-sectional study of 256,525 adult residents in the Illawarra-Shoalhaven region of the NSW, Australia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; INFORMATION-SYSTEMS; MULTILEVEL ANALYSIS; SPATIAL-ANALYSIS; PUBLIC-HEALTH; HEART; EPIDEMIOLOGY; OBESITY	Introduction Metabolic risk factors for cardiovascular disease (CVD) warrant significant public health concern globally. This study aims to utilise the regional database of a major laboratory network to describe the geographic distribution pattern of eight different cardiometabolic risk factors (CMRFs), which in turn can potentially generate hypotheses for future research into locality specific preventive approaches. Method A cross-sectional design utilising de-identified laboratory data on eight CMRFs including fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein (HDL); albumin creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body mass index (BMI); and diabetes mellitus (DM) status was used to undertake descriptive and spatial analyses. CMRF test results were dichotomised into 'higher risk' and 'lower risk' values based on existing risk definitions. Australian Census Statistical Area Level 1 (SA1) were used as the geographic units of analysis, and an Empirical Bayes (EB) approach was used to smooth rates at SA1 level. Choropleth maps demonstrating the distribution of CMRFs rates at SA1 level were produced. Spatial clustering of CMRFs was assessed using Global Moran's I test and Local Indicators of Spatial Autocorrelation (LISA). Results A total of 1,132,016 test data derived from 256,525 individuals revealed significant geographic variation in the distribution of 'higher risk' CMRF findings. The populated eastern seaboard of the study region demonstrated the highest rates of CMRFs. Global Moran's values were significant and positive at SA1 level for all CMRFs. The highest spatial auto-correlation strength was found among obesity rates (0.328), and the lowest for albuminuria (0.028). LISA tests identified significant High-High (HH) and Low-Low (LL) spatial clusters of CMRFs, with LL predominantly in the less populated northern, central and southern regions of the study area. Conclusion The study describes a range of CMRFs with different distributions in the study region. The results allow generation of hypotheses to test in future research concerning location specific population health approaches.	[Toms, Renin; Mayne, Darren J.; Bonney, Andrew] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Toms, Renin; Mayne, Darren J.; Feng, Xiaoqi; Bonney, Andrew] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Mayne, Darren J.] Illawarra Shoalhaven Local Hlth Dist, Publ Hlth Unit, Warrawong, NSW, Australia; [Mayne, Darren J.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Feng, Xiaoqi] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Feng, Xiaoqi] Univ Wollongong, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab PowerLab, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong; University of Sydney; University of New South Wales Sydney; University of Wollongong	Toms, R (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW, Australia.; Toms, R (corresponding author), Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	rmbst288@uowmail.edu.au	Feng, Xiaoqi/AAM-9592-2021	Toms, Renin/0000-0002-6922-1448; Feng, Xiaoqi/0000-0002-3421-220X; Bonney, Andrew/0000-0003-2477-1646	Australian Government	Australian Government(Australian GovernmentCGIAR)	The Australian Government Research Training Program Scholarship covers the university tuition fees of the PhD candidate who is the principal author in this study (RT).r We would like to thank Southern IML Pathology and staff for their generosity in providing data for the SIMLR Cohort Study and ongoing support. In particular we would like to thank Mr Bryan Jones for providing the technical expertise for the data acquisition and helpful comments on the manuscript. Southern IML Pathology are the owners of the data contained within this publication and the Illawarra Health and Medical Research Institute (IHMRI) is the custodian facilitating access to the data. https://www.ihmri.org.au/research-projects/simlr-cohort-study/	AIHW, 2014, AUSTR HLTH 2014; AIHW-Australian Institute of Health and Welfare, 2017, CARD DIS DIAB CHRON; Alkerwi A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060648; [Anonymous], 2016, MAIN STRUCT GREAT CA; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Ard JD, 2018, J GERONTOL A-BIOL, V73, P73, DOI 10.1093/gerona/glw237; Astell-Burt T, 2015, MED J AUSTRALIA, V203, P246, DOI 10.5694/mja15.00063; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV BIOM; Australian Bureau of Statistics, 2011, AUSTR HLTH SURV BIOM; Australian Bureau of Statistics [ABS], 2011, CENS DAT; Australian Institute of Health and Welfare, 2014, CARD DIAB CHRON KIDN, V3; Barber S, 2018, SOC SCI MED, V199, P67, DOI 10.1016/j.socscimed.2017.05.047; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bonney A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137261; Cheng FW, 2016, OBESITY, V24, P2232, DOI 10.1002/oby.21612; Craglia M, 2016, GIS PUBLIC HLTH PRAC, DOI [10.1201/9780203720349, DOI 10.1201/9780203720349]; Cromley EK, 2019, CURR EPIDEMIOL REP, V6, P162, DOI 10.1007/s40471-019-00193-6; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Dehghani Ali, 2015, Glob J Health Sci, V7, P6, DOI 10.5539/gjhs.v7n7p6; Environmental Systems Research Institute (ESRI), ARCGIS 10 4 1; Fradelos Evangelos C, 2014, Acta Inform Med, V22, P402, DOI 10.5455/aim.2014.22.402-405; Gabert R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159227; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jarrahi AM, 2017, ASIAN PAC J CANCER P, V2, P1, DOI [10.31557/APJCC.2017.2.1.1, DOI 10.31557/APJCC.2017.2.1.1]; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Lawson A, BAYESIAN DIS MAPPING; Lawson A. B., 2003, DIS MAPPING WINBUGS; Lawson AB, 2013, STAT METHODS SPATIAL; Lawson A, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, pXI; Li HF, 2007, GEOGR ANAL, V39, P357, DOI 10.1111/j.1538-4632.2007.00708.x; Li WJ, 2009, AM J PUBLIC HEALTH, V99, P511, DOI 10.2105/AJPH.2008.137364; Littman A, 2012, EVALUATION WEIGHT MA; Liu M, 2014, EUROPEAN REV MED PHA; Ma J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-71; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.102145; Merlo J, 2017, SSM-POPUL HLTH, V3, P684, DOI 10.1016/j.ssmph.2017.08.005; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; National Heart Foundation of Australia, LIP MAN PROF HLTH PR; Nissinen A., 2001, B WHO; Nykiforuk CIJ, 2011, HEALTH PROMOT PRACT, V12, P63, DOI 10.1177/1524839909334624; O'Connor Duffany K., 2011, CVD PREV CONTROL, V6, P47, DOI DOI 10.1016/J.CVDPC.2011.02.005; Ocana-Riola R, 2010, GEOSPATIAL HEALTH, V4, P139, DOI 10.4081/gh.2010.196; Paquet C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050519; Parker DR, 2005, PRIMARY CARE, V32, P865, DOI 10.1016/j.pop.2005.09.012; Portnov BA, 2007, J EXPO SCI ENV EPID, V17, P106, DOI 10.1038/sj.jes.7500533; R Core Team, 2018, R LANG ENV STAT COMP; Rezaeian M, 2007, J EPIDEMIOL COMMUN H, V61, P98, DOI 10.1136/jech.2005.043117; Shafran-Nathan R, 2017, AIR QUAL ATMOS HLTH, V10, P411, DOI 10.1007/s11869-016-0436-x; Stocks N, 2009, AUST J RURAL HEALTH, V17, P92, DOI 10.1111/j.1440-1584.2009.01043.x; Stocks NP, 2004, MED J AUSTRALIA, V180, P229, DOI 10.5694/j.1326-5377.2004.tb05891.x; The Royal Australian College of General Practitioners & Diabetes Australia, 2016, GEN PRACT MAN TYP 2, DOI [10.1007/s00125-010-2011-6, DOI 10.1007/S00125-010-2011-6]; Toms R, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-018-0165-5; Tourlouki E, 2009, CLIN INTERVENTIONS A; Valdes S, 2014, REV ESP CARDIOL, V67, P442, DOI [10.1016/j.rec.2013.09.029, 10.1016/j.recesp.2013.09.031]; Wadwa RP, 2008, CARDIOVASCULAR DIS R; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; WHO, 2017, WHO TOP 10 CAUS DEAT; World Health Organization, 2017, WHO NONC DIS; World Health Organization, 2000, WHO TECHN REP SER, V894; World Health Organization; World Heart Federation and World Stroke Organization, 2011, GLOB ATLAS CARDIOVAS, V155; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	68	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223179	10.1371/journal.pone.0223179	http://dx.doi.org/10.1371/journal.pone.0223179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574124	gold, Green Published			2022-12-26	WOS:000532376700033
J	Smith, AD; Foss, ED; Zhang, I; Hastie, JL; Giordano, NP; Gasparyan, L; VinhNguyen, LP; Schubert, AM; Prasad, D; McMichael, HL; Sun, JC; Beger, RD; Simonyan, V; Cowley, SC; Carlson, PE				Smith, Ashley D.; Foss, Elissa D.; Zhang, Irma; Hastie, Jessica L.; Giordano, Nicole P.; Gasparyan, Lusine; Phuc VinhNguyen, Lam; Schubert, Alyxandria M.; Prasad, Deepika; McMichael, Hannah L.; Sun, Jinchun; Beger, Richard D.; Simonyan, Vahan; Cowley, Siobhan C.; Carlson, Paul E., Jr.			Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection	PLOS ONE			English	Article							INVARIANT T-CELLS; MOUSE MODEL; MAIT CELLS; TRANSPLANTATION; COLITIS	Clostridium difficile (Cd) infection (CDI) typically occurs after antibiotic usage perturbs the gut microbiota. Mucosa-associated invariant T cells (MAIT) are found in the gut and their development is dependent on Major histocompatibility complex-related protein 1 (MR1) and the host microbiome. Here we were interested in determining whether the absence of MR1 impacts resistance to CDI. To this end, wild-type (WT) and MR1(-/-) mice were treated with antibiotics and then infected with Cd spores. Surprisingly, MR1(-/-) mice exhibited resistance to Cd colonization. 16S rRNA gene sequencing of feces revealed inherent differences in microbial composition. This colonization resistance was transferred from MR1(-/-) to WT mice via fecal microbiota transplantation, suggesting that MR1-dependent factors influence the microbiota, leading to CDI susceptibility.	[Smith, Ashley D.; Foss, Elissa D.; Zhang, Irma; Hastie, Jessica L.; Giordano, Nicole P.; Schubert, Alyxandria M.; Prasad, Deepika; McMichael, Hannah L.; Cowley, Siobhan C.; Carlson, Paul E., Jr.] US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Pathogens & Allergen Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Gasparyan, Lusine; Phuc VinhNguyen, Lam; Prasad, Deepika; Simonyan, Vahan] US FDA, High Performance Integrated Personal Environm, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Sun, Jinchun; Beger, Richard D.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Carlson, PE (corresponding author), US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Pathogens & Allergen Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Paul.Carlson@fda.hhs.gov	Smith, Ashley/GZB-0298-2022	Cowley, Siobhan/0000-0003-3073-0269	National Institutes for Health [AAI17016-001-00001]; University of Michigan Microbial Systems Molecular Biology Laboratory; Food and Drug administration [AAI17016-001-00001]	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Microbial Systems Molecular Biology Laboratory(University of Michigan System); Food and Drug administration(United States Department of Health & Human Services)	This work was also supported by an Inter-Agency Agreement to PC between the National Institutes for Health and Food and Drug administration (AAI17016-001-00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of CBER's Division of Veterinary Medicine for their help with animal care and handling. We would also like to acknowledge that this research was supported by work performed by The University of Michigan Microbial Systems Molecular Biology Laboratory.	Bernal I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02532; Bhattarai Y, 2016, METHODS MOL BIOL, V1438, P123, DOI 10.1007/978-1-4939-3661-8_8; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Chitrala KN, 2017, EUR J IMMUNOL, V47, P1188, DOI 10.1002/eji.201646792; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Collins J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0097-2; Cowley SC, 2014, CELL MOL LIFE SCI, V71, P4831, DOI 10.1007/s00018-014-1708-y; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Giordano N, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00326-18; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Graham ML, 2011, COMPARATIVE MED, V61, P356; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Jo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004210; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Johnson S, 2009, INT J ANTIMICROB AG, V33, pS33, DOI 10.1016/S0924-8579(09)70014-7; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kwon YS, 2015, TUBERCULOSIS, V95, P267, DOI 10.1016/j.tube.2015.03.004; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Leung DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003076; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Meierovics AI, 2016, J EXP MED, V213, P2793, DOI 10.1084/jem.20160637; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; Park SJ, 2017, BMB REP, V50, P578, DOI 10.5483/BMBRep.2017.50.11.165; Prevention CfDCa, 2013, ANT RES TREATS US 20; Rao K, 2015, INFECT DIS CLIN N AM, V29, P109, DOI 10.1016/j.idc.2014.11.009; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Seekatz AM, 2015, INFECT IMMUN, V83, P3838, DOI 10.1128/IAI.00459-15; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Theriot CM, 2011, GUT MICROBES, V2, P326, DOI [10.4161/gmic.2.6.19142, 10.4161/gmic.19142]; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tsukamoto K, 2013, IMMUNOGENETICS, V65, P115, DOI 10.1007/s00251-012-0666-5; Yamaguchi H, 1998, BIOCHEM BIOPH RES CO, V250, P558, DOI 10.1006/bbrc.1998.9353; Yoshida K, 2018, BIOCHEM BIOPH RES CO, V496, P934, DOI 10.1016/j.bbrc.2018.01.116; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223025	10.1371/journal.pone.0223025	http://dx.doi.org/10.1371/journal.pone.0223025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560732	gold, Green Published			2022-12-26	WOS:000532353700031
J	Ubanako, P; Xelwa, N; Ntwasa, M				Ubanako, Philemon; Xelwa, Ntombikayise; Ntwasa, Monde			LPS induces inflammatory chemokines via TLR-4 signalling and enhances the Warburg Effect in THP-1 cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; KAPPA-B; CANCER; METABOLISM; ACTIVATION; CYTOKINES; GENE; MACROPHAGES; INTEGRATION; PREDICTION	The Warburg Effect has emerged as a potential drug target because, in some cancer cell lines, it is sufficient to subvert it in order to kill cancer cells. It has also been shown that the Warburg Effect occurs in innate immune cells upon infection. Innate immune cells play critical roles in the tumour microenvironment but the Warburg Effect is not fully understood in monocytes. Furthermore, it is important to understand the impact of infections on key players in the tumour microenvironment because inflammatory conditions often precede carcinogenesis and mutated oncogenes induce inflammation. We investigated the metabolic programme in the acute monocytic leukaemia cell line, THP-1 in the presence and absence of lipopolysaccharide, mimicking bacterial infections. We found that stimulation of THP-1 cells by LPS induces a subset of pro-inflammatory chemokines and enhances the Warburg Effect. Surprisingly, perturbation of the Warburg Effect in these cells does not lead to cell death in contrast to what was observed in non-myeloid cancer cell lines in a previous study. These findings indicate that the Warburg Effect and inflammation are activated by bacterial lipopolysaccharide and may have a profound influence on the microenvironment.	[Ubanako, Philemon; Xelwa, Ntombikayise] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Ntwasa, Monde] Univ South Africa, Dept Life & Consumer Sci, Johannesburg, South Africa	University of Witwatersrand; University of South Africa	Ntwasa, M (corresponding author), Univ South Africa, Dept Life & Consumer Sci, Johannesburg, South Africa.	ntwasmm@unisa.ac.za			National Research Foundation (South Africa) [GUN: 105567]	National Research Foundation (South Africa)(National Research Foundation - South Africa)	The National Research Foundation (South Africa) [GUN: 105567] supported this research awarded to MN. PU conducted the bulk of the experiments analysis of results. NX conducted the metabolic studies. MN conceived the project and analysed the data. All authors participated in drafting the manuscript.	Birkenmeier G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161571; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; GRANA X, 1995, ONCOGENE, V11, P211; Ha TK, 2012, AUTOPHAGY, V8, P1684, DOI 10.4161/auto.21487; Haase M, 2016, GENE, V575, P171, DOI 10.1016/j.gene.2015.08.063; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jones VS, 2016, BBA-REV CANCER, V1865, P255, DOI 10.1016/j.bbcan.2016.03.005; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; Monchusi B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182789; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Oda T, 2006, AM J PHYSIOL-CELL PH, V291, pC104, DOI 10.1152/ajpcell.00614.2005; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Raulien N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00609; Rodriguez-Prados J-C, 2010, J IMMUNOLOGY; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Seuter S, 2013, J STEROID BIOCHEM, V136, P62, DOI 10.1016/j.jsbmb.2012.11.011; Shi L. Z., 2011, J CELL BIOL, V194, pi1; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Vadiveloo PK, 1996, ONCOGENE, V13, P599; Vadiveloo PK, 2001, BBA-MOL CELL RES, V1539, P140, DOI 10.1016/S0167-4889(01)00102-1; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wong AK, 2012, NUCLEIC ACIDS RES, V40, pW484, DOI 10.1093/nar/gks458; Wong LYF, 2005, ENDOCRINOLOGY, V146, P1321, DOI 10.1210/en.2004-1080; Wu XH, 2002, GENOMICS, V80, P553, DOI 10.1006/geno.2002.7010; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222614	10.1371/journal.pone.0222614	http://dx.doi.org/10.1371/journal.pone.0222614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560702	Green Published, gold			2022-12-26	WOS:000532353700017
J	Hernandez, AR; Gracia-Lazaro, C; Brigatti, E; Moreno, Y				Hernandez, Alexis R.; Gracia-Lazaro, Carlos; Brigatti, Edgardo; Moreno, Yamir			Analyzing a networked social algorithm for collective selection of representative committees	PLOS ONE			English	Article								A recent work (Hernandez, et al., 2018) introduced a networked voting rule supported by a trust-based social network, where indications of possible representatives were based on individuals opinions. Individual contributions went beyond a simple vote-counting and were based on proxy voting. This mechanism selects committees with high levels of representativeness, weakening the possibility of patronage relations. By incorporating the integrity of individuals and its perception, we here address the question of the resulting committee's trustability. Our results show that this voting rule provides sufficiently small committees with high levels of representativeness and integrity. Furthermore, the voting system displays robustness to strategic and untruthful application of the voting algorithm.	[Hernandez, Alexis R.; Brigatti, Edgardo] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [Gracia-Lazaro, Carlos; Moreno, Yamir] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Fac Sci, Dept Theoret Phys, Zaragoza, Spain; [Moreno, Yamir] ISI Fdn, Turin, Italy	Universidade Federal do Rio de Janeiro; University of Zaragoza; University of Zaragoza	Hernandez, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.	elchechi@gmail.com	Brigatti, Edgardo/ABD-4541-2021; Hernández, Alexis/GPG-2009-2022; Moreno, Yamir/A-1076-2009; Gracia-Lázaro, Carlos/K-9334-2014; Hernández, Alexis R/H-1631-2012; Brigatti, Edgardo/AAT-6945-2020	Hernández, Alexis/0000-0001-7242-5057; Moreno, Yamir/0000-0002-0895-1893; Gracia-Lázaro, Carlos/0000-0002-9769-8796; Hernández, Alexis R/0000-0001-7242-5057; Brigatti, Edgardo/0000-0002-2981-3270	Government of Aragon Spain [E3617R]; MINECO fund [FIS2017-87519P]; FEDER fund [FIS2017-87519P]; Intesa Sanpaolo Innovation Center	Government of Aragon Spain(Gobierno de Aragon); MINECO fund; FEDER fund; Intesa Sanpaolo Innovation Center	C. G-L and Y.M. acknowledge partial support from the Government of Aragon Spain through a grant to the group FENOL (E3617R: https://www.aragon.es/Departamentos OrganismosPublicos/Departamentos/InnovacionInvestigacionUniversidad), and by MINECO and FEDER funds (grant FIS2017-87519P: http://www.ciencia.gob.es/portal/site/MICINN? lang_choosen=en). Y.M. also acknowledges partial support by Intesa Sanpaolo Innovation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Chadwick, 2006, INTERNET POLITICS ST; Aurtenechea S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, PROCEEDINGS, VOLS 1-8, P901, DOI 10.1109/ISIE.2007.4374717; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boldi P, 2011, COMMUN ACM, V54, P129, DOI 10.1145/1953122.1953154; Boldi Paolo, 2009, P 18 ACM C INF KNOWL, P777, DOI DOI 10.1145/1645953.1646052; Condorcet MJ, 1785, ESSAI APPL ANAL LIFE, DOI [10.3931/e-rara-3791, DOI 10.3931/E-RARA-3791]; ERDOS P, 1960, B INT STATIST INST, V38, P343; Hernandez AR, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172265; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Katz Richard S., 1997, DEMOCRACY ELECTIONS; KELLY JS, 1991, SOC CHOICE WELFARE, V8, P97; Leskovec J., 2014, SNAP DATASETS STANFO; Rozemberczki B, 2018, GEMSEC GRAPH EMBEDDI; Scott Hindman Matthew, 2009, MYTH DIGITAL DEMOCRA; Shane Peter M., 2004, DEMOCRACY ONLINE PRO; Simone Noveck Beth, 2009, WIKI GOVT TECHNOLOGY; Stephen Coleman, 2009, INTERNET DEMOCRATIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yamakawa Hiroshi, 2007, INT J HUMAN SOCIAL S, V1; Yang J., 2012, ARXIV12056233	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222945	10.1371/journal.pone.0222945	http://dx.doi.org/10.1371/journal.pone.0222945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557209	Green Published, Green Submitted, gold			2022-12-26	WOS:000532345500049
J	Vennemann, B; Obrist, D; Rosgen, T				Vennemann, Bernhard; Obrist, Dominik; Rosgen, Thomas			Automated diagnosis of heart valve degradation using novelty detection algorithms and machine learning	PLOS ONE			English	Article							WAVELET PACKET DECOMPOSITION; PRINCIPAL COMPONENT ANALYSIS; ARTIFICIAL NEURAL-NETWORK; HIDDEN MARKOV MODEL; FUZZY K-NN; SOUND CLASSIFICATION; IMMUNE-SYSTEM; SUPPORT; DISEASE; MANAGEMENT	The blood flow through the major vessels holds great diagnostic potential for the identification of cardiovascular complications and is therefore routinely assessed with current diagnostic modalities. Heart valves are subject to high hydrodynamic loads which render them prone to premature degradation. Failing native aortic valves are routinely replaced with bio-prosthetic heart valves. This type of prosthesis is limited by a durability that is often less than the patient's life expectancy. Frequent assessment of valvular function can therefore help to ensure good long-term outcomes and to plan reinterventions. In this article, we describe how unsupervised novelty detection algorithms can be used to automate the interpretation of blood flow data to improve outcomes through early detection of adverse cardiovascular events without requiring repeated check-ups in a clinical environment. The proposed method was tested in an in-vitro flow loop which allowed simulating a failing aortic valve in a laboratory setting. Aortic regurgitation of increasing severity was deliberately introduced with tube-shaped inserts, preventing complete valve closure during diastole. Blood flow recordings from a flow meter at the location of the ascending aorta were analyzed with the algorithms introduced in this article and a diagnostic index was defined that reflects the severity of valvular degradation. The results indicate that the proposed methodology offers a high sensitivity towards pathological changes of valvular function and that it is capable of automatically identifying valvular degradation. Such methods may be a step towards computer-assisted diagnostics and telemedicine that provide the clinician with novel tools to improve patient care.	[Vennemann, Bernhard; Rosgen, Thomas] Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland; [Vennemann, Bernhard; Obrist, Dominik] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Vennemann, B (corresponding author), Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland.; Vennemann, B (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	bvennema@ethz.ch	Obrist, Dominik/AAT-3254-2020	Obrist, Dominik/0000-0002-6062-9076				Andrisevic N, 2005, J BIOMECH ENG-T ASME, V127, P899, DOI 10.1115/1.2049327; Avci E, 2009, EXPERT SYST APPL, V36, P10618, DOI 10.1016/j.eswa.2009.02.053; Babaei S, 2009, COMPUT BIOL MED, V39, P8, DOI 10.1016/j.compbiomed.2008.10.004; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bouril A, 2017, COMP CARD C CINC; Bozkurt B, 2018, COMPUT BIOL MED, V100, P132, DOI 10.1016/j.compbiomed.2018.06.026; Carabello BA, 2012, GOLDMANS CECIL MED, P453, DOI [10.1007/s10439-017-1790-z, DOI 10.1007/S10439-017-1790-Z]; Choi S, 2008, EXPERT SYST APPL, V35, P1679, DOI 10.1016/j.eswa.2007.08.078; Comak E, 2007, COMPUT BIOL MED, V37, P21, DOI 10.1016/j.compbiomed.2005.11.002; Comak E, 2012, J MED SYST, V36, P549, DOI 10.1007/s10916-010-9500-5; Das R, 2010, EXPERT SYST APPL, V107, P592; Das R, 2009, COMPUT METH PROG BIO, V93, P185, DOI 10.1016/j.cmpb.2008.09.005; Deperlioglu O, 2018, BRAIN-BROAD RES ARTI, V9, P22; Dominguez-Morales JP, 2018, IEEE T BIOMED CIRC S, V12, P24, DOI 10.1109/TBCAS.2017.2751545; El-Ramsisi AM, 2007, J APPL SCI, V163, P145; Geron A, 2017, HANDS ON MACHINE LEA; Gharehbaghi A, 2015, MED ENG PHYS, V37, P674, DOI 10.1016/j.medengphy.2015.04.013; GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709; Grunkemeier GL, 1998, J HEART VALVE DIS, V7, P163; Gupta CN, 2007, APPL SOFT COMPUT J, V4, P4251; Koydemir HC, 2018, ANNU REV ANAL CHEM, V11, P127, DOI 10.1146/annurev-anchem-061417-125956; Latif S, 2018, IEEE SENS J, V18, P9393, DOI 10.1109/JSEN.2018.2870759; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Low JX, 2018, P 2018 INT C COMM EN, P18; Maglogiannis I, 2009, COMPUT METH PROG BIO, V95, P47, DOI 10.1016/j.cmpb.2009.01.003; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Nassralla M, 2017, INT C ADV BIOM ENG I; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Noman F, 2019, INT CONF ACOUST SPEE, P1318, DOI 10.1109/ICASSP.2019.8682668; Okafor I, 2017, ANN BIOMED ENG, V45, P1305, DOI 10.1007/s10439-017-1790-z; Ozcan A, 2014, LAB CHIP, V14, P3187, DOI 10.1039/c4lc00010b; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Redlarski G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112673; Reed TR, 2004, SIMUL MODEL PRACT TH, V12, P129, DOI 10.1016/j.simpat.2003.11.005; Rodriguez-Gabella T, 2017, J AM COLL CARDIOL, V70, P1013, DOI 10.1016/j.jacc.2017.07.715; Rubin J, 2017, CEUR WORKSHOP P; Rubin J, 2017, COMP CARD C CINC; Safara F, 2013, COMPUT BIOL MED, V43, P1407, DOI 10.1016/j.compbiomed.2013.06.016; Saracoglu R, 2012, ENG APPL ARTIF INTEL, V25, P1523, DOI 10.1016/j.engappai.2012.07.005; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Sengur A, 2008, EXPERT SYST APPL, V35, P1011, DOI 10.1016/j.eswa.2007.08.003; Sengur A, 2008, EXPERT SYST APPL, V35, P214, DOI 10.1016/j.eswa.2007.06.012; Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004; Sengur A, 2012, J MED SYST, V36, P2649, DOI 10.1007/s10916-011-9740-z; Sinha RK, 2007, J MED SYST, V31, P205, DOI 10.1007/s10916-007-9056-1; Sujadevi VG, 2019, ADV INTELL SYS COMPU, P711; Turkoglu I, 2003, COMPUT BIOL MED, V33, P319, DOI 10.1016/S0010-4825(03)00002-7; Uguz H, 2007, PATTERN RECOGN LETT, V28, P395, DOI 10.1016/j.patrec.2006.08.009; Uguz H, 2012, J MED SYST, V36, P61, DOI 10.1007/s10916-010-9446-7; Vashist Sandeep Kumar, 2014, Anal Bioanal Chem, V406, P3263, DOI 10.1007/s00216-013-7473-1; Vennemann B., 2019, WIRELESS BLOOD FLOW; Vennemann B, 2018, ASAIO J, V64, P651, DOI 10.1097/MAT.0000000000000687; Wang P, 2007, ANN BIOMED ENG, V35, P367, DOI 10.1007/s10439-006-9232-3; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112; Yaseen, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122344; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Zabihi M, 2017, COMP CARD C CINC, DOI [10.1016/j.compbiomed.2018.06.026, DOI 10.1016/J.COMPBIOMED.2018.06.026]	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222983	10.1371/journal.pone.0222983	http://dx.doi.org/10.1371/journal.pone.0222983			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557196	Green Published, gold			2022-12-26	WOS:000532345500054
J	Watanabe, T; Honma, R; Kojima, M; Nomura, S; Furukawa, S; Soeda, S; Watanabe, S; Fujimori, K				Watanabe, Takafumi; Honma, Reiko; Kojima, Manabu; Nomura, Shinji; Furukawa, Shigenori; Soeda, Shu; Watanabe, Shinya; Fujimori, Keiya			Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; VASCULAR INVASION; PROGNOSTIC-FACTOR; RISK-FACTOR; CARCINOMA; INVOLVEMENT; RECURRENCE; PATTERNS; THERAPY; CELLS	Lymphovascular space invasion (LVSI) is considered to be the beginning of lymphogenous and hematogenous metastases. It is strongly related to dissemination, and therefore could be a valuable predictive sign of lymph node metastases and distant spread. Recently, the presence of LVSI in endometrial cancer (EC) has been shown to be an independent prognostic factor. The preoperative diagnosis of LVSI by pathological examination is difficult and LVSI is detected after surgery. The aim of the current study was to explore candidate genes as potential diagnostic biomarkers and determine whether they are predictors of LVSI in patients with EC. A total of 88 surgical specimens obtained from EC patients who had undergone surgical resection at Fukushima Medical University Hospital between 2010 and 2015 were analyzed using DNA microarray. LVSI was significantly associated with poor prognostic factors in EC such as higher tumor grade, lymph node metastasis, deep myometrium invasion, advanced stage and recurrence. Fifty-five candidate genes were significantly differentially expressed between 26 LVSI-positive and 62 LVSI-negative samples. All 88 samples were divided into two groups according to hierarchical clustering of 55 genes. Regarding diagnostic accuracy, sensitivity and negative predictive value were both high (92% and 95%, respectively); further, specificity and positive predictive value were both moderate (63% and 71%, respectively). Our data suggests that the 55-gene signature could contribute to predicting LVSI in EC, and provide clinically important information for better management. The molecular signatures of 55 genes may be also useful for understanding the underlying mechanism of LVSI.	[Watanabe, Takafumi; Kojima, Manabu; Nomura, Shinji; Furukawa, Shigenori; Soeda, Shu; Fujimori, Keiya] Fukushima Med Univ, Sch Med, Dept Obstet & Gynecol, Fukushima, Japan; [Honma, Reiko] Nippon Gene Co Ltd, Chiyoda Ku, Tokyo, Japan; [Watanabe, Shinya] Fukushima Med Univ, Sch Med, Med Ind Translat Res Ctr, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Watanabe, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Obstet & Gynecol, Fukushima, Japan.	t-wata@fmu.ac.jp			Nippon Gene Co., Ltd.	Nippon Gene Co., Ltd.	The Nippon Gene Co., Ltd. provided support in the form of salary for one of the authors [RH], but did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleskandarany MA, 2015, PATHOBIOLOGY, V82, P113, DOI 10.1159/000433583; Bosse T, 2015, EUR J CANCER, V51, P1742, DOI 10.1016/j.ejca.2015.05.015; Briet JM, 2005, GYNECOL ONCOL, V96, P799, DOI 10.1016/j.ygyno.2004.11.033; Cohn DE, 2002, GYNECOL ONCOL, V87, P243, DOI 10.1006/gyno.2002.6825; Colas E, 2011, INT J CANCER, V129, P2435, DOI 10.1002/ijc.25901; Creasman W T, 2001, J Epidemiol Biostat, V6, P47; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; dos Reis R, 2015, INT J GYNECOL CANCER, V25, P1292, DOI 10.1097/IGC.0000000000000490; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gu X, 2015, ONCOTARGET, V6, P20661, DOI 10.18632/oncotarget.3861; Guntupalli SR, 2012, GYNECOL ONCOL, V124, P31, DOI 10.1016/j.ygyno.2011.09.017; Kamal M, 2015, ANTICANCER RES, V35, P4053; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Koskas M, 2013, GYNECOL ONCOL, V129, P292, DOI 10.1016/j.ygyno.2013.02.027; Kuroda T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08014-w; Lawrenson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130909; Mannelqvist M, 2011, AM J PATHOL, V178, P861, DOI 10.1016/j.ajpath.2010.10.040; Mhawech-Fauceglia P, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015415, 10.1371/journal.pone.0015415.s001]; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; Miura A, 2006, FEBS LETT, V580, P6871, DOI 10.1016/j.febslet.2006.11.041; Mohammed RAA, 2007, AM J SURG PATHOL, V31, P1825, DOI 10.1097/PAS.0b013e31806841f6; Nofech-Mozes S, 2008, AM J CLIN PATHOL, V129, P912, DOI 10.1309/CP3HGX7H753QQU8T; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Press JZ, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/578490; Risinger JI, 2003, CANCER RES, V63, P6; Lino-Silva LS, 2013, CLIN TRANSL ONCOL, V15, P243, DOI 10.1007/s12094-012-0906-z; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tada T, 2017, INT J ONCOL, V51, P877, DOI 10.3892/ijo.2017.4075; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Yoshida E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14418-5; Zhou XC, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e11; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	33	4	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223178	10.1371/journal.pone.0223178	http://dx.doi.org/10.1371/journal.pone.0223178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557240	gold, Green Published			2022-12-26	WOS:000532345500086
J	Salcher, S; Spoden, G; Hagenbuchner, J; Fuhrer, S; Kaserer, T; Tollinger, M; Huber-Cantonati, P; Gruber, T; Schuster, D; Gust, R; Zwierzina, H; Muller, T; Kiechl-Kohlendorfer, U; Ausserlechner, MJ; Obexer, P				Salcher, Stefan; Spoden, Gilles; Hagenbuchner, Judith; Fuehrer, Sebastian; Kaserer, Teresa; Tollinger, Martin; Huber-Cantonati, Petra; Gruber, Thomas; Schuster, Daniela; Gust, Ronald; Zwierzina, Heinz; Mueller, Thomas; Kiechl-Kohlendorfer, Ursula; Ausserlechner, Michael J.; Obexer, Petra			A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; NEURONAL APOPTOSIS; CELLS; CANCER; EXPRESSION; RESISTANCE; AXIS; DIFFERENTIATION; INDUCTION; REPRESSION	The transcription factor FOXO3 has been associated in different tumor entities with hallmarks of cancer, including metastasis, tumor angiogenesis, maintenance of tumor-initiating stem cells, and drug resistance. In neuroblastoma (NB), we recently demonstrated that nuclear FOXO3 promotes tumor angiogenesis in vivo and chemoresistance in vitro. Hence, inhibiting the transcriptional activity of FOXO3 is a promising therapeutic strategy. However, as no FOXO3 inhibitor is clinically available to date, we used a medium-throughput fluorescence polarization assay (FPA) screening in a drug-repositioning approach to identify compounds that bind to the FOXO3-DNA-binding-domain (DBD). Carbenoxolone (CBX), a glycyrrhetinic acid derivative, was identified as a potential FOXO3-inhibitory compound that binds to the FOXO3-DBD with a binding affinity of 19 mu M. Specific interaction of CBX with the FOXO3-DBD was validated by fluorescence-based electrophoretic mobility shift assay (FAM-EMSA). CBX inhibits the transcriptional activity of FOXO3 target genes, as determined by chromatin immunoprecipitation (ChIP), DEPP-, and BIM promoter reporter assays, and real-time RT-PCR analyses. In high-stage NB cells with functional TP53, FOXO3 triggers the expression of SESN3, which increases chemoprotection and cell survival. Importantly, FOXO3 inhibition by CBX treatment at pharmacologically relevant concentrations efficiently repressed FOXO3-mediated SESN3 expression and clonogenic survival and sensitized high-stage NB cells to chemotherapy in a 2D and 3D culture model. Thus, CBX might be a promising novel candidate for the treatment of therapy-resistant high-stage NB and other "FOXO-resistant" cancers.	[Salcher, Stefan; Hagenbuchner, Judith; Kiechl-Kohlendorfer, Ursula; Obexer, Petra] Med Univ Innsbruck, Dept Pediat 2, Innsbruck, Austria; [Salcher, Stefan; Spoden, Gilles; Huber-Cantonati, Petra; Obexer, Petra] Tyrolean Canc Res Inst, Innsbruck, Austria; [Fuehrer, Sebastian; Tollinger, Martin] Univ Innsbruck, CMBI, Inst Organ Chem, Innsbruck, Austria; [Kaserer, Teresa; Schuster, Daniela; Gust, Ronald] Univ Innsbruck, CMBI, Inst Pharm Pharmaceut Chem, Innsbruck, Austria; [Gruber, Thomas] Med Univ Innsbruck, Div Translat Cell Genet, Innsbruck, Austria; [Schuster, Daniela] Paracelsus Med Univ Salzburg, Inst Pharm, Dept Pharmaceut & Med Chem, Salzburg, Austria; [Zwierzina, Heinz] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria; [Mueller, Thomas; Ausserlechner, Michael J.] Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; Paracelsus Private Medical University; Medical University of Innsbruck; Medical University of Innsbruck	Obexer, P (corresponding author), Med Univ Innsbruck, Dept Pediat 2, Innsbruck, Austria.; Obexer, P (corresponding author), Tyrolean Canc Res Inst, Innsbruck, Austria.; Ausserlechner, MJ (corresponding author), Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria.	Michael.J.Ausserlechner@i-med.ac.at; Petra.Obexer@i-med.ac.at	Führer, Sebastian/AAG-2389-2021; Tollinger, Martin/E-5896-2011; Schuster, Daniela/C-1024-2014	Führer, Sebastian/0000-0002-6523-1307; Tollinger, Martin/0000-0002-2177-983X; Schuster, Daniela/0000-0002-9933-8938; Gruber, Thomas/0000-0002-5796-7090; Hagenbuchner, Judith/0000-0003-1396-3407; Salcher, Stefan/0000-0003-2391-6954; Ausserlechner, Michael/0000-0002-1015-2302; Kaserer, Teresa/0000-0003-0372-1885	COMET center of excellence ONCOTYROL; Kinderkrebshilfe fur Tirol und Vorarlberg; Sudtiroler Krebshilfe; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen-Initiative; MFF-Tirol [296, 208]; Tirol-Kliniken GmbH; Tyrolean Cancer Society;  [FWF-I3089-B28]	COMET center of excellence ONCOTYROL; Kinderkrebshilfe fur Tirol und Vorarlberg; Sudtiroler Krebshilfe; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen-Initiative; MFF-Tirol; Tirol-Kliniken GmbH; Tyrolean Cancer Society; 	We thank Andreas Villunger, Domenico Accili, and Joan Massague for providing plasmids. This work was supported by grants by the COMET center of excellence ONCOTYROL, by the "Kinderkrebshilfe fur Tirol und Vorarlberg", the "Sudtiroler Krebshilfe", the "Kinderkrebshilfe Sudtirol-Regenbogen", the "SVP-Frauen-Initiative", the "MFF-Tirol (Project Nr. 296 and 208)", and the FWF-I3089-B28. The Tyrolean Cancer Research Institute and this study are supported by the "Tirol-Kliniken GmbH" and the "Tyrolean Cancer Society".	Arrozi AP, 2017, APPL BIOCHEM BIOTECH, V183, P853, DOI 10.1007/s12010-017-2468-6; Ausserlechner MJ, 2012, NEUROBLASTOMA PRESEN, P325; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; BARON JH, 1978, GUT, V19, P330, DOI 10.1136/gut.19.4.330; BERTACCINI G, 1985, DIGEST DIS SCI, V30, pS43, DOI 10.1007/BF01309384; Bingel C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.398; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; de Brachene AC, 2016, CELL MOL LIFE SCI, V73, P1159, DOI 10.1007/s00018-015-2112-y; Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550; Du YH, 2006, J BIOMOL SCREEN, V11, P269, DOI 10.1177/1087057105284862; Du Yuhong, 2008, Curr Chem Genomics, V2, P40, DOI 10.2174/1875397300802010040; Grignani F, 1998, CANCER RES, V58, P14; GROSS N, 1992, INT J CANCER, V52, P85, DOI 10.1002/ijc.2910520116; Hagenbuchner Judith, 2016, Oncotarget, V7, P77591, DOI 10.18632/oncotarget.12728; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hou J, 2015, LUMINESCENCE, V30, P780, DOI 10.1002/bio.2820; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Jiang JX, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0094-8; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Karki S, 2015, ARTERIOSCL THROM VAS, V35, P1498, DOI 10.1161/ATVBAHA.114.305139; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kumazoe M, 2017, ONCOGENE, V36, P2643, DOI 10.1038/onc.2016.426; Kumazoe M, 2017, J BIOL CHEM, V292, P10813, DOI 10.1074/jbc.M116.772111; Li DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132998; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Maiese Kenneth, 2016, J Transl Sci, V2, P241; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matkar S, 2015, CANCER CELL, V28, P472, DOI 10.1016/j.ccell.2015.09.005; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moosavi MA, 2011, DARU, V19, P455; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Naka K, 2010, CANCER SCI, V101, P1577, DOI 10.1111/j.1349-7006.2010.01584.x; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Narath R, 2005, CYTOM PART A, V68A, P113, DOI 10.1002/cyto.a.20190; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; O'Carroll SJ, 2013, METHODS MOL BIOL, V1037, P519, DOI 10.1007/978-1-62703-505-7_31; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Obsil T, 2011, BBA-MOL CELL RES, V1813, P1946, DOI 10.1016/j.bbamcr.2010.11.025; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pan CW, 2017, EMBO J, V36, P995, DOI 10.15252/embj.201695534; Pellicano F, 2014, STEM CELLS, V32, P2324, DOI 10.1002/stem.1748; Qian ZR, 2017, INT J CANCER, V140, P2792, DOI 10.1002/ijc.30690; Qin WP, 2008, ANN NY ACAD SCI, V1147, P335, DOI 10.1196/annals.1427.024; Rupp M, 2017, ONCOGENE, V36, P6190, DOI 10.1038/onc.2017.288; Saha P, 2015, MOL CELL NEUROSCI, V68, P203, DOI 10.1016/j.mcn.2015.08.002; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Sanna PP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.13; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Shi C, 2016, J BIOENERG BIOMEMBR, V48, P189, DOI 10.1007/s10863-016-9645-0; Shi C, 2016, J CELL SCI, V129, P1815, DOI 10.1242/jcs.185009; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tan P, 2015, SCI REP, V5; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van Boxtel R, 2013, CELL DEATH DIFFER, V20, P1219, DOI 10.1038/cdd.2013.81; Wilson MSC, 2011, CURR DRUG TARGETS, V12, P1256; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Xu K, 2017, ONCOL REP, V37, P2391, DOI 10.3892/or.2017.5459; Yoo KY, 2012, NEUROCHEM RES, V37, P588, DOI 10.1007/s11064-011-0648-2; Yu YY, 2016, ONCOTARGET, V7, P80888, DOI 10.18632/oncotarget.13105; Yulyana Y, 2013, STEM CELLS DEV, V22, P1870, DOI 10.1089/scd.2012.0529; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhou LQ, 2018, MOL MED REP, V17, P5684, DOI 10.3892/mmr.2018.8624; Zhou YP, 2018, IUBMB LIFE, V70, P276, DOI 10.1002/iub.1699; Zou P, 2014, CELL CYCLE, V13, P3759, DOI 10.4161/15384101.2014.965977	80	17	19	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1080	1097		10.1038/s41388-019-1044-7	http://dx.doi.org/10.1038/s41388-019-1044-7			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591479	hybrid, Green Published			2022-12-26	WOS:000511209700010
J	Singh, K; Pruski, MA; Polireddy, K; Jones, NC; Chen, QZ; Yao, J; Dar, WA; McAllister, F; Ju, C; Eltzschig, HK; Younes, M; Moran, C; Karmouty-Quintana, H; Ying, HQ; Bailey, JM				Singh, Kanchan; Pruski, Melissa A.; Polireddy, Kishore; Jones, Neal C.; Chen, Qingzheng; Yao, Jun; Dar, Wasim A.; McAllister, Florencia; Ju, Cynthia; Eltzschig, Holger K.; Younes, Mamoun; Moran, Cesar; Karmouty-Quintana, Harry; Ying, Haoqiang; Bailey, Jennifer M.			Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer	ONCOGENE			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-ASSOCIATED MACROPHAGES; HIPPO SIGNALING PATHWAY; ONCOGENIC KRAS; CLINICAL-IMPLICATIONS; MOUSE MODELS; GROWTH; YAP; MUTATIONS; PROLIFERATION	Non-small cell lung cancer remains a highly lethal malignancy. Using the tamoxifen inducible Hnf1b:CreER(T2) (H) transgenic mouse crossed to the LsL-Kras(G12D) (K) transgenic mouse, we recently discovered that an Hnf1b positive cell type in the lung is sensitive to adenoma formation when expressing a mutant Kras(G12D) allele. In these mice, we observe adenoma formation over a time frame of three to six months. To study specificity of the inducible Hnf1b:CreER(T2) in the lung, we employed lineage tracing using an mTmG (G) reporter allele. This technique revealed recombined, GFP+ cells were predominantly SPC+. We further employed this technique in HKG mice to determine Hnf1b+ cells give rise to adenomas that express SPC and TTF1. Review of murine lung tissue confirmed a diagnosis of adenoma and early adenocarcinoma, a pathologic subtype of non-small cell lung cancer. Our expanded mouse model revealed loss of Mst1/2 promotes aggressive lung adenocarcinoma and large-scale proteomic analysis revealed upregulation of PKM2 in the lungs of mice with genetic deletion of Mst1/2. PKM2 is a known metabolic regulator in proliferating cells and cancer. Using a human lung adenocarcinoma cell line, we show pharmacologic inhibition of Mst1/2 increases the abundance of PKM2, indicating genetic loss or pharmacologic inhibition of Mst1/2 directly modulates the abundance of PKM2. In conclusion, here we report a novel model of non-small cell lung cancer driven by a mutation in Kras and deletion of Mst1/2 kinases. Tumor development is restricted to a subset of alveolar type II cells expressing Hnf1b. Our data show loss of Mst1/2 regulates levels of a potent metabolic regulator, PKM2.	[Singh, Kanchan; Pruski, Melissa A.; Polireddy, Kishore; Jones, Neal C.; Chen, Qingzheng; Bailey, Jennifer M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Yao, Jun; Ying, Haoqiang] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Dar, Wasim A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA; [McAllister, Florencia] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Ju, Cynthia; Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA; [Younes, Mamoun] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pathol, Houston, TX 77030 USA; [Moran, Cesar] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Karmouty-Quintana, Harry] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Bailey, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	Jennifer.M.Bailey@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020; Ying, Haoqiang/AAK-4325-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Dar, Wasim/0000-0001-8095-248X; Bailey-Lundberg, Jennifer/0000-0002-4750-106X; Younes, Mamoun/0000-0001-9618-3451	AACR/Pancreatic Cancer Action Network Pathway to Leadership Award; NIH [T35 DK007676-22]; National Institute of Health Grants [R01 DK097075, POI-HL114457, R01-HL109233, R01-DK109574, R01-HL119837, R01-HL133900]	AACR/Pancreatic Cancer Action Network Pathway to Leadership Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Bingqian Hu and Junlan Zhang for assistance with lung perfusions. We also thank Naveen Manisundaram for intellectual insights and discussions. JMB is supported by the AACR/Pancreatic Cancer Action Network Pathway to Leadership Award. NCJ is supported by NIH T35 DK007676-22. HKE is supported by National Institute of Health Grants R01 DK097075, POI-HL114457, R01-HL109233, R01-DK109574, R01-HL119837, and R01-HL133900.	Abdulkareem FB, 2012, HISTOPATHOLOGY, V61, P74; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; [Anonymous], CURR PROTOC PHARM; Bailey JM, 2016, ONCOGENE, V35, P4282, DOI 10.1038/onc.2015.441; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen HY, 2015, J CLIN ONCOL, V33, P2303, DOI 10.1200/JCO.2014.59.3590; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Ciuffreda L, 2014, CURR PHARM DESIGN, V20, P3944, DOI 10.2174/13816128113196660763; Clarke CN, 2017, ANN SURG ONCOL, V24, P4051, DOI 10.1245/s10434-017-6054-5; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Creighton CJ, 2015, DRUG DES DEV THER, V9, P3519, DOI 10.2147/DDDT.S38375; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Dong GC, 2016, ONCOL LETT, V11, P1980, DOI 10.3892/ol.2016.4168; Du Di, 2018, Oncotarget, V9, P19704, DOI 10.18632/oncotarget.24803; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; Fritz JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00587; Gao YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5629; Gomez Daniel Richard, 2018, Oncotarget, V9, P14268, DOI 10.18632/oncotarget.24361; Guo LW, 2015, INT J ONCOL, V46, P1444, DOI 10.3892/ijo.2015.2877; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong H, 2019, CANCER RES, V79, P795, DOI 10.1158/0008-5472.CAN-18-2545; Johansson Leif, 2004, Ann Diagn Pathol, V8, P259, DOI 10.1016/j.anndiagpath.2004.07.001; Ju R, 2012, EUR J CANCER, V48, P1085, DOI 10.1016/j.ejca.2011.06.050; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim HB, 2018, BMB REP, V51, P119, DOI 10.5483/BMBRep.2018.51.3.018; Kimmelman AC, 2015, CLIN CANCER RES, V21, P1828, DOI 10.1158/1078-0432.CCR-14-2425; Kwak I, 2004, ANNU REV PHYSIOL, V66, P647, DOI 10.1146/annurev.physiol.66.032102.134301; Li H, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.04.001; Li RZ, 2018, CHEM BIOL DRUG DES, V92, P1851, DOI 10.1111/cbdd.13354; Liu VM, 2015, BRAIN PATHOL, V25, P781, DOI 10.1111/bpa.12311; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Ma YL, 2015, INT J CANCER, V137, P2275, DOI 10.1002/ijc.29073; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; MILLER MS, 1994, CHEM RES TOXICOL, V7, P471, DOI 10.1021/tx00040a001; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Polireddy K, 2019, CANCER LETT, V453, P122, DOI 10.1016/j.canlet.2019.03.047; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rizvi S, 2016, J BIOL CHEM, V291, P8031, DOI 10.1074/jbc.M115.698472; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schneider J, 2003, CANCER LETT, V193, P91, DOI 10.1016/S0304-3835(02)00720-6; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Teoh SL, 2017, CURR DRUG TARGETS, V18, P1880, DOI 10.2174/1389450117666160907153338; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Vasan N, 2014, CLIN CANCER RES, V20, P3921, DOI 10.1158/1078-0432.CCR-13-1762; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu CM, 2013, CANCER GENE THER, V20, P453, DOI 10.1038/cgt.2013.40; Xu Chen, 2012, Chinese Journal of Pathology, V41, P667, DOI 10.3760/cma.j.issn.0529-5807.2012.10.005; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Ye S, 2016, PHARMACOL RES, V103, P270, DOI 10.1016/j.phrs.2015.11.025; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626; Zou SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6696	73	10	11	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1152	1164		10.1038/s41388-019-1031-z	http://dx.doi.org/10.1038/s41388-019-1031-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31570790				2022-12-26	WOS:000511209700015
J	Jouvene, CC; Shay, AE; Soens, MA; Norris, PC; Haeggstrom, JZ; Serhan, CN				Jouvene, Charlotte C.; Shay, Ashley E.; Soens, Mieke A.; Norris, Paul C.; Haeggstrom, Jesper Z.; Serhan, Charles N.			Biosynthetic metabolomes of cysteinyl-containing immunoresolvents	FASEB JOURNAL			English	Article						maresin; protectin; resolvin; resolution; inflammation	PRO-RESOLVING MEDIATORS; TISSUE-REGENERATIVE RESOLVIN; FATTY-ACID SUPPLEMENTATION; GLUTATHIONE-S-TRANSFERASE; LIPID MEDIATORS; DOUBLE-BLIND; RESOLUTION; D1; INFLAMMATION; N-3	Resolution of inflammation is an active process regulated by specialized proresolving mediators where we identified 3 new pathways producing allylic epoxide derived mediators that stimulate regeneration [i.e., peptido-conjugates in tissue regeneration (CTRs)]. Here, using self-limited Escherichia coli peritonitis in mice, we identified endogenous maresin (MaR) CTR (MCTR), protectin (PD) CTR (PCTR), and resolvin CTR in infectious peritoneal exudates and distal spleens, as well as investigated enzymes involved in their biosynthesis. PCTRs were identified to be temporally regulated in peritoneal exudates and spleens. PCTR1 and MCTR1 were each produced by human recombinant leukotriene (LT) C-4 synthase (LTC4S) and glutathione S-transferases (GSTs) [microsomal GST (mGST)2, mGST3, and GST-mu(GSTM)4] from their epoxide precursors [16S,17S-epoxy-PD (ePD) and 13S,14-Sepoxy-MaR (eMaR)1, with preference for GSTM4. Both eMaR and ePD inhibited LTB4 production by LTA(4) hydrolase. LTC4S, mGST2, mGST3, and GSTM4 were each expressed in human M1- and M2-like macrophages where LTC4S inhibition increased CTRs. Finally, PCTR1 showed potent analgesic action. These results demonstrate CTR biosynthesis in mouse peritonitis, human spleens, and human macrophages, as well as identification of key enzymes in these pathways. Moreover, targeting LTC4S increases CTR metabolomes, giving a new strategy to stimulate resolution and tissue regeneration.	[Jouvene, Charlotte C.; Shay, Ashley E.; Soens, Mieke A.; Norris, Paul C.; Serhan, Charles N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 60 Fenwood Rd,HBTM 3-016, Boston, MA 02115 USA; [Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet	Serhan, CN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 60 Fenwood Rd,HBTM 3-016, Boston, MA 02115 USA.	cserhan@bwh.harvard.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [P01GM095467, 3T32GM007592-40S1]; Swedish Research Council [10350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary Halm Small (Brigham and Women's Hospital) for expert assistance in manuscript preparation. This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants P01GM095467 (to C.N.S.) and 3T32GM007592-40S1 (to M.A.S.), and Swedish Research Council Grant 10350 (to J.Z.H.). The authors declare no conflicts of interest.	Ahmad S, 2013, BIOCHEMISTRY-US, V52, P1755, DOI 10.1021/bi3014104; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Barden AE, 2016, PROSTAG LEUKOTR ESS, V107, P24, DOI 10.1016/j.plefa.2016.03.004; Bhatt L, 2017, SEMIN IMMUNOL, V33, P65, DOI 10.1016/j.smim.2017.08.007; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Chang M, 1987, Arch Biochem Biophys, V259, P536, DOI 10.1016/0003-9861(87)90520-0; Chen G, 2018, NEURON, V100, P1292, DOI 10.1016/j.neuron.2018.11.009; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; COMSTOCK KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P487, DOI 10.1006/abbi.1994.1266; Cox R, 2015, AM J RESP CELL MOL, V53, P422, DOI 10.1165/rcmb.2014-0339OC; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dantes RB, 2018, CLIN INFECT DIS, V67, P1300, DOI 10.1093/cid/ciy342; de la Rosa X, 2018, AM J PATHOL, V188, P950, DOI 10.1016/j.ajpath.2018.01.004; DOHERTY NS, 1987, BRIT J PHARMACOL, V91, P39, DOI 10.1111/j.1476-5381.1987.tb08981.x; Duffney PF, 2018, J CLIN INVEST, V128, P2724, DOI 10.1172/JCI97951; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Gilbert K, 2014, MAR DRUGS, V12, P5396, DOI 10.3390/md12115396; Haeggstrom JZ, 2018, J CLIN INVEST, V128, P2680, DOI 10.1172/JCI97945; Hellmann J, 2018, J INVEST DERMATOL, V138, P2051, DOI 10.1016/j.jid.2018.03.1498; Hong S, 2005, PROSTAG OTH LIPID M, V78, P107, DOI 10.1016/j.prostaglandins.2005.04.004; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Keelan JA, 2015, REPRODUCTION, V149, P171, DOI 10.1530/REP-14-0549; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Kleinschmidt TK, 2015, J PHARMACOL EXP THER, V355, P108, DOI 10.1124/jpet.115.227157; Lee CR, 2015, NEW ENGL J MED, V373, P2183, DOI 10.1056/NEJMcibr1511280; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Mueller MJ, 1998, J BIOL CHEM, V273, P11570, DOI 10.1074/jbc.273.19.11570; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Ono E, 2014, AM J RESP CRIT CARE, V190, P886, DOI 10.1164/rccm.201403-0544OC; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Prieto P, 2015, AUTOPHAGY, V11, P1729, DOI 10.1080/15548627.2015.1078958; Raatz SK, 2011, J AGR FOOD CHEM, V59, P11278, DOI 10.1021/jf202576k; Ramon S, 2016, AM J PATHOL, V186, P962, DOI 10.1016/j.ajpath.2015.12.012; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Robinson DT, 2017, PROSTAG LEUKOTR ESS, V121, P1, DOI 10.1016/j.plefa.2017.05.003; Rodriguez AR, 2017, TETRAHEDRON LETT, V58, P1662, DOI 10.1016/j.tetlet.2017.03.041; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P5811, DOI 10.1016/j.tetlet.2015.09.020; Rossi S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/149381; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; See VHL, 2017, PROSTAG LEUKOTR ESS, V126, P126, DOI 10.1016/j.plefa.2017.08.008; See VHL, 2017, BRIT J NUTR, V118, P971, DOI [10.1017/S0007114517002914, 10.1017/s0007114517002914]; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Ward P. A, 2010, FUNDAMENTALS INFLAMM, P1; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928	67	9	10	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13794	13807		10.1096/fj.201902003R	http://dx.doi.org/10.1096/fj.201902003R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31589826	Green Published, Bronze			2022-12-26	WOS:000507466100058
J	Nascimento, CHV; Webber, LP; Borgato, GB; Goloni-Bertollo, EM; Squarize, CH; Castilho, RM				Nascimento-Filho, Carlos H. V.; Webber, Liana P.; Borgato, Gabriell B.; Goloni-Bertollo, Eny M.; Squarize, Cristiane H.; Castilho, Rogerio M.			Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN	FASEB JOURNAL			English	Article						ROS; mTOR; EMT; epithelial-mesenchymal transition; cancer stem cell	CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; INDUCIBLE FACTOR-1-ALPHA; MAMMALIAN TARGET; PROGNOSTIC VALUE; BREAST-CANCER; EXPRESSION; HEAD; MARKER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is characterized by a fast-paced growth. Like other solid tumors, the HNSCC growth rate results in the development of hypoxic regions identified by the expression of hypoxia-inducible factor 1 alpha (HIF-1 alpha). Interestingly, clinical data have shown that pharmacological induction of intratumoral hypoxia caused an unexpected rise in tumor metastasis and the accumulation of cancer stem cells (CSCs). However, little is known on the molecular circuitries involved in the presence of intratumoral hypoxia and the augmented population of CSCs. Here we explore the impact of hypoxia on the behavior of HNSCC and define that the controlling function of phosphatase and tensin homolog (PTEN) over HIF-1 alpha expression and CSC accumulation are de-regulated during hypoxic events. Our findings indicate that hypoxic niches are poised to accumulate CSCs in a molecular process driven by the loss of PTEN activity. Furthermore, our data suggest that targeted therapies aiming at the PTEN/PI3K signaling may constitute an effective strategy to counteract the development of intratumoral hypoxia and the accumulation of CSCs.	[Nascimento-Filho, Carlos H. V.; Webber, Liana P.; Borgato, Gabriell B.; Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA; [Nascimento-Filho, Carlos H. V.; Goloni-Bertollo, Eny M.] Sch Med Sao Jose Rio Preto, Dept Mol Biol, Genet & Mol Biol Res Unit, Sao Paulo, Brazil; [Webber, Liana P.] Univ Fed Rio Grande do Sul, Sch Dent, Dept Oral Pathol, Porto Alegre, RS, Brazil; [Borgato, Gabriell B.] Univ Estadual Campinas, Sch Dent, Dept Oral Biol, Piracicaba, SP, Brazil; [Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade Federal do Rio Grande do Sul; Universidade Estadual de Campinas; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Univ Michigan, Lab Epithelial Biol, Dept Periodont & Oral Med, 1011 N Univ Ave,Room 2029c, Ann Arbor, MI 48109 USA.	rcastilh@umich.edu	Castilho, Rogerio M/E-4987-2010; do Nascimento Filho, Carlos Viesi/AAR-7766-2021	Castilho, Rogerio M/0000-0001-5358-612X; do Nascimento Filho, Carlos Viesi/0000-0002-6870-2602; Bonifacio Borgato, Gabriell/0000-0003-0798-2484; Squarize, Cristiane/0000-0002-6782-3429; Preto Webber, Liana/0000-0003-1812-5904	Capes Foundation within the Brazilian Ministry of Education [BEX/88881.135014/2016-01 PDSE]; University of Michigan Cancer Center Support Grant [P30 CA046592]; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant [5R01GM120056]; University of Michigan School of Dentistry faculty; Robert Wood Johnson Foundation [AMFDP-72425]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120056] Funding Source: NIH RePORTER	Capes Foundation within the Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Michigan Cancer Center Support Grant; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant; University of Michigan School of Dentistry faculty; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted during a visiting scholar period at the University of Michigan, sponsored by the Capes Foundation within the Brazilian Ministry of Education (Grant BEX/88881.135014/2016-01 PDSE). This work was partially supported by University of Michigan Cancer Center Support Grant P30 CA046592, and by the U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant 5R01GM120056. This grant was funded by the University of Michigan School of Dentistry faculty, and by The Robert Wood Johnson Foundation (AMFDP-72425). The monoclonal antibody AMF-17b, developed by A. B. Fulton, was obtained from the Developmental Studies Hybridoma Bank, created by the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and maintained at The University of Iowa (Iowa City, IA, USA). The authors declare no conflict of interest.	Aebersold DM, 2001, CANCER RES, V61, P2911; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Beasley NJP, 2002, CANCER RES, V62, P2493; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BOUSQUET PF, 1995, CANCER RES, V55, P1176; Brennan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120254; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Choi BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15139-5; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Enomoto K, 2017, J CLIN ENDOCR METAB, V102, P2268, DOI 10.1210/jc.2016-3771; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Feldman R, 2016, HEAD NECK-J SCI SPEC, V38, pE1625, DOI 10.1002/hed.24290; Flores IL, 2016, CLIN SCI, V130, P785, DOI 10.1042/CS20150646; Fukushima S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178064; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giudice FS, 2013, J CARCINOG MUTAGE S5, V5, P003, DOI [10.4172/2157-2518.S5-003., DOI 10.4172/2157-2518.S5-003]; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Ichikawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12841; Ito A, 2015, J STEM CELLS REGEN, V11, pP25; Itoi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047512; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lin CS, 2017, INT J MED SCI, V14, P785, DOI 10.7150/ijms.19512; Linge A, 2016, CLIN CANCER RES, V22, P2639, DOI 10.1158/1078-0432.CCR-15-1990; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Matsumoto CS, 2016, ONCOTARGET, V7, P42393, DOI 10.18632/oncotarget.9877; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Roh JL, 2009, ORAL ONCOL, V45, P63, DOI 10.1016/j.oraloncology.2008.03.017; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Squarize CH, 2013, NEOPLASIA, V15, P461, DOI 10.1593/neo.121024; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Webber LP, 2019, CANCER LETT, V461, P10, DOI 10.1016/j.canlet.2019.06.019; Wu Danli, 2011, J Vis Exp, DOI 10.3791/2899; Zagni C, 2017, STEM CELL REP, V9, P304, DOI 10.1016/j.stemcr.2017.05.006; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhang Y, 2013, STEM CELL RES, V11, P772, DOI 10.1016/j.scr.2013.04.011; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P19655, DOI 10.1073/pnas.0710050104; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	56	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13435	13449		10.1096/fj.201900722R	http://dx.doi.org/10.1096/fj.201900722R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560860	Green Submitted, Bronze, Green Published			2022-12-26	WOS:000507466100032
J	Chun, LY; Silas, MR; Dimitroyannis, RC; Ho, K; Skondra, D				Chun, Lindsay Y.; Silas, Megan R.; Dimitroyannis, Rose C.; Ho, Kimberly; Skondra, Dimitra			Differences in macular capillary parameters between healthy black and white subjects with Optical Coherence Tomography Angiography (OCTA)	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; DIABETIC-RETINOPATHY; VASCULAR DENSITY; RISK-FACTORS; ASSOCIATION; PLEXUSES; ADULTS; CHORIOCAPILLARIS; PREVALENCE; PERFUSION	Purpose To investigate if there are differences in macular capillaries between black and white subjects using optical coherence tomography angiography (OCTA) and identify potential factors underlying the epidemiologically-based higher vulnerability of black populations to diabetic retinopathy (DR). Methods This prospective, observational cross-sectional study included 93 eyes of 47 healthy subjects with no medical history and ocular history who self-identified as black or white and were matched for age, sex, refractive error, and image quality. Subjects underwent OCTA imaging (RTVue-XR Avanti) of the superficial (SCP) and deep (DCP) capillary plexuses and choriocapillaris. AngioAnalytics was used to analyze vessel density (VD) and choriocapillaris% blood flow area (BFA) in the 1mm-diameter fovea, parafovea, and 3mm-diameter circular area including the fovea and parafovea (3x3mm image). Foveal avascular zone (FAZ) was also analyzed. Linear mixed models were used to evaluate for differences between the study groups. Results Compared to the white subjects in this study, black subjects were found to have: lower foveal VD in the SCP (p<0.05); lower VD in the parafovea and in the 3x3mm image in the DCP (p<0.05); larger FAZ in SCP and DCP (p<0.05); and decreased choriocapillary BFA in the area underlying the fovea, parafovea, and 3x3mm image (p<0.05). Conclusion In our study, our black subjects had decreased macular capillary vasculature compared to matched white subjects, even in early adulthood and the absence of any systemic or ocular conditions. To our knowledge, this is the first report showing that retinal and choriocapillary vascular differences may contribute to racial disparities in vulnerability to DR.	[Chun, Lindsay Y.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Chun, Lindsay Y.; Silas, Megan R.; Dimitroyannis, Rose C.; Ho, Kimberly; Skondra, Dimitra] Univ Chicago, Med Ctr, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA; [Dimitroyannis, Rose C.; Ho, Kimberly] Univ Chicago, Chicago, IL 60637 USA; [Skondra, Dimitra] Univ Chicago, Med Ctr, J Terry Ernest Ocular Imaging Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago; University of Chicago Medical Center	Skondra, D (corresponding author), Univ Chicago, Med Ctr, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA.; Skondra, D (corresponding author), Univ Chicago, Med Ctr, J Terry Ernest Ocular Imaging Ctr, Chicago, IL 60637 USA.	Dskondra@bsd.uchicago.edu		Chun, Lindsay/0000-0001-7454-4199	University of Chicago Pritzker School of Medicine (Pritzker Research Fellowship); Illinois Society for the Prevention of Blindness	University of Chicago Pritzker School of Medicine (Pritzker Research Fellowship); Illinois Society for the Prevention of Blindness	LC; No grant number; University of Chicago Pritzker School of Medicine (Pritzker Research Fellowship); https://pritzker.uchicago.edu/page/pritzker-and-northshore-fellowships; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DS; No grant number; Illinois Society for the Prevention of Blindness (Research Grant); http://www.eyehealthillinois.org/researchgrants/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2015, FASEB J, V29, P662, DOI 10.1096/fj.14-255398; Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; Bazvand F, 2017, J GLAUCOMA, V26, P735, DOI 10.1097/IJG.0000000000000722; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20; Coscas F, 2016, INVEST OPHTH VIS SCI, V57, pOCT211, DOI 10.1167/iovs.15-18793; Couturier A, 2015, RETINA-J RET VIT DIS, V35, P2384, DOI 10.1097/IAE.0000000000000859; de Carlo TE, 2012, DETECTION MICROVASCU; Dimitrova G, 2001, EYE, V15, P602, DOI 10.1038/eye.2001.193; Dimitrova G, 2017, INVEST OPHTH VIS SCI, V58, P190, DOI 10.1167/iovs.16-20531; Dumser SM, 2013, DIABETES RES CLIN PR, V101, pE3, DOI 10.1016/j.diabres.2013.03.009; Emanuele N, 2005, DIABETES CARE, V28, P1954, DOI 10.2337/diacare.28.8.1954; Fields B., 2014, RACECRAFT SOUL INEQU; Freiberg FJ, 2016, GRAEF ARCH CLIN EXP, V254, P1051, DOI 10.1007/s00417-015-3148-2; Gao XY, 2014, INVEST OPHTH VIS SCI, V55, P6041, DOI 10.1167/iovs.14-15044; Garrity ST, 2017, INVEST OPHTH VIS SCI, V58, P5548, DOI 10.1167/iovs.17-22036; Hampton BM, 2015, CLIN OPHTHALMOL, V9, P2175, DOI 10.2147/OPTH.S94508; Harris EL, 1999, DIABETES CARE, V22, P779, DOI 10.2337/diacare.22.5.779; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hasegawa N, 2016, INVEST OPHTH VIS SCI, V57, pOCT348, DOI 10.1167/iovs.15-18782; Hassan Muhammad, 2017, Int J Retina Vitreous, V3, P27, DOI 10.1186/s40942-017-0080-0; Hietala K, 2008, DIABETES, V57, P2176, DOI 10.2337/db07-1495; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P1411, DOI 10.1001/jamaophthalmol.2016.4272; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280; Leasher JL, 2016, DIABETES CARE, V39, P1643, DOI 10.2337/dc15-2171; Lee J, 2016, OPHTHALMOLOGY, V123, P2368, DOI 10.1016/j.ophtha.2016.07.010; Leske MC, 2010, REV PANAM SALUD PUBL, V27, P259, DOI 10.1590/S1020-49892010000400004; Leske MC, 2005, OPHTHALMOLOGY, V112, P799, DOI 10.1016/j.ophtha.2004.11.054; Linderman R, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.16; Manalastas PIC, 2017, J GLAUCOMA, V26, P851, DOI 10.1097/IJG.0000000000000768; Mathur R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014444; National Eye Institute, 2010, DIABETIC RETINOPATHY; Nesper PL, 2017, INVEST OPHTH VIS SCI, V58, P307, DOI 10.1167/iovs.17-21787; Rao HL, 2017, J GLAUCOMA, V26, P491, DOI 10.1097/IJG.0000000000000655; Sampson DM, 2017, INVEST OPHTH VIS SCI, V58, P3065, DOI 10.1167/iovs.17-21551; Scarinci F, 2015, JAMA OPHTHALMOL, V133, P1036, DOI 10.1001/jamaophthalmol.2015.2183; Scott AW, 2016, JAMA OPHTHALMOL, V134, P1111, DOI 10.1001/jamaophthalmol.2016.2627; Simonett JM, 2017, ACTA OPHTHALMOL, V95, pe751, DOI 10.1111/aos.13404; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Sohn EH, 2016, P NATL ACAD SCI USA, V113, pE2655, DOI 10.1073/pnas.1522014113; Spanakis EK, 2013, CURR DIABETES REP, V13, P814, DOI 10.1007/s11892-013-0421-9; Sugahara M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46396; Tandon A, 2015, INVEST OPHTH VIS SCI, V56, P3999, DOI 10.1167/iovs.15-16674; Ting DSW, 2017, JAMA OPHTHALMOL, V135, P306, DOI 10.1001/jamaophthalmol.2016.5877; Uhlmann K, 2006, EXP CLIN ENDOCR DIAB, V114, P275, DOI 10.1055/s-2006-924260; US Department of Health and Human Services Office of Minority Health, 2016, DIAB AFR AM; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wang Q, 2016, AM J OPHTHALMOL, V168, P95, DOI 10.1016/j.ajo.2016.05.005; Wang XL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010791; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yiu G, 2016, INVEST OPHTH VIS SCI, V57, P5764, DOI 10.1167/iovs.16-20070; Yu DY, 2007, INVEST OPHTH VIS SCI, V48, P2290, DOI 10.1167/iovs.06-1197; Yu DY, 1999, INVEST OPHTH VIS SCI, V40, P2082; Yu J, 2015, INVEST OPHTH VIS SCI, V56, P3212, DOI 10.1167/iovs.14-16270; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1016/J.58578	65	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223142	10.1371/journal.pone.0223142	http://dx.doi.org/10.1371/journal.pone.0223142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596848	Green Published, gold			2022-12-26	WOS:000532444100020
J	Maina, M; Tosas-Auguet, O; McKnight, J; Zosi, M; Kimemia, G; Mwaniki, P; Schultsz, C; English, M				Maina, Michuki; Tosas-Auguet, Olga; McKnight, Jacob; Zosi, Mathias; Kimemia, Grace; Mwaniki, Paul; Schultsz, Constance; English, Mike			Evaluating the foundations that help avert antimicrobial resistance: Performance of essential water sanitation and hygiene functions in hospitals and requirements for action in Kenya	PLOS ONE			English	Article								Background Water Sanitation and Hygiene (WASH) in healthcare facilities is critical in the provision of safe and quality care. Poor WASH increases hospital-associated infections and contributes to the rise of antimicrobial resistance (AMR). It is therefore essential for governments and hospital managers to know the state of WASH in these facilities to set priorities and allocate resources. Methods Using a recently developed survey tool and scoring approach, we assessed WASH across four domains in 14 public hospitals in Kenya (65 indicators) with specific assessments of individual wards (34 indicators). Aggregate scores were generated for whole facilities and individual wards and used to illustrate performance variation and link findings to specific levels of health system accountability. To help interpret and contextualise these scores, we used data from key informant interviews with hospital managers and health workers. Results Aggregate hospital performance ranged between 47 and 71% with five of the 14 hospitals scoring below 60%. A total of 116 wards were assessed within these facilities. Linked to specific domains, ward scores varied within and across hospitals and ranged between 20% and 80%. At ward level, some critical indicators, which affect AMR like proper waste segregation and hand hygiene compliance activities had pooled aggregate scores of 45 and 35% respectively. From 31 interviews conducted, the main themes that explained this heterogenous performance across facilities and wards included differences in the built environment, resource availability, leadership and the degree to which local managers used innovative approaches to cope with shortages. Conclusion Significant differences and challenges exist in the state of WASH within and across hospitals. Whereas the senior hospital management can make some improvements, input and support from the national and regional governments are essential to improve WASH as a basic foundation for averting nosocomial infections and the spread of AMR as part of safe, quality hospital care in Kenya.	[Maina, Michuki; Zosi, Mathias; Kimemia, Grace; Mwaniki, Paul; English, Mike] KEMRI Wellcome Trust Res Programme, Hlth Serv Res Grp, Nairobi, Kenya; [Maina, Michuki; Schultsz, Constance] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Tosas-Auguet, Olga; McKnight, Jacob; English, Mike] Univ Oxford, Nuffield Dept Med, Oxford, England; [Schultsz, Constance] Amsterdam Inst Global Hlth & Dev Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Oxford	Maina, M (corresponding author), KEMRI Wellcome Trust Res Programme, Hlth Serv Res Grp, Nairobi, Kenya.; Maina, M (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands.	mmaina@kemri-wellcome.org	Maina, Michuki/AAD-4712-2022	English, Michael/0000-0002-7427-0826; Mwaniki, Paul/0000-0003-0359-8426; Maina, Jackson/0000-0001-6874-8929; Kimemia, Grace/0000-0003-0080-6322	Economic and Social Research Council ESRCS [ES/P004938/1]; Wellcome Trust [207522, 107769]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) [DEL-15-003]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; ESRC [ES/P004938/1] Funding Source: UKRI	Economic and Social Research Council ESRCS; Wellcome Trust(Wellcome TrustEuropean Commission); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MM, GK, JM, MZ and OT were supported by funds through a grant from the Economic and Social Research Council ESRCS (ES/P004938/1) awarded to ME. A Senior Research Fellowship awarded to ME by The Wellcome Trust (#207522, https://doi.org/10.35802/207522) supported PM. MM received additional support from a grant to the Initiative to Develop African Research Leaders (IDeAL) through the DELTAS Africa Initiative (DEL-15-003), an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (#107769, https://doi.org/10.35802/107769) and the UK government.	Adams J., 2008, ESSENTIAL ENV HLTH S; Amirabadi Zadeh Hassan, 2015, Glob J Health Sci, V8, P199, DOI 10.5539/gjhs.v8n3p199; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2019, WATER SANITATION HYG; Barasa E, 2018, HEALTH SYST REFORM, V4, P346, DOI 10.1080/23288604.2018.1513267; Desa U, 2016, TRANSF OUR WORLD 203; English M, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0172-1; Health Improvement Scotland, 2021, SAFE MANAGEMENT WAST; Ichoho JW, 2013, IMPLEMENTATION UNPUB; Kolmos Hans Jorn, 2012, INFECT CONTROL UPDAT; Maina M, 2019, EXTENDING USE WHO WA; Ministry of Health Kenya, 2017, NAT COUNT HLTH BUDG; QSR International Pty Ltd, 2018, NVIVO QUAL DAT AN SO; Weber N, 2019, J WATER SANIT HYG DE, V9, P380, DOI 10.2166/washdev.2019.090; Weber N, 2018, HEALTH SECUR, V16, pS54, DOI 10.1089/hs.2018.0042; WHO/UNICEF, 2019, WASH HLTH CAR FAC GL; World Health Organisation, 2016, GLOB STRAT BURD DIS; World Health Organization, 2016, GUID COR COMP INF PR; World Health Organization UNICEF, 2017, WAT SAN HLTH FAC IMP	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222922	10.1371/journal.pone.0222922	http://dx.doi.org/10.1371/journal.pone.0222922			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596861	Green Published, gold			2022-12-26	WOS:000532444100014
J	Pacheco, LS; Anderson, CAM; Lacey, JV; Giovannucci, EL; Lemus, H; Araneta, MRG; Sears, DD; Talavera, GA; Martinez, ME				Pacheco, Lorena S.; Anderson, Cheryl A. M.; Lacey, James V., Jr.; Giovannucci, Edward L.; Lemus, Hector; Araneta, Maria Rosario G.; Sears, Dorothy D.; Talavera, Gregory A.; Martinez, Maria Elena			Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; COLON CANCERS; ENERGY-INTAKE; CONSUMPTION; OBESITY; DISTAL; TRENDS; METAANALYSIS; ASSOCIATION; PATTERNS	Background The association between sugar-sweetened beverage (SSB) consumption and colorectal cancer (CRC) risk remains unclear and published data are limited. Methods The analytic cohort included 99,798 women, free of cancer at baseline, from the California Teachers Study, a longitudinal cohort comprised of 133,477 female teachers and administrators who were active or recently retired members of the California State Teachers Retirement System in 1995. SSB consumption constituted caloric soft drinks, sweetened bottled waters and teas, and fruit drinks, derived from a self-administered food frequency questionnaire. Consumption was divided into four categories: Rare or never, > rare/never to < 1 serving/week, >= 1 serving/week to < 1 serving/day, and >= 1 serving/day. CRC endpoints were based on annual linkage with California Cancer Registry, defined as first diagnosis of CRC, and classified following the Surveillance, Epidemiology, and End Results Program coding system. Multivariable-adjusted Cox proportional hazards models were used to generate hazard ratios (HR) and 95% confidence intervals (CI) for assessing the association between SSB consumption and incident CRC. Results A total of 1,318 incident CRC cases were identified over 20 years of follow-up (54.5% proximal colon and 45.5% distal colorectum). Compared with rare/never consumers, the multivariable-adjusted HRs (95% CI) were 1.14 (0.86, 1.53) for total CRC; 1.11 (0.73, 1.68) for proximal colon; and 1.22 (0.80, 1.86) for distal colorectum cancers among women consuming >= 1 serving/day of SSBs. Conclusion SSBs were not significantly associated with CRC risk. The biological effects of high SSB consumption make it important to continue to evaluate whether SSBs are associated with CRC. Additionally, future studies should further assess SSBs in large, racial/ethnically diverse cohorts of males and females, and, if feasible, address changes in SSB consumption over time.	[Pacheco, Lorena S.; Anderson, Cheryl A. M.; Araneta, Maria Rosario G.; Sears, Dorothy D.; Martinez, Maria Elena] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Pacheco, Lorena S.; Lemus, Hector; Talavera, Gregory A.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Lacey, James V., Jr.] City Hope Natl Med Ctr, Div Hlth Analyt, Dept Computat & Quantitat Med, Duarte, CA USA; [Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Sears, Dorothy D.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA; [Martinez, Maria Elena] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; California State University System; San Diego State University; City of Hope; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Arizona State University; Arizona State University-Downtown Phoenix; University of California System; University of California San Diego	Martinez, ME (corresponding author), Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Martinez, ME (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	e8martinez@ucsd.edu	pacheco, lorena/GXV-8639-2022; Sears, Dorothy D/AHE-5524-2022; Sears, Dorothy D/B-6979-2019	Sears, Dorothy D/0000-0002-9260-3540; Sears, Dorothy D/0000-0002-9260-3540; Pacheco, Lorena/0000-0002-0569-9506	National Cancer Institute of the National Institutes of Health [U01-CA199277, P30-CA033572, P30-CA023100, UM1-CA164917, R01-CA077398]; University of California San Diego Moores Cancer Center [CA023100-29]; National Heart, Lung, and Blood Institute [T32 HL079891-11]; NATIONAL CANCER INSTITUTE [P30CA023100, U01CA199277, P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079891] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California San Diego Moores Cancer Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The California Teachers Study and the research reported in this manuscript were supported by the National Cancer Institute (URL: https://www.cancer.gov/) of the National Institutes of Health under award number U01-CA199277 (JVL); P30-CA033572 (STR; not a co-author); P30-CA023100 (JAC; not a co-author); UM1-CA164917 (JVL); and R01-CA077398 (LB; not a co-author). Additionally, research reported in this manuscript was supported by grant CA023100-29 from the University of California San Diego Moores Cancer Center (URL: https://medschool.ucsd.edu/research/moores/Pages/default.aspx) (MEM), and grant T32 HL079891-11 from the National Heart, Lung, and Blood Institute (URL: https://www.nhlbi.nih.gov/) (MA; not a co-author, director of training program). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicr & WCRF, DIET NUTR PHYS ACTIV; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056; Bostick R. M., 1994, SUGAR MEAT FAT INTAK; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chan A. T., 2010, PRIMARY PREVENTION C; Chazelas E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2408; Chen L, 2013, CANCER CAUSE CONTROL, V24, P1837, DOI 10.1007/s10552-013-0261-6; Chi F., CIRCULATION INSULIN, DOI [10.1007/s11033-012-2432-z, DOI 10.1007/S11033-012-2432-Z]; Douaiher J, 2017, J SURG ONCOL, V115, P619, DOI 10.1002/jso.24578; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Fung Teresa T, 2013, Curr Nutr Rep, V2, P48; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Giovannucci E, 2018, CANCER CAUSE CONTROL, V29, P1, DOI 10.1007/s10552-017-0975-y; Hodge AM, 2018, PUBLIC HEALTH NUTR, V21, P1618, DOI 10.1017/S1368980017002555; Horn-Ross PL, 2008, CANCER CAUSE CONTROL, V19, P595, DOI 10.1007/s10552-008-9124-y; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Jacobs ET, 2007, J CLIN GASTROENTEROL, V41, P731, DOI 10.1097/MCG.0b013e3180338e56; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Klement R. J., 2016, NAT PUBL GR, V5, P193; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Koo JH, 2010, J GASTROEN HEPATOL, V25, P33, DOI 10.1111/j.1440-1746.2009.05992.x; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P1441, DOI 10.1053/j.gastro.2014.10.034; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P351, DOI 10.1053/j.gastro.2014.04.037; Ma Y., OBESITY RISK COLOREC; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Popkin BM., 2009, WORLD IS FAT FADS TR; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Slattery ML, 1999, INT J CANCER, V81, P199, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;199::AID-IJC6&gt;3.0.CO;2-7; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Tabung FK, 2018, AM J CLIN NUTR, V108, P363, DOI 10.1093/ajcn/nqy093; Tabung Fred K, 2016, Br J Nutr, V116, P1787, DOI 10.1017/S0007114516003755; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Zhang XH, 2010, JNCI-J NATL CANCER I, V102, P771, DOI 10.1093/jnci/djq107	46	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223638	10.1371/journal.pone.0223638	http://dx.doi.org/10.1371/journal.pone.0223638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596902	Green Published, gold			2022-12-26	WOS:000532444100052
J	Adane, D; Belay, G; Arega, A; Wassihun, B; Gedefaw, G; Gebayehu, K				Adane, Daniel; Belay, Getahun; Arega, Azimeraw; Wassihun, Biresaw; Gedefaw, Getnet; Gebayehu, Kassahun			Practice and factors associated with active management of third stage of labor among obstetric care providers in Amhara region referral hospitals, North Ethiopia, 2018: A cross sectional study	PLOS ONE			English	Article								Background Active management of third stage of labor is the most indispensable intervention to avert post-partum hemorrhage which is one of the typical causes of maternal morbidity and mortality. Therefore, the aim of the study was to assess practice and factors associated with active management of third stage of labor among obstetric care providers in referral hospitals. Methods Institution based cross-sectional study design was conducted from April 1-30, 2018. Simple random sampling technique was used to select a total of 356 obstetric care providers. Data were collected using pretested, structured and self-administered questionnaires. Data were entered to Epi data version 3.1 statistical software and exported to SPSS 23 for analysis. Bivariate and multivariate logistic regression analyses were performed to identify associated factors. P value <0.05 with 95% confidence level were used to declare statistical significance. Result This study revealed that practice of active management of third stage of labor was 61.2%. Age group of 20-30 years [AOR = 1.95 (95%C1;1.13-3.38)], Being male obstetric care provider [AOR = 1.74 (95%CI;1.03-2.94)], having work experience >= 2 years [AOR = 1.95(95% CI;1.13-3.38)], availability of oxytocin [AOR = 5.46 (95%Cl; 2.41-12.3)], having exposure to manage third stage of labor [AOR = 2.91(95%Cl; 1.55-5.48)], and having good knowledge [AOR = 2.67 (95%Cl; 1.46-4.90)], were the factors associated with practice. Conclusion This study showed that practice of active management of third stage of labor was high. Age group between 20-30 years, being a male obstetric care provider, having >= 2 years work experience, availability of oxytocin, exposure to third stage management and having good knowledge were factors associated with practice. Therefore, all referral hospitals and concerned bodies need efforts to focus on providing training to increase health care provider's knowledge so as to sustain good practice through appropriate interventions.	[Adane, Daniel] Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia; [Belay, Getahun; Arega, Azimeraw] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Midwifery, Bahir Dar, Ethiopia; [Wassihun, Biresaw] ArbaMinch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia; [Gedefaw, Getnet] Woldia Univ, Coll Hlth Sci, Dept Midwifery, Woldia, Ethiopia; [Gebayehu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Dept Nursing, Gondar, Ethiopia	Bahir Dar University; Arba Minch University; University of Gondar	Adane, D (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.	danieladane178@yahoo.com	Gebeyehu, Kassahun/AAD-8135-2021; Yazew, Birhaneslasie Gebeyehu/AAD-8139-2021; Gedefaw, Getnet/AAM-3344-2020	Gebeyehu, Kassahun/0000-0001-9324-3842; Gedefaw, Getnet/0000-0003-4906-2555; Endalew, daniel/0000-0002-3540-4844; Tesfu, Azimeraw/0000-0002-9627-0931	Bahir Dar University	Bahir Dar University	The study was funded by Bahir Dar University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajenifuja K, 2010, AFRICAN HLTH SCI, V10; Andualem Henok RY, 2015, RESOURCES DEV MANAGE, P10; [Anonymous], 2012, WHO REC PREV TREATM; Deepak NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062801; Demographic E., 2012, HLTH SURVEY 2011 CEN; Koblinsky M TF, 2010, ETHIOPIAN J REPRODUC, V4, P4; Lalonde A, 2012, INT J GYNECOL OBSTET, V117, P108, DOI 10.1016/j.ijgo.2012.03.001; Mfinanga Godfrey S, 2009, Health Res Policy Syst, V7, P6, DOI 10.1186/1478-4505-7-6; Oyetunde MO., 2015, J APPL MED SCI, V4, P17; Proviande, 2014, FAKT SCHWEIN; Stanton C, 2009, B WORLD HEALTH ORGAN, V87, P207, DOI 10.2471/BLT.08.052597; TENAW Z, 2017, BMC PREGNANCY CHILDB, V17, P60174, DOI DOI 10.1186/S12884-016-1217-0; Tenaw Z, 2016, DIVERSITY EQUALITY H, V13; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	14	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222843	10.1371/journal.pone.0222843	http://dx.doi.org/10.1371/journal.pone.0222843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581231	Green Published, gold			2022-12-26	WOS:000532398600018
J	Manis, PB; Kasten, MR; Xie, RL				Manis, Paul B.; Kasten, Michael R.; Xie, Ruili			Classification of neurons in the adult mouse cochlear nucleus: Linear discriminant analysis	PLOS ONE			English	Article							POTASSIUM CURRENTS; INTRACELLULAR-RECORDINGS; HORSERADISH-PEROXIDASE; CARTWHEEL NEURONS; STELLATE CELLS; BUSHY CELLS; MICE; EXPRESSION; MORPHOLOGY; PHYSIOLOGY	The cochlear nucleus (CN) transforms the spike trains of spiral ganglion cells into a set of sensory representations that are essential for auditory discriminations and perception. These transformations require the coordinated activity of different classes of neurons that are embryologically derived from distinct sets of precursors. Decades of investigation have shown that the neurons of the CN are differentiated by their morphology, neurotransmitter receptors, ion channel expression and intrinsic excitability. In the present study we have used linear discriminant analysis (LDA) to perform an unbiased analysis of measures of the responses of CN neurons to current injections to objectively categorize cells on the basis of both morphology and physiology. Recordings were made from cells in brain slices from CBA/CaJ mice and a transgenic mouse line, NF107, crossed against the Ai32 line. For each cell, responses to current injections were analyzed for spike rate, spike shape, input resistance, resting membrane potential, membrane time constant, hyperpolarization-activated sag and time constant. Cells were filled with dye for morphological classification, and visually classified according to published accounts. The different morphological classes of cells were separated with the LDA. Ventral cochlear nucleus (VCN) bushy cells, planar multipolar (T-stellate) cells, and radiate multipolar (D-stellate) cells were in separate clusters and separate from all of the neurons from the dorsal cochlear nucleus (DCN). Within the DCN, the pyramidal cells and tuberculoventral cells were largely separated from a distinct cluster of cartwheel cells. principal axes, whereas VCN cells were in 3 clouds approximately orthogonal to this plane. VCN neurons from the two mouse strains overlapped but were slightly separated, indicating either a strain dependence or differences in slice preparation methods. We conclude that cochlear nucleus neurons can be objectively distinguished based on their intrinsic electrical properties, but such distinctions are still best aided by morphological identification.	[Manis, Paul B.; Kasten, Michael R.] Univ N Carolina, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27515 USA; [Xie, Ruili] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University	Manis, PB (corresponding author), Univ N Carolina, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27515 USA.	paul_manis@med.unc.edu		Xie, Ruili/0000-0003-4573-9805; Kasten, Michael/0000-0002-3942-5036	National Institute on Deafness and other Communicative Disorders of the National Institutes of Health;  [R01 DC004551]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004551] Funding Source: NIH RePORTER	National Institute on Deafness and other Communicative Disorders of the National Institutes of Health; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	PBM and MRK were supported by R01 DC004551, from the National Institute on Deafness and other Communicative Disorders of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RX was supported by R03 DC013396, from the National Institute on Deafness and other Communicative Disorders of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOSTOLIDES PF, 2014, FRONT NEURAL CIRCUIT, V8, P60174, DOI DOI 10.3389/FNCIR.2014.00001; BLACKSTAD TW, 1984, NEUROSCIENCE, V13, P827, DOI 10.1016/0306-4522(84)90099-X; Campagnola L, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00003; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; CANT NB, 1979, NEUROSCIENCE, V4, P1909, DOI 10.1016/0306-4522(79)90065-4; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; Cao XJ, 2011, J NEUROPHYSIOL, V106, P630, DOI 10.1152/jn.00015.2010; deNo R Lorente, 1981, PRIMARY ACOUSTIC NUC; Doucet JR, 1997, J COMP NEUROL, V385, P245; Druckmann S, 2013, CEREB CORTEX, V23, P2994, DOI 10.1093/cercor/bhs290; Francis HW, 2000, HEARING RES, V149, P91, DOI 10.1016/S0378-5955(00)00165-9; Fujino K, 2001, J NEUROSCI, V21, P7372, DOI 10.1523/JNEUROSCI.21-18-07372.2001; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HIRSCH JA, 1988, J PHYSIOL-LONDON, V396, P535, DOI 10.1113/jphysiol.1988.sp016976; Kanold PO, 1999, J NEUROSCI, V19, P2195; Kuo SP, 2012, J NEUROPHYSIOL, V108, P1186, DOI 10.1152/jn.00778.2011; Lauer AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073308; Leao RM, 2012, J NEUROPHYSIOL, V107, P3008, DOI 10.1152/jn.00660.2011; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; MANIS PB, 1990, J NEUROSCI, V10, P2338; Molitor SC, 2003, J NEUROPHYSIOL, V89, P2225, DOI 10.1152/jn.00709.2002; MUGNAINI E, 1987, ARCH ITAL BIOL, V126, P41; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; OERTEL D, 1990, J COMP NEUROL, V295, P136, DOI 10.1002/cne.902950112; OERTEL D, 1983, J NEUROSCI, V3, P2043; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3070, DOI 10.1152/jn.00125.2002; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Street SE, 2007, J NEUROPHYSIOL, V97, P4162, DOI 10.1152/jn.00469.2006; Tavakoli A, 2018, J NEUROSCI, V38, P7204, DOI 10.1523/JNEUROSCI.0303-18.2018; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; Tripathy SJ, 2015, J NEUROPHYSIOL, V113, P3474, DOI 10.1152/jn.00237.2015; Typlt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029965; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; Weedman DL, 1996, J COMP NEUROL, V369, P345; WOUTERLOOD FG, 1984, J COMP NEUROL, V227, P136, DOI 10.1002/cne.902270114; WU SH, 1984, J NEUROSCI, V4, P1577; Xie RL, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00077; Xie RL, 2013, J NEUROSCI, V33, P1598, DOI 10.1523/JNEUROSCI.2541-12.2013; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384; ZHANG S, 1994, J NEUROPHYSIOL, V71, P914, DOI 10.1152/jn.1994.71.3.914; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1409, DOI 10.1152/jn.1993.69.5.1409	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223137	10.1371/journal.pone.0223137	http://dx.doi.org/10.1371/journal.pone.0223137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581200	Green Published, Green Submitted, gold			2022-12-26	WOS:000532398600035
J	Svoboda, Z; Bizovska, L; Gonosova, Z; Linduska, P; Kovacikova, Z; Vuillerme, N				Svoboda, Zdenek; Bizovska, Lucia; Gonosova, Zuzana; Linduska, Petr; Kovacikova, Zuzana; Vuillerme, Nicolas			Effect of aging on the association between ankle muscle strength and the control of bipedal stance	PLOS ONE			English	Article							POSTURAL CONTROL; BALANCE PERFORMANCE; ENTROPY ANALYSIS; STABILITY; KNEE; INDIVIDUALS; MOVEMENT; TASKS; FALLS; LIFE	Previous studies reported a significant association between postural control and lower-limb strength of several muscle groups, however, they were focused especially on knee muscles and ankle plantar and dorsal flexors. The aim of the present study is to examine the correlation between the muscle strength of ankle invertors, evertors, plantar flexors, and dorsal flexors and the control of bipedal stance in young and older adults. Thirty one young (aged 22.8 +/- 2.6 years) and thirty one older adults (aged 70.5 +/- 7.2 years) voluntarily participated in this study. Ankle muscle strength was evaluated by an isokinetic dynamometer. Normalized peak torque and work were averaged for four repetitions and for both lower limbs. The control of bipedal stance was evaluated by the sample entropy derived from an accelerometer placed on the lumbar spine while the subject stood on a foam pad with eyes open. Results showed significant age-related differences in ankle muscle strength and sample entropy in medial-lateral direction. More interestingly, the correlation between ankle muscle strength and the sample entropy was significantly different between young and older adults. Indeed, no significant correlation was observed in the younger adults. Conversely, in the older adults, the work of the ankle evertors positively correlated with sample entropy in the medial-lateral direction during bipedal stance (r = 0.36), whereas the peak torque and work of the dorsal flexors were significantly correlated with sample entropy in the anterior-posterior direction during bipedal stance (r = 0.44 for both variables). In the young adults, results suggest that, standing on foam with eyes open is a relatively easy postural task that does not require the full ankle muscle strength capacity. Taken together, the present findings suggest that older adults have a different association between ankle muscle strength and the sample entropy during bipedal stance.	[Svoboda, Zdenek; Bizovska, Lucia; Gonosova, Zuzana; Linduska, Petr; Kovacikova, Zuzana; Vuillerme, Nicolas] Palacky Univ Olomouc, Fac Phys Culture, Dept Nat Sci Kinanthropol, Olomouc, Czech Republic; [Bizovska, Lucia; Vuillerme, Nicolas] Univ Grenoble Alpes, AGEIS, Grenoble, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Palacky University Olomouc; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Svoboda, Z (corresponding author), Palacky Univ Olomouc, Fac Phys Culture, Dept Nat Sci Kinanthropol, Olomouc, Czech Republic.	zdenek.svoboda@upol.cz	Svoboda, Zdenek/D-6737-2014	Svoboda, Zdenek/0000-0002-0744-4689; Linduska, Petr/0000-0001-7834-9809	Czech Science Foundation [18-16107Y]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (grant no. 18-16107Y).	Alfieri FM, 2012, CLIN INTERV AGING, V7, P119, DOI 10.2147/CIA.S27747; Baltich J, 2014, GAIT POSTURE, V40, P327, DOI 10.1016/j.gaitpost.2014.04.208; Carter ND, 2002, GERONTOLOGY, V48, P360, DOI 10.1159/000065504; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; de Dieuleveult AL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00080; de Moura BM, 2018, AGING CLIN EXP RES, V30, P959, DOI 10.1007/s40520-017-0873-x; Edwards WT, 2007, GAIT POSTURE, V25, P432, DOI 10.1016/j.gaitpost.2006.05.009; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gonosova Z, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54030043; Granacher U, 2012, J STRENGTH COND RES, V26, P210, DOI 10.1519/JSC.0b013e31821b7c30; Hess JA, 2005, J MANIP PHYSIOL THER, V28, P582, DOI 10.1016/j.jmpt.2005.08.013; HOLM S, 1979, SCAND J STAT, V6, P65; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Izquierdo M, 1999, EUR J APPL PHYSIOL, V79, P260, DOI 10.1007/s004210050504; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Kim KJ, 2015, J PHYS THER SCI, V27, P3381, DOI 10.1589/jpts.27.3381; Koushyar H, 2017, J GERIATR PHYS THER, V40, P143, DOI 10.1519/JPT.0000000000000086; Lin WH, 2009, J SCI MED SPORT, V12, P42, DOI 10.1016/j.jsams.2007.10.001; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; LUUKINEN H, 1995, PUBLIC HEALTH, V109, P57, DOI 10.1016/S0033-3506(95)80076-X; Melzer I, 2009, AGE AGEING, V38, P119, DOI 10.1093/ageing/afn249; Moreland JD, 2004, J AM GERIATR SOC, V52, P1121, DOI 10.1111/j.1532-5415.2004.52310.x; Muehlbauer T, 2015, SPORTS MED, V45, P1671, DOI 10.1007/s40279-015-0390-z; Potvin-Desrochers A, 2017, GAIT POSTURE, V57, P40, DOI 10.1016/j.gaitpost.2017.05.019; Reinert SS, 2017, J APPL BIOMECH, V33, P419, DOI 10.1123/jab.2016-0019; Schniepp R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00115; Son SM, 2013, J PHYS THER SCI, V25, P1313, DOI 10.1589/jpts.25.1313; Spiliopoulou SI, 2013, J ATHL TRAINING, V48, P590, DOI 10.4085/1062-6050-48.4.03; Spink MJ, 2010, GERONTOLOGY, V56, P525, DOI 10.1159/000264655; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Terada M, 2018, GAIT POSTURE, V60, P88, DOI 10.1016/j.gaitpost.2017.11.009; Thompson C, 2018, SPORTS MED, V48, P189, DOI 10.1007/s40279-017-0781-4; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Wayne PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114731; Wiksten DL, 1996, ISOKINET EXERC SCI, V6, P125, DOI 10.3233/IES-1996-6208; Yamagata M, 2017, CLIN INTERV AGING, V12, P499, DOI 10.2147/CIA.S132425; Zhou J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03539-6	41	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223434	10.1371/journal.pone.0223434	http://dx.doi.org/10.1371/journal.pone.0223434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LI0YZ	31581217	gold, Green Published			2022-12-26	WOS:000529213800001
J	Wu, VCC; Chen, SW; Chou, AH; Ting, PC; Chang, CH; Wu, M; Hsieh, MJ; Wang, CY; Chang, SH; Lin, MS; Hung, KC; Hsieh, IC; Chu, PH; Wu, CS; Lin, YS				Wu, Victor Chien-Chia; Chen, Shao-Wei; Chou, An-Hsun; Ting, Pei-Chi; Chang, Chih-Hsiang; Wu, Michael; Hsieh, Ming-Jer; Wang, Chao-Yung; Chang, Shang-Hung; Lin, Ming-Shyan; Hung, Kuo-Chun; Hsieh, I-Chang; Chu, Pao-Hsien; Wu, Cheng-Shyong; Lin, Yu-Sheng			Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study	PLOS ONE			English	Article							RISK; DISEASE; STENTS; ASSOCIATION; SAFETY	Background Patients with cirrhosis and acute myocardial infarction (AMI) present dilemma whether dual antiplatelet therapy (DAPT) should be used. Methods Electronic medical records between 2001-2013 were retrieved from Taiwan National Health Insurance Research Database. Patients were excluded for missing information, age <20 years old, history of AMI, liver transplant, autoimmune disease, coagulopathy, taking DAPT 3 months before index date, follow-up <3 months, anticoagulation user, without DAPT, and events of myocardial infarction (MI), ischemic stroke, major bleeding, and heart failure within 3-month of enrollment. Primary outcomes were 1-year all-cause mortality, recurrent MI, major bleeding, and gastrointestinal bleeding. Results A total of 150,887 patients with AMI retrieved. After exclusion criteria and propensity score matching, 914 cirrhotic and 3,656 non-cirrhotic patients with AMI on DAPT were studied. During 1-year follow-up, there was significantly increased mortality in cirrhotic patients compared to non-cirrhotic patients (HR = 1.49, 95% CI = 1.28-1.74). There was significantly decreased recurrent MI in cirrhotic patients compared to non-cirrhotic patients (subdistribution HR [SHR] = 0.71, 95% CI = 0.54-0.92). However, non-significantly increased major bleeding (SHR = 1.23, 95% CI = 0.87-1.73) and significantly increased gastrointestinal bleeding (SHR = 1.49, 95% CI = 1.31-1.70). Conclusions In cirrhotic patients with AMI, DAPT offers benefit with decreased recurrent MI at the expense of increased gastrointestinal bleeding.	[Wu, Victor Chien-Chia; Hsieh, Ming-Jer; Wang, Chao-Yung; Chang, Shang-Hung; Hung, Kuo-Chun; Hsieh, I-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Linkou Med Ctr, Div Cardiol, Taoyuan, Taiwan; [Chen, Shao-Wei] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiothorac & Vasc Surg, Taoyuan, Taiwan; [Chou, An-Hsun; Ting, Pei-Chi] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Anesthesiol, Taoyuan, Taiwan; [Chang, Chih-Hsiang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Nephrol, Taoyuan, Taiwan; [Wu, Michael] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, Div Cardiovasc Med, Providence, RI 02903 USA; [Lin, Ming-Shyan; Lin, Yu-Sheng] Chang Gung Mem Hosp, Dept Cardiol, Chiayi, Taiwan; [Wu, Cheng-Shyong] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, YS (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, Chiayi, Taiwan.	dissertlin@gmail.com	Wu, Victor Chien-Chia/GXF-4623-2022; Wang, Chao-Yung/ABA-6757-2021; Wu, Victor Chien-Chia/ABB-6872-2021; Wu, Michael/ABL-0760-2022	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wang, Chao-Yung/0000-0003-1546-7298; Wu, Victor Chien-Chia/0000-0002-9918-4369; Lin, Ming-shyan/0000-0001-9348-8153				Azarbal B, 2011, LIVER TRANSPLANT, V17, P809, DOI 10.1002/lt.22301; Chang SH, 2017, JAMA-J AM MED ASSOC, V318, P1250, DOI 10.1001/jama.2017.13883; Chen CC, 2019, J NEUROSURG, V130, P302, DOI 10.3171/2017.8.JNS171103; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2014, J EPIDEMIOL; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Kalaitzakis E, 2010, DIGEST DIS SCI, V55, P467, DOI 10.1007/s10620-009-0738-z; Krill T, 2017, ALIMENT PHARM THER, V46, P183, DOI 10.1111/apt.14121; Lin YT, 2014, AM J EPIDEMIOL, V180, P103, DOI 10.1093/aje/kwu095; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026; Russo MW, 2012, J CLIN GASTROENTEROL, V46, P339, DOI 10.1097/MCG.0b013e3182371258; Tsai TT, 2011, J AM COLL CARDIOL, V58, P1859, DOI 10.1016/j.jacc.2011.06.056; WANG CL, 2018, J AM HEART ASSOC, V7, DOI DOI 10.1161/JAHA.118.008982; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	16	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223380	10.1371/journal.pone.0223380	http://dx.doi.org/10.1371/journal.pone.0223380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581275	Green Published, gold			2022-12-26	WOS:000532398600059
J	Brand, EM; Rossetto, M; Calvo, KD; Winkler, GB; da Silva, DAR; Hentges, B; Machado, FV; Duarte, ERM; da Silva, LC; Vasques, SC; Teixeira, LB				Brand, Evelin Maria; Rossetto, Maira; Calvo, Karen da Silva; Winkler, Gerson Barreto; Raenck da Silva, Daila Alena; Hentges, Bruna; Machado, Frederico Viana; Mallmann Duarte, Erica Rosalba; da Silva, Lucas Cardoso; Vasques, Samantha Correa; Teixeira, Luciana Barcellos			Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases in Porto Alegre, 2009-2013: A retrospective cohort	PLOS ONE			English	Article							INFECTED PATIENTS	Background TB/HIV coinfection is a serious public health issue in Brazil, and patients with coinfection have difficulty adhering to treatments. Directly observed treatment (DOT) has been recommended by the World Health Organization, considering the vulnerability of those affected. The purpose is to investigate the occurrence of DOT and associated factors compared to conventional treatment in Porto Alegre, Brazil. Methods A retrospective cohort study was carried out with all patients with coinfection from 2009 to 2013 in the city of Porto Alegre, Brazil, the state capital with the highest rate of coinfection in Brazil. The data came from national health information systems. The dependent variable was the performance of DOT. Bivariate and multivariable models were used to determine factors associated with DOT. The percentage of cure and death was verified in a period of two years, comparing patients who received and did not receive DOT. Results 2,400 cases of coinfection were reported, with 1,574 males and 826 females and a mean age of 38 years +/- 9.91 years. The occurrence of DOT was 16.9%. In the multivariable analysis, factors independently associated to DOT were the year (with greater chances of being received in 2012 and 2013), place of origin, non-white race (OR = 1.29, 95% CI = 1.08-1.54), cases of relapse (OR = 1.33; 95% CI = 1.03-1.73), readmission after abandonment (OR = 1.48, 95% CI = 1.20-1.83), transfer (OR = 2.04; 95% CI = 1.40-2.98), acid-fast bacilli (AFB) test with positive result in first sample (OR = 1.73, 95% CI = 1.24-2.42), alcohol abuse (OR = 1.39; 95% CI = 1.16-1.67), and mental disorders (OR = 1.83; 95% CI = 1.38-2.44.) Of the 532 cases of death, occurring in two years, 10.2% were in patients who underwent DOT and 89.8% in patients who did not undergo DOT (p<0.001). O percentual de obitos em pessoas que receberam DOT foi de 13% e o percentual de obitos para pessoas que receberam tratamento convencional foi de 24%. Conclusions There was an increase in the percentage of DOT over the years in the scenario studied, and the predictors for DOT were related to social vulnerability. In relation to death within two years, a lower proportion was found in patients who underwent DOT, suggesting a protective effect of the strategy.	[Brand, Evelin Maria; Calvo, Karen da Silva; Winkler, Gerson Barreto; Machado, Frederico Viana; da Silva, Lucas Cardoso; Vasques, Samantha Correa; Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Dept Publ Hlth, Porto Alegre, RS, Brazil; [Rossetto, Maira] Univ Fed Fronteira Sul, Dept Med, Chapeco, SC, Brazil; [Raenck da Silva, Daila Alena; Mallmann Duarte, Erica Rosalba] Univ Fed Rio Grande do Sul, Dept Profess Assistance & Guidance, Porto Alegre, RS, Brazil; [Hentges, Bruna] Univ Fed Rio Grande do Sul, Dept Social Med, Porto Alegre, RS, Brazil; [Brand, Evelin Maria] Univ Fed Rio Grande do Sul, Grad Studies Program Publ Hlth, Sch Nursing, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal da Fronteira Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Dept Publ Hlth, Porto Alegre, RS, Brazil.	luciana.barcellos@ufrgs.br	Duarte, Êrica/AAU-7328-2020; da Silva, Lucas Cardoso/AAU-9494-2020; Machado, Frederico/AAR-6665-2020	da Silva, Lucas Cardoso/0000-0003-3841-6055; Machado, Frederico/0000-0002-8884-1124; RAENCK DA SILVA, DAILA ALENA/0000-0002-0661-9328				Abreu GRF, 2013, REV BAIANA SAUDE PUB, V37, P407; Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Anand Tanu, 2017, Indian J Tuberc, V64, P291, DOI 10.1016/j.ijtb.2017.05.009; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2017, MUNICIPAL HLTH PLAN; Basta Paulo Cesar, 2013, Rev Saude Publica, V47, P854, DOI 10.1590/S0034-8910.2013047004628; Camara JT, 2016, REV ENFERM UFPE, V10, P4082; Coelho A, 2015, CADERNOS ESP, V9, P19; do Prado TN, 2017, BRAZ J INFECT DIS, V21, P162, DOI 10.1016/j.bjid.2016.11.006; dos Santos JN, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/s1679-49742018000300015, 10.5123/S1679-49742018000300015]; Fekadu S, 2015, J INFECT DEV COUNTR, V9, P898, DOI 10.3855/jidc.5667; Fregona G, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006688, 10.1590/s1518-8787.2017051006688]; Gesesew H, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0202-1; Gonzalez C, 2012, MEDICINA-BUENOS AIRE, V72, P371; Harling G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4435-0; Javaid A, 2018, CLIN MICROBIOL INFEC, V24, P612, DOI 10.1016/j.cmi.2017.09.012; Kapata N, 2013, MED J ZAMBIA, V40, P7; Maffacciolli R, 2017, SAUDE SOC-SAO PAULO, V26, P286, DOI [10.1590/s0104-12902017168038, 10.1590/S0104-12902017168038]; Meda ZC, 2013, AIDS RES HUM RETROV, V29, P1045, DOI [10.1089/aid.2012.0239, 10.1089/AID.2012.0239]; Ministry of Health, 2013, REC MAN TB HIV COINF; Ministry of Health, 2017, HIST FAM HLTH COV; Ministry of Health. Secretariat of Health Surveillance, 2017, EPIDEMIOLOGICAL B, V48, P40; Ministry of Health. Secretariat of Health Surveillance. Department of Surveillance of Communicable Diseases, 2017, NAT PLAN END TUB; Ministry of Health. Secretariat of Health Surveillance. National Program for Tuberculosis Control, 2011, MAN REC CONTR TUB BR; Municipal Health Department of Porto Alegre, 2015, EPIDEMIOLOGICAL B, V59; Nast K., 2014, THESIS; Oliveira GN, 2013, REV LAT-AM ENFERM, V21, P500, DOI 10.1590/S0104-11692013000200005; Pan American Health Organization, 2018, TUB AM 2018; Peruhype RC, 2014, REV ESC ENFERM USP, V48, P1032, DOI 10.1590/S0080-623420140000700011; Reddy Satti Siva Balaji, 2016, Indian J Community Med, V41, P120, DOI 10.4103/0970-0218.177529; Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2; ROSSETTO M, 2019, PLOS ONE, V14, DOI DOI 10.1371/JOURNAL; Rothman Kenneth J., 2011, MODERN EPIDEMIOLOGY, VThird; Snyder RE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1835-1; Souza W., 2010, NEGLECTED DIS; State Department of Health. State Center for Health Surveillance. Epidemiological Surveillance Division, 2010, STAT PLAN TUB CONTR; WHO, 2017, END TB STRAT; Woimo TT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4188-9; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2015, GLOB TUB REP 2015; Yamamura M, 2014, REV PANAM SALUD PUBL, V35, P270; Zambenedetti G, PHYS REV SAUD COLE, V26, P785; Zhao XQ, 2018, FRONT AGRIC SCI ENG, V5, P1, DOI 10.15302/J-FASE-2018203	44	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222786	10.1371/journal.pone.0222786	http://dx.doi.org/10.1371/journal.pone.0222786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577812	Green Published, gold			2022-12-26	WOS:000532388000013
J	Nigatu, D; Azage, M; Motbainor, A				Nigatu, Dabere; Azage, Muluken; Motbainor, Achenef			Effect of exclusive breastfeeding cessation time on childhood morbidity and adverse nutritional outcomes in Ethiopia: Analysis of the demographic and health surveys	PLOS ONE			English	Article							INFANTS; GROWTH	Background Though exclusive breastfeeding (EBF) for the first six months is recommended, it remains a debatable issue in both developed and developing countries. Thus, this study investigated the effect of EBF cessation time on childhood morbidity and adverse nutritional outcome in Ethiopia. Methods We used the 2011 and 2016 Ethiopian Demographic and Health Surveys. The study involved 2,433 children under six months of age. Logistic regression model was applied to determine the effect of EBF cessation time on outcome variables. Population Attributable Fraction was calculated to evaluate the public health impacts of EBF termination in the population. Results Discontinuing EBF at 0-3 months (adjusted odds ratio (AOR): 1.95, 95% confidence interval (CI): 1.08, 3.53)) and 4-6 months (AOR: 3.57, 95% CI: 2.19, 5.83) increased diarrhea occurrence compared to children who continued EBF up to 6 months. Children who had terminated EBF at 4-6 months had increased odds of fever (AOR: 1.73, 95% CI: 1.11, 2.68) and acute respiratory illnesses (ARIs) (AOR: 2.74, 95% CI: 1.61, 4.65). Cessation of EBF earlier than 4 months or between 4-6 months was associated with increased odds of having at least one childhood morbidity. Termination of EBF at 0-3 months and at 4-6 months were associated with increased occurrence of wasting (AOR: 2.32, 95% CI: 1.45, 3.74) and underweight (AOR: 2.30, 95% CI: 1.36, 3.91), respectively. Exclusive breastfeeding can avert 42% of diarrhea, 27% of ARI, 21% of fever, 26% of wasting and 23% of underweight burden among children under six months of age. Conclusions Termination of EBF before six months was associated with increased occurrence of diarrhea, fever and ARIs. It was also linked with increased occurrence of childhood wasting and underweight. The finding emphasized EBF for the first six months to reduce childhood morbidity and adverse nutritional outcomes.	[Nigatu, Dabere] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia; [Azage, Muluken; Motbainor, Achenef] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Nigatu, D (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	daberen@yahoo.com	Nigatu, Dabere/Q-9332-2018; Azage, Muluken/AAF-6515-2020	Nigatu, Dabere/0000-0001-7303-6723; Azage, Muluken/0000-0003-3222-0158; Motbainor, Achenef/0000-0001-7620-5780				Becker GE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006462.pub3; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Croft TN, 2018, GUIDE DHS STAT; CSA ICF, 2012, ETH DEM HLTH SURV 20; Dieterich CM, 2013, PEDIATR CLIN N AM, V60, P31, DOI 10.1016/j.pcl.2012.09.010; Fenta EH, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0126-9; Fewtrell MS, 2007, AM J CLIN NUTR; Haile D, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0057-2; Kalanda BF, 2006, EUR J CLIN NUTR, V60, P401, DOI 10.1038/sj.ejcn.1602330; Khan MN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4913-4; Kramer M., 2009, COCHRANE DATABASE SY; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kuchenbecker J, 2015, PAEDIATR INT CHILD H, V35, P14, DOI 10.1179/2046905514Y.0000000134; Kumar A, 2015, J STAT APPL PRO, V4, P435; Laaksonen M, 2010, POPULATION ATTRIBUTA; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Mansournia M. A, 2018, BMJ; Motee A, 2014, CURR RES NUTR FOOD S, V2, P56, DOI 10.12944/CRNFSJ.2.2.02; Muchina E. N., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2358; Mulol H, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0159-8; Ogbo FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171792; OGBO I, 2013, BMC PUBLIC HLTH S3, V13; PAHO, 2013, SURV INT DEL CAR PRA; Quigley MA, 2016, EUR J CLIN NUTR, V70, P1420, DOI 10.1038/ejcn.2016.135; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Roberts TJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-254; Sumiaty S, 2017, INT J SCI BASIC APPL, V35, P413; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACTION; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 2009, INF YOUNG CHILD FEED; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization, 2019, REC DAT COLL AN REP, P144; World Health Organization UNICEF, 2007, PLANN GUID NAT IMPL	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223379	10.1371/journal.pone.0223379	http://dx.doi.org/10.1371/journal.pone.0223379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577821	Green Published, Green Submitted, gold			2022-12-26	WOS:000532388000035
J	Lennon, RJ; Isaac, NJB; Shore, RF; Peach, WJ; Dunn, JC; Pereira, MG; Arnold, KE; Garthwaite, D; Brown, CD				Lennon, Rosie J.; Isaac, Nick J. B.; Shore, Richard F.; Peach, Will J.; Dunn, Jenny C.; Pereira, M. Gloria; Arnold, Kathryn E.; Garthwaite, David; Brown, Colin D.			Using long-term datasets to assess the impacts of dietary exposure to neonicotinoids on farmland bird populations in England	PLOS ONE			English	Article							POTENTIAL EXPOSURE; LOWLAND FARMLAND; DECLINES; PARTRIDGES; FIPRONIL; ECOLOGY; BRITAIN; TRENDS; PLANTS; SEEDS	Over the last 20 years, a new group of systemic insecticides-the neonicotinoids-has gained prominence in arable systems, and their application globally has risen year on year. Previous modelling studies using long-term data have suggested that neonicotinoid application has had a detrimental impact on bird populations, but these studies were either limited to a single species or neglected to analyse specific exposure pathways in conjunction with observed population trends. Using bird abundance data, neonicotinoid usage records and cropping data for England at a 5x5 km resolution, generalised linear mixed models were used to test for spatio-temporal associations between neonicotinoid use and changes in the populations of 22 farmland bird species between 1994 and 2014, and to determine whether any associations were explained by dietary preferences. We assigned farmland bird species to three categories of dietary exposure to neonicotinoids based on literature data for species diets and neonicotinoid residues present in dietary items. Significant estimates of neonicotinoid-related population change were obtained for 13 of the 22 species (9 positive effects, 4 negative effects). Model estimates for individual species were not collectively explained by dietary risk categories, so dietary exposure to neonicotinoids via ingestion of treated seeds and seedlings could not be confirmed as a causal factor in farmland bird declines. Although it is not possible to infer any generic effect of dietary exposure to neonicotinoids on farmland bird populations, our analysis identifies three species with significant negative estimates that may warrant further research (house sparrow Passer domesticus, skylark Alauda arvensis and red-legged partridge Alectoris rufa). We conclude that there was either no consistent effect of dietary exposure to neonicotinoids on farmland bird populations in England, or that any over-arching effect was not detectable using our study design. The potential for indirect effects of insecticide use on bird populations via reduced food availability was not considered here and should be a focus for future research.	[Lennon, Rosie J.; Arnold, Kathryn E.; Brown, Colin D.] Univ York, Dept Environm & Geog, York, N Yorkshire, England; [Isaac, Nick J. B.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Shore, Richard F.; Pereira, M. Gloria] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England; [Peach, Will J.] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy, Beds, England; [Dunn, Jenny C.] Univ Lincoln, Sch Life Sci, Joseph Banks Labs, Lincoln, England; [Garthwaite, David] Fera Sci Ltd, Natl Agrifood Innovat Campus, York, N Yorkshire, England	University of York - UK; UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Royal Society for Protection of Birds; University of Lincoln; Food & Environment Research Agency	Lennon, RJ (corresponding author), Univ York, Dept Environm & Geog, York, N Yorkshire, England.	rjl529@york.ac.uk	Dunn, Jenny C./H-2867-2019; Isaac, Nick/C-2716-2011; Pereira, M. Gloria/K-3024-2012	Dunn, Jenny C./0000-0002-6277-2781; Isaac, Nick/0000-0002-4869-8052; Pereira, M. Gloria/0000-0003-3740-0019	Natural Environment Research Council [NE/L002450/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research was funded by a Natural Environment Research Council (https://nerc.ukri.org/) as part of the ACCE (https://acce.shef.ac.uk/) doctoral training partnership (grant number NE/L002450/1). RL receives a PhD stipend plus payment of university PhD fees under this award. CB, KA, RS and WP are the primary PhD supervisors. The Royal Society for the Protection of Birds (RSPB) is the CASE partner for this PhD project (https://www.rspb.org.uk/).DG facilitated access to pesticide usage data held by Fera Science Ltd.; Fera Science Ltd. did not provide any additional funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors RJL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addy-Orduna LM, 2018, SCI TOTAL ENVIRON, V10, P1216; Agriculture and Horticulture Development Board, 2013, NEON INS DEB; Alford A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173836; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Bayer Crop Science UK, 2019, REDG DET LAB; Bolker B.M, 2018, GLMM FAQ; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Botias C, 2016, SCI TOTAL ENVIRON, V566, P269, DOI 10.1016/j.scitotenv.2016.05.065; British Trust for Ornithology, 2018, BBS REP; British Trust for Ornithology, 2017, DAT BTO JNCC RSPB BR; Bro E, 2016, ENVIRON SCI POLLUT R, V23, P9559, DOI 10.1007/s11356-016-6093-7; Bro E, 2015, SCI TOTAL ENVIRON, V521, P315, DOI 10.1016/j.scitotenv.2015.03.073; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Browne SJ, 2004, IBIS, V146, P125, DOI 10.1111/j.1474-919X.2004.00235.x; Burns F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151595; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Cramp S., 1985, HDB BIRDS EUROPE MID, VI-IX; Department of Environment Food and Rural Affairs, 2015, WILD BIRD POP UK 197; Donald PF, 2001, J APPL ECOL, V38, P536, DOI 10.1046/j.1365-2664.2001.00618.x; Dunn JC, 2018, MOL ECOL, V27, P3386, DOI 10.1111/mec.14766; EDINA, AGR CENS DAT; Eng ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15446-x; Ertl HMH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191100; Freeman SN, 2008, IBIS, V150, P250, DOI 10.1111/j.1474-919X.2007.00770.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Garthwaite D, 1994, 127 CENTR SCI LAB; Garthwaite D. G. S., 2013, PESTICIDE USAGE SURV; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hao CY, 2018, SCI TOTAL ENVIRON, V644, P1080, DOI 10.1016/j.scitotenv.2018.06.317; Hayhow D, 2016, STATUS UK BIRDS 2015; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; Humann-Guilleminot S, 2019, SCI TOTAL ENVIRON, V660, P1091, DOI 10.1016/j.scitotenv.2019.01.068; Hume R., 2014, RSPB BIRDS BRITAIN E; Lopez-Antia A, 2016, J APPL ECOL, V53, P1373, DOI 10.1111/1365-2664.12668; Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023; Lopez-Antia A, 2013, ECOTOXICOLOGY, V22, P125, DOI 10.1007/s10646-012-1009-x; MacDonald AM, 2018, ENVIRON SCI POLLUT R, V25, P16254, DOI 10.1007/s11356-018-2093-0; McGee S, 2018, PEERJ, V6, DOI 10.7717/peerj.5880; Millot F, 2017, ENVIRON SCI POLLUT R, V24, P5469, DOI 10.1007/s11356-016-8272-y; Mineau P., 2013, AM BIRD CONSERV; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Pandey SP, 2015, CHEMOSPHERE, V122, P227, DOI 10.1016/j.chemosphere.2014.11.061; Prosser P, 2005, ECOTOXICOLOGY, V14, P679, DOI 10.1007/s10646-005-0018-4; Prosser P., 2001, PN0907 CENTR SCI LAB; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Stanton RL, 2018, AGR ECOSYST ENVIRON, V254, P244, DOI 10.1016/j.agee.2017.11.028; TAITT MJ, 1973, BIRD STUDY, V20, P226, DOI 10.1080/00063657309476384; The Royal Society for the Protection of Birds, 2018, FARML BIRD IND; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	55	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223093	10.1371/journal.pone.0223093	http://dx.doi.org/10.1371/journal.pone.0223093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574132	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000532376700029
J	Gawande, SJ; Anandhan, S; Ingle, A; Roylawar, P; Khandagale, K; Gawai, T; Jacobson, A; Asokan, R; Singh, M				Gawande, Suresh J.; Anandhan, Sivalingam; Ingle, Ashish; Roylawar, Praveen; Khandagale, Kiran; Gawai, Tushar; Jacobson, Alana; Asokan, Ramasamy; Singh, Major			Microbiome profiling of the onion thrips, Thrips tabaci Lindeman (Thysanoptera: Thripidae)	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; GUT BACTERIA; DEVELOPMENTAL-STAGE; SYMBIONT; MICROORGANISMS; DIVERSITY; WOLBACHIA; HOST; DIET; INCOMPATIBILITY	The gut microbial community structure of adult Thrips tabaci collected from 10 different agro-climatically diverse locations of India was characterized by using the Illumina MiSeq platform to amplify the V3 region of the 16S rRNA gene of bacteria present in the sampled insects. Analyses were performed to study the bacterial communities associated with Thrips tabaci in India. The complete bacterial metagenome of T. tabaci was comprised of 1662 OTUs of which 62.25% belong to known and 37.7% of unidentified/unknown bacteria. These OTUs constituted 21 bacterial phyla of 276 identified genera. Phylum Proteobacteria was predominant, followed by Actinobacteria, Firmicutes, Bacteroidetes and Cyanobacteria. Additionally, the occurrence of the reproductive endosymbiont, Wolbachia was detected at two locations (0.56%) of the total known OTUs. There is high variation in diversity and species richness among the different locations. Alpha-diversity metrics indicated the higher gut bacterial diversity at Bangalore and lowest at Rahuri whereas higher bacterial species richness at T. tabaci samples from Imphal and lowest at Jhalawar. Beta diversity analyses comparing bacterial communities between the samples showed distinct differences in bacterial community composition of T. tabaci samples from different locations. This paper also constitutes the first record of detailed bacterial communities associated with T. tabaci. The location-wise variation in microbial metagenome profile of T. tabaci suggests that bacterial diversity might be governed by its population genetic structure, environment and habitat.	[Gawande, Suresh J.; Anandhan, Sivalingam; Ingle, Ashish; Roylawar, Praveen; Khandagale, Kiran; Gawai, Tushar; Singh, Major] ICAR Directorate Onion & Garl Res, Pune, Maharashtra, India; [Jacobson, Alana] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Asokan, Ramasamy] ICAR Indian Inst Hort Res, Bengaluru, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate on Onion & Garlic Research; Auburn University System; Auburn University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Gawande, SJ (corresponding author), ICAR Directorate Onion & Garl Res, Pune, Maharashtra, India.	sureshgawande76@gmail.com	Gawande, Suresh J./H-4180-2011; Roylawar, Praveen/GXG-9571-2022; Anandhan, Sivalingam/GVS-6218-2022	Gawande, Suresh J./0000-0001-8306-0719; Roylawar, Praveen/0000-0002-8511-9128	INDIAN COUNCIL OF AGRICULTURAL RESEARCH [HORTDOGRSIL201800400084]; Indian Council of Agricultural Research (ICAR)	INDIAN COUNCIL OF AGRICULTURAL RESEARCH(Indian Council of Agricultural Research (ICAR)); Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR))	This work was supported by HORTDOGRSIL201800400084, INDIAN COUNCIL OF AGRICULTURAL RESEARCH, https://icar.org.in/, to SJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Indian Council of Agricultural Research (ICAR) for funding.	Auer L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02623; Beukeboom LW, 2014, EVOLUTION OF SEX DETERMINATION, P1, DOI 10.1093/acprof:oso/9780199657148.001.0001; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Breeuwer JAJ, 1997, HEREDITY, V79, P41, DOI 10.1038/hdy.1997.121; Brown SD, 2012, J BACTERIOL, V194, P3290, DOI 10.1128/JB.00473-12; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cao Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01829; Chanbusarakum L, 2008, J INVERTEBR PATHOL, V99, P318, DOI 10.1016/j.jip.2008.09.001; Chen BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29505; Cheng DF, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0236-z; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; De Vries EJ, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2301; de Vries EJ, 2004, P ROY SOC B-BIOL SCI, V271, P2171, DOI 10.1098/rspb.2004.2817; Delalibera I, 2005, ENVIRON ENTOMOL, V34, P541, DOI 10.1603/0046-225X-34.3.541; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Dickey AM, 2014, FLA ENTOMOL, V97, P362, DOI 10.1653/024.097.0204; Dillon M.R., 2019, NAT BIOTECHNOL, V37, P1, DOI [10.1038/nbt.4341, DOI 10.1038/NBT.4341]; Dillon RJ, 2000, NATURE, V403, P851, DOI 10.1038/35002669; Douglas A.E., 1995, Advances in Ecological Research, V26, P69, DOI 10.1016/S0065-2504(08)60064-1; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gawande SJ, 2017, B ENTOMOL RES, V107, P534, DOI 10.1017/S0007485317000025; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Itoh H, 2018, NAT PROD REP, V35, P434, DOI 10.1039/c7np00051k; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054567; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kaczmarczyk A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32747-x; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim JM, 2017, J MICROBIOL, V55, P21, DOI 10.1007/s12275-017-6561-x; Koivisto RKK, 2003, BIOL J LINN SOC, V79, P43, DOI 10.1046/j.1095-8312.2003.00185.x; Krivosheina M, 2008, PALEONTOL J+, V42, P596, DOI 10.1134/S003103010806004X; Kumm S, 2008, ENVIRON ENTOMOL, V37, P1422, DOI 10.1603/0046-225X-37.6.1422; Lee FJ, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy113; Lewis T, 1997, THRIPS CROP PESTS; Lopez-Fernandez S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00834; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lv ZH, 2018, INFECT GENET EVOL, V63, P24, DOI 10.1016/j.meegid.2018.04.024; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; PASTI MB, 1985, FEMS MICROBIOL LETT, V26, P107, DOI 10.1016/0378-1097(85)90133-8; Powell CM, 2015, SOUTHWEST ENTOMOL, V40, P765, DOI 10.3958/059.040.0404; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Ranjith MT, 2016, J ASIA-PAC ENTOMOL, V19, P333, DOI 10.1016/j.aspen.2016.03.007; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Rotenberg D, 2015, CURR OPIN VIROL, V15, P80, DOI 10.1016/j.coviro.2015.08.003; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saurav GK, 2016, INDIAN J MICROBIOL, V56, P167, DOI 10.1007/s12088-016-0567-7; Schafer A, 1996, J APPL BACTERIOL, V80, P471, DOI 10.1111/j.1365-2672.1996.tb03245.x; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Vala F, 2002, EVOLUTION, V56, P1331, DOI 10.1111/j.0014-3820.2002.tb01447.x; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vorburger C, 2018, BIOL CONTROL, V116, P17, DOI 10.1016/j.biocontrol.2017.02.004; Xia XF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00025; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22958; Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	69	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223281	10.1371/journal.pone.0223281	http://dx.doi.org/10.1371/journal.pone.0223281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568480	gold, Green Published			2022-12-26	WOS:000532364900036
J	Marmet, S; Studer, J; Lemoine, M; Grazioli, VS; Bertholet, N; Gmel, G				Marmet, Simon; Studer, Joseph; Lemoine, Melissa; Grazioli, Veronique S.; Bertholet, Nicolas; Gmel, Gerhard			Reconsidering the associations between self-reported alcohol use disorder and mental health problems in the light of co-occurring addictions in young Swiss men	PLOS ONE			English	Article							IDENTIFICATION TEST CUDIT; SOCIAL ANXIETY DISORDER; SCREENING INSTRUMENT; NICOTINE DEPENDENCE; DRUG USE; SUBSTANCE; COMORBIDITY; SENSITIVITY; POPULATION; VALIDATION	Background Alcohol use disorder (AUD) is known to co-occur with other addictions, as well as with mental health problems. However, the effects of other addictions co-occurring with AUD on mental health problems were rarely studied and not considering them may bias estimates of the association between AUD and mental health problems. This study investigated which role co-occurring addictions play for the cross-sectional associations between self-reported AUD and mental health problems. Method Participants were 5516 young Swiss men (73.0% of those that gave written informed consent) who completed a self-report questionnaire. Using short screening questionnaires, we assessed three substance use disorders (alcohol, cannabis and tobacco), seven behavioural addictions (internet, gaming, smartphone, internet sex, gambling, work, exercise) and four mental health problems (major depression, bipolar disorder, attention deficit hyperactivity disorder (ADHD) and social anxiety disorder). Differences in the proportions of mental health problems were tested using logistic regressions between (1) participants with no AUD and AUD, (2) participants with no AUD and AUD alone and (3) participants with no AUD and AUD plus at least one co-occurring addiction. Results Overall, (1) participants with AUD had higher proportions of major depression (Odds ratio (OR [95% confidence interval]) = 3.51 [2.73, 4.52]; ADHD (OR = 3.12 [2.41, 4.03]); bipolar disorder (OR = 4.94 [3.38, 7.21]) and social anxiety (OR = 2.21 [1.79, 2.73])) compared to participants with no AUD. Considering only participants with AUD alone compared to participants with no AUD (2), differences in proportions were no longer significant for major depression (OR = 0.83 [0.42, 1.64]), bipolar disorder (OR = 1.69 [0.67, 4.22]), social anxiety (OR = 1.15 [0.77, 1.73]) and ADHD (OR = 1.65 [1.00, 2.72]) compared to participants with no AUD. In contrast, (3) proportions of mental health problems were considerably higher for participants with AUD plus at least one other addiction when compared to participants with no AUD, with OR's ranging from 2.90 [2.27, 3.70] for social anxiety, 4.03 [3.02, 5.38] for ADHD, 5.29 [4.02, 6.97] for major depression to 6.64 [4.44, 9.94] for bipolar disorder. Conclusions AUD was associated with all four measured mental health problems. However, these associations were mainly due to the high proportions of these mental health problems in participants with AUD plus at least one co-occurring addiction and only to a lesser degree due to participants with AUD alone (i.e. without any other co-occurring addictions). Hence, estimates of the association between AUD and mental health problems that do not consider other addictions may be biased (i.e. overestimated). These findings imply that considering addictions co-occurring with AUD, including behavioural addictions, is important when investigating associations between AUD and mental health problems, and for the treatment of AUD and co-morbid disorders.	[Marmet, Simon; Studer, Joseph; Lemoine, Melissa; Grazioli, Veronique S.; Bertholet, Nicolas; Gmel, Gerhard] Lausanne Univ Hosp, Addict Med, Lausanne, Switzerland; [Marmet, Simon; Studer, Joseph; Lemoine, Melissa; Grazioli, Veronique S.; Bertholet, Nicolas; Gmel, Gerhard] Univ Lausanne, Lausanne, Switzerland; [Gmel, Gerhard] Addict Switzerland, Lausanne, Switzerland; [Gmel, Gerhard] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gmel, Gerhard] Univ West England, Frenchay Campus, Bristol, Avon, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of West England	Marmet, S (corresponding author), Lausanne Univ Hosp, Addict Med, Lausanne, Switzerland.; Marmet, S (corresponding author), Univ Lausanne, Lausanne, Switzerland.	simon.marmet@chuv.ch	Bertholet, Nicolas/AAX-2061-2020; Gachoud, Céline/K-1104-2018	Bertholet, Nicolas/0000-0001-5064-6377; Studer, Joseph/0000-0002-1390-7707; Marmet, Simon/0000-0002-9060-8567	Swiss National Science Foundation [FN 33CSC0-122679, FN 33CS30_139467, FN 33CS30_148493]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants FN 33CSC0-122679, FN 33CS30_139467 and FN 33CS30_148493 from the Swiss National Science Foundation (www.snf.ch) to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarseth E, 2017, J BEHAV ADDICT, V6, P267, DOI 10.1556/2006.5.2016.088; Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andreas JB, 2015, ADDICT BEHAV, V48, P71, DOI 10.1016/j.addbeh.2015.05.001; Andreassen CS, 2012, SCAND J PSYCHOL, V53, P265, DOI 10.1111/j.1467-9450.2012.00947.x; Annaheim B, 2010, INT J METH PSYCH RES, V19, P142, DOI 10.1002/mpr.308; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bech P, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0529-3; Bhalla IP, 2017, MED CARE, V55, pS24, DOI 10.1097/MLR.0000000000000731; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Carnes PJ, 2009, SHADOWS NET BREAKING; Connor Jason P, 2013, Front Psychiatry, V4, P79, DOI 10.3389/fpsyt.2013.00079; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Dalrymple K, 2013, COMPR PSYCHIAT, V54, P758, DOI 10.1016/j.comppsych.2013.02.006; Delmonico D., 2003, SEX RELATSH THER, V18, P261, DOI [10.1080/1468199031000153900, DOI 10.1080/1468199031000153900]; Di Florio A, 2014, EUR PSYCHIAT, V29, P117, DOI 10.1016/j.eurpsy.2013.07.004; Dom G, 2015, COOCCURRING ADDICTIV, P375; Freimuth M, 2008, J GROUPS ADDICT RECO, V3, P137, DOI 10.1080/15560350802424944; Gmel G., 2015, SUCHT, V61, P251, DOI [10.1024/0939-5911.a000380, DOI 10.1024/0939-5911.A000380]; Gmel G, 2017, SUCHTMONITORING SCHW; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Griffiths MD, 2018, J BEHAV ADDICT, V7, P845, DOI 10.1556/2006.7.2018.05; Hakansson A, 2011, DRUG ALCOHOL DEPEN, V118, P5, DOI 10.1016/j.drugalcdep.2011.02.014; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; Heatherton T.F., 1992, ENT-EAR NOSE THROAT, V69, P763; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Kardefelt-Winther D, 2017, ADDICTION, V112, P1709, DOI 10.1111/add.13763; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Knight JR, 2002, J STUD ALCOHOL, V63, P263, DOI 10.15288/jsa.2002.63.263; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083558; Strat Y, 2010, ALCOHOL ALCOHOLISM, V45, P167, DOI 10.1093/alcalc/agp094; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; MacLean RR, 2018, ADDICT BEHAV, V78, P59, DOI 10.1016/j.addbeh.2017.11.006; Marmet S, 2014, SUCHTMONITORING SCHW; Marmet S, 2019, ADDICT RES THEORY, V27, P489, DOI 10.1080/16066359.2018.1547817; Meerkerk GJ, 2010, COMPUT HUM BEHAV, V26, P729, DOI 10.1016/j.chb.2010.01.009; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Moggi F., 2015, COOCCURRING ADDICTIV, P3, DOI DOI 10.1007/978-3-642-45375-5_1; Morisano D, 2014, NORD STUD ALCOHOL DR, V31, P5, DOI 10.2478/nsad-2014-0002; Moss HB, 2015, ADDICT BEHAV, V50, P192, DOI 10.1016/j.addbeh.2015.06.041; Office of Alcoholism and Substance Abuse Services, DSM 4 PATH GAMBL DIA; Rouget BW, 2005, J AFFECT DISORDERS, V88, P103, DOI 10.1016/j.jad.2005.06.005; Rumpf HJ, 2019, CURR ADDICT REP, V6, P331, DOI 10.1007/s40429-019-00262-2; Schluter MG, 2018, ADDICTION, V113, P1528, DOI 10.1111/add.14166; Schneier FR, 2010, PSYCHOL MED, V40, P977, DOI 10.1017/S0033291709991231; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Skinstad AH, 2001, AM J DRUG ALCOHOL AB, V27, P45, DOI 10.1081/ADA-100103118; Smith GW, 2011, DRUG ALCOHOL DEPEN, V113, P222, DOI 10.1016/j.drugalcdep.2010.08.010; Studer J, 2013, J STUD ALCOHOL DRUGS, V74, P931, DOI 10.15288/jsad.2013.74.931; Studer J, 2013, DRUG ALCOHOL DEPEN, V132, P316, DOI 10.1016/j.drugalcdep.2013.02.029; Sussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI 10.1177/0163278710380124; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Terry A, 2004, ADDICT RES THEORY, V12, P489, DOI 10.1080/16066350310001637363; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Thege BK, 2016, J BEHAV ADDICT, V5, P614, DOI 10.1556/2006.5.2016.079; van Emmerik-van Oortmerssen K, 2012, DRUG ALCOHOL DEPEN, V122, P11, DOI 10.1016/j.drugalcdep.2011.12.007; van Wamel A, 2015, COOCCURRING ADDICTIV, P27; White A, 2013, ADDICT BEHAV, V38, P2068, DOI 10.1016/j.addbeh.2013.01.001	61	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222806	10.1371/journal.pone.0222806	http://dx.doi.org/10.1371/journal.pone.0222806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6MW	31568530	Green Published, gold			2022-12-26	WOS:000532364900010
J	Santaus, TM; Zhang, F; Li, S; Stine, OC; Geddes, CD				Santaus, Tonya M.; Zhang, Fan; Li, Shan; Stine, O. Colin; Geddes, Chris D.			Effects of Lyse-It on endonuclease fragmentation, function and activity	PLOS ONE			English	Article							DNA	Nucleases are enzymes that can degrade genomic DNA and RNA that decrease the accuracy of quantitative measures of those nucleic acids. Here, we study conventional heating, standard microwave irradiation, and Lyse-It, a microwave-based lysing technology, for the potential to fragment and inactivate DNA and RNA endonucleases. Lyse-It employs the use of highly focused microwave irradiation to the sample ultimately fragmenting and inactivating RNase A, RNase B, and DNase I. Nuclease size and fragmentation were determined visually and quantitatively by SDS polyacrylamide gel electrophoresis and the mini-gel Agilent 2100 Bioanalyzer system, with a weighted size calculated to depict the wide range of nuclease fragmentation. Enzyme activity assays were conducted, and the rates were calculated to determine the effect of various lysing conditions on each of the nucleases. The results shown in this paper clearly demonstrate that Lyse-It is a rapid and highly efficient way to degrade and inactivate nucleases so that nucleic acids can be retained for downstream detection.	[Santaus, Tonya M.; Zhang, Fan; Geddes, Chris D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Santaus, Tonya M.; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA; [Li, Shan; Stine, O. Colin] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.; Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA.	geddes@umbc.edu		Santaus, Tonya/0000-0002-8643-2343; Geddes, Chris/0000-0002-9110-6374	National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship [T32GM066706-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship (T32GM066706-15). We note that the University of Maryland, Baltimore County (UMBC) has filed and has had issued several patents related to microwave-based lysing and DNA fragmentation. We note that those patents are licensed to Lyse-It LLC, a Maryland-based biotechnology company to which Dr. Geddes currently owns stock. Lyse-It LLC was not involved in the study design of the material within this paper, nor do any of the author receive any salaries or consultancies from Lyse-It LLC. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Agnez-Lima LF, 2012, MUTAT RES-REV MUTAT, V751, P15, DOI 10.1016/j.mrrev.2011.12.005; [Anonymous], 2018, STRUCTURE BOVINE PAN; [Anonymous], 2015, PROMEGA WIZARD GENOM; Arnold U, 1997, KINETIC THERMODYNAMI, V2166; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Chang SM, 2019, INT J RADIAT ONCOL, V103, P945, DOI 10.1016/j.ijrobp.2018.11.021; Del Vecchio P, 2000, THERMODYNAMIC STABIL, V363; Halliwell B., 1999, OXYGEN NITROGEN ARE, V37; KNIGHT JA, 1995, ANN CLIN LAB SCI, V25, P111; KREUDER V, 1984, EUR J BIOCHEM, V139, P389, DOI 10.1111/j.1432-1033.1984.tb08018.x; Krumova K, 2016, OVERVIEW REACTIVE OX, V3; Melendez JH, 2016, ANAL BIOCHEM, V510, P33, DOI 10.1016/j.ab.2016.06.017; Parsiegla G, 2012, STRUCTURE HUMAN DNAS, P10250; Probes M., 2003, J BIOL CHEM, P3170; Raines RT, 1998, RIBONUCLEASE A, V1045; Ray RS, 2013, TOXICOLOGY, V314, P229, DOI 10.1016/j.tox.2013.10.002; Ressler VT, 2019, CONSEQUENCES ENDOGEN, V1, P987; Santaus T., 2019, FOCUSED MICROWAVES C; Santaus T.M., 2017, MICROWAVE EFFECTS DN, P275, DOI [10.1007/978-3-319-50289-2_8, DOI 10.1007/978-3-319-50289-2_8]; Santaus TM, 2019, ELUCIDATION NON THER; Santaus TM, 2019, COMP LYSE IT OTHER C; Santaus TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201070; Schuch AP, 2017, FREE RADICAL BIO MED, V107, P110, DOI 10.1016/j.freeradbiomed.2017.01.029; Tripathy S, 2017, INT J PHARM SCI RES, V8, P1, DOI 10.13040/IJPSR.0975-8232.8(1).1-16; Wang Y, 2016, BIOENERG RES, V510, P33, DOI [10.1016/j.ab.2016.06.017, DOI 10.1016/J.AB.2016.06.017]; Waris G, 1998, ATTENUATED ANTIGENIC, V33; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhang YX, 2011, IEEE T BIO-MED ENG, V58, P781, DOI 10.1109/TBME.2010.2066275	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223008	10.1371/journal.pone.0223008	http://dx.doi.org/10.1371/journal.pone.0223008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT0QK	31568482	Green Published, gold			2022-12-26	WOS:000500703300001
J	Liu, B; Chen, AN; Lan, JY; Ren, L; Wei, YF; Gao, LN				Liu, Bo; Chen, Annan; Lan, Jinyi; Ren, Lei; Wei, Yifan; Gao, Lina			Protective mechanism of 1-methylhydantoin against lung injury induced by paraquat poisoning	PLOS ONE			English	Article							INTRINSIC ANTIOXIDANT; NZ-419; 5-HYDROXY-1-METHYLHYDANTOIN; STRATEGIES; CREATININE; TOXICITY; SERUM; RATS	Paraquat (PQ), one of the most widely used herbicides worldwide, causes severe toxic effects in humans and animals. 1-methylhydantoin (MH) is an active ingredient of Ranae Oviductus, which has broad pharmacological activities, e.g., eliminating reactive oxygen species and inhibiting inflammation. This study investigated the effects of MH on lung injury induced by PQ. A PQ poisoning model was established by intragastric infusion of PQ (25 mg/kg), and the control group was simultaneously gavaged with the same dose of saline. The MH group was intraperitoneally injected with 100 mg/kg once per day after intragastric infusion of PQ (25 mg/kg) for five consecutive days. All animals were sacrificed on the sixth day, and the lung tissues were dissected for metabolomics analysis. The lactate dehydrogenase (LDH) activity, superoxide dismutase (SOD) activity, TNF-alpha and malondialdehyde (MDA) content were determined according to the instructions of the detection kit. Compared with that in the control group, the content of LDH, TNF-alpha and MDA in the lung tissue of the PQ group was significantly higher, and the activity of SOD in the lung tissue was significantly lower (all p<0.05). Compared with that in the control group, the content of LDH, TNF-a and MDA in the MH group was significantly higher, and the activity of SOD was significantly lower (all p<0.05). However, the differences in SOD activity, LDH activity between the PQ and MH groups were not statistically significant (all p > 0.05). There were significant differences in MDA and TNF-alpha content between the PQ group and MH group (all p<0.05). MH decreased the production of malondialdehyde and TNF-alpha to protect against the lung injury caused by PQ poisoning, but it had no significant effect on the activity of LDH and SOD. There were significant differences in metabolomics between the MH group and the PQ poisoning group, primarily in bile acid biosynthesis and metabolism of cholesterol, nicotinate, nicotinamide, alanine, aspartate, glutamate, glycine, threonine, serine, phenylalanine and histidine. Therefore, this study highlights that MH has non-invasive mechanisms and may be a promising tool to treat lung injury induced by PQ poisoning.	[Liu, Bo; Chen, Annan; Lan, Jinyi; Ren, Lei] China Med Univ, Clin Dept 3, Shenyang, Liaoning, Peoples R China; [Wei, Yifan] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Gao, Lina] China Med Univ, Sch Forens Med, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Gao, LN (corresponding author), China Med Univ, Sch Forens Med, Shenyang, Liaoning, Peoples R China.	gaolina0114@sina.com			National Natural Science Foundation of China [81601644]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study received support in the form of grants from the National Natural Science Foundation of China (No.81601644). The funding bodies provided financial support, and the awardees performed the research. The funding sponsor had no role in the study design, performance, data collection and analysis, decision to publish, or preparation/writing of the manuscript.	Amberg A, 2017, METHODS MOL BIOL, V1641, P229, DOI 10.1007/978-1-4939-7172-5_13; Awadalla EA, 2012, EXP TOXICOL PATHOL, V64, P431, DOI 10.1016/j.etp.2010.10.009; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chang TH, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9110586; da Silva MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205535; DONNAHOO KK, 1999, AM J PHYSIOL-REG I, V277, pR92; Gales L, 2015, TOXICOLOGY, V336, P96, DOI 10.1016/j.tox.2015.08.005; Gao Lina, 2018, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V30, P1184, DOI 10.3760/cma.j.issn.2095-4352.2018.012.016; Gao Lina, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P246, DOI 10.3760/cma.j.issn.2095-4352.2015.04.004; Gao YQ, 2019, ACTA PHARM SIN B, V9, P157, DOI 10.1016/j.apsb.2018.09.006; [韩冬 Han Dong], 2014, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V40, P543; [韩宏伟 Han Hongwei], 2016, [精细石油化工, Speciality Petrochemicals], V33, P78; Hantson Philippe, 2008, J Forensic Leg Med, V15, P48, DOI 10.1016/j.jcfm.2006.09.003; Hasegawa G, 2011, CLIN NEPHROL, V76, P284, DOI 10.5414/CN107025; IENAGA K, 1988, BIOCHIM BIOPHYS ACTA, V967, P441, DOI 10.1016/0304-4165(88)90108-0; Ienaga K, 2013, EXP TOXICOL PATHOL, V65, P559, DOI 10.1016/j.etp.2012.05.001; Ienaga K, 2010, BIOL PHARM BULL, V33, P809, DOI 10.1248/bpb.33.809; Jian XD, 2011, HUM EXP TOXICOL, V30, P460, DOI 10.1177/0960327110372648; Kusonmano K, 2016, ADV EXP MED BIOL, V939, P91, DOI 10.1007/978-981-10-1503-8_5; Li WL, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2284720; Ling XM, 2017, J ETHNOPHARMACOL, V208, P138, DOI 10.1016/j.jep.2017.05.035; Liu G, 2015, J AM BOARD FAM MED, V28, P280, DOI 10.3122/jabfm.2015.02.140209; NAKAMURA K, 1991, NEPHRON, V58, P42, DOI 10.1159/000186376; Pakula MM, 2017, EXPERT OPIN THER TAR, V21, P611, DOI 10.1080/14728222.2017.1323879; Roede JR, 2014, TOXICOL REP, V1, P435, DOI 10.1016/j.toxrep.2014.07.006; Sun Baisheng, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P1043, DOI 10.3760/cma.j.issn.2095-4352.2017.11.018; [王永生 WANG Yongsheng], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P146; Wang YG, 2007, ACTA PHYTOTAXON SIN, V45, P1, DOI [10.1360/aps06106, 10.1111/j.1439-0469.2006.00384.x]; Yang Jingjing, 2018, J GUANGDONG PHARM U, V34, P417; You Jie-shu, 2013, Chinese Pharmacological Bulletin, V29, P1104, DOI 10.3969/j.issn.1001-1978.2013.08.015; Zhang Y, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9021371	34	15	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222521	10.1371/journal.pone.0222521	http://dx.doi.org/10.1371/journal.pone.0222521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560695	Green Published, gold			2022-12-26	WOS:000532353700014
J	Zhao, GY; Zhang, JY; Nie, DB; Zhou, YQ; Li, F; Onishi, K; Billiar, T; Wang, JHC				Zhao, Guangyi; Zhang, Jianying; Nie, Daibang; Zhou, Yiqin; Li, Feng; Onishi, Kentaro; Billiar, Timothy; Wang, James H-C			HMGB1 mediates the development of tendinopathy due to mechanical overloading	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; HUMAN TENDON FIBROBLASTS; INFLAMMATORY RESPONSE; PROTEIN HMGB1; GLYCYRRHIZIN; CELLS; PATHOGENESIS; DIFFERENTIATION; EXPRESSION; INCREASES	Mechanical overloading is a major cause of tendinopathy, but the underlying pathogenesis of tendinopathy is unclear. Here we report that high mobility group box1 (HMGB1) is released to the tendon extracellular matrix and initiates an inflammatory cascade in response to mechanical overloading in a mouse model. Moreover, administration of glycyrrhizin (GL), a naturally occurring triterpene and a specific inhibitor of HMGB1, inhibits the tendon's inflammatory reactions. Also, while prolonged mechanical overloading in the form of long-term intensive treadmill running induces Achilles tendinopathy in mice, administration of GL completely blocks the tendinopathy development. Additionally, mechanical overloading of tendon cells in vitro induces HMGB1 release to the extracellular milieu, thereby eliciting inflammatory and catabolic responses as marked by increased production of prostaglandin E2 (PGE2) and matrix metalloproteinase-3 (MMP-3) in tendon cells. Application of GL abolishes the cellular inflammatory/catabolic responses. Collectively, these findings point to HMGB1 as a key molecule that is responsible for the induction of tendinopathy due to mechanical overloading placed on the tendon.	[Zhao, Guangyi; Zhang, Jianying; Nie, Daibang; Zhou, Yiqin; Li, Feng; Wang, James H-C] Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA; [Nie, Daibang] Chongqing Med Univ, Coll Basic Med, Dept Immunol, Chongqing, Peoples R China; [Zhou, Yiqin] Second Mil Med Univ, Shanghai Changzheng Hosp, Joint Surg & Sports Med Dept, Shanghai, Peoples R China; [Onishi, Kentaro; Wang, James H-C] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Billiar, Timothy] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wang, James H-C] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chongqing Medical University; Naval Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	wanghc@pitt.edu			National Institutes of Health [AR061395, AR065949, AR070340]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK120531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (https://www.niams.nih.gov/) under award numbers AR061395 (JHW), AR065949 (JHW), and AR070340 (JHW). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; AKAMATSU H, 1991, PLANTA MED, V57, P119, DOI 10.1055/s-2006-960045; Akbar M, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000456; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Armanini D, 2003, CRIT REV CL LAB SCI, V40, P295, DOI 10.1080/713609355; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Dakin SG, 2018, BRIT J SPORT MED, V52, P359, DOI 10.1136/bjsports-2017-098161; Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801; Genovese T, 2009, SHOCK, V31, P367, DOI 10.1097/SHK.0b013e3181833b08; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Gwak GY, 2012, WORLD J GASTROENTERO, V18, P679, DOI 10.3748/wjg.v18.i7.679; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Irwin TA, 2010, FOOT ANKLE INT, V31, P933, DOI 10.3113/FAI.2010.0933; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kaux JF, 2011, J SPORT SCI MED, V10, P238; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kim YM, 2015, INT IMMUNOPHARMACOL, V26, P112, DOI 10.1016/j.intimp.2015.03.014; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lavagnino M, 2015, J ORTHOP RES, V33, P813, DOI 10.1002/jor.22871; Leclerc P, 2013, SCAND J IMMUNOL, V77, P350, DOI 10.1111/sji.12041; Li XL, 2011, INT J MOL SCI, V12, P905, DOI 10.3390/ijms12020905; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Lipman K, 2018, DRUG DES DEV THER, V12, P591, DOI 10.2147/DDDT.S154660; Lv SY, 2015, J MOL HISTOL, V46, P107, DOI 10.1007/s10735-014-9606-z; Magnusson SP, 2010, NAT REV RHEUMATOL, V6, P262, DOI 10.1038/nrrheum.2010.43; Millar NL, 2013, RHEUMATOLOGY, V52, P769, DOI 10.1093/rheumatology/kes409; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; Riley Graham, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008963; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SCHINKELIVY A, 2017, BMJ OPEN SPORT EXERC, V3, DOI DOI 10.1177/2333721417722709; Scott A, 2015, J ORTHOP SPORT PHYS, V45, P833, DOI 10.2519/jospt.2015.5884; SHAH R, 2018, EVID-BASED COMPL ALT, V2018, DOI DOI 10.1155/2018/8438101; Spiesz EM, 2015, J ORTHOP RES, V33, P889, DOI 10.1002/jor.22879; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Thankam FG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27250-2; Thankam FG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165492; Thorpe CT, 2015, SCAND J MED SCI SPOR, V25, pe381, DOI 10.1111/sms.12333; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wolf M, 2013, ROAD TO RECOVERY: HOW AND WHY ECONOMIC POLICY MUST CHANGE, P1; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yang H, 2015, MOL MED, V21, pS6, DOI 10.2119/molmed.2015.00087; Yang PS, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0148-4; Yuan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148557; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2012, J ORTHOP RES, V30, P47, DOI 10.1002/jor.21485; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	61	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222369	10.1371/journal.pone.0222369	http://dx.doi.org/10.1371/journal.pone.0222369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560698	Green Submitted, Green Published, gold			2022-12-26	WOS:000532353700009
J	Fede, C; Pirri, C; Fan, C; Albertin, G; Porzionato, A; Macchi, V; De Caro, R; Stecco, C				Fede, Caterina; Pirri, Carmelo; Fan, Chenglei; Albertin, Giovanna; Porzionato, Andrea; Macchi, Veronica; De Caro, Raffaele; Stecco, Carla			Sensitivity of the fasciae to sex hormone levels: Modulation of collagen-I, collagen-III and fibrillin production	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; REPRODUCTIVE HORMONES; CELLULAR-METABOLISM; MENSTRUAL-CYCLE; JOINT LAXITY; KNEE LAXITY; ESTROGEN; RELAXIN; PREGNANCY; TENDON	Although it is now recognized that women suffer from myofascial pain to a greater extent than men, and that the muscular fasciae can respond to hormonal stimuli, thanks to the expression of sex hormone receptors, how the fasciae can modify their structure under hormonal stimulation is not clear. In this work, an immunocytochemical analysis of collagen-I, collagen-III and fibrillin were carried out on fibroblasts isolated from human fascia lata after in vitro treatment with various levels of sex hormones beta-estradiol and/or relaxin-1, according to the phases of a woman's period (follicular, periovulatory, luteal, post-menopausal phases and pregnancy). This study demonstrates for the first time that fascial cells can modulate the production of some components of the extracellular matrix according to hormone levels, when treated with beta-estradiol: collagen-I falls from 6% of positivity in the follicular phase to 1.9 in the periovulatory phase. However, after the addition of relaxin-1 to the cell culture, the production of extracellular matrix decreased and remained at the same level (1.7% of collagen-I, at both follicular and periovulatory levels of hormones). These results confirm the anti-fibrotic function of relaxin-1, thanks to its ability to reduce matrix synthesis. They are also a first step in our understanding of how some hormonal dysfunctions in women can cause a dysregulation of extracellular matrix production in fasciae.	[Fede, Caterina; Fan, Chenglei; Albertin, Giovanna; Porzionato, Andrea; Macchi, Veronica; De Caro, Raffaele; Stecco, Carla] Univ Padua, Inst Human Anat, Dept Neurosci, Padua, Italy; [Pirri, Carmelo] Univ Roma Tor Vergata, Phys & Rehabil Med, Rome, Italy	University of Padua; University of Rome Tor Vergata	Stecco, C (corresponding author), Univ Padua, Inst Human Anat, Dept Neurosci, Padua, Italy.	carla.stecco@unipd.it	Macchi, Veronica/AAV-4514-2020	Macchi, Veronica/0000-0003-2335-6897; Stecco, Carla/0000-0002-8767-4555				Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Brauchle E, 2018, MATRIX BIOL, V68-69, P180, DOI 10.1016/j.matbio.2018.03.016; Bridgeman JT, 2010, FOOT ANKLE INT, V31, P1081, DOI 10.3113/FAI.2010.1081; Bridges R.S., 2009, ENCY NEUROSCIENCE, P333; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Chidi-Ogbolu N, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01834; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Dao TTT, 1998, J PROSTHET DENT, V79, P663, DOI 10.1016/S0022-3913(98)70073-3; Fede C, 2016, EUR J HISTOCHEM, V60, P224, DOI 10.4081/ejh.2016.2710; Fede C, 2016, EUR J HISTOCHEM, V60, P130, DOI 10.4081/ejh.2016.2643; Felson DT, 2005, ARTHRITIS RHEUM-US, V52, P2594, DOI 10.1002/art.21364; Freeman EW, 2007, OBSTET GYNECOL, V110, P230, DOI 10.1097/01.AOG.0000270153.59102.40; Goldsmith LT, 2009, ANN NY ACAD SCI, V1160, P130, DOI 10.1111/j.1749-6632.2008.03800.x; Gracovetsky S.A., 1988, THE SPINAL ENGINE; Guenzel-Apel AR, 2006, THERIOGENOLOGY, V66, P1431, DOI 10.1016/j.theriogenology.2006.01.030; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Hansen M, 2018, P NUTR SOC, V77, P32, DOI [10.1017/s0029665117001951, 10.1017/S0029665117001951]; Hansen M, 2009, J APPL PHYSIOL, V106, P1385, DOI 10.1152/japplphysiol.90935.2008; Konopka JA, 2016, AM J SPORT MED, V44, P2384, DOI 10.1177/0363546516646374; Lee CY, 2004, MATRIX BIOL, V23, P323, DOI 10.1016/j.matbio.2004.07.004; Lee H, 2018, J ATHL TRAINING, V53, P255, DOI 10.4085/1062-6050-2-17; Lee JW, 2015, J EXERC REHABIL, V11, P108, DOI 10.12965/jer.150188; Liu SH, 1997, AM J SPORT MED, V25, P704, DOI 10.1177/036354659702500521; Marnach ML, 2003, OBSTET GYNECOL, V101, P331, DOI 10.1016/S0029-7844(02)02447-X; Martineau PA, 2004, CLIN J SPORT MED, V14, P281, DOI 10.1097/00042752-200409000-00006; Nallasamy S, 2017, ENDOCRINOLOGY, V158, P950, DOI 10.1210/en.2016-1930; Ozturk Y, 2018, WORLD NEUROSURG, V111, pE941, DOI 10.1016/j.wneu.2018.01.004; Park YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176446; Pavan PG, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0441-4; Raine-Fenning NJ, 2003, AM J CLIN DERMATOL, V4, P371, DOI 10.2165/00128071-200304060-00001; Reed BG., 2018, ENDOTEXT, V2000; Sabino J, 2008, CURR REV MUSCULOSKE, V1, P137, DOI 10.1007/s12178-008-9021-8; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Sarajari S, 2010, EXP NEUROL, V224, P163, DOI 10.1016/j.expneurol.2010.03.006; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; Shultz SJ, 2012, MED SCI SPORT EXER, V44, P900, DOI 10.1249/MSS.0b013e31823bfb25; Shultz SJ, 2005, J SPORT MED PHYS FIT, V45, P594; Stecco C., 2015, FUNCTIONAL ATLAS HUM, P211; Stecco C, 2018, CLIN ANAT, V31, P667, DOI 10.1002/ca.23072; Stones RW, 2005, BRIT MED J, V331, P249, DOI 10.1136/bmj.331.7511.249; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wang SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193456; Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007; WREJE U, 1995, GYNECOL OBSTET INVES, V39, P197, DOI 10.1159/000292408; Yu WD, 1999, CLIN ORTHOP RELAT R, P229, DOI 10.1097/00003086-199909000-00030; Zazulak BT, 2006, SPORTS MED, V36, P847, DOI 10.2165/00007256-200636100-00004	47	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223195	10.1371/journal.pone.0223195	http://dx.doi.org/10.1371/journal.pone.0223195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557257	gold, Green Published			2022-12-26	WOS:000532345500087
J	Kanno, H; Aizawa, T; Hashimoto, K; Itoi, E				Kanno, Haruo; Aizawa, Toshimi; Hashimoto, Ko; Itoi, Eiji			Enhancing percutaneous pedicle screw fixation with hydroxyapatite granules: A biomechanical study using an osteoporotic bone model	PLOS ONE			English	Article							LUMBAR SPINAL-FUSION; PULLOUT STRENGTH; AUGMENTATION TECHNIQUES; CALCIUM-PHOSPHATE; IN-VITRO; DESIGNS; INSTRUMENTATION; COMPLICATIONS; STABILITY; CEMENT	Introduction Percutaneous pedicle screw (PPS) can provide internal fixation of the thoracolumbar spine through a minimally invasive surgical procedure. PPS fixation has been widely used to treat various spinal diseases. Rigid fixation of PPS is essential for managing osteoporotic spine in order to prevent the risks of screw loosening and implant failure. We recently developed a novel augmentation method using hydroxyapatite (HA) granules for PPS fixation. The aim of this study was to evaluate the strength and stiffness of PPS fixation augmented with HA granules using an osteoporotic bone model. Methods Screws were inserted into uniform synthetic bone (sawbones) with and without augmentation. The uniaxial pullout strength and insertion torque of the screws were evaluated. In addition, each screw underwent cyclic toggling under incrementally increasing physiological loads until 2 mm of screwhead displacement occurred. The maximal pullout strength (N), maximal insertion torque (N.cm), number of toggle cycles and maximal load (N) required to achieve 2-mm screwhead displacement were compared between the screws with and without augmentation. Results The maximal pullout strength was significantly stronger for screws with augmentation than for those without augmentation (302 +/- 19 N vs. 254 +/- 17 N, p < 0.05). In addition, the maximal insertion torque was significantly increased in screws with augmentation compared to those without augmentation (48 +/- 4 N.cm vs. 26 +/- 5 N.cm, p < 0.05). Furthermore, the number of toggle cycles and the maximal load required to reach 2 mm of displacement were significantly greater in screws with augmentation than in those without augmentation (106 +/- 9 vs. 52 +/- 10 cycles; 152 +/- 4 N vs. 124 +/- 5 N, p < 0.05). Conclusions Augmentation using HA granules significantly enhanced the rigidity of PPS fixation in the osteoporotic bone model. The present study suggested that novel augmentation with HA granules may be a useful technique for PPS fixation in patients with osteoporotic spine.	[Kanno, Haruo; Aizawa, Toshimi; Hashimoto, Ko; Itoi, Eiji] Tohoku Univ, Dept Orthoped Surg, Sch Med, Sendai, Miyagi, Japan	Tohoku University	Kanno, H (corresponding author), Tohoku Univ, Dept Orthoped Surg, Sch Med, Sendai, Miyagi, Japan.	kanno-h@isis.ocn.ne.jp	Kanno, Haruo/AAA-2187-2020	Kanno, Haruo/0000-0003-1985-2257; Hashimoto, Ko/0000-0002-9644-054X				[Anonymous], 2012, ANN BOOK ASTM STAND; Baluch DA, 2014, SPINE, V39, pE1297, DOI 10.1097/BRS.0000000000000553; Becker S, 2008, EUR SPINE J, V17, P1462, DOI 10.1007/s00586-008-0769-8; Brady PC, 2006, ARTHROSCOPY, V22, P925, DOI 10.1016/j.arthro.2006.04.103; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burval DJ, 2007, SPINE, V32, P1077, DOI 10.1097/01.brs.0000261566.38422.40; Chao KH, 2013, MED ENG PHYS, V35, P1506, DOI 10.1016/j.medengphy.2013.04.007; Chapman JR, 1996, J BIOMECH ENG-T ASME, V118, P391, DOI 10.1115/1.2796022; Cho W, 2010, J BONE JOINT SURG BR, V92B, P1061, DOI 10.1302/0301-620X.92B8.24237; Chutkan NB, 2008, SPINE, V33, pE828, DOI 10.1097/BRS.0b013e318183bb6d; Cook Stephen D, 2004, Spine J, V4, P402, DOI 10.1016/j.spinee.2003.11.010; Derincek A, 2006, J SPINAL DISORD TECH, V19, P286, DOI 10.1097/01.bsd.0000211203.31244.a0; DeWald CJ, 2006, SPINE, V31, pS144, DOI 10.1097/01.brs.0000236893.65878.39; Deyo RA, 2013, SPINE, V38, P1695, DOI 10.1097/BRS.0b013e31829f65c1; Elder BD, 2015, SPINE J, V15, P1432, DOI 10.1016/j.spinee.2015.03.016; ESSES SI, 1993, SPINE, V18, P2231, DOI 10.1097/00007632-199311000-00015; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; Foley KT., 2001, NEUROSURG FOCUS, V10, pE10, DOI [10.3171/foc.2001.10.4.11, DOI 10.3171/foc.2001.10.4.11]; Galbusera F, 2015, EUR SPINE J, V24, P1005, DOI 10.1007/s00586-015-3768-6; Gu GF, 2015, J SPINAL DISORD TECH, V28, pE522, DOI 10.1097/BSD.0b013e3182aab222; Hamasaki T, 2010, J SPINAL DISORD TECH, V23, P127, DOI 10.1097/BSD.0b013e31819942cd; Hasegawa K, 1998, ARCH ORTHOP TRAUM SU, V117, P175, DOI 10.1007/s004020050223; Hasegawa K, 1997, SPINE, V22, P958, DOI 10.1097/00007632-199705010-00004; Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010; Hashemi A, 2009, SPINE J, V9, P404, DOI 10.1016/j.spinee.2008.07.001; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hirano T, 1997, SPINE, V22, P2504, DOI 10.1097/00007632-199711010-00007; Hongo M, 2009, SPINE J, V9, P846, DOI [10.1016/j.spinee.2009.06.015, 10.1016/j.spinee.2009.06.019]; Hongo M, 2009, EUR SPINE J, V18, P1213, DOI 10.1007/s00586-009-0999-4; Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008; Hughes M, 2018, SICOT-J, V4, DOI 10.1051/sicotj/2018009; Inceoglu S, 2011, J NEUROSURG-SPINE, V14, P670, DOI 10.3171/2010.11.SPINE09886; Kanno H., 2018, J MIOS, V87, P81, DOI [10.1097/BRS.0000000000002789, DOI 10.1097/BRS.0000000000002789]; Kawakami J, 2018, ARTHROSCOPY, V34, P377, DOI 10.1016/j.arthro.2017.07.022; Kim YY, 2012, SPINE J, V12, P164, DOI 10.1016/j.spinee.2012.01.014; Kiyak G, 2018, ASIAN SPINE J, V12, P3, DOI 10.4184/asj.2018.12.1.3; Koller H, 2013, SPINE J, V13, P532, DOI 10.1016/j.spinee.2013.01.038; Kuklo TR, 2008, SPINE, V33, pE482, DOI 10.1097/BRS.0b013e31817c64d5; LAW M, 1993, SPINE, V18, P2438, DOI 10.1097/00007632-199312000-00012; Lehman RA, 2015, J AM ACAD ORTHOP SUR, V23, P253, DOI 10.5435/JAAOS-D-14-00042; Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020; Lotz JC, 1997, SPINE, V22, P2716, DOI 10.1097/00007632-199712010-00003; Matsuzaki H., 2001, CLIN ORTHOP SURG, V36, P529; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; Mobbs RJ, 2011, J CLIN NEUROSCI, V18, P741, DOI 10.1016/j.jocn.2010.09.019; Murakami H, 2006, SPINE, V31, P967, DOI 10.1097/01.brs.0000214932.49027.6a; Ohba T, 2019, SPINE SURG RELAT RES, V3, P79, DOI 10.22603/ssrr.2018-0018; Ohtori S, 2013, SPINE, V38, pE487, DOI 10.1097/BRS.0b013e31828826dd; OKUYAMA K, 1993, SPINE, V18, P2240, DOI 10.1097/00007632-199311000-00016; Okuyama K, 2001, Spine J, V1, P402, DOI 10.1016/S1529-9430(01)00078-X; Okuyama K, 2000, SPINE, V25, P858, DOI 10.1097/00007632-200004010-00015; Park Y, 2018, YONSEI MED J, V59, P524, DOI 10.3349/ymj.2018.59.4.524; Pfeiffer FM, 2006, SPINE, V31, pE867, DOI 10.1097/01.brs.0000244658.35865.59; Raley DA, 2012, SPINE, V37, P1092, DOI 10.1097/BRS.0b013e31823c80d8; Regev GJ, 2009, SPINE, V34, P1239, DOI 10.1097/BRS.0b013e31819e2c5c; Ringel F, 2006, NEUROSURGERY, V59, P361, DOI 10.1227/01.NEU.0000223505.07815.74; Sakamoto M, 2007, J BIOMED MATER RES A, V82A, P238, DOI 10.1002/jbm.a.31013; Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008; Schoenfeld AJ, 2013, SPINE J, V13, P1171, DOI 10.1016/j.spinee.2013.02.071; Seng WRD, 2019, SPINE, V44, pE144, DOI 10.1097/BRS.0000000000002789; Shin SJ, 2017, CLIN SPINE SURG, V30, pE819, DOI 10.1097/BSD.0000000000000405; Son Seong, 2012, Korean J Spine, V9, P352, DOI 10.14245/kjs.2012.9.4.352; Spivak JM, 2001, EUR SPINE J, V10, pS197, DOI 10.1007/s005860100286; SPIVAK JM, 1994, SPINE, V19, P955, DOI 10.1097/00007632-199404150-00015; Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222; Than KD, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17479; Tokuhashi Y, 2008, SPINE, V33, P903, DOI 10.1097/BRS.0b013e31816b1eff; Upasani VV, 2009, SPINE, V34, P335, DOI 10.1097/BRS.0b013e318194878d; Versteeg AL, 2016, ANN SURG ONCOL, V23, P2343, DOI 10.1245/s10434-016-5156-9; Vishnubhotla S, 2011, SPINE J, V11, P777, DOI 10.1016/j.spinee.2011.06.006; Wu ZX, 2012, ARCH ORTHOP TRAUM SU, V132, P471, DOI 10.1007/s00402-011-1439-6; Yerby SA, 1998, SPINE, V23, P1657, DOI 10.1097/00007632-199808010-00008; Yi S, 2015, WORLD NEUROSURG, V83, P976, DOI 10.1016/j.wneu.2015.01.056; Zhang W, 2016, SPINE, V41, pB23, DOI 10.1097/BRS.0000000000001814; Zhu Q, 2012, SPINE, V37, pE1030, DOI 10.1097/BRS.0b013e31825a676e	75	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223106	10.1371/journal.pone.0223106	http://dx.doi.org/10.1371/journal.pone.0223106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557234	gold, Green Published			2022-12-26	WOS:000532345500069
J	Smolyaninova, LV; Shiyan, AA; Kapilevich, LV; Lopachev, AV; Fedorova, TN; Klementieva, TS; Moskovtsev, AA; Kubatiev, AA; Orlov, SN				Smolyaninova, Larisa V.; Shiyan, Alexandra A.; Kapilevich, Leonid V.; Lopachev, Alexander V.; Fedorova, Tatiana N.; Klementieva, Tatiana S.; Moskovtsev, Aleksey A.; Kubatiev, Aslan A.; Orlov, Sergei N.			Transcriptomic changes triggered by ouabain in rat cerebellum granule cells: Role of alpha 3-and alpha 1-Na+,K+-ATPase-mediated signaling	PLOS ONE			English	Article							INTRACELLULAR SODIUM CONCENTRATION; NA-K-ATPASE; GENE-EXPRESSION; FUNCTIONAL INTERACTION; OLFACTORY RECEPTOR; NA,K-ATPASE ALPHA; NA+/K+-ATPASE; GLIAL-CELLS; ISOFORMS; CALCIUM	It was shown previously that inhibition of the ubiquitous alpha 1 isoform of Na+,K+-ATPase by ouabain sharply affects gene expression profile via elevation of intracellular [Na+](i)/[K+](i) ratio. Unlike other cells, neurons are abundant in the alpha 3 isoform of Na+,K+-ATPase, whose affinity in rodents to ouabain is 10(4)-fold higher compared to the alpha 1 isoform. With these sharp differences in mind, we compared transcriptomic changes in rat cerebellum granule cells triggered by inhibition of alpha 1- and alpha 3-Na+,K+-ATPase isoforms. Inhibition of alpha 1- and alpha 3-Na+,K+-ATPase isoforms by 1 mM ouabain resulted in dissipation of transmembrane Na+ and K+ gradients and differential expression of 994 transcripts, whereas selective inhibition of alpha 3-Na+,K+-ATPase isoform by 100 nM ouabain affected expression of 144 transcripts without any impact on the [Na+](i)/[K+](i) ratio. The list of genes whose expression was affected by 1 mM ouabain by more than 2-fold was abundant in intermediates of intracellular signaling and transcription regulators, including augmented content of Npas4, Fos, Junb, Atf3, and Klf4 mRNAs, whose upregulated expression was demonstrated in neurons subjected to electrical and glutamatergic stimulation. The role [Na+](i)/[K+](i)-mediated signaling in transcriptomic changes involved in memory formation and storage should be examined further.	[Smolyaninova, Larisa V.; Shiyan, Alexandra A.; Orlov, Sergei N.] Moscow MV Lomonosov State Univ, Dept Biomembranes, Fac Biol, Moscow, Russia; [Smolyaninova, Larisa V.; Kapilevich, Leonid V.; Orlov, Sergei N.] Natl Res Tomsk State Univ, Dept Sports Tourism Sports Physiol & Med, Tomsk, Russia; [Lopachev, Alexander V.; Fedorova, Tatiana N.] Res Ctr Neurol, Lab Clin & Expt Neurochem, Moscow, Russia; [Klementieva, Tatiana S.; Moskovtsev, Aleksey A.; Kubatiev, Aslan A.] Inst Gen Pathol & Pathophysiol, Dept Mol & Cell Pathophysiol, Moscow, Russia; [Orlov, Sergei N.] Siberian Med State Univ, Cent Res Lab, Tomsk, Russia	Lomonosov Moscow State University; Tomsk State University; Research Center of Neurology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Siberian State Medical University	Smolyaninova, LV; Orlov, SN (corresponding author), Moscow MV Lomonosov State Univ, Dept Biomembranes, Fac Biol, Moscow, Russia.; Smolyaninova, LV; Orlov, SN (corresponding author), Natl Res Tomsk State Univ, Dept Sports Tourism Sports Physiol & Med, Tomsk, Russia.; Orlov, SN (corresponding author), Siberian Med State Univ, Cent Res Lab, Tomsk, Russia.	smolyaninovalarisa1@gmail.com; sergeinorlov@yandex.ru	Moskovtsev, Alexey/AAF-8121-2021; Lopachev, Alexander/C-1498-2015; Fedorova, Tatiana N/B-4282-2012; Kapilevich, Leonid V./N-9196-2014; Kubatiev, Aslan/AAF-8186-2021; Lopachev, Alexander/AAD-3630-2022; Shiyan, Aleksandra/AAB-9820-2019	Lopachev, Alexander/0000-0002-5688-3899; Lopachev, Alexander/0000-0002-5688-3899; Kapilevich, Leonid/0000-0002-2316-576X	Russian Scientific Foundation RNF [16-15-10026-n]; Russian Foundation for Basic Research RFBR [18-04-00063]; Russian Science Foundation [19-15-13003] Funding Source: Russian Science Foundation	Russian Scientific Foundation RNF(Russian Science Foundation (RSF)); Russian Foundation for Basic Research RFBR(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grants from the Russian Scientific Foundation RNF http://rscf.ru/(#16-15-10026-n) (S.N.O) and the Russian Foundation for Basic Research RFBR http://www.rfbr.ru/rffi/ru/(#18-04-00063) (S.N.O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova OA, 2006, CELL MOL BIOL, V52, P71, DOI 10.1170/T763; Akimova OA, 2015, APOPTOSIS, V20, P1200, DOI 10.1007/s10495-015-1144-y; Akkuratov EE, 2015, MOL NEUROBIOL, V52, P1726, DOI 10.1007/s12035-014-8975-3; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; ATTERWILL CK, 1984, J NEUROCHEM, V43, P8, DOI 10.1111/j.1471-4159.1984.tb06672.x; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Bennay M, 2008, GLIA, V56, P1138, DOI 10.1002/glia.20685; BERREBIBERTRAND I, 1990, BIOCHIM BIOPHYS ACTA, V1021, P148, DOI 10.1016/0005-2736(90)90027-L; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco G, 2000, J HISTOCHEM CYTOCHEM, V48, P1023, DOI 10.1177/002215540004800801; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Dai WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8576; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gao T, 2019, BIOCHEM BIOPH RES CO, V512, P106, DOI 10.1016/j.bbrc.2019.02.155; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; HARA Y, 1988, FEBS LETT, V238, P27, DOI 10.1016/0014-5793(88)80218-7; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; HIEBER V, 1991, CELL MOL NEUROBIOL, V11, P253, DOI 10.1007/BF00769038; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Karpova LV, 2010, CELL BIOCHEM FUNCT, V28, P135, DOI 10.1002/cbf.1632; KIEDROWSKI L, 1994, MOL PHARMACOL, V45, P1050; Klimanova EA, 2017, SCI REP-UK, V7, DOI 10.1038/srep45403; Knopfel T, 1998, EUR J NEUROSCI, V10, P1926, DOI 10.1046/j.1460-9568.1998.00195.x; Kohl JV, 2001, NEUROENDOCRINOL LETT, V22, P309; Koltsova SV, 2015, CELL CALCIUM, V58, P317, DOI 10.1016/j.ceca.2015.06.009; Koltsova SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038032; La J, 2016, AM J PHYSIOL-LUNG C, V310, pL815, DOI 10.1152/ajplung.00322.2015; Landsberg JW, 2004, NEWS PHYSIOL SCI, V19, P44, DOI 10.1152/nips.01457.2003; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Li CM, 2005, J BIOL CHEM, V280, P42738, DOI 10.1074/jbc.M508451200; Lima LD, 2013, NEUROPHARMACOLOGY, V73, P327, DOI 10.1016/j.neuropharm.2013.06.006; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Lopachev AV, 2016, CELL BIOCHEM FUNCT, V34, P367, DOI 10.1002/cbf.3199; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; Olender Tsviya, 2008, Human Genomics, V3, P87; Orlov SN, 2017, MOLECULES, V22, DOI 10.3390/molecules22040635; Orlov SN, 2015, PFLUG ARCH EUR J PHY, V467, P489, DOI 10.1007/s00424-014-1650-8; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Peng L, 1997, J NEUROSCI, V17, P3488; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Riganti C, 2011, CURR MED CHEM, V18, P872, DOI 10.2174/092986711794927685; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Sidorenko S, 2018, CELL CALCIUM, V76, P72, DOI 10.1016/j.ceca.2018.09.007; Smolyaninova LV, 2017, CELL CALCIUM, V68, P5, DOI 10.1016/j.ceca.2017.10.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013	74	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222767	10.1371/journal.pone.0222767	http://dx.doi.org/10.1371/journal.pone.0222767			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JK8EZ	31557202	Green Published, gold			2022-12-26	WOS:000495073900001
J	Zhang, HW; Zhu, D; Zhang, ZB; Kaluz, S; Yu, B; Devi, NS; Olson, JJ; Van Meir, EG				Zhang, Hanwen; Zhu, Dan; Zhang, Zhaobin; Kaluz, Stefan; Yu, Bing; Devi, Narra S.; Olson, Jeffrey J.; Van Meir, Erwin G.			EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway	ONCOGENE			English	Article							BRAIN; P53; ANGIOGENESIS; PROTEINS; GENE	Medulloblastoma (MB) is a malignant pediatric brain tumor for which new therapies are urgently needed. We demonstrate that treatment with EPZ-6438 (Tazemetostat), an enhancer of zeste homolog 2 (EZH2) inhibitor approved for clinical trials, blocks MB cell growth in vitro and in vivo, and prolongs survival in orthotopic xenograft models. We show that the therapeutic effect is dependent on epigenetic reactivation of adhesion G-protein-coupled receptor B1 (BAI1/ADGRB1), a tumor suppressor that controls p53 stability by blocking Mdm2. Histone 3 trimethylated on lysine 27 (H3K27me3), a marker of silent chromatin conformation is present at the ADGRB1 promoter, and inhibition of EZH2, the catalytic component of the Polycomb Repressive complex 2 (PRC2) that methylates H3K27, switches the gene into an active chromatin status and reactivates BAI1 expression. Mechanistically, targeting EZH2 promotes transition from H3K27me3 to H3K27ac at the promoter, recruits the C/EBP beta (CREB-binding protein) and CBP transcription factors and activates ADGRB1 gene transcription. Taken together, our results identify key molecular players that regulate ADGRB1 gene expression in MB, demonstrate that reactivation of BAI1 expression underlies EPZ-6438 antitumorigenic action, and provide preclinical proof-of-principle evidence for targeting EZH2 in patients with MB.	[Zhang, Hanwen; Zhu, Dan; Zhang, Zhaobin; Kaluz, Stefan; Yu, Bing; Devi, Narra S.; Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg & Hematol & Med Oncol, Lab Mol Neurooncol, Atlanta, GA 30322 USA; [Zhang, Hanwen] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410013, Peoples R China; [Zhang, Hanwen] Cent S Univ, Sch Med, Changsha 410013, Peoples R China; [Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] UAB, Dept Neurosurg, WTI 520E,1720 2nd Ave, South Birmingham, AL 35294 USA; [Van Meir, Erwin G.] UAB, ONeal Comprehens Canc Ctr, WTI 520E,1720 2nd Ave, South Birmingham, AL 35294 USA	Emory University; Central South University; Central South University; Emory University; Emory University	Van Meir, EG (corresponding author), Emory Univ, Sch Med, Dept Neurosurg & Hematol & Med Oncol, Lab Mol Neurooncol, Atlanta, GA 30322 USA.; Van Meir, EG (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Van Meir, EG (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.; Van Meir, EG (corresponding author), UAB, Dept Neurosurg, WTI 520E,1720 2nd Ave, South Birmingham, AL 35294 USA.; Van Meir, EG (corresponding author), UAB, ONeal Comprehens Canc Ctr, WTI 520E,1720 2nd Ave, South Birmingham, AL 35294 USA.	evanmeir@uab.edu	Zhang, Hanwen/AFK-2928-2022; Zhang, Hanwen/AAG-1299-2022	Zhang, Hanwen/0000-0001-8955-7494; Zhang, Hanwen/0000-0001-8955-7494; Van Meir, Erwin G./0000-0003-2444-7707	NIH [CA163722, CA235162, NS096236, CA138292]; CURE Childhood Cancer Foundation; St. Baldrick's Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE Childhood Cancer Foundation; St. Baldrick's Foundation	This work was supported by grants from the NIH CA163722, CA235162, and NS096236 (to EGVM), CA138292 (to Winship Cancer Institute), the CURE Childhood Cancer Foundation and the St. Baldrick's Foundation.	Aust G, 2016, HANDB EXP PHARMACOL, V234, P369, DOI 10.1007/978-3-319-41523-9_17; Chan HM, 2001, J CELL SCI, V114, P2363; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mohammad F, 2017, NAT MED, V23, P483, DOI 10.1038/nm.4293; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Van Meir EG, 1997, INT J CANCER, V71, P310; Vo BT, 2017, CELL REP, V18, P2907, DOI 10.1016/j.celrep.2017.02.073; Yan WJ, 2016, EPIGENOMICS-UK, V8, P119, DOI 10.2217/epi.15.84; Zhang P, 2015, INT J CANCER, V137, P2007, DOI 10.1002/ijc.29566; Zhu D, 2018, CANCER CELL, V33, P1004, DOI 10.1016/j.ccell.2018.05.006; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	21	19	19	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1041	1048		10.1038/s41388-019-1036-7	http://dx.doi.org/10.1038/s41388-019-1036-7			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31582835	Green Accepted			2022-12-26	WOS:000511209700007
J	Tiek, DM; Khatib, SA; Trepicchio, CJ; Heckler, MM; Divekar, SD; Sarkaria, JN; Glasgow, E; Riggins, RB				Tiek, Deanna M.; Khatib, Subreen A.; Trepicchio, Colin J.; Heckler, Mary M.; Divekar, Shailaja D.; Sarkaria, Jann N.; Glasgow, Eric; Riggins, Rebecca B.			Estrogen-related receptor beta activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma	FASEB JOURNAL			English	Article						GBM; ERR-beta; alternative splicing; cortactin; CLK	BLOOD-BRAIN-BARRIER; THERAPEUTIC TARGET; PROSTATE-CANCER; ERR-BETA; IDENTIFICATION; EXPRESSION; GENE; CORTACTIN; GAMMA; PROLIFERATION	Glioblastoma (GBM; grade 4 glioma) is a highly aggressive and incurable tumor. GBM has recently been characterized as highly dependent on alternative splicing, a critical driver of tumor heterogeneity and plasticity. Estrogen-related receptor beta (ERR-beta) is an orphan nuclear receptor expressed in the brain, where alternative splicing of the 3' end of the pre-mRNA leads to the production of 3 validated ERR-beta protein products: ERR-beta short form (ERR-(beta sf), ERR-beta 2, and ERR-beta exon 10 deleted. Our prior studies have shown the ERR-beta isoform to play a role in G(2)/M cell cycle arrest and induction of apoptosis, in contrast to the function of the shorter ERR-beta 2 isoform in senescence and G1 cell cycle arrest. In this study, we sought to better define the role of the proapoptotic ERR-beta 2 isoform in GBM. We show that the ERR-beta 2 isoform is located not only in the nucleus but also in the cytoplasm. ERR-beta 2 suppresses GBM cell migration and interacts with the actin nucleation-promoting factor cortactin, and an ERR-beta agonist is able to remodel the actin cytoskeleton and similarly suppress GBM cell migration. We further show that inhibition of the splicing regulatory cdc2-like kinases in combination with an ERR-beta agonist shifts isoform expression in favor of ERR-beta 2 and potentiates inhibition of growth and migration in GBM cells and intracranial tumors.	[Tiek, Deanna M.; Khatib, Subreen A.; Trepicchio, Colin J.; Heckler, Mary M.; Divekar, Shailaja D.; Glasgow, Eric; Riggins, Rebecca B.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Khatib, Subreen A.] NCI, Human Carcinogenesis Lab, Bldg 37, Bethesda, MD 20892 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic	Tiek, DM; Riggins, RB (corresponding author), Georgetown Univ, Sch Med, E412 Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	dmt53@georgetown.edu; rbr7@georgetown.edu	Riggins, Rebecca/GQH-4466-2022	Glasgow, Eric/0000-0001-7729-3954	U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI) [R21 CA191444]; Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award; Partners in Research Breakthrough Award; NIH/NCI [F99 CA234799]; Medical Center Graduate Student Organization (MCGSO); Tumor Biology Training Grant [T32 CA009686]; NIH/NCI Cancer Center Support Grant [P30 CA051008];  [P50 CA108961]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI); Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award; Partners in Research Breakthrough Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Center Graduate Student Organization (MCGSO); Tumor Biology Training Grant; NIH/NCI Cancer Center Support Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of the R.B.R. laboratory, as well as Drs. Maria Laura Avantaggiati, Deborah Berry, Karen Creswell, Brent Harris, Peter Johnson, Supti Sen, Alexandra Taraboletti, Jeffrey Toretsky, Todd Waldman, and Dan Xun (Lombardi Comprehensive Cancer Center, Georgetown University) for sharing reagents, scientific insights, technical assistance, and/or editorial comments on the manuscript. This work was supported by U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI) R21 CA191444 (to R.B.R.), a Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award (to R.B.R.), and a Partners in Research Breakthrough Award (to R.B.R.), as well as NIH/NCI Grant F99 CA234799 (to D.M.T.) and a student research grant from the Medical Center Graduate Student Organization (MCGSO; to D.M.T.). Additional fellowship funding for D.M.T. and M.M.H. was provided by the Tumor Biology Training Grant [T32 CA009686, principal investigator (PI): Dr. Anna T. Riegel]. Technical services were provided by the GUMC Animal Models, Flow Cytometry and Cell Sorting, Histopathology and Tissue, Microscopy and Imaging, and Tissue Culture Shared Resources, which are supported, in part, by NIH/NCI Cancer Center Support Grant P30 CA051008 (PI: Dr. Louis M. Weiner). The Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource is supported, in part, by P50 CA108961 (to J.N.S., PI: Dr. Patrick O'Neill). The content of this article is the sole responsibility of the authors and does not represent the official views of the NIH. The authors declare no conflicts of interest.	[Anonymous], 2004, IMAGEJ COMPUTER PROG; Barriuso J, 2015, CLIN CANCER RES, V21, P969, DOI 10.1158/1078-0432.CCR-14-2921; Bidinosti M, 2016, SCIENCE, V351, P1199, DOI 10.1126/science.aad5487; Braun CJ, 2017, CANCER CELL, V32, P411, DOI 10.1016/j.ccell.2017.08.018; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Byerly Mardi S., 2013, BMC Physiology, V13, P10, DOI 10.1186/1472-6793-13-10; Byerly MS, 2013, EUR J NEUROSCI, V37, P1033, DOI 10.1111/ejn.12122; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Corkery DP, 2015, NUCLEUS-PHILA, V6, P279, DOI 10.1080/19491034.2015.1062194; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Craft B., 2019, BRILL REF LIBR JUD, DOI DOI 10.1163/9789004367135_002d; Das M, 2019, NUCLEIC ACID THER, V29, P61, DOI 10.1089/nat.2018.0762; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Fujimura A, 2013, NEOPLASIA, V15, P1272, DOI 10.1593/neo.131440; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Heckler MM, 2016, ONCOTARGET, V7, P47201, DOI 10.18632/oncotarget.9719; Heckler MM, 2015, CELL CYCLE, V14, P31, DOI 10.4161/15384101.2014.972886; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lim KRQ, 2018, METHODS MOL BIOL, V1828, P3, DOI 10.1007/978-1-4939-8651-4_1; Lindsay SJ, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00086; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Murnyak B, 2017, ONCOTARGET, V8, P46348, DOI 10.18632/oncotarget.18013; O'Brown NM, 2018, GENE DEV, V32, P466, DOI 10.1101/gad.309823.117; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Park SY, 2016, ONCOTARGET, V7, P26793, DOI 10.18632/oncotarget.8471; Parrish KE, 2015, CLIN PHARMACOL THER, V97, P336, DOI 10.1002/cpt.71; Patel SR, 2015, MOL CELL ENDOCRINOL, V418, P298, DOI 10.1016/j.mce.2015.07.009; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Perazzoli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140131; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Rahman MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13208; Robins HI, 2006, NEURO-ONCOLOGY, V8, P47, DOI 10.1215/S1522851705000311; Sakuma M, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0044-6; Seiler M, 2018, NAT MED, V24, P497, DOI 10.1038/nm.4493; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Tiek DM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25588-1; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang Y, 2012, ACS CHEM BIOL, V7, P1040, DOI 10.1021/cb300028a; Welker AM, 2017, NEUROSCIENCE, V356, P35, DOI 10.1016/j.neuroscience.2017.05.010; Welker AM, 2016, DIS MODEL MECH, V9, P199, DOI 10.1242/dmm.022921; Yu DD, 2005, BIOORG MED CHEM LETT, V15, P1311, DOI 10.1016/j.bmcl.2005.01.025; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	56	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13476	13491		10.1096/fj.201901075R	http://dx.doi.org/10.1096/fj.201901075R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570001	Green Published, Green Submitted			2022-12-26	WOS:000507466100035
J	Jiang, HJ; Thomas, SN; Chen, Z; Chiang, CY; Cole, PA				Jiang, Hanjie; Thomas, Stefani N.; Chen, Zan; Chiang, Claire Y.; Cole, Philip A.			Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; ubiquitin; allosteric regulation; E3 ubiquitin ligase; post-translational modification (PTM); enzyme homeostasis; NEDD4 E3 ubiquitin protein ligase (NEDD4); Nedd4 family interaction protein (Ndfip1); WW domain-binding protein 2 (WBP2); WW domain-containing E3 ubiquitin protein ligase 2 (WWP2)	HECT DOMAIN; E3 LIGASE; BREAST-CANCER; INSIGHTS; PROTEIN; FAMILY; PROMOTES; BINDING; DEGRADATION; ACTIVATION	NEDD4-1 E3 ubiquitin protein ligase (NEDD4-1) and WW domain-containing E3 ubiquitin ligase (WWP2) are HECT family ubiquitin E3 ligases. They catalyze Lys ubiquitination of themselves and other proteins and are important in cell growth and differentiation. Regulation of NEDD4-1 and WWP2 catalytic activities is important for controlling cellular protein homeostasis, and their dysregulation may lead to cancer and other diseases. Previous work has implicated noncatalytic regions, including the C2 domain and/or WW domain linkers in NEDD4-1 and WWP2, in contributing to autoinhibition of the catalytic HECT domains by intramolecular interactions. Here, we explored the molecular mechanisms of these NEDD4-1 and WWP2 regulatory regions and their interplay with allosteric binding proteins such as Nedd4 family-interacting protein (NDFIP1), engineered ubiquitin variants, and linker phosphomimics. We found that in addition to influencing catalytic activities, the WW domain linker regions in NEDD4-1 and WWP2 can impact product distribution, including the degree of polyubiquitination and Lys-48 versus Lys-63 linkages. We show that allosteric activation by NDFIP1 or engineered ubiquitin variants is largely mediated by relief of WW domain linker autoinhibition. WWP2-mediated ubiquitination of WW domain-binding protein 2 (WBP2), phosphatase and tensin homolog (PTEN), and p62 proteins by WWP2 suggests that substrate ubiquitination can also be influenced by WW linker autoinhibition, although to differing extents. Overall, our results provide a deeper understanding of the intricate and multifaceted set of regulatory mechanisms in the control of NEDD4-1-related ubiquitin ligases.	[Jiang, Hanjie; Cole, Philip A.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Cole, Philip A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jiang, Hanjie; Chen, Zan; Cole, Philip A.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Thomas, Stefani N.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Chiang, Claire Y.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Cole, PA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA.; Cole, PA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Cole, PA (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pacole@bwh.harvard.edu	Thomas, Stefani/AAF-4212-2021; Jiang, Hanjie/AAT-8422-2021	Thomas, Stefani/0000-0003-1679-5453; Chiang, Claire/0000-0002-0999-9856; Jiang, Hanjie/0000-0001-6090-4552	National Institutes of Health [R01CA74305]; NATIONAL CANCER INSTITUTE [R01CA074305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA74305. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Chen Z, 2016, BIOCHEMISTRY-US, V55, P3658, DOI 10.1021/acs.biochem.6b00448; Chen Z, 2016, J BIOL CHEM, V291, P14160, DOI 10.1074/jbc.M116.728980; Chu N, 2018, CELL, V174, P897, DOI 10.1016/j.cell.2018.07.003; Dempsey DR, 2018, J AM CHEM SOC, V140, P9374, DOI 10.1021/jacs.8b05098; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackl M, 2018, J MOL BIOL, V430, P3218, DOI 10.1016/j.jmb.2018.06.044; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kathman SG, 2015, J AM CHEM SOC, V137, P12442, DOI 10.1021/jacs.5b06839; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Lim SK, 2016, CANCER RES, V76, P6278, DOI 10.1158/0008-5472.CAN-15-3537; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Lin Q, 2017, J CELL SCI, V130, P3839, DOI 10.1242/jcs.207068; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Ries LK, 2019, J BIOL CHEM, V294, P6113, DOI 10.1074/jbc.RA118.007014; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11224-7; Weiser BP, 2017, BIOPHYS J, V113, P393, DOI 10.1016/j.bpj.2017.06.016; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yao WY, 2018, J BIOL CHEM, V293, P16697, DOI 10.1074/jbc.RA118.003781; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	62	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17421	17436		10.1074/jbc.RA119.009211	http://dx.doi.org/10.1074/jbc.RA119.009211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31578285	hybrid, Green Published			2022-12-26	WOS:000503173500021
J	Machackova, K; Mlcochova, K; Potalitsyn, P; Hankova, K; Socha, O; Budesinski, M; Muzdalo, A; Lepsik, M; Cernekova, M; Radosavljevic, J; Fabry, M; Mitrova, K; Chrudinova, M; Lin, JJ; Yurenko, Y; Hobza, P; Selicharova, I; Zakova, L; Jiracek, J				Machackova, Katerina; Mlcochova, Kvetoslava; Potalitsyn, Pavlo; Hankova, Katerina; Socha, Ondrej; Budesinski, Milos; Muzdalo, Anja; Lepsik, Martin; Cernekova, Michaela; Radosavljevic, Jelena; Fabry, Milan; Mitrova, Katarina; Chrudinova, Martina; Lin, Jingjing; Yurenko, Yevgen; Hobza, Pavel; Selicharova, Irena; Zakova, Lenka; Jiracek, Jiri			Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin-like growth factor (IGF); complex; mutagenesis; structural biology; structure-function; receptor tyrosine kinase; peptide hormone; hormone analog; molecular dynamics; NMR structure; receptor autophosphorylation; receptor binding	STRUCTURAL BASIS; LIGAND-BINDING; SIDE-CHAIN; B-CHAIN; CONFORMATION; RESISTANCE; RELEVANCE; TERMINUS; BACKBONE; AFFINITY	Information on how insulin and insulin-like growth factors 1 and 2 (IGF-1 and -2) activate insulin receptors (IR-A and -B) and the IGF-1 receptor (IGF-1R) is crucial for understanding the difference in the biological activities of these peptide hormones. Cryo-EM studies have revealed that insulin uses its binding sites 1 and 2 to interact with IR-A and have identified several critical residues in binding site 2. However, mutagenesis studies suggest that Ile-A10, Ser-A12, Leu-A13, and Glu-A17 also belong to insulin's site 2. Here, to resolve this discrepancy, we mutated these insulin residues and the equivalent residues in IGFs. Our findings revealed that equivalent mutations in the hormones can result in differential biological effects and that these effects can be receptor-specific. We noted that the insulin positions A10 and A17 are important for its binding to IR-A and IR-B and IGF-1R and that A13 is important only for IR-A and IR-B binding. The IGF-1/IGF-2 positions 51/50 and 54/53 did not appear to play critical roles in receptor binding, but mutations at IGF-1 position 58 and IGF-2 position 57 affected the binding. We propose that IGF-1 Glu-58 interacts with IGF-1R Arg-704 and belongs to IGF-1 site 1, a finding supported by the NMR structure of the less active Asp-58-IGF-1 variant. Computational analyses indicated that the aforementioned mutations can affect internal insulin dynamics and inhibit adoption of a receptor-bound conformation, important for binding to receptor site 1. We provide a molecular model and alternative hypotheses for how the mutated insulin residues affect activity.	[Machackova, Katerina; Mlcochova, Kvetoslava; Potalitsyn, Pavlo; Hankova, Katerina; Socha, Ondrej; Budesinski, Milos; Muzdalo, Anja; Lepsik, Martin; Cernekova, Michaela; Radosavljevic, Jelena; Mitrova, Katarina; Chrudinova, Martina; Lin, Jingjing; Yurenko, Yevgen; Hobza, Pavel; Selicharova, Irena; Zakova, Lenka; Jiracek, Jiri] Czech Acad Sci, Inst Organ Chem & Biochem, Prague 16610 6, Czech Republic; [Fabry, Milan] Czech Acad Sci, Inst Mol Genet, Prague 16637 6, Czech Republic; [Radosavljevic, Jelena] Univ Belgrade, Fac Chem, Studentski Trg 12-16, Belgrade, Serbia	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Belgrade	Jiracek, J (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague 16610 6, Czech Republic.	jiracek@uochb.cas.cz	Selicharova, Irena/G-5546-2014; Zakova, Lenka/A-7119-2008; Radosavljevic, Jelena/AAT-8714-2020; Lepsik, Martin/C-6614-2012; Černeková, Michaela/AFI-6074-2022; Fabry, Milan/G-3602-2014; Socha, Ondřej/AEV-7090-2022; Chrudinova, Martina/G-5597-2014; Jiracek, Jiri/A-7124-2008; Potalitsyn, Pavlo/L-7216-2017	Radosavljevic, Jelena/0000-0002-6123-5474; Lepsik, Martin/0000-0003-2607-8132; Černeková, Michaela/0000-0003-2213-9671; Socha, Ondřej/0000-0002-7218-9119; Zakova, Lenka/0000-0001-6439-2574; Chrudinova, Martina/0000-0003-2998-9476; lin, jingjing/0000-0001-9150-5079; Jiracek, Jiri/0000-0003-3848-2773; Potalitsyn, Pavlo/0000-0002-4703-6559	Medical Research Council Grants [MR/K000179/1, MR/R009066/1]; European Regional Development Fund (Operational Programme Research, Development and Education, Project "Chemical Biology for Drugging Undruggable Targets (ChemBioDrug)") [CZ.02.1.01/0.0/0.0/16_019/0000729]; Czech Academy of Sciences [61388963, 68378050]; Charles University in Prague; MRC [MR/R009066/1, MR/K000179/1] Funding Source: UKRI	Medical Research Council Grants(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Regional Development Fund (Operational Programme Research, Development and Education, Project "Chemical Biology for Drugging Undruggable Targets (ChemBioDrug)"); Czech Academy of Sciences(Czech Academy of Sciences); Charles University in Prague; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/K000179/1 and MR/R009066/1 and by Grant CZ.02.1.01/0.0/0.0/16_019/0000729 from the European Regional Development Fund (Operational Programme Research, Development and Education, Project "Chemical Biology for Drugging Undruggable Targets (ChemBioDrug)"). Institutional support was provided by projects 61388963 (for the Institute of Organic Chemistry and Biochemistry) and 68378050 (for the Institute of Molecular Genetics) of the Czech Academy of Sciences. This work was supported in part by Ph.D. scholarships from Charles University in Prague (to K. Machac. kova, K. Mlc. ochova, P. P., O. S., and M.Ch.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Belfiore A, 2017, ENDOCR REV, V38, P379, DOI 10.1210/er.2017-00073; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2012, J CHEM THEORY COMPUT, V8, P2247, DOI 10.1021/ct3002464; Brody H, 2012, NATURE, V485, pS1, DOI 10.1038/485S1a; Clemmons DR, 2016, TRENDS ENDOCRIN MET, V27, P375, DOI 10.1016/j.tem.2016.03.019; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Gallagher EJ, 2010, CURR DIABETES REP, V10, P93, DOI 10.1007/s11892-010-0101-y; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Gutmann T., 2019, CRYO EM STRUCTURE CO, DOI [10.1101/679233, DOI 10.1101/679233]; Hexnerova R, 2016, J BIOL CHEM, V291, P21234, DOI 10.1074/jbc.M116.741041; Izadi S, 2014, J PHYS CHEM LETT, V5, P3863, DOI 10.1021/jz501780a; Jiracek J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00167; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Krizkova K, 2016, BIOCHEMISTRY-US, V55, P2903, DOI 10.1021/acs.biochem.6b00140; Krizkova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112883; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Le Roith Derek, 2003, Exp Diabesity Res, V4, P205, DOI 10.1155/EDR.2003.205; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Machackova K, 2018, BIOCHEMISTRY-US, V57, P2373, DOI 10.1021/acs.biochem.7b01260; Machackova K, 2017, J MED CHEM, V60, P10105, DOI 10.1021/acs.jmedchem.7b01331; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mercadante D, 2018, BIOPHYS J, V114, P1267, DOI 10.1016/j.bpj.2018.01.033; Mynarcik DC, 1997, J BIOL CHEM, V272, P2077; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Uchikawa E, 2019, ELIFE, V8, DOI 10.7554/eLife.48630; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vikova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19431; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Weis F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06826-6; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; Xu YB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03219-7; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050	53	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17371	17382		10.1074/jbc.RA119.010072	http://dx.doi.org/10.1074/jbc.RA119.010072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31558604	Green Published, hybrid			2022-12-26	WOS:000503173500017
J	Yanda, MK; Cha, B; Cebotaru, CV; Cebotaru, L				Yanda, Murali K.; Cha, Boyoung; Cebotaru, Cristina, V; Cebotaru, Liudmila			Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; cystic fibrosis transmembrane conductance regulator (CFTR); ion channel; kidney; protein targeting; renal physiology; sodium?proton exchange; sodium channel; epithelial sodium channel (ENaC)	TRANSMEMBRANE CONDUCTANCE REGULATOR; BORDER NA+/H+ EXCHANGER; DEACETYLASE 6 ACTIVITY; PLASMA-MEMBRANE; NHE3 ACTIVITY; CA2+-DEPENDENT INHIBITION; FUNCTIONAL EXPRESSION; CFTR INHIBITORS; CL-CONDUCTANCE; IN-VITRO	Autosomal-dominant polycystic kidney disease (ADPKD) induces a secretory phenotype, resulting in multiple fluid-filled cysts. We have previously demonstrated that VX-809, a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR), reduces cyst growth. Here, we show that in normal mice CFTR is located within the cells and also at the apical and basolateral membranes. However, in polycystic kidney disease (pkd1)-knockout mice, CFTR was located at the plasma membrane, consistent with its role in cAMP-dependent fluid secretion. In cystic mice, VX-809 treatment increased CFTR levels at the apical membrane and reduced its association with the endoplasmic reticulum. Surprisingly, VX-809 treatment significantly increased CFTR's co-localization with the basolateral membrane in cystic mice. Na+/H+ exchanger 3 (NHE3) is present in pkd1-knockout and normal mice and in proximal tubule-derived, cultured pkd1-knockout cells. VX-809 increased the expression, activity, and apical plasma membrane localization of NHE3. Co-localization of epithelial sodium channel (ENaC) with the plasma membrane was reduced in cysts in pkd1-knockout mice, consistent with an inability of the cysts to absorb fluid. Interestingly, in the cystic mice, VX-809 treatment increased ENaC levels at the apical plasma membrane consistent with fluid absorption. Thus, VX-809 treatment of pkd1-null mouse kidneys significantly affected CFTR, NHE3, and ENaC, altering the cyst phenotype from one poised toward fluid secretion toward one more favorable for absorption. VX-809 also altered the location of CFTR but not of NHE3 or ENaC in normal mice. Given that VX-809 administration is safe, it may have potential utility for treating patients with ADPKD.	[Yanda, Murali K.; Cha, Boyoung; Cebotaru, Cristina, V; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Sch Med, Hunterian 415,725 North Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu		Cebotaru, Liudmila/0000-0002-4362-8995	Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; National Institutes of Health NIDDK [P30DK089502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate Deborah McClellan, Ph.D., for editing the manuscript. The functional assay for NHE3 was supported by the Hopkins Conte Digestive Diseases Basic and Translational Research Core Center and National Institutes of Health NIDDK Grant P30DK089502. We also thank the Yale Center for the Study of Polycystic Kidney Disease for providing the PN and PH cells and the Baltimore PKD Center for providing the mouse model. We thank William B. Guggino, Ph.D., for scientific discussions and help with the manuscript. We also thank Mark Donowitz, M.D., for the discussions on NHE3 physiology and functional assays.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Al-Bhalal L, 2005, ADV ANAT PATHOL, V12, P126, DOI 10.1097/01.pap.0000163959.29032.1f; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bagorda A, 2002, J BIOL CHEM, V277, P21480, DOI 10.1074/jbc.M112245200; Barbry P, 1997, AM J PHYSIOL-GASTR L, V273, pG571, DOI 10.1152/ajpgi.1997.273.3.G571; Bidaud-Meynard A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226886; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Borkan SC, 2002, ANNU REV PHYSIOL, V64, P503, DOI 10.1146/annurev.physiol.64.081501.155819; Bruser L, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029140; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chalumeau C, 2001, AM J PHYSIOL-RENAL, V280, pF283, DOI 10.1152/ajprenal.2001.280.2.F283; Chambers LA, 2007, RESP PHYSIOL NEUROBI, V159, P256, DOI 10.1016/j.resp.2007.06.005; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Davies JC, 2018, NEW ENGL J MED, V379, P1599, DOI 10.1056/NEJMoa1807119; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Devuyst O, 1996, AM J PHYSIOL-RENAL, V271, pF723, DOI 10.1152/ajprenal.1996.271.3.F723; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; Favia M, 2006, BIOCHEM BIOPH RES CO, V347, P452, DOI 10.1016/j.bbrc.2006.06.112; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Graffe CC, 2012, AM J PHYSIOL-RENAL, V302, pF917, DOI 10.1152/ajprenal.00616.2011; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Harris PC, 2006, CURR OPIN NEPHROL HY, V15, P456, DOI 10.1097/01.mnh.0000232888.65895.e7; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Ilatovskaya DV, 2019, EBIOMEDICINE, V40, P663, DOI 10.1016/j.ebiom.2019.01.006; Janecke AR, 2015, HUM MOL GENET, V24, P6614, DOI 10.1093/hmg/ddv367; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johansson S, 2017, CLIN EXP NEPHROL, V21, P407, DOI 10.1007/s10157-016-1302-8; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kaimori J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08284-4; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Koeppen B.M., 2012, RENAL PHYSL E BOOK M; Lee M G, 2001, JOP, V2, P203; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lopes-Pacheco M, 2015, J BIOL CHEM, V290, P25636, DOI 10.1074/jbc.M115.671925; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; McDonough AA, 1998, AM J PHYSIOL-CELL PH, V275, pC1179; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Milewski MI, 2001, J CELL SCI, V114, P719; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Morales MM, 1996, AM J PHYSIOL-RENAL, V270, pF1038, DOI 10.1152/ajprenal.1996.270.6.F1038; Morales MM, 2001, PFLUG ARCH EUR J PHY, V443, P202, DOI 10.1007/s004240100671; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; O'Sullivan DA, 1998, AM J KIDNEY DIS, V32, P976, DOI 10.1016/S0272-6386(98)70072-1; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Persu A, 2000, J AM SOC NEPHROL, V11, P2285, DOI 10.1681/ASN.V11122285; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; QUINTON PM, 1989, ANN NY ACAD SCI, V574, P438; Reddy M M, 1987, Prog Clin Biol Res, V254, P45; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; Reddy MM, 2003, PFLUG ARCH EUR J PHY, V445, P499, DOI 10.1007/s00424-002-0959-x; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rokaw MD, 1996, AM J PHYSIOL-CELL PH, V270, pC600, DOI 10.1152/ajpcell.1996.270.2.C600; Rosenbaum D., 2014, J AM SOC NEPHROL, V25, p72A; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Schwark JR, 1998, PFLUG ARCH EUR J PHY, V436, P797, DOI 10.1007/s004240050704; Seit-Nebi AS, 2010, CELL STRESS CHAPERON, V15, P233, DOI 10.1007/s12192-009-0141-x; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Talbot CL, 1999, AM J RESP CELL MOL, V20, P398, DOI 10.1165/ajrcmb.20.3.3283; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Vallon V, 2000, AM J PHYSIOL-RENAL, V278, pF375, DOI 10.1152/ajprenal.2000.278.3.F375; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Veizis EI, 2004, AM J PHYSIOL-RENAL, V286, pF244, DOI 10.1152/ajprenal.00169.2003; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wilson PD, 2011, BBA-MOL BASIS DIS, V1812, P1239, DOI 10.1016/j.bbadis.2011.05.008; Yanda MK, 2018, J BIOL CHEM, V293, P11513, DOI 10.1074/jbc.RA118.001846; Yanda MK, 2017, J BIOL CHEM, V292, P17897, DOI 10.1074/jbc.M117.803775; Yanda MK, 2017, AM J PHYSIOL-RENAL, V313, pF997, DOI 10.1152/ajprenal.00186.2017; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828; Yang LE, 2004, AM J PHYSIOL-RENAL, V287, pF896, DOI 10.1152/ajprenal.00160.2004; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhang W, 2016, DRUG TODAY, V52, P229, DOI 10.1358/dot.2016.52.4.2467205; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	105	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17090	17104		10.1074/jbc.RA119.010320	http://dx.doi.org/10.1074/jbc.RA119.010320			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31570523	hybrid, Green Published			2022-12-26	WOS:000501801900049
J	Zhou, PH; Wu, M; Ye, CY; Xu, QQ; Wang, L				Zhou, Peihui; Wu, Ming; Ye, Chaoyang; Xu, Qingqing; Wang, Li			Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m(6)A abrogation in RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA modification; apoptosis; RNA methylation; kidney; p53; cell signaling; caspase; acute kidney injury; AKI; cisplatin; Fat mass and obesity-associated protein; FTO; N6-methyladenosine; m6A	METHYLATION; APOPTOSIS; P53	The role of RNA methylation on the sixth N atom of adenylate (m(6)A) in acute kidney injury (AKI) is unknown. FTO (fat mass and obesity-associated protein) reverses the m(6)A modification in cisplatin-induced AKI. Here, we aimed to determine FTO's role in AKI. We induced AKI in c57BL/6 mice by intraperitoneal cisplatin injection and treated the animal with vehicle or an FTO inhibitor meclofenamic acid (MA) for 3 days. Moreover, as an in vitro model, human kidney proximal tubular cells (HK2 cells) were treated with cisplatin. We found that the cisplatin treatment reduces FTO expression and increases m(6)A levels in vivo and in vitro. MA aggravated renal damage and increased apoptosis in cisplatin-treated kidneys, phenotypes that were correlated with reduced FTO expression and increased m(6)A levels. Moreover, MA promoted apoptosis in cisplatin-treated HK2 cells, which was correlated with the reduced FTO expression and increased m(6)A in HK2 cells. FTO protein overexpression reduced m(6)A levels and inhibited apoptosis in cisplatin-treated HK2 cells and also blocked the MA-induced increase in m(6)A levels and apoptosis rates. In agreement, overexpression of the m(6)A-generating methyltransferase-like 3 and 14 (METTL3 and METTL14) or siRNA-mediated FTO knockdown promoted apoptosis and enhanced m(6)A levels in cisplatin-treated HK2 cells. MA increased p53 mRNA and protein levels in AKI both in vitro and in vivo, and FTO overexpression reduced p53 expression and reversed the MA-induced p53 increase in AKI. In conclusion, reduced renal FTO expression in cisplatin-induced AKI increases RNA m(6)A levels and aggravates renal damages.	[Zhou, Peihui; Wang, Li] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Nephrol, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Wu, Ming; Ye, Chaoyang] Shanghai Univ Tradit Chinese Med, Tradit Chinese Med Inst Kidney Dis, Shanghai Key Lab Tradit Chinese Clin Med, Dept Nephrol,Shuguang Hosp,Minist Educ,Key Lab Li, Shanghai 200011, Peoples R China; [Xu, Qingqing] Zhejiang Univ, Ningbo Hosp, Ningbo Hosp 1, Dept Nephrol, Ningbo 315000, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Zhejiang University	Wang, L (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Nephrol, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	wlyjy73122@126.com		Wu, Ming/0000-0002-8095-8766	Science and Technology Commission of Shanghai Municipality [16ZR1419400]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the Science and Technology Commission of Shanghai Municipality (No. 16ZR1419400). The authors declare that they have no conflicts of interest with the contents of this article.	Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276; Jiang M, 2009, AM J PHYSIOL-RENAL, V296, pF983, DOI 10.1152/ajprenal.90579.2008; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lu N, 2018, LIPIDS, V53, P53, DOI 10.1002/lipd.12023; Maity A, 2016, FEBS J, V283, P1607, DOI 10.1111/febs.13614; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Oh DJ, 2008, AM J PHYSIOL-RENAL, V294, pF264, DOI 10.1152/ajprenal.00204.2007; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Tian HY, 2018, RENAL FAILURE, V40, P527, DOI 10.1080/0886022X.2018.1487863; Wang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18874; Yamada K, 2019, BBA-MOL CELL RES, V1866, P839, DOI 10.1016/j.bbamcr.2019.02.009	16	27	28	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16908	16917		10.1074/jbc.RA119.011009	http://dx.doi.org/10.1074/jbc.RA119.011009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31578283	Green Published, hybrid			2022-12-26	WOS:000501801900035
J	Steinsberger, T; Muller, B; Gerber, C; Shafei, B; Schmid, M				Steinsberger, Thomas; Mueller, Beat; Gerber, Christoph; Shafei, Babak; Schmid, Martin			Modeling sediment oxygen demand in a highly productive lake under various trophic scenarios	PLOS ONE			English	Article							HIGH-RESOLUTION VARVE; ORGANIC-CARBON; REDUCED SUBSTANCES; EUTROPHIC LAKE; PHOSPHORUS; IRON; TRANSPORT; MANGANESE; PROFILES; METHANE	Hypolimnetic oxygen depletion in lakes is a widespread problem and is mainly controlled by the sediment oxygen uptake (SOU) and flux of reduced substances out of the sediments (F-red). Especially in eutrophic lakes, F-red may constitute a major fraction of the areal hypolimnetic mineralization rate, but its size and source is often poorly understood. Using a diagenetic reaction-transport model supported by a large data set of sediment porewater concentrations, bulk sediment core data and lake monitoring data, the behavior of F-red was simulated in eutrophic Lake Baldegg. Transient boundary conditions for the gross sedimentation of total organic carbon and for hypolimnetic O-2 concentrations were applied to simulate the eutrophication and re-oligotrophication history of the lake. According to the model, F-red is dominated by methanogenesis, where up to70% to the total CH4 is produced from sediments older than 20 years deposited during the time of permanent anoxia between 1890 and 1982. An implementation of simplified seasonal variations of the upper boundary conditions showed that their consideration is not necessary for the assessment of annual average fluxes in long-term simulations. Four lake management scenarios were then implemented to investigate the future development of F-red and SOU until 2050 under different boundary conditions. A comparison of three trophic scenarios showed that further reduction of the lake productivity to at least a mesotrophic state is required to significantly decrease F-red and SOU from the present state. Conversely, a termination of artificial aeration at the present trophic state would result in high rates of organic matter deposition and a long-term increase of F-red from the sediments of Lake Baldegg.	[Steinsberger, Thomas; Mueller, Beat; Gerber, Christoph; Shafei, Babak; Schmid, Martin] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland; [Steinsberger, Thomas] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Gerber, Christoph] CSIRO, Land & Water, Glen Osmond, SA, Australia; [Shafei, Babak] AquaNRG Consulting Inc, Houston, TX USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schmid, M (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland.	martin.schmid@eawag.ch	Schmid, Martin/C-3953-2009; Müller, Beat/J-8887-2016; Gerber, Christoph/AAF-7628-2021	Schmid, Martin/0000-0001-8699-5691; Müller, Beat/0000-0003-3696-9035; Gerber, Christoph/0000-0003-4339-5746	Swiss National Fund (SNF) Grant [200021_146234]	Swiss National Fund (SNF) Grant	The study was funded by supported by Swiss National Fund (SNF) Grant 200021_146234. The funder provided support in the form of salaries for authors Dr. Thomas Steinsberger, Dr. Babak Shafei and Dr. Christoph Gerber, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AquaRNG did not play a role in the funding or conception nor handling of the project.; We thank Robert Lovas (Environment and Energy, Canton of Lucerne) for providing data of Lake Baldegg. Arno Stockli (Dept. for the Environment, Canton of Aargau) is acknowledged for providing monitoring data of Lake Hallwil. We thank the reviewers for improving the manuscript. This work was financially supported by SNF Grant 200021_146234.	Aguilera DR, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000899; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Berg P, 2003, AM J SCI, V303, P905, DOI 10.2475/ajs.303.10.905; BLOESCH J, 1986, LIMNOL OCEANOGR, V31, P1094, DOI 10.4319/lo.1986.31.5.1094; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Canfield DE, 2009, GEOBIOLOGY, V7, P385, DOI 10.1111/j.1472-4669.2009.00214.x; Carey CC, 2018, LIMNOL OCEANOGR LETT, V3, P293, DOI 10.1002/lol2.10057; Couture RM, 2016, GEOCHIM COSMOCHIM AC, V194, P15, DOI 10.1016/j.gca.2016.08.029; Couture RM, 2010, ENVIRON SCI TECHNOL, V44, P197, DOI 10.1021/es902077q; Dittrich M, 2009, ECOL MODEL, V220, P2751, DOI 10.1016/j.ecolmodel.2009.07.015; Epping EHG, 1997, CONT SHELF RES, V17, P1737, DOI 10.1016/S0278-4343(97)00039-3; Gachter R, 1998, ENVIRON SCI TECHNOL, V32, P3659, DOI 10.1021/es980418l; Katsev S, 2006, CHEM GEOL, V234, P127, DOI 10.1016/j.chemgeo.2006.05.001; Katsev S, 2013, ECOL MODEL, V251, P246, DOI 10.1016/j.ecolmodel.2012.12.008; Koretsky CM, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-11; Lotter AF, 1997, AQUAT SCI, V59, P304, DOI 10.1007/BF02522361; MARTIN P, 1993, FRESHWATER BIOL, V29, P343, DOI 10.1111/j.1365-2427.1993.tb00768.x; Matzinger A, 2010, LIMNOL OCEANOGR, V55, P2073, DOI 10.4319/lo.2010.55.5.2073; Moosmann L, 2006, LIMNOL OCEANOGR, V51, P763, DOI 10.4319/lo.2006.51.1_part_2.0763; Muller B, 2012, ENVIRON SCI TECHNOL, V46, P9964, DOI 10.1021/es301422r; Muller B, 2003, WATER RES, V37, P4524, DOI 10.1016/S0043-1354(03)00381-6; Nordi KA, 2013, LIMNOL OCEANOGR, V58, P546, DOI 10.4319/lo.2013.58.2.0546; Schaller T, 1997, AQUAT SCI, V59, P326, DOI 10.1007/s000270050018; Schaller T, 1997, AQUAT SCI, V59, P345, DOI 10.1007/BF02522363; Schaller T, 1996, AQUAT GEOCHEM, V2, P359; Schubert CJ, 2012, ENVIRON SCI TECHNOL, V46, P4515, DOI 10.1021/es203465x; Schwefel R, 2018, LIMNOL OCEANOGR, V63, pS54, DOI 10.1002/lno.10723; Smemo KA, 2007, GEOMICROBIOL J, V24, P583, DOI 10.1080/01490450701672083; Sobek S, 2009, LIMNOL OCEANOGR, V54, P2243, DOI 10.4319/lo.2009.54.6.2243; Steinsberger T, 2017, BIOGEOSCIENCES, V14, P3275, DOI 10.5194/bg-14-3275-2017; SWEERTS JPRA, 1991, LIMNOL OCEANOGR, V36, P1124, DOI 10.4319/lo.1991.36.6.1124; Urban NR, 1997, AQUAT SCI, V59, P1; VanCappellen P, 1996, AM J SCI, V296, P197, DOI 10.2475/ajs.296.3.197; Wehrli B, 1997, AQUAT SCI, V59, P285, DOI 10.1007/s000270050015	34	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222318	10.1371/journal.pone.0222318	http://dx.doi.org/10.1371/journal.pone.0222318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JF4KX	31596854	Green Published, gold			2022-12-26	WOS:000491357800001
J	Bagga, S; Lucero, Y; Apodaca, K; Rajapakse, W; Lujan, P; Ortega, JL; Sengupta-Gopalan, C				Bagga, Suman; Lucero, Yvonne; Apodaca, Kimberly; Rajapakse, Wathsala; Lujan, Phillip; Ortega, Jose Luis; Sengupta-Gopalan, Champa			Chile (Capsicum annuum) plants transformed with the RB gene from Solanum bulbocastanum are resistant to Phytophthora capsici	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; BROAD-SPECTRUM RESISTANCE; DISEASE RESISTANCE; TRANSGENIC POTATO; FOLIAR BLIGHT; ROOT-ROT; EXPRESSION; PEPPER; SYSTEM; AGROINFILTRATION	Phytophthora capsici is a soil borne pathogen, and is among the most destructive pathogens for Capsicum annuum (chile). P. capsici is known to cause diseases on all parts of the chile plants. Therefore, it requires independent resistance genes to control disease symptoms that are induced by each of the P. capsicistrains. This requirement of multiple resistance genes to confer resistance to P. capsici, in chile makes breeding for resistance a daunting pursuit. Against this backdrop, a genetic engineering approach would be to introduce a broad host resistance gene into chile in order to protect it from different races of P. capsici. Notably, a broad host resistance gene RB from Solanum bulbocastanum has been shown to confer resistance to P. infestans in both S. tuberosum and S. lycopersicum. We agroinfiltrated the RB gene into the leaves of susceptible chile plants, demonstrating that the gene is also capable of lending resistance to P. capsici in chile. We introduced the RB gene into chile by developing an Agrobacterium tumefaciens mediated transformation system. The integration of the RB gene into the genome of the primary transformants and its subsequent transfer to the F1 generation was confirmed by genomic PCR using primers specific for the RB gene. A 3:1 ratio for the presence and absence of the RB gene was observed in the F1 progeny. In addition to showing resistance to P. capsici in a leaf inoculation experiment, about 30% of the F1 progeny also exhibited resistance to root inoculation. Our data, when taken together, suggests that the RB gene from S. bulbocastanum confers resistance against P. capsici in C. annuum, thereby demonstrating that the RB gene has an even broader host range than reported in the literature both in terms of the host and the pathogen.	[Bagga, Suman; Lucero, Yvonne; Apodaca, Kimberly; Rajapakse, Wathsala; Ortega, Jose Luis; Sengupta-Gopalan, Champa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Lujan, Phillip] New Mexico State Univ, Dept Entomol Plant Pathol Weed Sci, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University	Sengupta-Gopalan, C (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	csgopala@nmsu.edu		Apodaca, Kimberly/0000-0002-4218-3728; Lujan, Phillip/0000-0002-5640-7948	New Mexico Chile Association; Agricultural Experiment Station at New Mexico State University; Graduate Research Enhancement Program (GREG) at New Mexico State University; Howard Hughes Medical Institute's Science Education Program [52008103]	New Mexico Chile Association; Agricultural Experiment Station at New Mexico State University; Graduate Research Enhancement Program (GREG) at New Mexico State University; Howard Hughes Medical Institute's Science Education Program	This research was supported by grant from New Mexico Chile Association and by the Agricultural Experiment Station at New Mexico State University. WR was a recipient of a fellowship from Graduate Research Enhancement Program (GREG) at New Mexico State University. KA was supported by the Howard Hughes Medical Institute's Science Education Program, Grant #52008103.	Barchenger DW, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00628; Bashandy H, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0091-5; Borrelli VM, 2018, FRONT PLANT SCI, P9; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Chen Qiang, 2013, Adv Tech Biol Med, V1; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; DEVRIES SC, 1982, PLANTA, V156, P129, DOI 10.1007/BF00395427; Dong OX, 2019, PLANT PHYSIOL, V180, P26, DOI 10.1104/pp.18.01224; Ellis J, 2000, TRENDS PLANT SCI, V5, P373, DOI 10.1016/S1360-1385(00)01694-0; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fuchs M, 2017, CURR OPIN VIROL, V26, P36, DOI 10.1016/j.coviro.2017.07.004; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Horvath DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042036; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kuhl JC, 2007, J AM SOC HORTIC SCI, V132, P783, DOI 10.21273/JASHS.132.6.783; Kunwar S, 2018, PHYTOPATHOLOGY, V108, P1402, DOI 10.1094/PHYTO-12-17-0424-R; Liu JX, 2009, AGR SCI CHINA, V8, P947, DOI 10.1016/S1671-2927(08)60299-0; Liu WY, 2014, THEOR APPL GENET, V127, P2503, DOI 10.1007/s00122-014-2394-8; Ma L, PLANT FUNGAL PATHOGE, P61; Monroy-Barbosa A, 2008, J AM SOC HORTIC SCI, V133, P825, DOI 10.21273/JASHS.133.6.825; Monroy-Barbosa A, 2010, HORTSCIENCE, V45, P1563, DOI 10.21273/HORTSCI.45.10.1563; Mundt CC, 2018, PHYTOPATHOLOGY, V108, P792, DOI 10.1094/PHYTO-12-17-0426-RVW; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Norkunas K, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0343-2; Ortega JL, 2012, MOL GENET GENOMICS, V287, P881, DOI 10.1007/s00438-012-0724-6; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Reeves G, 2013, PHYTOPATHOLOGY, V103, P472, DOI 10.1094/PHYTO-09-12-0242-R; RICHTER HE, 1991, MOL GEN GENET, V229, P445, DOI 10.1007/BF00267468; ROMMENS CMT, 1995, PLANT CELL, V7, P1537, DOI 10.1105/tpc.7.10.1537; Seger M, 2015, PLANTA, V241, P69, DOI 10.1007/s00425-014-2165-4; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Sy O, 2005, J AM SOC HORTIC SCI, V130, P75, DOI 10.21273/JASHS.130.1.75; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Thabuis A, 2004, MOL BREEDING, V14, P9, DOI 10.1023/B:MOLB.0000037991.38278.82; Thabuis A, 2004, THEOR APPL GENET, V109, P342, DOI 10.1007/s00122-004-1633-9; Tuite J., 1967, PLANT PATHOLOGICAL M; Tzfira T, 2003, PLANT PHYSIOL, V133, P1011, DOI 10.1104/pp.103.032128; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; van der Vossen EAG, 2000, PLANT J, V23, P567, DOI 10.1046/j.1365-313x.2000.00814.x; Wang PY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0464-0; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Xu XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151401; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223213	10.1371/journal.pone.0223213	http://dx.doi.org/10.1371/journal.pone.0223213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589629	Green Published, gold			2022-12-26	WOS:000532427300013
J	Denk, N; Maloca, P; Steiner, G; Freichel, C; Bassett, S; Schnitzer, TK; Hasler, PW				Denk, Nora; Maloca, Peter; Steiner, Guido; Freichel, Christian; Bassett, Simon; Schnitzer, Tobias K.; Hasler, Pascal W.			Macular thickness measurements of healthy, naive cynomolgus monkeys assessed with spectral-domain optical coherence tomography (SD-OCT)	PLOS ONE			English	Article							EYES	The purpose of this study was to measure central macular thickness in an unprecedented number of cynomolgus monkeys. Macular thickness was measured with Heidelberg spectral-domain OCT in 320 eyes of healthy and treatment-naive cynomolgus monkeys (80 males and 80 females). The macula was successfully measured in all 320 eyes. Macular thickness was not significantly different between the sexes. The mean central macular thickness was 244 mu m (+/- 21 mu m). Macular thicknesses in the quadrants were 327 +/- 17 mu m (temporal inner), 339 +/- 17 mu m (inferior inner), 341 +/- 14 mu m (superior inner), 341 +/- 18 mu m (nasal inner), and 299 +/- 20 mu m (temporal outer), 320 +/- 16 mu m (superior outer), 332 +/- 23 mu m (inferior outer), and 337 +/- 18 mu m (nasal outer). Highly significant differences between the nasal and temporal quadrants were detected. This study successfully demonstrated the feasibility of retinal thickness measurements in healthy cynomolgus monkeys. The present findings indicate that the macula is thicker in cynomolgus monkeys than in humans and provide important normative data for future studies.	[Denk, Nora; Steiner, Guido; Freichel, Christian; Bassett, Simon; Schnitzer, Tobias K.] Roche Innovat Ctr Basel, Pharma Res & Early Dev pRED, Pharmaceut Sci PS, Basel, Switzerland; [Maloca, Peter; Hasler, Pascal W.] Univ Basel, Dept Ophthalmol, OCTIab Res Lab, Basel, Switzerland; [Maloca, Peter] Moorfields Eye Hosp, London, England; [Maloca, Peter] Inst Mol & Clin Ophthalmol Basel IOB, Basel, Switzerland	Roche Holding; University of Basel; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Denk, N (corresponding author), Roche Innovat Ctr Basel, Pharma Res & Early Dev pRED, Pharmaceut Sci PS, Basel, Switzerland.	nora.denk@roche.com	Maloca, Peter/N-4908-2018	Maloca, Peter/0000-0002-4794-5859; Denk, Nora/0000-0001-5840-425X	Hoffmann-La Roche Ltd.	Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was supported by Hoffmann-La Roche Ltd. The funder provided support in the form of salaries for authors ND, GS, CF, SB, TS (employees) as well as PM and PWH (consultants), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Barrio-Barrio J, 2013, ACTA OPHTHALMOL, V91, pe56, DOI 10.1111/j.1755-3768.2012.02562.x; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; El-Ashry M, 2008, CURR EYE RES, V33, P693, DOI 10.1080/02713680802323140; El-Dairi MA, 2009, ARCH OPHTHALMOL-CHIC, V127, P50, DOI 10.1001/archophthalmol.2008.553; Feltgen N, 2018, ACTA OPHTHALMOL, V96, pE933, DOI 10.1111/aos.13770; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gella L, 2015, SAUDI J OPHTHALMOL, V29, P121, DOI 10.1016/j.sjopt.2014.10.003; Gella L, 2012, INDIAN J OPHTHALMOL, V60, P53, DOI 10.4103/0301-4738.91347; Guedes V, 2003, OPHTHALMOLOGY, V110, P177, DOI 10.1016/S0161-6420(02)01564-6; Hee MR, 1998, OPHTHALMOLOGY, V105, P360, DOI 10.1016/S0161-6420(98)93601-6; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P2351, DOI 10.1167/iovs.05-1396; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Matas J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210799; Matet A, 2017, TRANSL RES, V188, P40, DOI 10.1016/j.trsl.2017.06.012; McLellan GJ, 2012, VET OPHTHALMOL, V15, P13, DOI 10.1111/j.1463-5224.2012.01045.x; Natung T, 2016, ASIA-PAC J OPHTHALMO, V5, P176, DOI 10.1097/APO.0000000000000153; Nieves-Moreno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180450; Nigam B, 2018, J OPHTHAL VIS RES, V13, P144, DOI 10.4103/jovr.jovr_51_17; Patel PJ, 2016, OPHTHALMOLOGY, V123, P829, DOI 10.1016/j.ophtha.2015.11.009; Peng YJ, 2018, DIABETES VASC DIS RE, V15, P165, DOI 10.1177/1479164117746023; Schmid MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135050; Team RDC, 2019, R LANG ENV STAT COMP; Wilkie DA, OCULAR PHARM TOXICOL, P143	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0222850	10.1371/journal.pone.0222850	http://dx.doi.org/10.1371/journal.pone.0222850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589624	Green Published, gold			2022-12-26	WOS:000532427300007
J	Reis-Cunha, JL; Bartholomeu, DC; Manson, AL; Earl, AM; Cerqueira, GC				Reis-Cunha, Joao L.; Bartholomeu, Daniella C.; Manson, Abigail L.; Earl, Ashlee M.; Cerqueira, Gustavo C.			ProphET, prophage estimation tool: A stand-alone prophage sequence prediction tool with self-updating reference database	PLOS ONE			English	Article							BACTERIAL; EVOLUTION; BACTERIOPHAGES; GENOMICS; DYNAMICS; VIRUSES; PHAGES	Background Prophages play a significant role in prokaryotic evolution, often altering the function of the cell that they infect via transfer of new genes e.g., virulence or antibiotic resistance factors, inactivation of existing genes or by modifying gene expression. Recently, phage therapy has gathered renewed interest as a promising alternative to control bacterial infections. Cataloging the repertoire of prophages in large collections of species' genomes is an important initial step in understanding their evolution and potential therapeutic utility. However, current widely-used tools for identifying prophages within bacterial genome sequences are mainly web-based, can have long response times, and do not scale to keep pace with the many thousands of genomes currently being sequenced routinely. Methodology In this work, we present ProphET, an easy to install prophage predictor to be used in Linux operation system, without the constraints associated with a web-based tool. ProphET predictions rely on similarity searches against a database of prophage genes, taking as input a bacterial genome sequence in FASTA format and its corresponding gene annotation in GFF. ProphET identifies prophages in three steps: similarity search, calculation of the density of prophage genes, and edge refinement. ProphET performance was evaluated and compared with other phage predictors based on a set of 54 bacterial genomes containing 267 manually annotated prophages. Findings and conclusions ProphET identifies prophages in bacterial genomes with high precision and offers a fast, highly scalable alternative to widely-used web-based applications for prophage detection.	[Reis-Cunha, Joao L.; Manson, Abigail L.; Earl, Ashlee M.; Cerqueira, Gustavo C.] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Reis-Cunha, Joao L.; Bartholomeu, Daniella C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Cerqueira, Gustavo C.] Personal Genome Diagnost, Baltimore, MD 21224 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade Federal de Minas Gerais	Reis-Cunha, JL; Cerqueira, GC (corresponding author), Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Reis-Cunha, JL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.; Cerqueira, GC (corresponding author), Personal Genome Diagnost, Baltimore, MD 21224 USA.	jaumlrc@gmail.com; cerca11@gmail.com	Reis-Cunha, João/AAX-6470-2020; Cerqueira, Gustavo/AAV-7398-2020; Bartholomeu, Daniella C./J-4714-2015; Manson, Abigail/B-7132-2016	Reis-Cunha, João/0000-0003-1034-0992; Cerqueira, Gustavo/0000-0002-7692-3886; Bartholomeu, Daniella C./0000-0003-0974-7357; Manson, Abigail/0000-0002-3800-0714	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [HHSN272200900018C, U19AI110818]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Council for Scientific and Technological Development (CNPq) Brazil; Personal Genome Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Personal Genome Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [Contract No.:HHSN272200900018C, Grant Number U19AI110818 to the Broad Institute]. JLRC received scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and National Council for Scientific and Technological Development (CNPq) Brazil. Personal Genome Diagnostics provided support in the form of salary to GCC as this manuscript was being finalized, but it did not have any additional role in the study design, data collection and analysis, shared computer infrastructure, decision to publish or direct funding of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Campbell A, 2003, RES MICROBIOL, V154, P277, DOI 10.1016/S0923-2508(03)00071-8; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davies EV, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw015; Faruque SM, 2012, VIRULENCE, V3, P556, DOI 10.4161/viru.22351; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Pope WH, 2015, ELIFE, V4, DOI [DOI 10.7554/ELIFE06416, DOI 10.7554/ELIFE.06416]; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Yan XH, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0413-9; Zhou Y, 2011, NUCL ACIDS RES S2, V39	19	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223364	10.1371/journal.pone.0223364	http://dx.doi.org/10.1371/journal.pone.0223364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577829	Green Published, Green Submitted, gold			2022-12-26	WOS:000532388000032
J	Olson, SH; Bounga, G; Ondzie, A; Bushmaker, T; Seifert, SN; Kuisma, E; Taylor, DW; Munster, VJ; Walzer, C				Olson, Sarah H.; Bounga, Gerard; Ondzie, Alain; Bushmaker, Trent; Seifert, Stephanie N.; Kuisma, Eeva; Taylor, Dylan W.; Munster, Vincent J.; Walzer, Chris			Lek-associated movement of a putative Ebolavirus reservoir, the hammer-headed fruit bat (Hypsignathus monstrosus), in northern Republic of Congo	PLOS ONE			English	Article								The biology and ecology of Africa's largest fruit bat remains largely understudied and enigmatic despite at least two highly unusual attributes. The acoustic lek mating behavior of the hammer-headed bat (Hypsignathus monstrosus) in the Congo basin was first described in the 1970s. More recently molecular testing implicated this species and other African bats as potential reservoir hosts for Ebola virus and it was one of only two fruit bat species epidemiologically linked to the 2008 Luebo, Democratic Republic of Congo, Ebola outbreak. Here we share findings from the first pilot study of hammer-headed bat movement using GPS tracking and accelerometry units and a small preceding radio-tracking trial at an apparent lekking site. The radio-tracking revealed adult males had high rates of nightly visitation to the site compared to females (only one visit) and that two of six females day-roosted similar to 100 m west of Libonga, the nearest village that is similar to 1.6 km southwest. Four months later, in mid-April 2018, five individual bats, comprised of four males and one female, were tracked from two to 306 days, collecting from 67 to 1022 GPS locations. As measured by mean distance to the site and proportion of nightly GPS locations within 1 km of the site (percent visitation), the males were much more closely associated with the site (mean distance 1.4 km; 51% visitation), than the female (mean 5.5 km; 2.2% visitation). Despite the small sample size, our tracking evidence supports our original characterization of the site as a lek, and the lek itself is much more central to male than female movement. Moreover, our pilot demonstrates the technical feasibility of executing future studies on hammer-headed bats that will help fill problematic knowledge gaps about zoonotic spillover risks and the conservation needs of fruit bats across the continent.	[Olson, Sarah H.; Taylor, Dylan W.; Walzer, Chris] Wildlife Conservat Soc, Hlth Program, Bronx, NY 10460 USA; [Bounga, Gerard; Ondzie, Alain; Kuisma, Eeva] Wildlife Conservat Soc, Brazzaville, Rep Congo; [Bushmaker, Trent; Seifert, Stephanie N.; Munster, Vincent J.] NIAID, Virus Ecol Sect, Lab Virol, Div Intramural Res,NIH, Hamilton, MT USA; [Walzer, Chris] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria	Wildlife Conservation Society; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Veterinary Medicine Vienna	Olson, SH (corresponding author), Wildlife Conservat Soc, Hlth Program, Bronx, NY 10460 USA.	solson@wcs.org	Munster, Vincent/I-7607-2018	Munster, Vincent/0000-0002-2288-3196; seifert, stephanie/0000-0002-4397-6156; Olson, Sarah/0000-0002-8484-9006; Walzer, Chris/0000-0002-0437-5147	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health [1ZIAAI001190-05]; WCS award (Julie Maher's WildView fund)	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); WCS award (Julie Maher's WildView fund)	Authors TB, SNS, and VJM received funding support from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health 1ZIAAI001190-05 (https://www.niaid.nih.gov/about/dir). Author SHO received a small award to assist with tracker purchase from an internal WCS award (Julie Maher's WildView fund, www.wcs.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Lartey M, 2016, GLOB ECOL CONSERV, V7, P12, DOI 10.1016/j.gecco.2016.03.005; de Oliveira JFA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01209-1; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Bradbury J.W., 1981, P138; BRADBURY JW, 1977, Z TIERPSYCHOL, V45, P225; De Nys HM, 2018, EMERG INFECT DIS, V24, P2228, DOI 10.3201/eid2412.180740; Field H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144055; Hayman DTS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2591; Hayman DTS, 2012, EMERG INFECT DIS, V18, P1207, DOI 10.3201/eid1807.111654; Hofman MPG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216223; Judson SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005780; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; O'Mara MT, 2014, METHODS ECOL EVOL, V5, P311, DOI 10.1111/2041-210X.12172; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; R Core Team, 2018, R LANG ENV STAT COMP; Rulli MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41613; Schuh AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43156-z; Tanshi I., 2016, IUCN RED LIST THREAT; Toth CA, 2013, J ZOOL, V291, P3, DOI 10.1111/jzo.12069; Wallace RG, 2014, ENVIRON PLANN A, V46, P2533, DOI 10.1068/a4712com; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	23	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223139	10.1371/journal.pone.0223139	http://dx.doi.org/10.1371/journal.pone.0223139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574111	Green Submitted, Green Published, gold			2022-12-26	WOS:000532376700030
J	Chudzik, B; Bonio, K; Dabrowski, W; Pietrzak, D; Niewiadomy, A; Olender, A; Pawlikowska-Pawlega, B; Gagos, M				Chudzik, Barbara; Bonio, Katarzyna; Dabrowski, Wojciech; Pietrzak, Daniel; Niewiadomy, Andrzej; Olender, Alina; Pawlikowska-Pawlega, Bozena; Gagos, Mariusz			Antifungal effects of a 1,3,4-thiadiazole derivative determined by cytochemical and vibrational spectroscopic studies	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; FUNGAL-INFECTIONS; IN-VITRO; MORPHOGENESIS; FTIR; CHITIN; ERGOSTEROL; CHITOSAN	Compounds belonging to the group of 5-substituted 4-(1,3,4-thiadiazol-2-yl) benzene-1,3diols exhibit a broad spectrum of biological activity, including antibacterial, antifungal, and anticancer properties. The mechanism of the antifungal activity of compounds from this group has not been described to date. Among the large group of 5-substituted 4-(1,3,4-thiadiazol-2-yl) benzene-1,3-diol derivatives, the compound 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol, abbreviated as C1, was revealed to be one of the most active agents against pathogenic fungi, simultaneously with the lowest toxicity to human cells. The C1 compound is a potent antifungal agent against different Candida species, including isolates resistant to azoles, and molds, with MIC100 values ranging from 8 to 96 mu g/ml. The antifungal activity of the C1 compound involves disruption of the cell wall biogenesis, as evidenced by the inability of cells treated with C1 to maintain their characteristic cell shape, increase in size, form giant cells and flocculate. C1-treated cells were also unable to withstand internal turgor pressure causing protoplast material to leak out, exhibited reduced osmotic resistance and formed buds that were not covered with chitin. Disturbances in the chitin septum in the neck region of budding cells was observed, as well as an uneven distribution of chitin and beta (1 -> 3) glucan, and increased sensitivity to substances interacting with wall polymerization. The ATR-FTIR spectral shifts in cell walls extracted from C. albicans cells treated with the C1 compound suggested weakened interactions between the molecules of beta(1 -> 3) glucans and beta(1 -> 6) glucans, which may be the cause of impaired cell wall integrity. Significant spectral changes in the C1-treated cells were also observed in bands characteristic for chitin. The C1 compound did not affect the ergosterol content in Candida cells. Given the low cytotoxicity of the C1 compound to normal human dermal fibroblasts (NHDF), it is possible to use this compound as a therapeutic agent in the treatment of surface and gastrointestinal tract mycoses.	[Chudzik, Barbara; Bonio, Katarzyna; Gagos, Mariusz] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Cell Biol, Lublin, Poland; [Dabrowski, Wojciech; Pietrzak, Daniel] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Lublin, Poland; [Niewiadomy, Andrzej] Inst Ind Organ Chem, Warsaw, Poland; [Niewiadomy, Andrzej] Med Univ Lublin, Dept Chem, Lublin, Poland; [Olender, Alina] Med Univ Lublin, Chair & Dept Med Microbiol, Lublin, Poland; [Pawlikowska-Pawlega, Bozena] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Comparat Anat & Anthropol, Lublin, Poland	Maria Curie-Sklodowska University; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Maria Curie-Sklodowska University	Chudzik, B; Gagos, M (corresponding author), Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Cell Biol, Lublin, Poland.; Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Lublin, Poland.	bchudzik@poczta.umcs.lublin.pl; w.dabrowski5@yahoo.com; mariusz.gagos@poczta.umcs.lublin.pl	Chudzik, Barbara/GOP-0350-2022	Niewiadomy, Andrzej/0000-0002-2393-2607; Chudzik, Barbara/0000-0001-5091-8846; Gagos, Mariusz/0000-0001-7139-4199; Pawlikowska-Pawlega, Bozena/0000-0001-5559-8546; Dabrowski, Wojciech/0000-0003-0449-2375; Pietrzak, Daniel/0000-0001-9814-5061				Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; CASSONE A, 1981, SABOURAUDIA, V19, P97; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; Day MJ, 2016, J COMP PATHOL, V155, P93, DOI 10.1016/j.jcpa.2016.07.001; Fera MT, 2009, EXPERT REV ANTI-INFE, V7, P981, DOI 10.1586/ERI.09.67; Galichet A, 2001, FEMS MICROBIOL LETT, V197, P179, DOI 10.1016/S0378-1097(01)00101-X; Gao YF, 2015, MOL MED REP, V11, P2585, DOI 10.3892/mmr.2014.3088; Gil-Bona A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00064; Gow NAR, 2017, MICROBIOL-SGM, V163, P1145, DOI 10.1099/mic.0.000499; Hernandez-Chavez MJ, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy053; Huprikar S, 2013, AM J TRANSPLANT, V13, P262, DOI 10.1111/ajt.12118; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; Jain AK, 2013, CHEM BIOL DRUG DES, V81, P557, DOI 10.1111/cbdd.12125; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kluczyk D, 2016, J PHYS CHEM B, V120, P12047, DOI 10.1021/acs.jpcb.6b09371; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Krizkova L, 2001, MUTAT RES-GEN TOX EN, V497, P213, DOI 10.1016/S1383-5718(01)00257-1; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Martinez-Lopez R, 2006, EUKARYOT CELL, V5, P140, DOI 10.1128/EC.5.1.140-147.2006; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Matysiak J, 2007, RUSS J BIOORG CHEM+, V33, P594, DOI 10.1134/S1068162007060106; Matysiak J, 2006, J HETEROCYCLIC CHEM, V43, P55, DOI 10.1002/jhet.5570430108; Matysiak J, 2006, EUR J MED CHEM, V41, P475, DOI 10.1016/j.ejmech.2005.12.007; Matysiak J, 2010, HETEROATOM CHEM, V21, P533, DOI 10.1002/hc.20645; Negrea P, 2015, DIG J NANOMATER BIOS, V10, P1129; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Novak M, 2012, CARBOHYD POLYM, V87, P2496, DOI 10.1016/j.carbpol.2011.11.031; Okada H, 2014, MOL BIOL CELL, V25, P222, DOI 10.1091/mbc.E13-07-0396; Ovalle R, 1998, YEAST, V14, P1159, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1159::AID-YEA317>3.0.CO;2-3; Pappas PG, 2010, AM J MED SCI, V340, P253, DOI 10.1097/MAJ.0b013e3181e99c88; Pfaller MA, 2011, DRUG RESIST UPDATE, V14, P164, DOI 10.1016/j.drup.2011.01.004; Piotrowski JS, 2015, P NATL ACAD SCI USA, V112, pE1490, DOI 10.1073/pnas.1410400112; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x; Sandula J, 1999, CARBOHYD POLYM, V38, P247, DOI 10.1016/S0144-8617(98)00099-X; Serban G, 2018, DRUG DES DEV THER, V12, P1545, DOI 10.2147/DDDT.S155958; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Singh N, 2012, AM J TRANSPLANT, V12, P2414, DOI 10.1111/j.1600-6143.2012.04100.x; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004; Castelli MV, 2017, EXPERT OPIN THER PAT, V27, P415, DOI 10.1080/13543776.2017.1261113; Zimkus A, 2013, CENT EUR J BIOL, V8, P724, DOI 10.2478/s11535-013-0186-1	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222775	10.1371/journal.pone.0222775	http://dx.doi.org/10.1371/journal.pone.0222775			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568502	gold, Green Published, Green Submitted			2022-12-26	WOS:000532364900009
J	Delecluse, S; Yu, JY; Bernhardt, K; Haar, J; Poirey, R; Tsai, MH; Kiblawi, R; Kopp-Schneider, A; Schnitzler, P; Zeier, M; Dreger, P; Wuchter, P; Bulut, OC; Behrends, U; Delecluse, HJ				Delecluse, Susanne; Yu, Jiyang; Bernhardt, Katharina; Haar, Janina; Poirey, Remy; Tsai, Ming-Han; Kiblawi, Rama; Kopp-Schneider, Annette; Schnitzler, Paul; Zeier, Martin; Dreger, Peter; Wuchter, Patrick; Bulut, Olcay Cem; Behrends, Uta; Delecluse, Henri-Jacques			Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs	PLOS ONE			English	Article								The Epstein-Barr virus (EBV) induces B-cell proliferation with high efficiency through expression of latent proteins and microRNAs. This process takes place in vivo soon after infection, presumably to expand the virus reservoir, but can also induce pathologies, e.g. an infectious mononucleosis (IM) syndrome after primary infection or a B-cell lymphoproliferation in immunosuppressed individuals. In this paper, we investigated the growth characteristics of EBV-infected B-cells isolated from transplant recipients or patients with IM. We found that these cells grew and withstood apoptosis at highly variable rates, suggesting that the expansion rate of the infected B-cells widely varies between individuals, thereby influencing the size of the B-cell reservoir and the ability to form tumors in infected individuals. All viruses investigated were type 1 and genetically close to western strains. EBV-infected Bcells expressed the transforming EBV latent genes and microRNAs (miRNAs) at variable levels. We found that the B-cell growth rates positively correlated with the BHRF1 miRNA levels. Comparative studies showed that infected B-cells derived from transplant recipients with iEBVL on average expressed higher levels of EBV miR-BHRF1 miRNAs and grew more rapidly than B-cells from IM patients, suggesting infection by more transforming viruses. Altogether, these findings suggest that EBV infection has a highly variable impact on the B-cell compartment that probably reflects the genetic diversity of both the virus and the host. It also demonstrates the unexpected finding that B-cells from different individuals can grow at different speed under the influence of the same virus infection.	[Delecluse, Susanne; Yu, Jiyang; Bernhardt, Katharina; Haar, Janina; Poirey, Remy; Tsai, Ming-Han; Kiblawi, Rama; Delecluse, Henri-Jacques] German Canc Res Ctr, Unit F100, Heidelberg, Germany; [Delecluse, Susanne; Yu, Jiyang; Bernhardt, Katharina; Haar, Janina; Poirey, Remy; Tsai, Ming-Han; Kiblawi, Rama; Delecluse, Henri-Jacques] Inst Natl Sante & Rech Med INSERM, Unit U1074, Heidelberg, Germany; [Delecluse, Susanne; Behrends, Uta; Delecluse, Henri-Jacques] German Ctr Infect Res DZIF, Braunschweig, Germany; [Delecluse, Susanne; Zeier, Martin] Nierenzentrum Heidelberg, Heidelberg, Germany; [Kopp-Schneider, Annette] German Canc Res Ctr, Unit C060, Heidelberg, Germany; [Schnitzler, Paul] Univ Hosp Heidelberg, Ctr Infect Dis, Virol, Heidelberg, Germany; [Dreger, Peter; Wuchter, Patrick] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Wuchter, Patrick] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Donor Serv Baden Wurttembe, Heidelberg, Germany; [Bulut, Olcay Cem] Univ Hosp Heidelberg, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Behrends, Uta] Tech Univ Muenchen, Childrens Hosp, Klinikum Rechts Isar, Munich, Germany; [Tsai, Ming-Han] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan	Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); German Center for Infection Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Munich; National Yang Ming Chiao Tung University	Delecluse, HJ (corresponding author), German Canc Res Ctr, Unit F100, Heidelberg, Germany.; Delecluse, HJ (corresponding author), Inst Natl Sante & Rech Med INSERM, Unit U1074, Heidelberg, Germany.; Delecluse, HJ (corresponding author), German Ctr Infect Res DZIF, Braunschweig, Germany.	h.delecluse@dkfz.de		Kiblawi, Rama/0000-0002-6887-5730; Poirey, Remy/0000-0001-8171-3317; Haar, Janina/0000-0002-7935-1369; Tsai, Ming-Han/0000-0001-5563-3057	DZIF; DKFZ; University of Heidelberg	DZIF; DKFZ(Helmholtz Association); University of Heidelberg	The DZIF (https://www.dzif.de/en), the DKFZ (https://www.dkfz.de/en/index.html) and the University of Heidelberg (https://www.heidelberg.edu/) funded this work.	Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bamoulid J, 2013, AM J TRANSPLANT, V13, P656, DOI 10.1111/ajt.12009; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bernhardt K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005405; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Carpenter B, 2010, TRANSPLANTATION, V90, P564, DOI 10.1097/TP.0b013e3181e7a3bf; Correia S, 2018, J VIROL, V92, DOI 10.1128/JVI.01132-18; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; DELECLUSE HJ, 1993, J VIROL, V67, P1292, DOI 10.1128/JVI.67.3.1292-1299.1993; Dharnidharka VR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.88; Evens AM, 2013, AM J TRANSPLANT, V13, P1512, DOI 10.1111/ajt.12211; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Fink S, 2017, TRANSPL INT, V30, P57, DOI 10.1111/tri.12871; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; Haar J, 2016, NUCLEIC ACIDS RES, V44, P1326, DOI 10.1093/nar/gkv1330; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Klinke O, 2014, SEMIN CANCER BIOL, V26, P52, DOI 10.1016/j.semcancer.2014.02.002; Lin XC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005344; Longnecker EK R.M., 2013, FIELDS VIROLOGY; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Montecucco A, 2015, EXCLI J, V14, P95, DOI 10.17179/excli2015-561; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Poirel HA, 2005, TRANSPLANTATION, V80, P176, DOI 10.1097/01.TP.0000163288.98419.0D; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; PULVERTAFT RJV, 1964, LANCET, V1, P238; ROWE M, 1985, INT J CANCER, V35, P435, DOI 10.1002/ijc.2910350404; SCULLEY TB, 1988, INTERVIROLOGY, V29, P77; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Shannon-Lowe C, 2005, J GEN VIROL, V86, P3009, DOI 10.1099/vir.0.81153-0; Shumilov A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14257; Skalsky RL, 2015, CURR TOP MICROBIOL, V391, P181, DOI 10.1007/978-3-319-22834-1_6; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Trappe R, 2012, LANCET ONCOL, V13, P196, DOI 10.1016/S1470-2045(11)70300-X; Tsai MH, 2017, ONCOTARGET, V8, P10238, DOI 10.18632/oncotarget.14380; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Tzellos S, 2014, J VIROL, V88, P8743, DOI 10.1128/JVI.01000-14	38	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222847	10.1371/journal.pone.0222847	http://dx.doi.org/10.1371/journal.pone.0222847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568538	gold, Green Published			2022-12-26	WOS:000532364900011
J	Manshouri, T; Verstovsek, S; Harris, DM; Veletic, I; Zhang, XR; Post, SM; Bueso-Ramos, CE; Estrov, Z				Manshouri, Taghi; Verstovsek, Srdan; Harris, David M.; Veletic, Ivo; Zhang, Xiaorui; Post, Sean M.; Bueso-Ramos, Carlos E.; Estrov, Zeev			Primary myelofibrosis marrow-derived CD14(+)/CD34(-) monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes	PLOS ONE			English	Article							FIBROCYTES; CELLS; PROGENITORS; EXPRESSION; ADHESION; FIBROSIS	To confirm that neoplastic monocyte-derived collagen- and fibronectin-producing fibrocytes induce bone marrow (BM) fibrosis in primary myelofibrosis (PMF), we injected PMF BM-derived fibrocyte-precursor CD14(+)/CD34(-) monocytes into the tail vein of NOD-SCID-gamma (NSG) mice. PMF BM-derived CD14(+)/CD34(-) monocytes engrafted and induced a PMF-like phenotype with splenomegaly, myeloid hyperplasia with clusters of atypical megakaryocytes, persistence of the JAK2(V617F) mutation, and BM and spleen fibrosis. As control we used normal human BM-derived CD14(+)/CD34(-) monocytes. These monocytes also engrafted and gave rise to normal megakaryocytes that, like PMF CD14(+)/CD34(-)-derived megakaryocytes, expressed HLA-ABC and human CD42b antigens. Using 2 clonogenic assays we confirmed that PMF and normal BM-derived CD14(+)/CD34(-) monocytes give rise to megakaryocyte colony-forming cells, suggesting that a subpopulation BM monocytes harbors megakaryocyte progenitor capacity. Taken together, our data suggest that PMF monocytes induce myelofibrosis-like phenotype in immunodeficient mice and that PMF and normal BM-derived CD14(+)/CD34(-) monocytes give rise to megakaryocyte progenitor cells.	[Manshouri, Taghi; Verstovsek, Srdan; Harris, David M.; Veletic, Ivo; Zhang, Xiaorui; Post, Sean M.; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos E.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Estrov, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org	Veletic, Ivo/P-9936-2016	Veletic, Ivo/0000-0001-5802-5313; Estrov, Zeev/0000-0002-1623-3613; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569	Hanns A. Pielenz family foundation; NIH/NCI through the Cancer Center Support Grant (CCSG) [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Hanns A. Pielenz family foundation; NIH/NCI through the Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a grant from the Hanns A. Pielenz family foundation. This work was performed in part in the Flow Cytometry and Cellular Imaging Core Facility, which is supported by the NIH/NCI through the Cancer Center Support Grant (CCSG) P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Debili N, 2001, BLOOD, V97, P2023, DOI 10.1182/blood.V97.7.2023; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; GROOPMAN JE, 1980, ANN INTERN MED, V92, P857, DOI 10.7326/0003-4819-92-6-857; Hamers AAJ, 2019, ARTERIOSCL THROM VAS, V39, P25, DOI 10.1161/ATVBAHA.118.311022; Hopman RK, 2014, BLOOD REV, V28, P31, DOI 10.1016/j.blre.2014.01.001; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Law HKW, 2000, CYTOMETRY, V41, P308, DOI 10.1002/1097-0320(20001201)41:4<308::AID-CYTO9>3.3.CO;2-E; Lundahl J, 1996, SCAND J IMMUNOL, V44, P143, DOI 10.1046/j.1365-3083.1996.d01-296.x; McLornan DP, 2012, BRIT J HAEMATOL, V157, P413, DOI 10.1111/j.1365-2141.2012.09107.x; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Quintas-Cardama A, 2011, INVEST NEW DRUG, V29, P818, DOI 10.1007/s10637-010-9429-z; Rampal R, 2014, BLOOD, V123, pE123, DOI 10.1182/blood-2014-02-554634; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Thiele J, 2006, ANN HEMATOL, V85, P226, DOI 10.1007/s00277-005-0042-8; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vener C, PROGNOSTIC IMPLICATI; Verstovsek S, 2016, J EXP MED, V213, P1723, DOI 10.1084/jem.20160283; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222912	10.1371/journal.pone.0222912	http://dx.doi.org/10.1371/journal.pone.0222912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31569199	gold, Green Published, Green Submitted			2022-12-26	WOS:000532364900016
J	Salecker, J; Dislich, C; Wiegand, K; Meyer, KM; Pe'er, G				Salecker, Jan; Dislich, Claudia; Wiegand, Kerstin; Meyer, Katrin M.; Pe'er, Guy			EFForTS-LGraf: A landscape generator for creating smallholder-driven land-use mosaics	PLOS ONE			English	Article							OIL PALM EXPANSION; COVER CHANGE; MODELS; SIMULATION; DYNAMICS; PROTOCOL; FARMERS; IMPACTS; FUTURE	Spatially-explicit simulation models are commonly used to study complex ecological and socio-economic research questions. Often these models depend on detailed input data, such as initial land-cover maps to set up model simulations. Here we present the landscape generator EFFortS-LGraf that provides artificially-generated land-use maps of agricultural landscapes shaped by small-scale farms. EFForTS-LGraf is a process-based landscape generator that explicitly incorporates the human dimension of land-use change. The model generates roads and villages that consist of smallholder farming households. These smallholders use different establishment strategies to create fields in their close vicinity. Crop types are distributed to these fields based on crop fractions and specialization levels. EFForTS-LGraf model parameters such as household area or field size frequency distributions can be derived from household surveys or geospatial data. This can be an advantage over the abstract parameters of neutral landscape generators. We tested the model using oil palm and rubber farming in Indonesia as a case study and validated the artificially-generated maps against classified satellite images. Our results show that EFForTS-LGraf is able to generate realistic land-cover maps with properties that lie within the boundaries of landscapes from classified satellite images. An applied simulation experiment on landscapelevel effects of increasing household area and crop specialization revealed that larger households with higher specialization levels led to spatially more homogeneous and less scattered crop type distributions and reduced edge area proportion. Thus, EFForTS-LGraf can be applied both to generate maps as inputs for simulation modelling and as a standalone tool for specific landscape-scale analyses in the context of ecological-economic studies of smallholder farming systems.	[Salecker, Jan; Dislich, Claudia; Wiegand, Kerstin; Meyer, Katrin M.] Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany; [Wiegand, Kerstin] Univ Goettingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Pe'er, Guy] German Ctr Integrat Biodivers Res & Div Halle Jen, Synth Ctr sDiv, Leipzig, Germany; [Pe'er, Guy] UFZ Helmholtz Ctr Environm Res, Dept Econ, Leipzig, Germany; [Pe'er, Guy] UFZ Helmholtz Ctr Environm Res, Dept Ecosyst Serv, Leipzig, Germany; [Pe'er, Guy] Univ Leipzig, Leipzig, Germany; [Dislich, Claudia] UFZ Helmholtz Ctr Environm Res, Grad Sch HIGRADE, Leipzig, Germany	University of Gottingen; University of Gottingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Salecker, J (corresponding author), Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany.	jsaleck@gwdg.de	Meyer, Katrin M/E-6839-2013	Meyer, Katrin M/0000-0002-9990-4047; Salecker, Jan/0000-0002-9000-4229; Wiegand, Kerstin/0000-0003-4854-0607	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [192626868 - SFB 990, CRC990]; iDiv	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); iDiv	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project number 192626868 - SFB 990 in the framework of the collaborative German - Indonesian research project CRC990. Guy Pe'er was funded by iDiv as an sDiv catalyst post-doc.	Ayllon D, 2016, ECOL MODEL, V326, P36, DOI 10.1016/j.ecolmodel.2015.07.026; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Chan K., 2000, SENSITIVITY ANAL, P167; Dislich C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190506; Dislich C, 2017, BIOL REV, V92, P1539, DOI 10.1111/brv.12295; Euler M, 2017, WORLD DEV, V93, P219, DOI 10.1016/j.worlddev.2016.12.019; Euler M, 2016, J AGR ECON, V67, P658, DOI 10.1111/1477-9552.12163; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gatto M, 2015, LAND USE POLICY, V46, P292, DOI 10.1016/j.landusepol.2015.03.001; Gaucherel C, 2006, ECOL MODEL, V194, P233, DOI 10.1016/j.ecolmodel.2005.10.026; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; Jansen MJW, 1999, COMPUT PHYS COMMUN, V117, P35, DOI 10.1016/S0010-4655(98)00154-4; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Klasen S, 2016, ECOL ECON, V122, P111, DOI 10.1016/j.ecolecon.2016.01.001; Koh LP, 2011, BASIC APPL ECOL, V12, P389, DOI 10.1016/j.baae.2011.05.004; Krishna V, 2017, AGR ECON-BLACKWELL, V48, P639, DOI 10.1111/agec.12363; Kumar M., 2010, J INF KNOWL MANAG, V2, P451, DOI [DOI 10.2139/SSRN.3529843, 10.2139/ssrn.3529843]; Lakner S., 2017, IS CAP FIT PURPOSE E; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Langhammer M, 2019, ECOL MODEL, V393, P135, DOI 10.1016/j.ecolmodel.2018.12.010; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; McGarigal K., 2012, TECH REP; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Melati D.N., 2017, THESIS; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Pe'er G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064968; R Core Team, 2018, R LANG ENV STAT COMP; Salecker J, 2019, METHODS ECOL EVOL, V10, P1854, DOI 10.1111/2041-210X.13286; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schroder B, 2006, ECOL MODEL, V199, P505, DOI 10.1016/j.ecolmodel.2006.05.036; Schulze J, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3423; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Tietjen B, 2016, ECOL MODEL, V326, P13, DOI 10.1016/j.ecolmodel.2015.06.013; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x	40	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222949	10.1371/journal.pone.0222949	http://dx.doi.org/10.1371/journal.pone.0222949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6IT	31560726	gold, Green Submitted, Green Published			2022-12-26	WOS:000532353700027
J	Champagne, J; Linares, LK; Maurel, B; Zampieri, A; Moreno, M; Fuentes, I; Dubois, E; Severac, D; Decorsiere, A; Bienvenu, F				Champagne, Julien; Linares, Laetitia K.; Maurel, Benjamin; Zampieri, Alexandre; Moreno, Maeva; Fuentes, Ivanna; Dubois, Emeric; Severac, Dany; Decorsiere, Adrien; Bienvenu, Frederic			TAG-RNAi overcomes off-target effects in cancer models	ONCOGENE			English	Article							CYCLIN D1; TRANSCRIPTIONAL ROLE; LARGE-SCALE; INTERFERENCE; REVEALS; DRIVE	RNA interference offers therapeutic opportunities for the clinical targeting of otherwise undruggable oncogenes. However RNAi can have off-target effects that considerably increase treatment risks. To manage these side effects and allow an easy subtraction of their activity in healthy tissues, we present here the TAG-RNAi approach where cells that are not designated targets do not have the mRNA tag. Using TAG-RNAi we first established the off-target signatures of three different siRNAs specific to the Cyclin D1 oncogene by RNA-sequencing of cultured cancer cells expressing a FLAG-HA-tagged-Cyclin D1. Then, by symmetrical allografts of tagged-cancer cells and untagged controls on the left and right flanks of model mice, we demonstrate that TAG-RNAi is a reliable approach to study the functional impact of any oncogene without off-target bias. Finally we show, as examples, that mutation-specific TAG-RNAi can be applied to downregulate two oncogenic mutants, KRAS-G12V or BRAF-V600E, while sparing the expression of the wild-type proteins. TAG-RNAi will thus avoid the traditional off-target limitations of RNAi in future experimental approaches.	[Champagne, Julien; Maurel, Benjamin; Zampieri, Alexandre; Moreno, Maeva; Fuentes, Ivanna; Decorsiere, Adrien; Bienvenu, Frederic] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France; [Champagne, Julien; Maurel, Benjamin; Zampieri, Alexandre; Moreno, Maeva; Fuentes, Ivanna; Decorsiere, Adrien; Bienvenu, Frederic] INSERM, U1191, F-34094 Montpellier, France; [Champagne, Julien; Maurel, Benjamin; Zampieri, Alexandre; Moreno, Maeva; Fuentes, Ivanna; Decorsiere, Adrien; Bienvenu, Frederic] Univ Montpellier, UMR 5203, F-34094 Montpellier, France; [Linares, Laetitia K.] Univ Montpellier, IRCM, INSERM U896, Inst Reg Canc Montpellier, F-34298 Montpellier, France; [Dubois, Emeric; Severac, Dany] Inst Genom Fonct, MGX Montpellier GenomiX, 141 Rue Cardonille, F-34094 Montpellier 5, France; [Bienvenu, Frederic] Lab Excellence Genome & Epigenome Mol Med EpiGenM, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Bienvenu, F (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France.; Bienvenu, F (corresponding author), INSERM, U1191, F-34094 Montpellier, France.; Bienvenu, F (corresponding author), Univ Montpellier, UMR 5203, F-34094 Montpellier, France.; Bienvenu, F (corresponding author), Lab Excellence Genome & Epigenome Mol Med EpiGenM, F-34094 Montpellier, France.	frederic.bienvenu@igf.cnrs.fr	Linares, Laetitia LKL/F-9901-2018	Linares, Laetitia LKL/0000-0003-1661-2119; Dubois, Emeric/0000-0002-6052-4178; bienvenu, frederic/0000-0003-2914-4051; decorsiere, adrien/0000-0002-5716-6154; CHAMPAGNE, Julien/0000-0001-8460-858X	Atip-Avenir program [RSE11003FSA]; Merieux Research Grant [060805]; FP7 Marie-Curie European IRG [277118]; EpiGenMed LabEx ("investissements d'avenir") [ANR-10-LABX-12-01]; Fondation pour la Recherche Medicale; Ligue Nationale contre le Cancer; University of Montpellier; SATT AxLR; Montpellier SIRIC; Canceropole GSO; Ligue Regionale contre le Cancer	Atip-Avenir program; Merieux Research Grant; FP7 Marie-Curie European IRG; EpiGenMed LabEx ("investissements d'avenir")(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); University of Montpellier; SATT AxLR; Montpellier SIRIC; Canceropole GSO; Ligue Regionale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Atip-Avenir program (RSE11003FSA), the Merieux Research Grant (060805), the FP7 Marie-Curie European IRG (277118), the EpiGenMed LabEx ("investissements d'avenir" reference ANR-10-LABX-12-01), the Fondation pour la Recherche Medicale, the Ligue Nationale and Regionale contre le Cancer, the University of Montpellier, the SATT AxLR, the Montpellier SIRIC, and the Canceropole GSO, all to FB. JC is the recipient of a Ligue Nationale contre le Cancer Ph.D. fellowship.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Casimiro MC, 2012, J CLIN INVEST, V122, P833, DOI 10.1172/JCI60256; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guo RL, 2017, TRANSCRIPTOMICS, P5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iribe H, 2017, ACS OMEGA, V2, P2055, DOI 10.1021/acsomega.7b00291; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kirk R., 2011, NAT REV CLIN ONCOL, V8, P691; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Lander E, 2019, NATURE, V567, P165, DOI 10.1038/d41586-019-00726-5; Lehmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088797; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Morrison C, 2018, NAT REV DRUG DISCOV, V17, P156, DOI 10.1038/nrd.2018.20; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Prenen H, 2010, CLIN CANCER RES, V16, P2921, DOI 10.1158/1078-0432.CCR-09-2029; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Setten RL, 2019, NAT REV DRUG DISCOV, V18, P421, DOI 10.1038/s41573-019-0017-4; Sheridan C., 2019, NAT BIOTECHNOL; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111; Yin H, 2019, NAT REV CLIN ONCOL, V16, P281, DOI 10.1038/s41571-019-0166-8; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Zampieri A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15739; Zhou CY, 2019, NATURE, V571, P275, DOI 10.1038/s41586-019-1314-0; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	38	3	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					935	945		10.1038/s41388-019-1020-2	http://dx.doi.org/10.1038/s41388-019-1020-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31558799				2022-12-26	WOS:000509197200014
J	Weinberg, F; Griffin, R; Frohlich, M; Heining, C; Braun, S; Spohr, C; Iconomou, M; Hollek, V; Roring, M; Horak, P; Kreutzfeldt, S; Warsow, G; Hutter, B; Uhrig, S; Neumann, O; Reuss, D; Heiland, DH; von Kalle, C; Weichert, W; Stenzinger, A; Brors, B; Glimm, H; Frohling, S; Brummer, T				Weinberg, Florian; Griffin, Ricarda; Froehlich, Martina; Heining, Christoph; Braun, Sandra; Spohr, Corinna; Iconomou, Mary; Hollek, Viola; Roering, Michael; Horak, Peter; Kreutzfeldt, Simon; Warsow, Gregor; Hutter, Barbara; Uhrig, Sebastian; Neumann, Olaf; Reuss, David; Heiland, Dieter Henrik; von Kalle, Christof; Weichert, Wilko; Stenzinger, Albrecht; Brors, Benedikt; Glimm, Hanno; Froehling, Stefan; Brummer, Tilman			Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains	ONCOGENE			English	Article							RAF INHIBITOR RESISTANCE; B-RAF; TWEETY FAMILY; MAPK PATHWAY; TARGETED THERAPY; GENE FUSIONS; IN-VIVO; KINASE; CANCER; DIMERIZATION	Fusion proteins involving the BRAF serine/threonine kinase occur in many cancers. The oncogenic potential of BRAF fusions has been attributed to the loss of critical N-terminal domains that mediate BRAF autoinhibition. We used whole-exome and RNA sequencing in a patient with glioblastoma multiforme to identify a rearrangement between TTYH3, encoding a membrane-resident, calcium-activated chloride channel, and BRAF intron 1, resulting in a TTYH3-BRAF fusion protein that retained all features essential for BRAF autoinhibition. Accordingly, the BRAF moiety of the fusion protein alone, which represents full-length BRAF without the amino acids encoded by exon 1 (BRAF(Delta E1)), did not induce MEK/ERK phosphorylation or transformation. Likewise, neither the TTYH3 moiety of the fusion protein nor full-length TTYH3 provoked ERK pathway activity or transformation. In contrast, TTYH3-BRAF displayed increased MEK phosphorylation potential and transforming activity, which were caused by TTYH3-mediated tethering of near-full-length BRAF to the (endo)membrane system. Consistent with this mechanism, a synthetic approach, in which BRAF(Delta E1) was tethered to the membrane by fusing it to the cytoplasmic tail of CD8 also induced transformation. Furthermore, we demonstrate that TTYH3-BRAF signals largely independent of a functional RAS binding domain, but requires an intact BRAF dimer interface and activation loop phosphorylation sites. Cells expressing TTYH3-BRAF exhibited increased MEK/ERK signaling, which was blocked by clinically achievable concentrations of sorafenib, trametinib, and the paradox breaker PLX8394. These data provide the first example of a fully autoinhibited BRAF protein whose oncogenic potential is dictated by a distinct fusion partner and not by a structural change in BRAF itself.	[Weinberg, Florian; Griffin, Ricarda; Braun, Sandra; Spohr, Corinna; Iconomou, Mary; Hollek, Viola; Roering, Michael; Brummer, Tilman] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany; [Weinberg, Florian; Braun, Sandra] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Froehlich, Martina; Hutter, Barbara; Uhrig, Sebastian; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Froehlich, Martina; Hutter, Barbara; Uhrig, Sebastian; Brors, Benedikt] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Heining, Christoph; Glimm, Hanno] NCT Dresden, Dept Translat Med Oncol, Heidelberg, Germany; [Heining, Christoph; Horak, Peter; Kreutzfeldt, Simon; von Kalle, Christof; Glimm, Hanno; Froehling, Stefan; Brummer, Tilman] DKFZ, Heidelberg, Germany; [Heining, Christoph; Glimm, Hanno] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Heining, Christoph; Glimm, Hanno] German Canc Consortium DKTK, Dresden, Germany; [Spohr, Corinna] Univ Freiburg, Fac Biol, Freiburg, Germany; [Spohr, Corinna] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Horak, Peter; Kreutzfeldt, Simon; Froehling, Stefan] NCT Heidelberg, Dept Translat Med Oncol, Heidelberg, Germany; [Horak, Peter; Kreutzfeldt, Simon; Neumann, Olaf; Reuss, David; Stenzinger, Albrecht; Brors, Benedikt; Froehling, Stefan] DKTK, Heidelberg, Germany; [Warsow, Gregor] DKFZ, Omics IT & Data Management Core Facil, Heidelberg, Germany; [Warsow, Gregor] DKFZ, Div Theoret Bioinformat, Heidelberg, Germany; [Uhrig, Sebastian] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Neumann, Olaf; Stenzinger, Albrecht] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Reuss, David] Heidelberg Univ Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Reuss, David] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Heiland, Dieter Henrik] Univ Freiburg, Fac Med, Med Ctr, Dept Neurosurg, Freiburg, Germany; [Heiland, Dieter Henrik] Univ Freiburg, Fac Med, Med Ctr, Translat NeuroOncol Res Grp, Freiburg, Germany; [von Kalle, Christof] NCT Heidelberg, Dept Translat Oncol, Heidelberg, Germany; [Weichert, Wilko] Tech Univ Munich, Inst Pathol, Munich, Germany; [Weichert, Wilko] DKTK, Munich, Germany; [Brummer, Tilman] Univ Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Brummer, Tilman] DKTK Partner Site Freiburg, Heidelberg, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; University of Freiburg	Brummer, T (corresponding author), Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany.; Frohling, S (corresponding author), NCT Heidelberg, Dept Translat Med Oncol, Heidelberg, Germany.; Frohling, S (corresponding author), DKTK, Heidelberg, Germany.; Brummer, T (corresponding author), Univ Freiburg, Comprehens Canc Ctr Freiburg, Freiburg, Germany.; Brummer, T (corresponding author), DKTK Partner Site Freiburg, Heidelberg, Germany.	stefan.froehling@nct-heidelberg.de; tilman.brummer@mol-med.uni-freiburg.de	Brummer, Tilman/AAA-9428-2020; Heiland, Dieter Henrik/ABE-8856-2020; Neumann, Olaf/GSO-3538-2022; Brummer, Tilman/B-6218-2016; Horak, Peter/ABC-1587-2021; Brors, Benedikt/E-5620-2013	Brummer, Tilman/0000-0003-4387-7905; Heiland, Dieter Henrik/0000-0002-9258-3033; Neumann, Olaf/0000-0003-2684-9187; Brummer, Tilman/0000-0003-4387-7905; Horak, Peter/0000-0003-4536-9306; Brors, Benedikt/0000-0001-5940-3101; Griffin, Ricarda/0000-0003-1368-2832; von Kalle, Christof/0000-0001-9221-3297; Hollek, Viola/0000-0001-9768-5568	German Research Foundation (DFG) [BR3662/4-1, SFB 850 B04, EXC 294 BIOSS]; DKFZ-Heidelberg Center for Personalized Oncology [021]; DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); DKFZ-Heidelberg Center for Personalized Oncology; DFG(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) by BR3662/4-1, SFB 850 B04, and EXC 294 BIOSS to TB, and by grant 021 from the DKFZ-Heidelberg Center for Personalized Oncology to HG and SF, TB is the recipient of a Heisenberg Professorship from the DFG. CS is supported in part by the DFG-funded Spemann Graduate School of Biology and Medicine (SGBM, GSC 4). We thank the DKFZ-HIPO Sample Processing Laboratory, the DKFZ Genomics and Proteomics Core Facility, the Omics IT and Data Management Core Facility for technical support. We also thank D. Richter, K. Beck, K. Willmund, R. Eils, and P. Lichter for infrastructure and program development within DKFZ-HIPO.	Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Behling F, 2019, CANCERS, V11, DOI 10.3390/cancers11060794; Bender S, 2016, NAT MED, V22, P1314, DOI 10.1038/nm.4204; Berghoff AS, 2014, CURR OPIN NEUROL, V27, P689, DOI 10.1097/WCO.0000000000000146; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Chmielecki J, 2014, CANCER DISCOV, V4, P1398, DOI 10.1158/2159-8290.CD-14-0617; Cin H, 2011, ACTA NEUROPATHOL, V121, P763, DOI 10.1007/s00401-011-0817-z; Dankner M, 2018, ONCOGENE, V37, P3183, DOI 10.1038/s41388-018-0171-x; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Diedrich B, 2017, EMBO J, V36, P646, DOI 10.15252/embj.201694732; Eisenhardt AE, 2016, ONCOTARGET, V7, P26628, DOI 10.18632/oncotarget.8427; Eisenhardt AE, 2011, INT J CANCER, V129, P2297, DOI 10.1002/ijc.25893; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Fangusaro J, 2019, LANCET ONCOL, V20, P1011, DOI 10.1016/S1470-2045(19)30277-3; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Han YE, 2019, EXP NEUROBIOL, V28, P183, DOI 10.5607/en.2019.28.2.183; He YW, 2008, J BIOL CHEM, V283, P24000, DOI 10.1074/jbc.M803361200; He YW, 2008, BIOCHEM J, V412, P45, DOI 10.1042/BJ20071722; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; Herr R, 2018, ONCOGENE, V37, P1576, DOI 10.1038/s41388-017-0063-5; Horak P, 2017, INT J CANCER, V141, P877, DOI 10.1002/ijc.30828; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Isaacson AL, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a003848; Jain P, 2017, ONCOGENE, V36, P6348, DOI 10.1038/onc.2017.276; Jang JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09755; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Jung E, 2017, J NEUROSCI, V37, P6837, DOI 10.1523/JNEUROSCI.3532-16.2017; Karajannis MA, 2014, NEURO-ONCOLOGY, V16, P1408, DOI 10.1093/neuonc/nou059; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; Kim HS, 2017, ONCOGENE, V36, P3334, DOI 10.1038/onc.2016.486; Kohler M, 2016, EMBO J, V35, P143, DOI 10.15252/embj.201592097; Kordes M, 2016, LEUKEMIA, V30, P937, DOI 10.1038/leu.2015.319; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; Lu HY, 2017, CANCER RES, V77, P3502, DOI 10.1158/0008-5472.CAN-16-2745; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Masilamani AP, 2017, ONCOGENE, V36, P3562, DOI 10.1038/onc.2016.507; McEvoy CR, 2019, J CLIN INVEST, V129, P1940, DOI 10.1172/JCI123089; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Ng PKS, 2018, CANCER CELL, V33, P450, DOI 10.1016/j.ccell.2018.01.021; Nicolaides TP, 2011, CLIN CANCER RES, V17, P7595, DOI 10.1158/1078-0432.CCR-11-1456; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Phuchareon J, 2015, P NATL ACAD SCI USA, V112, pE3855, DOI 10.1073/pnas.1510733112; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ramis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038770; Ricklefs FL, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1588555; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Robinson JP, 2010, ONCOGENE, V29, P335, DOI 10.1038/onc.2009.333; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Selt F, 2017, ONCOTARGET, V8, P11460, DOI 10.18632/oncotarget.14004; Selt F, 2016, BRAIN PATHOL, V26, P506, DOI 10.1111/bpa.12326; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Stefaniuk M, 2010, J NEUROCHEM, V115, P1183, DOI 10.1111/j.1471-4159.2010.07023.x; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Terrell Elizabeth M., 2018, COLD SPRING HARB PER, V9, pa033746; Tien AC, 2012, DEVELOPMENT, V139, P2477, DOI 10.1242/dev.077214; Turski ML, 2016, MOL CANCER THER, V15, P533, DOI 10.1158/1535-7163.MCT-15-0643; Yao Z, 2019, NAT MED, V25, P284, DOI 10.1038/s41591-018-0274-5; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3248-y; Yuan JM, 2018, ONCOGENE, V37, P5719, DOI 10.1038/s41388-018-0365-2; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	80	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					814	832		10.1038/s41388-019-1021-1	http://dx.doi.org/10.1038/s41388-019-1021-1			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31558800				2022-12-26	WOS:000509197200006
J	Ohno, R; Ichimaru, K; Tanaka, S; Sugawa, H; Katsuta, N; Sakake, S; Tominaga, Y; Ban, I; Shirakawa, J; Yamaguchi, Y; Ito, E; Taniguchi, N; Nagai, R				Ohno, Rei-ichi; Ichimaru, Kenta; Tanaka, Seitaro; Sugawa, Hikari; Katsuta, Nana; Sakake, Shiori; Tominaga, Yu-ki; Ban, Ikuho; Shirakawa, Jun-ichi; Yamaguchi, Yoshiki; Ito, Emi; Taniguchi, Naoyuki; Nagai, Ryoji			Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycation; post-translational modification (PTM); diabetes; mass spectrometry (MS); nuclear magnetic resonance (NMR); AGEs; glucoselysine; lens; polyclonal antibody; polyol pathway	GLYCATION END-PRODUCTS; MAILLARD REACTION; N-EPSILON-(CARBOXYETHYL)LYSINE CEL; N-EPSILON-(CARBOXYMETHYL) LYSINE; IN-VITRO; PROTEINS; AGE; PLASMA; QUANTIFICATION; GLYCOLALDEHYDE	Prolonged hyperglycemia generates advanced glycation end-products (AGEs), which are believed to be involved in the pathogenesis of diabetic complications. In the present study, we developed a polyclonal antibody against fructose-modified proteins (Fru-P antibody) and identified its epitope as glucoselysine (GL) by NMR and LC-electrospray ionization (ESI)-quadrupole TOF (QTOF) analyses and evaluated its potential role in diabetes sequelae. Although the molecular weight of GL was identical to that of fructoselysine (FL), GL was distinguishable from FL because GL was resistant to acid hydrolysis, which converted all of the FLs to furosine. We also detected GL in vitro when reduced BSA was incubated with fructose for 1 day. However, when we incubated reduced BSA with glucose, galactose, or mannose for 14 days, we did not detect GL, suggesting that GL is dominantly generated from fructose. LC-ESI-MS/MS experiments with synthesized [C-13(6)]GL indicated that the GL levels in the rat eye lens time-dependently increase after streptozotocin-induced diabetes. We observed a 31.3-fold increase in GL 8 weeks after the induction compared with nondiabetic rats, and N epsilon-(carboxymethyl)lysine and furosine increased by 1.7- and 21.5-fold, respectively, under the same condition. In contrast, sorbitol in the lens levelled off at 2 weeks after diabetes induction. We conclude that GL may be a useful biological marker to monitor and elucidate the mechanism of protein degeneration during progression of diabetes.	[Ohno, Rei-ichi; Sugawa, Hikari; Nagai, Ryoji] Tokai Univ, Grad Sch Biosci, Lab Food & Regulat Biol, Higashi Ku, 9-1-1 Toroku, Kumamoto, Kumamoto 8620970, Japan; [Ichimaru, Kenta; Tanaka, Seitaro; Katsuta, Nana; Sakake, Shiori; Tominaga, Yu-ki; Nagai, Ryoji] Tokai Univ, Grad Sch Agr, Lab Food & Regulat Biol, Higashi Ku, 9-1-1 Toroku, Kumamoto, Kumamoto 8620970, Japan; [Ban, Ikuho; Shirakawa, Jun-ichi] Tokai Univ, Sch Agr, Lab Food & Regulat Biol, Dept Biosci,Higashi Ku, 9-1-1 Toroku, Kumamoto, Kumamoto 8620970, Japan; [Yamaguchi, Yoshiki] Tohoku Med & Pharmaceut Univ, Lab Pharmaceut Phys Chem, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Ito, Emi] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Diabet Complicat,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan; [Taniguchi, Naoyuki] Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, 3-1-69 Otemae, Osaka 5418567, Japan	Tokai University; Tokai University; Tokai University; Tohoku Medical & Pharmaceutical University; National Center for Global Health & Medicine - Japan	Nagai, R (corresponding author), Tokai Univ, Lab Food & Regulat Biol, Dept Biosci, Sch Agr,Higashi Ku, Toroku 9-1-1, Kumamoto, Kumamoto 8628652, Japan.	nagai-883@umin.ac.jp	Taniguchi, Naoyuki/I-4182-2014; Yamaguchi, Yoshiki/N-5246-2015	Taniguchi, Naoyuki/0000-0001-5889-5968; Yamaguchi, Yoshiki/0000-0003-0100-5439				Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; ARAI K, 1987, J BIOL CHEM, V262, P16969; BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441; CHENG RZ, 1994, EUR J BIOCHEM, V223, P759, DOI 10.1111/j.1432-1033.1994.tb19050.x; Davidson MB, 1999, JAMA-J AM MED ASSOC, V281, P1203, DOI 10.1001/jama.281.13.1203; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; Duran-Jimenez B, 2009, DIABETES, V58, P2893, DOI 10.2337/db09-0320; GABBAY KH, 1975, ANNU REV MED, V26, P521, DOI 10.1146/annurev.me.26.020175.002513; Hayashi CM, 2002, LAB INVEST, V82, P795, DOI 10.1097/01.LAB.0000018826.59648.07; He GL, 2018, J CHROMATOGR B, V1081, P91, DOI 10.1016/j.jchromb.2018.02.025; HEYNS K, 1962, CHEM BER-RECL, V95, P720, DOI 10.1002/cber.19620950323; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; JONES IR, 1983, DIABETES CARE, V6, P501, DOI 10.2337/diacare.6.5.501; Kanska U, 2002, ARCH IMMUNOL THER EX, V50, P61; Kawasaki Y, 1998, FEBS LETT, V441, P116, DOI 10.1016/S0014-5793(98)01529-4; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; Li CT, 2018, INT J BIOL MACROMOL, V118, P442, DOI 10.1016/j.ijbiomac.2018.06.108; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Mera K, 2007, FREE RADICAL RES, V41, P713, DOI 10.1080/10715760701332425; Mera K, 2011, BIOCHEM BIOPH RES CO, V407, P420, DOI 10.1016/j.bbrc.2011.03.040; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Miyata TR, 1998, KIDNEY INT, V54, P1290, DOI 10.1046/j.1523-1755.1998.00093.x; Miyazawa N, 1998, BIOCHEM J, V336, P101, DOI 10.1042/bj3360101; MULLOKANDOV EA, 1994, DIABETOLOGIA, V37, P145, DOI 10.1007/s001250050085; Murata T, 1997, DIABETOLOGIA, V40, P764, DOI 10.1007/s001250050747; Nagai R, 1998, FEBS LETT, V425, P355, DOI 10.1016/S0014-5793(98)00263-4; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Nagai R, 2002, DIABETES, V51, P2833, DOI 10.2337/diabetes.51.9.2833; Nagai R, 1997, BIOCHEM BIOPH RES CO, V234, P167, DOI 10.1006/bbrc.1997.6608; Nagai R, 2010, BIOCHEM BIOPH RES CO, V393, P118, DOI 10.1016/j.bbrc.2010.01.095; NAKAYAMA H, 1993, DIABETES, V42, P345, DOI 10.2337/diabetes.42.2.345; Ni JQ, 2009, MOL CELL PROTEOMICS, V8, P1921, DOI 10.1074/mcp.M900127-MCP200; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Sajiki H, 1998, J ORG CHEM, V63, P7990, DOI 10.1021/jo9814694; Sakata N, 1998, ATHEROSCLEROSIS, V141, P61, DOI 10.1016/S0021-9150(98)00149-X; SCHLEICHER ED, 1984, DIABETES CARE, V7, P548, DOI 10.2337/diacare.7.6.548; Shirakawa J, 2016, FOOD FUNCT, V7, P2508, DOI [10.1039/C5FO01618E, 10.1039/c5fo01618e]; Sugawa H, 2016, FOOD FUNCT, V7, P2566, DOI [10.1039/c5fo01563d, 10.1039/C5FO01563D]; Swamy-Mruthinti S, 2002, CURR EYE RES, V25, P139, DOI 10.1076/ceyr.25.3.139.13480; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Turk Z, 1997, ACTA DIABETOL, V34, P49, DOI 10.1007/s005920050066; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; WellsKnecht KJ, 1996, NEPHROL DIAL TRANSPL, V11, P41; ZYZAK DV, 1995, ARCH BIOCHEM BIOPHYS, V316, P547, DOI 10.1006/abbi.1995.1073	45	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17326	17338		10.1074/jbc.RA119.010744	http://dx.doi.org/10.1074/jbc.RA119.010744			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31594865	hybrid, Green Published			2022-12-26	WOS:000503173500014
J	Troxler, LJ; Werren, JP; Schaffner, TO; Mostacci, N; Vermathen, P; Vermathen, M; Wuthrich, D; Simillion, C; Brugger, SD; Bruggmann, R; Hathaway, LJ; Furrer, J; Hilty, M				Troxler, Lukas J.; Werren, Joel P.; Schaffner, Thierry O.; Mostacci, Nadezda; Vermathen, Peter; Vermathen, Martina; Wuthrich, Daniel; Simillion, Cedric; Brugger, Silvio D.; Bruggmann, Remy; Hathaway, Lucy J.; Furrer, Julien; Hilty, Markus			Carbon source regulates polysaccharide capsule biosynthesis in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fructose; Streptococcus; nuclear magnetic resonance (NMR); bacterial metabolism; glucose; virulence factor; carbohydrate metabolism; exopolysaccharide capsule; serotype; Streptococcus pneumoniae; sucrose	UDP-N-ACETYLGLUCOSAMINE; EXOPOLYSACCHARIDE BIOSYNTHESIS; COMPLEMENT; METABOLISM; EXPRESSION; VARIANTS; FRUCTOSE	The exopolysaccharide capsule of Streptococcus pneumoniae is an important virulence factor, but the mechanisms that regulate capsule thickness are not fully understood. Here, we investigated the effects of various exogenously supplied carbohydrates on capsule production and gene expression in several pneumococcal serotypes. Microscopy analyses indicated a near absence of the capsular polysaccharide (CPS) when S. pneumoniae was grown on fructose. Moreover, serotype 7F pneumococci produced much less CPS than strains of other serotypes (6B, 6C, 9V, 15, and 23F) when grown on glucose or sucrose. RNA-sequencing revealed carbon source-dependent regulation of distinct genes of WT strains and capsule-switch mutants of serotypes 6B and 7F, but could not explain the mechanism of capsule thickness regulation. In contrast, P-31 NMR of whole-cell extract from capsule-knockout strains (Delta cps) clearly revealed the accumulation or absence of capsule precursor metabolites when cells were grown on glucose or fructose, respectively. This finding suggests that fructose uptake mainly results in intracellular fructose 1-phosphate, which is not converted to CPS precursors. In addition, serotype 7F strains accumulated more precursors than did 6B strains, indicating less efficient conversion of precursor metabolites into the CPS in 7F, in line with its thinner capsule. Finally, isotopologue sucrose labeling and NMR analyses revealed that the uptake of the labeled fructose subunit into the capsule is <10% that of glucose. Our findings on the effects of carbon sources on CPS production in different S. pneumoniae serotypes may contribute to a better understanding of pneumococcal diseases and could inform future therapeutic approaches.	[Troxler, Lukas J.; Werren, Joel P.; Schaffner, Thierry O.; Mostacci, Nadezda; Hathaway, Lucy J.; Hilty, Markus] Univ Bern, Inst Infect Dis, Fac Med, CH-3001 Bern, Switzerland; [Troxler, Lukas J.; Werren, Joel P.] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland; [Vermathen, Peter] Univ Bern, Dept BioMed Res & Radiol, CH-3012 Bern, Switzerland; [Vermathen, Peter] Inselspital Bern, CH-3012 Bern, Switzerland; [Vermathen, Martina; Furrer, Julien] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Wuthrich, Daniel; Simillion, Cedric; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland; [Wuthrich, Daniel; Simillion, Cedric; Bruggmann, Remy] Univ Bern, Swiss Inst Bioinformat, CH-3012 Bern, Switzerland; [Wuthrich, Daniel] Univ Basel, Dept Biomed, Appl Microbiol Res Unit, CH-4031 Basel, Switzerland; [Wuthrich, Daniel] Univ Hosp Basel, Div Clin Microbiol, CH-4031 Basel, Switzerland; [Brugger, Silvio D.] Univ Zurich, Univ Zurich Hosp, Dept Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Brugger, Silvio D.] Forsyth Inst Microbiol, Cambridge, MA 02142 USA; [Brugger, Silvio D.] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	University of Bern; University of Geneva; University of Bern; University of Bern; University of Bern; University of Bern; Swiss Institute of Bioinformatics; University of Bern; University of Basel; University of Basel; University of Zurich; University Zurich Hospital; Harvard University; Harvard School of Dental Medicine	Hilty, M (corresponding author), Univ Bern, Inst Infect Dis, Friedbuhlstr 51, CH-3001 Bern, Switzerland.	markus.hilty@ifik.unibe.ch	Wuethrich, Daniel/AAM-2321-2020; Brugger, Silvio Daniel/AAY-7090-2020; Vermathen, P./J-5789-2012; Vermathen, Martina/ABA-1385-2020	Brugger, Silvio Daniel/0000-0001-9492-9088; Vermathen, P./0000-0001-8649-1098; Bruggmann, Remy/0000-0001-5629-6363; Hilty, Markus/0000-0002-2418-6474; Vermathen, Martina/0000-0002-0796-1643; Hathaway, Lucy Jane/0000-0002-5361-5397	Microscopy Imaging Center (MIC) of the University of Bern	Microscopy Imaging Center (MIC) of the University of Bern	We thank Prof. Wolfgang Thormann for advice and help with analytical questions and Suzanne Aebi for excellent technical assistance. We also express our thanks to Stefan Weissen for technical support and NMR work. TEM sample preparation and imaging were performed with devices supported by the Microscopy Imaging Center (MIC) of the University of Bern.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; ADAMS MH, 1945, J BACTERIOL, V49, P401, DOI 10.1128/JB.49.4.401-409.1945; Aprianto R, 2018, NUCLEIC ACIDS RES, V46, P9990, DOI 10.1093/nar/gky750; Audy J, 2010, MICROBIOL-SGM, V156, P653, DOI 10.1099/mic.0.033720-0; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BROWN EJ, 1983, INFECT IMMUN, V39, P403, DOI 10.1128/IAI.39.1.403-409.1983; Brugger SD, 2016, INFECT IMMUN, V84, P3152, DOI 10.1128/IAI.00474-16; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058492; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Gates MA, 2004, MOL MICROBIOL, V52, P13, DOI 10.1111/j.1365-2958.2003.03957.x; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Hilty M, 2014, GENOME BIOL EVOL, V6, P3281, DOI 10.1093/gbe/evu263; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; HUNZIKER EB, 1986, J HISTOCHEM CYTOCHEM, V34, P1149, DOI 10.1177/34.9.2426342; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Kornberg HL, 2001, J MOL MICROB BIOTECH, V3, P355; LACKS S, 1966, GENETICS, V53, P207; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonarda A, 2018, INT J MED MICROBIOL, V308, P705, DOI 10.1016/j.ijmm.2018.01.001; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linke CM, 2013, J BACTERIOL, V195, P1031, DOI 10.1128/JB.01560-12; Looijesteijn PJ, 1999, APPL ENVIRON MICROB, V65, P5003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Paixao L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01041; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Rodriguez-Diaz J, 2012, BIOENGINEERED, V3, P339, DOI 10.4161/bioe.21271; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schaffner TO, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0210-x; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x; Valdes KM, 2016, INFECT IMMUN, V84, P1016, DOI 10.1128/IAI.01296-15; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warrier I, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007461; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2001, INFECT IMMUN, V69, P5430, DOI 10.1128/IAI.69.9.5430-5439.2001; WINKELSTEIN JA, 1980, J IMMUNOL, V124, P2502; WINKELSTEIN JA, 1984, CRC CR REV MICROBIOL, V11, P187, DOI 10.3109/10408418409105903; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	53	11	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17224	17238		10.1074/jbc.RA119.010764	http://dx.doi.org/10.1074/jbc.RA119.010764			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31594867	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000503173500006
J	Benicky, J; Sanda, M; Kennedy, ZB; Goldman, R				Benicky, Julius; Sanda, Miloslav; Kennedy, Zuzana Brnakova; Goldman, Radoslav			N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain-derived neurotrophic factor (BDNF); neurotrophin; glycosylation; glycoprotein; mass spectrometry (MS); LacdiNAc; maturation; N121Q; sulfation	SITE-SPECIFIC GLYCOFORMS; DIFFERENTIAL EXPRESSION; MOLECULAR-CLONING; LIVER-CIRRHOSIS; BDNF; SORTILIN; RECEPTOR; CELLS; TRAFFICKING; HAPTOGLOBIN	Brain-derived neurotrophic factor (BDNF) is generated by proteolytic cleavage of a prodomain from the proBDNF precursor either intracellularly by furin-like proteases or extracellularly by plasmin or matrix metalloproteinases. ProBDNF carries a single N-glycosylation sequon (Asn-127) that remains virtually unstudied despite being located in a highly conserved region proximal to the proteolytic site. To study the proBDNF structure and function, here we expressed the protein and its nonglycosylated N127Q mutant in HEK293F cells. We found that mutation of the Asn-127 prevents intracellular maturation and secretion, an effect reproduced in WT proBDNF by tunicamycin-induced inhibition of N-glycosylation. Absence of the N-glycan did not affect the kinetics of proBDNF cleavage by furin in vitro, indicating that effects other than a direct furin?proBDNF interaction may regulate proBDNF maturation. Using an optimized LC-MS/MS workflow, we demonstrate that secreted proBDNF is fully glycosylated and carries rare N-glycans terminated by GalNAc?1?4GlcNAc?1-R (LacdiNAc) extensively modified by terminal sulfation. We and others noted that this type of glycosylation is protein-specific, extends to proBDNF expressed in PC12 cells, and implies the presence of interacting partners that recognize this glycan epitope. The findings of our study reveal that proBDNF carries an unusual type of N-glycans important for its processing and secretion. Our results open new opportunities for functional studies of these protein glycoforms in different cells and tissues.	[Benicky, Julius; Sanda, Miloslav; Kennedy, Zuzana Brnakova; Goldman, Radoslav] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Benicky, Julius; Sanda, Miloslav; Kennedy, Zuzana Brnakova; Goldman, Radoslav] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Goldman, Radoslav] Georgetown Univ, Clin & Translat Glycosci Res Ctr, 3970 Reservoir Rd NW,NRB-E207, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Goldman, R (corresponding author), Georgetown Univ, Clin & Translat Glycosci Res Ctr, 3970 Reservoir Rd NW,NRB-E207, Washington, DC 20057 USA.	rg26@georgetown.edu	; Sanda, Miloslav/P-1631-2017	Benicky, Julius/0000-0002-1941-1622; Sanda, Miloslav/0000-0002-7735-3635	Cancer Center Support Grant Grant, Proteomics and Metabolomics Shared Resource, Georgetown University Medical Center [P30 CA51008]; NATIONAL CANCER INSTITUTE [U01CA168926, R01CA135069, P30CA051008] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023557] Funding Source: NIH RePORTER	Cancer Center Support Grant Grant, Proteomics and Metabolomics Shared Resource, Georgetown University Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Kelly Moremen, Complex Carbohydrate Research Center, University of Georgia, Athens, GA, for generous help with setting the optimal conditions for culture and transfection of suspension for HEK293F cells. We also thank Dr. Italo Mocchetti and Dr. Patrick Forcelli, Department of Neuroscience, Georgetown University, Washington, D.C., for valuable discussions and advice regarding neurotrophin biology. The Lombardi Comprehensive Cancer Center is supported by Cancer Center Support Grant Grant P30 CA51008, supporting the Proteomics and Metabolomics Shared Resource, Georgetown University Medical Center.	Anastasia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3490; Baenziger JU, 2003, BIOCHEM SOC T, V31, P326, DOI 10.1042/BST0310326; Bonar D, 2014, J BIOL CHEM, V289, P29677, DOI 10.1074/jbc.M114.596049; Boregowda RK, 2005, GLYCOBIOLOGY, V15, P1349, DOI 10.1093/glycob/cwj024; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chacon-Fernandez P, 2016, J BIOL CHEM, V291, P9872, DOI 10.1074/jbc.M116.720029; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kermani P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00455; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kozlik P, 2017, ELECTROPHORESIS, V38, P2193, DOI 10.1002/elps.201600547; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Madinier A, 2013, NEUROSCIENCE, V231, P169, DOI 10.1016/j.neuroscience.2012.11.054; Meng LB, 2019, ONCOL LETT, V17, P2031, DOI 10.3892/ol.2018.9854; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pompach P, 2013, MOL CELL PROTEOMICS, V12, P1281, DOI 10.1074/mcp.M112.023259; Radin DP, 2017, ANTICANCER RES, V37, P3983, DOI 10.21873/anticanres.11783; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Sanda M, 2017, ANAL BIOANAL CHEM, V409, P619, DOI 10.1007/s00216-016-0041-8; Sanda M, 2016, ANAL CHEM, V88, P10118, DOI 10.1021/acs.analchem.6b02554; Sanda M, 2013, MOL CELL PROTEOMICS, V12, P1294, DOI 10.1074/mcp.M112.023325; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tettamanti G, 2010, GENE, V450, P85, DOI 10.1016/j.gene.2009.07.023; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; West A E, 2014, Handb Exp Pharmacol, V220, P67, DOI 10.1007/978-3-642-45106-5_4; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469	49	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16816	16830		10.1074/jbc.RA119.009989	http://dx.doi.org/10.1074/jbc.RA119.009989			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31558607	Green Published, hybrid			2022-12-26	WOS:000501801900028
J	Gupta, K; Schnell, E				Gupta, Kunal; Schnell, Eric			Neuronal network remodeling and Wnt pathway dysregulation in the intra-hippocampal kainate mouse model of temporal lobe epilepsy	PLOS ONE			English	Article							GRANULE CELL DISPERSION; ABERRANT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; SPONTANEOUS SEIZURES; STATUS EPILEPTICUS; FOS EXPRESSION; ANIMAL-MODELS; BETA-CATENIN; INHIBITION; REORGANIZATION	Mouse models of mesial temporal lobe epilepsy recapitulate aspects of human epilepsy, which is characterized by neuronal network remodeling in the hippocampal dentate gyrus. Observational studies suggest that this remodeling is associated with altered Wnt pathway signaling, although this has not been experimentally examined. We used the well-characterized mouse intrahippocampal kainate model of temporal lobe epilepsy to examine associations between hippocampal neurogenesis and altered Wnt signaling after seizure induction. Tissue was analyzed using immunohistochemistry and confocal microscopy, and gene expression analysis was performed by RT-qPCR on RNA extracted from anatomically micro-dissected dentate gyri. Seizures increased neurogenesis and dendritic arborization of newborn hippocampal dentate granule cells in peri-ictal regions, and decreased neurogenesis in the ictal zone, 2-weeks after kainate injection. Interestingly, administration of the novel canonical Wnt pathway inhibitor XAV939 daily for 2-weeks after kainate injection further increased dendritic arborization in peri-ictal regions after seizure, without an effect on baseline neurogenesis in control animals. Transcriptome analysis of dentate gyri demonstrated significant canonical Wnt gene dysregulation in kainate-injected mice across all regions for Wnt3, 5a and 9a. Intriguingly, certain Wnt genes demonstrated differential patterns of dysregulation between the ictal and peri-ictal zones, most notably Wnt5B, 7B and DKK-1. Together, these results demonstrate regional variation in Wnt pathway dysregulation early after seizure induction, and surprisingly, suggest that some Wnt-mediated effects might actually temper aberrant neurogenesis after seizures. The Wnt pathway may therefore provide suitable targets for novel therapies that prevent network remodeling and the development of epileptic foci in high-risk patients.	[Gupta, Kunal] Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; [Schnell, Eric] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Schnell, Eric] VA Portland Hlth Care Syst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Schnell, E (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.; Schnell, E (corresponding author), VA Portland Hlth Care Syst, Portland, OR 97239 USA.	schneler@ohsu.edu		Gupta, Kunal/0000-0002-9847-0099	Department of Veterans Affairs Merit Review Award [I01-BX002949]; Department of Defense CDMRP Award [W81XWH-18-1-0598]; Neurosurgery Research and Education Foundation Fellowship [ANEUS0125, P30NS061800]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002949] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Department of Defense CDMRP Award(United States Department of Defense); Neurosurgery Research and Education Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This material was supported in part by the Department of Veterans Affairs Merit Review Award I01-BX002949 (ES), a Department of Defense CDMRP Award W81XWH-18-1-0598 (ES), a Neurosurgery Research and Education Foundation Fellowship (https://www.nref.org) ANEUS0125 (KG) and P30NS061800 (OHSU) awards.; This material was supported in part by the Department of Veterans Affairs Merit Review Award I01-BX002949 (ES), a Department of Defense CDMRP Award W81XWH-18-1-0598 (ES), a Neurosurgery Research and Education Foundation Fellowship (KG) and P30NS061800 (OHSU) awards. We thank Dr. Gary Westbrook of the Vollum Institute for comments on our manuscript, Dr. Stefanie Kaech-Petrie of the OHSU Advanced Light Microscopy Core for assistance with imaging, and research assistants Sarah Mader and Alexandria Wilson for technical support. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	BARONE P, 1993, SYNAPSE, V14, P1, DOI 10.1002/syn.890140102; Bouilleret V, 2000, NEUROSCIENCE, V97, P47, DOI 10.1016/S0306-4522(00)00017-8; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Chai XJ, 2014, CEREB CORTEX, V24, P2130, DOI 10.1093/cercor/bht067; Chen CM, 2017, P NATL ACAD SCI USA, V114, pE619, DOI 10.1073/pnas.1615792114; Chen LP, 2019, J BIOL CHEM, V294, P2486, DOI 10.1074/jbc.RA118.006319; Chen X, 2016, EXP MOL PATHOL, V101, P22, DOI 10.1016/j.yexmp.2016.04.003; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Choe Y, 2012, DEV NEUROSCI-BASEL, V34, P502, DOI 10.1159/000345353; Clark CEJ, 2012, NEUROSIGNALS, V20, P202, DOI 10.1159/000332153; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; David MD, 2010, J NEUROSCI RES, V88, P3011, DOI 10.1002/jnr.22464; Dingledine R, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.61; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; French JA, 2012, NEUROLOGY, V79, pE80, DOI 10.1212/WNL.0b013e31826aa902; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gordon R Ya, 2014, Tsitologiia, V56, P919; Grone BP, 2015, NAT NEUROSCI, V18, P339, DOI 10.1038/nn.3934; Haussler U, 2012, CEREB CORTEX, V22, P26, DOI 10.1093/cercor/bhr054; Harroud Adil, 2012, Epilepsy Res Treat, V2012, P201651, DOI 10.1155/2012/201651; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Hendricks WD, 2017, J NEUROSCI, V37, P5722, DOI 10.1523/JNEUROSCI.0761-17.2017; Hodges SL, 2018, EPILEPSY RES, V146, P9, DOI 10.1016/j.eplepsyres.2018.07.002; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kiasalari Z, 2013, PHARM BIOL, V51, P1572, DOI 10.3109/13880209.2013.803128; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Lanoue V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06140-z; Lee JM, 2018, EXP NEUROBIOL, V27, P226, DOI 10.5607/en.2018.27.3.226; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher W, 2017, NEUROCHEM RES, V42, P1873, DOI 10.1007/s11064-017-2222-z; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Marx M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00167; Matsumoto R, 2015, EPILEPTIC DISORD, V17, P89, DOI 10.1684/epd.2015.0725; Mendes A, 2016, SEIZURE-EUR J EPILEP, V38, P63, DOI 10.1016/j.seizure.2016.04.007; Myint PK, 2006, POSTGRAD MED J, V82, P568, DOI 10.1136/pgmj.2005.041426; Nadler JV, 2014, ADV EXP MED BIOL, V813, P55, DOI 10.1007/978-94-017-8914-1_4; Nitta N, 2008, EPILEPSIA, V49, P1711, DOI 10.1111/j.1528-1167.2008.01595.x; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Powell TR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15042-z; Qu ZY, 2017, CELL BIOCHEM FUNCT, V35, P472, DOI 10.1002/cbf.3306; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramantani G, 2017, EPILEPTIC DISORD, V19, P117, DOI 10.1684/epd.2017.0916; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Scharfman HE, 2003, J NEUROPHYSIOL, V90, P2536, DOI 10.1152/jn.00251.2003; Schouten M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.68; Sheybani L, 2018, J NEUROSCI, V38, P3776, DOI 10.1523/JNEUROSCI.2193-17.2018; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Theilhaber J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074428; Twele Friederike, 2017, Epilepsia Open, V2, P180, DOI 10.1002/epi4.12044; Twele F, 2016, EPILEPSY BEHAV, V55, P47, DOI 10.1016/j.yebeh.2015.11.027; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Wang C, 2014, AM J PHYSIOL-CELL PH, V307, pC234, DOI 10.1152/ajpcell.00366.2013; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	77	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0215789	10.1371/journal.pone.0215789	http://dx.doi.org/10.1371/journal.pone.0215789			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596871	Green Published, gold, Green Submitted			2022-12-26	WOS:000532444100003
J	Shively, RD; Crouse, JA; Thompson, DP; Barboza, PS				Shively, Rachel D.; Crouse, John A.; Thompson, Dan P.; Barboza, Perry S.			Is summer food intake a limiting factor for boreal browsers? Diet, temperature, and reproduction as drivers of consumption in female moose	PLOS ONE			English	Article							TANNIN-BINDING PROTEINS; MOUNTAIN NATIONAL-PARK; ALCES-ALCES; DERMACENTOR-ALBIPICTUS; CARRYING-CAPACITY; BODY-TEMPERATURE; CLIMATE-CHANGE; PLANT; RESPONSES; ENERGY	Food intake may limit the ability of browsing mammals to gain body mass during the growing season when the leaves and stems of woody plants are most abundant. Moose are highly productive browsers with high demands for energy and nutrients, particularly during lactation. Using an indigestible marker, we estimated dry matter intake of free ranging adult female moose with and without calves over three growing seasons. During the same period, we analyzed forage quality. Intakes were highest in late spring (280 +/- 19 g.kg(-0.75).d(-1)) when forage quality peaked; however, intakes declined by 39% throughout the summer as temperatures increased and as acid detergent fiber content of browse increased. Digestibility of dry matter declined over summer from 71% to 57% among browse. Intakes were similar for moose with and without calves. Heat loads may impair the ability of moose to consume sufficient energy and nutrients. Warming and habitat change can adversely affect browser populations when poor forage qualities and low dry matter intakes combine to suppress digestible intakes of energy and nutrients.	[Shively, Rachel D.; Barboza, Perry S.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Crouse, John A.; Thompson, Dan P.] Kenai Moose Res Ctr, Alaska Dept Fish & Game, Div Wildlife Conservat, Soldotna, AK USA	Texas A&M University System; Texas A&M University College Station; Alaska Department of Fish & Game	Shively, RD (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	rdshively@exchange.tamu.edu		Shively, Rachel/0000-0002-5968-5476	Boone AMP; Crockett James H. "Red" Duke Wildlife Conservation and Policy Program; Alaska Department of Fish and Game; Pittman-Robertson Wildlife Restoration program	Boone AMP; Crockett James H. "Red" Duke Wildlife Conservation and Policy Program; Alaska Department of Fish and Game; Pittman-Robertson Wildlife Restoration program	The funding sources for this study are Boone & Crockett James H. "Red" Duke Wildlife Conservation and Policy Program, Alaska Department of Fish and Game and Pittman-Robertson Wildlife Restoration program.	Ahrestani Farshid S., 2016, Ecological Studies, V225, P99; Allman BP, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0192-x; AUSTIN PJ, 1989, J CHEM ECOL, V15, P1335, DOI 10.1007/BF01014834; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Barboza PS, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2073; Beale PK, 2018, BIOL REV, V93, P674, DOI 10.1111/brv.12364; Billor N, 2000, COMPUT STAT DATA AN, V34, P279, DOI 10.1016/S0167-9473(99)00101-2; Bjorneraas K, 2012, OECOLOGIA, V168, P231, DOI 10.1007/s00442-011-2072-3; BRISSON GERMAIN J., 1957, CANADIAN JOUR ANIMAL SCI, V37, P90; Broders Hugh G., 2012, Alces, V48, P53; Bryant JP, 2014, ECOGRAPHY, V37, P204, DOI 10.1111/j.1600-0587.2013.00436.x; Cook John G., 2002, P259; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; DelGiudice GD, 1997, J WILDLIFE MANAGE, V61, P895, DOI 10.2307/3802198; Denryter KA, 2017, CAN J ZOOL, V95, P81, DOI 10.1139/cjz-2016-0114; Diamond HJ, 2013, B AM METEOROL SOC, V94, P485, DOI 10.1175/BAMS-D-12-00170.1; Ditmer MA, 2018, CURR ZOOL, V64, P419, DOI 10.1093/cz/zox047; Dou HL, 2013, ECOL RES, V28, P625, DOI 10.1007/s11284-013-1054-9; Dove H, 2006, NAT PROTOC, V1, P1680, DOI 10.1038/nprot.2006.225; Dungan Jason D., 2010, Alces, V46, P71; Dungan Jason D., 2005, Alces, V41, P139; Durden LA, 2016, J MED ENTOMOL, V53, P1391, DOI 10.1093/jme/tjw128; Felton AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150870; Flook D. R., 1959, Journal of Mammalogy, V40, P455, DOI 10.2307/1376592; Fulbright T.E., 2013, WHITE TAILED DEER HA, Vsecond; Fuller G, 2011, ZOO BIOL, V30, P379, DOI 10.1002/zoo.20339; Gustine D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171807; HAGERMAN AE, 1993, CAN J ZOOL, V71, P628, DOI 10.1139/z93-085; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hoy SR, 2017, GLOBAL CHANGE BIOL, P1; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Johnson HE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2461; Joly K, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00012.1; Juntheikki MR, 1996, BIOCHEM SYST ECOL, V24, P595, DOI 10.1016/S0305-1978(97)81203-3; KLEIN D R, 1990, Rangifer, P123; Lauper M, 2013, MAMM BIOL, V78, P142, DOI 10.1016/j.mambio.2012.06.001; Lechner I, 2010, COMP BIOCHEM PHYS A, V155, P211, DOI 10.1016/j.cbpa.2009.10.040; Lenarz MS, 2009, J WILDLIFE MANAGE, V73, P503, DOI 10.2193/2008-265; LERESCHE RE, 1973, J WILDLIFE MANAGE, V37, P279, DOI 10.2307/3800118; LESLIE DM, 1983, J RANGE MANAGE, V36, P730, DOI 10.2307/3898197; MacCracken James G., 1997, Wildlife Monographs, V136, P1; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McCann NP, 2013, CAN J ZOOL, V91, P893, DOI 10.1139/cjz-2013-0175; Melin M, 2014, GLOBAL CHANGE BIOL, V20, P1115, DOI 10.1111/gcb.12405; Miner B, 2000, FOREST REGENERATION; MIQUELLE DG, 1992, WILDLIFE MONOGR, P1; Monteith KL, 2015, OECOLOGIA, V178, P1137, DOI 10.1007/s00442-015-3296-4; Mooring MS, 1999, CAN J ZOOL, V77, P148, DOI 10.1139/cjz-77-1-148; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Nissinen K, 2017, CAN J FOREST RES, V47, P1350, DOI 10.1139/cjfr-2017-0188; Oftedal OT, 1985, PREGNANCY LACTATION, P216; Paragi Thomas F., 2015, Alces, V51, P1; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PEEK J M, 1974, Naturaliste Canadien (Quebec), V101, P195; Rabe-Hesketh S., 2010, INT ENCY ED, V3, P171, DOI [10.1016/B978-0-08-044894-7.01332-4, DOI 10.1016/B978-0-08-044894-7.01332-4]; RENECKER LA, 1989, J WILDLIFE MANAGE, V53, P296, DOI 10.2307/3801126; RENECKER LA, 1986, J WILDLIFE MANAGE, V50, P143, DOI 10.2307/3801504; Renecker LA, 1997, ECOLOGY MANAGEMENT N; Renecker Lyle A., 1990, Alces, V26, P66; RUGGIERO LF, 1977, J RANGE MANAGE, V30, P61, DOI 10.2307/3897339; Samuel B., 2004, WHITE GHOST WINTER T; Schwartz C.C., 1992, ALCES S, P139; SCHWARTZ CC, 1987, J WILDLIFE MANAGE, V51, P352, DOI 10.2307/3801015; SCHWARTZ CC, 1993, J WILDLIFE MANAGE, V57, P454, DOI 10.2307/3809270; SCHWARTZ CC, 1988, J WILDLIFE MANAGE, V52, P26, DOI 10.2307/3801052; Schwartz CC, 1984, ALCES, V20, P223; Seaton CT, 2011, WILDLIFE BIOL, V17, P55, DOI 10.2981/10-010; SHIPLEY LA, 1992, CAN J ZOOL, V70, P1743, DOI 10.1139/z92-242; Shipley Lisa A., 2010, Alces, V46, P1; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Skarpe Christina, 2008, V195, P217, DOI 10.1007/978-3-540-72422-3_9; Sprinkle JE, 2000, J ANIM SCI, V78, P1608; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Street GM, 2016, LANDSCAPE ECOL, V31, P1939, DOI 10.1007/s10980-016-0372-z; Tape K. D., 2016, PLOS ONE, V11, P1; Thompson DP, 2017, J MAMMAL, V98, P1558, DOI 10.1093/jmammal/gyx132; Thompson DP, 2018, WILDLIFE SOC B, V42, P321, DOI 10.1002/wsb.857; Timmerman HR, 1988, FORESTRY CHRONIC JUN, P238; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VanSomeren LL, 2015, CAN J ZOOL, V93, P187, DOI 10.1139/cjz-2014-0207; Wam HK, 2018, ECOL EVOL, V8, P1117, DOI 10.1002/ece3.3715; Welch JH, 2015, J FISH WILDL MANAG, V6, P158, DOI 10.3996/062014-JFWM-045; Welsch R, 1980, REGRESSION DIAGNOSTI; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Windels SK, 2011, RANGELAND ECOL MANAG, V64, P264, DOI 10.2111/REM-D-10-00078.1; ZARNKE RL, 1990, J WILDLIFE DIS, V26, P412, DOI 10.7589/0090-3558-26.3.412	88	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223617	10.1371/journal.pone.0223617	http://dx.doi.org/10.1371/journal.pone.0223617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KW9JJ	31596894	Green Published, gold			2022-12-26	WOS:000521499000001
J	Ito, F; Tsutsumi, Y; Shinohara, K; Fukuhara, S; Kurita, N				Ito, Fumihito; Tsutsumi, Yusuke; Shinohara, Kazuaki; Fukuhara, Shunichi; Kurita, Noriaki			Vehicle configurations associated with anatomical-specific severe injuries resulting from traffic collisions	PLOS ONE			English	Article							FRONTAL CRASHES; TRUCK	Vehicles can be classified by configuration as either bonnet-type or cab-over type according to engine location. Compared to bonnet-type, the front compartment of cab-over type vehicles is considerably shorter; thus, it may be less likely to absorb the energy generated in a collision, and in turn be unable to prevent deformation of the occupant space and protect occupants from injury. This study was a cohort study involving 943 occupants of mini-vehicles who were injured in frontal collision accidents between 2001 and 2015 and transferred to Ohta Nishinouchi Hospital. The vehicle configuration was divided into bonnet-type and cab-over type (i.e., truck-type and wagon-type). The tested outcomes were anatomical-specific severe injury of the pelvis and extremities, the head and neck, the abdomen, and the chest. To estimate adjusted odds ratios (AOR) for associations between vehicle configuration and anatomical-specific severe injury, we fitted generalized estimating equations for each outcome. Compared with bonnet-type vehicles, a greater risk of serious pelvis and extremities injury was found for both truck (AOR: 2.21; 95% Confidence Interval [95% CI]: 1.22-4.00) and wagon-type vehicles (AOR: 3.43; 95%CI 1.60-7.39). For serious head and neck injury, truck-type vehicles were associated with greater risk (AOR: 2.04; 95% CI: 1.10-3.79) than bonnet-type vehicles, whereas wagon-type vehicles were not. Compared with the occupants of bonnet-type vehicles, cab-over type vehicle occupants were more likely to have serious pelvis and extremities injury during frontal collisions. Additionally, truck-type vehicle occupants were more likely to have serious head and neck injury than bonnet-type vehicle occupants. These findings are expected to promote safer behaviors for vehicle occupants and the automobile industry.	[Ito, Fumihito; Kurita, Noriaki] Fukushima Med Univ, Dept Clin Epidemiol, Fukushima, Fukushima, Japan; [Ito, Fumihito; Fukuhara, Shunichi; Kurita, Noriaki] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Fukushima, Japan; [Ito, Fumihito] Fukushima Med Univ, Dept Sport Med, Fukushima, Fukushima, Japan; [Tsutsumi, Yusuke] Natl Hosp Org Mito Med Ctr, Dept Emergency Med, Mito, Ibaraki, Japan; [Tsutsumi, Yusuke; Fukuhara, Shunichi] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Japan; [Shinohara, Kazuaki] Ohta Nishinouchi Hosp, Dept Emergency & Crit Care Med, Koriyama, Fukushima, Japan; [Kurita, Noriaki] Fukushima Med Univ Hosp, DiRECT, Fukushima, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Kyoto University; Fukushima Medical University	Kurita, N (corresponding author), Fukushima Med Univ, Dept Clin Epidemiol, Fukushima, Fukushima, Japan.; Kurita, N (corresponding author), Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Fukushima, Japan.; Kurita, N (corresponding author), Fukushima Med Univ Hosp, DiRECT, Fukushima, Fukushima, Japan.	kuritanoriaki@gmail.com	Tsutsumi, Yusuke/AAO-4750-2021; Kurita, Noriaki/I-6023-2019	Tsutsumi, Yusuke/0000-0002-9160-0241; Kurita, Noriaki/0000-0003-4127-7500	Fukushima Medical University	Fukushima Medical University	This study was supported by a Grant for Research Support of Fukushima Medical University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braver ER, 1997, JAMA-J AM MED ASSOC, V278, P1437, DOI 10.1001/jama.278.17.1437; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Eichelberger AH, 2015, J SAFETY RES, V55, P1, DOI 10.1016/j.jsr.2015.07.006; Hellinga LA, 2007, J SAFETY RES, V38, P707, DOI 10.1016/j.jsr.2007.10.003; Japan Light Motor Vehicle and Motorcycle Association, 2018, TRENDS VEH OWN VEH T; Jeon HJ, 2017, TRAFFIC INJ PREV, V18, P839, DOI 10.1080/15389588.2017.1315413; Kazuaki S., 2010, JAPANESE J ACUTE MED, V34, P557; Ma CX, 2018, J ADV TRANSPORT, DOI 10.1155/2018/9841498; Siegel JH, 2001, J TRAUMA, V51, P975, DOI 10.1097/00005373-200111000-00024; World Health Organisation, 2018, NONC DIS COUNTR PROF	11	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223388	10.1371/journal.pone.0223388	http://dx.doi.org/10.1371/journal.pone.0223388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7KN	31589637	Green Published, gold, Green Submitted			2022-12-26	WOS:000532427300021
J	Foster, DM; Jacob, ME; Farmer, KA; Callahan, BJ; Theriot, CM; Kathariou, S; Cernicchiaro, N; Prange, T; Papich, MG				Foster, Derek M.; Jacob, Megan E.; Farmer, Kyle A.; Callahan, Benjamin J.; Theriot, Casey M.; Kathariou, Sophia; Cernicchiaro, Natalia; Prange, Timo; Papich, Mark G.			Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers	PLOS ONE			English	Article							CRYSTALLINE-FREE ACID; FEEDLOT CATTLE; DAIRY-CATTLE; PHARMACOKINETICS; ENROFLOXACIN; CALVES; PLASMA; DANOFLOXACIN; METABOLITE; BACTERIA	Antimicrobial drug concentrations in the gastrointestinal tract likely drive antimicrobial resistance in enteric bacteria. Our objective was to determine the concentration of ceftiofur and its metabolites in the gastrointestinal tract of steers treated with ceftiofur crystalline-free acid (CCFA) or ceftiofur hydrochloride (CHCL), determine the effect of these drugs on the minimum inhibitory concentration (MIC) of fecal Escherichia coli, and evaluate shifts in the microbiome. Steers were administered either a single dose (6.6 mg/kg) of CCFA or 2.2 mg/kg of CHCL every 24 hours for 3 days. Ceftiofur and its metabolites were measured in the plasma, interstitium, ileum and colon. The concentration and MIC of fecal E. coli and the fecal microbiota composition were assessed after treatment. The maximum concentration of ceftiofur was higher in all sampled locations of steers treated with CHCL. Measurable drug persisted longer in the intestine of CCFA-treated steers. There was a significant decrease in E. coli concentration (P = 0.002) within 24 hours that persisted for 2 weeks after CCFA treatment. In CHCL-treated steers, the mean MIC of ceftiofur in E. coli peaked at 48 hours (mean MIC = 20.45 ug/ml, 95% CI = 10.29-40.63 ug/ml), and in CCFA-treated steers, mean MIC peaked at 96 hours (mean MIC = 10.68 ug/ml, 95% CI = 5.47-20.85 ug/ml). Shifts in the microbiome of steers in both groups were due to reductions in Firmicutes and increases in Bacteroidetes. CCFA leads to prolonged, low intestinal drug concentrations, and is associated with decreased E. coli concentration, an increased MIC of ceftiofur in E. coli at specific time points, and shifts in the fecal microbiota. CHCL led to higher intestinal drug concentrations over a shorter duration. Effects on E. coli concentration and the microbiome were smaller in this group, but the increase in the MIC of ceftiofur in fecal E. coli was similar.	[Foster, Derek M.; Jacob, Megan E.; Farmer, Kyle A.; Callahan, Benjamin J.; Theriot, Casey M.] NC State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Kathariou, Sophia] NC State Univ, Coll Agr & Life Sci, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA; [Cernicchiaro, Natalia] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Prange, Timo] NC State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Papich, Mark G.] NC State Univ, Coll Vet Med, Dept Mol & Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kansas State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Foster, DM (corresponding author), NC State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	derek_foster@ncsu.edu	Callahan, Benjamin John/HCH-8214-2022	Callahan, Benjamin/0000-0002-8752-117X; Foster, Derek/0000-0002-6859-9801; Papich, Mark/0000-0002-7591-7898	USDA National Institute of Food and Agriculture [1010130]; University of Michigan Microbial Systems Molecular Biology Laboratory	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Michigan Microbial Systems Molecular Biology Laboratory(University of Michigan System)	DMF: This work is/was supported by the USDA National Institute of Food and Agriculture, project 1010130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by work performed by The University of Michigan Microbial Systems Molecular Biology Laboratory. The authors thank Delta R. Dise of the NC State University Clinical Pharmacology Laboratory for her expertise performing the drug assays.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Boyer TC, 2012, FOODBORNE PATHOG DIS, V9, P1022, DOI 10.1089/fpd.2012.1198; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; CLARKE CR, 1989, J VET PHARMACOL THER, V12, P349, DOI 10.1111/j.1365-2885.1989.tb00686.x; CLSI, 2013, PERFORMANCE STAN; Cunha CS, 2019, J SCI FOOD AGR, V99, P210, DOI 10.1002/jsfa.9162; Davis JL, 2007, J VET PHARMACOL THER, V30, P564, DOI 10.1111/j.1365-2885.2007.00914.x; Ferguson KM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02190; Foster DM, 2016, J VET PHARMACOL THER, V39, P62, DOI 10.1111/jvp.12236; Foster DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149100; Gorden PJ, 2018, J VET PHARMACOL THER, V41, P76, DOI 10.1111/jvp.12437; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; HOLM S, 1979, SCAND J STAT, V6, P65; JAGLAN PS, 1990, J ASSOC OFF ANA CHEM, V73, P26; Kanwar N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05100; Kanwar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080575; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Li J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01711; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Mann S, 2011, FOODBORNE PATHOG DIS, V8, P861, DOI 10.1089/fpd.2010.0751; McKellar Q, 1999, ANTIMICROB AGENTS CH, V43, P1988, DOI 10.1128/AAC.43.8.1988; Munoz-Vargas L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196171; National Animal Health Monitoring System, 2011, BEEF FEEDL; Pereira RV, 2014, J DAIRY SCI, V97, P7644, DOI 10.3168/jds.2014-8521; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schmidt JW, 2013, APPL ENVIRON MICROB, V79, P2273, DOI 10.1128/AEM.03592-12; Seekatz AM, 2015, INFECT IMMUN, V83, P3838, DOI 10.1128/IAI.00459-15; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; TerHune TN, 2005, AM J VET RES, V66, P342, DOI 10.2460/ajvr.2005.66.342; Tukey J.W., 1953, MULTIPLE COMP 1948 1; USDA, 2018, ALL DAIR GROUP; USDA APHIS VS CEAH NAHMS, 2014, DAIR 2014 MILK QUAL; Volkova VV, 2017, EPIDEMIOL INFECT, V145, P2081, DOI [10.1017/S095026881700084X, 10.1017/s095026881700084x]; Wagner RD, 2011, ANTIMICROB AGENTS CH, V55, P4990, DOI 10.1128/AAC.00008-11; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warren CD, 2014, RES VET SCI, V97, P611, DOI 10.1016/j.rvsc.2014.10.012; Washburn K, 2005, J VET PHARMACOL THER, V28, P247, DOI 10.1111/j.1365-2885.2005.00642.x; Woodrow JS, 2016, J VET PHARMACOL THER, V39, P271, DOI 10.1111/jvp.12275	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223378	10.1371/journal.pone.0223378	http://dx.doi.org/10.1371/journal.pone.0223378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584976	gold, Green Published			2022-12-26	WOS:000532407600025
J	Luo, DH; Wang, ZJ; Nie, KY				Luo, Dianhui; Wang, Zhaojing; Nie, Kaiying			Structural characterization of a novel polysaccharide from Sargassum thunbergii and its antioxidant and anti-inflammation effects	PLOS ONE			English	Article							ANTIINFLAMMATORY PROPERTIES; BROWN SEAWEED; IN-VITRO; LIPOPOLYSACCHARIDE; EXTRACT; L.; HETEROPOLYSACCHARIDE; MUSHROOM; FUCOIDAN; MICE	A novel polysaccharide STSP-I was isolated and purified from Sargassum thunbergii. Its structure and bioactivity were studied using gas chromatography (GC), fourier transform infrared spectroscopy (FTIR), periodate oxidation-smith degradation, partial acid hydrolysis, methylation-GC-MS, nuclear magnetic resonance (NMR), transmission electron microscopy (TEM), radicals scavenging assays and anti-inflammatory assays. STSP-I was consisted of fucose and galactose with a molar ratio of 1.2:1, and its mass was 373 kDa. The main structural components of STSP-I were -> 4)-alpha-D-Galp-(1 -> and -> 3)-beta-L-Fucp-(1 ->, STSP-I was a non-branched polysaccharide, and TEM further revealed the existence of entangled chains and linear forms. Compared with Vitamin C (Vc), STSP-I showed a higher scavenging effect of superoxide radical (EC50 = 0.22 mg/mL) and an equivalent scavenging effect of hydroxyl radical (EC50 = 0.88 mg/mL). STSP-I also exhibited good inhibitory effects of TNF-alpha, IL-6 and COX-2 mRNA expressions in LPS-stimulated RAW 264.7 mouse macrophage cells, and the inhibitory effects were more than 91% at the concentrations of 75 and 150 mu g/ml. The results indicate that the polysaccharide STSP-I from S. thunbergii with the linear structure may serve as potential antioxidant and anti-inflammatory agents.	[Luo, Dianhui; Wang, Zhaojing; Nie, Kaiying] Huaqiao Univ, Dept Bioengn & Biotechnol, Fujian Prov Key Lab Biochem Technol, Xiamen, Fujian, Peoples R China	Huaqiao University	Luo, DH (corresponding author), Huaqiao Univ, Dept Bioengn & Biotechnol, Fujian Prov Key Lab Biochem Technol, Xiamen, Fujian, Peoples R China.	dianhuiluo@163.com			Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University [ZQN-PY316]; National Nature Science Foundation of China [31201314]	Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (Grant number ZQN-PY316 awarded to Dr. Luo) and the National Nature Science Foundation of China (Grant number 31201314 awarded to Dr. Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiracci M, 2012, J AGR FOOD CHEM, V60, P12304, DOI 10.1021/jf302468h; Chen L, 2015, J AGR FOOD CHEM, V63, P3219, DOI 10.1021/acs.jafc.5b00494; Chen L, 2014, J AGR FOOD CHEM, V62, P2891, DOI 10.1021/jf500112j; Coker RK, 1998, EUR RESPIR J, V11, P1218, DOI 10.1183/09031936.98.11061218; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dung NT, 2009, FOOD CHEM TOXICOL, V47, P449, DOI 10.1016/j.fct.2008.11.033; Fu X, 2018, CARBOHYD POLYM, V183, P230, DOI 10.1016/j.carbpol.2017.12.048; Huang Zhi-xuan, 2005, Zhongguo Zhongyao Zazhi, V30, P211; [江茜 Jiang Qian], 2012, [中国药学杂志, Chinese Pharmaceutical Journal], V47, P948; Jin W, 2019, MAR DRUGS, V17, DOI 10.3390/md17010052; Jin WH, 2018, INT J BIOL MACROMOL, V108, P307, DOI 10.1016/j.ijbiomac.2017.12.009; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Kanno S, 2006, LIFE SCI, V78, P673, DOI 10.1016/j.lfs.2005.04.051; Kazlowska K, 2010, J ETHNOPHARMACOL, V128, P123, DOI 10.1016/j.jep.2009.12.037; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Khan SB, 2010, BIOTECHNOL BIOPROC E, V15, P191, DOI 10.1007/s12257-009-0052-9; Kocharova NA, 2005, CARBOHYD RES, V340, P775, DOI 10.1016/j.carres.2005.01.007; Lee MY, 2011, FOOD CHEM TOXICOL, V49, P1047, DOI 10.1016/j.fct.2011.01.010; Li B, 2006, CARBOHYD RES, V341, P1135, DOI 10.1016/j.carres.2006.03.035; Liu J, 2015, J AGR FOOD CHEM, V63, P225, DOI 10.1021/jf505172m; Luo DH, 2008, CARBOHYD POLYM, V72, P376, DOI 10.1016/j.carbpol.2007.09.006; Luo DH, 2018, INT J BIOL MACROMOL, V112, P921, DOI 10.1016/j.ijbiomac.2018.02.051; Luo DH, 2016, CARBOHYD POLYM, V143, P1, DOI 10.1016/j.carbpol.2016.01.049; Mueller M, 2010, FOOD CHEM, V122, P987, DOI 10.1016/j.foodchem.2010.03.041; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pramanik M, 2005, CARBOHYD RES, V340, P629, DOI 10.1016/j.carres.2004.12.032; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; [汤志宏 Tang Zhihong], 2015, [中国海洋大学学报. 自然科学版, Periodical of Ocean University of China], V45, P35; Van Q, 2009, J ETHNOPHARMACOL, V125, P487, DOI 10.1016/j.jep.2009.06.026; Wang K, 2015, GLYCOCONJUGATE J, V32, P17, DOI 10.1007/s10719-014-9567-1; Wang L, 2009, INT J BIOL MACROMOL, V44, P211, DOI 10.1016/j.ijbiomac.2008.12.006; Wang ZY, 2014, INT J BIOL MACROMOL, V64, P139, DOI 10.1016/j.ijbiomac.2013.11.038; Wang ZJ, 2007, CARBOHYD POLYM, V68, P54, DOI 10.1016/j.carbpol.2006.07.022; [魏玉西 WEI Yuxi], 2007, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V28, P227; [魏玉西 Wei Yuxi], 2006, [中国海洋药物, Chinese Journal of Marine Drugs], V25, P41; [杨方美 Yang Fangmei], 2005, [食品科学, Food Science], V26, P224; Yang F, 2013, J AGR FOOD CHEM, V61, P12646, DOI 10.1021/jf404726z; Yuan XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144773; Zhang XW, 2012, J AGR FOOD CHEM, V60, P10027, DOI 10.1021/jf303039a; ZHUANG C, 1995, BIOSCI BIOTECH BIOCH, V59, P563, DOI 10.1271/bbb.59.563	41	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223198	10.1371/journal.pone.0223198	http://dx.doi.org/10.1371/journal.pone.0223198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584975	Green Published, gold			2022-12-26	WOS:000532407600014
J	Titus, DJ; Johnstone, T; Johnson, NH; London, SH; Chapalamadugu, M; Hogenkamp, D; Gee, KW; Atkins, CM				Titus, David J.; Johnstone, Timothy; Johnson, Nathan H.; London, Sidney H.; Chapalamadugu, Meghana; Hogenkamp, Derk; Gee, Kelvin W.; Atkins, Coleen M.			Positive allosteric modulation of the alpha 7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SUBUNIT MESSENGER-RNAS; NERVE GROWTH-FACTOR; CHOLINERGIC DYSFUNCTION; RAT MODEL; IN-VIVO; CHOLINESTERASE INHIBITOR; MICROGLIAL ACTIVATION; DEPENDENT ALTERATIONS; TARGET LOCALIZATION	Cognitive impairments are a common consequence of traumatic brain injury (TBI). The hippocampus is a subcortical structure that plays a key role in the formation of declarative memories and is highly vulnerable to TBI. The alpha 7 nicotinic acetylcholine receptor (nAChR) is highly expressed in the hippocampus and reduced expression and function of this receptor are linked with cognitive impairments in Alzheimer's disease and schizophrenia. Positive allosteric modulation of alpha 7 nAChRs with AVL-3288 enhances receptor currents and improves cognitive functioning in nave animals and healthy human subjects. Therefore, we hypothesized that targeting the alpha 7 nAChR with the positive allosteric modulator AVL-3288 would enhance cognitive functioning in the chronic recovery period of TBI. To test this hypothesis, adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury or sham surgery. At 3 months after recovery, animals were treated with vehicle or AVL-3288 at 30 min prior to cue and contextual fear conditioning and the water maze task. Treatment of TBI animals with AVL-3288 rescued learning and memory deficits in water maze retention and working memory. AVL-3288 treatment also improved cue and contextual fear memory when tested at 24 hr and 1 month after training, when TBI animals were treated acutely just during fear conditioning at 3 months post-TBI. Hippocampal atrophy but not cortical atrophy was reduced with AVL-3288 treatment in the chronic recovery phase of TBI. AVL-3288 application to acute hippocampal slices from animals at 3 months after TBI rescued basal synaptic transmission deficits and long-term potentiation (LTP) in area CA1. Our results demonstrate that AVL-3288 improves hippocampal synaptic plasticity, and learning and memory performance after TBI in the chronic recovery period. Enhancing cholinergic transmission through positive allosteric modulation of the alpha 7 nAChR may be a novel therapeutic to improve cognition after TBI.	[Titus, David J.; Johnson, Nathan H.; London, Sidney H.; Chapalamadugu, Meghana; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Johnstone, Timothy; Hogenkamp, Derk; Gee, Kelvin W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92717 USA	University of Miami; University of California System; University of California Irvine	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@miami.edu		Johnson, Nathan/0000-0002-4857-2273; Titus, David/0000-0001-7819-734X	NIH/NINDS [NS069721]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069721] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023579] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant awarded to C.M.A. by the NIH/NINDS NS069721 and the Miami Project to Cure Paralysis.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P98, DOI 10.1097/HTR.0b013e31820516cb; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Christensen DZ, 2010, J NEUROCHEM, V114, P1205, DOI 10.1111/j.1471-4159.2010.06845.x; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Drever BD, 2011, BEHAV BRAIN RES, V221, P505, DOI 10.1016/j.bbr.2010.11.037; Fabian-Fine R, 2001, J NEUROSCI, V21; Frieden T. R., 2015, REPORT C TRAUMATIC B; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gee KW, 2017, J PSYCHOPHARMACOL, V31, P434, DOI 10.1177/0269881117691590; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Guseva MV, 2006, PHARMACOL BIOCHEM BE, V84, P26, DOI 10.1016/j.pbb.2006.04.002; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hernandez CM, 2006, J PHARMACOL EXP THER, V316, P679, DOI 10.1124/jpet.105.093047; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Hogenkamp DJ, 2013, J MED CHEM, V56, P8352, DOI 10.1021/jm400704g; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Johnstone TB, 2011, J PHARMACOL EXP THER, V336, P908, DOI 10.1124/jpet.110.176255; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim SY, 2014, DEMENT GERIATR COGN, V37, P232, DOI 10.1159/000355373; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Koola MM, 2019, ASIAN J PSYCHIATR, V42, P115, DOI 10.1016/j.ajp.2017.11.008; Koola MM, 2019, ASIAN J PSYCHIATR, V40, P100, DOI 10.1016/j.ajp.2019.02.007; Koola MM, 2018, PRIM CARE COMPANION, V20, DOI [10.1002/hipo.20902, DOI 10.1002/HIPO.20902]; Lagostena L, 2008, NEUROPHARMACOLOGY, V54, P676, DOI 10.1016/j.neuropharm.2007.11.016; Lewis AS, 2017, PROG NEURO-PSYCHOPH, V75, P45, DOI 10.1016/j.pnpbp.2017.01.001; Lombardo S, 2015, NEUROPHARMACOLOGY, V96, P255, DOI 10.1016/j.neuropharm.2014.11.018; Ma LY, 2014, NEUROSCI LETT, V570, P97, DOI 10.1016/j.neulet.2014.04.018; Maier DL, 2011, NEUROPHARMACOLOGY, V61, P161, DOI 10.1016/j.neuropharm.2011.03.024; Massey KA, 2006, MOL CELL NEUROSCI, V33, P381, DOI 10.1016/j.mcn.2006.08.011; Matsuzono K, 2015, J ALZHEIMERS DIS, V45, P771, DOI 10.3233/JAD-143084; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McQuiston A Rory, 2014, Front Synaptic Neurosci, V6, P20, DOI 10.3389/fnsyn.2014.00020; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Nakauchi S, 2012, EUR J NEUROSCI, V35, P1381, DOI 10.1111/j.1460-9568.2012.08056.x; Navakkode S, 2012, HIPPOCAMPUS, V22, P335, DOI 10.1002/hipo.20902; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Nirogi R, 2012, J PHARMACOL TOX MET, V66, P22, DOI 10.1016/j.vascn.2012.05.003; Njoku I, 2019, EXP NEUROL, V315, P32, DOI 10.1016/j.expneurol.2019.01.019; Noble JM, 2007, NEUROLOGY, V68, P1749, DOI 10.1212/01.wnl.0000266745.86958.ce; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reid RT, 2003, J ALZHEIMERS DIS, V5, P429, DOI 10.3233/JAD-2003-5602; ROBINSON SE, 1989, BRAIN RES, V503, P32, DOI 10.1016/0006-8993(89)91699-5; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shao ZQ, 2015, INT J CLIN EXP MED, V8, P2944; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143490; Targowska-Duda KM, 2016, BEHAV BRAIN RES, V302, P142, DOI 10.1016/j.bbr.2016.01.002; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Thomsen MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027014; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2018, NEUROBIOL LEARN MEM, V148, P38, DOI 10.1016/j.nlm.2017.12.008; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tsoi KKF, 2016, J AM MED DIR ASSOC, V17, P1063, DOI 10.1016/j.jamda.2016.08.010; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Werkheiser JL, 2011, NEUROSCIENCE, V186, P76, DOI 10.1016/j.neuroscience.2011.04.033; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang L, 2013, J NEUROSCI RES, V91, P1581, DOI 10.1002/jnr.23263; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	105	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223180	10.1371/journal.pone.0223180	http://dx.doi.org/10.1371/journal.pone.0223180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581202	Green Published, gold			2022-12-26	WOS:000532398600039
J	Fezza, M; Moussa, M; Aoun, R; Haber, R; Hilal, G				Fezza, Maha; Moussa, Mayssam; Aoun, Rita; Haber, Rita; Hilal, George			DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-beta 1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; CATENIN PATHWAY; DICKKOPF-1; METASTASIS; CANCER; MECHANISMS; GENE; HEPATOBLASTOMAS; PROLIFERATION	Dickkopf-1 (DKK1), an inhibitor of the most frequently impaired signaling pathway in hepatocellular carcinoma (HCC), the Wnt/beta-catenin pathway, seems to fulfill contradictory functions in the process of tumorigenesis, acting either as an oncogenic promoter of metastasis or as a tumor suppressor. Elevated serum levels of DKK1 have been reported in HCC; however, little is known about its functional significance. In the current study, we treated HepG2/C3A and PLC/PRF/5 with the recombinant protein DKK1. Cytotoxicity was first determined by the WST-8 assay. AFP expression was measured at both the mRNA and protein levels. Expression of the oncogenes MYC, CCND1, hTERT, and MDM2 and the tumor suppressor genes TP53, P21 and RB was assessed. Western blot analysis of non-phosphorylated beta-catenin and Sanger sequencing were performed to explain the functional differences between the two cell lines. Subsequently, inflammation, migration and invasion were evaluated by qPCR, ELISA, the Boyden chamber assay, zymography, and MMP-2 and MMP-9 western blot analysis. Knockdown of DKK1 and TGF-beta 1 were also performed. Our results suggest that DKK1 exerts an oncogenic effect on HepG2/C3A cell line by upregulating the expression of oncogenes and downregulating that of tumor suppressor genes, whereas the opposite effect was demonstrated in PLC/PRF/5 cells. This differential impact of DKK1 can be explained by the mutations that affect the canonical Wnt pathway that were detected in exon 3 of the CTNNB1 gene in the HepG2 cell line. We further confirmed that DKK1 promotes inflammation, tumor invasion and migration in both cell types. The canonical pathway was not responsible for the DKK1 proinvasive effect, as indicated by the active beta-catenin levels in the two cell lines upon DKK1 treatment. Interestingly, knockdown of TGF-beta 1 negatively affected the DKK1 proinvasive effect. Taken together, DKK1 appears to facilitate tumor invasion and migration through TGF-beta 1 by remodeling the tumor microenvironment and inducing inflammation. This finding endorses the relevance of TGF-beta 1 as a therapeutic target.	[Fezza, Maha; Moussa, Mayssam; Aoun, Rita; Haber, Rita; Hilal, George] St Joseph Univ, Fac Med, Canc & Metab Lab, Beirut, Lebanon		Hilal, G (corresponding author), St Joseph Univ, Fac Med, Canc & Metab Lab, Beirut, Lebanon.	george.hilal@usj.edu.lb			Council for Scientific Research of the Saint-Joseph University	Council for Scientific Research of the Saint-Joseph University	In this study, all experiments were funded by grants from the Council for Scientific Research of the Saint-Joseph University.	Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen C, 2015, WORLD J HEPATOL, V7, P1964, DOI 10.4254/wjh.v7.i15.1964; Chen WJ, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0047-0; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Fako V, 2016, INT J BIOL SCI, V12, P768, DOI 10.7150/ijbs.14718; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gao C, 2017, ONCOTARGET, V9, P5492, DOI DOI 10.18632/ONCOTARGET.23695; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Goossens N, 2015, HEPAT ONCOL, V2, P371, DOI 10.2217/hep.15.26; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Huang JW, 2018, CELL PHYSIOL BIOCHEM, V45, P1690, DOI 10.1159/000487737; Khalaf AM, 2018, J HEPATOCELL CARCINO, V5, P61, DOI 10.2147/JHC.S156701; Khalaf N, 2017, CLIN GASTROENTEROL H, V15, P273, DOI 10.1016/j.cgh.2016.07.033; Kim ES, 2004, INT J ONCOL, V25, P1375; Koch A, 1999, CANCER RES, V59, P269; Krstic J, 2014, SCI WORLD J, DOI 10.1155/2014/521754; Kwack Mi Hee, 2007, Cancer Res Treat, V39, P30, DOI 10.4143/crt.2007.39.1.30; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Licchesi JDF, 2010, ONCOGENE, V29, P5923, DOI 10.1038/onc.2010.322; Lin SW, 2001, CLIN EXP METASTAS, V18, P493; Marquardt JU, 2015, NAT REV CANCER, V15, P653, DOI 10.1038/nrc4017; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pang HL, 2018, ONCOL LETT, V15, P6739, DOI 10.3892/ol.2018.8160; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Ringelhan M, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2017.0339; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Tao YM, 2013, DIGEST LIVER DIS, V45, P251, DOI 10.1016/j.dld.2012.10.020; Tsai JF, 2012, LANCET ONCOL, V13, pE410, DOI 10.1016/S1470-2045(12)70416-3; Waisberg J, 2015, WORLD J HEPATOL, V7, P2631, DOI 10.4254/wjh.v7.i26.2631; Wang S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0894-1; Wang WH, 2017, J GASTROENTEROL, V52, P419, DOI 10.1007/s00535-016-1299-5; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Zhang J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317703820; Zhuang XQ, 2017, NAT CELL BIOL, V19, P1274, DOI 10.1038/ncb3613; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	48	15	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223252	10.1371/journal.pone.0223252	http://dx.doi.org/10.1371/journal.pone.0223252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568519	Green Published, gold			2022-12-26	WOS:000532364900033
J	Anaparti, V; Meng, XB; Hemshekhar, M; Smolik, I; Mookherjee, N; El-Gabalawy, H				Anaparti, Vidyanand; Meng, Xiaobo; Hemshekhar, Mahadevappa; Smolik, Irene; Mookherjee, Neeloffer; El-Gabalawy, Hani			Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis	PLOS ONE			English	Article							VITAMIN-D STATUS; DISEASE; RISK; PROTECTION; HEALTH	Objective Epidemiological studies suggest vitamin D deficiency as a potential risk factor for rheumatoid arthritis (RA) development, a chronic autoimmune disorder highly prevalent in indigenous North American (INA) population. We therefore profiled the circulating levels of 25-hydroxyvitaminD [25(OH)D], an active metabolite of vitamin D, in a cohort of at-risk first-degree relatives (FDR) of INA RA patients, a subset of whom subsequently developed RA (progressors). Methods 2007 onward, serum samples from INA RA patients and FDR were collected at the time of a structured baseline visit and stored at -20 degrees C. Anti-citrullinated protein antibodies (ACPA), 25 (OH)D, hs-CRP, vitamin-D binding protein (VDBP) and parathyroid hormone (PTH) levels were determined using ELISA and rheumatoid factor (RF) seropositivity was determined by nephelometry. Results We demonstrate that 25 (OH) D concentrations were lower in winter than summer (P = 0.0538), and that serum 25(OH)D levels were higher in samples collected and stored after 2013 (P< 0.0001). Analysis of samples obtained after 2013 demonstrated that 37.6% of study participants were 25(OH)D insufficient (< 75nmol/L). Also, seropositive RA patients and FDR had lower 25(OH)D levels compared to ACPA-/FDR (P< 0.05, P< 0.01 respectively). Linear regression analysis showed 25(OH)D insufficiency was inversely associated with presence of RA autoantibodies. Longitudinal samples from 14 progressors demonstrated a consistent increase in 25(OH)D levels at the time they exhibited clinically detectable joint inflammation, without any significant change in VDBP or PTH levels. Spearman rank correlation analysis showed significant association between 25(OH)D and PTH levels, both in RA patients and progressors at RA onset time. Conclusion We demonstrate that 25(OH)D levels in serum increased at RA onset in progressors. The potential role that vitamin D metabolites and their downstream effects play in RA transition requires further investigation.	[Anaparti, Vidyanand; Meng, Xiaobo; Hemshekhar, Mahadevappa; Smolik, Irene; Mookherjee, Neeloffer; El-Gabalawy, Hani] Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Winnipeg, MB, Canada; [Anaparti, Vidyanand; Meng, Xiaobo; Hemshekhar, Mahadevappa; Mookherjee, Neeloffer; El-Gabalawy, Hani] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Anaparti, V (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Winnipeg, MB, Canada.; Anaparti, V (corresponding author), Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.	vidyanand.anaparti@umanitoba.ca	Anaparti, Vidyanand/H-8943-2019	Anaparti, Vidyanand/0000-0002-9290-8555; Hemshekhar, Mahadevappa/0000-0002-5016-501X	Canadian Institute of Health Research (CIHR) [MOP77700]; Research Manitoba; Arthritis Society of Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Research Manitoba; Arthritis Society of Canada	The study was supported by individual grants to Dr. Hani El-Gabalawy from the Canadian Institute of Health Research (CIHR; MOP77700). V. Anaparti received Postdoctoral Fellowships from Research Manitoba and Arthritis Society of Canada.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Anaparti V, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1459-x; Ashenafi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060721; Bellan M, 2017, ADV EXP MED BIOL, V996, P155, DOI 10.1007/978-3-319-56017-5_13; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bragazzi NL, 2017, CURR OPIN RHEUMATOL, V29, P378, DOI 10.1097/BOR.0000000000000397; Chow LNY, 2014, MOL IMMUNOL, V57, P86, DOI 10.1016/j.molimm.2013.08.011; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Deane KD, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0754-0; Deane KD, 2017, BEST PRACT RES CL RH, V31, P3, DOI 10.1016/j.berh.2017.08.003; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; El-Gabalawy HS, 2012, ARTHRITIS RHEUM-US, V64, P1720, DOI 10.1002/art.34449; El-Gabalawy HS, 2009, J RHEUMATOL, V36, P1130, DOI 10.3899/jrheum.080855; Feser M, 2009, J RHEUMATOL, V36, P943, DOI 10.3899/jrheum.080764; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Hayes CE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00100; Hiraki LT, 2014, RHEUMATOLOGY, V53, P2243, DOI 10.1093/rheumatology/keu276; Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Hurd K, 2018, SEMIN ARTHRITIS RHEU, V47, P586, DOI 10.1016/j.semarthrit.2017.07.009; Kagi L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195427; Khundmiri SJ, 2016, COMPR PHYSIOL, V6, P561, DOI 10.1002/cphy.c140071; Langlois Kellie, 2010, Health Rep, V21, P47; Larcombe L, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.28952; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049872; Lin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146351; Liu Y, 2018, Z RHEUMATOL, V77, P833, DOI 10.1007/s00393-018-0426-5; Nishikawa M, 2019, J STEROID BIOCHEM, V185, P71, DOI 10.1016/j.jsbmb.2018.07.012; Piccolo BD, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz065; Russo A, 2018, J ONCOL, V2018, DOI 10.1155/2018/6301980; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; Shapira Y, 2010, NAT REV RHEUMATOL, V6, P468, DOI 10.1038/nrrheum.2010.86; Sparks JA, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0563-2; Tanner S, 2019, ARTHRITIS RHEUMATOL, V71, P1494, DOI 10.1002/art.40880; Thacher TD, 2017, J STEROID BIOCHEM, V173, P333, DOI 10.1016/j.jsbmb.2016.07.014; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Wang YN, 2016, ARCH RHEUMATOL, V31, P64, DOI 10.5606/ArchRheumatol.2016.5556; Weiler HA, 2007, J NUTR, V137, P461, DOI 10.1093/jn/137.2.461; Young KA, 2017, ANN RHEUM DIS, V76, P153, DOI 10.1136/annrheumdis-2016-209157; Zerwekh JE, 2004, ANN CLIN BIOCHEM, V41, P272, DOI 10.1258/0004563041201464	42	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0219109	10.1371/journal.pone.0219109	http://dx.doi.org/10.1371/journal.pone.0219109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557191	Green Published, gold, Green Submitted			2022-12-26	WOS:000532345500007
J	Claude, KM; Underschultz, J; Hawkes, MT				Claude, Kasereka Masumbuko; Underschultz, Jack; Hawkes, Michael T.			Social resistance drives persistent transmission of Ebola virus disease in Eastern Democratic Republic of Congo: A mixed-methods study	PLOS ONE			English	Article							PUBLIC-HEALTH; ATTITUDES; KNOWLEDGE; EPIDEMIC; TRUST	Background The second largest Ebola virus disease (EVD) epidemic in history is currently raging in Eastern Democratic Republic of Congo (DRC). Stubbornly persistent EVD transmission has been associated with social resistance, ranging from passive non-compliance to overt acts of aggression toward EVD reponse teams. Methods We explored community resistance using focus group discussions and assessed the prevalence of resistant views using standardized questionnaires. Results Despite being generally cooperative and appreciative of the EVD response (led by the government of DRC with support from the international community), focus group participants provided eyewitness accounts of aggressive resistance to control efforts, consistent with recent media reports. Mistrust of EVD response teams was fueled by perceived inadequacies of the response effort ("herd medicine"), suspicion of mercenary motives, and violation of cultural burial mores ("makeshift plastic morgue"). Survey questionnaires found that the majority of respondents had compliant attitudes with respect to EVD control. Nonetheless, 78/630 (12%) respondents believed that EVD was fabricated and did not exist in the area, 482/630 (72%) were dissatisfied with or mistrustful of the EVD response, and 60/630 (9%) sympathized with perpetrators of overt hostility. Furthermore, 102/630 (15%) expressed non-compliant intentions in the case of EVD illness or death in a family member, including hiding from the health authorities, touching the body, or refusing to welcome an official burial team. Denial of the biomedical discourse and dissatisfaction/mistrust of the EVD response were statistically significantly associated with indicators of social resistance. Conclusions We concluded that social resistance to EVD control efforts was prevalent among focus group and survey participants. Mistrust, with deep political and historical roots in this area besieged by chronic violence and neglected by the outside world, may fuel social resistance. Resistant attitudes may be refractory to short-lived community engagement efforts targeting the epidemic but not the broader humanitarian crisis in Eastern DRC.	[Claude, Kasereka Masumbuko] Univ Catholique Graben, Dept Med, Butembo, DEM REP CONGO; [Underschultz, Jack; Hawkes, Michael T.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Hawkes, Michael T.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Hawkes, Michael T.] Univ Alberta, Sch Publ Hlth, Dept Global Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hawkes, MT (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.; Hawkes, MT (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Hawkes, MT (corresponding author), Univ Alberta, Sch Publ Hlth, Dept Global Hlth, Edmonton, AB, Canada.	mthawkes@ualberta.ca		Hawkes, Michael/0000-0002-4122-0937	Association for Health Innovation in Africa (AFHIA) [2018-03]; Women and Children's Health Research Institute	Association for Health Innovation in Africa (AFHIA); Women and Children's Health Research Institute	This study was supported by Association for Health Innovation in Africa (AFHIA, Grant Number 2018-03 [KMC]). This work was also supported by the Women and Children's Health Research Institute and is a Distinguished Researcher, Stollery Science Lab to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz SA, 2018, J INFECT DIS, V218, P1730, DOI 10.1093/infdis/jiy387; Adams V, 2009, AM ETHNOL, V36, P615, DOI 10.1111/j.1548-1425.2009.01199.x; [Anonymous], AP NEWS; [Anonymous], WASHINGTON POST; Blackley DJ, 2015, MMWR-MORBID MORTAL W, V64, P175; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Centers for Disease Control and Prevention, 2014, EB EB VIR DIS; Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5; Claude KM, 2018, LANCET, V392, P1399, DOI 10.1016/S0140-6736(18)32419-X; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; EDWARDS AWF, 1963, J R STAT SOC SER A-G, V126, P109, DOI 10.2307/2982448; Graham JE, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000990; Jalloh MF, 2017, MMWR-MORBID MORTAL W, V66, P1109, DOI 10.15585/mmwr.mm6641a4; Jalloh MF, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0304; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jiang H, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0142-9; JOHNSON R. B., 2004, EDUC RESEARCHER, V33, P14, DOI 10.3102/0013189X033007014; Kamara S., 2014, SIERRA LEONE NE 0731; Kasereka MC, 2019, VACCINE, V37, P2174, DOI 10.1016/j.vaccine.2019.03.004; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Loignon C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201091; MACKENZIE D, CNN NEWS; McCallister Edward, INDEPENDENT; Miller NP, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020601; Moran B, 2018, LANCET, V392, P1295, DOI 10.1016/S0140-6736(18)32512-1; Nuriddin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000410; Obenauer J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5543-1; Ostlund U, 2011, INT J NURS STUD, V48, P369, DOI 10.1016/j.ijnurstu.2010.10.005; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Salama Peter, TWITTER FEED; Salmon DA, 2015, VACCINE, V33, pD66, DOI 10.1016/j.vaccine.2015.09.035; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schnirring Lisa, 2018, CIDRAP NEWS     0905; Schnirring Lisa, 2018, CIDRAP NEWS     1001; Schnirring Lisa, 2018, CIDRAP NEWS     0924; Social Science in Humanitarian Action, 2019, SOC SCI BEH DAT COMP; Southall HG, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00005; Tariq Shema, 2013, JRSM Short Rep, V4, p2042533313479197, DOI 10.1177/2042533313479197; Whetten K, 2006, AM J PUBLIC HEALTH, V96, P716, DOI 10.2105/AJPH.2005.063255; Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305; Wilkinson A, 2017, CRIT PUBLIC HEALTH, V27, P14, DOI 10.1080/09581596.2016.1252034; 2016, WHO EBOLA VIRUS DIS	44	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223104	10.1371/journal.pone.0223104	http://dx.doi.org/10.1371/journal.pone.0223104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557243	Green Published, gold			2022-12-26	WOS:000532345500067
J	Ebert, K; Mattes, J; Kunzke, T; Zwingenberger, G; Luber, B				Ebert, Karolin; Mattes, Julian; Kunzke, Thomas; Zwingenberger, Gwen; Luber, Birgit			MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells	PLOS ONE			English	Article							CETUXIMAB SENSITIVITY; E-CADHERIN; AMPLIFICATION; ACTIVATION; SURVIVAL; DISEASE; IMPACT; GROWTH	The therapeutic options for advanced gastric cancer are still limited. Several drugs targeting the epidermal growth factor receptor family have been developed. So far, the HER2 antibody trastuzumab is the only drug targeting the HER-family that is available to gastric cancer patients. The pan-HER inhibitor afatinib is currently investigated in clinical trials and shows promising results in cell culture experiments and patient-derived xenograft (PDX) models. However, some cell lines do not respond to afatinib treatment. The determination of resistance factors in these cell lines can help to find the best treatment option for gastric cancer patients. In this study, we analyzed the role of MET as a resistance factor for afatinib therapy in a gastric cancer cell line. MET expression in afatinib-resistant MET-amplified Hs746T cells was reduced by means of siRNA transfection. The effects of MET knockdown on signal transduction, cell proliferation and motility were examined. In addition to the manual assessment of cell motility, a computational motility analysis involving parameters such as (approximate) average speed, displacement entropy or radial effectiveness was realized. Moreover, the impact of afatinib was compared between MET knockdown cells and control cells. MET knockdown in Hs746T cells resulted in impaired signal transduction and reduced cell proliferation and motility. Moreover, the afatinib resistance of Hs746T cells was reversed after MET knockdown. Therefore, the amplification of MET is confirmed as a resistance factor in gastric cancer cells. Whether MET is a useful resistance marker for afatinib therapy or other HER-targeting drugs in patients should be investigated in clinical trials.	[Ebert, Karolin; Kunzke, Thomas; Zwingenberger, Gwen; Luber, Birgit] Tech Univ Munich, Fak Med, Klinikum Rechts Isar, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany; [Mattes, Julian] MATTES Med Imaging GmbH, Softwarepk, Hagenberg, Austria	Technical University of Munich	Luber, B (corresponding author), Tech Univ Munich, Fak Med, Klinikum Rechts Isar, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany.	birgit.luber@tum.de		Ebert, Karolin/0000-0002-6657-0191	German Federal Ministry of Education and Research (BMBF) [01ZX1610A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant #01ZX1610A, SYSStomach project). The authors are grateful to Dr. Elena Barbaria for her assistance during the writing process. We also thank Dr. Tomas Kazmar for his indication to use the parameter "radial effectiveness" as a more robust variation of the "displacement effectiveness". The authors declare that they have no conflicts of interest.; This study was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant #01ZX1610A, SYS-Stomach project). The funder provided support in the form of salaries for authors [KE and GZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The MATTES Medical Imaging GmbH received funding as a subcontractor of the SYS-Stomach project and did not fund the project. It covered its costs for manuscript preparation by its own financial means.	Anestis A, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.42; Apicella M, 2017, ONCOTARGET, V8, P57654, DOI 10.18632/oncotarget.14825; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Booth L, 2016, ONCOTARGET, V7, P19620, DOI 10.18632/oncotarget.7746; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Catenacci DVT, 2017, LANCET ONCOL, V18, P1467, DOI 10.1016/S1470-2045(17)30566-1; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Chen GJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-3; Chen ZH, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0563-y; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Costa LD, 2005, CYTOM PART A, V68A, P92, DOI 10.1002/cyto.a.20191; Debeir O, 2005, IEEE T MED IMAGING, V24, P697, DOI 10.1109/TMI.2005.846851; Fuchs M, 2002, EXP CELL RES, V276, P129, DOI 10.1006/excr.2002.5518; Fuse N, 2016, GASTRIC CANCER, V19, P183, DOI 10.1007/s10120-015-0471-6; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Heindl S, 2012, J CANCER RES CLIN, V138, P843, DOI 10.1007/s00432-011-1128-4; Huang LY, 2017, AM J CANCER RES, V7, P203; Janjigian YY, 2013, J NUCL MED, V54, P936, DOI 10.2967/jnumed.112.110239; Kazmar T, 2010, IEEE ENG MED BIO, P49, DOI 10.1109/IEMBS.2010.5626299; Keller S, 2018, MOL ONCOL, V12, P441, DOI 10.1002/1878-0261.12170; Keller S, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3822-3; Kim HS, 2018, J SURG ONCOL, V117, P1679, DOI 10.1002/jso.25097; Kim HJ, 2018, INT J CANCER, V143, P151, DOI 10.1002/ijc.31304; Kneissl J, 2012, INT J ONCOL, V41, P733, DOI 10.3892/ijo.2012.1479; Kwak EL, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.tps3087; Lai AZ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004839; Li CX, 2017, P NATL ACAD SCI USA, V114, pE2852, DOI 10.1073/pnas.1618297114; Lordick F, 2017, ANN ONCOL, V28, P1767, DOI 10.1093/annonc/mdx051; Lordick F, 2016, NAT REV CLIN ONCOL, V13, P348, DOI 10.1038/nrclinonc.2016.15; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Park CH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2058-y; Sanchez-Vega F, 2019, CANCER DISCOV, V9, P199, DOI 10.1158/2159-8290.CD-18-0598; Shah MA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.2; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; STRICKLER JH, 2014, J CLIN ONCOL S, V32; Torigoe H, 2018, CANCER SCI, V109, P1493, DOI 10.1111/cas.13571; Van der Steen N, 2016, J THORAC ONCOL, V11, P1423, DOI 10.1016/j.jtho.2016.05.005; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Yan SB, 2018, INVEST NEW DRUG, V36, P536, DOI 10.1007/s10637-017-0545-x; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yoshioka T, 2018, CANCER SCI, V109, P1166, DOI 10.1111/cas.13546	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223225	10.1371/journal.pone.0223225	http://dx.doi.org/10.1371/journal.pone.0223225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557260	Green Published, Green Submitted, gold			2022-12-26	WOS:000532345500090
J	Grycz, K; Glowacka, A; Ji, BJ; Czarkowska-Bauch, J; Gajewska-Wozniak, O; Skup, M				Grycz, Kamil; Glowacka, Anna; Ji, Benjun; Czarkowska-Bauch, Julita; Gajewska-Wozniak, Olga; Skup, Malgorzata			Early pre- and postsynaptic decrease in glutamatergic and cholinergic signaling after spinalization is not modified when stimulating proprioceptive input to the ankle extensor alpha-motoneurons: Anatomical and neurochemical study	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SYNAPTIC COMPOSITION; GENE-EXPRESSION; RECEPTOR; MUSCLE; TRANSPORTERS; SYNAPTOLOGY; PLASTICITY; DENDRITES; TERMINALS	Alpha-motoneurons (MNs) innervating ankle extensor muscles show reduced peripheral inputs from Ia proprioceptive afferents and cholinergic afferents after chronic spinalization (SCT). That phenomenon is not observed on ankle flexor MNs, indicating a smaller vulnerability of the latter MNs circuit to SCT. Locomotor training of spinal rats which partially restored those inputs to extensor MNs tended to hyper innervate flexor MNs, disclosing a need for selective approaches. In rats with intact spinal cord 7-days of low-threshold proprioceptive stimulation of the tibial nerve enriched glutamatergic Ia and cholinergic innervation of lateral gastrocnemius (LG) MNs, suggesting usefulness of selective stimulation for restoration of inputs to extensor MNs after SCT. Accordingly, to examine its effectiveness after SCT, tibial nerves and soleus muscles were implanted bilaterally, and for MN identification fluorescence tracers to LG and tibialis anterior (TA) muscles were injected two weeks prior to spinalization. Stimulation of tibial nerve, controlled by H-reflex recorded in the soleus muscle, started on the third post-SCT day and continued for 7 days. Nine days post-SCT the number and volume of glutamatergic Ia and of cholinergic C-boutons on LG MNs was decreased, but stimulation affected neither of them. Postsynaptically, a threefold decrease of NMDAR NR1 subunit and thirtyfold decrease of M2 muscarinic receptor transcripts caused by SCT were not counteracted by stimulation, whereas a threefold decrease of AMPAR GluR2 subunit tended to deepen after stimulation. We conclude that LG MNs, supported with proprioceptive stimuli after SCT, do not transcribe the perceived cues into compensatory response at the transcriptional level in the early post-SCT period.	[Grycz, Kamil; Glowacka, Anna; Ji, Benjun; Czarkowska-Bauch, Julita; Gajewska-Wozniak, Olga; Skup, Malgorzata] Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Gajewska-Wozniak, O; Skup, M (corresponding author), Nencki Inst Expt Biol, Warsaw, Poland.	o.gajewska@nencki.gov.pl; m.skup@nencki.gov.pl	Głowacka, Anna/AAC-7236-2020	Głowacka, Anna/0000-0001-9223-5226; Grycz, Kamil/0000-0002-1821-2453; Gajewska-Wozniak, Olga/0000-0003-3529-5788; Skup, Malgorzata/0000-0002-2605-0124	Polish National Center of Science [NCN UMO-2013/09/B/NZ4/03306]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [665735]; Polish Ministry of Science and Higher Education [3548/H2020/COFUND/2016/2];  [400.1]	Polish National Center of Science; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); 	This work was supported by the Polish National Center of Science grant NCN UMO-2013/09/B/NZ4/03306 (to MS), the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no 665735 (Bio4Med to MS) and by the funding from Polish Ministry of Science and Higher Education within 2016-2020 funds for the implementation of international projects (agreement no 3548/H2020/COFUND/2016/2) (to MS), and a statutory grant 400.1 for the Nencki Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Bawa P, 2008, MUSCLE NERVE, V38, P1604, DOI 10.1002/mus.21184; BRANNSTROM T, 1993, J COMP NEUROL, V330, P439, DOI 10.1002/cne.903300311; Chopek JW, 2015, J NEUROPHYSIOL, V113, P1369, DOI 10.1152/jn.00550.2014; CONRADI S, 1979, J COMP NEUROL, V184, P741, DOI 10.1002/cne.901840407; Csaba Z, 2013, J COMP NEUROL, V521, P2008, DOI 10.1002/cne.23268; CZEH G, 1978, J PHYSIOL-LONDON, V281, P239, DOI 10.1113/jphysiol.1978.sp012419; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; Dupont-Versteegden EE, 2004, MUSCLE NERVE, V29, P73, DOI 10.1002/mus.10511; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Gajewska-Wozniak O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161614; Gajewska-Wozniak O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065937; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Gransee HM, 2017, J COMP NEUROL, V525, P1192, DOI 10.1002/cne.24125; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Hoy KC, 2013, BEHAV BRAIN RES, V236, P319, DOI 10.1016/j.bbr.2012.09.007; Huie JR, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0091-15.2015; Ichiyama RM, 2006, J COMP NEUROL, V499, P306, DOI 10.1002/cne.21110; Lee-Liu D, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-12; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; Liu TT, 2010, J PHYSIOL-LONDON, V588, P4217, DOI 10.1113/jphysiol.2010.192211; Loeb GE, 1986, ELECTROMYOGRAPHY EXP, P394; Martinez-Galvez G, 2016, EXP NEUROL, V276, P31, DOI 10.1016/j.expneurol.2015.11.007; Mejia-Gervacio S, 2012, J PHYSIOL-LONDON, V590, P4663, DOI 10.1113/jphysiol.2012.238444; Mendell LM, 1999, J NEUROSCI, V19, P3162; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; QUEVEDO J, 1993, J NEUROPHYSIOL, V70, P1899, DOI 10.1152/jn.1993.70.5.1899; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; Ryge J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-365; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Traynelis SF, 2014, PHARMACOL REV, V66, P1141, DOI 10.1124/pr.113.002451err; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wieckowska A, 2018, J NEUROCHEM, V147, P361, DOI 10.1111/jnc.14567; Wienecke J, 2010, J NEUROPHYSIOL, V103, P761, DOI 10.1152/jn.00609.2009	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222849	10.1371/journal.pone.0222849	http://dx.doi.org/10.1371/journal.pone.0222849			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557259	Green Published, gold			2022-12-26	WOS:000532345500041
J	Guin, D; Gelman, H; Wang, YH; Gruebele, M				Guin, Drishti; Gelman, Hannah; Wang, Yuhan; Gruebele, Martin			Heat shock-induced chaperoning by Hsp70 is enabled in-cell	PLOS ONE			English	Article							PROTEIN STABILITY; SUBSTRATE-BINDING; PHOSPHOGLYCERATE KINASE; FOLDING KINETICS; DYNAMICS; DNAK; CONFORMATION; TEMPERATURE; SPECIFICITY; EXPRESSION	Recent work has shown that weak protein-protein interactions are susceptible to the cellular milieu. One case in point is the binding of heat shock proteins (Hsps) to substrate proteins in cells under stress. Upregulation of the Hsp70 chaperone machinery at elevated temperature was discovered in the 1960s, and more recent studies have shown that ATPase activity in one Hsp70 domain is essential for control of substrate binding by the other Hsp70 domain. Although there are several denaturant-based assays of Hsp70 activity, reports of ATP-dependent binding of Hsp70 to a globular protein substrate under heat shock are scarce. Here we show that binding of heat-inducible Hsp70 to phosphoglycerate kinase (PGK) is remarkably different in vitro compared to in-cell. We use fluorescent-labeled mHsp70 and ePGK, and begin by showing that mHsp70 passes the standard beta-galactosidase assay, and that it does not self-aggregate until 50 degrees C in presence of ATP. Yet during denaturant refolding or during in vitro heat shock, mHsp70 shows only ATP-independent non-specific sticking to ePGK, as evidenced by nearly identical results with an ATPase activity-deficient K71M mutant of Hsp70 as a control. Addition of Hsp40 (co-factor) or Ficoll (crowder) does not reduce non-specific sticking, but cell lysate does. Therefore, Hsp70 does not act as an ATP-dependent chaperone on its substrate PGK in vitro. In contrast, we observe only specific ATP-dependent binding of mHsp70 to ePGK in mammalian cells, when compared to the inactive Hsp70 K71M mutant. We hypothesize that enhanced in-cell activity is not due to an unknown co-factor, but simply to a favorable shift in binding equilibrium caused by the combination of crowding and osmolyte/macromolecular interactions present in the cell. One candidate mechanism for such a favorable shift in binding equilibrium is the proven ability of Hsp70 to bind near-native states of substrate proteins in vitro. We show evidence for early onset of binding in-cell. Our results suggest that Hsp70 binds PGK preemptively, prior to its full unfolding transition, thus stabilizing it against further unfolding. We propose a "preemptive holdase" mechanism for Hsp70-substrate binding. Given our result for PGK, more proteins than one might think based on in vitro assays may be chaperoned by Hsp70 in vivo. The cellular environment thus plays an important role in maintaining proper Hsp70 function.	[Guin, Drishti; Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61820 USA; [Gelman, Hannah; Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61820 USA; [Wang, Yuhan; Gruebele, Martin] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61820 USA; [Gelman, Hannah] US Dept Vet Affairs, Seattle, WA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs	Gruebele, M (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61820 USA.; Gruebele, M (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61820 USA.; Gruebele, M (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61820 USA.	mgruebel@illinois.edu		Wang, Yuhan/0000-0001-6807-3968	NSF [MCB 1803786]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant MCB 1803786.	Fernandez-Higuero JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24140-5; Behnke J, 2016, MOL CELL, V63, P739, DOI 10.1016/j.molcel.2016.07.012; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Carbonell P, 2009, PROTEOMICS, V9, P1744, DOI 10.1002/pmic.200800425; Chien P, 2014, MOL BIOL CELL, V25, P3474, DOI 10.1091/mbc.E14-06-1035; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Dave K, 2016, J PHYS CHEM B, V120, P2878, DOI 10.1021/acs.jpcb.5b11915; Dhar A, 2011, BIOPHYS J, V101, P421, DOI 10.1016/j.bpj.2011.05.071; Dhar A, 2010, BIOPHYS J, V99, pL69, DOI 10.1016/j.bpj.2010.08.066; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Ervin J, 2002, BIOPHYS J, V83, P473, DOI 10.1016/S0006-3495(02)75183-7; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Freeman BC, 2000, METH MOL B, V99, P393; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guzman I, 2014, J MOL BIOL, V426, P11, DOI 10.1016/j.jmb.2013.08.024; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Inoue R, 2010, BIOPHYS J, V99, P2309, DOI 10.1016/j.bpj.2010.08.017; Kisley L, 2017, ACS APPL MATER INTER, V9, P21606, DOI 10.1021/acsami.7b01371; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Monteith WB, 2015, P NATL ACAD SCI USA, V112, P1739, DOI 10.1073/pnas.1417415112; Monteith WB, 2014, P NATL ACAD SCI USA, V111, P11335, DOI 10.1073/pnas.1406845111; Mu X, 2017, P NATL ACAD SCI USA, V114, pE4556, DOI 10.1073/pnas.1621227114; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Osvath S, 2003, J MOL BIOL, V333, P187, DOI 10.1016/j.jmb.2003.08.011; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; Platkov M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4887360; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Rosenzweig R, 2017, ELIFE, V6, DOI 10.7554/eLife.28030; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; Sekhar A, 2018, ELIFE, V7, DOI 10.7554/eLife.32764; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sukenik S, 2017, P NATL ACAD SCI USA, V114, P6776, DOI 10.1073/pnas.1700818114; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Wang SH, 2008, BIOTECHNOL BIOENG, V99, P146, DOI 10.1002/bit.21512; Wirth AJ, 2013, BIOESSAYS, V35, P984, DOI 10.1002/bies.201300080; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222990	10.1371/journal.pone.0222990	http://dx.doi.org/10.1371/journal.pone.0222990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557226	Green Published, Green Submitted, gold			2022-12-26	WOS:000532345500057
J	Hu, XY; Li, XL; Yang, LN; Zhu, YL; Shi, YY; Li, YM; Wang, HW; Gong, QG				Hu, Xinyao; Li, Xuanling; Yang, Lingna; Zhu, Yilin; Shi, Yunyu; Li, Yinmei; Wang, Haowei; Gong, Qingguo			Conformation and mechanical property of rpoS mRNA inhibitory stem studied by optical tweezers and X-ray scattering	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; ESCHERICHIA-COLI; PROGRAM PACKAGE; HFQ	3' downstream inhibitory stem plays a crucial role in locking rpoS mRNA 5' untranslated region in a self-inhibitory state. Here, we used optical tweezers to study the unfolding/refolding of rpoS inhibitory stem in the absence and presence of Mg2+. We found adding Mg2+ decreased the free energy of the RNA junction without re-arranging its secondary structure, through confirming that this RNA formed a canonical RNA three-way junction. We suspected increased free energy might change the relative orientation of different stems of rpoS and confirmed this by small angle X-ray scattering. Such changed conformation may improve Hfq-bridged annealing between sRNA and rpoS RNA inhibitory stem. We established a convenient route to analyze the changes of RNA conformation and folding dynamics by combining optical tweezers with X-ray scattering methods. This route can be easily applied in the studies of other RNA structure and ligand-RNA.	[Hu, Xinyao; Li, Xuanling; Zhu, Yilin; Shi, Yunyu; Li, Yinmei; Wang, Haowei; Gong, Qingguo] Univ Sci & Technol China, Dept Opt & Opt Engn, Hefei, Anhui, Peoples R China; [Hu, Xinyao; Li, Xuanling; Zhu, Yilin; Shi, Yunyu; Li, Yinmei; Wang, Haowei; Gong, Qingguo] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Yang, Lingna; Shi, Yunyu; Gong, Qingguo] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, HW; Gong, QG (corresponding author), Univ Sci & Technol China, Dept Opt & Opt Engn, Hefei, Anhui, Peoples R China.; Wang, HW; Gong, QG (corresponding author), Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Gong, QG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.	whw93@ustc.edu.cn; qgg@ustc.edu.cn			National Natural Science Foundation of China [31870759, 61535011, 91540103]; Ministry of science and technology of China [2016YFA0500700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of science and technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the grants from the National Natural Science Foundation of China (grant 31870759, 61535011, 91540103), the Ministry of science and technology of China (2016YFA0500700) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB10). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anthony PC, 2012, P NATL ACAD SCI USA, V109, P1485, DOI 10.1073/pnas.1115045109; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361; Fang XY, 2015, CURR OPIN STRUC BIOL, V30, P147, DOI 10.1016/j.sbi.2015.02.010; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Fazal FM, 2011, NAT PHOTONICS, V5, P318, DOI 10.1038/nphoton.2011.100; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Li H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02923-8; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Miao ZC, 2017, ANNU REV BIOPHYS, V46, P483, DOI 10.1146/annurev-biophys-070816-034125; Peng Y, 2014, P NATL ACAD SCI USA, V111, P17134, DOI 10.1073/pnas.1410114111; Ritchie DB, 2015, CURR OPIN STRUC BIOL, V34, P43, DOI 10.1016/j.sbi.2015.06.006; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222938	10.1371/journal.pone.0222938	http://dx.doi.org/10.1371/journal.pone.0222938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557220	Green Published, gold			2022-12-26	WOS:000532345500047
J	Narang, A; Garima, K; Porwal, S; Bhandekar, A; Shrivastava, K; Giri, A; Sharma, NK; Bose, M; Varma-Basil, M				Narang, Anshika; Garima, Kushal; Porwal, Shraddha; Bhandekar, Archana; Shrivastava, Kamal; Giri, Astha; Sharma, Naresh Kumar; Bose, Mridula; Varma-Basil, Mandira			Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India	PLOS ONE			English	Article							RPOB MUTATIONS; DRUG-RESISTANCE; EXPRESSION; PCR; MECHANISM	Despite the consideration of chromosomal mutations as the major cause of rifampicin (RIF) resistance in M. tuberculosis, the role of other mechanisms such as efflux pumps cannot be ruled out. We evaluated the role of four efflux pumps viz., MmpL2 (Rv0507), MmpL5 (Rv0676c), Rv0194 and Rv1250 in providing RIF resistance in M. tuberculosis. The real time expression of the efflux pumps was analyzed in 16 RIF resistant and 11 RIF susceptible clinical isolates of M. tuberculosis after exposure to RIF. Expression of efflux pumps in these isolates was also correlated with mutations in the rpoB gene and MICs of RIF in the presence and absence of efflux pump inhibitors. Under RIF stress, Rv0194 was induced in 8/16 (50%) RIF resistant and 2/11 (18%) RIF susceptible isolates; mmpL5 in 7/16 (44%) RIF resistant and 1/11 (9%) RIF susceptible isolates; Rv1250 in 4/16 (25%) RIF resistant and 2/11 (18%) RIF susceptible isolates; and mmpL2 was upregulated in 2/16 (12.5%) RIF resistant and 1/11 (9%) RIF susceptible isolates. This preliminary study did not find any association between Rv0194, MmpL2, MmpL5 and Rv1250 and RIF resistance. However, the overexpression of Rv0194 and mmpL5 in greater number of RIF resistant isolates as compared to RIF susceptible isolates and expression of Rv0194 in wild type (WT) resistant isolates suggests a need for further investigations.	[Narang, Anshika; Garima, Kushal; Porwal, Shraddha; Bhandekar, Archana; Shrivastava, Kamal; Giri, Astha; Sharma, Naresh Kumar; Bose, Mridula; Varma-Basil, Mandira] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, Delhi, India; [Narang, Anshika] Rutgers State Univ, Publ Hlth Res Inst Ctr, Int Ctr Publ Hlth, Newark, NJ USA; [Garima, Kushal] Gennova Vaccine Formulat Ctr & Res Lab, Pune, Maharashtra, India	University of Delhi; Rutgers State University Newark; Rutgers State University New Brunswick	Varma-Basil, M (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, Delhi, India.	mandirav@rediffmail.com	Shrivastava, Kamal/ABC-4341-2020	Varma-Basil, Mandira/0000-0001-5562-015X; Shrivastava, Kamal/0000-0002-8904-5859	Department of Biotechnology, Government of India [BT/PR1597/MED/29/308/2011, 80/697/2011-ECD-I]; Indian Council of Medical Research, Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by a grant from the Department of Biotechnology, Government of India: No. BT/PR1597/MED/29/308/2011. AN received Senior Research Fellowship (Project No. 80/697/2011-ECD-I) from Indian Council of Medical Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, DIAGN MICR INFEC DIS, V44, P245, DOI 10.1016/S0732-8893(02)00457-1; Ahmad S, 2012, INDIAN J MED RES, V135, P756; [Anonymous], STAND OP PROC C DST; Banerjee SK, 2000, MOL GEN GENET, V262, P949, DOI 10.1007/PL00008663; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Caleffi-Ferracioli KR, 2016, TUBERCULOSIS, V97, P65, DOI 10.1016/j.tube.2015.12.010; Calgin MK, 2013, DIAGN MICR INFEC DIS, V76, P291, DOI 10.1016/j.diagmicrobio.2013.02.033; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Deepa P., 2005, Indian Journal of Tuberculosis, V52, P132; FELMLEE TA, 1995, J CLIN MICROBIOL, V33, P1617, DOI 10.1128/JCM.33.6.1617-1623.1995; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Fu Li M, 2009, Int J Microbiol, V2009, P879621, DOI 10.1155/2009/879621; Garcia de Viedma D, 2002, J CLIN MICROBIOL, V40, P988, DOI 10.1128/JCM.40.3.988-995.2002; Garima K, 2015, TUBERCULOSIS, V95, P155, DOI 10.1016/j.tube.2015.01.005; Genolist.pasteur. fr, 2008, TUBERCULIST WEB SERV; Gillespie SH, 2002, MICROB DRUG RESIST, V8, P273, DOI 10.1089/10766290260469534; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Heym B, 1997, INT J ANTIMICROB AG, V8, P61, DOI 10.1016/S0924-8579(96)00356-1; Heymann SJ, 1999, JAMA-J AM MED ASSOC, V281, P2138, DOI 10.1001/jama.281.22.2138; Huitric E, 2006, ANTIMICROB AGENTS CH, V50, P2860, DOI 10.1128/AAC.00303-06; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lam THJ, 2008, MICROB PATHOGENESIS, V45, P12, DOI 10.1016/j.micpath.2008.01.006; Li GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Masiewicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043651; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Ohno H, 1996, ANTIMICROB AGENTS CH, V40, P1053, DOI 10.1128/AAC.40.4.1053; Osdd.net, OP SOURC DRUG DISC; Pang Y, 2013, ANTIMICROB AGENTS CH, V57, P893, DOI 10.1128/AAC.01024-12; Pule CM, 2016, J ANTIMICROB CHEMOTH, V71, P17, DOI 10.1093/jac/dkv316; Qazi O, 2014, INT J MYCOBACT, V3, P173, DOI 10.1016/j.ijmyco.2014.06.004; Rabori Eshagh Dortaj, 2006, Journal of Communicable Diseases, V37, P249; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Varma-Basil M, 2013, J CLIN MICROBIOL, V51, P1165, DOI 10.1128/JCM.03067-12; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833	45	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223163	10.1371/journal.pone.0223163	http://dx.doi.org/10.1371/journal.pone.0223163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557231	gold, Green Published			2022-12-26	WOS:000532345500084
J	Zhang, AQ; Wang, HD; Wang, B; Yuan, YG; Klein, JD; Wang, XNH				Zhang, Aiqing; Wang, Haidong; Wang, Bin; Yuan, Yanggang; Klein, Janet D.; Wang, Xiaonan H.			Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease	FASEB JOURNAL			English	Article						exosome; UUO; muscle atrophy; CTGF; TGF-beta 1	EXOSOMES; MICRORNA-26A; ATROPHY; CTGF; METABOLISM; MECHANISMS; INHIBITION; MYOGENESIS; MEDIATOR; MODEL	Kidney fibrosis occurs in almost every type of chronic kidney disease. We found that microRNA (miR)-26a was decreased in the kidney, muscle, and exosomes of unilateral ureteral obstruction (UUO) mice. We hypothesized that exogenous miR-26 could suppresses renal fibrosis and muscle wasting in obstructive kidney disease. For this purpose, we generated exosomes that encapsulated miR-26, then injected these into skeletal muscle of UUO mice. The expression of miR-26a was elevated in serum exosomes from UUO mice following exosome-miR-26a injection. In these mice, muscle wasting has been ameliorated as evidenced by increased muscle weights. In addition, a muscle atrophy marker, myostatin, is increased in UUO muscle; provision of miR-26a abolished this increase. We detected a remote effect of exosomes containing miR-26a in UUO-induced renal fibrosis. The intervention of miR-26a attenuated UUO-induced renal fibrosis as determined by immunohistological assessment of alpha-smooth muscle actin and Masson's trichrome staining. Furthermore, exogenous miR-26a decreased the protein levels of 2 profibrosis proteins, connective tissue growth factor (CTGF) and TGF-beta 1, in UUO kidney. Our data showed that exosomes containing miR-26a prevented muscle atrophy by inhibiting the transcription factor forkhead box O1. Likewise, the exosome-carried miR-26a limited renal fibrosis by directly suppressing CTGF. Our findings provide an experimental basis for exosome-mediated therapy of muscle atrophy and renal fibrosis.	[Zhang, Aiqing] Nanjing Med Univ, Affiliated Hosp 2, Dept Pediat Nephrol, Nanjing, Peoples R China; [Zhang, Aiqing; Wang, Haidong; Wang, Bin; Klein, Janet D.; Wang, Xiaonan H.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Wang, Haidong] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China; [Wang, Bin] Southeast Univ, Zhong Da Hosp, Inst Nephrol, Nanjing, Peoples R China; [Yuan, Yanggang] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Nephrol, Nanjing, Peoples R China	Nanjing Medical University; Emory University; Shanxi Agricultural University; Southeast University - China; Nanjing Medical University	Wang, XNH (corresponding author), Emory Univ, Sch Med, Dept Med, Div Renal, WMB Room 338C,M-S 1930-001-1AG,1639 Pierce, Atlanta, GA 30322 USA.	xwang03@emory.edu			U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR060268]; American Heart Association by the Bayer Group [17IBDG33780000]; National Natural Science Foundation of China [81670628]; Jangsu Province Science Foundation of China [BK20161071]; Nanjing Medical Science and Technique Foundation [YKK17213]; Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD)] [P51OD011132]; Emory Integrated Genomics Core (EIGC) [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association by the Bayer Group; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jangsu Province Science Foundation of China; Nanjing Medical Science and Technique Foundation; Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD)]; Emory Integrated Genomics Core (EIGC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Matthew Wood and Dr. Yiqi Seow (University of Oxford, Oxford, United Kingdom) for providing the pLamp2b-Flag vector. This research was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01 AR060268), American Heart Association Discover and Innovation grants supported by the Bayer Group (17IBDG33780000 to X.W.), the National Natural Science Foundation of China (81670628 to Y.Y.), and the Jangsu Province Science Foundation of China (BK20161071) and Nanjing Medical Science and Technique Foundation (YKK17213 to A.Z.). This research was also supported, in part (microRNA deep sequencing), by the Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD) P51OD011132] and, in part (luciferase constructs), by the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities (UL1TR000454). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH or the U.S. Government. The authors declare no conflicts of interest.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Bivol LM, 2016, J PHYSIOL-LONDON, V594, P1709, DOI 10.1113/JP271578; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chen X, 2017, CELL DEATH DIFFER, V24, P1990, DOI 10.1038/cdd.2017.147; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Hanatani S, 2014, J AM SOC NEPHROL, V25, P2800, DOI 10.1681/ASN.2013091025; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hu L, 2015, J AM SOC NEPHROL, V26, P626, DOI 10.1681/ASN.2014020144; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Koga K, 2015, DIABETOLOGIA, V58, P2169, DOI 10.1007/s00125-015-3642-4; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Liang HH, 2014, MOL THER, V22, P1122, DOI 10.1038/mt.2014.42; LIN J, 2015, SCI WORLD J, V15, DOI DOI 10.1155/2015/657086; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Su Z, 2017, AM J PHYSIOL-RENAL, V312, pF1128, DOI 10.1152/ajprenal.00600.2016; Su Z, 2016, J APPL PHYSIOL, V120, P426, DOI 10.1152/japplphysiol.00175.2015; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Vinas JL, 2016, KIDNEY INT, V90, P1238, DOI 10.1016/j.kint.2016.07.015; Wang B, 2019, THERANOSTICS, V9, P1864, DOI 10.7150/thno.29579; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang B, 2016, MOL THER, V24, P1290, DOI 10.1038/mt.2016.90; Wang HD, 2019, MOL THER, V27, P571, DOI 10.1016/j.ymthe.2019.01.008; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2013, INT J BIOCHEM CELL B, V45, P2230, DOI 10.1016/j.biocel.2013.06.027; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Zhang AQ, 2018, J CACHEXIA SARCOPENI, V9, P755, DOI 10.1002/jcsm.12296; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zheng ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37492	47	23	23	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13590	13601		10.1096/fj.201900884R	http://dx.doi.org/10.1096/fj.201900884R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31593640	Bronze, Green Published			2022-12-26	WOS:000507466100043
J	Levenson, R; Bracken, C; Sharma, C; Santos, J; Arata, C; Malady, B; Morse, DE				Levenson, Robert; Bracken, Colton; Sharma, Cristian; Santos, Jerome; Arata, Claire; Malady, Brandon; Morse, Daniel E.			Calibration between trigger and color: Neutralization of a genetically encoded coulombic switch and dynamic arrest precisely tune reflectin assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomaterials; intrinsically disordered protein; protein aggregation; protein assembly; protein self-assembly; protein-protein interaction; biophotonics; iridescence; liquid-liquid phase separation; reflectins	PHASE-SEPARATION; PROTEINS; IRIDESCENCE; ORGANIZATION; SEQUENCE	Reflectin proteins are widely distributed in reflective structures in cephalopods. However, only in loliginid squids are they and the subwavelength photonic structures they control dynamically tunable, driving changes in skin color for camouflage and communication. The reflectins are block copolymers with repeated canonical domains interspersed with cationic linkers. Neurotransmitter-activated signal transduction culminates in catalytic phosphorylation of the tunable reflectins' cationic linkers; the resulting charge neutralization overcomes coulombic repulsion to progressively allow condensation, folding, and assembly into multimeric spheres of tunable well-defined size and low polydispersity. Here, we used dynamic light scattering, transmission EM, CD, atomic force microscopy, and fluorimetry to analyze the structural transitions of reflectins A1 and A2. We also analyzed the assembly behavior of phosphomimetic, deletion, and other mutants in conjunction with pH titration as an in vitro surrogate of phosphorylation. Our experiments uncovered a previously unsuspected, precisely predictive relationship between the extent of neutralization of a reflectin's net charge density and the size of resulting multimeric protein assemblies of narrow polydispersity. Comparisons of mutants revealed that this sensitivity to neutralization resides in the linkers and is spatially distributed along the protein. Imaging of large particles and analysis of sequence composition suggested that assembly may proceed through a dynamically arrested liquid?liquid phase-separated intermediate. Intriguingly, it is this dynamic arrest that enables the observed fine-tuning by charge and the resulting calibration between neuronal trigger and color in the squid. These results offer insights into the basis of reflectin-based biophotonics, opening paths for the design of new materials with tunable properties.	[Levenson, Robert; Bracken, Colton; Sharma, Cristian; Santos, Jerome; Arata, Claire; Malady, Brandon; Morse, Daniel E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Levenson, Robert; Bracken, Colton; Sharma, Cristian; Santos, Jerome; Arata, Claire; Malady, Brandon; Morse, Daniel E.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Morse, DE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	d_morse@lifesci.ucsb.edu	Levenson, Robert/AAD-6906-2022	Levenson, Robert/0000-0001-8251-626X; Bracken, Colton/0000-0003-3499-7032; Sharma, Cristian/0000-0003-4699-623X; Malady, Brandon/0000-0001-6649-8639	Materials Research Science and Engineering Center Program of the National Science Foundation under Materials Research Award [1121053]	Materials Research Science and Engineering Center Program of the National Science Foundation under Materials Research Award	We thank Cristophe A. Monnier for assistance with AFM measurements. Use of the University of California, Santa Barbara, Materials Research Laboratory Shared Experimental Facilities, a member of the National Science Foundation-funded Materials Research Facilities Network, was supported by the Materials Research Science and Engineering Center Program of the National Science Foundation under Materials Research Award 1121053. We are grateful to Youli Li for insightful discussions.	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Andouche A, 2013, DEV DYNAM, V242, P560, DOI 10.1002/dvdy.23938; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Bromley KM, 2011, J BIOL CHEM, V286, P34643, DOI 10.1074/jbc.M111.250928; Chong PA, 2018, J MOL BIOL, V430, P4650, DOI 10.1016/j.jmb.2018.06.014; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; COOPER KM, 1986, J EXP BIOL, V121, P451; Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeMartini DG, 2015, J BIOL CHEM, V290, P15238, DOI 10.1074/jbc.M115.638254; DeMartini DG, 2013, J EXP BIOL, V216, P3733, DOI 10.1242/jeb.090415; DeMartini DG, 2013, P NATL ACAD SCI USA, V110, P2552, DOI 10.1073/pnas.1217260110; Dennis PB, 2017, APL MATER, V5, DOI 10.1063/1.4997199; Dzuricky M, 2018, BIOCHEMISTRY-US, V57, P2405, DOI 10.1021/acs.biochem.8b00056; Ghoshal A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0106; Ghoshal A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0386; Guan Z, 2017, CURR BIOL, V27, P2833, DOI 10.1016/j.cub.2017.07.061; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; Hierrezuelo J, 2010, LANGMUIR, V26, P15109, DOI 10.1021/la102912u; Izumi M, 2010, J R SOC INTERFACE, V7, P549, DOI 10.1098/rsif.2009.0299; Klein R, 2001, PURE APPL CHEM, V73, P1705, DOI 10.1351/pac200173111705; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Kreit E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0601; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levenson R, 2017, APL MATER, V5, DOI 10.1063/1.4985758; Levenson R, 2016, J BIOL CHEM, V291, P4058, DOI 10.1074/jbc.M115.686014; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Phan L, 2013, ADV MATER, V25, P5621, DOI 10.1002/adma.201301472; Mathger LM, 2013, ADV FUNCT MATER, V23, P3980, DOI 10.1002/adfm.201203705; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Naughton KL, 2016, ADV MATER, V28, P8405, DOI 10.1002/adma.201601666; Ordinario DD, 2016, RSC ADV, V6, pS7103, DOI 10.1039/c6ra05405f; Ordinario DD, 2016, CHEM MATER, V28, P3703, DOI 10.1021/acs.chemmater.6b00336; Ordinario DD, 2014, NAT CHEM, V6, P597, DOI [10.1038/NCHEM.1960, 10.1038/nchem.1960]; Phan L, 2016, CHEM MATER, V28, P6804, DOI 10.1021/acs.chemmater.6b01532; Phan L, 2016, ACS APPL MATER INTER, V8, P278, DOI 10.1021/acsami.5b08717; Phan L, 2015, J MATER CHEM C, V3, P6493, DOI 10.1039/c5tc00125k; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Qin GK, 2013, J POLYM SCI POL PHYS, V51, P254, DOI 10.1002/polb.23204; Ruff KM, 2018, J MOL BIOL, V430, P4619, DOI 10.1016/j.jmb.2018.06.031; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tao AR, 2010, BIOMATERIALS, V31, P793, DOI 10.1016/j.biomaterials.2009.10.038; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	56	16	16	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16804	16815		10.1074/jbc.RA119.010339	http://dx.doi.org/10.1074/jbc.RA119.010339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31558609	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000501801900027
J	Rossi, M; De Battisti, D; Niven, JE				Rossi, Marta; De Battisti, Davide; Niven, Jeremy Edward			Transepithelial transport of P-glycoprotein substrate by the Malpighian tubules of the desert locust	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FLUID SECRETION; SCHISTOCERCA-GREGARIA; INSECTICIDE RESISTANCE; MULTIDRUG-RESISTANCE; DIURETIC HORMONE; ACTIVE-TRANSPORT; ORGANIC CATION; AEDES-AEGYPTI; IN-VITRO	Extrusion of xenobiotics is essential for allowing animals to remove toxic substances present in their diet or generated as a biproduct of their metabolism. By transporting a wide range of potentially noxious substrates, active transporters of the ABC transporter family play an important role in xenobiotic extrusion. One such class of transporters are the multidrug resistance P-glycoprotein transporters. Here, we investigated P-glycoprotein transport in the Malpighian tubules of the desert locust (Schistocerca gregaria), a species whose diet includes plants that contain toxic secondary metabolites. To this end, we studied transporter physiology using a modified Ramsay assay in which ex vivo Malpighian tubules are incubated in different solutions containing the P-glycoprotein substrate dye rhodamine B in combination with different concentrations of the P-glycoprotein inhibitor verapamil. To determine the quantity of the P-glycoprotein substrate extruded we developed a simple and cheap method as an alternative to liquid chromatography-mass spectrometry, radiolabelled alkaloids or confocal microscopy. Our evidence shows that: (i) the Malpighian tubules contain a P-glycoprotein; (ii) tubule surface area is positively correlated with the tubule fluid secretion rate; and (iii) as the fluid secretion rate increases so too does the net extrusion of rhodamine B. We were able to quantify precisely the relationships between the fluid secretion, surface area, and net extrusion. We interpret these results in the context of the life history and foraging ecology of desert locusts. We argue that P-glycoproteins contribute to the removal of xenobiotic substances from the haemolymph, thereby enabling gregarious desert locusts to maintain toxicity through the ingestion of toxic plants without suffering the deleterious effects themselves.	[Rossi, Marta; Niven, Jeremy Edward] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [De Battisti, Davide] Swansea Univ, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales; [Niven, Jeremy Edward] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England	University of Sussex; Swansea University; University of Sussex	Rossi, M; Niven, JE (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.; Niven, JE (corresponding author), Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England.	M.Rossi@sussex.ac.uk; J.E.Niven@sussex.ac.uk	De Battisti, Davide/AAF-1434-2020	Rossi, Marta/0000-0002-9178-620X	School of Life Sciences, University of Sussex; Welsh government/HEFCW RESILCOAST project	School of Life Sciences, University of Sussex; Welsh government/HEFCW RESILCOAST project	M.R. was financially supported by a graduate studentship from the School of Life Sciences, University of Sussex. D.D.B. was financially supported by the Welsh government/HEFCW RESILCOAST project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.R. was financially supported by a graduate studentship from the School of Life Sciences, University of Sussex. D.D.B was financially supported by the Welsh government/HEFCW RESILCOAST project.	Abernethy DR, 1999, NEW ENGL J MED, V341, P1447, DOI 10.1056/NEJM199911043411907; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Akbar SM, 2014, CELL BIOCHEM BIOPHYS, V70, P651, DOI 10.1007/s12013-014-9969-5; Al-Qadi S, 2015, BBA-GEN SUBJECTS, V1850, P2439, DOI 10.1016/j.bbagen.2015.09.002; Andersson O, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.50; Andersson O, 2013, J PHARMACOL EXP THER, V346, P211, DOI 10.1124/jpet.113.205476; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEYENBACH KW, 1993, J INSECT PHYSIOL, V39, P639, DOI 10.1016/0022-1910(93)90069-4; BRADLEY TJ, 1983, J CELL SCI, V60, P117; COAST GM, 1988, PHYSIOL ENTOMOL, V13, P381, DOI 10.1111/j.1365-3032.1988.tb01120.x; COAST GM, 1993, J EXP BIOL, V175, P1; COLE SPC, 1989, BRIT J CANCER, V59, P42, DOI 10.1038/bjc.1989.9; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Despland E, 2005, ANIM BEHAV, V69, P471, DOI 10.1016/j.anbehav.2004.04.018; Eytan GD, 1997, EUR J BIOCHEM, V248, P104, DOI 10.1111/j.1432-1033.1997.00104.x; Eytan GD, 1996, J BIOL CHEM, V271, P12897, DOI 10.1074/jbc.271.22.12897; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Guseman AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148242; Halberg KA, 2012, J EXP BIOL, V215, P497, DOI 10.1242/jeb.065987; HAMADA H, 1987, CANCER RES, V47, P2860; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; JAMES PJ, 1993, J INSECT PHYSIOL, V39, P797, DOI 10.1016/0022-1910(93)90056-W; Karnaky Jr KJ, 2000, B MT DES ISL BIOL LA, V39, P52; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lanning CL, 1996, BBA-GEN SUBJECTS, V1291, P155, DOI 10.1016/0304-4165(96)00060-8; Leader JP, 2005, J EXP BIOL, V208, P4363, DOI 10.1242/jeb.01911; Lenth R., 2018, AM STAT, V34, P216; MacPherson MR, 2001, AM J PHYSIOL-CELL PH, V280, pC394, DOI 10.1152/ajpcell.2001.280.2.C394; MADDRELL SH, 1973, J INSECT PHYSIOL, V19, P1369, DOI 10.1016/0022-1910(73)90167-4; MADDRELL SH, 1974, J EXP BIOL, V61, P357; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; Mainguet AM, 2000, ENTOMOL EXP APPL, V94, P309, DOI 10.1023/A:1003931105857; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; Nielsen PA, 2011, DRUG DISCOV TODAY, V16, P472, DOI 10.1016/j.drudis.2011.04.004; O'Donnell M, 2008, ADV INSECT PHYSIOL, V35, P1, DOI 10.1016/S0065-2806(08)00001-5; O'Donnell MJ, 2006, ARCH INSECT BIOCHEM, V63, P123, DOI 10.1002/arch.20148; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Paluzzi JP, 2013, J INSECT PHYSIOL, V59, P1179, DOI 10.1016/j.jinsphys.2013.09.005; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; PHILLIPS JE, 1964, J EXP BIOL, V41, P15; PROUX JP, 1988, J INSECT PHYSIOL, V34, P919, DOI 10.1016/0022-1910(88)90127-8; R Core Team, 2021, R LANGUAGE ENV STAT; RAMSAY JA, 1954, J EXP BIOL, V31, P104; RAMSAY JA, 1958, J EXP BIOL, V35, P871; Rheault MR, 2006, J INSECT PHYSIOL, V52, P487, DOI 10.1016/j.jinsphys.2006.01.008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Simoes PMV, 2013, CURR BIOL, V23, P2407, DOI 10.1016/j.cub.2013.10.016; Srinivas R, 2004, COMP BIOCHEM PHYS C, V137, P261, DOI 10.1016/j.cca.2004.02.002; Sword GA, 1999, NATURE, V397, P217, DOI 10.1038/16609; Sword GA, 2000, P ROY SOC B-BIOL SCI, V267, P63, DOI 10.1098/rspb.2000.0967; Sword GA, 2001, OECOLOGIA, V128, P416, DOI 10.1007/s004420100666; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; TSURUO T, 1981, CANCER RES, V41, P1967; Ugwu MC, 2016, J PHARMACOL TOX MET, V82, P9, DOI 10.1016/j.vascn.2016.05.014; Van Huis A., 2007, P285; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WIECZOREK H, 1992, J EXP BIOL, V172, P335; WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003	62	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0223569	10.1371/journal.pone.0223569	http://dx.doi.org/10.1371/journal.pone.0223569			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593571	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000532431700009
J	Ogi, M; Yamagishi, T; Tsukano, H; Nishio, N; Hishida, R; Takahashi, K; Horii, A; Shibuki, K				Ogi, Manabu; Yamagishi, Tatsuya; Tsukano, Hiroaki; Nishio, Nana; Hishida, Ryuichi; Takahashi, Kuniyuki; Horii, Arata; Shibuki, Katsuei			Associative responses to visual shape stimuli in the mouse auditory cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PLASTICITY; DEPRESSION	Humans can recall various aspects of a characteristic sound as a whole when they see a visual shape stimulus that has been intimately associated with the sound. In subjects with audio-visual associative memory, auditory responses that code the associated sound may be induced in the auditory cortex in response to presentation of the associated visual shape stimulus. To test this possibility, mice were pre-exposed to a combination of an artificial sound mimicking a cat's "meow" and a visual shape stimulus of concentric circles or stars for more than two weeks, since such passive exposure is known to be sufficient for inducing audio-visual associative memory in mice. After the exposure, we anesthetized the mice, and presented them with the associated visual shape stimulus. We found that associative responses in the auditory cortex were induced in response to the visual stimulus. The associative auditory responses were observed when complex sounds such as "meow" were used for formation of audio-visual associative memory, but not when a pure tone was used. These results suggest that associative auditory responses in the auditory cortex represent the characteristics of the complex sound stimulus as a whole.	[Ogi, Manabu; Yamagishi, Tatsuya; Tsukano, Hiroaki; Nishio, Nana; Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Chuo Ku, Asahi Machi, Niigata, Japan; [Ogi, Manabu; Yamagishi, Tatsuya; Takahashi, Kuniyuki; Horii, Arata] Niigata Univ, Grad Sch Med & Dent Sci, Dept Otolaryngol Head & Neck Surg, Chuo Ku, Asahi Machi, Niigata, Japan	Niigata University; Niigata University	Shibuki, K (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurophysiol, Chuo Ku, Asahi Machi, Niigata, Japan.	shibuki@bri.niigata-u.ac.jp	Tsukano, Hiroaki/G-5053-2013	Tsukano, Hiroaki/0000-0001-8511-7256	 [22115011];  [16H01892]	; 	This work was supported by Grant-in-Aid for Scientific Research (no. 22115011 and no.16H01892 to K.S.). URL:https://www.jsps.go.jp/english/e-grants/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Atencio CA, 2013, J NEUROSCI, V33, P18503, DOI 10.1523/JNEUROSCI.2014-13.2013; Baba H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34421; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burwick T, 2014, WIRES COGN SCI, V5, P305, DOI 10.1002/wcs.1279; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; D'amour JA, 2015, NEURON, V86, P514, DOI 10.1016/j.neuron.2015.03.014; D'Souza RD, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00071; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Fairhurst MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177622; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; Gruart A, 2015, NEUROBIOL LEARN MEM, V124, P3, DOI 10.1016/j.nlm.2015.04.006; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Jack BN, 2019, BRAIN RES, V1706, P86, DOI 10.1016/j.brainres.2018.10.034; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; King AJ, 2018, F1000RES, V7; Kitaura H, 2007, NEUROSCI RES, V59, P160, DOI 10.1016/j.neures.2007.06.1469; Koldenkova VP, 2013, BBA-MOL CELL RES, V1833, P1787, DOI 10.1016/j.bbamcr.2013.01.011; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Kudoh M, 1997, J NEUROSCI, V17, P9458; Maniwa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193017; Miniaci MC, 2016, BRAIN RES, V1646, P426, DOI 10.1016/j.brainres.2016.06.030; Nishio N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29530-3; Ohga S, 2018, CEREB CORTEX, V28, P4424, DOI 10.1093/cercor/bhy234; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Ohshima S, 2010, NEUROSCI RES, V67, P51, DOI 10.1016/j.neures.2010.01.005; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Rose D, 1996, PERCEPTION, V25, P881, DOI 10.1068/p250881; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Tsukano H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00014; Tsukano H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22315; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; Watanabe K, 2007, BRAIN RES, V1166, P20, DOI 10.1016/j.brainres.2007.06.049; Yamagishi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28034-4; Yoshitake K, 2013, CELL REP, V5, P1365, DOI 10.1016/j.celrep.2013.11.006	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223242	10.1371/journal.pone.0223242	http://dx.doi.org/10.1371/journal.pone.0223242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581242	Green Published, gold			2022-12-26	WOS:000532398600042
J	Shao, ML; Lin, HY; Yin, DS; Li, YJ; Wang, YF; Ma, JP; Yin, JZ; Jin, H				Shao, Mengling; Lin, Huiyan; Yin, Desheng; Li, Yongjie; Wang, Yifan; Ma, Junpeng; Yin, Jianzhong; Jin, Hua			Learning to play badminton altered resting state activity and functional connectivity of the cerebellar sub-regions in adults	PLOS ONE			English	Article							EXPERT-NOVICE DIFFERENCES; TALENT IDENTIFICATION; BRAIN ACTIVITY; MOTOR; FMRI; ANTICIPATION; NETWORKS; SKILL; ACTIVATION; PLASTICITY	Previous studies have shown that sport experts are different from novices in functions and structures of the cerebellar sub-regions and the functional connectivity (FC) associated with the cerebellum, suggesting the role of the cerebellum on motor skill learning (MSL). However, the manipulation of individuals with different motor skills fails to exclude the effects of innate talents. In addition, individuals with higher motor skills often start with the MSL in their young ages. It is still unclear whether the effects regarding the cerebellum would be shown at one's adult age. The present study was to directly alter individuals' motor skills to investigate whether MSL (taking learning to play badminton as an example) in adulthood influences resting-state activity in the cerebellum. To this end, young adults without ball training experience were recruited as participants and were assigned randomly into the experimental group and the control group. Participants in the experimental group were asked to attend a badminton training course for 12 weeks, while the control group did not regularly attend any ball sports during this period. Resting-state functional magnetic resonance imaging (fMRI) was recorded before and after the training. Results showed that compared to the control group, the experimental group had smaller amplitude of low-frequency fluctuation (ALFF) in right cerebellar hemispheric VI and left VIII after training. For the experimental group, right hemispheric VIII had a stronger FC with left hemispheric IV-V, cerebellar vermal IX, left middle cingulate gyrus and right hippocampus after training. Taken together, these findings suggested that MSL, at least learning to play badminton in adulthood, reduces resting-state activity in different sub-regions in the cerebellum but increases FC between sub-regions of the cerebellum as well as between sub-regions of the cerebellum and cerebral cortices (e.g., middle cingulate cortex and hippocampus).	[Shao, Mengling; Yin, Desheng; Li, Yongjie; Wang, Yifan; Ma, Junpeng; Jin, Hua] Tianjin Normal Univ, Acad Psychol & Behav, Ctr Cooperat Innovat Assessment & Promot Natl Men, Key Res Base Humanities & Social Sci,Minist Educ, Tianjin, Peoples R China; [Lin, Huiyan] Guangdong Univ Finance, Sch Publ Adm, Inst Appl Psychol, Guangzhou, Peoples R China; [Yin, Jianzhong] Tianjin First Ctr Hosp, Dept Radiol, Tianjin, Peoples R China	Tianjin Normal University; Guangdong University of Finance	Jin, H (corresponding author), Tianjin Normal Univ, Acad Psychol & Behav, Ctr Cooperat Innovat Assessment & Promot Natl Men, Key Res Base Humanities & Social Sci,Minist Educ, Tianjin, Peoples R China.	jinhua@mail.tjnu.edu.cn	li, yong/HDN-3885-2022	jin, hua/0000-0003-2105-393X	National Natural Science Foundation of China [31471003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by grants from the National Natural Science Foundation of China (31471003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Fucheng Liang and Haixiao Hong for badminton training, Miaomiao Long, Haizhen Sun and Hui Zhang for imaging data collection, Nan Yang, Huan Xu, Ting Liu, Ruru Yin and Peng Li for participant recruitments and experimental implementation and Fengyu Cong, Guoqiang Hu and Wei Zhao for data analysis.	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Alahmadi AAS, 2017, HUM BRAIN MAPP, V38, P2566, DOI 10.1002/hbm.23541; Bernardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077764; Bishop DT, 2013, J SPORT EXERCISE PSY, V35, P98, DOI 10.1123/jsep.35.1.98; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Grimaldi G, 2012, CEREBELLUM, V11, P336, DOI 10.1007/s12311-011-0247-4; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Kim JH, 2015, J SPORT SCI, V33, P1980, DOI 10.1080/02640414.2015.1022570; Kim W, 2014, COGN BEHAV NEUROL, V27, P173, DOI 10.1097/WNN.0000000000000042; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Muller RA, 1999, PROG NEURO-PSYCHOPH, V23, P657, DOI 10.1016/S0278-5846(99)00024-X; Nishiguchi S, 2015, J AM GERIATR SOC, V63, P1355, DOI 10.1111/jgs.13481; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Park IS, 2018, J CLIN NEUROL, V14, P1, DOI 10.3988/jcn.2018.14.1.1; Park IS, 2015, ANAT CELL BIOL, V48, P262, DOI 10.5115/acb.2015.48.4.262; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Schlerf JE, 2010, J NEUROPHYSIOL, V103, P3330, DOI 10.1152/jn.01117.2009; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VAHEDI K, 1995, J NEUROL NEUROSUR PS, V58, P91, DOI 10.1136/jnnp.58.1.91; Wang CQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00188; Wang JJ, 2016, BRAIN STRUCT FUNCT, V221, P3503, DOI 10.1007/s00429-015-1116-6; Werkiani ME, 2012, PROCD SOC BEHV, V31, P834, DOI 10.1016/j.sbspro.2011.12.151; Wimshurst ZL, 2016, NEUROSCIENCE, V315, P31, DOI 10.1016/j.neuroscience.2015.11.064; Woods CT, 2016, J SPORT SCI MED, V15, P548; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	48	3	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223234	10.1371/journal.pone.0223234	http://dx.doi.org/10.1371/journal.pone.0223234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574108	gold, Green Published			2022-12-26	WOS:000532376700039
J	Addai-Mensah, O; Annani-Akollor, ME; Nsafoah, FO; Fondjo, LA; Owiredu, EW; Danquah, KO; Duneeh, RV; Amponsah, FA				Addai-Mensah, Otchere; Annani-Akollor, Max Efui; Nsafoah, Frederick Obeng; Fondjo, Linda Ahenkorah; Owiredu, Eddie-Williams; Danquah, Kwabena Owusu; Duneeh, Richard Vikpebah; Amponsah, Francis Agyei			Effect of poor glycaemic control on plasma levels and activity of protein C, protein S, and antithrombin III in type 2 diabetes mellitus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; COMPLICATIONS; HYPERTENSION; PROGRESSION; THERAPY; STATINS; DISEASE; ADULTS	Background Type 2 diabetes mellitus (T2DM) patients are predisposed to several diabetes-related complications. Dysregulation of the haemostatic mechanisms have been implicated. There are however no current studies assessing the levels and activity of protein C (PC), protein S (PS), and antithrombin III (AT III), which are essential in haemostatic regulation, in a single cohort of T2DM patients. This study evaluated the effect of poorly-managed T2DM on the levels and activity of PC, PS, and AT III. Methods This cross-sectional study was conducted at the Diabetes Clinic, Cocoa Clinic in Kumasi, Ghana. A total of 242 T2DM patients, comprising 152 patients with poorly-managed diabetes and 90 well-managed diabetes patients, were recruited for the study. Fasting blood glucose, liver function tests and lipid profile were performed for each respondent. Glycated haemoglobin (HbA1c) was estimated by turbidimetric inhibition immunoassay. The levels and activity of PC, PS and AT III were measured by solid phase sandwich ELISA method. Results There was a negative correlation between HbA1c and the levels and activity of PC, PS and AT III. The levels and activity of PC [(5.78 vs 4.64 mu g/ml, p<0.0001) and (42.22 vs 36.21 U/ml, p = 0.01) respectively], PS [(22.55 vs 20.29 mu g/ml, p = 0.010) and (235.94 vs 211.67 U/ml, p<0.0001) respectively] and AT III [(16.28 vs 14.41 mu g/ml, p<0.0001) and (176.01 vs 160.09 U/ml, p = 0.03) respectively] were significantly increased in patients with well-managed T2DM compared to the poorly-managed diabetes patients. Likewise, the levels and activity of PC, PS, and AT III was higher among T2DM patients using statins than patients who were statin-naive. Among patients with well-managed T2DM, those who were on statins had significantly higher levels and activities of PC, PS, and AT III compared to well-managed T2DM patients not on statins. However, there no statistically significant differences between the level and activity of PC, PS, and AT III among poorly-managed T2DM patients with respect to statin status. Conclusion Poorly-managed type 2 diabetes mellitus is associated with reduced levels and activity of PC, PS and AT III compared to well-managed T2DM. Though use of statins may improve the levels and activity of the PC, PS and AT III in T2DM, their effect is limited in the presence of poorly-controlled T2DM. Proper management of diabetes is essential to reduce the likelihood of thrombotic events among T2DM patients.	[Addai-Mensah, Otchere; Nsafoah, Frederick Obeng; Danquah, Kwabena Owusu] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Med Diagnost, Kumasi, Ghana; [Annani-Akollor, Max Efui; Fondjo, Linda Ahenkorah; Owiredu, Eddie-Williams] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Duneeh, Richard Vikpebah] Komfo Anokye Teaching Hosp, Dept Haematol, Kumasi, Ghana; [Amponsah, Francis Agyei] St John God Hosp, Duayaw Nkwanta, Sunyani, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Addai-Mensah, O (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Med Diagnost, Kumasi, Ghana.	drmedmozart@yahoo.com	Williams, Eddie/Q-1518-2019; Addai-Mensah, Otchere/AAI-6182-2021	Williams, Eddie/0000-0003-4499-0678; addai-mensah, otchere/0000-0001-9225-5876; Annani-Akollor, Max Efui/0000-0003-1369-3750				Addai-Mensah O, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7467512; Aktas S, 2018, DIABETES RES CLIN PR, V135, P88, DOI 10.1016/j.diabres.2017.11.004; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; Annani-Akollor ME, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0423-0; ANNANIAKOLLOR ME, 2019, MEDICINA-LITHUANIA, V55, DOI DOI 10.3390/MEDICINA55050125; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Danquah I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-210; Erem C, 2005, MED PRIN PRACT, V14, P22, DOI 10.1159/000081919; Fattah MA, 2003, DIS MARKERS, V19, P251, DOI 10.1155/2004/797458; Fleming JK, 2007, CLIN BIOCHEM, V40, P822, DOI 10.1016/j.clinbiochem.2007.03.017; Fondjo LA, 2018, BIOMED RES INT, V2018, P12; Fondjo LA, 2017, PLOS ONE, V12; Gatimu SM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3845-8; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Hernandez-Espinosa D, 2009, THROMB RES, V124, P483, DOI 10.1016/j.thromres.2009.05.020; Jax TW, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-48; Ji L, 2016, DIABETES RES CLIN PR, V112, P82, DOI 10.1016/j.diabres.2015.08.005; Kaiser AB, 2018, DIABETES, V67, DOI 10.2337/db18-202-LB; Kim HK, 2014, J DIABETES COMPLICAT, V28, P365, DOI 10.1016/j.jdiacomp.2014.01.006; Li XR, 2014, INT UROL NEPHROL, V46, P2207, DOI 10.1007/s11255-014-0764-4; Muldur F, 2005, TURK J MED SCI, V35, P305; Nazimek-Siewniak B, 2002, J DIABETES COMPLICAT, V16, P271, DOI 10.1016/S1056-8727(01)00184-2; Onbasi K, 1999, TURKISH J ENDOCRINOL, V2, P53; Owiredu EW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1764079; Owusu-Ansah A, 2018, ROUTL ST REAL EST, P182; Qaseem A, 2018, ANN INTERN MED, V168, P569, DOI 10.7326/M17-0939; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Service GS Ghana Research NMIfM Legon GaOm Calverton Maryland, 2003, GHAN DEM HLTH SURV; Soares Anna Letícia, 2010, Rev. Bras. Hematol. Hemoter., V32, P482, DOI 10.1590/S1516-84842010000600013; Sommeijer DW, 2006, J THROMB HAEMOST, V4, P574, DOI 10.1111/j.1538-7836.2005.01763.x; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Thisiadou K, 2010, EUR C END; Tripodi A, 2001, CLIN CHEM, V47, P1597; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Verkleij CJN, 2011, CLIN APPL THROMB-HEM, V17, pE57, DOI 10.1177/1076029610384112; Yamada T, 2000, DIABETES RES CLIN PR, V49, P23, DOI 10.1016/S0168-8227(00)00134-0; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	39	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223171	10.1371/journal.pone.0223171	http://dx.doi.org/10.1371/journal.pone.0223171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560710	gold, Green Published			2022-12-26	WOS:000532353700039
J	Chang, YLK; Miyazawa, Y; Miller, MJ; Tsukamoto, K				Chang, Yu-Lin K.; Miyazawa, Yasumasa; Miller, Michael J.; Tsukamoto, Katsumi			Influence of ocean circulation and the Kuroshio large meander on the 2018 Japanese eel recruitment season	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; FRESH-WATER EELS; ANGUILLA-JAPONICA; LARVAL TRANSPORT; EUROPEAN EEL; VARIABILITY; MIGRATION; OSCILLATION; DISPERSAL; SALINITY	Japanese eel (Anguilla japonica) recruitment to Japan was very low during the early 2017-2018 recruitment season when most glass eels are usually caught, but catches increased in the late recruitment season when recruitment usually decreases. Concurrently, the Kuroshio meander south of Japan had formed again after the previous event ended in 2005. The role of the large meander and ocean circulation features such as the North Equatorial Current (NEC) in the unusual 2017-2018 Japanese eel recruitment timing-pattern was investigated using a three-dimensional particle tracking model that simulated swimming behaviors of virtual larvae (v-larvae) in addition to their drift in ocean currents. Four recruitment seasons were selected for when the Kuroshio large meander was present (2004-2005, 2017-2018) or absent (2009-2010, 2015-2016), and when NEC was shifted north (2004-2005, 2015-2016) or south (2009-2010, 2017-2018). The simulated recruitment timing-patterns were similar to the actual recent-year recruitment, with no early recruitment period v-larvae arrival to southern Japan and increased late period recruitment occurring. Rather than being related to the presence of the Kuroshio large meander, the late arrival appeared to be caused by a southward shifted, weak North Equatorial Current near the spawning area, a longer Subtropical Countercurrent eddy region retention time, and a weak Kuroshio during the early migration and recruitment period of those years. In the late recruitment period, the Kuroshio was stronger than other selected years near the East China Sea and south of Japan and v-larvae were transported more rapidly. The Kuroshio large meander may influence local eel recruitment in Japan, and the recirculation formed by the large meander could potentially enhance recruitment to the Tokai region. Oriented (northwestward) swimming v-larvae were less affected by the large meander, and showed higher recruitment success than those using along-current swimming. Although the Kuroshio large meander did not seem to be responsible for the unusual recruitment pattern in 2018, how Japanese eel larvae and glass eels actually cross out of the Kuroshio and reach coastal waters in Japan remains to be explored.	[Chang, Yu-Lin K.; Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Miller, Michael J.; Tsukamoto, Katsumi] Univ Tokyo, Dept Aquat Biosci, Tokyo, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo	Chang, YLK (corresponding author), Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan.	ychang@jamstec.go.jp	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272				Aida K, 2003, EEL BIOL, P497, DOI DOI 10.1007/978-4-431-65907-5; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Aoyama J, 2012, FISHERIES SCI, V78, P1195, DOI 10.1007/s12562-012-0544-y; Baltazar-Soares M, 2014, CURR BIOL, V24, P104, DOI 10.1016/j.cub.2013.11.031; Beguer-Pon M, 2016, MAR ECOL PROG SER, V549, P183, DOI 10.3354/meps11706; Beguer-Pon M, 2016, ICES J MAR SCI, V73, P57, DOI 10.1093/icesjms/fsv169; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Chang YL, 2012, J CLIMATE, V25, P1597, DOI 10.1175/JCLI-D-11-00158.1; Chang YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172501; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chang YLK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208704; Chang YLK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23820-6; Chang YLK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23392-5; Cresci A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602007; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Dekker W, 2004, SLIPPING OUR HANDS P; Durif CMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059212; Endoh T, 2011, J PHYS OCEANOGR, V41, P1624, DOI 10.1175/JPO-D-11-074.1; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Hsu AC, 2017, FISH OCEANOGR, V26, P251, DOI 10.1111/fog.12189; ICES, 2013, REP EIF ICES WORK GR, P2013; Iinuma N., 2005, SHIZUOKA PREFECTURE, P8; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; Kawabe M, 1995, J PHYS OCEANOGR, V25, P3103, DOI 10.1175/1520-0485(1995)025<3103:VOCPVA>2.0.CO;2; Kawabe M, 2005, J OCEANOGR, V61, P529, DOI 10.1007/s10872-005-0060-0; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kuroki M, 2014, CAN J ZOOL, V92, P749, DOI 10.1139/cjz-2013-0303; Marshall J, 2007, ATMOSPHERE OCEAN CLI, P344; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Miller MJ, 2016, ICES J MAR SCI, V73, P43, DOI 10.1093/icesjms/fsv063; Miller MJ, 2009, AM FISH S S, V69, P231; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Ohashi K, 2015, ATMOS OCEAN, P1, DOI [10.1080/07055900.2015.1090390, DOI 10.1080/07055900.2015.1090390]; OKUBO A, 1970, DEEP-SEA RES, V17, P445, DOI 10.1016/0011-7471(70)90059-8; Press W., 1992, NUMERICAL RECIPES FO; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Qiu B, 2015, OCEANOGRAPHY, V28, P24, DOI 10.5670/oceanog.2015.78; Qiu B, 2012, J PHYS OCEANOGR, V42, P193, DOI 10.1175/JPO-D-11-061.1; Rypina II, 2014, LIMNOL OCEANOGR, V59, P1704, DOI 10.4319/lo.2014.59.5.1704; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Soeyanto E, 2014, J GEOPHYS RES-OCEANS, V119, P3595, DOI 10.1002/2013JC009529; Tesch F.W., 2003, EEL, P408, DOI DOI 10.1111/J.0022-1112.2004.00509A.X; TOSI L, 1990, J FISH BIOL, V36, P327, DOI 10.1111/j.1095-8649.1990.tb05613.x; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 1990, MER, V28, P188; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Tsukamoto Katsumi, 1990, Mer (Tokyo), V28, P188; Usui N, 2013, J OCEANOGR, V69, P647, DOI 10.1007/s10872-013-0197-1; Usui N, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004266; WEISS J, 1991, PHYSICA D, V48, P273, DOI 10.1016/0167-2789(91)90088-Q; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Zenimoto K, 2011, MAR ECOL PROG SER, V438, P219, DOI 10.3354/meps09255	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223262	10.1371/journal.pone.0223262	http://dx.doi.org/10.1371/journal.pone.0223262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560733	Green Published, gold			2022-12-26	WOS:000532353700042
J	Rashel, RH; Patino, R				Rashel, Rakib H.; Patino, Reynaldo			Growth response of the ichthyotoxic haptophyte, Prymnesium parvum Carter, to changes in sulfate and fluoride concentrations	PLOS ONE			English	Article							FRESH-WATER; TRANSCRIPTOME ANALYSIS; MAGNESIUM-DEFICIENCY; SULFUR ASSIMILATION; ALGA; SALINITY; TOXICITY; PHYTOPLANKTON; PRYMNESIOPHYCEAE; AVAILABILITY	Golden alga Prymnesium parvum Carter is a euryhaline, ichthyotoxic haptophyte (Chromista). Because of its presumed coastal/marine origin where SO42- levels are high, the relatively high SO2-4 concentration of its brackish inland habitats, and the sensitivity of marine chromists to sulfur deficiency, this study examined whether golden alga growth is sensitive to SO42- concentration. Fluoride is a ubiquitous ion that has been reported at higher levels in golden alga habitat; thus, the influence of F- on growth also was examined. In low-salinity (5 psu) artificial seawater medium, overall growth was SO42- dependent up to 1000 mg l(-1) using MgSO4 or Na2SO4 as source; the influence on growth rate, however, was more evident with MgSO4. Transfer from 5 to 30 psu inhibited growth when salinity was raised with NaCl but in the presence of seawater levels of SO42-, these effects were fully reversed with MgSO4 as source and only partially reversed with Na2SO4. Growth inhibition was not observed after acute transfer to 30 psu in a commercial sea salt mixture. In 5-psu medium, F-inhibited growth at all concentrations tested. These observations support the hypothesis that spatial differences in SO42--but not F--concentration help drive the inland distribution and growth of golden alga and also provide physiological relevance to reports of relatively high Mg2+ concentrations in golden alga habitat. At high salinity, however, the ability of sulfate to maintain growth under osmotic stress was weak and overshadowed by the importance of Mg2+. A mechanistic understanding of growth responses of golden alga to SO42-, Mg2+ and other ions at environmentally relevant levels and under different salinity scenarios will be necessary to clarify their ecophysiological and evolutionary relevance.	[Rashel, Rakib H.; Patino, Reynaldo] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Rashel, Rakib H.] Texas Tech Univ, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Patino, Reynaldo] Texas Tech Univ, Texas Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lubbock, TX 79409 USA; [Patino, Reynaldo] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Texas Tech University System; Texas Tech University	Patino, R (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.; Patino, R (corresponding author), Texas Tech Univ, Texas Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lubbock, TX 79409 USA.; Patino, R (corresponding author), Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA.	reynaldo.patino@ttu.edu	Rashel, Rakib/AAM-1576-2021	Rashel, Rakib/0000-0002-9218-0226; Patino, Reynaldo/0000-0002-4831-8400	U.S. Geological Survey; Texas Tech University; Texas Parks and Wildlife Department; Wildlife Management Institute; U.S. Fish and Wildlife Service	U.S. Geological Survey(United States Geological Survey); Texas Tech University; Texas Parks and Wildlife Department; Wildlife Management Institute; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This study was facilitated by Texas Tech University intramural funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Jennifer Graham (U.S. Geological Survey) read and critiqued an earlier version of this manuscript. The Texas Cooperative Fish and Wildlife Unit is sponsored by U.S. Geological Survey, Texas Tech University, Texas Parks and Wildlife Department, Wildlife Management Institute, and U.S. Fish and Wildlife Service. This study was facilitated by Texas Tech University intramural funds. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Atkinson MJ, 1998, J AQUARICULTURE AQUA, V8, P39; Baker JW, 2007, J PHYCOL, V43, P219, DOI 10.1111/j.1529-8817.2007.00323.x; Bhatnagar M, 2000, FLUORIDE, V33, P55; Bochenek M, 2013, NEW PHYTOL, V199, P650, DOI 10.1111/nph.12303; Camargo JA, 1996, B ENVIRON CONTAM TOX, V56, P643, DOI 10.1007/s001289900094; Camargo JA, 2003, CHEMOSPHERE, V50, P251, DOI 10.1016/S0045-6535(02)00498-8; Cavalier-Smith T, 2018, PROTOPLASMA, V255, P297, DOI 10.1007/s00709-017-1147-3; Chen L, 2016, ENVIRON SCI POLLUT R, V23, P3586, DOI 10.1007/s11356-015-5605-1; DILLON PJ, 1975, WATER RES, V9, P135, DOI 10.1016/0043-1354(75)90002-0; DOBBS CG, 1974, FLUORIDE, V7, P123; Edvardsen B, 2006, ECOL STU AN, V189, P67, DOI 10.1007/978-3-540-32210-8_6; Esakkimuthu S, 2016, BIOMASS BIOENERG, V88, P126, DOI 10.1016/j.biombioe.2016.03.019; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; FINKLE BJ, 1953, PLANT PHYSIOL, V28, P664, DOI 10.1104/pp.28.4.664; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Giordano M, 2005, NEW PHYTOL, V166, P371, DOI 10.1111/j.1469-8137.2005.01335.x; Giordano M, 2014, AQUAT BOT, V118, P45, DOI 10.1016/j.aquabot.2014.06.012; Gou W., 1983, J DALIAN FISH COLL, V1, P43, DOI DOI 10.1016/j.hal.2014.06.012; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Guo MX, 1996, J APPL PHYCOL, V8, P111, DOI 10.1007/BF02186313; Hambright KD, 2014, FRESHW SCI, V33, P745, DOI 10.1086/677198; Hambright KD, 2010, HARMFUL ALGAE, V9, P568, DOI 10.1016/j.hal.2010.04.006; HEKMAN WE, 1984, J PHYCOL, V20, P243, DOI 10.1111/j.0022-3646.1984.00243.x; HILT KL, 1987, J PROTOZOOL, V34, P192, DOI 10.1111/j.1550-7408.1987.tb03159.x; HOLM S, 1979, SCAND J STAT, V6, P65; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Igamberdiev AU, 2011, BIOCHEM J, V437, P373, DOI 10.1042/BJ20110213; Israel NMD, 2014, HARMFUL ALGAE, V39, P81, DOI 10.1016/j.hal.2014.06.012; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kobayashi NI, 2015, INT J MOL SCI, V16, P23076, DOI 10.3390/ijms160923076; Larsen A, 1998, SARSIA, V83, P409, DOI 10.1080/00364827.1998.10413700; Lutz-Carrillo DJ, 2010, J AM WATER RESOUR AS, V46, P24, DOI 10.1111/j.1752-1688.2009.00388.x; Moestrup O, 1994, HAPTOPHYTE ALGAE, P265; Nicholls Kenneth H., 2003, P511, DOI 10.1016/B978-012741550-5/50014-3; Norici A, 2005, PHOTOSYNTH RES, V86, P409, DOI 10.1007/s11120-005-3250-0; Ochoa-Herrera V, 2009, WATER RES, V43, P3177, DOI 10.1016/j.watres.2009.04.032; PADILLA GM, 1970, J PROTOZOOL, V17, P456, DOI 10.1111/j.1550-7408.1970.tb04714.x; Patino R, 2014, HARMFUL ALGAE, V33, P1, DOI 10.1016/j.hal.2013.12.006; Prioretti L, 2016, J PHYCOL, V52, P1094, DOI 10.1111/jpy.12468; Rashel RH, 2017, HARMFUL ALGAE, V66, P97, DOI 10.1016/j.hal.2017.05.010; Ratti S, 2011, GEOBIOLOGY, V9, P301, DOI 10.1111/j.1472-4669.2011.00284.x; Roelke DL, 2016, HYDROBIOLOGIA, V764, P29, DOI 10.1007/s10750-015-2273-6; Roelke DL, 2012, CAN J FISH AQUAT SCI, V69, P1389, DOI [10.1139/F2012-019, 10.1139/f2012-019]; Srivastava G, 2017, BIORESOURCE TECHNOL, V242, P244, DOI 10.1016/j.biortech.2017.03.175; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Talarski A, 2016, PHYCOLOGIA, V55, P33, DOI 10.2216/15-74.1; VanLandeghem MM, 2015, J AM WATER RESOUR AS, V51, P487, DOI 10.1111/jawr.12261; VanLandeghem MM, 2015, J AM WATER RESOUR AS, V51, P471, DOI 10.1111/jawr.12262; VanLandeghem MM, 2012, WATER RES, V46, P6638, DOI 10.1016/j.watres.2012.05.002; Weiss M, 2001, J PLANT PHYSIOL, V158, P1519, DOI 10.1078/0176-1617-00584; Wood AM, 2005, ALGAL CULTURING TECH, P598; Wu YY, 2007, FLUORIDE, V40, P51; YILDIZ FH, 1994, PLANT PHYSIOL, V104, P981, DOI 10.1104/pp.104.3.981	53	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223266	10.1371/journal.pone.0223266	http://dx.doi.org/10.1371/journal.pone.0223266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560717	Green Published, gold			2022-12-26	WOS:000532353700043
J	Weiss, NM; Dhanasingh, A; Schraven, SP; Schulze, M; Langner, S; Mlynski, R				Weiss, Nora M.; Dhanasingh, Anandhan; Schraven, Sebastian P.; Schulze, Marko; Langner, Soenke; Mlynski, Robert			Surgical approach for complete cochlear coverage in EAS-patients after residual hearing loss	PLOS ONE			English	Article							IMPLANT ELECTRODE ARRAY; FULL INSERTION; PRESERVATION	Introduction In cases with residual-hearing (RH) loss after cochlear implantation, a safe method is needed to provide full spectral resolution and as much auditory information as possible without implant replacement. Aim of this study was to prove the feasibility of accessing a partially inserted cochlear-implant-electrode for complete insertion to its maximum length through the external ear canal using a transcanal approach. Methods Two CI electrodes were customized with 18 stimulating channels. The electrode design enables the use of 12 active channels available for electrical stimulation inside the cochlea both after partial and full insertion. 10 CI electrodes were implanted in 10 fresh human cadaveric temporal bones. After initial partial insertion by posterior tympanotomy, the electrode was inserted to its maximum length via a transcanal approach. Radiographs and CT scans were performed to confirm the electrode position. The electrodes were investigated via x-ray after removal. Results X-ray and CT-scans confirmed the electrode prototypes covering an angular insertion depth between 236 degrees to 307 degrees after initial insertion. Accessing the electrode in the middle ear space was feasible and insertion to its full length was successful. Post-insertion CT confirmed insertion of the 28mm and 31.5mm electrode arrays covering an angular insertion depth between 360 degrees and 540 degrees respectively. No tip foldovers were detected. Conclusion This study confirms the feasibility of extending the electrode insertion to its maximum insertion length using a transcanal approach in temporal bone specimens. This constitutes a second stage procedure on demand in EAS-surgery. This may be beneficial for EAS-patients providing electrical stimulation beyond the basal turn of the cochlea once the functional residual hearing is lost, without replacing the entire CI.	[Weiss, Nora M.; Schraven, Sebastian P.; Mlynski, Robert] Otto Koerner Rostock Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Dhanasingh, Anandhan] MED EL, Innsbruck, Austria; [Schulze, Marko] Rostock Univ, Med Ctr, Inst Anat, Gertrudenstr, Rostock, Germany; [Langner, Soenke] Rostock Univ, Inst Diagnost & Intervent Radiol, Pediat & Neuroradiol, Med Ctr, Rostock, Germany	University of Rostock; University of Rostock	Weiss, NM (corresponding author), Otto Koerner Rostock Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany.	nora-magdalena.weiss@med.uni-rostock.de	Langner, Soenke/ABB-6744-2021	Langner, Soenke/0000-0001-7241-1173; Schulze, Marko/0000-0002-8189-811X; Mlynski, Robert/0000-0001-6404-6364				Buchner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174900; Carlson Matthew L, 2012, Cochlear Implants Int, V13, P148, DOI 10.1179/1754762811Y.0000000003; Dhanasingh A, 2017, HEARING RES, V356, P93, DOI 10.1016/j.heares.2017.10.005; Fitzgerald MB, 2008, OTOL NEUROTOL, V29, P168, DOI 10.1097/mao.0b013e31815c4875; Friedmann David R, 2015, Cochlear Implants Int, V16, P277, DOI 10.1179/1754762815Y.0000000008; Heba I, 2019, P 42 ANN MIDWINTER M; Hiraumi H, 2013, EUR ARCH OTO-RHINO-L, V270, P477, DOI 10.1007/s00405-012-2004-9; Jurawitz MC, 2014, AUDIOL NEURO-OTOL, V19, P293, DOI 10.1159/000360601; Lenarz T., 2017, 15 S COCHL IMPL CHIL; Lenarz T, 2019, OTOL NEUROTOL, V40, pE326, DOI 10.1097/MAO.0000000000002127; Mady LJ, 2017, OTOLARYNG HEAD NECK, V157, P837, DOI 10.1177/0194599817707167; Manrique-Huarte R, 2018, J INT ADV OTOL, V14, P5, DOI 10.5152/iao.2018.5233; Mick P, 2014, OTOL NEUROTOL, V35, pE40, DOI 10.1097/MAO.0b013e318291c66d; Snels C, 2019, OTOL NEUROTOL, V40, P145, DOI 10.1097/MAO.0000000000002083; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Usami SI, 2014, ACTA OTO-LARYNGOL, V134, P717, DOI 10.3109/00016489.2014.894254; Van Abel KM, 2015, OTOL NEUROTOL, V36, P416, DOI 10.1097/MAO.0000000000000703	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223121	10.1371/journal.pone.0223121	http://dx.doi.org/10.1371/journal.pone.0223121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557251	gold, Green Published			2022-12-26	WOS:000532345500075
J	Li, XJ; Ding, JY; Wang, XY; Cheng, ZN; Zhu, QB				Li, Xiaojing; Ding, Junyao; Wang, Xueying; Cheng, Zeneng; Zhu, Qubo			NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma	ONCOGENE			English	Article							CIRCULAR RNA; POLYADENYLATION; IDENTIFICATION	Circular RNAs (circRNAs) are a novel class of RNAs, which involve in many physiological processes and participate in many diseases, especially in cancer. Previous reports showed circRNAs were globally downregulated in hepatocellular carcinoma (HCC) and a lot of circRNAs involved in the tumorigenesis and metastasis of HCC. To understand the underlying mechanism of circRNAs' reduction, we explored the relationship between circRNA biogenesis and NUDT21, which was a RNA splice factor downregulated in HCC, and we found that NUDT21 elevated the formation of circRNA, and the UGUA sequences were critical for the cyclization of circRNA. Knockdown of NUDT21 disrupted the competitive endogenous RNA (ceRNA) pathway of circRNA-miRNA-mRNA, and overexpression of the downregulated circRNA could assist the NUDT21-mediated tumor suppression in HCC cells. In conclusion, the loss of NUDT21 prevented the cyclization of circRNA in HCC; without circRNA absorption, miRNAs were released to suppress the tumor-suppressor genes, leading to the uncontrolled cell proliferation.	[Li, Xiaojing; Ding, Junyao; Wang, Xueying; Cheng, Zeneng; Zhu, Qubo] Cent S Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Hunan, Peoples R China	Central South University	Zhu, QB (corresponding author), Cent S Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Hunan, Peoples R China.	qubozhu@csu.edu.cn	Zhu, Qubo/ACT-7180-2022		National Natural Science Foundation of China [C0709-31201056]; Hunan Provincial Natural Science Foundation of China [2018JJ2493]; Hunan Provincial Innovation Foundation for Postgraduate [CX20190244]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan Provincial Innovation Foundation for Postgraduate	We thank the KangChen Bio-tech (Shanghai, China) for providing RNA sequencing and data analysis and the Molecular Medical Center in the Xiangya Hospital (Changsha, China) for the confocal microscopy. We thank Shifu Luo for data analysis. We also thank Dr Wang for kindly supplying the IRES-drived pCircGFP reporter. This research is supported by the National Natural Science Foundation of China (C0709-31201056), the Hunan Provincial Natural Science Foundation of China (2018JJ2493) and the Hunan Provincial Innovation Foundation for Postgraduate (CX20190244).	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Ding JY, 2019, BIOL CHEM, V400, P247, DOI 10.1515/hsz-2018-0232; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Fu LY, 2017, ONCOTARGET, V8, P58405, DOI 10.18632/oncotarget.16881; Gao B, 2014, BIOMED PHARMACOTHER, V68, P143, DOI 10.1016/j.biopha.2013.09.005; Greene J, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00038; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Kelly S, 2015, J MOL BIOL, V427, P2414, DOI 10.1016/j.jmb.2015.02.018; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Liang DM, 2017, MOL CELL, V68, P940, DOI 10.1016/j.molcel.2017.10.034; Lin XM, 2018, MED SCI MONIT BASIC, V24, P70, DOI 10.12659/MSMBR.909737; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Meng XW, 2017, BIOINFORMATICS, V33, P3314, DOI 10.1093/bioinformatics/btx446; Park HJ, 2018, NAT GENET, V50, P783, DOI 10.1038/s41588-018-0118-8; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Song CL, 2019, J CELL PHYSIOL, V234, P2460, DOI 10.1002/jcp.26764; Sun M, 2017, CANCER LETT, V410, P158, DOI 10.1016/j.canlet.2017.09.026; Tan S, 2018, ONCOGENE, V37, P4887, DOI 10.1038/s41388-018-0280-6; Verheijen BM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00412; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Xu S, 2018, PEERJ, V6, DOI 10.7717/peerj.5503; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yao RZ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00332; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zhang H, 2015, CANCER LETT, V367, P49, DOI 10.1016/j.canlet.2015.07.010; Zhang XW, 2018, ONCOTARGETS THER, V11, P2853, DOI 10.2147/OTT.S158008; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8	38	60	60	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					891	904		10.1038/s41388-019-1030-0	http://dx.doi.org/10.1038/s41388-019-1030-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31570791				2022-12-26	WOS:000509197200011
J	Veschi, V; Mangiapane, LR; Nicotra, A; Di Franco, S; Scavo, E; Apuzzo, T; Sardina, DS; Fiori, M; Benfante, A; Colorito, ML; Cocorullo, G; Giuliante, F; Cipolla, C; Pistone, G; Bongiorno, MR; Rizzo, A; Tate, CM; Wu, XH; Rowlinson, S; Stancato, LF; Todaro, M; De Maria, R; Stassi, G				Veschi, Veronica; Mangiapane, Laura R.; Nicotra, Annalisa; Di Franco, Simone; Scavo, Emanuela; Apuzzo, Tiziana; Sardina, Davide S.; Fiori, Micol; Benfante, Antonina; Colorito, Maria L.; Cocorullo, Gianfranco; Giuliante, Felice; Cipolla, Calogero; Pistone, Giuseppe; Bongiorno, Maria Rita; Rizzo, Aroldo; Tate, Courtney M.; Wu, Xiaohua; Rowlinson, Scott; Stancato, Louis F.; Todaro, Matilde; De Maria, Ruggero; Stassi, Giorgio			Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; CONSENSUS MOLECULAR SUBTYPES; STEM-CELLS; COLON-CANCER; MICROSATELLITE-INSTABILITY; EXPRESSION PATTERNS; JUVENILE POLYPOSIS; TGF-BETA; DIFFERENTIATION	Despite intense research and clinical efforts, patients affected by advanced colorectal cancer (CRC) have still a poor prognosis. The discovery of colorectal (CR) cancer stem cell (CSC) as the cell compartment responsible for tumor initiation and propagation may provide new opportunities for the development of new therapeutic strategies. Given the reduced sensitivity of CR-CSCs to chemotherapy and the ability of bone morphogenetic proteins (BMP) to promote colonic stem cell differentiation, we aimed to investigate whether an enhanced variant of BMP7 (BMP7v) could sensitize to chemotherapy-resistant CRC cells and tumors. Thirty-five primary human cultures enriched in CR-CSCs, including four from chemoresistant metastatic lesions, were used for in vitro studies and to generate CR-CSC-based mouse avatars to evaluate tumor growth and progression upon treatment with BMP7v alone or in combination with standard therapy or PI3K inhibitors. BMP7v treatment promotes CR-CSC differentiation and recapitulates the cell differentiation-related gene expression profile by suppressing Wnt pathway activity and reducing mesenchymal traits and survival of CR-CSCs. Moreover, in CR-CSC-based mouse avatars, BMP7v exerts an antiangiogenic effect and sensitizes tumor cells to standard chemotherapy regardless of the mutational, MSI, and CMS profiles. Of note, tumor harboring PIK3CA mutations were affected to a lower extent by the combination of BMP7v and chemotherapy. However, the addition of a PI3K inhibitor to the BMP7v-based combination potentiates PIK3CA-mutant tumor drug response and reduces the metastatic lesion size. These data suggest that BMP7v treatment may represent a useful antiangiogenic and prodifferentiation agent, which renders CSCs sensitive to both standard and targeted therapies.	[Veschi, Veronica; Mangiapane, Laura R.; Nicotra, Annalisa; Di Franco, Simone; Scavo, Emanuela; Apuzzo, Tiziana; Sardina, Davide S.; Benfante, Antonina; Colorito, Maria L.; Cocorullo, Gianfranco; Cipolla, Calogero; Stassi, Giorgio] Univ Palermo, Dept Surg Oncol & Stomatol Sci DICHIRONS, I-90127 Palermo, Italy; [Fiori, Micol] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [Giuliante, Felice; De Maria, Ruggero] Univ Cattolica Sacro Cuore, Ist Patol Gen, I-00168 Rome, Italy; [Giuliante, Felice; De Maria, Ruggero] Fdn Policlin Univ A Gemelli, IRCCS, I-00168 Rome, Italy; [Pistone, Giuseppe; Bongiorno, Maria Rita; Todaro, Matilde] Univ Palermo, Dept Hlth Promot Sci Internal Med & Med Specialti, I-90127 Palermo, Italy; [Rizzo, Aroldo] Osped Riuniti Villa Sofia Cervello, Pathol Unit, Palermo, Italy; [Tate, Courtney M.; Wu, Xiaohua; Rowlinson, Scott; Stancato, Louis F.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Palermo; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; Eli Lilly	Stassi, G (corresponding author), Univ Palermo, Dept Surg Oncol & Stomatol Sci DICHIRONS, I-90127 Palermo, Italy.; De Maria, R (corresponding author), Univ Cattolica Sacro Cuore, Ist Patol Gen, I-00168 Rome, Italy.; De Maria, R (corresponding author), Fdn Policlin Univ A Gemelli, IRCCS, I-00168 Rome, Italy.	ruggero.demaria@unicatt.it; giorgio.stassi@unipa.it	di franco, simone/M-3714-2019; Sardina, Davide Stefano/AAI-9559-2020; Fiori, Micol Eleonora/J-7295-2016; Veschi, Veronica/K-4143-2018; Stassi, Giorgio/AAC-1175-2022; Fiori, Micol E/J-4043-2014; todaro, matilde/AAC-1003-2022; Cipolla, Calogero/H-2568-2018; Cocorullo, Gianfranco/L-3744-2016	di franco, simone/0000-0002-6217-2161; Sardina, Davide Stefano/0000-0003-1161-3016; Fiori, Micol Eleonora/0000-0002-1813-7035; Veschi, Veronica/0000-0002-6379-7366; Fiori, Micol E/0000-0002-1813-7035; todaro, matilde/0000-0001-8686-8043; Cipolla, Calogero/0000-0003-4396-3563; Giuliante, Felice/0000-0003-2087-2589; Mangiapane, Laura Rosa/0000-0003-4186-0157; Cocorullo, Gianfranco/0000-0003-2660-6724	AIRC [5x1000 (9979)]	AIRC(Fondazione AIRC per la ricerca sul cancro)	We are thankful to Alessandro Gorgone for technical support, Francesco Calo' for graphics and Tatiana Terranova for editing the manuscript. The research leading to these results has received funding from AIRC under 5x1000 (9979) project-P.I. SG and RDM.	Arends JW, 2000, J PATHOL, V190, P412; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005; Brosens LAA, 2011, WORLD J GASTROENTERO, V17, P4839, DOI 10.3748/wjg.v17.i44.4839; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Caja L, 2018, ONCOGENE, V37, P2515, DOI 10.1038/s41388-018-0136-0; CASTAIGNE S, 1990, BLOOD, V76, P1704; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hemminki A, 2000, GASTROENTEROLOGY, V119, P921, DOI 10.1053/gast.2000.18161; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Irshad S, 2017, J PATHOL, V242, P178, DOI 10.1002/path.4891; Jover R, 2006, GUT, V55, P1819, DOI 10.1136/gut.2006.105627; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Laurila R, 2013, INT J CLIN EXP PATHO, V6, P1400; Linnekamp JF, 2018, CELL DEATH DIFFER, V25, P616, DOI 10.1038/s41418-017-0011-5; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcucci F, 2016, NAT REV DRUG DISCOV, V15, P311, DOI 10.1038/nrd.2015.13; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Song N, 2016, JAMA ONCOL, V2, P1162, DOI 10.1001/jamaoncol.2016.2314; Swenckl-Underwood B, 2008, PROTEIN EXPRES PURIF, V57, P312, DOI 10.1016/j.pep.2007.09.016; Tate CM, 2012, CELL DEATH DIFFER, V19, P1644, DOI 10.1038/cdd.2012.44; Tate CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125697; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Zeng YH, 2017, ONCOL REP, V38, P456, DOI 10.3892/or.2017.5662; Zeuner A, 2014, CELL STEM CELL, V15, P692, DOI 10.1016/j.stem.2014.11.012	51	21	22	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					987	1003		10.1038/s41388-019-1047-4	http://dx.doi.org/10.1038/s41388-019-1047-4			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591478	hybrid, Green Published			2022-12-26	WOS:000511209700003
J	Xie, Y; Liu, J; Jiang, HM; Wang, JY; Li, X; Wang, JJ; Zhu, S; Guo, J; Li, T; Zhong, YP; Zhang, QG; Liu, ZQ				Xie, Ying; Liu, Jing; Jiang, Hongmei; Wang, Jingya; Li, Xin; Wang, Jingjing; Zhu, Shuai; Guo, Jing; Li, Tao; Zhong, Yuping; Zhang, Qiguo; Liu, Zhiqiang			Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma	ONCOGENE			English	Article							PHASE-II TRIAL	Multiple myeloma (MM) is still incurable despite the successful application of proteasome inhibitors in clinic. Bortezomib represents the most common chemotherapy for MM, whereas acquired drug resistance and eventually developed relapse remain the major obstruction. In the current study, we established bortezomib-resistant myeloma cell lines and screened gene expression profiles using single cell RNA-sequencing. Resistant MM cells exhibited increased clonogenic potential, specific metabolic, and epigenetic signatures, along with the self-renewal signaling characteristic of MM stem-like cells. Aberrant activation of hedgehog (Hh) signaling was correlated with drug resistance and stem cell-like transcriptional program. The key transcriptional factor GLI2 of the Hh pathway was restricted in the high acetylation and low ubiquitination states in bortezomib-resistant myeloma cells. Further investigation revealed that SIRT1 deacetylates and stabilizes GLI2 protein at lysine 757 and consequentially activates the Hh signaling, and itself serves as a direct target of Hh signaling to format a positive regulating loop. Using combination screening with an epigenetic compound library, we identified the SIRT1 specific inhibitor S1541 and S2804 had very obvious synergetic antimyeloma effect. Sirt1 inhibition could partially impeded the Hh pathway and conferred bortezomib sensitivity in vitro and in vivo. Notably, elevated SIRT1 level was also a prominent hallmark for the resistant myeloma cells, and this expression pattern was confirmed in myeloma patients, but independent of RAS/RAF mutations. Clinically, SIRT1 expression in patients with complete response was suppressed but elevated in relapsed patients, and retrospective analysis showed patients with higher SIRT1 expression had poorer outcomes. In conclusion, the cooperation of SIRT1 and Hh is an important mechanism of drug resistance in myeloma, and therapeutics combining SIRT1 inhibitors will sensitize myeloma cells to proteasome inhibitors.	[Xie, Ying; Liu, Jing; Jiang, Hongmei; Wang, Jingya; Li, Xin; Wang, Jingjing; Zhu, Shuai; Guo, Jing; Liu, Zhiqiang] Tianjin Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China; [Li, Tao] Hunan Normal Univ, Sch Med, Changsha 410006, Hunan, Peoples R China; [Zhong, Yuping] Capital Med Univ, Beijing Chao Yang Hosp, Myeloma Res Ctr Beijing, Dept Hematol, Beijing 100020, Peoples R China; [Zhang, Qiguo] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Hematol, Nanjing 210008, Jiangsu, Peoples R China	Tianjin Medical University; Hunan Normal University; Capital Medical University; Nanjing University	Liu, ZQ (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China.	zhiqiangliu@tmu.edu.cn	wang, jing/GRS-7509-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; WANG, JINGYI/GSJ-1241-2022; Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097; Xie, Ying/0000-0003-1197-3222; Liu, Jing/0000-0002-2112-2416	National Natural Science Foundation of China [81670201, 81870161]; Natural Science Foundation of Tianjin [16JCYBJC42600]; Talent Project of Tianjin Medical University [11601501/2016KJ0317]; Nanjing Key Medical Science and Technology Development Project [ZKX18023]; Chuzhou Science and Technology Development Project [2018zd004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Talent Project of Tianjin Medical University; Nanjing Key Medical Science and Technology Development Project; Chuzhou Science and Technology Development Project	This work was supported by the National Natural Science Foundation of China (81670201, 81870161, ZL), the Natural Science Foundation of Tianjin (16JCYBJC42600, ZL), the Talent Project of Tianjin Medical University (11601501/2016KJ0317, ZL), the Nanjing Key Medical Science and Technology Development Project (ZKX18023, QZ), and the Chuzhou Science and Technology Development Project (2018zd004, QZ).	Amodio N, 2016, MOL CANCER THER, V15, P1364, DOI [10.1158/1535-7163.MCT-15-0985-T, 10.1158/1535-7163.MCT-15-0985]; Armas-Lopez L, 2017, ONCOTARGET, V8, P60684, DOI 10.18632/oncotarget.19527; Avigan D, 2014, NEW ENGL J MED, V371, P961, DOI 10.1056/NEJMe1407442; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Cappellacci L, 2018, CURR MED CHEM, V25, P1; Chauhan D, 2002, BLOOD, V100, P2187, DOI 10.1182/blood-2002-02-0376; Chauhan D, 2011, BRIT J HAEMATOL, V155, P588, DOI 10.1111/j.1365-2141.2011.08888.x; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Delude C, 2011, NATURE, V480, pS43, DOI 10.1038/480S43a; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; Harada T, 2017, LEUKEMIA, V31, P2670, DOI 10.1038/leu.2017.144; Hatayama M, 2012, VITAM HORM, V88, P73, DOI 10.1016/B978-0-12-394622-5.00004-3; Islam S, 2019, ONCOL LETT, V17, P729, DOI 10.3892/ol.2018.9722; Kumar SK, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.46; Laubach JP, 2017, EXPERT REV HEMATOL, V10, P229, DOI 10.1080/17474086.2017.1280388; Li BZ, 2015, J BIOL CHEM, V290, P29854, DOI 10.1074/jbc.M115.664953; Liu H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8949; Liu Z, 2014, ONCOGENE, V33, P65, DOI 10.1038/onc.2012.544; Liu ZQ, 2015, ONCOTARGET, V6, P34329, DOI 10.18632/oncotarget.6020; Liu ZQ, 2014, BLOOD, V124, P2061, DOI 10.1182/blood-2014-03-557298; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Nunes T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124036; Ohguchi H, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0119-y; Ok CY, 2012, AM J PATHOL, V180, P2, DOI 10.1016/j.ajpath.2011.09.009; Robak P, 2018, CANCER TREAT REV, V70, P199, DOI 10.1016/j.ctrv.2018.09.001; Sari IN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110208; Simmons GE, 2015, INT J MOL SCI, V16, P950, DOI 10.3390/ijms16010950; Wallington-Beddoe CT, 2018, BRIT J HAEMATOL, V182, P11, DOI 10.1111/bjh.15210; Wolf JL, 2012, LEUKEMIA LYMPHOMA, V53, P1820, DOI 10.3109/10428194.2012.661175; Yazbeck V, 2018, CL LYMPH MYELOM LEUK, V18, P569, DOI 10.1016/j.clml.2018.05.023; Zaal EA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00500	31	18	20	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					922	934		10.1038/s41388-019-1037-6	http://dx.doi.org/10.1038/s41388-019-1037-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31576013				2022-12-26	WOS:000509197200013
J	Tilstam, PV; Pantouris, G; Corman, M; Andreoli, M; Mahboubi, K; Davis, G; Du, X; Leng, L; Lolis, E; Bucala, R				Tilstam, Pathricia Veronica; Pantouris, Georgios; Corman, Michael; Andreoli, Monica; Mahboubi, Keyvan; Davis, Gary; Du, Xin; Leng, Lin; Lolis, Elias; Bucala, Richard			A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibitor; cytokine; signal transduction; high-throughput screening (HTS); cancer; inflammation; D-dopachrome tautomerase; D-DT; MIF; MIF-2; small-molecule inhibitor	D-DOPACHROME TAUTOMERASE; FACTOR PROMOTER POLYMORPHISMS; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURE; D-DT; GENE POLYMORPHISMS; DISCOVERY; HOMOLOG; TARGET; SEVERITY	Cytokine macrophage migration inhibitory factor-2 (MIF-2 or D-dopachrome tautomerase) is a recently characterized second member of the MIF cytokine superfamily in mammalian genomes. MIF-2 shares pro-inflammatory and tumorigenic properties with the clinical target MIF (MIF-1), but the precise contribution of MIF-2 to immune physiology or pathology is unclear. Like MIF-1, MIF-2 has intrinsic keto-enol tautomerase activity and mediates biological functions by engaging the cognate, common MIF family receptor CD74. Evidence that the catalytic site of MIF family cytokines has a structural role in receptor binding has prompted exploration of tautomerase inhibitors as potential biological antagonists and therapeutic agents, although few catalytic inhibitors inhibit receptor activation. Here we describe the discovery and biochemical characterization of a selective small-molecule inhibitor of MIF-2. An in silico screen of 1.6 million compounds targeting the MIF-2 tautomerase site yielded several hits for potential catalytic inhibitors of MIF-2 and identified 4-(3-carboxyphenyl)-2,5-pyridinedicarboxylic acid (4-CPPC) as the most functionally potent compound. We found that 4-CPPC has an enzymatic IC50 of 27 ?m and 17-fold selectivity for MIF-2 versus MIF-1. An in vitro binding assay for MIF-1/MIF-2 to the CD74 ectodomain (sCD74) indicated that 4-CPPC inhibits MIF-2?CD74 binding in a dose-dependent manner (0.01?10 ?m) without influencing MIF-1?CD74 binding. Notably, 4-CPPC inhibited MIF-2?mediated activation of CD74 and reduced CD74-dependent signal transduction. These results open opportunities for development of more potent and pharmacologically auspicious MIF-2 inhibitors to investigate the distinct functions of this MIF family member in vivo.	[Tilstam, Pathricia Veronica; Du, Xin; Leng, Lin; Bucala, Richard] Yale Sch Med, Dept Med, New Haven, CT 06510 USA; [Pantouris, Georgios; Lolis, Elias] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lolis, Elias; Bucala, Richard] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Corman, Michael; Andreoli, Monica; Mahboubi, Keyvan; Davis, Gary] Inst Pharmaceut Discovery LLC, Branford, CT 06405 USA	Yale University; Yale University; Yale University	Bucala, R (corresponding author), Yale Univ, Dept Med, Sch Med, POB 208031,300 Cedar St, New Haven, CT 06520 USA.	richard.bucala@yale.edu	Pantouris, Georgios/CAH-4690-2022	Pantouris, Georgios/0000-0001-5547-1406; Lolis, Elias/0000-0002-7902-7868; Leng, Lin/0000-0002-0605-358X	Arthritis Foundation Award [548970]; National Institutes of Health Grants [AR049610, HL130669, AI065029, AI082295]; Robert E. Leet and Clara Guthrie Patterson Trust Fellowship Program in Clinical Research, Bank of America, N.A.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Arthritis Foundation Award; National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert E. Leet and Clara Guthrie Patterson Trust Fellowship Program in Clinical Research, Bank of America, N.A.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Arthritis Foundation Award 548970 (to P. V. T.); National Institutes of Health Grants AR049610 and HL130669 (to R. B.) and AI065029 and AI082295 (to E. L.), and the Robert E. Leet and Clara Guthrie Patterson Trust Fellowship Program in Clinical Research, Bank of America, N.A., Trustee (to G. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Awandare GA, 2009, J INFECT DIS, V200, P629, DOI 10.1086/600894; Bai FW, 2012, J BIOL CHEM, V287, P30653, DOI 10.1074/jbc.M112.385583; Benedek G, 2017, P NATL ACAD SCI USA, V114, pE8421, DOI 10.1073/pnas.1712288114; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Bucala R, 2013, J CLIN IMMUNOL, V33, pS72, DOI 10.1007/s10875-012-9781-1; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Cho Y, 2011, CHEM BIOL, V18, P1089, DOI 10.1016/j.chembiol.2011.07.011; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crisman TJ, 2008, J CHEM INF MODEL, V48, P1955, DOI 10.1021/ci800229q; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Fox RJ, 2018, NEW ENGL J MED, V379, P846, DOI 10.1056/NEJMoa1803583; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Hare AA, 2010, BIOORG MED CHEM LETT, V20, P5811, DOI 10.1016/j.bmcl.2010.07.129; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kim BS, 2017, J CELL MOL MED, V21, P35, DOI 10.1111/jcmm.12936; Kobold S, 2014, ONCOTARGET, V5, P103, DOI 10.18632/oncotarget.1560; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mawhinney L, 2014, MOL MED, V20, P729, DOI 10.2119/molmed.2014.00136; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Meza-Romero R, 2016, CYTOKINE, V88, P62, DOI 10.1016/j.cyto.2016.08.024; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Pantouris G, 2018, BIOCHEMISTRY-US, V57, P3599, DOI 10.1021/acs.biochem.8b00344; Pantouris G, 2018, ANGEW CHEM INT EDIT, V57, P7116, DOI 10.1002/anie.201803191; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Poulsen KL, 2019, ALCOHOL CLIN EXP RES, V43, P1439, DOI 10.1111/acer.14065; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sauler M, 2015, FASEB J, V29, P1940, DOI 10.1096/fj.14-260299; Schr?dinger, 2017, SCHRODINGER RELEASE; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Soares TA, 2000, J MOL RECOGNIT, V13, P146, DOI 10.1002/1099-1352(200005/06)13:3<146::AID-JMR497>3.0.CO;2-4; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Wu SP, 2006, ARTHRITIS RHEUM-US, V54, P3661, DOI 10.1002/art.22179; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113	61	8	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18522	18531		10.1074/jbc.RA119.009860	http://dx.doi.org/10.1074/jbc.RA119.009860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31578280	hybrid, Green Published			2022-12-26	WOS:000507618800001
J	Mewes, M; Lenders, M; Stappers, F; Scharnetzki, D; Nedele, J; Fels, J; Wedlich-Soldner, R; Brand, SM; Schmitz, B; Brand, E				Mewes, Mirja; Lenders, Malte; Stappers, Franciska; Scharnetzki, David; Nedele, Johanna; Fels, Johannes; Wedlich-Soeldner, Roland; Brand, Stefan-Martin; Schmitz, Boris; Brand, Eva			Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium	FASEB JOURNAL			English	Article						IP3R; endoplasmic reticulum; vasoconstriction; protein kinase A; actin	SMOOTH-MUSCLE; CA2+; ACTIVATION; PERMEABILITY; DEFINES; IP3	The vascular endothelium acts as a selective barrier between the bloodstream and extravascular tissues. Intracellular [Ca2+](i) signaling is essential for vasoactive agonist induced stimulation of endothelial cells (ECs), typically including Ca2+ release from the endoplasmic reticulum (ER). Although it is known that interactions of Ca2+ and cAMP as ubiquitous messengers are involved in this process, the individual contribution of cAMP-generating adenylyl cyclases (ACs), including the only soluble AC (sAC; ADCY10), remains less clear. Using life-cell microscopy and plate reader based [Ca2+](i) measurements, we found that human immortalized ECs, primary aortic and cardiac microvascular ECs, and primary vascular smooth muscle cells treated with sAC-specific inhibitor KH7 or anti-sAC-small interfering RNA did not show endogenous or exogenous ATP-induced [Ca2+](i) elevation. Of note, a transmembrane AC (tmAC) inhibitor did not prevent ATP-induced [Ca2+](i) elevation in ECs. Moreover, L-phenylephrine dependent constriction of ex vivo mouse aortic ring segments was also reduced by KH7. Analysis of the inositol-1,4,5-trisphosphate (IP3) pathway revealed reduced IP3 receptor phosphorylation after KH7 application, which also prevented [Ca2+](i) elevation induced by IP3 receptor agonist adenophostin A. Our results suggest that sAC rather than tmAC controls the agonist-induced ER-dependent Ca2+ response in ECs and may represent a treatment target in arterial hypertension and heart failure.	[Mewes, Mirja; Lenders, Malte; Stappers, Franciska; Scharnetzki, David; Nedele, Johanna; Brand, Eva] Univ Hosp Muenster, Internal Med D, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Brand, Stefan-Martin; Schmitz, Boris] Univ Hosp Muenster, Inst Sports Med Mol Genet Cardiovasc Dis, Horstmarer Landweg 39, D-48149 Munster, Germany; [Fels, Johannes; Wedlich-Soeldner, Roland] Univ Munster, Fac Med, Inst Cell Dynam & Imaging, Munster, Germany; [Fels, Johannes] Univ Witten Herdecke, Dept Physiol Pathophysiol & Toxicol, Witten, Germany; [Fels, Johannes] Univ Witten Herdecke, Ctr Biomed Educ & Res ZBAF, Witten, Germany	University of Munster; University of Munster; University of Munster; Witten Herdecke University; Witten Herdecke University	Schmitz, B (corresponding author), Univ Hosp Muenster, Inst Sports Med Mol Genet Cardiovasc Dis, Horstmarer Landweg 39, D-48149 Munster, Germany.	boris.schmitz@ukmuenster.de	Schmitz, Boris/M-3205-2019	Schmitz, Boris/0000-0001-7041-7424	German Research Foundation via the Collaborative Research Centre 1009; Interdisciplinary Centre for Clinical Research (IZKF) Munster [Wed2/022/18]; German Research Foundation via the Cluster of Excellence 1003-Cells in Motion (CiM)	German Research Foundation via the Collaborative Research Centre 1009; Interdisciplinary Centre for Clinical Research (IZKF) Munster; German Research Foundation via the Cluster of Excellence 1003-Cells in Motion (CiM)	The authors thank Samira Schiwek and Birgit Orlowski (both from University Hospital Muenster) for excellent technical assistance. R.W.-S. and J.F. were supported by the German Research Foundation via the Collaborative Research Centre 1009 and the Cluster of Excellence 1003-Cells in Motion (CiM), and by the Interdisciplinary Centre for Clinical Research (IZKF) Munster (Wed2/022/18). The authors declare no conflicts of interest.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Boulanger CM, 2016, ARTERIOSCL THROM VAS, V36, pE26, DOI 10.1161/ATVBAHA.116.306940; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; CABLE HC, 1995, BIOCHEM J, V307, P169, DOI 10.1042/bj3070169; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Denelavas A, 2011, BBA-MOL CELL RES, V1813, P754, DOI 10.1016/j.bbamcr.2011.01.016; Dermitzaki E, 2001, ENDOCRINOLOGY, V142, P2022, DOI 10.1210/en.142.5.2022; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; HALLAM TJ, 1986, FEBS LETT, V207, P95, DOI 10.1016/0014-5793(86)80019-9; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hobi N, 2012, AM J PHYSIOL-LUNG C, V303, pL117, DOI 10.1152/ajplung.00340.2011; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Jackson WF, 2008, BRIT J PHARMACOL, V155, P514, DOI 10.1038/bjp.2008.276; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Kuszak A. J., 2010, HDB CELL SIGNALING, P1389; Lu XA, 2011, AM J PHYSIOL-HEART C, V300, pH94, DOI 10.1152/ajpheart.00708.2010; Mewes M, 2017, PFLUG ARCH EUR J PHY, V469, P1401, DOI 10.1007/s00424-017-1999-6; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Raabe I, 2009, J MICROSC-OXFORD, V234, P1, DOI 10.1111/j.1365-2818.2009.03142.x; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Saleem H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058027; Schmitz B, 2014, BBA-MOL BASIS DIS, V1842, P2601, DOI 10.1016/j.bbadis.2014.05.036; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor CW, 2017, CELL CALCIUM, V63, P48, DOI 10.1016/j.ceca.2016.10.005; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Valsecchi F, 2017, J CELL SCI, V130, P3713, DOI 10.1242/jcs.206318; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Viana F, 1998, CELL CALCIUM, V24, P117, DOI 10.1016/S0143-4160(98)90079-3; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wang LW, 2002, J CARDIOVASC PHARM, V40, P841, DOI 10.1097/00005344-200212000-00005; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Zhang AY, 2006, J CELL MOL MED, V10, P407, DOI 10.1111/j.1582-4934.2006.tb00408.x; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2010, J INVEST DERMATOL, V130, P1279, DOI 10.1038/jid.2009.440	49	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13762	13774		10.1096/fj.201900724R	http://dx.doi.org/10.1096/fj.201900724R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585052	Bronze			2022-12-26	WOS:000507466100056
J	Hoang, NH; Strogolova, V; Mosley, JJ; Stuart, RA; Hosler, J				Hoang, Ngoc H.; Strogolova, Vera; Mosley, Jaramys J.; Stuart, Rosemary A.; Hosler, Jonathan			Hypoxia-inducible gene domain 1 proteins in yeast mitochondria protect against proton leak through complex IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial membrane potential; mitochondria; respiration; cytochrome c oxidase (complex IV); lipid-protein interaction; hypoxia-inducible gene domain 1 (HIGD1); oxidative phosphorylation; proton leak; Rcf; suicide inactivation	CYTOCHROME-C-OXIDASE; SUBUNIT-III; SUICIDE INACTIVATION; ENERGY TRANSDUCTION; BC(1) COMPLEX; EXIT PATHWAY; Q-CYCLE; RCF1; MECHANISM; MODULATION	Hypoxia-inducible gene domain 1 (HIGD1) proteins are small integral membrane proteins, conserved from bacteria to humans, that associate with oxidative phosphorylation supercomplexes. Using yeast as a model organism, we have shown previously that its two HIGD1 proteins, Rcf1 and Rcf2, are required for the generation and maintenance of a normal membrane potential (Delta Psi) across the inner mitochondrial membrane (IMM). We postulated that the lower Delta Psi observed in the absence of the HIGD1 proteins may be due to decreased proton pumping by complex IV (CIV) or enhanced leak of protons across the IMM. Here we measured the Delta Psi generated by complex III (CIII) to discriminate between these possibilities. First, we found that the decreased Delta Psi observed in the absence of the HIGD1 proteins cannot be due to decreased proton pumping by CIV because CIII, operating alone, also exhibited a decreased Delta Psi when HIGD1 proteins were absent. Because CIII can neither lower its pumping stoichiometry nor transfer protons completely across the IMM, this result indicates that HIGD1 protein ablation enhances proton leak across the IMM. Second, we demonstrate that this proton leak occurs through CIV because Delta Psi generation by CIII is restored when CIV is removed from the cell. Third, the proton leak appeared to take place through an inactive population of CIV that accumulates when HIGD1 proteins are absent. We conclude that HIGD1 proteins in yeast prevent CIV inactivation, likely by preventing the loss of lipids bound within the Cox3 protein of CIV.	[Hoang, Ngoc H.; Mosley, Jaramys J.; Hosler, Jonathan] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA; [Strogolova, Vera; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	University of Mississippi; University of Mississippi Medical Center; Marquette University	Hosler, J (corresponding author), Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA.	jhosler@umc.edu		Stuart, Rosemary/0000-0002-9751-5494	NIGMS, National Institutes of Health [P20GM121334, R15GM101594, R15GM117551]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121334, R15GM117551] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health Grants P20GM121334 (to J. H.) and R15GM101594 and R15GM117551 (to R. A. S). The authors declare that they have no conflicts of interest with the contents of this article.	Bratton MR, 1999, BIOCHEMISTRY-US, V38, P16236, DOI 10.1021/bi9914107; Brzezinski P, 2010, BBA-BIOENERGETICS, V1797, P710, DOI 10.1016/j.bbabio.2010.02.020; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1044, DOI 10.1016/j.bbabio.2008.04.008; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Ferguson-Miller S., 2018, MECH PRIMARY ENERGY, P215; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Garlich J, 2017, J BIOL CHEM, V292, P5216, DOI 10.1074/jbc.M116.758045; HALTIA T, 1994, BIOCHEMISTRY-US, V33, P9731, DOI 10.1021/bi00198a044; Hartley AM, 2019, NAT STRUCT MOL BIOL, V26, P78, DOI 10.1038/s41594-018-0172-z; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Hosler JP, 2004, BBA-BIOENERGETICS, V1655, P332, DOI 10.1016/j.bbabio.2003.06.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Li T, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6051262; Liang RB, 2016, P NATL ACAD SCI USA, V113, P7420, DOI 10.1073/pnas.1601982113; Lundin CR, 2017, FEBS LETT, V591, P4049, DOI 10.1002/1873-3468.12918; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; Mills DA, 2005, BIOCHEMISTRY-US, V44, P4656, DOI 10.1021/bi0475774; Mills DA, 2003, BIOCHEMISTRY-US, V42, P7410, DOI 10.1021/bi0341307; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Nguyen XT, 2002, PROTEIN EXPRES PURIF, V26, P122, DOI 10.1016/S1046-5928(02)00503-X; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Rathore S, 2019, NAT STRUCT MOL BIOL, V26, P50, DOI 10.1038/s41594-018-0169-7; Rompler K, 2016, J BIOL CHEM, V291, P23769, DOI 10.1074/jbc.M116.734665; SARTI P, 1985, P NATL ACAD SCI USA, V82, P4876, DOI 10.1073/pnas.82.15.4876; Schafer J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29567-4; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strogolova V, 2019, J BIOL CHEM, V294, P4867, DOI 10.1074/jbc.RA118.006888; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Thompson AK, 2010, BIOCHEMISTRY-US, V49, P5651, DOI 10.1021/bi1003876; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1986, J BIOL CHEM, V261, P7163; Varanasi L, 2006, BIOCHEMISTRY-US, V45, P14896, DOI 10.1021/bi061390q; Varanasi L, 2012, BBA-BIOENERGETICS, V1817, P545, DOI 10.1016/j.bbabio.2011.10.001; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Zhou S, 2018, P NATL ACAD SCI USA, V115, P3048, DOI 10.1073/pnas.1712061115	44	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17669	17677		10.1074/jbc.RA119.010317	http://dx.doi.org/10.1074/jbc.RA119.010317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31591265	Green Published, hybrid			2022-12-26	WOS:000503173500039
J	Nosrati, M; Dey, D; Mehrani, A; Strassler, SE; Zelinskaya, N; Hoffer, ED; Stagg, SM; Dunham, CM; Conn, GL				Nosrati, Meisam; Dey, Debayan; Mehrani, Atousa; Strassler, Sarah E.; Zelinskaya, Natalia; Hoffer, Eric D.; Stagg, Scott M.; Dunham, Christine M.; Conn, Graeme L.			Functionally critical residues in the aminoglycoside resistance-associated methyltransferase RmtC play distinct roles in 30S substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); ribosome; RNA methylation; RNA methyltransferase; aminoglycoside antibiotics; m1A1408; m7G1405; RmtC	16S RIBOSOMAL-RNA; M(1)A1408 METHYLTRANSFERASE; CATALYTIC-ACTIVITY; STRUCTURAL BASIS; ANTIBIOTICS; METHYLATION; ENTEROBACTERIACEAE; CONTRIBUTES; SELECTIVITY; MECHANISMS	Methylation of the small ribosome subunit rRNA in the ribosomal decoding center results in exceptionally high-level aminoglycoside resistance in bacteria. Enzymes that methylate 16S rRNA on N7 of nucleotide G1405 (m(7)G1405) have been identified in both aminoglycoside-producing and clinically drug-resistant pathogenic bacteria. Using a fluorescence polarization 30S-binding assay and a new crystal structure of the methyltransferase RmtC at 3.14 angstrom resolution, here we report a structure-guided functional study of 30S substrate recognition by the aminoglycoside resistance-associated 16S rRNA (m(7)G1405) methyltransferases. We found that the binding site for these enzymes in the 30S subunit directly overlaps with that of a second family of aminoglycoside resistance-associated 16S rRNA (m(1)A1408) methyltransferases, suggesting that both groups of enzymes may exploit the same conserved rRNA tertiary surface for docking to the 30S. Within RmtC, we defined an N-terminal domain surface, comprising basic residues from both the N1 and N2 subdomains, that directly contributes to 30S-binding affinity. In contrast, additional residues lining a contiguous adjacent surface on the C-terminal domain were critical for 16S rRNA modification but did not directly contribute to the binding affinity. The results from our experiments define the critical features of m(7)G1405 methyltransferase-substrate recognition and distinguish at least two distinct, functionally critical contributions of the tested enzyme residues: 30S-binding affinity and stabilizing a binding-induced 16S rRNA conformation necessary for G1405 modification. Our study sets the scene for future high-resolution structural studies of the 30S-methyltransferase complex and for potential exploitation of unique aspects of substrate recognition in future therapeutic strategies.	[Nosrati, Meisam; Dey, Debayan; Strassler, Sarah E.; Zelinskaya, Natalia; Hoffer, Eric D.; Dunham, Christine M.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA; [Mehrani, Atousa; Stagg, Scott M.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	Emory University; State University System of Florida; Florida State University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Dey, Debayan/AAI-9790-2020; Stagg, Scott/AAW-9294-2020	Stagg, Scott/0000-0001-8855-4152; Conn, Graeme/0000-0002-2419-380X; Strassler, Sarah/0000-0001-7555-9608; Dey, Debayan/0000-0002-0222-6092; Mehrani, Atousa/0000-0001-5239-955X	National Institutes of Health [S10 RR25528, S10 RR028976]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Conn and Dunham labs at Emory University for helpful discussions throughout the course of this work. The Southeast Regional Collaborative Access Team is supported by its member institutions and Equipment Grants S10 RR25528 and S10 RR028976 from the National Institutes of Health. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggen JB, 2010, ANTIMICROB AGENTS CH, V54, P4636, DOI 10.1128/AAC.00572-10; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Correa LL, 2016, ANTIMICROB AGENTS CH, V60, P699, DOI 10.1128/AAC.02482-15; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Doi Y, 2016, INFECT DIS CLIN N AM, V30, P523, DOI 10.1016/j.idc.2016.02.011; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garneau-Tsodikova S, 2016, MEDCHEMCOMM, V7, P11, DOI 10.1039/c5md00344j; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Hall T., 2011, GERF B BIOSCI, V2, P60; Husain N, 2011, NUCLEIC ACIDS RES, V39, P1903, DOI 10.1093/nar/gkq1033; Husain N, 2010, NUCLEIC ACIDS RES, V38, P4120, DOI 10.1093/nar/gkq122; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin JZ, 2018, ANNU REV BIOCHEM, V87, P451, DOI 10.1146/annurev-biochem-062917-011942; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Long HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37125-1; Macmaster R, 2010, NUCLEIC ACIDS RES, V38, P7791, DOI 10.1093/nar/gkq627; Matsushita T, 2019, J AM CHEM SOC, V141, P5051, DOI 10.1021/jacs.9b01693; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rahman M, 2014, INT J ANTIMICROB AG, V44, P30, DOI 10.1016/j.ijantimicag.2014.03.003; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08; Savic M, 2015, ANTIMICROB AGENTS CH, V59, P2807, DOI 10.1128/AAC.00056-15; Schmitt E, 2009, J MOL BIOL, V388, P570, DOI 10.1016/j.jmb.2009.03.034; Sonousi A, 2018, ACS INFECT DIS, V4, P1114, DOI 10.1021/acsinfecdis.8b00052; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Takahashi Y, 2018, J ANTIBIOT, V71, P4, DOI 10.1038/ja.2017.117; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vinal K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00077-17; Vlahovicek GM, 2008, BBA-PROTEINS PROTEOM, V1784, P582, DOI 10.1016/j.bbapap.2007.09.009; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wachino JI, 2007, ANTIMICROB AGENTS CH, V51, P4401, DOI 10.1128/AAC.00926-07; Wachino J, 2012, DRUG RESIST UPDATE, V15, P133, DOI 10.1016/j.drup.2012.05.001; Wang CY, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700195; Witek MA, 2017, J BIOL CHEM, V292, P1977, DOI 10.1074/jbc.M116.752659; Witek MA, 2016, NUCLEIC ACIDS RES, V44, P342, DOI 10.1093/nar/gkv1306; Witek MA, 2014, BBA-PROTEINS PROTEOM, V1844, P1648, DOI 10.1016/j.bbapap.2014.06.012; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	49	22	23	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17642	17653		10.1074/jbc.RA119.011181	http://dx.doi.org/10.1074/jbc.RA119.011181			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31594862	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000503173500037
J	Nystrom, EEL; Arike, L; Ehrencrona, E; Hansson, GC; Johansson, MEV				Nystrom, Elisabeth E. L.; Arike, Liisa; Ehrencrona, Erik; Hansson, Gunnar C.; Johansson, Malin E., V			Calcium-activated chloride channel regulator 1 (CLCA1) forms non-covalent oligomers in colonic mucus and has mucin 2?processing properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; intestine; colitis; protease; metalloprotease; gastrointestinal tract; Gob-5; mouse Clca3; mucin-2 (MUC2); von Willebrand type D domain (VWD)	O-GLYCOSYLATION; MCLCA3 PROTEIN; FAMILY; IDENTIFICATION; CLEAVAGE; DOMAIN; METALLOPROTEASE; TERMINUS; BIOPSIES; RELEASE	Calcium-activated chloride channel regulator 1 (CLCA1) is one of the major nonmucin proteins found in intestinal mucus. It is part of a larger family of CLCA proteins that share highly conserved features and domain architectures. The CLCA domain arrangement is similar to proteins belonging to the ADAM (a disintegrin and metalloproteinase) family, known to process extracellular matrix proteins. Therefore, CLCA1 is an interesting candidate in the search for proteases that process intestinal mucus. Here, we investigated CLCA1's biochemical properties both in vitro and in mucus from mouse and human colon biopsy samples. Using immunoblotting with CLCA1-specific antibodies and recombinant proteins, we observed that the CLCA1 C-terminal self-cleavage product forms a disulfide-linked dimer that noncovalently interacts with the N-terminal part of CLCA1, which further interacts to form oligomers. We also characterized a second, more catalytically active, N-terminal product of CLCA1, encompassing the catalytic domain together with its von Willebrand domain type A (VWA). This fragment was unstable but could be identified in freshly prepared mucus. Furthermore, we found that CLCA1 can cleave the N-terminal part of the mucus structural component MUC2. We propose that CLCA1 regulates the structural arrangement of the mucus and thereby takes part in the regulation of mucus processing.	[Nystrom, Elisabeth E. L.; Arike, Liisa; Ehrencrona, Erik; Hansson, Gunnar C.; Johansson, Malin E., V] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden	University of Gothenburg	Johansson, MEV (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Johansson, Malin E. V./HCH-7451-2022; Arike, Liisa/AAF-7698-2020	Hansson, Gunnar C/0000-0002-1900-1869; Arike, Liisa/0000-0002-2184-0960; Nystrom, Elisabeth/0000-0002-6970-7894; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Swedish Cancer Foundation; Hasselblad Foundation; Knut and Alice Wallenberg Foundation; National Institutes of Health (NIAID) [U01AI095473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Hasselblad Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council, Swedish Cancer Foundation, Hasselblad Foundation, Knut and Alice Wallenberg Foundation, and National Institutes of Health (NIAID) Grant U01AI095473. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Lisle RC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009753; Deng JJ, 2015, METHODS MOL BIOL, V1295, P249, DOI 10.1007/978-1-4939-2550-6_19; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; Erickson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131991; Fernandez-Blanco JA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120994; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Goettig P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121969; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Issa SMA, 2011, ELECTROPHORESIS, V32, P3554, DOI 10.1002/elps.201100374; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Mundhenk L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191512; Nilsson HE, 2014, J MOL BIOL, V426, P2567, DOI 10.1016/j.jmb.2014.04.027; Nystrom EEL, 2018, EBIOMEDICINE, V33, P134, DOI 10.1016/j.ebiom.2018.05.031; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Sala-Rabanal M, 2017, J BIOL CHEM, V292, P9164, DOI 10.1074/jbc.M117.788232; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Schroeder BO, 2018, CELL HOST MICROBE, V23, P27, DOI 10.1016/j.chom.2017.11.004; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	43	15	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17075	17089		10.1074/jbc.RA119.009940	http://dx.doi.org/10.1074/jbc.RA119.009940			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31570526	Green Published, hybrid			2022-12-26	WOS:000501801900048
J	Mathais, Q; Montcriol, A; Cotte, J; Gil, C; Contargyris, C; Lacroix, G; Prunet, B; Bordes, J; Meaudre, E				Mathais, Quentin; Montcriol, Ambroise; Cotte, Jean; Gil, Celine; Contargyris, Claire; Lacroix, Guillaume; Prunet, Bertrand; Bordes, Julien; Meaudre, Eric			Anesthesia during deployment of a military forward surgical unit in low income countries: A register study of 1547 anesthesia cases	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; US-MARINE-CORPS; REGIONAL ANESTHESIA; HUMANITARIAN; CARE; OPERATION; CASUALTIES; LESSONS; TEAM; AFGHANISTAN	Background Military anesthesia meets unique logistical, technical, tactical, and human constraints, but to date limited data have been published on anesthesia management during military operations. Objective This study aimed to describe and analyze French anesthetic activity in a deployed military setting. Methods Between October 2015 and February 2018, all patients managed by Sainte-Anne Military Hospital anesthesiologists deployed in mission were included. Anesthesia management was described and compared with the same surgical procedures in France performed by the same anesthesia team (hernia repair, lower and upper limb surgeries). Demographics, type of surgical procedure, and surgical activity were also described. The primary endpoint was to describe anesthesia management during the deployment of forward surgical teams (FST). The secondary endpoint was to compare anesthesia modalities during FST deployment with those usually used in a military teaching hospital. Results During the study period, 1547 instances of anesthesia were performed by 11 anesthesiologists during 20 missions, totaling 1237 days of deployment in nine different theaters. The majority consisted of regional anesthesia, alone (43.5%) or associated with general anesthesia (21%). Compared with France, there was a statistically significant increase in the use of regional anesthesia in hernia repair, lower and upper limb surgeries during deployment. The majority of patients were civilians as part of medical support to populations. Conclusion In the context of an austere environment, the use of regional anesthesia techniques pre-dominated when possible. These results show that the training of military anesthetists must be complete, including anesthesia, intensive care, pediatrics, and regional anesthesia.	[Mathais, Quentin; Montcriol, Ambroise; Cotte, Jean; Gil, Celine; Contargyris, Claire; Lacroix, Guillaume; Bordes, Julien; Meaudre, Eric] Mil Hosp St Anne, Dept Anesthesiol & Intens Care, Toulon, France; [Prunet, Bertrand] Serv Med Brigade Sapeurs Pompiers Paris, Paris, France; [Prunet, Bertrand; Bordes, Julien; Meaudre, Eric] Ecole Val De Grace, French Mil Hlth Serv Acad Unit, Paris, France		Mathais, Q (corresponding author), Mil Hosp St Anne, Dept Anesthesiol & Intens Care, Toulon, France.	quentin.mathais@orange.fr						Agazio J, 2010, INT J NURS PRACT, V16, P166, DOI 10.1111/j.1440-172X.2010.01826.x; Ariyo P, 2016, ANESTHESIOLOGY, V124, P561, DOI 10.1097/ALN.0000000000000985; Bansal T, 2013, JIMSA, V26, P127; Barbier O, 2017, MIL MED, V182, pE1756, DOI 10.7205/MILMED-D-16-00121; Bilski TR, 2003, J TRAUMA, V54, P814, DOI 10.1097/01.TA.0000046627.87250.1D; Bonnet S, 2015, MIL MED, V180, P1075, DOI 10.7205/MILMED-D-14-00688; Bourgouin S, 2017, HERNIA, V21, P749, DOI 10.1007/s10029-017-1631-x; Brethauer SA, 2008, ARCH SURG-CHICAGO, V143, P564, DOI 10.1001/archsurg.143.6.564; Buckenmaier CC, 2003, REGION ANESTH PAIN M, V28, P321, DOI 10.1016/S1098-7339(03)00198-6; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Chmatal P, 2005, MIL MED, V170, P473, DOI 10.7205/MILMED.170.6.473; Cozowicz C, 2016, REGION ANESTH PAIN M, V41, P43, DOI 10.1097/AAP.0000000000000342; d'Aranda Erwan, 2016, J Spec Oper Med, V16, P30, DOI 10.55460/CD5C-3NPJ; De Oliveira GS, 2014, ANESTH ANALG, V118, P454, DOI 10.1213/ANE.0000000000000066; Debas HT, 2015, ESSENTIAL SURG, V1; Donat N, 2017, ANESTH REANIM, V3, P440, DOI 10.1016/j.anrea.2017.06.006; Drifmeyer J, 2004, MIL MED, V169, P23, DOI 10.7205/MILMED.169.1.23; Forrester JD, 2017, SURGERY, V162, P366, DOI 10.1016/j.surg.2017.03.001; French Military Doctrine:, 2014, MED SUPP OP DIA 4 0; French Military Doctrine, 2009, MED AID POP DIA3 10; Gordon S, 2014, SOC SCI MED, V120, P421, DOI 10.1016/j.socscimed.2014.04.025; Gyedu A, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0308-4; Jenkins CL, 2006, MIL MED, V171, P762, DOI 10.7205/MILMED.171.8.762; Kelly J, 2015, J ROY ARMY MED CORPS, V161, P10, DOI 10.1136/jramc-2015-000545; Koscielniak-Nielsen ZJ, 2008, ACTA ANAESTH SCAND, V52, P727, DOI 10.1111/j.1399-6576.2008.01666.x; Lagrew J, 2012, MIL MED, V177, P939, DOI 10.7205/MILMED-D-12-00044; Le TD, 2018, JAMA SURG, V153, P800, DOI 10.1001/jamasurg.2018.1166; Malgras B, 2015, MIL MED, V180, P533, DOI 10.7205/MILMED-D-14-00212; Mercer SJ, 2010, BRIT J ANAESTH, V105, P9, DOI 10.1093/bja/aeq110; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Moss NE, 2002, SOC SCI MED, V54, P649, DOI 10.1016/S0277-9536(01)00115-0; NATO, 1997, NATO LOG HDB; Raju M S V K, 2014, Ind Psychiatry J, V23, P149, DOI 10.4103/0972-6748.151693; Ramasamy A, 2009, INJURY, V40, P493, DOI 10.1016/j.injury.2008.03.028; Reade MC, 2000, MED J AUSTRALIA, V173, P586, DOI 10.5694/j.1326-5377.2000.tb139350.x; Tobin J, 2005, J MED ETHICS, V31, P571, DOI 10.1136/jme.2004.008839; Trelles M, 2016, SURGERY, V160, P1414, DOI 10.1016/j.surg.2016.05.024; VLASSOFF C, 1994, SOC SCI MED, V39, P1249, DOI 10.1016/0277-9536(94)90357-3; Walker KJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006459.pub2; White RL, 2007, ANESTHESIOLOGY, V107, P1003, DOI 10.1097/01.anes.0000290605.55736.e1; Wilder A, 2010, DISASTERS, V34, pS406, DOI 10.1111/j.1467-7717.2010.01209.x; Wilensky Robert J., 2004, MILITARY MED WIN HEA; Woll M, 2013, MIL MED, V178, P385, DOI 10.7205/MILMED-D-12-00411; Wong EG, 2014, SURGERY, V156, P642, DOI 10.1016/j.surg.2014.02.002; World Health Organization, 2013, WHO MOD LIST ESS MED	46	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223497	10.1371/journal.pone.0223497	http://dx.doi.org/10.1371/journal.pone.0223497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584991	gold, Green Published			2022-12-26	WOS:000532407600042
J	Tirado, C; Lunden, P; Nilsson, ME				Tirado, Carlos; Lunden, Peter; Nilsson, Mats E.			The Echobot: An automated system for stimulus presentation in studies of human echolocation	PLOS ONE			English	Article							BLIND; LOCALIZATION; PERCEPTION; DISTANCE; ABILITY; VISION	Echolocation is the detection and localization of objects by listening to the sounds they reflect. Early studies of human echolocation used real objects that the experimental leader positioned manually before each experimental trial. The advantage of this procedure is the use of realistic stimuli; the disadvantage is that manually shifting stimuli between trials is very time consuming making it difficult to use psychophysical methods based on the presentation of hundreds of stimuli. The present study tested a new automated system for stimulus presentation, the Echobot, that overcomes this disadvantage. We tested 15 sighted participants with no prior experience of echolocation on their ability to detect the reflection of a loudspeaker-generated click from a 50 cm circular aluminum disk. The results showed that most participants were able to detect the sound reflections. Performance varied considerably, however, with mean individual thresholds of detection ranging from 1 to 3.2 m distance from the disk. Three participants in the loudspeaker experiment also tested using self-generated vocalization. One participant performed better using vocalization and one much worse than in the loudspeaker experiment, illustrating that performance in echolocation experiments using vocalizations not only measures the ability to detect sound reflections, but also the ability to produce efficient echolocation signals. Overall, the present experiments show that the Echobot may be a useful tool in research on human echolocation.	[Tirado, Carlos; Lunden, Peter; Nilsson, Mats E.] Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden; [Lunden, Peter] Res Inst Sweden, Boras, Sweden	Stockholm University; RISE Research Institutes of Sweden	Tirado, C (corresponding author), Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden.	carlos.tirado@psychology.su.se		Nilsson, Mats/0000-0002-2081-7144	Swedish Research Council [2016-02100]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was sponsored by grants to M.E.N. from the Swedish Research Council (2016-02100). URL: https://www.vr.se/english.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was sponsored by grants to M.E.N. from the Swedish Research Council (2016-02100). We would like to thank research assistant Jennie Lagerstedt BSc for help with collecting data.	KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; Kingdom FAA, 2016, PSYCHOPHYSICS PRACTI; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Moore BC, 2012, INTRO PSYCHOL HEARIN; Nilsson ME, 2019, J ACOUST SOC AM, V145, P512, DOI 10.1121/1.5087707; Norman LJ, 2018, I-PERCEPTION, V9, DOI 10.1177/2041669518776984; Pelegrin-Garcia D, 2018, APPL ACOUST, V139, P82, DOI 10.1016/j.apacoust.2018.04.018; RICE CE, 1965, J EXP PSYCHOL, V70, P246, DOI 10.1037/h0022215; Rosenblum LD, 2000, ECOL PSYCHOL, V12, P181, DOI 10.1207/S15326969ECO1203_1; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; SCHENKMAN BN, 1986, HUM FACTORS, V28, P607, DOI 10.1177/001872088602800510; Schenkman BN, 2011, PERCEPTION, V40, P840, DOI 10.1068/p6898; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2013, ADV EXP MED BIOL, V787, P311, DOI 10.1007/978-1-4614-1590-9_35; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shepherd D, 2011, ATTEN PERCEPT PSYCHO, V73, P1934, DOI 10.3758/s13414-011-0137-3; Stockholm University, 2019, ECH NEW SYST STUD HU; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Team R Core, 2018, R LANG ENV STAT COMP; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2014, J NEUROPHYSIOL, V111, P112, DOI 10.1152/jn.00501.2013; Thaler L, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005670; Thaler L, 2016, WIRES COGN SCI, V7, P382, DOI 10.1002/wcs.1408; Thaler L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154868; Tonelli A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156654	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223327	10.1371/journal.pone.0223327	http://dx.doi.org/10.1371/journal.pone.0223327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584971	Green Published, gold			2022-12-26	WOS:000532407600019
J	Yoshida, T; Yasui, N; Kusakabe, Y; Ito, C; Akamatsu, M; Yamashita, A				Yoshida, Takashi; Yasui, Norihisa; Kusakabe, Yuko; Ito, Chiaki; Akamatsu, Miki; Yamashita, Atsuko			Differential scanning fluorimetric analysis of the amino-acid binding to taste receptor using a model receptor protein, the ligand-binding domain of fish T1r2a/T1r3	PLOS ONE			English	Article							RECOMBINANT EXPRESSION; SWEET; EVOLUTION; DYNAMICS; SUBUNITS; STRATEGY; CELLS	Taste receptor type 1 (T1r) is responsible for the perception of essential nutrients, such as sugars and amino acids, and evoking sweet and umami (savory) taste sensations. T1r receptors recognize many of the taste substances at their extracellular ligand-binding domains (LBDs). In order to detect a wide array of taste substances in the environment, T1r receptors often possess broad ligand specificities. However, the entire ranges of chemical spaces and their binding characteristics to any T1rLBDs have not been extensively analyzed. In this study, we exploited the differential scanning fluorimetry (DSF) to medaka T1r2a/T1r3LBD, a current sole T1rLBD heterodimer amenable for recombinant preparation, and analyzed their thermal stabilization by adding various amino acids. The assay showed that the agonist amino acids induced thermal stabilization and shifted the melting temperatures (T-m) of the protein. An agreement between the DSF results and the previous biophysical assay was observed, suggesting that DSF can detect ligand binding at the orthostericbinding site in T1r2a/T1r3LBD. The assay further demonstrated that most of the tested Lamino acids, but no D-amino acid, induced T-m shifts of T1r2a/T1r3LBD, indicating the broad L-amino acid specificities of the proteins probably with several different manners of recognition. The T-m shifts by each amino acid also showed a fair correlation with the responses exhibited by the full-length receptor, verifying the broad amino-acid binding profiles at the orthosteric site in LBD observed by DSF.	[Yoshida, Takashi; Yasui, Norihisa; Ito, Chiaki; Yamashita, Atsuko] Okayama Univ, Grad Sch Med, Dent & Pharmaceut Sci, Okayama, Japan; [Kusakabe, Yuko] Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki, Japan; [Akamatsu, Miki] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Okayama University; National Agriculture & Food Research Organization - Japan; Kyoto University	Yamashita, A (corresponding author), Okayama Univ, Grad Sch Med, Dent & Pharmaceut Sci, Okayama, Japan.	a_yama@okayama-u.ac.jp	Yamashita, Atsuko/H-5566-2017; Yasui, Norihisa/V-8252-2019	Yamashita, Atsuko/0000-0002-8001-4642; Yasui, Norihisa/0000-0001-7117-3070	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [18H04621, 17H03644]; Japan Society for the Promotion of Science (JSPS), Japan [15H05370]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Grant Number 18H04621 and 17H03644 to AY), and Japan Society for the Promotion of Science (JSPS), Japan (Grant Number 15H05370 to NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1964, J AM CHEM SOC, V86, P1616, DOI DOI 10.1021/JA01062A035; Asao M, 1997, 205 QREG; Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Assadi-Porter FM, 2018, MOLECULES, V23, DOI 10.3390/molecules23102531; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; BJORK I, 1992, FEBS LETT, V299, P66, DOI 10.1016/0014-5793(92)80102-M; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Luan CH, 2014, METHODS MOL BIOL, V1140, P263, DOI 10.1007/978-1-4939-0354-2_20; Maitrepierre E, 2012, PROTEIN EXPRES PURIF, V83, P75, DOI 10.1016/j.pep.2012.03.006; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Nango E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25745; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nuemket N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15530; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Poklar N, 1997, BIOCHEMISTRY-US, V36, P14345, DOI 10.1021/bi971719v; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yamashita A, 2017, PROTEIN SCI, V26, P2291, DOI 10.1002/pro.3271; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0218909	10.1371/journal.pone.0218909	http://dx.doi.org/10.1371/journal.pone.0218909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584955	Green Published, Green Submitted, gold			2022-12-26	WOS:000532407600003
J	Baumberger, KL; Eitzel, MV; Kirby, ME; Horn, MH				Baumberger, Katherine L.; Eitzel, M., V; Kirby, Matthew E.; Horn, Michael H.			Movement and habitat selection of the western spadefoot (Spea hammondii) in southern California	PLOS ONE			English	Article							BOREAL TOADS; HOME RANGES; AMPHIBIANS; CONSEQUENCES; CONSERVATION; DISPERSAL; ECOLOGY	Agricultural activity, urban development and habitat alteration have caused the disappearance of the western spadefoot (Spea hammondil) from 80% of its geographic range in southern California. Despite the western spadefoot's continuing decline, little research has been conducted on its natural history. The home range of adult spadefoots is unknown, and their use of upland habitat is poorly understood. Both factors are important for the long-term conservation of the species because adult spadefoots spend the majority of their lives away from breeding pools in self-excavated burrows. Between January 2012 and January 2013, we surgically implanted radio transmitters in 15 spadefoots at two locations and recorded their movements and habitat use. The mean distance moved between burrow locations was 18 m (SD +/- 24.1 m, rangel-204 m). The mean distance of burrows from the breeding pools was 40 m (SD +/- 37.42 m, range 1-262 m). Rain was a significant predictor of spadefoot movement, with more rain predicting higher probability of movement and larger distances moved. At remote sensing scale (1 m) spadefoots selected grassland habitat for their burrow locations. At the microsite scale (< 1 m) spadefoots strongly selected duff over grass or shrub cover. Spadefoots burrowed in friable, sandy/loam soil with significantly less clay than random pseudoabsence points. This research enhances our understanding of a little-studied species and will contribute to the development of effective management plans for the western spadefoot.	[Baumberger, Katherine L.] Calif State Univ Fullerton, Environm Studies Program, Fullerton, CA 92634 USA; [Eitzel, M., V] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kirby, Matthew E.] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92634 USA; [Horn, Michael H.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Baumberger, Katherine L.] US Geol Survey, Western Ecol Res Ctr, Santa Ana, CA 33116 USA; [Eitzel, M., V] Univ Calif Santa Cruz, Sci & Justice Res Ctr, Santa Cruz, CA 95064 USA	California State University System; California State University Fullerton; University of California System; University of California Berkeley; California State University System; California State University Fullerton; California State University System; California State University Fullerton; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Cruz	Baumberger, KL (corresponding author), Calif State Univ Fullerton, Environm Studies Program, Fullerton, CA 92634 USA.; Baumberger, KL (corresponding author), US Geol Survey, Western Ecol Res Ctr, Santa Ana, CA 33116 USA.	kbaumberger@usgs.gov		Baumberger, Katherine/0000-0002-2150-6372	Laguna Canyon Foundation; Association of Zoos and Aquariums Amphibian Taxon Advisory Group Conservation Fund; Natural Communities Coalition	Laguna Canyon Foundation; Association of Zoos and Aquariums Amphibian Taxon Advisory Group Conservation Fund; Natural Communities Coalition	K. B. received funding from the Laguna Canyon Foundation (https://lagunacanyon.org/), the Association of Zoos and Aquariums Amphibian Taxon Advisory Group Conservation Fund (https://www.aza.org/amphibian-conservation), and the Natural Communities Coalition (formally the Nature Reserve of Orange County) (https://occonservation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Bartelt PE, 2004, HERPETOLOGICA, V60, P455, DOI 10.1655/01-50; Beaupre SJ., 2004, HERP AN CAR US COMM; Beyer H. L, 2012, GEOSPATIAL MODELLING; BRATTSTROM BAYARD H., 1955, COPEIA, V1955, P181, DOI 10.2307/1440458; [California Department of Fish and Wildlife Horizon Water and Environment], 2013, SAN JOAQ RIV REST PR, pI1; Collins J.P., 2009, EXTINCTION OUR TIMES; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; D'Antonio C., 2007, CALIFORNIA GRASSLAND, P67; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DIMMITT MA, 1980, J HERPETOL, V14, P21, DOI 10.2307/1563871; EGGERT C, 2002, ATT 3 CONV SALV ANF, P47; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Garner J. A., 2012, THESIS; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Goates MC, 2007, BIOL CONSERV, V138, P474, DOI 10.1016/j.biocon.2007.05.016; Goldberg Caren S., 2002, Herpetological Review, V33, P191; Gray Matthew J., 2005, Herpetological Review, V36, P285; Harper EB, 2008, CONSERV BIOL, V22, P1205, DOI 10.1111/j.1523-1739.2008.01015.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; HOOVER MD, 1952, SOIL SCI SOC AM PRO, V16, P368, DOI 10.2136/sssaj1952.03615995001600040012x; Keeley Jon E., 1998, P1; Kirby ME, 2010, J PALEOLIMNOL, V44, P819, DOI 10.1007/s10933-010-9454-0; LAUNDRE JW, 1993, OECOLOGIA, V94, P43, DOI 10.1007/BF00317299; Manly B.F.J., 2002, RESOURCE SELECTION A; McDonough C, 2007, J WILDLIFE MANAGE, V71, P1163, DOI 10.2193/2006-380; Morey SR, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P508; Muths E, 2003, COPEIA, P160, DOI 10.1643/0045-8511(2003)003[0160:HRAMOB]2.0.CO;2; NOAA, 2016, DAIL SUMM DET LAG BE; Orange County Public Works, 2013, OC WATERSHEDS LAGUNA; Reichman OJ, 2002, TRENDS ECOL EVOL, V17, P44, DOI 10.1016/S0169-5347(01)02329-1; Richardson JS, 2013, CRITICAL BREEDING FO; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; RUIBAL R, 1969, COPEIA, P571; Schmetterling DA, 2008, J HERPETOL, V42, P111, DOI 10.1670/07-125R1.1; Scott DE, 2013, ECOLOGY, V94, P2537, DOI 10.1890/12-1999.1; Searcy CA, 2013, BIOL CONSERV, V158, P80, DOI 10.1016/j.biocon.2012.08.033; Semlitsch Raymond D., 2007, P127; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Sheldrick B.H., 1993, SOIL SAMPLING METHOD, P499; Signer J, 2015, WILDLIFE SOC B, V39, P358, DOI 10.1002/wsb.539; Smith MA, 2005, ECOGRAPHY, V28, P110; Stebbins R.C., 2012, FIELD GUIDE AMPHIBIA; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thomson R.C., 2016, CALIFORNIA AMPHIBIAN; Timm BC, 2014, J HERPETOL, V48, P84, DOI 10.1670/12-201; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; U. S. Fish and Wildlife Service, 2005, RECOVERY PLAN VERNAL; U. S. Fish and Wildlife Service, 2015, FED REGISTER, V80, P37578; University of Texas McDonald Observatory, 2013, STARDATE MOON PHAS; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Zuur Alain F., 2009, P1	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222532	10.1371/journal.pone.0222532	http://dx.doi.org/10.1371/journal.pone.0222532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581232	Green Published, gold			2022-12-26	WOS:000532398600012
J	Brock, GN; Washburn, K; Marvin, MR				Brock, Guy N.; Washburn, Kenneth; Marvin, Michael R.			Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing	PLOS ONE			English	Article							SERUM SODIUM; HEPATOCELLULAR-CARCINOMA; PREDICTS MORTALITY; SCORE; SURVIVAL; DELTA; RISK	The Model for End-Stage Liver Disease (MELD) score has been successfully used to prioritize patients on the United States liver transplant waiting list since its adoption in 2002. The United Network for Organ Sharing (UNOS)/Organ Procurement Transplantation Network (OPTN) allocation policy has evolved over the years, and notable recent changes include Share 35, inclusion of serum sodium in the MELD score, and a 'delay and cap' policy for hepatocellular carcinoma (HCC) patients. We explored the potential of a registrant's change in 30-day MELD scores (Delta MELD30) to improve allocation both before and after these policy changes. Current MELD and Delta MELD30 were evaluated using cause-specific hazards models for waitlist dropout based on US liver transplant registrants added to the waitlist between 06/30/2003 and 6/30/2013. Two composite scores were constructed and then evaluated on UNOS data spanning the current policy era (01/02/2016 to 09/07/2018). Predictive accuracy was evaluated using the C-index for model discrimination and by comparing observed and predicted waitlist dropout probabilities for model calibration. After the change to MELD-Na, increased dropout associated with Delta MELD30 jumps is no longer evident at MELD scores below 30. However, the adoption of Share 35 has potentially resulted in discrepancies in waitlist dropout for patients with sharp MELD increases at higher MELD scores. Use of the Delta MELD30 to add additional points or serve as a potential tiebreaker for patients with rapid deterioration may extend the benefit of Share 35 to better include those in most critical need.	[Brock, Guy N.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Brock, Guy N.] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Brock, Guy N.; Washburn, Kenneth] Ohio State Univ, Wexner Med Ctr, Div Transplantat Surg, Dept Surg, Columbus, OH 43210 USA; [Brock, Guy N.] Ohio State Univ, Wexner Med Ctr, Ctr Surg Hlth Assessment Res & Policy SHARP, Columbus, OH 43210 USA; [Marvin, Michael R.] Geisinger Med Ctr, Dept Transplantat & Liver Surg, Danville, PA 17822 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Geisinger Medical Center	Brock, GN (corresponding author), Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA.; Brock, GN (corresponding author), Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA.; Brock, GN (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Transplantat Surg, Dept Surg, Columbus, OH 43210 USA.; Brock, GN (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Surg Hlth Assessment Res & Policy SHARP, Columbus, OH 43210 USA.	guy.brock@osumc.edu			Health Resources and Services Administration [234-2005-370011C]; National Institute of Health from the National Cancer Institute [P30CA016058]; National Institute of Health from the National Center for Advancing Translational Sciences [UL1TR002733]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002733] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institute of Health from the National Cancer Institute; National Institute of Health from the National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by Health Resources and Services Administration contract 234-2005-370011C. GNB was partially funded by National Institute of Health grants P30CA016058 from the National Cancer Institute and UL1TR002733 from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REV LIV POL REG HCC; Bambha K, 2004, AM J TRANSPLANT, V4, P1798, DOI 10.1111/j.1600-6143.2004.00550.x; Bernardi M, 2011, J HEPATOL, V54, P1297, DOI 10.1016/j.jhep.2010.11.008; Berumen J, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12937; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Biggins SW, 2005, HEPATOLOGY, V41, P32, DOI 10.1002/hep.20517; D'Amico G, 2005, J HEPATOL, V42, P790, DOI 10.1016/j.jhep.2005.03.009; Freeman RB, 2004, LIVER TRANSPLANT, V10, P7, DOI 10.1002/lt.20024; Goldberg DS, 2017, LIVER TRANSPLANT, V23, P604, DOI 10.1002/lt.24749; Gyori GP, 2012, TRANSPL INT, V25, P935, DOI 10.1111/j.1432-2277.2012.01519.x; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Huo TI, 2005, J HEPATOL, V42, P826, DOI 10.1016/j.jhep.2005.01.019; Ishaque T, 2019, AM J TRANSPLANT, V19, P564, DOI 10.1111/ajt.15144; Kalra A, 2016, CURR OPIN ORGAN TRAN, V21, P120, DOI 10.1097/MOT.0000000000000281; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kwong AJ, 2018, HEPATOLOGY, V67, P273, DOI 10.1002/hep.29301; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Marvin MR, 2015, LIVER TRANSPL; Massie AB, 2015, LIVER TRANSPLANT, V21, P683, DOI 10.1002/lt.24102; Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009; Northup PG, 2004, AM J TRANSPLANT, V4, P1643, DOI 10.1111/j.1600-6143.2004.00593.x; R Foundation for Statistical Computing, 2019, R LANG ENV STAT COMP; Said A, 2004, J HEPATOL, V40, P897, DOI 10.1016/j.jhep.2004.02.010; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Sharma P, 2015, LIVER TRANSPLANT, V21, P308, DOI 10.1002/lt.24063; Therneau T.M., 2000, MODELING SURVIVAL DA; Wedd JP, 2015, LIVER TRANSPLANT, V21, P1543, DOI 10.1002/lt.24356	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223053	10.1371/journal.pone.0223053	http://dx.doi.org/10.1371/journal.pone.0223053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581270	Green Published, gold			2022-12-26	WOS:000532398600027
J	Hu, SY; Santus, E; Forsyth, AW; Malhotra, D; Haimson, J; Chatterjee, NA; Kramer, DB; Barzilay, R; Tulsky, JA; Lindvall, C				Hu, Szu-Yeu; Santus, Enrico; Forsyth, Alexander W.; Malhotra, Devvrat; Haimson, Josh; Chatterjee, Neal A.; Kramer, Daniel B.; Barzilay, Regina; Tulsky, James A.; Lindvall, Charlotta			Can machine learning improve patient selection for cardiac resynchronization therapy?	PLOS ONE			English	Article							HEART-FAILURE; BIG DATA; PREDICTORS	Rationale Multiple clinical trials support the effectiveness of cardiac resynchronization therapy (CRT); however, optimal patient selection remains challenging due to substantial treatment heterogeneity among patients who meet the clinical practice guidelines. Objective To apply machine learning to create an algorithm that predicts CRT outcome using electronic health record (EHR) data avaible before the procedure. Methods and results We applied machine learning and natural language processing to the EHR of 990 patients who received CRT at two academic hospitals between 2004-2015. The primary outcome was reduced CRT benefit, defined as <0% improvement in left ventricular ejection fraction (LVEF) 6-18 months post-procedure or death by 18 months. Data regarding demographics, laboratory values, medications, clinical characteristics, and past health services utilization were extracted from the EHR available before the CRT procedure. Bigrams (i.e., two-word sequences) were also extracted from the clinical notes using natural language processing. Patients accrued on average 75 clinical notes (SD, 29) before the procedure including data not captured anywhere else in the EHR. A machine learning model was built using 80% of the patient sample (training and validation dataset), and tested on a held-out 20% patient sample (test dataset). Among 990 patients receiving CRT the mean age was 71.6 (SD, 11.8), 78.1% were male, 87.2% non-Hispanic white, and the mean baseline LVEF was 24.8% (SD, 7.69). Out of 990 patients, 403 (40.7%) were identified as having a reduced benefit from the CRT device (<0% LVEF improvement in 25.2%, death by 18 months in 15.6%). The final model identified 26% of these patients at a positive predictive value of 79% (model performance: F-beta (beta = 0.1): 77%; recall 0.26; precision 0.79; accuracy 0.65). Conclusions A machine learning model that leveraged readily available EHR data and clinical notes identified a subset of CRT patients who may not benefit from CRT before the procedure.	[Hu, Szu-Yeu] Masachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Santus, Enrico; Forsyth, Alexander W.; Haimson, Josh; Barzilay, Regina] MIT, Dept Elect Engn & Comp Sci, CSAIL, Cambridge, MA 02139 USA; [Malhotra, Devvrat] Harvard Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Chatterjee, Neal A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res, Div Cardiol, Boston, MA 02215 USA; [Tulsky, James A.; Lindvall, Charlotta] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Tulsky, James A.; Lindvall, Charlotta] Brigham & Womens Hosp, Dept Med, Div Palliat Med, 75 Francis St, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Lindvall, C (corresponding author), Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA.; Lindvall, C (corresponding author), Brigham & Womens Hosp, Dept Med, Div Palliat Med, 75 Francis St, Boston, MA 02115 USA.	Charlotta_lindvall@DFCI.harvard.edu		Lindvall, Charlotta/0000-0003-2090-2039	Junior Faculty Research Award from the National Palliative Care Research Center (NPCRC); Pilot Award from the Palliative Care Research Cooperative Group (PCRC) - National Institute of Nursing Research [U24NR014637]; NATIONAL INSTITUTE OF NURSING RESEARCH [U24NR014637] Funding Source: NIH RePORTER	Junior Faculty Research Award from the National Palliative Care Research Center (NPCRC); Pilot Award from the Palliative Care Research Cooperative Group (PCRC) - National Institute of Nursing Research; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Dr. Lindvall is supported by a Junior Faculty Research Award from the National Palliative Care Research Center (NPCRC - http://npcrc.org/) and a Pilot Award from the Palliative Care Research Cooperative Group (PCRC - https://palliativecareresearch.org/) funded by the National Institute of Nursing Research U24NR014637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Arras L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181142; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P2356, DOI 10.1001/jama.2017.16635; Carita P, 2016, INT J CARDIOLOGY; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chatterjee NA, 2015, HEART FAIL CLIN, V11, P287, DOI 10.1016/j.hfc.2014.12.007; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chung ES, 2008, ECHOCARDIOGR-J CARD, V2608, P2616; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Coppola G, 2016, INT J CARDIOL; Coppola G, 2014, INT J CARDIOL; Databases H, 2008, HEALTHC COST UT PROJ; Downing NS, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1322-4; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Evert Stefan, 2005, STAT WORD COOCCURREN; Friedman DJ, 2014, HEART RHYTHM, V11, P1991, DOI 10.1016/j.hrthm.2014.08.005; Kalscheur MM, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005499; Linde C, 2017, EUR J HEART FAIL, V19, P1056, DOI 10.1002/ejhf.795; Lindvall C, 2016, CIRCULATION, V133, P273, DOI 10.1161/CIRCULATIONAHA.115.018830; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Motwani M, 2017, EUR HEART J, V38, P500, DOI 10.1093/eurheartj/ehw188; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nordon C, 2016, VALUE HEALTH, V19, P75, DOI 10.1016/j.jval.2015.09.2938; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rehurek R., 2010, P LREC 2010 WORKSH N; Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247; Stearns MQ, 2001, J AM MED INFORM ASSN, P662; Szlosek Donald A, 2016, EGEMS (Wash DC), V4, P1222, DOI 10.13063/2327-9214.1222; Vanderkam D., 2018, LOCAL TURK; Weiss ST, 2016, J PERS MED, V6, DOI 10.3390/jpm6010013; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222397	10.1371/journal.pone.0222397	http://dx.doi.org/10.1371/journal.pone.0222397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581234	Green Published, gold			2022-12-26	WOS:000532398600011
J	Li, Y; Huang, HR; Dong, WJ; Lan, TL; Fan, J; Wen, SA; Zhang, TT; Qin, SB; Guo, A				Li, Yuan; Huang, Hairong; Dong, Weijie; Lan, Tinglong; Fan, Jun; Wen, Shu'an; Zhang, Tingting; Qin, Shibing; Guo, Ai			Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis	PLOS ONE			English	Article							EFFICACY; SAFETY; TOLERABILITY; REGIMENS; DRUGS; TB	Background Linezolid has shown strong antimicrobial activity against multidrug-resistant (MDR)/rifampin-resistant strains of Mycobacterium tuberculosis. Linezolid achieves clinical efficacy mainly through area under the concentration time curve/minimum inhibitory concentration ratio in the infected lesion site. Previous studies mainly focused on the relationship between linezolid concentrations in the blood and infected bone tissue when the blood drug concentration reached the peak 2 h after administration. However, we do not know whether linezolid can maintain the same bone/plasma ratio in infected bone tissue when the blood concentration reaches the trough level. Therefore, this study aimed to evaluate the penetrability of linezolid into bone tissue 24 h after administration in patients with MDR spinal tuberculosis (TB). Methods Nine MDR spinal TB patients, who received a treatment regimen including linezolid and underwent surgery, were enrolled prospectively from April 2017 to March 2019. Blood and diseased bone tissue specimens were collected simultaneously during operations 24 h after taking 600 mg of linezolid orally. Linezolid concentrations in plasma and diseased bone tissue specimens were determined by high-performance liquid chromatography tandem mass spectrometry. Results Following a 600 mg oral administration of linezolid 24 h before surgery, median concentrations of linezolid in plasma and diseased bone tissue for the 9 patients were 1.98 mg/L (range 0.30-3.44 mg/L) and 0.60 mg/L (range 0.18-2.13 mg/L), respectively, at resection time. The median diseased bone/plasma linezolid concentration ratio was 0.48 (range 0.30 0.67). Pearson's correlation analysis showed that linezolid concentrations in the plasma were positively related to those in diseased bone tissue (r = 0.949, p < 0.001). Conclusions After 24 h of medication, linezolid still had good penetrability into diseased bone tissue in patients with MDR spinal TB.	[Li, Yuan; Guo, Ai] Capital Med Univ, Beijing Friendship Hosp, Dept Orthoped, Beijing, Peoples R China; [Li, Yuan; Dong, Weijie; Lan, Tinglong; Fan, Jun; Qin, Shibing] Capital Med Univ, Beijing Chest Hosp, Dept Orthoped, Beijing, Peoples R China; [Huang, Hairong; Wen, Shu'an; Zhang, Tingting] Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistant TB Res, Beijing TB & Thorac Tumor Inst,Natl Clin Lab TB, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Guo, A (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Orthoped, Beijing, Peoples R China.; Qin, SB (corresponding author), Capital Med Univ, Beijing Chest Hosp, Dept Orthoped, Beijing, Peoples R China.	qinshibing17@163.com; guoaij@139.com			National Science and Technology Major Project [2017ZX09304009-004]	National Science and Technology Major Project	This study was funded by the National Science and Technology Major Project (grant number 2017ZX09304009-004) (http://www.nmp.gov.cn/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman AA, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0156-y; Bolhuis MS, 2018, CLIN INFECT DIS, V67, pS327, DOI 10.1093/cid/ciy625; Cattaneo D, 2016, EXPERT OPIN DRUG MET, V12, P533, DOI 10.1517/17425255.2016.1166204; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Kempker RR, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02166-2017; Kutscha-Lissberg F, 2003, ANTIMICROB AGENTS CH, V47, P3964, DOI 10.1128/AAC.47.12.3964-3966.2003; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Lovering AM, 2002, J ANTIMICROB CHEMOTH, V50, P73, DOI 10.1093/jac/dkf066; Magombedze G, 2017, ANTIMICROB AGENTS CH, V61; McGee B, 2009, ANTIMICROB AGENTS CH, V53, P3981, DOI 10.1128/AAC.01378-08; Migliori GB, 2009, EUR RESPIR J, V34, P387, DOI 10.1183/09031936.00009509; Nuermberger E, 2016, INT J TUBERC LUNG D, V20, pS48, DOI 10.5588/ijtld.16.0113; Rana B, 2002, J ANTIMICROB CHEMOTH, V50, P747, DOI 10.1093/jac/dkf207; Rodriguez JC, 2004, J ANTIMICROB CHEMOTH, V53, P441, DOI 10.1093/jac/dkh119; Schon T, 2011, INT J TUBERC LUNG D, V15, P502, DOI 10.5588/ijtld.10.0238; Singh B, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012836.pub2; Song T, 2015, EBIOMEDICINE, V2, P1627, DOI 10.1016/j.ebiom.2015.09.051; Tang SJ, 2015, EUR RESPIR J, V45, P161, DOI 10.1183/09031936.00035114; Traunmuller F, 2010, INT J ANTIMICROB AG, V36, P84, DOI 10.1016/j.ijantimicag.2010.03.007; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Word Health Organization, 2018, WHO TREATM GUID MULT, DOI [10.1128/AAC.01378-08, DOI 10.1128/AAC.01378-08]; Zhang X, 2015, J THORAC DIS, V7, P603, DOI 10.3978/j.issn.2072-1439.2015.03.10	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223391	10.1371/journal.pone.0223391	http://dx.doi.org/10.1371/journal.pone.0223391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581274	Green Published, gold			2022-12-26	WOS:000532398600062
J	Otalora, L; Chavez, E; Watford, D; Tueros, L; Correa, M; Nair, V; Ruiz, P; Wahl, P; Eddy, S; Martini, S; Kretzler, M; Burke, GW; Fornoni, A; Merscher, S				Otalora, Lilian; Chavez, Efren; Watford, Daniel; Tueros, Lissett; Correa, Mayrin; Nair, Viji; Ruiz, Philip; Wahl, Patricia; Eddy, Sean; Martini, Sebastian; Kretzler, Matthias; Burke, George W., III; Fornoni, Alessia; Merscher, Sandra			Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis	PLOS ONE			English	Article							MICROARRAY ANALYSIS; NEPHROTIC SYNDROME; PERMEABILITY; CHANNELS; CHILDREN	Focal segmental glomerulosclerosis (FSGS) accounts for about 40% of all nephrotic syndrome cases in adults. The presence of several potential circulating factors has been suggested in patients with primary FSGS and particularly in patients with recurrent disease after transplant. Irrespectively of the nature of the circulating factors, this study was aimed at identifying early glomerular/podocyte-specific pathways that are activated by the sera of patients affected by FSGS. Kidney biopsies were obtained from patients undergoing kidney transplantation due to primary FSGS. Donor kidneys were biopsied pre-reperfusion (PreR) and a subset 1-2 hours after reperfusion of the kidney (PostR). Thirty-one post reperfusion (PostR) and 36 PreR biopsy samples were analyzed by microarray and gene enrichment KEGG pathway analysis. Data were compared to those obtained from patients with incident primary FSGS enrolled in other cohorts as well as with another cohort to correct for pathways activated by ischemia reperfusion. Using an ex-vivo cell-based assay in which human podocytes were cultured in the presence of sera from patients with recurrent and non recurrent FSGS, the molecular signature of podocytes exposed to sera from patients with REC was compared to the one established from patients with NON REC. We demonstrate that inflammatory pathways, including the TNF pathway, are primarily activated immediately after exposure to the sera of patients with primary FSGS, while phagocytotic pathways are activated when proteinuria becomes clinically evident. The TNF pathway activation by one or more circulating factors present in the sera of patients with FSGS supports prior experimental findings from our group demonstrating a causative role of local TNF in podocyte injury in FSGS. Correlation analysis with clinical and histological parameters of disease was performed and further supported a possible role for TNF pathway activation in FSGS. Additionally, we identified a unique set of genes that is specifically activated in podocytes when cultured in the presence of serum of patients with REC FSGS. This clinical translational study supports our prior experimental findings describing a potential role of the TNF pathway in the pathogenesis of FSGS. Validation of these findings in larger cohorts may lay the ground for the implementation of integrated system biology approaches to risk stratify patients affected by FSGS and to identify novel pathways relevant to podocyte injury.	[Otalora, Lilian; Chavez, Efren; Wahl, Patricia; Fornoni, Alessia; Merscher, Sandra] Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, Miami, FL 33136 USA; [Otalora, Lilian; Chavez, Efren; Wahl, Patricia; Burke, George W., III; Fornoni, Alessia; Merscher, Sandra] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miller Sch Med, Miami, FL 33136 USA; [Chavez, Efren; Watford, Daniel] Univ Miami, Jackson Mem Hosp, Dept Internal Med, Miami, FL 33136 USA; [Tueros, Lissett; Ruiz, Philip; Burke, George W., III] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Tueros, Lissett; Ruiz, Philip; Burke, George W., III] Univ Miami, Miami Transplant Inst, Miller Sch Med, Miami, FL 33136 USA; [Correa, Mayrin; Ruiz, Philip] Univ Miami, Dept Pathol, Miller Sch Med, Miami, FL 33136 USA; [Nair, Viji; Eddy, Sean; Martini, Sebastian; Kretzler, Matthias] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Burke, George W., III] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Michigan System; University of Michigan; University of Miami	Fornoni, A; Merscher, S (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, Miami, FL 33136 USA.; Fornoni, A; Merscher, S (corresponding author), Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miller Sch Med, Miami, FL 33136 USA.	afornoni@med.miami.edu; smerscher@med.miami.edu		fornoni, Alessia/0000-0002-1313-7773; Merscher, Sandra/0000-0002-4757-7494; Eddy, Sean/0000-0001-8578-3443	NIH [DK090316, DK104753]; National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through NCATS [U54-DK083912]; National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through National Institute of Diabetes, Digestive, and Kidney Diseases [U54-DK083912]; University of Michigan; NephCure Kidney International; Halpin Foundation; National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through Office of Rare Diseases Research (ORDR) [U54-DK083912];  [U24DK076169];  [U54DK083912];  [UM1DK100846];  [1UL1TR000460]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, U54DK083912, UM1DK100846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through NCATS; National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through National Institute of Diabetes, Digestive, and Kidney Diseases; University of Michigan(University of Michigan System); NephCure Kidney International; Halpin Foundation; National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) through Office of Rare Diseases Research (ORDR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AF and S. Merscher are supported by the NIH grants DK090316, DK104753. AF is supported by U24DK076169, U54DK083912, UM1DK100846, and 1UL1TR000460. G.W.B. is supported by the NIH grant DK090316. The Nephrotic Syndrome Study Network Consortium (NEPTUNE), U54-DK083912, is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, the NephCure Kidney International and the Halpin Foundation.	Beaudreuil S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219353; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Besbas N, 2015, RENAL FAILURE, V37, P1435, DOI 10.3109/0886022X.2015.1074474; Braden GL, 2000, AM J KIDNEY DIS, V35, P878, DOI 10.1016/S0272-6386(00)70258-7; Chung CF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216426; Dryer SE, 2019, BBA-MOL BASIS DIS, V1865, P1041, DOI 10.1016/j.bbadis.2019.04.001; Fogo AB, 2015, NAT REV NEPHROL, V11, P76, DOI 10.1038/nrneph.2014.216; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; HAAS M, 1995, AM J KIDNEY DIS, V26, P740, DOI 10.1016/0272-6386(95)90437-9; Hickson LJ, 2009, TRANSPLANTATION, V87, P1232, DOI 10.1097/TP.0b013e31819f12be; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Huang K, 2004, AM J KIDNEY DIS, V43, P1082, DOI 10.1053/j.ajkd.2004.03.017; Joy MS, 2010, AM J KIDNEY DIS, V55, P50, DOI 10.1053/j.ajkd.2009.08.019; Kim EY, 2017, BBA-MOL BASIS DIS, V1863, P2342, DOI 10.1016/j.bbadis.2017.06.010; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kreepala C, 2013, AM J TRANSPLANT, V13, P415, DOI 10.1111/ajt.12043; Maas RJH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-47; Mariani LH, 2018, BIORXIV, DOI [10.1101/427880, DOI 10.1101/427880]; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Nehus EJ, 2013, TRANSPLANTATION, V96, P550, DOI 10.1097/TP.0b013e31829c2431; Pedigo CE, 2016, J CLIN INVEST, V126, P3336, DOI 10.1172/JCI85939; Peyser A, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-2; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; SURANYI MG, 1993, AM J KIDNEY DIS, V21, P251, DOI 10.1016/S0272-6386(12)80742-6; Tong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140453; Wasilewska A, 2011, SCAND J UROL NEPHROL, V45, P52, DOI 10.3109/00365599.2010.526140; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wen YM, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00098	31	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222948	10.1371/journal.pone.0222948	http://dx.doi.org/10.1371/journal.pone.0222948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581251	Green Published, gold			2022-12-26	WOS:000532398600023
J	Sandoval, LA; Carpio, CE; Sanchez-Plata, M				Sandoval, Luis A.; Carpio, Carlos E.; Sanchez-Plata, Marcos			The effect of 'Traffic-Light' nutritional labelling in carbonated soft drink purchases in Ecuador	PLOS ONE			English	Article							FOOD PURCHASES; DEMAND; FRONT; INFORMATION; IMPACT; WARNINGS; DESIGN; CHOICE; SYSTEM	Overweight and obesity have become global concerns in developed and developing countries due to their rise in recent years and their association with the prevalence of non-communicable diseases including diabetes, hypertension and cardiovascular diseases. In fact, it is estimated that roughly 39% of adults worldwide are overweight and 13% are obese. Ecuador is an example of a developing country concerned with the overweight and obesity problem, where it is estimated that 30% of children, 26% of teenagers and 63% of adults are either overweight or obese and where 1 in 4 deaths are attributed to chronic diseases. To address the overweight and obesity problem via the promotion of healthy eating habits, in 2013 the country approved technical regulation for the labelling of packed processed food products. The regulation included a mandatory traffic-light (TL) supplemental nutritional information labelling system to be displayed on the package of all processed foods for sale in the country. This new labelling system displays a traffic light panel for the product content of sugar, fat and salt in addition to the traditional nutrient declaration label. The objective of this paper was to evaluate the effect of the TL supplemental nutritional information on consumers' buying behavior in Ecuador. More specifically, we concentrated on the purchasing behavior of carbonated soft drinks. For our analysis, we used monthly aggregated purchase data (total expenditures, quantities and average prices) of carbonated soft drinks from January 2013 to December 2015 obtained from Kantar World Panel Ecuador. We estimated a non-linear Almost Ideal Demand System where we model the demand for high sugar and low sugar carbonated soft drinks. We found that the introduction of the traffic light supplemental nutrition labelling did not have the expected effect of reducing purchases of carbonated soft drinks during its first year of implementation, especially those high in sugar. Additionally, we found that lower income-status households tend to spend more on and consume more calories from CSD than households with higher socio-economic status. Finally, we identified that over time purchases of high sugar soft drinks decreased while purchases of low and no sugar soft drinks increased. Beyond our contribution of evaluating the effect of the traffic light on the purchases of carbonated soft drinks, we also estimated price and income elasticities of carbonated soft drinks which can be useful in the evaluation of fiscal policies.	[Sandoval, Luis A.] Zamorano Univ, Dept Agribusiness, Tegucigalpa, Honduras; [Carpio, Carlos E.] Texas Tech Univ, Dept Agr & Appl Econ, Lubbock, TX 79409 USA; [Sanchez-Plata, Marcos] Texas Tech Univ, Dept Anim & Food Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Sandoval, LA (corresponding author), Zamorano Univ, Dept Agribusiness, Tegucigalpa, Honduras.	lsandoval@zamorano.edu	Sandoval, Luis/GWC-1709-2022; Sanchez-Plata, Marcos X./AAG-4240-2021	Sandoval, Luis/0000-0002-2621-933X; Carpio, Carlos/0000-0002-5889-9245	International Center for Food Industry Excellent (ICFIE) at Texas Tech University	International Center for Food Industry Excellent (ICFIE) at Texas Tech University	Funding for this project was provided by the International Center for Food Industry Excellent (ICFIE) at Texas Tech University. The funder played a role in the revision of the manuscript for publication by reviewing it prior to submission.	Acosta S., COMMUNICATION; Ares G, 2016, FOOD QUAL PREFER, V53, P1, DOI 10.1016/j.foodqual.2016.05.006; Arrua A, 2017, PUBLIC HEALTH NUTR, V20, P2308, DOI 10.1017/S1368980017000866; Arrua A, 2017, APPETITE, V116, P139, DOI 10.1016/j.appet.2017.04.012; BARTEN AP, 1969, EUR ECON REV, V1, P7, DOI 10.1016/0014-2921(69)90017-8; Biblioteca del Congreso Nacional de Chile, COMP NUTR AL PUBL; Boonsaeng T., 2008, Journal of Agricultural and Applied Economics, V40, P941; Casella G, 2002, STAT INFERENCE, V2; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Cornelsen L, 2016, APPL ECON PERSPECT P, V38, P546, DOI 10.1093/aepp/ppw010; Crockett RA, 2018, NUTR LABELLING HEALT; Deaton AS, 1980, AM ECON REV, V70, P418; DIAZ AA, 2017, REV PANAMERICANA SAL, V41, P60174; Dodds P, 2014, APPETITE, V73, P23, DOI 10.1016/j.appet.2013.10.013; Franklin RS, 2018, POPULATION LOSS: THE ROLE OF TRANSPORTATION AND OTHER ISSUES, VOL 2, P1, DOI 10.1016/bs.atpp.2018.09.008; Freire W., 2014, ENCUESTA NACL SALUD, VI; Freire WB, 2017, PUBLIC HEALTH NUTR, V20, P805, DOI 10.1017/S1368980016002457; Goncalves S, 2005, J AM STAT ASSOC, V100, P970, DOI 10.1198/016214504000002087; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Hieke S, 2012, PUBLIC HEALTH NUTR, V15, P773, DOI 10.1017/S1368980011002874; Johnson JP, 2006, AM ECON REV, V96, P756, DOI 10.1257/aer.96.3.756; Kelly B, 2009, DIET ASS AUSTR 27 NA, pA17; KLEIN LR, 1960, ECONOMETRICA, V28, P866, DOI 10.2307/1907568; Kutner M. H., 2005, APPL LINEAR STAT MOD, V5; Lewbel A, 2009, AM ECON REV, V99, P827, DOI 10.1257/aer.99.3.827; Maya ME, 2015, THESIS; Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Roberto CA, 2012, AM J PREV MED, V43, P134, DOI 10.1016/j.amepre.2012.04.022; Sacks G, 2011, AUST NZ J PUBL HEAL, V35, P122, DOI 10.1111/j.1753-6405.2011.00684.x; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Sexton RJ, 1979, P7935 U MINN DEP AGR; SOUZA Jose Edimar de, 2015, THESIS; Teisl MF, 2001, AM J AGR ECON, V83, P133, DOI 10.1111/0002-9092.00142; THEIL H, 1965, ECONOMETRICA, V33, P67, DOI 10.2307/1911889; World Bank, 2017, WORLD BANK DAT EC; World Health Organization, OB OV FACT SHEET; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049; Zheng YQ, 2010, APPL ECON, V42, P1601, DOI 10.1080/00036840701721570	39	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222866	10.1371/journal.pone.0222866	http://dx.doi.org/10.1371/journal.pone.0222866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581272	Green Published, gold			2022-12-26	WOS:000532398600019
J	Lind, A; Akel, O; Wallenius, M; Ramelius, A; Maziarz, M; Zhao, LP; Geraghty, DE; Palm, L; Lernmark, A; Larsson, HE				Lind, Alexander; Akel, Omar; Wallenius, Madeleine; Ramelius, Anita; Maziarz, Marlena; Zhao, Lue Ping; Geraghty, Daniel E.; Palm, Lars; Lernmark, Ake; Larsson, Helena Elding			HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy	PLOS ONE			English	Article							ALLELE COMPETITION; LINKAGE PHASE; DQB1 LOCUS; RISK; ASSOCIATION; PROTECTION; AUTOANTIBODIES; VACCINATION; HAPLOTYPES; CATAPLEXY	The incidence of narcolepsy type 1 (NT1) increased in Sweden following the 2009-2010 mass-vaccination with the influenza Pandemrix-vaccine. NT1 has been associated with Human leukocyte antigen (HLA) DQB1* 06:02 but full high-resolution HLA-typing of all loci in vaccine-induced NT1 remains to be done. Therefore, here we performed HLA typing by sequencing HLA-DRB3, DRB4, DRB5, DRB1, DQA1, DQB1, DPA1 and DPB1 in 31 vaccine-associated NT1 patients and 66 of their first-degree relatives (FDR), and compared these data to 636 Swedish general population controls (GP). Previously reported disease-related alleles in the HLA-DRB5* 01:01:01-DRB1* 15:01:01-DQA1* 01:02:01-DQB1* 06: 02:01 extended haplotype were increased in NT1 patients (34/62 haplotypes, 54.8%) compared to GP (194/1272 haplotypes, 15.3%, p = 6.17E(-16)). Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. Among subjects with the HLA-DRB5* 01:01:01-DRB1* 15:01:01-DQA1* 01:02-DQB1* 06:02 haplotype, a second DRB4* 01:03:01-DRB1* 04:01:01-DQA1* 03:02//*03:03:01-DQB1* 03:01:01 haplotype (p = 2.02E(-2)), but not homozygosity for DRB1* 15:01:01-DQB1* 06:02:01 (p = 7.49E(-1)) conferred association to NT1. Alleles with increased frequency in DQA1* 01:02:01 (p = 1.07E(-2)) and DQA1* 03:02//* 03:03:01 (p = 3.26E(-2)), as well as with decreased frequency in DRB3* 01:01:02 (p = 8.09E(-3)), DRB1* 03:01:01 (p = 1.40E(-2)), and DQB1* 02:01:01 (p = 1.40E-2) were found among patients compared to their FDR. High-resolution HLA sequencing in Pandemrix-associated NT1 confirmed the strong association with the DQB1* 06: 02:01-containing haplotype but also revealed an increased association to the not previously reported extended HLA-DRB4* 01:03:01-DRB1* 04:01:01-DQA1* 03:02//* 03:03:01-DQB1* 03:01:01 haplotype. High-resolution HLA typing should prove useful in dissecting the immunological mechanisms of vaccination-associated NT1.	[Lind, Alexander; Akel, Omar; Wallenius, Madeleine; Ramelius, Anita; Maziarz, Marlena; Lernmark, Ake; Larsson, Helena Elding] Lund Univ, CRC, Skane Univ Hosp SUS, Dept Clin Sci Malmo, Malmo, Sweden; [Zhao, Lue Ping; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Palm, Lars] Skane Univ Hosp SUS, Dept Paediat, Sect Paediat Neurol, Malmo, Sweden	Lund University; Skane University Hospital; Fred Hutchinson Cancer Center; Lund University; Skane University Hospital	Lind, A (corresponding author), Lund Univ, CRC, Skane Univ Hosp SUS, Dept Clin Sci Malmo, Malmo, Sweden.	Alexander.lind@med.lu.se	Maziarz, Marlena/AAL-3798-2021; Lernmark, Åke/F-8140-2015; Lind, Alexander/ABA-4178-2020	Maziarz, Marlena/0000-0003-1417-6050; Lernmark, Åke/0000-0003-1735-0499; Elding Larsson, Helena/0000-0003-3306-1742; Lind, Alexander/0000-0002-1473-5468	Alfred Osterlunds stiftelse; Anna och Edvin Bergers Stiftelse; Magnus Bergvalls Stiftelse; Crafoord Foundation; Filip Lundbergs stiftelse; Fredrik och Ingrid Thurings Stiftelse; Royal Physiographic Society of Lund- Hedda and John Forssmans foundation; Gunvor och Josef Aners stiftelse; Jerringfonden; Kronprinsessan Lovisas Forening For Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Linnea och Josef Carlssons Stiftelse; Neuro Sweden; Rune Ljungdahls Stiftelse; Stiftelsen Samariten; Stiftelsen till minne av Personalforeningarna i Holmia Forsakring AB; Gun and Bertil Stohne's foundation; Segerfalk Foundation; Svenska Lakaresallskapet; Region Skane FoU; Tage Bluchers stiftelse; Gyllenstiernska Krapperupsstiftelsen; ALF grants	Alfred Osterlunds stiftelse; Anna och Edvin Bergers Stiftelse; Magnus Bergvalls Stiftelse; Crafoord Foundation; Filip Lundbergs stiftelse; Fredrik och Ingrid Thurings Stiftelse; Royal Physiographic Society of Lund- Hedda and John Forssmans foundation; Gunvor och Josef Aners stiftelse; Jerringfonden; Kronprinsessan Lovisas Forening For Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Linnea och Josef Carlssons Stiftelse; Neuro Sweden; Rune Ljungdahls Stiftelse; Stiftelsen Samariten; Stiftelsen till minne av Personalforeningarna i Holmia Forsakring AB; Gun and Bertil Stohne's foundation; Segerfalk Foundation; Svenska Lakaresallskapet; Region Skane FoU; Tage Bluchers stiftelse; Gyllenstiernska Krapperupsstiftelsen; ALF grants	Our investigation was supported by Alfred Osterlunds stiftelse, Anna och Edvin Bergers Stiftelse, Magnus Bergvalls Stiftelse, Crafoord Foundation, Filip Lundbergs stiftelse, Fredrik och Ingrid Thurings Stiftelse, the Royal Physiographic Society of Lund- Hedda and John Forssmans foundation, Gunvor och Josef Aners stiftelse, Jerringfonden, Kronprinsessan Lovisas Forening For Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond, Linnea och Josef Carlssons Stiftelse, Neuro Sweden, Rune Ljungdahls Stiftelse, Stiftelsen Samariten, Stiftelsen till minne av Personalforeningarna i Holmia Forsakring AB, The Gun and Bertil Stohne's foundation, the Segerfalk Foundation, Svenska Lakaresallskapet, Region Skane FoU, Tage Bluchers stiftelse, Gyllenstiernska Krapperupsstiftelsen, and ALF grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomfim IL, 2017, GENES IMMUN, V18, P75, DOI 10.1038/gene.2017.1; Dauvilliers Y, 2004, NEUROLOGY, V62, P2137, DOI 10.1212/WNL.62.11.2137; Hallberg P, 2019, EBIOMEDICINE, V40, P595, DOI 10.1016/j.ebiom.2019.01.041; Han F, 2012, TISSUE ANTIGENS, V80, P328, DOI 10.1111/j.1399-0039.2012.01948.x; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hong SC, 2007, HUM IMMUNOL, V68, P59, DOI 10.1016/j.humimm.2006.10.006; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Latorre D, 2018, NATURE, V562, P63, DOI 10.1038/s41586-018-0540-1; Luo G, 2018, P NATL ACAD SCI USA, V115, pE12323, DOI 10.1073/pnas.1818150116; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Moss AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071376; Nelson WC, 2015, HUM IMMUNOL, V76, P928, DOI 10.1016/j.humimm.2015.05.001; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Ollila HM, 2015, AM J HUM GENET, V96, P136, DOI 10.1016/j.ajhg.2014.12.010; Ollila HM, 2015, SLEEP, V38, P147, DOI 10.5665/sleep.4342; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Pedersen NW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08774-1; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Regnell SE, 2017, DIABETOLOGIA, V60, P1370, DOI 10.1007/s00125-017-4308-1; Sarkanen TO, 2018, SLEEP MED REV, V38, P177, DOI 10.1016/j.smrv.2017.06.006; Scammell TE, 2015, NEW ENGL J MED, V373, P2654, DOI 10.1056/NEJMra1500587; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith AG, 2014, HUM IMMUNOL, V75, P1040, DOI 10.1016/j.humimm.2014.08.206; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wallenius M, 2019, AUTOIMMUNITY, V52, P185, DOI 10.1080/08916934.2019.1643843; Zhao LP, 2016, DIABETES, V65, P710, DOI 10.2337/db15-1115	36	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222882	10.1371/journal.pone.0222882	http://dx.doi.org/10.1371/journal.pone.0222882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577807	gold, Green Submitted, Green Published			2022-12-26	WOS:000532388000014
J	Melkov, A; Baskar, R; Shachal, R; Alcalay, Y; Abdu, U				Melkov, Anna; Baskar, Raju; Shachal, Rotem; Alcalay, Yehonathan; Abdu, Uri			The organization of Golgi in Drosophila bristles requires microtubule motor protein function and a properly organized microtubule array	PLOS ONE			English	Article							CELL ELONGATION; LAVA LAMP; DYNEIN; TRANSPORT; LOCALIZATION; ORIENTATION; DENDRITES; OUTPOSTS; TRAFFICKING; BIOGENESIS	In the present report, we used highly elongated Drosophila bristle cells to dissect the role of dynein heavy chain (Dhc64C) in Golgi organization. We demonstrated that whereas in the bristle "somal" region Golgi units are composed of cis-, medial, and trans-Golgi compartments ("complete Golgi"), the bristle shaft contains Golgi satellites that lack the trans-Golgi compartment (hereafter referred to as "incomplete Golgi") and which are static and localized at the base area. However, in Dhc64C mutants, the entire bristle shaft was filled with complete Golgi units containing ectopic trans-Golgi components. To further understand Golgi bristle organization, we tested the roles of microtubule (MT) polarity and the Dhc-opposing motor, kinesin heavy chain (Khc). For our surprise, we found that in Khc and Ik2(Dominant-negative) ((DN)) flies in which the polarized organization of MTs is affected, the bristle shaft was filled with complete Golgi, similarly to what is seen in Dhc64C flies. Thus, we demonstrated that MTs and the motor proteins Dhc and Khc are required for bristle Golgi organization. However, the fact that both Dhc64C and Khc flies showed similar Golgi defects calls for an additional work to elucidate the molecular mechanism describing why these factors are required for bristle Golgi organization.	[Melkov, Anna; Baskar, Raju; Shachal, Rotem; Alcalay, Yehonathan; Abdu, Uri] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University	Abdu, U (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	abdu@bgu.ac.il		Abdu, Uri/0000-0003-1226-0750; Baskar, Raju/0000-0003-2450-0598	Israel Science Foundation (ISF) [278/16]	Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Israel Science Foundation (ISF) (grant 278/16) to U.A.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Ayala I, 2017, TISSUE CELL, V49, P133, DOI 10.1016/j.tice.2016.11.007; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Bitan A, 2012, DEVELOPMENT, V139, P1987, DOI 10.1242/dev.076893; Boulay AC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.5; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Dubin-Bar D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-51; Fari K, 2016, BIOL OPEN, V5, P1102, DOI 10.1242/bio.018275; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Gepner J, 1996, GENETICS, V142, P865; Guild GM, 2002, J CELL SCI, V115, P641; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Hanus C, 2016, CURR OPIN NEUROBIOL, V39, P8, DOI 10.1016/j.conb.2016.03.004; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HO WC, 1989, EUR J CELL BIOL, V48, P250; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, J NEUROSCI, V23, P6188; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Kelliher MT, 2018, J CELL BIOL, V217, P2531, DOI 10.1083/jcb.201708096; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Li ZH, 2008, J CELL BIOL, V180, P31, DOI 10.1083/jcb.200707007; Lin CH, 2015, J CELL BIOL, V210, P471, DOI 10.1083/jcb.201411033; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Melkov A, 2018, CELL MOL LIFE SCI, V75, P163, DOI 10.1007/s00018-017-2590-1; Melkov A, 2016, DEVELOPMENT, V143, P4203, DOI 10.1242/dev.138289; Melkov A, 2015, BIOL OPEN, V4, P1696, DOI 10.1242/bio.015206; Nagaraj R, 2012, DEVELOPMENT, V139, P906, DOI 10.1242/dev.074252; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nguyen MM, 2014, MOL BIOL CELL, V25, P2039, DOI 10.1091/mbc.E13-09-0515; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Otani T, 2011, DEV CELL, V20, P219, DOI 10.1016/j.devcel.2011.02.001; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Rabouille C, 1999, J CELL SCI, V112, P3319; Shapiro RS, 2006, DEVELOPMENT, V133, P1467, DOI 10.1242/dev.02318; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Stone MC, 2008, MOL BIOL CELL, V19, P4122, DOI 10.1091/mbc.E07-10-1079; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; Yadav S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005322; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008	51	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223174	10.1371/journal.pone.0223174	http://dx.doi.org/10.1371/journal.pone.0223174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577833	Green Published, gold			2022-12-26	WOS:000532388000023
J	Nagai, K; Yamagata, K; Iseki, K; Moriyama, T; Tsuruya, K; Fujimoto, S; Narita, I; Konta, T; Kondo, M; Kasahara, M; Shibagaki, Y; Asahi, K; Watanabe, T				Nagai, Kei; Yamagata, Kunihiro; Iseki, Kunitoshi; Moriyama, Toshiki; Tsuruya, Kazuhiko; Fujimoto, Shouichi; Narita, Ichiei; Konta, Tsuneo; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi			Cause-specific mortality in the general population with transient dipstick-proteinuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; SUBSEQUENT RISK; LIFETIME RISK; GFR DECLINE; END-POINT; OUTCOMES; CKD; ALBUMINURIA	Recently, changes in urinary albumin and in GFR have been recognized as risk factors for the development of end-stage kidney disease and mortality. Though most clinical epidemiology studies of chronic kidney disease (CKD) used renal function and proteinuria at baseline alone, definitive diagnosis of CKD with multiple measurements intensifies the differences in the risk for mortality between the CKD and non-CKD populations. We hypothesized that a transient diagnosis of proteinuria and reduced renal function each indicate a significantly higher mortality compared to definitive non-CKD as the negative control and lower mortality compared with definitive CKD as the positive control. The present longitudinal study evaluated a general-population cohort of 338,094 persons who received annual health checkups, with a median 4.3-year study period. There were 2,481 deaths, including 510 CVD deaths (20.6%) and 1,328 cancer deaths (53.5%), and mortality risk was evaluated for transient proteinuria and for transiently reduced renal function. The hazard ratios (HRs) for all-cause mortality and cancer mortality were not significant, but that for cardiovascular mortality was significantly higher for transient proteinuria (HR, 1.94 [95% confidence interval, 1.27-2.96] in men and 2.78 [1.50-5.16] in women). On the other hand, transiently reduced renal function was not significant for either cardiovascular mortality risk or cancer mortality risk. We surmise that this is the first study of the mortality risk of transient dipstick proteinuria in a large general-population cohort with cause-specific death registration. Transiently positive proteinuria appears to be a significant risk specifically for cardiovascular mortality compared with definitely negative for proteinuria.	[Nagai, Kei; Yamagata, Kunihiro; Kondo, Masahide] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yamagata, Kunihiro; Iseki, Kunitoshi; Moriyama, Toshiki; Tsuruya, Kazuhiko; Fujimoto, Shouichi; Narita, Ichiei; Konta, Tsuneo; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Design Comprehens Hlth Care Syst Ch, Tsukuba, Ibaraki, Japan; [Iseki, Kunitoshi] Okinawa Heart & Renal Assoc, Naha, Okinawa, Japan; [Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr, Suita, Osaka, Japan; [Tsuruya, Kazuhiko] Nara Med Univ, Nara, Japan; [Fujimoto, Shouichi] Univ Miyazaki, Miyazaki, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Konta, Tsuneo] Yamagata Univ, Grad Sch Med Sci, Yamagata, Japan; [Kasahara, Masato] Nara Med Univ Hosp, Inst Clin & Translat Sci, Nara, Japan; [Shibagaki, Yugo] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; [Asahi, Koichi] Iwate Med Univ, Morioka, Iwate, Japan; [Watanabe, Tsuyoshi] Fukushima Rosai Hosp, Iwaki, Fukushima, Japan	University of Tsukuba; Osaka University; Nara Medical University; University of Miyazaki; Niigata University; Yamagata University; Nara Medical University; Saint Marianna University; Iwate Medical University	Yamagata, K (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.; Yamagata, K (corresponding author), Steering Comm Design Comprehens Hlth Care Syst Ch, Tsukuba, Ibaraki, Japan.	k-yamaga@md.tsukuba.ac.jp	Narita, Ichiei/G-5204-2017; Konta, Tsuneo/AAO-9286-2021	Narita, Ichiei/0000-0001-7692-3096; Yamagata, Kunihiro/0000-0002-7407-0410; Nagai, Kei/0000-0001-5050-5291	Japan Agency for Medical Research and Development (AMED) [JP17ek0310005, JP18ek0310010, JP19ek0310010, JP18lk1010033]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	KY was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP17ek0310005, JP18ek0310010, JP19ek0310010 and JP18lk1010033. (https://www.amed.go.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Carrero JJ, 2017, KIDNEY INT, V91, P244, DOI 10.1016/j.kint.2016.09.037; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Delanaye P, 2017, CLIN KIDNEY J, V10, P370, DOI 10.1093/ckj/sfw154; Delanaye P, 2015, CLIN J AM SOC NEPHRO, V10, P1504, DOI 10.2215/CJN.07860715; Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2016, J AM SOC NEPHROL, V27, P2851, DOI 10.1681/ASN.2015070829; Heerspink HJL, 2015, J AM SOC NEPHROL, V26, P2055, DOI 10.1681/ASN.2014070688; Heerspink HJL, 2014, AM J KIDNEY DIS, V64, P860, DOI 10.1053/j.ajkd.2014.08.018; Inker LA, 2015, CLIN J AM SOC NEPHRO, V10, P1575, DOI 10.2215/CJN.00180115; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Iseki K, 2017, CLIN EXP NEPHROL, P2531, DOI [10.1001/jama.2014.6634, DOI 10.1001/JAMA.2014.6634]; Jun M, 2015, J AM SOC NEPHROL, V26, P2289, DOI 10.1681/ASN.2014040396; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Nagai K, 2014, NEPHROLOGY, V19, P574, DOI 10.1111/nep.12286; Nagai K, 2013, CLIN EXP NEPHROL, V17, P255, DOI 10.1007/s10157-012-0692-5; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Sumida K, 2017, CLIN J AM SOC NEPHRO, V12, P1941, DOI 10.2215/CJN.02720317; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223005	10.1371/journal.pone.0223005	http://dx.doi.org/10.1371/journal.pone.0223005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577820	Green Published, Green Submitted, gold			2022-12-26	WOS:000532388000020
J	Panday, RSN; Minderhoud, TC; Chantalou, DS; Alam, N; Nanayakkara, PWB				Panday, R. S. Nannan; Minderhoud, T. C.; Chantalou, D. S.; Alam, N.; Nanayakkara, P. W. B.			Health related quality of life in sepsis survivors from the Prehospital Antibiotics Against Sepsis (PHANTASi) trial	PLOS ONE			English	Article							SEPTIC SHOCK; INTENSIVE-CARE; SF-36; MORTALITY; DEFINITIONS; DEPRESSION; COMMUNITY; IMPACT; ADULTS	Background Due to the rise in incidence, the long term effect of sepsis are becoming more evident. There is increasing evidence that sepsis may result in an impaired health related quality of life. The aim of this study was to investigate whether health related quality of life is impaired in sepsis survivors and which clinical parameters are associated with the affected health related quality of life. Methods We analyzed 880 Short Form 36 (SF-36) questionnaires that were sent to sepsis survivors who participated in the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. These questionnaires were sent by email, 28 days after discharge. Data entry and statistical analyses were performed in SPSS. The data from the general Dutch population, was obtained from the Netherlands Cancer Institute (NKI-AVL) and served as a control group. Subsequently, 567 sepsis survivors were matched to 567 controls. Non-parametric Wilcoxon signed-rank test was performed to compare these two groups. Within the group, we sought to explain the diminished health related quality of life by factor analysis. Results We found that sepsis survivors have a worse health related quality of life compared to the general Dutch population. This negative effect was more evident for the physical component than the mental component of health related quality of life. We found that health related quality of life was significantly altered by advancing age and female sex. We also found that the total length of stay (in the hospital) and (previous) comorbidity negatively affect the physical component of health related quality of life. Conclusion In our study we found that health related quality of life in sepsis survivors, 28 days after discharge, is severely diminished in comparison with the general Dutch population. The physical domain is severely affected, whereas the mental domain is less influenced. The length of stay, comorbidity, advancing age and female sex all have a negative effect on the Physical Component Scale of the health related quality of life.	[Panday, R. S. Nannan; Minderhoud, T. C.; Chantalou, D. S.; Alam, N.; Nanayakkara, P. W. B.] Vrije Univ Amsterdam, Dept Internal Med, Sect Acute Med, Amsterdam UMC, Amsterdam, Netherlands; [Panday, R. S. Nannan] Univ Amsterdam, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [Panday, R. S. Nannan] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Nanayakkara, PWB (corresponding author), Vrije Univ Amsterdam, Dept Internal Med, Sect Acute Med, Amsterdam UMC, Amsterdam, Netherlands.	p.nanayakkara@vumc.nl		Nanayakkara, Prabath WB/0000-0002-1555-3682				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Alam N, 2017, Acute Med, V16, P164; Alam N, 2018, LANCET RESP MED, V6, P40, DOI 10.1016/S2213-2600(17)30469-1; Alam Nadia, 2016, Acute Med, V15, P176; Brower Roy G, 2009, Crit Care Med, V37, pS422, DOI 10.1097/CCM.0b013e3181b6e30a; Charafeddine R, 2017, PREV MED, V105, P280, DOI 10.1016/j.ypmed.2017.09.016; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc12616; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Dhingra SS, 2009, INT J PUBLIC HEALTH, V54, P16, DOI 10.1007/s00038-009-0002-5; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gerth AMJ, 2019, ANAESTHESIA, V74, P100, DOI 10.1111/anae.14444; Gijsberts CM, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000231; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Granja C, 2004, CRIT CARE, V8, pR91, DOI 10.1186/cc2818; Groenewoudt M, 2014, EUR J EMERG MED, V21, P330, DOI 10.1097/MEJ.0000000000000091; Hajian-Tilaki K, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/ijpvm.IJPVM_197_16; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Heyland DK, 2005, CRIT CARE MED, V33, P1549, DOI 10.1097/01.CCM.0000168609.98847.50; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Kadri SS, 2017, CHEST, V151, P278, DOI 10.1016/j.chest.2016.07.010; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lyons RA, 1999, J PUBLIC HEALTH MED, V21, P41, DOI 10.1093/pubmed/21.1.41; Myhren H, 2010, CRIT CARE MED, V38, P1554, DOI 10.1097/CCM.0b013e3181e2c8b1; Needham DM, 2014, AM J RESP CRIT CARE, V189, P1214, DOI 10.1164/rccm.201401-0158OC; Nesseler N, 2013, INTENS CARE MED, V39, P881, DOI 10.1007/s00134-013-2815-1; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Paratz JD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004966; Perkins JJ, 1998, J CLIN EPIDEMIOL, V51, P969, DOI 10.1016/S0895-4356(98)00088-2; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tiru B, 2015, PHARMACOECONOMICS, V33, P925, DOI 10.1007/s40273-015-0282-y; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Ware JE, 1994, SF36 HLTH I NEW ENGL; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222450	10.1371/journal.pone.0222450	http://dx.doi.org/10.1371/journal.pone.0222450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574094	gold, Green Published			2022-12-26	WOS:000532376700008
J	Pilia, M; Kullberg, J; Ahlstrom, H; Malmberg, F; Ekstrom, S; Strand, R				Pilia, Martino; Kullberg, Joel; Ahlstrom, Hakan; Malmberg, Filip; Ekstrom, Simon; Strand, Robin			Average volume reference space for large scale registration of whole-body magnetic resonance images	PLOS ONE			English	Article							SIMULATION; ATROPHY	Background and objectives The construction of whole-body magnetic resonance (MR) imaging atlases allows to perform statistical analysis with applications in anomaly detection, longitudinal, and correlation studies. Atlas-based methods require a common coordinate system to which all the subjects are mapped through image registration. Optimisation of the reference space is an important aspect that affects the subsequent analysis of the registered data, and having a reference space that is neutral with respect to local tissue volume is valuable in correlation studies. The purpose of this work is to generate a reference space for whole-body imaging that has zero voxel-wise average volume change when mapped to a cohort. Methods This work proposes an approach to register multiple whole-body images to a common template using volume changes to generate a synthetic reference space, starting with an initial reference and refining it by warping it with a deformation that brings the voxel-wise average volume change associated to the mappings of all the images in the cohort to zero. Results Experiments on fat/water separated whole-body MR images show how the method effectively generates a reference space neutral with respect to volume changes, without reducing the quality of the registration nor introducing artefacts in the anatomy, while providing better alignment when compared to an implicit reference groupwise approach. Conclusions The proposed method allows to quickly generate a reference space neutral with respect to local volume changes, that retains the registration quality of a sharp template, and that can be used for statistical analysis of voxel-wise correlations in large datasets of whole-body image data.	[Pilia, Martino; Kullberg, Joel; Ahlstrom, Hakan; Malmberg, Filip; Ekstrom, Simon; Strand, Robin] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Pilia, Martino; Malmberg, Filip; Strand, Robin] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden; [Kullberg, Joel; Ahlstrom, Hakan] Antaros Med, Uppsala, Sweden	Uppsala University; Uppsala University	Pilia, M (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.; Pilia, M (corresponding author), Uppsala Univ, Dept Informat Technol, Uppsala, Sweden.	martino.pilia.2834@student.uu.se	Kullberg, Joel/ABE-3997-2021	Strand, Robin/0000-0001-7764-1787; Pilia, Martino/0000-0002-6842-9140	Swedish Research Council [2016-01040]; Swedish Heart-Lung Foundation [HLF 20170492]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	Partial funding for this work was provided to H.A. by the Swedish Research Council (https://www.vr.se), grant number 2016-01040, and by the Swedish Heart-Lung Foundation (https://www.hjart-lungfonden.se), grant number HLF 20170492. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. J.K. and H.A. are cofounders, co-owners of and employed at Antaros Medical AB, BioVenture Hub, Molndal, Sweden. The funder provided support in the form of salaries for authors J.K. and H.A., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. There was no additional external funding received for this study.	Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Balci SK, 2006, FREE FORM B SPLINE D, V10, P23; Camara-Rey O, 2006, LECT NOTES COMPUT SC, V4191, P937; Carlbom L., 2018, THESIS; Christensen GE, 2001, IEEE T MED IMAGING, V20, P568, DOI 10.1109/42.932742; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ekstrom S, 2018, PREPRINT; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Huizinga W, 2016, MED IMAGE ANAL, V29, P65, DOI 10.1016/j.media.2015.12.004; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Karacali B, 2006, IEEE T MED IMAGING, V25, P649, DOI 10.1109/TMI.2006.873221; Khanal B, 2016, NEUROIMAGE, V134, P35, DOI 10.1016/j.neuroimage.2016.03.061; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lind L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43690-w; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Modersitzki J., 2004, NUMER MATH SCI COMP; Rohlfing T, 2012, IEEE T MED IMAGING, V31, P153, DOI 10.1109/TMI.2011.2163944; Smith ADC, 2003, PROC SPIE, V5032, P481, DOI 10.1117/12.480412; Strand R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169966; van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Vovk U, 2006, NEUROIMAGE, V32, P54, DOI 10.1016/j.neuroimage.2006.03.020; Wu GR, 2011, NEUROIMAGE, V56, P1968, DOI 10.1016/j.neuroimage.2011.03.050	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222700	10.1371/journal.pone.0222700	http://dx.doi.org/10.1371/journal.pone.0222700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574093	gold, Green Published			2022-12-26	WOS:000532376700011
J	Geidenstam, N; Hsu, YHH; Astley, CM; Mercader, JM; Ridderstrale, M; Gonzalez, ME; Gonzalez, C; Hirschhorn, JN; Salem, RM				Geidenstam, Nina; Hsu, Yu-Han H.; Astley, Christina M.; Mercader, Josep M.; Ridderstrale, Martin; Gonzalez, Maria E.; Gonzalez, Clicerio; Hirschhorn, Joel N.; Salem, Rany M.			Using metabolite profiling to construct and validate a metabolite risk score for predicting future weight gain	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; INSULIN-RESISTANCE; BRANCHED-CHAIN; OBESE ADULTS; LOCI; GLUCOSE; DIET; METAANALYSIS; SENSITIVITY	Background Excess weight gain throughout adulthood can lead to adverse clinical outcomes and are influenced by complex factors that are difficult to measure in free-living individuals. Metabolite profiling offers an opportunity to systematically discover new predictors for weight gain that are relatively easy to measure compared to traditional approaches. Methods and results Using baseline metabolite profiling data of middle-aged individuals from the Framingham Heart Study (FHS; n = 1,508), we identified 42 metabolites associated (p < 0.05) with longitudinal change in body mass index (BMI). We performed stepwise linear regression to select 8 of these metabolites to build a metabolite risk score (MRS) for predicting future weight gain. We replicated the MRS using data from the Mexico City Diabetes Study (MCDS; n = 768), in which one standard deviation increase in the MRS corresponded to -0.03 increase in BMI (kg/m(2)) per year (i.e. -0.09 kg/year for a 1.7 m adult). We observed that none of the available anthropometric, lifestyle, and glycemic variables fully account for the MRS prediction of weight gain. Surprisingly, we found the MRS to be strongly correlated with baseline insulin sensitivity in both cohorts and to be negatively predictive of T2D in MCDS. Genome-wide association study of the MRS identified 2 genome-wide (p < 5 x 10(-8)) and 5 suggestively (p < 1 x 10(-6)) significant loci, several of which have been previously linked to obesity-related phenotypes. Conclusions We have constructed and validated a generalizable MRS for future weight gain that is an independent predictor distinct from several other known risk factors. The MRS captures a composite biological picture of weight gain, perhaps hinting at the anabolic effects of preserved insulin sensitivity. Future investigation is required to assess the relationships between MRS-predicted weight gain and other obesity-related diseases.	[Geidenstam, Nina; Ridderstrale, Martin] Lund Univ, Inst Clin Sci, Clin Obes, Malmo, Sweden; [Hsu, Yu-Han H.; Hirschhorn, Joel N.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hsu, Yu-Han H.; Astley, Christina M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hsu, Yu-Han H.; Astley, Christina M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Hsu, Yu-Han H.; Astley, Christina M.; Mercader, Josep M.; Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Metab, Cambridge, MA 02142 USA; [Hsu, Yu-Han H.; Astley, Christina M.; Mercader, Josep M.; Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Med, Cambridge, MA 02142 USA; [Hsu, Yu-Han H.; Astley, Christina M.; Mercader, Josep M.; Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Populat Genet, Cambridge, MA 02142 USA; [Mercader, Josep M.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Mercader, Josep M.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Gonzalez, Maria E.; Gonzalez, Clicerio] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Gonzalez, Maria E.; Gonzalez, Clicerio] Ctr Estudios Diabet, Mexico City, DF, Mexico; [Salem, Rany M.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA	Lund University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Instituto Nacional de Salud Publica; University of California System; University of California San Diego	Hirschhorn, JN (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Hirschhorn, JN (corresponding author), Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.; Hirschhorn, JN (corresponding author), Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA.; Hirschhorn, JN (corresponding author), Broad Inst Harvard & MIT, Program Metab, Cambridge, MA 02142 USA.; Hirschhorn, JN (corresponding author), Broad Inst Harvard & MIT, Program Med, Cambridge, MA 02142 USA.; Hirschhorn, JN (corresponding author), Broad Inst Harvard & MIT, Program Populat Genet, Cambridge, MA 02142 USA.; Salem, RM (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA.	Joel.Hirschhorn@childrens.harvard.edu; rsalem@ucsd.edu		Salem, Rany/0000-0001-8816-6862; /0000-0002-5063-8470	National Heart, Lung, and Blood Institute [F31HL126581, R00HL122515]; National Institute of Diabetes and Digestive and Kidney Diseases [T32DK110919, K12DK094721, R01DK075787]; Endocrine Scholars Award; Doris Duke Charitable Foundation [215205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL126581, R00HL122515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK110919, K12DK094721, R01DK075787] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Endocrine Scholars Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Broad Metabolomics Platform and SIGMA T2D Consortium for sharing data resources. This work was supported by the National Heart, Lung, and Blood Institute grants F31HL126581 (Y.H.H.) and R00HL122515 (R.M. S), National Institute of Diabetes and Digestive and Kidney Diseases grants T32DK110919 (Y.H.H.), K12DK094721 (C.M.A), and R01DK075787 (J.N. H.), Endocrine Scholars Award (C.M.A.), and Doris Duke Charitable Foundation (http://www.ddcf.org) grant 215205 (J.N.H.). Genome-wide genotyping and metabolite profiling of the MCDS cohort was performed as part of the Slim Initiative in Genomic Medicine for the Americas (SIGMA) T2D Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, METABOLOMICS, V10, P141, DOI 10.1007/s11306-013-0565-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Astley CM, 2018, CLIN CHEM, V64, P192, DOI 10.1373/clinchem.2017.280727; Bachlechner U, 2017, EUR J PUBLIC HEALTH, V27, P768, DOI 10.1093/eurpub/ckw216; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chaput JP, 2008, AM J CLIN NUTR, V87, P303, DOI 10.1093/ajcn/87.2.303; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Dombrowski SU, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2646; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Geidenstam N, 2017, INT J OBESITY, V41, P1369, DOI 10.1038/ijo.2017.124; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Ho JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148361; Hsu YHH, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006734; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kang HM, EPACTS EFFICIENT PAR, DOI [10.1006/geno.2000.6196, DOI 10.1006/GENO.2000.6196]; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lauffart B, 2003, GENOMICS, V81, P192, DOI 10.1016/S0888-7543(02)00039-3; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mandviwala T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0575-4; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Menni C, 2017, OBESITY, V25, P1618, DOI 10.1002/oby.21922; Mozaffarian D, 2015, AM J CLIN NUTR, V101, P398, DOI 10.3945/ajcn.114.094557; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rukh G, 2016, INT J OBESITY, V40, P252, DOI 10.1038/ijo.2015.180; SWINBURN BA, 1991, J CLIN INVEST, V88, P168, DOI 10.1172/JCI115274; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van Buuren S, 2011, J STAT SOFTW, V45, P1; Verweij N, 2014, CIRC-CARDIOVASC GENE, V7, P475, DOI 10.1161/CIRCGENETICS.113.000373; Wahl S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0282-y; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wedick NM, 2009, OBESITY, V17, P1609, DOI 10.1038/oby.2008.666; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Yang SJ, 2014, J NUTR BIOCHEM, V25, P66, DOI 10.1016/j.jnutbio.2013.09.004; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zhao H, 2016, OBES SCI PRACT, V2, P309, DOI 10.1002/osp4.63	61	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222445	10.1371/journal.pone.0222445	http://dx.doi.org/10.1371/journal.pone.0222445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560688	Green Published, Green Submitted, gold			2022-12-26	WOS:000532353700010
J	Yokochi, Y; Sugiura, K; Takemura, K; Yoshida, K; Hara, S; Wakabayashi, K; Kitao, A; Hisabori, T				Yokochi, Yuichi; Sugiura, Kazunori; Takemura, Kazuhiro; Yoshida, Keisuke; Hara, Satoshi; Wakabayashi, Ken-ichi; Kitao, Akio; Hisabori, Toru			Impact of key residues within chloroplast thioredoxin-f on recognition for reduction and oxidation of target proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thioredoxin; redox regulation; chloroplast; oxidation-reduction (redox); photosynthesis; atypical Cys His-rich thioredoxin; disulfide bond; protein-protein interaction; target selectivity	PLASTIDIAL THIOREDOXINS; LIGHT-INTENSITY; AMINO-ACID; ARABIDOPSIS; IDENTIFICATION; EVOLUTIONARY; FERREDOXIN; MUTATION; ENZYMES; FOLD	Thioredoxin (Trx) is a redox-responsive protein that modulates the activities of its target proteins mostly by reducing their disulfide bonds. In chloroplasts, five Trx isoforms (Trx-f, Trx-m, Trx-x, Trx-y, and Trx-z) regulate various photosynthesis-related enzymes with distinct target selectivity. To elucidate the determinants of the target selectivity of each Trx isoform, here we investigated the residues responsible for target recognition by Trx-f, the most well-studied chloroplast-resident Trx. As reported previously, we found that positively-charged residues on the Trx-f surface are involved in the interactions with its targets. Moreover, several residues that are specifically conserved in Trx-f (e.g. Cys-126 and Thr-158) were also involved in interactions with target proteins. The validity of these residues was examined by the molecular dynamics simulation. In addition, we validated the impact of these key residues on target protein reduction by studying (i) Trx-m variants into which we introduced the key residues for Trx-f and (ii) Trx-like proteins, named atypical Cys His-rich Trx 1 (ACHT1) and ACHT2a, that also contain these key residues. These artificial or natural protein variants could reduce Trx-f-specific targets, indicating that the key residues for Trx-f are critical for Trx-f-specific target recognition. Furthermore, we demonstrate that ACHT1 and ACHT2a efficiently oxidize some Trx-f-specific targets, suggesting that its target selectivity also contributes to the oxidative regulation process. Our results reveal the key residues for Trx-f-specific target recognition and uncover ACHT1 and ACHT2a as oxidation factors of their target proteins, providing critical insight into redox regulation of photosynthesis.	[Yokochi, Yuichi; Sugiura, Kazunori; Yoshida, Keisuke; Wakabayashi, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Nagatsuta Cho 4259-R1-8, Yokohama, Kanagawa 2268503, Japan; [Yokochi, Yuichi; Yoshida, Keisuke; Hara, Satoshi; Wakabayashi, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuta Cho 4259-R1-8, Yokohama, Kanagawa 2268503, Japan; [Takemura, Kazuhiro; Kitao, Akio] Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Nagatsuta Cho 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Yoshida, Keisuke/E-5231-2014; Wakabayashi, Ken-ichi/AAI-8617-2021; Kitao, Akio/B-8371-2008; Wakabayashi, Ken-ichi/D-2440-2015; Hisabori, Toru/E-5205-2014; Hara, Satoshi/C-1341-2015	Yoshida, Keisuke/0000-0001-6542-6254; Kitao, Akio/0000-0002-5221-0806; Wakabayashi, Ken-ichi/0000-0002-1025-9249; Hisabori, Toru/0000-0003-2046-0277; Takemura, Kazuhiro/0000-0001-5946-4502; Hara, Satoshi/0000-0001-6275-6469	RIKEN Advanced Institute for Computational Science through the HPCI System Research Project [hp150270, hp160207, hp170254, hp180201, hp190181]	RIKEN Advanced Institute for Computational Science through the HPCI System Research Project	We thank the Biomaterials Analysis Division, Tokyo Institute of Technology, for supporting DNA sequencing analysis, and the Suzukakedai Materials Analysis Division, Tokyo Institute of Technology, for supporting MS analysis. The computations were partly performed using the supercomputers at the RCCS, National Institute of Natural Science, and ISSP, University of Tokyo. This research also used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research Project IDs hp150270, hp160207, hp170254, hp180201, and hp190181.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Capitani G, 2000, J MOL BIOL, V302, P135, DOI 10.1006/jmbi.2000.4006; Cerveau D, 2016, PLANT SCI, V252, P30, DOI 10.1016/j.plantsci.2016.07.003; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; Chibani K, 2012, PLANT PHYSIOL, V159, P592, DOI 10.1104/pp.112.197723; Chibani K, 2009, MOL PLANT, V2, P308, DOI 10.1093/mp/ssn076; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Dangoor I, 2012, PLANT CELL, V24, P1894, DOI 10.1105/tpc.112.097139; Dangoor I, 2009, PLANT PHYSIOL, V149, P1240, DOI 10.1104/pp.108.128314; DELAMOTTEGUERY F, 1991, EUR J BIOCHEM, V196, P287; Diaz MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02468-2; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Eliyahu E, 2015, P NATL ACAD SCI USA, V112, P12876, DOI 10.1073/pnas.1515513112; Geck MK, 2000, J BIOL CHEM, V275, P18034, DOI 10.1074/jbc.M001936200; Geck RK, 1996, J BIOL CHEM, V271, P24736, DOI 10.1074/jbc.271.40.24736; Geigenberger P, 2017, TRENDS PLANT SCI, V22, P249, DOI 10.1016/j.tplants.2016.12.008; Gutle DD, 2017, PLANT SCI, V255, P1, DOI 10.1016/j.plantsci.2016.11.003; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020; JACQUOT JP, 1978, FEBS LETT, V96, P243, DOI 10.1016/0014-5793(78)80410-4; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lemaire SD, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120171; Lindahl M, 2009, J PROTEOMICS, V72, P416, DOI 10.1016/j.jprot.2009.01.003; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Perez-Ruiz JM, 2017, P NATL ACAD SCI USA, V114, P12069, DOI 10.1073/pnas.1706003114; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; MILLS JD, 1980, FEBS LETT, V112, P173, DOI 10.1016/0014-5793(80)80173-6; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mora-Garcia S, 1998, J BIOL CHEM, V273, P16273, DOI 10.1074/jbc.273.26.16273; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Ojeda V, 2018, MOL PLANT, V11, P1377, DOI 10.1016/j.molp.2018.09.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Schroter Y, 2010, PROTEOMICS, V10, P2191, DOI 10.1002/pmic.200900678; SCHURMANN P, 1981, EUR J BIOCHEM, V116, P37, DOI 10.1111/j.1432-1033.1981.tb05297.x; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Sugiura K, 2019, J BIOL CHEM, V294, P12091, DOI 10.1074/jbc.RA119.007616; Takemura K, 2012, J PHYS CHEM B, V116, P6279, DOI 10.1021/jp301100g; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Vanacker H, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120183; Vaseghi MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.38194; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wenderoth I, 1997, J BIOL CHEM, V272, P26985, DOI 10.1074/jbc.272.43.26985; Wimmelbacher M, 2014, J EXP BOT, V65, P2405, DOI 10.1093/jxb/eru122; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; WOLOSIUK RA, 1979, J BIOL CHEM, V254, P1627; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998; Yoshida K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7110153; Yoshida K, 2018, P NATL ACAD SCI USA, V115, pEB296, DOI 10.1073/pnas.1808284115; Yoshida K, 2017, BIOCHEM J, V474, P1347, DOI 10.1042/BCJ20161089; Yoshida K, 2016, P NATL ACAD SCI USA, V113, pE3967, DOI 10.1073/pnas.1604101113; Yoshida K, 2015, J BIOL CHEM, V290, P19540, DOI 10.1074/jbc.A115.647545	67	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17437	17450		10.1074/jbc.RA119.010401	http://dx.doi.org/10.1074/jbc.RA119.010401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31597700	Green Published, hybrid			2022-12-26	WOS:000503173500022
J	Custodio, E; Herrador, Z; Nkunzimana, T; Weziak-Bialowolska, D; Perez-Hoyos, A; Kayitakire, F				Custodio, Estefania; Herrador, Zaida; Nkunzimana, Tharcisse; Weziak-Bialowolska, Dorota; Perez-Hoyos, Ana; Kayitakire, Francois			Children's dietary diversity and related factors in Rwanda and Burundi: A multilevel analysis using 2010 Demographic and Health Surveys	PLOS ONE			English	Article							NUTRITIONAL-STATUS; FEEDING PRACTICES; MARKET ACCESS; DETERMINANTS; IMPACT	Background One of the reported causes of high malnutrition rates in Burundi and Rwanda is children's inadequate dietary habits. The diet of children may be affected by individual characteristics and by the characteristics of the households and the communities in which they live. We used the minimum dietary diversity of children (MDD-C) indicator as a proxy of diet quality aiming at: 1) assess how much of the observed variation in MDD-C was attributed to community clustering, and 2) to identify the MDD-C associated factors. Methods Data was obtained from the 2010 Demographic and Health Surveys of Burundi and Rwanda, from which only children 6 to 23 months from rural areas were analysed. The MDD-C was calculated according to the 2007 WHO/UNICEF guidelines. We computed the intra-class coefficient to assess the percentage of variation attributed to the clustering effect of living in the same community. And then we applied two-level logit regressions to investigate the association between MDD-C and potential risk factors following the hierarchical survey structure of DHS. Results The MDD-C was 23% in rural Rwanda and 16% in rural Burundi, and a 29% of its variation in Rwanda and 17% in Burundi was attributable to community clustering. Increasing age and living standards were associated with higher MDD-C in both countries, and only in Burundi also increasing level of education of the mother's partner. In Rwanda alone, the increasing ages of the head of the household and of the mother at first birth were also positively associated with it. Despite the identification of an important proportion of the MDD-C variation due to clustering, we couldn't identify any community variable significantly associated with it. Conclusions We recommend further research using hierarchical models, and to integrate dietary diversity in holistic interventions which take into account both the household's and the community's characteristics the children live in.	[Custodio, Estefania; Nkunzimana, Tharcisse; Perez-Hoyos, Ana; Kayitakire, Francois] European Commiss, Joint Res Ctr, Ispra, Italy; [Herrador, Zaida] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Weziak-Bialowolska, Dorota] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Sustainabil & Hlth Initiat SHINE, Boston, MA USA	European Commission Joint Research Centre; EC JRC ISPRA Site; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Harvard University; Harvard T.H. Chan School of Public Health	Custodio, E (corresponding author), European Commiss, Joint Res Ctr, Ispra, Italy.	ecustodio2014@gmail.com	Weziak-Bialowolska, Dorota/AAF-7827-2020; Kayitakire, Francois/ABC-4911-2021	Weziak-Bialowolska, Dorota/0000-0003-2711-2283; 				Abay K, 2017, J DEV STUD, V53, P1414, DOI 10.1080/00220388.2016.1251586; Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Afolabi KD, 2013, SUSTAINABLE FOOD SEC, P217; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Bizimana C, 2012, TRENDS KEY AGR RURAL; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Burgert CR, 2012, COMPUT ENVIRON URBAN, V36, P626, DOI 10.1016/j.compenvurbsys.2012.09.002; Curtis M., 2013, INDEP DEV POLICY ANA; Danielson J. J., 2011, GLOBAL MULTIRESOLUTI, DOI 10.3133/ofr20111073; Decancq K, 2013, ECONOMET REV, V32, P7, DOI 10.1080/07474938.2012.690641; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Frempong RB, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00298; Headey D., 2014, 70 INT FOOD POL RES; Herrador Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133435; Hirvonen K., 2012, ETHIOPIA; Hirvonen K, 2017, AGR ECON-BLACKWELL, V48, P469, DOI 10.1111/agec.12348; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; ICF International.ICF International.ICF InternationalIC NI of S of R (NISR), 2012, RWAND DEM HLTH SURV; Issaka AI, 2015, MATERN CHILD NUTR, V11, P14, DOI 10.1111/mcn.12194; Johnson K, 2014, APPL GEOGR, V54, P209, DOI 10.1016/j.apgeog.2014.08.007; Kennedy G., 2017, NUTR BASELINE SURVEY; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Koppmair S, 2017, PUBLIC HEALTH NUTR, V20, P325, DOI [10.1017/S1368980016002135, 10.1017/s1368980016002135]; Kumar N, 2015, J DEV STUD, V51, P1060, DOI 10.1080/00220388.2015.1018901; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Ministry of Finance and Economic Planning (MINECOFIN) NI of S of R (NISR), 2012, RWAND 4 POP HOUS CEN; Na MZ, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12696; Na MZ, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12463; National Institure of Statistics of Rwanda (NISR), 2016, ENV NAT RES; National Institute of Statistics of Rwanda (NIRS), 2016, RWAND DEM HLTH SURV; Ng CS, 2012, PUBLIC HEALTH NUTR, V15, P827, DOI 10.1017/S1368980011002485; Nkunzimana T., 2016, POVERTY WELL BEING E, P61; Oniang'o RK, 2003, ASIA PAC J CLIN NUTR, V12, P331; Rakotonirainy NH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200235; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Republic du Burundi. Ministere de l'Interieur, 2008, REC GEN POP HAB BUR, V3; Robert RC, 2017, FASEB J, V31; San Pedro Paula, INVESTING AGR BURUND; Sawadogo SP, 2010, NUTRITION, V26, P746, DOI 10.1016/j.nut.2010.02.010; UNICEF, 2021, UNICEF DAT MON SIT C; United Nations Children's Fund (UNICEF), 2003, STRAT RED MAT CHILD; United States Agency for International Development (USAID), 2015, US GOV FEED FUT PROJ; United States Agency for International Development (USAID), DHS PROGR; USAID, 2020, GUID DHS STAT DEM HL, P1; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; Van Velthuizen H., 2007, MAPPING BIOPHYSICAL; World Health Organization, 2005, GUID PRINC FEED NONB; World Health Organization (WHO), 2014, 2012 2013 BIENN REP	48	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223237	10.1371/journal.pone.0223237	http://dx.doi.org/10.1371/journal.pone.0223237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596868	Green Submitted, Green Published, gold			2022-12-26	WOS:000532444100025
J	Smith, RP; Easson, C; Lyle, SM; Kapoor, R; Donnelly, CP; Davidson, EJ; Parikh, E; Lopez, JV; Tartar, JL				Smith, Robert P.; Easson, Cole; Lyle, Sarah M.; Kapoor, Ritishka; Donnelly, Chase P.; Davidson, Eileen J.; Parikh, Esha; Lopez, Jose, V; Tartar, Jaime L.			Gut microbiome diversity is associated with sleep physiology in humans	PLOS ONE			English	Article							INTERLEUKIN-6; CYTOKINES; DURATION; TRANSPLANTATION; INFLAMMATION; DEPRIVATION; HEALTH; BRAIN; AXIS; METABOLITES	The human gut microbiome can influence health through the brain-gut-microbiome axis. Growing evidence suggests that the gut microbiome can influence sleep quality. Previous studies that have examined sleep deprivation and the human gut microbiome have yielded conflicting results. A recent study found that sleep deprivation leads to changes in gut microbiome composition while a different study found that sleep deprivation does not lead to changes in gut microbiome. Accordingly, the relationship between sleep physiology and the gut microbiome remains unclear. To address this uncertainty, we used actigraphy to quantify sleep measures coupled with gut microbiome sampling to determine how the gut microbiome correlates with various measures of sleep physiology. We measured immune system biomarkers and carried out a neurobehavioral assessment as these variables might modify the relationship between sleep and gut microbiome composition. We found that total microbiome diversity was positively correlated with increased sleep efficiency and total sleep time, and was negatively correlated with wake after sleep onset. We found positive correlations between total microbiome diversity and interleukin-6, a cytokine previously noted for its effects on sleep. Analysis of microbiome composition revealed that within phyla richness of Bacteroidetes and Firmicutes were positively correlated with sleep efficiency, interleukin-6 concentrations and abstract thinking. Finally, we found that several taxa (Lachnospiraceae, Corynebacterium, and Blautia) were negatively correlated with sleep measures. Our findings initiate linkages between gut microbiome composition, sleep physiology, the immune system and cognition. They may lead to mechanisms to improve sleep through the manipulation of the gut microbiome.	[Smith, Robert P.; Easson, Cole; Donnelly, Chase P.; Davidson, Eileen J.; Lopez, Jose, V] Nova Southeastern Univ, Halmos Coll Nat Sci & Oceanog, Dept Biol Sci, Ft Lauderdale, FL 33314 USA; [Easson, Cole] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Lyle, Sarah M.; Kapoor, Ritishka; Parikh, Esha; Tartar, Jaime L.] Nova Southeastern Univ, Dept Psychol & Neurosci, Ft Lauderdale, FL 33314 USA	Nova Southeastern University; Middle Tennessee State University; Nova Southeastern University	Tartar, JL (corresponding author), Nova Southeastern Univ, Dept Psychol & Neurosci, Ft Lauderdale, FL 33314 USA.	tartar@nova.edu		Tartar, Jaime/0000-0002-3452-0579	Presidents Faculty Research and Development Grant through Nova Southeastern University [335411]	Presidents Faculty Research and Development Grant through Nova Southeastern University	This research was supported by a Presidents Faculty Research and Development Grant #335411 through Nova Southeastern University awarded to JLT. This program played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Presidents Faculty Research and Development Grant #335411 through Nova Southeastern University.	Anderson JR, 2017, SLEEP MED, V38, P104, DOI 10.1016/j.sleep.2017.07.018; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Armitage R., 2001, SLEEP, V4, P33; Bajaj JS, 2019, GASTROENTEROLOGY, V156, P1921, DOI 10.1053/j.gastro.2019.01.033; Basner M, 2015, AEROSP MED HUM PERF, V86, P942, DOI 10.3357/AMHP.4343.2015; BAUER J, 1994, CLIN INVESTIGATOR, V72, P315; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benedict C, 2016, MOL METAB, V5, P1175, DOI 10.1016/j.molmet.2016.10.003; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2016, MOL METAB, V5, P743, DOI 10.1016/j.molmet.2016.05.011; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Ferrie JE, 2011, SLEEP, V34, P565, DOI 10.1093/sleep/34.5.565; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; Gobin CM, 2015, J SLEEP RES, V24, P535, DOI 10.1111/jsr.12302; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; He Z, 2017, WORLD J GASTROENTERO, V23, P3565, DOI 10.3748/wjg.v23.i19.3565; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kang DW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42183-0; Kapsimalis F, 2005, CURR OPIN PULM MED, V11, P481, DOI 10.1097/01.mcp.0000183062.98665.6b; Knutson KL, 2017, SLEEP HEALTH, V3, P234, DOI 10.1016/j.sleh.2017.05.011; Ko CY, 2019, CLIN SCI, V133, P905, DOI [10.1042/CS20180891, 10.1042/cs20180891]; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Levy M, 2017, CURR OPIN MICROBIOL, V35, P8, DOI 10.1016/j.mib.2016.10.003; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Menees Stacy, 2018, F1000Res, V7, DOI 10.12688/f1000research.14592.1; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Moreno-Indias I, 2015, EUR RESPIR J, V45, P1055, DOI 10.1183/09031936.00184314; Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609; Nelson KE, 2015, ENCYCLOPEDIA OF META; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Oksanen J., 2010, R PROJ ORG ACESS EM, V23, P2010; Parkar SG, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020041; Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405; Ranjbaran Z, 2007, INFLAMM RES, V56, P51, DOI 10.1007/s00011-006-6067-1; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.93, 10.1038/NMICROBIOL.2016.93]; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Sano C, 2009, AM J CLIN NUTR, V90, p728S, DOI 10.3945/ajcn.2009.27462F; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3; Tahara Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19836-7; Tartar JL, 2015, SLEEP HEALTH, V1, P249, DOI 10.1016/j.sleh.2015.09.007; Team R. c, 2013, R A LANGUAGE AND ENV; Ursin R, 2002, SLEEP MED REV, V6, P57, DOI 10.1053/smrv.2001.0174; Valles-Colomer M, 2019, NAT MICROBIOL, P1, DOI [10.1038/s41564-018-0331-3, DOI 10.1038/S41564-018-0331-3]; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019; Yeung CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138746; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Yunes RA, 2016, ANAEROBE, V42, P197, DOI 10.1016/j.anaerobe.2016.10.011; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang SL, 2017, P NATL ACAD SCI USA, V114, pE1564, DOI 10.1073/pnas.1620673114; Zhu XQ, 2017, ONCOTARGET, V8, P53829, DOI 10.18632/oncotarget.17754	83	79	87	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0222394	10.1371/journal.pone.0222394	http://dx.doi.org/10.1371/journal.pone.0222394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JF4OE	31589627	Green Published, gold			2022-12-26	WOS:000491366400001
J	Zhai, QL; Fan, JW; Lin, QL; Liu, X; Li, JT; Hong, RX; Wang, SS				Zhai, Qinglian; Fan, Jiawen; Lin, Qiulian; Liu, Xia; Li, Jinting; Hong, Ruoxi; Wang, Shusen			Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer	PLOS ONE			English	Article							SURVIVAL; RATIO; MICROENVIRONMENT; CARCINOMA; SUBTYPES; THERAPY	Background/Aim The aim of this study is to determine the relationship between stromal types, PD-L1 status and clinicopathological characteristics in patients with different molecular subtypes of breast cancer. Materials and methods Protein expression levels of PD-L1 were determined by immunohistochemistry assay. Stromal type was classified based on the maturity of the tumor stroma. Results Different subtypes of breast cancer had distinct stromal types. Tumors from patients with mature stroma had lower pathological N stage and AJCC stage, more frequent high p53 expression and positive stromal PD-L1 staining. Hormone receptor negative patients had higher frequency of positive stromal PD-L1 staining. Stromal PD-L1 status was also associated with different breast cancer subtypes and EGFR expression level. Importantly, our data revealed that stromal types and stromal PD-L1 status were independent prognostic factors. Conclusion This study highlighted the importance of stromal types and stromal PD-L1 status in determining clinical outcomes in patients with breast cancer, and suggested that stromal type classification might be readily incorporated into routine clinical risk assessment following curative resection or optimal therapeutic design.	[Zhai, Qinglian; Lin, Qiulian; Liu, Xia; Hong, Ruoxi; Wang, Shusen] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China; [Fan, Jiawen; Li, Jinting] Peking Univ, Canc Hosp & Inst, Lab Mol Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Peking University	Hong, RX; Wang, SS (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China.	hongrx@sysucc.org.cn; wangshus@sysucc.org.cn			National Natural Science Foundation of China [81602342, 81802780]; Natural Science Foundation of Guangdong Province, China [2017A030313466]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (81602342, 81802780), Natural Science Foundation of Guangdong Province, China (2017A030313466).	Ahn S, 2012, TUMOR BIOL, V33, P1573, DOI 10.1007/s13277-012-0411-6; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Chen IX, 2019, P NATL ACAD SCI US; Cimino-Mathews A, 2015, ONCOLOGY-NY, V29, P375; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; de Kruijf EM, 2014, MOL ONCOL, V8, P1014, DOI 10.1016/j.molonc.2014.03.022; Dekker TJA, 2013, BREAST CANCER RES TR, V139, P371, DOI 10.1007/s10549-013-2571-5; Dill EA, 2017, AM J SURG PATHOL, V41, P334, DOI 10.1097/PAS.0000000000000780; Dong HD, 1999, NAT MED, V5, P1365; Emens LA, 2012, EXPERT REV ANTICANC, V12, P1597, DOI [10.1586/era.12.147, 10.1586/ERA.12.147]; Fu R, 2019, THERM SCI ENG PROG, V10, P1, DOI 10.1016/j.tsep.2019.01.001; Gao Z, 2018, ANN SURG; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Kim JB, 2005, TUMOR BIOL, V26, P173, DOI 10.1159/000086950; Lee HH, 2019, CANCER CELL, V36, P168, DOI 10.1016/j.ccell.2019.06.008; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Matikas A, 2019, CLIN CANC RES; Mesker WE, 2007, CELL ONCOL, V29, P387; Mohammed ZMA, 2012, BRIT J CANCER, V107, P864, DOI 10.1038/bjc.2012.347; Park JH, 2014, ANN ONCOL, V25, P644, DOI 10.1093/annonc/mdt593; Press MF, 2016, J CLIN ONCOL, V34, P3518, DOI 10.1200/JCO.2016.66.6693; Santa-Maria CA, 2018, J NATL COMPR CANC NE, V16, P1259, DOI 10.6004/jnccn.2018.7046; Sau S, 2019, CANCERS, V11, DOI 10.3390/cancers11020232; Shi JH, 2018, LAB INVEST, V98, P1423, DOI 10.1038/s41374-018-0099-3; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Stein Y, 2019, J MOL CELL BIOL; Stovgaard ES, 2019, BREAST CANC RES TREA; Tawfik O, 2018, HUM PATHOL, V80, P170, DOI 10.1016/j.humpath.2018.06.008; Thompson E, 2016, MODERN PATHOL, V29, P249, DOI 10.1038/modpathol.2015.158; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Ueno H, 2004, GUT, V53, P581, DOI 10.1136/gut.2003.028365; Vennin C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10968-6; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wang K, 2012, J THORAC ONCOL, V7, P1457, DOI 10.1097/JTO.0b013e318260dfe8; Wormann SM, 2016, GASTROENTEROLOGY, V151, P180, DOI 10.1053/j.gastro.2016.03.010; Yasunaga M, 2013, CANCER SCI, V104, P231, DOI 10.1111/cas.12062; Zhang MH, 2017, ONCOTARGET, V8, P31347, DOI 10.18632/oncotarget.15532; Zhang W, 2017, ONCOGENE, V36, P3890, DOI 10.1038/onc.2017.15	41	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223325	10.1371/journal.pone.0223325	http://dx.doi.org/10.1371/journal.pone.0223325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584964	Green Published, gold			2022-12-26	WOS:000532407600018
J	Wu, XW; Benov, A; Darlington, DN; Keesee, JD; Liu, B; Cap, AP				Wu, Xiaowu; Benov, Avi; Darlington, Daniel N.; Keesee, Jeffrey D.; Liu, Bin; Cap, Andrew P.			Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage	PLOS ONE			English	Article							MACROPHAGE-MIGRATION; PLASMINOGEN; MODEL; RESUSCITATION; TRANSFUSION; DEGRADATION; ACTIVATION; FIBRINOGEN; MORTALITY; CRASH-2	Trauma and hemorrhagic shock can lead to acute traumatic coagulopathy (ATC) that is not fully reversed by prehospital resuscitation as simulated with a limited volume of fresh whole blood (FWB) in a rat model. Tranexamic Acid (TXA) is used as an anti-fibrinolytic agent to reduce surgical bleeding if administered prior to or during surgery, and to improve survival in trauma if given early after trauma. It is not clear from the existing clinical literature whether TXA has the same mechanism of action in both settings. This study sought to explore the molecular mechanisms of TXA activity in trauma and determine whether administration of TXA as a supplement to FWB resuscitation could attenuate the established ATC in a rat model simulating prehospital resuscitation of polytrauma and hemorrhagic shock. In a parallel in -vitro study, the effects on clotting assays of adding plasmin at varying doses along with either simultaneous addition of TXA or pre-incubation with TXA were measured, and the results suggested that maximum anti-fibrinolytic effect of TXA on plasmin-induced fibrinolysis required pre-incubation of TXA and plasmin prior to clot initiation. In the rat model, ATC was induced by polytrauma followed by 40% hemorrhage. One hour after trauma, the rats were resuscitated with FWB collected from donor rats. Vehicle or TXA (10mg/kg) was given as bolus either before trauma (TXA-BT), or 45min after trauma prior to resuscitation (TXA-AT). The TXA-BT group was included to contrast the coagulation effects of TXA when used as it is in elective surgery vs. what is actually feasible in real trauma patients (TXA-AT group). A single dose of TXA prior to trauma significantly delayed the onset of ATC from 30min to 120min after trauma as measured by a rise in prothrombin time (PT). The plasma d-dimer as well as plasminogen/fibrinogen ratio in traumatized liver of TXA-BT were significantly lower as compared to vehicle and TXA-AT. Wet/dry weight ratio and leukocytes infiltration of lungs were significantly decreased only if TXA was administrated later, prior to resuscitation (TXA-AT). In conclusion: Limited prehospital trauma resuscitation that includes FWB and TXA may not correct established systemic ATC, but rather may improve overall outcomes of resuscitation by attenuation of acute lung injury. By contrast, TXA given prior to trauma reduced levels of fibrinolysis at the site of tissue injury and circulatory d-dimer, and delayed development of coagulopathy independent of reduction of fibrinogen levels following trauma. These findings highlight the importance of early administration of TXA in trauma, and suggest that further optimization of dosing protocols in trauma to exploit TXA's various sites and modes of action may further improve patient outcomes.	[Wu, Xiaowu; Darlington, Daniel N.; Keesee, Jeffrey D.; Liu, Bin; Cap, Andrew P.] US Army, Coagulat & Blood Res Program, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Benov, Avi] Tel Aviv Univ, Kfar Saba & Sackler Sch Med, Meir Med Ctr, Dept Surg A, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Wu, XW (corresponding author), US Army, Coagulat & Blood Res Program, Inst Surg Res, Ft Sam Houston, TX 78234 USA.	xiaowu.wu.civ@mail.mil	Darlington, Daniel/CAG-1917-2022; Cap, Andrew Peter/GQZ-4426-2022; Benov, Avi/AAZ-7750-2020; Benov, Avi/GYR-1158-2022	Benov, Avi/0000-0003-1901-9038	US Army Medical Research Materiel Command	US Army Medical Research Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	US Army Medical Research Materiel Command;	Boutonnet M, 2018, J TRAUMA ACUTE CARE, V84, pS54, DOI 10.1097/TA.0000000000001880; Butler FK., 2014, J SPEC OPER MED, V14, P13; Cap AP, 2016, BLOOD, V128, P2375, DOI 10.1182/blood-2016-09-735720; Carter DW, 2019, J TRAUMA ACUTE CARE, V86, P617, DOI 10.1097/TA.0000000000002177; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Chen J, 2017, SHOCK, V47, P208, DOI 10.1097/SHK.0000000000000748; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Darlington DN, 2015, SHOCK, V44, P129, DOI 10.1097/SHK.0000000000000354; Darlington DN, 2013, SHOCK, V39, P440, DOI 10.1097/SHK.0b013e31829040e3; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; HAVERKATE F, 1979, EUR J CLIN INVEST, V9, P253, DOI 10.1111/j.1365-2362.1979.tb00881.x; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Lighvani S, 2011, BLOOD, V118, P5622, DOI 10.1182/blood-2011-03-344242; MCLAUGHLIN DF, 2008, J TRAUMA, V64, pS5, DOI DOI 10.1097/TA.0B013E318174E8BC; Mischke R, 2000, HAEMOSTASIS, V30, P123; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Peng ZL, 2016, J TRAUMA ACUTE CARE, V81, P358, DOI 10.1097/TA.0000000000001056; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Tengborn L, 2015, THROMB RES, V135, P231, DOI 10.1016/j.thromres.2014.11.012; Wu XW, 2017, SHOCK, V47, P500, DOI 10.1097/SHK.0000000000000758; Wu XW, 2016, AM J PHYSIOL-REG I, V310, pR323, DOI 10.1152/ajpregu.00401.2015; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837	35	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223406	10.1371/journal.pone.0223406	http://dx.doi.org/10.1371/journal.pone.0223406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581265	Green Published, gold			2022-12-26	WOS:000532398600064
J	Bell, AM; Robinson, JT				Bell, A. Martin; Robinson, Jacob T.			The rotating magnetocaloric effect as a potential mechanism for natural magnetic senses	PLOS ONE			English	Article							LIGHT-DEPENDENT MAGNETORECEPTION; RADICAL-PAIR MECHANISM; EUROPEAN ROBINS; COMPASS ORIENTATION; BEHAVIORAL EVIDENCE; FIELD DETECTION; BIRDS; CHANNEL; PULSE; WAVELENGTH	Many animals are able to sense the earth's magnetic field, including varieties of arthropods and members of all major vertebrate groups. While the existence of this magnetic sense is widely accepted, the mechanism of action remains unknown. Building from recent work on synthetic magnetoreceptors, we propose a new model for natural magnetosensation based on the rotating magnetocaloric effect (RME), which predicts that heat generated by magnetic nanoparticles may allow animals to detect features of the earth's magnetic field. Using this model, we identify the conditions for the RME to produce physiological signals in response to the earth's magnetic field and suggest experiments to distinguish between candidate mechanisms of magnetoreception.	[Bell, A. Martin] Rice Univ, Appl Phys Program, Houston, TX USA; [Bell, A. Martin; Robinson, Jacob T.] Rice Univ, Dept Elect & Comp Engn, POB 1892, Houston, TX 77251 USA; [Robinson, Jacob T.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Robinson, Jacob T.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Rice University; Rice University; Rice University; Baylor College of Medicine	Robinson, JT (corresponding author), Rice Univ, Dept Elect & Comp Engn, POB 1892, Houston, TX 77251 USA.; Robinson, JT (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Robinson, JT (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	jtrobinson@rice.edu			National Science Foundation [1707562]; Welch Foundation [C-1963-20180324]	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation)	JTR received the NeuroNex Innovation Award 1707562 from the National Science Foundation. JTR received the Welch Foundation Award C-1963-20180324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki A, 2014, MOL MICROBIOL, V93, P554, DOI 10.1111/mmi.12683; Balli M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880818; BEASON RC, 1995, J EXP BIOL, V198, P141; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Bruno P., 1993, PHYS ORIGINS THEORET, V65, P257; Cain SD, 2005, INTEGR COMP BIOL, V45, P539, DOI 10.1093/icb/45.3.539; Chen CJ, 2010, J PHYS CHEM C, V114, P4258, DOI 10.1021/jp908153y; Chiolerio A, 2014, HANDBOOK OF NANOMATERIALS PROPERTIES, P213, DOI 10.1007/978-3-642-31107-9_34; COLLINS BA, 1986, MICRON MICROSC ACTA, V17, P259, DOI 10.1016/0739-6260(86)90007-9; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Davila AF, 2003, PHYS CHEM EARTH, V28, P647, DOI 10.1016/S1474-7065(03)00118-9; de Oliveira JF, 2010, J R SOC INTERFACE, V7, P143, DOI 10.1098/rsif.2009.0102; Deatsch AE, 2014, J MAGN MAGN MATER, V354, P163, DOI 10.1016/j.jmmm.2013.11.006; Duret G, 2019, BIOPHYS J; Edelman NB, 2015, P NATL ACAD SCI USA, V112, P262, DOI 10.1073/pnas.1407915112; FANNIN PC, 1994, J PHYS D APPL PHYS, V27, P185, DOI 10.1088/0022-3727/27/2/001; Fatemi-Ardekani A., 2008, TRANSCRANIAL MAGNETI, V36; Franco V, 2012, ANNU REV MATER RES, V42, P305, DOI 10.1146/annurev-matsci-062910-100356; Galvez N, 2008, J AM CHEM SOC, V130, P8062, DOI 10.1021/ja800492z; Gorobets O, 2017, INT J NANOMED, V12, P4371, DOI 10.2147/IJN.S130565; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Guler AD, 2002, J NEUROSCI, V22, P6408; Held Katharina, 2015, Temperature (Austin), V2, P201, DOI 10.4161/23328940.2014.988524; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Holland RA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1047; Holland RA, 2010, J R SOC INTERFACE, V7, P1617, DOI 10.1098/rsif.2010.0159; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Irwin WP, 2005, J COMP PHYSIOL A, V191, P475, DOI 10.1007/s00359-005-0609-9; Jandacka P, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1087; JILES DC, 1984, J PHYS D APPL PHYS, V17, P1265, DOI 10.1088/0022-3727/17/6/023; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KALMIJN AJ, 1981, IEEE T MAGN, V17, P1113, DOI 10.1109/TMAG.1981.1061156; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Kletetschka G, 2002, PHYS EARTH PLANET IN, V129, P173, DOI 10.1016/S0031-9201(01)00271-0; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Li JH, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1288; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Martin-Hernandez F, 2010, GEOPHYS J INT, V181, P756, DOI 10.1111/j.1365-246X.2010.04566.x; Martin-Hernandez F, 2012, INT J EARTH SCI, V101, P637, DOI 10.1007/s00531-011-0665-z; Martinez L, 2011, J PHYS CHEM LETT, V2, P2073, DOI 10.1021/jz200830g; Martinez-Perez MJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/46/465707; Melemedjian OK, 2015, PROG MOL BIOL TRANSL, V131, P185, DOI 10.1016/bs.pmbts.2014.11.006; Mercante LA, 2012, J MAGN MAGN MATER, V324, P3029, DOI 10.1016/j.jmmm.2012.04.049; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mouritsen H, 2018, NATURE, V558, P50, DOI 10.1038/s41586-018-0176-1; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Muheim R, 2002, J EXP BIOL, V205, P3845; Munro U, 1997, AUST J ZOOL, V45, P189, DOI 10.1071/ZO96066; NADOL JB, 1990, J ELECTRON MICR TECH, V15, P187, DOI 10.1002/jemt.1060150210; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Nordmann GC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003234; Ozdemir O, 2014, J GEOPHYS RES-SOL EA, V119, P2582, DOI 10.1002/2013JB010739; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pertusa M., 2012, MUTAGENESIS, P221; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Phillips JB, 2010, J R SOC INTERFACE, V7, pS241, DOI 10.1098/rsif.2009.0459.focus; Pinol R, 2015, ACS NANO, V9, P3134, DOI 10.1021/acsnano.5b00059; Pinzon-Rodriguez A, 2017, J EXP BIOL, V220, P1202, DOI 10.1242/jeb.148098; Polo-Corrales L, 2012, J APPL PHYS, V111, DOI 10.1063/1.3680532; QUINN TP, 1981, J EXP ZOOL, V217, P137, DOI 10.1002/jez.1402170114; Quintana C, 2004, J STRUCT BIOL, V147, P166, DOI 10.1016/j.jsb.2004.03.001; Raghunathan A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3249581; Ramesh A, 1997, J APPL PHYS, V81, P5585, DOI 10.1063/1.364843; Reeves Daniel B., 2014, Critical Reviews in Biomedical Engineering, V42, P85; Reznicek R, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/5/055501; Riedinger A, 2013, NANO LETT, V13, P2399, DOI 10.1021/nl400188q; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Roberts AP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000336; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schron A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115134; Schultens HA, 1992, SENSORS SENSORY SYST, P13, DOI [10.1146/annurev-matsci-062910-100356, DOI 10.1146/ANNUREV-MATSCI-062910-100356]; Schwarze S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00055; Shaw J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0499; Silva NJO, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336083; STACEY FD, 1963, ADV PHYS, V12, P45, DOI 10.1080/00018736300101263; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Thebault E, 2015, EARTH PLANETS SPACE, V67, DOI 10.1186/s40623-015-0228-9; Timmel CR, 1996, CHEM PHYS LETT, V257, P401, DOI 10.1016/0009-2614(96)00466-6; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Uebe R, 2016, NAT REV MICROBIOL, V14, P621, DOI 10.1038/nrmicro.2016.99; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang XM, 2016, ENVIRON SCI-NANO, V3, P190, DOI 10.1039/c5en00191a; Wheeler MA, 2016, NAT NEUROSCI, V19, P756, DOI 10.1038/nn.4265; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; WILTSCHKO W, 1994, EXPERIENTIA, V50, P697, DOI 10.1007/BF01952877; Wiltschko W, 2002, J EXP BIOL, V205, P3031; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363; Wiltschko W, 2001, J EXP BIOL, V204, P3295; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS131, DOI 10.1098/rsif.2010.0010.focus; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yamagishi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29785; Yuan Z, 2006, J APPL PHYS, V99, DOI 10.1063/1.2172546; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	106	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222401	10.1371/journal.pone.0222401	http://dx.doi.org/10.1371/journal.pone.0222401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574085	Green Submitted, Green Published, gold			2022-12-26	WOS:000532376700007
J	Kjork, EK; Gunnel, C; Lundgren-Nilsson, A; Sunnerhagen, KS				Kjork, Emma K.; Gunnel, Carlsson; Lundgren-Nilsson, Asa; Sunnerhagen, Katharina S.			Experiences, needs, and preferences for follow-up after stroke perceived by people with stroke and healthcare professionals: A focus group study	PLOS ONE			English	Article							QUALITATIVE RESEARCH; REHABILITATION; CHALLENGES; CHECKLIST; SERVICES; LIFE	Purpose The aim of this study was to explore the experiences, needs, and preferences regarding follow-up perceived by people with stroke and healthcare professionals. Methods This is a qualitative exploratory study using focus groups. Patients and healthcare professionals, participating in a clinical visit in primary care or specialised care, were purposively sampled. Data were analysed using a framework of analysis developed by Krueger. Results Focus groups were conducted with two patient groups (n = 10, range 45-78 years) and two multidisciplinary healthcare professional groups (n = 8, range 35-55 years). The overarching theme elucidates stroke as a long-term condition requiring complex follow-up. Three organisational themes and six subthemes were identified. People with stroke discovered feelings and changes after returning home. In daily life, problems and feelings of abandonment became evident. Participants expressed experiences of unequal access to health care services. Barriers for accessing appropriate treatment and support included difficulties in communicating one's needs and lack of coherent follow-up. Follow-up activities were well functioning in certain clinics but did not provide continuity over the long term. Participants made suggestions for a comprehensive, planned, and tailored follow-up to meet patient needs. Conclusion Comprehensive long-term follow-up that is accessible to all patients is essential for equal support. Our findings raised awareness about problems discovered after returning home and the obstacles individuals face in communicating their needs. Structured follow-up, which is individually tailored, can empower patients.	[Kjork, Emma K.; Gunnel, Carlsson; Lundgren-Nilsson, Asa; Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden; [Kjork, Emma K.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Kjork, EK (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden.; Kjork, EK (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	emma.kjork@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Kjork, Emma K/0000-0002-1005-7444	Swedish Stroke Association; Swedish state under Swedish government; Swedish state under Swedish county councils, the ALF [71980]; Local Research and Development Board for Gothenburg and Sodra Bohuslan; Swedish Heart and Lung Foundation; Swedish Brain Foundation; Allergan; Hjalmar Svensson's Foundation; Swedish NeuroFoundation (Neuro); Rune and Ulla Amlov's Foundation; Per-Olof Ahl's Foundation; John and Brit Wennerstrom's Foundation; Swedish Science Council [VR2017-00946]	Swedish Stroke Association; Swedish state under Swedish government; Swedish state under Swedish county councils, the ALF; Local Research and Development Board for Gothenburg and Sodra Bohuslan; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; Allergan(AbbVieAllergan); Hjalmar Svensson's Foundation; Swedish NeuroFoundation (Neuro); Rune and Ulla Amlov's Foundation; Per-Olof Ahl's Foundation; John and Brit Wennerstrom's Foundation; Swedish Science Council	This study was supported by grants from the Swedish Stroke Association; the Swedish state under the agreement of the Swedish government and the county councils, the ALF agreement 71980; the Local Research and Development Board for Gothenburg and Sodra Bohuslan; the Swedish Heart and Lung Foundation; the Swedish Brain Foundation; unconditional grants from Allergan; Hjalmar Svensson's Foundation; Swedish NeuroFoundation (Neuro); Rune and Ulla Amlov's Foundation; Per-Olof Ahl's Foundation; John and Brit Wennerstrom's Foundation; and the Swedish Science Council VR2017-00946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Hou SI, 2014, HEALTH PROMOT PRACT, V15, P619, DOI 10.1177/1524839914538045; Ivanoff Synneve Dahlin, 2006, Scand J Occup Ther, V13, P125, DOI 10.1080/11038120600691082; Kjork EK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028218; Kjork E, 2016, ACTA NEUROL SCAND, V133, P103, DOI 10.1111/ane.12435; Krueger RA, 2014, FOCUS GROUPS PRACTIC; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Langhorne P, 2007, J REHABIL MED, V39, P103, DOI 10.2340/16501977-0042; Lawton J, 2013, QUAL HEALTH RES, V23, P876, DOI 10.1177/1049732313485161; Lincoln YS., 1985, BLACKWELL ENCY SOCIO, P416; Lindsay M, 2016, COMMUNITY REINTEGRAT; Lindsay P, 2014, INT J STROKE, V9, P4, DOI 10.1111/ijs.12371; Lynch EA, 2017, TOP STROKE REHABIL, V24, P619, DOI 10.1080/10749357.2017.1366010; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Martinsen R, 2015, J NEUROSCI NURS, V47, P27, DOI 10.1097/JNN.0000000000000107; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Norrving B, 2018, EUR STROKE J, V3, P309, DOI 10.1177/2396987318808719; Philp I, 2013, J STROKE CEREBROVASC, V22, pE173, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.016; Pindus DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192533; Stevens E., 2017, BURDEN STROKE EUROPE; Taule T, 2015, SCAND J CARING SCI, V29, P651, DOI 10.1111/scs.12193; Tellier M, 2009, TOP STROKE REHABIL, V16, P454, DOI 10.1310/tsr1606-454; Tistad M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-40; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ullberg T, 2016, STROKE, V47, P539, DOI 10.1161/STROKEAHA.115.011670; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538; VanderKaay S, 2018, DISABIL REHABIL, V40, P705, DOI 10.1080/09638288.2016.1261414; Walters K, 2001, FAM PRACT, V18, P277, DOI 10.1093/fampra/18.3.277	31	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223338	10.1371/journal.pone.0223338	http://dx.doi.org/10.1371/journal.pone.0223338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574135	Green Published, gold			2022-12-26	WOS:000532376700044
J	Pal, RK; Gadhiya, S; Ramsey, S; Cordone, P; Wickstrom, L; Harding, WW; Kurtzman, T; Gallicchio, E				Pal, Rajat Kumar; Gadhiya, Satishkumar; Ramsey, Steven; Cordone, Pierpaolo; Wickstrom, Lauren; Harding, Wayne W.; Kurtzman, Tom; Gallicchio, Emilio			Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexes	PLOS ONE			English	Article							PROTEIN SIDE-CHAIN; NATURAL-PRODUCT (-)-STEPHOLIDINE; WATER SITES; CURRENT PERSPECTIVES; FORCE-FIELD; THERMODYNAMICS; ANTAGONIST; SPECIFICITY; ADDICTION; MOLECULES	Confined hydration and conformational flexibility are some of the challenges encountered for the rational design of selective antagonists of G-protein coupled receptors. We present a set of C3-substituted (-)-stepholidine derivatives as potent binders of the dopamine D3 receptor. The compounds are characterized biochemically, as well as by computer modeling using a novel molecular dynamics-based alchemical binding free energy approach which incorporates the effect of the displacement of enclosed water molecules from the binding site. The free energy of displacement of specific hydration sites is obtained using the Hydration Site Analysis method with explicit solvation. This work underscores the critical role of confined hydration and conformational reorganization in the molecular recognition mechanism of dopamine receptors and illustrates the potential of binding free energy models to represent these key phenomena.	[Pal, Rajat Kumar; Gallicchio, Emilio] Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA; [Pal, Rajat Kumar; Ramsey, Steven; Cordone, Pierpaolo; Harding, Wayne W.; Kurtzman, Tom; Gallicchio, Emilio] CUNY, PhD Program Biochem, Grad Ctr, New York, NY 10016 USA; [Gadhiya, Satishkumar; Harding, Wayne W.; Kurtzman, Tom; Gallicchio, Emilio] CUNY, PhD Program Chem, Grad Ctr, New York, NY 10016 USA; [Gadhiya, Satishkumar; Cordone, Pierpaolo; Harding, Wayne W.] Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA; [Ramsey, Steven; Kurtzman, Tom] Lehman Coll, Dept Chem, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA; [Wickstrom, Lauren] Borough Manhattan Community Coll, Dept Sci, 199 Chambers St, New York, NY 10007 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Lehman College (CUNY)	Gallicchio, E (corresponding author), Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.; Gallicchio, E (corresponding author), CUNY, PhD Program Biochem, Grad Ctr, New York, NY 10016 USA.; Gallicchio, E (corresponding author), CUNY, PhD Program Chem, Grad Ctr, New York, NY 10016 USA.	egallicchio@brooklyn.cuny.edu		Gallicchio, Emilio/0000-0002-2606-4913	City University of New York [CIRG 2313]; National Science Foundation [NSF CAREER 1750511]; CUNY PSC program [PSC-CUNY 61211-00 49]; Levy-Kosminsky Professorship in Physical Chemistry at Brooklyn College; NIH SCORE grant [SC3-GM095417]; NSF XSEDE award [TG-MCB150001]; National Institute of Mental Health's Psychoactive Drug Screening Program [HHSN-271-2008-00025-C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM095417] Funding Source: NIH RePORTER	City University of New York; National Science Foundation(National Science Foundation (NSF)); CUNY PSC program; Levy-Kosminsky Professorship in Physical Chemistry at Brooklyn College; NIH SCORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF XSEDE award; National Institute of Mental Health's Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an Interdisciplinary Research Grant from the City University of New York (CIRG 2313 to E.G., L.W., T.K., and W.W.H.). R.K.P and E.G. acknowledge support from the National Science Foundation (NSF CAREER 1750511 to E.G.). E.G. acknowledges support from the CUNY PSC program (PSC-CUNY 61211-00 49) and Levy-Kosminsky Professorship in Physical Chemistry at Brooklyn College. T.K. and S.R. acknowledge support from NIH SCORE grant SC3-GM095417. Molecular simulations were conducted on the SuperMIC cluster at the Louisiana State University High Performance Computing Center and the Stampede II supercomputer cluster at the Texas Advanced Computing Center supported by NSF XSEDE award TG-MCB150001 to E.G. Ki determinations and receptor binding profiles were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2008-00025-C (NIMH PDSP).; This work was supported in part by an Interdisciplinary Research Grant from the City University of New York (CIRG 2313, to E.G., L.W., T.K., and W.W.H.). R.K.P and E.G. acknowledge support from the National Science Foundation (NSF CAREER 1750511). E.G. acknowledges support from the CUNY PSC program (PSC-CUNY 61211-00 49) and Levy-Kosminsky Professorship in Physical Chemistry at Brooklyn College. T.K. and S.R. acknowledge support from NIH SCORE grant SC3-GM095417. Molecular simulations were conducted on the WEB computational grid at Brooklyn College of the City University of New York, SuperMIC cluster at the Louisiana State University High Performance Computing Center and the Stampede II supercomputer cluster at the Texas Advanced Computing Center supported by NSF XSEDE award TG-MCB150001. Ki determinations and receptor binding profiles were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2008-00025-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth MD, PhD, at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda MD, USA.	Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Bodnarchuk MS, 2014, J CHEM INF MODEL, V54, P1623, DOI 10.1021/ci400674k; Brooks DJ, 2000, J NEUROL NEUROSUR PS, V68, P685, DOI 10.1136/jnnp.68.6.685; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Clark M, 2009, J CHEM INF MODEL, V49, P934, DOI 10.1021/ci8004397; de Beer SBA, 2010, CURR TOP MED CHEM, V10, P55, DOI 10.2174/156802610790232288; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Ferruz N., 2018, SCI REP, V8, P1; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fu W, 2007, BIOPHYS J, V93, P1431, DOI 10.1529/biophysj.106.088500; Gadhiya S, 2018, ACS MED CHEM LETT, V9, P990, DOI 10.1021/acsmedchemlett.8b00229; Gallicchio E, 2008, J COMPUT CHEM, V29, P788, DOI 10.1002/jcc.20839; Gallicchio E, 2015, COMPUT PHYS COMMUN, V196, P236, DOI 10.1016/j.cpc.2015.06.010; Gallicchio E, 2014, J COMPUT AID MOL DES, V28, P475, DOI 10.1007/s10822-014-9711-9; Gallicchio E, 2012, J COMPUT AID MOL DES, V26, P505, DOI 10.1007/s10822-012-9552-3; Gallicchio E, 2011, ADV PROTEIN CHEM STR, V85, P27, DOI 10.1016/B978-0-12-386485-7.00002-8; Gallicchio E, 2010, J CHEM THEORY COMPUT, V6, P2961, DOI 10.1021/ct1002913; Gallicchio E, 2009, J CHEM THEORY COMPUT, V5, P2544, DOI 10.1021/ct900234u; Graham SE, 2018, J CHEM INF MODEL, V58, P305, DOI 10.1021/acs.jcim.7b00268; Haider K, 2016, J PHYS CHEM B, V120, P8743, DOI 10.1021/acs.jpcb.6b01094; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Huggins DJ, 2012, PHYS CHEM CHEM PHYS, V14, P15106, DOI 10.1039/c2cp42631e; Izadi S, 2014, J PHYS CHEM LETT, V5, P3863, DOI 10.1021/jz501780a; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Keck TM, 2015, J MED CHEM, V58, P5361, DOI 10.1021/jm501512b; Knable MB, 1997, PSYCHIAT RES-NEUROIM, V75, P91, DOI 10.1016/S0925-4927(97)00023-1; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Li B, 2012, J PHYS CHEM B, V116, P8121, DOI 10.1021/jp3049235; Li Z, 2007, PHYS CHEM CHEM PHYS, V9, P573, DOI 10.1039/b612449f; Macdonald HEB, 2018, J CHEM THEORY COMPUT, V14, P6586, DOI 10.1021/acs.jctc.8b00614; Madapa S, 2017, EUR J MED CHEM, V125, P255, DOI 10.1016/j.ejmech.2016.09.036; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mancera RL, 2007, CURR OPIN DRUG DISC, V10, P275; Manuszak M, 2018, DRUG ALCOHOL DEPEN, V189, P49, DOI 10.1016/j.drugalcdep.2018.04.030; Maramai S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00451; Meade JA, 2015, PSYCHOPHARMACOLOGY, V232, P917, DOI 10.1007/s00213-014-3726-8; Michel J, 2009, J PHYS CHEM B, V113, P13337, DOI 10.1021/jp9047456; Michino M, 2017, J MED CHEM, V60, P580, DOI 10.1021/acs.jmedchem.6b01148; Mo J, 2007, CURR MED CHEM, V14, P2996, DOI 10.2174/092986707782794050; Newman AH, 2012, J MED CHEM, V55, P6689, DOI 10.1021/jm300482h; Nguyen C. N., 2012, J CHEM PHYS, V137, P973; Nguyen CN, 2014, J CHEM THEORY COMPUT, V10, P2769, DOI 10.1021/ct401110x; Oroguchi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26302; Pal RK, 2017, J COMPUT AID MOL DES, V31, P29, DOI 10.1007/s10822-016-9956-6; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Ross GA, 2015, J AM CHEM SOC, V137, P14930, DOI 10.1021/jacs.5b07940; Ross GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032036; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sindhikara DJ, 2013, J PHYS CHEM B, V117, P6718, DOI 10.1021/jp4046116; Song R, 2014, NEUROPHARMACOLOGY, V77, P398, DOI 10.1016/j.neuropharm.2013.10.010; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Tan ZQ, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3701175; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733; Zhang B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03680-2	67	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222902	10.1371/journal.pone.0222902	http://dx.doi.org/10.1371/journal.pone.0222902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568493	Green Submitted, Green Published, gold			2022-12-26	WOS:000532364900013
J	Zhou, HM; Wang, P; Wang, CX; Deng, XZ; Liu, K				Zhou, Huimin; Wang, Pei; Wang, Chengxin; Deng, Xiangzheng; Liu, Kai			Investigation of a spatial coupling relationship between carbon emission performance and regional urbanization in China	PLOS ONE			English	Article							ENERGY-CONSUMPTION; ECOSYSTEM SERVICES; DIOXIDE EMISSIONS; DECOMPOSITION; CITIES; CITY	In light of the problem of environmental pollution caused by fossil fuel combustion, and its association with rapid urbanization, China is grappling with the question of how to reduce carbon emissions through more efficient energy consumption while simultaneously advancing its economic development. We applied a directional distance function to estimate the carbon emission performance of 30 provinces in China during the period 2000-2016. We selected an index system to assess urbanization processes in these provinces and conducted a spatial analysis to investigate the relationship between urbanization and carbon emission performance. We obtained the following results. First, the carbon emission performance of the eastern region, valued at 0.853, was relatively higher than the corresponding values of 0.810, 0.804, and 0.843 in the central, western, and northeastern regions, respectively. However, during this period, disparities among provinces increased. Second, the average urbanization value for each province showed an upward trend during the study period, and urbanization assumed a "striped" spatial agglomeration pattern. A third finding was that carbon emission performance and urbanization demonstrated a relationship of positive spatial dependence. The average value of their coordinated coupling indicated an upward trend, with an annual increase of 0.85%. Last, we found that efforts to reduce carbon emissions that are solely based on carbon emission performance do not yield reliable results. Accordingly, measurements of urbanization values can enable more detailed differentiation. In conclusion, reasonable measures should be implemented to improve carbon emission performance and urbanization that are in alignment with the actual situation within a given region.	[Zhou, Huimin; Wang, Chengxin; Liu, Kai] Shandong Normal Univ, Collaborat Innovat Ctr Human Nat & Green Dev Univ, Coll Geog & Environm, Jinan, Shandong, Peoples R China; [Wang, Pei; Deng, Xiangzheng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Wang, Pei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Pei] Chinese Acad Sci, Ctr Chinese Agr Policy, Beijing, Peoples R China	Shandong Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Wang, CX; Liu, K (corresponding author), Shandong Normal Univ, Collaborat Innovat Ctr Human Nat & Green Dev Univ, Coll Geog & Environm, Jinan, Shandong, Peoples R China.	404122665@qq.com; liukaisdnu@163.com	Liu, Kai/GOP-2349-2022	Liu, Kai/0000-0002-8762-6609	National Key Research and Development Program of China [2016YFA0602500]; National Natural Science Foundation of China [41371170]; Key Technology Research and Development Program of Shandong [2017GSF22102]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology Research and Development Program of Shandong	This work was supported by National Key Research and Development Program of China grant No. 2016YFA0602500, National Natural Science Foundation of China grant 41371170, and Key Technology Research and Development Program of Shandong grant 2017GSF22102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley R, 2011, AGENDA, V6, P333; Auffhammer M, 2016, J ECON SURV, V30, P460, DOI 10.1111/joes.12158; Bilgili F, 2017, ENERGY, V133, P242, DOI 10.1016/j.energy.2017.05.121; Boot-Handford ME, 2014, ENERG ENVIRON SCI, V7, P130, DOI 10.1039/c3ee42350f; CHOI Y, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10010173; Chuai XW, 2012, J GEOGR SCI, V22, P630, DOI 10.1007/s11442-012-0952-z; FARE R, 1989, REV ECON STAT, V71, P90; Hao Y, 2017, ENERG ECON, V68, P31, DOI 10.1016/j.eneco.2017.09.008; He JQ, 2017, ECOL INDIC, V77, P185, DOI 10.1016/j.ecolind.2017.01.017; International Energy Agency, 2016, KEY WORLD EN STAT; Lin T, 2017, NAT HAZARDS, V88, P721, DOI 10.1007/s11069-017-2888-1; Liu BQ, 2018, J CLEAN PROD, V197, P1374, DOI 10.1016/j.jclepro.2018.06.295; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; NASA, GLOBAL CLIMATE CHANG; National development and reform commission, 2014, GEN OFF NAT DEV REF; National development and reform commission, 2014, NOT GEN OFF NAT DEV; National Development and Reform Commission of the people's Republic of China, 2016, NOT GEN OFF NAT DEV; Peng J, 2017, SCI TOTAL ENVIRON, V607, P706, DOI 10.1016/j.scitotenv.2017.06.218; Shen LY, 2018, J CLEAN PROD, V174, P343, DOI 10.1016/j.jclepro.2017.10.333; Shephard RW, 1970, THEORY COST PRODUCTI; Wang GF, 2019, CHINA ECON REV, V56, DOI 10.1016/j.chieco.2019.101313; Wang QW, 2013, RENEW SUST ENERG REV, V21, P324, DOI 10.1016/j.rser.2012.12.061; Wang Z, 2019, J CLEAN PROD, V211, P1201, DOI 10.1016/j.jclepro.2018.11.272; Xu XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121604; Yang Y, 2019, SUSTAINABLE CITIES S, V47, P2210; Yang Y, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101466; Yao XL, 2018, ENVIRON IMPACT ASSES, V71, P70, DOI 10.1016/j.eiar.2018.04.005; Yuan YJ, 2018, ECOL INDIC, V95, P917, DOI 10.1016/j.ecolind.2018.07.056; Zhang XC, 2012, CHINA PROCEDIA ENV S, V13, P21; Zhang XL, 2016, ENERG ECON, V54, P388, DOI 10.1016/j.eneco.2015.12.002; Zhao JC, 2018, ECOL INDIC, V91, P410, DOI 10.1016/j.ecolind.2018.04.016; Zhou CS, 2019, SCI TOTAL ENVIRON, V675, P472, DOI 10.1016/j.scitotenv.2019.04.269; Zhou P, 2010, ENERG ECON, V32, P194, DOI 10.1016/j.eneco.2009.10.003; Zhou ZB, 2018, J CLEAN PROD, V172, P1254, DOI 10.1016/j.jclepro.2017.10.208	34	1	1	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222534	10.1371/journal.pone.0222534	http://dx.doi.org/10.1371/journal.pone.0222534			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KD7CX	31568514	Green Published, gold			2022-12-26	WOS:000508023000001
J	James, PB; Wardle, J; Steel, A; Adams, J				James, Peter Bai; Wardle, Jon; Steel, Amie; Adams, Jon			Pattern of health care utilization and traditional and complementary medicine use among Ebola survivors in Sierra Leone	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; HERBAL MEDICINE; SEEKING; HIV	Background It is well established that Ebola Survivors experience a myriad of physical and psychological sequelae. However, little is known about how they seek care to address their health needs. Our study determines the current healthcare seeking behaviour among Ebola survivors and determines the prevalence, pattern of use and correlates of traditional and complementary medicine (T&CM) use among Ebola survivors in Sierra Leone. Methods We conducted a nationwide questionnaire survey among a cross-sectional sample of Ebola Survivors in Sierra Leone between January and August 2018. We employed descriptive statistics, chi-square test, Fisher exact two-tailed test and backward stepwise binary regression analysis for data analysis. A p-value less than 0.05 was considered statistically significant. Results Ebola Survivors who participated in our study (n = 358), visited a healthcare provider (n = 308, 86.0%), self-medicated with conventional medicines (n = 255, 71.2%) and visited a private pharmacy outlet (n = 141, 39.4%). Survivors also self-medicated with T&CM products (n = 107, 29.9%), concurrently self-medicated with conventional and T&CM products (n = 62, 17.3%), and visited a T&CM practitioner (n = 41, 11.5%). Almost half of (n = 163, 45.5%) Ebola survivors reported using T&CM treatments for post ebola related symptoms and non-Ebola related symptoms since their discharge from an Ebola treatment centre. Ebola survivors who considered their health to be fair or poor (AOR = 4.08; 95%CI: 2.22-7.50; p<0.01), presented with arthralgia (AOR = 2.52; 95%CI: 1.11-5.69, p = 0.026) and were discharged three years or less (AOR = 3.14; 95%CI: 1.13-8.73, p = 0.028) were more likely to use T&CM. Family (n = 101,62.0%) and friends (n = 38,23.3%) were the common sources of T&CM information. Abdominal pain (n = 49, 30.1%) followed by joint pain (n = 46, 28.2%) and back pain (n = 43, 26.4%) were the most cited post-Ebola indications for T&CM use. More than three-quarters of T&CM users (n = 135, 82.8%) failed to disclose their use of T&CM to their healthcare providers. Conclusion Ebola survivors in Sierra Leone employ a myriad of healthcare options including T&CM in addressing their healthcare needs. Researchers, health policy makers and healthcare providers should be aware of the substantial role of T&CM in the health seeking of survivors, and this topic that should be factored into future research, policy formulation and implementation as well as routine practice regarding Ebola survivors.	[James, Peter Bai; Wardle, Jon; Steel, Amie; Adams, Jon] Univ Technol Sydney, Fac Hlth, Australian Res Ctr Inw Complementary & Integrat M, Sydney, NSW, Australia; [James, Peter Bai] Univ Sierra Leone, Coll Med & Allied Hlth Sci, Fac Pharmaceut Sci, Freetown, Sierra Leone	University of Technology Sydney	James, PB (corresponding author), Univ Technol Sydney, Fac Hlth, Australian Res Ctr Inw Complementary & Integrat M, Sydney, NSW, Australia.; James, PB (corresponding author), Univ Sierra Leone, Coll Med & Allied Hlth Sci, Fac Pharmaceut Sci, Freetown, Sierra Leone.	Peter.B.James@students.uts.edu.au	James, Peter Bai/P-8492-2015	James, Peter Bai/0000-0002-6373-5704; Steel, Amie/0000-0001-6643-9444; Wardle, Jonathan/0000-0001-8813-3542	Faculty of Health, University of Technology Sydney	Faculty of Health, University of Technology Sydney	This research received support from the Faculty of Health, University of Technology Sydney.	Artus M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-26; Auerbach BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041737; Bakshi SS, 2013, ACTA TROP, V127, P46, DOI 10.1016/j.actatropica.2013.03.010; Corp N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200879; De Roo A, 1998, TROPICAL MED INT HLT, V3; de St Maurice A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy239; Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005; Diaz T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-157; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Draucker CB, 2009, ARCH PSYCHIAT NURS, V23, P343, DOI 10.1016/j.apnu.2008.10.008; Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3; Falci L, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150501; Foley H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38279-8; Government of Sierra Leone Ministry of Health and Sanitation, 2016, ANN HLTH SECT PERF R; Hsu CH, 2008, EVID-BASED COMPL ALT, V5, P355, DOI 10.1093/ecam/nem035; James PB, 2019, TROP MED INT HEALTH, V24, P671, DOI 10.1111/tmi.13226; James PB, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2479-7; James PB, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000895; James PB, 2018, WOMEN BIRTH, V31, pE302, DOI 10.1016/j.wombi.2017.12.006; James PB, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/9493807; James PB, 2018, COMPLEMENT THER CLIN, V31, P7, DOI 10.1016/j.ctcp.2018.01.001; James PB, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1102-4; Lee LS, 2006, CLIN INFECT DIS, V43, P1052, DOI 10.1086/507894; Lorenc A, 2013, AIDS PATIENT CARE ST, V27, P503, DOI 10.1089/apc.2013.0175; Lotsch F, 2017, TRAVEL MED INFECT DI, V18, P18, DOI 10.1016/j.tmaid.2017.05.001; Manguvo A, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6190; Mbizo J, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2342-2; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; Ministry of Health and Sanitation, 2017, NATL HLTH SECT STRAT; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Naidoo P, 2014, S AFR FAM PRACT, V56, P223, DOI 10.1080/20786190.2014.953884; National Malaria Control Programme (NMCP) [Sierra Leone] SSL University of Sierra Leone Catholic Relief Services and ICF, SIERR LEON MAL IND S; Nlooto M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170983; Peltzer K, 2010, AFRICAN J TRADITIONA, V7; Peltzer K, 2018, CHIN J INTEGR MED, V24, P584, DOI 10.1007/s11655-016-2748-y; Ranasinghe S, 2015, J ETHNOPHARMACOL, V166, P200, DOI 10.1016/j.jep.2015.03.028; Scott JT, 2016, EMERG INFECT DIS, V22, P641, DOI 10.3201/eid2204.151302; Statistics Sierra Leone, 2017, SIERR LEON 2015 POP; Stawicki SP, 2017, J GLOB INFECT DIS, V9, P41, DOI 10.4103/jgid.jgid_20_17; Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3; Wardle JL, 2014, EUR J INTEGR MED, V6, P409, DOI 10.1016/j.eujim.2014.01.001; Warren N, 2013, HEALTH-LONDON, V17, P323, DOI 10.1177/1363459312460699; WHO, 2017, SIERR LEON TRAD HEAL; WHO, 2016, GEOGR DISTR NEW TOT; Wilson HW, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1909410; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2016, CLIN CAR SURV EB VIR; World Health Organization, 2017, TOP 10 CAUS DEATH LE; World Health Organization, 2013, WHO TRAD MED STRAT 2; World Health Organization, 2007, WORLD HLTH REP 2007; World Health Organization, 2004, SARS CLIN TRIALS TRE	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223068	10.1371/journal.pone.0223068	http://dx.doi.org/10.1371/journal.pone.0223068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560708	Green Published, gold			2022-12-26	WOS:000532353700034
J	Niederle, MV; Bosch, J; Ale, CE; Nader-Macias, ME; Ficoseco, CA; Toledo, LF; Valenzuela-Sanchez, A; Soto-Azat, C; Pasteris, SE				Niederle, M., V; Bosch, J.; Ale, C. E.; Nader-Macias, M. E.; Aristimuno Ficoseco, C.; Toledo, L. F.; Valenzuela-Sanchez, A.; Soto-Azat, C.; Pasteris, S. E.			Skin-associated lactic acid bacteria from North American bullfrogs as potential control agents of Batrachochytrium dendrobatidis	PLOS ONE			English	Article							BIOFILM FORMATION; AMPHIBIAN CHYTRIDIOMYCOSIS; JANTHINOBACTERIUM-LIVIDUM; LETHAL CHYTRIDIOMYCOSIS; SYMBIOTIC BACTERIA; SURFACE-PROPERTIES; INHIBIT GROWTH; SP-NOV; PROBIOTICS; DIVERSITY	The fungal pathogen Batrachochytrium dendrobatidis (Bd) is the causative agent of chytridiomycosis and has been a key driver in the catastrophic decline of amphibians globally. While many strategies have been proposed to mitigate Bd outbreaks, few have been successful. In recent years, the use of probiotic formulations that protect an amphibian host by killing or inhibiting Bd have shown promise as an effective chytridiomycosis control strategy. The North American bullfrog (Lithobates catesbeianus) is a common carrier of Bd and harbours a diverse skin microbiota that includes lactic acid bacteria (LAB), a microbial group containing species classified as safe and conferring host benefits. We investigated beneficial/probiotic properties: anti-Bd activity, and adhesion and colonisation characteristics (hydrophobicity, biofilm formation and exopolysaccharide-EPS production) in two confirmed LAB (cLAB-Enterococcus gallinarum CRL 1826, Lactococcus garvieae CRL 1828) and 60 presumptive LAB (pLAB) [together named as LABs] isolated from bullfrog skin. We challenged LABs against eight genetically diverse Bd isolates and found that 32% of the LABs inhibited at least one Bd isolate with varying rates of inhibition. Thus, we established a score of sensitivity from highest (BdGPL AVS7) to lowest (BdGPL C2A) for the studied Bd isolates. We further reveal key factors underlying host adhesion and colonisation of LABs. Specifically, 90.3% of LABs exhibited hydrophilic properties that may promote adhesion to the cutaneous mucus, with the remaining isolates (9.7%) being hydrophobic in nature with a surface polarity compatible with colonisation of acidic, basic or both substrate types. We also found that 59.7% of LABs showed EPS synthesis and 66.1% produced biofilm at different levels: 21% weak, 29% moderate, and 16.1% strong. Together all these properties enhance colonisation of the host surface (mucus or epithelial cells) and may confer protective benefits against Bd through competitive exclusion. Correspondence analysis indicated that biofilm synthesis was LABs specific with high aggregating bacteria correlating with strong biofilm producers, and EPS producers being correlated to negative biofilm producing LABs. We performed Random Amplified Polymorphic DNA (RAPD)-PCR analysis and demonstrated a higher degree of genetic diversity among rod-shaped pLAB than cocci. Based on the LAB genetic analysis and specific probiotic selection criteria that involve beneficial properties, we sequenced 16 pLAB which were identified as Pediococcus pentosaceus, Enterococcus thailandicus, Lactobacillus pentosus/L. plantarum, L. brevis, and L. curvatus. Compatibility assays performed with cLAB and the 16 species described above indicate that all tested LAB can be included in a mixed probiotic formula. Based on our analyses, we suggest that E. gallinarum CRL 1826, L. garvieae CRL 1828, and P. pentosaceus 15 and 18B represent optimal probiotic candidates for Bd control and mitigation.	[Niederle, M., V; Ale, C. E.; Pasteris, S. E.] Univ Nacl Tucuman UNT, Consejo Nacl Invest Cient & Tecn CONICET, Inst Super Invest Biolog INSIBIO, San Miguel De Tucuman, Tucuman, Argentina; [Niederle, M., V; Ale, C. E.; Pasteris, S. E.] Univ Nacl Tucuman UNT, Fac Bioquirn Quit Nice & Farm, Inst Biol Dr Francisco D Barbieri, San Miguel De Tucuman, Tucuman, Argentina; [Bosch, J.] CSIC, Museo Nacl Ciencias Nat, Madrid, Spain; [Bosch, J.] Oviedo Univ, Res Unit Biodivers, CSIC, UO,PA, Campus Mieres, Oviedo, Spain; [Nader-Macias, M. E.; Aristimuno Ficoseco, C.] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Referencia Lactobacilos CERELA, San Miguel De Tucuman, Tucuman, Argentina; [Toledo, L. F.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Campinas, SP, Brazil; [Valenzuela-Sanchez, A.; Soto-Azat, C.] Univ Andres Bello, Fac Ciencias Vida, Ctr Invest Sustentabilidad, Santiago, Chile; [Valenzuela-Sanchez, A.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Valenzuela-Sanchez, A.] Org Gubernamental ONG Ranita Darwin, Santiago, Chile; [Valenzuela-Sanchez, A.] Org Gubernamental ONG Ranita Darwin, Valdivia, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Nacional de Tucuman; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Andres Bello; Universidad Austral de Chile	Pasteris, SE (corresponding author), Univ Nacl Tucuman UNT, Consejo Nacl Invest Cient & Tecn CONICET, Inst Super Invest Biolog INSIBIO, San Miguel De Tucuman, Tucuman, Argentina.; Pasteris, SE (corresponding author), Univ Nacl Tucuman UNT, Fac Bioquirn Quit Nice & Farm, Inst Biol Dr Francisco D Barbieri, San Miguel De Tucuman, Tucuman, Argentina.	pasteris@fbqf.unt.edu.ar	Bosch, Jaime/H-3042-2011; Valenzuela-Sánchez, Andrés/AAG-2762-2019	Bosch, Jaime/0000-0002-0099-7934; Valenzuela-Sánchez, Andrés/0000-0002-0445-9156; Pasteris, Sergio/0000-0003-1965-6854; Azat, Claudio/0000-0001-9201-7886; ALE, CESAR EMMANUEL/0000-0002-3891-3628	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 063]; Consejo de Investigaciones de la Universidad Nacional de Tucuman [PIUNT 26/D 414, PIUNT 26/D 645, PIUNT 528]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2017-2244, PICT 20152467, PICT2017-4324]; Ministerio de Economia y Competitividad de Espana [CGL2015-70070-R]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1181758, 3180107]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/25358-3]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigaciones de la Universidad Nacional de Tucuman; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Economia y Competitividad de Espana(Spanish Government); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 063 to SEP), Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 26/D 414 and 26/D 645 to SEP, and PIUNT 528), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2017-2244 to SEP, PICT 20152467 to CEA, and PICT2017-4324 to MENM), Ministerio de Economia y Competitividad de Espana (CGL2015-70070-R to JB), Fondo Nacional de Desarrollo Cientifico y Tecnologico (1181758 to CSA and 3180107 to AVS), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2016/25358-3 to LFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 063 to SEP), Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 26/D 414 and 26/D 645 to SEP, and PIUNT 528), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2017-2244 to SEP, PICT 2015-2467 to CEA, and PICT20174324 to MENM), Ministerio de Economia y Competitividad de Espana (CGL2015-70070-R to JB), Fondo Nacional de Desarrollo Cientifico y Tecnologico (1181758 to CSA and 3180107 to AVS), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2016/25358-3 to LFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank to Daniel Medina and Kieran Bates for useful suggestions and comments on the manuscript provided.	Ahmed FE, 2003, TRENDS BIOTECHNOL, V21, P491, DOI 10.1016/j.tibtech.2003.09.006; Amaral-Machado L, 2016, MOLECULES, V21, DOI 10.3390/molecules21050585; Antwis RE, 2018, MOL ECOL, V27, P577, DOI 10.1111/mec.14456; Antwis RE, 2015, APPL ENVIRON MICROB, V81, P3706, DOI 10.1128/AEM.00010-15; Antwis RE, 2017, MICROBIOL-SGM, V163, P1835, DOI 10.1099/mic.0.000570; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Batista S, 2016, APPL MICROBIOL BIOT, V100, P7223, DOI 10.1007/s00253-016-7592-7; Becker MH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2881; Becker MH, 2015, MOL ECOL, V24, P1628, DOI 10.1111/mec.13135; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Borges SF, 2011, FEMS IMMUNOL MED MIC, V62, P315, DOI 10.1111/j.1574-695X.2011.00815.x; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; Borisa S, 2017, MICROBES INFECT, V2, P543; Bosch J, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0874; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Catenazzi A, 2015, ANNU REV ENV RESOUR, V40, P91, DOI 10.1146/annurev-environ-102014-021358; Sanchez-Ortiz AC, 2015, LAT AM J AQUAT RES, V43, P123, DOI 10.3856/vol43-issue1-fulltext-11; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Dertli E, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0347-2; Digaitiene A, 2012, J APPL MICROBIOL, V112, P732, DOI 10.1111/j.1365-2672.2012.05249.x; Etzold S, 2014, CURR OPIN STRUC BIOL, V28, P23, DOI 10.1016/j.sbi.2014.07.002; FAO/WHO, 2001, HLTH NUTR PROP PROB, V85; Fdhila K, 2017, MICROB PATHOGENESIS, V110, P654, DOI 10.1016/j.micpath.2017.07.017; Fites JS, 2014, INFECT IMMUN, V82, P4698, DOI 10.1128/IAI.02231-14; Fontana C, 2006, APPL ENVIRON MICROB, V72, P5618, DOI 10.1128/AEM.00029-06; Fraga J, 2004, REV VENEZ MICROBI S4, V24, P238; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Fusco V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00155; Gao XL, 2018, FISH SHELLFISH IMMUN, V78, P42, DOI 10.1016/j.fsi.2018.04.010; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0207; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Graham CE, 2017, P NATL ACAD SCI USA, V114, P4507, DOI 10.1073/pnas.1620432114; Greenspan SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27828-w; Grogan LF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02536; Hai NV, 2015, J APPL MICROBIOL, V119, P917, DOI 10.1111/jam.12886; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Heras J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0703-0; HUEY B, 1989, J BACTERIOL, V171, P2528, DOI 10.1128/jb.171.5.2528-2532.1989; Puertas AI, 2018, LWT-FOOD SCI TECHNOL, V90, P469, DOI 10.1016/j.lwt.2017.12.048; Kobyliak N, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0451-2; Kueneman JG, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1553; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; Kullen MJ, 2000, J APPL MICROBIOL, V89, P511, DOI 10.1046/j.1365-2672.2000.01146.x; Lamari F, 2016, J FISH DIS, V39, P1421, DOI 10.1111/jfd.12479; Lambertini C, 2017, DIS AQUAT ORGAN, V124, P109, DOI 10.3354/dao03114; Lazado CC, 2014, FISH SHELLFISH IMMUN, V39, P78, DOI 10.1016/j.fsi.2014.04.015; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Terraf MCL, 2014, J APPL MICROBIOL, V117, P1761, DOI 10.1111/jam.12642; Terraf MCL, 2012, J APPL MICROBIOL, V113, P1517, DOI 10.1111/j.1365-2672.2012.05429.x; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Loudon AH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00441; Ly MH, 2006, COLLOID SURFACE B, V52, P149, DOI 10.1016/j.colsurfb.2006.04.015; Kaktcham PM, 2018, PROBIOTICS ANTIMICRO, V10, P98, DOI 10.1007/s12602-017-9312-8; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Martin Rebeca, 2008, Int Microbiol, V11, P261; Mastromarino P, 2015, PHARMACOL RES, V95-96, P63, DOI 10.1016/j.phrs.2015.03.013; Mercier-Bonin M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02247; Mesquita AFC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16425-y; Mendoza GM, 2012, RES VET SCI, V93, P1160, DOI 10.1016/j.rvsc.2012.05.007; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Mozzi F, 2009, J APPL MICROBIOL, V107, P56, DOI 10.1111/j.1365-2672.2009.04182.x; Muletz-Wolz CR, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00186-17; Tu NHK, 2018, TOXINS, V10, DOI 10.3390/toxins10070288; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; OFEK I, 1994, BACTERIAL ADHESION C, P16; Park Shawna T, 2014, Microbiol Insights, V7, P1, DOI 10.4137/MBI.S13639; Pasteris S. E., 2009, ANTON LEEUW INT J G, V95, P375; Pasteris SE, 2006, AQUACULTURE, V251, P11, DOI 10.1016/j.aquaculture.2005.05.007; Pasteris SE, 2017, AQUAC RES, V48, P2157, DOI 10.1111/are.13053; Pasteris SE, 2009, AQUAC RES, V40, P1605, DOI 10.1111/j.1365-2109.2009.02261.x; Piovia-Scott J, 2017, MICROB ECOL, V74, P217, DOI 10.1007/s00248-016-0916-4; Polak-Berecka M, 2014, ANTON LEEUW INT J G, V106, P751, DOI 10.1007/s10482-014-0245-x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Quintana G, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2353-z; Rebollar EA, 2016, APPL ENVIRON MICROB, V82, P2457, DOI 10.1128/AEM.04147-15; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Rendle M, 2015, J ZOO AQUAR RES, V3, P137; Reyes-Escogido L, 2010, ANTON LEEUW INT J G, V98, P465, DOI 10.1007/s10482-010-9462-0; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Ringo E, 2010, AQUAC RES, V41, P451, DOI 10.1111/j.1365-2109.2009.02339.x; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rosenberg M., 1990, MICROBIAL CELL SURFA, P1; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Ruas-Madiedo P, 2006, J FOOD PROTECT, V69, P2011, DOI 10.4315/0362-028X-69.8.2011; Sarika AR, 2017, J FOOD MICROBIOL SAF, V2, P4; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Silva LF, 2015, J FOOD SCI, V80, pM411, DOI 10.1111/1750-3841.12771; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Touret T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203501; Valenzuela-Sanchez A, 2018, TRANSBOUND EMERG DIS, V65, P309, DOI 10.1111/tbed.12775; Van Rooij P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186269; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Virchenko O V, 2015, Fiziol Zh, V61, P35; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Wang X, 2017, INT J BIOL MACROMOL, V103, P1173, DOI 10.1016/j.ijbiomac.2017.05.118; Watters C, 2016, PROG MOL BIOL TRANSL, V142, P193, DOI 10.1016/bs.pmbts.2016.05.007; Woodhams DC, 2018, MICROB ECOL, V75, P1049, DOI 10.1007/s00248-017-1095-7; Woodhams DC, 2016, TRENDS MICROBIOL, V24, P161, DOI 10.1016/j.tim.2015.12.010; Zorriehzahra MJ, 2016, VET QUART, V36, P228, DOI 10.1080/01652176.2016.1172132	111	13	13	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223020	10.1371/journal.pone.0223020	http://dx.doi.org/10.1371/journal.pone.0223020			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560707	Green Published, gold			2022-12-26	WOS:000532353700030
J	Fink, DL; Collins, S; Barret, R; Pollara, G; Marks, M; Logan, S				Fink, Doug L.; Collins, Steven; Barret, Ronnie; Pollara, Gabriele; Marks, Michael; Logan, Sarah			Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; METAANALYSIS; BACTEREMIA; IMPACT	Background The incidence of multi-drug resistant ESBL-associated urinary tract infections (UTIs) is increasing globally. Patients with abnormal renal tract anatomy and other co-morbidities are at increased risk of complicated UTI and ESBL-associated infections. The duration and safety of OPAT for this cohort of patients is unknown. Objectives This study aims to provide an evidence base to support decision-making regarding duration of antibiotic treatment for complicated UTIs. Methods We retrospectively reviewed all patients receiving ertapenem with or without adjunctive fosfomycin for complicated UTIs in the OPAT service of our tertiary infectious diseases hospital. All data had been collected prospectively as part of routine clinical care. Our primary outcomes were microbiological and clinical cure of UTI. Results We identified 33 treatment episodes of ertapenem use for UTIs. 76% episodes related to pyelonephritis or urosepsis diagnoses. Renal tract abnormalities or prior urological surgery were present in 45% of patients. The median duration of appropriate parenteral antibiotic therapy in our study was 6 days. Clinical cure was achieved with short-course parenteral treatment alone in 81% of patients and this increased to 96% when adjunctive fosfomycin was used. There was a single treatment failure resulting in hospital admission. Conclusions Short duration ertapenem via OPAT with or without adjunctive fosfomycin is safe and effective for the treatment of complicated UTIs. Further studies are required to inform optimal treatment strategies and publication of guidelines in this field.	[Fink, Doug L.; Pollara, Gabriele] Univ Coll London Hosp, Dept Microbiol, London, England; [Fink, Doug L.; Pollara, Gabriele] UCL, Div Infect & Immun, London, England; [Collins, Steven; Barret, Ronnie; Marks, Michael; Logan, Sarah] Univ Coll London Hosp, Hosp Trop Dis, London, England; [Marks, Michael] Univ Coll London Hosp NHS Trust, London Sch Hyg & Trop Med Hosp Trop Dis, Fac Infect & Trop Dis, Clin Res Dept, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Marks, M (corresponding author), Univ Coll London Hosp, Hosp Trop Dis, London, England.; Marks, M (corresponding author), Univ Coll London Hosp NHS Trust, London Sch Hyg & Trop Med Hosp Trop Dis, Fac Infect & Trop Dis, Clin Res Dept, London, England.	michael.marks@lshtm.ac.uk		Logan, Sarah/0000-0001-8527-450X; Marks, Michael/0000-0002-7585-4743	Wellcome Trust [WT102807, WT205236, WT101766]; NIHR Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	MM (WT102807), DF (WT205236) and GP (WT101766) are supported by the Wellcome Trust. All authors are supported by NIHR Biomedical Research Centre funding to UCLH and UCL. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman ALN, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1585; Eliakim-Raz N, 2013, J ANTIMICROB CHEMOTH, V68, P2183, DOI 10.1093/jac/dkt177; EUA, UROLOGICAL INFECT; Kyriakidou KG, 2008, CLIN THER, V30, P1859, DOI 10.1016/j.clinthera.2008.10.007; Lee S, 2014, MICROB DRUG RESIST, V20, P39, DOI 10.1089/mdr.2013.0075; Marks M, 2015, J INFECTION, V71, P402, DOI 10.1016/j.jinf.2015.04.007; Matthews PC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1888-1; NICE, MULT RES UR TRACT IN; Park SH, 2015, ANTIMICROB AGENTS CH, V59, P1962, DOI 10.1128/AAC.04821-14; Qureshi ZA, 2014, ANTIMICROB AGENTS CH, V58, P3437, DOI 10.1128/AAC.02721-14; Rosso-Fernandez C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007363; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Senol S, 2010, J CHEMOTHERAPY, V22, P355, DOI 10.1179/joc.2010.22.5.355; Teillant A, 2015, LANCET INFECT DIS, V15, P1429, DOI 10.1016/S1473-3099(15)00270-4; Toner L, 2016, WORLD J UROL, V34, P1031, DOI 10.1007/s00345-015-1718-x; Trad MA, 2017, J CHEMOTHERAPY, V29, P25, DOI 10.1080/1120009X.2016.1158937; Underwood J, 2019, J ANTIMICROB CHEMOTH, V74, P787, DOI 10.1093/jac/dky474; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Yilmaz E, 2008, J CHEMOTHERAPY, V20, P581, DOI 10.1179/joc.2008.20.5.581	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223130	10.1371/journal.pone.0223130	http://dx.doi.org/10.1371/journal.pone.0223130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557236	Green Published, Green Accepted, gold			2022-12-26	WOS:000532345500077
J	Wang, DM; Cheng, XH; Li, Y; Guo, MW; Zhao, WJ; Qiu, J; Zheng, Y; Meng, MY; Ping, XD; Chen, X; Wang, S; Luo, J; Luo, QQ; Ma, XR; Xu, LY				Wang, Dongmei; Cheng, Xinghua; Li, Yu; Guo, Mingwei; Zhao, Wenjun; Qiu, Jin; Zheng, Ying; Meng, Meiyao; Ping, Xiaodan; Chen, Xin; Wang, Shu; Luo, Jian; Luo, Qingquan; Ma, Xinran; Xu, Lingyan			C/EBP delta-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FATTY-ACID SYNTHASE; TRANSCRIPTIONAL REGULATION; C/EBP-DELTA; STEM-CELLS; CANCER; RECEPTOR; BINDING; LOX-1; METABOLISM	Cancer cells undergo significant lipid metabolic reprogramming to ensure sufficient energy supply for survival and progression. However, how cancer cells integrate lipid metabolic signaling with cancer progression is not well understood. In the present study, we demonstrated that C/EBP delta, a critical lipid metabolic regulator, is a TGF-beta 1 downstream gene and promotes lung adenocarcinoma metastasis. Importantly, C/EBP delta caused significant oscillations in both lipid metabolic and epithelial to mesenchymal transition (EMT) gene networks. Mechanistically, we demonstrated that C/EBP delta recruited oncogene NCOA3 to transcriptionally activate Slug, a canonical EMT transcription factor, which in turn induced oxLDL receptor-1 (Lox1) expression and enhanced oxLDL uptake to promote cancer metastasis, which could be blocked with LOX1 neutralizing antibody. In summary, our results unveiled a previously unappreciated interplay between lipid metabolic and metastatic program, as well as the existence of a pivotal C/EBP delta-Slug-Lox1 transcription axis to promote oxLDL levels and cancer metastasis.	[Wang, Dongmei; Li, Yu; Guo, Mingwei; Zhao, Wenjun; Qiu, Jin; Zheng, Ying; Meng, Meiyao; Ping, Xiaodan; Chen, Xin; Luo, Jian; Ma, Xinran; Xu, Lingyan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dong Chuan Rd, Shanghai 200241, Peoples R China; [Wang, Dongmei; Li, Yu; Guo, Mingwei; Zhao, Wenjun; Qiu, Jin; Zheng, Ying; Meng, Meiyao; Ping, Xiaodan; Chen, Xin; Luo, Jian; Ma, Xinran; Xu, Lingyan] East China Normal Univ, Sch Life Sci, 500 Dong Chuan Rd, Shanghai 200241, Peoples R China; [Cheng, Xinghua; Luo, Qingquan] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Pulm Tumor Med Ctr, Dept Oncol, 241 West Huai Hai Rd, Shanghai 200030, Peoples R China; [Wang, Shu; Ma, Xinran; Xu, Lingyan] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Sch Med,Dept Endocrinol & Metab, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China	East China Normal University; East China Normal University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ma, XR; Xu, LY (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dong Chuan Rd, Shanghai 200241, Peoples R China.; Ma, XR; Xu, LY (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dong Chuan Rd, Shanghai 200241, Peoples R China.; Ma, XR; Xu, LY (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Sch Med,Dept Endocrinol & Metab, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.	xrma@bio.ecnu.edu.cn; lyxu@ecnu.edu.cn			National Natural Science Foundation of China [31770840, 31800989, 81902980, 81502480]; Shanghai Pujiang Program [17PJ1402600, 17PJ1402700]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [TP2017042]; Shanghai Young Top Notch Talents; China Postdoctoral Science Foundation [2017M611499]; ECNU public platform for Innovation [011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Young Top Notch Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); ECNU public platform for Innovation	We are thankful to Dr Yan Lu (Zhongshan Hospital, Shanghai) and Zhenfei Li (SIBS, Shanghai) for reading the paper and for discussions throughout the project. This project is supported by funds from the National Natural Science Foundation of China (31770840 to XM, 31800989 to LX, 81902980 to DW, and 81502480 to XC), Shanghai Pujiang Program (17PJ1402600 to XM and 17PJ1402700 to LX), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (TP2017042 to XM), Shanghai Young Top Notch Talents (to XM), the China Postdoctoral Science Foundation (2017M611499 to DW), and ECNU public platform for Innovation (011).	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; Balamurugan K, 2019, ONCOGENE, V38, P3765, DOI 10.1038/s41388-018-0516-5; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balzan S, 2018, LIFE SCI, V198, P79, DOI 10.1016/j.lfs.2018.02.024; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Garcia MR, 2017, CELL METAB, V26, P842, DOI 10.1016/j.cmet.2017.09.018; Gonzalez-Chavarria I, 2018, CANCER LETT, V414, P34, DOI 10.1016/j.canlet.2017.10.035; Hou SD, 2017, AM J PATHOL, V187, P954, DOI 10.1016/j.ajpath.2017.01.009; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Kobayashi K, 2003, J LIPID RES, V44, P716, DOI 10.1194/jlr.M200329-JLR200; Li Z, 2017, CELL METAB, V25, P228, DOI 10.1016/j.cmet.2017.01.016; Lin HP, 2016, CANCER RES, V76, P6924, DOI 10.1158/0008-5472.CAN-16-1597; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; Lue HW, 2017, GENE DEV, V31, P2067, DOI 10.1101/gad.305292.117; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mendoza-Villanueva D, 2016, ONCOGENE, V35, P6166, DOI 10.1038/onc.2016.156; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Nishimura S, 2004, OSTEOARTHR CARTILAGE, V12, P568, DOI 10.1016/j.joca.2004.04.005; Noto A, 2017, ONCOGENE, V36, P4573, DOI [10.1038/onc.2017.75, 10.1038/onc.2017.212]; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rosen ED, 2000, GENE DEV, V14, P1293; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tregnago C, 2016, LEUKEMIA, V30, P1887, DOI 10.1038/leu.2016.98; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang WJ, 2017, CLIN CANCER RES, V23, P503, DOI 10.1158/1078-0432.CCR-15-1169; Wang YW, 2014, J INVEST DERMATOL, V134, P2016, DOI 10.1038/jid.2014.84; Ye HB, 2016, CELL STEM CELL, V19, P23, DOI 10.1016/j.stem.2016.06.001; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897	41	11	11	2	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					833	848		10.1038/s41388-019-1015-z	http://dx.doi.org/10.1038/s41388-019-1015-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31562393				2022-12-26	WOS:000509197200007
J	Xu, Y; Surman, DR; Diggs, L; Xi, SC; Gao, SJ; Gurusamy, D; McLoughlin, K; Drake, J; Feingold, P; Brown, K; Wangsa, D; Wangsa, D; Zhang, X; Ried, T; Davis, JL; Hernandez, J; Hoang, CD; Souza, RF; Schrump, DS; Ripley, RT				Xu, Yuan; Surman, Deborah R.; Diggs, Laurence; Xi, Sichuan; Gao, Shaojian; Gurusamy, Devikala; McLoughlin, Kaitlin; Drake, Justin; Feingold, Paul; Brown, Kate; Wangsa, Danny; Wangsa, Darawalee; Zhang, Xi; Ried, Thomas; Davis, Jeremy L.; Hernandez, Jonathan; Hoang, Chuong D.; Souza, Rhonda F.; Schrump, David S.; Ripley, R. Taylor			Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1	ONCOGENE			English	Article							CAUSES DNA-DAMAGE; ADENOCARCINOMA INCIDENCE; BARRETTS-ESOPHAGUS; CANCER-CELLS; MITOCHONDRIAL; ROS; INSTABILITY; EXPRESSION; SURVIVAL; BCL-2	Barrett's esophagus (BE) is associated with reflux and is implicated the development of esophageal adenocarcinoma (EAC). Apoptosis induces cell death through mitochondrial outer membrane permeabilization (MOMP), which is considered an irreversible step in apoptosis. Activation of MOMP to levels that fail to reach the apoptotic threshold may paradoxically promote cancer-a phenomenon called "Minority MOMP." We asked whether reflux-induced esophageal carcinogenesis occurred via minority MOMP and whether compensatory resistance mechanisms prevented cell death during this process. We exposed preneoplastic, hTERT-immortalized Barrett's cell, CP-C and CP-A, to the oncogenic bile acid, deoxycholic acid (DCA), for 1 year. Induction of minority MOMP was tested via comet assay, CyQuant, annexin V, JC-1, cytochrome C subcellular localization, caspase 3 activation, and immunoblots. We used bcl-2 homology domain-3 (BH3) profiling to test the mitochondrial apoptotic threshold. One-year exposure of Barrett's cells to DCA induced a malignant phenotype noted by clone and tumor formation. DCA promoted minority MOMP noted by minimal release of cytochrome C and limited caspase 3 activation, which resulted in DNA damage without apoptosis. Upregulation of the antiapoptotic protein, Mcl-1, ROS generation, and NF-kappa B activation occurred in conjunction with minority MOMP. Inhibition of ROS blocked minority MOMP and Mcl-1 upregulation. Knockdown of Mcl-1 shifted minority MOMP to complete MOMP as noted by dynamic BH3 profiling and increased apoptosis. Minority MOMP contributes to DCA induced carcinogenesis in preneoplastic BE. Mcl-1 provided a balance within the mitochondria that induced resistance complete MOMP and cell death. Targeting Mcl-1 may be a therapeutic strategy in EAC.	[Xu, Yuan; Surman, Deborah R.; Diggs, Laurence; Xi, Sichuan; Gao, Shaojian; McLoughlin, Kaitlin; Drake, Justin; Feingold, Paul; Brown, Kate; Davis, Jeremy L.; Hernandez, Jonathan; Hoang, Chuong D.; Schrump, David S.; Ripley, R. Taylor] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Surman, Deborah R.; Ripley, R. Taylor] Baylor Coll Med, Michael E DeBakey Dept Gen Surg, Div Gen Thorac Surg, Houston, TX 77030 USA; [Gurusamy, Devikala] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wangsa, Danny; Wangsa, Darawalee; Ried, Thomas] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhang, Xi; Souza, Rhonda F.] Baylor Univ, Med Ctr, Ctr Esophageal Dis, Dept Med, Dallas, TX USA; [Wangsa, Danny; Wangsa, Darawalee; Ried, Thomas] Baylor Scott & White Res Inst, Ctr Esophageal Res, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor University; Baylor University Medical Center; Baylor Health Care System; Baylor University Medical Center	Ripley, RT (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Ripley, RT (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Gen Surg, Div Gen Thorac Surg, Houston, TX 77030 USA.	R.Taylor.Ripley@bcm.edu	Davis, Jeremy/GLT-7151-2022; Gurusamy, Devikala/T-3410-2019; Davis, Jeremy/GQA-5941-2022	Davis, Jeremy/0000-0002-6334-6936; Davis, Jeremy/0000-0002-6334-6936; Gurusamy, Devikala/0000-0002-1727-8653; DRAKE, JUSTIN/0000-0002-2500-7044				Araghi RR, 2018, P NATL ACAD SCI USA, V115, pE886, DOI 10.1073/pnas.1712952115; Bajpai M, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-43; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Byun JY, 2009, MOL PHARMACOL, V76, P734, DOI 10.1124/mol.109.056259; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hormi-Carver K, 2009, CANCER RES, V69, P672, DOI 10.1158/0008-5472.CAN-08-3703; Huo XF, 2011, AM J PHYSIOL-GASTR L, V301, pG278, DOI 10.1152/ajpgi.00092.2011; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Kim MJ, 2013, CANCER LETT, V339, P15, DOI 10.1016/j.canlet.2013.07.027; Kong CY, 2014, CANCER EPIDEM BIOMAR, V23, P997, DOI 10.1158/1055-9965.EPI-13-1233; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Lovric MM, 2010, ONCOGENE, V29, P5048, DOI 10.1038/onc.2010.242; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Potter DS, 2016, COLD SH Q B, V81, P131, DOI 10.1101/sqb.2016.81.030841; Runge TM, 2015, GASTROENTEROL CLIN N, V44, P203, DOI 10.1016/j.gtc.2015.02.001; Ryan J, 2016, BIOL CHEM, V397, P671, DOI 10.1515/hsz-2016-0107; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sobieraj DM, 2011, AM J MANAG CARE, V17, pE449; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Williams MM, 2017, MOL CANCER RES, V15, P259, DOI 10.1158/1541-7786.MCR-16-0280-T; Xu Y, 2017, ONCOTARGET, V8, P101057; Yadav N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.305; Yen CJ, 2008, CANCER RES, V68, P2632, DOI 10.1158/0008-5472.CAN-07-5460; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200	39	12	13	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					877	890		10.1038/s41388-019-1029-6	http://dx.doi.org/10.1038/s41388-019-1029-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31570787	Green Accepted			2022-12-26	WOS:000509197200010
J	Yagi, H; Onoyama, I; Asanoma, K; Hori, E; Yasunaga, M; Kodama, K; Kijima, M; Ohgami, T; Kaneki, E; Okugawa, K; Yahata, H; Kato, K				Yagi, Hiroshi; Onoyama, Ichiro; Asanoma, Kazuo; Hori, Emiko; Yasunaga, Masafumi; Kodama, Keisuke; Kijima, Masako; Ohgami, Tatsuhiro; Kaneki, Eisuke; Okugawa, Kaoru; Yahata, Hideaki; Kato, Kiyoko			G alpha(13)-mediated LATS1 down-regulation contributes to epithelial-mesenchymal transition in ovarian cancer	FASEB JOURNAL			English	Article						EMT; ITCH; GPCR; Hippo signaling pathway; ubiquitination	PROMOTES CELL-PROLIFERATION; HETEROTRIMERIC G-PROTEINS; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; BREAST-CANCER; ALPHA-SUBUNIT; SIZE-CONTROL; G12 FAMILY; YAP; ACTIVATION	G alpha(13), a heterotrimeric G-protein of the G alpha(12/13) subfamily, is associated with aggressive phenotypes in various human cancers. However, the mechanisms by which G alpha(13) promotes cancer progression have not been fully elucidated. Here, we demonstrate that the activation of G alpha(13) induces epithelial-mesenchymal transition in ovarian cancer (OvCa) cells through down-regulation of large tumor suppressor kinase (LATS) 1, a critical component of the Hippo signaling pathway. A synthetic biology approach using a mutant GPCR and chimeric G-protein revealed that G alpha(13)-regulated phosphorylation of LATS1 at serine 909 within its activation loop induced recruitment of the itchy E3 ubiquitin protein ligase to trigger LATS1 degradation. Our findings uncover novel mechanisms through which G alpha(13) activation induces dysregulation of the Hippo signaling pathway, which leads to aggressive cancer phenotypes, and thereby identify a potential target for preventing the metastatic spread of OvCa.	[Yagi, Hiroshi; Onoyama, Ichiro; Asanoma, Kazuo; Hori, Emiko; Yasunaga, Masafumi; Kodama, Keisuke; Kijima, Masako; Ohgami, Tatsuhiro; Kaneki, Eisuke; Okugawa, Kaoru; Yahata, Hideaki; Kato, Kiyoko] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Japan	Kyushu University	Yagi, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yagih@med.kyushu-u.ac.jp	Yasunaga, Masafumi/ABE-4630-2021	Yasunaga, Masafumi/0000-0002-0545-0428; kodama, keisuke/0000-0001-7031-6359	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K11282]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Liwen Bianji (Edanz Group China, Beijing, China; www.liwenbianji.cn/ac) for editing the English text of a draft of this manuscript. The authors are grateful to Akari Yasumoto and the Research Support Center of the Graduate School of Medical Science at Kyushu University for technical support. This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17K11282). The authors declare no conflicts of interest.	Allred DC, 1998, MODERN PATHOL, V11, P155; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cancer Genome Atlas Research Network, 2011, NATURE, V490, P298; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Deng J, 2016, ONCOTARGET, V7, P10037, DOI 10.18632/oncotarget.7048; Domingo E, 2018, LANCET GASTROENTEROL, V3, P635, DOI 10.1016/S2468-1253(18)30117-1; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim Y, 2018, BMB REP, V51, P143, DOI 10.5483/BMBRep.2018.51.3.017; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Patra KC, 2018, NAT CELL BIOL, V20, P811, DOI 10.1038/s41556-018-0122-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35948; Yabuta N, 2013, J CELL SCI, V126, P508, DOI 10.1242/jcs.113431; Yagi H, 2016, ONCOGENE, V35, P4471, DOI 10.1038/onc.2015.505; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhang JX, 2016, ONCOTARGET, V7, P4414, DOI 10.18632/oncotarget.6780; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	51	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13683	13694		10.1096/fj.201901278R	http://dx.doi.org/10.1096/fj.201901278R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31569999	Bronze			2022-12-26	WOS:000507466100050
J	Newhardt, MF; Batushansky, A; Matsuzaki, S; Young, ZT; West, M; Chin, NC; Szweda, LI; Kinter, M; Humphries, KM				Newhardt, Maria F.; Batushansky, Albert; Matsuzaki, Satoshi; Young, Zachary T.; West, Melinda; Chin, Ngun Cer; Szweda, Luke, I; Kinter, Michael; Humphries, Kenneth M.			Enhancing cardiac glycolysis causes an increase in PDK4 content in response to short-term high-fat diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac metabolism; mitochondria; glycolysis; proteomics; phosphofructokinase; branched chain amino acids; pyruvate dehydrogenase kinase (PDC kinase)	AMINO-ACID CATABOLISM; PYRUVATE-DEHYDROGENASE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; HEART-DISEASE; MECHANISMS; EXPRESSION; PHOSPHATASE; KINASE; PHOSPHORYLATION	The healthy heart has a dynamic capacity to respond and adapt to changes in nutrient availability. Metabolic inflexibility, such as occurs with diabetes, increases cardiac reliance on fatty acids to meet energetic demands, and this results in deleterious effects, including mitochondrial dysfunction, that contribute to pathophysiology. Enhancing glucose usage may mitigate metabolic inflexibility and be advantageous under such conditions. Here, we sought to identify how mitochondrial function and cardiac metabolism are affected in a transgenic mouse model of enhanced cardiac glycolysis (Glyco(Hi)) basally and following a short-term (7-day) high-fat diet (HFD). Glyco(Hi) mice constitutively express an active form of phosphofructokinase-2, resulting in elevated levels of the PFK-1 allosteric activator fructose 2,6-bisphosphate. We report that basally Glyco(Hi) mitochondria exhibit augmented pyruvate-supported respiration relative to fatty acids. Nevertheless, both WT and Glyco(Hi) mitochondria had a similar shift toward increased rates of fatty acid?supported respiration following HFD. Metabolic profiling by GC-MS revealed distinct features based on both genotype and diet, with a unique increase in branched-chain amino acids in the Glyco(Hi) HFD group. Targeted quantitative proteomics analysis also supported both genotype- and diet-dependent changes in protein expression and uncovered an enhanced expression of pyruvate dehydrogenase kinase 4 (PDK4) in the Glyco(Hi) HFD group. These results support a newly identified mechanism whereby the levels of fructose 2,6-bisphosphate promote mitochondrial PDK4 levels and identify a secondary adaptive response that prevents excessive mitochondrial pyruvate oxidation when glycolysis is sustained after a high-fat dietary challenge.	[Newhardt, Maria F.; Batushansky, Albert; Matsuzaki, Satoshi; Young, Zachary T.; West, Melinda; Chin, Ngun Cer; Kinter, Michael; Humphries, Kenneth M.] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA; [Newhardt, Maria F.; Humphries, Kenneth M.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Szweda, Luke, I] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Humphries, KM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kenneth-humphries@omrf.org		Newhardt, Maria/0000-0001-6049-1284; Humphries, Kenneth/0000-0002-6167-3175	National Institutes of Health [R01HL125625, P30AG050911, P20GM103447]; Oklahoma Center for the Advancement of Science [HR17-094]; National Science Foundation [1849507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01HL125625 (to K. M. H.), P30AG050911 (to M. K.), and P20GM103447 (to M. K.); by Grant HR17-094 (to K. M. H.) from the Oklahoma Center for the Advancement of Science; and by National Science Foundation Graduate Research Fellowship Program Grant 1849507 (to M. F. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; [Anonymous], 2018, R PACKAGE VERSION 20; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baily CN, 2011, ARCH BIOCHEM BIOPHYS, V514, P68, DOI 10.1016/j.abb.2011.08.003; Batushansky A, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1478-5; Bockus LB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007159; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Depre C, 1998, J CLIN INVEST, V101, P390, DOI 10.1172/JCI1168; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Ferreira R, 2018, METABOLISM, V87, P98, DOI 10.1016/j.metabol.2018.07.004; Fukushima A, 2016, BBA-MOL CELL BIOL L, V1861, P1525, DOI 10.1016/j.bbalip.2016.03.020; Gibb AA, 2017, CIRCULATION, V136, P2144, DOI 10.1161/CIRCULATIONAHA.117.028274; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lopaschuk GD, 2017, CAN J CARDIOL, V33, P838, DOI 10.1016/j.cjca.2016.12.013; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Neishabouri SH, 2015, AMINO ACIDS, V47, P1167, DOI 10.1007/s00726-015-1944-y; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; RANDLE PJ, 1963, LANCET, V1, P785; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Ruiz-Villalba A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00043-9; Schafer C, 2018, J BIOL CHEM, V293, P6915, DOI [10.1074/jbc.RA117.000268, 10.1074/jbc.ra117.000268]; Shin AC, 2014, CELL METAB, V20, P898, DOI 10.1016/j.cmet.2014.09.003; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Tsai SY, 2016, CELL REP, V16, P1903, DOI 10.1016/j.celrep.2016.07.029; Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361; Vadvalkar SS, 2017, J BIOL CHEM, V292, P4423, DOI 10.1074/jbc.M116.753509; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017	59	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16831	16845		10.1074/jbc.RA119.010371	http://dx.doi.org/10.1074/jbc.RA119.010371			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31562244	Green Published, hybrid			2022-12-26	WOS:000501801900029
J	Seo, AN; Jung, Y; Jang, H; Lee, E; Bae, HI; Son, T; Kwon, O; Chung, HY; Yu, W; Lee, YM				Seo, An Na; Jung, Yukdong; Jang, Hyeonha; Lee, Eunhye; Bae, Han-Ik; Son, Taekwon; Kwon, Ohkyung; Chung, Ho Young; Yu, Wansik; Lee, You Mie			Clinical significance and prognostic role of hypoxia-induced microRNA 382 in gastric adenocarcinoma	PLOS ONE			English	Article							CANCER-CELLS; INDUCED RESISTANCE; DOWN-REGULATION; MIR-210; HIF-1-ALPHA; CARCINOMAS; INCREASES; CISPLATIN; INVASION; GROWTH	Hypoxia and angiogenesis are critical components in the progression of solid cancer, including gastric cancers (GCs). miR-382 has been identified as a hypoxia-induced miR (hypoxamiR), but the clinical significance in GCs has not been identified yet. To explore the clinical and prognostic importance of miR-382 in GCs, the surgical specimens of 398 patients with GCs in KNU hospital in Korea, the total of 183 patients was randomly selected using simple sampling methods and big data with 446 GCs and 45 normal tissues from the data portal (https://portal.gdc. cancer.gov/) were analysed. Expression of miR-382 as well as miR-210, as a positive control hypoxamiR by qRT-PCR in histologically malignant region of GCs showed significantly positive correlation (R = 0.516, p<0.001). High miR-210 and miR-382 expression was significantly correlated with unfavorable prognosis including advanced GCs (AGC), higher T category, N category, pathologic TNM stage, lymphovascular invasion, venous invasion, and perinueral invasion, respectively (all p < 0.05). In univariate analysis, high miR-210 expression was significantly associated with worse overall survival (OS) (p = 0.036) but not high miR-382. In paired 60 gastric normal and cancer tissues, miR-382 expression in cancer tissues was significantly higher than normal counterpart (p = 0.003), but not miR-210 expression. However, by increasing the patient number from the big data analysis, miR-210 as well as miR-382 expression in tumor tissues was significantly higher than the normal tissues. Our results suggest that miR-382, as novel hypoxamiR, can be a prognostic marker for advanced GCs and might be correlated with metastatic potential. miR-382 might play important roles in the aggressiveness, progression and prognosis of GCs. In addition, miR-382 give a predictive marker for progression of GCs compared to the normal or preneoplastic lesion.	[Seo, An Na; Lee, Eunhye; Bae, Han-Ik] Kyungpook Natl Univ, Sch Med, Dept Pathol, Daegu, South Korea; [Seo, An Na; Bae, Han-Ik] Kyungpook Natl Univ, Dept Pathol, Chilgok Hosp, Daegu, South Korea; [Jung, Yukdong; Jang, Hyeonha; Lee, You Mie] Kyungpook Natl Univ, Coll Pharm, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea; [Jang, Hyeonha; Lee, You Mie] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Daegu, South Korea; [Son, Taekwon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kwon, Ohkyung; Yu, Wansik] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea; [Chung, Ho Young] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu, South Korea; [Jung, Yukdong] Cellivery Therapeut Inc, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea.; Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Daegu, South Korea.	lym@knu.ac.kr		Son, Taekwon/0000-0002-6096-2231	National Research Foundation (NRF) - Korean government (MSIP) [NRF2012R1A4A1028835, NRF2017R1A2B3002227]	National Research Foundation (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation (NRF) grant funded by the Korean government (MSIP) (NRF2012R1A4A1028835 and NRF2017R1A2B3002227) to Y.M.L. as a PI. These funders have no role for this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar I, 2017, J HISTOCHEM CYTOCHEM, V65, P335, DOI 10.1369/0022155417702849; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Doktorova H, 2015, BIOMED PAP, V159, P166, DOI 10.5507/bp.2015.025; Edge S, 2010, AJCC CANC STAGING MA, V7th; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Ho JY, 2017, ONCOTARGET, V8, P22443, DOI 10.18632/oncotarget.12338; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kiga K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5497; Kirsch R, 2013, AM J SURG PATHOL, V37, P200, DOI 10.1097/PAS.0b013e31826a92cd; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Patnaik SK, 2010, ANAL BIOCHEM, V407, P147, DOI 10.1016/j.ab.2010.08.004; Qi B, 2015, WORLD J GASTROENTERO, V21, P6884, DOI 10.3748/wjg.v21.i22.6884; Rakha EA, 2012, CANCER-AM CANCER SOC, V118, P3670, DOI 10.1002/cncr.26711; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rotkrua P, 2013, BRIT J CANCER, V108, P932, DOI 10.1038/bjc.2013.30; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Seok JK, 2014, NUCLEIC ACIDS RES, V42, P8062, DOI 10.1093/nar/gku515; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; SOO KC, 1986, LARYNGOSCOPE, V96, P1145; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Xu M, 2014, ONCOTARGET, V5, P9472, DOI 10.18632/oncotarget.2418; Yamada Y, 2015, ANN ONCOL, V26, P141, DOI 10.1093/annonc/mdu472; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yoo SB, 2010, LUNG CANCER, V67, P301, DOI 10.1016/j.lungcan.2009.05.002; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11251	36	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223608	10.1371/journal.pone.0223608	http://dx.doi.org/10.1371/journal.pone.0223608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596872	gold, Green Published			2022-12-26	WOS:000532444100048
J	Theuerkauf, SJ; Morris, JA; Waters, TJ; Wickliffe, LC; Alleway, HK; Jones, RC				Theuerkauf, Seth J.; Morris, James A., Jr.; Waters, Tiffany J.; Wickliffe, Lisa C.; Alleway, Heidi K.; Jones, Robert C.			A global spatial analysis reveals where marine aquaculture can benefit nature and people	PLOS ONE			English	Article							MUSSEL FARM; COASTAL; CONSERVATION	Aquaculture of bivalve shellfish and seaweed represents a global opportunity to simultaneously advance coastal ecosystem recovery and provide substantive benefits to humanity. To identify marine ecoregions with the greatest potential for development of shellfish and seaweed aquaculture to meet this opportunity, we conducted a global spatial analysis using key environmental (e.g., nutrient pollution status), socioeconomic (e.g., governance quality), and human health factors (e.g., wastewater treatment prevalence). We identify a substantial opportunity for strategic sector development, with the highest opportunity marine ecoregions for shellfish aquaculture centered on Oceania, North America, and portions of Asia, and the highest opportunity for seaweed aquaculture distributed throughout Europe, Asia, Oceania, and North and South America. This study provides insights into specific areas where governments, international development organizations, and investors should prioritize new efforts to drive changes in public policy, capacity-building, and business planning to realize the ecosystem and societal benefits of shellfish and seaweed aquaculture.	[Theuerkauf, Seth J.; Waters, Tiffany J.; Jones, Robert C.] Nature Conservancy, Global Oceans Team, Arlington, VA 22203 USA; [Morris, James A., Jr.] NOAA, Natl Ocean Serv, Beaufort, NC USA; [Wickliffe, Lisa C.] NOAA, CSS Inc, Beaufort, NC USA; [Alleway, Heidi K.] Govt South Australia, Dept Primary Ind & Reg, Adelaide, SA, Australia; [Alleway, Heidi K.] Univ Adelaide, Adelaide, SA, Australia	Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Adelaide	Theuerkauf, SJ (corresponding author), Nature Conservancy, Global Oceans Team, Arlington, VA 22203 USA.	seth.theuerkauf@tnc.org	Theuerkauf, Seth/AAB-3290-2020	/0000-0001-9798-2490; Theuerkauf, Seth/0000-0003-2556-5174; Alleway, Heidi/0000-0002-9322-5967	NOAA; The Nature Conservancy; The Builders Initiative	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); The Nature Conservancy; The Builders Initiative	Funding for this project was provided by NOAA, The Nature Conservancy, and The Builders Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2002, FOOD POLICY, V27, P125, DOI 10.1016/S0306-9192(02)00007-6; Alleway HK, 2019, BIOSCIENCE, V69, P59, DOI 10.1093/biosci/biy137; Allison E. H., 2011, 201165 WORLDFISH CTR, P62; Asian LM, 2015, OCEAN COAST MANAGE, V116, P44, DOI 10.1016/j.ocecoaman.2015.06.028; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bayraktarov E, 2016, ECOL APPL, V26, P1055, DOI 10.1890/15-1077; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Cape Cod Commission, 2015, 208 PLAN CAP COD AR, P254; Carlozo N., 8192014724 MAR DEP N; Costa-Pierce BA, RESPONSIBLE MARINE A; ESRI, 2018, ARCGIS DESKT VERS 10; Fitriana R., 2017, GENDER AQUACULTURE F, V30S, P245; Food and Agriculture Organization of the United Nations, 2020, STATE WORLD FISHERIE, DOI [10.18356/8d6ea4b6-en, DOI 10.18356/8D6EA4B6-EN]; Froehlich HE, 2017, BIOL CONSERV, V215, P162, DOI 10.1016/j.biocon.2017.09.012; Gentry RR, 2017, NAT ECOL EVOL, V1, P1317, DOI 10.1038/s41559-017-0257-9; Gentry RR, 2019, REV AQUACULT, DOI [10.1111/raq.12328:1-14, DOI 10.1111/RAQ.12328:1-14]; Gillies CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190914; Handisyde N, 2017, FISH FISH, V18, P466, DOI 10.1111/faf.12186; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; International Oceanographic Data and Information Exchange of the Intergovernemntal Oceanographic Commission of the UNESCO (IODE-UNESCO), 2018, HARMF ALG EV DAT; Kalfagianni A, 2013, MAR POLICY, V38, P124, DOI 10.1016/j.marpol.2012.05.028; Kraufvelin P, 2015, BOREAL ENVIRON RES, V20, P378; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Lester SE, 2018, P NATL ACAD SCI USA, V115, P7162, DOI 10.1073/pnas.1808737115; Mongin M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034023; National Research Council, 2010, ECOSYSTEM CONCEPTS S, P190; Nature Conservancy, 2017, NATURE CONSERVANCY; Neveux N., 2018, BLUE BIOTECHNOLOGY, P217, DOI [10.1002/9783527801718.ch7, DOI 10.1002/9783527801718.CH7]; Powers MJ, 2007, MAR ECOL PROG SER, V339, P109, DOI 10.3354/meps339109; Primavera JH, 2006, OCEAN COAST MANAGE, V49, P531, DOI 10.1016/j.ocecoaman.2006.06.018; Rabiei R, 2014, IRAN J FISH SCI, V13, P621; Rose JM, 2015, MAR POLLUT BULL, V91, P185, DOI 10.1016/j.marpolbul.2014.12.006; Sapkota A, 2008, ENVIRON INT, V34, P1215, DOI 10.1016/j.envint.2008.04.009; Schroder T, 2014, OCEAN COAST MANAGE, V101, P42, DOI 10.1016/j.ocecoaman.2014.04.034; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stevant P, 2017, AQUACULT INT, V25, P1373, DOI 10.1007/s10499-017-0120-7; Tallman JC, 2011, T AM FISH SOC, V136, P790; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; United Nations Food and Agriculture Organization, 2008, NAT AQ SECT OV AUSTR, P9; Waugh P, 2019, CRIT CARE MED, V47; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	41	33	33	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222282	10.1371/journal.pone.0222282	http://dx.doi.org/10.1371/journal.pone.0222282			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596860	gold, Green Published			2022-12-26	WOS:000532444100010
J	Gu, K; Lee, HY; Lee, K; Choi, JY; Woo, SY; Sohn, I; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM				Gu, Kyowon; Lee, Ho Yun; Lee, Kyungjong; Choi, Joon Young; Woo, Sook Young; Sohn, Insuk; Kim, Hong Kwan; Choi, Yong Soo; Kim, Jhingook; Zo, Jae Ill; Shim, Young Mog			Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung	PLOS ONE			English	Article							COMBINED PULMONARY-FIBROSIS; LYMPH-NODE RATIO; CANCER PATIENTS; EMPHYSEMA; EPIDEMIOLOGY; SURVIVAL; NECROSIS; IMPACT	Objective Little is known about prognostic factors for lung squamous cell carcinoma (SCC). We aimed to explore radiologic and clinical factors affecting prognosis and to compare the prognosis of both central and peripheral lung SCCs. Materials and methods Radiologic, clinical, and pathologic profiles of surgically confirmed SCCs from 382 patients were retrospectively reviewed. Tumor location, enhancement, necrosis, the presence of obstructive pneumonitis/atelectasis and underlying lung disease were evaluated on chest CT examination. Age, pulmonary function, tumor marker, and cancer stage were also assessed. Univariate and multivariate Cox regression analyses were performed to identify any correlation to overall survival (OS) and disease-free survival (DFS). Hazard rate estimation and competing risk analysis were done to evaluate recurrence pattern. Results The median follow-up period was 56.2 months. Tumors were located centrally in 230 patients (60.2%) and peripherally in 152 patients (39.8%). Age (p = 0.002, hazard ratio [HR] 1.03, 95% confidence interval [CI] = [1.01, 1.06]) and interstitial lung abnormalities (ILAs) (p<0.001, HR 5.41, 95% CI = [3.08, 9.52]) were associated with poor OS on multivariate analysis. ILAs also had a strong association to DFS (p<0.001, HR 4.25, 95% CI = [3.08, 9.52]). Central cancers had two peaks of local recurrence development at 15 and 60 months after surgery, and peripheral tumors showed rising curves for metastasis development at 60 months. Conclusions CT-determined ILAs are a strong biomarker predicting poor outcome. Prognosis may not vary according to tumor location, but the two groups exhibited different recurrence patterns.	[Gu, Kyowon; Lee, Ho Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Gu, Kyowon; Lee, Ho Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Lee, Kyungjong] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea; [Choi, Joon Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea; [Woo, Sook Young; Sohn, Insuk] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Kim, Hong Kwan; Choi, Yong Soo; Kim, Jhingook; Zo, Jae Ill; Shim, Young Mog] Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.; Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea.	hoyunlee96@gmail.com	Kim, Hong Kwan/AAR-4892-2020; Lee, Ho Yun/D-6086-2012	Kim, Hong Kwan/0000-0002-7815-3336; Gu, Kyowon/0000-0003-2494-018X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HI17C0086]; National Research Foundation of Korea (NRF) grants - Korean government (MSIP; Ministry of Science, ICT & Future Planning) [NRF-2016R1A2B4013046, NRF2017M2A2A7A02018568]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; National Research Foundation of Korea (NRF) grants - Korean government (MSIP; Ministry of Science, ICT & Future Planning)	This research was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which was funded by Ministry of Health & Welfare (HI17C0086) and National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP; Ministry of Science, ICT & Future Planning) (No. NRF-2016R1A2B4013046 and NRF2017M2A2A7A02018568) to HYL.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Derman BA, 2015, TRANSL LUNG CANCER R, V4, P524, DOI 10.3978/j.issn.2218-6751.2015.06.07; Edge SB, 2010, AJCC CANC STAGING MA; Funai K, 2003, AM J SURG PATHOL, V27, P978, DOI 10.1097/00000478-200307000-00013; Gao L, 2018, CLIN RESPIR J, V12, P652, DOI 10.1111/crj.12575; Gurel D, 2016, PATHOL RES PRACT, V212, P1, DOI 10.1016/j.prp.2015.10.006; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Inoue M, 2008, J THORAC CARDIOV SUR, V135, P830, DOI 10.1016/j.jtcvs.2007.10.034; Kato E, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00111-2016; Kilicgun A, 2010, THORAC CARDIOV SURG, V58, P93, DOI 10.1055/s-0029-1186240; Kinoshita T, 2014, J THORAC ONCOL, V9, P1779, DOI 10.1097/JTO.0000000000000338; Langer CJ, 2016, J THORAC ONCOL, V11, P2066, DOI 10.1016/j.jtho.2016.08.138; Lee J, 2018, LUNG CANCER, V115, P89, DOI 10.1016/j.lungcan.2017.11.020; Li C, 2017, J THORAC DIS, V9, P5322, DOI 10.21037/jtd.2017.12.72; Nwogu CE, 2012, ANN THORAC SURG, V93, P1614, DOI 10.1016/j.athoracsur.2012.01.065; Pilotto S, 2015, J THORAC ONCOL, V10, P1341, DOI 10.1097/JTO.0000000000000628; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; Saijo T, 2006, LUNG CANCER, V52, P37, DOI 10.1016/j.lungcan.2005.12.006; Smith BM, 2012, LUNG CANCER, V76, P61, DOI 10.1016/j.lungcan.2011.09.003; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Swinson DEB, 2002, LUNG CANCER, V37, P235, DOI 10.1016/S0169-5002(02)00172-1; Takenaka T, 2018, SURG TODAY, V48, P229, DOI 10.1007/s00595-017-1577-8; Urban D, 2013, J THORAC ONCOL, V8, P940, DOI 10.1097/JTO.0b013e318292c53e; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Weichert W, 2016, EUR RESPIR J, V47, P938, DOI 10.1183/13993003.00937-2015; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223298	10.1371/journal.pone.0223298	http://dx.doi.org/10.1371/journal.pone.0223298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584965	Green Published, gold			2022-12-26	WOS:000532407600017
J	Alfaro, AU; Guthrie, DM; Phillips, NA; Pichora-Fuller, MK; Mick, P; McGraw, C; Wittich, W				Alfaro, Andrea Urqueta; Guthrie, Dawn M.; Phillips, Natalie A.; Pichora-Fuller, M. Kathleen; Mick, Paul; McGraw, Cathy; Wittich, Walter			Detection of vision and/or hearing loss using the interRAI Community Health Assessment aligns well with common behavioral vision/hearing measurements	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DUAL SENSORY IMPAIRMENT; STANDARDIZED ASSESSMENT; ADULTS; RELIABILITY; SERVICES	This study's main objective was to assess the sensitivity and specificity of the interRAl Community Health Assessment (CHA) for detecting the presence of vision loss (VL), hearing loss (HL) or both (Dual Sensory Loss, DSL) when compared against performance-based measures of vision and hearing. The interRAl CHA and the Montreal Cognitive Assessment (MoCA) were administered to 200 adults (61+ years of age) who had VL, HL or DSL. We calculated the sensitivity and specificity of the interRAl CHA for detecting sensory impairments using as the gold standard performance based measurements of hearing (pure-tone audiogram) and vision (distance acuity) as determined from the rehabilitation centre record. Results were divided according to participants' cognitive status, as measured by the MoCA and the Cognitive Performance Scale (CPS, embedded within the interRAl CHA). Overall, sensitivity was 100% for VL, 97.1% for HL, and 96.9% for DSL. Specificity was at least 93% in all three groups. In participants who failed the MoCA (i.e., at risk of mild cognitive impairment), the sensitivity was 100% for VL, 96.8% for HL and 96.2% for DSL; in those who were not at risk, the sensitivity was 100% for VL, and 97.4% for HL and DSL. In participants classified by the CPS as borderline intact or mild cognitively impaired, sensitivity was 100% in all groups; in those classified as cognitively intact, sensitivity was 100% for VL, 97.0% for HL, and 96.8% for DSL. These results suggest that the interRAl CHA detects VL, HL, and DSL in high agreement with performance-based measurements of vision and hearing. The interRAl CHA shows high accuracy even in participants with mild cognitive difficulties. Since results were found in a specific population of older rehabilitation clients who all had sensory difficulties, further research is needed to understand its role in screening in other more diverse groups.	[Alfaro, Andrea Urqueta; Wittich, Walter] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Alfaro, Andrea Urqueta] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Guthrie, Dawn M.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON, Canada; [Guthrie, Dawn M.] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON, Canada; [Phillips, Natalie A.] Concordia Univ, Dept Psychol, Montreal, PQ, Canada; [Pichora-Fuller, M. Kathleen] Univ Toronto, Dept Psychol, Mississauga, ON, Canada; [Mick, Paul] Univ Saskatchewan, Coll Med, Dept Surg, Saskatoon, SK, Canada; [McGraw, Cathy; Wittich, Walter] Lethbridge Layton Mackay Rehabil Ctr West Central, CRIR, Montreal, PQ, Canada; [Wittich, Walter] Inst Nazareth & Louis Braille CISSS Monteregie Ct, CRIR, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Wilfrid Laurier University; Wilfrid Laurier University; Concordia University - Canada; University of Toronto; University Toronto Mississauga; University of Saskatchewan; Universite de Montreal; Universite de Montreal	Alfaro, AU (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.; Alfaro, AU (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada.	andrea.urqueta.alfaro@umontreal.ca	Guthrie, Dawn/AAO-6453-2021; Wittich, Walter/AAH-2145-2020	Guthrie, Dawn/0000-0003-3241-6580; Wittich, Walter/0000-0003-2184-6139	Canadian Consortium on Neurodegeneration and Aging (CCNA); Canadian Institutes of Health Research (CIHR); Foundation of the CRIR/Centre de readaptation MAB-Mackay du CIUSSS du Centre-Ouest-de-l'Ile-de-Montreal; Fondation En Vue of the CRIR/Institut Nazareth et Louis-Braille du CISSS de la Monteregie-Centre; Canadian Institute of Health Research [CAN 137794]	Canadian Consortium on Neurodegeneration and Aging (CCNA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation of the CRIR/Centre de readaptation MAB-Mackay du CIUSSS du Centre-Ouest-de-l'Ile-de-Montreal; Fondation En Vue of the CRIR/Institut Nazareth et Louis-Braille du CISSS de la Monteregie-Centre; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Consortium on Neurodegeneration and Aging (CCNA; http://ccna-ccnv.ca/en).The CCNA is supported by a grant from the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html) with funding from several partners. Funding was also provided by the Foundation of the CRIR/Centre de readaptation MAB-Mackay du CIUSSS du Centre-Ouest-de-l'Ile-de-Montreal, and the Fondation En Vue of the CRIR/Institut Nazareth et Louis-Braille du CISSS de la Monteregie-Centre.; The authors gratefully acknowledge the contribution of the study participants and participating organizations, CRIR/Centre de readaptation MAB-Mackay du CIUSSS du Centre-Ouestde-l'I le-de-Montreal, CRIR/Institut Nazareth et Louis-Braille du CISSS de la Monteregie-Centre and CRIR/Institut Raymond-Dewar of the CIUSSS du Centre-Sud-de-l'I le-de-Montreal, along with Martine Gendron. The Canadian Consortium on Neurodegeneration in Aging is supported by a grant from the Canadian Institute of Health Research (CAN 137794) with funding from several partners. We also acknowledge the contributions of Manon Pilon, Audiologist, Marie-Noelle Labrie, Orientation & Mobility Specialist, and Ste ' fanie Parenteau, Optometrist, whose reviews of the manuscript were invaluable. Also appreciated was the attention to detail given by research assistants, Alexandre Beaulieu and Jonathan Jarry.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Dalby DM, 2009, J VISUAL IMPAIR BLIN, V103, P7, DOI 10.1177/0145482X0910300103; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Guthrie DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192971; Guthrie DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155073; Guthrie DM, 2011, J REHABIL RES DEV, V48, P545, DOI 10.1682/JRRD.2010.09.0175; Hamalainen A, 2019, EAR HEAR; Hawes C, 2007, GERONTOLOGIST, V47, P378, DOI 10.1093/geront/47.3.378; Heine C, 2015, GERONTOLOGIST, V55, P913, DOI 10.1093/geront/gnv074; Hirdes J, 2007, INTERRAI DEAFBLIND S; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hogeveen SE, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0547-9; Humes LE, AGING AUDITORY SYSTE; Kim H, 2015, GERIATR GERONTOL INT, V15, P220, DOI 10.1111/ggi.12330; LAGATI S, 1995, J VISUAL IMPAIR BLIN, V89, P306; LIN VYW, 2017, LARYNGOSCOPE, V127, pS, DOI DOI 10.1002/LARY.26350; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mick P, 2014, J AM GERIATR SOC, V62, P2207, DOI 10.1111/jgs.13113; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Morris JN, 2010, INTERRAI COMMUNITY H; Morris PJ, 2010, INT J AEROACOUST, V9, P1, DOI 10.1260/1475-472X.9.1-2.1; Munroe S., 2001, DEV NATL VOLUNTEER R, V2011, P1; Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115; Nasreddine ZS, 2005, MONTREAL COGNITIVE A, P695; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Regie de l'assurance maladie du Quebec/RAMQ, 2006, HEARING AIDS; Regie de l'assurance maladie du Quebec/RAMQ, 2006, VIS AIDS; Schneider J, 2014, EAR HEARING, V35, pE153, DOI 10.1097/AUD.0000000000000038; Schneider JM, 2014, J AGING HEALTH, V26, P231, DOI 10.1177/0898264313513610; Statement STROBE, 2007, STROBE CHECKL COH CA, P12, DOI [10.1016/S0140-6736(07)61602-X, DOI 10.1016/S0140-6736(07)61602-X]; Viljanen A, 2014, EUR J AGEING, V11, P155, DOI 10.1007/s10433-013-0291-7; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Wittich W, 2019, ROUTLEDGE HDB VISUAL; Wittich W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027803; Wittich W, 2013, BRIT J VISUAL IMPA, V31, P198, DOI 10.1177/0264619613490519; Wittich W, 2010, J VISUAL IMPAIR BLIN, V104, P360, DOI 10.1177/0145482X1010400606; World Federation of the Deafblind, 2018, RISK EXCL CRPD SDGS	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223123	10.1371/journal.pone.0223123	http://dx.doi.org/10.1371/journal.pone.0223123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581243	Green Published, gold			2022-12-26	WOS:000532398600031
J	Reynolds, DJ; Hertel, KJ				Reynolds, Derrick J.; Hertel, Klemens J.			Ultra-deep sequencing reveals pre-mRNA splicing as a sequence driven high-fidelity process	PLOS ONE			English	Article							CATALYTIC STEP; CRITICAL EXON; TRANSCRIPTION; TRANSLATION; SITE; ELONGATION; NUCLEOTIDE; PROOFREAD; CLEAVAGE; SUBUNIT	Alternative splicing diversifies mRNA transcripts in human cells. While the spliceosome pairs exons with a high degree of accuracy, the rates of rare aberrant and non-canonical pre-mRNA splicing have not been evaluated at the nucleotide level to determine the quantity and identity of these events across splice junctions. Using ultra-deep sequencing the frequency of aberrant and non-canonical splicing events for three splice junctions flanking exon 7 of SMN1 were determined at single nucleotide resolution. After correction for background noise introduced by PCR amplification and sequencing steps, pre-mRNA splicing was shown to maintain a low overall rate of aberrant and non-canonically spliced events. Several previously unannotated splicing events across 3 exonlintron junctions in SMN1 were identified. Mutations within SMN exon 7 were shown to affect splicing fidelity by modulating RNA secondary structures, by altering the binding site of regulatory proteins and by changing the 5' splice site strength. Mutations also create a truncated SMN1 exon 7 through the introduction of a de novo non-canonical 5' splice site. The results from the ultra-deep sequencing approach highlight the impressive fidelity of pre-mRNA splicing and demonstrate that the immediate sequence context around splice sites is the main driving force behind non-canonical splice site pairing.	[Reynolds, Derrick J.; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hertel, KJ (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	khertel@uci.edu		Hertel, Klemens/0000-0002-7560-9529	NIH [R01 GM062287, R01 GM110244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110244, R01GM062287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to funding support from the NIH (R01 GM062287 and R01 GM110244 to K.J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2016, RNA, V22, P1302, DOI 10.1261/rna.056911.116; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chen L, 2014, MOL BIOL EVOL, V31, P1402, DOI 10.1093/molbev/msu083; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Daguenet E, 2015, EMBO REP, V16, P1640, DOI 10.15252/embr.201541116; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dou YM, 2006, RNA, V12, P2047, DOI 10.1261/rna.151106; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; Imashimizu M, 2013, NUCLEIC ACIDS RES, V41, P9090, DOI 10.1093/nar/gkt698; Inada T, 2013, BBA-GENE REGUL MECH, V1829, P634, DOI 10.1016/j.bbagrm.2013.02.004; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mellert K, 2011, GENES-BASEL, V2, P562, DOI 10.3390/genes2030562; Mueller WF, 2015, J BIOL CHEM, V290, P27700, DOI 10.1074/jbc.M115.684035; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Singh NN, 2017, SPINAL MUSCULAR ATROPHY: DISEASE MECHANISMS AND THERAPY, P75, DOI 10.1016/B978-0-12-803685-3.00005-7; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Szadeczky-Kardoss I, 2018, NUCLEIC ACIDS RES, V46, P4632, DOI 10.1093/nar/gky279; Tsai KW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-34; Ustianenko D, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1418; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoshimoto Satomi, 2016, Hum Genome Var, V3, P16040	51	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223132	10.1371/journal.pone.0223132	http://dx.doi.org/10.1371/journal.pone.0223132			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581208	gold, Green Published			2022-12-26	WOS:000532398600034
J	Takei, R; Inoue, T; Sonoda, N; Kohjima, M; Okamoto, M; Sakamoto, R; Inoguchi, T; Ogawa, Y				Takei, Ryoko; Inoue, Tomoaki; Sonoda, Noriyuki; Kohjima, Motoyuki; Okamoto, Misato; Sakamoto, Ryuichi; Inoguchi, Toyoshi; Ogawa, Yoshihiro			Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; ADIPOSE-TISSUE; OXIDATIVE STRESS; WEIGHT-GAIN; RISK; FAT; ANTIOXIDANT; RECRUITMENT; SENSITIVITY; GLUCOSE	Objective Although previous studies have reported a negative relationship between serum bilirubin concentration and the development of diabetes mellitus (DM), the relationship between bilirubin and insulin resistance has not been thoroughly assessed. This study was designed to determine the relationships between bilirubin, body fat distribution, and adipose tissue inflammation in patients with type 2 DM and the effect of bilirubin in an obese animal model. Method Body fat distribution was measured using an abdominal dual bioelectrical impedance analyzer in patients with type 2 DM. We also measured glycemic control, lipid profile, serum bilirubin concentration and other clinical characteristics, and determined their relationships with body fat distribution. In the animal study, biliverdin (20 mg/kg daily) was orally administered to high-fat diet (HFD)-induced obese (DIO) mice for 2 weeks, after which intraperitoneal insulin tolerance testing was performed. Then, adipocyte area, adipocytokine expression, and macrophage polarization were evaluated in epididymal adipose tissues. Results In the clinical study, univariate analysis showed that a lower bilirubin concentration was significantly correlated with higher body mass index, waist circumference, triglyceride, uric acid, creatinine, visceral fat area and lower HDL-C. In multivariate analyses, bilirubin concentration significantly correlated with diastolic blood pressure, creatinine, and visceral fat area. However, there was no association between bilirubin concentration and subcutaneous fat area. In the animal study, DIO mice treated with biliverdin had smaller adipocytes than untreated DIO mice and biliverdin improved HFD-induced insulin resistance. Biliverdin treatment reversed the higher gene expression of Cd11c, encoding an M1 macrophage marker, and Tnfa, encoding the proinflammatory cytokine tumor necrosis factor-alpha, in the adipose tissues of DIO mice. These data suggest biliverdin administration alleviates insulin resistance by ameliorating inflammation and the dysregulation of adipocytokine expression in adipose tissues of DIO mice. Conclusions Bilirubin may protect against insulin resistance by ameliorating visceral obesity and adipose tissue inflammation.	[Takei, Ryoko; Inoue, Tomoaki; Sonoda, Noriyuki; Kohjima, Motoyuki; Okamoto, Misato; Sakamoto, Ryuichi; Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Takei, Ryoko; Inoguchi, Toyoshi] Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Metab, Tokyo, Japan	Kyushu University; Tokyo Medical & Dental University (TMDU)	Inoguchi, T (corresponding author), Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan.	toyoshi.inoguchi@gmail.com		Ogawa, Yoshihiro/0000-0002-0834-2836; Inoguchi, Toyoshi/0000-0002-7344-6199	Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation")	Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation")	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; BANERJI MA, 1995, INT J OBESITY, V19, P846; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cimini FA, 2019, BBA-MOL BASIS DIS, V1865, P1490, DOI 10.1016/j.bbadis.2019.02.021; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DESPRES JP, 1995, INT J OBESITY, V19, pS76; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Fujii M, 2010, KIDNEY INT, V78, P905, DOI 10.1038/ki.2010.265; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gordon DM, 2019, PHYSIOL GENOMICS, V51, P234, DOI 10.1152/physiolgenomics.00028.2019; Hinds TD, 2018, HYPERTENSION, V72, P788, DOI 10.1161/HYPERTENSIONAHA.118.11130; Hinds TD, 2017, AM J PHYSIOL-ENDOC M, V312, pE291, DOI 10.1152/ajpendo.00396.2016; Hinds TD, 2016, J BIOL CHEM, V291, P25179, DOI 10.1074/jbc.M116.731703; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ikeda N, 2011, DIABETOLOGIA, V54, P2183, DOI 10.1007/s00125-011-2197-2; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Inoguchi T, 2016, DIABETOL INT, V7, P338, DOI 10.1007/s13340-016-0288-5; Liu JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09886; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang J, 2017, MOL CELL ENDOCRINOL, V454, P103, DOI 10.1016/j.mce.2017.06.012	34	37	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223302	10.1371/journal.pone.0223302	http://dx.doi.org/10.1371/journal.pone.0223302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577826	Green Published, gold			2022-12-26	WOS:000532388000027
J	Borowicz, A; Le, H; Humphries, G; Nehls, G; Hoschle, C; Kosarev, V; Lynch, HJ				Borowicz, Alex; Le, Hieu; Humphries, Grant; Nehls, Georg; Hoeschle, Caroline; Kosarev, Vladislav; Lynch, Heather J.			Aerial-trained deep learning networks for surveying cetaceans from satellite imagery	PLOS ONE			English	Article							BLUE WHALES; ABUNDANCE; MOVEMENTS; HABITATS; CENSUS; OCEAN	Most cetacean species are wide-ranging and highly mobile, creating significant challenges for researchers by limiting the scope of data that can be collected and leaving large areas un-surveyed. Aerial surveys have proven an effective way to locate and study cetacean movements but are costly and limited in spatial extent. Here we present a semi-automated pipeline for whale detection from very high-resolution (sub-meter) satellite imagery that makes use of a convolutional neural network (CNN). We trained ResNet, and DenseNet CNNs using down-scaled aerial imagery and tested each model on 31 cm-resolution imagery obtained from the WorldView-3 sensor. Satellite imagery was tiled and the trained algorithms were used to classify whether or not a tile was likely to contain a whale. Our best model correctly classified 100% of tiles with whales, and 94% of tiles containing only water. All model architectures performed well, with learning rate controlling performance more than architecture. While the resolution of commercially-available satellite imagery continues to make whale identification a challenging problem, our approach provides the means to efficiently eliminate areas without whales and, in doing so, greatly accelerates ocean surveys for large cetaceans.	[Borowicz, Alex; Lynch, Heather J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Borowicz, Alex; Le, Hieu; Lynch, Heather J.] SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA; [Le, Hieu] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Humphries, Grant] HiDef Aerial Surveying Ltd, Cleator Moor, Cumbria, England; [Nehls, Georg; Hoeschle, Caroline; Kosarev, Vladislav] BioConsult SH GmbH & Co KG, Husum, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Borowicz, A (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.; Borowicz, A (corresponding author), SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA.	aborowicz@coa.edu	Borowicz, Alex/AAW-9390-2021; Le, Hieu/AAQ-1681-2021	Borowicz, Alex/0000-0001-5888-5137; 	Directorate for Computer and Information Science and Engineering grant [1531492]; Digital Globe Foundation; European Space Agency; BioConsult; NSF [1531492]	Directorate for Computer and Information Science and Engineering grant; Digital Globe Foundation; European Space Agency(European Space AgencyEuropean Commission); BioConsult; NSF(National Science Foundation (NSF))	This work was supported by the Directorate for Computer and Information Science and Engineering grant 1531492 and by a satellite imagery grant from the Digital Globe Foundation (http://foundation.digitalglobe.com/) to A.B. and through a kick-starter grant from the European Space Agency (http://www.esa.int/ESA) to G.N. BioConsult SH GmbH & Co. (https://bioconsult-sh.de/en/).G.N., C.H., and V.K are employed by BioConsult and G.H. is employed by HiDef Aerial Surveying Ltd. (http://www.hidefsurveying.com/), which provided aerial imagery and is a subsidiary of BioConsult. A sub-award from BioConsult to the Stony Brook Research Foundation supported H. Le and H. Lynch's contributions to this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is part of the kick-start activity SPACEWHALE, funded by the European Space Agency to BioConsult SH. The authors gratefully acknowledge an imagery grant to AB from the Digital Globe Foundation, computational time from the Seawulf Cluster at the Institute of Advanced Computational Science (NSF grant #1531492), aerial imagery from HiDef Aerial Surveying Ltd., and enlightening discussion with Bento Goncalves, Peter Fretwell, and Ellie Bowler.	Abileah R., 2002, US NAVY J UNDERWATER, V52, P709; [Anonymous], 2019, IM CYB INTR EXT BUIL; Aodha OM, 2018, PLOS COMPUT BIOL, V14; Barber-Meyer SM, 2007, POLAR BIOL, V30, P1565, DOI 10.1007/s00300-007-0317-8; Barlow Jay, 2001, Journal of Cetacean Research and Management, V3, P201; Bedrinana-Romano L, 2018, DIVERS DISTRIB, V24, P991, DOI 10.1111/ddi.12739; Bodey TW, 2018, METHODS ECOL EVOL, V9, P946, DOI 10.1111/2041-210X.12934; Boski M, 2017, 2017 10TH INTERNATIONAL WORKSHOP ON MULTIDIMENSIONAL (ND) SYSTEMS (NDS); Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Browning E, 2018, METHODS ECOL EVOL, V9, P681, DOI 10.1111/2041-210X.12926; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cubaynes HC, 2019, MAR MAMM SCI; DeMaster DP, 2001, FISH B-NOAA, V99, P197; Fretwell PT, 2017, IBIS, V159, P481, DOI 10.1111/ibi.12482; Fretwell PT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085285, 10.1371/journal.pone.0088655]; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Grecian WJ, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0084; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Hammond P.S., 2017, ESTIMATES CETACEAN A; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Humphries G.R.W., 2018, MACHINE LEARNING ECO, DOI [10.1007/978-3-319-96978-7, DOI 10.1007/978-3-319-96978-7]; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kot CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012990; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lesage V, 2017, ENDANGER SPECIES RES, V34, P27, DOI 10.3354/esr00838; Lv YS, 2015, IEEE T INTELL TRANSP, V16, P865, DOI 10.1109/TITS.2014.2345663; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; McKinnon EA, 2018, AUK, V135, P834, DOI 10.1642/AUK-17-202.1; Moore SE, 2010, J CETACEAN RES MANAG, V2, P227; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platonov NG, 2013, BIOL BULL+, V40, P197, DOI 10.1134/S1062359013020106; Ramp C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121374; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiferling I, 2017, LANDSCAPE URBAN PLAN, V165, P93, DOI 10.1016/j.landurbplan.2017.05.010; Seymour AC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45127; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Tapiquen CE, 2015, PORLAMAR; Teilmann Jonas, 2003, Journal of Cetacean Research and Management, V5, P85; Weinstein B., 2017, J ANIM ECOL, V87, P1; Weinstein BG, 2017, OECOLOGIA, V185, P427, DOI 10.1007/s00442-017-3949-6; Weiss F., 2016, SEEVOGEL, V37, P14; Willi, 2019, METHODS ECOL EVOL; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zhang Z, 2016, IEEE T MULTIMEDIA, V18, P2079, DOI 10.1109/TMM.2016.2594138	55	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0212532	10.1371/journal.pone.0212532	http://dx.doi.org/10.1371/journal.pone.0212532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574136	gold, Green Published, Green Submitted			2022-12-26	WOS:000532376700002
J	Aperstein, Y; Cohen, L; Bendavid, I; Cohen, J; Grozovsky, E; Rotem, T; Singer, P				Aperstein, Yehudit; Cohen, Lidor; Bendavid, Itai; Cohen, Jonathan; Grozovsky, Elad; Rotem, Tammy; Singer, Pierre			Improved ICU mortality prediction based on SOFA scores and gastrointestinal parameters	PLOS ONE			English	Article							INTENSIVE-CARE; ORGAN DYSFUNCTION/FAILURE; FAILURE; GUT; SYMPTOMS; MOTOR	Background The Sequential Organ Failure Assessment (SOFA) score is commonly used in ICUs around the world, designed to assess the severity of the patient's clinical state based on function/ dysfunction of six major organ systems. The goal of this work is to build a computational model to predict mortality based on a series of SOFA scores. In addition, we examined the possibility of improving the prediction by incorporating a new component designed to measure the performance of the gastrointestinal system, added to the other six components. Methods In this retrospective study, we used patients' three latest SOFA scores recorded during an individual ICU stay as input to different machine learning models and ensemble learning models. We added three validated parameters representing gastrointestinal failure. Among others, we used classification models such as Support Vector Machines (SVMs), Neural Networks, Logistic Regression and a penalty function used to increase model robustness in regard to certain extreme cases, which may be found in ICU population. We used the Area under Curve (AUC) performance metric to examine performance. Results We found an ensemble model of linear and logistic regression achieves a higher AUC compared related works in past years. After incorporating the gastrointestinal failure score along with the penalty function, our best performing ensemble model resulted in an additional improvement in terms of AUC metrics. We implemented and compared 36 different models that were built using both the information from the SOFA score as well as that of the gastrointestinal system. All compared models have approximately similar and relatively large AUC (between 0.8645 and 0.9146) with the best results are achieved by incorporating the gastrointestinal parameters into the prediction models. Conclusions Our findings indicate that gastrointestinal parameters carry significant information as a mortality predictor in addition to the conventional SOFA score. This information improves the predictive power of machine learning models by extending the SOFA to include information related to gastrointestinal organ system. The described method improves mortality prediction by considering the dynamics of the extended SOFA score. Although tested on a limited data set, the results' stability across different models suggests robustness in real-time use.	[Aperstein, Yehudit; Cohen, Lidor; Rotem, Tammy] Afeka Acad Coll Engn, Dept Ind Engn & Management, Tel Aviv, Israel; [Bendavid, Itai; Cohen, Jonathan; Grozovsky, Elad; Singer, Pierre] Beilinson Med Ctr, Rabin Med Ctr, Dept Gen Intens Care, Petah Tiqwa, Israel; [Bendavid, Itai; Cohen, Jonathan; Grozovsky, Elad; Singer, Pierre] Beilinson Med Ctr, Rabin Med Ctr, Inst Nutr Res, Petah Tiqwa, Israel	Rabin Medical Center; Rabin Medical Center	Bendavid, I (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Dept Gen Intens Care, Petah Tiqwa, Israel.; Bendavid, I (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Inst Nutr Res, Petah Tiqwa, Israel.	itbd@gmail.com	Cohen, Jonathan/AGE-8832-2022					Abed N, 2011, CRIT CARE S1, V15, pP509; Alverdy JC, 2008, J LEUKOCYTE BIOL, V83, P461, DOI 10.1189/jlb.0607372; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Blaser AR, 2017, ANAESTH INTENSIVE TH, V49, P146, DOI 10.5603/AIT.a2017.0026; Blaser AR, 2016, CURR OPIN CRIT CARE, V22, P128, DOI 10.1097/MCC.0000000000000286; Blaser AR, 2015, ANAESTH INTENSIVE TH, V47, P379, DOI 10.5603/AIT.a2015.0022; Blaser AR, 2015, CLIN NUTR, V34, P956, DOI 10.1016/j.clnu.2014.10.006; Blaser AR, 2013, INTENS CARE MED, V39, P899, DOI 10.1007/s00134-013-2831-1; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Faisy C, 2003, AM J CLIN NUTR, V78, P241, DOI 10.1093/ajcn/78.2.241; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Guillen Joseph, 2015, 2015 Systems and Information Engineering Design Symposium. proceedings, P182, DOI 10.1109/SIEDS.2015.7116970; Houthooft R, 2015, ARTIF INTELL MED, V63, P191, DOI 10.1016/j.artmed.2014.12.009; Hu BC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1780-4; Jain Aditi, 2016, J Anaesthesiol Clin Pharmacol, V32, P364, DOI 10.4103/0970-9185.168165; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Patel JJ, 2016, CURR OPIN CRIT CARE, V22, P339, DOI 10.1097/MCC.0000000000000331; Piton G, 2011, INTENS CARE MED, V37, P911, DOI 10.1007/s00134-011-2172-x; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Reintam A, 2008, CRIT CARE, V12, DOI 10.1186/cc6958; REINTAM BA, 2012, INTENS CARE MED, V38, P384, DOI DOI 10.1007/S00134-011-2459-Y; Sandri M, 2014, J BIOMED INFORM, V48, P106, DOI 10.1016/j.jbi.2013.12.008; Sun JK, 2013, SURG TODAY, V43, P506, DOI 10.1007/s00595-013-0496-6; Toma T, 2007, J BIOMED INFORM, V40, P649, DOI 10.1016/j.jbi.2007.03.007; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong LSS, 1999, ANAESTHESIA, V54, P1048, DOI 10.1046/j.1365-2044.1999.01104.x	29	7	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222599	10.1371/journal.pone.0222599	http://dx.doi.org/10.1371/journal.pone.0222599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568512	gold, Green Published			2022-12-26	WOS:000532364900005
J	Dumidae, A; Janthu, P; Subkrasae, C; Dekumyoy, P; Thanwisai, A; Vitta, A				Dumidae, Abdulhakam; Janthu, Pichamon; Subkrasae, Chanakan; Dekumyoy, Paron; Thanwisai, Aunchalee; Vitta, Apichat			Genetic characterization of Angiostrongylus larvae and their intermediate host, Achatina fulica, in Thailand	PLOS ONE			English	Article							CANTONENSIS NEMATODA ANGIOSTRONGYLIDAE; ABDOMINAL ANGIOSTRONGYLIASIS; OCULAR ANGIOSTRONGYLIASIS; RAT LUNGWORM; METASTRONGYLOIDEA; SNAILS	Angiostrongyliasis is a parasitic disease caused by nematodes of the genus Angiostrongylus. Distribution of this worm corresponds to the dispersal of its main intermediate host, the giant African land snail Achatina fulica. Genetic characterization can help identify parasitic pathogens and control the spreading of disease. The present study describes infection of A. fulica by Angiostrongylus, and provides a genetic outlook based on sequencing of specific regions. We collected 343 land snails from 22 provinces across six regions of Thailand between May 2017 and July 2018. Artificial digestion and Baermann's technique were employed to isolate Angiostrongylus larvae. The worm and its intermediate host were identified by sequencing with specific nucleotide regions. Phylogenetic tree was constructed to evaluate the relationship with other isolates. A. fulica from Chaiyaphum province was infected with A. cantonensis, whereas snails collected from Phrae and Chiang Rai provinces were infected with A. malaysiensis. The maximum likelihood tree based on 74 A. fulica COI sequences revealed monophyletic groups and identified two haplotypes: AF1 and AF2. Only AF1, which is distributed in all regions of Thailand, harbored the larvae of A. cantonensis and A. malaysiensis. Two mitochondrial genes (COI and cytb) and two nuclear regions (ITS2 and SSU rRNA) were sequenced in 41 Angiostrongylus specimens. The COI gene indicated that A. cantonensis was closely related to the AC10 haplotype; whereas the cytb gene revealed two new haplotypes: AC19 and AC20. SSU rRNA was useful for the identification of A. cantonensis; whereas ITS2 was a good genetic marker for differentiating between A. cantonensis and A. malaysiensis. This study provides genetic information about the parasite Angiostrongylus and its snail intermediate host. The data in this work may be useful for further study on the identification of Angiostrongylus spp., the genetic relationship between intermediate host and parasite, and control of parasites.	[Dumidae, Abdulhakam; Janthu, Pichamon; Subkrasae, Chanakan; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Dekumyoy, Paron] Mahidol Univ, Fac Trop Med, Dept Helminthol, Ratchavithi Rd, Bangkok, Thailand; [Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand	Naresuan University; Mahidol University; Naresuan University	Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand.	apichatv@nu.ac.th	Vitta, Apichat/HHZ-5460-2022	Vitta, Apichat/0000-0002-2483-0100	Naresuan University [R2562B079]	Naresuan University	This work was supported by Naresuan University (Grant number R2562B079) to AV.	ALICATA JE, 1966, CAN J ZOOLOG, V44, P1041, DOI 10.1139/z66-111; Ayyagari VS, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0877-4; Bhaibulaya M, 1971, SE Asian J trop Med pub Hlth, V2, P527; Cervena B, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3491-y; Diao ZL, 2011, TROP DOCT, V41, P76, DOI 10.1258/td.2010.100294; Dusitsittipon S, 2015, J HELMINTHOL, V89, P545, DOI 10.1017/S0022149X14000388; Eamsobhana P, 2015, J HELMINTHOL, V89, P317, DOI 10.1017/S0022149X14000108; Eamsobhana P, 2019, PARASITOL INT, V68, P24, DOI 10.1016/j.parint.2018.09.006; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Eamsohana P., 2006, RAT LUNGWORM PARASTR; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feng Y, 2013, KOREAN J PARASITOL, V51, P613, DOI 10.3347/kjp.2013.51.6.613; Fontanilla IKC, 2008, ACTA TROP, V105, P181, DOI 10.1016/j.actatropica.2007.10.007; Fontanilla IKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105151; Foronda P, 2010, ACTA TROP, V114, P123, DOI 10.1016/j.actatropica.2010.02.004; Harinasuta C, 1965, J MED ASSOC THAILAND, V48, P158; Jefferies R, 2009, PARASITOLOGY, V136, P107, DOI 10.1017/S0031182008005258; Jena C, 2017, NATL ACAD SCI LETT, V40, P101, DOI 10.1007/s40009-017-0538-5; Kerdpreedee S., 1956, KASIKORN, V29, P511; Kim JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193556; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu CY, 2011, J ANIM VET ADV, V10, P593, DOI 10.3923/javaa.2011.593.596; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Marquardt WC, 2000, PARASITOLOGY VECTOR, V2nd, P702; Mead AR, 1979, PULMONATES, V2, P150; Mead AR., 1961, GIANT AFRICAN SNAIL; Monte TCC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-248; OHBAYASHI M, 1979, JPN J VET RES, V27, P5; Pipitgool V, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P190; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Quiros JL, 2011, REV INST MED TROP SP, V53, P219, DOI 10.1590/S0036-46652011000400008; Raut S. K., 2002, P55, DOI 10.1079/9780851993201.0055; Rodpai R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161128; Rodriguez R, 2008, REV INST MED TROP SP, V50, P339, DOI 10.1590/S0036-46652008000600005; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schotman C.Y.L., 1989, 19 PROVEG FAO REG OF, P16; SETASUBUN P, 1968, Journal of the Medical Association of Thailand, V51, P156; Spratt DM, 2015, INT J PARASITOL-PAR, V4, P178, DOI 10.1016/j.ijppaw.2015.02.006; Tesana S, 2009, AM J TROP MED HYG, V80, P983, DOI 10.4269/ajtmh.2009.80.983; Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18; Tokiwa T, 2012, PARASITOL INT, V61, P431, DOI 10.1016/j.parint.2012.02.005; Tsai Hung-Chin, 2013, Hawaii J Med Public Health, V72, P26; UPATHAM ES, 1988, J SCI SOC THAILAND, V14, P25; Venette RC, 2004, MINIRISK ASSESSMENT; Vitta A, 2016, SE ASIAN J TROP MED, V47, P377; Wan KS, 2004, ACTA TROP, V90, P51, DOI 10.1016/j.actatropica.2003.09.019; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Yong HS, 2015, ACTA TROP, V152, P157, DOI 10.1016/j.actatropica.2015.09.001; Yong HS, 2015, ACTA TROP, V148, P66, DOI 10.1016/j.actatropica.2015.04.020	49	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223257	10.1371/journal.pone.0223257	http://dx.doi.org/10.1371/journal.pone.0223257			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560712	gold, Green Published			2022-12-26	WOS:000532353700041
J	Roux, G; Ravel, C; Varlet-Marie, E; Jendrowiak, R; Bastien, P; Sterkers, Y				Roux, Guillaume; Ravel, Christophe; Varlet-Marie, Emmanuelle; Jendrowiak, Rachel; Bastien, Patrick; Sterkers, Yvon			Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification	PLOS ONE			English	Article							TOXOPLASMA-GONDII DETECTION; CONGENITAL TOXOPLASMOSIS; INTERNAL CONTROL; MOLECULAR DIAGNOSIS; PCR ASSAY; TIME; DNA; BLOOD	PCR inhibition is frequent in medical microbiology routine practice and may lead to falsenegative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (.Cp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0%), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden's index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays.	[Roux, Guillaume] Univ Montpellier, Nimes, France; [Roux, Guillaume] Ctr Hosp Univ CHU Nimes, Lab Microbiol, Nimes, France; [Ravel, Christophe; Varlet-Marie, Emmanuelle; Jendrowiak, Rachel; Bastien, Patrick; Sterkers, Yvon] Univ Montpellier, Ctr Hosp Univ CHU Montpellier, Dept Parasitol Mycol, Res Unit MiVEGEC,CNRS,IRD, Montpellier, France; [Roux, Guillaume] Ctr Hosp Gap, Lab Biol, Gap, France	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier	Sterkers, Y (corresponding author), Univ Montpellier, Ctr Hosp Univ CHU Montpellier, Dept Parasitol Mycol, Res Unit MiVEGEC,CNRS,IRD, Montpellier, France.	yvon.sterkers@umontpellier.fr		ravel, christophe/0000-0002-7590-582X	RSI Assurance Maladie Professions Libe'-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort	RSI Assurance Maladie Professions Libe'-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort	RSI Assurance Maladie Professions Libe ' rales -Provinces. C.A.M.P.L.P."has paid the LightCycler 480 (Roche (R)) real-time PCR equipment in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Brenier-Pinchart MP, 2007, PARASITE, V14, P149, DOI 10.1051/parasite/2007142149; Buckwalter SP, 2014, J CLIN MICROBIOL, V52, P2139, DOI 10.1128/JCM.03389-13; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chabbert E, 2004, J CLIN MICROBIOL, V42, P1719, DOI 10.1128/JCM.42.4.1719-1722.2004; Daval S, 2010, PATHOL BIOL, V58, P104, DOI 10.1016/j.patbio.2009.07.013; Delhaes L, 2014, DIAGN MICR INFEC DIS, V80, P197, DOI 10.1016/j.diagmicrobio.2014.08.007; Doskaya M, 2011, J MED MICROBIOL, V60, P937, DOI 10.1099/jmm.0.030775-0; Fillaux Judith, 2013, Methods Mol Biol, V943, P159, DOI 10.1007/978-1-60327-353-4_11; Hedman Johannes, 2013, Methods Mol Biol, V943, P17, DOI 10.1007/978-1-60327-353-4_2; HOHLFELD P, 1994, NEW ENGL J MED, V331, P695, DOI 10.1056/NEJM199409153311102; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Maaroufi Y, 2006, FEMS IMMUNOL MED MIC, V48, P183, DOI 10.1111/j.1574-695X.2006.00125.x; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Pionzio AM, 2014, FORENSIC SCI INT-GEN, V9, P55, DOI 10.1016/j.fsigen.2013.10.010; R Core Team, 2017, R LANG ENV STAT COMP; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Rosenstraus M, 1998, J CLIN MICROBIOL, V36, P191, DOI 10.1128/JCM.36.1.191-197.1998; RStudio Team, 2015, R STUD INT DEV R; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sterkers Y, 2010, CLIN MICROBIOL INFEC, V16, P1594, DOI [10.1111/j.1469-0691.2009.03101.x, 10.1111/j.1469-0691.2010.03101.x]; Sterkers Y, 2012, J CLIN MICROBIOL, V50, P3944, DOI 10.1128/JCM.00918-12; Varlet-Marie E, 2014, J CLIN MICROBIOL, V52, P3952, DOI 10.1128/JCM.01906-14; Wallace Paul S, 2013, Methods Mol Biol, V943, P49, DOI 10.1007/978-1-60327-353-4_3; WESTGARD JO, 1981, CLIN CHEM, V27, P493	26	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0219276	10.1371/journal.pone.0219276	http://dx.doi.org/10.1371/journal.pone.0219276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560697	gold, Green Published			2022-12-26	WOS:000532353700004
J	Mensah, RA; Kirton, SB; Cook, MT; Styliari, ID; Hutter, V; Chau, DYS				Mensah, R. A.; Kirton, S. B.; Cook, M. T.; Styliari, I. D.; Hutter, V; Chau, D. Y. S.			Optimising poly(lactic-co-glycolic acid) microparticle fabrication using a Taguchi orthogonal array design-of-experiment approach	PLOS ONE			English	Article							SOLVENT-EVAPORATION; POLYMERIC NANOPARTICLES; FORMULATION VARIABLES; PROCESS PARAMETERS; MICROSPHERES; DRUG; RELEASE; OPTIMIZATION; MICROENCAPSULATION; ENCAPSULATION	The objective of this study was to identify, understand and generate a Taguchi orthogonal array model for the formation of 10-50 mu m microparticles with applications in topical/ocular controlled drug delivery. Poly(lactic-co-glycolic acid) (PLGA) microparticles were fabricated by the single emulsion oil-in-water method and the particle size was characterized using laser diffraction and scanning electronic microscopy (SEM). Sequential Taguchi L-12 and L-18 orthogonal array (OA) designs were employed to study the influence of ten and eight parameters, respectively, on microparticle size (response). The first optimization step using the L-12 design showed that all parameters significantly influenced the particle size of the prepared PLGA microparticles with exception of the concentration of poly(vinyl alcohol) (PVA) in the hardening bath. The smallest mean particle size obtained from the L-12 design was 54.39 mu m. A subsequent L-18 design showed that the molecular weight of PLGA does not significantly affect the particle size. An experimental run comprising of defined parameters including molecular weight of PLGA (89 kDa), concentration of PLGA (20% w/v), concentration of PVA in the emulsion (0.8% w/v), solvent type (ethyl acetate), organic/aqeuous phase ratio (1:1 v/v), vortexing speed (9), vortexing duration (60 seconds), concentration of PVA in hardening bath (0.8% w/v), stirring speed of hardening bath (1200 rpm) and solvent evaporation duration (24 hours) resulted in the lowest mean particle size of 23.51 mu m which was predicted and confirmed by the L-18 array. A comparable size was demonstrated during the fabrication of BSA-incorporated microparticles. Taguchi OA design proved to be a valuable tool in determining the combination of process parameters that can provide the optimal condition for microparticle formulation. Taguchi OA design can be used to correctly predict the size of microparticles fabricated by the single emulsion process and can therefore, ultimately, save time and costs during the manufacturing process of drug delivery formulations by minimising experimental runs.	[Mensah, R. A.; Kirton, S. B.; Cook, M. T.; Styliari, I. D.; Hutter, V; Chau, D. Y. S.] Univ Hertfordshire, Sch Life & Med Sci, Dept Clin & Pharmaceut Sci, Hatfield, Herts, England; [Mensah, R. A.; Chau, D. Y. S.] UCL, Dept Biomat & Tissue Engn, Eastman Dent Inst, London, England	University of Hertfordshire; University of London; University College London	Chau, DYS (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Dept Clin & Pharmaceut Sci, Hatfield, Herts, England.; Chau, DYS (corresponding author), UCL, Dept Biomat & Tissue Engn, Eastman Dent Inst, London, England.	d.chau@ucl.ac.uk	Kirton, Stewart B/AID-6427-2022; Cook, Michael T./U-2208-2019	Kirton, Stewart B/0000-0002-1567-0061; Cook, Michael T./0000-0002-0772-682X; Styliari, Ioanna Danai/0000-0002-7476-2994; Chau, David/0000-0001-9200-6749	Engineering and Physical Sciences Research Council [EP/N025075/1]; EPSRC [EP/N025075/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors are thankful to the Engineering and Physical Sciences Research Council (grant number: EP/N025075/1) for partly funding this work to IDS, VH, and DYSC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagusundaram M., 2009, INT J CHEMTECH RES, V1, P526; Anarjan N, 2015, INT J NANOMED, V10, P1109, DOI 10.2147/IJN.S72835; Bement T, 1989, TECHNOMETRICS, V31, P254; Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156; Bidone J, 2009, MAT SCI ENG C-BIO S, V29, P588, DOI 10.1016/j.msec.2008.10.016; BODMEIER R, 1987, PHARMACEUT RES, V4, P465, DOI 10.1023/A:1016419303727; Bourke SL, 2003, AAPS PHARMSCI, V5; Caetano LA, 2016, MAR DRUGS, V14, DOI 10.3390/md14050090; Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285; Chau DYS, 2010, BRIT J OPHTHALMOL, V94, P648, DOI 10.1136/bjo.2009.163642; Coates N., 1988, ACAD MANAG EXEC, V2, P69; Deshmukh R, 2016, DRY TECHNOL, V34, P1758, DOI 10.1080/07373937.2016.1232271; Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006; Ferreira JA, 2012, CHEM BIOCHEM ENG Q, V26, P331; Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015; Giri TK, 2013, SAUDI PHARM J, V21, P125, DOI 10.1016/j.jsps.2012.05.009; Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5; Hoffart V, 2002, DRUG DEV IND PHARM, V28, P1091, DOI 10.1081/DDC-120014576; Huang ML, 2016, MEASUREMENT, V94, P284, DOI 10.1016/j.measurement.2016.08.006; Jafari SM, 2008, FOOD HYDROCOLLOID, V22, P1191, DOI 10.1016/j.foodhyd.2007.09.006; Jelvehgari M, 2010, INDIAN J PHARM SCI, V72, P72, DOI 10.4103/0250-474X.62251; Kemala T, 2012, ARAB J CHEM, V5, P103, DOI 10.1016/j.arabjc.2010.08.003; Khaled K, 2010, AAPS PHARMSCITECH, V11, P859, DOI 10.1208/s12249-010-9445-5; Kim KD, 2005, COLLOID SURFACE A, V254, P99, DOI 10.1016/j.colsurfa.2004.11.033; Lai MK, 2005, J MICROENCAPSUL, V22, P261, DOI 10.1080/02652040500100261; Mahalingam M, 2015, INT J PHARM INVESTIG, V5, P147, DOI 10.4103/2230-973X.160852; Mondal N, 2008, YAKUGAKU ZASSHI, V128, P595, DOI 10.1248/yakushi.128.595; Montgomery DC, 1999, J ROY STAT SOC D-STA, V48, P159, DOI 10.1111/1467-9884.00179; Nair V, 2000, J AM STAT ASSOC, V95, P1002, DOI 10.2307/2669486; NIHANT N, 1995, J COLLOID INTERF SCI, V173, P55, DOI 10.1006/jcis.1995.1296; Packianather MS, 2000, QUAL RELIAB ENG INT, V16, P461, DOI 10.1002/1099-1638(200011/12)16:6<461::AID-QRE341>3.0.CO;2-G; Pang J., 2014, HBRC J, V10, P138, DOI [DOI 10.1016/J.HBRCJ.2013.09.007, 10.1016/j.hbrcj.2013.09.007]; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Patil Siddhesh D, 2004, Diabetes Technol Ther, V6, P887, DOI 10.1089/dia.2004.6.887; Prior S, 2000, INT J PHARM, V196, P115, DOI 10.1016/S0378-5173(99)00448-2; QuintanarGuerrero D, 1996, INT J PHARMACEUT, V143, P133, DOI 10.1016/S0378-5173(96)04697-2; Riahi S, 2012, MATER DESIGN, V37, P443, DOI 10.1016/j.matdes.2012.01.030; Rodriguez LB, 2017, AAPS PHARMSCITECH, V18, P1084, DOI 10.1208/s12249-016-0677-x; Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007; Sharma N, 2016, ASIAN J PHARM SCI, V11, P404, DOI 10.1016/j.ajps.2015.09.004; STEINBERG DM, 1984, TECHNOMETRICS, V26, P71, DOI 10.2307/1268097; Tamboli V., 2012, ADV OCUL DRUG DELIV, V2012, P65; Torkaman R, 2010, CHEM ENG TECHNOL, V33, P902, DOI 10.1002/ceat.200900367; Vikrant K, 2012, INT J PHARM CHEM SCI, V1, P113; Vyslouzil J, 2014, ACTA PHARMACEUT, V64, P403, DOI 10.2478/acph-2014-0032; Wagh V., 2014, J NANOTECHNOL, P1; Yang RD, 2012, J APPL POLYM SCI, V124, P3606, DOI 10.1002/app.34738; ZAHN DA, 1975, TECHNOMETRICS, V17, P201, DOI 10.2307/1268352; Zweers MLT, 2003, J BIOMED MATER RES B, V66B, P559, DOI 10.1002/jbm.b.10046	49	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222858	10.1371/journal.pone.0222858	http://dx.doi.org/10.1371/journal.pone.0222858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557205	Green Published, gold			2022-12-26	WOS:000532345500043
J	Ying, Y; Wang, YJ; Huang, XY; Sun, YM; Zhang, JB; Li, MQ; Zeng, JH; Wang, ML; Xiao, WJ; Zhong, L; Xu, B; Li, LL; Tao, Q; Wang, XM; Shu, XS				Ying, Ying; Wang, Yejun; Huang, Xiaoyan; Sun, Yanmei; Zhang, Junbao; Li, Meiqi; Zeng, Junhui; Wang, Maolin; Xiao, Wenjun; Zhong, Lan; Xu, Bo; Li, Lili; Tao, Qian; Wang, Xiaomei; Shu, Xing-sheng			Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1	ONCOGENE			English	Article							OXIDATIVE STRESS-RESPONSE; LONG-RANGE INTERACTION; TRANSCRIPTION FACTORS; CELL DEVELOPMENT; GENES; DIFFERENTIATION; DEREGULATION; METASTASIS; INHIBITION; EXPRESSION	Aberrant activation of Homeobox genes in human cancers has long been documented, whereas the mechanisms underlying remain largely obscure. Super-enhancers (SEs) act as key regulatory elements for both cell identity genes and cancer genes. Herein, we reported that SE-associated HOXB gene cluster represented a common feature of colorectal cancer (CRC) cell lines and multiple HOXB genes within this cluster were overexpressed in CRC. Among them, we found that HOXB8 was oncogenic and its activation in CRC was driven by SE instead of genetic alteration. We further demonstrated that the master transcription factor MYC preferentially occupied SEs over TEs (typical enhancers) and regulated HOXB8 transcription by binding to the active elements of its SE. HOXB8 silencing induced reversal of transcriptional signatures associated with malignant phenotypes of CRC. Mechanistically, HOXB8 interacted with a key metastasis regulator BACH1 and instigated BACH1-mediated transcriptional cascade by directly occupying and activating BACH1 gene transcription together with BACH1 itself. Lastly, the relevance of HOXB8 activation in clinical settings was strengthened by its close association with prognostic outcomes of CRC patients.	[Ying, Ying; Wang, Yejun; Huang, Xiaoyan; Sun, Yanmei; Zhang, Junbao; Li, Meiqi; Zeng, Junhui; Wang, Maolin; Xiao, Wenjun; Wang, Xiaomei; Shu, Xing-sheng] Shenzhen Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, Shenzhen 518060, Peoples R China; [Zhong, Lan] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China; [Xu, Bo] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin 300070, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab, Hong Kong 00000, Peoples R China	Shenzhen University; Sichuan University; Tianjin Medical University; Chinese University of Hong Kong	Shu, XS (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, Shenzhen 518060, Peoples R China.	shu@szu.edu.cn	Li, Lili/Q-5750-2018	Li, Lili/0000-0002-0292-5889	Shenzhen Commission of Science and Innovation Programs [JCYJ20170817101008912, JCYJ20170818143305472, JCYJ20160331114230843]; National Key Projects of Research and Development of China [2016YFC0904600]; Natural Science Foundation of Shenzhen University for Overseas High-Caliber Personnel [827000111]; National Natural Science Foundation of China [81670760]; Guangdong Health Committee [B2019104]	Shenzhen Commission of Science and Innovation Programs; National Key Projects of Research and Development of China; Natural Science Foundation of Shenzhen University for Overseas High-Caliber Personnel; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Health Committee	This work was supported by Shenzhen Commission of Science and Innovation Programs [JCYJ20170817101008912, JCYJ20170818143305472, JCYJ20160331114230843], National Key Projects of Research and Development of China [2016YFC0904600], Natural Science Foundation of Shenzhen University for Overseas High-Caliber Personnel [827000111], National Natural Science Foundation of China [81670760] and grant from Guangdong Health Committee [B2019104]. We thank technical support from Instrumental Analysis Center of Shenzhen University (Xili Campus), and thank Mr Shikang Liu, and Ms Danhong Qiu for technical assistance.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; BLATT C, 1992, CELL GROWTH DIFFER, V3, P671; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Cohen AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14400; Ding WJ, 2017, J CANCER RES CLIN, V143, P385, DOI 10.1007/s00432-016-2283-4; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Ke LR, 2017, P NATL ACAD SCI USA, V114, P9683, DOI 10.1073/pnas.1705236114; Knoepfler PS, 2001, ONCOGENE, V20, P5440, DOI 10.1038/sj.onc.1204710; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Sengupta S, 2017, TRENDS CANCER, V3, P269, DOI 10.1016/j.trecan.2017.03.006; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shajari N, 2018, ARTIF CELL NANOMED B, V46, P1495, DOI 10.1080/21691401.2017.1374284; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shu XS, 2018, J PATHOL, V244, P36, DOI 10.1002/path.4986; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur I, 2016, NAT REV CANCER, V16, P483, DOI 10.1038/nrc.2016.62; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xiong X, 2017, ACS SYNTH BIOL, V6, P1034, DOI 10.1021/acssynbio.6b00358; Zhang XY, 2018, CANCER DISCOV, V8, P108, DOI 10.1158/2159-8290.CD-17-0532; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhu GD, 2018, BIOCHEM BIOPH RES CO, V499, P120, DOI 10.1016/j.bbrc.2018.02.178	45	29	29	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1004	1017		10.1038/s41388-019-1013-1	http://dx.doi.org/10.1038/s41388-019-1013-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591481				2022-12-26	WOS:000511209700004
J	Sakuma, M; Khan, MAS; Yasuhara, S; Martyn, JA; Palaniyar, N				Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades			Mechanism of pulmonary immunosuppression: extrapulmonary burn injury suppresses bacterial endotoxin-induced pulmonary neutrophil recruitment and neutrophil extracellular trap (NET) formation	FASEB JOURNAL			English	Article						lung; animal model; cytokines; LPS	INFLAMMATORY CYTOKINES; IMPROVES SURVIVAL; FAMILY CYTOKINES; IL-12 FAMILY; TH17 CELLS; T-CELLS; LUNG; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INTERLEUKIN-6	Pulmonary immunosuppression often occurs after burn injury (BI). However, the reasons for BI-induced pulmonary immunosuppression are not clearly understood. Neutrophil recruitment and neutrophil extracellular trap (NET) formation (NETosis) are important components of a robust pulmonary immune response, and we hypothesized that pulmonary inflammation and NETosis are defective after BI. To test this hypothesis, we established a mouse model with intranasal LPS instillation in the presence or absence of BI (15% of body surface burn) and determined the degree of immune cell infiltration, NETosis, and the cytokine levels in the airways and blood on d 2. Presence of LPS recruited monocytes and large numbers of neutrophils to the airways and induced NETosis (citrullinated histone H3, DNA, myeloperoxidase). By contrast, BI significantly reduced LPS-mediated leukocyte recruitment and NETosis. This BI-induced immunosuppression is attributable to the reduction of chemokine (C-C motif) ligand (CCL) 2 (monocyte chemoattractant protein 1) and CCL3 (macrophage inflammatory protein 1 alpha). BI also suppressed LPS-induced increase in IL-17A, IL-17C, and IL-17E/IL-25 levels in the airways. Therefore, BI-mediated reduction in leukocyte recruitment and NETosis in the lungs are attributable to these cytokines. Regulating the levels of some of these key cytokines represents a potential therapeutic option for mitigating BI-mediated pulmonary immunosuppression.	[Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades] Harvard Med Sch, Shriners Hosp Children Boston, Boston, MA 02115 USA; [Palaniyar, Nades] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [Palaniyar, Nades] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Palaniyar, N (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Translat Med, 686 Bay St, Toronto, ON M5G0A4, Canada.	nades.palaniyar@sickkids.ca	Sakuma, Miyuki/ABA-3498-2021	Palaniyar, Nades/0000-0002-2170-8548	Centre for the Study of Inflammatory Bowel Disease [DK043351]; Boston Area Diabetes and Endocrinology Research Center (BADERC) Award [DK057521]; U.S. National Institutes of Health (NIH) Shared Instrumentation Grant [1S10OD021577-01]; Canadian Institutes of Health Research [MOP-111012]; NIH National Institute of General Medical Sciences Grant [RO1 GM 11847]; Shriners Hospital Philanthropy [86300, 85124]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021577] Funding Source: NIH RePORTER	Centre for the Study of Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center (BADERC) Award; U.S. National Institutes of Health (NIH) Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH National Institute of General Medical Sciences Grant; Shriners Hospital Philanthropy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Most of the work for this study was performed at Shriners Hospitals for Children-Boston. The authors thank Dr. YongMing Yu and Dr. Sarah S. Kelangi (Massachusetts General Hospital and Shriners Hospitals for Children-Boston) for administrative support. The authors also thank the Scadden laboratory (Massachusetts General Hospital) for the use their equipment. Animals were housed at Center for Comparative Medicine (CCM) in Shriners Hospitals for Children-Boston. Immunofluorescent imaging was performed at the Microscopy Core of the Program in Membrane Biology, which is partially supported by a Centre for the Study of Inflammatory Bowel Disease Grant DK043351 and Boston Area Diabetes and Endocrinology Research Center (BADERC) Award DK057521. The Zeiss LSM 800 Airyscan confocal microscope was purchased using U.S. National Institutes of Health (NIH) Shared Instrumentation Grant 1S10OD021577-01. Pulmonary neutrophil extracellular trap formation (NETosis) studies of N.P. were supported by Canadian Institutes of Health Research (MOP-111012). This work was also partially supported by NIH National Institute of General Medical Sciences Grant RO1 GM 11847, and from Shriners Hospital Philanthropy (86300 and 85124 to J.A.M.). The authors thank Dr. Anil V. Nair and Dr. Richard Bouley (both from Massachusetts General Hospital) for technical support at the Core. Meso scale analysis was performed at the Metabolism and Mitochondrial Research Core (Beth Israel Deaconess Medical Center, Boston, MA, USA). The authors also thank Dr. Xiaowen Liu (Beth Israel Deaconess Medical Center) for technical support at the Core. The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; American Burn Association, BURN INC TREATM US; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Colgan J, 2006, NAT IMMUNOL, V7, P899, DOI 10.1038/ni0906-899; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; Davis CS, 2012, J BURN CARE RES, V33, P26, DOI 10.1097/BCR.0b013e318234d903; Delgado-Rizo V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00081; Ding FX, 2018, CELL PHYSIOL BIOCHEM, V46, P1263, DOI 10.1159/000489109; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Douda DN, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-29; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guillot L, 2008, INFECT IMMUN, V76, P4745, DOI 10.1128/IAI.00341-08; Gupta S, 1996, AM J RESP CELL MOL, V15, P656, DOI 10.1165/ajrcmb.15.5.8918372; Gurczynski SJ, 2018, AM J PHYSIOL-LUNG C, V314, pL6, DOI 10.1152/ajplung.00344.2017; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; HUANG S, 1992, AM J PATHOL, V141, P981; Hur J, 2015, ANN LAB MED, V35, P105, DOI 10.3343/alm.2015.35.1.105; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Inoue G, 2000, J Infect Chemother, V6, P51, DOI 10.1007/s101560050050; Iwasaki Y, 2015, INT J MOL SCI, V16, P2851, DOI 10.3390/ijms16022851; Jakiela B, 2012, RHEUMATOLOGY, V51, P1887, DOI 10.1093/rheumatology/kes171; Kang JW, 2017, AM J PHYSIOL-LUNG C, V313, pL466, DOI 10.1152/ajplung.00103.2017; Kariya S, 2013, LARYNGOSCOPE, V123, P1514, DOI 10.1002/lary.23795; Kaufman T, 2017, CLIN IMMUNOL, V183, P254, DOI 10.1016/j.clim.2017.08.014; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Khan MAS, 2017, SHOCK, V48, P227, DOI 10.1097/SHK.0000000000000849; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; Kim A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040758; Korkmaz HI, 2017, WOUND REPAIR REGEN, V25, P609, DOI 10.1111/wrr.12560; Kundu-Raychaudhuri S, 2016, CYTOKINE, V79, P45, DOI 10.1016/j.cyto.2015.12.020; Laan M, 1999, J IMMUNOL, V162, P2347; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; Lenzo JC, 2012, IMMUNOL CELL BIOL, V90, P429, DOI 10.1038/icb.2011.58; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu H, 2019, BIOL OPEN, V8, DOI 10.1242/bio.046342; Ma L, 2019, SHOCK, V51, P569, DOI 10.1097/SHK.0000000000001300; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Masuda S, 2016, CLIN CHIM ACTA, V459, P89, DOI 10.1016/j.cca.2016.05.029; Neely CJ, 2011, J TRAUMA, V70, P681, DOI 10.1097/TA.0b013e31820d18a6; Ovrevik J, 2009, TOXICOLOGY, V259, P46, DOI 10.1016/j.tox.2009.01.028; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; PRUITT BA, 1975, J TRAUMA, V15, P369; Pujic R, 2007, EUR J PHARMACOL, V557, P230, DOI 10.1016/j.ejphar.2006.11.023; Rathore JS, 2016, VACCINE, V34, P1504, DOI 10.1016/j.vaccine.2016.02.021; Reber LL, 2017, J EXP MED, V214, P1249, DOI 10.1084/jem.20161238; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Rimington Tracy L, 2017, F1000Res, V6, P460, DOI 10.12688/f1000research.10961.1; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Robins E V, 1989, Crit Care Nurs Clin North Am, V1, P767; Sasaki JR, 2011, BURNS, V37, P646, DOI 10.1016/j.burns.2011.01.028; Schwacha MG, 2002, INT J MOL MED, V10, P239; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sedgwick JB, 2002, J ALLERGY CLIN IMMUN, V110, P752, DOI 10.1067/mai.2002.128581; Silva L, 2016, Ann Burns Fire Disasters, V29, P178; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782, DOI 10.1002/jlb.57.5.782; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun L, 2015, CYTOKINE, V75, P249, DOI 10.1016/j.cyto.2015.01.030; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; Tanimoto N, 2007, BIOCHEM BIOPH RES CO, V361, P533, DOI 10.1016/j.bbrc.2007.07.060; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thurley K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004206; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; VANOTTEREN GM, 1994, AM J RESP CELL MOL, V10, P8, DOI 10.1165/ajrcmb.10.1.8292385; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Whittaker L, 2002, AM J RESP CELL MOL, V27, P593, DOI 10.1165/rcmb.4838; Williams AE, 2017, THORAX, V72, P66, DOI 10.1136/thoraxjnl-2016-208597; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yildiz C, 2015, ANESTHESIOLOGY, V122, P864, DOI 10.1097/ALN.0000000000000605; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zhang Y, 2014, ADV EXP MED BIOL, V841, P15, DOI 10.1007/978-94-017-9487-9_2	97	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13602	13616		10.1096/fj.201901098R	http://dx.doi.org/10.1096/fj.201901098R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31577450	Green Published, Bronze			2022-12-26	WOS:000507466100044
J	Kwok, E; Rodriguez, DJ; Kremerskothen, J; Nyarko, A				Kwok, Ethiene; Rodriguez, Diego J.; Kremerskothen, Joachim; Nyarko, Afua			Intrinsic disorder and amino acid specificity modulate binding of the WW2 domain in kidney and brain protein (KIBRA) to synaptopodin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); circular dichroism (CD); protein-protein interaction; intrinsically disordered protein; PPXY motif; proline-rich motif; scaffolding protein; synaptopodin (SYNPO); WW domain	BACKBONE DYNAMICS; FUZZY COMPLEXES; LIGAND; MEMORY; POLYMORPHISM; EQUILIBRIUM; REGULATOR; TRANSPORT; SINGLE	The second WW domain (WW2) of the kidney and brain scaffolding protein, KIBRA, has an isoleucine (Ile-81) rather than a second conserved tryptophan and is primarily unstructured. However, it adopts the canonical triple-stranded antiparallel beta-sheet structure of WW domains when bound to a two-PPXY motif peptide of the synaptic protein Dendrin. Here, using a series of biophysical experiments, we demonstrate that the WW2 domain remains largely disordered when bound to a 69-residue two-PPXY motif polypeptide of the synaptic and podocyte protein synaptopodin (SYNPO). Isothermal titration calorimetry and CD experiments revealed that the interactions of the disordered WW2 domain with SYNPO are significantly weaker than SYNPO's interactions with the well-folded WW1 domain and that an I81W substitution in the WW2 domain neither enhances binding affinity nor induces substantial WW2 domain folding. In the tandem polypeptide, the two WW domains synergized, enhancing the overall binding affinity with the I81W variant tandem polypeptide 2-fold compared with the WT polypeptide. Solution NMR results showed that SYNPO binding induces small but definite chemical shift perturbations in the WW2 domain, confirming the disordered state of the WW2 domain in this complex. These analyses also disclosed that SYNPO binds the tandem WW domain polypeptide in an antiparallel manner, that is, the WW1 domain binds the second PPXY motif of SYNPO. We propose a binding model consisting of a bipartite interaction mode in which the largely disordered WW2 forms a "fuzzy" complex with SYNPO. This binding mode may be important for specific cellular functions.	[Kwok, Ethiene; Rodriguez, Diego J.; Nyarko, Afua] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Kremerskothen, Joachim] Univ Hosp, Dept Mol Nephrol, D-48149 Munster, Germany	Oregon State University; University of Munster	Nyarko, A (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	nyarkoa@oregonstate.edu		Rodriguez, Diego/0000-0002-0053-8674	National Institutes of Health HEI [1S10OD018518]; M. J. Murdock Charitable Trust [2014162]	National Institutes of Health HEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust	We thank Professors Elisar Barbar and Andy Karplus for helpful discussions. NMR experiments were collected at the Oregon State UniversityNMRFacility funded in part by National Institutes of Health HEI Grant 1S10OD018518 and M. J. Murdock Charitable Trust Grant 2014162.	ANDRE B, 1994, BIOCHEM BIOPH RES CO, V205, P1201, DOI 10.1006/bbrc.1994.2793; Anuj, 2017, BRIT J CANCER, V117, P553, DOI 10.1038/bjc.2017.192; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2011, AM J NEPHROL, V33, P537, DOI 10.1159/000327995; Chalovich Joseph M, 2010, Biophys Rev, V2, P181, DOI 10.1007/s12551-010-0040-5; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Garner, 1998, Genome Inform Ser Workshop Genome Inform, V9, P201; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Goddard T. D., 2005, SPARKY 3; Iglesias-Bexiga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113828; Ji ZY, 2019, CELL REP, V26, P2064, DOI 10.1016/j.celrep.2019.01.097; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Koepf EK, 1999, BIOCHEMISTRY-US, V38, P14338, DOI 10.1021/bi991105l; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lin T, 2017, MOL MED REP, V16, P8685, DOI 10.3892/mmr.2017.7708; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Martinez-Rodriguez S, 2015, J STRUCT BIOL, V191, P381, DOI 10.1016/j.jsb.2015.08.001; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nyarko A, 2018, BIOCHEMISTRY-US, V57, P547, DOI 10.1021/acs.biochem.7b00973; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Schuchardt BJ, 2014, BIOCHIMIE, V101, P192, DOI 10.1016/j.biochi.2014.01.011; Schuchardt BJ, 2013, BIOCHEMISTRY-US, V52, P9223, DOI 10.1021/bi400987k; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Stauffer S, 2016, FEBS J, V283, P1800, DOI 10.1111/febs.13718; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vogt-Eisele A, 2014, J NEUROCHEM, V128, P686, DOI 10.1111/jnc.12480; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Witte AV, 2016, NEUROPSYCHOPHARMACOL, V41, P781, DOI 10.1038/npp.2015.203; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Zhang XL, 2013, J NEUROSCI, V33, P12510, DOI 10.1523/JNEUROSCI.2983-12.2013	47	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17383	17394		10.1074/jbc.RA119.009589	http://dx.doi.org/10.1074/jbc.RA119.009589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31597702	hybrid, Green Published			2022-12-26	WOS:000503173500018
J	Godwin, WC; Hoffmann, GF; Gray, TJ; Hughes, RM				Godwin, Walton C.; Hoffmann, George F.; Gray, Taylor J.; Hughes, Robert M.			Imaging of morphological and biochemical hallmarks of apoptosis with optimized optogenetic tools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						optogenetics; actin; cryptochrome; cytoskeleton; Bax; apoptosis; mitochondrial apoptosis; BCL2-associated X apoptosis regulator (BAX); cytoskeletal dynamics; effector molecule; mitochondrial outer membrane permeabilization (MOMP); OptoBAX 2; 0 system	BAX TRANSLOCATION; ACTIN CYTOSKELETON; CELL-DEATH; MITOCHONDRIA; PROTEIN; PATHWAYS; COFILIN; INHIBITORS	Creation of optogenetic switches for specific activation of cell death pathways can provide insights into apoptosis and could also form a basis for noninvasive, next-generation therapeutic strategies. Previous work has demonstrated that cryptochrome 2 (Cry2)/cryptochrome-interacting ? helix?loop?helix (CIB), a blue light?activated protein?protein dimerization module from the plant Arabidopsis thaliana, together with BCL2-associated X apoptosis regulator (BAX), an outer mitochondrial membrane?targeting pro-apoptotic protein, can be used for light-mediated initiation of mitochondrial outer membrane permeabilization (MOMP) and downstream apoptosis. In this work, we further developed the original light-activated Cry2-BAX system (hereafter referred to as OptoBAX) by improving the photophysical properties and light-independent interactions of this optogenetic switch. The resulting optogenetic constructs significantly reduced the frequency of light exposure required for membrane permeabilization activation and also decreased dark-state cytotoxicity. We used OptoBAX in a series of experiments in Neuro-2a and HEK293T cells to measure the timing of the dramatic morphological and biochemical changes occurring in cells after light-induced MOMP. In these experiments, we used OptoBAX in tandem with fluorescent reporters to image key events in early apoptosis, including membrane inversion, caspase cleavage, and actin redistribution. We then used these data to construct a timeline of biochemical and morphological events in early apoptosis, demonstrating a direct link between MOMP-induced redistribution of actin and apoptosis progression. In summary, we created a next-generation Cry2/CIB?BAX system requiring less frequent light stimulation and established a timeline of critical apoptotic events, providing detailed insights into key steps in early apoptosis.	[Godwin, Walton C.; Hoffmann, George F.; Hughes, Robert M.] East Carolina Univ, Dept Chem, Greenville, NC 27858 USA; [Gray, Taylor J.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Hughes, RM (corresponding author), East Carolina Univ, Dept Chem, Greenville, NC 27858 USA.	hughesr16@ecu.edu		Hughes, Robert/0000-0002-4465-4212	East Carolina University Division of Research, Economic Development and Engagement; East Carolina University Thomas Harriot College of Arts and Sciences; East Carolina University Department of Chemistry	East Carolina University Division of Research, Economic Development and Engagement; East Carolina University Thomas Harriot College of Arts and Sciences; East Carolina University Department of Chemistry	Funding was provided by the East Carolina University Division of Research, Economic Development and Engagement, Thomas Harriot College of Arts and Sciences, and the Department of Chemistry. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bleger D, 2015, ANGEW CHEM INT EDIT, V54, P11338, DOI 10.1002/anie.201500628; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Gelles JD, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.156; Gelles JD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.332; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Haar LL, 2019, METHOD ENZYMOL, V622, P309, DOI 10.1016/bs.mie.2019.02.020; Hughes RM, 2018, CRIT REV BIOCHEM MOL, V53, P453, DOI 10.1080/10409238.2018.1487382; Hughes RM, 2015, ANGEW CHEM INT EDIT, V54, P12064, DOI 10.1002/anie.201506346; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kihlmark M, 2004, EXP CELL RES, V293, P346, DOI 10.1016/j.yexcr.2003.10.019; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Martin S, 2001, MOL CELL BIOL, V21, P6529, DOI 10.1128/MCB.21.19.6529-6536.2001; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meijerman I, 1999, TOXICOL APPL PHARM, V156, P46, DOI 10.1006/taap.1998.8616; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Muhlhauser WWD, 2017, METHODS MOL BIOL, V1596, P257, DOI 10.1007/978-1-4939-6940-1_16; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nakamura-Lopez Y, 2009, CELL BIOL INT, V33, P1026, DOI 10.1016/j.cellbi.2009.06.010; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Puigvert J C, 2010, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1810s47; Rehklau K, 2012, CELL DEATH DIFFER, V19, P958, DOI 10.1038/cdd.2011.180; Rhind N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005942; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Stein V, 2015, TRENDS BIOTECHNOL, V33, P101, DOI 10.1016/j.tibtech.2014.11.010; Strasser C, 2012, NUCLEUS-PHILA, V3, P540, DOI 10.4161/nucl.21982; Tang HL, 2006, BIOCHEM J, V396, P1, DOI 10.1042/BJ20060241; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zeng WB, 2015, THERANOSTICS, V5, P559, DOI 10.7150/thno.11548; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	52	6	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16918	16929		10.1074/jbc.RA119.009141	http://dx.doi.org/10.1074/jbc.RA119.009141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31582560	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000501801900036
J	Perl, AL; O'Connor, CM; Fa, PY; Pozo, FM; Zhang, JR; Zhang, YW; Narla, G				Perl, Abbey L.; O'Connor, Caitlin M.; Fa, Pengyan; Pozo, Franklin Mayca; Zhang, Junran; Zhang, Youwei; Narla, Goutham			Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase 2 (PP2A); DNA damage response; DNA replication; cell cycle; DNA-protein interaction; cell division cycle 45 (CDC45); replisome; genome stability; small molecule activator of PP2A (SMAP); cell cycle checkpoint	SMALL T-ANTIGEN; PP2A; CHROMATIN; SUBUNIT	Genomic replication is a highly regulated process and represents both a potential benefit and liability to rapidly dividing cells; however, the precise post-translational mechanisms regulating genomic replication are incompletely understood. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that regulates a diverse array of cellular processes. Here, utilizing both a gain-of-function chemical biology approach and loss-of-function genetic approaches to modulate PP2A activity, we found that PP2A regulates DNA replication. We demonstrate that increased PP2A activity can interrupt ongoing DNA replication, resulting in a prolonged S phase. The impaired replication resulted in a collapse of replication forks, inducing dsDNA breaks, homologous recombination, and a PP2A-dependent replication stress response. Additionally, we show that during replication, PP2A exists in complex with cell division cycle 45 (CDC45) and that increased PP2A activity caused dissociation of CDC45 and polymerase ? from the replisome. Furthermore, we found that individuals harboring mutations in the PP2A A? gene have a higher fraction of genomic alterations, suggesting that PP2A regulates ongoing replication as a mechanism for maintaining genomic integrity. These results reveal a new function for PP2A in regulating ongoing DNA replication and a potential role for PP2A in the intra-S-phase checkpoint.	[Perl, Abbey L.; O'Connor, Caitlin M.; Pozo, Franklin Mayca; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Narla, Goutham] Case Western Reserve Univ, Dept Internal Med, Sch Med, Cleveland, OH 44106 USA; [Fa, Pengyan; Zhang, Junran] Ohio State Univ, James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Fa, Pengyan; Zhang, Junran] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Narla, Goutham] Univ Michigan, Dept Internal Med, Div Genet Med, Ann Arbor, MI 48105 USA	Case Western Reserve University; Case Western Reserve University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Narla, G (corresponding author), Univ Michigan, Dept Internal Med, Div Genet Med, Ann Arbor, MI 48105 USA.	gnarla@med.umich.edu	O'Connor, Caitlin M./AAC-5203-2020; Narla, Goutham/AAZ-5710-2020	O'Connor, Caitlin M./0000-0002-7840-6399; Narla, Goutham/0000-0003-4098-4203; Fa, Pengyan/0000-0001-7533-007X; Perl, Abbey/0000-0002-4093-1833	NCI, National Institutes of Health [F31 CA213554, R01CA181654, R01CA240993]; NATIONAL CANCER INSTITUTE [R01CA181654, F31CA213554, R01CA240993] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health, Grant F31 CA213554 (to A. L. P.), R01CA181654 and R01CA240993 (to G. N.). The Icahn School of Medicine at Mount Sinai has filed patents covering composition of matter on the small molecules disclosed herein for the treatment of human cancer and other diseases (International Application Numbers: PCT/US15/19770, PCT/US15/19764; and United States Patent: US 9,540,358 B2). Mount Sinai is actively seeking commercial partners for the further development of the technology. G. N. has a financial interest in the commercialization of the technology (NCI NIH R01CA181654; NCI NIH R01CA240993). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen-Petersen BL, 2019, CANCER RES, V79, P209, DOI 10.1158/0008-5472.CAN-18-0717; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Chou DM, 2002, J BIOL CHEM, V277, P40520, DOI 10.1074/jbc.M207226200; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; Duderstadt KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a010157; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Feng JJ, 2009, MOL CELL BIOL, V29, P5696, DOI 10.1128/MCB.00191-09; Gao YZ, 2014, J BIOL CHEM, V289, P35987, DOI 10.1074/jbc.M114.589119; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Gutierrez A, 2014, J CLIN INVEST, V124, P644, DOI 10.1172/JCI65093; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; Kauko O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1093; Kotsantis P., 2015, CANC THERAPY REPLICA, P91; Lai TY, 2016, ONCOTARGET, V7, P4542, DOI 10.18632/oncotarget.6609; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; McClinch K, 2018, CANCER RES, V78, P2065, DOI 10.1158/0008-5472.CAN-17-0123; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; O'Connor CM, 2018, INT J BIOCHEM CELL B, V96, P182, DOI 10.1016/j.biocel.2017.10.008; Qiu ZJ, 2018, RADIOTHER ONCOL, V126, P450, DOI 10.1016/j.radonc.2017.09.043; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sangodkar J, 2017, J CLIN INVEST, V127, P2081, DOI 10.1172/JCI89548; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Sangodkar J, 2012, J CLIN INVEST, V122, P2637, DOI 10.1172/JCI62058; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimada M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00008; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Taylor SE, 2019, CANCER RES, V79, P4242, DOI 10.1158/0008-5472.CAN-19-0218; Tohme R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125693; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Wiredja DD, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700214; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Zech J, 2014, SEMIN CELL DEV BIOL, V30, P144, DOI 10.1016/j.semcdb.2014.03.026	43	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17043	17059		10.1074/jbc.RA119.010432	http://dx.doi.org/10.1074/jbc.RA119.010432			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31562245	Green Published, hybrid			2022-12-26	WOS:000501801900046
J	Munoz-Cabrera, JM; Sandoval-Hernandez, AG; Nino, A; Baez, T; Bustos-Rangel, A; Cardona-Gomez, GP; Munera, A; Arboleda, G				Mauricio Munoz-Cabrera, Jonathan; Gabriel Sandoval-Hernandez, Adrian; Nino, Andrea; Baez, Tatiana; Bustos-Rangel, Angie; Patricia Cardona-Gomez, Gloria; Munera, Alejandro; Arboleda, Gonzalo			Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer's disease	PLOS ONE			English	Article							STIMULATED PROINFLAMMATORY RESPONSES; APOLIPOPROTEIN-E; A-BETA; SYNAPTIC PLASTICITY; TAU; RECEPTORS; PROTEIN; EXPRESSION; MEMORY; NEUN	Introduction Bexarotene, a retinoid X receptor agonist, improves cognition in murine models of Alzheimer's disease (AD). This study evaluated the effects of bexarotene on pathological and electrophysiological changes in very old triple transgenic AD mice (3xTg-AD mice). Methods 24-month-old 3xTg-AD mice were treated with bexarotene (100 mg/kg/day for 30 days). The Morris water maze was used to evaluate spatial memory; immunofluorescence and confocal microscopy were used to evaluate pathological changes; and in vivo electrophysiological recordings were used to evaluate basal transmission and plasticity in the commissural CA3-CA1 pathway. Results In addition to cognitive improvement, bexarotene-treated 3xTg-AD mice were found to have 1) reductions of astrogliosis and reactive microglia both in cortex and hippocampus; 2) increased ApoE expression restricted to CA1; 3) increased number of cells co-labeled with ApoE and NeuN; 4) recovery of NeuN expression, suggesting neuronal protection; and, 5) recovery of basal synaptic transmission and synaptic plasticity. Discussion These results indicate that bexarotene-induced improvement in cognition is due to multiple changes that contribute to recovery of synaptic plasticity.	[Mauricio Munoz-Cabrera, Jonathan; Munera, Alejandro] Univ Nacl Colombia, Sch Med, Behav Neurophysiol Lab, Bogota, Colombia; [Gabriel Sandoval-Hernandez, Adrian; Nino, Andrea; Baez, Tatiana; Bustos-Rangel, Angie; Arboleda, Gonzalo] Univ Nacl Colombia, Inst Genet, Grp Muerte Celular, Bogota, Colombia; [Patricia Cardona-Gomez, Gloria] Univ Antioquia, Fac Med, Grp Neurociencias Antioquia, Area Neurobiol Celular & Mol, Medellin, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad de Antioquia	Munera, A (corresponding author), Univ Nacl Colombia, Sch Med, Behav Neurophysiol Lab, Bogota, Colombia.; Sandoval-Hernandez, AG; Arboleda, G (corresponding author), Univ Nacl Colombia, Inst Genet, Grp Muerte Celular, Bogota, Colombia.	agsandovalh@unal.edu.co; famunerag@unal.edu.co; gharboledab@unal.edu.co	Cardona-Gomez, Gloria Patricia/D-8100-2016	Cardona-Gomez, Gloria Patricia/0000-0002-3814-4494; Sandoval-Hernandez, Adrian Gabriel/0000-0002-0661-6872	Colombian Science, Technology and Innovation Department (Colciencias) [621-2014-110165843270, 727-2018-110180763833, 761-2013110161538259, RC110189666226]; DIEB-Universidad Nacional de Colombia	Colombian Science, Technology and Innovation Department (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); DIEB-Universidad Nacional de Colombia	This research was funded by Colombian Science, Technology and Innovation Department (Colciencias) grants (621-2014-110165843270), (727-2018-110180763833), (761-2013110161538259), and (RC110189666226); and by DIEB-Universidad Nacional de Colombia. funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Caruso D, 2013, NEUROBIOL AGING, V34, P1080, DOI 10.1016/j.neurobiolaging.2012.10.007; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Clark JK, 2015, NEUROBIOL LEARN MEM, V125, P152, DOI 10.1016/j.nlm.2015.09.003; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Combs CK, 2001, NEUROCHEM INT, V39, P449, DOI 10.1016/S0197-0186(01)00052-3; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Crespo-Biel Natalia, 2012, Int J Alzheimers Dis, V2012, P251426, DOI 10.1155/2012/251426; Davis KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091203; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Dheer Y, 2019, EXP NEUROL, V314, P111, DOI 10.1016/j.expneurol.2019.01.015; Dickey AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2332; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Huang Z, 2009, MOL CELL NEUROSCI, V42, P11, DOI 10.1016/j.mcn.2009.06.003; Jawed SI, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.08.033; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Landreth GE, 2013, SCIENCE, V340, DOI 10.1126/science.1234114; Lavezzi AM, 2013, J NEUROL SCI, V329, P45, DOI 10.1016/j.jns.2013.03.012; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Moreno H, 2016, NEUROSCIENCE, V325, P30, DOI 10.1016/j.neuroscience.2016.03.044; Mounier A, 2015, J NEUROSCI, V35, P11862, DOI 10.1523/JNEUROSCI.1001-15.2015; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Paxinos G, 2013, PAXINOS FRANKLINS MO; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Sandoval-Hernandez AG, 2016, J MOL NEUROSCI, V58, P243, DOI 10.1007/s12031-015-0665-8; Sandoval-Hernandez AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145467; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Skerrett R, 2015, J BIOL CHEM, V290, P21591, DOI 10.1074/jbc.M115.652008; Tachibana M, 2016, EXP NEUROL, V277, P1, DOI 10.1016/j.expneurol.2015.12.003; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang QG, 2013, BRAIN, V136, P1432, DOI 10.1093/brain/awt046; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhou HY, 2015, INT J OPHTHALMOL-CHI, V8, P826, DOI [10.3980/j.issn.2222-3959.2015.04.32, 10.3980/j.issn.2222-395.2015.04.32]	58	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223578	10.1371/journal.pone.0223578	http://dx.doi.org/10.1371/journal.pone.0223578			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596896	gold, Green Submitted, Green Published			2022-12-26	WOS:000532444100044
J	Mishima, K; Nakasatomi, M; Takahashi, S; Ikeuchi, H; Sakairi, T; Kaneko, Y; Hiromura, K; Nojima, Y; Maeshima, A				Mishima, Keiichiro; Nakasatomi, Masao; Takahashi, Shunsuke; Ikeuchi, Hidekazu; Sakairi, Toru; Kaneko, Yoriaki; Hiromura, Keiju; Nojima, Yoshihisa; Maeshima, Akito			Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel	PLOS ONE			English	Article							CA2+ CHANNELS; NOREPINEPHRINE RELEASE; TYROSINE-HYDROXYLASE; ALPHA(1B) SUBUNIT; ACTIVIN-A; CILNIDIPINE; INVOLVEMENT; MECHANISMS; SYSTEM; STIMULATION	The N-type Ca2+ channel (Cav2.2) is distributed in sympathetic nerves that innervate the tubules, the vessels, and the juxtaglomerular granular cells of the kidney. However, the role of N-type Ca2+ channels in renal disease remains unknown. To address this issue, Cav2.2 knockout mice were utilized. Immunoreactive Cav2.2 was undetectable in normal kidneys of C57BL/6N mice, but it became positive in the interstitial S100-positive nerve fibers after unilateral ureteral obstruction (UUO). There were no significant differences in mean blood pressure, heart rate, and renal function between wild-type littermates and Cav2.2-knockout mice at baseline, as well as after UUO. Cav2.2 deficiency significantly reduced the EVG-positive fibrotic area, alpha-SMA expression, the production of type I collagen, and the hypoxic area in the obstructed kidneys. The expression of tyrosine hydroxylase, a marker for sympathetic neurons, was significantly increased in the obstructed kidneys of wild-type mice, but not in Cav2.2-knockout mice. These data suggest that increased Cav2.2 is implicated in renal nerve activation leading to the progression of renal fibrosis. Blockade of Cav2.2 might be a novel therapeutic approach for preventing renal fibrosis.	[Mishima, Keiichiro; Nakasatomi, Masao; Takahashi, Shunsuke; Ikeuchi, Hidekazu; Sakairi, Toru; Kaneko, Yoriaki; Hiromura, Keiju; Nojima, Yoshihisa; Maeshima, Akito] Gunma Univ, Dept Nephrol & Rheumatol, Grad Sch Med, Maebashi, Gunma, Japan	Gunma University	Maeshima, A (corresponding author), Gunma Univ, Dept Nephrol & Rheumatol, Grad Sch Med, Maebashi, Gunma, Japan.	amaesima@jichi.ac.jp	; IKEUCHI, HIDEKAZU/M-1721-2017	Sakairi, Toru/0000-0003-2804-485X; IKEUCHI, HIDEKAZU/0000-0002-0768-7090	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17K16069, 20590946]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grants-inAid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (20590946) to AM, by a Grants-in-Aid for Young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (17K16069) to MN, and by a Grant-in-aid for Progressive Renal Diseases Research and Research on Intractable Disease from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (20590946) to AM, by a Grants-in-Aid for Young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (17K16069) to MN, and by a Grant-in-aid for Progressive Renal Diseases Research and Research on Intractable Disease from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAJAS L, 1990, AM J PHYSIOL, V259, pF503, DOI 10.1152/ajprenal.1990.259.3.F503; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bowersox SS, 1997, BRAIN RES, V747, P343; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Chung YH, 2001, BRAIN RES, V902, P294, DOI 10.1016/S0006-8993(01)02443-X; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; Fan YY, 2010, J HYPERTENS, V28, P1034, DOI 10.1097/HJH.0b013e328336ade3; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; Kobayashi N, 2001, EUR J PHARMACOL, V422, P149, DOI 10.1016/S0014-2999(01)01067-6; Konda Tomoyuki, 2005, Nephron Physiology, V101, pP1, DOI 10.1159/000085713; Lei B, 2012, J PHARMACOL SCI, V119, P359, DOI 10.1254/jphs.12075FP; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma MC, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341008; Maeshima A, 2002, J AM SOC NEPHROL, V13, P2850, DOI 10.1097/01.ASN.0000035086.93977.E9; Maeshima A, 2001, J AM SOC NEPHROL, V12, P1685, DOI 10.1681/ASN.V1281685; Mishima K, 2013, AM J PHYSIOL-RENAL, V304, pF665, DOI 10.1152/ajprenal.00561.2012; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Ohno S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27192; RITTENHOUSE AR, 1991, J NEUROCHEM, V56, P615, DOI 10.1111/j.1471-4159.1991.tb08194.x; Saegusa H, 2002, NEUROSCI RES, V43, P1, DOI 10.1016/S0168-0102(02)00017-2; Toba H, 2011, HYPERTENS RES, V34, P521, DOI 10.1038/hr.2010.279; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Veelken R, 2008, J AM SOC NEPHROL, V19, P1371, DOI 10.1681/ASN.2007050552; Yamashita S, 2004, J AM SOC NEPHROL, V15, P91, DOI 10.1097/01.ASN.0000103225.68136.E6; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhou XY, 2002, J HYPERTENS, V20, P993, DOI 10.1097/00004872-200205000-00035; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223496	10.1371/journal.pone.0223496	http://dx.doi.org/10.1371/journal.pone.0223496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596895	gold, Green Published			2022-12-26	WOS:000532444100039
J	Pierandrei, S; Blacon, G; Fabrizzi, B; Cimino, G; Cirilli, N; Caporelli, N; Angeloni, A; Cipolli, M; Lucarelli, M				Pierandrei, Silvia; Blacon, Giovanna; Fabrizzi, Benedetta; Cimino, Giuseppe; Cirilli, Natalia; Caporelli, Nicole; Angeloni, Antonio; Cipolli, Marco; Lucarelli, Marco			Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CLINICAL MACROCATEGORIES; MUTATIONAL PATTERNS; RECOMMENDATIONS; CLASSIFICATION; MANAGEMENT; PHENOTYPE; DIAGNOSIS; GENOTYPE	Two novel and related pathogenic variants of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene were structurally and functionally characterized. These alterations have not been previously described in literature. Two patients with diagnosis of Cystic Fibrosis (CF) based on the presence of one mutated allele, p.Phe508del, pathological sweat test and clinical symptoms were studied. To complete the genotypes of both patients, an extensive genetic and functional analysis of the CFTR gene was performed. Extensive genetic characterization confirmed the presence of p.Phe508del pathogenic variant and revealed, in both patients, the presence of an insertion of part of intron 10 in intron 9 of the CFTR gene, within the (TG)m repeat, with a variable poly-T stretch. The molecular lesions resulted to be very similar in both patients, with only a difference in the number of T in the poly-T stretch. The functional characterization at RNA level revealed a complete anomalous splicing, without exon 10, from the allele with the insertion of both patients. Consequently, the alleles with the insertions are expected not to contribute to the formation of a functional CFTR protein. Molecular and functional features of these alterations are compatible with the definition of novel CF-causing variants of the CFTR gene. This also allowed the completion of the genetic characterization of both patients.	[Pierandrei, Silvia] Sapienza Univ Rome, Dept Mother Child & Urol Sci, Rome, Italy; [Blacon, Giovanna; Angeloni, Antonio; Lucarelli, Marco] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Fabrizzi, Benedetta; Cirilli, Natalia; Caporelli, Nicole; Cipolli, Marco] United Hosp, Cyst Fibrosis Care Ctr, Mother Child Dept, Ancona, Italy; [Cimino, Giuseppe] Umberto I Hosp, Cyst Fibrosis Care Ctr, Rome, Italy; [Lucarelli, Marco] Cenci Bolognetti Fdn, Pasteur Inst, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Fondazione Cenci Bolognetti	Lucarelli, M (corresponding author), Sapienza Univ Rome, Dept Expt Med, Rome, Italy.; Lucarelli, M (corresponding author), Cenci Bolognetti Fdn, Pasteur Inst, Rome, Italy.	marco.lucarelli@uniroma1.it	Angeloni, Antonio/J-9392-2018; Cipolli, Marco/AAL-1419-2020	Angeloni, Antonio/0000-0003-4969-9548; Cipolli, Marco/0000-0001-5652-7248; Lucarelli, Marco/0000-0002-5538-2494	Regione Lazio	Regione Lazio(Regione Lazio)	This work was supported by Regione Lazio (research projects 2008 -2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Regione Lazio (research projects 2008-2012).	Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Audrezet M, 2004, HUM MUTAT, V23, P343, DOI 10.1002/humu.20009; Auriche C, 2010, GENE THER, V17, P1341, DOI 10.1038/gt.2010.89; Bergougnoux A, 2018, CLIN CHEM LAB MED, V56, P1046, DOI 10.1515/cclm-2017-0553; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bombieri C, 2015, SEMIN RESP CRIT CARE, V36, P180, DOI 10.1055/s-0035-1547318; Chang EH, 2015, CTS-CLIN TRANSL SCI, V8, P606, DOI 10.1111/cts.12292; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Corvol H, 2016, TRANSL RES, V168, P40, DOI 10.1016/j.trsl.2015.04.008; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Farrell PM, 2017, J PEDIATR-US, V181, pS4, DOI 10.1016/j.jpeds.2016.09.064; Ferraguti G, 2011, CLIN CHEM LAB MED, V49, P1447, DOI 10.1515/CCLM.2011.604; GIBSON LE, 1959, PEDIATRICS, V23, P545; Gullo L, 1997, EUR J PEDIATR, V156, P770, DOI 10.1007/s004310050709; Heap S, 2014, GUIDELINES PERFORMAN; Ivanov M, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0328-z; Jiang LY, 2017, GENE, V626, P282, DOI 10.1016/j.gene.2017.04.044; Lucarelli M., 2017, WORLD J MED GENETICS, V4, P224; Lucarelli M, 2012, CYSTIC FIBROSIS RENE, P91; Lucarelli M, 2006, ANAL BIOCHEM, V353, P226, DOI 10.1016/j.ab.2006.03.022; Lucarelli M, 2017, J MOL DIAGN, V19, P788, DOI 10.1016/j.jmoldx.2017.06.002; Lucarelli M, 2016, J MOL DIAGN, V18, P554, DOI 10.1016/j.jmoldx.2016.02.007; Lucarelli M, 2015, MOL MED, V21, P257, DOI 10.2119/molmed.2014.00229; Lucarelli M, 2010, GENET MED, V12, P548, DOI 10.1097/GIM.0b013e3181ead634; Machogu E, 2016, PEDIATR PULM, V51, pS45, DOI 10.1002/ppul.23478; Munck A, 2015, J CYST FIBROS, V14, P706, DOI 10.1016/j.jcf.2015.01.001; Radtke T, 2018, ANN AM THORAC SOC, V15, P209, DOI 10.1513/AnnalsATS.201707-570OC; Rossi T, 2004, FERTIL STERIL, V82, P1316, DOI 10.1016/j.fertnstert.2004.03.065; Savi D, 2019, J CYST FIBROS, V18, P420, DOI 10.1016/j.jcf.2019.03.001; Savi D, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0151-7; Slieker Martijn G, 2005, J Cyst Fibros, V4 Suppl 2, P7, DOI 10.1016/j.jcf.2005.05.006; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Terlizzi V, 2015, J CYST FIBROS; Terlizzi V, 2017, J MED GENET, V54, P224, DOI 10.1136/jmedgenet-2016-103985; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wayne PA, 2009, SWEAT TESTING SAMPLE	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0222838	10.1371/journal.pone.0222838	http://dx.doi.org/10.1371/journal.pone.0222838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593572	Green Published, gold			2022-12-26	WOS:000532431700003
J	Da'as, SR; Azzeh, M				Da'as, Sahar Rayan; Azzeh, Maysa			Subgenotyping and genetic variability of hepatitis C virus in Palestine	PLOS ONE			English	Article							HEPATOCARCINOGENESIS FOLLOWING ERADICATION; AMINO-ACID SUBSTITUTIONS; CORE REGION; GENOTYPE DISTRIBUTION; HCV RNA; MUTATIONS; INFECTION; EGYPT; E1	Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. Genotyping of HCV is crucial for successful therapy. To determine the HCV subgenotypes circulating in Palestine and to study the genetic variability of their core, we collected 84 serum samples which had tested positive for anti-HCV antibodies. Thirty-seven of these samples came from hemodialysis patients. Serum samples were subjected to viral RNA isolation and amplification of the HCV core gene. Thirty-three of the samples (39%) tested positive for HCV RNA. The HCV subgenotypes circulating in Palestine included 1 a, 3a, and 4a, detected in 38%, 25%, and 22% of the samples, respectively. Furthermore, subgenotype 1 b was present in three samples (9%), while the rare subgenotype 4v was present in two samples (6%). We identified a number of substitutions in the retrieved HCV core sequences, such as HCV 1 b substitutions R700 and M91L, which some studies have associated with hepatocellular carcinoma risk and poor virological response. In contrast to two previous studies reporting that HCV genotype 4 was predominant in the Gaza strip (present in just over 70% of samples), genotype 4 was detected in only 31% of the samples in our current study, whereas genotype 1 and 3 were present in 69% of samples. These differences may relate to the fact that many of our samples came from the West Bank and East Jerusalem. The co-circulation of different HCV genotypes and subgenotypes in Palestine suggests that subgenotyping prior to treatment is crucial in Palestinian patients.	[Da'as, Sahar Rayan; Azzeh, Maysa] Al Quds Univ, Virol Res Lab, Med Res Ctr, Abu Dies East Jerusalem, West Bank, Palestine; [Azzeh, Maysa] Touro Coll Osteopath Med, Dept Basic Biomed Sci, New York, NY 10027 USA		Azzeh, M (corresponding author), Al Quds Univ, Virol Res Lab, Med Res Ctr, Abu Dies East Jerusalem, West Bank, Palestine.; Azzeh, M (corresponding author), Touro Coll Osteopath Med, Dept Basic Biomed Sci, New York, NY 10027 USA.	maysa.azzeh@gmail.com						AASLD/IDSA, 2018, HCV GUID REC TEST MA; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2007, HEPATOLOGY, V46, P1357, DOI 10.1002/hep.21836; Akuta N, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01463-18; Akuta N, 2015, J CLIN MICROBIOL, V53, P3039, DOI 10.1128/JCM.01457-15; Akuta N, 2011, J MED VIROL, V83, P1016, DOI 10.1002/jmv.22094; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Alagoz GK, 2014, TURK J GASTROENTEROL, V25, P405, DOI 10.5152/tjg.2014.7083; Alfaresi MS, 2011, MOL BIOL REP, V38, P2719, DOI 10.1007/s11033-010-0415-5; Alhamlan FS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-91; Ayesh BM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-105; Budkowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015871; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; El-Shamy A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27025; Elkady A, 2009, J MED VIROL, V81, P1015, DOI 10.1002/jmv.21492; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Ezzikouri S, 2013, J MED VIROL, V85, P1542, DOI 10.1002/jmv.23643; Fishman SL, 2009, CLIN CANCER RES, V15, P3205, DOI 10.1158/1078-0432.CCR-08-2418; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Genovese D, 2005, J CLIN MICROBIOL, V43, P1902, DOI 10.1128/JCM.43.4.1902-1909.2005; Ghaderi-Zefrehi H, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.40357; Hu ZJ, 2009, CANCER SCI, V100, P2465, DOI 10.1111/j.1349-7006.2009.01338.x; Janahi EM, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.30300; Jaspe RC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-214; Kandeel A, 2017, LIVER INT, V37, P45, DOI 10.1111/liv.13186; Kartashev V, 2016, J CLIN VIROL, V81, P82, DOI 10.1016/j.jcv.2016.05.010; Korba B, 2015, J GEN VIROL, V96, P2928, DOI 10.1099/jgv.0.000219; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Nguyen LT, 2015, J CLIN MICROBIOL, V53, P2697, DOI 10.1128/JCM.01062-15; Lole KS, 2003, J CLIN MICROBIOL, V41, P5240, DOI 10.1128/JCM.41.11.5240-5244.2003; Mahmud S, 2018, J MED VIROL, V90, P131, DOI 10.1002/jmv.24921; Murayama A, 2012, J CLIN MICROBIOL, V50, P1943, DOI 10.1128/JCM.00487-12; Ogata F, 2018, J MED VIROL, V90, P1087, DOI 10.1002/jmv.25047; Sharara AI, 2007, EPIDEMIOL INFECT, V135, P427, DOI 10.1017/S0950268806006911; Shemer-Avni Y, 1998, J MED VIROL, V56, P230, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;230::AID-JMV9&gt;3.0.CO;2-8; World Health Organization, GUID SCREEN CAR TREA; World Health Organization, 2017, GLOB HEP REP 2017 WH	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0222799	10.1371/journal.pone.0222799	http://dx.doi.org/10.1371/journal.pone.0222799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589628	gold, Green Published			2022-12-26	WOS:000532427300006
J	Chaves, MHM; Wolf, ARS; Nascimento, KAL; Nawcki, D; Feustel, GM; Bettega, PVC; Ignacio, SA; Brancher, JA; Tannous, LA; Werneck, RI; Souza, PHC; de Barros, MMT; Johann, ACBR				Madruga Chaves, Maria Heloisa; Silveira Wolf, Amanda Rebeca; Lima Nascimento, Kelly Aline; Nawcki, Danielle; Feustel, Gabriele Muller; Cassi Bettega, Patricia Vida; Ignacio, Sergio Aparecido; Brancher, Joao Armando; Tannous, Luana Alves; Werneck, Renata Iani; Couto Souza, Paulo Henrique; Tourais de Barros, Marlene Maria; Batista Rodrigues Johann, Aline Cristina			Sialochemical analysis in polytraumatized patients in intensive care units	PLOS ONE			English	Article							BLOOD-GLUCOSE MEASUREMENTS; CHRONIC HEALTH EVALUATION; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; TRAUMA PATIENTS; APACHE-II; ILL; BIOMARKERS; ACCURACY; CALCIUM	The profiles of polytraumatized patients in intensive care units were characterized. Serum and salivary markers were compared with normality between Classes I and II of APACHE II and between periods of hospitalization; these results were correlated. This was a prospective study on saliva charts and collection (n = 70). Profile: male, 27 years old, blunt traumas and collisions. Serum parameters with normality: decrease in pH, creatinine at admission to Class I, and at 48 and 72 hours in both classes; K+ at 48 h in Class II; Ca+ on admission in both classes and at 72 h in Class I. Increase in urea at 72 h in Class II, glucose at all times and in all classes, and Ca+ at 48 h in both classes. Class II had high Na+ at 48 and 72 h compared to Class I. In Class I, creatinine reduction occurred in 48 h and 72 h compared to admission and an increase of Ca+ at 48 h with admission. In Class II, pH and Na+ increased at 48 h and 72 h compared to admission. K+ decreased from admission to 48 h and increased from 48 h to 72 h. Urea increased from 48 to 72 hours. Creatinine decreased from admission to 48 and 72 hours. Ca+ increased from admission to 48 hours and decreased from 48 to 72 hours. There was an increase in the saliva levels in both classes and times in relation to normality. There was an increase in urea at admission, glucose at 72 h, and Ca+ at 48 h in Class II compared with Class I. Class I urea increased from admission to 48 h and Ca+ decreased from admission to 48 h. Class II urea decreased from 48 h to 72 h. Strong or very strong positive correlation was identified between blood and creatinine saliva at all times and regular and negative Ca+ at 72 h. This study provides evidence that salivary and serum biomarkers can be used together to monitor the evolution of the clinical symptoms of ICU patients.	[Madruga Chaves, Maria Heloisa; Silveira Wolf, Amanda Rebeca; Lima Nascimento, Kelly Aline; Nawcki, Danielle; Feustel, Gabriele Muller] Pontificia Univ Catolica Parana, Dept Nursing, Sch Life Sci, Curitiba, Parana, Brazil; [Cassi Bettega, Patricia Vida; Ignacio, Sergio Aparecido; Brancher, Joao Armando; Werneck, Renata Iani; Couto Souza, Paulo Henrique; Batista Rodrigues Johann, Aline Cristina] Pontificia Univ Catolica Parana, Sch Life Sci, Dept Dent, Curitiba, Parana, Brazil; [Tannous, Luana Alves] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil; [Tourais de Barros, Marlene Maria] Univ Catolica Portuguesa Viseu, Inst Ciencias Saude, Viseu, Portugal; [Madruga Chaves, Maria Heloisa; Silveira Wolf, Amanda Rebeca; Lima Nascimento, Kelly Aline; Nawcki, Danielle; Feustel, Gabriele Muller; Cassi Bettega, Patricia Vida; Ignacio, Sergio Aparecido; Brancher, Joao Armando; Tannous, Luana Alves; Werneck, Renata Iani; Couto Souza, Paulo Henrique; Batista Rodrigues Johann, Aline Cristina] Pontificia Univ Catolica Parana, Imaculada Conceicao, Curitiba, Parana, Brazil	Pontificia Universidade Catolica do Parana; Pontificia Universidade Catolica do Parana; Pontificia Universidade Catolica do Parana; Universidade Catolica Portuguesa; Pontificia Universidade Catolica do Parana	Johann, ACBR (corresponding author), Pontificia Univ Catolica Parana, Sch Life Sci, Dept Dent, Curitiba, Parana, Brazil.; Johann, ACBR (corresponding author), Pontificia Univ Catolica Parana, Imaculada Conceicao, Curitiba, Parana, Brazil.	aline.johann@pucpr.br	Barros, Marlene/AAG-6405-2021; Brancher, João Armando/AAQ-4858-2020; Couto Souza, Paulo Henrique/I-9989-2016; Batista Rodrigues Johann, Aline Cristina/G-7190-2012	Barros, Marlene/0000-0003-0631-4062; Brancher, João Armando/0000-0002-8914-702X; Couto Souza, Paulo Henrique/0000-0003-3655-397X; Batista Rodrigues Johann, Aline Cristina/0000-0002-1678-9363				American College of Surgeons, 2018, ADV TRAUM LIF SUPP A; [Anonymous], 2014, SOC BRAS AT INT TRAU; [Anonymous], 2003, REV MEX PATOL CLIN, V50, P209; Association of Brazilian Intensive Medicine Mechanical Ventilation Committee; Brazilian Society of Pulmonology and Tisiology SBPT Intensive Care Committee, 2013, BRAZ GUID MECH VENT; Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069; Bales ME, 2011, AM J PREV MED, V41, P112, DOI 10.1016/j.amepre.2011.03.018; Bartanusz V, 2014, J CLIN NEUROSCI, V21, P2150, DOI 10.1016/j.jocn.2014.04.018; Batista PBP, 1997, ACUTE RENAL FAILURE, P333; Bilancio G, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22449; BRUNNER R, 2012, CRIT CARE, V16, DOI DOI 10.1186/C011657; Canova JCM, 2010, ARQ CIENC SAUDE, V17, P9; Car MR, 1986, THESIS; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; Chiappelli F, 2006, BIOINFORMATION, V1, P331, DOI 10.6026/97320630001331; Cook A, 2009, AM J CRIT CARE, V18, P65, DOI 10.4037/ajcc2009626; Costa J I, 1999, Sao Paulo Med J, V117, P205; Couto RC, 2005, RATTON EMERGENCIAS M; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; DARWAZEH AMG, 1991, J ORAL PATHOL MED, V20, P280, DOI 10.1111/j.1600-0714.1991.tb00928.x; DAWES C, 1993, ANN NY ACAD SCI, V694, P265, DOI 10.1111/j.1749-6632.1993.tb18359.x; Diabetes in Control, 2017, SUMM ADAS NEW 2018 S; Evora PRB, 2008, MED RIB PRETO, V41, P301; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Flabouris A, 2000, ANAESTH INTENS CARE, V28, P562, DOI 10.1177/0310057X0002800515; Gamarra G, 1981, ACTA MED COLOMB, V6, P17; Garcia TPR., 2005, ARQ CIENC SAUDE, V12, P146; Greabu Maria, 2009, J Med Life, V2, P124; Gross T, 2010, J AM COLL SURGEONS, V211, P81, DOI 10.1016/j.jamcollsurg.2010.02.042; Guyton AC, 2006, TREATY MED PHYSL; HOLZINGER U, 2010, CARE, V33, P467, DOI DOI 10.2337/D009-1352; Ichai C, 2010, CRIT CARE, V14, DOI 10.1186/cc9258; Inoue S, 2013, CRIT CARE, V17, DOI 10.1186/cc12567; Inzucchi SE, 2009, NEW ENGL J MED, V360, P1346, DOI 10.1056/NEJMe0901507; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kellum JA, 2007, CRIT CARE MED, V35, P2630, DOI 10.1097/01.CCM.0000286399.21008.64; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kovalcikova A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200391; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krokoscz DVC, 2007, THESIS; Lima DP, 2014, REV REG ARACATUBA, V35, P55; Lima OPSC, 2008, READING INTERPRETATI; Mata AD, 2004, MOL CELL BIOCHEM, V261, P137, DOI 10.1023/B:MCBI.0000028748.40917.6f; Mehari SM, 1997, ANAESTH INTENS CARE, V25, P33, DOI 10.1177/0310057X9702500106; Melo REVAM, 2005, INT J DENT, V4, P31; Montori VM, 2002, JAMA-J AM MED ASSOC, V288, P2167, DOI 10.1001/jama.288.17.2167; Moura SAB, 2004, THESIS; Moura SAB, 2007, PESQUISA BRASILERIA, V7, P187, DOI 10.4034/pboci.v7i2.200; Ordonez CA, 2011, AM SURGEON, V77, P778; Palevsky Paul M, 2002, Curr Opin Crit Care, V8, P515, DOI 10.1097/00075198-200212000-00006; Polita JR, 2014, REV ASSOC MED BRAS, V60, P381, DOI 10.1590/1806-9282.60.04.018; dos Santos AMR, 2008, CAD SAUDE PUBLICA, V24, P1927, DOI 10.1590/S0102-311X2008000800021; Riella MC, 2003, PRINCIPLES NEPHROLOG; Rodrigues VP, 2016, ARCH ORAL BIOL, V62, P58, DOI 10.1016/j.archoralbio.2015.11.016; Santos AACS, 1999, PEDIATRICS, V2, P215; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Tolotti VC, 2004, REV CONTEXTO SAUDE, V4, P191, DOI [10.2152/2176-771142004.07.191-198, DOI 10.2152/2176-771142004.07.191-198]; Tranquitelli AM, 2007, REV ESC ENFERM USP, V41, P371, DOI 10.1590/S0080-62342007000300005; Tzira D, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118802452; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; WANG B, 2017, BIOMED RES INT, V2017, P1, DOI DOI 10.1155/2017/2569707; Webster S, 2016, EMERG MED J, V33, P569, DOI 10.1136/emermed-2015-205096; Wilson Jorge L, 2011, Rev. Col. Bras. Cir., V38, P122; World Health Organization, 2010, INJ VIOL FACTS; World Health Organization Pan American Health Organization Brazil [World Health Organization Pan American Health Organization Brazil], 2016, TRAUM KILL MOR THAN; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0; Zimmerman JE, 1997, CRIT CARE MED, V25, P737, DOI 10.1097/00003246-199705000-00006; 2018, DIABETES CARE S1, V41, pS1, DOI DOI 10.2337/DC18-6002	70	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222974	10.1371/journal.pone.0222974	http://dx.doi.org/10.1371/journal.pone.0222974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581248	gold, Green Published, Green Submitted			2022-12-26	WOS:000532398600024
J	Kobayashi, E; Sano, M				Kobayashi, Eiji; Sano, Motoaki			Organ preservation solution containing dissolved hydrogen gas from a hydrogen-absorbing alloy canister improves function of transplanted ischemic kidneys in miniature pigs	PLOS ONE			English	Article							VIVO LUNG PERFUSION; INTESTINAL GRAFT; COLD ISCHEMIA; RAT MODEL; INHALATION; REPERFUSION; INJURY; CLASSIFICATION; REJECTION	Various methods have been devised to dissolve hydrogen gas in organ preservation solutions, including use of a hydrogen gas cylinder, electrolysis, or a hydrogen-generating agent. However, these methods require considerable time and effort for preparation. We investigated a practical technique for rapidly dissolving hydrogen gas in organ preservation solutions by using a canister containing hydrogen-absorbing alloy. The efficacy of hydrogen-containing organ preservation solution created by this method was tested in a miniature pig model of kidney transplantation from donors with circulatory arrest. The time required for dissolution of hydrogen gas was only 2-3 minutes. When hydrogen gas was infused into a bag containing cold ETK organ preservation solution at a pressure of 0.06 MPa and the bag was subsequently opened to the air, the dissolved hydrogen concentration remained at 1.0 mg/L or more for 4 hours. After warm ischemic injury was induced by circulatory arrest for 30 minutes, donor kidneys were harvested and perfused for 5 minutes with hydrogen-containing cold ETK solution or hydrogen-free cold ETK solution. The perfusion rate was faster from the initial stage with hydrogen-containing cold ETK solution than with hydrogen-free ETK solution. After storage of the kidney in hydrogen-free preservation solution for 1 hour before transplantation, no urine production was observed and blood flow was not detected in the transplanted kidney at sacrifice on postoperative day 6. In contrast, after storage in hydrogen-containing preservation solution for either 1 or 4 hours, urine was detected in the bladder and blood flow was confirmed in the transplanted kidney. This method of dissolving hydrogen gas in organ preservation solution is a practical technique for potentially converting damaged organs to transplantable organs that can be used safely in any clinical setting where organs are removed from donors.	[Kobayashi, Eiji; Sano, Motoaki] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan; [Kobayashi, Eiji; Sano, Motoaki] Keio Univ, Ctr Mol Hydrogen Med, Tokyo, Japan	Keio University; Keio University; Keio University	Sano, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.; Sano, M (corresponding author), Keio Univ, Ctr Mol Hydrogen Med, Tokyo, Japan.	msano@a8.keio.jp	Sano, Motoaki/L-3405-2013	Sano, Motoaki/0000-0003-1771-8310	Doctors Man Co., Ltd.	Doctors Man Co., Ltd.	This study was funded by Doctors Man Co., Ltd. (to Eiji Kobayashi). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2012, TRANSPLANTATION, V94, P14, DOI 10.1097/TP.0b013e318255f8be; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Buchholz BM, 2011, TRANSPLANTATION, V92, P985, DOI 10.1097/TP.0b013e318230159d; Erpicum P, 2019, KIDNEY INT, V95, P693, DOI 10.1016/j.kint.2018.08.046; Haam S, 2018, J HEART LUNG TRANSPL, V37, P1271, DOI 10.1016/j.healun.2018.06.007; Haam S, 2015, EUR J CARDIO-THORAC, V48, P542, DOI 10.1093/ejcts/ezv057; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Ishikawa T, 2018, SURG TODAY, V48, P1081, DOI 10.1007/s00595-018-1693-0; Iwai S, 2014, TRANSPL P, V46, P1578, DOI 10.1016/j.transproceed.2013.12.068; Iwai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033157; Kaimori JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063573; Katsumata Y, 2017, CIRC J, V81, P940, DOI 10.1253/circj.CJ-17-0105; Kawamura T, 2011, SURGERY, V150, P240, DOI 10.1016/j.surg.2011.05.019; Kawamura T, 2010, TRANSPLANTATION, V90, P1344, DOI 10.1097/TP.0b013e3181fe1357; Kobayashi E, 2019, TRANSPLANT DIRECT, V5, DOI 10.1097/TXD.0000000000000882; Loupy A, 2017, AM J TRANSPLANT, V17, P28, DOI 10.1111/ajt.14107; Matsuoka T, 2017, J TRAUMA ACUTE CARE, V83, P469, DOI 10.1097/TA.0000000000001620; Meng C, 2016, LIFE SCI, V151, P199, DOI 10.1016/j.lfs.2016.03.015; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Noda K, 2014, TRANSPLANTATION, V98, P499, DOI 10.1097/TP.0000000000000254; Noda K, 2013, J HEART LUNG TRANSPL, V32, P241, DOI 10.1016/j.healun.2012.11.004; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Shimada S, 2016, ARTIF ORGANS, V40, P1128, DOI 10.1111/aor.12710; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Tamaki I, 2018, LIVER TRANSPLANT, V24, P1589, DOI 10.1002/lt.25326; Tan MW, 2013, INT J CARDIOL, V167, P383, DOI 10.1016/j.ijcard.2011.12.109; Tohyama S, 2019, CELL TRANSPLANT, V28, P224, DOI 10.1177/0963689718817477; Torai S, 2019, TRANSPL P, V51, P1442, DOI 10.1016/j.transproceed.2019.01.136; Uto K, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0939-7; Wamser P, 2003, TRANSPL INT, V16, P191, DOI 10.1111/j.1432-2277.2003.tb00285.x; Yamada Takuya, 2014, ScientificWorldJournal, V2014, P109876, DOI 10.1155/2014/109876; Zhou HC, 2013, J HEART LUNG TRANSPL, V32, P251, DOI 10.1016/j.healun.2012.11.007	33	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222863	10.1371/journal.pone.0222863	http://dx.doi.org/10.1371/journal.pone.0222863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574107	Green Submitted, Green Published, gold			2022-12-26	WOS:000532376700017
J	Telfer, E; Graham, N; Macdonald, L; Li, YJ; Klapste, J; Resende, M; Neves, LG; Dungey, H; Wilcox, P				Telfer, Emily; Graham, Natalie; Macdonald, Lucy; Li, Yongjun; Klapste, Jaroslav; Resende, Marcio, Jr.; Neves, Leandro Gomide; Dungey, Heidi; Wilcox, Phillip			A high-density exome capture genotype-by-sequencing panel for forestry breeding in Pinus radiata	PLOS ONE			English	Article							WOOD PROPERTIES; LINKAGE DISEQUILIBRIUM; ALLELIC VARIATION; GENOME; MICROSATELLITES; SINGLE; IDENTIFICATION; ASSOCIATION; RESISTANCE; RESOURCES	Development of genome-wide resources for application in genomic selection or genome-wide association studies, in the absence of full reference genomes, present a challenge to the forestry industry, where longer breeding cycles could benefit from the accelerated selection possible through marker-based breeding value predictions. In particular, large conifer megagenomes require a strategy to reduce complexity, whilst ensuring genome-wide coverage is achieved. Using a transcriptome-based reference template, we have successfully developed a high density exome capture genotype-by-sequencing panel for radiata pine (Pinus radiata D.Don), capable of capturing in excess of 80,000 single nucleotide polymorphism (SNP) markers with a minor allele frequency above 0.03 in the population tested. This represents approximately 29,000 gene models from a core set of 48,914 probes. A set of 704 SNP markers capable of pedigree reconstruction and differentiating individual genotypes were tested within two full-sib mapping populations. While as few as 70 markers could reconstruct parentage in almost all cases, the impact of missing genotypes was noticeable in several offspring. Therefore, 60 sets of 110 randomly selected SNP markers were compared for both parentage reconstruction and clone differentiation. The performance in parentage reconstruction showed little variation over 60 iterations. However, there was notable variation in discriminatory power between closely related individuals, indicating a higher density SNP marker panel may be required to elucidate hidden relationships in complex pedigrees.	[Telfer, Emily; Graham, Natalie; Macdonald, Lucy; Li, Yongjun; Klapste, Jaroslav; Dungey, Heidi] New Zealand Forest Res Inst LTD Trading Scion, Rotorua, New Zealand; [Resende, Marcio, Jr.] Univ Florida, Hort Sci, Gainesville, FL USA; [Resende, Marcio, Jr.; Neves, Leandro Gomide] RAPiD Genom LLC, Gainesville, FL USA; [Wilcox, Phillip] Univ Otago, Dept Math & Stat, Dunedin, New Zealand; [Li, Yongjun] Agr Victoria, Agr Res Div, AgriBio Ctr, 5 Ring Rd, Bundoora, Vic 3083, Australia	State University System of Florida; University of Florida; University of Otago	Telfer, E (corresponding author), New Zealand Forest Res Inst LTD Trading Scion, Rotorua, New Zealand.	emily.telfer@scionresearch.com	Klapste, Jaroslav/B-6668-2016	Klapste, Jaroslav/0000-0001-5504-3735; Telfer, Emily/0000-0001-5269-6589; Dungey, Heidi/0000-0003-2589-3928; Resende Jr., Marcio/0000-0002-2367-0766; Graham, Natalie/0000-0002-0676-8403	New Zealand Ministry of Business, Innovation and Employment [RPBC1301]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work has been funded through the New Zealand Ministry of Business, Innovation and Employment, awarded to the Radiata Pine Breeding Company contract number RPBC1301. Two authors (LGN and MRJr) are affiliated with RAPiD Genomics LLC and undertook probe design with input from the remaining authors, and dataset generation. The New Zealand Ministry of Business, Innovation and Employment provided support in the form of salaries, at the time of the study, for authors [ET, NG, LM, JK, YL, HD, PW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Affymetrix, AFF MY GENECHIP CUST; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Bradshaw RE, 2004, FOREST PATHOL, V34, P163, DOI 10.1111/j.1439-0329.2004.00356.x; Burdon R, 2017, DOMESTICATION RADIAT, V83; Campbell MR, 2019, T AM FISHERIES SOC; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; Castedo-Dorado F, 2016, NZ J FORESTRY SCI, V46, DOI 10.1186/s40490-016-0074-y; Crawley MJ, 2005, STAT INTRO USING R; Dick MA, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0006-7; Dillon SK, 2010, AUST FORESTRY, V73, P185, DOI 10.1080/00049158.2010.10676326; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Dungey Heidi, 2015, New Zealand Journal of Forestry, V60, P12; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Eliott F., 2005, Forest Genetics, V12, P81; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Espinoza SE, 2016, ANN FOREST SCI, V73, P267, DOI 10.1007/s13595-015-0498-1; Faivre-Rampant P, 2016, MOL ECOL RESOUR, V16, P1023, DOI 10.1111/1755-0998.12513; Fisher PJ, 1998, THEOR APPL GENET, V96, P969, DOI 10.1007/s001220050828; Forest Owners Association, 2016, FACTS FIG; Frewen BE, 2000, GENETICS, V154, P837; Garrison E, 2012, HAPLOTYPE BASED VARI; Gomory D., 2000, Forest Genetics, V7, P65; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hansen OK, 2006, CAN J FOREST RES, V36, P1054, DOI 10.1139/X05-299; Howe GT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-137; Illumina, INF ISELECT HD HTS C; Illumina, GEN DAT AN SOFTW; Isik F, 2014, NEW FOREST, V45, P379, DOI 10.1007/s11056-014-9422-z; Jacobs MD, 2000, PLANT SYST EVOL, V223, P71, DOI 10.1007/BF00985327; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Kirst M., 2014, PLANT ANIMAL GENOME; Kiyotani K, 2017, J HUM GENET, V62, P397, DOI 10.1038/jhg.2016.141; Klapste J, 2018, J HERED, V109, P802, DOI 10.1093/jhered/esy051; Leache AD, 2017, ANNU REV ECOL EVOL S, V48, P69, DOI 10.1146/annurev-ecolsys-110316-022645; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Lepoittevin C, 2012, TREE GENET GENOMES, V8, P113, DOI 10.1007/s11295-011-0426-y; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058677; Li Y, BMC GENOMICS; Li YJ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1019-6; Liu JJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3079-2; Liu T, 2017, AQUACULT INT, V25, P1507, DOI 10.1007/s10499-017-0127-0; Lu MM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3081-8; Meuwissen THE, 2001, GENETICS, V157, P1819; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Moriguchi Y., 2005, Journal of the Japanese Forest Society, V87, P161; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; Southerton SG, 2010, AUST FORESTRY, V73, P259, DOI 10.1080/00049158.2010.10676337; Stevens KA, 2016, GENETICS, V204, P1613, DOI 10.1534/genetics.116.193227; Storer AJ, 1999, FOREST SCI, V45, P500; Tchin B. L., 2011, Biotechnology, V10, P303; Telfer E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205835; Telfer E, 2013, NEW ZEAL J FOR SCI, V43, DOI 10.1186/1179-5395-43-3; Telfer EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130601; Thistlethwaite FR, 2019, HEREDITY, P1; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Ooijen J., 2006, KYAZMA BV WAGENINGEN, V33, P1371, DOI DOI 10.1016/J.ACTBIO.2006.02.004; Vidalis A., 2018, BIORXIV; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Wilcox P. L., 2001, FOR GENET, V8, P111; Xue JM, 2013, J PLANT NUTR SOIL SC, V176, P724, DOI 10.1002/jpln.201200272; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	71	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222640	10.1371/journal.pone.0222640	http://dx.doi.org/10.1371/journal.pone.0222640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568509	Green Published, gold			2022-12-26	WOS:000532364900006
J	Borghezan, ED; Pinto, KD; Zuanon, J; Pires, THD				Borghezan, Elio de Almeida; Pinto, Kalebe da Silva; Zuanon, Jansen; da Silva Pires, Tiago Henrique			Someone like me: Size-assortative pairing and mating in an Amazonian fish, sailfin tetra Crenuchus spilurus	PLOS ONE			English	Article							FEMALE MATE CHOICE; MALE-MALE COMPETITION; BODY-SIZE; FILIAL CANNIBALISM; LIFE-HISTORY; PHENOTYPIC PLASTICITY; SEXUAL SELECTION; PREDATION RISK; LOW-QUALITY; PREFERENCE	In the absence of constraints, preference for larger mates is expected to evolve, as larger individuals are typical of higher potential fitness. Large females are often more fecund and carry larger eggs (which result in higher number and better quality of offspring), whereas large males usually have more conspicuous ornaments and are better at defending resources. However, intrasexual competition can constrain the access to larger partners, especially when opportunities for mate takeover abound. Here we investigate the relationship between individual's size and mate choice in relation to one's own size and their respective mate's size using the sailfin tetra, a sexually dimorphic Amazonian fish species. We show that ornaments of larger males are exponentially more conspicuous, and larger females are more fecund and carry larger eggs. Contrary to expectation, neither males nor females associated for longer with the larger of two offered potential mates. Instead, individuals of both genders chose opposite-sex individuals of similar sizes to themselves. Additionally, similar-sized pairs were more likely to spawn than couples with higher size asymmetries. Grounded on field observations, we propose that prudent choice should be particularly important in this system, since courtship is long (often taking several days), which offers opportunities for mate takeover. Intrasexual competition, however, cannot readily explain female choice for similar-sized males. We thus suggest that such preference might be best explained by avoidance of filial cannibalism.	[Borghezan, Elio de Almeida; Pinto, Kalebe da Silva; Zuanon, Jansen; da Silva Pires, Tiago Henrique] Inst Nacl de Pesquisas da Amazonia, Lab Ecol Comportamental & Evolucao, Av Andre Araujo, Manaus, Amazonas, Brazil; [Borghezan, Elio de Almeida] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan	Institute Nacional de Pesquisas da Amazonia; Kyoto University	Borghezan, ED (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Ecol Comportamental & Evolucao, Av Andre Araujo, Manaus, Amazonas, Brazil.; Borghezan, ED (corresponding author), Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan.	borghezan.ea@gmail.com	Borghezan, Elio/N-6125-2019; Zuanon, Jansen A. S./E-5791-2013	Borghezan, Elio/0000-0002-3239-8557; Zuanon, Jansen A. S./0000-0001-8354-2750; Pires, Tiago/0000-0002-4095-7777	CNPq [313183/2014-7, 313999/2017-1]; MEXT (Monbukagakusho) [183957]; FIXAM/FAPEAM [005/2018]; CAPES; Japan Science and Technology Agency/Japan International Cooperation Agency; Science and Technology Research Partnership for Sustainable Development	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MEXT (Monbukagakusho)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FIXAM/FAPEAM; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Japan Science and Technology Agency/Japan International Cooperation Agency; Science and Technology Research Partnership for Sustainable Development(Japan Science & Technology Agency (JST))	We are thankful to CNPq for financial support to KSP and THSP, and for supporting JZ with a productivity grant (#313183/2014-7) and for providing EAB with a research grant (#313999/2017-1). EAB is grateful to MEXT (Monbukagakusho #183957). THSP is thankful to FIXAM/FAPEAM (005/2018). We also thank CAPES for providing scholarships and to Japan Science and Technology Agency/Japan International Cooperation Agency; Science and Technology Research Partnership for Sustainable Development for financing this study. This is contribution #60 of Projeto Igarape ' s. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Franziska Schaedelin, Francois-Xavier Dechaume-Moncharmont, David Saenz, Luke Bower, Gabriel Stefanelli-Silva, Matthew Grober and an anonymous reviewer for constructive criticisms and review. We thank Daniele Campos for the measurements of fecundity and oocyte diameter.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Andersson Malte, 1994; Baldauf SA, 2011, BEHAV ECOL, V22, P478, DOI 10.1093/beheco/arq226; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; BASOLO A, 1990, ANIM BEHAV, V40, P339; Bel-Venner MC, 2008, P ROY SOC B-BIOL SCI, V275, P77, DOI 10.1098/rspb.2007.1278; Bel-Venner MC, 2006, ANIM BEHAV, V71, P1315, DOI 10.1016/j.anbehav.2005.08.010; BISAZZA A, 1988, ANIM BEHAV, V36, P1352, DOI 10.1016/S0003-3472(88)80204-5; BISCHOFF RJ, 1985, BEHAV ECOL SOCIOBIOL, V17, P253, DOI 10.1007/BF00300143; Bortolottia GR, 2008, BEHAV PROCESS, V78, P100, DOI 10.1016/j.beproc.2008.01.007; Briffa M, 2010, ANIM BEHAV, V80, P583, DOI 10.1016/j.anbehav.2010.06.009; BROWN WD, 1990, ANIM BEHAV, V40, P901, DOI 10.1016/S0003-3472(05)80992-3; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; COTE IM, 1989, ANIM BEHAV, V38, P78, DOI 10.1016/S0003-3472(89)80067-3; CRESPI BJ, 1989, ANIM BEHAV, V38, P980, DOI 10.1016/S0003-3472(89)80138-1; Darwin C., 1871, P423; de Merona B, 2009, NEOTROP ICHTHYOL, V7, P683, DOI 10.1590/S1679-62252009000400018; Dechaume-Moncharmont FX, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-69; Dechaume-Moncharmont FX, 2011, CR BIOL, V334, P906, DOI 10.1016/j.crvi.2011.08.004; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Dougherty LR, 2015, BEHAV ECOL, V26, P311, DOI 10.1093/beheco/aru125; Duponchelle F, 2007, J FISH BIOL, V71, P1113, DOI 10.1111/j.1095-8649.2007.01583.x; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; ELWOOD R, 1987, ANIM BEHAV, V35, P1, DOI 10.1016/S0003-3472(87)80203-8; Fawcett TW, 2003, BEHAV ECOL, V14, P771, DOI 10.1093/beheco/arg075; Ferrer M, 2003, ANIM BEHAV, V66, P137, DOI 10.1006/anbe.2003.2158; FITZGERALD GJ, 1992, TRENDS ECOL EVOL, V7, P7, DOI 10.1016/0169-5347(92)90190-M; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Franceschi N, 2010, ANIM BEHAV, V79, P911, DOI 10.1016/j.anbehav.2010.01.002; Freyhof J., 1988, Aquarien- und Terrarien-Zeitschrift, V41, P209; Gabor C, 1999, BEHAV ECOL SOCIOBIOL, V46, P333, DOI 10.1007/s002650050627; Gagliardi-Seeley JL, 2006, J FISH BIOL, V69, P1239, DOI 10.1111/j.1095-8649.2006.01174.x; Galipaud M, 2013, ANIM BEHAV, V85, P35, DOI 10.1016/j.anbehav.2012.09.038; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Harari AR, 1999, ANIM BEHAV, V58, P1191, DOI 10.1006/anbe.1999.1257; Hardling R, 2005, EVOL ECOL RES, V7, P697; Helfenstein F, 2004, WATERBIRDS, V27, P350, DOI 10.1675/1524-4695(2004)027[0350:AMASSD]2.0.CO;2; Henry LM, 2008, BIOL LETTERS, V4, P508, DOI 10.1098/rsbl.2008.0369; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hume KD, 2002, ANIM BEHAV, V64, P239, DOI 10.1006/anbe.2002.3045; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kidd MR, 2013, GEN COMP ENDOCR, V180, P56, DOI 10.1016/j.ygcen.2012.10.014; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; LEBOEUF BJ, 1974, AM ZOOL, V14, P163; Lindstrom K, 2000, EVOLUTION, V54, P617, DOI 10.1111/j.0014-3820.2000.tb00063.x; Lochmatter T, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P4004, DOI 10.1109/IROS.2008.4650937; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; Manica A, 2002, BEHAV ECOL SOCIOBIOL, V51, P319, DOI 10.1007/s00265-001-0444-0; Masonjones HD, 1996, COPEIA, P634, DOI 10.2307/1447527; Michiels NK, 2001, BEHAV ECOL, V12, P612, DOI 10.1093/beheco/12.5.612; Oliveira RF, 2000, J FISH BIOL, V57, P1416; OLSSON M, 1993, BEHAV ECOL SOCIOBIOL, V32, P337; Pack AA, 2012, ANIM BEHAV, V84, P983, DOI 10.1016/j.anbehav.2012.07.024; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P315, DOI 10.1098/rspb.1996.0048; PETERSEN CW, 1989, EVOLUTION, V43, P158, DOI 10.1111/j.1558-5646.1989.tb04214.x; Pires THS, 2019, BIOL J LINN SOC, V127, P351, DOI 10.1093/biolinnean/blz054; Pires THS, 2018, J EVOLUTION BIOL, V31, P882, DOI 10.1111/jeb.13272; Pires THS, 2016, ENVIRON BIOL FISH, V99, P925, DOI 10.1007/s10641-016-0534-5; Prum RO, 2012, PHILOS T R SOC B, V367, P2253, DOI 10.1098/rstb.2011.0285; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; R Core Team, 2018, R LANG ENV STAT COMP; RIDLEY M, 1979, Z TIERPSYCHOL, V51, P380; Rosenthal G, 2017, MATE CHOICE; Rosenthal GG, 2002, ANIM BEHAV, V63, P37, DOI 10.1006/anbe.2001.1887; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; ROWLAND WJ, 1989, ANIM BEHAV, V37, P282, DOI 10.1016/0003-3472(89)90117-6; Sacchi R, 2009, AGGRESSIVE BEHAV, V35, P274, DOI 10.1002/ab.20305; Shine R, 2001, ANIM BEHAV, V61, P1133, DOI 10.1006/anbe.2001.1712; Stefanelli-Silva G, 2019, HYDROBIOLOGIA, V830, P151, DOI 10.1007/s10750-018-3860-0; Taborsky B, 2014, J EVOLUTION BIOL, V27, P1217, DOI 10.1111/jeb.12398; Taborsky B, 2009, ANIM BEHAV, V77, P439, DOI 10.1016/j.anbehav.2008.10.020; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Venner S, 2010, AM NAT, V175, P650, DOI 10.1086/652432; Wada S, 2011, BEHAV ECOL, V22, P114, DOI 10.1093/beheco/arq183; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Werner NY, 2003, ANIM BEHAV, V66, P293, DOI 10.1006/anbe.2003.2208; Whiteman EA, 2003, ANIM BEHAV, V66, P281, DOI 10.1006/anbe.2003.2200; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809	88	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222880	10.1371/journal.pone.0222880	http://dx.doi.org/10.1371/journal.pone.0222880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6IT	31560725	Green Published, gold			2022-12-26	WOS:000532353700023
J	Nell, C; Bulow, R; Hosten, N; Schmidt, CO; Hegenscheid, K				Nell, Christopher; Buelow, Robin; Hosten, Norbert; Schmidt, Carsten Oliver; Hegenscheid, Katrin			Reference values for the cervical spinal canal and the vertebral bodies by MRI in a general population	PLOS ONE			English	Article							STENOSIS; CORD; PREVALENCE; NEURAPRAXIA; MYELOPATHY; DIAMETER; RATIO; AGE	Purpose To provide population-based reference values for cervical spinal canal parameters and vertebral body (VB) width and to study their associations with sex, age, body height, body weight and body mass index (BMI) using MRI. Methods Cross-sectional analyses included data from 2,453 participants, aged 21-89 years, of the population-based Study of Health in Pomerania (SHIP) who underwent whole-body MRI at 1.5 Tesla between July 2008 and March 2011. A standardised reading was performed for the C2-C7 cervical spine levels at sagittal T2 TSE weighted sequences. Results Reference intervals for spinal canal parameters were similar in males and females, while VB width was on average 2.1-2.2 mm larger in males. Age effects were only substantial regarding VB width with a 0.5 mm per ten-year age increase. Body height effects were only substantial regarding the osseous spinal canal and VB width. Body weight and BMI effects are mostly not substantial. Conclusions Our study provides MRI-based reference values for the cervical spinal canal parameters in an adult Caucasian population. Except for VB width, associations with sex, age and somatometric measures are mostly small and thus have only limited clinical implications. Some available cut-off values may need a revision because they likely overestimate risks.	[Nell, Christopher; Buelow, Robin; Hosten, Norbert; Hegenscheid, Katrin] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Wes, Germany; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, Greifswald, Mecklenburg Wes, Germany	Greifswald Medical School; Greifswald Medical School	Nell, C (corresponding author), Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Wes, Germany.	nellc@uni-greifswald.de	Schmidt, Carsten Oliver/AAH-2778-2019	Schmidt, Carsten Oliver/0000-0001-5266-9396	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF) [01ZZ0701, 01ZZ96030]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation) [393148499]; University of Greifswald	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation)(German Research Foundation (DFG)); University of Greifswald	SHIP is part of the Community Medicine Research network of the University of Greifswald which is funded by the Federal Ministry of Education and Research (www.bmbf.de/en/index.html, 01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012), the Ministry of Cultural Affairs (www.regierung-mv.de/Landesregierung/bm) as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (www.regierungmv.de/Landesregierung/sm) and the German Federal Ministry of Education and Research (BMBF, grant 01ZZ96030, 01ZZ0701). Wholebody MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. We also acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebli N, 2013, SPINE J, V13, P597, DOI 10.1016/j.spinee.2013.02.006; Busija L, 2011, ARTHRIT CARE RES, V63, pS383, DOI 10.1002/acr.20541; Countee R W, 1979, J Natl Med Assoc, V71, P257; Cushnie D, 2018, SPINE J, V18, P407, DOI 10.1016/j.spinee.2017.07.177; EPSTEIN NE, 1984, NEUROSURGERY, V15, P489, DOI 10.1227/00006123-198410000-00003; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Fries P, 2008, SEMIN MUSCULOSKEL R, V12, P238, DOI 10.1055/s-0028-1083107; Goto S, 2010, J ORTHOP SCI, V15, P97, DOI 10.1007/s00776-009-1427-7; Grasbeck R., 2008, MCGRAW HILL YB SCI T, P286; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; Hukuda S, 2002, SPINE, V27, P250, DOI 10.1097/00007632-200202010-00009; Ishikawa M, 2003, SPINAL CORD, V41, P159, DOI 10.1038/sj.sc.3101375; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Lee MJ, 2007, J BONE JOINT SURG AM, V89A, P376, DOI 10.2106/JBJS.F.00437; Lindberg PG, 2012, J NEURORADIOLOGY, V39, P236, DOI 10.1016/j.neurad.2011.09.004; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Morishita Y, 2009, EUR SPINE J, V18, P877, DOI 10.1007/s00586-009-0968-y; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; OKADA Y, 1994, SPINE, V19, P2331, DOI 10.1097/00007632-199410150-00014; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Phalke VV, 2006, NEUROIMAG CLIN N AM, V16, P241, DOI 10.1016/j.nic.2006.02.005; Prasad SS, 2003, SPINE, V28, P1263, DOI 10.1097/00007632-200306150-00009; Premchandran D, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/8448.5097; Royston P., 2008, MULTIVARIABLE MODEL; Sasiadek MJ, 2012, ADV CLIN EXP MED, V21, P133; Schmidt CO, 2015, EUR J EPIDEMIOL, P1, DOI [10.1007/s10654-015-9996-6, DOI 10.1007/S10654-015-9996-6]; Schmidt GP, 2007, INVEST RADIOL, V42, P449, DOI 10.1097/01.rli.0000262089.55618.18; Shapiro M, 2012, NEUROIMAG CLIN N AM, V22, P315, DOI 10.1016/j.nic.2012.03.001; Tang YC, 2014, CHINESE MED J-PEKING, V127, P3857, DOI 10.3760/cma.j.issn.0366-6999.20141653; Tatarek Nancy E, 2005, Spine J, V5, P623, DOI 10.1016/j.spinee.2005.07.009; Tierney RT, 2002, J ATHL TRAINING, V37, P190; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222682	10.1371/journal.pone.0222682	http://dx.doi.org/10.1371/journal.pone.0222682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560692	gold, Green Published			2022-12-26	WOS:000532353700019
J	Machts, R; Hunold, A; Drebenstedt, C; Rock, M; Leu, C; Haueisen, J				Machts, Rene; Hunold, Alexander; Drebenstedt, Christian; Rock, Michael; Leu, Carsten; Haueisen, Jens			Measurement and analysis of partial lightning currents in a head phantom	PLOS ONE			English	Article							INJURIES	Direct lightning strikes to the human head can lead to various effects, ranging from burnings to death. The biological and physical mechanisms of a direct lightning strike in the human head are not well understood. The aim of this paper is to design an experimental setup to measure the spatial and temporal current distribution during a direct lightning strike to physical head phantoms to establish normative values for personal lightning protection equipment design and testing. We created head phantoms made of agarose, replicating the geometric and dielectric properties of scalp, skull, and intracranial volume. The bases of the three compartments were galvanically contacted via copper electrodes to measure the current per compartment. We used pulse generators to apply aperiodic voltage and current signals that modelled lightning components. Our experiments indicated that the scalp compartment was exposed to the current with a fraction of 80-90%. The brain and skull compartments were exposed between 6-13% and 3-6% of the total measured current respectively. In case of a flashover, most of the current (98-99%) flowed through the discharge channel. Unlike previous theoretical estimates and measurements in technical setups, we observed considerably longer times for the flashover to build up. In our experiments, the time to build up a fully formed flashover varied from approximately 30-700 mu s. The observed current patterns in cases without and with flashover provided information on regions of possible damage in the human head. Consequently, we identified the phenomenon of a flashover as a potential mechanism for humans to survive a lightning strike. Our measured current distributions and amplitudes formed the base for normative values, which can be used in later experimental investigations regarding the possibilities of individual lightning protection equipment for humans.	[Machts, Rene; Hunold, Alexander; Haueisen, Jens] Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany; [Drebenstedt, Christian; Rock, Michael] Tech Univ Ilmenau, Grp Lightning & Overvoltage Protect, Ilmenau, Germany; [Leu, Carsten] Tech Univ Ilmenau, Res Unit High Voltage Technol, Ilmenau, Germany	Technische Universitat Ilmenau; Technische Universitat Ilmenau; Technische Universitat Ilmenau	Machts, R (corresponding author), Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany.	rene.machts@tu-ilmenau.de	Haueisen, Jens/B-7183-2011	Haueisen, Jens/0000-0003-3871-2890; Machts, Rene/0000-0002-9155-5639	Carl Zeiss foundation (Stuttgart, Germany); European Union [686865]; German Research Foundation (DFG); Open Access Publication Fund of the Technische Universitat Ilmenau	Carl Zeiss foundation (Stuttgart, Germany); European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the Technische Universitat Ilmenau	The authors thank the Carl Zeiss foundation (Stuttgart, Germany) for funding this work. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 686865 (project BREAKBEN). We acknowledge support for the Article Processing Charge by the German Research Foundation (DFG) and the Open Access Publication Fund of the Technische Universitat Ilmenau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov GS, 1996, BURNS, V22, P602, DOI 10.1016/S0305-4179(96)00055-1; Andrews CJ, 2017, NEURAL REGEN RES, V12, P677, DOI 10.4103/1673-5374.206636; Andrews CJ, 1992, ELECT MED LEGAL ASPE; [Anonymous], 2018, 11495201811 DIN EN, DOI [10.31030/2826749, DOI 10.31030/2826749]; [Anonymous], 2013, 623052013 IEC; [Anonymous], 2014, 61000452014 IEC; Bazelian EM, 1998, SPARK DISCHARGE, P256; Bhatt DL, 1990, PLASTIC RECON STRUCT, DOI [10.1097/00006534-199007000-00001, DOI 10.1097/00006534-199007000-00001]; Bier M, 2005, NEUROREHABILITATION, V20, P53; Birgersson U, 2011, PHYSIOL MEAS, V32, P1, DOI 10.1088/0967-3334/32/1/001; Cooper MA, 2019, SPRINGER NAT HAZARDS, P1, DOI 10.1007/978-3-319-77563-0; COOPER MA, 1980, ANN EMERG MED, V9, P134, DOI 10.1016/S0196-0644(80)80268-X; Cooray V., 2015, INTRO LIGHTNING; Elsom DM, 2001, ATMOS RES, V56, P325, DOI 10.1016/S0169-8095(00)00083-1; Elsom DM, 1996, INT J METEOROL, V21, P197; Freeman CB, 2004, AM J NEURORADIOL, V25, P851; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Kind D., 2016, PROC 33 INT C LIGHTN, P1, DOI [10.1109/ICLP.2016.7791358, DOI 10.1109/ICLP.2016.7791358]; Kitagawa N., 1985, Conference Proceedings. ICLP '85: 18th International Conference on Lightning Protection, P435; Kuffel E., 2000, HIGH VOLTAGE ENG FUN, V2nd; Lee RC, 1997, CURR PROB SURG, V34, P682, DOI 10.1016/S0011-3840(97)80007-X; Machts R, 2016, IEEE ENG MED BIO, P3590, DOI 10.1109/EMBC.2016.7591504; MANN H, 1983, AM J NEURORADIOL, V4, P976; Mikhailov M, 2016, ROUTL CORP LINGUIST, P60; Oftering HP, 2018, INT CONF HIGH VOLTA; Price TG, 2013, ELECT LIGHTNING INJU; Rakov VA, 2006, LIGHTNING PHYS EFFEC; Sperandio M, 2012, IEEE T BIO-MED ENG, V59, P383, DOI 10.1109/TBME.2011.2173197; STANLEY LD, 1985, NEUROSURGERY, V16, P686, DOI 10.1227/00006123-198505000-00020; Tidswell AT, 2003, PHYSIOL MEAS, V24, P527, DOI 10.1088/0967-3334/24/2/363; Uman M., 2010, ART SCI LIGHTNING PR; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741; Zack F., 2007, DEUT ARZTEBLATT, V104, P3545, DOI DOI 10.3238/ARZTEBL.2008.0224A	34	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223133	10.1371/journal.pone.0223133	http://dx.doi.org/10.1371/journal.pone.0223133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557252	gold, Green Published			2022-12-26	WOS:000532345500078
J	Odoyo-June, E; Owuor, N; Kassim, S; Davis, S; Agot, K; Serrem, K; Otieno, G; Awori, Q; Hines, J; Toledo, C; Laube, C; Kisia, C; Aoko, A; Ojiambo, V; Mwandi, Z; Juma, A; Kigen, B				Odoyo-June, Elijah; Owuor, Nandi; Kassim, Saida; Davis, Stephanie; Agot, Kawango; Serrem, Kennedy; Otieno, George; Awori, Quentin; Hines, Jonas; Toledo, Carlos; Laube, Catey; Kisia, Christine; Aoko, Appolonia; Ojiambo, Vincent; Mwandi, Zebedee; Juma, Ambrose; Kigen, Bartilol			Rollout of ShangRing circumcision with active surveillance for adverse events and monitoring for uptake in Kenya	PLOS ONE			English	Article							ADULT MALE CIRCUMCISION; RING; SAFETY; TRIAL	Introduction Since 2011, Kenya has been evaluating ShangRing device for use in its voluntary medical male circumcision (VMMC) program according to World Health Organization (WHO) guidelines. Compared to conventional surgical circumcision, the ShangRing procedure is shorter, does not require suturing and gives better cosmetic outcomes. After a pilot evaluation of ShangRing in 2011, Kenya conducted an active surveillance for adverse events associated with its use from 2016-2018 to further assess its safety, uptake and to identify any operational bottlenecks to its widespread use based on data from a larger pool of procedures in routine health care settings. Methods From December 2017 to August 2018, HIV-negative VMMC clients aged 13 years or older seeking VMMC at six sites across five counties in Kenya were offered ShangRing under injectable local anesthetic as an alternative to conventional surgical circumcision. Providers described both procedures to clients before letting them make a choice. Outcome measures recorded for clients who chose ShangRing included the proportions who were clinically eligible, had successful device placement, experienced adverse events (AEs), or failed to return for device removal. Clients failing to return for follow up were sought through phone calls, text messages or home visits to ensure removal and complete information on adverse events. Results Out of 3,692 eligible clients 1,079 (29.2%) chose ShangRing; of these, 11 (1.0%) were excluded due to ongoing clinical conditions, 17 (1.6%) underwent conventional surgery due to lack of appropriate device size at the time of the procedure, 97.3% (1051/1079) had ShangRing placement. Uptake of ShangRing varied from 11% to 97% across different sites. There was one severe AE, a failed ShangRing placement (0.1%) managed by conventional wound suturing, plus two moderate AEs (0.2%), post removal wound dehiscence and bleeding, that resolved without sequelae. The overall AE rate was 0.3%. All clients returned for device removal from fifth to eleventh day after placement. Conclusion ShangRing circumcision is effective and safe in the Kenyan context but its uptake varies widely in different settings. It should be rolled out under programmatic implementation for eligible males to take advantage of its unique benefits and the freedom of choice beyond conventional surgical MMC. Public education on its availability and unique advantages is necessary to optimize its uptake and to actualize the benefit of its inclusion in VMMC programs.	[Odoyo-June, Elijah; Aoko, Appolonia] US Ctr Dis Control & Prevent, Div Global HIV & TB, Kisumu, Kenya; [Owuor, Nandi; Laube, Catey; Mwandi, Zebedee] Jhpiego, Nairobi, Kenya; [Kassim, Saida; Serrem, Kennedy; Juma, Ambrose; Kigen, Bartilol] Minist Hlth, MOH NASCOP Natl STD AIDS Control Program, Nairobi, Kenya; [Davis, Stephanie; Hines, Jonas; Toledo, Carlos] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Otieno, George] Univ Maryland Baltimore, Migori, Kenya; [Awori, Quentin] Populat Council Engender Hlth, Nairobi, Kenya; [Kisia, Christine] WHO Kenya Off, Nairobi, Kenya; [Ojiambo, Vincent] USAID Kenya East Africa, Nairobi, Kenya	Jhpiego; Centers for Disease Control & Prevention - USA	Odoyo-June, E (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Kisumu, Kenya.	Yed0@cdc.gov	Odoyo-June, Elijah/AAJ-6074-2021	Odoyo-June, Elijah/0000-0002-1370-2306	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [GH001953, GH001952, GH009163, GH001957, GH001948, GH001946]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC), under the terms of Award numbers GH001953, GH001952, GH009163, GH001957; GH001948; GH001946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate male circumcision providers and various VMMC implementing partners including Impact Research and Development Organization (IRDO), ICAP at Colombia University, Eastern Deanery AIDS Relief Program (EDARP) and Center for Health Solutions (CHS) for supporting actual implementation in various facilities and for ensuring timely reporting of data. The authors are grateful to the VMMC service provision team members including Godfrey Onchiri (CHS-Kenya), Tuma Noah (CHS-Kenya), Rachel Odhiambo ICAP), Mourine Ongoro (ICAP), Charles Nderitu (EDARP-Kenya), Maurice Magudha (CMMB), Felix Njue (CMMB), Lilian Oduri(CMMB) among many others. Without their collective support, the active surveillance could not have been done.; Special thanks go to Jhpiego for providing technical and logistical support for the national coordination of the active AE surveillance and to the President's Emergency Plan for AIDS Relief (PEPFAR) for funding the active AE surveillance through Centers for Disease Control and Prevention (CDC). Finally we gratefully acknowledge Rinee Ridzon and Paul Musingila both of CDC Kenya for their review and assistance with editing the manuscript.	[Anonymous], 2009, CLIN MAN MAL CIRC LO; Bakare N., 2008, MALE CIRCUMCISION LE; Barone MA, 2011, J ACQUIR IMMUNE DEFI, V57; Barone MA, 2012, JAIDS-J ACQ IMM DEF, V60, pE82, DOI 10.1097/QAI.0b013e31824ea1f2; FELDBLUM PJ, 2016, J ACQUIR IMMUNE D S1, V72, pS3; Kigozi G., 2014, UG 20 INT AIDS C MEL; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Mavhu W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213399; PSI/COSECA, 2016, ADV EV ACT GUID VOL; Sokal D, 2012, J ACQUIR IMMUNE DEFI, V59; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V67, P430, DOI 10.1097/QAI.0000000000000321; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V65, P447, DOI 10.1097/QAI.0000000000000061; WHO, 2019, WHO PREQ MAL CIRC DE; WHO, 2013, GUID US DEV AD MAL C; WHO, 2015, WHO PREQ MAL CIRC DE; WHO/UNAIDS/JHPIEGO, 2009, MAN MAL CIRC LOC AN; World Health Organization, 2011, OV PREQ MAL CIRC DEV, V2019; World Health Organization (WHO), 2012, FRAM CLIN EV DEV MAL	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222942	10.1371/journal.pone.0222942	http://dx.doi.org/10.1371/journal.pone.0222942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557208	gold, Green Published			2022-12-26	WOS:000532345500048
J	Ravindran, D; Cartland, SP; Bursill, CA; Kavurma, MM				Ravindran, Dhanya; Cartland, Sian P.; Bursill, Christina A.; Kavurma, Mary M.			Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis	FASEB JOURNAL			English	Article						M3; chemokine blockade; blood vessel remodeling	SMOOTH-MUSCLE-CELLS; FRACTALKINE RECEPTOR CX(3)CR1; ENDOTHELIAL GROWTH-FACTOR; INTIMAL HYPERPLASIA; MOUSE MODEL; NEOINTIMA FORMATION; IN-VIVO; TUMOR ANGIOGENESIS; LIMB ISCHEMIA; INJURY	M3 is a broad-spectrum chemokine-binding protein that inactivates inflammatory chemokines, including CCL2, CCL5, and CX(3)CL1. The aim of this study was to compare whether M3 could inhibit angiogenesis driven by inflammation or ischemia. Here, apolipoprotein E-/- mice were injected with adenoviral M3 (AdM3) or control adenoviral green fluorescent protein (AdGFP) 3 d prior to stimulating angiogenesis using 2 established models that distinctly represent inflammatory or ischemia-driven angiogenesis, namely the periarterial femoral cuff and hind limb ischemia. AdM3 reduced intimal thickening, adventitial capillary density, and macrophage accumulation in femoral arteries 21 d after periarterial femoral cuff placement compared with AdGFP-treated mice (P < 0.05). AdM3 also reduced mRNA expression of proangiogenic VEGF, inflammatory markers IL-6 and IL-1 beta, and vascular smooth muscle cell (VSMC)-activated synthetic markers Kriippel-like family of transcription factor 4 (KLF4) and platelet-derived growth factor receptor beta (PDGFR beta) in the inflammatory cuff model. In contrast, capillary density, VSMC content, blood flow perfusion, and VEGF gene expression were unaltered between groups in skeletal muscle following hind limb ischemia. In vitro, AdM3 significantly reduced human microvascular endothelial cell 1 proliferation, migration, and tubule formation by similar to 17, 71.3, and 8.7% (P < 0.05) in macrophage-conditioned medium associating with reduced VEGF and hypoxia-inducible factor la mRNA but not in hypoxia (1% O-2). Compared with AdGFP, AdM3 also inhibited VSMC proliferation and migration and reduced mRNA expression of KLF4 and PDGFRI3 under inflammatory conditions. In contrast, AdM3 had no effect on VSMC processes in response to hypoxia in vitro. Our findings show that broad-spectrum inhibition of inflammatory chemokines by M3 inhibits inflammatory-driven but not ischemia-driven angiogenesis, presenting a novel strategy for the treatment of diseases associated with inflammatory-driven angiogenesis.	[Ravindran, Dhanya; Cartland, Sian P.; Kavurma, Mary M.] Heart Res Inst, 7 Eliza St, Sydney, NSW 2042, Australia; [Ravindran, Dhanya; Cartland, Sian P.; Kavurma, Mary M.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Bursill, Christina A.] South Australian Hlth & Med Res Inst, Heart Hlth, Adelaide, SA, Australia	University of Sydney; Heart Research Institute; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Kavurma, MM (corresponding author), Heart Res Inst, 7 Eliza St, Sydney, NSW 2042, Australia.	mary.kavurma@hri.org.au		Bursill, Christina/0000-0002-0682-8760; Cartland, Sian/0000-0003-1723-2679				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Barcelos LS, 2004, INFLAMM RES, V53, P576, DOI 10.1007/s00011-004-1299-4; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Bhardwaj S, 2011, ATHEROSCLEROSIS, V219, P84, DOI 10.1016/j.atherosclerosis.2011.07.103; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; Cai JJ, 2015, ARTERIOSCL THROM VAS, V35, P2579, DOI 10.1161/ATVBAHA.115.305789; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Carmeliet P, 1998, CARDIOVASC RES, V39, P8, DOI 10.1016/S0008-6363(98)00108-4; Cartland SP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122025; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Chen TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113752; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Denger S, 1999, ATHEROSCLEROSIS, V144, P15, DOI 10.1016/S0021-9150(99)00033-7; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Di Bartolo BA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002527; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Elice F, 2012, THROMB RES, V129, pS50, DOI 10.1016/S0049-3848(12)70016-6; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; INDOLFI C, 1995, CIRCULATION, V92, P1230, DOI 10.1161/01.CIR.92.5.1230; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jensen KK, 2003, J VIROL, V77, P624, DOI 10.1128/JVI.77.1.624-630.2003; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Lee Kyung-Bok, 2009, Int J Stem Cells, V2, P11; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lin CS, 2018, CELL PHYSIOL BIOCHEM, V47, P707, DOI 10.1159/000490024; Lira SA, 2009, METHOD ENZYMOL, V460, P193, DOI 10.1016/S0076-6879(09)05209-4; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Madeddu P, 2006, VASC PHARMACOL, V45, P281, DOI 10.1016/j.vph.2006.08.008; Martin AP, 2006, J IMMUNOL, V177, P7296, DOI 10.4049/jimmunol.177.10.7296; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pyo R, 2004, AM J PATHOL, V164, P2289, DOI 10.1016/S0002-9440(10)63785-6; Ravindran D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173224; Ridiandries A, 2017, FASEB J, V31, P1179, DOI 10.1096/fj.201600540R; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; SAREMBOCK IJ, 1989, CIRCULATION, V80, P1029, DOI 10.1161/01.CIR.80.4.1029; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Simas JP, 1999, J GEN VIROL, V80, P75, DOI 10.1099/0022-1317-80-1-75; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strasly M, 2004, BLOOD, V103, P40, DOI 10.1182/blood-2003-05-1387; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tang G, 2004, J VASC SURG, V40, P786, DOI 10.1016/j.jvs.2004.07.012; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Ucuzian AA, 2010, J BURN CARE RES, V31, P158, DOI 10.1097/BCR.0b013e3181c7ed82; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P1426, DOI 10.1161/ATVBAHA.107.139642; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Wang SW, 2015, CARCINOGENESIS, V36, P104, DOI 10.1093/carcin/bgu218; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	68	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13423	13434		10.1096/fj.201900232RR	http://dx.doi.org/10.1096/fj.201900232RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31574232				2022-12-26	WOS:000507466100031
J	Paterson, JM; Shaw, AJ; Burns, I; Dodds, AW; Prasad, A; Reid, KB; Greenhough, TJ; Shrive, AK				Paterson, Janet M.; Shaw, Amy J.; Burns, Ian; Dodds, Alister W.; Prasad, Alpana; Reid, Ken B.; Greenhough, Trevor J.; Shrive, Annette K.			Atomic-resolution crystal structures of the immune protein conglutinin from cow reveal specific interactions of its binding site with N-acetylglucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collectin; complement; crystal structure; carbohydrate-binding protein; host-pathogen interaction; innate immunity; structural biology; lectin; conglutinin; surfactant protein	CARBOHYDRATE-RECOGNITION DOMAIN; RECOMBINANT BOVINE CONGLUTININ; SURFACTANT-PROTEIN; MANNAN-BINDING; ANTIINFLUENZA ACTIVITY; LIGAND-BINDING; COLLECTINS; COMPLEMENT; CORE; LECTIN	Bovine conglutinin is an immune protein that is involved in host resistance to microbes and parasites and interacts with complement component iC3b, agglutinates erythrocytes, and neutralizes influenza A virus. Here, we determined the high-resolution (0.97?1.46 ?) crystal structures with and without bound ligand of a recombinant fragment of conglutinin's C-terminal carbohydrate-recognition domain (CRD). The structures disclosed that the high-affinity ligand N-acetyl-d-glucosamine (GlcNAc) binds in the collectin CRD calcium site by interacting with the O3? and O4? hydroxyls alongside additional specific interactions of the N-acetyl group oxygen and nitrogen with Lys-343 and Asp-320, respectively. These residues, unique to conglutinin and differing both in sequence and in location from those in other collectins, result in specific, high-affinity binding for GlcNAc. The binding pocket flanking residue Val-339, unlike the equivalent Arg-343 in the homologous human surfactant protein D, is sufficiently small to allow conglutinin Lys-343 access to the bound ligand, whereas Asp-320 lies in an extended loop proximal to the ligand-binding site and bounded at both ends by conserved residues that coordinate to both calcium and ligand. This loop becomes ordered on ligand binding. The electron density revealed both ? and ? anomers of GlcNAc, consistent with the added ?/?GlcNAc mixture. Crystals soaked with ?1?2 mannobiose, a putative component of iC3b, reported to bind to conglutinin, failed to reveal bound ligand, suggesting a requirement for presentation of mannobiose as part of an extended physiological ligand. These results reveal a highly specific GlcNAc-binding pocket in conglutinin and a novel collectin mode of carbohydrate recognition.	[Paterson, Janet M.; Shaw, Amy J.; Burns, Ian; Greenhough, Trevor J.; Shrive, Annette K.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England; [Dodds, Alister W.; Prasad, Alpana; Reid, Ken B.] Univ Oxford, Dept Biochem, MRC Immunochem Unit, South Parks Rd, Oxford OX1 3QU, England; [Prasad, Alpana] Eurofins DiscoverX Corp, 42501 Albrae St, Fremont, CA 94538 USA; [Reid, Ken B.] Univ Oxford, Green Templeton Coll, Oxford, England	Keele University; University of Oxford; University of Oxford	Shrive, AK (corresponding author), Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England.	a.k.shrive@keele.ac.uk			Medical Research Council [G0400743, MC_U138284129]; Science and Technology Facilities Council; Diamond Light Source Awards [MX310, MX6388, MX8359, MX10369]; MRC [G0400743] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Diamond Light Source Awards; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants G0400743 and MC_U138284129 (to K. B. R., A. K. S., T. J. G.), Science and Technology Facilities Council, and Diamond Light Source Awards MX310, MX6388, MX8359, and MX10369 (to T. J. G. and A. K. S.) and by the former CLRC Daresbury Laboratory. The authors declare that they have no conflicts of interest with the contents of this article.	Allen MJ, 2004, GLYCOBIOLOGY, V14, P693, DOI 10.1093/glycob/cwh088; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark HW, 2016, INFECT IMMUN, V84, P1585, DOI 10.1128/IAI.01239-15; Crispin MDM, 2004, FEBS LETT, V566, P270, DOI 10.1016/j.febslet.2004.04.045; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Dec M, 2006, POL J VET SCI, V9, P265; Dec M, 2011, VET MED-CZECH, V56, P510, DOI 10.17221/3296-VETMED; Eda S, 1996, BIOCHEM J, V316, P43, DOI 10.1042/bj3160043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRIISCHRISTIANSEN P, 1990, SCAND J IMMUNOL, V31, P453, DOI 10.1111/j.1365-3083.1990.tb02792.x; Girija UV, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0136-2; Hansen S, 2002, IMMUNOBIOLOGY, V205, P498, DOI 10.1078/0171-2985-00150; Hansen S, 2002, J IMMUNOL, V169, P5726, DOI 10.4049/jimmunol.169.10.5726; Hansen SWK, 2016, IMMUNOBIOLOGY, V221, P1058, DOI 10.1016/j.imbio.2016.05.012; Hartshorn KL, 2010, SCAND J IMMUNOL, V72, P22, DOI 10.1111/j.1365-3083.2010.02409.x; Hartshorn KL, 2000, AM J PHYSIOL-LUNG C, V278, pL90, DOI 10.1152/ajplung.2000.278.1.L90; HIRANI S, 1986, BIOCHEM J, V233, P613, DOI 10.1042/bj2330613; HOLMSKOV U, 1995, BIOCHEM J, V305, P889, DOI 10.1042/bj3050889; Holmskov U, 1998, IMMUNOLOGY, V93, P431, DOI 10.1046/j.1365-2567.1998.00452.x; HOLMSKOV U, 1993, J BIOL CHEM, V268, P10120; Holmskov UL, 2000, APMIS, V108, P7; JANSSON PE, 1981, EUR J BIOCHEM, V115, P571; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAURSEN SB, 1994, IMMUNOLOGY, V81, P648; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Lim BL, 1996, BIOCHEM BIOPH RES CO, V218, P260, DOI 10.1006/bbrc.1996.0046; Littlejohn JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199175; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; LU JH, 1993, BIOCHEM J, V292, P157, DOI 10.1042/bj2920157; LUK JMC, 1991, J BIOL CHEM, V266, P23215; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mehmood A, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03159; MIZUOCHI T, 1989, J BIOL CHEM, V264, P13834; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Nnalue NA, 1998, INFECT IMMUN, V66, P4389; Prasad A., 2000, THESIS; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; SOLIS D, 1994, J BIOL CHEM, V269, P11555; Suzuki Y, 1997, BIOCHEM BIOPH RES CO, V238, P856, DOI 10.1006/bbrc.1997.7402; THIEL S, 1992, IMMUNOPHARMACOLOGY, V24, P91, DOI 10.1016/0162-3109(92)90015-5; van Eijk M, 2018, J BIOL CHEM, V293, P10646, DOI 10.1074/jbc.RA117.001430; van Eijk M, 2012, J BIOL CHEM, V287, P26666, DOI 10.1074/jbc.M112.368571; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WANG JY, 1995, FEBS LETT, V376, P6, DOI 10.1016/0014-5793(95)01232-4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YOUNG NM, 1987, BIOCHEM BIOPH RES CO, V143, P645, DOI 10.1016/0006-291X(87)91402-1; Zhang PN, 2001, J BIOL CHEM, V276, P19862, DOI 10.1074/jbc.M100597200	57	2	2	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17155	17165		10.1074/jbc.RA119.010271	http://dx.doi.org/10.1074/jbc.RA119.010271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31562242	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000501801900054
J	Chen, HL; Guo, AP; Lu, ZW; Tan, SB; Wang, J; Gao, JM; Zhang, SQ; Huang, X; Zheng, JL; Xi, JG; Yi, KX				Chen, Helong; Guo, Anping; Lu, Zhiwei; Tan, Shibei; Wang, Jian; Gao, Jianming; Zhang, Shiqing; Huang, Xing; Zheng, Jinlong; Xi, Jingen; Yi, Kexian			Agrobacterium tumefaciens-mediated transformation of a hevein-like gene into asparagus leads to stem wilt resistance	PLOS ONE			English	Article							OFFICINALIS L; RUBBER TREE	Asparagus stem wilt, is a significant and devastating disease, typically leading to extensive economic losses in the asparagus industry. To obtain transgenic plants resistant to stem wilt, the hevein-like gene, providing broad spectrum bacterial resistance was inserted into the asparagus genome through Agrobacterium tumefaciens-mediated transformation. The optimal genetic transformation system for asparagus was as follows: pre-culture of embryos for 2 days, inoculation using a bacterial titre of OD600 = 0.6, infection time 10 min and co-culturing for 4 days using an Acetosyringone concentration of 200 mu mol/L. Highest transformation frequencies reached 21% and ten transgenic asparagus seedlings carrying the hevein-like gene were identified by polymerase chain reaction. Moreover, integration of the hevein-like gene in the T1 generation of transgenic plants was confirmed by southern blot hybridization. Analysis showed that resistance to stem wilt was enhanced significantly in the transgenic plants, in comparison to non-transgenic plants. The results provide additional data for genetic improvement and are of importance for the development of new disease-resistant asparagus varieties.	[Chen, Helong; Guo, Anping; Wang, Jian] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China; [Chen, Helong; Guo, Anping; Gao, Jianming; Zhang, Shiqing] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Minist Agr,Hainan Acad Trop Agr Resource, Haikou, Hainan, Peoples R China; [Tan, Shibei; Huang, Xing; Zheng, Jinlong; Xi, Jingen; Yi, Kexian] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China; [Lu, Zhiwei] Chinese Acad Trop Agr Sci, South Subtrop Crops Inst, Zhanjiang City Key Lab Trop Crops Genet Improveme, Zhanjiang, Guangdong, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Chen, HL (corresponding author), Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China.; Chen, HL (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Minist Agr,Hainan Acad Trop Agr Resource, Haikou, Hainan, Peoples R China.; Yi, KX (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China.	chenhelong951@126.com; yikexian@126.com	huang, xing/T-3308-2017	huang, xing/0000-0003-3950-0080	Special Fund for Agro-scientific Research in the Public Interest [201003074]; Technology Project of Hainan [ZDXM2015047]	Special Fund for Agro-scientific Research in the Public Interest; Technology Project of Hainan	This work was sponsored by the Special Fund for Agro-scientific Research in the Public Interest (201003074) and Technology Project of Hainan (ZDXM2015047). And the funders had no role in study design, design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYTEBIER B, 1987, P NATL ACAD SCI USA, V84, P5345, DOI 10.1073/pnas.84.15.5345; CabreraPonce JL, 1997, PLANT CELL REP, V16, P255, DOI 10.1007/BF01088276; [陈河龙 Chen Helong], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P210; Davis EG, 2004, VET IMMUNOL IMMUNOP, V99, P127, DOI 10.1016/j.vetimm.2003.12.010; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; DELBREIL B, 1993, PLANT CELL REP, V12, P129, DOI 10.1007/BF00239092; Duan Y., 2006, STAGE MODELS PHYS AC; Gao ZhongJiang, 2008, Progress in Modern Biomedicine, V8, P2116; Garrison S A, 2005, 11 INT ASP S HORST V; GIDROL X, 1994, J BIOL CHEM, V269, P9278; Gnasekaran P., 2014, SCI WORLD J, V2014, P1; [韩庆典 Han Qingdian], 2016, [分子植物育种, Molecular Plant Breeding], V14, P2803; HERNALSTEENS JP, 1984, EMBO J, V3, P3039, DOI 10.1002/j.1460-2075.1984.tb02254.x; INNIS MA, 1985, SCIENCE, V228, P21, DOI 10.1126/science.228.4695.21; Kim HY, 2016, J KOREAN SOC NONDES, V36, P225, DOI 10.7779/JKSNT.2016.36.3.225; LEE H, 1991, J BIOL CHEM, V266, P15944; Limanton-Grevet A, 2001, MOL BREEDING, V7, P141, DOI 10.1023/A:1011310604393; [刘燕蓉 Liu Yanrong], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P80; Lopez Anido Fernando, 2008, P87; MUKHOPADHYAY S, 1994, PLANT CELL REP, V13, P421, DOI 10.1007/BF00231959; Slavokhotova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1659, DOI 10.1134/S0006297917130065; [宋培玲 Song Peiling], 2015, [华北农学报, Acta Agriculturae Boreali-Sinica], V30, P110; [杨迎青 Yang Yingqing], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P649; Zhai J., 2006, THESIS; Zhou Yue, 2014, Sheng Wu Gong Cheng Xue Bao, V30, P931	25	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223331	10.1371/journal.pone.0223331	http://dx.doi.org/10.1371/journal.pone.0223331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589638	Green Published, gold			2022-12-26	WOS:000532427300017
J	Al-Omar, HA; Sherif, HM; Mayet, AY				Al-Omar, Hussain Abdulrahman; Sherif, Hadeel Magdy; Mayet, Ahmed Yaccob			Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; FACTOR-ALPHA INHIBITORS; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; CLINICAL-PRACTICE; MANAGEMENT; AGENTS	Objective Anti-tumor necrosis factor (Anti-TNF) therapy improves the prognosis and reduces the morbidity and mortality associated with many chronic inflammatory autoimmune diseases. However, as it is linked to an increased infection risk, appropriate vaccination is required. The study aimed at investigating the vaccination status of patients receiving Anti-TNF therapy and physicians' perceptions of and views about vaccinating these patients. Methods A sequential explanatory mixed-methods approach was used. The study comprised a quantitative, retrospective drug utilization review for determining institutional consumption of Anti-TNF therapy and an assessment of vaccination status in patients prescribed Anti-TNF therapy to audit physicians' adherence to Anti-TNF therapy-related vaccination recommendations. Patient data from electronic medical records (EMRs) obtained from tertiary care hospitals between September 2015 and September 2017 were used. Further, a qualitative study using a phenomenographic approach with semi-structured interviews of 12 physicians was carried out to explore the physicians' perceptions, views, and recommendations of vaccinating patients who are undergoing Anti-TNF therapy and identifying factors that may cause poor adherence to vaccination recommendations. Results Forty-three of 310 patients receiving Anti-TNF therapy were vaccinated. Infliximab was the most frequently prescribed agent, accounting for 96.7% of total orders. Eight of the 12 physicians stated that they were aware of vaccination guidelines and seven viewed pre-Anti-TNF therapy vaccination as essential because of the high infection risk and claimed to incorporate it in their daily practice. Barriers to adherence included ignorance of recommendations, workload, vaccine unavailability, and advanced disease state. Conclusion Although the recommendations published by professional medical societies emphasized the importance of vaccination before initiating Anti-TNF therapy, few patients were vaccinated. Medical administration in hospitals should develop policies, procedures, and guidelines for vaccination; implement education programs for physicians and patients and procure vaccines in a timely way to improve their use.	[Al-Omar, Hussain Abdulrahman; Sherif, Hadeel Magdy; Mayet, Ahmed Yaccob] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia	King Saud University	Al-Omar, HA (corresponding author), King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.	halomar@ksu.edu.sa		Al-Omar, Hussain/0000-0002-0765-0466	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	The authors acknowledge the financial support from the College of Pharmacy Research Center and the Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonhomme A, 2017, ANN DERMATOL VENER, V144, P92, DOI 10.1016/j.annder.2016.09.035; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Callhoff J, 2015, ANN RHEUM DIS, V74, P1241, DOI 10.1136/annrheumdis-2014-205322; Chaudrey K, 2015, WORLD J GASTROENTERO, V21, P3184, DOI 10.3748/wjg.v21.i11.3184; Corace KM, 2016, VACCINE, V34, P3235, DOI 10.1016/j.vaccine.2016.04.071; Dahlgren L.O., 1991, RES SOC ADMIN PHARM, V8, P150, DOI DOI 10.1080/17482620601068105; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Esteve M, 2004, GUT, V53, P1363, DOI 10.1136/gut.2004.040675; Ferreira I, 2014, ANN RHEUM DIS, V73, P1446, DOI 10.1136/annrheumdis-2014-205246; Feuchtenberger M, 2012, RHEUMATOL INT, V32, P1533, DOI 10.1007/s00296-011-1808-z; Germano V, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-77; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Goyal A, 2015, AM J CLIN DERMATOL, V16, P179, DOI 10.1007/s40257-015-0124-x; Gupta A, 2011, INTERN MED J, V41, P462, DOI 10.1111/j.1445-5994.2009.02114.x; Gurvits GE, 2017, POSTGRAD MED J, V93, P333, DOI 10.1136/postgradmedj-2016-134266; Hatemi G, 2008, ANN RHEUM DIS, V67, P1656, DOI 10.1136/ard.2007.080432; Hua C, 2015, RHEUMATOLOGY, V54, P748, DOI 10.1093/rheumatology/keu531; Kantso B, 2015, VACCINE, V33, P5464, DOI 10.1016/j.vaccine.2015.08.011; Krasich M., 2016, RAMS 2016 P ANN REL, P1, DOI [DOI 10.1007/S00296-015-3319-9, 10.1007/s00296-015-3319-9]; Malhi G, 2015, J CROHNS COLITIS, V9, P439, DOI 10.1093/ecco-jcc/jjv064; Mao EJ, 2017, ALIMENT PHARM THER, V45, P3, DOI 10.1111/apt.13847; Montiel PM, 2008, LIVER INT, V28, P718, DOI 10.1111/j.1478-3231.2007.01665.x; McCarthy EM, 2012, JCR-J CLIN RHEUMATOL, V18, P237, DOI 10.1097/RHU.0b013e3182611547; Melmed GY, 2006, AM J GASTROENTEROL, V101, P1834, DOI 10.1111/j.1572-0241.2006.00646.x; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Minozzi S, 2016, EXPERT OPIN DRUG SAF, V15, P11, DOI 10.1080/14740338.2016.1240783; Nguyen CM, 2012, PHARMACOECONOMICS, V30, P575, DOI 10.2165/11594990-000000000-00000; Nguyen DL, 2015, DIGEST DIS SCI, V60, P2446, DOI 10.1007/s10620-015-3631-y; OTSUKA S, 2013, AM J MED, V126, P832, DOI DOI 10.1016/J.AMJMED.2013.02.018; Papadopoulou D, 2014, RHEUMATOL INT, V34, P151, DOI 10.1007/s00296-013-2907-9; Lemos LLP, 2014, RHEUMATOL INT, V34, P1345, DOI 10.1007/s00296-014-3006-2; Rahier JF, 2010, RHEUMATOLOGY, V49, P1815, DOI 10.1093/rheumatology/keq183; Ramos AL, 2016, RHEUMATOL INT, V36, P1255, DOI 10.1007/s00296-016-3516-1; Sandler DS, 2016, AM J MANAG CARE, V22, pE161; Shah ED, 2017, INFLAMM BOWEL DIS, V23, P570, DOI 10.1097/MIB.0000000000001049; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Spalding JR, 2006, PHARMACOECONOMICS, V24, P1221, DOI 10.2165/00019053-200624120-00006; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Walsh A J, 2013, J Crohns Colitis, V7, pe449, DOI 10.1016/j.crohns.2013.02.019; Wasan SK, 2014, INFLAMM BOWEL DIS, V20, P246, DOI 10.1097/01.MIB.0000437737.68841.87; Wasan SK, 2010, AM J GASTROENTEROL, V105, P1231, DOI 10.1038/ajg.2009.733; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wilckens V, 2011, SCAND J GASTROENTERO, V46, P855, DOI 10.3109/00365521.2011.574734; Yeung JH, 2012, INFLAMM BOWEL DIS, V18, P34, DOI 10.1002/ibd.21668; Zhou Y, 2016, EXPERT REV RESP MED, V10, P577, DOI 10.1586/17476348.2016.1164602; Zhou Z, 2015, HEPATO-GASTROENTEROL, V62, P309, DOI 10.5754/hge13279	48	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223594	10.1371/journal.pone.0223594	http://dx.doi.org/10.1371/journal.pone.0223594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584996	Green Published, gold			2022-12-26	WOS:000532407600046
J	Kouser, S; Spielman, DJ; Qaim, M				Kouser, Shahzad; Spielman, David J.; Qaim, Matin			Transgenic cotton and farmers' health in Pakistan	PLOS ONE			English	Article							GENETICALLY-MODIFIED COTTON; DOUBLE-HURDLE MODEL; WILLINGNESS-TO-PAY; BT-COTTON; PESTICIDE USE; ENVIRONMENTAL BENEFITS; SMALLHOLDER AGRICULTURE; FERTILIZER DEMAND; ADOPTION; EXPOSURE	Despite substantial research on the economic effects of transgenic insect-resistant Bacillus thuringiensis (Bt) cotton, there is still limited work on this technology's impacts on human health. Due to the inbuilt insect resistance, Bt cotton requires fewer pesticide sprays than conventional cotton, which is not only advantageous from economic and environmental perspectives, but may also result in health benefits for farmers. Using socioeconomic and biophysical data from Pakistan, we provide the first evidence of a direct association between Bt gene expression in the plant and health benefits. A key feature of this study is that Bt cotton cultivation in Pakistan occurs in a poorly regulated market: farmers are often mistaken in their beliefs about whether they have planted Bt cotton or conventional cotton, which may affect their pesticide-use strategies and thus their pesticide exposure. We employ a cost-of-illness approach and variations in the measurement of Bt adoption to estimate the relationship between Bt cotton and farmers' health. Bt adoption based on farmers' beliefs does not reduce the pesticide-induced cost of illness. However, adoption based on measuring Bt gene expression is associated with significant health cost savings. Extrapolating the estimates for true Bt seeds to Pakistan's entire Bt cotton area results in annual health cost savings of around US$ 7 million. These findings have important implications for the regulation of seed markets in Pakistan and beyond: improved regulations that ensure claimed crop traits are really expressed can increase the benefits for farmers and society at large.	[Kouser, Shahzad] COMSATS Univ Islamabad, Dept Econ, Islamabad, Pakistan; [Spielman, David J.] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Qaim, Matin] Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Germany	COMSATS University Islamabad (CUI); CGIAR; International Food Policy Research Institute (IFPRI); University of Gottingen	Kouser, S (corresponding author), COMSATS Univ Islamabad, Dept Econ, Islamabad, Pakistan.	drskouser@comsats.edu.pk	Kouser, Shahzad/ABD-7680-2020; Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763; Spielman, David/0000-0002-6889-7358	U.S. Agency for International Development [AID-391-IO-00002]; CGIAR Research Program on Policies, Institutions, and Markets (PIM); CGIAR Fund	U.S. Agency for International Development(United States Agency for International Development (USAID)); CGIAR Research Program on Policies, Institutions, and Markets (PIM)(CGIAR); CGIAR Fund(CGIAR)	This research was funded by the U.S. Agency for International Development (AID-391-IO-00002) to DS; and by the CGIAR Research Program on Policies, Institutions, and Markets (PIM), led by the International Food Policy Research Institute (IFPRI) and carried out with support from the CGIAR Fund contributors (https://www.cgiar.org/funders/).	Abedullah, 2016, HUM ECOL RISK ASSESS, V22, P941, DOI 10.1080/10807039.2015.1121375; Abedullah, 2015, J AGR ECON, V66, P66, DOI 10.1111/1477-9552.12072; Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Ali S, 2012, CURR SCI INDIA, V102, P1632; [Anonymous], 1994, PESTICIDES ENV SITUA; Arshad M, 2009, INT J AGRIC BIOL, V11, P473; Asfaw S, 2010, AGR ECON-BLACKWELL, V41, P251, DOI 10.1111/j.1574-0862.2010.00443.x; Ashour M, 2019, J DEV STUD, V55, P1285, DOI 10.1080/00220388.2018.1464143; Athukorala W, 2012, J AGR ECON, V63, P158, DOI 10.1111/j.1477-9552.2011.00326.x; Atreya K, 2008, SOC SCI MED, V67, P511, DOI 10.1016/j.socscimed.2008.04.005; Bakhsh K, 2016, BMC PUBLIC HELATH, V16, P1; Bakhsh K, 2017, ENVIRON DEV ECON, V22, P373, DOI [10.1017/s1355770x17000080, 10.1017/S1355770X17000080]; Bakhsh K, 2017, SCI TOTAL ENVIRON, V598, P1058, DOI 10.1016/j.scitotenv.2017.04.043; Bennett R, 2003, OUTLOOK AGR, V32, P123, DOI 10.5367/000000003101294361; Bold T, 2017, Q J ECON, V132, P1055, DOI 10.1093/qje/qjx009; Brethour C, 2001, AGR ECON-BLACKWELL, V25, P219, DOI 10.1111/j.1574-0862.2001.tb00202.x; Burke WJ, 2009, STATA J, V9, P584, DOI 10.1177/1536867X0900900405; Cooper JC, 1996, AM J AGR ECON, V78, P54, DOI 10.2307/1243778; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Cuyno LCM, 2001, AGR ECON-BLACKWELL, V25, P227, DOI 10.1111/j.1574-0862.2001.tb00203.x; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Garming H, 2009, EUR J HEALTH ECON, V10, P125, DOI 10.1007/s10198-008-0110-9; Gebregziabher G., 2011, Journal of Development and Agricultural Economics, V3, P514; Gesesew HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162527; Guillemaud T., 2016, SUSTAIN AGR REV, V19, P35, DOI [10.1007/978-3-319-26777-7_2, DOI 10.1007/978-3-319-26777-7_2]; Hayat K, 2019, SCI TOTAL ENVIRON, V655, P102, DOI 10.1016/j.scitotenv.2018.11.175; Herring R, 2016, ANNU REV RESOUR ECON, V8, P397, DOI 10.1146/annurev-resource-100815-095506; Herring RJ, 2007, J DEV STUD, V43, P130, DOI 10.1080/00220380601055601; Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296; Hu RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124921; Huang JK, 2014, PLANT BIOTECHNOL J, V12, P399, DOI 10.1111/pbi.12189; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Ishtiaq M, 2011, J ECON ENTOMOL, V104, P1343, DOI 10.1603/EC10383; JONES AM, 1989, J APPL ECONOM, V4, P23, DOI 10.1002/jae.3950040103; Karim S., 2000, PAKISTAN J BIOL SCI, V3, P1213, DOI DOI 10.3923/PJBS.2000.1213.1222; Khan M. A., 2007, Pakistan Development Review, V46, P1119; Khan M. A., 2002, Pakistan Development Review, V41, P683; Khan M, 2015, CROP PROT, V77, P45, DOI 10.1016/j.cropro.2015.07.014; Khan M, 2015, INT J ENVIRON HEAL R, V25, P508, DOI 10.1080/09603123.2014.980781; Khan M, 2015, SCI TOTAL ENVIRON, V530, P297, DOI 10.1016/j.scitotenv.2015.05.110; Khan M, 2015, CROP PROT, V67, P184, DOI 10.1016/j.cropro.2014.10.013; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kouser S, 2017, NEW BIOTECHNOL, V34, P40, DOI 10.1016/j.nbt.2016.05.004; Kouser S, 2014, ENVIRON DEV ECON, V19, P704, DOI 10.1017/S1355770X1300051X; Kouser S, 2013, AGR ECON-BLACKWELL, V44, P323, DOI 10.1111/agec.12014; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Krishna VV, 2008, AGR ECON-BLACKWELL, V38, P167, DOI 10.1111/j.1574-0862.2008.00290.x; Lee WJ, 2012, AM J IND MED, V55, P799, DOI 10.1002/ajim.22024; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Ma XL, 2017, J AGR ECON, V68, P366, DOI 10.1111/1477-9552.12174; Maredia M, 2016, INT DEV WORKING PAPE, V246950; Maumbe BM, 2003, SOC SCI MED, V57, P1559, DOI 10.1016/S0277-9536(03)00016-9; Memon QU, 2019, SCI TOTAL ENVIRON, V685, P659, DOI 10.1016/j.scitotenv.2019.05.173; Morse S, 2004, NAT BIOTECHNOL, V22, P379, DOI 10.1038/nbt0404-379b; Muhammad Khan, 2009, Pakistan Development Review, V48, P459; NFDC, 2002, PEST US SURV REP 200; Noltze M, 2012, AGR SYST, V108, P64, DOI 10.1016/j.agsy.2012.01.003; Pemsl DE, 2008, ECOL ECON, V66, P177, DOI 10.1016/j.ecolecon.2007.08.022; Pemsl DE, 2011, INT J AGR SUSTAIN, V9, P508, DOI 10.1080/14735903.2011.603904; PINGALI PL, 1994, AM J AGR ECON, V76, P587, DOI 10.2307/1243669; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Rana MA, 2014, 19 INT FOOD POL RES; Rao EJO, 2013, FOOD POLICY, V38, P165, DOI 10.1016/j.foodpol.2012.11.008; Ricker-Gilbert J, 2011, AM J AGR ECON, V93, P26, DOI 10.1093/ajae/aaq122; Saeed MF, 2017, SCI TOTAL ENVIRON, V587, P137, DOI 10.1016/j.scitotenv.2017.02.086; Shiferaw BA, 2008, AGR ECON-BLACKWELL, V39, P309, DOI 10.1111/j.1574-0862.2008.00335.x; Spielman D. J., 2015, AgBioForum, V18, P98; Spielman DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176592; Veettil PC, 2017, AUST J AGR RESOUR EC, V61, P115, DOI 10.1111/1467-8489.12171; Wei JZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204154; Wilson C, 2003, ENVIRON RESOUR ECON, V24, P97, DOI 10.1023/A:1022838112228; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Xu NY, 2008, CROP PROT, V27, P1269, DOI 10.1016/j.cropro.2008.04.003; Xu Z, 2009, AGR ECON-BLACKWELL, V40, P79, DOI 10.1111/j.1574-0862.2008.00361.x; Yao YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166771; Zehr UB, 2010, BIOTECH AGR FOREST, V65, P1; Zhang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep34918	78	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222617	10.1371/journal.pone.0222617	http://dx.doi.org/10.1371/journal.pone.0222617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KY9HW	31577819	gold, Green Published			2022-12-26	WOS:000522886500001
J	Mietani, K; Sumitani, M; Ogata, T; Shimojo, N; Inoue, R; Abe, H; Kawamura, G; Yamada, Y				Mietani, Kazuhito; Sumitani, Masahiko; Ogata, Toru; Shimojo, Nobutake; Inoue, Reo; Abe, Hiroaki; Kawamura, Gaku; Yamada, Yoshitsugu			Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; NF-H; SUBTYPES; INJURY	Background Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. Methods Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. Results Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). Conclusions Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium related CNS damage.	[Mietani, Kazuhito; Inoue, Reo; Kawamura, Gaku; Yamada, Yoshitsugu] Univ Tokyo Hosp, Dept Anesthesiol, Tokyo, Japan; [Mietani, Kazuhito; Inoue, Reo; Kawamura, Gaku; Yamada, Yoshitsugu] Univ Tokyo Hosp, Pain Relief Ctr, Tokyo, Japan; [Sumitani, Masahiko; Abe, Hiroaki] Univ Tokyo Hosp, Dept Pain & Palliat Med, Tokyo, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan; [Shimojo, Nobutake] Tsukuba Univ Hosp, Dept Emergency & Crit Care Med, Ibaraki, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Sumitani, M (corresponding author), Univ Tokyo Hosp, Dept Pain & Palliat Med, Tokyo, Japan.	sumitanim-ane@h.u-tokyo.ac.jp	Ogata, Toru/ADC-3560-2022	Ogata, Toru/0000-0001-9011-8640; Abe, Hiroaki/0000-0002-2493-302X	Ministry of Health, Labour, and Welfare Science Research Grant [H26-Cancer-060]; JSPS KAKENHI [JP 16H06276]	Ministry of Health, Labour, and Welfare Science Research Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a Ministry of Health, Labour, and Welfare Science Research Grant (H26-Cancer-060) and partially JSPS KAKENHI Grant Number JP 16H06276 (AdAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Franco K, 2001, PSYCHOSOMATICS, V42, P68, DOI 10.1176/appi.psy.42.1.68; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Hughes CG, 2016, CRIT CARE MED, V44, pE809, DOI 10.1097/CCM.0000000000001739; Inoue R, 2017, NEUROSCI LETT, V653, P39, DOI 10.1016/j.neulet.2017.05.023; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Matsushige T, 2012, J NEUROL SCI, V321, P39, DOI 10.1016/j.jns.2012.07.043; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Park OK, 2010, ANAT CELL BIOL, V43, P54, DOI 10.5115/acb.2010.43.1.54; Pasternak LR., 1996, ASA REFRESHER COURSE, V24, P205, DOI DOI 10.1097/00126869-199624000-00016; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Rengel KF, 2018, PRESSE MED, V47, pE53, DOI 10.1016/j.lpm.2018.03.012; Robinson TN, 2011, ARCH SURG-CHICAGO, V146, P295, DOI 10.1001/archsurg.2011.14; Saxena S, 2018, PRESSE MED, V47, pE73, DOI 10.1016/j.lpm.2018.03.011; Schrijver EJM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-96; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shi QY, 2013, NEUROPSYCH DIS TREAT, V9, P1359, DOI 10.2147/NDT.S49520; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tomasi CD, 2017, MOL NEUROBIOL, V54, P722, DOI 10.1007/s12035-016-9708-6; Ueno T, 2011, SPINAL CORD, V49, P333, DOI 10.1038/sc.2010.116; Vainer B, 2000, CLIN EXP IMMUNOL, V121, P242, DOI 10.1046/j.1365-2249.2000.01296.x; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; Van Munster BC, 2009, BMC NEUROL, V27, P9; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222721	10.1371/journal.pone.0222721	http://dx.doi.org/10.1371/journal.pone.0222721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574089	gold, Green Published			2022-12-26	WOS:000532376700012
J	Mortreux, M; Semple, C; Riveros, D; Nagy, JA; Rutkove, SB				Mortreux, Marie; Semple, Carson; Riveros, Daniela; Nagy, Janice A.; Rutkove, Seward B.			Electrical impedance myography for the detection of muscle inflammation induced by lambda-carrageenan	PLOS ONE			English	Article							SKELETAL-MUSCLE	Electrical impedance myography (EIM) is a technique for the assessment of muscle health and composition and has been shown to be sensitive to a variety of muscle pathologies including neurogenic atrophy and connective tissue deposition. However, it has been minimally studied in pure inflammation. In this study, we sought to assess EIM sensitivity to experimental inflammation induced by the localized intramuscular injection of lambda-carrageenan. A total of 91 mice underwent 1-1000 kHz EIM measurements of gastrocnemius using a needle array, followed by injection of either 0.3% lambda-carrageenan in phosphate-buffered saline (PBS) or PBS alone. Animals were then remeasured with EIM at 4, 24, 48, or 72 hours and euthanized and quantitative assessment of muscle histology was performed. Parallel alterations in both 5 and 50 kHz EIM values were identified at 4 and 24 hours, including reductions in phase, reactance, and resistance. In PBS-treated animals these values normalized by 48 hours, whereas substantial reductions in phase and reactance in 5 kHz EIM values persisted at 48 and 72 hours (i.e., values of phase 72 hours post-injection were 6.51 0.40 degrees for lambda-carrageenan versus 8.44 0.35 degrees for PBS p<0.001, n = 11 per group). The degree of basophilic area observed in muscle sections by histology correlated to the degree of phase change at these two time points (R-spearman =-0.51, p = 0.0029). Changes in low frequency EIM parameters are sensitive to the presence of inflammatory infiltrates, and have the potential of serving as a simple means of quantifying the presence and extent of muscle inflammation without the need for biopsy.	[Mortreux, Marie; Semple, Carson; Riveros, Daniela; Nagy, Janice A.; Rutkove, Seward B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rutkove, SB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	srutkove@bidmc.harvard.edu	Mortreux, Marie/P-5087-2019	Mortreux, Marie/0000-0001-8567-8184; Rutkove, Seward/0000-0002-6375-3312	National Institutes of Health [R01 NS091159]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a grant from the National Institutes of Health and awarded to Dr. Seward B. Rutkove (R01 NS091159).	Auerbach A, 2009, AM J SURG PATHOL, V33, P1016, DOI 10.1097/PAS.0b013e31819e63fe; DIEHL B, 1988, AGENTS ACTIONS, V25, P210, DOI 10.1007/BF01965013; Gautam M, 2010, NEUROSCIENCE, V170, P893, DOI 10.1016/j.neuroscience.2010.08.003; Gdynia HJ, 2009, EUR J NEUROL, V16, P1151, DOI 10.1111/j.1468-1331.2009.02663.x; Grimnes S., 2014, BIOIMPEDANCE BIOELEC, VVolume 4; Kuo GP, 2007, CURR OPIN RHEUMATOL, V19, P530, DOI 10.1097/BOR.0b013e3282efdc66; Li JLL, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-678; Pinniger GJ, 2012, MUSCLE NERVE, V46, P413, DOI 10.1002/mus.23318; Radhakrishnan R, 2004, CURR PROTOC PHARM, DOI [10.1002/0471141755.ph0535s25, DOI 10.1002/0471141755.PH0535S25CH5]; Rutkove SB, 2017, ANN NEUROL, V81, P622, DOI 10.1002/ana.24874; Sanchez B, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0793-3; Shefner JM, 2018, AMYOTROPH LATERAL SC; Tanaka S, 2013, RHEUMATOLOGY, V52, P1271, DOI 10.1093/rheumatology/ket112; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wang LL, 2011, CLIN NEUROPHYSIOL, V122, P2505, DOI 10.1016/j.clinph.2011.04.021	16	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223265	10.1371/journal.pone.0223265	http://dx.doi.org/10.1371/journal.pone.0223265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574117	gold, Green Published			2022-12-26	WOS:000532376700041
J	Marshall, JAR; Reina, A; Bose, T				Marshall, James A. R.; Reina, Andreagiovanni; Bose, Thomas			Multiscale Modelling Tool: Mathematical modelling of collective behaviour without the maths	PLOS ONE			English	Article							STOCHASTIC SIMULATION; SOFTWARE; SYSTEMS	Collective behaviour is of fundamental importance in the life sciences, where it appears at levels of biological complexity from single cells to superorganisms, in demography and the social sciences, where it describes the behaviour of populations, and in the physical and engineering sciences, where it describes physical phenomena and can be used to design distributed systems. Reasoning about collective behaviour is inherently difficult, as the non-linear interactions between individuals give rise to complex emergent dynamics. Mathematical techniques have been developed to analyse systematically collective behaviour in such systems, yet these frequently require extensive formal training and technical ability to apply. Even for those with the requisite training and ability, analysis using these techniques can be laborious, time-consuming and error-prone. Together these difficulties raise a barrier-to-entry for practitioners wishing to analyse models of collective behaviour. However, rigorous modelling of collective behaviour is required to make progress in understanding and applying it. Here we present an accessible tool which aims to automate the process of modelling and analysing collective behaviour, as far as possible. We focus our attention on the general class of systems described by reaction kinetics, involving interactions between components that change state as a result, as these are easily understood and extracted from data by natural, physical and social scientists, and correspond to algorithms for component-level controllers in engineering applications. By providing simple automated access to advanced mathematical techniques from statistical physics, nonlinear dynamical systems analysis, and computational simulation, we hope to advance standards in modelling collective behaviour. At the same time, by providing expert users with access to the results of automated analyses, sophisticated investigations that could take significant effort are substantially facilitated. Our tool can be accessed online without installing software, uses a simple programmatic interface, and provides interactive graphical plots for users to develop understanding of their models.	[Marshall, James A. R.; Reina, Andreagiovanni; Bose, Thomas] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England	University of Sheffield	Marshall, JAR (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England.	james.marshall@sheffield.ac.uk	Reina, Andreagiovanni/ABA-3754-2021	Reina, Andreagiovanni/0000-0003-4745-992X; Marshall, James/0000-0002-1506-167X	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [647704]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC))	JARM acknowledges funding by the European Research Council (ERC - https://erc.europa.eu) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 647704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel John H, 2016, IEEE Life Sci Lett, V2, P35, DOI 10.1109/LLS.2017.2652448; Adalsteinsson D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-24; Mendes JA, 2009, ESTUD HUMAN, P17; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beer RD, 2018, DYNAMICA MATH PACKAG; Clewley R H, 2007, PYDSTOOL SOFTWARE EN; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Drawert B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005220; Galla T, 2010, J THEOR BIOL, V262, P186, DOI 10.1016/j.jtbi.2009.09.007; Gillespie DT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4801941; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Israel G., 1996, MATH REEL; Jones E., 2001, SCIPY OPEN SOURCE SC; Kiran M., 2010, P P 9 INT C AUTONOMO, P1633; Lee BD, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006561; Leff A, 2001, FIFTH IEEE INTERNATIONAL ENTERPRISE DISTRIBUTED OBJECT COMPUTING CONFERENCE, PROCEEDINGS, P118, DOI 10.1109/EDOC.2001.950428; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Maarleveld TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079345; Marshall James A R, 2019, MUMOT ONLINE MANUAL; Marshall James A R, 2019, MUMOT 1 0 0 RELEASE; Marshall JAR, 2007, VIENNA SERIES THEORE, P335; Mauch S, 2011, IEEE ACM T COMPUT BI, V8, P27, DOI 10.1109/TCBB.2009.47; Medley JK, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006220; Meurer A, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.103; Murray J. D., 2002, MATH BIOL; Pais D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073216; Penrose M., 2003, OXFORD STUDIES PROBA; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Reina A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140950; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Sayama H, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-2; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Thomas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041006; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; van Rossum G, 2008, PYTHON 3; Van Rossum Guido, 2001, PEP 8 STYLE GUIDE PY, P1565; Wilensky U., 1999, NETLOGO; Yildiz ME., 2013, ACM T EC COMPUTATION, V1, p19:1, DOI DOI 10.1145/2538508	42	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222906	10.1371/journal.pone.0222906	http://dx.doi.org/10.1371/journal.pone.0222906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568526	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000532364900015
J	Agi, A; Junin, R; Arsad, A; Abbas, A; Gbadamosi, A; Azli, NB; Oseh, J				Agi, Augustine; Junin, Radzuan; Arsad, Agus; Abbas, Azza; Gbadamosi, Afeez; Azli, Nur Bashirah; Oseh, Jeffrey			Synergy of the flow behaviour and disperse phase of cellulose nanoparticles in enhancing oil recovery at reservoir condition	PLOS ONE			English	Article							STARCH NANOPARTICLES; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL PROPERTIES; INTERFACIAL-TENSION; ACID-HYDROLYSIS; OKRA EXTRACTS; ULTRASOUND; SURFACTANT; WATER; NANOEMULSION	Ascorbic acid was used for the first time to synthesize cellulose nanoparticles (CNP) extracted from okra mucilage. The physical properties of the CNP including their size distribution, and crystalline structures were investigated. The rheological properties of the cellulose nanofluid (CNF) were compared with the bulk okra mucilage and commercial polymer xanthan. The interfacial properties of the CNF at the interface of oil-water (O/W) system were investigated at different concentrations and temperatures. The effects of the interaction between the electrolyte and ultrasonic were determined. Core flooding experiment was conducted at reservoir condition to justify the effect of the flow behaviour and disperse phase behaviour of CNF on additional oil recovery. The performance of the CNF was compared to conventional EOR chemical. The combined method of ultrasonic, weak-acid hydrolysis and nanoprecipitation were effective in producing spherical and polygonal nanoparticles with a mean diameter of 100 nm, increased yield of 51% and preserved crystallinity respectively. The zeta potential result shows that the CNF was stable, and the surface charge signifies long term stability of the fluid when injected into oil field reservoirs. The CNF, okra and xanthan exhibited shear-thinning and pseudoplastic behaviour. The IFT decreased with increase in concentration of CNF, electrolyte and temperature. The pressure drop data confirmed the stability of CNF at 120 degrees C and the formation of oil bank was enough to increase the oil recovery by 20%. CNF was found to be very effective in mobilizing residual oil at high-temperature high-pressure (HTHP) reservoir condition. The energy and cost estimations have shown that investing in ultrasonic-assisted weak-acid hydrolysis is easier, cost-effective, and can reduce energy consumption making the method economically advantageous compared to conventional methods.	[Agi, Augustine; Junin, Radzuan; Gbadamosi, Afeez; Azli, Nur Bashirah; Oseh, Jeffrey] Univ Teknol Malaysia, Fac Engn, Sch Chem & Energy Engn, Dept Petr Engn, Johor Baharu, Malaysia; [Junin, Radzuan; Arsad, Agus] Univ Teknol Malaysia, Inst Oil & Gas, Johor Baharu, Malaysia; [Abbas, Azza] Sudan Univ Sci & Technol, Khartoum, Sudan	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Abbas, A (corresponding author), Sudan Univ Sci & Technol, Khartoum, Sudan.	azzahashim2008@gmail.com	Arsad, Agus/E-5205-2011; Gbadamosi, Afeez/AAT-7679-2020; Aja, Agi Augustine/ABG-8655-2021	Arsad, Agus/0000-0002-0111-1939; AUGUSTINE, AGI/0000-0001-9586-2102; Oseh, Dr. Jeffrey Onuoma/0000-0003-4287-7591				Acikgoz C, 2016, ANADOLU U J SCI TE A, V17, P766; Adewuyi YG, 2015, ENERG FUEL, V29, P4998, DOI 10.1021/acs.energyfuels.5b00661; Agi Augustine, 2019, Journal of King Saud University - Engineering Sciences, V31, P296, DOI 10.1016/j.jksues.2018.01.002; Agi A, 2019, CHEM ENG PROCESS, V142, DOI 10.1016/j.cep.2019.107556; Agi A, 2019, ULTRASON SONOCHEM, V51, P214, DOI 10.1016/j.ultsonch.2018.10.023; Agi A, 2018, J PET EXPLOR PROD TE, V8, P1349, DOI 10.1007/s13202-018-0434-7; Agi A, 2018, J PETROL SCI ENG, V166, P577, DOI 10.1016/j.petrol.2018.03.097; Agoda-Tandjawa G, 2010, CARBOHYD POLYM, V80, P677, DOI 10.1016/j.carbpol.2009.11.045; Alba K, 2013, FOOD RES INT, V54, P1730, DOI 10.1016/j.foodres.2013.09.051; [Anonymous], [No title captured]; [Anonymous], 2008, J PHYS D APPL PHYS; [Anonymous], 2016, SOC PSYCHIAT PSYCHIA; Bayat AE, 2014, ENERG FUEL, V28, P6255, DOI 10.1021/ef5013616; Beck S, 2011, BIOMACROMOLECULES, V12, P167, DOI 10.1021/bm1010905; Bera A, 2014, J CHEM ENG DATA, V59, P89, DOI 10.1021/je400850c; Boufi S, 2018, ULTRASON SONOCHEM, V41, P327, DOI 10.1016/j.ultsonch.2017.09.033; Bubalo MC, 2013, GREEN PROCESS SYNTH, V2, P579, DOI 10.1515/gps-2013-0086; Chen WS, 2014, CELLULOSE, V21, P1517, DOI 10.1007/s10570-014-0172-z; Chin SF, 2011, CARBOHYD POLYM, V86, P1817, DOI 10.1016/j.carbpol.2011.07.012; De Rosa IM, 2010, COMPOS SCI TECHNOL, V70, P116, DOI 10.1016/j.compscitech.2009.09.013; Dickinson E, 1999, COLLOID SURFACE B, P139; Dong MZ, 2009, FUEL, V88, P1049, DOI 10.1016/j.fuel.2008.11.014; Dufresne A, 2008, MONOMERS, POLYMERS AND COMPOSITES FROM RENEWABLE RESOURCES, P401, DOI 10.1016/B978-0-08-045316-3.00019-3; Faiyas APA, 2017, DRY TECHNOL, V35, P1874, DOI 10.1080/07373937.2017.1283515; Gaikwad SG, 2008, ULTRASON SONOCHEM, V15, P554, DOI 10.1016/j.ultsonch.2007.06.011; GARCIAOCHOA F, 1992, J SCI FOOD AGR, V59, P97, DOI 10.1002/jsfa.2740590114; Ghorbanizadeh S, 2017, ENERG FUEL, V31, P9117, DOI 10.1021/acs.energyfuels.7b01394; Ghori MU, 2014, FOOD HYDROCOLLOID, V42, P342, DOI 10.1016/j.foodhyd.2014.04.024; Goncalves PM, 2014, LWT-FOOD SCI TECHNOL, V58, P21, DOI 10.1016/j.lwt.2014.03.015; Haaj SB, 2013, CARBOHYD POLYM, V92, P1625, DOI 10.1016/j.carbpol.2012.11.022; Haldorai Y, 2013, COMPOS INTERFACE, V20, P365, DOI 10.1080/15685543.2013.806124; Hielscher, 2005, ULTRASONIC PRODUCTIO, P138; James B. D., 2009, TECHNOECONOMIC ANAL; Karambeigi MS, 2015, J IND ENG CHEM, V29, P382, DOI 10.1016/j.jiec.2015.04.019; Kim HY, 2013, CARBOHYD POLYM, V98, P295, DOI 10.1016/j.carbpol.2013.05.085; Kumar N, 2018, ENERG FUEL, V32, P6452, DOI 10.1021/acs.energyfuels.8b00043; Le Corre D, 2010, BIOMACROMOLECULES, V11, P1139, DOI 10.1021/bm901428y; Leonelli C, 2010, CHEM ENG PROCESS, V49, P885, DOI 10.1016/j.cep.2010.05.006; Li MC, 2015, ACS SUSTAIN CHEM ENG, V3, P821, DOI 10.1021/acssuschemeng.5b00144; Li X, 2018, J CHEM-NY, V2018, DOI 10.1155/2018/7218901; Md Shahrodin NS., 2015, ADV MAT RES, V1113, P446, DOI [10.4028/www.scientific.net/AMR.1113.446, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.1113.446]; Montalbo-Lomboy M, 2011, BIOTECHNOL PROGR, V27, P1561, DOI 10.1002/btpr.677; Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b; Mullick A, 2018, ULTRASON SONOCHEM, V45, P65, DOI 10.1016/j.ultsonch.2018.03.002; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P2741, DOI 10.1016/j.biortech.2009.10.075; O'Sullivan J, 2016, FOOD HYDROCOLLOID, V53, P141, DOI 10.1016/j.foodhyd.2015.02.009; Ogunlaja S, 2017, CAN J CHEM ENG, V9999, P1; Ouajai S, 2005, POLYM DEGRAD STABIL, V89, P327, DOI 10.1016/j.polymdegradstab.2005.01.016; Patel VR, 2011, J ADV PHARM TECHNOL, V2, P81, DOI 10.4103/2231-4040.82950; Pei HH, 2012, ENERG FUEL, V26, P2911, DOI 10.1021/ef300206u; Pei XP, 2017, LANGMUIR, V33, P3787, DOI 10.1021/acs.langmuir.7b00035; Peshkovsky AS, 2014, CHEM ENG PROCESS, V82, P132, DOI 10.1016/j.cep.2014.05.007; Qiao CD, 2016, FOOD HYDROCOLLOID, V55, P19, DOI 10.1016/j.foodhyd.2015.11.005; Qin Y, 2016, IND CROP PROD, V87, P182, DOI 10.1016/j.indcrop.2016.04.038; Saha R, 2018, IND ENG CHEM RES, V57, P6364, DOI 10.1021/acs.iecr.8b00540; Sengkhamparn N, 2010, FOOD HYDROCOLLOID, V24, P35, DOI 10.1016/j.foodhyd.2009.07.007; Shafiei-Sabet S, 2014, CELLULOSE, V21, P3347, DOI 10.1007/s10570-014-0407-z; Shiran BS, 2013, ENERG FUEL, V27, P1223, DOI 10.1021/ef301538e; Singh V, 2006, INT J FOOD PROP, V9, P845, DOI 10.1080/10942910600698922; Suslick KS, 2011, ENCY PHYS SCI TECHNO; Thanatcha R., 2011, INT FOOD RES J, V18, P201; Trache D, 2017, NANOSCALE, V9, P1763, DOI 10.1039/c6nr09494e; Velmurugan R, 2012, BIOCHEM ENG J, V63, P1, DOI 10.1016/j.bej.2012.01.001; Wongsagonsup R, 2005, STARCH-STARKE, V57, P32, DOI 10.1002/star.200400311; Ye F, 2017, FOOD HYDROCOLLOID, V67, P37, DOI 10.1016/j.foodhyd.2016.12.041; Zabala A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148087; Zaharuddin ND, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/735891; Zhou L, 2016, CARBOHYD POLYM, V153, P445, DOI 10.1016/j.carbpol.2016.07.119	68	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0220778	10.1371/journal.pone.0220778	http://dx.doi.org/10.1371/journal.pone.0220778			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560699	gold, Green Published			2022-12-26	WOS:000532353700005
J	Balasuriya, CND; Larose, TL; Mosti, MP; Evensen, KAI; Jacobsen, GW; Thorsby, PM; Stunes, AK; Syversen, U				Balasuriya, Chandima N. D.; Larose, Tricia L.; Mosti, Mats P.; Evensen, Kari Anne, I; Jacobsen, Geir W.; Thorsby, Per M.; Stunes, Astrid Kamilla; Syversen, Unni			Maternal serum retinol, 25(OH)D and 1,25 (OH)(2)D concentrations during pregnancy and peak bone mass and trabecular bone score in adult offspring at 26-year follow-up	PLOS ONE			English	Article							VITAMIN-D STATUS; DEVELOPMENTAL ORIGINS; MINERAL CONTENT; BETA-CAROTENE; HIP FRACTURE; A-DEFICIENCY; RISK; ACID; METABOLISM; SUPPLEMENTATION	Background Vitamin A and D deficiency is prevalent in pregnant women worldwide. Both vitamins are involved in fetal skeletal development. A positive association between maternal vitamin D levels and offspring bone mineral density (BMD) at adulthood has been observed. The impact of maternal vitamin A status in pregnancy on offspring peak bone mass remains unclear. Method and findings Forty-one mother-child pairs were recruited from a population-based prospective cohort study in Trondheim, Norway, where pregnant women were followed from gestational week 17. Their term-born infants were followed from birth (1986-88). Regression analyses were performed for vitamin A (retinol), 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] in maternal serum (gestational weeks 17, 33, 37) and cord blood. Offspring BMD and spine trabecular bone score (TBS), a measure of bone quality, were analyzed by dual x-ray absorptiometry at 26 years. Average levels during pregnancy of retinol, 25(OH)D and 1,25(OH)2D were 1.66 (0.32) mu mol/ L, 59.0 (20.6) nmol/L, and 251.3 (62.4) pmol/L, respectively. 1,25(OH)2D levels were similar in those with 25(OH)D levels < 30 and > 75 nmol/L. After adjustment for maternal age, BMI, smoking, and education, and offspring birth weight, maternal serum retinol was positively associated with offspring spine BMD [mean change 30.8 (CI 7.6, 54.0) mg/cm(2) per 0.2 mu mol/L retinol], and with offspring TBS, although non-significant (p = 0.08). No associations were found between maternal 25(OH)D and 1,25 (OH)2D levels and offspring bone parameters. Vitamin levels in cord blood were not associated with offspring BMD or TBS. Conclusions This is the first study to show an association between maternal vitamin A status and offspring peak bone mass. Our findings may imply increase future risk for osteoporotic fracture in offspring of mothers with suboptimal vitamin A level. No associations were observed between 25(OH)D and 1,25(OH)2D and offspring BMD.	[Balasuriya, Chandima N. D.; Larose, Tricia L.; Mosti, Mats P.; Evensen, Kari Anne, I; Stunes, Astrid Kamilla; Syversen, Unni] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, NTNU, Trondheim, Norway; [Balasuriya, Chandima N. D.; Syversen, Unni] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Larose, Tricia L.] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Nursing,NTNU, Trondheim, Norway; [Mosti, Mats P.; Stunes, Astrid Kamilla] Trondheim Reg & Univ Hosp, St Olavs Hosp, Trondheim, Norway; [Evensen, Kari Anne, I; Jacobsen, Geir W.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, NTNU, Trondheim, Norway; [Evensen, Kari Anne, I] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway; [Thorsby, Per M.] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Aker Hosp, Oslo, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Balasuriya, CND (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, NTNU, Trondheim, Norway.; Balasuriya, CND (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway.	Chandima.balasuriya@ntnu.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Stunes, Astrid Kamilla/B-9901-2008; Thorsby, Per Medboe/A-1268-2017	Stunes, Astrid Kamilla/0000-0003-1074-5199; Jacobsen, Geir/0000-0002-3564-0871; Evensen, Kari Anne I./0000-0002-0129-0164; Thorsby, Per Medboe/0000-0002-9615-1035	Central Norway Regional Health Authority; Norwegian University of Science and Technology;  [2013/636/REK]	Central Norway Regional Health Authority; Norwegian University of Science and Technology; 	This study was supported by grants from the Liaison Committee between Central Norway Regional Health Authority and the Norwegian University of Science and Technology. Grant nr: 2013/636/REK (midt) was received by the corresponding author CNDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WHO GLOBAL DATABASE; BAKKETEIG LS, 1993, ACTA OBSTET GYN SCAN, V72, P273, DOI 10.3109/00016349309068037; Bar-El Dadon S, 2017, CRIT REV FOOD SCI, V57, P2404, DOI 10.1080/10408398.2015.1060940; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Caire-Juvera G, 2009, AM J CLIN NUTR, V89, P323, DOI 10.3945/ajcn.2008.26451; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Chen GD, 2015, BONE, V79, P110, DOI 10.1016/j.bone.2015.05.028; Conaway HH, 2013, ENDOCR REV, V34, P766, DOI 10.1210/er.2012-1071; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Cruz S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090989; De Luca F, 2000, ENDOCRINOLOGY, V141, P346, DOI 10.1210/en.141.1.346; Delgado-Calle J, 2012, CURR GENOMICS, V13, P252, DOI 10.2174/138920212800543129; Elder CJ, 2014, LANCET, V383, P1665, DOI 10.1016/S0140-6736(13)61650-5; Faure H, 2006, EUR J CLIN NUTR, V60, P706, DOI 10.1038/sj.ejcn.1602372; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Garcia AH, 2017, LANCET DIABETES ENDO, V5, P367, DOI 10.1016/S2213-8587(17)30064-5; Green AC, 2016, J STEROID BIOCHEM, V155, P135, DOI 10.1016/j.jsbmb.2015.09.036; Green AC, 2015, J STEROID BIOCHEM, V150, P46, DOI 10.1016/j.jsbmb.2015.03.005; Gustafsson MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195041; Handel MN, 2016, AM J CLIN NUTR, V104, P1183, DOI 10.3945/ajcn.116.130146; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Harvey NC, 2014, J BONE MINER RES, V29, P600, DOI 10.1002/jbmr.2056; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Holvik K, 2015, AM J CLIN NUTR, V102, P1289, DOI 10.3945/ajcn.115.110528; Hyde NK, 2017, OSTEOPOROSIS INT, V28, P3407, DOI 10.1007/s00198-017-4208-8; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kaiser ME, 2003, DEV BIOL, V257, P14, DOI 10.1016/S0012-1606(03)00044-7; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; Lim LS, 2004, OSTEOPOROSIS INT, V15, P552, DOI 10.1007/s00198-003-1577-y; Maia SB, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030681; Maia SB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091271; Mata-Granados JM, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0124-5; Mata-Granados JM, 2010, CLIN BIOCHEM, V43, P1064, DOI 10.1016/j.clinbiochem.2010.06.001; Mattinzoli D, 2012, EUR CELLS MATER, V24, P403, DOI 10.22203/eCM.v024a29; McCauley ME, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008666.pub3; Moon RJ, 2015, EUR J ENDOCRINOL, V173, pR69, DOI 10.1530/EJE-14-0826; Niemeier A, 2008, BONE, V43, P230, DOI 10.1016/j.bone.2008.03.022; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Soliman Ashraf, 2013, Indian J Endocrinol Metab, V17, P697, DOI 10.4103/2230-8210.113764; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Wirth JP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030190; Wood CL, 2015, CURR GENOMICS, V16, P411, DOI 10.2174/1389202916666150817202217; Wu AM, 2014, J BONE MINER RES, V29, P2032, DOI 10.1002/jbmr.2237; Yakoob MY, 2017, J DEV BEHAV PEDIATR, V38, P665, DOI 10.1097/DBP.0000000000000482; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222712	10.1371/journal.pone.0222712	http://dx.doi.org/10.1371/journal.pone.0222712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557195	Green Published, gold			2022-12-26	WOS:000532345500030
J	de Oliveira, AS; Gazolla, PAR; Oliveira, AFCD; Pereira, WL; Viol, LCD; Maia, AFD; Santos, EG; da Silva, IEP; Mendes, TAD; da Silva, AM; Dias, RS; da Silva, CC; Poleto, MD; Teixeira, RR; de Paula, SO				de Oliveira, Andre S.; Gazolla, Poliana A. R.; Oliveira, Ana Flavia C. da S.; Pereira, Wagner L.; Viol, Livia C. de S.; Maia, Angelica F. da S.; Santos, Edjon G.; da Silva, Italo E. P.; de Oliveira Mendes, Tiago A.; da Silva, Adalberto M.; Dias, Roberto S.; da Silva, Cynthia C.; Poleto, Marcelo D.; Teixeira, Robson R.; de Paula, Sergio O.			Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-11; SMALL-MOLECULE INHIBITORS; DENGUE VIRUS; MEDICINAL CHEMISTRY; ESSENTIAL OIL; ANTIPLATELET ACTIVITY; FLAVIVIRAL PROTEASES; NS2B-NS3 PROTEASE; NS3 PROTEIN; ZIKA	The West Nile Virus (WNV) NS2B-NS3 protease is an attractive target for the development of therapeutics against this arboviral pathogen. In the present investigation, the screening of a small library of fifty-eight synthetic compounds against the NS2-NB3 protease of WNV is described. The following groups of compounds were evaluated: 3-(2-aryl-2-oxoethyl)isobenzofuran-1(3H)-ones; eugenol derivatives bearing 1,2,3-triazolic functionalities; and indan-1,3-diones with 1,2,3-triazolic functionalities. The most promising of these was a eugenol derivative, namely 4-(3-(4-allyl-2-methoxyphenoxy)-propyl)-1-(2-bromobenzyl)-1H-1,2,3-triazole (35), which inhibited the protease with IC50 of 6.86 mu mol L-1. Enzyme kinetic assays showed that this derivative of eugenol presents competitive inhibition behaviour. Molecular docking calculations predicted a recognition pattern involving the residues His(51) and Ser(135), which are members of the catalytic triad of the WNV NS2B-NS3 protease.	[de Oliveira, Andre S.; Oliveira, Ana Flavia C. da S.; Santos, Edjon G.; da Silva, Italo E. P.; Dias, Roberto S.; da Silva, Cynthia C.; Poleto, Marcelo D.; de Paula, Sergio O.] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [de Oliveira, Andre S.; Gazolla, Poliana A. R.; Oliveira, Ana Flavia C. da S.; Pereira, Wagner L.; Viol, Livia C. de S.; Maia, Angelica F. da S.] Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Fazenda Biribiri, MG, Brazil; [de Oliveira Mendes, Tiago A.] Univ Fed Vicosa, Dept Bioquim Biol Mol, Vicosa, MG, Brazil; [da Silva, Adalberto M.; Teixeira, Robson R.] Univ Fed Vicosa, Dept Quim, Vicosa, MG, Brazil; [da Silva, Adalberto M.] Inst Fed Educ Ciencia & Tecnol Catarinense, Araquari, SC, Brazil	Universidade Federal de Vicosa; Instituto Federal do Norte de Minas Gerais (IFNMG); Universidade Federal de Vicosa; Universidade Federal de Vicosa	de Paula, SO (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.; Teixeira, RR (corresponding author), Univ Fed Vicosa, Dept Quim, Vicosa, MG, Brazil.	robsonr.teixeira@ufv.br; depaula@ufv.br	Polêto, Marcelo D./GVU-7635-2022; Mendes, Tiago/AAG-1709-2021	Polêto, Marcelo D./0000-0001-9210-690X; Mendes, Tiago/0000-0002-5569-4893; Silva, Italo/0000-0003-0579-8157; Teixeira, Robson R/0000-0003-3181-1108	Instituto Federal de Educacao, Ciencia e Tecnologia do Norte de Minas Gerais (IFNMG); Fundacao de Amparo a Pesquisa Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Instituto Federal de Educacao, Ciencia e Tecnologia do Norte de Minas Gerais (IFNMG); Fundacao de Amparo a Pesquisa Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The following authors of this paper received scholarships during this research: ASO and AFCSO from the Instituto Federal de Educacao, Ciencia e Tecnologia do Norte de Minas Gerais (IFNMG - www.ifnmg.edu.br); EGS, IEPS and AMS from the Fundacao de Amparo a Pesquisa Estado de Minas Gerais (FAPEMIG - www.fapemig.br); RSD, TAOM and SOP from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ -www.memoria.cnpq.br); PARG, WLP, LCSV and AFSM from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -www.capes.gov.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; [Anonymous], 2016, LIGPREP SR; Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055; Artico M, 1998, J MED CHEM, V41, P3948, DOI 10.1021/jm9707232; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014; Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653; Benencia F, 2000, PHYTOTHER RES, V14, P495, DOI 10.1002/1099-1573(200011)14:7&lt;495::AID-PTR650&gt;3.0.CO;2-8; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Bhakat S, 2014, EUR J MED CHEM, V87, P677, DOI 10.1016/j.ejmech.2014.10.010; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Borgati TF, 2013, J BRAZIL CHEM SOC, V24, P953, DOI 10.5935/0103-5053.20130121; Cardozo JAB-F, 2005, REV COLOMB CIENC QUI, V34, P69; Moreira FJC, 2016, WATER RESOUR IRRIG M, V5, P9; Chaskopoulou A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1736-6; Chaskopoulou A, 2013, VECTOR-BORNE ZOONOT, V13, P723, DOI 10.1089/vbz.2012.1176; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Dai JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061026; Daniel AN, 2009, REV BRAS FARMACOGN, V19, P212, DOI 10.1590/S0102-695X2009000200006; Davidson W, 2004, ANAL CHEM, V76, P2095, DOI 10.1021/ac035335o; de Oliveira AS, 2014, J BRAZIL CHEM SOC, V25, P1759, DOI 10.5935/0103-5053.20140057; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FLATAU E, 1981, ISRAEL J MED SCI, V17, P1057; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fujisawa S, 2016, ADV EXP MED BIOL, V929, P45, DOI 10.1007/978-3-319-41342-6_3; Goudreau N, 2007, BIOORGAN MED CHEM, V15, P2690, DOI 10.1016/j.bmc.2007.01.036; Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497; Huang XZ, 2012, MOLECULES, V17, P4219, DOI 10.3390/molecules17044219; Islamuddin M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005011; Khalilzadeh E, 2016, RES PHARM SCI, V11, P293, DOI 10.4103/1735-5362.189297; Kildea MA, 2004, AQUACULTURE, V232, P265, DOI 10.1016/S0044-8486(03)00483-6; Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280; Kurian R., 2006, Indian Journal of Pharmacology, V38, P341; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Lionnet L, 2010, PHYTOTHER RES, V24, P1645, DOI 10.1002/ptr.3174; Liu YY, 2003, BIOCHEMISTRY-US, V42, P8862, DOI 10.1021/bi034661v; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Ma FF, 2012, J THROMB THROMBOLYS, V33, P64, DOI 10.1007/s11239-011-0647-9; Mahadlek J, 2010, J MET MAT MINER, V20, P159; Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Ohkubo T, 1997, J DENT RES, V76, P848, DOI 10.1177/00220345970760040501; Oliveira AFCD, 2018, EUR J MED CHEM, V149, P98, DOI 10.1016/j.ejmech.2018.02.037; Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081; Park SH, 2011, ARCH PHARM RES, V34, P501, DOI 10.1007/s12272-011-0320-z; Peng Y, 2004, J CARDIOVASC PHARM, V43, P876, DOI 10.1097/00005344-200406000-00018; Perrin DD, 1988, PURIFICATION LAB CHE; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Schrodinger, 2016, GLID; Schrodinger, 2016, SCHRODINGER RELEASE; Schrodinger, 2016, MAESTR; Serkedjieva J, 1999, J ETHNOPHARMACOL, V64, P59, DOI 10.1016/S0378-8741(98)00095-6; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6; Tanaka S, 2004, CONTACT DERMATITIS, V51, P288, DOI 10.1111/j.0105-1873.2004.00446.x; Teixeira RR, 2013, MOLECULES, V18, P1881, DOI 10.3390/molecules18021881; Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337; Tiew KC, 2012, BIOORGAN MED CHEM, V20, P1213, DOI 10.1016/j.bmc.2011.12.047; Timiri AK, 2016, EUR J MED CHEM, V117, P125, DOI 10.1016/j.ejmech.2016.04.008; Tragoolpua Y, 2007, PHYTOTHER RES, V21, P1153, DOI 10.1002/ptr.2226; Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yang H, 2007, BIOORG MED CHEM LETT, V17, P5210, DOI 10.1016/j.bmcl.2007.06.082; Yoakim C, 2003, BIOORG MED CHEM LETT, V13, P2539, DOI 10.1016/S0960-894X(03)00510-9; Yoganathan K, 2003, J NAT PROD, V66, P1116, DOI 10.1021/np030146m	72	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223017	10.1371/journal.pone.0223017	http://dx.doi.org/10.1371/journal.pone.0223017			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557229	Green Submitted, gold, Green Published			2022-12-26	WOS:000532345500060
J	Im, I; Son, YS; Jung, KB; Kang, I; Teh, BE; Lee, KB; Son, MY; Kim, J				Im, Ilkyun; Son, Ye Seul; Jung, Kwang Bo; Kang, Insoo; Teh, Boon-Eng; Lee, Kyung-Bok; Son, Mi-Young; Kim, Janghwan			Mass cytometry?based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						induced pluripotent stem cell; iPS cell; iPSC; reprogramming; pluripotency; cell cycle; computational biology; mass cytometry; OCT4; single-cell analysis; spanning-tree progression analysis of density-normalized events (SPADE); TRA-1?60	SOMATIC-CELLS; MOUSE FIBROBLASTS; MOLECULAR ROADMAP; CYCLE; STATE; PHOSPHORYLATION; PROGRESSION; MECHANISMS; TRA-1-60; DISTINCT	Human induced pluripotent stem cells (hiPSCs) are reprogrammed from somatic cells and are regarded as promising sources for regenerative medicine and disease research. Recently, techniques for analyses of individual cells, such as single-cell RNA-Seq and mass cytometry, have been used to understand the stem cell reprogramming process in the mouse. However, the reprogramming process in hiPSCs remains poorly understood. Here we used mass cytometry to analyze the expression of pluripotency and cell cycle markers in the reprogramming of human stem cells. We confirmed that, during reprogramming, the main cell population was shifted to an intermediate population consisting of neither fibroblasts nor hiPSCs. Detailed population analyses using computational approaches, including dimensional reduction by spanning-tree progression analysis of density-normalized events, PhenoGraph, and diffusion mapping, revealed several distinct cell clusters representing the cells along the reprogramming route. Interestingly, correlation analysis of various markers in hiPSCs revealed that the pluripotency marker TRA-1?60 behaves in a pattern that is different from other pluripotency markers. Furthermore, we found that the expression pattern of another pluripotency marker, octamer-binding protein 4 (OCT4), was distinctive in the pHistone-H3(high) population (M phase) of the cell cycle. To the best of our knowledge, this is the first mass cytometry?based investigation of human reprogramming and pluripotency. Our analysis elucidates several aspects of hiPSC reprogramming, including several intermediate cell clusters active during the process of reprogramming and distinctive marker expression patterns in hiPSCs.	[Im, Ilkyun; Son, Ye Seul; Jung, Kwang Bo; Son, Mi-Young; Kim, Janghwan] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahag Ro, Daejeon 34141, South Korea; [Son, Ye Seul; Jung, Kwang Bo; Son, Mi-Young; Kim, Janghwan] Sch Biosci, Korea Res Inst Biosci & Biotechnol, Korea Univ Sci & Technol, Dept Funct Genom, 217 Gajeong Ro, Daejeon 34113, South Korea; [Kang, Insoo] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Kang, Insoo] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Kang, Insoo] Yale Univ, Sch Med, Dept Orthoped & Rehabil, New Haven, CT 06520 USA; [Teh, Boon-Eng] Fluidigm Corp, San Francisco, CA 94080 USA; [Lee, Kyung-Bok] Korea Basic Sci Inst, Ctr Res Equipment, 162 Yeongudanji Ro, Cheongju 28119, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Yale University; Yale University; Yale University; Korea Basic Science Institute (KBSI)	Son, MY; Kim, J (corresponding author), Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahag Ro, Daejeon 34141, South Korea.; Son, MY; Kim, J (corresponding author), Sch Biosci, Korea Res Inst Biosci & Biotechnol, Korea Univ Sci & Technol, Dept Funct Genom, 217 Gajeong Ro, Daejeon 34113, South Korea.	myson@kribb.re.kr; janghwan.kim@kribb.re.kr			Samsung Research Funding Center of Samsung Electronics [SRFC-MA1601-06]; Korea Research Institute of Bioscience and Biotechnology initiative program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Samsung Research Funding Center of Samsung Electronics(Samsung); Korea Research Institute of Bioscience and Biotechnology initiative program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Samsung Research Funding Center of Samsung Electronics under Project SRFC-MA1601-06 and a Korea Research Institute of Bioscience and Biotechnology initiative program. The authors declare that they have no conflicts of interest with the contents of this article.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Badcock G, 1999, CANCER RES, V59, P4715; Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bang JS, 2018, ANIM CELLS SYST, V22, P132, DOI 10.1080/19768354.2018.1451367; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Brimble SN, 2007, STEM CELLS, V25, P54, DOI 10.1634/stemcells.2006-0232; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Cols M, 2016, J ALLERGY CLIN IMMUN, V137, P1206, DOI 10.1016/j.jaci.2015.09.013; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Emmett Stevan R., 2004, V296, P197; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzales KAU, 2015, CELL, V162, P564, DOI 10.1016/j.cell.2015.07.001; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hindley C, 2013, BIOCHEM J, V451, P135, DOI 10.1042/BJ20121627; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katz RA, 2005, J CELL BIOCHEM, V94, P880, DOI 10.1002/jcb.20358; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu LJ, 2017, NAT CELL BIOL, V19, P177, DOI 10.1038/ncb3474; Lujan E, 2015, NATURE, V521, P352, DOI 10.1038/nature14274; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasque V, 2010, COLD SH Q B, V75, P189, DOI 10.1101/sqb.2010.75.002; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schoeftner S, 2013, STEM CELLS, V31, P717, DOI 10.1002/stem.1315; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Son MY, 2017, NEUROPATH APPL NEURO, V43, P584, DOI 10.1111/nan.12396; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang Q, 2011, ONCOGENE, V30, P3943, DOI 10.1038/onc.2011.105; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017; Zhou Yi-ye, 2013, Genomics Proteomics & Bioinformatics, V11, P284, DOI 10.1016/j.gpb.2013.09.008; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	56	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18547	18556		10.1074/jbc.RA119.009061	http://dx.doi.org/10.1074/jbc.RA119.009061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31570522	hybrid, Green Published			2022-12-26	WOS:000507618800005
J	Park, SH; Ham, S; Lee, A; Moller, A; Kim, TS				Park, Su-Ho; Ham, Sunyoung; Lee, Arim; Moller, Andreas; Kim, Tae Sung			NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NLRP3; nuclear translocation; T-cell biology; cell differentiation; forkhead box P3 (FOXP3); protein-protein interaction; gene knockout; transfection; Western blot; immunosuppression; Inflammasome-independent pathway; Kpna2; negative regulator; Treg differentiation	LEUCINE-RICH REPEAT; FOXP3 EXPRESSION; INFLAMMASOME; PROTEIN; CELLS; ACTIVATION; PYROPTOSIS; MECHANISM	Na?ve CD4(+) T cells in the periphery differentiate into regulatory T cells (Tregs) in which Foxp3 is expressed for their suppressive function. NLRP3, a pro-inflammatory molecule, is known to be involved in inflammasome activation associated with several diseases. Recently, the expression of NLRP3 in CD4(+) T cells, as well as in myeloid cells, has been described; however, a role of T cell?intrinsic NLRP3 in Treg differentiation remains unknown. Here, we report that NLRP3 impeded the expression of Foxp3 independent of inflammasome activation in Tregs. NLRP3-deficient mice elevate Treg generation in various organs in the de novo pathway. NLRP3 deficiency increased the amount and suppressive activity of Treg populations, whereas NLRP3 overexpression reduced Foxp3 expression and Treg abundance. Importantly, NLRP3 interacted with Kpna2 and translocated to the nucleus from the cytoplasm under Treg-polarizing conditions. Taken together, our results identify a novel role for NLRP3 as a new negative regulator of Treg differentiation, mediated via its interaction with Kpna2 for nuclear translocation.	[Park, Su-Ho; Lee, Arim; Kim, Tae Sung] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, 145 Anam Ro, Seoul 02841, South Korea; [Ham, Sunyoung; Moller, Andreas] QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Brisbane, Qld 4006, Australia; [Ham, Sunyoung; Moller, Andreas] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld, Australia	Korea University; QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT)	Kim, TS (corresponding author), Korea Univ, Rm 607,Hana Sci Bldg,145 Anam Ro, Seoul 02841, South Korea.	tskim@korea.ac.kr	Möller, Andreas/O-1063-2015	Möller, Andreas/0000-0002-8618-6998	National Research Foundation of Korea (NRF) [NRF-2017R1A2B2009442]; Global Ph.D. Fellowship Program through the National Research Foundation of Korea - Ministry of Education [2015H1A2A1031021]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Global Ph.D. Fellowship Program through the National Research Foundation of Korea - Ministry of Education	This work was supported by National Research Foundation of Korea (NRF) Grant NRF-2017R1A2B2009442 (to T.S.K) and by the Global Ph.D. Fellowship Program, Project No.: 2015H1A2A1031021, through the National Research Foundation of Korea funded by the Ministry of Education (to S.-H.P). The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 2016, CIRC RES, V118, P1457, DOI 10.1161/CIRCRESAHA.116.308699; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Bullon P, 2017, CURR DRUG TARGETS, V18, P997, DOI 10.2174/1389450117666160709013850; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; Chen SZ, 2013, PROTEIN CELL, V4, P251, DOI 10.1007/s13238-013-2128-8; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fan MY, 2018, CELL REP, V25, P1204, DOI 10.1016/j.celrep.2018.10.002; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; Gu J, 2018, MICROB PATHOGENESIS, V121, P40, DOI 10.1016/j.micpath.2018.05.009; Huehn J, 2015, SEMIN IMMUNOL, V27, P10, DOI 10.1016/j.smim.2015.02.002; Hwang SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07254-2; Ichiyama K, 2009, INT IMMUNOL, V21, P881, DOI 10.1093/intimm/dxp054; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim MS, 2014, J LEUKOCYTE BIOL, V95, P461, DOI 10.1189/jlb.0613310; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lech M, 2015, ANN RHEUM DIS, V74, P2224, DOI 10.1136/annrheumdis-2014-205496; Lee W, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.157; Liu RR, 2015, ONCOTARGET, V6, P33456, DOI 10.18632/oncotarget.5587; Lo YH, 2013, BLOOD, V121, P3185, DOI 10.1182/blood-2012-05-432104; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Schonle A, 2016, BLOOD, V127, P1930, DOI 10.1182/blood-2015-09-672428; Shalev I, 2011, SEMIN IMMUNOL, V23, P282, DOI 10.1016/j.smim.2011.04.003; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Singh Y, 2016, JOVE-J VIS EXP, DOI 10.3791/54698; Vakrakou AG, 2018, J AUTOIMMUN, V91, P23, DOI 10.1016/j.jaut.2018.02.010; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115; Zhang A, 2018, HUM IMMUNOL, V79, P57, DOI 10.1016/j.humimm.2017.10.013; Zhang XL, 2018, CELL REP, V24, P607, DOI 10.1016/j.celrep.2018.06.052; Zhao CM, 2018, CLIN IMMUNOL, V197, P154, DOI 10.1016/j.clim.2018.09.007	40	19	20	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17951	17961		10.1074/jbc.RA119.010545	http://dx.doi.org/10.1074/jbc.RA119.010545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31597697	hybrid, Green Published			2022-12-26	WOS:000504206800021
J	Chen, J; Wang, SK; Zhang, ZH; Richards, CI; Xu, R				Chen, Jie; Wang, Shike; Zhang, Zhihui; Richards, Christopher, I; Xu, Ren			Heat shock protein 47 (HSP47) binds to discoidin domain?containing receptor 2 (DDR2) and regulates its protein stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein (HSP); protein stability; protein?protein interaction; cell invasion; protein dynamic	CHAPERONE HSP47; STRESS-PROTEIN; COLLAGEN; GLYCOSYLATION; METASTASIS; EXPRESSION; INVASION	Cell?collagen interactions are crucial for cell migration and invasion during cancer development and progression. Heat shock protein 47 (HSP47) is an endoplasmic reticulum?resident molecular chaperone that facilitates collagen maturation and deposition. It has been previously shown that HSP47 expression in cancer cells is crucial for cancer invasiveness. However, exogenous collagen cannot rescue cell invasion in HSP47-silenced cancer cells, suggesting that other HSP47 targets contribute to cancer cell invasion. Here, we show that HSP47 expression is required for the stability and cell-surface expression of discoidin domain?containing receptor 2 (DDR2) in breast cancer tissues. HSP47 silencing reduced DDR2 protein stability, accompanied by suppressed cell migration and invasion. Co-immunoprecipitation results revealed that HSP47 binds to the DDR2 ectodomain. Using a photoconvertible technique and total internal reflection fluorescence microscopy, we further demonstrate that HSP47 expression significantly sustains the membrane localization of the DDR2 protein. These results suggest that binding of HSP47 to DDR2 increases DDR2 stability and regulates its membrane dynamics and thereby enhances cancer cell migration and invasion. Given that DDR2 has a crucial role in the epithelial-to-mesenchymal transition and cancer progression, targeting the HSP47?DDR2 interaction might be a potential strategy for inhibiting DDR2-dependent cancer progression.	[Chen, Jie; Wang, Shike; Xu, Ren] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Xu, Ren] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Zhang, Zhihui; Richards, Christopher, I] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Chen, Jie] Univ Pittsburgh, Pulm Allergy & Crit Care Med, 3459 5th Ave, Pittsburgh, PA 15213 USA	University of Kentucky; University of Kentucky; University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xu, R (corresponding author), 789 S Limestone Rd,Biopharm 553, Lexington, KY 40536 USA.	ren.xu2010@uky.edu	zhang, zh/GWV-4677-2022; wang, shike/AAR-3956-2020		NCI, National Institutes of Health [1R01CA207772, 1R01CA215095]; Department of Defense Grant [W81XWH-15-1-0052]; NATIONAL CANCER INSTITUTE [R01CA207772, R01CA215095] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants 1R01CA207772 and 1R01CA215095 from NCI, National Institutes of Health (to R. X.) and Department of Defense Grant W81XWH-15-1-0052 (to R. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Bertoletti F, 2017, NUCLEIC ACIDS RES, V45, P9441, DOI 10.1093/nar/gkx619; Chen JJ, 2007, BRIT J DERMATOL, V156, P1188, DOI 10.1111/j.1365-2133.2007.07898.x; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Gonzalez ME, 2017, CELL REP, V18, P1215, DOI 10.1016/j.celrep.2016.12.079; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hebert C, 1999, J CELL BIOCHEM, V73, P248, DOI 10.1002/(SICI)1097-4644(19990501)73:2<248::AID-JCB11>3.0.CO;2-A; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Ishikawa Y, 2018, J BIOL CHEM, V293, P13707, DOI 10.1074/jbc.RA117.000758; Ito S, 2019, J BIOL CHEM, V294, P2133, DOI 10.1074/jbc.TM118.002812; Itoh Y, 2018, CELL ADHES MIGR, V12, P378, DOI 10.1080/19336918.2018.1460011; Jayaprakash NG, 2017, BIOCHEM J, V474, P2333, DOI 10.1042/BCJ20170111; Jiang XC, 2017, ACS CHEM NEUROSCI, V8, P128, DOI 10.1021/acschemneuro.6b00253; Kuroda K, 1998, J INVEST DERMATOL, V111, P1023, DOI 10.1046/j.1523-1747.1998.00437.x; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Maeyama M, 2008, CANCER, V113, P2823, DOI 10.1002/cncr.23900; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; TAKECHI H, 1992, EUR J BIOCHEM, V206, P323, DOI 10.1111/j.1432-1033.1992.tb16930.x; Phan TN, 2013, BIOSCI BIOTECH BIOCH, V77, P1907, DOI 10.1271/bbb.130351; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Walsh LA, 2011, MATRIX BIOL, V30, P243, DOI 10.1016/j.matbio.2011.03.007; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wu ZB, 2016, BRAIN PATHOL, V26, P31, DOI 10.1111/bpa.12256; Xie BH, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0218-6; Xiong GF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06893-9; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang H, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1030-y; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang Zhihui, 2018, Journal of Biological Methods, V5, pe105, DOI 10.14440/jbm.2018.266; Zhu JQ, 2015, CANCER RES, V75, P1580, DOI 10.1158/0008-5472.CAN-14-1027; Zurlo G, 2016, BBA-REV CANCER, V1866, P208, DOI 10.1016/j.bbcan.2016.09.004	39	6	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16846	16854		10.1074/jbc.RA119.009312	http://dx.doi.org/10.1074/jbc.RA119.009312			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31570520	Green Published, hybrid			2022-12-26	WOS:000501801900030
J	Wu, LZ; Belyaeva, O; Adams, MK; Klyuyeva, AV; Lee, SA; Goggans, KR; Kesterson, RA; Popov, KM; Kedishvili, NY				Wu, Lizhi; Belyaeva, Olga; Adams, Mark K.; Klyuyeva, Alla, V; Lee, Seung-Ah; Goggans, Kelli R.; Kesterson, Robert A.; Popov, Kirill M.; Kedishvili, Natalia Y.			Mice lacking the epidermal retinol dehydrogenases SDR16C5 and SDR16C6 display accelerated hair growth and enlarged meibomian glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin A; retinol; carotenoid; dehydrogenase; retinoic acid; retinaldehyde; retinol dehydrogenase epidermal (RDHE); short-chain dehydrogenase; hair follicle; epidermis; meibomian gland	SHORT-CHAIN DEHYDROGENASE/REDUCTASE; ALL-TRANS-RETINOL; FOLLICLE STEM-CELLS; BETA-CATENIN; ACID BIOSYNTHESIS; ADULT; SKIN; EXPRESSION; DEFINES; RDH10	Retinol dehydrogenases catalyze the rate-limiting step in the biosynthesis of retinoic acid, a bioactive lipid molecule that regulates the expression of hundreds of genes by binding to nuclear transcription factors, the retinoic acid receptors. Several enzymes exhibit retinol dehydrogenase activities in vitro; however, their physiological relevance for retinoic acid biosynthesis in vivo remains unclear. Here, we present evidence that two murine epidermal retinol dehydrogenases, short-chain dehydrogenase/reductase family 16C member 5 (SDR16C5) and SDR16C6, contribute to retinoic acid biosynthesis in living cells and are also essential for the oxidation of retinol to retinaldehyde in vivo. Mice with targeted knockout of the more catalytically active SDR16C6 enzyme have no obvious phenotype, possibly due to functional redundancy, because Sdr16c5 and Sdr16c6 exhibit an overlapping expression pattern during later developmental stages and in adulthood. Mice that lack both enzymes are viable and fertile but display accelerated hair growth after shaving and also enlarged meibomian glands, consistent with a nearly 80% reduction in the retinol dehydrogenase activities of skin membrane fractions from the Sdr16c5/Sdr16c6 double-knockout mice. The up-regulation of hair-follicle stem cell genes is consistent with reduced retinoic acid signaling in the skin of the double-knockout mice. These results indicate that the retinol dehydrogenase activities of murine SDR16C5 and SDR16C6 enzymes are not critical for survival but are responsible for most of the retinol dehydrogenase activity in skin, essential for the regulation of the hair-follicle cycle, and required for the maintenance of both sebaceous and meibomian glands.	[Wu, Lizhi; Belyaeva, Olga; Adams, Mark K.; Klyuyeva, Alla, V; Lee, Seung-Ah; Goggans, Kelli R.; Popov, Kirill M.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Adams, Mark K.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lee, Seung-Ah] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 03080, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stowers Institute for Medical Research; Seoul National University (SNU)	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.; Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	nkedishvili@uab.edu	Goggans, Kelli/HHS-2351-2022	Beliaeva, Olga/0000-0003-2512-925X; Goggans, Kelli/0000-0002-7008-7506	National Institutes of Health [P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, P60 DK079626]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Human HA-tagged RALDH1 expression construct in pcDNA3.1-neo (CMV promoter) was a generous gift of Dr. Sylvie Mader (Department of Biochemistry, University of Montreal, Canada). HA epitope antibodies were received as a gift from Dr. Hengbin Wang (Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham School of Medicine). Weare grateful to Dr. Anil K. Challa (University of Alabama, Birmingham, AL) for help with performing CRISPR-mediated gene mutations. Services provided in this publication through the University of Alabama at Birmingham Transgenic and Genetically Engineered Models facility (R. A. K.) are supported by National Institutes of Health Grants P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, and P60 DK079626.	Adams MK, 2017, CHEM-BIOL INTERACT, V276, P88, DOI 10.1016/j.cbi.2016.10.019; Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Ahmed NS, 2017, MOL THER, V25, P2502, DOI 10.1016/j.ymthe.2017.07.010; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Ashmore JH, 2018, CARCINOGENESIS, V39, P1079, DOI 10.1093/carcin/bgy065; Bai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107050; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2015, CHEM-BIOL INTERACT, V234, P135, DOI 10.1016/j.cbi.2014.10.026; Belyaeva OV, 2012, J BIOL CHEM, V287, P9061, DOI 10.1074/jbc.M111.336727; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Benbrook DM, 2014, SUBCELL BIOCHEM, V70, P1, DOI 10.1007/978-94-017-9050-5_1; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Challa AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155812; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chen CC, 2016, J MOL BIOL, V428, P1423, DOI 10.1016/j.jmb.2015.07.009; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Clarke SB, 2007, DERMATOL CLIN, V25, P137, DOI 10.1016/j.det.2007.01.004; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Ding J, 2013, INVEST OPHTH VIS SCI, V54, P4341, DOI 10.1167/iovs.13-11863; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Estrach S, 2008, J INVEST DERMATOL, V128, P825, DOI 10.1038/sj.jid.5701113; Everts HB, 2012, BBA-MOL CELL BIOL L, V1821, P222, DOI 10.1016/j.bbalip.2011.08.017; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Genander M, 2014, CELL STEM CELL, V15, P619, DOI 10.1016/j.stem.2014.09.009; Goldstein J, 2012, CELL MOL LIFE SCI, V69, P2573, DOI 10.1007/s00018-012-0943-3; Gonzales KAU, 2017, DEV CELL, V43, P387, DOI 10.1016/j.devcel.2017.10.001; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Iskakova M, 2015, CAN J PHYSIOL PHARM, V93, P1065, DOI 10.1139/cjpp-2014-0522; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiao S, 2014, J ANIM SCI, V92, P2846, DOI 10.2527/jas.2014-7337; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KREMER I, 1994, OPHTHALMIC RES, V26, P124, DOI 10.1159/000267402; LABRIE F, 1992, J STEROID BIOCHEM, V41, P421, DOI 10.1016/0960-0760(92)90368-S; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Lee SA, 2009, CHEM-BIOL INTERACT, V178, P182, DOI 10.1016/j.cbi.2008.09.019; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Myung P, 2012, J CLIN INVEST, V122, P448, DOI 10.1172/JCI57414; Nagy A., 2003, MANIPULATING MOUSE E; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; Napoli JL, 2001, MOL CELL ENDOCRINOL, V171, P103, DOI 10.1016/S0303-7207(00)00392-0; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Pan J, 2017, AM J THER, V24, pE207, DOI 10.1097/MJT.0000000000000390; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Qi F, 2019, ONCOL LETT, V17, P2905, DOI 10.3892/ol.2019.9884; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sahu B, 2015, J BIOL CHEM, V290, P27239, DOI 10.1074/jbc.M115.682096; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sellheyer K, 2010, J CUTAN PATHOL, V37, P362, DOI 10.1111/j.1600-0560.2009.01434.x; Shannon SR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.264; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Winkler KP, 2017, OPHTHAL PLAST RECONS, V33, P483, DOI 10.1097/IOP.0000000000000996; WOLBACH SB, 1978, NUTR REV, V36, P16; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Xiong XW, 2015, PHYSIOL GENOMICS, V47, P274, DOI 10.1152/physiolgenomics.00005.2015; Zhang L, 2006, PEPTIDES, V27, P413, DOI 10.1016/j.peptides.2005.05.030; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zouboulis CC, 2016, REV ENDOCR METAB DIS, V17, P319, DOI 10.1007/s11154-016-9389-5	90	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17060	17074		10.1074/jbc.RA119.010835	http://dx.doi.org/10.1074/jbc.RA119.010835			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31562240	hybrid, Green Published			2022-12-26	WOS:000501801900047
J	Acharya, Y; Luke, N; Haro, MF; Rose, W; Russell, PSS; Oommen, AM; Minz, S				Acharya, Yubraj; Luke, Nancy; Haro, Marco Faytong; Rose, Winsley; Russell, Paul Swamidhas Sudhakar; Oommen, Anu Mary; Minz, Shantidani			Nutritional status, cognitive achievement, and educational attainment of children aged 8-11 in rural South India	PLOS ONE			English	Article							LONG-TERM CONSEQUENCES; EARLY-CHILDHOOD; GROWTH; HEALTH; GIRLS; CASTE	Background Malnutrition among children is one of the most pressing health concerns middle- and low-income countries face today, particularly those in Sub-Saharan Africa and South Asia. Early-life malnutrition has been shown to affect long-term health and income. One hypothesized channel linking early-life malnutrition and long-term outcomes is cognitive development. However, there is limited empirical evidence on the relationship between nutritional status and cognitive achievement in middle childhood. Study design As part of the South India Community Health Study (SICHS), we collected educational attainment and anthropometric data from 1,194 children in rural Vellore district of Tamil Nadu, India, and assessed their math and reading skills. We analyzed the relationship between continuous and binary anthropometric measures of nutritional status and three measures of cognitive achievement (reading, math, and grade level), adjusting for potential confounders, using a regression framework. Results Lower height-for-age and weight-for-age and their corresponding binary measures (stunting, underweight) were associated with lower reading scores, lower math scores, and lower grade level, with the exception of the association between weight-for-age and reading, which was marginally significant. A stunted child had one-third of a grade disadvantage compared to a non-stunted counterpart, whereas an underweight child had one-fourth of a grade disadvantage compared to a non-underweight counterpart. Lower BMI-for-age was associated with grade level and marginally associated with lower math scores, and its binary measure (thinness) was marginally associated with lower math scores. Conclusions Acute and chronic malnutrition in middle childhood were negatively associated with math scores, reading scores, and educational attainment. Our study provides new evidence that cognitive achievement during middle childhood could be an important mechanism underlying the association between early-life malnutrition and long-term wellbeing.	[Acharya, Yubraj] Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA; [Luke, Nancy; Haro, Marco Faytong] Penn State Univ, Dept Sociol & Criminol, University Pk, PA 16802 USA; [Rose, Winsley] Christian Med Coll & Hosp, Dept Pediat, Vellore, Tamil Nadu, India; [Russell, Paul Swamidhas Sudhakar] Christian Med Coll & Hosp, Dept Psychiat, Vellore, Tamil Nadu, India; [Oommen, Anu Mary; Minz, Shantidani] Christian Med Coll & Hosp, Dept Community Hlth, Vellore, Tamil Nadu, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Acharya, Y (corresponding author), Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA.	yua36@psu.edu	Russell, Paul/R-6310-2019; Acharya, Yubraj/ABD-9569-2021	Russell, Paul/0000-0001-6463-2750; Acharya, Yubraj/0000-0002-9003-636X; Oommen, Anu Mary/0000-0003-2932-7827	Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) [R01 HD058831-01]; Population Research Institute at Penn State University - NICHD [P2CHD041025]; Keyes Fund through the Faculty of Economics at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041025] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD); Population Research Institute at Penn State University - NICHD; Keyes Fund through the Faculty of Economics at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The data used in this paper are from the South India Community Health Study (SICHS). SICHS was supported by a grant (R01 HD058831-01) from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD). Support was also provided by the Population Research Institute at Penn State University, which is supported by an infrastructure grant from NICHD (P2CHD041025); the Keyes Fund through the Faculty of Economics at the University of Cambridge; and the Population Studies and Training Center at Brown University.	Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; ASER Centre, 2019, ANN STAT ED REP RUR, P1; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; Cashin K, 2018, FOOD NUTR TECH ASSIS, P93; Crookston BT, 2013, AM J CLIN NUTR, V98, P1555, DOI 10.3945/ajcn.113.067561; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; Currie J, 2013, EARLY LIFE HLTH ADUL, DOI [10.1146/annurev-economics-081412-103704, DOI 10.1146/ANNUREV-ECONOMICS-081412-103704]; Cusick SE, 2016, J PEDIATR-US, V175, P16, DOI 10.1016/j.jpeds.2016.05.013; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Diamond-Smith N, 2008, CULT HEALTH SEX, V10, P697, DOI 10.1080/13691050802061665; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P53; GULDAN GS, 1993, SOC SCI MED, V36, P925, DOI 10.1016/0277-9536(93)90084-H; Jayachandran S, 2011, Q J ECON, V126, P1485, DOI 10.1093/qje/qjr029; Kingdon G, 201014 CSEA; Lelijveld N, 2019, PUBLIC HEALTH NUTR, V22, P1406, DOI 10.1017/S1368980018003282; Luke N, 2007, J DEV ECON, V83, P256, DOI 10.1016/j.jdeveco.2006.07.005; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Pollitt E., 1984, NUTR ED SER; Pratham, ASER ASS SURV FRAM; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Sandjaja, 2013, BRIT J NUTR, V110, pS57, DOI 10.1017/S0007114513002079; Scientific Advisory Committee on Nutrition; Royal College of Paediatrics and Child Health, 2007, APPL WHO GROWTH STAN; Sharma S, 2015, J COMP ECON, V43, P204, DOI 10.1016/j.jce.2014.10.005; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; Spears D, 2016, J HUM RESOUR, V51, P298, DOI 10.3368/jhr.51.2.0712-5051R1; Spears D, 2012, ECON HUM BIOL, V10, P210, DOI 10.1016/j.ehb.2011.08.005; StataCorp, 2019, STATA STAT SOFTWARE, DOI [10.2307/2234838, DOI 10.2307/2234838]; Swaminathan Soumya., 2018, WEALTH MARRIAGE SEX; United Nations, 2017, SUSTAINABLE DEV GOAL; van den Heuvel M, 2017, J GLOB HEALTH, V7, DOI [10.7189/jogh.07.020416, 10.7189/jogh.07.020702416]; Variyam JN, 1999, AM J AGR ECON, V81, P373, DOI 10.2307/1244588; Vereecken CA, 2004, APPETITE, V43, P93, DOI 10.1016/j.appet.2004.04.002; Vidmar SI, 2013, STATA J, V13, P366, DOI 10.1177/1536867X1301300211; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227; WHO, 2006, WHO CHILD GROWTH STA	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223001	10.1371/journal.pone.0223001	http://dx.doi.org/10.1371/journal.pone.0223001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596845	Green Published, gold			2022-12-26	WOS:000532444100018
J	Ha, JY; Sung, MS; Heo, H; Park, SW				Ha, Jun Young; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo			Trends in the characteristics of acute primary angle closure in Korea over the past 10-years	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ANTERIOR SEGMENT; EARLY PHACOEMULSIFICATION; PERIPHERAL IRIDOTOMY; RANDOMIZED-TRIAL; LENS VAULT; MECHANISMS; SUSPECTS; GLAUCOMA; SUBTYPES	Purpose To investigate the changes in the demographic, clinical, and biometric characteristics of APAC patients in South Korea during the last decade. Methods Medical records of patients with APAC who visit the emergency department or the glaucoma clinic of Chonnam National University Hospital, a tertiary referral center in Gwangju, South Korea in 2007 and 2017 were analyzed. Demographics, clinical characteristics, and treatment modality were compared between the APAC patients in 2007 and 2017. Results The number of patients with APAC increased from 54 in 2007 to 68 in 2017. Female patients in their 60s were most common in both groups and there was no significant difference in IOP, cataract grade, gonioscopic grading, PAS, or optic nerve damage between the two groups at baseline visit (all P > 0.05). However, APAC eyes in 2017 had a shallower ACD (1.74 +/- 0.28 mm vs 1.87 +/- 0.35 mm; P = 0.024) and greater LV (1.05 +/- 0.26 mm vs 0.93 +/- 0.19 mm; P = 0.001) than those of APAC eyes in 2007. During one year follow-up, 25 patients (51.02%) received LPI only, and 18 patients (36.73%) required LE, and 6 patients (12.24%) required phacotrabeculectomy or sequential LE and trabeculectomy. However, in 2017, LPI alone was sufficient in 23 patients (38.33%), 29 patients (48.33%) required further LE, and 8 patients (13.33%) required phacotrabeculectomy or sequential LE and trabeculectomy for the treatment of APAC (P = 0.015). Conclusions Compared to older cases of APAC, recent cases received LE more frequently, which suggests an increasing trend of LE as a treatment option for APAC. In addition, recent cases had a greater LV and shallower ACD than older cases and these biometric differences may be one of the reasons for increasing rate of LE in this study.	[Ha, Jun Young; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Dept Ophthalmol, Med Sch & Hosp, Gwangju, South Korea; [Ha, Jun Young; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Res Inst Med Sci, Med Sch & Hosp, Gwangju, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Dept Ophthalmol, Med Sch & Hosp, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Res Inst Med Sci, Med Sch & Hosp, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea.	exo70@naver.com			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A 01059630]; Bio & Medical Technology Development Program of the NRF - Korean government [MSIP-2017M3A9E8023019]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Bio & Medical Technology Development Program of the NRF - Korean government	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A 01059630), and the Bio & Medical Technology Development Program of the NRF funded by the Korean government (MSIP-2017M3A9E8023019). The funding organizations had no role in the design or conduct of this research.	Aung T, 2001, AM J OPHTHALMOL, V131, P7, DOI 10.1016/S0002-9394(00)00621-8; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Baek S, 2013, INVEST OPHTH VIS SCI, V54, P848, DOI 10.1167/iovs.12-10391; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Dada T, 2007, J CATARACT REFR SURG, V33, P837, DOI 10.1016/j.jcrs.2007.01.021; Dorairaj S, 2008, EXP EYE RES, V86, P220, DOI 10.1016/j.exer.2007.10.023; EDWARDS RS, 1982, BRIT J OPHTHALMOL, V66, P576, DOI 10.1136/bjo.66.9.576; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; He MG, 2007, OPHTHALMOLOGY, V114, P494, DOI 10.1016/j.ophtha.2006.06.053; Husain R, 2012, OPHTHALMOLOGY, V119, P2274, DOI 10.1016/j.ophtha.2012.06.015; Jacobi PC, 2002, PRIMARY PHACOEMULSIF, V109, P7; Kim DY, 2011, ACTA OPHTHALMOL, V89, P435, DOI 10.1111/j.1755-3768.2009.01714.x; Kumar RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1269, DOI 10.1001/archophthalmol.2009.241; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Li MW, 2018, INVEST OPHTH VIS SCI, V59, P1354, DOI 10.1167/iovs.17-23711; Lowe R F, 1962, Br J Ophthalmol, V46, P641, DOI 10.1136/bjo.46.11.641; Moghimi S, 2014, EYE, V28, P337, DOI 10.1038/eye.2013.296; Moghimi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199157; Moghimi S, 2018, AM J OPHTHALMOL, V186, P59, DOI 10.1016/j.ajo.2017.11.013; Moghimi S, 2016, J CURR OPHTHALMOL, V28, P170, DOI 10.1016/j.joco.2016.06.005; Moghimi S, 2015, J CURR OPHTHALMOL, V27, P70, DOI 10.1016/j.joco.2015.12.001; Moghimi S, 2014, CLIN EXP OPHTHALMOL, V42, P615, DOI 10.1111/ceo.12285; Moghimi S, 2013, AM J OPHTHALMOL, V155, P664, DOI 10.1016/j.ajo.2012.10.014; Ng WT, 2012, CLIN EXP OPHTHALMOL, V40, pE218, DOI 10.1111/j.1442-9071.2011.02604.x; Nongpiur ME, 2013, OPHTHALMOLOGY, V120, P2525, DOI 10.1016/j.ophtha.2013.05.028; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Ozaki M, 2012, GRAEF ARCH CLIN EXP, V250, P1863, DOI 10.1007/s00417-012-2011-y; Romkens HCS, 2018, J GLAUCOMA, V27, P711, DOI 10.1097/IJG.0000000000000998; Su WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020056; Suwan Y, 2017, CLIN EXP OPHTHALMOL, V45, P366, DOI 10.1111/ceo.12867; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223527	10.1371/journal.pone.0223527	http://dx.doi.org/10.1371/journal.pone.0223527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596882	Green Published, gold			2022-12-26	WOS:000532444100041
J	Orlowska, K; Swigonska, S; Sadowska, A; Ruszkowska, M; Nynca, A; Molcan, T; Zmijewska, A; Ciereszko, RE				Orlowska, Karina; Swigonska, Sylwia; Sadowska, Agnieszka; Ruszkowska, Monika; Nynca, Anna; Molcan, Tomasz; Zmijewska, Agata; Ciereszko, Renata E.			Proteomic changes of aryl hydrocarbon receptor (AhR)-silenced porcine granulosa cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; ANNEXIN A5; APOPTOSIS; CALCIUM; EXPRESSION; DIOXINS; PROTEIN; SECRETION; AHR; INHIBITORS	2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a toxic man-made chemical compound contaminating the environment and affecting human/animal health and reproduction. Intracellular TCDD action usually involves the activation of aryl hydrocarbon receptor (AhR). The aim of the current study was to examine TCDD-induced changes in the proteome of AhR-silenced porcine granulosa cells. The AhR-silenced cells were treated with TCDD (100 nM) for 3, 12 or 24 h. Total protein was isolated, labeled with cyanines and next, the samples were separated by isoelectric focusing and SDS-PAGE. Proteins of interest were identified by MALDI-TOF/TOF mass spectrometry (MS) analysis and confirmed by western blotting and fluorescence immunocytochemistry. The AhR-targeted siRNA transfection reduced the granulosal expression level of AhR by 60-70%. In AhR-silenced porcine granulosa cells, TCDD influenced the abundance of only three proteins: annexin V, protein disulfide isomerase and ATP synthase subunit beta. The obtained results revealed the ability of TCDD to alter protein abundance in an AhR-independent manner. This study offers a new insight into the mechanism of TCDD action and provide directions for future functional studies focused on molecular effects exerted by TCDD.	[Orlowska, Karina; Sadowska, Agnieszka; Ruszkowska, Monika; Molcan, Tomasz; Zmijewska, Agata; Ciereszko, Renata E.] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Anat & Physiol, Oczapowskiego, Olsztyn, Poland; [Swigonska, Sylwia; Nynca, Anna; Ciereszko, Renata E.] Univ Warmia & Mazury, Fac Biol & Biotechnol, Lab Mol Diagnost, Prawochenskiego, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury	Orlowska, K (corresponding author), Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Anim Anat & Physiol, Oczapowskiego, Olsztyn, Poland.	karina.orlowska@uwm.edu.pl	Swigonska, Sylwia/I-6352-2012; Ciereszko, Renata E./J-4098-2012	Ruszkowska, Monika/0000-0002-7554-6433; Zmijewska, Agata/0000-0002-0661-130X; Ciereszko, Renata E./0000-0002-6896-5023; Swigonska, Sylwia/0000-0003-2287-3243; , Anna/0000-0002-1807-6148; Sadowska, Agnieszka/0000-0003-3188-792X; Molcan, Tomasz/0000-0002-0380-0156	National Science Centre, Poland [2012/05/B/NZ9/03333]; Ministry of Science and Higher Education in Poland [528.0206.0806]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	This study was supported by National Science Centre, Poland (2012/05/B/NZ9/03333; https://www.ncn.gov.pl/) and The Ministry of Science and Higher Education in Poland (UWM No. 528.0206.0806; https://www.gov.pl/web/nauka).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Boersma HH, 2005, J NUCL MED, V46, P2035; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Carmeille R, 2015, BBA-MOL CELL RES, V1853, P2033, DOI 10.1016/j.bbamcr.2014.12.038; Chen SC, 2010, MOL HUM REPROD, V16, P361, DOI 10.1093/molehr/gaq004; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Comelli M, 2003, FREE RADICAL BIO MED, V34, P1190, DOI 10.1016/S0891-5849(03)00107-2; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ghotbaddini M, 2015, INT J ENV RES PUB HE, V12, P7506, DOI 10.3390/ijerph120707506; Gidon-Jeangirard C, 1999, BIOCHEM BIOPH RES CO, V265, P709, DOI 10.1006/bbrc.1999.1752; Gregoraszczuk EL, 2000, J PHYSIOL PHARMACOL, V51, P127; Gregoraszczuk Ewa L., 2002, Cad. Saúde Pública, V18, P453, DOI 10.1590/S0102-311X2002000200010; Grochowalski A, 2001, CHEMOSPHERE, V43, P823, DOI 10.1016/S0045-6535(00)00440-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Horisberger MA, 2006, IN VITRO CELL DEV-AN, V42, P143; Jablonska O, 2014, ACTA VET HUNG, V62, P408, DOI 10.1556/AVet.2014.015; Jablonska O, 2011, ANIM REPROD SCI, V126, P221, DOI 10.1016/j.anireprosci.2011.05.010; Jeong JJ, 2014, J BIOL CHEM, V289, P2469, DOI 10.1074/jbc.M113.450163; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Khan MF, 2017, TOXICOL MECH METHOD, V27, P151, DOI 10.1080/15376516.2016.1273423; Kulkarni PS, 2008, ENVIRON INT, V34, P139, DOI 10.1016/j.envint.2007.07.009; Larigot Lucie, 2018, Biochim Open, V7, P1, DOI 10.1016/j.biopen.2018.05.001; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; MACER DRJ, 1988, J CELL SCI, V91, P61; Marton A, 1997, EUR J BIOCHEM, V250, P467, DOI 10.1111/j.1432-1033.1997.0467a.x; Matsumura F., 2012, NONGENOMIC ROUTE ACT, P197; Mayati A, 2012, ENVIRON TOXICOL, V27, P556, DOI 10.1002/tox.20675; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Onda M, 2004, ENDOCR-RELAT CANCER, V11, P843, DOI 10.1677/erc.1.00818; Orlowska K, 2018, CHEMOSPHERE, V212, P170, DOI 10.1016/j.chemosphere.2018.08.046; Piasecka-Srader J, 2016, J REPROD DEVELOP, V62, P103, DOI 10.1262/jrd.2015-125; Pieklo R, 2000, EXP CLIN ENDOCR DIAB, V108, P299, DOI 10.1055/s-2000-7757; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Ravassa S, 2010, CARDIOVASC RES, V88, P304, DOI 10.1093/cvr/cvq183; Ruszkowska M, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0288-3; Sadowska A, 2015, FOLIA BIOL-PRAGUE, V61, P184; Sadowska A, 2017, CHEMOSPHERE, V178, P368, DOI 10.1016/j.chemosphere.2017.03.055; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Sweeney MH, 2000, FOOD ADDIT CONTAM, V17, P303, DOI 10.1080/026520300283379; Terminella C, 2002, AM J PHYSIOL-LUNG C, V283, pL1291, DOI 10.1152/ajplung.00246.2001; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Verma G, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2651; Wang YM, 2012, EXPERT OPIN DRUG MET, V8, P803, DOI 10.1517/17425255.2012.685237; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984	55	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223420	10.1371/journal.pone.0223420	http://dx.doi.org/10.1371/journal.pone.0223420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584984	gold, Green Published			2022-12-26	WOS:000532407600032
J	Barrasso, C; Memah, MM; Genard, M; Quilot-Turion, B				Barrasso, Caterina; Memah, Mohamed-Mahmoud; Genard, Michel; Quilot-Turion, Benedicte			Model-based QTL detection is sensitive to slight modifications in model formulation	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PARAMETER-ESTIMATION; GENETIC ALGORITHMS; FRUIT-QUALITY; LEAF-AREA; GROWTH; OPTIMIZATION; GENOTYPE; PLANTS; GRAIN	Classical crop models have been developed to predict crop yield and quality, and they are based on physiological and environmental inputs. After molecular discoveries, models should integrate genetic variation to allow predictions that are more genotype-dependent. An interesting approach, Quantitative Trait Locus (QTL)-based ecophysiological modeling, has shown promising results for the design of ideotypes that are adapted to biotic and abiotic stresses, but there are still limitations to attaining a fully integrated model. The aim of this case study is to clarify the impact of choosing different model equations (closely related and with different numbers of parameters) and optimization methods on the detection of QTLs controlling the parameters of crop growth. Different growth equations were parameterized based on a genetic population by following different approaches. The correlations between parameters were analyzed, and two different strategies were adopted to address the correlation issue. QTL analysis was performed on the optimized values of the parameters of the growth equations and on the observed dry mass (DM) data to validate the QTLs detected. Overall, models and strategies resulted in different QTLs being detected. Similar LOD profiles but with peaks of different heights were observed, some of which were significant, resulting in different numbers of QTLs. In some cases, peaks had slightly different positions or were absent. Even closely related growth models led to the detection of different QTLs. The goodness of fit and complexity of the growth models were found to be insufficient to select the best model. Calculating parameters independently of observed data may not be a good strategy, whereas setting parameters independent of the genotype is recommended. Given the large-scale global optimization problem and the strong correlations between parameters, the two algorithms tested showed poor performance. Currently, the lack of effective algorithms is the main obstacle to answering the question posed. The authors therefore suggest testing different model formulations and comparing the QTLs detected before choosing the best formulation to use in an ecophysiological modeling approach based on QTLs.	[Barrasso, Caterina; Quilot-Turion, Benedicte] INRA, GAFL, F-84143 Montfavet, France; [Barrasso, Caterina; Memah, Mohamed-Mahmoud; Genard, Michel] INRA, PSH, F-84914 Avignon, France	INRAE; INRAE	Quilot-Turion, B (corresponding author), INRA, GAFL, F-84143 Montfavet, France.	benedicte.quilot-turion@inra.fr	Quilot-Turion, Bénédicte/AAT-2958-2020	Quilot-Turion, Bénédicte/0000-0003-4095-1399; MEMAH, Mohamed-Mahmoud/0000-0003-3850-0134				Salazar JA, 2014, PLANT MOL BIOL REP, V32, P1, DOI 10.1007/s11105-013-0643-7; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Bertin N, 2010, J EXP BOT, V61, P955, DOI 10.1093/jxb/erp377; Boote KJ, 2001, AGR SYST, V70, P395, DOI 10.1016/S0308-521X(01)00053-1; Chen S, 2015, ARTIF INTELL, DOI [10.1016/j.artint.2014.11.008, DOI 10.1016/J.ARTINT.2014.11.008]; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; Cirilli M, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2015.67; Comets E, 2017, J STAT SOFTW, V80, P1; Constantinescu D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01841; Desnoues E, 2016, J EXP BOT, V67, P3419, DOI 10.1093/jxb/erw169; Gibert C, 2005, ANN BOT-LONDON, V95, P673, DOI 10.1093/aob/mci067; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; GOUDRIAAN J, 1990, ANN BOT-LONDON, V66, P695, DOI 10.1093/oxfordjournals.aob.a088084; Grechi I, 2010, ECOL MODEL, V221, P2363, DOI 10.1016/j.ecolmodel.2010.06.015; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hou W, 2008, HEREDITY, DOI [10.1038/hdv.2008.53, DOI 10.1038/HDV.2008.53]; Huang ZW, 2014, BRIEF BIOINFORM, V15, P562, DOI 10.1093/bib/bbt019; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Jian-Bing Y, 2006, ACTA GENET SINICA, V33, P617, DOI [10.1016/S0379-4172(06)60091-7, DOI 10.1016/S0379-4172(06)60091-7]; KRUGLYAK L, 1995, GENETICS, V139, P1421; Kwak IY, 2014, GENETICS, V197, P1409, DOI 10.1534/genetics.114.166306; Lechaudel M, 2005, TREE PHYSIOL, V25, P583, DOI 10.1093/treephys/25.5.583; Lescourret F, 2005, TREE PHYSIOL, V25, P1303, DOI 10.1093/treephys/25.10.1303; Li P, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0234-3; Li P, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-91; Li Q, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-13; Li Y, 2010, BIOL REV, V85, P207, DOI 10.1111/j.1469-185X.2009.00096.x; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; LUCASIUS CB, 1994, CHEMOMETR INTELL LAB, V25, P99, DOI 10.1016/0169-7439(94)85038-0; Ma CX, 2002, GENETICS, V161, P1751; Mandavi S, 2015, INFORM SCIENCES, V295, P407, DOI 10.1016/j.ins.2014.10.042; Martre P, 2011, NEW PHYTOL, V191, P601, DOI 10.1111/j.1469-8137.2011.03747.x; Mei Y, 2016, ACM T MATH SOFTWARE, V42, DOI 10.1145/2791291; Podisi BK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-22; Quilot B, 2005, J EXP BOT, V56, P3071, DOI 10.1093/jxb/eri304; Quilot B, 2004, THEOR APPL GENET, V109, P884, DOI 10.1007/s00122-004-1703-z; Quilot-Turion B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01873; Quilot-Turion B, 2012, EUR J AGRON, V42, P34, DOI 10.1016/j.eja.2011.11.008; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Sundararajan PK, 2016, P 8 INT C PROB GRAPH; Tardieu F, 2003, TRENDS PLANT SCI, V8, P9, DOI 10.1016/S1360-1385(02)00008-0; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wang MY, 2019, HEREDITY, V123, P287, DOI 10.1038/s41437-019-0205-3; Wei K, 2018, PLANT J, V95, P775, DOI 10.1111/tpj.13986; Willighagen E., 2015, GENALG R BASED GENET; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Xing J, 2012, GENET RES, V94, P85, DOI 10.1017/S0016672312000249; YIN S, 2016, CROP SYSTEMS BIOL, P193, DOI DOI 10.1007/978-3-319-20562-5J; Yin XY, 1999, HEREDITY, V82, P415, DOI 10.1038/sj.hdy.6885030; Yin XY, 2003, AGRON J, V95, P90, DOI 10.2134/agronj2003.0090; Yin XY, 2003, ANN BOT-LONDON, V91, P361, DOI 10.1093/aob/mcg029; Yin XY, 2000, HEREDITY, V85, P539, DOI 10.1046/j.1365-2540.2000.00790.x	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222764	10.1371/journal.pone.0222764	http://dx.doi.org/10.1371/journal.pone.0222764			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581203	Green Published, gold			2022-12-26	WOS:000532398600016
J	Latten, GHP; Spek, M; Muris, JWM; Cals, JWL; Stassen, PM				Latten, Gideon H. P.; Spek, Michelle; Muris, Jean W. M.; Cals, Jochen W. L.; Stassen, Patricia M.			Accuracy and interobserver-agreement of respiratory rate measurements by healthcare professionals, and its effect on the outcomes of clinical prediction/diagnostic rules	PLOS ONE			English	Article							EARLY WARNING SCORE; INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; SEPSIS; RELIABILITY; GUIDELINE; ARREST	Objective In clinical prediction/diagnostic rules aimed at early detection of critically ill patients, the respiratory rate plays an important role. We investigated the accuracy and interobserver-agreement of respiratory rate measurements by healthcare professionals, and the potential effect of incorrect measurements on the scores of 4 common clinical prediction/diagnostic rules: Systemic Inflammatory Response Syndrome (SIRS) criteria, quick Sepsis-related Organ Failure Assessment (qSOFA), National Early Warning Score (NEWS), and Modified Early Warning Score (MEWS). Methods Using an online questionnaire, we showed 5 videos with a healthy volunteer, breathing at a fixed (true) rate (13-28 breaths/minute). Respondents measured the respiratory rate, and categorized it as low, normal, or high. We analysed how accurate the measurements were using descriptive statistics, and calculated interobserver-agreement using the intraclass correlation coefficient (ICC), and agreement between measurements and categorical judgments using Cohen's Kappa. Finally, we analysed how often incorrect measurements led to under/overestimation in the selected clinical rules. Results In total, 448 healthcare professionals participated. Median measurements were slightly higher (1-3/min) than the true respiratory rate, and 78.2% of measurements were within 4/min of the true rate. ICC was moderate (0.64, 95% CI 0.39-0.94). When comparing the measured respiratory rates with the categorical judgments, 14.5% were inconsistent. Incorrect measurements influenced the 4 rules in 8.8% (SIRS) to 37.1% (NEWS). Both underestimation (4.5-7.1%) and overestimation (3.9-32.2%) occurred. Conclusions The accuracy and interobserver-agreement of respiratory rate measurements by healthcare professionals are suboptimal. This leads to both over- and underestimation of scores of four clinical prediction/diagnostic rules. The clinically most important effect could be a delay in diagnosis and treatment of (critically) ill patients.	[Latten, Gideon H. P.] Zuyderland Med Ctr, Emergency Dept, Heerlen, Netherlands; [Latten, Gideon H. P.; Muris, Jean W. M.; Cals, Jochen W. L.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Family Med, Maastricht, Netherlands; [Spek, Michelle; Stassen, Patricia M.] Maastricht Univ, Dept Internal Med, Div Gen Med, Sect Acute Med,Med Ctr MUMC, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Latten, GHP (corresponding author), Zuyderland Med Ctr, Emergency Dept, Heerlen, Netherlands.; Latten, GHP (corresponding author), Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Dept Family Med, Maastricht, Netherlands.	g.latten@zuyderland.nl	Cals, Jochen/A-1262-2007	Cals, Jochen/0000-0001-9550-5674; Spek, Michelle/0000-0002-5914-4231; Muris, Jean/0000-0002-8780-476X				Bianchi W, 2013, ANN EMERG MED, V61, P37, DOI 10.1016/j.annemergmed.2012.05.030; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Brabrand M, 2018, J CRIT CARE, V44, P404, DOI 10.1016/j.jcrc.2017.12.020; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; FIESELMANN JF, 1993, J GEN INTERN MED, V8, P354, DOI 10.1007/BF02600071; Flenady T, 2017, INT J NURS STUD, V74, P67, DOI 10.1016/j.ijnurstu.2017.06.001; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mukkamala SG, 2008, AM J EMERG MED, V26, P237, DOI 10.1016/j.ajem.2007.05.001; Nielsen LG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129493; Peltan ID, 2019, CHEST, V155, P938, DOI 10.1016/j.chest.2019.02.008; Semler MW, 2013, CHEST, V143, P1740, DOI 10.1378/chest.12-1837; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223155	10.1371/journal.pone.0223155	http://dx.doi.org/10.1371/journal.pone.0223155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581207	gold, Green Published			2022-12-26	WOS:000532398600036
J	Tian, K; Rubadue, CA; Lin, DI; Veta, M; Pyle, ME; Irshad, H; Heng, YJJ				Tian, Katherine; Rubadue, Christopher A.; Lin, Douglas, I; Veta, Mitko; Pyle, Michael E.; Irshad, Humayun; Heng, Yujing J.			Automated clear cell renal carcinoma grade classification with prognostic significance	PLOS ONE			English	Article							PATHOLOGY; SYSTEM; TRANSFORMATION; DIAGNOSIS; MODELS	We developed an automated 2-tiered Fuhrman's grading system for clear cell renal cell carcinoma (ccRCC). Whole slide images (WSI) and clinical data were retrieved for 395 The Cancer Genome Atlas (TCGA) ccRCC cases. Pathologist 1 reviewed and selected regions of interests (ROls). Nuclear segmentation was performed. Quantitative morphological, intensity, and texture features (n = 72) were extracted. Features associated with grade were identified by constructing a Lasso model using data from cases with concordant 2-tiered Fuhrman's grades between TCGA and Pathologist 1 (training set n = 235; held-out test set n = 42). Discordant cases (n = 118) were additionally reviewed by Pathologist 2. Cox proportional hazard model evaluated the prognostic efficacy of the predicted grades in an extended test set which was created by combining the test set and discordant cases (n = 160). The Lasso model consisted of 26 features and predicted grade with 84.6% sensitivity and 81.3% specificity in the test set. In the extended test set, predicted grade was significantly associated with overall survival after adjusting for age and gender (Hazard Ratio 2.05; 95% CI 1.21-3.47); manual grades were not prognostic. Future work can adapt our computational system to predict WHO/ISUP grades, and validating this system on other ccRCC cohorts.	[Tian, Katherine; Rubadue, Christopher A.; Lin, Douglas, I; Pyle, Michael E.; Irshad, Humayun; Heng, Yujing J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Tian, Katherine] Harker Sch, San Jose, CA USA; [Veta, Mitko] Eindhoven Univ Technol, Med Image Anal Grp, Eindhoven, Netherlands; [Heng, Yujing J.] Beth Israel Deaconess Canc Ctr, Canc Res Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eindhoven University of Technology; Harvard University; Beth Israel Deaconess Medical Center	Heng, YJJ (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA.; Heng, YJJ (corresponding author), Beth Israel Deaconess Canc Ctr, Canc Res Inst, Boston, MA 02215 USA.	yheng@bidmc.harvard.edu		Lin, Douglas/0000-0003-0105-9760	Klarman Family Foundation; BIDMC High School Summer Research Program	Klarman Family Foundation; BIDMC High School Summer Research Program	YJH is supported by the Klarman Family Foundation. KT was supported by the BIDMC High School Summer Research Program. At the time of this work, Drs. Lin and Irshad were both employees of BIDMC, and were not at commercial companies (i.e., Foundation Medicine for Lin and Figure-Eight Technologies Inc for Irshad). Those two commercial affiliations did not provide salaries for Lin and Irshad at the time of the study, and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2002, AM J SURG PATHOL, V26, P281, DOI 10.1097/00000478-200203000-00001; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; de Peralta-Venturina M, 2001, AM J SURG PATHOL, V25, P275, DOI 10.1097/00000478-200103000-00001; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Delahunt B, 2009, MODERN PATHOL, V22, pS24, DOI 10.1038/modpathol.2008.183; Dong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114885; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Goyal R, 2013, ARCH PATHOL LAB MED, V137, P467, DOI 10.5858/arpa.2012-0085-RA; Gutman DA, 2013, J AM MED INFORM ASSN, V20, P1091, DOI 10.1136/amiajnl-2012-001469; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatipoglu N, 2017, MED BIOL ENG COMPUT, V55, P1829, DOI 10.1007/s11517-017-1630-1; Heng YJ, 2017, J PATHOL, V241, P375, DOI 10.1002/path.4847; Holdbrook DA, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00100; Hong SK, 2011, BJU INT, V107, P409, DOI 10.1111/j.1464-410X.2010.09561.x; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Khan AM, 2014, IEEE T BIO-MED ENG, V61, P1729, DOI 10.1109/TBME.2014.2303294; Kruk M, 2017, BIOCYBERN BIOMED ENG, V37, P357, DOI 10.1016/j.bbe.2017.04.005; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar N, 2017, IEEE T MED IMAGING, V36, P1550, DOI 10.1109/TMI.2017.2677499; Lang H, 2005, CANCER, V103, P625, DOI 10.1002/cncr.20812; Lin H, 2002, TECHNOMETRICS, V44, P85, DOI http://dx.doi.org/10.1198/tech.2002.s656; Louis DN, 2016, ARCH PATHOL LAB MED, V140, P41, DOI 10.5858/arpa.2015-0093-SA; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Rioux-Leclercq N, 2007, CANCER, V109, P868, DOI 10.1002/cncr.22463; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuffler PJ, 2010, LECT NOTES COMPUT SC, V6376, P202; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Yeh Fang-Cheng, 2014, J Pathol Inform, V5, P23, DOI 10.4103/2153-3539.137726; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222641	10.1371/journal.pone.0222641	http://dx.doi.org/10.1371/journal.pone.0222641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581201	Green Published, gold, Green Submitted			2022-12-26	WOS:000532398600014
J	Lai, A; Ho, L; Evashwick-Rogler, TW; Watanabe, H; Salandra, J; Winkelstein, BA; Laudier, D; Hecht, AC; Pasinetti, GM; Iatridis, JC				Lai, Alon; Ho, Lap; Evashwick-Rogler, Thomas W.; Watanabe, Hironobu; Salandra, Jonathan; Winkelstein, Beth A.; Laudier, Damien; Hecht, Andrew C.; Pasinetti, Giulio M.; Iatridis, James C.			Dietary polyphenols as a safe and novel intervention for modulating pain associated with intervertebral disc degeneration in an in-vivo rat model	PLOS ONE			English	Article							ISSLS PRIZE WINNER; LOW-BACK-PAIN; NEUROPATHIC PAIN; NEEDLE PUNCTURE; MECHANICAL ALLODYNIA; SENSORY INNERVATION; DORSAL PORTION; ORAL TOXICITY; NERVE INJURY; MOUSE MODEL	Developing effective therapies for back pain associated with intervertebral disc (IVD) degeneration is a research priority since it is a major socioeconomic burden and current conservative and surgical treatments have limited success. Polyphenols are naturally occurring compounds in plant-derived foods and beverages, and evidence suggests dietary supplementation with select polyphenol preparations can modulate diverse neurological and painful disorders. This study tested whether supplementation with a select standardized Bioactive-Dietary-Polyphenol-Preparation (BDPP) may alleviate pain symptoms associated with IVD degeneration. Painful IVD degeneration was surgically induced in skeletally-mature rats by intradiscal saline injection into three consecutive lumbar IVDs. Injured rats were given normal or BDPP-supplemented drinking water. In-vivo hindpaw mechanical allodynia and IVD height were assessed weekly for 6 weeks following injury. Spinal column, dorsal-root-ganglion (DRG) and serum were collected at 1 and 6 weeks post-operative (post-op) for analyses of IVD-related mechanical and biological pathogenic processes. Dietary BDPP significantly alleviated the typical behavioral sensitivity associated with surgical procedures and IVD degeneration, but did not modulate IVD degeneration nor changes of pro-inflammatory cytokine levels in IVD. Gene expression analyses suggested BDPP might have an immunomodulatory effect in attenuating the expression of pro-inflammatory cytokines in DRGs. This study supports the idea that dietary supplementation with BDPP has potential to alleviate IVD degeneration-related pain, and further investigations are warranted to identify the mechanisms of action of dietary BDPP.	[Lai, Alon; Evashwick-Rogler, Thomas W.; Laudier, Damien; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA; [Ho, Lap; Pasinetti, Giulio M.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Ho, Lap; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Watanabe, Hironobu] Keiyu Orthoped Hosp, Tatebayashi, Japan; [Salandra, Jonathan] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Winkelstein, Beth A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Pennsylvania	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.	james.iatridis@mssm.edu		Lai, Alon/0000-0002-0163-4588; Pasinetti, Giulio/0000-0002-1524-5196; Iatridis, James/0000-0002-2186-0590	NIAMS/NIH [R01AR064157, R01AR057397]; NCCIH/DODS [P50 AT008661-01]; Senior VA Career Scientist Award; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064157, R01AR057397] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCCIH/DODS; Senior VA Career Scientist Award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS/NIH grant numbers R01AR064157 & R01AR057397 (JCI) and NCCIH/DODS grant number P50 AT008661-01 (GMP). GMP holds a Senior VA Career Scientist Award. We acknowledge that the contents of this study do not represent the views of the NCCIH, the ODS, the NIH, the U.S. Department of Veterans Affairs, or the United States Government.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Al-Amin H, 2011, EXP NEUROL, V228, P30, DOI 10.1016/j.expneurol.2010.11.005; Apkarian AV, 2006, NEUROSCI LETT, V407, P176, DOI 10.1016/j.neulet.2006.08.034; Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Aziz MH, 2005, PHOTOCHEM PHOTOBIOL, V81, P25, DOI 10.1562/2004-08-13-RA-274.1; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Blom SM, 2014, J NEUROSCI, V34, P5754, DOI 10.1523/JNEUROSCI.3667-13.2014; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Brox JI, 2010, ANN RHEUM DIS, V69, P1643, DOI 10.1136/ard.2009.108902; Buckley CT, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1029; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen TY, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700111; Covey WC, 2000, BRAIN RES, V859, P113, DOI 10.1016/S0006-8993(00)01965-X; Dong L, 2012, BRAIN RES, V1461, P51, DOI 10.1016/j.brainres.2012.04.026; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Elmali N, 2005, INFLAMM RES, V54, P158, DOI 10.1007/s00011-004-1341-6; Evashwick-Rogler TW, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1014; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Frolinger T, 2018, BIOL OPEN, V7, DOI 10.1242/bio.035196; Frolinger T, 2018, FASEB J, V32, P5390, DOI 10.1096/fj.201800030R; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Gordon FT, 1996, HORM BEHAV, V30, P244, DOI 10.1006/hbeh.1996.0029; Hadipour-Jahromy M, 2010, PHYTOTHER RES, V24, P182, DOI 10.1002/ptr.2880; Hall H, 2008, BMJ CLIN EVID 2008; Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Ignatowski TA, 2005, NEUROPHARMACOLOGY, V48, P448, DOI 10.1016/j.neuropharm.2004.11.001; Ignatowski TA, 1999, BRAIN RES, V841, P70, DOI 10.1016/S0006-8993(99)01782-5; Janle EM, 2010, J MED FOOD, V13, P926, DOI 10.1089/jmf.2009.0157; Jaumard NV, 2015, SPINE, V40, pE1084, DOI 10.1097/BRS.0000000000001021; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kim JS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3485; Krikorian R, 2012, J AGR FOOD CHEM, V60, P5736, DOI 10.1021/jf300277g; Krupkova O, 2014, EUR CELLS MATER, V28, P372, DOI 10.22203/eCM.v028a26; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; LaCroix-Fralish ML, 2005, SPINE, V30, P1821, DOI 10.1097/01.brs.0000174122.63291.38; Lai A, 2007, MED ENG PHYS, V29, P814, DOI 10.1016/j.medengphy.2006.08.013; Lai A, 2016, SPINE J, V16, P420, DOI 10.1016/j.spinee.2015.11.019; Lai A, 2015, J ORTHOP RES, V33, P755, DOI 10.1002/jor.22833; Lee M, 2009, ANESTH ANALG, V109, P1287, DOI 10.1213/ane.0b013e3181b31f39; Li CL, 2016, CELL RES, V26, P967, DOI 10.1038/cr.2016.90; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Luchtmann M, 2015, NEURAL REGEN RES, V10, P1234, DOI 10.4103/1673-5374.162754; Luchtmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090816; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Miyagi M, 2012, SPINE, V37, P1810, DOI 10.1097/BRS.0b013e31824ffac6; Miyagi M, 2011, SPINE, V36, P2260, DOI 10.1097/BRS.0b013e31820e68c7; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Mosley GE, 2019, SPINE, V44, P1257, DOI 10.1097/BRS.0000000000003055; Mosley GE, 2017, ANN NY ACAD SCI, V1409, P51, DOI 10.1111/nyas.13429; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; National Research Council Committee on Pesticides in the Diets of Infants and Children, 1993, PEST DIETINF CHILD; Ohtori S, 1999, SPINE, V24, P2295, DOI 10.1097/00007632-199911150-00002; Ohtori S, 2001, SPINE, V26, P946, DOI 10.1097/00007632-200104150-00020; PRICE J, 1985, J NEUROSCI, V5, P2051; Rusanescu G, 2017, J CELL MOL MED, V21, P299, DOI 10.1111/jcmm.12965; Rutges JPHJ, 2013, OSTEOARTHR CARTILAGE, V21, P2039, DOI 10.1016/j.joca.2013.10.001; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sivaprakasapillai B, 2009, METABOLISM, V58, P1743, DOI 10.1016/j.metabol.2009.05.030; Sorge RE, 2017, J NEUROSCI RES, V95, P1271, DOI 10.1002/jnr.23841; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00042; Wang J, 2013, MOL NUTR FOOD RES, V57, P2091, DOI 10.1002/mnfr.201300230; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wang X, 2009, DETC 2008: PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATIONAL IN ENGINEERING CONFERENCE, VOL 3, PTS A AND B, P1541; Weisshaar CL, 2010, J NEUROTRAUM, V27, P2261, DOI 10.1089/neu.2010.1460; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w; Wuertz K, 2011, SPINE, V36, pE1373, DOI 10.1097/BRS.0b013e318221e655; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Xu YP, 2011, J AGR FOOD CHEM, V59, P10586, DOI 10.1021/jf202438d; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Zhao W, 2015, NEUROCHEM INT, V89, P191, DOI 10.1016/j.neuint.2015.07.023	80	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223435	10.1371/journal.pone.0223435	http://dx.doi.org/10.1371/journal.pone.0223435			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577822	Green Published, gold			2022-12-26	WOS:000532388000036
J	Sun, CY; Sung, JM; Wang, JD; Li, CY; Kuo, YT; Lee, CC; Wu, JL; Chang, YT				Sun, Chien-Yao; Sung, Junne-Ming; Wang, Jung-Der; Li, Chung-Yi; Kuo, Yi-Ting; Lee, Chia-Chun; Wu, Jia-Ling; Chang, Yu-Tzu			A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; P-CRESOL; DEATH; ASSOCIATION; MORTALITY; THERAPY	Introduction Congestive heart failure (CHF) is associated with high mortality and a heavy financial and healthcare burden in the dialysis population. Determining which dialysis modality is associated with a higher risk of developing CHF might facilitate clinical decision making and surveillance programs in the dialysis population. Methods Using the Taiwan National Health Insurance Database, we recruited all incident dialysis patients during the period from January 1, 1998 to December 31, 2010. The propensity score matching method was applied to establish the matched hemodialysis (HD) and peritoneal dialysis (PD) cohort. Incidence rates and cumulative incidence rates of CHF-related hospitalization were first compared for the HD and PD patients. Multivariable subdistribution hazards models were then constructed to control for potential confounders. Results Among a total of 65,899 enrolled dialysis patients, 4,754 matched pairs of HD and PD patients were identified. The incidence rates of CHF in the matched HD and PD patients were 25.98 and 19.71 per 1000 patient-years, respectively (P = 0.001). The cumulative incidence rate of CHF was also higher in the matched HD patients (0.16, 95% confidence interval (CI)(0.12-0.21)] than in the corresponding PD patients (0.09, 95% CI [0.08-0.11]) (P<0.0001). HD was consistently associated with an increased subdistribution hazard ratio (HR) of CHF compared with PD in the matched cohort (HR: 1.45, 95% CI [1.23-1.7]). Similar phenomenons were observed in either the subgroup analysis stratified by selected confounders or in the HD and PD group without matching. Conclusions HD is associated with a higher risk of developing CHF-related hospitalization than PD. The surveillance program for CHF should differ in patients receiving different dialysis modalities.	[Sun, Chien-Yao; Sung, Junne-Ming; Wang, Jung-Der; Kuo, Yi-Ting; Lee, Chia-Chun; Wu, Jia-Ling; Chang, Yu-Tzu] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Wang, Jung-Der; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Environm & Occupat Hlth, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Chang, YT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan.	kangxiemperor@gmail.com	sun, chienyao/ADD-3507-2022; LI, CHUNG-YI/ABI-1419-2020; Chang, Yu-Tzu/AAE-6781-2022	sun, chienyao/0000-0001-6236-6022; LI, CHUNG-YI/0000-0002-0321-8908; Chang, Yu-Tzu/0000-0003-1449-9431	National ChengKung University Hospital, Tainan, Taiwan, ROC [NCKUH-10702005, NCKUH-10802052]	National ChengKung University Hospital, Tainan, Taiwan, ROC	Our research was partly supported by the grants of NCKUH-10702005 and NCKUH-10802052 to Chang YT from the National ChengKung University Hospital, Tainan, Taiwan, ROC (http://crc.hosp.ncku.edu.tw).None of the funding sources had any role in the study design, analysis, and interpretation of the data, the preparation, review, or approval of the manuscript.	Barrett BJ, 1997, AM J KIDNEY DIS, V29, P214, DOI 10.1016/S0272-6386(97)90032-9; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cao XS, 2015, CLIN J AM SOC NEPHRO, V10, P111, DOI 10.2215/CJN.04730514; Chang YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep30266; Chang YT, 2014, DIABETES CARE, V37, P277, DOI 10.2337/dc13-0781; Chawla LS, 2014, J AM COLL CARDIOL, V63, P1246, DOI 10.1016/j.jacc.2014.01.020; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; Evenepoel P, 2006, KIDNEY INT, V70, P794, DOI 10.1038/sj.ki.5001640; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 2003, SEMIN DIALYSIS, V16, P111, DOI 10.1046/j.1525-139X.2003.160271.x; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; HARNETT JD, 1995, KIDNEY INT, V47, P884, DOI 10.1038/ki.1995.132; Hiramatsu Takeyuki, 2007, Adv Perit Dial, V23, P62; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Kontodimopoulos N, 2008, HEALTH POLICY, V86, P85, DOI 10.1016/j.healthpol.2007.10.002; Lekawanvijit S, 2015, J RENAL NUTR, V25, P149, DOI 10.1053/j.jrn.2014.10.009; Locatelli F, 2001, J AM SOC NEPHROL, V12, P2411, DOI 10.1681/ASN.V12112411; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Ministry of Health and Welfare R.O.C. (Taiwan), 2017, 2015 TAIW HLTH WELF; Puttagunta H, 2015, PERITON DIALYSIS INT, V35, P645, DOI 10.3747/pdi.2014.00340; Ranasinghe P, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-42; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SCHURIG R, 1979, ARTIF ORGANS, V3, P215; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sniderman AD, 2010, CLIN J AM SOC NEPHRO, V5, P335, DOI 10.2215/CJN.06300909; Su VYF, 2019, AGING-US, V11, P3650, DOI 10.18632/aging.102004; Taiwan Society of Nephrology, 2015, 2015 ANN REP KIDN DI; Trespalacios FC, 2003, AM J KIDNEY DIS, V41, P1267, DOI 10.1016/S0272-6386(03)00359-7; United States Renal Data System, END STAG REN DIS ESR, V2; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wang IK, 2016, INT J CARDIOL, V218, P219, DOI 10.1016/j.ijcard.2016.05.036; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	38	7	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223336	10.1371/journal.pone.0223336	http://dx.doi.org/10.1371/journal.pone.0223336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574134	Green Published, gold			2022-12-26	WOS:000532376700043
J	Arroyo, P; Ho, BS; Sau, L; Kelley, ST; Thackray, VG				Arroyo, Pablo; Ho, Bryan S.; Sau, Lillian; Kelley, Scott T.; Thackray, Varykina G.			Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; HORMONE NEURONS; ANIMAL-MODELS; SYNDROME PCOS; MOUSE MODEL; HYPERANDROGENEMIA; ANDROGENS; CONSENSUS; EXPOSURE; SEX	Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women that is comprised of two out of the following three features: hyperandrogenism, oligo- or amenorrhea, or polycystic ovaries. In addition to infertility, many women with PCOS have metabolic dysregulation that increases the risk of developing type 2 diabetes, hypertension, and non-alcoholic fatty liver disease. Changes in the gut microbiome are associated with PCOS and gut microbes may be involved in the pathology of this disorder. Since PCOS often manifests in the early reproductive years, puberty is considered to be a critical time period for the development of PCOS. Exposure to sex steroid hormones during development results in permanent, organizational effects, while activational effects are transient and require the continued presence of the hormone. Androgens exert organizational effects during prenatal or early post-natal development, but it is unclear whether androgen excess results in organizational or activational effects during puberty. We recently developed a letrozole-induced PCOS mouse model that recapitulates both reproductive and metabolic phenotypes of PCOS. In this study, we investigated whether letrozole treatment of pubertal female mice exerts organizational or activational effects on host physiology and the gut microbiome. Two months after letrozole removal, we observed recovery of reproductive and metabolic parameters, as well as diversity and composition of the gut microbiome, indicating that letrozole treatment of female mice during puberty resulted in predominantly activational effects. These results suggest that if exposure to excess androgens during puberty leads to the development of PCOS, reduction of androgen levels during this time may improve reproductive and metabolic phenotypes in women with PCOS. These results also imply that continuous letrozole exposure is required to model PCOS in pubertal female mice since letrozole exerts activational rather than organizational effects during puberty.	[Arroyo, Pablo; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Ho, Bryan S.; Sau, Lillian; Thackray, Varykina G.] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, La Jolla, CA 92093 USA.	vthackray@ucsd.edu		Sau, Lillian/0000-0001-8649-6681	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P50 HD012303, R01 HD095412]; Doris A. Howell Foundation Research Scholarship for Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, R24HD102061, P50HD028934] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Doris A. Howell Foundation Research Scholarship for Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	V.G.T. was funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development P50 HD012303 and R01 HD095412. L.S. was funded by a Doris A. Howell Foundation Research Scholarship for Women's Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank members of the Kelley and Thackray labs for insightful comments and suggestions. Hormone levels were measured by the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core Facility (P50 HD28934) and the University of California, Davis Mouse Metabolic Phenotyping Core (U24 DK092993). V.G.T. was funded by P50 HD012303 and R01 HD095412. L.S. was funded by a Doris A. Howell Foundation Research Scholarship for Women's Health.	Abbott DH, 2013, FERTIL STERIL, V100, P2, DOI 10.1016/j.fertnstert.2013.05.023; Abbott DH, 2013, MOL CELL ENDOCRINOL, V373, P21, DOI 10.1016/j.mce.2013.01.013; Anderson AD, 2014, SEMIN REPROD MED, V32, P202, DOI 10.1055/s-0034-1371092; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Barber TM, 2013, FRONT HORM RES, V40, P28, DOI 10.1159/000341682; Barthelmess Erin K, 2014, Front Biosci (Elite Ed), V6, P104; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fernandez EDT, 2018, J ENDOCR SOC, V2, P949, DOI 10.1210/js.2018-00131; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Franks S, 2012, ENDOCRINOLOGY, V153, P2536, DOI 10.1210/en.2012-1366; Guo YW, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156323, 10.1007/s11468-015-0008-1]; Hu M, 2015, P NATL ACAD SCI USA, V112, P14348, DOI 10.1073/pnas.1507514112; Karateke A, 2018, MED PRIN PRACT, V27, P515, DOI 10.1159/000494300; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Kelley ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146509; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Lindheim L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168390; Liu R, 2017, FRONTIERS MICROBIOLO, V8, DOI [10.3389/fmicb.2017.00008, DOI 10.3389/FMICB.2017.00008]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Moore AM, 2015, P NATL ACAD SCI USA, V112, P596, DOI 10.1073/pnas.1415038112; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Padmanabhan V, 2013, STEROIDS, V78, P734, DOI 10.1016/j.steroids.2013.05.004; Patel R, 2018, MOL REPROD DEV, V85, P778, DOI 10.1002/mrd.23059; Rajan RK, 2017, PHARM BIOL, V55, P242, DOI 10.1080/13880209.2016.1258425; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Skarra DV, 2017, ENDOCRINOLOGY, V158, P2988, DOI 10.1210/en.2016-1898; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Teede HJ, 2011, MED J AUSTRALIA, V195, pS69, DOI 10.5694/mja11.10915; Thackray VG, 2019, TRENDS ENDOCRIN MET, V30, P54, DOI 10.1016/j.tem.2018.11.001; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Torres PJ, 2019, ENDOCRINOLOGY, V160, P1193, DOI 10.1210/en.2019-00050; Torres PJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1425-7; Torres PJ, 2018, J CLIN ENDOCR METAB, V103, P1502, DOI 10.1210/jc.2017-02153; van Houten ELAF, 2014, REPROD BIOL, V14, P32, DOI 10.1016/j.repbio.2013.09.007; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Walters KA, 2018, BEST PRACT RES CL EN, V32, P271, DOI 10.1016/j.beem.2018.03.008; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Watson M, 2013, PLOS ONE, V8; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Yao K, 2017, EXP THER MED, V14, P1271, DOI 10.3892/etm.2017.4642	49	21	22	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223274	10.1371/journal.pone.0223274	http://dx.doi.org/10.1371/journal.pone.0223274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568518	Green Published, gold			2022-12-26	WOS:000532364900035
J	Dunk, JR; Woodbridge, B; Lickfett, TM; Bedrosian, G; Noon, BR; LaPlante, DW; Brown, JL; Tack, JD				Dunk, Jeffrey R.; Woodbridge, Brian; Lickfett, Todd M.; Bedrosian, Geoffrey; Noon, Barry R.; LaPlante, David W.; Brown, Jessi L.; Tack, Jason D.			Modeling spatial variation in density of golden eagle nest sites in the western United States	PLOS ONE			English	Article							GREATER SAGE-GROUSE; HABITAT SUITABILITY MODELS; TERRITORY-SIZE REGULATION; POINT PROCESS MODELS; AQUILA-CHRYSAETOS; HOME-RANGE; CONSERVATION FRAMEWORK; RESOURCE SELECTION; ABSENCE; AREAS	In order to contribute to conservation planning efforts for golden eagles (Aquila chrysaetos) in the western U.S., we developed nest site models using > 6,500 nest site locations throughout a > 3,483,000 km(2) area of the western U.S. We developed models for twelve discrete modeling regions, and estimated relative density of nest sites for each region. Cross-validation showed that, in general, models accurately estimated relative nest site densities within regions and sub-regions. Areas estimated to have the highest densities of breeding golden eagles had from 132-2,660 times greater densities compared to the lowest density areas. Observed nest site densities were very similar to those reported from published studies. Large extents of each modeling region consisted of low predicted nest site density, while a small percentage of each modeling region contained disproportionately high nest site density. For example, we estimated that areas with relative nest density values < 0.3 represented from 62.8-97.8% (<(x)over bar> = 82.5%) of each modeling area, and those areas contained from 14.7-30.0% ((x) over bar = 22.1%) of the nest sites. In contrast, areas with relative nest density values > 0.5 represented from 1.0-12.8% ((x) over bar = 6.3%) of modeling areas, and those areas contained from 47.7-66.9% ((x) over bar = 57.3%) of the nest sites. Our findings have direct application to: 1) large-scale conservation planning efforts, 2) risk analyses for land-use proposals such as recreational trails or wind power development, and 3) identifying mitigation areas to offset the impacts of human disturbance.	[Dunk, Jeffrey R.] Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA; [Woodbridge, Brian] US Fish & Wildlife Serv, Corvallis, OR USA; [Lickfett, Todd M.; Bedrosian, Geoffrey] US Fish & Wildlife Serv, Denver Fed Ctr, Denver, CO USA; [Noon, Barry R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Noon, Barry R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [LaPlante, David W.] Nat Resource Geospatial, Montague, CA USA; [Brown, Jessi L.] Univ Nevada Reno, Dept Biol, Reno, NV USA; [Tack, Jason D.] US Fish & Wildlife Serv, Missoula, MT USA	California State University System; California State Polytechnic University, Humboldt; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Colorado State University; Colorado State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; US Fish & Wildlife Service	Dunk, JR (corresponding author), Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA.	Jeffrey.Dunk@humboldt.edu		Dunk, Jeffrey/0000-0002-3213-9272	U.S. Department of the Interior, Fish and Wildlife Service [F14AC00691, F17AC00995, F14AC00569, F14AP00144, F17AC01011, F14AC00264, F17AC00824]	U.S. Department of the Interior, Fish and Wildlife Service(US Fish & Wildlife Service)	This work was funded through U.S. Department of the Interior, Fish and Wildlife Service Agreements F14AC00691 and F17AC00995 to JRD, F14AC00569 to BRN and JDT, F14AP00144 and F17AC01011 to DL, and F14AC00264 and F17AC00824 to JLB.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Adhikari D, 2019, J ENVIRON MANAGE, V243, P299, DOI 10.1016/j.jenvman.2019.05.036; [Anonymous], 2013, EAGL CONS PLAN GUID; [Anonymous], 2002, BIRDS N AM; Baruch-Mordo S, 2013, BIOL CONSERV, V167, P233, DOI 10.1016/j.biocon.2013.08.017; Bedrosian BE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205204; Bedrosian G, 2020, J RAPTOR RES; Bedrosian G, 2017, J RAPTOR RES, V51, P347, DOI 10.3356/JRR-16-38.1; Bosso L, 2018, ECOL ENTOMOL, V43, P192, DOI 10.1111/een.12485; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Braham M, 2015, BIOL CONSERV, V186, P225, DOI 10.1016/j.biocon.2015.03.020; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Carlisle J. D., 2017, INFLUENCE GREATER SA; Carlisle JD, 2018, J WILDLIFE MANAGE, V82, P948, DOI 10.1002/jwmg.21460; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Cleland DT, 2007, WO76 DEP AGR FOR SER; Collopy MW, 2017, J RAPTOR RES, V51, P193, DOI 10.3356/0892-1016-51.3.193; Commission for Environmental Cooperation, 2011, N AM TERR EC LEV BAC; Crandall RH, 2015, J RAPTOR RES, V49, P413, DOI 10.3356/rapt-49-04-413-428.1; Doherty KE, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1462; Donnelly JP, 2017, RANGELAND ECOL MANAG, V70, P95, DOI 10.1016/j.rama.2016.10.009; Dudik M., 2004, P 17 ANN C COMP LEAR, P655; Duflot R, 2018, J NAT CONSERV, V46, P38, DOI 10.1016/j.jnc.2018.08.005; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dunk JR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210643; Dunk JR, 2009, FOREST ECOL MANAG, V258, P626, DOI 10.1016/j.foreco.2009.04.041; DUNK JR, 1994, AUK, V111, P588; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Dwyer JF, 2017, J RAPTOR RES, V51, P293, DOI 10.3356/JRR-16-93.1; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Fish US and Service Wildlife, 2015, GREAT SAG GROUS FACT; Fithian W, 2013, ANN APPL STAT, V7, P1917, DOI 10.1214/13-AOAS667; FRETWELL S D, 1972, P217; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Halvorsen R., 2012, SOMMERFELTIA, V35, P1, DOI DOI 10.2478/V10208-011-0015-3; Herring G, 2017, J RAPTOR RES, V51, P273, DOI 10.3356/JRR-16-19.1; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Hunt WG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172232; Ibanez E., 2016, NRELTP500061750; Kochert MN, 2012, J RAPTOR RES, V46, P239, DOI 10.3356/JRR-12-00001.1; Kochert MN, 1999, J WILDLIFE MANAGE, V63, P773, DOI 10.2307/3802790; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lebeau CW, 2015, J RAPTOR RES, V49, P29, DOI 10.3356/JRR-13-00052.1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; McIntyre CL, 2008, AUK, V125, P214, DOI 10.1525/auk.2008.125.1.214; McLeod David R.A., 2002, Avian Science, V2, P183; Millsap BA, 2015, GLOB ECOL CONSERV, V3, P234, DOI 10.1016/j.gecco.2014.11.017; Millsap BA, 2013, J WILDLIFE MANAGE, V77, P1436, DOI 10.1002/jwmg.588; Mojica EK, 2018, J WILDLIFE MANAGE, V82, P495, DOI 10.1002/jwmg.21412; Murphy RK, 2017, J RAPTOR RES, V51, P216, DOI 10.3356/JRR-16-80.1; New L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130978; Olson LE, 2015, J RAPTOR RES, V49, P400, DOI 10.3356/rapt-49-04-400-412.1; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POSTUPALSKY S, 1974, MANAGEMENT RAPTORS, P21; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Schumaker NH, 2014, LANDSCAPE ECOL, V29, P579, DOI 10.1007/s10980-014-0004-4; Spaul RJ, 2016, ECOL EVOL, V6, P8037, DOI 10.1002/ece3.2540; Steenhof K, 2017, J RAPTOR RES, V51, P378, DOI 10.3356/JRR-16-46.1; Tack JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134781; TEMELES EJ, 1987, OECOLOGIA, V74, P286, DOI 10.1007/BF00379372; UNITED STATES FISH AND WILDLIFE SERVICE, 2016, BALD GOLDEN EAGLES P; US Fish and Wildlife Service, 2016, FIN PROGR ENV IMP ST; VILLAGE A, 1982, J ANIM ECOL, V51, P413, DOI 10.2307/3974; VILLAGE A, 1987, ORNIS SCAND, V18, P198, DOI 10.2307/3676767; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Watson J, 2002, J RAPTOR RES, V36, P41; Watson JW, 2014, J WILDLIFE MANAGE, V78, P1012, DOI 10.1002/jwmg.745; Whitfield DP, 2006, BIOL CONSERV, V130, P465, DOI 10.1016/j.biocon.2006.01.008; Wiens JD, 2018, CONDOR, V120, P106, DOI [10.1650/CONDOR-17-96.1, 10.1650/condor-17-96.1]; Wiens JD, 2017, J RAPTOR RES, V51, P234, DOI 10.3356/JRR-16-77.1; Zielinski WJ, 2012, FOREST ECOL MANAG, V275, P35, DOI 10.1016/j.foreco.2012.03.008; Zimmerman GS, 2003, BEHAV ECOL, V14, P433, DOI 10.1093/beheco/14.3.433	84	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223143	10.1371/journal.pone.0223143	http://dx.doi.org/10.1371/journal.pone.0223143			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568505	Green Published, Green Submitted, gold			2022-12-26	WOS:000532364900024
J	Henke, M; Junker, A; Neumann, K; Altmann, T; Gladilin, E				Henke, Michael; Junker, Astrid; Neumann, Kerstin; Altmann, Thomas; Gladilin, Evgeny			Comparison of feature point detectors for multimodal image registration in plant phenotyping	PLOS ONE			English	Article							FUSION	With the introduction of multi-camera systems in modern plant phenotyping new opportunities for combined multimodal image analysis emerge. Visible light (VIS), fluorescence (FLU) and near-infrared images enable scientists to study different plant traits based on optical appearance, biochemical composition and nutrition status. A straightforward analysis of high-throughput image data is hampered by a number of natural and technical factors including large variability of plant appearance, inhomogeneous illumination, shadows and reflections in the background regions. Consequently, automated segmentation of plant images represents a big challenge and often requires an extensive human-machine interaction. Combined analysis of different image modalities may enable automatisation of plant segmentation in "difficult" image modalities such as VIS images by utilising the results of segmentation of image modalities that exhibit higher contrast between plant and background, i.e. FLU images. For efficient segmentation and detection of diverse plant structures (i.e. leaf tips, flowers), image registration techniques based on feature point (FP) matching are of particular interest. However, finding reliable feature points and point pairs for differently structured plant species in multimodal images can be challenging. To address this task in a general manner, different feature point detectors should be considered. Here, a comparison of seven different feature point detectors for automated registration of VIS and FLU plant images is performed. Our experimental results show that straightforward image registration using FP detectors is prone to errors due to too large structural difference between FLU and VIS modalities. We show that structural image enhancement such as background filtering and edge image transformation significantly improves performance of FP algorithms. To overcome the limitations of single FP detectors, combination of different FP methods is suggested. We demonstrate application of our enhanced FP approach for automated registration of a large amount of FLU/VIS images of developing plant species acquired from high-throughput phenotyping experiments.	[Henke, Michael; Junker, Astrid; Neumann, Kerstin; Altmann, Thomas; Gladilin, Evgeny] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, OT Gatersleben, Corrensstr 3, D-06466 Stadt Seeland, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Gladilin, E (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, OT Gatersleben, Corrensstr 3, D-06466 Stadt Seeland, Germany.	gladilin@ipk-gatersleben.de	Henke, Michael/N-2634-2014	Henke, Michael/0000-0003-0673-3873; Neumann, Kerstin/0000-0001-7451-7086; Altmann, Thomas/0000-0002-3759-360X	German Plant Phenotyping Network (DPPN) - German Federal Ministry of Education and Research (BMBF) [031A053]	German Plant Phenotyping Network (DPPN) - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was partially funded by the German Plant Phenotyping Network (DPPN) which is funded by the German Federal Ministry of Education and Research (BMBF) under the project identification number 031A053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no further funding.	Alcantarilla PF, 2012, LECT NOTES COMPUT SC, V7577, P214, DOI 10.1007/978-3-642-33783-3_16; Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Berenstein R, 2015, SENSORS-BASEL, V15, P20845, DOI 10.3390/s150820845; Brock KK, 2017, MED PHYS, V44, pE43, DOI 10.1002/mp.12256; De Vylder J, 2012, P SPIE SENSING AGR F, V8369, P6; Gauglitz S, 2011, INT J COMPUT VISION, V94, P335, DOI 10.1007/s11263-011-0431-5; Goshtasby A.A., 2017, THEORY APPL IMAGE RE; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; Henriques JF, 2010, COLOREDGES EDGES COL; Klukas C, 2014, PLANT PHYSIOL, V165, P506, DOI 10.1104/pp.113.233932; Lahat D, 2015, P IEEE, V103, P1449, DOI 10.1109/JPROC.2015.2460697; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Nixon M. S., 2002, FEATURE EXTRACTION I, V1st; Raza SEA, 2015, PATTERN RECOGN, V48, P2119, DOI 10.1016/j.patcog.2015.01.027; Rodehorst V., 2006, P 5 INT S TURKISH GE, P1; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Wang ZL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122738; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	25	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0221203	10.1371/journal.pone.0221203	http://dx.doi.org/10.1371/journal.pone.0221203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568494	Green Published, gold, Green Submitted			2022-12-26	WOS:000532364900002
J	Yang, W; Li, YY; Gao, RL; Xiu, ZH; Sun, T				Yang, Wei; Li, Yanyan; Gao, Ruoling; Xiu, Zenghe; Sun, Ting			MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/beta-catenin signaling pathway	ONCOGENE			English	Article							DENDRITIC CELLS; T-CELLS; CANCER; RECOGNITION; EXPRESSION; SENSITIVITY; INHIBITORS; MEMORY; P53	Glioma stem cells (GSCs) decrease T cells cognition and evade systemic immunosurveillance via downregulations or defects of major histocompatibility complex class I (MHC-I) molecule and antigen-processing machinery (APM) components. Improvement of tumor surface antigens of GSCs may be effective strategy to trigger an adaptive immune response and activate cytotoxic T cells (CTLs) to eliminate glioma. In this study, our data indicated that downregulations of MHC-I and APM components expressions were associated with Wnt pathway activation in GSCs. Histone deacetylases (HDAC) inhibition improved MHC-I and APM components expressions, which could be partly reverted by Wnt pathway activation. Blocking CTLs-mediated killing decreased the anti-tumor effect of tumor lysate vaccine. The enhancement of T cells immune response resulting from HDAC inhibition was dependent on CTLs cognition on tumor antigens presented by upregulated MHC-I molecule in GSCs. These data suggest that suppression of stemness pathway may be effective for GSCs-based immunotherapy against immune-escaped tumors.	[Yang, Wei; Gao, Ruoling; Xiu, Zenghe] Soochow Univ, Sch Radiat Med & Protect, State Key Lab Radiat Med & Protect, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Wei; Gao, Ruoling; Xiu, Zenghe] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Suzhou 215123, Jiangsu, Peoples R China; [Li, Yanyan; Sun, Ting] Soochow Univ, Neurosurg & Brain & Nerve Res Lab, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Yang, W (corresponding author), Soochow Univ, Sch Radiat Med & Protect, State Key Lab Radiat Med & Protect, Suzhou 215123, Jiangsu, Peoples R China.; Yang, W (corresponding author), Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Suzhou 215123, Jiangsu, Peoples R China.; Sun, T (corresponding author), Soochow Univ, Neurosurg & Brain & Nerve Res Lab, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.	detachedy@aliyun.com; sunting1979st@aliyun.com			National Natural Science Foundation of China [81874080, 31870844, 31570851]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81874080, 31870844, 31570851) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; Brown SD, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1556080; Cai L, 2019, CLIN CANCER RES, V25, P2644, DOI 10.1158/1078-0432.CCR-18-1401; Carugo A, 2019, CANCER CELL, V35, P204, DOI 10.1016/j.ccell.2019.01.006; Chang CC, 2015, J BIOL CHEM, V290, P26562, DOI 10.1074/jbc.M115.676130; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Durgeau A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00014; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Finocchiaro G, 2016, CANCER IMMUNOL IMMUN, V65, P101, DOI 10.1007/s00262-015-1754-9; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; JEFFERIES WA, 1993, J IMMUNOL, V151, P2974; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Lou YM, 2007, VACCINE, V25, P2331, DOI 10.1016/j.vaccine.2006.11.064; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Morgan MA, 2018, CANCER RES, V78, P6713, DOI 10.1158/0008-5472.CAN-18-2439; Morrison BJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4389-3; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Sadahiro H, 2014, BRAIN TUMOR PATHOL, V31, P77, DOI 10.1007/s10014-013-0149-x; Setiadi AF, 2007, MOL CELL BIOL, V27, P7886, DOI 10.1128/MCB.01547-07; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Sun T, 2017, ONCOTARGET, V8, P74451, DOI 10.18632/oncotarget.20165; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; VERSTEEG R, 1988, EMBO J, V7, P1023, DOI 10.1002/j.1460-2075.1988.tb02909.x; Vik-Mo EO, 2013, CANCER IMMUNOL IMMUN, V62, P1499, DOI 10.1007/s00262-013-1453-3; Wang B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3359; Woan KV, 2012, IMMUNOL CELL BIOL, V90, P55, DOI 10.1038/icb.2011.96; Wong TS, 2018, ONCOL LETT, V16, P2887, DOI 10.3892/ol.2018.9041; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yang W, 2018, CANCER LETT, V415, P164, DOI 10.1016/j.canlet.2017.12.005; Yang W, 2016, ONCOTARGET, V7, P41505, DOI 10.18632/oncotarget.9214; Yang W, 2014, EXP CELL RES, V326, P22, DOI 10.1016/j.yexcr.2014.05.022; Zhu KC, 1999, ONCOGENE, V18, P7740, DOI 10.1038/sj.onc.1203235	34	41	44	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1098	1111		10.1038/s41388-019-1045-6	http://dx.doi.org/10.1038/s41388-019-1045-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591480				2022-12-26	WOS:000511209700011
J	Chen, YL; Chen, JL; Zhang, CX; Yang, SS; Zhang, XP; Liu, Y; Su, ZG				Chen, Yulong; Chen, Jinglu; Zhang, Caixia; Yang, Shanshan; Zhang, Xueping; Liu, Yin; Su, Zhiguang			Deficiency in the short-chain acyl-CoA dehydrogenase protects mice against diet-induced obesity and insulin resistance	FASEB JOURNAL			English	Article						SCAD; lipogenesis; AMPK; PKC-epsilon; GRP78	ENDOPLASMIC-RETICULUM STRESS; HORMONE-SENSITIVE LIPASE; FATTY-ACID OXIDATION; KINASE; PHOSPHORYLATION; DYSFUNCTION; ACTIVATION; GRP78/BIP; LIPOLYSIS; KNOCKOUT	Acyl-CoA dehydrogenases (CADs) participate in mitochondrial fatty acid oxidation; abnormal fatty acid oxidation is associated with obesity and related metabolic disorders. We decipher the impact of short-chain CAD (SCAD) on adiposity and insulin resistance. BALB/cBy strain mice derived from BALB/c strain are deficient in SCAD activity because of a spontaneous deletion in the acyl-CoA dehydrogenases (Acads) gene. Adiposity, lipogenesis, and insulin sensitivity were compared in BALB/c and BALB/cBy mice subjected to high-fat diets (HFDs). A whole hepatic transcriptome profiling experiment with microarrays was performed to evaluate the mechanisms by which SCAD deficiency protects against insulin resistance. Acads-deficient mice were significantly resistant to HFD-induced obesity and insulin resistance as compared with control mice. Reduced obesity results from decreased triglyceride content due to activation of AMPK in liver that would reduce hepatic content of malonyl-CoA, resulting in decreased hepatic de novo lipogenesis. Improved insulin sensitivity was associated with reduced diacylglycerol content commensurate with reduced PKC-epsilon activity and increased protein kinase B (AKT) activation in liver and skeletal muscle. Additionally, Acads-deficient mice displayed significantly higher expression of the endoplasmic chaperone 78-kDa glucose-regulated protein, which was further associated with the AKT activation in the primary hepatocytes. Modulation of SCAD expression may therefore be a novel therapeutic approach to manage and prevent obesity and related metabolic diseases, such as diabetes.	Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu, Peoples R China; Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China	Sichuan University; Sichuan University	Su, ZG (corresponding author), Sichuan Univ, West China Hosp, Mol Med Res Ctr, 1 Keyuan 4th Rd,Gaopeng St, Chengdu 610041, Peoples R China.	zhiguang.su@scu.edu.cn	Su, Zhiguang/AFS-0022-2022	Su, Zhiguang/0000-0001-8635-9310	National Natural Science Foundation of China [81770814]; Sichuan Province Science and Technology Support Program [2018SZ0171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Support Program	Funding for this study was provided by the National Natural Science Foundation of China (81770814) and the Sichuan Province Science and Technology Support Program (2018SZ0171). The authors declare no conflicts of interest.	Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003; An Se Jin, 2016, Korean J Pediatr, V59, pS45, DOI 10.3345/kjp.2016.59.11.S45; Bi XK, 2018, CIRC RES, V122, P1545, DOI 10.1161/CIRCRESAHA.117.312641; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cerezo M, 2017, AUTOPHAGY, V13, P216, DOI 10.1080/15548627.2016.1246107; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Ghosh S, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0075-0; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hornbak M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kruger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041709; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Li Y, 2012, INT J OBESITY, V36, P1503, DOI 10.1038/ijo.2011.279; Liu Y, 2017, J BIOL CHEM, V292, P13959, DOI [10.1074/jbc.M117.782391, 10.1074/jbc.m117.782391]; Liu YL, 2017, MOL CELL BIOCHEM, V426, P47, DOI 10.1007/s11010-016-2879-7; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merritt JL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.57; Moller CL, 2011, MOL CELL ENDOCRINOL, V341, P9, DOI 10.1016/j.mce.2011.03.010; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pieralisi A, 2016, REDOX BIOL, V9, P39, DOI 10.1016/j.redox.2016.05.006; Shirao K, 2010, HUM GENET, V127, P619, DOI 10.1007/s00439-010-0822-7; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012; Zhang XP, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00802; Zhang YJ, 2018, J BIOL CHEM, V293, P7894, DOI 10.1074/jbc.RA117.000508; Zhang YJ, 2013, ENGINEERING, V5, P4, DOI DOI 10.1371/J0URNAL.P0NE.0080071	41	10	11	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13722	13733		10.1096/fj.201901474RR	http://dx.doi.org/10.1096/fj.201901474RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585505	Bronze			2022-12-26	WOS:000507466100053
J	Nguyen, TV; Yao, SH; Wang, YH; Rolfe, A; Selvaraj, A; Darman, R; Ke, JY; Warmuth, M; Smith, PG; Larsen, NA; Yu, LH; Zhu, P; Fekkes, P; Vaillancourt, FH; Bolduc, DM				Tuong-Vi Nguyen; Yao, Shihua; Wang, Yahong; Rolfe, Alan; Selvaraj, Anand; Darman, Rachel; Ke, Jiyuan; Warmuth, Markus; Smith, Peter G.; Larsen, Nicholas A.; Yu, Lihua; Zhu, Ping; Fekkes, Peter; Vaillancourt, Frederic H.; Bolduc, David M.			The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cancer biology; DNA methyltransferase; DNA methylation; oligomerization; oligomer; DNMT3A; epigenetics; R882H	ACUTE MYELOID-LEUKEMIA; DE-NOVO METHYLATION; INITIAL-CHARACTERIZATION; PWWP DOMAIN; MECHANISM; BINDING; GENE; 3A; ESTABLISHMENT; STIMULATION	DNMT3A (DNA methyltransferase 3A) is a de novo DNA methyltransferase responsible for establishing CpG methylation patterns within the genome. DNMT3A activity is essential for normal development, and its dysfunction has been linked to developmental disorders and cancer. DNMT3A is frequently mutated in myeloid malignancies with the majority of mutations occurring at Arg-882, where R882H mutations are most frequent. The R882H mutation causes a reduction in DNA methyltransferase activity and hypomethylation at differentially-methylated regions within the genome, ultimately preventing hematopoietic stem cell differentiation and leading to leukemogenesis. Although the means by which the R882H DNMT3A mutation reduces enzymatic activity has been the subject of several studies, the precise mechanism by which this occurs has been elusive. Herein, we demonstrate that in the context of the full-length DNMT3A protein, the R882H mutation stabilizes the formation of large oligomeric DNMT3A species to reduce the overall DNA methyltransferase activity of the mutant protein as well as the WT?R882H complex in a dominant-negative manner. This shift in the DNMT3A oligomeric equilibrium and the resulting reduced enzymatic activity can be partially rescued in the presence of oligomer-disrupting DNMT3L, as well as DNMT3A point mutations along the oligomer-forming interface of the catalytic domain. In addition to modulating the oligomeric state of DNMT3A, the R882H mutation also leads to a DNA-binding defect, which may further reduce enzymatic activity. These findings provide a mechanistic explanation for the observed loss of DNMT3A activity associated with the R882H hot spot mutation in cancer.	[Tuong-Vi Nguyen; Yao, Shihua; Rolfe, Alan; Selvaraj, Anand; Darman, Rachel; Ke, Jiyuan; Warmuth, Markus; Smith, Peter G.; Larsen, Nicholas A.; Yu, Lihua; Zhu, Ping; Fekkes, Peter; Vaillancourt, Frederic H.; Bolduc, David M.] H3 Biomed Inc, 300 Technol Sq, Cambridge, MA 02139 USA; [Wang, Yahong] ChemPartner Co Ltd, 998 Halei Rd, Shanghai 201203, Peoples R China		Bolduc, DM (corresponding author), H3 Biomed Inc, 300 Technol Sq, Cambridge, MA 02139 USA.	david_bolduc@h3biomedicine.com						Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Aapola U, 2001, CYTOGENET CELL GENET, V92, P122, DOI 10.1159/000056881; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Cole CB, 2017, J CLIN INVEST, V127, P3657, DOI 10.1172/JCI93041; Dai YJ, 2017, P NATL ACAD SCI USA, V114, P5237, DOI 10.1073/pnas.1703476114; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Emperle M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31635-8; Emperle M, 2014, J BIOL CHEM, V289, P29602, DOI 10.1074/jbc.M114.572032; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hata K, 2002, DEVELOPMENT, V129, P1983; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Lu R, 2019, CANCER RES, V79, P3583, DOI 10.1158/0008-5472.CAN-18-3275; Lu R, 2016, CANCER CELL, V30, P92, DOI 10.1016/j.ccell.2016.05.008; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Scourzic L, 2016, LEUKEMIA, V30, P1388, DOI 10.1038/leu.2016.29; Spencer DH, 2017, CELL, V168, P801, DOI 10.1016/j.cell.2017.01.021; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Veland N, 2019, NUCLEIC ACIDS RES, V47, P152, DOI 10.1093/nar/gky947; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yuan XQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003519; Zhang ZM, 2018, NATURE, V554, P387, DOI 10.1038/nature25477	47	15	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16966	16977		10.1074/jbc.RA119.010126	http://dx.doi.org/10.1074/jbc.RA119.010126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31582562	Green Published, hybrid			2022-12-26	WOS:000501801900040
J	Ling, J; Wang, H; Li, GM; Feng, Z; Song, YF; Wang, P; Shao, H; Zhou, H; Chen, G				Ling, Jin; Wang, Hong; Li, Gaomin; Feng, Zhen; Song, Yufei; Wang, Peng; Shao, Hong; Zhou, Hu; Chen, Gang			A novel short-term high-lactose culture approach combined with a matrix-assisted laser desorption ionization-time of flight mass spectrometry assay for differentiating Escherichia coli and Shigella species using artificial neural networks	PLOS ONE			English	Article							MALDI BIOTYPER; IDENTIFICATION; ALGORITHM; DATABASE	Background Escherichia coli is currently unable to be reliably differentiated from Shigella species by routine matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis. In the present study, a reliable and rapid identification method was established for Escherichia coli and Shigella species based on a short-term high-lactose culture using MALDI-TOF MS and artificial neural networks (ANN). Materials and methods The Escherichia coli and Shigella species colonies, treated with (Condition 1)/without (Condition 2) a short-term culture with an in-house developed high-lactose fluid medium, were prepared for MALDI-TOF MS assays. The MS spectra were acquired in linear positive mode, with a mass range from 2000 to 12000 Da and were then compared to discover new biomarkers for identification. Finally, MS spectra data sets 1 and 2, extracted from the two conditions, were used for ANN training to investigate the benefit on bacterial classification produced by the new biomarkers. Results Twenty-seven characteristic MS peaks from the Escherichia coli and Shigella species were summarized. Seven unreported MS peaks, with m/z 2330.745, m/z 2341.299, m/z 2371.581, m/z 2401.038, m/z 3794.851, m/z 3824.839 and m/z 3852.548, were discovered in only the spectra from the E. coli strains after a short-term high-lactose culture and were identified as belonging to acid shock protein. The prediction accuracies of the ANN models, based on data set 1 and 2, were 97.71 +/- 0.16% and 74.39 +/- 0.34% (n = 5), with an extremely remarkable difference (p < 0.001), and the areas under the curve of the receiver operating characteristic curve were 0.72 and 0.99, respectively. Conclusions In summary, adding a short-term high-lactose culture approach before the analysis enabled a reliable and easy differentiation of Escherichia coli from the Shigella species using MALDI-TOF MS and ANN.	[Ling, Jin; Wang, Hong; Li, Gaomin; Shao, Hong; Chen, Gang] Shanghai Inst Food & Drug Control, Dept Biochem Drugs & Biol Prod, Shanghai, Peoples R China; [Ling, Jin; Wang, Hong; Li, Gaomin; Shao, Hong; Chen, Gang] Shanghai Inst Food & Drug Control, NMPA Key Lab Qual Control Therapeut Monoclonal An, Shanghai, Peoples R China; [Ling, Jin] Zhejiang Jinhua Guangfu Hosp, Dept Pharm, Jinhua, Zhejiang, Peoples R China; [Feng, Zhen] Shanghai Inst Food & Drug Control, Dept Antibiot & Microbiol, Shanghai, Peoples R China; [Song, Yufei] Ningbo Med Ctr, Lihuili Hosp, Dept Gastroenterol, Ningbo, Peoples R China; [Wang, Peng] Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China; [Zhou, Hu] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, G (corresponding author), Shanghai Inst Food & Drug Control, Dept Biochem Drugs & Biol Prod, Shanghai, Peoples R China.; Chen, G (corresponding author), Shanghai Inst Food & Drug Control, NMPA Key Lab Qual Control Therapeut Monoclonal An, Shanghai, Peoples R China.	chengang@sifdc.org.cn		Shao, Hong/0000-0002-4353-5609; Ling, Jin/0000-0002-2163-9992	Shanghai Municipal Food and Drug Administration Research Projects [KT-201708210037]; Chinese Pharmacopoeia Commission Research Projects [2019S05]	Shanghai Municipal Food and Drug Administration Research Projects; Chinese Pharmacopoeia Commission Research Projects	This work was supported by the Shanghai Municipal Food and Drug Administration Research Projects, No. KT-201708210037 (http://www.shfda.gov.cn/) to JL, and a grant from the Chinese Pharmacopoeia Commission Research Projects (No. 2019S05; http://www.chp.org.cn) to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Shanghai Municipal Food and Drug Administration Research Projects (No. KT-201708210037).	Buchanan R, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.06.010; Campilongo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106589; Chattaway MA, 2017, J CLIN MICROBIOL, V55, P616, DOI 10.1128/JCM.01790-16; Chen YD, 2004, CLIN CANCER RES, V10, P8380, DOI 10.1158/1078-0432.CCR-1162-03; Dallagassa CB, 2014, GENET MOL RES, V13, P716, DOI 10.4238/2014.January.29.2; Fangous MS, 2014, J CLIN MICROBIOL, V52, P3362, DOI 10.1128/JCM.00788-14; Feng L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061944; Harju I, 2017, J CLIN MICROBIOL, V55, P914, DOI 10.1128/JCM.01990-16; Huang B, 2017, J CLIN MICROBIOL, V55, P1488, DOI 10.1128/JCM.02549-16; Khot PD, 2013, J CLIN MICROBIOL, V51, P3711, DOI 10.1128/JCM.01526-13; Krieg NR, 2010, BERGEYS MANUAL SYSTE, V2nd; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Mari-Almirall M, 2017, CLIN MICROBIOL INFEC, V23, DOI [10.1016/j.culher.2016.11.020, 10.1016/j.cmi.2016.11.020]; Paauw A, 2015, INT J MED MICROBIOL, V305, P446, DOI 10.1016/j.ijmm.2015.04.001; Ragupathi N. K. Devanga, 2018, New Microbes and New Infections, V21, P58, DOI 10.1016/j.nmni.2017.09.003; Schulthess B, 2014, J CLIN MICROBIOL, V52, P1089, DOI 10.1128/JCM.02399-13; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Seputiene V, 2003, J BACTERIOL, V185, P2475, DOI 10.1128/JB.185.8.2475-2484.2003; Ud-Din A, 2014, BRAZ J MICROBIOL, V45, P1131, DOI 10.1590/S1517-83822014000400002; Veloo ACM, 2016, CLIN MICROBIOL INFEC, V22, P793, DOI 10.1016/j.cmi.2016.06.016; Yu JJ, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0274-9	21	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0222636	10.1371/journal.pone.0222636	http://dx.doi.org/10.1371/journal.pone.0222636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593573	Green Published, gold			2022-12-26	WOS:000532431700002
J	Casaril, AE; Alonso, DP; Franco, KG; Alvarez, MVN; Barrios, SPG; Fernandes, WD; Infran, JDM; Rodrigues, ACM; Ribolla, PEM; de Oliveira, AG				Casaril, Aline Etelvina; Alonso, Diego Peres; Franco, Karina Garcia; Niz Alvarez, Marcus Vinicius; Gomes Barrios, Suellem Petilim; Fernandes, Wagner de Souza; Moura Infran, Jucelei de Oliveira; Moura Rodrigues, Ana Caroline; Martins Ribolla, Paulo Eduardo; de Oliveira, Alessandra Gutierrez			Macrogeographic genetic structure of Lutzomyia longipalpis complex populations using Next Generation Sequencing	PLOS ONE			English	Article							MALE SEX-PHEROMONES; SAND FLIES DIPTERA; VISCERAL LEISHMANIASIS; BRAZILIAN POPULATIONS; PERIOD GENE; 1ST REPORT; PSYCHODIDAE; SANDFLIES; NEIVA; LUTZ	Lutzomyia longipalpis is the main vector of Leishmania infantum, the causative agent of visceral leishmaniasis in the Neotropical realm. Its taxonomic status has been widely discussed once it encompasses a complex of species. The knowledge about the genetic structure of insect vector populations helps the elucidation of components and interactions of the disease ecoepidemiology. Thus, the objective of this study was to genotypically analyze populations of the Lu. longipalpis complex from a macrogeographic perspective using Next Generation Sequencing. Polymorphism analysis of three molecular markers was used to access the levels of population genetic structure among nine different populations of sand flies. Illumina Amplicon Sequencing Protocol' was used to identify possible polymorphic sites. The library was sequenced on paired-end Illumina MiSeq platform. Significant macro geographical population differentiation was observed among Lu. longipalpis populations via PCA and DAPC analyses. Our results revealed that populations of Lu. longipalpis from the nine municipalities were grouped into three clusters. In addition, it was observed that the levels of Lu. longipalpis population structure could be associated with distance isolation. This new sequencing method allowed us to study different molecular markers after a single sequencing run, and to evaluate population and inter-species differences on a macrogeographic scale.	[Casaril, Aline Etelvina; Gomes Barrios, Suellem Petilim; Fernandes, Wagner de Souza; de Oliveira, Alessandra Gutierrez] Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil; [Casaril, Aline Etelvina; Franco, Karina Garcia; Moura Infran, Jucelei de Oliveira; de Oliveira, Alessandra Gutierrez] Univ Fed Mato Grosso do Sul, Lab Parasitol Humana, Campo Grande, MS, Brazil; [Alonso, Diego Peres; Niz Alvarez, Marcus Vinicius; Martins Ribolla, Paulo Eduardo] Univ Estadual Paulista, Dept Parasitol, Lab Pesquisas & Anal Genet, Botucatu, SP, Brazil; [Moura Rodrigues, Ana Caroline] Univ Estadual Ceara, Lab Doencas Parasitarias, Fortaleza, Ceara, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Estadual do Ceara	de Oliveira, AG (corresponding author), Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.; de Oliveira, AG (corresponding author), Univ Fed Mato Grosso do Sul, Lab Parasitol Humana, Campo Grande, MS, Brazil.	alessandra.oliveira@ufms.br	Fernandes, Wagner/CAH-5898-2022; Alonso, Diego P/C-1079-2012; Alonso, Diego/GRO-4526-2022	Alonso, Diego/0000-0003-4992-6253; Oliveira, Alessandra/0000-0002-7677-9351; DE OLIVEIRA MOURA INFRAN, JUCELEI/0000-0002-8970-157X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) -Finance Code 001 (https://www.capes.gov.br/) to AEC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RE, 1993, MED VET ENTOMOL, V7, P203, DOI 10.1111/j.1365-2915.1993.tb00677.x; Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Andrade JD, 2003, MEM I OSWALDO CRUZ, V98, P145, DOI 10.1590/S0074-02762003000900022; [Anonymous], 2014, THESIS; Araki AS, 2009, PLOS NEGLECT TROP D, V3, P1, DOI DOI 10.1371/J0URNAL.PNTD.0000365.G001; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Aransay AM, 1999, INSECT MOL BIOL, V8, P179, DOI 10.1046/j.1365-2583.1999.820179.x; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Arrivillaga JC, 2001, J MED ENTOMOL, V38, P783, DOI 10.1603/0022-2585-38.6.783; Bauzer LGSR, 2002, MOL BIOL EVOL, V19, P1624, DOI 10.1093/oxfordjournals.molbev.a004224; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Beati L, 2004, INT J PARASITOL, V34, P225, DOI 10.1016/j.ijpara.2003.10.012; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Coutinho-Abreu IV, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-16; Salomon OD, 2011, MEM I OSWALDO CRUZ, V106, P381, DOI 10.1590/S0074-02762011000300023; Darwin C., 1859, ELETRONIC CLASSIC SE; de Souza NA, 2002, T ROY SOC TROP MED H, V96, P102, DOI 10.1016/S0035-9203(02)90258-0; de Souza NA, 2017, MEM I OSWALDO CRUZ, V112, P161, DOI 10.1590/0074-02760160463; Deane L. M., 1954, Hospital, V45, P419; Deane LM, 1956, ESTUDOS RESERVATORIO, Vviii, P82; Depaquit J, COMPTES RENDUS ACAD; Ebrahimi S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1603-5; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Galati E.A.B., 2018, BRAZILIAN SAND FLIES, P9, DOI [10.1007/978, 10.1007/978-3-319-75544-1_2]; Golczer G, 2015, B MALARIOL SALUD AMB, V55, P19; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Hamilton JGC, 2005, MED VET ENTOMOL, V19, P480, DOI 10.1111/j.1365-2915.2005.00594.x; HAMILTON JGC, 1994, J CHEM ECOL, V20, P141, DOI 10.1007/BF02065997; Hamilton JGC, 1996, J CHEM ECOL, V22, P1477, DOI 10.1007/BF02027726; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hongyu K., 2016, E S ENG SCI, V5, P83, DOI [DOI 10.18607/ES201653398, 10.18607/ES201653398]; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; LAINSON R, 1977, NATURE, V266, P628, DOI 10.1038/266628a0; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LANE R, 1985, ANN TROP MED PARASIT, V79, P225, DOI 10.1080/00034983.1985.11811912; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lins RMMA, 2008, MEM I OSWALDO CRUZ, V103, P736, DOI 10.1590/S0074-02762008000700019; Lins RMMA, 2002, INSECT MOL BIOL, V11, P117, DOI 10.1046/j.1365-2583.2002.00315.x; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Lutz A., 1912, Memorias do Instituto Oswaldo Cruz, V4, DOI 10.1590/S0074-02761912000100006; Maingon R., 1993, Archives de l'Institut Pasteur de Tunis, V70, P309; Maingon RDC, 2003, MOL ECOL, V12, P1879, DOI 10.1046/j.1365-294X.2003.01871.x; Mangabeira Filho O., 1969, REV BRASILEIRA MALAR, V21, P3; MANTEL N, 1967, CANCER RES, V27, P209; Ribolla PEM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9249217; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Ogawa LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-748; Polato NR, 2017, HEREDITY, V119, P107, DOI 10.1038/hdy.2017.23; Ridley M, 2006, EVOLUCAO; Santos M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076788; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Spiegel CN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1866-x; Star B, 2013, GENETICS, V194, P235, DOI 10.1534/genetics.113.149781; Vigoder FM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0900-8; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Vivero RJ, 2007, BIOMEDICA, V27, P429, DOI 10.7705/biomedica.v27i3.205; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2022, LEISHM FACT SHEET; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wright S., 1978, EVOLUTION GENETICS P; Zhang J, 2013, J MATER CHEM A, V1, P14000, DOI 10.1039/c3ta12311a	69	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223277	10.1371/journal.pone.0223277	http://dx.doi.org/10.1371/journal.pone.0223277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581227	Green Published, gold			2022-12-26	WOS:000532398600046
J	Soffian, SSS; Ahmad, SB; Chan, HK; Soelar, SA; Abu Hassan, MR; Ismail, N				Soffian, Sharifah Saffinas Syed; Ahmad, Shahrul Bariyah; Chan, Huan-Keat; Soelar, Shahrul Aiman; Abu Hassan, Muhammad Radzi; Ismail, Norhizan			Management and glycemic control of patients with type 2 diabetes mellitus at primary care level in Kedah, Malaysia: A statewide evaluation	PLOS ONE			English	Article							RISK-FACTORS; INSULIN; POPULATION; BARRIERS; SAMPLE; TRENDS; IMPACT	Introduction While Kedah has recorded the highest prevalence of diabetes among all the states in Malaysia, the information on the practice and effectiveness of disease management in public health institutions remains limited. This study aimed to evaluate the management and glycemic control of patients with type-2 diabetes mellitus (T2DM) at the primary care level in Kedah. Methods All T2DM patients, who made at least one visit to any of the 58 public health clinics in Kedah during August 2016 and July 2017, were included in this study. The sample was selected from the National Diabetes Registry using the stratified random sampling method. The information on the demographic and clinical characteristics, laboratory findings and pharmacological treatment was gathered from medical records of patients. The differences in mean HbA1C levels across subgroups of each variable were tested using the general linear model. The evaluation of the appropriateness of treatment was performed based on the recommendations of the latest Clinical Practice Guidelines for T2DM. Results The patients (n = 23,557) were mainly female (63.4%), of Malay ethnicity (80.1%) and middle-aged (62.2%), with a mean duration of T2DM of 6.2 +/- 7.16 years. Only 15.6% of them had a HbA1C level <6.5%, and 28.6% did not have their HbA1C levels tested over the 12-month period. Yet, the underutilization of combination treatment (>= 2 antidiabetic agents) and insulin in the patients with a poor glycemic control was evident. Retinopathy emerged as the most prevalent diabetes-related complication (12.6%). Along with those with a longer duration of T2DM, the patients who were younger, female and of Indian ethnicity were found to generally have a poorer glycemic control. Conclusion This study discloses the suboptimal T2DM management at the primary care level in Kedah, which warrants a statewide plan for improvement.	[Soffian, Sharifah Saffinas Syed; Ahmad, Shahrul Bariyah; Ismail, Norhizan] Minist Hlth Malaysia, State Hlth Dept, Alor Setar, Kedah, Malaysia; [Chan, Huan-Keat; Soelar, Shahrul Aiman; Abu Hassan, Muhammad Radzi] Minist Hlth Malaysia, Clin Res Ctr, Hosp Sultanah Bahiyah, Alor Setar, Kedah, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Soffian, SSS (corresponding author), Minist Hlth Malaysia, State Hlth Dept, Alor Setar, Kedah, Malaysia.	huankeat123@yahoo.com						Butt M, 2016, SAUDI PHARM J, V24, P40, DOI 10.1016/j.jsps.2015.02.023; Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Endocrine Malaysian and Society Metabolic, 2016, MANAGEMENT TYPE 2 DI; Firouzi S, 2015, J RES MED SCI, V20, P40; Hieng YC, 2017, MALAYS J MED SCI, V24, P55, DOI 10.21315/mjms2017.24.2.7; Hussein Z, 2015, ANN GLOB HEALTH, V81, P851, DOI 10.1016/j.aogh.2015.12.016; KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308; Lee YK, 2013, PATIENT PREFER ADHER, V7, P103, DOI 10.2147/PPA.S36791; Macioch T, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0587-y; Mafauzy M, 2016, Med J Malaysia, V71, P177; Malaysian Healthcare Performance Unit, 2016, DIAB CAR PERF REP 20; Ministry of Health Malaysia, 2009, NATL DIABETES REGIST, V1; Mohamed HJBJ, 2015, ASIA-PAC J PUBLIC HE, V27, P123, DOI 10.1177/1010539514562447; Moodahadu Latha Subramanya, 2014, Heart Views, V15, P111, DOI 10.4103/1995-705X.151084; Morgan L, 2017, AM HEALTH DRUG BENEF, V10, P197; Ong SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195086; Papatheodorou K, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3086167; Pfeiffer AFH, 2014, DTSCH ARZTEBL INT, V111, P69, DOI 10.3238/arztebl.2014.0069; Reaney Matthew, 2015, Diabetes Spectr, V28, P227, DOI 10.2337/diaspect.28.4.227; Ross SA, 2013, AM J MED, V126, pS38, DOI 10.1016/j.amjmed.2013.06.012; Samiei V, 2016, MALAYS J MED SCI, V23, P44; Selvin E, 2016, DIABETES CARE, V39, pE33, DOI 10.2337/dc15-2229; Tan WL, 2015, SINGAP MED J, V56, P224, DOI 10.11622/smedj.2014170; Thomas S, 2011, J PUBLIC HEALTH AFR, V2, P93, DOI 10.4081/jphia.2011.e23; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Jimenez-Baez MV, 2015, COLOMB MEDICA, V46, P14, DOI 10.25100/cm.v46i1.1681; Wilmot E, 2014, THER ADV CHRONIC DIS, V5, P234, DOI 10.1177/2040622314548679; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223383	10.1371/journal.pone.0223383	http://dx.doi.org/10.1371/journal.pone.0223383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581261	Green Published, gold, Green Submitted			2022-12-26	WOS:000532398600061
J	Yen, YH; Chen, CH; Hung, CH; Wang, JH; Lu, SN; Kee, KM; Hu, TH				Yen, Yi-Hao; Chen, Chien-Hung; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Kee, Kwong-Ming; Hu, Tsung-Hui			Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data	PLOS ONE			English	Article							HEPATITIS-C; LIVER FIBROSIS; THERAPY; MANAGEMENT; RESISTANCE; ALGORITHM; ACCURACY	Background & aims Previous studies from western countries have reported that active hepatocellular carcinoma (HCC) was associated with direct-acting antiviral (DAA) treatment failure. We sought to examine this issue in an Asian cohort. Methods A retrospective cohort study was conducted on hepatitis C virus (HCV)-infected patients with advanced fibrosis who were treated with DAAs at our hospital between January 2017 and June 2018. Results We treated 1021 HCV-infected patients during this period. A total of 976 of those patients were enrolled in a per-protocol analysis, including 556 (57.2%) who had genotype 1 b infections, and 314 (32.3%) who had genotype 2 infections. The mean age of all 976 patients was 65.5 years, and 44.5% were male. 781 of the patients had no HCC, 172 had inactive HCC, and 23 had active HCC. Non-sustained virologic response (SVR) was noted in 10 (1.3%) patients without HCC, 5 (2.9%) patients with inactive HCC, and 4 (13.0%) patients with active HCC. After adjustment for confounders, active HCC (versus inactive HCC and non-HCC) was associated with non-SVR (adjusted odds ratio [AOR] = 24.5 (95% confidence interval [CI] = 4.4-136.9), P<0.001). Next, we excluded the 23 patients with active HCC from the multivariate analysis. After adjustment for confounders, inactive HCC (versus non-HCC) was not associated with non-SVR (AOR = 3.1 (95% CI = 0.94-9.95), P = 0.06). Conclusion Active HCC was associated with non-SVR, while inactive HCC was not. We thus suggest the deferral of DAA treatment until after the complete radiological response of HCCs to treatment.	[Yen, Yi-Hao; Chen, Chien-Hung; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Kee, Kwong-Ming; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Yen, Yi-Hao; Chen, Chien-Hung; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Kee, Kwong-Ming] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net			Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8H1331]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This study was supported by Grant CMRPG8H1331 from the Kaohsiung Chang Gung Memorial Hospital, Taiwan. Grant Recipient is YiHao Yen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2015, CLIN GASTROENTEROL H, V13, P772, DOI 10.1016/j.cgh.2014.12.014; [Anonymous], 2017, J HEPATOL, V66; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beste LA, 2017, J HEPATOL, V67, P32, DOI 10.1016/j.jhep.2017.02.027; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabibbo G, 2018, LIVER INT, V38, P2108, DOI 10.1111/liv.13918; Cabibbo G, 2017, J HEPATOL, V67, P65, DOI 10.1016/j.jhep.2017.01.033; Cheng PN, 2019, J FORMOS MED ASSOC, V118, P907, DOI 10.1016/j.jfma.2018.09.016; Chtioui H, 2017, HEPATOLOGY, V66, P2091, DOI 10.1002/hep.29556; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hu XD, 2017, MED ULTRASON, V19, P23, DOI 10.11152/mu-942; Ji FP, 2019, J HEPATOL, V71, P473, DOI 10.1016/j.jhep.2019.04.017; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Kudo M, 2014, ONCOLOGY-BASEL, V87, P7, DOI 10.1159/000368141; Kushner T, 2018, CURR OPIN GASTROEN, V34, P132, DOI 10.1097/MOG.0000000000000431; Liu C, 2019, EURASIP J ADV SIG PR, DOI 10.1186/s13634-019-0605-9; Majumdar A, 2016, ALIMENT PHARM THER, V43, P1276, DOI 10.1111/apt.13633; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Perez Ana Belen, 2017, Germs, V7, P40, DOI 10.18683/germs.2017.1107; Prenner SB, 2017, J HEPATOL, V66, P1173, DOI 10.1016/j.jhep.2017.01.020; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Sterling RK, 2020, HEPATOLOGY, V71, P411, DOI 10.1002/hep.30825; Sugiura A, 2018, J VIRAL HEPATITIS, V25, P1462, DOI 10.1111/jvh.12973; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Zarski JP, 2010, LIVER INT, V30, P1049, DOI 10.1111/j.1478-3231.2010.02265.x	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222605	10.1371/journal.pone.0222605	http://dx.doi.org/10.1371/journal.pone.0222605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581209	Green Published, gold			2022-12-26	WOS:000532398600013
J	Majumder, A; Biswal, MR; Prakash, MK				Majumder, Ayan; Biswal, Malay Ranjan; Prakash, Meher K.			Computational screening of antimicrobial peptides for Acinetobacter baumannii	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; MULTIDRUG-RESISTANCE; MECHANISMS; QSAR; CYTOTOXICITY; TRANSLATION; INFECTIONS; OUTBREAK; DATABASE; TARGETS	Acinetobacter baumannii, has been developing resistance to even the last line of drugs. Antimicrobial peptides (AMPs) to which bacteria do not develop resistance easily may be the last hope. A few independent experimental studies have designed and studied the activity of AMPs on A. baumannii, however the number of such studies are still limited. With the goal of developing a rational approach to the screening of AMPs against A. baumannii, we carefully curated the drug activity data from 75 cationic AMPs, all measured with a similar protocol, and on the same ATCC 19606 strain. A quantitative model developed and validated with a part of the data. While the model may be used for predicting the activity of any designed AMPs, in this work, we perform an in silico screening for the entire database of naturally occurring AMPs, to provide a rational guidance in this urgently needed drug development.	[Majumder, Ayan; Biswal, Malay Ranjan; Prakash, Meher K.] Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur, Bengaluru, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Prakash, MK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur, Bengaluru, India.	meher@jncasr.ac.in		Biswal, Malay Ranjan/0000-0003-0473-0505; Prakash, Meher/0000-0002-0091-4158	DBT-JNCASR "Life Science Research, Education and Training at JNCASR" [BT/INF/22/SP27679/2018]	DBT-JNCASR "Life Science Research, Education and Training at JNCASR"	M.K.P. gratefully acknowledges funding from DBT-JNCASR "Life Science Research, Education and Training at JNCASR" (BT/INF/22/SP27679/2018).	Almaaytah A, 2018, INFECT DRUG RESIST, V11, P835, DOI 10.2147/IDR.S166236; Almaaytah A, 2017, INFECT DRUG RESIST, V10, P1, DOI 10.2147/IDR.S118877; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44305; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dangel A, 2013, FASEB J, V27, P4476, DOI 10.1096/fj.13-234575; das Neves RC, 2019, TOXINS, V11, DOI 10.3390/toxins11040216; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Di Bonaventura I, 2018, CHEM COMMUN, V54, P5130, DOI [10.1039/c8cc02412j, 10.1039/C8CC02412J]; EHRENSTEIN G, 1977, Q REV BIOPHYS, V10, P1, DOI 10.1017/S0033583500000123; Falagas ME, 2008, CLIN INFECT DIS, V46, P1121, DOI 10.1086/528867; Fan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157757; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ghosh A, 2014, CHEMMEDCHEM, V9, P2052, DOI 10.1002/cmdc.201402215; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; GUPTA S, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0073957; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao G, 2013, J MICROBIOL, V51, P200, DOI 10.1007/s12275-013-2441-1; Hirsch R, 2019, J ANTIMICROB CHEMOTH, V74, P96, DOI 10.1093/jac/dky386; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jayamani E, 2015, ANTIMICROB AGENTS CH, V59, P1733, DOI 10.1128/AAC.04198-14; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kim WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150642; Kohn EM, 2018, MOLECULES, V23, DOI 10.3390/molecules23020329; Krizsan A, 2014, ANGEW CHEM INT EDIT, V53, P12236, DOI 10.1002/anie.201407145; Kustanovich I, 2002, J BIOL CHEM, V277, P16941, DOI 10.1074/jbc.M111071200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li Di, 2017, ONCOTARGET, V8, P55958, DOI 10.18632/oncotarget.18124; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Majumder A, 2019, ACS OMEGA, V4, P4977, DOI 10.1021/acsomega.8b02862; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mohamed MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07440-0; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Pachon J, 2009, CURR OPIN INVEST DR, V10, P150; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poole Keith, 2003, Curr Opin Investig Drugs, V4, P128; Rao GG, 2016, INT J ANTIMICROB AG, V48, P331, DOI 10.1016/j.ijantimicag.2016.06.006; Roy RN, 2015, NAT STRUCT MOL BIOL, V22, P466, DOI 10.1038/nsmb.3031; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Sayiner HS, 2018, MED CHEM, V14, P253, DOI 10.2174/1573406413666171002124408; Seefeldt AC, 2015, NAT STRUCT MOL BIOL, V22, P470, DOI 10.1038/nsmb.3034; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; STRUELENS MJ, 1993, J HOSP INFECT, V25, P15, DOI 10.1016/0195-6701(93)90005-K; Tan SYY, 2013, GENOME BIOL EVOL, V5, P807, DOI 10.1093/gbe/evt047; Thomsen TT, 2016, PEPTIDE ANTIBIOTICS; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vila-Farres X, 2012, CLIN MICROBIOL INFEC, V18, P383, DOI 10.1111/j.1469-0691.2011.03581.x; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Wikler M., 2006, METHODS DILUTION ANT; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Young LS, 2007, INFECT CONT HOSP EP, V28, P1247, DOI 10.1086/521660; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao LL, 2017, ACS OMEGA, V2, P2805, DOI 10.1021/acsomega.7b00274	71	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0219693	10.1371/journal.pone.0219693	http://dx.doi.org/10.1371/journal.pone.0219693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LF4GQ	31577808	gold, Green Published, Green Submitted			2022-12-26	WOS:000527377900001
J	Pardoe, C; Fullagar, R; Hayes, E				Pardoe, Colin; Fullagar, Richard; Hayes, Elspeth			Quandong stones: A specialised Australian nut-cracking tool	PLOS ONE			English	Article							SOUTHEASTERN PRE-PYRENEES; MESOLITHIC SITE; SUBSISTENCE; SANTALUM	The quandong or native peach (Santalum acuminatum R.Br.) has been recognised as an important and tasty food resource among Aboriginal Australians in arid and semi-arid areas of southern Australia. It is valued for its fruit that is consumed raw or dried, and for its kernel, which is eaten raw or ground into paste for medicinal and skin care purposes. This paper reports on a study of ground stone implements within the Murray Darling Basin that has identified quandong stones as a distinct type of implement made specifically for the efficient cracking of quandong nuts. Data are presented on 1,327 ground stone implements from collections in 12 different locations in the Murray-Darling Basin (MDB), an area almost completely devoid of stone sources. Given the paucity of stone, multi-purpose use of implements is widely documented. Although it was common to find pits present in mortars and other ground stone tools demonstrating multiple functions, including use as anvils, a class of single purpose stones with multiple pits and distinctive form was identified. Most of these were found in areas known for groves of quandong and four were analysed for use-wear and residues along with two other ground stone items from the MDB. The results support their identification as specialised anvil stones for cracking quandong nuts.	[Pardoe, Colin] Australian Natl Univ, Archaeol & Nat Hist, Canberra, ACT, Australia; [Fullagar, Richard; Hayes, Elspeth] Univ Wollongong, Sch Earth Atmospher & Life Sci, Ctr Archaeol Sci, Wollongong, NSW, Australia	Australian National University; University of Wollongong	Pardoe, C (corresponding author), Australian Natl Univ, Archaeol & Nat Hist, Canberra, ACT, Australia.	colin.pardoe@ozemail.com.au	Fullagar, Richard/AAT-1155-2020	, Colin/0000-0002-6288-6375; Fullagar, Richard/0000-0003-1047-1466	Australian Research Council [LP130100748]	Australian Research Council(Australian Research Council)	CP received partial funding from the Australian Research Council under grant award number LP130100748. There was no additional external funding received for this study. The external funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J.L., 2002, GROUND STONE ANAL TE; Agrifutures Australia, 2018, QUAND; Balme J., 1991, AUST ARCHAEOL, V32, P3; BINFORD LR, 1978, AM ANTIQUITY, V43, P330, DOI 10.2307/279390; de Beaune SA, 2004, CURR ANTHROPOL, V45, P139, DOI 10.1086/381045; Dickson F, 1977, QUARTZ FLAKING STONE, P97; Dubreuil L, 2004, J ARCHAEOL SCI, V31, P1613, DOI 10.1016/j.jas.2004.04.003; Dubreuil L, 2013, J ARCHAEOL SCI, V48; Enright N., 2018, POO PLATE EMUS HELP; Field J, 2009, TERRA AUSTRALIS, V30, P228; Fuentes-Cross P., 2016, UNDERSTANDING DISTRI; George AS, 1996, AUSTR PLANTS, V13, P318; Goddard C, 1985, PUNU YANKUNYATJARA P; Gorecki P., 1997, ARCHAEOL OCEAN, V32, P141; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gould R.A., 1980, LIVING ARCHAEOLOGY; GOULD RA, 1969, OCEANIA, V39, P253, DOI 10.1002/j.1834-4461.1969.tb01026.x; Grey G., 1841, J 2 EXPEDITIONS DISC, V2, P265; Hader DP, 2003, PHOTOCH PHOTOBIO SCI, V2, P39, DOI 10.1039/b211160h; Hamon C, 2008, J ARCHAEOL SCI, V35, P1502, DOI 10.1016/j.jas.2007.10.017; Harbaugh DT, 2007, AM J BOT, V94, P1028, DOI 10.3732/ajb.94.6.1028; Hayes E., 2015, THESIS; Hayes E, 2018, J ARCHAEOL SCI-REP, V20, P97, DOI 10.1016/j.jasrep.2018.04.021; Hiscock P., 2008, ARCHAEOLOGY ANCIENT; Holst D, 2010, J ARCHAEOL SCI, V37, P2871, DOI 10.1016/j.jas.2010.06.028; Howchin W., 1934, STONE IMPLEMENTS ADE; Jones G. P., 1985, Journal of Plant Foods, V6, P239; JONES GP, 1995, INT J PHARMACOGN, V33, P120, DOI 10.3109/13880209509055210; Konczak I, 2009, RIRDC PUB; Konczak I, 2010, FOOD CHEM, V123, P1048, DOI 10.1016/j.foodchem.2010.05.060; Latz P.K., 2018, BUSHFIRES BUSHTUCKER; Leakey MD, 1994, EXCAVATIONS BEDS 3 4; Maiden J.H.., 1889, USEFUL NATIVE PLANTS; McCarthy FD, 1967, STONE IMPLEMENTS AUS; MCGUIRE J. D, 1891, AM ANTHROPOL, V44, P301; Mitchell T, 1839, FROGS ARISTOPHANES; Mitchell T. L., 1838, 3 EXPEDITIONS INTERI; Mountford C. P., 1960, RECORDS AM AUSTR SCI, V2, P215; National Museum of Australia, 2018, RET ANC REM SECR SAC; Odell G.H., 1998, ARCHAEOLOGY PREHISTO, P652; Pardoe C, AUSTRALAS J ENV MAN, DOI [10.1016/j.jenvman.2006.04.008, DOI 10.1016/J.JENVMAN.2006.04.008]; Pardoe C., 2015, INFORM PAMPHLET WIRA; Pardoe C., 2003, AUST ARCHAEOL, V57, P42; Pardoe C., 2006, FARMING, V2006, P1; Pardoe Colin, 1994, Archaeology in Oceania, V29, P182; Peterson N., 1977, NUTR ABORIGINES RELA, P25; Peterson N., 1968, MANKIND, V6, P567; Rivett DE, 1989, NEW CROPS FOOD IND, P208; Gilabert XR, 2016, J ARCHAEOL SCI-REP, V5, P209, DOI 10.1016/j.jasrep.2015.11.023; Gilabert XR, 2012, J ARCHAEOL SCI, V39, P1587, DOI 10.1016/j.jas.2011.12.017; Sakulnarmrat K, 2014, LWT-FOOD SCI TECHNOL, V57, P366, DOI 10.1016/j.lwt.2014.01.002; SMITH H, 2005, ABORIGINAL HIST MONO, V12, DOI DOI 10.1063/1.2148966; SMITH M A, 1986, Archaeology in Oceania, V21, P29; Smith M. A., 1985, BEAGLE, V2, P23; Smyth RB., 1878, ABORIGINES VICTORIA; Spencer B., 1922, GUIDE AUSTR ETHNOLOG; Spry C, 2019, AUST ARCHAEOL, V85, P95, DOI 10.1080/03122417.2019.1595906; Sturt C., 1849, NARRATIVE EXPEDITION, P416; Thomson D., 1929, THE ADVERTISER, P10; Thomson DonaldFergusson., 1949, EC STRUCTURE CEREMON; Walter M, 2015, J NE TEXAS ARCHAEOLO, V54, P93; Williams C., 2010, MED PLANTS AUSTR, V1; Wright K., 1992, PALEORIENT, V18, P53, DOI 10.3406/pa-leo.1992.4573; Yellen J.E., 1977, STUDIES ARCHEOLOGY	64	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222680	10.1371/journal.pone.0222680	http://dx.doi.org/10.1371/journal.pone.0222680			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6VM	31577798	Green Published, gold			2022-12-26	WOS:000532388000011
J	Talani, C; Makitie, A; Beran, M; Holmberg, E; Laurell, G; Farnebo, L				Talani, Charbel; Makitie, Antti; Beran, Martin; Holmberg, Erik; Laurell, Goren; Farnebo, Lovisa			Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; HUMAN-PAPILLOMAVIRUS; EARLY DEATH; SURVIVAL; OUTCOMES; PREDICTORS; THERAPY	Background Cancers of the head and neck have a high mortality rate, and roughly 10% of the patients die within six months of diagnosis. To our knowledge little has been written about this group. We wished to identify risk factors for early death, to predict and monitor patients at risk better and, if possible, avoid unjustified major treatment. Methods and findings This population-based nationwide study from the Swedish Head and Neck Cancer Register (SweHNCR) included data from 2008-2015 and 9733 patients at potential risk of early death. A total of 925 (9.5%) patients died within six months. For every year older the patients became, the risk of early death increased by 2.3% (p<0.001). The relative risk of death was 3.37 times higher (237%) for patients with WHO score 1 compared with WHO score 0. A primary tumour in the hypopharynx correlated with a 24% increased risk over the oral cavity (p<0.024). Patients with stage IV disease had a 3.7 times greater risk of early death than those with stage I (p<0.001). As expected, a 12 times increased risk of early death was noted in the palliative treatment group, compared to the curative group. Limitations to this study were that the actual cause of death was not recorded in the SweHNCR, and that socioeconomic factors, alcohol consumption, smoking habits, and HPV status, were not reported in SweHNCR until 2015. However, the fact that this is a population-based nationwide study including 9733 patients compensates for some of these limitations. Conclusions Identification of patients at increased risk of early death shows that older patients with advanced disease, increased WHO score, primary tumour in the hypopharynx, and those given palliative treatment, are more likely than the others to die from head and neck cancer within six months of diagnosis.	[Talani, Charbel; Farnebo, Lovisa] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Speech Language Pathol Audiol & Otorhinolaryn, Linkoping, Sweden; [Talani, Charbel; Farnebo, Lovisa] Reg Ostergotland, Anaesthet Operat & Specialty Surg Ctr, Dept Otorhinolaryngol Linkoping, Linkoping, Sweden; [Makitie, Antti] Helsinki Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland; [Makitie, Antti] Univ Helsinki, Helsinki, Finland; [Makitie, Antti] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden; [Makitie, Antti] Karolinska Hosp, Stockholm, Sweden; [Makitie, Antti] Univ Helsinki, Fac Med, Res Programme Syst Oncol, Helsinki, Finland; [Beran, Martin] NAL Med Ctr Hosp, Dept ENT & Maxillofacial Surg, Trollhattan, Sweden; [Holmberg, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Laurell, Goren] Uppsala Univ, Dept Clin Sci, ENT, Uppsala, Sweden	Linkoping University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Gothenburg; Uppsala University	Farnebo, L (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Speech Language Pathol Audiol & Otorhinolaryn, Linkoping, Sweden.; Farnebo, L (corresponding author), Reg Ostergotland, Anaesthet Operat & Specialty Surg Ctr, Dept Otorhinolaryngol Linkoping, Linkoping, Sweden.	lovisa.farnebo@regionostergotland.se		Talani, Charbel/0000-0003-0597-3883; Holmberg, Erik/0000-0001-5107-4550				Abrahao R, 2016, BRIT J HAEMATOL, V173, P292, DOI 10.1111/bjh.13944; Almangush A, 2015, INT J ORAL MAX SURG, V44, P143, DOI 10.1016/j.ijom.2014.10.004; [Anonymous], 2017, STAT STAT SOFTW REL; Cancercentrum. Arsrapport nationellt kvalitetsregister, 2016, REGIONALA CANCERCENT; Cao W, 2016, BRIT J ORAL MAX SURG, V54, P818, DOI 10.1016/j.bjoms.2016.06.013; Estomba CMC, 2017, BRAZ J OTORHINOLAR, V83, P653, DOI 10.1016/j.bjorl.2016.08.013; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Divi V, 2016, J CLIN ONCOL, V34, P3892, DOI 10.1200/JCO.2016.67.3863; Farnebo L, 2016, CURR OPIN OTOLARYNGO, V24, P115, DOI 10.1097/MOO.0000000000000236; Hagedoorn P, 2016, ORAL ONCOL, V61, P76, DOI 10.1016/j.oraloncology.2016.08.014; Hegde JV, 2018, INT J RADIAT ONCOL, V100, P647, DOI 10.1016/j.ijrobp.2017.10.045; Heinonen T, 2018, EUR ARCH OTO-RHINO-L, V275, P545, DOI 10.1007/s00405-017-4843-x; Jakobsen KK, 2018, ACTA ONCOL, V57, P1143, DOI 10.1080/0284186X.2018.1438657; Kang HS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003403; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15974-6; Kowalski LP, 2000, EUR J CANCER, V36, P1032, DOI 10.1016/S0959-8049(00)00054-X; Lal P, 2018, J CANCER RES THER, V14, P1196, DOI 10.4103/jcrt.JCRT_200_17; Ledeboer QCP, 2011, HEAD NECK-J SCI SPEC, V33, P1021, DOI 10.1002/hed.21572; Loizou C, 2015, ONCOL LETT, V10, P3565, DOI 10.3892/ol.2015.3775; Lop J, 2019, HEAD NECK-J SCI SPEC, V41, P1328, DOI 10.1002/hed.25559; Massa ST, 2019, LARYNGOSCOPE, V129, P146, DOI 10.1002/lary.27289; Massa ST, 2017, ORAL ONCOL, V65, P8, DOI 10.1016/j.oraloncology.2016.12.006; Mroueh R, 2019, EUR ARCH OTO-RHINO-L, DOI [10.1002/hed.21572, DOI 10.1002/HED.21572]; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Peng LC, 2018, ORAL ONCOL, V84, P25, DOI 10.1016/j.oraloncology.2018.05.012; Rettig EM, 2015, SURG ONCOL CLIN N AM, V24, P379, DOI 10.1016/j.soc.2015.03.001; Rieke K, 2017, ORAL ONCOL, V65, P76, DOI 10.1016/j.oraloncology.2016.12.014; Santos TS, 2016, J LARYNGOL OTOL, V130, P948, DOI 10.1017/S002221511600880X; Sawabe M, 2017, CANCER SCI, V108, P91, DOI 10.1111/cas.13115; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Sinevici N, 2016, ORAL ONCOL, V61, P12, DOI 10.1016/j.oraloncology.2016.07.013; Sivars L, 2016, MOL CLIN ONCOL, V5, P671, DOI 10.3892/mco.2016.1050; Spiotto MT, 2015, J COMMUNITY SUPPORT, V13, P367, DOI 10.12788/jcso.0175; Svahn MF, 2016, ACTA ONCOL, V55, P1084, DOI 10.1080/0284186X.2016.1185148; Urban RR, 2016, GYNECOL ONCOL, V140, P474, DOI 10.1016/j.ygyno.2015.12.021; van Imhoff LCR, 2016, HEAD NECK-J SCI SPEC, V38, pE2214, DOI 10.1002/hed.24082; Wikland EMaR, 2016, HUVUD HALS CANC	41	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223154	10.1371/journal.pone.0223154	http://dx.doi.org/10.1371/journal.pone.0223154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577831	Green Published, gold			2022-12-26	WOS:000532388000022
J	Villanueva-Bonilla, GA; Safuan-Naide, S; Pires, MM; Vasconcellos-Neto, J				Villanueva-Bonilla, German Antonio; Safuan-Naide, Suyen; Pires, Mathias Mistretta; Vasconcellos-Neto, Joao			Niche partitioning and coexistence of two spiders of the genus Peucetia (Araneae, Oxyopidae) inhabiting Trichogoniopsis adenantha plants (Asterales, Asteraceae)	PLOS ONE			English	Article							WEB-CONSTRUCTION; COMPETITION; HABITAT; LYCOSIDAE; ABUNDANCE; DYNAMICS; ECOLOGY; FOREST; ASSEMBLAGES; MECHANISMS	Niche theory suggests that the coexistence of ecologically similar species in the same site requires some form of resource partitioning that reduces or avoids interspecific competition. Here, from July 2013 to December 2015, we investigated spatial niche differentiation at three different scales of two sympatric congeneric spiders, Peucetia rubrolineata and P. flava, along an altitudinal gradient in shaded and open areas in an Atlantic forest in Serra do Japi, SP, Brazil. These spiders are peculiar in that they present an exclusive association with the plant Trichogoniopsis adenantha (Asteraceae). In theory, the coexistence of two Peucetia species could be explained by: (1) microhabitat segregation with individuals from different species occupying different parts of the same plants; (2) mesohabitat segregation with different species using plant in different environments; (3) macrohabitat segregation, where different species would not co-occur along the altitudinal gradient. With respect to micro-habitat use, in both species, different instars used different plant parts, while the same instars of both species used the same type of substrate. However, the two Peucetia species segregated by meso-habitat type, with P. rubrolineata preferring T. adenantha plants in shaded areas and P. flava preferring those in open areas. Our results support the hypothesis of niche partitioning begetting diversity, and highlight the importance of analyzing habitat use at multiple scales to understand mechanisms related to coexistence.	[Villanueva-Bonilla, German Antonio] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil; [Safuan-Naide, Suyen] Univ Estadual Paulista, Inst Biociencias, Campus Botucatu, Botucatu, SP, Brazil; [Pires, Mathias Mistretta; Vasconcellos-Neto, Joao] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Villanueva-Bonilla, GA (corresponding author), Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.	germanvillanueva9@gmail.com	Villanueva-Bonilla, German Antonio/D-7082-2016; Pires, Mathias/I-4489-2012	Villanueva-Bonilla, German Antonio/0000-0002-9599-8496; Pires, Mathias/0000-0003-2500-4748	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 (G.A. Villanueva-Bonilla). http://www.capes.gov.br/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer S, 2006, ACTA OECOL, V29, P16, DOI 10.1016/j.actao.2005.07.002; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Carrel JE, 2003, J KANSAS ENTOMOL SOC, V76, P16; Castanheira P, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7055; Cernecka L, 2017, J ARACHNOL, V45, P213, DOI 10.1636/JoA-S-15-005.1; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chillo V, 2010, ACTA OECOL, V36, P611, DOI 10.1016/j.actao.2010.09.006; Cumming MS, 2004, J ZOOL, V262, P1, DOI 10.1017/S0952836903004461; DeVito J, 2004, CAN J ZOOL, V82, P1119, DOI 10.1139/Z04-090; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Cardoso JCF, 2018, OECOLOGIA, V188, P343, DOI 10.1007/s00442-018-4163-x; Frick Holger, 2007, Bulletin of the British Arachnological Society, V14, P45; Gasnier TR, 2001, J ARACHNOL, V29, P95, DOI 10.1636/0161-8202(2001)029[0095:POAOFS]2.0.CO;2; GAUSE G. F., 1934, SCIENCE, V79, P16, DOI 10.1126/science.79.2036.16-a; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harwood JD, 2005, J INSECT BEHAV, V18, P593, DOI 10.1007/s10905-005-7013-8; Henaut Y, 2006, J ARACHNOL, V34, P234, DOI 10.1636/S02-65.1; Hendrickx F, 2001, BELG J ZOOL, V131, P79; Herberstein Marie Elisabeth, 1997, Bulletin of the British Arachnological Society, V10, P233; HERBERSTEIN ME, 1994, AUST J ECOL, V19, P451, DOI 10.1111/j.1442-9993.1994.tb00511.x; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hubbell S.P., 2001, MG POP BIOL, V32; Huber BA, 2016, ZOOTAXA, V4177, P1, DOI 10.11646/zootaxa.4177.1.1; Kelly CK, 2009, THEOR ECOL-NETH, V2, P161, DOI 10.1007/s12080-008-0037-x; KRUMPALOVA O, 2016, J ARACHNOL, V44, P547; Krumpalova Z, 2013, POL J ECOL, V61, P575; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Mammola S, 2016, ACTA OECOL, V75, P35, DOI 10.1016/j.actao.2016.06.011; Mammola S, 2014, INT J SPELEOL, V43, P343, DOI 10.5038/1827-806X.43.3.11; Marshall SD, 1999, J ARACHNOL, V27, P343; Michalko R, 2015, ECOL ENTOMOL, V40, P22, DOI 10.1111/een.12149; Novak T, 2010, ACTA OECOL, V36, P522, DOI 10.1016/j.actao.2010.07.005; Novcic I, 2016, ACTA OECOL, V75, P68, DOI 10.1016/j.actao.2016.07.002; Nyffeler M, 1999, J ARACHNOL, V27, P317; Nyffeler M, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1440-1; OLIVE CW, 1980, ECOLOGY, V61, P1133, DOI 10.2307/1936833; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Petillon J, 2018, TROP ZOOL, V31, P85, DOI 10.1080/03946975.2018.1448531; Pinto HS, 2012, HIST NATURAL SERRA J; Portela E, 2013, J ARACHNOL, V41, P85, DOI 10.1636/P12-59.1; R Core Team, 2021, R LANGUAGE ENV STAT; Raub Florian, 2017, Ecology, V98, P1975, DOI 10.1002/ecy.1854; Rodrigues ENL, 2016, ZOOLOGIA-CURITIBA, V33, DOI 10.1590/S1984-4689zool-20150102; Romero GQ, 2003, J ARACHNOL, V31, P297, DOI 10.1636/02-19; Romero GQ, 2001, THESIS; Romero Gustavo Q, 2005, Braz. J. Bot., V28, P171, DOI 10.1590/S0100-84042005000100014; Romero GQ, 2008, ECOLOGY, V89, P3105, DOI 10.1890/08-0267.1; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Santos AJ, 2003, INSECT SYST EVOL, V34, P95, DOI 10.1163/187631203788964863; Segurado P, 2007, ACTA OECOL, V32, P134, DOI 10.1016/j.actao.2007.03.015; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; Souza HD, 2015, J ARACHNOL, V43, P59; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; SUWA M, 1986, RES POPUL ECOL, V28, P231, DOI 10.1007/BF02515452; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TOFT CA, 1985, COPEIA, P1; TURNBULL AL, 1973, ANNU REV ENTOMOL, V18, P305, DOI 10.1146/annurev.en.18.010173.001513; TURNER M, 1979, J ANIM ECOL, V48, P509, DOI 10.2307/4177; UETZ GW, 1977, J ANIM ECOL, V46, P531, DOI 10.2307/3828; VANCE RR, 1984, ECOLOGY, V65, P1349, DOI 10.2307/1939115; Vasconcellos-Neto J, 2017, BEHAV ECOLOGY SPIDER, P165, DOI [DOI 10.1007/978-3-319-65717-2_7, 10.1007/978-3-319-65717-2_7]; Vasconcellos J, 2007, BIOTROPICA, V39, P221, DOI 10.1111/j.1744-7429.2006.00250.x; Villanueva-Bonilla GA, 2018, J NAT HIST, V52, P361, DOI 10.1080/00222933.2018.1433339; Villanueva-Bonilla GA, 2016, STUD NEOTROP FAUNA E, V51, P215, DOI 10.1080/01650521.2016.1234848; Wise D.H., 1995, SPIDERS ECOLOGICAL W; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; World Spider Catalog, 2019, WORLD SPIDER CATALOG; Yamanoi Takahiro, 2005, Acta Arachnologica, V54, P13, DOI 10.2476/asjaa.54.13; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478	70	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0213887	10.1371/journal.pone.0213887	http://dx.doi.org/10.1371/journal.pone.0213887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577810	Green Published, Green Submitted, gold			2022-12-26	WOS:000532388000001
J	Serrano-Barroso, A; Vargas, JP; Diaz, E; O'Donnell, P; Lopez, JC				Serrano-Barroso, Almudena; Pedro Vargas, Juan; Diaz, Estrella; O'Donnell, Patricio; Carlos Lopez, Juan			Sign and goal tracker rats process differently the incentive salience of a conditioned stimulus	PLOS ONE			English	Article							DOPAMINE; REWARD; NUCLEUS; MODULATION; AFFERENTS; ADDICTION; BEHAVIOR; SYSTEM; CORTEX; MODEL	Sign and goal tracker animals show different behavioral patterns in response to conditioned stimuli, which may be driven by different neural circuits involved in processing stimuli. Here, we explored whether sign and goal-tracker profiles implicated different brain regions and responses to incentive salience of stimuli. We performed three experiments using male Wistar rats. Experiment 1 showed that lesioning the medial prefrontal cortex increased the prevalence of the goal-tracker phenotype. Experiment 2 assessed the developmental trajectory of the salience incentive attribution to a conditioned stimulus, showing that increased incentive salience of stimuli increased the prevalence of the sign-tracker phenotype in mature, but not preadolescent rats. In experiment 3, the functional impact of the medial prefrontal cortex circuits was analyzed with a latent inhibition procedure. Sign tracker rats showed a reduced latent inhibition to stimuli previously exposed when compared to goal tracker or intermediate rats. The overall results of this study highlight a key role of the medial prefrontal cortex for sign tracking behavior. The expression of sign and goal tracker phenotypes changed after lesion to the medial prefrontal cortex (experiment 1), differed across development (experiment 2), and showed differences in the attentional processes to previously exposed stimuli, as preexposure to CS was ineffective in sign tracker animals (experiment 3). These data indicate that the responses to the incentive salience of stimuli in sign tracker and goal tracker profiles are likely driven by different neural circuitry, with a different role of prefrontal cortical function.	[Serrano-Barroso, Almudena; Pedro Vargas, Juan; Diaz, Estrella; Carlos Lopez, Juan] Univ Seville, Dept Psicol Expt, Seville, Spain; [O'Donnell, Patricio] Takeda Pharmaceut, Translat Res & Expt Med, Cambridge, MA USA	University of Sevilla	Vargas, JP (corresponding author), Univ Seville, Dept Psicol Expt, Seville, Spain.	vargas@us.es	Vargas, Juan Pedro/H-6950-2015; Lopez, Juan C/H-6028-2015	Vargas, Juan Pedro/0000-0002-4358-5737; Lopez-Garcia, Juan-Carlos/0000-0001-8106-5006	MINECO, FEDER, UE [PSI2015-65500-P]; Ministerio de Educacion, Cultura y Deporte [Fulbright PR2016-0100]	MINECO, FEDER, UE; Ministerio de Educacion, Cultura y Deporte	This research was supported by PSI2015-65500-P grant (MINECO, FEDER, UE) and Fulbright PR2016-0100 (Ministerio de Educacion, Cultura y Deporte). The authors declare no conflict of interest. one of the authors (P O'Donnell), is employed by a commercial company: "Takeda Pharmaceuticals". This company have not played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The specific roles of this author is articulated in the `author contributions' section.	Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Caballero A, 2016, TRENDS NEUROSCI, V39, P441, DOI 10.1016/j.tins.2016.04.010; Caballero A, 2014, BRAIN STRUCT FUNCT, V219, P395, DOI 10.1007/s00429-013-0508-8; Campus P, 2016, PSYCHOPHARMACOLOGY, V233, P1157, DOI 10.1007/s00213-015-4192-7; Lopez JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2096, DOI 10.1038/npp.2015.68; Eliot Hearst, 1974, SIGN TRACKING STIMUL; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2017, CURR OPIN BEHAV SCI, V13, P178, DOI 10.1016/j.cobeha.2016.12.004; Flagel SB, 2016, P NATL ACAD SCI USA, V113, pE2861, DOI 10.1073/pnas.1520491113; Flagel SB, 2014, NEUROPHARMACOLOGY, V76, P425, DOI 10.1016/j.neuropharm.2013.04.033; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Franken IHA, 2005, EUR J PHARMACOL, V526, P199, DOI 10.1016/j.ejphar.2005.09.025; Goto Y, 2002, J NEUROSCI, V22, P9070; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Gray JA, 1997, BEHAV BRAIN RES, V88, P27, DOI 10.1016/S0166-4328(97)02313-9; Groenewegen H, 1999, PSYCHOBIOLOGY, DOI [10.3758/bf03332111, DOI 10.3758/BF03332111]; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Haight JL, 2017, NEUROSCIENCE, V340, P135, DOI 10.1016/j.neuroscience.2016.10.043; Haight JL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00079; Homayoun H, 2009, EUR J NEUROSCI, V29, P1461, DOI 10.1111/j.1460-9568.2009.06679.x; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; LAVIN A, 1994, SYNAPSE, V18, P104, DOI 10.1002/syn.890180205; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; O'Donnell P, 2011, SCHIZOPHRENIA BULL, V37, P484, DOI 10.1093/schbul/sbr028; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pearce JM, 2002, ANIM LEARN BEHAV, V30, P73, DOI 10.3758/BF03192911; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Perez-Diaz F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189630; Pitchers KK, 2018, LEARN MEMORY, V25, P474, DOI 10.1101/lm.046995.117; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sarter M, 2018, BEHAV NEUROSCI, V132, P1, DOI 10.1037/bne0000226; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Toates F., 1986, MOTIVATIONAL SYSTEMS; Tomie A, 2008, BRAIN RES REV, V58, P121, DOI 10.1016/j.brainresrev.2007.12.003; Vargas JP, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00206	44	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223109	10.1371/journal.pone.0223109	http://dx.doi.org/10.1371/journal.pone.0223109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568533	Green Published, gold, Green Submitted			2022-12-26	WOS:000532364900023
J	Rienth, M; Crovadore, J; Ghaffari, S; Lefort, F				Rienth, Markus; Crovadore, Julien; Ghaffari, Sana; Lefort, Francois			Oregano essential oil vapour prevents Plasmopara viticola infection in grapevine (Vitis Vinifera) and primes plant immunity mechanisms	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; DOWNY MILDEW; TRANSCRIPTION FACTORS; INDUCED RESISTANCE; DEFENSE RESPONSES; INNATE IMMUNITY; FUNGICIDE RESISTANCE; SIGNALING PATHWAYS; GENE-EXPRESSION; JASMONATE	The reduction of synthetic fungicides in agriculture is necessary to guarantee a sustainable production that protects the environment and consumers' health. Downy mildew caused by the oomycete Plasmopara viticola is the major pathogen in viticulture worldwide and responsible for up to 60% of pesticide treatments. Alternatives to reduce fungicides are thus utterly needed to ensure sustainable vineyard-ecosystems, consumer health and public acceptance. Essential oils (EOs) are amongst the most promising natural plant protection alternatives and have shown their antibacterial, antiviral and antifungal properties on several agricultural crops. However, the efficiency of EOs highly depends on timing, application method and the molecular interactions between the host, the pathogen and EO. Despite proven EO efficiency, the underlying processes are still not understood and remain a black box. The objectives of the present study were: a) to evaluate whether a continuous fumigation of a particular EO can control downy mildew in order to circumvent the drawbacks of direct application, b) to decipher molecular mechanisms that could be triggered in the host and the pathogen by EO application and c) to try to differentiate whether essential oils directly repress the oomycete or act as plant resistance primers. To achieve this a custommade climatic chamber was constructed that enabled a continuous fumigation of potted vines with different EOs during long-term experiments. The grapevine (Vitis vinifera) cv Chasselas was chosen in reason of its high susceptibility to Plasmopara viticola. Grapevine cuttings were infected with P. viticola and subsequently exposed to continuous fumigation of different EOs at different concentrations, during 2 application time spans (24 hours and 10 days). Experiments were stopped when infection symptoms were clearly observed on the leaves of the control plants. Plant physiology (photosynthesis and growth rate parameters) were recorded and leaves were sampled at different time points for subsequent RNA extraction and transcriptomics analysis. Strikingly, the Oregano vulgare EO vapour treatment during 24h post-infection proved to be sufficient to reduce downy mildew development by 95%. Total RNA was extracted from leaves of 24h and 10d treatments and used for whole transcriptome shotgun sequencing (RNA-seq). Sequenced reads were then mapped onto the V. vinifera and P. viticola genomes. Less than 1% of reads could be mapped onto the P. viticola genome from treated samples, whereas up to 30% reads from the controls mapped onto the P. viticola genome, thereby confirming the visual observation of P. viticola absence in the treated plants. On average, 80% of reads could be mapped onto the V. vinifera genome for differential expression analysis, which yielded 4800 modulated genes. Transcriptomic data clearly showed that the treatment triggered the plant's innate immune system with genes involved in salicylic, jasmonic acid and ethylene synthesis and signaling, activating Pathogenesis-Related-proteins as well as phytoalexin synthesis. These results elucidate EO-host-pathogen interactions for the first time and indicate that the antifungal efficiency of EO is mainly due to the triggering of resistance pathways inside the host plants. This is of major importance for the production and research on biopesticides, plant stimulation products and for resistance-breeding strategies.	[Rienth, Markus; Ghaffari, Sana] HES SO Univ Appl Sci & Arts Western Switzerland, Changins, Nyon, Switzerland; [Crovadore, Julien; Lefort, Francois] HES SO Univ Appl Sci & Arts Western Switzerland, Plants & Pathogens Grp, Inst Land Nat & Environm, Hepia, Geneva, Switzerland	University of Applied Sciences & Arts Western Switzerland	Rienth, M (corresponding author), HES SO Univ Appl Sci & Arts Western Switzerland, Changins, Nyon, Switzerland.	markus.rienth@changins.ch	LEFORT, Francois/L-3831-2016; Rienth, Markus/AAI-5448-2021; Rienth, Markus/AAK-3241-2021	LEFORT, Francois/0000-0002-9977-9952; Rienth, Markus/0000-0002-6302-6297	Research thematic Healthfood programme of the HES-SO University of Applied Sciences and Arts Western Switzerland [73312, 73354]; Swiss Government Excellence Scholarship; HealthFood Research Programme of the HES-SO University of Applied Sciences and Arts Western Switzerland; COST (European Cooperation in Science & technology)-action -INTEGRAPE [CA17111]	Research thematic Healthfood programme of the HES-SO University of Applied Sciences and Arts Western Switzerland; Swiss Government Excellence Scholarship; HealthFood Research Programme of the HES-SO University of Applied Sciences and Arts Western Switzerland; COST (European Cooperation in Science & technology)-action -INTEGRAPE	This study was funded by grants No 73312 (MR) and No 73354 (FL) within the Research thematic Healthfood programme of the HES-SO University of Applied Sciences and Arts Western Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Sana Ghaffari obtained funding from the Swiss Government Excellence Scholarship.; The authors are grateful to the HealthFood Research Programme of the HES-SO University of Applied Sciences and Arts Western Switzerland for funding this study. The authors also gratefully acknowledge Marylin Cle ' roux for the GC-FID analysis, Arnaud Pernet for constructing the vaporisation system, Jean-Philippe Burdet for fruitful discussions and suggestions, Raphael Gonzales and Eric Remolif for support with plant cutting preparations and Romain Chablais for technical assistance during sequencing work. Furthermore, authors would like to thank the COST (European Cooperation in Science & technology)-action CA17111 -INTEGRAPE that permitted valuable exchange with another scientist on data analysis and integration and the Swiss Government excellence scholarship for financing the postdoctoral position of Dr. Sana Ghaffari.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allegre M, 2009, MOL PLANT MICROBE IN, V22, P977, DOI 10.1094/MPMI-22-8-0977; Amri I., 2012, INT J APPL BIOL PHAR, V4, P96; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Aziz A, 2006, PHYTOPATHOLOGY, V96, P1188, DOI 10.1094/PHYTO-96-1188; Backer R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00102; Bahieldin A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0908-z; Ballabio C, 2018, SCI TOTAL ENVIRON, V636, P282, DOI 10.1016/j.scitotenv.2018.04.268; Bektas Y, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00804; Belhadj A, 2008, PLANT PHYSIOL BIOCH, V46, P493, DOI 10.1016/j.plaphy.2007.12.001; Bisht D, 2009, IND CROP PROD, V30, P422, DOI 10.1016/j.indcrop.2009.07.014; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boruga O, 2014, J Med Life, V7 Spec No. 3, P56; Boubakri H, 2012, PLANT PHYSIOL BIOCH, V57, P120, DOI 10.1016/j.plaphy.2012.05.016; Bozin B, 2006, J AGR FOOD CHEM, V54, P1822, DOI 10.1021/jf051922u; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Burketova L, 2015, BIOTECHNOL ADV, V33, P994, DOI 10.1016/j.biotechadv.2015.01.004; Burruano Santella, 2000, Mycologist, V14, P179, DOI 10.1016/S0269-915X(00)80040-3; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Chavan PS, 2014, FOOD CONTROL, V46, P115, DOI 10.1016/j.foodcont.2014.05.007; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Dagostin S, 2010, PLANT DIS, V94, P575, DOI 10.1094/PDIS-94-5-0575; Delaunois B, 2014, ENVIRON SCI POLLUT R, V21, P4837, DOI 10.1007/s11356-013-1841-4; Duchene E, 2014, AUST J GRAPE WINE R, V20, P91, DOI 10.1111/ajgw.12051; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Fofana B, 2002, PHYSIOL MOL PLANT P, V61, P121, DOI 10.1016/S0885-5765(02)90420-0; Furuya S, 2010, PEST MANAG SCI, V66, P1268, DOI 10.1002/ps.2012; Gao QM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00228; Gauthier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088145; Genot B, 2017, PLANT PHYSIOL, V174, P1238, DOI 10.1104/pp.17.00378; Gessler C, 2011, PHYTOPATHOL MEDITERR, V50, P3; Gisi U, 2008, EUR J PLANT PATHOL, V122, P157, DOI 10.1007/s10658-008-9290-5; Godard S, 2009, PLANT PHYSIOL BIOCH, V47, P827, DOI 10.1016/j.plaphy.2009.04.003; Gomes E., 2009, GRAPEVINE MOL PHYSL, P407, DOI DOI 10.1007/978-90-481-2305-6_15; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Gullner G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01836; Gutierrez-Gamboa G, 2019, OENO ONE, V53, P1, DOI 10.20870/oeno-one.2019.53.1.2163; Hakim, 2018, PLANT PHYSIOL BIOCH, V123, P149, DOI 10.1016/j.plaphy.2017.12.012; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Holl J, 2013, PLANT CELL, V25, P4135, DOI 10.1105/tpc.113.117127; Janatova A, 2015, IND CROP PROD, V67, P216, DOI 10.1016/j.indcrop.2015.01.019; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Kumar M, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8070088; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; La Torre A, 2014, J ESSENT OIL RES, V26, P282, DOI 10.1080/10412905.2014.889049; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Larrieu A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0308-8; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Lloreda MD, 2018, OENO ONE, V52, P231, DOI 10.20870/oeno-one.oeno-one.2018.52.3.2312; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Merdinoglu D, 2018, OENO ONE, V52, P203, DOI 10.20870/oeno-one.2018.52.3.2116; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mohamed A, 2016, PLANT PROTECT SCI, V52, P1, DOI 10.17221/63/2015-PPS; Nazzaro F, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040086; Nobrega RD, 2016, PHARM BIOL, V54, P2591, DOI 10.3109/13880209.2016.1172319; Oliveira TD, 2017, REV BRAS FRUTIC, V39, P1, DOI 10.1590/0100-29452017911; Pajerowska-Mukhtar KM, 2013, TRENDS PLANT SCI, V18, P402, DOI 10.1016/j.tplants.2013.04.004; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Paul PK, 2002, PHYSIOL MOL PLANT P, V61, P3, DOI 10.1006/pmpp.2002.0412; Peressotti E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-147; Piasecka A, 2015, NEW PHYTOL, V206, P948, DOI 10.1111/nph.13325; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pina-Vaz C, 2004, J EUR ACAD DERMATOL, V18, P73, DOI 10.1111/j.1468-3083.2004.00886.x; Proietti S, 2018, PLANT CELL ENVIRON, V41, P2342, DOI 10.1111/pce.13357; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Richard T, 2016, OENO ONE, V50, P137, DOI 10.20870/oeno-one.2016.50.4.1178; Rienth M, 2014, AUST J GRAPE WINE R, V20, P247, DOI 10.1111/ajgw.12077; Rienth M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0850-0; Rienth M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-108; Rienth M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088844; de Almeida LFR, 2010, MOLECULES, V15, P4309, DOI 10.3390/molecules15064309; Sakkas H, 2017, J MICROBIOL BIOTECHN, V27, P429, DOI 10.4014/jmb.1608.08024; Salmon JM, 2015, INT J APPL EARTH OBS, V38, P321, DOI 10.1016/j.jag.2015.01.014; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Scholasch T, 2019, OENO ONE, V53, DOI [10.1016/J.6352465, DOI 10.1016/J.6352465]; Shoresh M, 2006, PLANT PHYSIOL, V142, P1169, DOI 10.1104/pp.106.082107; Soylu EM, 2010, INT J FOOD MICROBIOL, V143, P183, DOI 10.1016/j.ijfoodmicro.2010.08.015; Soylu S, 2007, J APPL MICROBIOL, V103, P1021, DOI 10.1111/j.1365-2672.2007.03310.x; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stael S, 2015, TRENDS PLANT SCI, V20, P3, DOI 10.1016/j.tplants.2014.10.002; Su JB, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004122; Suzuki N, 2011, PLANT J, V66, P844, DOI 10.1111/j.1365-313X.2011.04550.x; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Teixeira B, 2013, J SCI FOOD AGR, V93, P2707, DOI 10.1002/jsfa.6089; Torregrosa L, 2019, OENO ONE, V53, P373, DOI 10.20870/oeno-one.2019.53.3.2409; Torregrosa L, 2017, OENO ONE, V51, P155, DOI 10.20870/oeno-one.2016.0.0.1587; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vergnes S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00477; Viret O, 2018, OENO ONE, V52, P235, DOI 10.20870/oeno-one.2018.52.3.2033; von Rad U, 2005, NEW PHYTOL, V165, P191, DOI 10.1111/j.1469-8137.2004.01211.x; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Yi SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088951; Yin L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46553; Yobregat O, 2018, OENO ONE, V52, P241, DOI 10.20870/oeno-one.2018.52.3.2220; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu XH, 2010, EMBO J, V29, P1007, DOI 10.1038/emboj.2009.402	107	22	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222854	10.1371/journal.pone.0222854	http://dx.doi.org/10.1371/journal.pone.0222854			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560730	Green Published, gold, Green Submitted			2022-12-26	WOS:000532353700022
J	Coope, A; Pascoal, LB; Botezelli, JD; da Silva, FAR; Ayrizono, MDS; Rodrigues, BL; Milanski, M; Carvalho, RB; Fagundes, JJ; Velloso, LA; Leal, RF				Coope, Andressa; Pascoal, Livia Bitencourt; Botezelli, Jose Diego; Ramos da Silva, Francesca Aparecida; Setsuko Ayrizono, Maria de Lourdes; Rodrigues, Bruno Lima; Milanski, Marciane; Carvalho, Rita Barbosa; Fagundes, Joao Jose; Velloso, Licio Augusto; Leal, Raquel Franco			ER stress activation in the intestinal mucosa but not in mesenteric adipose tissue is associated with inflammation in Crohn's disease patients	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; PATHWAY; GRP78; RISK; MECHANISMS; AUTOPHAGY; IMPACT; CANCER	Chronic/abnormal activation of endoplasmic reticulum (ER) stress is linked to the exacerbation of the inflammatory process and has been recently linked to Crohn's disease (CD) pathophysiology. We investigated the intestinal mucosa and the mesenteric adipose tissue (MAT) collected from CD patients with active disease (CD group) and from non-IBD patients (CTR group) to study ER stress activation and to address tissue-specific modulation in CD. The intestinal mucosa of CD patients showed an upregulation in the expression of ER stress related genes, including ATF3, DNAJC3, STC2, DDIT3, CALR, HSPA5 and HSP90B1. Results showed that EIF2AK3 gene was upregulated, along with increased protein expression of p-eIF2 alpha and p-eIF2 alpha/eIF2 alpha ratio. Additionally, ERN1 gene expression was upregulated, along with an increased spliced/activated form sXBP1 protein. Despite the upregulation of ATF6 gene expression in the intestinal mucosa of CD patients, no differences were found in ATF6 protein expression. Lastly, the analysis of MAT revealed unchanged levels of ER stress markers along with no differences in the activation of UPR. However, chaperone gene expression was modulated in the MAT of CD patients. To conclude, our results address tissue-specific differences in UPR activation in CD and point the ER stress as an important pro-inflammatory mechanism in CD, specifically in the intestinal mucosa.	[Coope, Andressa; Pascoal, Livia Bitencourt; Botezelli, Jose Diego; Ramos da Silva, Francesca Aparecida; Setsuko Ayrizono, Maria de Lourdes; Rodrigues, Bruno Lima; Fagundes, Joao Jose; Leal, Raquel Franco] Univ Estadual Campinas, UNICAMP, Sch Med Sci, IBD Res Lab,Colorectal Surg Unit, Campinas, SP, Brazil; [Milanski, Marciane] Univ Estadual Campinas, UNICAMP, Sch Appl Sci, Lab Metab Disorders, Limeira, SP, Brazil; [Carvalho, Rita Barbosa] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Pathol,Gastroctr, Campinas, SP, Brazil; [Velloso, Licio Augusto] Univ Estadual Campinas, UNICAMP, Lab Cell Signaling, Sch Med Sci, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Leal, RF (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, IBD Res Lab,Colorectal Surg Unit, Campinas, SP, Brazil.	rafranco.unicamp@gmail.com	Velloso, Licio/AAJ-3778-2020; Milanski, Marciane/F-5410-2012; Rodrigues, Bruno/AAS-7670-2021	Milanski, Marciane/0000-0002-6322-5368; Rodrigues, Bruno/0000-0002-5794-2950; Coope, Andressa/0000-0002-7356-9690	FAPESP (Sao Paulo Research Foundation) [2016/01638-7]; CNPq (National Council for Scientific and Technological Development) [401270/2016-5]; CAPES (Coordination for the Improvement of Higher Education Personnel - Brazil) [02-P-28707/2012]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination for the Improvement of Higher Education Personnel - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support was received by: FAPESP (Sao Paulo Research Foundation) [Grant number 2016/01638-7 for R.F.L.]; CNPq (National Council for Scientific and Technological Development) [Grant number 401270/2016-5 for R.F.L.]. A.C. received Post-doctoral scholarship from CAPES (Coordination for the Improvement of Higher Education Personnel - Brazil) [02-P-28707/2012]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Coffey JC, 2016, LANCET GASTROENTEROL, V1, P238, DOI 10.1016/S2468-1253(16)30026-7; Coope A, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/7646859; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dias CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098547; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Fazio EN, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-17; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hoefkens E, 2013, AUTOPHAGY, V9, P2046, DOI 10.4161/auto.26337; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Leal RF, 2012, CELL TISSUE RES, V350, P549, DOI 10.1007/s00441-012-1491-8; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lewy TG, 2017, YALE J BIOL MED, V90, P291; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551; Mao R, 2019, INFLAMM BOWEL DIS, V25, P421, DOI 10.1093/ibd/izy331; Maruri-Avidal L, 2008, J VIROL, V82, P5368, DOI 10.1128/JVI.02751-07; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pott J, 2018, AUTOPHAGY, V14, P1460, DOI 10.1080/15548627.2018.1450021; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Roobol A, 2015, BIOCHEM J, V465, P213, DOI 10.1042/BJ20140852; Fortes MAS, 2016, ANAL BIOCHEM, V504, P38, DOI 10.1016/j.ab.2016.03.023; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van Der Sloot KWJ, 2017, INFLAMM BOWEL DIS, V23, P82, DOI 10.1097/MIB.0000000000000978; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhou H, 2011, J BIOL CHEM, V286, P25687, DOI 10.1074/jbc.M110.212944; Zhu GY, 2015, J CELL PHYSIOL, V230, P1413, DOI 10.1002/jcp.24923	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223105	10.1371/journal.pone.0223105	http://dx.doi.org/10.1371/journal.pone.0223105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557250	Green Published, Green Submitted, gold			2022-12-26	WOS:000532345500068
J	Qian, P; Li, J; Zhang, XH; Li, F; Bei, SH; Li, HQ; Sun, Q; Feng, L				Qian, Peiyu; Li, Jian; Zhang, Xiaohong; Li, Fan; Bei, Songhua; Li, Huanqing; Sun, Qi; Feng, Li			LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer	PLOS ONE			English	Article							CELLS	Our research group has showed that the LIM homeobox transcription factor 1 alpha (LMX1A) is inactivated in gastric cancers. Overexpression of LMX1A inhibits tumor growth. However, the mechanisms remains unclear. Considering LMX1A as a transcription factor, a comparison of RNA-seq between gastric cancer cells (GCCs) and GCCs with LMX1A over-expressed was performed to identify genes transcriptionally activated by LMX1A. Among the potential LMX1A target genes, angiopoietin-like 4 (ANGPTL4) has been reported to be an important tumor suppressor and thus was selected for further validation and research. Both LMX1A and ANGPTL4 showed downregulated expression in gastric cancer samples. More importantly, the expression of LMX1A is positively correlated with ANGPTL4, without including other family members in gastric cancer cell lines. What's more, knockdown of ANGPTL4 rescued the tumor suppressive phenotype of LMX1A overexpression, which indicated that LMX1A upregulates ANGPTL4 to exert its role. Mechanistically, we found that LMX1A inhibited the expression of the oncogene C-Myc, which is alleviated by ANGPTL4 knockdown. In general, our results showed that LMX1A exerts its tumor suppressive role by activating ANGPTL4 to inhibit C-Myc.	[Qian, Peiyu] Fudan Univ, Minhang Hosp, Minhang Fudan Med Res Cooperat Dev Res Inst, Shanghai, Peoples R China; [Li, Jian; Zhang, Xiaohong; Li, Fan; Bei, Songhua; Li, Huanqing; Sun, Qi; Feng, Li] Fudan Univ, Minhang Hosp, Endoscopy Ctr, Shanghai, Peoples R China	Fudan University; Fudan University	Sun, Q; Feng, L (corresponding author), Fudan Univ, Minhang Hosp, Endoscopy Ctr, Shanghai, Peoples R China.	sunqish@sina.com; Fenglikjk@163.com			Shanghai Municipal Health and Family Planning Commission Science Foundation [201540035]; Shanghai Health and Family Planning commission [20154Y0141]; Minhang Hospital, Fudan University [2017MHJCO3]	Shanghai Municipal Health and Family Planning Commission Science Foundation; Shanghai Health and Family Planning commission; Minhang Hospital, Fudan University	The project was funded by Shanghai Municipal Health and Family Planning Commission Science Foundation under the grant 201540035 (to LF), the Shanghai Health and Family Planning commission under the grant 20154Y0141 and Minhang Hospital, Fudan University under the grant 2017MHJCO3 (to PQ). And it is great thankful for that the Talent Development Fund of Minhang District provided 150,000 RMB for our project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Chao TK, 2013, GYNECOL ONCOL, V128, P475, DOI 10.1016/j.ygyno.2012.12.018; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Dong WJ, 2011, CANCER SCI, V102, P361, DOI 10.1111/j.1349-7006.2010.01804.x; Feng L, 2016, CELL BIOL TOXICOL, V32, P133, DOI 10.1007/s10565-016-9326-0; GERMAN MS, 1994, GENOMICS, V24, P403, DOI 10.1006/geno.1994.1639; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Xu AG, 2001, WORLD J GASTROENTERO, V7, P403; Zhang XN, 2016, J CLIN INVEST, V126, P1079, DOI 10.1172/JCI83339	14	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221640	10.1371/journal.pone.0221640	http://dx.doi.org/10.1371/journal.pone.0221640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557193	Green Published, gold			2022-12-26	WOS:000532345500011
J	Smeester, BA; Slipek, NJ; Pomeroy, EJ; Bomberger, HE; Shamsan, GA; Peterson, JJ; Crosby, MR; Draper, GM; Becklin, KL; Rahrmann, EP; McCarthy, JB; Odde, DJ; Wood, DK; Largaespada, DA; Moriarity, BS				Smeester, Branden A.; Slipek, Nicholas J.; Pomeroy, Emily J.; Bomberger, Heather E.; Shamsan, Ghaidan A.; Peterson, Joseph J.; Crosby, Margaret R.; Draper, Garrett M.; Becklin, Kelsie L.; Rahrmann, Eric P.; McCarthy, James B.; Odde, David J.; Wood, David K.; Largaespada, David A.; Moriarity, Branden S.			SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC SCREEN; CELL-GROWTH; TUMOR; SEMAPHORINS; EXPRESSION; PLEXIN-B2	Semaphorins, specifically type IV, are important regulators of axonal guidance and have been increasingly implicated in poor prognoses in a number of different solid cancers. In conjunction with their cognate PLXNB family receptors, type IV members have been increasingly shown to mediate oncogenic functions necessary for tumor development and malignant spread. In this study, we investigated the role of semaphorin 4C (SEMA4C) in osteosarcoma growth, progression, and metastasis. We investigated the expression and localization of SEMA4C in primary osteosarcoma patient tissues and its tumorigenic functions in these malignancies. We demonstrate that overexpression of SEMA4C promotes properties of cellular transformation, while RNAi knockdown of SEMA4C promotes adhesion and reduces cellular proliferation, colony formation, migration, wound healing, tumor growth, and lung metastasis. These phenotypic changes were accompanied by reductions in activated AKT signaling, G1 cell cycle delay, and decreases in expression of mesenchymal marker genes SNAI1, SNAI2, and TWIST1. Lastly, monoclonal antibody blockade of SEMA4C in vitro mirrored that of the genetic studies. Together, our results indicate a multi-dimensional oncogenic role for SEMA4C in metastatic osteosarcoma and more importantly that SEMA4C has actionable clinical potential.	[Smeester, Branden A.; Slipek, Nicholas J.; Pomeroy, Emily J.; Peterson, Joseph J.; Crosby, Margaret R.; Draper, Garrett M.; Becklin, Kelsie L.; Largaespada, David A.; Moriarity, Branden S.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Smeester, Branden A.; Slipek, Nicholas J.; Pomeroy, Emily J.; Peterson, Joseph J.; Crosby, Margaret R.; Draper, Garrett M.; Becklin, Kelsie L.; Largaespada, David A.; Moriarity, Branden S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Smeester, Branden A.; Slipek, Nicholas J.; Pomeroy, Emily J.; Shamsan, Ghaidan A.; Peterson, Joseph J.; Crosby, Margaret R.; Draper, Garrett M.; Becklin, Kelsie L.; McCarthy, James B.; Odde, David J.; Largaespada, David A.; Moriarity, Branden S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bomberger, Heather E.; Shamsan, Ghaidan A.; Odde, David J.; Wood, David K.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Rahrmann, Eric P.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [McCarthy, James B.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities	Moriarity, BS (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.; Moriarity, BS (corresponding author), Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA.; Moriarity, BS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	mori0164@umn.edu	Shamsan, Ghaidan A./X-3338-2019; Smeester, Branden A/E-7655-2013; Odde, David/AAY-1720-2020	Shamsan, Ghaidan A./0000-0003-0884-7540; Smeester, Branden A/0000-0001-9421-1711; Odde, David/0000-0001-7731-2799; Pomeroy, Emily/0000-0001-7690-3570	NIH NIAMS [T32 AR050938]; NIH NIAID [T32 AI997313]; Sobiech Osteosarcoma Fund Award; Randy Shaver Cancer and Community Fund; University of Minnesota Foundation; Rein in Sarcoma Foundation; Aflac-AACR Career Development Award; Children's Cancer Research Fund; National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) [ECCS-1542202]	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sobiech Osteosarcoma Fund Award; Randy Shaver Cancer and Community Fund; University of Minnesota Foundation(University of Minnesota System); Rein in Sarcoma Foundation; Aflac-AACR Career Development Award; Children's Cancer Research Fund; National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI)	The authors would like to thank Dr. Kyle Williams for helpful discussion throughout the study, Dr. Sterbs for her intoxicating enthusiasm during the preparation of this paper, Dr. Juan Abrahante for statistical advice, and the Clinical and Translational Science Institute (CSTI) Histology and Research Laboratory team members Dr. Colleen Forester and Lori Holm for tissue preparation and histology services. Author BAS is supported by an NIH NIAMS T32 AR050938 Musculoskeletal Training Grant. Author EJP is supported by an NIH NIAID T32 AI997313 Immunology Training Grant. This work was made possible through funding from the Sobiech Osteosarcoma Fund Award, Randy Shaver Cancer and Community Fund, University of Minnesota Foundation, Rein in Sarcoma Foundation, Aflac-AACR Career Development Award, and the Children's Cancer Research Fund to author BSM Portions of this work were conducted in the Minnesota Nano Center, which is supported by the National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) under Award Number ECCS-1542202. SEMA4C RNA expression results in data set #2 were in whole or part based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, phs000218, managed by the NCI. The data used are available (dbGaP accession phs000218.v21.p7). Information about TARGET can be found at http://ocg.cancer.gov/programs/target.	Abarrategi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3631764; Alto LT, 2017, METHODS MOL BIOL, V1493, P1, DOI 10.1007/978-1-4939-6448-2_1; Brett ME, 2018, INTEGR BIOL-UK, V10, P242, DOI 10.1039/c7ib00173h; Butti R, 2018, BREAST CANCER-TARGET, V10, P79, DOI 10.2147/BCTT.S135753; Chan CKF, 2018, CELL, V175, P43, DOI 10.1016/j.cell.2018.07.029; Choo S, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26721; Clavijo PE, 2019, CANCER IMMUNOL RES, V7, P282, DOI 10.1158/2326-6066.CIR-18-0156; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Evans EE, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1054599; Evans EE, 2015, CANCER IMMUNOL RES, V3, P689, DOI 10.1158/2326-6066.CIR-14-0171; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gianferante DM, 2017, NAT REV ENDOCRINOL, V13, P480, DOI 10.1038/nrendo.2017.16; Gurrapu S, 2018, CELL DEATH DIFFER, V25, P1259, DOI 10.1038/s41418-018-0097-4; Horvai AE, 2012, MODERN PATHOL, V25, P1452, DOI 10.1038/modpathol.2012.110; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kumar S, 2014, MOL BIOSYST, V10, P838, DOI 10.1039/c3mb70431a; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le AP, 2015, ONCOTARGET, V6, P7293, DOI 10.18632/oncotarget.3421; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lee KW, 2014, CANCER LETT, V343, P62, DOI 10.1016/j.canlet.2013.09.013; Lu J, 2018, FASEB J, V32, pfj201800113R; Marko TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep39059; Meazza C, 2016, EXPERT REV ANTICANC, V16, P543, DOI 10.1586/14737140.2016.1168697; Meyer LAT, 2016, CELL ADHES MIGR, V10, P700, DOI 10.1080/19336918.2016.1261785; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Morrow James J., 2015, Critical Reviews in Oncogenesis, V20, P173, DOI 10.1615/CritRevOncog.2015013713; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Paldy E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00341-w; Poleszczuk J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3923527; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; Rickel K, 2017, BONE, V102, P69, DOI 10.1016/j.bone.2016.10.017; Roche J, 2018, CANCERS, V10, DOI 10.3390/cancers10020052; Smeester BA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/387169; Smeester BA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/671386; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Wei JC, 2017, CLIN CANCER RES, V23, P214, DOI 10.1158/1078-0432.CCR-16-0741; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Xue D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00558; Yan GN, 2016, CANCER LETT, V370, P268, DOI 10.1016/j.canlet.2015.11.003; Yang QL, 2015, ONCOTARGET, V6, P3268, DOI 10.18632/oncotarget.3065; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yin K, 2012, MED ONCOL, V29, P3449, DOI 10.1007/s12032-012-0317-6; Zhou QD, 2013, J HUAZHONG U SCI-MED, V33, P672, DOI 10.1007/s11596-013-1179-7	49	3	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1049	1062		10.1038/s41388-019-1041-x	http://dx.doi.org/10.1038/s41388-019-1041-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31582836	Green Submitted			2022-12-26	WOS:000511209700008
J	Adhikari, A; Mainali, P; Davie, JK				Adhikari, Abhinav; Mainali, Pramish; Davie, Judith K.			JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cyclin D1; retinoblastoma protein (pRb; RB); polycomb; skeletal muscle; cyclin E1; EZH2; JARID2; Jumonji; polycomb repressive complex 2 (PRC2); histone demethylase; chromatin state; gene regulation	HISTONE METHYLTRANSFERASE ACTIVITY; TUMOR-SUPPRESSOR; GENE-EXPRESSION; H3 LYSINE-27; TARGET GENES; SELF-RENEWAL; DIFFERENTIATION; PROLIFERATION; MYOD; RB	JARID2 is a noncatalytic member of the polycomb repressive complex 2 (PRC2) which methylates of histone 3 lysine 27 (H3K27). In this work, we show that JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle cells to control proliferation and mitotic exit. We found that the stable depletion of JARID2 leads to increased proliferation and cell accumulation in S phase. The regulation of the cell cycle by JARID2 is mediated by direct repression of both cyclin D1 and cyclin E1, both of which are targets of PRC2-mediated H3K27 methylation. Intriguingly, we also find that the retinoblastoma protein (RB1) is a direct target of JARID2 and the PRC2 complex. The depletion of JARID2 is not sufficient to activate RB1. However, the ectopic expression of RB1 can suppress cyclin D1 expression in JARID2-depleted cells. Transient depletion of JARID2 in skeletal muscle cells leads to a transient up-regulation of cyclin D1 that is quickly suppressed with no resulting effect on proliferation, Taken together, we show that JARID2 and the PRC2 complex regulate skeletal muscle proliferation in a precise manner that involves the repression of cyclin D1, thus restraining proliferation and repressing RB1, which is required for mitotic exit and terminal differentiation.	Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; Southern Illinois Univ, Sch Med, Simmons Canc Inst, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Davie, JK (corresponding author), 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu	Adhikari, Abhinav/J-5224-2019	Adhikari, Abhinav/0000-0002-9228-480X	NIAMS, National Institutes of Health [RAR068622]	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grant RAR068622. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0217-x; Alonso SB, 2019, EMBO J, V38, DOI 10.15252/embj.201798791; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Celik H, 2018, CANCER CELL, V34, P741, DOI 10.1016/j.ccell.2018.10.008; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Cho EJ, 2018, J BIOL CHEM, V293, P11659, DOI 10.1074/jbc.RA118.002482; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; MARTELLI F, 1994, ONCOGENE, V9, P3579; Mohamed TMA, 2018, CELL, V173, P104, DOI 10.1016/j.cell.2018.02.014; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Su CL, 2015, INT J HEMATOL, V102, P76, DOI 10.1007/s12185-015-1797-x; Takahashi M, 2004, BIOCHEM BIOPH RES CO, V324, P1319, DOI 10.1016/j.bbrc.2004.09.203; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46	43	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19451	19464		10.1074/jbc.RA119.010060	http://dx.doi.org/10.1074/jbc.RA119.010060			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31578284	hybrid, Green Published			2022-12-26	WOS:000504093200001
J	Allawzi, A; McDermott, I; Delaney, C; Nguyen, K; Banimostafa, L; Trumpie, A; Hernandez-Lagunas, L; Riemondy, K; Gillen, A; Hesselberth, J; El Kasmi, K; Sucharov, CC; Janssen, WJ; Stenmark, K; Bowler, R; Nozik-Grayck, E				Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; Riemondy, Kent; Gillen, Austin; Hesselberth, Jay; El Kasmi, Karim; Sucharov, Carmen C.; Janssen, William J.; Stenmark, Kurt; Bowler, Russell; Nozik-Grayck, Eva			Redistribution of EC-SOD resolves bleomycin-induced inflammation via increased apoptosis of recruited alveolar macrophages	FASEB JOURNAL			English	Article						SOD3; extracellular superoxide dismutase; acute lung injury; pulmonary fibrosis	EXTRACELLULAR-SUPEROXIDE DISMUTASE; LUNG; RESOLUTION; POLYMORPHISM; ACTIVATION; CLEARANCE; FIBROSIS; MODEL; MICE	A human single nucleotide polymorphism (SNP) in the matrix-binding domain of extracellular superoxide dismutase (EC-SOD), with arginine to glycine substitution at position 213 (R213G), redistributes EC-SOD from the matrix into extracellular fluids. We reported that, following bleomycin (bleo), knockin mice harboring the human R213G SNP (R213G mice) exhibit enhanced resolution of inflammation and protection against fibrosis, compared with wild-type (WT) littermates. In this study, we tested the hypothesis that the EC-SOD R213G SNP promotes resolution via accelerated apoptosis of recruited alveolar macrophage (AM). RNA sequencing and Ingenuity Pathway Analysis 7 d postbleo in recruited AM implicated increased apoptosis and blunted inflammatory responses in the R213G strain exhibiting accelerated resolution. We validated that the percentage of apoptosis was significantly elevated in R213G recruited AM vs. WT at 3 and 7 d postbleo in vivo. Recruited AM numbers were also significantly decreased in R213G mice vs. WT at 3 and 7 d postbleo. ChaC glutathione-specific gamma-glutamylcyclotransferase 1 (Chad), a proapoptotic gamma-glutamyl cyclotransferase that depletes glutathione, was increased in the R213G recruited AM. Overexpression of Chad in vitro induced apoptosis of macrophages and was blocked by administration of cell-permeable glutathione. In summary, we provide new evidence that redistributed EC-SOD accelerates the resolution of inflammation through redox-regulated mechanisms that increase recruited AM apoptosis.	[Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; El Kasmi, Karim; Stenmark, Kurt; Nozik-Grayck, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Dept Pediat, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA; [Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; El Kasmi, Karim; Stenmark, Kurt; Nozik-Grayck, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Dept Med, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA; [Riemondy, Kent; Gillen, Austin; Hesselberth, Jay] Univ Colorado, RNA Biosci Initiat, Anschutz Med Campus, Aurora, CO USA; [Hesselberth, Jay] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Sucharov, Carmen C.] Univ Colorado, Dept Med, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [El Kasmi, Karim] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Janssen, William J.; Bowler, Russell] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Boehringer Ingelheim; National Jewish Health	Nozik-Grayck, E (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Dept Pediat, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA.; Nozik-Grayck, E (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Dept Med, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA.	eva.grayck@ucdenver.edu	stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020	Gillen, Austin/0000-0003-2928-6308; Allawzi, Ayed/0000-0002-1178-8927; Nguyen, Kianna/0000-0003-0186-2510	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [T32 HL007171]; AHA [19POST34380396, R01 HL119533, 5 R01 HL086680, 1R35HL139726-01]; University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI) [P30CA046934]; RNA Bioscience Initiative at the University of Colorado School of Medicine; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086680, T32HL007171, R35HL139726, R01HL119533] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI); RNA Bioscience Initiative at the University of Colorado School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Alexandra McCubbrey for technical insight and feedback. This work was funded by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants T32 HL007171 (to A.A.), AHA 19POST34380396 (to A.A.), R01 HL119533, 5 R01 HL086680, and 1R35HL139726-01 (to E.N.-G.). This work was supported, in part, by the University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI; P30CA046934). This work was also supported by the RNA Bioscience Initiative at the University of Colorado School of Medicine (to K.R. and A.G.). The authors declare no conflicts of interest.	Allawzi AM, 2018, AM J RESP CELL MOL, V58, P658, DOI 10.1165/rcmb.2016-0344OC; Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; Dahl M, 2008, AM J RESP CRIT CARE, V178, P906, DOI 10.1164/rccm.200804-549OC; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; El Kasmi KC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03764-1; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Garcia AM, 2018, PHYSIOL GENOMICS, V50, P807, DOI 10.1152/physiolgenomics.00053.2018; Gaurav R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95072; Good RJ, 2018, AM J PHYSIOL-LUNG C, V315, pL584, DOI 10.1152/ajplung.00073.2017; Gottfredsen RH, 2014, FREE RADICAL BIO MED, V69, P348, DOI 10.1016/j.freeradbiomed.2014.01.038; Hartney JM, 2014, CIRC-CARDIOVASC GENE, V7, P659, DOI 10.1161/CIRCGENETICS.113.000504; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kolahian S, 2016, AM J RESP CELL MOL, V55, P309, DOI 10.1165/rcmb.2016-0121TR; Loenders B, 1998, FREE RADICAL BIO MED, V24, P1097, DOI 10.1016/S0891-5849(97)00434-6; Lopes F, 2011, ARTHRITIS RHEUM-US, V63, P2651, DOI 10.1002/art.30448; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mouradian GC, 2017, AM J RESP CELL MOL, V56, P362, DOI 10.1165/rcmb.2016-0153OC; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Ortiz LA, 1998, AM J PHYSIOL-LUNG C, V275, pL1208, DOI 10.1152/ajplung.1998.275.6.L1208; Patel BV, 2015, AM J PHYSIOL-LUNG C, V309, pL639, DOI 10.1152/ajplung.00140.2015; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Pugliese SC, 2017, J IMMUNOL, V198, P4802, DOI 10.4049/jimmunol.1601692; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Reis AC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.580; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Zgheib C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177453; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	34	5	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13465	13475		10.1096/fj.201901038RR	http://dx.doi.org/10.1096/fj.201901038RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560857	Green Published, Bronze			2022-12-26	WOS:000507466100034
J	Kalpage, HA; Vaishnav, A; Liu, J; Varughese, A; Wan, JM; Turner, AA; Ji, QQ; Zurek, MP; Kapralov, AA; Kagan, VE; Brunzelle, JS; Recanati, MA; Grossman, LI; Sanderson, TH; Lee, I; Salomon, AR; Edwards, BFP; Huttemann, M				Kalpage, Hasini A.; Vaishnav, Asmita; Liu, Jenney; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Ji, Qinqin; Zurek, Matthew P.; Kapralov, Alexandr A.; Kagan, Valerian E.; Brunzelle, Joseph S.; Recanati, Maurice-Andre; Grossman, Lawrence I.; Sanderson, Thomas H.; Lee, Icksoo; Salomon, Arthur R.; Edwards, Brian F. P.; Huttemann, Maik			Serine-47 phosphorylation of cytochrome c in the mammalian brain regulates cytochrome c oxidase and caspase-3 activity	FASEB JOURNAL			English	Article						apoptosis; electron transport chain; ischemia; respiration; signaling	OXIDATIVE-PHOSPHORYLATION; IN-VIVO; MITOCHONDRIA; RESPIRATION; CARDIOLIPIN; MECHANISMS; LIPIDOMICS; DYNAMICS; COMPLEX; LIVER	Cytochrome c (Cytc) is a multifunctional protein that operates as an electron carrier in the mitochondrial electron transport chain and plays a key role in apoptosis. We have previously shown that tissue-specific phosphorylations of Cytc in the heart, liver, and kidney play an important role in the regulation of cellular respiration and cell death. Here, we report that Cytc purified from mammalian brain is phosphorylated on S47 and that this phosphorylation is lost during ischemia. We have characterized the functional effects in vitro using phosphorylated Cytc purified from pig brain tissue and a recombinant phosphomimetic mutant (S47E). We crystallized S47E phosphomimetic Cytc at 1.55 angstrom and suggest that it spatially matches S47-phosphorylated Cytc, making it a good model system. Both S47-phosphorylated and phosphomimetic Cytc showed a lower oxygen consumption rate in reaction with isolated Cytc oxidase, which we propose maintains intermediate mitochondrial membrane potentials under physiologic conditions, thus minimizing production of reactive oxygen species. S47-phosphorylated and phosphomimetic Cytc showed lower caspase-3 activity. Furthermore, phosphomimetic Cytc had decreased cardiolipin peroxidase activity and is more stable in the presence of H2O2. Our data suggest that S47 phosphorylation of Cytc is tissue protective and promotes cell survival in the brain.	[Kalpage, Hasini A.; Liu, Jenney; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Zurek, Matthew P.; Recanati, Maurice-Andre; Grossman, Lawrence I.; Huttemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Vaishnav, Asmita; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Edwards, Brian F. P.; Huttemann, Maik] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Recanati, Maurice-Andre] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Ji, Qinqin; Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow Med State Univ, Lab Nav Redox Lipid, Moscow, Russia; [Brunzelle, Joseph S.] Northwestern Univ, Ctr Synchrotron Res, Argonne, IL USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sanderson, Thomas H.; Huttemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, South Korea	Wayne State University; Wayne State University; Wayne State University; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 East Canfield St, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	; Sanderson, Thomas/K-6656-2012	Recanati, Maurice Andre/0000-0003-0974-3962; Sanderson, Thomas/0000-0003-0112-8164; Huttemann, Maik/0000-0001-6310-7081; Kagan, Valerian E./0000-0002-7245-1885; Kapralov, Oleksandr/0000-0002-3006-916X; Brunzelle, Joseph/0000-0001-9197-0018	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM116807, R01 GM113908]; NIH National Institute of Neurological Disorders and Stroke [R01 NS091242, R42 NS105238]; Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-16-1-0175]; Department of Defense or the NIH; U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Wayne State University Office of the Vice-President for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113908, R01GM116807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091242, R42NS105238] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; Department of Defense or the NIH; U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Wayne State University Office of the Vice-President for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01 GM116807 and R01 GM113908, NIH National Institute of Neurological Disorders and Stroke Grants R01 NS091242 and R42 NS105238, and by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award W81XWH-16-1-0175. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies including the Department of Defense or the NIH. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corp., the Michigan Technology Tri-Corridor (Grant 085P1000817), and Wayne State University Office of the Vice-President for Research. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Cammack R., 1995, BIOENERGETICS PRACTI, P93; Cheng TC, 2016, ELIFE, V5, DOI 10.7554/eLife.17755; Dalmonte ME, 2009, J BIOL CHEM, V284, P32331, DOI 10.1074/jbc.M109.050146; Deacon OM, 2018, BIOCHEMISTRY-US, V57, P4276, DOI 10.1021/acs.biochem.8b00520; Dickerson R., 1975, ENZYMES, V11, P397; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Guerra-Castellano A, 2016, BBA-BIOENERGETICS, V1857, P387, DOI 10.1016/j.bbabio.2016.01.011; Hannibal L, 2016, BIOCHEMISTRY-US, V55, P407, DOI 10.1021/acs.biochem.5b01385; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hojlund K, 2009, J PROTEOME RES, V8, P4954, DOI 10.1021/pr9007267; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jaradat SA, 1998, GENOMICS, V49, P363, DOI 10.1006/geno.1998.5279; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kalpage HA, 2019, FASEB J, V33, P1540, DOI 10.1096/fj.201801417R; Karsisiotis AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep30447; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; KUHNNENTWIG L, 1985, EUR J BIOCHEM, V149, P147, DOI 10.1111/j.1432-1033.1985.tb08905.x; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lee I, 2009, METHOD ENZYMOL, V457, P193, DOI 10.1016/S0076-6879(09)05011-3; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Mahapatra G, 2017, J BIOL CHEM, V292, P64, DOI 10.1074/jbc.M116.744664; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MICHEL B, 1984, J BIOL CHEM, V259, P85; Nicholls D. G., 1992, BIOENERGETICS; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Pierron D, 2012, ADV EXP MED BIOL, V748, P185, DOI 10.1007/978-1-4614-3573-0_8; Pierron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026269; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; SANISHVILI R, 1995, STRUCTURE, V3, P707, DOI 10.1016/S0969-2126(01)00205-2; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Sinkler CA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1534056; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	60	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13503	13514		10.1096/fj.201901120R	http://dx.doi.org/10.1096/fj.201901120R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570002	Bronze, Green Submitted, Green Published			2022-12-26	WOS:000507466100037
J	McMurray, F; MacFarlane, M; Kim, K; Patten, DA; Wei-LaPierre, L; Fullerton, MD; Harper, ME				McMurray, Fiona; MacFarlane, Megan; Kim, Kijoo; Patten, David A.; Wei-LaPierre, Lan; Fullerton, Morgan D.; Harper, Mary-Ellen			Maternal diet-induced obesity alters muscle mitochondrial function in offspring without changing insulin sensitivity	FASEB JOURNAL			English	Article						type 2 diabetes; mitochondria; reactive oxygen species; maternal overnutrition; insulin resistance	PROTEIN-KINASE-C; SKELETAL-MUSCLE; OXIDATIVE STRESS; SUPEROXIDE FLASHES; METABOLIC SYNDROME; ANIMAL-MODELS; BIRTH-WEIGHT; RESISTANCE; PREGNANCY; PHOSPHORYLATION	In utero overnutrition can predispose offspring to metabolic disease. Although the mechanisms are unclear, increased oxidative stress accelerating cellular aging has been shown to play a role. Mitochondria are the main site of reactive oxygen species (ROS) production in most cell types. Levels of ROS and the risk for oxidative damage are dictated by the balance between ROS production and antioxidant defense mechanisms. Originally considered as toxic species, physiologic levels of ROS are now known to be essential cell signaling molecules. Using a model of maternal over-nutrition in C57BL6N mice, we investigate the mechanisms involved in the development of insulin resistance (IR) in muscle. In red and white gastrocnemius musdes of offspring, we are the first to report characteristics of oxidative phosphorylation, H2O2 production, activity of mitoflashes, and electron transport chain supercomplex formation. Results demonstrate altered mitochondrial function with reduced response to glucose in offspring of mice fed a high-fat and high-sucrose diet, increases in mitochondrial leak respiration, and a reduction in ROS production in red gastrocnemius in response to palmitoyl carnitine. We also demonstrate differences in supercomplex formation between red and white gastrocnemius, which may be integral to fiber-type specialization. We condude that in this model of maternal overnutrition, mitochondrial alterations occur before the development of IR.	[McMurray, Fiona; MacFarlane, Megan; Kim, Kijoo; Patten, David A.; Fullerton, Morgan D.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [McMurray, Fiona; Patten, David A.; Harper, Mary-Ellen] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Wei-LaPierre, Lan] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY USA	University of Ottawa; University of Ottawa; University of Rochester	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca			Canadian Institutes of Health Research (CIHR) [FDN143278, PJT148634]; CIHR New Investigator Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	The authors thank Jian Xuan and the animal care staff at the University of Ottawa for dedicated assistance during this study. The authors thank Chantal Pileggi and Gaganvir Parmar (University of Ottawa) for technical assistance addressing the reviewer comments. The authors also thank Prof. Robert Dirksen (University of Rochester) for providing us with the mitochondrially targeted circularly permuted yellow fluorescent protein (mt-cpYFP) mice. This work was also supported by Canadian Institutes of Health Research (CIHR) funding to M.E.H. (FDN143278) and to M.D.F. (PJT148634). M.D.F. is supported by a CIHR New Investigator Award. The authors declare no conflicts of interest.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Battista MC, 2005, J PHYSIOL-LONDON, V565, P197, DOI 10.1113/jphysiol.2004.078139; Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Ding Y, 2015, J MOL MED, V93, P1119, DOI 10.1007/s00109-015-1278-y; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gale CR, 2007, J CLIN ENDOCR METAB, V92, P3904, DOI 10.1210/jc.2007-0088; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Gonzalez-Franquesa A., 2017, ADV EXPT MED BIOL, V982; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kanaan GN, 2019, CAN J DIABETES, V43, P67, DOI 10.1016/j.jcjd.2018.05.007; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Latouche C, 2014, J NUTR, V144, P237, DOI 10.3945/jn.113.186775; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lee JH, 1997, INT J OBESITY, V21, P935, DOI 10.1038/sj.ijo.0800498; Lehtovirta M, 2000, DIABETOLOGIA, V43, P285, DOI 10.1007/s001250050046; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McBride S, 2019, ARCH BIOCHEM BIOPHYS, V663, P239, DOI 10.1016/j.abb.2019.01.018; McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654; McMurray F, 2011, MAMM GENOME, V22, P390, DOI 10.1007/s00335-011-9345-3; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; National Center for Chronic Disease Prevention and Health Promotion, 2017, NAT DIAB STAT REP 20; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2002, DIABETOLOGIA, V45, P1649, DOI 10.1007/s00125-002-0983-6; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00014; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schwarzlander M, 2014, NATURE, V514, pE12, DOI 10.1038/nature13858; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wei-LaPierre L, 2013, J BIOL CHEM, V288, P10567, DOI 10.1074/jbc.M113.455709; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251	68	8	8	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13515	13526		10.1096/fj.201901150R	http://dx.doi.org/10.1096/fj.201901150R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31581846	Bronze			2022-12-26	WOS:000507466100038
J	Srivastava, AC; Thompson, YG; Singhal, J; Stellern, J; Srivastava, A; Du, J; O'Connor, TR; Riggs, AD				Srivastava, Avinash C.; Thompson, Yesenia Guadalupe; Singhal, Jyotsana; Stellern, Jordan; Srivastava, Anviksha; Du, Juan; O'Connor, Timothy R.; Riggs, Arthur D.			Elimination of human folypolyglutamate synthetase alters programming and plasticity of somatic cells	FASEB JOURNAL			English	Article						C1 metabolism; CRISPR/Cas9; GABA; glutamate-induced pluripotency	GAMMA-GLUTAMATE SYNTHETASE; ONE-CARBON METABOLISM; GLOBAL DNA METHYLATION; FOLYLPOLYGLUTAMATE SYNTHETASE; SERINE HYDROXYMETHYLTRANSFERASE; GENE-EXPRESSION; MOLECULAR-MECHANISMS; FOLATE-DEFICIENCY; PROTEIN; CANCER	Folates are vital cofactors for the regeneration of S-adenosyl methionine, which is the methyl source for DNA methylation, protein methylation, and other aspects of one-carbon (C1) metabolism. Thus, folates are critical for establishing and preserving epigenetic programming. Folypolyglutamate synthetase (FPGS) is known to play a crucial role in the maintenance of intracellular folate levels. Therefore, any modulation in FPGS is expected to alter DNA methylation and numerous other metabolic pathways. To explore the role of polyglutamylation of folate, we eliminated both isoforms of FPGS in human cells (293T), producing FPGS knockout (FPGS(ko)) cells. The elimination of FPGS significantly decreased cell proliferation, with a major effect on oxidative phosphorylation and a lesser effect on glycolysis. We found a substantial reduction in global DNA methylation and noteworthy changes in gene expression related to C1 metabolism, cell division, DNA methylation, pluripotency, Glu metabolism, neurogenesis, and cardiogenesis. The expression levels of NANOG, octamer-binding transcription factor 4, and sex-determining region Y-box 2 levels were increased in the mutant, consistent with the transition to a stem cell like state. Gene expression and metabolite data also indicate a major change in Glu and GABA metabolism. In the appropriate medium, FPGS(ko) cells can differentiate to produce mainly cells with characteristics of either neural stem cells or cardiomyocytes.	[Srivastava, Avinash C.; Singhal, Jyotsana; Riggs, Arthur D.] City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Thompson, Yesenia Guadalupe; Stellern, Jordan; Srivastava, Anviksha; O'Connor, Timothy R.] City Hope Natl Med Ctr, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Du, Juan] City Hope Natl Med Ctr, Integrat Genom Core Facil, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; City of Hope; City of Hope	Srivastava, AC; Riggs, AD (corresponding author), City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	asrivastava@coh.org; ariggs@coh.org		O'Connor, Timothy/0000-0001-5848-3592	Diabetes and Metabolism Research Institute; City of Hope National Medical Center Tobacco-Related Disease Research Program [28IR-0050]; City of Hope Cancer Center [P30 CA 033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	Diabetes and Metabolism Research Institute; City of Hope National Medical Center Tobacco-Related Disease Research Program; City of Hope Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Xiwei Wu, Hanjun Qin, and Chao Guo (City of Hope Integrative Genomics Core) and Lucy Brown, Shaun Hsueh, and Alexander Spalla (Analytical Cytometry Core, City of Hope) for helping with the transcriptomics and single-cell sorting. The authors also thank Prof. Oliver Fiehn and his team (U.S. National Institutes of Health West Coast Metabolomics Center, University of California-Davis Genome Center, Davis, CA, USA) for support in metabolomics. The authors thank Avinash Srivastava for designing and producing Figure 1 using BioRender (https://biorender.com/).This work was supported by the Diabetes and Metabolism Research Institute, City of Hope National Medical Center Tobacco-Related Disease Research Program (28IR-0050 to T.R.O.), and the City of Hope Cancer Center (P30 CA 033572). A.C.S., T.R.O., and A.D.R. contributed equally to this work. The authors declare no conflicts of interest.	Jimenez NA, 2018, DEV BIOL, V444, pS193, DOI 10.1016/j.ydbio.2018.08.001; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andreassi JL, 2002, BIOCHEMISTRY-US, V41, P226, DOI 10.1021/bi015644d; Atkinson IJ, 1998, PHYTOCHEMISTRY, V49, P2221, DOI 10.1016/S0031-9422(98)00317-3; Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Bienemann K, 2013, CANCER GENE THER, V20, P514, DOI 10.1038/cgt.2013.48; Burgos-Barragan G, 2017, NATURE, V548, P549, DOI 10.1038/nature23481; Cajka T, 2016, ANAL CHEM, V88, P524, DOI 10.1021/acs.analchem.5b04491; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen L, 1996, J BIOL CHEM, V271, P13077, DOI 10.1074/jbc.271.22.13077; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; CODY V, 1992, J MOL BIOL, V224, P1179, DOI 10.1016/0022-2836(92)90480-8; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; El Fadili A, 2002, MOL BIOCHEM PARASIT, V124, P63, DOI 10.1016/S0166-6851(02)00163-9; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; Feng HC, 2017, INT J CANCER, V141, P2537, DOI 10.1002/ijc.31008; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonda TA, 2012, GASTROENTEROLOGY, V142, P824, DOI 10.1053/j.gastro.2011.12.058; Hanafy S. M., 2011, AM J MOL BIOL, V1, P62; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Hu JW, 2018, CELLS TISSUES ORGANS, V205, P1, DOI 10.1159/000485501; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang Z, 2016, MED SCI MONITOR, V22, P4967, DOI 10.12659/MSM.899021; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Kang Eunchai, 2015, Neurogenesis (Austin), V2, pe1081715, DOI 10.1080/23262133.2015.1081715; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim SE, 2016, J NUTR BIOCHEM, V29, P27, DOI 10.1016/j.jnutbio.2015.10.019; Kim SE, 2015, GENES NUTR, V10, DOI [10.1007/s12263-014-0444-0, 10.1007/s12263-015-0475-1]; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Korshunova I, 2008, J NEUROSCI RES, V86, P2201, DOI 10.1002/jnr.21678; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lawrence SA, 2014, J BIOL CHEM, V289, P29386, DOI 10.1074/jbc.M114.593244; Leclerc GJ, 2001, CLIN CANCER RES, V7, P942; Leil TA, 2007, CANCER RES, V67, P8772, DOI 10.1158/0008-5472.CAN-07-0156; Li Y, 2018, PHYSIOL GENOMICS, V50, P158, DOI 10.1152/physiolgenomics.00094.2017; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; LIN BF, 1993, J BIOL CHEM, V268, P21674; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lorente P, 2000, P NATL ACAD SCI USA, V97, P8664, DOI 10.1073/pnas.97.15.8664; Luciano-Mateo F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020121; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MORAN RG, 1988, BIOCHEM PHARMACOL, V37, P1997, DOI 10.1016/0006-2952(88)90547-3; Moran RG, 1999, SEMIN ONCOL, V26, P24; Morrissey C, 2008, CANCER RES, V68; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Padron-Barthe L, 2018, J AM COLL CARDIOL, V71, P654, DOI 10.1016/j.jacc.2017.11.067; Pahnke A, 2016, BIOCHEM BIOPH RES CO, V473, P698, DOI 10.1016/j.bbrc.2015.11.060; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Piyathilake CJ, 2000, NUTR CANCER, V37, P99, DOI 10.1207/S15327914NC3701_13; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Rosowsky A, 1999, J MED CHEM, V42, P3510, DOI 10.1021/jm9807205; Roxburgh J, 2016, CYTOTECHNOLOGY, V68, P957, DOI 10.1007/s10616-015-9848-y; Salabei JK, 2015, STEM CELLS, V33, P2613, DOI 10.1002/stem.2047; Schlett K, 2006, CURR TOP MED CHEM, V6, P949, DOI 10.2174/156802606777323665; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Srivastava AC, 2011, PLANT PHYSIOL, V155, P1237, DOI 10.1104/pp.110.168278; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tyagi N, 2007, CLIN CHEM LAB MED, V45, P1777, DOI 10.1515/CCLM.2007.342; Vicini S, 2008, J PHYSIOL-LONDON, V586, P3737, DOI 10.1113/jphysiol.2008.159046; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Walls AB, 2015, NEUROCHEM RES, V40, P402, DOI 10.1007/s11064-014-1473-1; Wang INE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038328; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; Wojtuszkiewicz A, 2016, INT J CANCER, V138, P1645, DOI 10.1002/ijc.29919; Yannarelli G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189131; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao RB, 2000, CLIN CANCER RES, V6, P3687; Zhou HR, 2013, PLANT CELL, V25, P2545, DOI 10.1105/tpc.113.114678; Ziller MJ, 2018, CELL STEM CELL, V22, P559, DOI 10.1016/j.stem.2018.02.012	94	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13747	13761		10.1096/fj.201901721R	http://dx.doi.org/10.1096/fj.201901721R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585510	Bronze, Green Published			2022-12-26	WOS:000507466100055
J	Blythe, NM; Muraki, K; Ludlow, MJ; Stylianidis, V; Gilbert, HTJ; Evans, EL; Cuthbertson, K; Foster, R; Swift, J; Li, J; Drinkhill, MJ; van Nieuwenhoven, FA; Porter, KE; Beech, DJ; Turner, NA				Blythe, Nicola M.; Muraki, Katsuhiko; Ludlow, Melanie J.; Stylianidis, Vasili; Gilbert, Hamish T. J.; Evans, Elizabeth L.; Cuthbertson, Kevin; Foster, Richard; Swift, Joe; Li, Jing; Drinkhill, Mark J.; van Nieuwenhoven, Frans A.; Porter, Karen E.; Beech, David J.; Turner, Neil A.			Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; calcium; p38 MAPK; mitogen-activated protein kinase (MAPK); IL-6; fibroblast; heart; mechanotransduction; patch clamp; signal transduction; cardiac fibroblast	PROLIFERATION; DYSFUNCTION; FIBROSIS; IL-6	Piezo1 is a mechanosensitive cation channel with widespread physiological importance; however, its role in the heart is poorly understood. Cardiac fibroblasts help preserve myocardial integrity and play a key role in regulating its repair and remodeling following stress or injury. Here we investigated Piezo1 expression and function in cultured human and mouse cardiac fibroblasts. RT-PCR experiments confirmed that Piezo1 mRNA in cardiac fibroblasts is expressed at levels similar to those in endothelial cells. The results of a Fura-2 intracellular Ca2+ assay validated Piezo1 as a functional ion channel that is activated by its agonist, Yoda1. Yoda1-induced Ca2+ entry was inhibited by Piezo1 blockers (gadolinium and ruthenium red) and was reduced proportionally by siRNA-mediated Piezo1 knockdown or in murine Piezo1(+/-) cells. Results from cell-attached patch clamp recordings on human cardiac fibroblasts established that they contain mechanically activated ion channels and that their pressure responses are reduced by Piezo1 knockdown. Investigation of Yoda1 effects on selected remodeling genes indicated that Piezo1 activation increases both mRNA levels and protein secretion of IL-6, a pro-hypertrophic and profibrotic cytokine, in a Piezo1-dependent manner. Moreover, Piezo1 knockdown reduced basal IL-6 expression from cells cultured on softer collagen-coated substrates. Multiplex kinase activity profiling combined with kinase inhibitor experiments and phosphospecific immunoblotting established that Piezo1 activation stimulates IL-6 secretion via the p38 mitogen-activated protein kinase downstream of Ca2+ entry. In summary, cardiac fibroblasts express mechanically activated Piezo1 channels coupled to secretion of the paracrine signaling molecule IL-6. Piezo1 may therefore be important in regulating cardiac remodeling.	[Blythe, Nicola M.; Ludlow, Melanie J.; Stylianidis, Vasili; Evans, Elizabeth L.; Li, Jing; Drinkhill, Mark J.; Porter, Karen E.; Beech, David J.; Turner, Neil A.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Sch Med, Discovery & Translat Sci Dept, Leeds LS2 9JT, W Yorkshire, England; [Blythe, Nicola M.; Ludlow, Melanie J.; Stylianidis, Vasili; Evans, Elizabeth L.; Li, Jing; Drinkhill, Mark J.; Porter, Karen E.; Beech, David J.; Turner, Neil A.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan; [van Nieuwenhoven, Frans A.] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Gilbert, Hamish T. J.; Swift, Joe] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Wellcome Ctr Cell Matrix Res,Div Cell Matrix Biol, Manchester M13 9PL, Lancs, England; [Cuthbertson, Kevin; Foster, Richard] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; Aichi Gakuin University; Maastricht University; University of Manchester; University of Leeds	Turner, NA (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Discovery & Translat Sci Dept, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	n.a.turner@leeds.ac.uk	Gilbert, Hamish TJ/AAW-9066-2021	van Nieuwenhoven, Frans/0000-0002-5757-0069; Foster, Richard/0000-0002-2361-3884; Gilbert, Hamish T J/0000-0003-2571-765X; Ludlow, Melanie/0000-0002-0720-5581; Beech, David/0000-0002-7683-9422	University of Leeds Alumni; BBSRC [BB/L024551/1] Funding Source: UKRI	University of Leeds Alumni; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Ardem Patapoutian (Scripps Research Institute) for providing the pcDNA3_mouse Piezo1_IRES_GFP plasmid. We also thank Savithri Rangarajan (PamGene) for assistance with analysis of data from the PamChip kinase activity arrays, David Eisner's group at the University of Manchester for supplying the mouse cardiomyocyte fraction, and the University of Leeds Alumni for a scholarship to N. M. B.	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bageghni SA, 2018, FASEB J, V32, P4941, DOI 10.1096/fj.201701455RR; Banerjee I, 2009, AM J PHYSIOL-HEART C, V296, pH1694, DOI 10.1152/ajpheart.00908.2008; Bauer CC, 2010, ATHEROSCLEROSIS, V209, P374, DOI 10.1016/j.atherosclerosis.2009.10.004; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Deb A, 2014, J MOL CELL CARDIOL, V70, P47, DOI 10.1016/j.yjmcc.2014.02.017; del Marmol JI, 2018, ELIFE, V7, DOI 10.7554/eLife.33149; dela Paz NG, 2018, BIOCHEM BIOPH RES CO, V497, P220, DOI 10.1016/j.bbrc.2018.02.058; Di Virgilio F., 1989, METHOD CELL BIOL, P453; Evans EL, 2018, BRIT J PHARMACOL, V175, P1744, DOI 10.1111/bph.14188; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Herum KM, 2017, MOL BIOL CELL, V28, P1871, DOI 10.1091/mbc.E17-01-0014; Herum KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050053; House M, 2012, AM J OBSTET GYNECOL, V206, pS231, DOI 10.1016/j.ajog.2011.10.528; Lacroix JJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04405-3; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Li JM, 2013, INT J BIOL MACROMOL, V59, P105, DOI 10.1016/j.ijbiomac.2013.03.053; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liang JL, 2017, AM J TRANSL RES, V9, P2945; Martin TP, 2014, PFLUG ARCH EUR J PHY, V466, P319, DOI 10.1007/s00424-013-1326-9; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Reed Alistair, 2014, Glob Cardiol Sci Pract, V2014, P9, DOI 10.5339/gcsp.2014.19; Saucerman JJ, 2019, NAT REV CARDIOL, V16, P361, DOI 10.1038/s41569-019-0155-8; Schmitz ML, 2016, TRENDS PHARMACOL SCI, V37, P101, DOI 10.1016/j.tips.2015.10.004; Schwill M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau2875; Sinfield JK, 2013, BIOCHEM BIOPH RES CO, V430, P419, DOI 10.1016/j.bbrc.2012.11.071; Skutek M, 2001, KNEE SURG SPORT TR A, V9, P322; Sugimoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18089-0; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tarone G, 2003, TRENDS MOL MED, V9, P376, DOI 10.1016/S1471-4914(03)00164-3; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; Turner NA, 2001, CELL SIGNAL, V13, P269, DOI 10.1016/S0898-6568(01)00135-8; Turner NA, 2019, J CARDIOVASC DEV DIS, V6, DOI 10.3390/jcdd6030027; Turner NA, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-5; Ugolini GS, 2017, ELIFE, V6, DOI 10.7554/eLife.22847; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173; Zhang XY, 2014, CELL PHYSIOL BIOCHEM, V33, P557, DOI 10.1159/000358634	40	47	50	8	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17395	17408		10.1074/jbc.RA119.009167	http://dx.doi.org/10.1074/jbc.RA119.009167			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31586031	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000503173500019
J	Tang, WJ; Unrath, WC; Desetty, R; Yengo, CM				Tang, Wanjian; Unrath, William C.; Desetty, Rohini; Yengo, Christopher M.			Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; actin; cardiomyopathy; enzyme kinetics; heart failure; omecamtiv mecarbil	STRUCTURAL KINETICS; CALCIUM SENSITIVITY; FORCE DEVELOPMENT; ACTIN-BINDING; MUSCLE; ADP; ACTIVATION; MECHANISM; MAGNESIUM; INCREASES	We investigated a dilated cardiomyopathy (DCM) mutation (F764L) in human beta-cardiac myosin by determining its motor properties in the presence and absence of the heart failure drug omecamtive mecarbil (OM). The mutation is located in the converter domain, a key region of communication between the catalytic motor and lever arm in myosins, and is nearby but not directly in the OM-binding site. We expressed and purified human beta-cardiac myosin subfragment 1 (M2 beta-S1) containing the F764L mutation, and compared it to WT with in vitro motility as well as steady-state and transient kinetics measurements. In the absence of OM we demonstrate that the F764L mutation does not significantly change maximum actin-activated ATPase activity but slows actin sliding velocity (15%) and the actomyosin ADP release rate constant (25%). The transient kinetic analysis without OM demonstrates that F764L has a similar duty ratio as WT in unloaded conditions. OM is known to enhance force generation in cardiac muscle while it inhibits the myosin power stroke and enhances actin-attachment duration. We found that OM has a reduced impact on F764L ATPase and sliding velocity compared with WT. Specifically, the EC50 for OM induced inhibition of in vitro motility was 3-fold weaker in F764L. Also, OM reduces maximum actin-activated ATPase 2-fold in F764L, compared with 4-fold with WT. Overall, our results suggest that F764L attenuates the impact of OM on actin-attachment duration and/or the power stroke. Our work highlights the importance of mutation-specific considerations when pursuing small molecule therapies for cardiomyopathies.	[Tang, Wanjian; Unrath, William C.; Desetty, Rohini; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Tang, Wanjian/0000-0001-7374-6442; Yengo, Christopher/0000-0003-3987-9019	National Institutes of Health [HL127699]; American Heart Association [19PRE34380569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL127699 (to C. M. Y.) and American Heart Association Grant 19PRE34380569 (to W. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Alamo L, 2017, ELIFE, V6, DOI 10.7554/eLife.24634; Baumketner A, 2012, PROTEINS, V80, P2701, DOI 10.1002/prot.24155; Billington N, 2014, J MOL BIOL, V426, P894, DOI 10.1016/j.jmb.2013.11.028; Bloemink MJ, 2016, J BIOL CHEM, V291, P1763, DOI 10.1074/jbc.M115.688002; CHALOVICH JM, 1984, BIOCHEMISTRY-US, V23, P4885, DOI 10.1021/bi00316a011; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; Glasheen BM, 2018, BIOPHYS J, V114, P1142, DOI 10.1016/j.bpj.2017.12.045; Gunther LK, 2019, J BIOL CHEM, V294, P1554, DOI 10.1074/jbc.RA118.006128; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; Japp AG, 2016, J AM COLL CARDIOL, V67, P2996, DOI 10.1016/j.jacc.2016.03.590; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Liu C, 2018, NAT STRUCT MOL BIOL, V25, P505, DOI 10.1038/s41594-018-0069-x; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Mamidi R, 2015, J MOL CELL CARDIOL, V85, P262, DOI 10.1016/j.yjmcc.2015.06.011; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; McNamara James W, 2015, Biophys Rev, V7, P5, DOI 10.1007/s12551-014-0151-5; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Nagy L, 2015, BRIT J PHARMACOL, V172, P4506, DOI 10.1111/bph.13235; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Palmer BM, 2013, J MOL CELL CARDIOL, V57, P23, DOI 10.1016/j.yjmcc.2012.12.022; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Planelles-Herrero VJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00176-5; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Robert-Paganin J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06191-4; Rohde JA, 2017, P NATL ACAD SCI USA, V114, pE1796, DOI 10.1073/pnas.1611698114; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Swenson AM, 2017, J BIOL CHEM, V292, P3768, DOI 10.1074/jbc.M116.748780; Swenson AM, 2014, J BIOL CHEM, V289, P23977, DOI 10.1074/jbc.M114.562231; Teerlink JR, 2016, LANCET, V388, P2895, DOI 10.1016/S0140-6736(16)32049-9; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Ujfalusi Z, 2018, J BIOL CHEM, V293, P9017, DOI 10.1074/jbc.RA118.001938; Utter MS, 2015, J CARDIOVASC PHARM, V66, P347, DOI 10.1097/FJC.0000000000000286; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Winkelmann DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8974; Woody MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06193-2; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7	55	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17314	17325		10.1074/jbc.RA119.010217	http://dx.doi.org/10.1074/jbc.RA119.010217			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31578282	hybrid, Green Published			2022-12-26	WOS:000503173500013
J	Holland, CK; Westfall, CS; Schaffer, JE; De Santiago, A; Zubieta, C; Alvarez, S; Jez, JM				Holland, Cynthia K.; Westfall, Corey S.; Schaffer, Jason E.; De Santiago, Alejandro; Zubieta, Chloe; Alvarez, Sophie; Jez, Joseph M.			Brassicaceae-specific Gretchen Hagen 3 acyl acid amido synthetases conjugate amino acids to chorismate, a precursor of aromatic amino acids and salicylic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; enzyme; substrate specificity; X-ray crystallography; plant biochemistry	PLANT HORMONES; ISOCHORISMATE SYNTHASE; MAXIMUM-LIKELIHOOD; DEFENSE RESPONSES; ENZYME ACTION; GH3 FAMILY; ARABIDOPSIS; AUXIN; GENE; BIOSYNTHESIS	To modulate responses to developmental or environmental cues, plants use Gretchen Hagen 3 (GH3) acyl acid amido synthetases to conjugate an amino acid to a plant hormone, a reaction that regulates free hormone concentration and downstream responses. The model plant Arabidopsis thaliana has 19 GH3 proteins, of which 8 have confirmed biochemical functions. One Brassicaceae-specific clade of GH3 proteins was predicted to use benzoate as a substrate and includes AtGH3.7 and AtGH3.12/PBS3. Previously identified as a 4-hydroxybenzoic acid-glutamate synthetase, AtGH3.12/PBS3 influences pathogen defense responses through salicylic acid. Recent work has shown that AtGH3.12/PBS3 uses isochorismate as a substrate, forming an isochorismate-glutamate conjugate that converts into salicylic acid. Here, we show that AtGH3.7 and AtGH3.12/PBS3 can also conjugate chorismate to cysteine and glutamate, which act as precursors to aromatic amino acids and salicylic acid, respectively. The X-ray crystal structure of AtGH3.12/PBS3 in complex with AMP and chorismate at 1.94 ? resolution, along with site-directed mutagenesis, revealed how the active site potentially accommodates this substrate. Examination of Arabidopsis knockout lines indicated that the gh3.7 mutants do not alter growth and showed no increased susceptibility to the pathogen Pseudomonas syringae, unlike gh3.12 mutants, which were more susceptible than WT plants, as was the gh3.7/gh3.12 double mutant. The findings of our study suggest that GH3 proteins can use metabolic precursors of aromatic amino acids as substrates.	[Holland, Cynthia K.; Westfall, Corey S.; Schaffer, Jason E.; De Santiago, Alejandro; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zubieta, Chloe] Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, CNRS, INRA,IRIG,CEA, Grenoble, France; [Alvarez, Sophie] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA	Washington University (WUSTL); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Nebraska System; University of Nebraska Lincoln	Jez, JM (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	jjez@wustl.edu		Holland, Cynthia/0000-0001-6099-7998; De Santiago, Alejandro/0000-0001-9086-3050	National Science Foundation [DGE-1143954, MCB-1614539]; United States Department of Agriculture National Institute of Food and Agriculture predoctoral fellowship [MOW-2010-05240]; Howard Hughes Medical Institute Exceptional Research Opportunities Program	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture predoctoral fellowship; Howard Hughes Medical Institute Exceptional Research Opportunities Program	This work was supported by National Science Foundation Grant MCB-1614539 (to J. M. J.), National Science Foundation Graduate Research Fellowship Program Grant DGE-1143954 (to C. K. H.), United States Department of Agriculture National Institute of Food and Agriculture predoctoral fellowship MOW-2010-05240 (to C. S. W.), and the Howard Hughes Medical Institute Exceptional Research Opportunities Program (to A. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Colquhoun TA, 2010, PLANT J, V61, P145, DOI 10.1111/j.1365-313X.2009.04042.x; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Dean JV, 2004, PHYSIOL PLANTARUM, V120, P603, DOI 10.1111/j.0031-9317.2004.0263.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kroll K, 2017, BIOCHEM J, V474, P3705, DOI 10.1042/BCJ20170549; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Manandhar M, 2013, CHEM BIOL, V20, P1441, DOI 10.1016/j.chembiol.2013.10.010; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Rekhter D, 2019, SCIENCE, V365, P498, DOI 10.1126/science.aaw1720; Round A, 2013, ACTA CRYSTALLOGR D, V69, P2072, DOI 10.1107/S0907444913019276; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sherp AM, 2018, J BIOL CHEM, V293, P17731, DOI 10.1074/jbc.RA118.004975; Sherp AM, 2018, J BIOL CHEM, V293, P4277, DOI 10.1074/jbc.RA118.002006; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Warren RF, 1999, GENETICS, V152, P401; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Westfall CS, 2014, J BIOL CHEM, V289, P28619, DOI 10.1074/jbc.M114.591123; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3	48	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16855	16864		10.1074/jbc.RA119.009949	http://dx.doi.org/10.1074/jbc.RA119.009949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31575658	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000501801900031
J	Ruan, ZY; Zhao, D				Ruan, Zhengyi; Zhao, Dong			Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-kappa B1	FASEB JOURNAL			English	Article						mesoderm-specific transcript; proliferation; apoptosis; tumorigenicity	KAPPA-B; PROMOTES PROLIFERATION; EXPRESSION; INVASION; PROGRESSION; PEG1/MEST; GENE; OVEREXPRESSION; FIBROBLASTS; METASTASIS	Ovarian cancer (OC) is one of the major causes of cancer-related mortality in women worldwide. Long noncoding RNAs might play a role as oncogenes or tumor suppressors. Therefore, we investigated the effect and underlying mechanisms of long intergenic noncoding RNA (LINC00) 284 on angiogenesis in OC cells. Expression of LINC00284 in OC tissues and cells was determined. Next, the interaction between LINC00284 and mesoderm-specific transcript (MEST) was evaluated. Subsequently, OC cells were transfected with overexpressed (oe)-LINC00284, silenced (si)-LINC00284, si-NF-kappa B1, oe-MEST, or si-MEST plasmids to investigate the underlying mechanism of LINC00284 in OC. Afterwards, the expression of matrix metalloproteinase (MMP)-2, MMP-9, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated protein x (Bax), VEGF, and CD31 was determined to assess the effect of LINC00284 on OC cell proliferation, invasion, migration angiogenesis, and apoptosis. Finally, the effect of LINC00284 on tumorigenesis was investigated in nude mice models of OC. LINC00284 was highly expressed in OC. si-LINC00284 increased expression of MEST. si-LINC00284 or si-NF-kappa B1 led to the reduction in cell proliferation, migration, invasion, tube formation, angiogenesis, and tumorigenic ability and promoted apoptosis in OC by down-regulating MMP-2, MMP-9, Bcl-2, VEGF, and CD31 and up-regulating Bax. These effects were all reversed following the si-MEST. In vivo experiments found the same results, confirming the aforementioned findings. Taken together, LINC00284 is involved in angiogenesis during OC development by recruiting NF-kappa B1 and down-regulating MEST.-Ruan, Z., Zhao, D. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-kappa B1.	[Ruan, Zhengyi; Zhao, Dong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Obstet & Gynecol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Ruan, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Obstet & Gynecol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	hendryz@gmail.com	Ruan, Zhengyi/GZK-9467-2022		National Science Foundation of China [81771548]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge and appreciate their colleagues for their valuable efforts and comments on this article. This study was supported by the National Science Foundation of China (81771548). The authors declare no conflicts of interest.	An JH, 2017, ONCOTARGETS THER, V10, P5377, DOI 10.2147/OTT.S147586; Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Bamias A, 2012, CRIT REV ONCOL HEMAT, V84, P314, DOI 10.1016/j.critrevonc.2012.04.002; Cai H, 2017, ONCOGENE, V36, P318, DOI 10.1038/onc.2016.212; Chen Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0243-0; Cheng ZP, 2015, ONCOTARGET, V6, P25381, DOI 10.18632/oncotarget.4541; Dong R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.143; Dunagin M, 2015, METHODS MOL BIOL, V1262, P3, DOI 10.1007/978-1-4939-2253-6_1; Fu X, 2017, AM J TRANSL RES, V9, P4094; Gao Y, 2015, HUM MOL GENET, V24, P841, DOI 10.1093/hmg/ddu502; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge J, 2018, EUR REV MED PHARMACO, V22, P329, DOI 10.26355/eurrev_201801_14176; Giopanou I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/178410; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Huang SY, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0499-x; Huntriss JD, 2013, EUR J HUM GENET, V21, P40, DOI 10.1038/ejhg.2012.102; Huo ZH, 2013, GENET MOL RES, V12, P3435, DOI 10.4238/2013.March.11.6; Jin Y, 2017, EUR REV MED PHARMACO, V21, P3176; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kataoka H, 2009, YONAGO ACTA MED, V52, P85; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Kim T. H., 2018, COLD SPRING HARB PRO, V2018; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Kuang DF, 2016, EXP MOL PATHOL, V101, P267, DOI 10.1016/j.yexmp.2016.09.008; Lili LN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/846387; Liu EL, 2015, INT J CLIN EXP MED, V8, P20565; Lu ZL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0518-0; Lv Y, 2017, CANCER BIOTHER RADIO, V32, P91, DOI 10.1089/cbr.2017.2178; Ma X, 2017, AM J TRANSL RES, V9, P5012; Mao XH, 2017, IMMUNOLOGY, V150, P379, DOI 10.1111/imm.12698; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; Nakanishi H, 2004, ONCOL REP, V12, P1273; Pedersen IS, 1999, CANCER RES, V59, P5449; Peng WZ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0197-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Svalkauskiene Vilma, 2015, Stomatologija, V17, P3; Tee AE, 2016, ONCOTARGET, V7, P8663, DOI 10.18632/oncotarget.6675; Vidal AC, 2014, CLIN TRANSL ONCOL, V16, P266, DOI 10.1007/s12094-013-1067-4; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7; Xing C, 2018, CLIN LAB, V64, P1661, DOI 10.7754/Clin.Lab.2018.180419; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yang Fangfang, 2015, Eur J Pharmacol, V754, P105, DOI 10.1016/j.ejphar.2015.02.015; Yang ZF, 2010, J CELL PHYSIOL, V225, P266, DOI 10.1002/jcp.22261; Yildiz-Arslan S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.140327; Yu Y, 2015, ONCOL REP, V33, P1683, DOI 10.3892/or.2015.3755; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhang LQ, 2017, ANAL CELL PATHOL, V2017, P1, DOI 10.1155/2017/8267863; Zhao LJ, 2017, CANCER RES, V77, P1369, DOI 10.1158/0008-5472.CAN-16-1615; Zhao YJ, 2018, ONCOL REP, V39, P1197, DOI 10.3892/or.2018.6207; Zheng XG, 2013, CANCER LETT, V329, P146, DOI 10.1016/j.canlet.2012.10.026; Zhou JF, 2017, MOL MED REP, V16, P5235, DOI 10.3892/mmr.2017.7233; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181	54	23	23	4	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12047	12059		10.1096/fj.201900101RR	http://dx.doi.org/10.1096/fj.201900101RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31574234	Green Published, Bronze			2022-12-26	WOS:000507461600035
J	Kato, H; Takayama-Ito, M; Iizuka-Shiota, I; Fukushi, S; Posadas-Herrera, G; Horiya, M; Satoh, M; Yoshikawa, T; Yamada, S; Harada, S; Fujii, H; Shibamura, M; Inagaki, T; Morimoto, K; Saijo, M; Lim, CK				Kato, Hirofumi; Takayama-Ito, Mutsuyo; Iizuka-Shiota, Itoe; Fukushi, Shuetsu; Posadas-Herrera, Guillermo; Horiya, Madoka; Satoh, Masaaki; Yoshikawa, Tomoki; Yamada, Souichi; Harada, Shizuko; Fujii, Hikaru; Shibamura, Miho; Inagaki, Takuya; Morimoto, Kinjiro; Saijo, Masayuki; Lim, Chang-Kweng			Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; NEUTRALIZING ANTIBODY; SINGLE IMMUNIZATION; IMMUNE-RESPONSES; DROMEDARY CAMELS; TYPE-1 GAG; S-PROTEIN; GLYCOPROTEIN	Middle East respiratory syndrome-coronavirus (MERS-CoV) is an emerging virus that causes severe disease with fatal outcomes; however, there are currently no approved vaccines or specific treatments against MERS-CoV. Here, we developed a novel bivalent vaccine against MERS-CoV and rabies virus (RV) using the replication-incompetent P-gene deficient RV (RV Delta P), which has been previously established as a promising and safe viral vector. MERS-CoV spike glycoprotein comprises S1 and S2 subunits, with the S1 subunit being a primary target of neutralizing antibodies. Recombinant RV Delta P, which expresses S1 fused with transmembrane and cytoplasmic domains together with 14 amino acids from the ectodomains of the RV-glycoprotein (RV-G), was developed using a reverse genetics method and named RV Delta P-MERS/S1. Following generation of RV Delta P-MERS/S1 and RV Delta P, our analysis revealed that they shared similar growth properties, with the expression of S1 in RV Delta P-MERS/S1-infected cells confirmed by immunofluorescence and western blot, and the immunogenicity and pathogenicity evaluated using mouse infection experiments. We observed no rabies-associated signs or symptoms in mice inoculated with RV Delta P-MERS/S1. Moreover, virus-specific neutralizing antibodies against both MERS-CoV and RV were induced in mice inoculated intraperitoneally with RV Delta P-MERS/S1. These findings indicate that RV Delta P-MERS/S1 is a promising and safe bivalent-vaccine candidate against both MERS-CoV and RV.	[Kato, Hirofumi; Takayama-Ito, Mutsuyo; Iizuka-Shiota, Itoe; Fukushi, Shuetsu; Posadas-Herrera, Guillermo; Horiya, Madoka; Satoh, Masaaki; Yoshikawa, Tomoki; Yamada, Souichi; Harada, Shizuko; Fujii, Hikaru; Shibamura, Miho; Inagaki, Takuya; Saijo, Masayuki; Lim, Chang-Kweng] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo, Japan; [Inagaki, Takuya] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Morimoto, Kinjiro] Yasuda Womens Univ, Dept Pharm, Hiroshima, Japan	National Institute of Infectious Diseases (NIID); Waseda University	Takayama-Ito, M; Lim, CK (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo, Japan.	mutsuito@niid.go.jp; ck@niid.go.jp	Posadas-Herrera, Guillermo/AAG-3466-2021; Lim, Chang Kweng/AAA-7551-2021; Takayama-Ito, Mutsuyo/AAK-7971-2020	Posadas-Herrera, Guillermo/0000-0003-1622-8571; Lim, Chang Kweng/0000-0001-5823-8300; Takayama-Ito, Mutsuyo/0000-0002-3805-4165; Saijo, Masayuki/0000-0001-5458-7298	Ministry of Health, Labour and Welfare of Japan [H30-SinkogyouseiShitei-10109700]; Japan Agency for Medical Research and Development [18fk0108070j0101, 18fk0108072j0001]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan (H30-SinkogyouseiShitei-10109700) and by grants for the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [http://www.amed.go.jp/] under Grant Numbers 18fk0108070j0101 and 18fk0108072j0001. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-amri SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44875; Alharbi NK, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1917; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P77; Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11; Cenna J, 2009, J INFECT DIS, V200, P1251, DOI 10.1086/605949; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chenik M, 1998, J VIROL, V72, P1925, DOI 10.1128/JVI.72.3.1925-1930.1998; Chi H, 2017, VACCINE, V35, P2069, DOI 10.1016/j.vaccine.2017.02.063; Cho H, 2018, HUM VACC IMMUNOTHER, V14, P304, DOI 10.1080/21645515.2017.1389362; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; Dacheux Laurent, 2011, Infectious Disorders - Drug Targets, V11, P251; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Faber M, 2005, J GEN VIROL, V86, P1435, DOI 10.1099/vir.0.80844-0; Foley HD, 2000, P NATL ACAD SCI USA, V97, P14680, DOI 10.1073/pnas.011510698; Fukushi S, 2006, J MED VIROL, V78, P1509, DOI 10.1002/jmv.20732; Fukushi S, 2018, J VIROL METHODS, V251, P22, DOI 10.1016/j.jviromet.2017.10.008; Gomme EA, 2011, ADV VIRUS RES, V79, P139, DOI 10.1016/B978-0-12-387040-7.00009-3; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Guo XJ, 2015, IMMUNOLOGY, V145, P476, DOI 10.1111/imm.12462; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Ito N, 2005, MICROBIOL IMMUNOL, V49, P973, DOI 10.1111/j.1348-0421.2005.tb03692.x; Iwata-Yoshikawa N, 2014, J VIROL, V88, P8597, DOI 10.1128/JVI.00983-14; Kim E, 2014, VACCINE, V32, P5975, DOI 10.1016/j.vaccine.2014.08.058; Kim Yunhwan, 2016, Osong Public Health Res Perspect, V7, P49, DOI 10.1016/j.phrp.2016.01.001; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; KOPROWSKI H, 1954, J IMMUNOL, V72, P94; Kramer B, 2009, BIOLOGICALS, V37, P119, DOI 10.1016/j.biologicals.2009.01.001; Kramer B, 2010, Pharmeur Bio Sci Notes, V2010, P37; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li Y, 2015, CELL RES, V25, P1237, DOI 10.1038/cr.2015.113; Liu RQ, 2018, ANTIVIR RES, V150, P30, DOI 10.1016/j.antiviral.2017.12.007; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Luo TR, 1997, VIRUS RES, V51, P35, DOI 10.1016/S0168-1702(97)00080-4; Ma CQ, 2014, VACCINE, V32, P2100, DOI 10.1016/j.vaccine.2014.02.004; Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003; McGettigan JP, 2001, J VIROL, V75, P8724, DOI 10.1128/JVI.75.18.8724-8732.2001; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P7310, DOI 10.1073/pnas.93.14.7310; Mebatsion T, 1999, J VIROL, V73, P242, DOI 10.1128/JVI.73.1.242-250.1999; Modjarrad K, 2016, VACCINE, V34, P2982, DOI 10.1016/j.vaccine.2016.03.104; Morimoto K, 2005, VIRUS RES, V111, P61, DOI 10.1016/j.virusres.2005.03.011; Orciari LA, 2001, VACCINE, V19, P4511, DOI 10.1016/S0264-410X(01)00186-4; Papaneri AB, 2012, VIROLOGY, V434, P18, DOI 10.1016/j.virol.2012.07.020; Papaneri AB, 2012, VACCINE, V30, P6136, DOI 10.1016/j.vaccine.2012.07.073; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Schnell MJ, 1995, VIROLOGY, V214, P522, DOI 10.1006/viro.1995.0063; Schnell MJ, 2000, P NATL ACAD SCI USA, V97, P3544, DOI 10.1073/pnas.050589197; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Shirato K, 2015, JPN J INFECT DIS, V68, P256, DOI 10.7883/yoken.JJID.2015.094; Shoji Y, 2004, VIROLOGY, V318, P295, DOI 10.1016/j.virol.2003.10.001; Siler CA, 2002, VIROLOGY, V292, P24, DOI 10.1006/viro.2001.1212; Song F, 2013, J VIROL, V87, P11950, DOI 10.1128/JVI.01672-13; Takayama-Ito M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006398; Uyeki TM, 2016, EMERG INFECT DIS, V22; Wirblich C, 2017, J VIROL, V91, DOI 10.1128/JVI.02040-16; World Health Organization, 2018, Weekly Epidemiological Record, V93, P201; World Health Organization, MIDDL E RESP SYNDR C; Yu GM, 2017, J VET SCI, V18, P351, DOI [10.4142/jvs.2017.18.S1.351, 10.4142/jvs.2017.18.s1.351]; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	65	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223684	10.1371/journal.pone.0223684	http://dx.doi.org/10.1371/journal.pone.0223684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589656	Green Published, gold			2022-12-26	WOS:000532427300035
J	Nordberg, RC; Mellor, LF; Krause, AR; Donahue, HJ; Loboa, EG				Nordberg, Rachel C.; Mellor, Liliana F.; Krause, Andrew R.; Donahue, Henry J.; Loboa, Elizabeth G.			LRP receptors in chondrocytes are modulated by simulated microgravity and cyclic hydrostatic pressure	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CARTILAGE DEGRADATION; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; WNT; CHONDROGENESIS; SCLEROSTIN; EXPRESSION; INCREASES; CULTURE	Mechanical loading is essential for the maintenance of musculoskeletal homeostasis. Cartilage has been demonstrated to be highly mechanoresponsive, but the mechanisms by which chondrocytes respond to mechanical stimuli are not clearly understood. The goal of the study was to determine how LRP4, LRP5, and LRP6 within canonical Wnt-signaling are regulated in simulated microgravity and cyclic hydrostatic pressure, and to investigate the potential role of LRP 4/5/6 in cartilage degeneration. Rat chondrosacroma cell (RCS) pellets were stimulated using either cyclic hydrostatic pressure (1Hz, 7.5 MPa, 4hr/day) or simulated microgravity in a rotating wall vessel (RWV) bioreactor (11RPM, 24hr/day). LRP4/5/6 mRNA expression was assessed by RT-qPCR and LRP5 protein expression was determined by fluorescent immunostaining. To further evaluate our in vitro findings in vivo, mice were subjected to hindlimb suspension for 14 days and the femoral heads stained for LRP5 expression. We found that, in vitro, LRP4/5/6 mRNA expression is modulated in a time-dependent manner by mechanical stimulation. Additionally, LRP5 protein expression is upregulated in response to both simulated microgravity and cyclic hydrostatic pressure. LRP5 is also upregulated in vivo in the articular cartilage of hindlimb suspended mice. This is the first study to examine how LRP4/5/6, critical receptors within musculoskeletal biology, respond to mechanical stimulation. Further elucidation of this mechanism could provide significant clinical benefit for the identification of pharmaceutical targets for the maintenance of cartilage health.	[Nordberg, Rachel C.; Loboa, Elizabeth G.] Univ Missouri, Coll Engn, Columbia, MO 65211 USA; [Mellor, Liliana F.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Krause, Andrew R.] Vancouver Isl Univ, Sport Hlth & Phys Educ, Nanaimo, BC, Canada; [Donahue, Henry J.] Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA USA; [Donahue, Henry J.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA	University of Missouri System; University of Missouri Columbia; Centro Nacional de Investigaciones Oncologicas (CNIO); Vancouver Island University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Virginia Commonwealth University	Loboa, EG (corresponding author), Univ Missouri, Coll Engn, Columbia, MO 65211 USA.	egloboa@missouri.edu		Nordberg, Rachel/0000-0001-6047-6009	NC Space Grant Graduate Research Fellowship; UNC Summer Research Fellowship; National Space Biomedical Research Institute through NASA [NCC9-58]; NIH/NIBIB [1R03EB008790]; NIH/CTSA [550KR71418, 550KR61325]; NSF/CBET [1133427, 1702841]; William R. Kenan Institute for Engineering, Technology and Science	NC Space Grant Graduate Research Fellowship; UNC Summer Research Fellowship; National Space Biomedical Research Institute through NASA; NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH/CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NSF/CBET(National Science Foundation (NSF)); William R. Kenan Institute for Engineering, Technology and Science	This study was funded by an NC Space Grant Graduate Research Fellowship (RCN), UNC Summer Research Fellowship (RCN), the National Space Biomedical Research Institute through NASA NCC9-58 (LFM), NIH/NIBIB 1R03EB008790 (EGL), NIH/CTSA 550KR71418 (EGL), NIH/CTSA 550KR61325 (EGL), and NSF/CBET 1133427 and 1702841 (EGL), and the William R. Kenan Institute for Engineering, Technology and Science (EGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2017, DEVELOPMENT, V144, P2824, DOI 10.1242/dev.150680; Akhter MP, 2011, BIOMECH MODEL MECHAN, V10, P423, DOI 10.1007/s10237-010-0244-4; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Asai N, 2014, BIOCH BIOPHYS RES CO; Bader DL, 2011, ARTHRITIS, DOI 10.1155/2011/979032; Baker TL, 1997, IN VITRO CELL DEV-AN, V33, P358; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Brown RJ, 2011, PROTEOMICS, V11, P4660, DOI 10.1002/pmic.201100058; Chan BY, 2011, OSTEOARTHR CARTILAGE, V19, P874, DOI 10.1016/j.joca.2011.04.014; Cheleschi S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010133; Chen YW, 2001, MATRIX BIOL, V20, P589, DOI 10.1016/S0945-053X(01)00169-X; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435; Emin N, 2008, ARTIF CELL BLOOD SUB, V36, P123, DOI 10.1080/10731190801932116; Finger AR, 2007, TISSUE ENG, V13, P1151, DOI 10.1089/ten.2006.0290; Fioravanti A, 2007, CLIN EXP RHEUMATOL, V25, P690; Fioravanti A, 2010, INDIAN J MED RES, V132, P209; FREEMAN PM, 1994, J ORTHOPAED RES, V12, P311, DOI 10.1002/jor.1100120303; Frings-Meuthen P, 2013, J MUSCULOSKEL NEURON, V13, P45; Hanson AD, 2009, ANN BIOMED ENG, V37, P955, DOI 10.1007/s10439-009-9648-7; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Horisberger M, 2013, CLIN BIOMECH, V28, P536, DOI 10.1016/j.clinbiomech.2013.04.009; Jin L, 2013, SPINE J, V13, P235, DOI 10.1016/j.spinee.2012.01.022; Joiner DM, 2013, OSTEOARTHR CARTILAGE, V21, P1576, DOI 10.1016/j.joca.2013.05.019; Kang KS, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00246; Karamesinis K, 2017, J OROFAC ORTHOP, V78, P21, DOI 10.1007/s00056-016-0061-1; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Liphardt AM, 2009, OSTEOARTHR CARTILAGE, V17, P1598, DOI 10.1016/j.joca.2009.07.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodewyckx L, 2012, RHEUMATOLOGY, V51, P1973, DOI 10.1093/rheumatology/kes178; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; Manninen P, 2001, RHEUMATOLOGY, V40, P432, DOI 10.1093/rheumatology/40.4.432; Mayer-Wagner S, 2014, INT ORTHOP, V38, P2615, DOI 10.1007/s00264-014-2454-3; Mellor LF, 2017, AEROSP MED HUM PERF, V88, P377, DOI 10.3357/AMHP.4743.2017; Mellor LF, 2014, AVIAT SPACE ENVIR MD, V85, P798, DOI 10.3357/ASEM.3905.2014; Milstead JR, 2004, TECH PAPERS ISA, V449, P105; Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Moran Conor J, 2016, J Exp Orthop, V3, P1, DOI 10.1186/s40634-015-0037-x; Niu QN, 2016, INT J MOL MED, V37, P755, DOI 10.3892/ijmm.2016.2463; Ogawa R, 2014, TISSUE ENG A; Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]; Papathanasiou I, 2010, J ORTHOP RES, V28, P348, DOI 10.1002/jor.20993; Parkinson IH, 1990, J HISTOTECHNOL, P13; Praxenthaler H, 2018, BBA-MOL BASIS DIS, V1864, P851, DOI 10.1016/j.bbadis.2017.12.024; Puetzer J, 2013, TISSUE ENG PT A, V19, P299, DOI [10.1089/ten.tea.2012.0015, 10.1089/ten.TEA.2012.0015]; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; Sakai S, 2009, J ORTHOP RES, V27, P517, DOI 10.1002/jor.20566; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sharma L, 2007, ANN RHEUM DIS, V66, P141, DOI 10.1136/ard.2006.059931; Shin Y, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4466; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Stevens JW, 2013, CONNECT TISSUE RES, V54, P252, DOI 10.3109/03008207.2013.806913; Takahashi I, 2019, OSTEOARTHR CARTILAGE, V27, P1084, DOI 10.1016/j.joca.2019.03.001; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Usami Y, 2016, LAB INVEST, V96, P186, DOI 10.1038/labinvest.2015.142; Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259; Yingst S, 2009, J BIOMED MATER RES A, V90A, P247, DOI 10.1002/jbm.a.32078; Youssef AR, 2009, OSTEOARTHR CARTILAGE, V17, P1228, DOI 10.1016/j.joca.2009.03.017; Yu B, 2011, BIOCHEM BIOPH RES CO, V414, P412, DOI 10.1016/j.bbrc.2011.09.103	77	4	4	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223245	10.1371/journal.pone.0223245	http://dx.doi.org/10.1371/journal.pone.0223245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584963	Green Published, gold			2022-12-26	WOS:000532407600015
J	Zimba, C; Maman, S; Rosenberg, NE; Mutale, W; Mweemba, O; Dunda, W; Phanga, T; Chibwe, KF; Matenga, T; Freeborn, K; Schrubbe, L; Vwalika, B; Chi, BH				Zimba, Chifundo; Maman, Suzanne; Rosenberg, Nora E.; Mutale, Wilbroad; Mweemba, Oliver; Dunda, Wezzie; Phanga, Twambilile; Chibwe, Kasapo F.; Matenga, Tulani; Freeborn, Kellie; Schrubbe, Leah; Vwalika, Bellington; Chi, Benjamin H.			The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study	PLOS ONE			English	Article							WOMEN; PREVENTION; RISK; PREP; OUTCOMES; ACQUISITION; EXPERIENCES; ATTITUDES	High HIV incidence rates have been observed among pregnant and breastfeeding women in sub-Saharan Africa. Oral pre-exposure prophylaxis (PrEP) can effectively reduce HIV acquisition in women during these periods; however, understanding of its acceptability and feasibility in antenatal and postpartum populations remains limited. To address this gap, we conducted in-depth interviews with 90 study participants in Malawi and Zambia: 39 HIV-negative pregnant/breastfeeding women, 14 male partners, 19 healthcare workers, and 18 policymakers. Inductive and deductive approaches were used to identify themes related to PrEP. As a public health intervention, PrEP was not well-known among patients and health-care workers; however, when it was described to participants, most expressed positive views. Concerns about safety and adherence were raised, highlighting two critical areas for community outreach. The feasibility of introducing PrEP into antenatal services was also a concern, especially if introduced within already strained health systems. Support for PrEP varied among policymakers in Malawi and Zambia, reflecting the ongoing policy discussions in their respective countries. Implementing PrEP during the pregnancy and breastfeeding periods will require addressing barriers at the individual, facility, and policy levels. Multilevel approaches should be considered in the design of new PrEP programs for antenatal and postpartum populations.	[Zimba, Chifundo; Dunda, Wezzie; Phanga, Twambilile] Tidziwe Ctr, UNC Project Malawi, Lilongwe, Malawi; [Maman, Suzanne; Rosenberg, Nora E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Mutale, Wilbroad] Univ Zambia, Sch Publ Hlth, Dept Hlth Policy, Ridgeway Campus, Lusaka, Zambia; [Mweemba, Oliver; Chibwe, Kasapo F.; Matenga, Tulani] Univ Zambia, Sch Publ Hlth, Dept Hlth Promot & Educ, Ridgeway Campus, Lusaka, Zambia; [Freeborn, Kellie; Schrubbe, Leah; Chi, Benjamin H.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Vwalika, Bellington] Univ Zambia, Sch Med, Dept Obstet & Gynecol, Ridgeway Campus, Lusaka, Zambia	University of North Carolina; University of North Carolina Chapel Hill; University of Zambia; University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Zambia	Zimba, C (corresponding author), Tidziwe Ctr, UNC Project Malawi, Lilongwe, Malawi.	czimba@unclilongwe.org		Schrubbe, Leah/0000-0002-3039-7155; Rosenberg, Nora/0000-0002-9759-9966	National Institutes of Health [R01 AI131060, K24AI120796, R00MH104154, P30AI050410, D43 TW009340]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI131060, K24AI120796, P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH104154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work received funding from the following sources: National Institutes of Health, R01 AI131060, Associated author(s): BHC, WM https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health, K24AI120796, Associated author(s): BHC, https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health, R00MH104154, Associated author(s): NER, https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health, P30AI050410, Associated author(s): BHC, https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health, D43 TW009340, Associated author(s): BHC, CZ, and KF, https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ZAMBIA POPULATION BA; [Anonymous], MALAWI POPULATION BA; Auerbach J, 2012, J INT AIDS SOC, V15, P193; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Caceres CF, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21108; Caceres CF, 2015, J INT AIDS SOC, V18, P5, DOI [10.7448/IAS.18.4.19949, 10.7448/IAS.18.4.20527]; Chi BH, 2018, B WORLD HEALTH ORGAN, V96, P69, DOI 10.2471/BLT.17.200139; Claassen C, 2018, 22 INT AIDS C; Cowan FM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21101; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197143; Davies N, 2018, SEX HEALTH, V15, P501, DOI 10.1071/SH18067; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fowler N, 2014, J INT AIDS SOC, V17, P151, DOI 10.7448/IAS.17.4.19563; Fowler N, 2015, AIDS PATIENT CARE ST, V29, P33, DOI 10.1089/apc.2014.0210; Govender E, 2018, AIDS CARE, V30, P1311, DOI 10.1080/09540121.2018.1488027; [Health MMo Unit HA], 2011, MAL INT GUID CLIN MA; Health Mo, 2018, FIN COP REV NAT HIV; [Health ZMo Health Mo], 2018, ZAMB CONS GUID PREV; Heffron R, 2018, AIDS, V32, P1707, DOI 10.1097/QAD.0000000000001867; Joint United Nations Programme for HIV/AIDS, START FREE STAY FREE; Joint United Nations Programme on HIV/AIDS, FAST TRACK END AIDS; Keating MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039109; Krakower DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132398; MAXWELL JA, 1992, HARVARD EDUC REV, V62, P279, DOI 10.17763/haer.62.3.8323320856251826; MIOTTI P, 1994, AIDS RES HUM RETROV, V10, pS239; Mofenson LM, 2018, J INFECT DIS, V218, P1, DOI 10.1093/infdis/jiy118; Mofenson LM, 2017, AIDS, V31, P213, DOI 10.1097/QAD.0000000000001313; Mugo NR, 2014, JAMA-J AM MED ASSOC, V312, P362, DOI 10.1001/jama.2014.8735; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Pintye J, 2018, JAIDS-J ACQ IMM DEF, V79, P590, DOI 10.1097/QAI.0000000000001850; Pintye J, 2017, J INFECT DIS, V216, P1561, DOI 10.1093/infdis/jix542; Pintye J, 2017, JAIDS-J ACQ IMM DEF, V76, P259, DOI 10.1097/QAI.0000000000001516; Pintye J, 2017, CLIN INFECT DIS, V64, P751, DOI 10.1093/cid/ciw850; Price JT, 2016, JAIDS-J ACQ IMM DEF, V72, pS145, DOI 10.1097/QAI.0000000000001063; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Sandelowski M, 2000, RES NURSING HLTH, V23; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thomson KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI 10.1097/COH.0000000000000207; [UNAIDS] JUNPoHA, 2016, GLOB AIDS UPD; World Health Organization, 2015, GUID START ANT THER	43	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223487	10.1371/journal.pone.0223487	http://dx.doi.org/10.1371/journal.pone.0223487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584987	Green Published, gold			2022-12-26	WOS:000532407600040
J	Agrawal, U; Berde, CB; Cornelissen, L				Agrawal, Uday; Berde, Charles B.; Cornelissen, Laura			Electroencephalographic features of discontinuous activity in anesthetized infants and children	PLOS ONE			English	Article							BURST SUPPRESSION; POSTOPERATIVE DELIRIUM; CARDIAC-SURGERY; ANESTHESIA; DYNAMICS; MODEL	Background Discontinuous electroencephalographic activity in children is thought to reflect brain inactivation. Discontinuity has been observed in states of pathology, where it is predictive of adverse neurological outcome, as well as under general anesthesia. Though in preterm-infants discontinuity reflects normal brain development, less is known regarding its role in term children, particularly in the setting of general anesthesia. Here, we conduct a post-hoc exploratory analysis to investigate the spectral features of discontinuous activity in children under general anesthesia. Methods We previously recorded electroencephalography in children less than forty months of age under general anesthesia (n = 65). We characterized the relationship between age, anesthetic depth, and discontinuous activity, and used multitaper spectral methods to compare the power spectra of subjects with (n = 35) and without (n = 30) discontinuous activity. In the subjects with discontinuous activity, we examined the amplitude and power spectra associated with the discontinuities and analyzed how these variables varied with age. Results Cumulative time of discontinuity was associated with increased anesthetic depth and younger age. In particular, age-matched children with discontinuity received higher doses of propofol during induction as compared with children without discontinuity. In the tens of seconds preceding the onset of discontinuous activity, there was a decrease in high-frequency power in children four months and older that could be visually observed with spectrograms. During discontinuous activity, there were distinctive patterns of amplitude, spectral edge, and power in canonical frequency bands that varied with age. Notably, there was a decline in spectral edge in the seconds immediately following each discontinuity. Conclusion Discontinuous activity in children reflects a state of a younger or more deeply anesthetized brain, and characteristic features of discontinuous activity evolve with age and may reflect neurodevelopment.	[Agrawal, Uday; Berde, Charles B.; Cornelissen, Laura] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Cornelissen, L (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.	laura.cornelissen@childrens.harvard.edu		Cornelissen, Laura/0000-0001-8579-0870; Agrawal, Uday/0000-0003-3899-316X	Harvard Medical School Scholars in Medicine Office; HarvardMIT Division of Health Sciences Technology; Anesthesia Research Trailblazer Award, Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital; International Anesthesia Research Society; Sara Page Mayo Endowment for Pediatric Pain Research Treatment	Harvard Medical School Scholars in Medicine Office; HarvardMIT Division of Health Sciences Technology; Anesthesia Research Trailblazer Award, Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital; International Anesthesia Research Society; Sara Page Mayo Endowment for Pediatric Pain Research Treatment	U.A. was funded by Harvard Medical School Scholars in Medicine Office and HarvardMIT Division of Health Sciences & Technology (https://hst.mit.edu); L.C. was supported by Anesthesia Research Trailblazer Award, Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital (https://on.bchil.org/2PfcPFY); International Anesthesia Research Society (http://iars.org).C.B.B.was supported by Sara Page Mayo Endowment for Pediatric Pain Research & Treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Pre-operative and Operating Room staff at Boston Children's Hospital for their assistance during these studies, as well as the families who took part in the study. We also thank Dr. Ann-Marie Bergin for reviewing all EEG recordings for potential incidental findings.	Akeju O, 2015, BRIT J ANAESTH, V115, P66, DOI 10.1093/bja/aev114; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Chalia M, 2016, NEUROPHOTONICS, V3, DOI DOI 10.1117/1.NPH.3.3.031408; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; Chang PS, 2016, ANESTHESIOLOGY, V124, P885, DOI 10.1097/ALN.0000000000001017; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Chini M, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00038; Cornelissen L, 2018, BRIT J ANAESTH, DOI [10.1101/165902, DOI 10.1101/165902]; Cornelissen L, 2018, EUR J ANAESTH, V35, P49, DOI 10.1097/EJA.0000000000000739; Cornelissen L, 2017, PEDIATR ANESTH, V27, P251, DOI 10.1111/pan.13061; Cornelissen L, 2015, ELIFE, V4, DOI 10.7554/eLife.06513; Davidson A, 2019, CURR OPIN ANESTHESIO, V32, P370, DOI 10.1097/ACO.0000000000000732; Davidson AJ, 2008, PEDIATR ANESTH, V18, P60, DOI 10.1111/j.1460-9592.2007.02359.x; Fleischmann A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00368; Hayashi K, 2012, NEUROSCI LETT, V517, P87, DOI 10.1016/j.neulet.2012.04.028; Hendrikx D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00065; Hesse S, 2019, BRIT J ANAESTH, V122, P622, DOI 10.1016/j.bja.2018.09.016; Iyer KK, 2014, ANN CLIN TRANSL NEUR, V1, P209, DOI 10.1002/acn3.32; Japaridze N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123807; Kenny JD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00237; Kirch C, 2011, ANN STAT, V39, P1427, DOI 10.1214/10-AOS868; Lee JM, 2017, ANESTHESIOLOGY, V127, P293, DOI 10.1097/ALN.0000000000001717; Lewis LD, 2013, BRAIN, V136, P2727, DOI 10.1093/brain/awt174; Liu SS, 2017, J MATH BIOL, V74, P1011, DOI 10.1007/s00285-016-1048-7; Menache CC, 2002, PEDIATR NEUROL, V27, P93, DOI 10.1016/S0887-8994(02)00396-X; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Seltzer L, 2016, J THORAC CARDIOV SUR, V151, P1137, DOI 10.1016/j.jtcvs.2015.10.065; Soehle M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0051-7; Sonkajarvi E, 2009, ACTA ANAESTH SCAND, V53, P77, DOI 10.1111/j.1399-6576.2008.01725.x; Stolwijk LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183581; Sury MRJ, 2014, BRIT J ANAESTH, V112, P686, DOI 10.1093/bja/aet409; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tsuchida TN, 2013, J CLIN NEUROPHYSIOL, V30, P161, DOI 10.1097/WNP.0b013e3182872b24; Vasung L, 2019, NEUROIMAGE, V187, P226, DOI 10.1016/j.neuroimage.2018.07.041; Volpe J.J., 2008, NEUROLOGY NEWBORN; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Walsh EC, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00023; Yuan I, 2019, PEDIATR ANESTH, V29, P243, DOI 10.1111/pan.13589; Zehendner CM, 2013, PLOS ONE, P8, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]	39	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223324	10.1371/journal.pone.0223324	http://dx.doi.org/10.1371/journal.pone.0223324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581269	gold, Green Published			2022-12-26	WOS:000532398600054
J	Eijgelaar, R; Hamer, PCD; Peeters, CFW; Barkhof, F; van Herk, M; Witte, MG				Eijgelaar, Roelant; Hamer, Philip C. De Witt; Peeters, Carel F. W.; Barkhof, Frederik; van Herk, Marcel; Witte, Marnix G.			Voxelwise statistical methods to localize practice variation in brain tumor surgery	PLOS ONE			English	Article							TRUE NULL HYPOTHESES; FALSE DISCOVERY RATE	Purpose During resections of brain tumors, neurosurgeons have to weigh the risk between residual tumor and damage to brain functions. Different perspectives on these risks result in practice variation. We present statistical methods to localize differences in extent of resection between institutions which should enable to reveal brain regions affected by such practice variation. Methods Synthetic data were generated by simulating spheres for brain, tumors, resection cavities, and an effect region in which a likelihood of surgical avoidance could be varied between institutions. Three statistical methods were investigated: a non-parametric permutation based approach, Fisher's exact test, and a full Bayesian Markov chain Monte Carlo (MCMC) model. For all three methods the false discovery rate (FDR) was determined as a function of the cut-off value for the q-value or the highest density interval, and receiver operating characteristic and precision recall curves were created. Sensitivity to variations in the parameters of the synthetic model were investigated. Finally, all these methods were applied to retrospectively collected data of 77 brain tumor resections in two academic hospitals. Results Fisher's method provided an accurate estimation of observed FDR in the synthetic data, whereas the permutation approach was too liberal and underestimated FDR. AUC values were similar for Fisher and Bayes methods, and superior to the permutation approach. Fisher's method deteriorated and became too liberal for reduced tumor size, a smaller size of the effect region, a lower overall extent of resection, fewer patients per cohort, and a smaller discrepancy in surgical avoidance probabilities between the different surgical practices. In the retrospective patient data, all three methods identified a similar effect region, with lower estimated FDR in Fisher's method than using the permutation method. Conclusions Differences in surgical practice may be detected using voxel statistics. Fisher's test provides a fast method to localize differences but could underestimate true FDR. Bayesian MCMC is more flexible and easily extendable, and leads to similar results, but at increased computational cost.	[Eijgelaar, Roelant; Witte, Marnix G.] Netherlands Canc Inst, Cluster Radiat Oncol, Amsterdam, Netherlands; [Hamer, Philip C. De Witt] Univ Amsterdam, Neurosurg Ctr Amsterdam, Brain Tumor Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands; [Peeters, Carel F. W.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Med Ctr,VUmc, Amsterdam, Netherlands; [Barkhof, Frederik] Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, VUmc, Amsterdam, Netherlands; [Barkhof, Frederik] UCL, Inst Neurol, London, England; [Barkhof, Frederik] UCL, Inst Healthcare Engn, London, England; [van Herk, Marcel] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Canc Res Ctr,Div Canc Sci,Sch Med Sci, Manchester, Lancs, England	Netherlands Cancer Institute; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of London; University College London; University of London; University College London; University of Manchester	Witte, MG (corresponding author), Netherlands Canc Inst, Cluster Radiat Oncol, Amsterdam, Netherlands.	m.witte@nki.nl	; van Herk, Marcel/P-6307-2015	Barkhof, Frederik/0000-0003-3543-3706; van Herk, Marcel/0000-0001-6448-898X; Peeters, Carel/0000-0001-5766-9969	Netherlands Organization for Scientific Research (NWO) [10-10400-96-14003]; NIHR Biomedical Research Centre at UCLH; NIHR Biomedical Research Centre in Manchester	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIHR Biomedical Research Centre at UCLH; NIHR Biomedical Research Centre in Manchester	This research is part of the program Innovative Medical Devices Initiative with project number 10-10400-96-14003, which is financed by the Netherlands Organization for Scientific Research (NWO). FB is supported by the NIHR Biomedical Research Centre at UCLH. MH is supported by the NIHR Biomedical Research Centre in Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is part of the program Innovative Medical Devices Initiative with project number 10-10400-96-14003, which is financed by the Netherlands Organization for Scientific Research (NWO). FB is supported by the NIHR Biomedical Research Centre at UCLH. MH is supported by the NIHR Biomedical Research Centre in Manchester.	Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benjamini Y, 2007, J AM STAT ASSOC, V102, P1272, DOI 10.1198/016214507000000941; Betancourt M., 2015, CURRENT TRENDS BAYES; Carlson J, 2009, ESTIMATING FALSE DIS, P1; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chen R, 2010, NEUROIMAGE, V49, P597, DOI 10.1016/j.neuroimage.2009.07.061; Dialsingh I, 2015, BIOINFORMATICS, V31, P2303, DOI 10.1093/bioinformatics/btv104; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Gilbert PB, 2005, J R STAT SOC C-APPL, V54, P143, DOI 10.1111/j.1467-9876.2005.00475.x; Hamer PCD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073353; Kruschke J.K., 2015, OXFORD HDB COMPUTATI, P279; Muller DMJ, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00089; Nettleton D, 2006, J AGR BIOL ENVIR ST, V11, P337, DOI 10.1198/108571106X129135; Nichols T., 2004, HUM BRAIN MAPP, V15, P887, DOI [10.1016/B978-012264841-0/50048-2, DOI 10.1016/B978-012264841-0/50048-2]; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Visser M, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101727	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222939	10.1371/journal.pone.0222939	http://dx.doi.org/10.1371/journal.pone.0222939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560705	Green Published, gold			2022-12-26	WOS:000532353700024
J	Ryu, S; Lee, JM; Bae, CA; Moon, CE; Cho, KO				Ryu, Sun; Lee, Jae-Min; Bae, Cheong A.; Moon, Chae-Eun; Cho, Kyung-Ok			Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke	PLOS ONE			English	Article							MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA; RAT-BRAIN; UP-REGULATION; NEUROLOGICAL DEFICITS; FUNCTIONAL RECOVERY; EXPRESSION; RECEPTOR; INJURY; ERBB4	Adipose-derived mesenchymal stem cells (AdMSCs) have been reported to ameliorate neurological deficits after acute ischemic stroke. As neuregulin 1 (NRG1, or heregulin 1), a growth factor with versatile functions in the central nervous system, has demonstrated protective effects against ischemic brain injuries, we have generated NRG1-overexpressing AdMSCs in order to investigate whether NRG1-AdMSCs could enhance therapeutic benefits of AdMSCs in ischemic stroke. After AdMSCs were infected with adenoviral NRG1, increased NRG1 secretion in NRG1-AdMSCs was confirmed with ELISA. At 1 d after ischemic stroke that was induced by the occlusion of middle cerebral artery (MCAo) for 60 min in Sprague Dawley (SD) rats, adenoviral NRG1, AdMSCs, NRG1-AdMSCs, or PBS were injected into the striatum and serial neurologic examinations were performed. Administration of NRG1-AdMSCs resulted in significant improvement of functional outcome following stroke compared to AdMSCs- or adenoviral NRG1-treated group, in addition to the reduction in the infarct size evaluated by hematoxylin and eosin staining. When NRG1 expression in the brain was examined by double immunofluorescence to human nuclei (HuNu)/NRG1 and ELISA, NRG1-AdMSCs demonstrated marked increase in NRG1 expression. Moreover, western blot analysis further showed that transplantation of NRG1-AdMSCs significantly increased both endogenous and adenoviral NRG1 expression compared to AdMSCstreated group. To elucidate molecular mechanisms, NRG1-associated downstream molecules were evaluated by western blot analysis. Expression of ErbB4, a receptor for NRG1, was markedly increased by NRG1-AdMSCs administration, in addition to pMAPK and pAkt, crucial molecules of NRG1-ErbB4 signaling. Taken together, our data suggest that NRG1AdMSCs can provide excellent therapeutic potential in ischemic stroke by activating NRG1ErbB4 signaling network.	[Ryu, Sun; Lee, Jae-Min; Bae, Cheong A.; Moon, Chae-Eun; Cho, Kyung-Ok] Catholic Univ Korea, Coll Med, Dept Pharmacol, Seoul, South Korea; [Lee, Jae-Min; Bae, Cheong A.; Cho, Kyung-Ok] Catholic Univ Korea, Catholic Neurosci Inst, Coll Med, Seoul, South Korea; [Cho, Kyung-Ok] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Cho, Kyung-Ok] Catholic Univ Korea, Coll Med, Inst Aging & Metab Dis, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Cho, KO (corresponding author), Catholic Univ Korea, Coll Med, Dept Pharmacol, Seoul, South Korea.; Cho, KO (corresponding author), Catholic Univ Korea, Catholic Neurosci Inst, Coll Med, Seoul, South Korea.; Cho, KO (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.; Cho, KO (corresponding author), Catholic Univ Korea, Coll Med, Inst Aging & Metab Dis, Seoul, South Korea.	kocho@catholic.ac.kr		Cho, Kyung-Ok/0000-0002-1314-7584	Ministry of Food and Drug Safety [14172MFDS974]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HI15C2854]; National Research Foundation of Korea (NRF) - Korean government [NRF-2019R1A2C1003958]; Catholic Medical Center Research Foundation	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Korean government; Catholic Medical Center Research Foundation	This work was supported by a grant (14172MFDS974) from Ministry of Food and Drug Safety in 2016, the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare (HI15C2854), National Research Foundation of Korea (NRF) grants funded by the Korean government (NRF-2019R1A2C1003958), and the Catholic Medical Center Research Foundation made in the program year of 2019 (awarded to KOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2012, CELL MED, V4, P65, DOI 10.3727/215517912X647172; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cannella B, 1999, J NEUROIMMUNOL, V100, P233, DOI 10.1016/S0165-5728(99)00201-5; Castillo Marianne, 2007, Int J Biomed Sci, V3, P76; Chan TM, 2014, CELL TRANSPLANT, V23, P541, DOI 10.3727/096368914X678409; Chang KA, 2014, J PHARMACOL SCI, V126, P293, DOI 10.1254/jphs.14R10CP; Chen B, 2016, TURK NEUROSURG, V26, P8, DOI 10.5137/1019-5149.JTN.11488-14.3; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; De Luca A, 2014, ONCOTARGET, V5, P10518; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Guan YF, 2015, NEUROSCIENCE, V307, P151, DOI 10.1016/j.neuroscience.2015.08.047; Guo WP, 2006, BRAIN RES, V1087, P180, DOI 10.1016/j.brainres.2006.03.007; Gutierrez-Fernandez M, 2015, EXPERT OPIN BIOL TH, V15, P873, DOI 10.1517/14712598.2015.1040386; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Iwakura Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00004; Jeong CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129145; Joung I, 2010, MOL CELLS, V30, P477, DOI 10.1007/s10059-010-0137-5; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kim HG, 2013, J NEUROCHEM, V124, P502, DOI 10.1111/jnc.12109; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lai TB, 2012, J HUAZHONG U SCI-MED, V32, P724, DOI 10.1007/s11596-012-1025-3; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Lim H, 2018, INT NEUROUROL J, V22, pS131, DOI 10.5213/inj.1836220.110; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000290907.30814.42; Mu JW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00235; Napoli E, 2016, TRANSL STROKE RES, V7, P452, DOI 10.1007/s12975-016-0490-6; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567; Parker MW, 2002, NEUROSCI LETT, V334, P169, DOI 10.1016/S0304-3940(02)01126-6; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ryu S, 2016, NEURAL REGEN RES, V11, P298, DOI 10.4103/1673-5374.177739; Shyu WC, 2004, NEUROBIOL AGING, V25, P935, DOI 10.1016/j.neurobiolaging.2003.10.012; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; Tokita Y, 2001, J NEUROSCI, V21, P1257; Wang SL, 2015, J NEUROL SCI, V357, P28, DOI 10.1016/j.jns.2015.06.055; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Xu ZF, 2005, NEUROSCI LETT, V375, P181, DOI 10.1016/j.neulet.2004.11.039; Yang Z, 2016, MOL MED REP, V14, P790, DOI 10.3892/mmr.2016.5325; Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150	57	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222587	10.1371/journal.pone.0222587	http://dx.doi.org/10.1371/journal.pone.0222587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560696	Green Published, gold, Green Submitted			2022-12-26	WOS:000532353700015
J	Ruan, Y; Zhang, Q; Li, JJ; Wan, R; Bai, J; Wang, WZ; Zhou, YT; Wan, QQ; Zhao, J; Yu, SY; Peng, M; Liu, ZT				Ruan, Yuan; Zhang, Qiang; Li, Juanjuan; Wan, Rong; Bai, Jun; Wang, Wenzhong; Zhou, Yutong; Wan, Qingqing; Zhao, Jiang; Yu, Siyang; Peng, Min; Liu, Zhitao			Factors associated with exclusive breastfeeding: A cross-sectional survey in Kaiyuan, Yunnan, Southwest China	PLOS ONE			English	Article							INFECTIOUS-DISEASES; CHILD; INTELLIGENCE; INITIATION; MORTALITY; INFANCY; MOTHERS; RATES; RISK	Breastfeeding has a wide range of benefits for both infants and mothers. The identification of factors associated with exclusive breastfeeding (EBF) are important to increase the prevalence of EBF. The study aimed to determine the prevalence of EBF within the first six months and its associated factors in Kaiyuan, Yunnan Province, Southwest China. This cross-sectional study was conducted in Kaiyuan, a middle-sized city of Yunnan Province, Southwest China. Mothers of infants under twelve months were randomly selected for a face to face interview in four towns (two in urban areas and two in rural areas) in Kaiyuan. A structured questionnaire was applied for collection of sociodemographic information, mothers' and infants' health, and breastfeeding information. A 24-hour food recall survey was used to collect infant feeding information. A logistic regression analysis was performed to identify the factors independently associated with exclusive breastfeeding for infants up to six months of age. The number of 417 mothers with infants under six months was interviewed. The prevalence of EBF at six months was 27.34%. Logistic regression indicated that EBF within six months was more likely to be practiced by mothers who had higher average household income per year (OR = 2.09, 95% CI: 1.05-4.17 p = 0.037; OR = 1.85, 95% CI: 1.04-3.28 p = 0.037), and mothers who received breastfeeding information (OR = 2.46, (95%CI: 1.45-4.18, p = 0.0009). The prevalence of EBF in Kaiyuan, Southwest China is considerably lower than national and international recommendations. Yearly household income, and mothers who received breastfeeding information are associated with higher EBF prevalence. Breastfeeding information should be given to mothers in order to increase the prevalence of EBF.	[Ruan, Yuan; Zhang, Qiang; Li, Juanjuan; Wan, Rong; Wan, Qingqing; Zhao, Jiang; Yu, Siyang; Peng, Min; Liu, Zhitao] Yunnan Ctr Dis Control & Prevent CDC, Dept Nutr & Food Hyg, Kunming, Yunnan, Peoples R China; [Bai, Jun; Wang, Wenzhong; Zhou, Yutong] Kaiyuan Ctr Dis Control & Prevent CDC, Dept Publ Hlth, Honghe, Yunnan, Peoples R China		Liu, ZT (corresponding author), Yunnan Ctr Dis Control & Prevent CDC, Dept Nutr & Food Hyg, Kunming, Yunnan, Peoples R China.	yncdcyy@163.com		Ruan, Yuan/0000-0002-0118-1603	National Institute for Nutrition and Health, China National CDC	National Institute for Nutrition and Health, China National CDC	The authors received the funding from National Institute for Nutrition and Health, China National CDC.	Acharya P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2405-y; Al-Sahab B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-20; Amin T, 2011, BREASTFEED MED, V6, P59, DOI 10.1089/bfm.2010.0018; Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028; Azzeh FS, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5010008; Balogun OO, 2016, MATERN CHILD HLTH J, V20, P363, DOI 10.1007/s10995-015-1835-6; Chen TL, 2011, J HUM LACT, V27, P41, DOI 10.1177/0890334410376519; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; Colombo L, 2018, NUTRIENTS, P10; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Guo SF, 2013, B WORLD HEALTH ORGAN, V91, P322, DOI 10.2471/BLT.12.111310; Hauck YL, 2011, MATERN CHILD HLTH J, V15, P260, DOI 10.1007/s10995-009-0554-2; Hawkins SS, 2015, PUBLIC HEALTH NUTR, V18, P189, DOI 10.1017/S1368980014000238; Hector Debra, 2005, N S W Public Health Bull, V16, P52; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Jama NA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0135-8; Jessri M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-77; Kaneko A, 2006, J EPIDEMIOL, V16, P57, DOI 10.2188/jea.16.57; Kang NM, 2015, J KOREAN ACAD NURS, V45, P449, DOI 10.4040/jkan.2015.45.3.449; Khanal V, 2015, INT J ENV RES PUB HE, V12, P9562, DOI 10.3390/ijerph120809562; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Kristiansen AL, 2010, PUBLIC HEALTH NUTR, V13, P2087, DOI 10.1017/S1368980010002156; Lamberti LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S18; Mirkovic KR, 2014, J HUM LACT, V30, P416, DOI 10.1177/0890334414543522; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Saffari M, 2017, HEALTH PROMOT PERSPE, V7, P34, DOI 10.15171/hpp.2017.07; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; WHO, IND ASS INF YOUNG CH; World Health Organization, ESS NUTR ACT IMPR MA; World Health Organization, BAB MOTH WORLDW FAIL; World Health Organization, WHAT AG CAN BAB STAY	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223251	10.1371/journal.pone.0223251	http://dx.doi.org/10.1371/journal.pone.0223251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596897	Green Published, gold			2022-12-26	WOS:000532444100028
J	Alvarez-Varas, R; Veliz, D; Velez-Rubio, GM; Fallabrino, A; Zarate, P; Heidemeyer, M; Godoy, DA; Benitez, HA				Alvarez-Varas, Rocio; Veliz, David; Velez-Rubio, Gabriela M.; Fallabrino, Alejandro; Zarate, Patricia; Heidemeyer, Maike; Godoy, Daniel A.; Benitez, Hugo A.			Identifying genetic lineages through shape: An example in a cosmopolitan marine turtle species using geometric morphometrics	PLOS ONE			English	Article							CHELONIA-MYDAS; GREEN TURTLE; POPULATION-STRUCTURE; CARETTA-CARETTA; SHELL SHAPE; SKULL MORPHOLOGY; PHYLOGEOGRAPHY; CONSERVATION; PACIFIC; DIMORPHISM	The green turtle (Chelonia mydas) is a globally distributed marine species whose evolutionary history has been molded by geological events and oceanographic and climate changes. Divergence between Atlantic and Pacific clades has been associated with the uplift of the Panama Isthmus, and inside the Pacific region, a biogeographic barrier located west of Hawaii has restricted the gene flow between Central/Eastern and Western Pacific populations. We investigated the carapace shape of C. mydas from individuals of Atlantic, Eastern Pacific, and Western Pacific genetic lineages using geometric morphometrics to evaluate congruence between external morphology and species' phylogeography. Furthermore, we assessed the variation of carapace shape according to foraging grounds. Three morphologically distinctive groups were observed which aligned with predictions based on the species' lineages, suggesting a substantial genetic influence on carapace shape. Based on the relationship between this trait and genetic lineages, we propose the existence of at least three distinct morphotypes of C. mydas. Well-defined groups in some foraging grounds (Galapagos, Costa Rica and New Zealand) may suggest that ecological or environmental conditions in these sites could also be influencing carapace shape in C. mydas. Geometric morphometrics is a suitable tool to differentiate genetic lineages in this cosmopolitan marine species. Consequently, this study opens new possibilities to explore and test ecological and evolutionary hypotheses in species with wide morphological variation and broad geographic distribution range.	[Alvarez-Varas, Rocio; Veliz, David] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Alvarez-Varas, Rocio; Veliz, David] Univ Catolica Norte, Dept Biol Marina, Nucleo Milenio Ecol & Manejo Sustentable Isl Ocea, ESMOI, Coquimbo, Chile; [Velez-Rubio, Gabriela M.; Fallabrino, Alejandro] Karumbe NGO, Montevideo, Uruguay; [Velez-Rubio, Gabriela M.] Univ Republ, CURE, Rocha, Uruguay; [Zarate, Patricia] Inst Fomento Pesquero, Dept Oceanog & Medio Ambiente, Valparaiso, Chile; [Heidemeyer, Maike] Univ Costa Rica, CIBCM, San Jose, Costa Rica; [Heidemeyer, Maike] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, CIMAR, San Jose, Costa Rica; [Heidemeyer, Maike] Asociac Conservac Integral Recursos Nat Equipo To, ETC, La Cruz, Guanacaste, Costa Rica; [Godoy, Daniel A.] Massey Univ, Inst Nat & Math Sci, Coastal Marine Res Grp, Auckland, New Zealand; [Benitez, Hugo A.] Univ Tarapaca, Fac Ciencias, Dept Biol, Arica, Chile	Universidad de Chile; Universidad Catolica del Norte; Universidad de la Republica, Uruguay; Instituto de Fomento Pesquero (Valparaiso); Universidad Costa Rica; Universidad Costa Rica; Massey University; Universidad de Tarapaca	Benitez, HA (corresponding author), Univ Tarapaca, Fac Ciencias, Dept Biol, Arica, Chile.	hbenitez@uta.cl	Véliz, David/J-4205-2013	Véliz, David/0000-0002-5768-9887; Benitez, Hugo/0000-0001-7553-9893; Zarate Bustamante, Patricia/0000-0002-9236-6936; Velez-Rubio, Gabriela M/0000-0002-6033-0920	Vice-Rectory of Research of the University of Costa Rica through the Integral Network of Marine Turtles in the Eastern Pacific (RITMA); Leatherback Trust; Veritas University; Surfari del Mar; Centro de Rescate de Especies Marinas Amenazadas (CREMA); National Marine Fisheries Service; Turner Foundation; National Oceanic and Atmospheric Administration (NOAA); Rufford Small Grant; Idea Wild; Chilean Government Environmental Protection Fund (FPA); Institute of Natural and Mathematical Sciences, Massey University, Auckland	Vice-Rectory of Research of the University of Costa Rica through the Integral Network of Marine Turtles in the Eastern Pacific (RITMA); Leatherback Trust; Veritas University; Surfari del Mar; Centro de Rescate de Especies Marinas Amenazadas (CREMA); National Marine Fisheries Service; Turner Foundation; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Rufford Small Grant; Idea Wild; Chilean Government Environmental Protection Fund (FPA); Institute of Natural and Mathematical Sciences, Massey University, Auckland	Financial support for this study was provided by the Vice-Rectory of Research of the University of Costa Rica through the Integral Network of Marine Turtles in the Eastern Pacific (RITMA), The Leatherback Trust, Veritas University, Surfari del Mar, Centro de Rescate de Especies Marinas Amenazadas (CREMA), National Marine Fisheries Service and the Turner Foundation, the National Oceanic and Atmospheric Administration (NOAA), Rufford Small Grant, Idea Wild, Chilean Government Environmental Protection Fund (FPA), and the Institute of Natural and Mathematical Sciences, Massey University, Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic analyses were performed at the Centro de Investigacion en Biologia Celular y Molecular (CIBCM) of the University of Costa Rica (San Jose, Costa Rica); at the Molecular Genetics Laboratory from the South West Fisheries Science Center (NOAA-NMFS; La Jolla, San Diego, California, US) by Dr. Peter Dutton and his team; Laboratorio de Biodiversidad Molecular, Pontificia Universidad Catolica de Chile (Santiago, Chile); and the Griffith School of Environment, Griffith University with assistance from N. FitzSimmons (Brisbane, Australia).	Abreu-Grobois FA, 2006, P 26 ANN S SEA TURTL, P179; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Alvarez-Varas R, 2017, LAT AM J AQUAT RES, V45, P540, DOI 10.3856/vol45-issue3-fulltext-4; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Baums IB, 2012, MOL ECOL, V21, P5418, DOI 10.1111/j.1365-294X.2012.05733.x; Benson Scott R., 2012, P88; Bonnet X, 2001, BIOL J LINN SOC, V72, P357, DOI 10.1006/bijl.2000.0504; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Caraccio MN, 2008, THESIS; Casale P, 2017, AMPHIBIA-REPTILIA, V38, P145, DOI 10.1163/15685381-00003096; Chaves JA, 2017, ENDANGER SPECIES RES, V32, P251, DOI 10.3354/esr00809; Chiari Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15787-7; Chiari Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006272; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Duchene S, 2012, MOL PHYLOGENET EVOL, V65, P241, DOI 10.1016/j.ympev.2012.06.010; Dutton PH, 2014, ECOL EVOL, V4, P4317, DOI 10.1002/ece3.1269; Dutton Peter H., 2008, Endangered Species Research, V5, P37, DOI 10.3354/esr00101; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Encalada SE, 1996, MOL ECOL, V5, P473; Ferreira PD, 2011, BRAZ J BIOL, V71, P151, DOI 10.1590/S1519-69842011000100022; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; FRAZIER J, 1971, PHILOS T ROY SOC B, V260, P373, DOI 10.1098/rstb.1971.0019; Gaubert P, 2005, BIOL J LINN SOC, V86, P11, DOI 10.1111/j.1095-8312.2005.00518.x; Godoy DA, 2016, NEW ZEAL J MAR FRESH, V50, P549, DOI 10.1080/00288330.2016.1182034; Godoy DA., 2016, THESIS; Groombridge B., 1989, GREEN TURTLE HAWKSBI; Heidemeyer M., 2014, CTR AM REV BIOL TROP, V62, P109, DOI DOI 10.15517/RBT.V62I4.20037; Jensen MP, 2013, CRC MAR BIOL SER, P135; Juarez J.A., 2003, NOAA TECHNICAL MEMOR, P70; KAMEZAKI N, 1995, J HERPETOL, V29, P51, DOI 10.2307/1565085; Karl SA, 1999, CONSERV BIOL, V13, P990, DOI 10.1046/j.1523-1739.1999.97352.x; Kircher L., 2017, Marine Turtle Newsletter, P12; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; LAMB T, 1992, J HERED, V83, P262, DOI 10.1093/oxfordjournals.jhered.a111211; Monteiro DS, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3018-4; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Myers EM, 2006, EVOLUTION, V60, P563; Naro-Maciel E, 2014, J EXP MAR BIOL ECOL, V461, P306, DOI 10.1016/j.jembe.2014.08.020; Naro-Maciel E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0888; Nishizawa Hideaki, 2010, Current Herpetology, V29, P97, DOI 10.3105/018.029.0205; Okamoto Kei, 2014, Current Herpetology, V33, P46, DOI 10.5358/hsj.33.46; Parker DM, 2011, PAC SCI, V65, P419, DOI 10.2984/65.4.419; Poulakakis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138779; Pritchard P. C. H., 1971, J Herpet, V5, P1, DOI 10.2307/1562836; Pritchard P.C.H., 1999, RES MANAGEMENT TECHN, V4, P21; Reece JS, 2005, CONSERV GENET, V6, P235, DOI 10.1007/s10592-004-7821-y; Reiber CL, 1999, J HERPETOL, V33, P234, DOI 10.2307/1565720; Rivera G, 2014, EVOL BIOL, V41, P29, DOI 10.1007/s11692-013-9243-6; Rivera G, 2011, J MORPHOL, V272, P1192, DOI 10.1002/jmor.10974; Rivera G, 2008, INTEGR COMP BIOL, V48, P769, DOI 10.1093/icb/icn088; Roden SE, 2013, ENDANGER SPECIES RES, V20, P227, DOI 10.3354/esr00500; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2017, TPSDIG VERSION 2 30; Seminoff J.A., 2015, NOAATMNMFSSWFSC539 C; Sonmez B, 2019, NESCIENCES, V4, P42; Sonmez B, 2019, ZOOL STUD, V58, DOI 10.6620/ZS.2019.58-16; SWINGLAND IR, 1989, J ANIM ECOL, V58, P971, DOI 10.2307/5136; Vega C, 2011, HERPETOLOGICA, V67, P397, DOI 10.1655/HERPETOLOGICA-D-10-00037.1; Velez-Rubio GM, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2827-9; Wyneken Jeanette, 1999, Chelonian Conservation and Biology, V3, P491; Zarate PM, 2015, J HERPETOL, V49, P641, DOI 10.1670/14-078	64	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223587	10.1371/journal.pone.0223587	http://dx.doi.org/10.1371/journal.pone.0223587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA1RQ	31589640	Green Published, gold			2022-12-26	WOS:000505576600001
J	Gimenez-Lirola, LG; Meiroz-De-Souza-Almeida, H; Magtoto, RL; McDaniel, AJ; Merodio, MM; Ferreyra, FSM; Poonsuk, K; Gatto, IRH; Baum, DH; Ross, RF; Arruda, PHE; Schwartz, KJ; Zimmerman, JJ; Derscheid, RJ; Arruda, BL				Gimenez-Lirola, Luis G.; Meiroz-De-Souza-Almeida, Henrique; Magtoto, Ronaldo L.; McDaniel, Aric J.; Merodio, Maria M.; Matias Ferreyra, Franco S.; Poonsuk, Korakrit; Gatto, Igor R. H.; Baum, David H.; Ross, Richard F.; Arruda, Paulo H. E.; Schwartz, Kent J.; Zimmerman, Jeffrey J.; Derscheid, Rachel J.; Arruda, Bailey L.			Early detection and differential serodiagnosis of Mycoplasma hyorhinis and Mycoplasma hyosynoviae infections under experimental conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ORAL FLUID SAMPLES; IMMUNE-RESPONSE; SYNOVIAL-FLUID; CARRIER STATE; PIG HERDS; HYOPNEUMONIAE; SWINE; FLOCCULARE; ARTHRITIS	Mycoplasma hyorhinis (MHR) and Mycoplasma hyosynoviae (MHS) are common opportunistic pathogens in the upper respiratory tract and tonsils of swine. The identification of the specific species involved in clinical cases using conventional diagnostic methods is challenging. Therefore, a recombinant chimeric polypeptide based on the seven known variable lipoproteins (A-G) specific of MHR and a cocktail of surface proteins detergent-extracted from MHS cultures were generated and their suitability as antemortem biomarkers for serodiagnosis of MHR- and MHS-infection were evaluated by ELISA. M. hyorhinis and MHS ELISA performance, evaluated using serum samples collected over a 56-day observation period from pigs inoculated with MHR, MHS, M. hyopneumoniae, M. flocculare, or Friis medium, varied by assay, targeted antibody isotype, and cutoffs. The progressions of MHR and MHS clinical diseases were evaluated in relation to the kinetics of the isotype-specific antibody response in serum and bacterial shedding in oral fluids during the observation period. In pigs inoculated with MHR, bacterial DNA was detected in one or more of the 5 pens at all sampling points throughout the study, IgA was first detected at DPI 7, one week before the first clinical signs, with both IgA and IgG detected in all samples collected after DPI 14. The peak of MHS shedding (DPI 8) coincided with the onset of the clinical signs, with both IgA and IgG detected in all serum samples collected >= DPI 14. This study demonstrated, under experimental conditions, that both ELISAs were suitable for early detection of specific antibodies against MHR or MHS. The diagnostic performance of the MHR and MHS ELISAs varied depending on the selected cutoff and the antibody isotype evaluated. The high diagnostic and analytical specificity of the ELISAs was particularly remarkable. This study also provides insights into the infection dynamics of MHR-associated disease and MHS-associated arthritis not previously described.	[Gimenez-Lirola, Luis G.; Magtoto, Ronaldo L.; McDaniel, Aric J.; Merodio, Maria M.; Matias Ferreyra, Franco S.; Poonsuk, Korakrit; Baum, David H.; Ross, Richard F.; Arruda, Paulo H. E.; Schwartz, Kent J.; Zimmerman, Jeffrey J.; Derscheid, Rachel J.; Arruda, Bailey L.] Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA; [Meiroz-De-Souza-Almeida, Henrique; Gatto, Igor R. H.] Sao Paulo State Univ Unesp, Sch Agr & Veterinarian Sci, Jaboticabal, SP, Brazil	Iowa State University; Universidade Estadual Paulista	Gimenez-Lirola, LG (corresponding author), Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA.	luisggl@iastate.edu	Zimmerman, Jeff/ABC-6361-2020; Derscheid, Rachel/AAV-9043-2021; Gatto, Igor Renan Honorato/Y-6956-2018	Zimmerman, Jeff/0000-0002-8107-2422; Merodio, Maria/0000-0003-4724-2720; Gatto, Igor Renan Honorato/0000-0001-9335-5983	Iowa the National Pork Board [16-107]	Iowa the National Pork Board	This study was supported by Iowa the National Pork Board (PO Box 9114, Des Moines, Iowa 526 USA 50306) (Project identification number: #16-107).	Ames RR., 1999, MYCOPLASMAL DIS DIS; ARMSTRONG CH, 1987, ISRAEL J MED SCI, V23, P654; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; BINDER A, 1989, BERL MUNCH TIERARZTL, V102, P11; Caron J, 2000, J CLIN MICROBIOL, V38, P1390, DOI 10.1128/JCM.38.4.1390-1396.2000; Citti C, 2000, J BACTERIOL, V182, P1356, DOI 10.1128/JB.182.5.1356-1363.2000; Clavijo MJ, 2017, VET REC, V181, P68, DOI 10.1136/vr.104064; Clavijo MJ, 2014, J VET DIAGN INVEST, V26, P755, DOI 10.1177/1040638714555175; CLEAVINGER CM, 1994, J BACTERIOL, V176, P2463, DOI 10.1128/JB.176.8.2463-2467.1994; EVANS AS, 1976, YALE J BIOL MED, V49, P175; FREEMAN MJ, 1984, CAN J COMP MED, V48, P202; FRIIS NF, 1994, ACTA VET SCAND, V35, P93; FRIIS NF, 1974, ACTA VET SCAND, V15, P507; FRIIS NF, 1971, ACTA VET SCAND, V12, P69; FRIIS NF, 1991, ACTA VET SCAND, V32, P425; GOIS M, 1972, ZENTRALB VET RIEHE B, V19, P379; GOIS M, 1969, Zentralblatt fuer Veterinaermedizin Reihe B, V16, P253; Neto JCG, 2012, J SWINE HEALTH PROD, V20, P82; Neto JCG, 2014, VET MICROBIOL, V174, P163, DOI 10.1016/j.vetmic.2014.08.008; Gonzalez W, 2017, J VET RES, V61, P163, DOI 10.1515/jvetres-2017-0021; Hagedorn-Olsen T, 1999, J VET MED A, V46, P555, DOI 10.1046/j.1439-0442.1999.00246.x; Hagedorn-Olsen T, 1999, APMIS, V107, P201, DOI 10.1111/j.1699-0463.1999.tb01545.x; HARIHARAN H, 1992, J VET DIAGN INVEST, V4, P28, DOI 10.1177/104063879200400107; HAYFLICK L, 1965, BACTERIOL REV, V29, P185, DOI 10.1128/MMBR.29.2.185-221.1965; Kang I, 2012, CAN J VET RES, V76, P195; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; KOBISCH M, 1983, YALE J BIOL MED, V56, P922; Leuwerke B., 2009, MYCOPLASMA HYORHINIS; Lin JH, 2006, VET MICROBIOL, V115, P111, DOI 10.1016/j.vetmic.2006.02.004; Makhanon M, 2012, TROP ANIM HEALTH PRO, V44, P313, DOI 10.1007/s11250-011-0022-z; Neto JCG, 2015, J VET SCI, V16, P195, DOI 10.4142/jvs.2015.16.2.195; Nielsen EO, 2005, VET MICROBIOL, V111, P41, DOI 10.1016/j.vetmic.2005.08.009; Pedersen MW, 1996, IOM LETT, V4, P90; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; ROSENGARTEN R, 1990, SCIENCE, V247, P315, DOI 10.1126/science.1688663; ROSENGARTEN R, 1991, J BACTERIOL, V173, P4782, DOI 10.1128/jb.173.15.4782-4793.1991; ROSS RF, 1971, AM J VET RES, V32, P1743; ROSS RF, 1970, J BACTERIOL, V103, P707, DOI 10.1128/JB.103.3.707-713.1970; ROSS RF, 1963, AM J VET RES, V24, P622; ROSS RF, 1973, AM J VET RES, V34, P367; Ross RF, 2012, METHODS MYCOPLASMOLO, V2, P115; Rotolo ML, 2018, VET MICROBIOL, V214, P13, DOI 10.1016/j.vetmic.2017.11.011; Rovira A., 2009, P AD LEM SWIN C, P87; Simecka Jerry W., 1992, P391; Stakenborg T, 2006, VET RES COMMUN, V30, P239, DOI 10.1007/s11259-006-3226-3; STEMKE GW, 1994, AM J VET RES, V55, P81; Strait EL, 2008, J CLIN MICROBIOL, V46, P2491, DOI 10.1128/JCM.02366-07; STRASSER M, 1992, VET IMMUNOL IMMUNOP, V31, P141, DOI 10.1016/0165-2427(92)90092-5; SWITZER WP, 1955, AM J VET RES, V16, P540; Timenetsky J, 2006, BRAZ J MED BIOL RES, V39, P907, DOI 10.1590/S0100-879X2006000700009; TURNER GVS, 1982, J S AFR VET ASSOC, V53, P99; [熊祺琰 Xiong Qiyan], 2013, [中国人兽共患病学报, Chinese Journal of Zoonoses], V29, P877; YOGEV D, 1991, EMBO J, V10, P4069, DOI 10.1002/j.1460-2075.1991.tb04983.x; YOGEV D, 1995, J BACTERIOL, V177, P5636, DOI 10.1128/jb.177.19.5636-5643.1995; ZIMMERMANN BJ, 1977, AM J VET RES, V38, P2075; ZIMMERMANN BJ, 1982, VET MICROBIOL, V7, P135, DOI 10.1016/0378-1135(82)90025-6	56	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223459	10.1371/journal.pone.0223459	http://dx.doi.org/10.1371/journal.pone.0223459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589633	gold, Green Published			2022-12-26	WOS:000532427300023
J	Rao, SY; Peri, S; Hoffmann, J; Cai, KQ; Harris, B; Rhodes, M; Connolly, DC; Testa, JR; Wiest, DL				Rao, Shuyun; Peri, Suraj; Hoffmann, Jens; Cai, Kathy Q.; Harris, Bryan; Rhodes, Michele; Connolly, Denise C.; Testa, Joseph R.; Wiest, David L.			RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; MGMT EXPRESSION; STAGE-II; COLON; PROTEIN; DNA; 5-FLUOROURACIL; SURVIVAL; METHYLTRANSFERASE; FLUOROURACIL	We have previously demonstrated that loss of the tumor suppressive activity of ribosomal protein (RP) RPL22 predisposes to development of leukemia in mouse models and aggressive disease in human patients; however, the role of RPL22 in solid tumors, specifically colorectal cancer (CRC), had not been explored. We report here that RPL22 is either deleted or mutated in 36% of CRC and provide new insights into its mechanism of action. Indeed, Rpl22 inactivation causes the induction of its highly homologous paralog, RPL22L1, which serves as a driver of cell proliferation and anchorage-independent growth in CRC cells. Moreover, RPL22L1 protein is highly expressed in patient CRC samples and correlates with poor survival. Interestingly, the association of high RPL22L1 expression with poor prognosis appears to be linked to resistance to 5-Fluorouracil, which is a core component of most CRC therapeutic regimens. Indeed, in an avatar trial, we found that human CRC samples that were unresponsive to 5-Fluorouracil in patient-derived xenografts exhibited elevated expression levels of RPL22L1. This link between RPL22L1 induction and 5-Fluorouracil resistance appears to be causal, because ectopic expression or knockdown of RPL22L1 in cell lines increases and decreases 5-Fluorouracil resistance, respectively, and this is associated with changes in expression of the DNA-repair genes, MGMT and MLH1. In summary, our data suggest that RPL22L1 might be a prognostic marker in CRC and predict 5-FU responsiveness.	[Rao, Shuyun] George Washington Univ, Dept Surg, Ctr Translat Med, Washington, DC 20052 USA; [Peri, Suraj; Harris, Bryan; Rhodes, Michele; Wiest, David L.] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Hoffmann, Jens] Expt Pharmacol & Oncol Berlin Buch GMBH, Berlin, Germany; [Cai, Kathy Q.; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Connolly, Denise C.] Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA	George Washington University; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Rao, SY (corresponding author), George Washington Univ, Dept Surg, Ctr Translat Med, Washington, DC 20052 USA.; Wiest, DL (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	raoshuyun@gmail.com; david.wiest@fccc.edu		Hoffmann, Jens/0000-0003-3880-1658; Wiest, David/0000-0002-0792-3188	NIH [R01AI110985, R21CA21682, P30CA006927, R01CA077429]; Bishop Fund; Commonwealth of Pennsylvania; Department of Defense Bone Marrow Failure Postdoctoral Fellowship [W81XWH-13-1-0403]; NATIONAL CANCER INSTITUTE [R21CA216825, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bishop Fund; Commonwealth of Pennsylvania; Department of Defense Bone Marrow Failure Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI110985, R21CA21682, core grant P30CA006927, the Bishop Fund, and an appropriation from the Commonwealth of Pennsylvania. S. Rao was supported by a Department of Defense Bone Marrow Failure Postdoctoral Fellowship W81XWH-13-1-0403. J.R. Testa and D.L. Wiest also received support from NIH grant R01CA077429. SP, BH, MR, AND DW received salary support from R01AI110985, R21CA21682, and R01CA077429. SR received salary support from W81XWH-13-1-0403 and JT received salary support from R01CA077429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Richard Blumberg (Harvard) for Mode K cells and Cara Dubyk for technical assistance in generation of the tissue microarrays. They gratefully acknowledge the assistance of the following core facilities of the Fox Chase Cancer Center: Biosample Repository, Biostatistics and Bioinformatics, Cell Culture, Cell Sorting, DNA Sequencing, Histopathology and Laboratory Animal. This work was supported by NIH grants R01AI110985, R21CA21682, core grant P30CA006927, the Bishop Fund, and an appropriation from the Commonwealth of Pennsylvania. S. Rao was supported by a Department of Defense Bone Marrow Failure Postdoctoral Fellowship W81XWH-13-1-0403. J.R. Testa and D.L. Wiest also received support from NIH grant R01CA077429.	Amatu A, 2013, CLIN CANCER RES, V19, P2265, DOI 10.1158/1078-0432.CCR-12-3518; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Cohen R, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0453-5; Copija A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010107; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9; Ferreira AM, 2014, HUM MUTAT, V35, P1442, DOI 10.1002/humu.22686; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Fischer F, 2007, GASTROENTEROLOGY, V133, P1858, DOI 10.1053/j.gastro.2007.09.003; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Gustavsson B, 2015, CLIN COLORECTAL CANC, V14, P1, DOI 10.1016/j.clcc.2014.11.002; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Kenmochi Naoya, 2013, Seikagaku, V85, P909; Kishi K, 2003, CLIN CANCER RES, V9, P4368; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; Klingbiel D, 2015, ANN ONCOL, V26, P126, DOI 10.1093/annonc/mdu499; Konduri SD, 2009, CLIN CANCER RES, V15, P6087, DOI 10.1158/1078-0432.CCR-09-0887; Liu H, 2014, PROCEEDINGS OF 2014 INTERNATIONAL CONFERENCE ON PUBLIC ADMINISTRATION (10TH), VOL II, P536; Lonardi S, 2016, ANN ONCOL, V27, P2074, DOI 10.1093/annonc/mdw404; Mehra R, 2013, CLIN CANCER RES, V19, P6633, DOI 10.1158/1078-0432.CCR-13-0152; Meyers M, 2001, CANCER RES, V61, P5193; Midgley RS, 2009, NAT CLIN PRACT GASTR, V6, P108, DOI 10.1038/ncpgasthep1337; Minoo P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00266; Murakami J, 2007, ONCOL REP, V17, P1461; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Novetsky AP, 2013, GYNECOL ONCOL, V128, P470, DOI 10.1016/j.ygyno.2012.10.026; O'Leary MN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003708; Prudnikova TY, 2016, ONCOGENE, V35, P2178, DOI 10.1038/onc.2015.278; Rao SY, 2016, CANCER RES, V76, P3387, DOI 10.1158/0008-5472.CAN-15-2698; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Stelloo E, 2017, ANN ONCOL, V28, P96, DOI 10.1093/annonc/mdw542; Zhang Y, 2017, CELL REP, V18, P545, DOI 10.1016/j.celrep.2016.12.034; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zheng SY, 2016, CANCER CELL, V29, P723, DOI 10.1016/j.ccell.2016.04.002; Zou Y, 2015, BIOMED REP, V3, P33, DOI 10.3892/br.2014.378	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222392	10.1371/journal.pone.0222392	http://dx.doi.org/10.1371/journal.pone.0222392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581233	Green Published, gold			2022-12-26	WOS:000532398600010
J	Polito, A; Combescure, C; Levy-Jamet, Y; Rimensberger, P				Polito, Angelo; Combescure, Christophe; Levy-Jamet, Yann; Rimensberger, Peter		Swiss Soc Intensive Care Med	Long-stay patients in pediatric intensive care unit: Diagnostic-specific definition and predictors	PLOS ONE			English	Article							CRITICAL ILLNESS; PALLIATIVE CARE; CHILDREN; QUALITY	Aims To stipulate a new definition for long-stay patients (LSPs) in pediatric intensive care unit (PICU). We defined LSPs as the 10% of patients with the longest PICU length-of-stay (LOS) for each age and diagnostic group. To assess whether the thresholds (days of PICU stay) for the definition of LSPs in PICU significantly differ among diagnostic and age categories. To determine whether independent associations exist between patients' characteristics at admission and LSPs diagnosis in pre-specified diagnostic and age groups. Methods This was a multicenter retrospective cohort study including all PICUs in Switzerland. Multivariable regression analysis was used to seek for association between patients' variables at admission and LSPs Results We included 22,284 patients with a median (IQR) age of 12 (1-84) months. Significantly different thresholds across diagnostic and age subgroups are identified. Readmission to PICU, higher PIM2 and NEMS (a score used to quantify nursing workload at intensive care unit level) at admission were associated with higher likelihood of becoming LSPs. Conclusions Our results showed a significantly different definitions of LSPs for specific diagnoses and age categories. Readmission to PICU and higher acuity at admission are associated with longer PICU length-of-stay in the majority of diagnostic groups. A more personalized definition of LSPs in children based on actual patients' characteristics should probably be used in an effort to optimize care and reduce costs.	[Polito, Angelo; Levy-Jamet, Yann; Rimensberger, Peter] Univ Hosp Geneva, Dept Pediat, Pediat & Neonatal Intens Care Unit, Geneva, Switzerland; [Combescure, Christophe] Univ Geneva, Fac Med, Div Clin Epidemiol, Geneva, Switzerland; [Combescure, Christophe] Geneva Univ Hosp, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Polito, A (corresponding author), Univ Hosp Geneva, Dept Pediat, Pediat & Neonatal Intens Care Unit, Geneva, Switzerland.	angelo.polito@hcuge.ch		Rimensberger, Peter/0000-0002-9760-9220; Polito, Angelo/0000-0003-4686-726X				Bagshaw SM, 2018, INTENS CARE MED, V44, P2134, DOI 10.1007/s00134-018-5440-1; Boss R, 2014, PEDIATR CRIT CARE ME, V15, P762, DOI 10.1097/PCC.0000000000000209; Briassoulis G, 2005, J CRIT CARE, V20, P139, DOI 10.1016/j.jcrc.2005.04.003; Chen F, 2016, ARCH DIS CHILD-FETAL, V101, pF377, DOI 10.1136/archdischild-2015-308579; Fraser LK, 2018, ARCH DIS CHILD, V103, P540, DOI 10.1136/archdischild-2017-312638; Iapichino G, 2001, INTENS CARE MED, V27, P131, DOI 10.1007/s001340000776; Iwashyna TJ, 2016, LANCET RESP MED, V4, P566, DOI 10.1016/S2213-2600(16)30098-4; Kahn JM, 2015, LANCET RESP MED, V3, P501, DOI 10.1016/S2213-2600(15)00205-2; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Nelson JE, 2005, J CRIT CARE, V20, P79, DOI 10.1016/j.jcrc.2004.11.003; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2012, RESP CARE, V57, P1004, DOI 10.4187/respcare.01624; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Pagowska-Klimek I, 2011, EUR J CARDIO-THORAC, V40, P179, DOI 10.1016/j.ejcts.2010.11.038; PON S, 1993, J PEDIATR-US, V123, P355, DOI 10.1016/S0022-3476(05)81732-9; Shapiro Miriam C, 2017, Hosp Pediatr, V7, P236, DOI 10.1542/hpeds.2016-0107; Simon TD, 2014, PEDIATRICS, V133, pE1647, DOI 10.1542/peds.2013-3875; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223369	10.1371/journal.pone.0223369	http://dx.doi.org/10.1371/journal.pone.0223369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577836	gold, Green Published			2022-12-26	WOS:000532388000033
J	Zhang, MW; Zhang, SC; Harn, L				Zhang, Mingwu; Zhang, Shaochen; Harn, Lein			An efficient and adaptive data-hiding scheme based on secure random matrix	PLOS ONE			English	Article								There is a vivid research on securely deliver a secret message by using a data hiding technique in digital images. However, most existing solutions of data-hiding need to encrypt secret data first, and embed the encrypt message into cover image, which is not promising any security once the embedding algorithm is leaked. In this paper, an efficient and adaptive data hiding scheme is presented which is based on a new reference matrix named secure reference matrix. The scheme is flexible enough to meet different data hiding capacities and image quality as needed, and we allow the reference matrix to be more secure since it is randomly generated each time and make it much harder for being attack with exhaustive manner by extending the possible solution. We give the detail protocol for our scheme and provide the practical test and performance analysis. Experimental results show that our scheme has a better flexibility and efficiency in embedding process, and the average value of Peak Signal to Noise Ratio (PSNR) for the stego-images which are generated by our scheme have a higher visual quality for different embedding capacities, and our scheme is more efficient compared with related work.	[Zhang, Mingwu; Zhang, Shaochen] Hubei Univ Technol, Sch Comp Sci, Wuhan, Hubei, Peoples R China; [Zhang, Mingwu] China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan, Hubei, Peoples R China; [Harn, Lein] Univ Missouri, Dept Comp Sci Elect Engn, Kansas City, MO 64110 USA	Hubei University of Technology; China University of Geosciences; University of Missouri System; University of Missouri Kansas City	Zhang, MW (corresponding author), Hubei Univ Technol, Sch Comp Sci, Wuhan, Hubei, Peoples R China.; Zhang, MW (corresponding author), China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan, Hubei, Peoples R China.	csmwzhang@gmail.com			National Natural Science Foundation of China [61702168, 61672010]; Hubei Key Laboratory of Intelligent Geo-Information Processing [KLIGIP-2017A11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Key Laboratory of Intelligent Geo-Information Processing	This work is supported by the National Natural Science Foundation of China under grants 61702168 and 61672010, the fund of The Hubei Key Laboratory of Intelligent Geo-Information Processing (KLIGIP-2017A11).	Chang C, 2018, J REAL TIME IMAGE PR; Chang C.-C., 2008, P 3 INT C INN COMP I, P17; Chang CC, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING (IIH-MSP 2014), P89, DOI 10.1109/IIH-MSP.2014.29; Chen J, 2014, SIGNAL PROCESS-IMAGE, V29, P375, DOI 10.1016/j.image.2014.01.003; Cheng K., 2017, IEEE T BIG DATA; Martinez-Gonzalez RF, 2016, COMPUT ELECTR ENG, V54, P435, DOI 10.1016/j.compeleceng.2015.12.005; HONG W, 2012, J REAL-TIME IMAGE PR, V7, P176, DOI DOI 10.1109/TIFS.2011.2155062; Hong W, 2012, IEEE T INF FOREN SEC, V7, P176, DOI 10.1109/TIFS.2011.2155062; Hong W, 2008, ISISE 2008: INTERNATIONAL SYMPOSIUM ON INFORMATION SCIENCE AND ENGINEERING, VOL 1, P515, DOI 10.1109/ISISE.2008.153; Kim HJ, 2010, COMPUT MATH APPL, V60, P319, DOI 10.1016/j.camwa.2010.01.006; Lee CF, 2008, IMAGE VISION COMPUT, V26, P1670, DOI 10.1016/j.imavis.2008.05.005; Liu L, 2017, MULTIMED TOOLS APPL, V76, P12233, DOI 10.1007/s11042-016-3624-7; Liu YN, 2017, IET INFORM SECUR, V11, P250, DOI 10.1049/iet-ifs.2016.0103; Mielikainen J, 2006, IEEE SIGNAL PROC LET, V13, P285, DOI 10.1109/LSP.2006.870357; Wang F., 2018, P COMPUT SCI, V131, P800; Wang H, 2018, WORLD WIDE WEB, V21, P1, DOI 10.1007/s11280-017-0490-9; Yadav GS, 2018, COMPUT ELECTR ENG, V69, P447, DOI 10.1016/j.compeleceng.2018.02.022; Zhang M, 2015, IEEE SYSTEMS J, V11, P1018; Zhang MW, 2019, IEEE SYST J, V13, P1478, DOI 10.1109/JSYST.2019.2900723; Zhang MW, 2018, J AMB INTEL HUM COMP, V9, P1889, DOI 10.1007/s12652-017-0672-4; Zhang XP, 2006, IEEE COMMUN LETT, V10, P781, DOI 10.1109/LCOMM.2006.060863	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222892	10.1371/journal.pone.0222892	http://dx.doi.org/10.1371/journal.pone.0222892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577802	Green Published, gold			2022-12-26	WOS:000532388000015
J	Jiang, S; Li, FQ; Li, XL; Wang, LL; Zhang, L; Lu, C; Zheng, L; Yan, MH				Jiang, Shan; Li, Fuqiang; Li, Xiuli; Wang, Lili; Zhang, Li; Lu, Chao; Zheng, Li; Yan, Minghua			Transcriptome analysis of PK-15 cells in innate immune response to porcine deltacoronavirus infection	PLOS ONE			English	Article							DIARRHEA; CORONAVIRUSES; MODULATION; EXPRESSION; EVASION; PDCOV; PEDV; PIGS	Porcine deltacoronavirus (PDCoV) is a newly emerged swine enteropathogenic coronavirus affecting pigs of all ages and causing diarrhea problems. Research findings indicate that PDCoV has evolved strategies to escape innate immune response in host cells, but mechanism of PDCoV in innate immune modulation is not well understood. In this study, we report our findings on identifying the alterations of host cell innate immune response affected by PDCoV infection and exploring the gene expression profiles of PK-15 cells at 0, 24, and 36 h PDCoV post infection by RNA sequencing. A total of 3,762 and 560 differentially expressed genes (DEGs) were screened by comparison of uninfected PK-15 cells and infected PK-15 cells at 24 h post infection (hpi) (INF_24h versus NC), and also comparison of infected PK-15 cells between 24 and 36 hpi (INF_36h versus INF_24h), which included 156 and 23 porcine innate immune-related genes in the DEGs of INF_24h versus NC and INF_36h versus INF_24h, respectively. Gene Ontology function classification and Kyoto Encyclopedia of Genes and Genomes signaling pathway enrichment analysis were performed based on the DEGs that exhibited the same expression tendencies with most of the innate immune-associated genes among these PK-15 cell samples described above. The enrichment results indicated that extensive gene functions and signaling pathways including innate immune associated functions and pathways were affected by PDCoV infection. Particularly, 4 of 5 innate immune signaling pathways, which were primarily affected by PDCoV, played important roles in I-IFNs antiviral function in innate immune response. Additionally, 16 of the host cell endogenous miRNAs were predicted as potential contributors to the modulation of innate immune response affected by PDCoV. Our research findings indicated that the innate immune-associated genes and signaling pathways in PK-15 cells could be modified by the infection of PDCoV, which provides a fundamental foundation for further studies to better understand the mechanism of PDCoV infections, so as to effectively control and prevent PDCoV-induced swine diarrheal disease outbreaks.	[Jiang, Shan; Li, Fuqiang; Li, Xiuli; Wang, Lili; Zhang, Li; Lu, Chao; Zheng, Li; Yan, Minghua] Tianjin Acad Agr Sci, Tianjin Inst Anim Husb & Vet Med, Tianjin, Peoples R China; [Jiang, Shan; Li, Fuqiang; Li, Xiuli; Wang, Lili; Zhang, Li; Lu, Chao; Zheng, Li; Yan, Minghua] Minist Agr Peoples Republ China, Tianjin Sci Observat Expt Stn Vet Med & Diag Tech, Tianjin, Peoples R China	Ministry of Agriculture & Rural Affairs	Yan, MH (corresponding author), Tianjin Acad Agr Sci, Tianjin Inst Anim Husb & Vet Med, Tianjin, Peoples R China.; Yan, MH (corresponding author), Minist Agr Peoples Republ China, Tianjin Sci Observat Expt Stn Vet Med & Diag Tech, Tianjin, Peoples R China.	yanmh81971@126.com	wang, lili/HDL-7210-2022		Key Projects of Advanced Manufacturing Technology for High Quality Veterinary Drugs [17ZXGSNC00080]; Tianjin Modern Agricultural Industry Technology System Project [ITTPRS2017003]; Innovative Research and Experimental Project of Young Scientific Researchers [201912]	Key Projects of Advanced Manufacturing Technology for High Quality Veterinary Drugs; Tianjin Modern Agricultural Industry Technology System Project; Innovative Research and Experimental Project of Young Scientific Researchers	This work is supported by Key Projects of Advanced Manufacturing Technology for High Quality Veterinary Drugs (grant number: 17ZXGSNC00080); Tianjin Modern Agricultural Industry Technology System Project (grant number: ITTPRS2017003); Innovative Research and Experimental Project of Young Scientific Researchers (grant number: 201912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi T, 2018, TRANSBOUND EMERG DIS, V65, P1197, DOI 10.1111/tbed.12858; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Devhare Pradip B., 2017, Gene Expression, V17, P89, DOI 10.3727/105221616X693594; Ding Z, 2017, ONCOTARGET, V8, P49655, DOI 10.18632/oncotarget.17912; Fang PX, 2018, J VIROL, V92, DOI [10.1128/JVI.00712-18, 10.1128/jvi.00712-18]; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Hu H, 2016, ARCH VIROL, V161, P3421, DOI 10.1007/s00705-016-3056-8; Hu H, 2015, J CLIN MICROBIOL, V53, P1537, DOI 10.1128/JCM.00031-15; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang Jianbo, 2016, Bing Du Xue Bao, V32, P465; Janetanakit T, 2016, EMERG INFECT DIS, V22, P757, DOI 10.3201/eid2204.151852; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; LEE S, 2014, ADV NEUR IN, V27, pNI433; Li Q, 2016, CIVIL ENGINEERING AND URBAN PLANNING IV, P55; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120377; Luo JY, 2016, VIROLOGY, V495, P10, DOI 10.1016/j.virol.2016.04.025; Ma YL, 2018, J VIROL, V92, DOI 10.1128/JVI.00728-18; Ma YM, 2015, MBIO, V6, DOI 10.1128/mBio.00064-15; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Masuda T, 2016, JPN J VET RES, V64, P5; Thachil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124363; Thompson H W, 1998, Nutr Neurosci, V1, P165, DOI 10.1080/1028415X.1998.11747226; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756; Wang YW, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00945-15; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Yu LP, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1253-7; Zhang HW, 2018, MICROB PATHOGENESIS, V117, P247, DOI 10.1016/j.micpath.2018.02.004; Zhang JL, 2019, J BIOL CHEM, V294, P9830, DOI 10.1074/jbc.RA119.007779; Zhang QZ, 2017, VIROLOGY, V510, P111, DOI 10.1016/j.virol.2017.07.009; Zhang QZ, 2016, VIRUS RES, V226, P128, DOI 10.1016/j.virusres.2016.05.015; Zheng L., 2018, CHINA ANIM HUSBANDRY, V45, P219; Zheng LH, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON APPLIED SUPERCONDUCTIVITY AND ELECTROMAGNETIC DEVICES (ASEMD), P5, DOI 10.1109/ASEMD.2015.7453439; Zhu XY, 2017, J VIROL, V91, DOI [10.1128/JVI.00003-17, 10.1128/jvi.00003-17]	36	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223177	10.1371/journal.pone.0223177	http://dx.doi.org/10.1371/journal.pone.0223177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574122	Green Published, gold			2022-12-26	WOS:000532376700032
J	Peng, MJ; Wang, ZH; Peng, S; Zhang, ML; Duan, YH; Li, FN; Shi, SY; Yang, QL; Zhang, CW				Peng, Mijun; Wang, Zhihong; Peng, Sheng; Zhang, Minglong; Duan, Yehui; Li, Fengna; Shi, Shuyun; Yang, Qiuling; Zhang, Changwei			Dietary supplementation with the extract from Eucommia ulmoides leaves changed epithelial restitution and gut microbial community and composition of weanling piglets	PLOS ONE			English	Article							GROWTH-PERFORMANCE; EXPRESSION; POWDER; OLIV.; ALTERNATIVES; RESISTANCE; MUSCLE; SERUM; ALTER; PH	This study was conducted to compare the effects of Eucommia ulmoides leaves (EL) in different forms (EL extract, fermented EL, and EL powder) with antibiotics on growth performance, intestinal morphology, and the microbiota composition and diversity of weanling piglets. Compared to the control group, the antibiotics and EL extract significantly increased the average daily gain and decreased the feed: gain ratio as well as the diarrhea rate (P < 0.05). The EL extract significantly decreased the crypt depth and increased the ratio of villus height to crypt depth (P < 0.05), while the fermented EL group did the opposite (P < 0.05). The crypt depth in the antibiotics group was of similar value to the EL extract group, and was lower than the fermented EL and EL powder groups (P < 0.05). Compared to the control and antibiotics groups, the jejunul claudin-3 mRNA expression and the concentrations of total VFA, Chao 1, and ACE were significantly augmented in the EL extract group of piglets (P < 0.05). The EL extract groups also showed elevated Shannon (P < 0.05) and Simpson (P = 0.07) values relative to the control and antibiotics groups. At the phylum level, the EL extract group exhibited a reduced abundance of Bacteroidetes and an enhanced abundance of Firmicutes. At the genus level, the abundance of Prevotella was augmented in the EL extract group. Moreover, compared with the antibiotic group, the acetate concentration was enhanced in the EL extract and fermented EL groups. Overall, dietary supplementation with the EL extract, but not the fermented EL or EL powder, improved growth performance, jejunul morphology and function, as well as changed colonic microbial composition and diversity, which might be an alternative to confer protection against weanling stress in weanling piglets.	[Peng, Mijun; Wang, Zhihong; Zhang, Minglong; Yang, Qiuling] Guangdong Inst Anal, Guangdong Prov Publ Lab Anal & Testing Technol, Guangzhou, Peoples R China; [Peng, Sheng] Jishou Univ, Natl & Local United Engn Lab Integrat Utilizat Te, Zhangjiajie, Peoples R China; [Duan, Yehui; Li, Fengna] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg,Sci Observing &, Inst Subtrop Agr,Minist Agr,Hunan Prov Engn Res C, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Changsha, Peoples R China; [Li, Fengna] Hunan Collaborat Innovat Ctr Utilizat Bot Funct I, Hunan Coinnovat Ctr Anim Prod Safety, CICAPS, Changsha, Hunan, Peoples R China; [Shi, Shuyun] Cent South Univ, Coll Chem & Chem Engineer, Changsha, Hunan, Peoples R China; [Zhang, Changwei] CAF, Inst Chem Ind Forest Prod, Nanjing, Peoples R China	Guangdong Academy of Sciences; Institute of Analysis, Guangdong Academy of Sciences; Jishou University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Central South University; Chinese Academy of Forestry; Institute of Chemical Industry of Forest Products, CAF	Peng, MJ (corresponding author), Guangdong Inst Anal, Guangdong Prov Publ Lab Anal & Testing Technol, Guangzhou, Peoples R China.	pengmj163@163.com			GDAS' Project of Science and Technology Development [2019GDASYL-0502003, 2019GDASYL-0103024]; National Natural Science Foundation of China [31660181]; Educational Commission of Hunan Province of China [16A175]; National & local United Engineering Laboratory of Integrative Utilization Technology of Eucommia ulmoides [NLE201602, NLE201704]	GDAS' Project of Science and Technology Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission of Hunan Province of China; National & local United Engineering Laboratory of Integrative Utilization Technology of Eucommia ulmoides	This study was financially supported by the GDAS' Project of Science and Technology Development (2019GDASYL-0502003, 2019GDASYL-0103024) and the Project supported by the National Natural Science Foundation of China (31660181) and the Educational Commission of Hunan Province of China (16A175) and the National & local United Engineering Laboratory of Integrative Utilization Technology of Eucommia ulmoides (NLE201602 and NLE201704).	Abreu AC, 2012, NAT PROD REP, V29, P1007, DOI 10.1039/c2np20035j; Canh TT, 1998, J ANIM SCI, V76, P1887; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Chen YuMin, 2015, Chinese Journal of Animal Nutrition, V27, P2224; Cheng GY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00217; Dai XP, 2013, FOOD CHEM, V139, P563, DOI 10.1016/j.foodchem.2013.02.006; Duan YH, 2018, NUTRITION, V54, P173, DOI 10.1016/j.nut.2018.03.057; Duan YH, 2015, ANIM NUTR, V1, P30, DOI 10.1016/j.aninu.2015.02.005; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng HB, 2016, CARBOHYD POLYM, V136, P803, DOI 10.1016/j.carbpol.2015.09.079; Guo FC, 2003, WORLD POULTRY SCI J, V59, P427, DOI 10.1079/WPS20030026; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hashemi S. R., 2008, IJP - International Journal of Pharmacology, V4, P352; Hashemi SR, 2011, VET RES COMMUN, V35, P169, DOI 10.1007/s11259-010-9458-2; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hu CH, 2013, J ANIM SCI, V91, P1094, DOI 10.2527/jas.2012-5796; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kong XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37224; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; [李凤龙 Li Fenglong], 2016, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V25, P1137; LIN J, 2014, FRONT MICROBIOL, V5, DOI DOI 10.3389/FMICB.2014.00033; Liu SJ, 2018, J SCI FOOD AGR, V98, P5816, DOI 10.1002/jsfa.9131; Long CM, 2016, ANIM NUTR, V2, P271, DOI 10.1016/j.aninu.2016.08.006; Luo XB, 2004, J LIQ CHROMATOGR R T, V27, P63, DOI 10.1081/JLC-120027086; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; Myer PR, 2015, J ANIM SCI, V93, P5327, DOI 10.2527/jas.2015-9415; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; SALYERS AA, 1984, ANNU REV MICROBIOL, V38, P293, DOI 10.1146/annurev.mi.38.100184.001453; Savoia D, 2012, FUTURE MICROBIOL, V7, P979, DOI [10.2217/FMB.12.68, 10.2217/fmb.12.68]; Shi SY, 2019, FOOD CHEM, V288, P215, DOI 10.1016/j.foodchem.2019.03.013; Shi Ying, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P200; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stanton TB, 2013, TRENDS MICROBIOL, V21, P111, DOI 10.1016/j.tim.2012.11.002; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wang J, 2015, J ANIM SCI, V93, P1679, DOI 10.2527/jas.2014-8230; Wang ZY, 2017, LIVEST SCI, V206, P1, DOI 10.1016/j.livsci.2017.09.026; Wu SG, 2013, WORLD J MICROB BIOT, V29, P1585, DOI 10.1007/s11274-013-1322-4; Yen GC, 2000, J AGR FOOD CHEM, V48, P3431, DOI 10.1021/jf000150t; Zhang Q, 2013, MOLECULES, V18, P1857, DOI 10.3390/molecules18021857; ZHOU YS, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0138277; Zhu MO, 2018, J AGR FOOD CHEM, V66, P5433, DOI 10.1021/acs.jafc.8b01312	47	11	13	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223002	10.1371/journal.pone.0223002	http://dx.doi.org/10.1371/journal.pone.0223002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557247	Green Published, gold			2022-12-26	WOS:000532345500058
J	Taniue, K; Hayashi, T; Kamoshida, Y; Kurimoto, A; Takeda, Y; Negishi, L; Iwasaki, K; Kawamura, Y; Goshima, N; Akiyama, T				Taniue, Kenzui; Hayashi, Tomoatsu; Kamoshida, Yuki; Kurimoto, Akiko; Takeda, Yasuko; Negishi, Lumi; Iwasaki, Kei; Kawamura, Yoshifumi; Goshima, Naoki; Akiyama, Tetsu			UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells	ONCOGENE			English	Article							DNA METHYLATION; PROMOTES PROLIFERATION; BURKITT-LYMPHOMA; STRUCTURAL BASIS; GENE-REGULATION; MYST FAMILY; STEM-CELLS; SRA DOMAIN; UHRF1; PROTEIN	The epigenetic factor UHRF1 regulates transcription by modulating DNA methylation and histone modification, and plays critical roles in proliferation, development, and tumorigenesis. Here, we show that Wnt/c-Myc signaling upregulates UHRF1, which in turn downregulates TUSC3, a candidate tumor suppressor gene that is frequently deleted or downregulated in several cancers. We also show that UHRF1-mediated downregulation of TUSC3 is required for the proliferation of colon cancer cells. Furthermore, we demonstrate that UHRF1 suppresses TUSC3 expression by interacting with methylated H3K14 and thereby suppressing the acetylation of H3K14 by the histone acetyltransferase KAT7. Our study provides evidence for the significance of UHRF1-KAT7-mediated regulation of histone methylation/acetylation in the proliferation of tumor cells and in a diverse set of biological processes controlled by Wnt/c-Myc signaling.	[Taniue, Kenzui; Hayashi, Tomoatsu; Kamoshida, Yuki; Kurimoto, Akiko; Takeda, Yasuko; Negishi, Lumi; Iwasaki, Kei; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan; [Kurimoto, Akiko] Daiichi Sankyo Co Ltd, Oncol Res Labs, Shinagawa Ku, Tokyo, Japan; [Kawamura, Yoshifumi] Japan Biol Informat Consortium, Koto Ku, Tokyo, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan	University of Tokyo; Daiichi Sankyo Company Limited; National Institute of Advanced Industrial Science & Technology (AIST)	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan.	akiyama@iam.u-tokyo.ac.jp		Negishi, Lumi/0000-0002-7297-0634	MEXT, Japan [17H06325, 15H01464]; Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development [17cm0106103h0002]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Analysis and Regulation of Cellular Diversity, no. 17H06325 and Non-coding RNA neo-taxonomy, no. 15H01464) from MEXT, Japan, and Project for Cancer Research and Therapeutic Evolution (P-CREATE, no. 17cm0106103h0002) from the Japan Agency for Medical Research and Development.	Ahuja N, 1998, CANCER RES, V58, P5489; Arbieva ZH, 2000, GENOME RES, V10, P244, DOI 10.1101/gr.10.2.244; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Bookstein R, 1997, BRIT J UROL, V79, P28, DOI 10.1111/j.1464-410X.1997.tb00798.x; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; De Vos M, 2014, J BIOL CHEM, V289, P16223, DOI 10.1074/jbc.M113.527424; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149028; Feng YP, 2016, EMBO J, V35, P176, DOI 10.15252/embj.201591293; Ferraro A, 2013, J CLIN ENDOCR METAB, V98, P2834, DOI 10.1210/jc.2012-2926; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jiang ZF, 2016, TUMOR BIOL, V37, P12039, DOI 10.1007/s13277-016-5072-4; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Maruyama Y, 2012, NUCLEIC ACIDS RES, V40, pD924, DOI 10.1093/nar/gkr1188; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pils D, 2013, CANCER-AM CANCER SOC, V119, P946, DOI 10.1002/cncr.27850; Pronobis MI, 2012, CURR BIOL, V22, pR137, DOI 10.1016/j.cub.2012.01.002; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rolando M, 2013, CELL HOST MICROBE, V13, P395, DOI 10.1016/j.chom.2013.03.004; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Taniue K, 2016, P NATL ACAD SCI USA, V113, P12739, DOI 10.1073/pnas.1605938113; Taniue K, 2016, P NATL ACAD SCI USA, V113, P1273, DOI 10.1073/pnas.1500992113; Taniue K, 2011, EMBO REP, V12, P682, DOI 10.1038/embor.2011.81; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Vanhara P, 2013, INT J ONCOL, V42, P1383, DOI 10.3892/ijo.2013.1824; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Walczak EM, 2014, MOL ENDOCRINOL, V28, P1471, DOI 10.1210/me.2014-1060; Zhang Y, 2014, CANCER EPIDEM BIOMAR, V23, P2019, DOI 10.1158/1055-9965.EPI-13-0994; Zong HL, 2005, FEBS LETT, V579, P3579, DOI 10.1016/j.febslet.2005.05.039	69	10	10	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1018	1030		10.1038/s41388-019-1032-y	http://dx.doi.org/10.1038/s41388-019-1032-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31582837				2022-12-26	WOS:000511209700005
J	Mukherjee, AK; Sharma, S; Bagri, S; Kutum, R; Kumar, P; Hussain, A; Singh, P; Saha, D; Kar, A; Dash, D; Chowdhury, S				Mukherjee, Ananda Kishore; Sharma, Shalu; Bagri, Sulochana; Kutum, Rintu; Kumar, Pankaj; Hussain, Asgar; Singh, Prateek; Saha, Dhurjhoti; Kar, Anirban; Dash, Debasis; Chowdhury, Shantanu			Telomere repeat?binding factor 2 binds extensively to extra-telomeric G-quadruplexes and regulates the epigenetic status of several gene promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA transcription; DNA-binding protein; G-quadruplex; epigenetics; telomere; extra-telomeric; genome-wide; telomere repeat-binding factor 2; TRF2; gene regulation; shelterin complex; DNA secondary structure; histone mark	INTERCALATOR DISPLACEMENT ASSAY; GENOME-WIDE; DNA STRUCTURES; CHIP-SEQ; MOTIFS; END; PROTEINS; PROTOONCOGENE; CHROMOSOMES; EXPRESSION	The role of the telomere repeat-binding factor 2 (TRF2) in telomere maintenance is well-established. However, recent findings suggest that TRF2 also functions outside telomeres, but relatively little is known about this function. Herein, using genome-wide ChIP-Seq assays of TRF2-bound chromatin from HT1080 fibrosarcoma cells, we identified thousands of TRF2-binding sites within the extra-telomeric genome. In light of this observation, we asked how TRF2 occupancy is organized within the genome. Interestingly, we found that extra-telomeric TRF2 sites throughout the genome are enriched in potential G-quadruplex?forming DNA sequences. Furthermore, we validated TRF2 occupancy at several promoter G-quadruplex motifs, which did adopt quadruplex forms in solution. TRF2 binding altered expression and the epigenetic state of several target promoters, indicated by histone modifications resulting in transcriptional repression of eight of nine genes investigated here. Furthermore, TRF2 occupancy and target gene expression were also sensitive to the well-known intracellular G-quadruplex?binding ligand 360A. Together, these results reveal an extensive genome-wide association of TRF2 outside telomeres and that it regulates gene expression in a G-quadruplex?dependent fashion.	[Mukherjee, Ananda Kishore; Sharma, Shalu; Bagri, Sulochana; Saha, Dhurjhoti; Kar, Anirban] CSIR, IGIB, Integrat & Funct Biol Unit, Mathura Rd, New Delhi 110025, India; [Mukherjee, Ananda Kishore; Sharma, Shalu; Kutum, Rintu; Kumar, Pankaj; Hussain, Asgar; Singh, Prateek; Saha, Dhurjhoti; Dash, Debasis; Chowdhury, Shantanu] CSIR, IGIB, Acad Sci & Innovat Res AcSIR, Mathura Rd, New Delhi 110025, India; [Kutum, Rintu; Kumar, Pankaj; Hussain, Asgar; Singh, Prateek; Dash, Debasis; Chowdhury, Shantanu] CSIR, IGIB, GNR Knowledge Ctr Genome Informat, Mathura Rd, New Delhi 110025, India; [Kutum, Rintu; Dash, Debasis; Chowdhury, Shantanu] CSIR, IGIB, CSIR Ayurgen Unit TRISUTRA, Mathura Rd, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Chowdhury, S (corresponding author), CSIR, IGIB, Acad Sci & Innovat Res AcSIR, Mathura Rd, New Delhi 110025, India.; Chowdhury, S (corresponding author), CSIR, IGIB, GNR Knowledge Ctr Genome Informat, Mathura Rd, New Delhi 110025, India.; Chowdhury, S (corresponding author), CSIR, IGIB, CSIR Ayurgen Unit TRISUTRA, Mathura Rd, New Delhi 110025, India.	shantanuc@igib.res.in	HUSSAIN, ASGAR/ABE-9859-2021; Kar, Anirban/ABF-9178-2021; Dash, Debasis/F-3137-2012	HUSSAIN, ASGAR/0000-0002-1172-9521; Mukherjee, Ananda Kishore/0000-0002-3082-6749; Bagri, Sulochana/0000-0001-7407-2558; KUMAR, PANKAJ/0000-0002-8411-1634; Dash, Debasis/0000-0002-5647-3785; Sharma, Shalu/0000-0003-1079-6498; SHARMA, SHALU/0000-0002-0443-3650	Council of Scientific and Industrial Research (CSIR); Wellcome Trust/Department of Biotechnology (DBT) India Alliance; DBT; Wellcome Trust/DBT India Alliance Fellowship [500127/Z/09/Z]; CSIR (GENCODE)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust/Department of Biotechnology (DBT) India Alliance(Wellcome Trust DBT India Alliance); DBT(Department of Biotechnology (DBT) India); Wellcome Trust/DBT India Alliance Fellowship(Wellcome Trust DBT India Alliance); CSIR (GENCODE)	This work was supported by research fellowships from the Council of Scientific and Industrial Research (CSIR) (to A. K. M., S. S., and P. K.) and Wellcome Trust/Department of Biotechnology (DBT) India Alliance (to D. S.) and DBT (to S. B.). This work was supported by the Wellcome Trust/DBT India Alliance Fellowship (Grant 500127/Z/09/Z) (to S. C.) and a research grant from CSIR (GENCODE). The authors declare that they have no conflicts of interest with the contents of this article.	Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; El Mai M, 2014, CELL REP, V9, P1047, DOI 10.1016/j.celrep.2014.09.038; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hussain T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11177-1; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Largy E, 2011, ANAL BIOANAL CHEM, V400, P3419, DOI 10.1007/s00216-011-5018-z; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Majumdar A, 2002, ACCOUNTS CHEM RES, V35, P1, DOI 10.1021/ar010097+; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mirkin SM, 2008, FRONT BIOSCI-LANDMRK, V13, P1064, DOI 10.2741/2744; Mukherjee AK, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007782; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Pandita TK, 2009, DNA DAMAGE RESPONSE: IMPLICATIONS ON CANCER FORMATION AND TREATMENT, P133, DOI 10.1007/978-90-481-2561-6_7; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Paramasivam M, 2009, NUCLEIC ACIDS RES, V37, P2841, DOI 10.1093/nar/gkp138; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Purohit G, 2018, BIOCHEMISTRY-US, V57, P2317, DOI 10.1021/acs.biochem.8b00019; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Saha D, 2017, J BIOL CHEM, V292, P15205, DOI 10.1074/jbc.M117.792077; Schaffitzel C, 2010, METHODS MOL BIOL, V608, P159, DOI 10.1007/978-1-59745-363-9_11; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Tran PLT, 2011, BIOCHIMIE, V93, P1288, DOI 10.1016/j.biochi.2011.05.011; Tse WC, 2004, ACCOUNTS CHEM RES, V37, P61, DOI 10.1021/ar030113y; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Wang Q, 2011, NUCLEIC ACIDS RES, V39, P6229, DOI 10.1093/nar/gkr164; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; Wood AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6467; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Xing YP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08125; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048	64	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17709	17722		10.1074/jbc.RA119.008687	http://dx.doi.org/10.1074/jbc.RA119.008687			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31575660	Green Published, hybrid			2022-12-26	WOS:000504206800001
J	Qin, L; Mizrak, A; Guimaraes, DSPSF; Tambrin, HM; Morgan, DO; Hall, MC				Qin, Liang; Mizrak, Arda; Guimaraes, Dimitrius Santiago P. S. F.; Tambrin, Hana M.; Morgan, David O.; Hall, Mark C.			The pseudosubstrate inhibitor Acm1 inhibits the anaphase-promoting complex/cyclosome by combining high-affinity activator binding with disruption of Doc1/Apc10 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; proteolysis; inhibitor; E3 ubiquitin ligase; inhibition mechanism; Acm1; anaphase-promoting complex; APC; C; destruction box; pseudosubstrate inhibitor	MITOTIC CHECKPOINT COMPLEX; PROCESSIVITY FACTOR; REGULATORY NETWORK; SUBSTRATE-BINDING; UBIQUITIN LIGASE; APC/C; DESTRUCTION; MECHANISM; RECOGNITION; CDH1	The anaphase-promoting complex/cyclosome (APC/C) is a large, multisubunit ubiquitin ligase involved in regulation of cell division. APC/C substrate specificity arises from binding of short degron motifs in its substrates to transient activator subunits, Cdc20 and Cdh1. The destruction box (D-box) is the most common APC/C degron and plays a crucial role in substrate degradation by linking the activator to the Doc1/Apc10 subunit of core APC/C to stabilize the active holoenzyme and promote processive ubiquitylation. Degrons are also employed as pseudosubstrate motifs by APC/C inhibitors, and pseudosubstrates must bind their cognate activators tightly to outcompete substrate binding while blocking their own ubiquitylation. Here we examined how APC/C activity is suppressed by the small pseudosubstrate inhibitor Acm1 from budding yeast (Saccharomyces cerevisiae). Mutation of a conserved D-box converted Acm1 into an efficient ABBA (cyclin A, BubR1, Bub1, Acm1) motif-dependent APC/C-Cdh1 substrate in vivo, suggesting that this D-box somehow inhibits APC/C. We then identified a short conserved sequence at the C terminus of the Acm1 D-box that was necessary and sufficient for APC/C inhibition. In several APC/C substrates, the corresponding D-box region proved to be important for their degradation despite poor sequence conservation, redefining the D-box as a 12-amino acid motif. Biochemical analysis suggested that the Acm1 D-box extension inhibits reaction processivity by perturbing the normal interaction with Doc1/Apc10. Our results reveal a simple, elegant mode of pseudosubstrate inhibition that combines high-affinity activator binding with specific disruption of Doc1/Apc10 function in processive ubiquitylation.	[Qin, Liang; Guimaraes, Dimitrius Santiago P. S. F.; Tambrin, Hana M.; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Qin, Liang; Guimaraes, Dimitrius Santiago P. S. F.; Tambrin, Hana M.; Hall, Mark C.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Mizrak, Arda; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Mizrak, Arda; Morgan, David O.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Hall, MC (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011	Morgan, David/0000-0001-8753-4416; Tambrin, Hana Maldivita/0000-0002-3951-4266	Purdue Center for Cancer Research Shared Resources Program via NIH NCI Grant [P30 CA023168]; Purdue University Office of the Executive Vice President for Research and Partnerships; College of Agriculture; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118053] Funding Source: NIH RePORTER	Purdue Center for Cancer Research Shared Resources Program via NIH NCI Grant; Purdue University Office of the Executive Vice President for Research and Partnerships; College of Agriculture; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the Purdue Center for Cancer Research Shared Resources Program via NIH NCI Grant P30 CA023168. We thank the Purdue University Office of the Executive Vice President for Research and Partnerships as well as the College of Agriculture for funding support.	Alfieri C, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170204; Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold L, 2015, MOL BIOL CELL, V26, P843, DOI 10.1091/mbc.E14-09-1342; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Kimata Y, 2011, MOL BIOL CELL, V22, P1486, DOI 10.1091/mbc.E10-09-0774; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Martinez JS, 2012, CELL CYCLE, V11, P384, DOI 10.4161/cc.11.2.18944; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Qin L, 2016, J BIOL CHEM, V291, P15564, DOI 10.1074/jbc.M116.731190; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Zhang SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11833-2	44	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17249	17261		10.1074/jbc.RA119.009468	http://dx.doi.org/10.1074/jbc.RA119.009468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31562243	Green Published, hybrid			2022-12-26	WOS:000503173500008
J	Shen, XF; Zhao, L; Chen, PH; Gong, YQ; Liu, DD; Zhang, X; Dai, LZ; Sun, QX; Lou, JZ; Jin, Z; Zhang, BH; Niu, DW; Chen, CS; Qi, XB; Jia, D				Shen, Xiaofei; Zhao, Lin; Chen, Peihao; Gong, Yanqiu; Liu, Dingdong; Zhang, Xia; Dai, Lunzhi; Sun, Qingxiang; Lou, Jizhong; Jin, Zhong; Zhang, Baohua; Niu, Dawen; Chen, Ceshi; Qi, Xiangbing; Jia, Da			A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						STAT3; allosteric regulation; anticancer drug; chemical biology; cell signaling; allosteric effect; anticancer therapeutics; gene regulation; oridonin analogue; ovarian cancer	SIGNAL TRANSDUCER; GP130 INHIBITOR; CANCER; TRANSCRIPTION-3; ACTIVATION; DISCOVERY; TARGET; DOMAIN; EXPRESSION; PATHWAY	Constitutive activation of signal transducer and activator of transcription 3 (STAT3) occurs in similar to 70% of human cancers, and STAT3 is regarded as one of the most promising targets for cancer therapy. However, specific direct STAT3 inhibitors remain to be developed. Oridonin is an ent-kaurane plant-derived diterpenoid with anti-cancer and anti-inflammatory activities. Here, using an array of cell-based and biochemical approaches, including cell proliferation and apoptosis assays, pulldown and reporter gene assays, site-directed mutagenesis, and molecular dynamics analyses, we report that a thiazole-derived oridonin analogue, CYD0618, potently and directly inhibits STAT3. We found that CYD0618 covalently binds to Cys-542 in STAT3 and suppresses its activity through an allosteric effect, effectively reducing STAT3 dimerization and nuclear translocation, as well as decreasing expression of STAT3-targeted oncogenes. Remarkably, CYD0618 not only strongly inhibited growth of multiple cancer cell lines that harbor constitutive STAT3 activation, but it also suppressed in vivo tumor growth via STAT3 inhibition. Taken together, our findings suggest Cys-542 as a druggable site for selectively inhibiting STAT3 and indicate that CYD0618 represents a promising lead compound for developing therapeutic agents against STAT3-driven diseases.	[Shen, Xiaofei; Zhao, Lin; Gong, Yanqiu; Liu, Dingdong; Zhang, Xia; Dai, Lunzhi; Sun, Qingxiang; Niu, Dawen; Jia, Da] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Peoples R China; [Shen, Xiaofei; Zhao, Lin; Gong, Yanqiu; Liu, Dingdong; Zhang, Xia; Dai, Lunzhi; Sun, Qingxiang; Niu, Dawen; Jia, Da] Sichuan Univ, West China Univ Hosp 2, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Shen, Xiaofei; Zhao, Lin; Gong, Yanqiu; Liu, Dingdong; Zhang, Xia; Dai, Lunzhi; Sun, Qingxiang; Niu, Dawen; Jia, Da] Collaborat Innovat Ctr, Chengdu 610041, Peoples R China; [Chen, Peihao] Peking Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chen, Peihao; Qi, Xiangbing] NIBS, Beijing 102206, Peoples R China; [Lou, Jizhong] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Jin, Zhong; Zhang, Baohua] Chinese Acad Sci, Comp Network Informat Ctr, Beijing 100190, Peoples R China; [Jin, Zhong; Zhang, Baohua] Chinese Acad Sci, Ctr Sci Comp Applicat & Res, Beijing 100190, Peoples R China; [Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China	Sichuan University; Sichuan University; Peking University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Computer Network Information Center, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology	Jia, D (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Peoples R China.; Jia, D (corresponding author), Sichuan Univ, West China Univ Hosp 2, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Jia, D (corresponding author), Collaborat Innovat Ctr, Chengdu 610041, Peoples R China.	Jiada@scu.edu.cn	; qi, xiangbing/A-4043-2019	Jia, Da/0000-0002-2205-1998; Gong, Yanqiu/0000-0001-7890-5158; qi, xiangbing/0000-0002-7139-5164; Dai, Lunzhi/0000-0002-3003-8910	National Key Research and Development Program of China [2018YFC1005004]; Natural Science Foundation of China (NSFC) [91854121, 31871429, 31671477]; West China Second University Hospital of Sichuan University; Health and Family Planning Commission of Sichuan Province [17PJ485]; Department of Science and Technology of Sichuan Province [2018RZ0128, 2018GZ0043]	National Key Research and Development Program of China; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); West China Second University Hospital of Sichuan University; Health and Family Planning Commission of Sichuan Province; Department of Science and Technology of Sichuan Province	This work was supported by National Key Research and Development Program of China Grant 2018YFC1005004; Natural Science Foundation of China (NSFC) Grants 91854121, 31871429, and 31671477; West China Second University Hospital of Sichuan University (Xin-ya fund); Health and Family Planning Commission of Sichuan Province Grant 17PJ485; and Department of Science and Technology of Sichuan Province Grants 2018RZ0128 and 2018GZ0043. The authors declare that they have no conflicts of interest with the contents of this article.	Bauer RA, 2015, DRUG DISCOV TODAY, V20, P1061, DOI 10.1016/j.drudis.2015.05.005; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Butturini E, 2014, ACS CHEM BIOL, V9, P1885, DOI 10.1021/cb500407d; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Ding CY, 2013, J MED CHEM, V56, P5048, DOI 10.1021/jm400367n; Ding Y, 2016, EUR J MED CHEM, V122, P102, DOI 10.1016/j.ejmech.2016.06.015; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Furtek SL, 2016, ACS CHEM BIOL, V11, P308, DOI 10.1021/acschembio.5b00945; Grimster NP, 2018, J MED CHEM, V61, P5235, DOI 10.1021/acs.jmedchem.8b00076; Groner B, 2017, MOL CELL ENDOCRINOL, V451, P1, DOI 10.1016/j.mce.2017.05.033; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Huang M, 2018, NUCLEIC ACIDS RES, V46, pW451, DOI 10.1093/nar/gky374; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igbe I, 2017, ONCOTARGET, V8, P113734, DOI 10.18632/oncotarget.22556; Kadioglu O, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00355; Karnezis AN, 2017, NAT REV CANCER, V17, P65, DOI 10.1038/nrc.2016.113; Kim M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092708; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; Krause A, 2002, J IMMUNOL, V169, P6610, DOI 10.4049/jimmunol.169.11.6610; Lampela O, 2003, J PHYS CHEM A, V107, P9208, DOI 10.1021/jp030556j; Lan CY, 2018, LANCET ONCOL, V19, P1239, DOI 10.1016/S1470-2045(18)30349-8; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mertens C, 2015, P NATL ACAD SCI USA, V112, P14811, DOI 10.1073/pnas.1515876112; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nam S, 2013, MOL ONCOL, V7, P369, DOI 10.1016/j.molonc.2012.10.013; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Nussinov R, 2015, ANNU REV PHARMACOL, V55, P249, DOI 10.1146/annurev-pharmtox-010814-124401; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prele Cecilia M, 2012, Proc Am Thorac Soc, V9, P177, DOI 10.1513/pats.201201-007AW; Qiao L, 2009, DRUG RESIST UPDATE, V12, P55, DOI 10.1016/j.drup.2009.02.002; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Wong ALA, 2017, EXPERT OPIN INV DRUG, V26, P883, DOI 10.1080/13543784.2017.1351941; Wu J, 2016, CANCER LETT, V380, P393, DOI 10.1016/j.canlet.2016.06.024; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Wu XJ, 2016, MOL CANCER THER, V15, P2609, DOI 10.1158/1535-7163.MCT-15-0921; Xu SL, 2013, MOL CANCER THER, V12, P937, DOI 10.1158/1535-7163.MCT-12-1082; Xu W, 2006, ACTA PHARMACOL SIN, V27, P1642, DOI 10.1111/j.1745-7254.2006.00440.x; Yeh JE, 2016, CHEMMEDCHEM, V11, P795, DOI 10.1002/cmdc.201500482; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yue PB, 2016, CANCER RES, V76, P652, DOI 10.1158/0008-5472.CAN-14-3558; Zhang T, 2017, ONCOGENE, V36, P6627, DOI 10.1038/onc.2017.270; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	55	13	14	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17471	17486		10.1074/jbc.RA119.009801	http://dx.doi.org/10.1074/jbc.RA119.009801			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31594861	Green Published, hybrid			2022-12-26	WOS:000503173500025
J	Chen, YC; Su, YC; Shieh, GS; Su, BH; Su, WC; Huang, PH; Jiang, ST; Shiau, AL; Wu, CL				Chen, Yi-Cheng; Su, Yu-Chu; Shieh, Gia-Shing; Su, Bing-Hua; Su, Wen-Cheng; Huang, Pei-Hsin; Jiang, Si-Tse; Shiau, Ai-Li; Wu, Chao-Liang			Prothymosin alpha promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice	FASEB JOURNAL			English	Article						polycystic kidney disease; HDAC3; tubulogenesis	POLYCYSTIC KIDNEY-DISEASE; CYSTIC KIDNEY; PRIMARY CILIA; OVEREXPRESSION; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; MODULATION; EXPRESSION; PROTEIN	Polycystic kidney disease (PKD) is characterized by the expansion of fluid-filled cysts in the kidney, which impair the function of kidney and eventually leads to end-stage renal failure. It has been previously demonstrated that transgenic overexpression of prothymosin alpha (ProT) induces the development of PKD; however, the underlying mechanisms remain unclear. In this study, we used a mouse PKD model that sustains kidney-specific low-expression of Pkd1 to illustrate that aberrant up-regulation of ProT occurs in cyst-lining epithelial cells, and we further developed an in vitro cystogenesis model to demonstrate that the suppression of ProT is sufficient to reduce cyst formation. Next, we found that the expression of ProT was accompanied with prominent augmentation of protein acetylation in PKD, which results in the activation of downstream signal transducer and activator of transcription (STAT) 3. The pathologic role of STAT3 in PKD has been previously reported. We determined that this molecular mechanism of protein acetylation is involved with the interaction between ProT and STAT3; consequently, it causes the deprivation of histone deacetylase 3 from the indicated protein. Conclusively, these results elucidate the significant role of ProT, including protein acetylation and STAT3 activation in PKD, which represent potential for ameliorating the disease progression of PKD.	[Chen, Yi-Cheng; Su, Yu-Chu; Su, Bing-Hua; Su, Wen-Cheng; Wu, Chao-Liang] Natl Cheng Kung Univ Hosp, Dept Biochem & Mol Biol, Tainan, Taiwan; [Su, Yu-Chu] Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan, Taiwan; [Shiau, Ai-Li] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, 1 Univ Rd, Tainan 70101, Taiwan; [Shieh, Gia-Shing] Minist Hlth & Welf Execut Yuan, Tainan Hosp, Dept Urol, Tainan, Taiwan; [Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Jiang, Si-Tse] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital; National Applied Research Laboratories - Taiwan	Shiau, AL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, 1 Univ Rd, Tainan 70101, Taiwan.; Wu, CL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, 1 Univ Rd, Tainan 70101, Taiwan.	alshiau@mail.ncku.edu.tw; wumolbio@mail.ncku.edu.tw		Chen, Yi-Cheng/0000-0002-7255-2176	Ministry of Science and Technology (MOST) [103-2320-B-006-047-MY3, 105-2320-B-006-038-MY3]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	The authors are grateful to Dr. A. B. Vartapetian (Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia) for generously providing the anti-ProT mAb (clone 2F11). The RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center (Academia Sinica, Taipei, Taiwan). This work was supported by grants from the Ministry of Science and Technology (MOST) (103-2320-B-006-047-MY3 and 105-2320-B-006-038-MY3). The authors declare no conflicts of interest.	Avasthi P, 2017, RESULTS PROBL CELL D, V60, P281, DOI 10.1007/978-3-319-51436-9_11; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Cotter MA, 2000, MOL CELL BIOL, V20, P5722, DOI 10.1128/MCB.20.15.5722-5735.2000; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Ghataand J, 2017, COMPR PHYSIOL, V7, P945, DOI 10.1002/cphy.c160018; Gomez-Marquez J, 2007, ANN NY ACAD SCI, V1112, P201, DOI 10.1196/annals.1415.020; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Jou YC, 2013, UROL ONCOL-SEMIN ORI, V31, P1806, DOI 10.1016/j.urolonc.2012.03.011; Karetsou Z, 2002, EMBO REP, V3, P361, DOI 10.1093/embo-reports/kvf071; Ko JY, 2016, ADV EXP MED BIOL, V933, P45, DOI 10.1007/978-981-10-2041-4_5; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Kwon SH, 2011, CURR BIOL, V21, P161, DOI 10.1016/j.cub.2010.12.037; Leonhard WN, 2011, AM J PHYSIOL-RENAL, V300, pF1193, DOI 10.1152/ajprenal.00419.2010; Letsas KP, 2006, NEOPLASMA, V53, P92; Li JS, 2017, HUM MOL GENET, V26, P2949, DOI 10.1093/hmg/ddx183; Li KJ, 2005, KIDNEY INT, V67, P1710, DOI 10.1111/j.1523-1755.2005.00268.x; Liu B, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-109; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049418; Ma M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028209; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Moreira D, 2013, BIOCHEM CELL BIOL, V91, P265, DOI 10.1139/bcb-2012-0090; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nigro EA, 2015, CELLS-BASEL, V4, P687, DOI 10.3390/cells4040687; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin S, 2012, J AM SOC NEPHROL, V23, P1309, DOI 10.1681/ASN.2011030277; SANTOS OFP, 1993, DEV BIOL, V159, P535, DOI 10.1006/dbio.1993.1262; Su BH, 2016, J PATHOL, V238, P412, DOI 10.1002/path.4664; Su BH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2906; Subramanian C, 2002, J VIROL, V76, P4699, DOI 10.1128/JVI.76.10.4699-4708.2002; Sukhacheva EA, 2002, J IMMUNOL METHODS, V266, P185, DOI 10.1016/S0022-1759(02)00098-4; Takakura A, 2011, HUM MOL GENET, V20, P4143, DOI 10.1093/hmg/ddr338; Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; Ueda H, 2010, ANN NY ACAD SCI, V1194, P20, DOI 10.1111/j.1749-6632.2010.05466.x; Ueda H, 2009, PHARMACOL THERAPEUT, V123, P323, DOI 10.1016/j.pharmthera.2009.05.007; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401	44	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13051	13061		10.1096/fj.201900504R	http://dx.doi.org/10.1096/fj.201900504R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31589480	Bronze, Green Published			2022-12-26	WOS:000507461600111
J	Choonoo, G; Blucher, AS; Higgins, S; Boardman, M; Jeng, S; Zheng, C; Jacobs, J; Anderson, A; Chamberlin, S; Evans, N; Vigoda, M; Cordier, B; Tyner, JW; Kulesz-Martin, M; McWeeney, SK; Laderas, T				Choonoo, Gabrielle; Blucher, Aurora S.; Higgins, Samuel; Boardman, Mitzi; Jeng, Sophia; Zheng, Christina; Jacobs, James; Anderson, Ashley; Chamberlin, Steven; Evans, Nathaniel; Vigoda, Myles; Cordier, Benjamin; Tyner, Jeffrey W.; Kulesz-Martin, Molly; McWeeney, Shannon K.; Laderas, Ted			Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; SYNTHETIC LETHALITY; CANCER; GENOME; RISK; COMBINATION; EXPRESSION; LANDSCAPE; MUTATION; THERAPY	Head and neck squamous cell carcinoma (HNSCC) remains a morbid disease with poor prognosis and treatment that typically leaves patients with permanent damage to critical functions such as eating and talking. Currently only three targeted therapies are FDA approved for use in HNSCC, two of which are recently approved immunotherapies. In this work, we identify biological pathways involved with this disease that could potentially be targeted by current FDA approved cancer drugs and thereby expand the pool of potential therapies for use in HNSCC treatment. We analyzed 508 HNSCC patients with sequencing information from the Genomic Data Commons (GDC) database and assessed which biological pathways were significantly enriched for somatic mutations or copy number alterations. We then further classified pathways as either "light" or "dark" to the current reach of FDA-approved cancer drugs using the Cancer Targetome, a compendium of drug-target information. Light pathways are statistically enriched with somatic mutations (or copy number alterations) and contain one or more targets of current FDA-approved cancer drugs, while dark pathways are enriched with somatic mutations (or copy number alterations) but not currently targeted by FDA-approved cancer drugs. Our analyses indicated that approximately 35-38% of disease-specific pathways are in scope for repurposing of current cancer drugs. We further assess light and dark pathways for subgroups of patient tumor samples according to HPV status. The framework of light and dark pathways for HNSCC-enriched biological pathways allows us to better prioritize targeted therapies for further research in HNSCC based on the HNSCC genetic landscape and FDA-approved cancer drug information. We also highlight the importance in the identification of sub-pathways where targeting and cross targeting of other pathways may be most beneficial to predict positive or negative synergy with potential clinical significance. This framework is ideal for precision drug panel development, as well as identification of highly aberrant, untargeted candidates for future drug development.	[Choonoo, Gabrielle; Blucher, Aurora S.; Jeng, Sophia; Zheng, Christina; Jacobs, James; Tyner, Jeffrey W.; McWeeney, Shannon K.; Laderas, Ted] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Choonoo, Gabrielle; Higgins, Samuel; Boardman, Mitzi; Zheng, Christina; Jacobs, James; Chamberlin, Steven; Evans, Nathaniel; Cordier, Benjamin; McWeeney, Shannon K.; Laderas, Ted] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [Blucher, Aurora S.; Vigoda, Myles; Tyner, Jeffrey W.; Kulesz-Martin, Molly] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Jeng, Sophia; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Jacobs, James] OHSU Doernbecher Childrens Hosp, Pediat Hematol & Oncol, Portland, OR USA; [Anderson, Ashley; Vigoda, Myles; Kulesz-Martin, Molly] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Choonoo, Gabrielle] Regeneron Pharmaceut, Tarrytown, NY USA; [Higgins, Samuel] Roche Sequencing Solut, Santa Clara, CA USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Regeneron	Blucher, AS (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Blucher, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.	blucher@ohsu.edu		Blucher, Aurora/0000-0001-6460-010X; Anderson, Ashley/0000-0002-7522-846X; Cordier, Benjamin/0000-0001-5122-7879	National Cancer Institute [1R01CA192405]; National Library of Medicine Informatics Training Grant [T15LM007088]; Knight Cancer Institute [P30 CA069533]; National Center for Advancing Translational Sciences [5UL1TR000128]; NATIONAL CANCER INSTITUTE [R01CA192405, P30CA069533] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine Informatics Training Grant; Knight Cancer Institute; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Cancer Institute 1R01CA192405 (MKM, SKM), National Library of Medicine Informatics Training Grant T15LM007088 (ASB, MB, SC, BC), Knight Cancer Institute P30 CA069533 and the National Center for Advancing Translational Sciences 5UL1TR000128 (SKM). Samuel Higgins is now employed by Roche Sequencing Solutions and Gabrielle Choonoo is now employed by Regeneron Pharmaceuticals. Their contributions to this paper as outlined in the author contributions section were made while they were employed by Oregon Health & Science University, and as such their current employers did not play a role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	American Cancer Society, 2018, CANC FACTS FIG 2018; Benjamini Y, 2001, ANN STAT, V29, P1165; Blucher Aurora S, 2019, F1000Res, V8, P908, DOI 10.12688/f1000research.19592.1; Blucher AS, 2017, TRENDS PHARMACOL SCI, V38, P1085, DOI 10.1016/j.tips.2017.08.006; Brand TM, 2018, CANCER RES, V78, P2383, DOI 10.1158/0008-5472.CAN-17-1672; Chen JJ, 2013, ONCOTARGET, V4, P206, DOI 10.18632/oncotarget.813; Chin D, 2004, BRIT J PLAST SURG, V57, P595, DOI 10.1016/j.bjps.2004.06.010; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Eckhardt M, 2018, CANCER DISCOV, V8, P1474, DOI 10.1158/2159-8290.CD-17-1018; Economopoulou P, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000122; Ferrari E, 2010, EUR J CANCER, V46, P2889, DOI 10.1016/j.ejca.2010.07.031; Fukusumi T, 2018, J DENT RES, V97, P645, DOI 10.1177/0022034518760297; Furquim CP, 2018, CRIT REV ONCOL HEMAT, V125, P35, DOI 10.1016/j.critrevonc.2018.02.013; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2019, GENOME RES, V29, P1, DOI 10.1101/gr.241141.118; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gross AM, 2014, NAT GENET, V46, P939, DOI 10.1038/ng.3051; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hedberg ML, 2019, J EXP MED, V216, P419, DOI 10.1084/jem.20181936; Higgins S., 2016, DRUG SENSITIVITIES C, DOI [10.6083/m48k7732, DOI 10.6083/M48K7732]; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jung AC, 2013, CLIN CANCER RES, V19, P4174, DOI 10.1158/1078-0432.CCR-12-3690; Jung M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020273; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kurtz SE, 2017, P NATL ACAD SCI USA, V114, pE7554, DOI 10.1073/pnas.1703094114; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Moskovitz J, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0654-5; Murphy BA, 2007, CRIT REV ONCOL HEMAT, V62, P251, DOI 10.1016/j.critrevonc.2006.07.005; National Cancer Institute (NCI), 2019, TARG CANC THER; Nulton TJ, 2017, ONCOTARGET, V8, P17684, DOI 10.18632/oncotarget.15179; Nyman PE, 2018, CLIN CANCER RES, V24, P6308, DOI 10.1158/1078-0432.CCR-17-3535; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Perdomo S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191701; Scheckenbach K, 2012, KLIN PADIATR, V224, P132, DOI 10.1055/s-0032-1308989; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siu LL, 2019, JAMA ONCOL, V5, P195, DOI 10.1001/jamaoncol.2018.4628; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taberna M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00383; Teng MS, 2005, ARCH OTOLARYNGOL, V131, P407, DOI 10.1001/archotol.131.5.407; Union for International Cancer Control, 2014, LOC ADV SQUAM CELL C; Velleuer Eunike, 2014, Mol Cell Pediatr, V1, P9, DOI 10.1186/s40348-014-0009-8; Worsham MJ, 2011, EXPERT REV ANTICANC, V11, P1321, DOI [10.1586/era.11.135, 10.1586/ERA.11.135]; Wu Guanming, 2014, F1000Res, V3, P146, DOI 10.12688/f1000research.4431.1; Zhou LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051545	50	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223639	10.1371/journal.pone.0223639	http://dx.doi.org/10.1371/journal.pone.0223639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596908	gold, Green Published			2022-12-26	WOS:000532444100053
J	Descamps, AMK; Vandijck, DM; Buylaert, WA; Mostin, MA; De Paepe, P				Descamps, Anne-Marie K.; Vandijck, Dominique M.; Buylaert, Walter A.; Mostin, Martine A.; De Paepe, Peter			Characteristics and costs in adults with acute poisoning admitted to the emergency department of a university hospital in Belgium	PLOS ONE			English	Article							ACUTE INTOXICATION; UNITED-STATES; ALCOHOL; VISITS; IMPACT; OSLO	Objective The aims of this study were to assess the characteristics of all acute poisoning admissions among adult emergency department (ED) patients, to identify factors associated with admission and to calculate direct medical cost. Methods Data of 2017 (1st January to 31st December) were collected and analyzed retrospectively using patients' medical records and hospital invoices. Factors associated with type of hospitalization were identified using appropriate statistics. Results A total of 1,214 hospital admissions were included, accounting for 3.6% of all ED admissions. Men (62.2%) and the age group 21-40 years (43.0%) accounted for the largest proportion. Substances most commonly involved were ethanol (52.9%), benzodiazepines (9.7%), cocaine (4.9%), cannabis (4.6%), antidepressants (4.6%) and psychostimulants (4.6%). A total of 4,561 treatment acts were recorded, most commonly monitoring of vital signs (63.6%) and medication and/or intravenous drip administration (62.9%). Patients were discharged home after having received care in the emergency department (ED-amb) in 54.5% of admissions, were admitted to the emergency-department-24-hours-observation unit (ED-24h) or were hospitalized (Hosp) in 24.6% and 20.9% of admissions, respectively. Factors found to be associated with hospitalization type were age, hour of admission, victim location, degree of severity, use of antidotes, involvement of antidepressants, antipsychotics, psychostimulants, benzodiazepines and ethanol. Total cost was (sic)1,512,346 with an average of (sic)1,287 per admission. Conclusion Poisonings entail a considerable percentage of patients admitted to an ED and financial burden. In particular, ethanol poisonings account for the largest proportion of all ED admissions. Comparison of our figures with other data is hampered by the heterogeneity in inclusion criteria. Availability of a uniform template would facilitate comparison and allow better monitoring policies for prevention and cost reduction.	[Descamps, Anne-Marie K.; Mostin, Martine A.] Ctr Antipoisons, Antigifctr, Brussels, Belgium; [Descamps, Anne-Marie K.; Vandijck, Dominique M.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Descamps, Anne-Marie K.; Vandijck, Dominique M.] Hasselt Univ, Dept Med & Hlth Sci, Diepenbeek, Belgium; [Buylaert, Walter A.; De Paepe, Peter] Ghent Univ Hosp, Dept Emergency Med, Ghent, Belgium	Ghent University; Hasselt University; Ghent University; Ghent University Hospital	Descamps, AMK (corresponding author), Ctr Antipoisons, Antigifctr, Brussels, Belgium.; Descamps, AMK (corresponding author), Univ Ghent, Dept Publ Hlth, Ghent, Belgium.; Descamps, AMK (corresponding author), Hasselt Univ, Dept Med & Hlth Sci, Diepenbeek, Belgium.	annemarie.descamps@ugent.be		Descamps, Anne-Marie/0000-0003-0448-4420				Akkas M, 2004, VET HUM TOXICOL, V46, P213; Anderson P., 2006, ALCOHOL EUROPE; Burillo-Putze G, 2003, EUR J EMERG MED, V10, P101, DOI 10.1097/00063110-200306000-00006; Cronin J G, 2003, Accid Emerg Nurs, V11, P121, DOI 10.1016/S0965-2302(02)00218-7; Cummins RO, 1997, ANN EMERG MED, V29, P650, DOI 10.1016/S0196-0644(97)70256-7; Duineveld C, 2012, CLIN TOXICOL, V50, P120, DOI 10.3109/15563650.2011.649092; Guloglu C, 2005, HUM EXP TOXICOL, V24, P49, DOI 10.1191/0960327105ht499oa; Hendrix L, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-201033; Heyerdahl F, 2008, CLIN TOXICOL, V46, P42, DOI [10.1080/15563650701210048, 10.3109/15563650701210048]; Heyerdahl F, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-15; Hovda KE, 2008, CLIN TOXICOL, V46, P35, DOI 10.1080/15563650601185969; Inocencio TJ, 2013, PAIN MED, V14, P1534, DOI 10.1111/pme.12183; Jang HS, 2013, J KOREAN MED SCI, V28, P1424, DOI 10.3346/jkms.2013.28.10.1424; Kapur N, 1999, POSTGRAD MED J, V75, P599, DOI 10.1136/pgmj.75.888.599; Kavalci G, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10856; Kaya E, 2015, WORLD J EMERG MED, V6, P54, DOI 10.5847/wjem.j.1920-8642.2015.01.010; Krajewski AK, 2015, CLIN TOXICOL, V53, P433, DOI 10.3109/15563650.2015.1030677; Kristinsson J, 2008, CLIN TOXICOL, V46, P126, DOI 10.1080/15563650701438268; LAMMINPAA A, 1993, J CLIN EPIDEMIOL, V46, P47, DOI 10.1016/0895-4356(93)90008-O; Lipnik-Stangelj M, 2010, WIEN KLIN WOCHENSCHR, V122, P54, DOI 10.1007/s00508-010-1338-9; Lund C, 2012, SCAND J TRAUMA RESUS, V20; Lund C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-1; Majori S, 2012, J Prev Med Hyg, V53, P8; McCaig LF, 1999, J TOXICOL-CLIN TOXIC, V37, P817, DOI 10.1081/CLT-100102460; McMahon A, 2014, IRISH J MED SCI, V183, P391, DOI 10.1007/s11845-013-1026-7; Munoz R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152876; OECD, 2017, HLTH GLANC, DOI 10.1787/health_glance-2017-en; Okumura Y, 2012, GEN HOSP PSYCHIAT, V34, P681, DOI 10.1016/j.genhosppsych.2012.07.009; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Riddell S, 2008, AUST NZ J PUBL HEAL, V32, P156, DOI 10.1111/j.1753-6405.2008.00193.x; Satar S, 2009, BRATISL MED J, V110, P404; Serinken M, 2008, MED SCI MONITOR, V14, pCR152; Vallersnes Odd Martin, 2016, BMC Res Notes, V9, P398, DOI 10.1186/s13104-016-2200-6; Verelst S, 2012, ALCOHOL ALCOHOLISM, V47, P433, DOI 10.1093/alcalc/ags035; Verstraete A G, 1995, Eur J Emerg Med, V2, P217, DOI 10.1097/00063110-199512000-00008; White AM, 2011, J STUD ALCOHOL DRUGS, V72, P774, DOI 10.15288/jsad.2011.72.774; World Health Organization, POIS PREV MAN; Xiang Y, 2010, AM J EMERG MED, V30, P293; Zohre E, 2015, ARCH IRAN MED, V18, P117, DOI 015182/AIM.0011	39	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223479	10.1371/journal.pone.0223479	http://dx.doi.org/10.1371/journal.pone.0223479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584988	Green Published, gold			2022-12-26	WOS:000532407600039
J	Alleaume, C; Bendiane, MK; Peretti-Watel, P; Bouhnik, AD				Alleaume, Caroline; Bendiane, Marc-Karim; Peretti-Watel, Patrick; Bouhnik, Anne-Deborah			Inequality in income change among cancer survivors five years after diagnosis: Evidence from a French national survey	PLOS ONE			English	Article							BREAST-CANCER; EMPLOYMENT; IMPACT; WORK; RETURN	Worldwide, around 18 million people receive a cancer diagnosis each year, most of whom survive long enough to face additional cancer-related costs. In France, most costs directly related to cancer are covered by the National Health Insurance Fund, and cancer patients can receive treatments without paying advance fees. In this context, the costs faced by cancer survivors are mostly social costs. Drawing on fundamental cause theory, this study aimed to explore the socially-differentiated evolution of cancer survivor's income five years after diagnosis. Our study draws on the findings of VICAN5, a French national survey that was conducted in 2015/2016 in a representative sample of 4,174 cancer survivors to obtain information on living conditions five years after diagnosis, and that was restricted to 12 tumour sites accounting for 88% of global cancer incidence in France. We used the multiple imputation method and the Heckman selection model to identify the factors associated with a decrease in household income per consumption unit (HICU), while accounting for missing data. Among survivors still working five years after diagnosis, 17.6% reported lower income at survey than at diagnosis. After adjustment for socio-demographic and medical characteristics, the decrease in HICU was more frequent in women, singles, low educated survivors, and survivors with reduced working time. Finally, subjective measures of income variation and economic well-being were a useful complement to objective measures since 31.6% of cancer survivors still working five years after diagnosis reported a perceived decrease in household income. In conclusion, inequalities in economic well-being persist long after diagnosis in France, and this despite the fact that most cancer-related costs are covered by the French National Health Insurance Fund. Consequently, more attention should be paid to cancer patients with low socio-economic status to help reduce inequalities in post-diagnosis living conditions.	[Alleaume, Caroline; Bendiane, Marc-Karim; Bouhnik, Anne-Deborah] Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, SESSTIM, INSERM,IRD, Marseille, France; [Peretti-Watel, Patrick] Aix Marseille Univ, AP HM, VITROME, SSA,IRD,IHU Mediterranee Infect, Marseille, France; [Peretti-Watel, Patrick] Observ Reg Sante Provence Alpes Cote Azur, ORS PACA, Marseille, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Bouhnik, AD (corresponding author), Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, SESSTIM, INSERM,IRD, Marseille, France.	anne-deborah.bouhnik@inserm.fr	Bendiane, Marc-Karim K/F-5414-2010; Alleaume, Caroline/GQB-3994-2022; Bouhnik, Anne-Deborah/M-2829-2019	Bendiane, Marc-Karim K/0000-0003-4329-8807; Bouhnik, Anne-Deborah/0000-0002-5418-4592	National Institute of Cancer (INCa), Contrat de recherche et developpement [05-2011]; French league against cancer La Ligue contre le cancer	National Institute of Cancer (INCa), Contrat de recherche et developpement; French league against cancer La Ligue contre le cancer	The VICAN survey was funded by the National Institute of Cancer (INCa), Contrat de recherche et developpement No. 05-2011. However, this institute did not fund this study.; The survey was funded by the National Institute of Cancer (INCa), "Contrat de recherche et developpement no. 05-2011 ". The authors would like to thank the French league against cancer La Ligue contre le cancer for the doctoral fellowship. Many thanks also go to Berengere Davin, Camelia Protopopescu, Asmaa Janah, Marwan-al-Qays Bousmah and Sebastien Cortaredona for their precious advices. Thanks also to all the members of the VICAN team. Lastly, the authors thank Arianne Dorval for revising the English manuscript.	Barbareschi G, 2008, PSYCHO-ONCOL, V17, P373, DOI 10.1002/pon.1243; Bouhnik AD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005971; Bower JE, 2005, ANN BEHAV MED, V29, P236, DOI 10.1207/s15324796abm2903_10; Fenn KM, 2014, J ONCOL PRACT, V10, P332, DOI 10.1200/JOP.2013.001322; FRANCIES FZ, 2015, BMC CANCER, V15, P60174, DOI DOI 10.1186/S12885-015-1168-2; Hagenaars A., 1994, POVERTY STAT LATE 19; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; INCa, 2018, ET LIEUX CONN RECH; INCa (Institut National du Cancer), 2015, CANC FRANC; Insee, 2018, TAUX INFL 2017 DONN; INSEE, 2017, EC SAL ENTR HOMM FEM; Jensen LS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4839-x; Jeon SH, 2017, HEALTH ECON, V26, P671, DOI 10.1002/hec.3342; La Ligue contre le cancer, 2011, RAPP OBS SOC CANC, V140; La Ligue contre le cancer, 2016, IMP SOC CANC, V8; Lauzier S, 2010, QUAL LIFE RES, V19, P177, DOI 10.1007/s11136-009-9575-y; Lee MK, 2008, BRIT J CANCER, V98, P708, DOI 10.1038/sj.bjc.6604236; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Little R. J. A., 1987, STAT ANAL MISSING DA; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; Morin T, 2013, REVENU SALARIAL FEMM; O'Prey S., 2008, NONREPONSE PARTIELLE; Paalman CH, 2016, BRIT J CANCER, V114, P81, DOI 10.1038/bjc.2015.431; Paraponaris A, 2010, HEALTH POLICY, V98, P144, DOI 10.1016/j.healthpol.2010.06.013; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Roth RS, 2002, CLIN J PAIN, V18, P286, DOI 10.1097/00002508-200209000-00003; Rubin D. B., 2004, MULTIPLE IMPUTATION; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Short PF, 2006, MED CARE, V44, P16, DOI 10.1097/01.mlr.0000188986.84819.3a; Singh SR, 2014, CONCEPT SOCIAL VULNE, V1, P12; Syse A, 2012, ACTA ONCOL, V51, P480, DOI 10.3109/0284186X.2011.640710; Syse A, 2009, CANCER-AM CANCER SOC, V115, P4350, DOI 10.1002/cncr.24582; Tiedtke C, 2014, J OCCUP REHABIL, V24, P399, DOI 10.1007/s10926-013-9465-6; Timmons A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077549; Torp S, 2017, J CANCER SURVIV, V11, P189, DOI 10.1007/s11764-016-0578-8; Zajacova A, 2015, CANCER-AM CANCER SOC, V121, P4425, DOI 10.1002/cncr.29510	36	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222832	10.1371/journal.pone.0222832	http://dx.doi.org/10.1371/journal.pone.0222832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581224	Green Published, gold			2022-12-26	WOS:000532398600017
J	Genberg, BL; Hogan, JW; Xu, YZ; Nyambura, M; Tarus, C; Rotich, E; Kafu, C; Wachira, J; Goodrich, S; Braitstein, P				Genberg, Becky L.; Hogan, Joseph W.; Xu, Yizhen; Nyambura, Monicah; Tarus, Caren; Rotich, Elyne; Kafu, Catherine; Wachira, Juddy; Goodrich, Suzanne; Braitstein, Paula			Population-based estimates of engagement in HIV care and mortality using double-sampling methods following home-based counseling and testing in western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; LINKAGE; PROGRAM	Introduction Data on engagement in HIV care from population-based samples in sub-Saharan Africa are limited. The objective of this study was to use double-sampling methods to estimate linkage to HIV care, ART initiation, and mortality among all adults diagnosed with HIV by a comprehensive home-based counseling and testing (HBCT) program in western Kenya. Methods HBCT was conducted door-to-door from December 2009 to April 2011 in three sub-counties of western Kenya by AMPATH (Academic Model Providing Access to Healthcare). For those identified as HIV-positive, data were merged with electronic medical records to determine engagement with HIV care. A randomly-drawn follow-up sample of 120 adults identified via HBCT who had not linked to care as of June 2015 in Bunyala sub-county were visited by trained fieldworkers to ascertain HIV care engagement and vital status. Double-sampled data were used to generate, via multinomial regression, predicted probabilities of engagement in care and mortality among those whose status could not be ascertained by matching with the electronic medical records in the three catchments. Results Incorporating information from the double-sampling yielded estimates of prospective linkage to HIV care that ranged from 40-45%. Mortality estimates of those who did not engage in care following HBCT ranged from 12-16%. Among those who linked to care following HBCT, between 72-81% initiated ART. Discussion In settings without universal national identifiers, rates of linkage to care from community-based programs may be subject to substantial underestimation. Follow-up samples of those with missing information can be used to partially correct this bias, as has been demonstrated previously for mortality among those who were lost-to-care programs. There is a need for harmonized data systems across health systems and programs.	[Genberg, Becky L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Genberg, Becky L.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Hogan, Joseph W.; Xu, Yizhen] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Hogan, Joseph W.; Nyambura, Monicah; Tarus, Caren; Rotich, Elyne; Kafu, Catherine; Wachira, Juddy; Braitstein, Paula] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Wachira, Juddy; Braitstein, Paula] Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya; [Goodrich, Suzanne] Indiana Univ, Sch Med, Div Infect Dis, Indianapolis, IN USA; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Off Global Publ Hlth Educ & Training, Epidemiol Div, Toronto, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Brown University; Brown University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto	Braitstein, P (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Braitstein, P (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya.; Braitstein, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Off Global Publ Hlth Educ & Training, Epidemiol Div, Toronto, ON, Canada.	pbraitstein@gmail.com		Braitstein, Paula/0000-0003-0541-2955; Genberg, Becky/0000-0002-9450-5311; Kafu, Catherine/0000-0003-4890-4458	National Institute of Allergy And Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD); National Institute On Drug Abuse (NIDA); National Cancer Institute (NCI); National Institute of Mental Health (NIMH); National Institutes of Health [U01AI069911]; NIMH [K01MH099966]; NIAD [R01AI108441]; Providence-Boston CFAR [P30AI042853]; Regenstrief Institute; President's Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-623-A-12-0001]; United States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, U01AI069911, R01AI108441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099966] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute On Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Providence-Boston CFAR; Regenstrief Institute; President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), National Institute On Drug Abuse (NIDA), National Cancer Institute (NCI), and the National Institute of Mental Health (NIMH), in accordance with the regulatory requirements of the National Institutes of Health under award number U01AI069911 East Africa IeDEA Consortium (PB). Additional support was provided by NIMH (K01MH099966; BLG), NIAD (R01AI108441; JWH), Providence-Boston CFAR (P30AI042853; JWH) and the Regenstrief Institute (PB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of cooperative agreement no. AID-623-A-12-0001. It is made possible through joint support of the United States Agency for International Development (USAID). The contents of this journal article are the sole responsibility of AMPATH and do not necessarily reflect the views of USAID or the United States Government.	Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Haber N, 2017, LANCET HIV, V4, pE223, DOI 10.1016/S2352-3018(16)30224-7; Inui TS, 2007, J GEN INTERN MED, V22, P1745, DOI 10.1007/s11606-007-0437-4; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Kimaiyo S, 2010, East Afr Med J, V87, P100; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Rachlis B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3462-6; Rachlis B, 2015, JAIDS-J ACQ IMM DEF, V68, pE46, DOI 10.1097/QAI.0000000000000492; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Ruzagira E, 2017, TROP MED INT HEALTH, V22, P807, DOI 10.1111/tmi.12888; Sayers A, 2016, INT J EPIDEMIOL, V45, P954, DOI 10.1093/ije/dyv322; UNAIDS, 2014, 90 90 90 AMB TREATM; Wachira J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0646-6	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223187	10.1371/journal.pone.0223187	http://dx.doi.org/10.1371/journal.pone.0223187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577834	gold, Green Published			2022-12-26	WOS:000532388000024
J	Guomundsdottir, R; Kreiling, AK; Kristjansson, BK; Marteinsson, VP; Palsson, S				Guomundsdottir, Ragnhildur; Kreiling, Agnes-Katharina; Kristjansson, Bjarni Kristofer; Marteinsson, Viggo Por; Palsson, Snaebjorn			Bacterial diversity in Icelandic cold spring sources and in relation to the groundwater amphipod Crangonyx islandicus	PLOS ONE			English	Article							SP NOV.; SUBTERRANEAN ECOSYSTEMS; WATER; FAUNA; BIODIVERSITY; COMMUNITIES; PATTERNS; AQUIFERS; ECOLOGY; BASALT	Crangonyx islandicus is a groundwater amphipod endemic to Iceland, considered to have survived the Ice Ages in subglacial refugia. Currently the species is found in spring sources in lava fields along the tectonic plate boundary of the country. The discovery of a groundwater species in this inaccessible habitat indicates a hidden ecosystem possibly based on che-moautotrophic microorganisms as primary producers. To explore this spring ecosystem, we assessed its microbial diversity and analysed whether and how the diversity varied between the amphipods and the spring water, and if was dependent on environmental factors and geological settings. Isolated DNA from spring water and from amphipods was analysed using metabarcoding methods, targeting the 16S rRNA gene. Two genera of bacteria, Halomonas and Shewanella were dominating in the amphipod samples in terms of relative abundance, but not in the groundwater samples where Flavobacterium, Pseudomonas and Alkanindiges among others were dominating. The richness of the bacteria taxa in the microbial community of the groundwater spring sources was shaped by pH level and the beta diversity was shaped by geographic locations.	[Guomundsdottir, Ragnhildur; Kreiling, Agnes-Katharina; Palsson, Snaebjorn] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Kreiling, Agnes-Katharina; Kristjansson, Bjarni Kristofer] Holar Univ, Dept Aquaculture & Fish Biol, Sauoarkrokur, Iceland; [Marteinsson, Viggo Por] Matis Ohf Iceland Food & Biotech R&D, Reykjavik, Iceland; [Marteinsson, Viggo Por] Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland	University of Iceland; University of Iceland	Guomundsdottir, R (corresponding author), Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland.	rag41@hi.is	Kristjánsson, Bjarni K./B-4349-2013	Kristjánsson, Bjarni K./0000-0001-6984-5771; Marteinsson, Viggo/0000-0001-8340-821X	Icelandic Research Council [130244-051, 141863-051]; University of Iceland	Icelandic Research Council; University of Iceland	This work was supported by the Icelandic Research Council [grant number: 130244-051 to SP and 141863-051 to BKK] and by the doctoral fund at the University of Iceland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NUMERICAL ECOLOGY; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Barquin J, 2008, AQUAT CONSERV, V18, P580, DOI 10.1002/aqc.884; Bartram AK, 2014, FEMS MICROBIOL ECOL, V87, P403, DOI 10.1111/1574-6941.12231; Bartrons M, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00392.1; Bauermeister J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050254; Besemer K, 2012, ISME J, V6, P1459, DOI 10.1038/ismej.2011.205; Bowman J.P., 2015, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608.gbm01183, DOI 10.1002/9781118960608.GBM01183]; Bowman JP, 1997, INT J SYST BACTERIOL, V47; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; BUCKLAND PC, 1986, BOREAS, V15, P173; Cantonati M, 2006, HYDROBIOLOGIA, V562, P59, DOI 10.1007/s10750-005-1806-9; Cantonati M, 2012, FRESHW SCI, V31, P463, DOI 10.1899/11-111.1; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chang HW, 2008, INT J SYST EVOL MICR, V58, P1907, DOI 10.1099/ijs.0.65725-0; Chen H P, 2016, APPL SCI, V179, P1, DOI DOI 10.1038/SREP28902; Cockell CS, 2011, ASTROBIOLOGY, V11, P679, DOI 10.1089/ast.2011.0606; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Falasco E, 2014, INT J SPELEOL, V43, P231, DOI 10.5038/1827-806X.43.3.1; Farnleitner AH, 2005, ENVIRON MICROBIOL, V7, P1248, DOI 10.1111/j.1462-2920.2005.00810.x; Flot JF, 2014, MOL ECOL, V23, P1405, DOI 10.1111/mec.12461; Foulquier A, 2010, FRESHWATER BIOL, V55, P1560, DOI 10.1111/j.1365-2427.2010.02385.x; Fritscher J., 2004, THESIS; Galdenzi S, 2008, J CAVE KARST STUD, V70, P94; Gavish Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109677; Geirsdottir A, 2007, J GEODYN, V43, P170, DOI 10.1016/j.jog.2006.09.017; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 1994, AQUATIC BIOL SERIES; Gislason SR, 1996, AM J SCI, V296, P837, DOI 10.2475/ajs.296.8.837; Glazier D.S., 2009, ENCY INLAND WATERS, VVolume 1, P734, DOI DOI 10.1016/B978-012370626-3.00259-3; Govoni DP, 2018, HYDROBIOLOGIA, V808, P315, DOI 10.1007/s10750-017-3434-6; Griebler C, 2002, AQUAT MICROB ECOL, V28, P117, DOI 10.3354/ame028117; Guomundsson K., 2014, ENV MICROBIAL DIVERS; Hancock PJ, 2005, HYDROGEOL J, V13, P98, DOI 10.1007/s10040-004-0421-6; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Koreimann C, 1996, 141996 EUR ENV AG; Kornobis E, 2010, MOL ECOL, V19, P2516, DOI 10.1111/j.1365-294X.2010.04663.x; Koskinen K, 2017, MBIO, V8, DOI 10.1128/mBio.00824-17; Kreiling AK, 2018, J LIMNOL, V77, P145, DOI 10.4081/jlimnol.2018.1754; Kristjansson BK, 2007, AM NAT, V170, P292, DOI 10.1086/518951; Lascu C., 1989, Miscellanea Speologica Romanica, V1, P13; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Manzari C, 2015, BIOL INVASIONS, V17, P923, DOI 10.1007/s10530-014-0810-2; Mogna M, 2015, ACTA BOT CROAT, V74, P265, DOI 10.1515/botcro-2015-0024; Narrowe AB, 2017, ENVIRON MICROBIOL, V19, P2192, DOI 10.1111/1462-2920.13703; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Newsome L, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy104; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orcutt BN, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.90400904, 10.3389/fmicb.2015.00904]; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Ortiz-Alvarez R, 2016, ENV MICROBIOL REP, V8, P210, DOI 10.1111/1758-2229.12370; Pakes MJ, 2014, J CRUSTACEAN BIOL, V34, P334, DOI 10.1163/1937240X-00002238; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Por FD, 2013, NAT SCI, V5, P7; Por FD, 2007, HYDROBIOLOGIA, V592, P1, DOI 10.1007/s10750-007-0795-2; Power JF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05020-y; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Sarbu SM, 1996, SCIENCE, V272, P1953, DOI 10.1126/science.272.5270.1953; Schmidt SI, 2012, LIMNOLOGICA, V42, P1, DOI 10.1016/j.limno.2011.08.002; Sigurdsson O., 2002, GEOLOGY, V51, P33; Simon KS, 2001, ARCH HYDROBIOL, V151, P67; Simon-Colin C, 2008, J APPL MICROBIOL, V104, P1425, DOI 10.1111/j.1365-2672.2007.03667.x; Svavarsson J, 2006, ZOOTAXA, P1; SVEINBJORNSDOTTIR AE, 1992, OIKOS, V64, P136, DOI 10.2307/3545049; Szczucinska AM, 2013, QUAEST GEOGR, V32, P111, DOI 10.2478/quageo-2013-0019; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tandberg AH, 2012, POLAR BIOL, V35, P705, DOI 10.1007/s00300-011-1115-x; Trias R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01288-8; Tuxen SL, 1944, HOT SPRINGS THEIR AN; VANDERKAMP G, 1995, J KANSAS ENTOMOL SOC, V68, P4; Voisin J, 2016, ECOL INDIC, V71, P577, DOI 10.1016/j.ecolind.2016.07.035; Vreeland RH, 2015, BERGEYS MANUAL SYSTE; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yun Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01955	82	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222527	10.1371/journal.pone.0222527	http://dx.doi.org/10.1371/journal.pone.0222527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577799	Green Published, gold			2022-12-26	WOS:000532388000010
J	de Oliveira, CC; Alves, FV; Martins, PGMD; Karvatte, N; Alves, GF; de Almeida, RG; Mastelaro, AP; Silva, EVDE				de Oliveira, Caroline Carvalho; Alves, Fabiana Villa; Macedo de Almeida Martins, Paulo Gustavo; Karvatte Junior, Nivaldo; Alves, Geovani Ferreira; de Almeida, Roberto Giolo; Mastelaro, Ariadne Pegoraro; da Costa e Silva, Eliane Vianna			Vaginal temperature as indicative of thermoregulatory response in Nellore heifers under different microclimatic conditions	PLOS ONE			English	Article							COWS	The objective was to evaluate vaginal temperature as a thermoregulatory response of Nellore heifers under different microclimatic conditions. The study was conducted during one year in an experimental area located at 54 37'W, 20 27'S, and 530 m of altitude in Brazil. Twenty-four Nellore females were reared in integrated crop-livestock-forestry systems with different shading patterns. The randomized complete block experimental design was utilized with a sub subdivided plots scheme, with plot corresponding to the production systems, the subplot to the season of the year, and the sub subplot, the hours of the day. To characterize the microclimate, data regarding air and black globe temperatures, and air relative humidity were collected and from them, temperature-humidity index was calculated. Vaginal temperature was obtained by using a bottom-type temperature logger (i-button) attached to an adapted intravaginal device. The black-globe temperature explained the variation on vaginal temperature. Increases on vaginal temperature were only observed, on average, two hours after the increase of black-globe temperature. The microclimatic conditions found in the systems, resulting from the various tree densities, modify the vaginal temperature in different degrees, demonstrating that the shading effect is not always accompanied by improvements in thermal comfort. The system with intermediate density showed a better microclimatic condition and, consequently, a lower increase in vaginal temperature. The interaction between air temperature, humidity and solar radiation resulted in adverse environmental conditions, however, Nellore heifers showed good adaptation to the environment. In conclusion, vaginal temperature is a good indicator to evaluate the thermoregulatory response in Nellore heifers.	[de Oliveira, Caroline Carvalho; da Costa e Silva, Eliane Vianna] Univ Fed Mato Grosso do Sul, Fac Vet Med & Anim Sci, Campo Grande, MS, Brazil; [Alves, Fabiana Villa; de Almeida, Roberto Giolo] Embrapa Beef Cattle, Campo Grande, MS, Brazil; [Macedo de Almeida Martins, Paulo Gustavo] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Anim Sci, Diamantina, MG, Brazil; [Karvatte Junior, Nivaldo] Univ Fed Goias, Fac Vet & Anim Sci, Goiania, Go, Brazil; [Alves, Geovani Ferreira] Univ Fed Mato Grosso do Sul, Fac Engn Architecture & Urbanism & Geog, Campo Grande, MS, Brazil; [Mastelaro, Ariadne Pegoraro] Univ Fed Parana, Fac Anim Sci, Curitiba, Parana, Brazil	Universidade Federal de Mato Grosso do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Goias; Universidade Federal de Mato Grosso do Sul; Universidade Federal do Parana	de Oliveira, CC (corresponding author), Univ Fed Mato Grosso do Sul, Fac Vet Med & Anim Sci, Campo Grande, MS, Brazil.	oliveirac.caroline@gmail.com	Almeida, Roberto G./H-3052-2013; Macedo de Almeida Martins, Paulo Gustavo/D-1042-2015	Almeida, Roberto G./0000-0002-8048-2833; Karvatte Junior, Nivaldo/0000-0002-2442-8189; Vianna da Costa-e-Silva, Eliane/0000-0003-1575-8490; Mastelaro, Ariadne/0000-0003-3510-2085; Macedo de Almeida Martins, Paulo Gustavo/0000-0002-5446-0331; Oliveira, Caroline Carvalho de/0000-0002-9865-3813	'Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul' -FUNDECT [082/2015, 59/300.118/2015, 024463]; CNPq (`Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]	'Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul' -FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CNPq (`Conselho Nacional de Desenvolvimento Cientifico e Tecnologico')(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was supported by the 'Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul' -FUNDECT (FUNDECT number 082/2015; process number 59/300.118/2015; SIAFEM number 024463; URL: http://www.fundect.ms.gov.br), CNPq (`Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'), and in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript that could inappropriately influence the current scientific work.; The present study was supported by the 'Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul'-FUNDECT (FUNDECT number 082/2015; process number 59/300.118/2015; SIAFEM number 024463; URL: http://www.fundect.ms.gov.br), CNPq (`Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico'), and in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorBrasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript that could inappropriately influence the current scientific work.	Azevedo M., 2005, REV BRAS ZOOTECN, V34, P2000, DOI DOI 10.1590/S1516-35982005000600025; Baeta FC, 1985, THESIS; Barbosa Bruna Rocha Passos, 2014, Rev. bras. saúde prod. anim., V15, P854; BUFFINGTON DE, 1981, T ASAE, V24, P711, DOI 10.13031/2013.34325; Burdick NC, 2012, J THERM BIOL, V37, P339, DOI 10.1016/j.jtherbio.2011.10.007; de Oliveira CC, 2018, AGROFOREST SYST, V92, P1659, DOI 10.1007/s10457-017-0114-5; de Oliveira CC, 2014, TROP ANIM HEALTH PRO, V46, P167, DOI 10.1007/s11250-013-0469-1; Ferreira F, 2006, ARQ BRAS MED VET ZOO, V58, P732, DOI 10.1590/S0102-09352006000500005; Flumignan DL, 1672, CLIMA MATO GROSSO, DOI [10.1007/s10457-017-0114-5, DOI 10.1007/S10457-017-0114-5]; Hooper HB, 2017, 7 BRAZ C BIOM AMB BE, DOI [10.6084/m9.figshare.5176753, DOI 10.6084/M9.FIGSHARE.5176753]; Karvatte N, 2016, INT J BIOMETEOROL, V60, P1933, DOI 10.1007/s00484-016-1180-5; Kelly C.F., 1971, NATL ACAD SCI GUIDE; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Maia ASC, 2003, REV BRAS ZOOTECN, V32, P843, DOI 10.1590/S1516-35982003000400009; Marcuzzo F., 2012, RBRH, V17, P77, DOI [10.21168/rbrh.v17n1.p77-86, DOI 10.21168/RBRH.V17N1.P77-86]; Sandeville E, 2004, PAISAGEM AMBIENTE EN, V18, P71, DOI [10.11606/issn.2359-5361.v0i18p71-98, DOI 10.11606/ISSN.2359-5361.V0I18P71-98]; Silanikove Nissim, 2009, BMC Physiology, V9, P13, DOI 10.1186/1472-6793-9-13; Souza CF, 2002, CIENC AGROTEC, V26, P157; Trumbo BA, 2012, J NAT ENV SCI, V3, P42; Wenz JR, 2011, J DAIRY SCI, V94, P1864, DOI 10.3168/jds.2010-3924	20	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223190	10.1371/journal.pone.0223190	http://dx.doi.org/10.1371/journal.pone.0223190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574119	Green Published, gold			2022-12-26	WOS:000532376700034
J	Dadshani, S; Sharma, RC; Baum, M; Ogbonnaya, FC; Leon, J; Ballvora, A				Dadshani, Said; Sharma, Ram C.; Baum, Michael; Ogbonnaya, Francis Chuks; Leon, Jens; Ballvora, Agim			Multi-dimensional evaluation of response to salt stress in wheat	PLOS ONE			English	Article							SYNTHETIC HEXAPLOID WHEAT; TURGIDUM SSP DICOCCOIDES; QUANTITATIVE TRAIT LOCI; BACKCROSS QTL ANALYSIS; SALINITY TOLERANCE; WINTER-WHEAT; AEGILOPS-SQUARROSA; TRITICUM-TAUSCHII; VEGETATIVE GROWTH; DROUGHT TOLERANCE	Soil salinity is a major threat to crop production worldwide. The global climate change is further accelerating the process of soil salinization, particularly in dry areas of the world. Increasing genetic variability of currently used wheat varieties by introgression of exotic alleles/genes from related progenitors' species in breeding programs is an efficient approach to overcome limitations due to the absence of valuable genetic diversity in elite cultivars. Synthetic hexaploid wheat (SHW) is widely regarded as donor of favourable exotic alleles to improve tolerance against biotic and abiotic stresses such as salinity stress. In this study, synthetic backcross lines (SBLs) winter wheat population "Z86", derived from crosses involving synthetic hexaploid wheat Syn86L with German elite winter wheat cultivar Zentos, was evaluated for salinity tolerance at different developmental stages under controlled and field conditions in three growing seasons. High genetic variability was detected across the SBLs and their parents at various growth stages under controlled as well as under salt stress field trials. Greater performance of Zentos over Syn86L was detected at germination stage across all salt treatments and with respect to shoot dry weight (SDW) and root dry weight (RDW) at seedling stage. Whereas for the root length (RL) and the shoot length (SL) Syn86L surpassed the elite cultivar and most of the progenies. Our experiments revealed for almost all traits that some genotypes among the SBLs showed higher performance than their parents. Furthermore, positive transgressive segregations were detected among the SBLs for germination at high salinity levels, as well as for RDW and SDW at seedling stage. Therefore, the studied Z86 population is a suitable population for assessment of salinity stress on morphological and physiological traits at different plant growth stages. The identified SBLs provide a valuable source for genetic gain through recombination of superior alleles that can be directly applied in breeding programs for efficiently breeding cultivars with improved salinity tolerance and desired agronomic traits.	[Dadshani, Said; Leon, Jens; Ballvora, Agim] Rheinische Friedrich Wilhelms Univ, INRES Plant Breeding, Bonn, Germany; [Sharma, Ram C.] Int Ctr Agr Res Dry Areas ICARDA, Tashkent, Uzbekistan; [Baum, Michael] Int Ctr Agr Res Dry Areas ICARDA, Rabat, Morocco; [Ogbonnaya, Francis Chuks] Grains Res & Dev Corp, Barton, ACT, Australia	University of Bonn; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Ballvora, A (corresponding author), Rheinische Friedrich Wilhelms Univ, INRES Plant Breeding, Bonn, Germany.	ballvora@uni-bonn.de	Dadshani, Said/AAC-9842-2020	Dadshani, Said/0000-0001-9194-1372; Sharma, Ram/0000-0002-7785-363X	Bundesministerium fur wirtschaftliche Zusammenarbeit und Entwicklung (BMZ) via German Agency for International Cooperation (GIZ), Germany [09.7860.1001.00]; International Center for Research in Dryland Agriculture (ICARDA)	Bundesministerium fur wirtschaftliche Zusammenarbeit und Entwicklung (BMZ) via German Agency for International Cooperation (GIZ), Germany; International Center for Research in Dryland Agriculture (ICARDA)	This study was financially supported by the Bundesministerium fur wirtschaftliche Zusammenarbeit und Entwicklung (BMZ) via German Agency for International Cooperation (GIZ), Germany (Project number: 09.7860.1001.00), and the International Center for Research in Dryland Agriculture (ICARDA). The funder provided support in the form of salaries for authors SD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section". The commercial affiliation of the co-author FO did not play any role in this study.	Adem GD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-113; Aflaki F, 2017, EMIR J FOOD AGR, V29, P222, DOI 10.9755/ejfa.2016-12-1940; Ahmad P, 2013, SALT STRESS PLANTS S, DOI DOI 10.1007/978-1-4614-6108-1_4; Almansouri M, 2001, PLANT SOIL, V231, P243, DOI 10.1023/A:1010378409663; Almeida DM, 2017, GENET MOL BIOL, V40, P326, DOI [10.1590/1678-4685-gmb-2016-0106, 10.1590/1678-4685-GMB-2016-0106]; [Anonymous], 2013, WASSERANALYSE; [Anonymous], [No title captured]; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Badridze G, 2009, GENET RESOUR CROP EV, V56, P1125, DOI 10.1007/s10722-009-9436-0; Becker SR, 2016, EUPHYTICA, V207, P213, DOI 10.1007/s10681-015-1574-1; Chabot P., 2011, REGIONAL VIEW WHEAT; Chandna R., 2013, SALT STRESS PLANTS, P1; Charu S Vibhut, 2015, INDIAN J AGR SCI, V85, P1134; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Daniells IG, 2001, AUST J EXP AGR, V41, P211, DOI 10.1071/EA00084; del Blanco IA, 2000, CROP SCI, V40, P1257, DOI 10.2135/cropsci2000.4051257x; De Leon JLD, 2010, CEREAL RES COMMUN, V38, P15, DOI 10.1556/CRC.38.2010.1.2; Dreisigacker S, 2008, AUST J AGR RES, V59, P413, DOI 10.1071/AR07225; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; El-Hendawy SE, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00435; Fernandez GCJ, 1992, CROP SCI, P257; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Flowers TJ, 2005, AGR WATER MANAGE, V78, P15, DOI 10.1016/j.agwat.2005.04.015; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Foolad MR, 1999, GENOME, V42, P727, DOI 10.1139/gen-42-4-727; FRANCOIS LE, 1986, AGRON J, V78, P1053, DOI 10.2134/agronj1986.00021962007800060023x; FRANCOIS LE, 1994, AGRON J, V86, P100, DOI 10.2134/agronj1994.00021962008600010019x; Genc Y, 2007, PLANT CELL ENVIRON, V30, P1486, DOI 10.1111/j.1365-3040.2007.01726.x; Genc Y, 2016, NEW PHYTOL, V210, P145, DOI 10.1111/nph.13757; Gintzburger G, 2005, ARID LAND RES MANAG, V19, P215, DOI 10.1080/15324980590951360; GORHAM J, 1990, J EXP BOT, V41, P1095, DOI 10.1093/jxb/41.9.1095; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Holland JB, 2002, PL BRED RE, V22, P9; JAFARISHABESTARI J, 1995, GENET RESOUR CROP EV, V42, P147, DOI 10.1007/BF02539518; Juenger TE, 2005, PLANT CELL ENVIRON, V28, P697, DOI 10.1111/j.1365-3040.2004.01313.x; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; KENT LM, 1985, PLANT CELL ENVIRON, V8, P155, DOI 10.1111/j.1365-3040.1985.tb01223.x; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; LANGE W, 1992, EUPHYTICA, V59, P197, DOI 10.1007/BF00041273; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; LAUTER DJ, 1986, PLANT SOIL, V95, P271, DOI 10.1007/BF02375078; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Li A, 2018, SYNTHETIC HEXAPLOID; Li Q, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1089-0; Lindsay MP, 2004, FUNCT PLANT BIOL, V31, P1105, DOI 10.1071/FP04111; Littell RC, 1990, ANAL REPEATED MEASUR; Lopes MS, 2011, CROP SCI, V51, P1617, DOI 10.2135/cropsci2010.07.0445; Luo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170379; MAAS EV, 1989, IRRIGATION SCI, V10, P313, DOI 10.1007/BF00257496; MAAS EV, 1990, CROP SCI, V30, P1309, DOI 10.2135/cropsci1990.0011183X003000060031x; Madejczyk M, 2008, ANAL CHIM ACTA, V617, P11, DOI 10.1016/j.aca.2008.01.038; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mano Y, 1996, BREEDING SCI, V46, P137; Mano Y, 1996, BREEDING SCI, V46, P227; Mansour MMF, 2014, J PLANT PHYSIOL, V171, P1787, DOI 10.1016/j.jplph.2014.08.016; Muhammad I, 2008, GENETICS; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Munns R, 2000, AUST J PLANT PHYSIOL, V27, P949; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2015, NEW PHYTOL, V208, P668, DOI 10.1111/nph.13519; Munns R, 2011, ADV BOT RES, V57, P1, DOI 10.1016/B978-0-12-387692-8.00001-1; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Naz AA, 2008, THEOR APPL GENET, V116, P1095, DOI 10.1007/s00122-008-0738-y; Neumann P. M., 1995, Structure and function of roots. Proceedings of the Fourth International Symposium, Stara Lesna, Slovakia, 20-26 June 1993., P299; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Oyiga BC, 2016, J AGRON CROP SCI, V202, P472, DOI 10.1111/jac.12178; Plamenov D, 2011, J PLANT PATHOL, V93, P251; Pritchard DJ, 2002, CEREAL RES COMMUN, V30, P261; Puntamkar S, 1970, INDIAN J PLANT PHYSL, V13, P233; Rhodes D, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P181; RICHARDS RA, 1983, EUPHYTICA, V32, P431, DOI 10.1007/BF00021452; RICHARDS RA, 1987, FIELD CROP RES, V15, P277, DOI 10.1016/0378-4290(87)90017-7; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Sanchez DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017094; SAS Institute C NC USA, 2015, SAS SYST WIND REL 9; SAYED HI, 1985, THEOR APPL GENET, V69, P651, DOI 10.1007/BF00251118; Shannon M.C., 1984, CALIF AGR, V38, P33; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Sharma Rohit, 2015, Asset Management Conference 2015; Sharma RC, 2004, EUPHYTICA, V139, P33, DOI 10.1007/s10681-004-2292-2; Shavrukov Y, 2012, HYDROPONICS STANDARD, P39; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Singh Jogendra, 2012, Physiology and Molecular Biology of Plants, V18, P45, DOI 10.1007/s12298-011-0097-z; Sohail Q, 2011, BREEDING SCI, V61, P347, DOI 10.1270/jsbbs.61.347; Talbot S, 2008, P 11 INT WHEAT GEN S; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tardieu F, 2017, J EXP BOT, V68, P1393, DOI 10.1093/jxb/erx042; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Wang HL, 2014, EUPHYTICA, V196, P117, DOI 10.1007/s10681-013-1019-7; Wilson C, 2000, ANN BOT-LONDON, V85, P501, DOI 10.1006/anbo.1999.1086; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Yang C, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1454-7	103	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222659	10.1371/journal.pone.0222659	http://dx.doi.org/10.1371/journal.pone.0222659			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568491	Green Published, gold			2022-12-26	WOS:000532364900007
J	Oud, L				Oud, Lavi			In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; EPIDEMIOLOGY; OUTCOMES; LIVER; SURVIVAL; DISEASES; BURDEN; TRENDS; DEATH	Objective To examine the epidemiology and outcomes of in-hospital cardiopulmonary resuscitation (CPR) among patients with cirrhosis. Methods We used the Texas Inpatient Public Use Data File to identify hospitalizations aged. 18 years with and without cirrhosis during 2009-2014 and those in each group who have undergone in-hospital CPR. Short-term survival (defined as absence of hospital mortality or discharge to hospice) following in-hospital CPR was examined. Multivariate logistic regression modeling was used to assess the prognostic impact of cirrhosis following in-hospital CPR and predictors of short-term survival among cirrhosis hospitalizations. Results In-hospital CPR was reported in 2,511 and 51,969 hospitalizations with and without cirrhosis, respectively. The rate of in-hospital CPR (per 1,000 hospitalizations) was 7.6 and 4.0 among hospitalizations with and without cirrhosis, respectively. The corresponding rate of in-hospital CPR among decedents was 10.7% and 13.4%, respectively. Short-term survival following in-hospital CPR among hospitalizations with and without cirrhosis was 14.9% and 27.3%, respectively, and remained unchanged over time on adjusted analyses among the former (p = 0.1753), while increasing among the latter (p = 0.0404). Cirrhosis was associated with lower odds of short-term survival following in-hospital CPR (adjusted odds ratio [aOR] 0.55 [95% CI: 0.49-0.62]). Lack of health insurance (vs. Medicare) (aOR] 0.47 [95% CI: 0.34-0.67]) and sepsis ([aOR] 0.67 [95% CI: 0.53-85]) were associated with lower odds of short-term survival following in-hospital CPR among cirrhosis hospitalizations. Conclusions The rate of in-hospital CPR was nearly 2-fold higher among hospitalizations with cirrhosis than among those without it, though it was used more selectively among the former. Short-term survival following in-hospital CPR remained markedly lower among cirrhosis hospitalizations, while progressively improving among those without cirrhosis. Strategies to increase access to health insurance and improve early identification and control of infection should be explored in future preventive and interventional efforts.	[Oud, Lavi] Texas Tech Univ, Dept Internal Med, Div Pulm & Crit Care Med, Hlth Sci Ctr Permian Basin, Odessa, TX 79763 USA	Texas Tech University System; Texas Tech University	Oud, L (corresponding author), Texas Tech Univ, Dept Internal Med, Div Pulm & Crit Care Med, Hlth Sci Ctr Permian Basin, Odessa, TX 79763 USA.	lavi.oud@ttuhsc.edu		Oud, Lavi/0000-0002-9003-6845				Ahmad S, 2013, GASTROENTEROLOGY, V144, pS1000; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; de Vos R, 1999, ARCH INTERN MED, V159, P845, DOI 10.1001/archinte.159.8.845; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Kazaure HS, 2013, RESUSCITATION, V84, P1255, DOI 10.1016/j.resuscitation.2013.02.021; Khera R, 2017, JAMA CARDIOL, V2, P1275, DOI 10.1001/jamacardio.2017.2904; Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Majumdar A, 2017, J HEPATOL, V67, P1185, DOI 10.1016/j.jhep.2017.07.024; Mallikethi-Reddy S, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003194; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Oud L, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/618067; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Reinders ME, 2017, CLIN GASTROENTEROL H, V15, P1808, DOI 10.1016/j.cgh.2017.05.044; Roedl K, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0322-1; Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208; Schmidt ML, 2015, GASTROENTEROLOGY, V148, P967, DOI 10.1053/j.gastro.2015.01.032; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Shahreyar Muhammad, 2017, JACC Clin Electrophysiol, V3, P174, DOI 10.1016/j.jacep.2016.08.011; Singal AK, 2014, ALIMENT PHARM THER, V40, P105, DOI 10.1111/apt.12797; Stapleton RD, 2014, CHEST, V146, P1214, DOI 10.1378/chest.13-2110; Zoch TW, 2000, ARCH INTERN MED, V160, P1969, DOI 10.1001/archinte.160.13.1969	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222873	10.1371/journal.pone.0222873	http://dx.doi.org/10.1371/journal.pone.0222873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568520	gold, Green Published			2022-12-26	WOS:000532364900012
J	van Heijl, I; Schweitzer, VA; Boel, CHE; Oosterheert, JJ; Huijts, SM; Dorigo-Zetsma, W; van der Linden, PD; Bonten, MJM; van Werkhoven, CH				van Heijl, Inger; Schweitzer, Valentijn A.; Boel, C. H. Edwin; Oosterheert, Jan Jelrik; Huijts, Susanne M.; Dorigo-Zetsma, Wendelien; van der Linden, Paul D.; Bonten, Marc J. M.; van Werkhoven, Cornelis H.			Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; SEVERE SEPSIS; ADULTS; MANAGEMENT; CONTINUATION; GUIDELINES; IMPACT; TIME	Observational studies have demonstrated that de-escalation of antimicrobial therapy is independently associated with lower mortality. This most probably results from confounding by indication. Reaching clinical stability is associated with the decision to de-escalate and with survival. However, studies rarely adjust for this confounder. We quantified the potential confounding effect of clinical stability on the estimated impact of de-escalation on mortality in patients with community-acquired pneumonia. Data were used from the CommunityAcquired Pneumonia immunization Trial in Adults (CAPiTA). The primary outcome was 30-day mortality. We performed Cox proportional-hazards regression with de-escalation as time-dependent variable and adjusted for baseline characteristics using propensity scores. The potential impact of unmeasured confounding was quantified through simulating a variable representing clinical stability on day three, using data on prevalence and associations with mortality from the literature. Of 1,536 included patients, 257 (16.7%) were de-escalated, 123 (8.0%) were escalated and in 1156 (75.3%) the antibiotic spectrum remained unchanged. Crude 30-day mortality was 3.5% (9/257) and 10.9% (107/986) in the de-escalation and continuation groups, respectively. The adjusted hazard ratio of de-escalation for 30-day mortality (compared to patients with unchanged coverage), without adjustment for clinical stability, was 0.39 (95%CI: 0.19-0.79). If 90% to 100% of de-escalated patients were clinically stable on day three, the fully adjusted hazard ratio would be 0.56 (95%CI: 0.27-1.12) to 1.04 (95%CI: 0.49-2.23), respectively. The simulated confounder was substantially stronger than any of the baseline confounders in our dataset. Quantification of effects of de-escalation on patient outcomes without proper adjustment for clinical stability results in strong negative bias. This study suggests the effect of de-escalation on mortality needs further well-designed prospective research to determine effect size more accurately.	[van Heijl, Inger; van der Linden, Paul D.] Tergooi Hosp, Dept Clin Pharm, Hilversum, Netherlands; [van Heijl, Inger; Schweitzer, Valentijn A.; Bonten, Marc J. M.; van Werkhoven, Cornelis H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Boel, C. H. Edwin; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Oosterheert, Jan Jelrik] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Huijts, Susanne M.] Univ Med Ctr Utrecht, Dept Pulm Med, Utrecht, Netherlands; [Dorigo-Zetsma, Wendelien] Tergooi Hosp, Dept Med Microbiol, Hilversum, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Heijl, I (corresponding author), Tergooi Hosp, Dept Clin Pharm, Hilversum, Netherlands.; van Heijl, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	Ivanheijl@tergooi.nl		Oosterheert, Jan Jelrik/0000-0001-6146-3808; van Heijl, Inger/0000-0002-0160-715X	Pfizer	Pfizer(Pfizer)	This work received funding from Pfizer for the CAPiTA study to MB, CvW and SH. The funder had a role in the design of the original study and monitored data collection. They had no role in the study design, data analysis, decision to publish, or preparation of the current manuscript.	[Anonymous], ERJ OPEN RES; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Carugati M, 2015, CLIN MICROBIOL INFEC, V21, pE87, DOI [10.1016/j.cmi.2015.06.015, 10.1016/j.cmi.2015.10.011]; Castro-Guardiola A, 2001, AM J MED, V111, P367, DOI 10.1016/S0002-9343(01)00868-3; Cremers AJH, 2014, J ANTIMICROB CHEMOTH, V69, P2258, DOI 10.1093/jac/dku109; Danish Society of Infectious Diseases, 2019, BEH SAMF PNEUM 2011; Davey P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub4; Garnacho-Montero J, 2014, INTENS CARE MED, V40, P32, DOI 10.1007/s00134-013-3077-7; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Jones M, 2016, J CRIT CARE, V36, P195, DOI 10.1016/j.jcrc.2016.07.017; Joung MK, 2011, CRIT CARE, V15, DOI 10.1186/cc10072; Kim J, 2012, CRIT CARE, V16, P1; Kohno N, 2013, NEUROL INT, V5, P23, DOI 10.4081/ni.2013.e8; Lee CC, 2017, INT J ANTIMICROB AG, V50, P371, DOI 10.1016/j.ijantimicag.2017.03.024; Leone M, 2014, INTENS CARE MED, V40, P1399, DOI 10.1007/s00134-014-3411-8; Montravers P, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1267-8; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Oosterheert JJ, 2006, BMJ-BRIT MED J, V333, P1193, DOI 10.1136/bmj.38993.560984.BE; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Spindler C, 2012, SCAND J INFECT DIS, V44, P885, DOI 10.3109/00365548.2012.700120; SWAB (The Dutch Working Party on Antibiotic Policy), 2018, A TEAMS PRAKT ANT ST, P21; Viasus D, 2017, J ANTIMICROB CHEMOTH, V72, P547, DOI 10.1093/jac/dkw441; Wiersinga WJ, 2018, NETH J MED, V76, P4; Yamana H, 2016, J INFECTION, V73, P314, DOI 10.1016/j.jinf.2016.07.001	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0218062	10.1371/journal.pone.0218062	http://dx.doi.org/10.1371/journal.pone.0218062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560686	Green Published, Green Submitted, gold			2022-12-26	WOS:000532353700003
J	Barratclough, A; Sanz-Requena, R; Marti-Bonmati, L; Schmitt, TL; Jensen, E; Garcia-Parraga, D				Barratclough, Ashley; Sanz-Requena, Roberto; Marti-Bonmati, Luis; Schmitt, Todd L.; Jensen, Eric; Garcia-Parraga, Daniel			Radiographic assessment of pectoral flipper bone maturation in bottlenose dolphins (Tursiops truncatus), as a novel technique to accurately estimate chronological age	PLOS ONE			English	Article							MEDITERRANEAN STRIPED DOLPHIN; PORPOISE PHOCOENA-PHOCOENA; WHALES BALAENA-MYSTICETUS; PHYSICAL MATURITY; GROWTH; PATTERNS; OSSIFICATION; HYPERPHALANGY; INDICATOR; ENDOCRINE	Accurate age estimation in wildlife conservation is an important diagnostic tool in the interpretation of biological data, necropsy examination, reproductive status and population demographics. The most frequently utilized methods to age bottlenose dolphins (Tursiops truncatus) include tooth extraction; counting dental growth layer groups and dental radiography. These methods are inaccurate in dolphins > 13 years old, due to overlapping of the growth layer groups in dolphins and worn teeth. Establishing a non-invasive method of accurately aging bottlenose dolphins across the entire age range is important to long term conservation efforts to understand health status, lifespan, reproduction and survivability. A database of 126 radiographs from 94 dolphins of known chronological age was utilized to establish the stages of skeletal ossification over time. A numerical score from -1 to 8 was assigned to 16 anatomic locations on the pectoral radiograph, to create a formula to estimate age. The most informative areas to evaluate morphologically were the metaphyseal regions of the radius and ulna, and the proximal and distal epiphysis of metacarpals II and III. Third order polynomial regression calculated separate age predictor formulas for male and female dolphins, with females reaching sexual maturity earlier than males. Completion of epiphyseal closure of the long bones correlated with average sexual maturity. Managed care dolphin ages could be properly estimated with decreasing precision from within 3 months in animals < 5 years old, to within 5 years in animals > 30 years old. This diagnostic tool could also be applied to diagnose atypical ossification patterns consistent with nutritional, developmental or growth abnormalities, and identifying subclinical health issues. In conclusion, knowledge of the lifespan and the onset of sexual maturity for each species will allow this model to be applied to other cetaceans, facilitating age estimation via pectoral radiography in future research.	[Barratclough, Ashley] Natl Marine Mammal Fdn, San Diego, CA 92106 USA; [Sanz-Requena, Roberto; Marti-Bonmati, Luis] Hosp Quironsalud Valencia, Radiol Dept, Valencia, Spain; [Schmitt, Todd L.] SeaWorld, San Diego, CA USA; [Jensen, Eric] US Navy Marine Mammal Program, San Diego, CA USA; [Garcia-Parraga, Daniel] Fdn Oceanog Comunidad Valenciana, Valencia, Spain	quironsalud Group; United States Department of Defense; United States Navy	Barratclough, A (corresponding author), Natl Marine Mammal Fdn, San Diego, CA 92106 USA.	ashley.barratclough@nmmf.org	Sanz-Requena, Roberto/I-2032-2017	Sanz-Requena, Roberto/0000-0002-3659-1389; Garcia Parraga, Daniel/0000-0002-3335-5831; Barratclough, Ashley/0000-0003-3027-5892	Gulf of Mexico Research Institute [GOMRI2015-V-186]; Gulf of Mexico Research Initiative	Gulf of Mexico Research Institute; Gulf of Mexico Research Initiative	Seaworld provided support this study in the form of salaries for TS. SeaWorld provided the radiographic equipment used to take the radiographs of the dolphins at SeaWorld as well as the salaries of veterinary technicians and trainers involved in the logistics of obtaining the radiographs. SeaWorld did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Partial funding for this study was also received from the Gulf of Mexico Research Institute Grant Number GOMRI2015-V-186.; The authors would like to thank all the institutions, trainers and veterinarians worldwide that participated submitting images for this study including members of EAAM, EAZA and AZA associations (Zoomarine Portugal, Mundomar Benidorm, Zoomarine Italy, Nuremberg Zoo, Zoo-Aquarium Madrid, Zoo Barcelona, Dolphinarium of Brugge, Costa Edutainment, SeaWorld South Africa, Harderwijk Dolphinarium, The Mirage Las Vegas and Ocean Park Hong Kong). The authors would like to thank Veronica Cendejas for her incredible artwork in creating Figs 2 and 3. Also thanks to Dr. Geraldine Lacave and Dr. Tania Monreal as independent veterinarians and special thanks to all the marine mammal and veterinary staff involved in the project from the Oceanografic where the project started and SeaWorld San Diego and the U.S. Navy Marine Mammal Program as essential partners for their great effort and dedication without which this project would never have been possible. This is a SeaWorld Parks and Entertainment technical contribution number 2019-9. This research was made possible in part by a grant from The Gulf of Mexico Research Initiative. This is scientific contribution 241 of the National Marine Mammal Foundation.	AGUILAR A, 1987, CAN J ZOOL, V65, P253, DOI 10.1139/z87-040; ANDERSEN E, 1971, AM J PHYS ANTHROPOL, V35, P373, DOI 10.1002/ajpa.1330350312; Bada J.L., 1980, International Whaling Commission Report of the Commission, P113; Barratclough A, IAAAM C P 46 ANN IAA; Baumann U, 2009, FORENSIC SCI INT, V191, P15, DOI 10.1016/j.forsciint.2009.05.023; Benjaminsen T., 1973, Fiskeridirektoratets Skr (Havundersok), V16, P159; Benke Harald, 1993, Investigations on Cetacea, V24, P9; Butti C, 2007, J ANAT, V211, P639, DOI 10.1111/j.1469-7580.2007.00805.x; BYERS S, 1991, AM J PHYS ANTHROPOL, V85, P339, DOI 10.1002/ajpa.1330850314; Calzada N, 1996, ANAT REC, V245, P708; Calzada N, 1997, CAN J ZOOL, V75, P632, DOI 10.1139/z97-078; Cameriere R, 2004, J FORENSIC SCI, V49, P1, DOI DOI 10.1520/JFS2003259; Campana SE, 2014, NAMMCO SCI PUBLICATI, V10; Choo AD, 2013, J CHILD ORTHOP, V7, P449, DOI 10.1007/s11832-013-0544-1; COLE AJL, 1988, BRIT J RADIOL, V61, P683, DOI 10.1259/0007-1285-61-728-683; Colegrove KM, 2016, DIS AQUAT ORGAN, V119, P1, DOI 10.3354/dao02969; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; Dawson SD, 2003, J MORPHOL, V258, P200, DOI 10.1002/jmor.10146; Ferrero RC, 1999, MAR MAMMAL SCI, V15, P273, DOI 10.1111/j.1748-7692.1999.tb00803.x; Galatius A, 2006, ACTA ZOOL-STOCKHOLM, V87, P77, DOI 10.1111/j.1463-6395.2006.00223.x; Galatius A, 2005, MAR MAMMAL SCI, V21, P401, DOI 10.1111/j.1748-7692.2005.tb01240.x; Garcia-Parraga D, 2011, IAAAM C; Garde E, 2010, J MAMMAL, V91, P1365, DOI 10.1644/10-MAMM-A-080.1; GARN SM, 1965, J DENT RES, V44, P243, DOI 10.1177/00220345650440012001; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; George J, 2012, BRIT J SPORT MED, V46, P273, DOI 10.1136/bjsm.2010.074948; Gilsanz V, 2005, HAND BONE AGE DIGITA, DOI DOI 10.1007/978-3-642-23762-1; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Guglielmini C, 2002, ANAT REC, V267, P225, DOI 10.1002/ar.10107; HARRISON RJ, 1971, J ZOOL, V165, P355; HOHN A A, 1980, Scientific Reports of the Whales Research Institute Tokyo, P39; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hui CA, 1978, RELIABILITY USING DE; Kastelle CR, 2003, CAN J ZOOL, V81, P21, DOI 10.1139/Z02-214; KELLER EE, 1970, J AM DENT ASSOC, V81, P415, DOI 10.14219/jada.archive.1970.0173; KERLEY ER, 1965, AM J PHYS ANTHROPOL, V23, P149, DOI 10.1002/ajpa.1330230215; Kim JR, 2017, AM J ROENTGENOL, V209, P1374, DOI 10.2214/AJR.17.18224; Kimura M., 1980, AGE DETERMINATION TO, V161; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; LEWALL EF, 1963, CAN J ZOOLOG, V41, P629, DOI 10.1139/z63-035; Lewis M, 1997, INT J OSTEOARCHAEOL, V7, P581, DOI 10.1002/(SICI)1099-1212(199711/12)7:6<581::AID-OA325>3.3.CO;2-3; Loch C, 2013, NAMMCO SCI PUBLICATI, P10; LOCKYER C, 1972, J CONSEIL, V34, P276; Lockyer C, 2011, NAMMCO SCI PUBLICATI, V10; Lockyer Christina, 2010, NAMMCO Scientific Publications, V8, P245; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Marsh H., 1980, AGE DETERMINATION DU; de Carvalho APM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127435; McMillan CJ, 2006, J AM ANIM HOSP ASSOC, V42, P57, DOI 10.5326/0420057; Mellor L, 2009, PAEDOMORPHIC OSSIFIC; OGDEN JA, 1981, SKELETAL RADIOL, V7, P119, DOI 10.1007/BF00347376; Oginni LM, 2003, ARCH DIS CHILD, V88, P812, DOI 10.1136/adc.88.9.812; Paul E, 2013, ILAR J, V54, P14, DOI 10.1093/ilar/ilt013; Perrin WF, 1980, P INT C DETERMINING; Powell JWB, 2019, MAR MAM SCI; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; SCHAEFER F, 1990, PEDIATR RES, V28, P5, DOI 10.1203/00006450-199007000-00002; Schmeling A, 2006, FORENSIC SCI INT, V159, pS61, DOI 10.1016/j.forsciint.2006.02.017; Schmeling Andreas, 2003, Leg Med (Tokyo), V5 Suppl 1, pS367; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Schwarz LK, 2009, CAN J FISH AQUAT SCI, V66, P1775, DOI 10.1139/F09-117; Smith CR, 2017, ENDANGER SPECIES RES, V33, P127, DOI 10.3354/esr00778; Solovieva S, 2005, RHEUMATOLOGY, V44, P521, DOI 10.1093/rheumatology/keh534; Steele J, 2000, LATERALITY, V5, P193, DOI 10.1080/135765000406067; Stockin KA, 2008, NEW ZEAL J MAR FRESH, V42, P307, DOI 10.1080/00288330809509958; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Sweeny MM, 2005, J WILDLIFE DIS, V41, P717, DOI 10.7589/0090-3558-41.4.717; Thacher TD, 2000, J TROP PEDIATRICS, V46, P132, DOI 10.1093/tropej/46.3.132; Wells R.S., 1991, P199; Whitaker JM, 2002, AM J PHYS ANTHROPOL, V118, P385, DOI 10.1002/ajpa.10109; Zweifel J.R., 1980, International Whaling Commission Report of the Commission, P216	73	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222722	10.1371/journal.pone.0222722	http://dx.doi.org/10.1371/journal.pone.0222722			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557197	Green Published, gold			2022-12-26	WOS:000532345500032
J	Cai, ZQ; Jia, PL; Zhang, JQ; Gan, P; Shao, Q; Jin, G; Wang, LP; Jin, J; Yang, JY; Luo, JJ				Cai, Zhongquan; Jia, Peilong; Zhang, Jiaqiang; Gan, Ping; Shao, Qi; Jin, Gang; Wang, Liping; Jin, Jian; Yang, Jiangyi; Luo, Jijing			Genetic analysis and fine mapping of a qualitative trait locus wpb1 for albino panicle branches in rice	PLOS ONE			English	Article							CHLOROPLAST DEVELOPMENTAL DEFECTS; BULKED-SEGREGANT ANALYSIS; EARLY LEAF DEVELOPMENT; REPEAT PROTEIN; NUCLEAR GENE; MUTANT; EXPRESSION; GENOME; ENCODES; IDENTIFICATION	Chloroplast plays an important role in the plant life cycle. However, the details of its development remain elusive in rice. In this study, we report the fine-mapping of a novel rice gene wpb1 (white panicle branch 1), which affects chloroplast biogenesis, from a tropical japonica variety that results in an albino panicle branches at and after the heading stage. The wpb1 variety was crossed with Nipponbare to generate the F-2 and BC1F2 populations. Green and white panicle branch phenotypes with a 3:1 segregation ratio was observed in the F-2 population. Bulked segregant analysis (BSA) based on whole genome resequencing was conducted to determine the wpb1 locus. A candidate interval spanning from 11.35 to 23.79M (physical position) on chromosome 1 was identified. The results of BSA analysis were verified by a 40K rice SNP-array using the BC1F2 population. A large-scale F-2 population was used to pinpoint wpb1, and the locus was further narrowed down to a 95-kb interval. Furthermore, our results showed that the expression levels of the majority of the genes involved in Chl biosynthesis, photosynthesis and chloroplast development were remarkably affected in wpb1 variety and in F-2 plants with a white panicle branch phenotype. In line with the results mentioned above, anatomical structural examination and chlorophyll (Chl) content measurement suggested that wpb1 might play an important role in the regulation of chloroplast development. Further cloning and functional characterization of the wpb1 gene will shed light on the molecular mechanism underlying chloroplast development in rice.	[Cai, Zhongquan; Gan, Ping; Shao, Qi; Jin, Jian; Yang, Jiangyi; Luo, Jijing] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China; [Cai, Zhongquan; Jia, Peilong] Guangxi Univ, Inst New Rural Dev, Natl Demonstrat Ctr Expt Plant Sci Educ, Coll Agr, Nanning, Guangxi, Peoples R China; [Zhang, Jiaqiang] Zhejiang Acad Agr Sci, Res & Dev Ctr Flower, Hangzhou, Peoples R China; [Jin, Gang; Wang, Liping] Guangxi Subtrop Crops Res Inst, Nanning, Peoples R China	Guangxi University; Guangxi University; Zhejiang Academy of Agricultural Sciences	Jin, J; Yang, JY; Luo, JJ (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China.	jinjianes@outlook.com; yangjy598@163.com; jjluo@gxu.edu.cn	Luo, Jijing/Q-3687-2018	Yang, Jiangyi/0000-0002-5626-1037; Luo, Jijing/0000-0001-5664-0881	National Natural Science Foundation of China(CN) [31671646]; Natural Science Foundation of Guangxi, China [2014GXNSFBA118126, 2018GXNSFBA281109, 2018GXNSFBA138022]; Project of High Level Innovation Team and Outstanding Scholar in Guangxi Colleges and Universities (Third batch)	National Natural Science Foundation of China(CN)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi, China(National Natural Science Foundation of Guangxi Province); Project of High Level Innovation Team and Outstanding Scholar in Guangxi Colleges and Universities (Third batch)	Funded by JL, 31671646, The National Natural Science Foundation of China (CN) JL, 2015, Guangxi Hundred-Talents Program ZC, 2014GXNSFBA118126, 2018GXNSFBA281109, 2018GXNSFBA138022, The Natural Science Foundation of Guangxi, China JY, 2016, The Project of High Level Innovation Team and Outstanding Scholar in Guangxi Colleges and Universities (Third batch) JZ, 2016. The study abroad program of the Zhejiang Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Bae CH, 2001, ANN BOT-LONDON, V88, P545, DOI 10.1006/anbo.2001.1495; BREINHOLT V, 1995, CHEM RES TOXICOL, V8, P506, DOI 10.1021/tx00046a004; Chen De-xi, 2012, Chinese Journal of Rice Science, V26, P677, DOI 10.3969/j.issn.1001-7216.2012.06.007; [陈叶平 Chen Yeping], 2015, [核农学报, Journal of Nuclear Agricultural Sciences], V29, P1246; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; GOLDEN SS, 1986, EMBO J, V5, P2789, DOI 10.1002/j.1460-2075.1986.tb04569.x; Gong XD, 2013, G3-GENES GENOM GENET, V3, P1769, DOI 10.1534/g3.113.007856; Hayashi-Tsugane M, 2014, PLANT CELL PHYSIOL, V55, P3, DOI 10.1093/pcp/pct149; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Hou DY, 2009, BMB REP, V42, P450, DOI 10.5483/BMBRep.2009.42.7.450; IWATA N, 1978, SCI B FAC AGR KYUSHU, V33, P11; Jin Yi, 2011, Zhongguo Shuidao Kexue, V25, P461, DOI 10.3969/j.issn.1001-7216.2011.05.002; Klein H, 2018, G3-GENES GENOM GENET, V8, P3583, DOI 10.1534/g3.118.200499; Kusumi K, 1997, PLANT J, V12, P1241, DOI 10.1046/j.1365-313x.1997.12061241.x; Kusumi K, 2000, PLANT CELL PHYSIOL, V41, P158, DOI 10.1093/pcp/41.2.158; Kusumi K, 2011, PLANT J, V68, P1039, DOI 10.1111/j.1365-313X.2011.04755.x; KYOZUKA J, 1993, PLANT PHYSIOL, V102, P991, DOI 10.1104/pp.102.3.991; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00762; Li Lingfeng, 2018, Chinese Journal of Rice Science, V32, P538, DOI 10.16819/j.1001-7216.2018.7144; Lin D, 2015, PLANT BIOLOGY, V17, P599, DOI 10.1111/plb.12271; Lin DZ, 2015, RICE, V8, DOI 10.1186/s12284-015-0050-9; Liu CH, 2016, J EXP BOT, V67, P5339, DOI 10.1093/jxb/erw296; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv YS, 2017, J EXP BOT, V68, P5147, DOI 10.1093/jxb/erx332; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; [邱念伟 Qiu Nianwei], 2016, [植物学报, Chinese Bulletin of Botany], V51, P667; SANCHEZ AC, 1994, J HERED, V85, P297, DOI 10.1093/oxfordjournals.jhered.a111461; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Song J, 2014, PLANT MOL BIOL, V84, P301, DOI 10.1007/s11103-013-0134-0; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Sun J, 2018, RICE, V11, DOI 10.1186/s12284-018-0218-1; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2016, PLANT MOL BIOL, V92, P1; Wang XiaoWen, 2015, Acta Agronomica Sinica, V41, P838; Wang Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01116; Wang YL, 2016, PLANT PHYSIOL, V170, P2110, DOI 10.1104/pp.15.01949; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Yoo SC, 2009, PLANT PHYSIOL, V150, P388, DOI 10.1104/pp.109.136648; Zeng XY, 2017, PLANT MOL BIOL, V94, P137, DOI 10.1007/s11103-017-0598-4; [曾跃辉 Zeng Yuehui], 2018, [分子植物育种, Molecular Plant Breeding], V16, P1955; Zhang ZM, 2016, PLANT PHYSIOL, V171, P1182, DOI 10.1104/pp.16.00325; Zhang ZG, 2017, MOL PLANT, V10, P86, DOI 10.1016/j.molp.2016.08.009; Zhangt T, 2018, J EXP BOT, V69, P4791, DOI 10.1093/jxb/ery250; Zhou Kunneng, 2018, Chinese Journal of Rice Science, V32, P325, DOI 10.16819/j.1001-7216.2018.7122; Zhou KN, 2017, PLANTA, V245, P45, DOI 10.1007/s00425-016-2590-7; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1	58	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223228	10.1371/journal.pone.0223228	http://dx.doi.org/10.1371/journal.pone.0223228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557269	gold, Green Published			2022-12-26	WOS:000532345500091
J	Tung, CH; Kuo, LW; Huang, MF; Wu, YY; Tsai, YT; Wu, JE; Hsu, KF; Chen, YL; Hong, TM				Tung, Chia-Hao; Kuo, Li-Wei; Huang, Meng-Fan; Wu, Yi-Ying; Tsai, Yao-Tsung; Wu, Jia-En; Hsu, Keng-Fu; Chen, Yuh-Ling; Hong, Tse-Ming			MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; MONOCLONAL-ANTIBODY; COLORECTAL-CANCER; EARLY RELAPSE; MIR-150; EXPRESSION; METASTASIS; INVASION; ACTIVATION; SIGNATURES	Treatment of ovarian cancer (OvCa) remains challenging owing to its high recurrence rates. Detachment of cancer cells into the peritoneal fluid plays a key role in OvCa relapse, but how this occurs remains incompletely understood. Here we examined global miRNA expression profiles of paired primary/recurrent OvCa specimens and identified a novel biomarker, microRNA-150-5p (miR-150-5p), that was significantly upregulated in 16 recurrent OvCa tissues compared with their matched primary specimens. Analyses of cohorts from two other groups confirmed that expression of miR-150-5p was associated with early relapse and poor survival of OvCa patients. Inhibition of miR-150-5p significantly inhibited the migration and invasion of OvCa cells and induced a mesenchymal-epithelial transition (MET) phenotype. We demonstrated that the proto-oncogene, MYB, is an miR-150-5p target in OvCa cells and that the miR-150-5p/c-Myb/Slug axis plays important roles in regulating epithelial-mesenchymal transition (EMT) in OvCa cells. Expression of MYB was significantly correlated with good clinical outcome in OvCa and was negatively correlated with Slug expression in late-stage clinical specimens. These results suggest that miR-150-5p upregulation mediates the progression of recurrent OvCa by targeting the c-Myb/Slug pathway. Inhibition of miR-150-5p may serve as a new therapeutic strategy for preventing recurrence of OvCa.	[Tung, Chia-Hao; Tsai, Yao-Tsung; Wu, Jia-En] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Kuo, Li-Wei; Huang, Meng-Fan; Hsu, Keng-Fu; Hong, Tse-Ming] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Wu, Yi-Ying; Hong, Tse-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Clin Med Res Ctr, Tainan, Taiwan; [Hsu, Keng-Fu] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Obstet & Gynecol, Tainan, Taiwan; [Chen, Yuh-Ling] Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Hong, TM (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan.; Hong, TM (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Clin Med Res Ctr, Tainan, Taiwan.; Chen, YL (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan, Taiwan.	yuhling@mail.ncku.edu.tw; tmhong@mail.ncku.edu.tw	Tung, Chia-Hao/AAI-7923-2020; Chen, Yuh-Ling/AAS-7957-2021	Huang, Meng-Fan/0000-0001-5113-1746; Tung, Chia-Hao/0000-0001-5638-4216; Kuo, Li-Wei/0000-0002-1135-8740	Ministry of Science and Technology, Taiwan [MOST 107-2314-B-006-068-MY3, MOST 108-2314-B-006-004, MOST 108-2321-B-006-010, MOST 106-2314-B-006-015-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	We are grateful for providing the services from the RNAi Core Lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital, Taiwan. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taiwan. This study was supported by grants MOST 107-2314-B-006-068-MY3, MOST 108-2314-B-006-004, MOST 108-2321-B-006-010, and MOST 106-2314-B-006-015-MY2 from the Ministry of Science and Technology, Taiwan.	Bagnoli M, 2016, LANCET ONCOL, V17, P1137, DOI 10.1016/S1470-2045(16)30108-5; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BENARD J, 1985, CANCER RES, V45, P4970; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bureau of Health Promotion DoH, 2018, CANC REG ANN REP 201; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chan CK, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160275; Cordero Alexis B, 2010, J Vis Exp, DOI 10.3791/2125; Cormio G, 2003, INT J GYNECOL CANCER, V13, P125, DOI 10.1046/j.1525-1438.2003.13054.x; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Dong Peixin, 2018, Oncotarget, V9, P23253, DOI 10.18632/oncotarget.25298; Feng JL, 2014, J CELL MOL MED, V18, P2125, DOI 10.1111/jcmm.12398; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Goonewardene TI, 2007, LANCET ONCOL, V8, P813, DOI 10.1016/S1470-2045(07)70273-5; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Guo YH, 2016, ONCOTARGET, V7, P42513, DOI 10.18632/oncotarget.9893; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hsu IL, 2016, ONCOTARGET, V7, P62925, DOI 10.18632/oncotarget.7497; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jia LY, 2016, ONCOTARGET, V7, P36743, DOI 10.18632/oncotarget.9163; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Karlan BY, 2014, GYNECOL ONCOL, V132, P334, DOI 10.1016/j.ygyno.2013.12.021; Konecny GE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju249; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39001; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; MAINGUENE C, 1986, J NUCL MED ALLIED S, V30, P19; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Narod S, 2016, NAT REV CLIN ONCOL, V13, P255, DOI 10.1038/nrclinonc.2015.224; NOSEDA A, 1987, LIPIDS, V22, P878, DOI 10.1007/BF02535548; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith BN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020017; Smolle E, 2014, ANTICANCER RES, V34, P1553; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2015, J PATHOL, V235, P25, DOI 10.1002/path.4443; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wang F, 2015, ONCOL LETT, V10, P11, DOI 10.3892/ol.2015.3170; Wang F, 2018, PEERJ, V6, DOI 10.7717/peerj.5912; Wang WH, 2014, ASIAN PAC J CANCER P, V15, P6269, DOI 10.7314/APJCP.2014.15.15.6269; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu L, 2017, NEOPLASIA, V19, P374, DOI 10.1016/j.neo.2017.01.011; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zhang HY, 2017, GENE, V633, P61, DOI 10.1016/j.gene.2017.08.009; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao LJ, 2019, ONCOGENE, V38, P2305, DOI 10.1038/s41388-018-0577-5	66	14	15	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					862	876		10.1038/s41388-019-1025-x	http://dx.doi.org/10.1038/s41388-019-1025-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31570789				2022-12-26	WOS:000509197200009
J	Eisa, A; Bolter, B; Schwenkert, S				Eisa, Ahmed; Boelter, Bettina; Schwenkert, Serena			The ACT domain in chloroplast precursor-phosphorylating STY kinases binds metabolites and allosterically regulates kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; posttranslational modification (PTM); protein import; protein kinase; protein phosphorylation; Arabidopsis; ACT domain; allostery; chloroplast development; kinase signaling; ligand-binding protein	TRANSIT PEPTIDES; PROTEINS; FAMILY; SITE; ENZYMES	Protein import of nucleus-encoded proteins into plant chloroplasts is a highly regulated process, requiring fine-tuning mechanisms especially during chloroplast differentiation. One way of altering import efficiency is phosphorylation of chloroplast transit peptides in the cytosol. We recently investigated the role of three serine/threonine/tyrosine (STY) kinases, STY8, STY17, and STY46, in precursor phosphorylation. These three kinases have a high degree of similarity and harbor a conserved aspartate kinase-chorismate mutase-tyrA (prephenate dehydrogenase) (ACT) domain upstream of the kinase domain. The ACT domain is a widely distributed structural motif known to be important for allosteric regulation of many enzymes. In this work, using biochemical and biophysical techniques in vitro and in planta, including kinase assays, microscale thermophoresis, size exclusion chromatography, as well as site-directed mutagenesis approaches, we show that the ACT domain regulates autophosphorylation and substrate phosphorylation of the STY kinases. We found that isoleucine and S-adenosylmethionine bind to the ACT domain, negatively influencing its autophosphorylation ability. Moreover, we investigated the role of the ACT domain in planta and confirmed its involvement in chloroplast differentiation in vivo. Our results provide detailed insights into the regulation of enzyme activity by ACT domains and establish that it has a role in binding amino acid ligands during chloroplast biogenesis.	[Eisa, Ahmed; Boelter, Bettina; Schwenkert, Serena] Ludwig Maximilians Univ Munchen, Dept Biol 1, Bot, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany	University of Munich	Schwenkert, S (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 1, Bot, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	serena.schwenkert@lmu.de			German Research Foundation (DFG) [CRC TR175]	German Research Foundation (DFG)(German Research Foundation (DFG))	Supported by German Research Foundation (DFG) CRC TR175, Project B06.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fellerer C, 2011, MOL PLANT, V4, P1133, DOI 10.1093/mp/ssr037; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hsieh MH, 2002, PLANT PHYSIOL, V130, P1797, DOI 10.1104/pp.007484; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lamberti G, 2011, PLANT SIGNAL BEHAV, V6, P1918, DOI 10.4161/psb.6.12.18127; Lamberti G, 2011, PLANT PHYSIOL, V157, P70, DOI 10.1104/pp.111.182774; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martin T, 2006, J BIOL CHEM, V281, P40216, DOI 10.1074/jbc.M606580200; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Meng JJ, 2018, PLANT PHYSIOL, V177, P652, DOI 10.1104/pp.18.00183; Nickel C, 2015, FEBS LETT, V589, P1301, DOI 10.1016/j.febslet.2015.04.033; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Romani I, 2015, PLANT PHYSIOL, V169, P627, DOI 10.1104/pp.15.00964; Schertl P, 2017, PLANT PHYSIOL, V175, P51, DOI 10.1104/pp.17.00649; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; Voigt C, 2010, PHYSIOL PLANTARUM, V138, P503, DOI 10.1111/j.1399-3054.2009.01343.x; Waegemann K, 1996, J BIOL CHEM, V271, P6545, DOI 10.1074/jbc.271.11.6545; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998	27	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17278	17288		10.1074/jbc.RA119.010298	http://dx.doi.org/10.1074/jbc.RA119.010298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31594863	Green Published, hybrid			2022-12-26	WOS:000503173500010
J	Bae, SM				Bae, Sung-Man			The prediction model of suicidal thoughts in Korean adults using Decision Tree Analysis: A nationwide cross-sectional study	PLOS ONE			English	Article							OLDER-ADULTS; RISK-FACTORS; DEPRESSION; IDEATION; BEHAVIOR; PEOPLE; JOB; STRESSORS; STRAIN; COHORT	The purpose of this retrospective decisional analysis study is to develop the prediction model of suicidal ideation. We used a Decision Tree Analysis using SPSS 23.0 program to explore predictors of suicide thoughts for 12,015 Korean adults aged 19-98 years. As a result, the most powerful predictor of suicidal ideation was the level of depression. Of people who suspected depression (CESD-11>16), 32.6% experienced suicidal ideation, which is 12 times higher than that of total subjects. The group with the highest rate of suicidal ideation was people who experienced financial difficulties in depression-suspected group and the rate of suicidal thoughts in this group was 56.7%, which was the highest rate. However, in the non-depressive group, the satisfaction of family relationship was the strongest predictor of suicidal ideation. In the non-depressive group, the rate of suicidal thoughts of people with high level of family relationship satisfaction and high level of health satisfaction was 0.6%, which was the lowest rate. The contribution of this study was that it provided the combination of variables to predict the risk groups of adult suicide. This study suggests that researchers and clinicians should consider comprehensively depressive symptoms, family relationships, economic difficulties, and health status to prevent the suicide of adults.	[Bae, Sung-Man] Dankook Univ, Coll Hlth Sci, Dept Psychol & Psychotherapy, Cheonan, Chungnam, South Korea	Dankook University	Bae, SM (corresponding author), Dankook Univ, Coll Hlth Sci, Dept Psychol & Psychotherapy, Cheonan, Chungnam, South Korea.	spirit73@hanmail.net		Bae, Sung Man/0000-0001-5762-4306	Korea Institute for Health and Social Affairs	Korea Institute for Health and Social Affairs	This study used the data derived from Korean Welfare Panel Survey (2016 year) collected by the Korea Institute for Health and Social Affairs.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Bagge CL, 2014, J AFFECT DISORDERS, V165, P53, DOI 10.1016/j.jad.2014.04.010; Barzilay-Levkovitz S, 2012, ADOLES PSYCHIAT-NETH, V2, P289, DOI 10.2174/2210676611202040289; Bruffaerts R, 2010, BRIT J PSYCHIAT, V197, P20, DOI 10.1192/bjp.bp.109.074716; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Cheng JKY, 2010, ASIAN AM J PSYCHOL, V1, P18, DOI 10.1037/a0018799; Coope C, 2015, J AFFECT DISORDERS, V183, P98, DOI 10.1016/j.jad.2015.04.045; Crump C, 2014, PSYCHOL MED, V44, P279, DOI 10.1017/S0033291713000810; CURRIER D, 2016, BMC PUBLIC HEALTH, V16, P43, DOI DOI 10.1186/S12889-016-3702-9; Eikelenboom M, 2012, J PSYCHIATR RES, V46, P608, DOI 10.1016/j.jpsychires.2012.01.025; Elbogen EB, 2005, LAW HUMAN BEHAV, V29, P563, DOI 10.1007/s10979-005-7120-2; Elbogen EB, 2008, J TRAUMA STRESS, V21, P113, DOI 10.1002/jts.20283; Erlangsen A, 2015, SOC PSYCH PSYCH EPID, V50, P1427, DOI 10.1007/s00127-015-1051-0; Fairweather AK, 2006, PSYCHOL MED, V36, P1235, DOI 10.1017/S0033291706007823; Franks R., 2012, ALA COUNS ASS J, V38, P32; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Hempstead KA, 2015, AM J PREV MED, V48, P491, DOI 10.1016/j.amepre.2014.11.006; Hung GCL, 2015, J AFFECT DISORDERS, V172, P165, DOI 10.1016/j.jad.2014.09.037; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Knipe DW, 2015, BMC PUBLIC HEALTH, V15, P2301; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Kuroki Y, 2015, AM J ORTHOPSYCHIAT, V85, P34, DOI 10.1037/ort0000018; Kuroki Y, 2012, ASIAN AM J PSYCHOL, V3, P17, DOI 10.1037/a0026586; Liu RT, 2014, CLIN PSYCHOL REV, V34, P181, DOI 10.1016/j.cpr.2014.01.006; Meltzer H, 2011, PSYCHOL MED, V41, P771, DOI 10.1017/S0033291710001261; Milner A, 2017, PUBLIC HEALTH, V147, P72, DOI 10.1016/j.puhe.2017.02.003; Organization for Economic Cooperation Development, 2015, HLTH DAT 2015; Oyesanya M, 2015, WORLD J PSYCHIATR, V5, P243, DOI 10.5498/wjp.v5.i2.243; Perry Elizabeth J., 2003, CHINESE SOC CHANGE C; Power J, 2016, SUICIDE LIFE-THREAT, V46, P745, DOI 10.1111/sltb.12263; Seo HJ, 2015, COMPR PSYCHIAT, V56, P85, DOI 10.1016/j.comppsych.2014.10.003; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Song Yan-Yan, 2015, Shanghai Arch Psychiatry, V27, P130, DOI 10.11919/j.issn.1002-0829.215044; Stack S, 2007, SUICIDE LIFE-THREAT, V37, P103, DOI 10.1521/suli.2007.37.1.103; Sun WJ, 2012, SOC PSYCH PSYCH EPID, V47, P505, DOI 10.1007/s00127-011-0362-z; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Williams J. M. G., 1997, CRY PAIN UNDERSTANDI; Wu J, 2014, EUR J AGEING, V11, P131, DOI 10.1007/s10433-013-0297-1; Zhang J, 2017, COMPR PSYCHIAT, V74, P1, DOI 10.1016/j.comppsych.2016.12.002	40	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223220	10.1371/journal.pone.0223220	http://dx.doi.org/10.1371/journal.pone.0223220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JI6AQ	31596870	Green Published, gold			2022-12-26	WOS:000493549100001
J	Gaines, A; Ludovice, M; Xu, J; Zanghi, M; Meinersmann, RJ; Berrang, M; Daley, W; Britton, D				Gaines, Anna; Ludovice, Miranda; Xu, Jie; Zanghi, Marc; Meinersmann, Richard J.; Berrang, Mark; Daley, Wayne; Britton, Doug			The dialogue between protozoa and bacteria in a microfluidic device	PLOS ONE			English	Article							CHEMOSENSORY BEHAVIOR; PHAGOTROPHIC PROTISTS; ESCHERICHIA-COLI; TETRAHYMENA; PREDATION; SURVIVAL; IDENTIFICATION; CONSEQUENCES; CHEMOTAXIS; DETERMINES	In nature, protozoa play a major role in controlling bacterial populations. This paper proposes a microfluidic device for the study of protozoa behaviors change due to their chemotactic response in the presence of bacterial cells. A three-channel microfluidic device was designed using a nitrocellulose membrane into which channels were cut using a laser cutter. The membrane was sandwiched between two glass slides; a Euglena suspension was then allowed to flow through the central channel. The two side channels were filled with either, 0.1% peptone as a negative control, or a Listeria suspension respectively. The membrane design prevented direct interaction but allowed Euglena cells to detect Listeria cells as secretions diffused through the nitrocellulose membrane. A significant number of Euglena cells migrated toward the chambers near the bacterial cells, indicating a positive chemotactic response of Euglena toward chemical cues released from Listeria cells. Filtrates collected from Listeria suspension with a series of molecular weight cutoffs (3k, 10k and 100k) were examined in Euglena chemotaxis tests. Euglena cells were attracted to all filtrates collected from the membrane filtration with different molecular weight cutoffs, suggesting small molecules from Listeria might be the chemical cues to attract protozoa. Headspace volatile organic compounds (VOC) released from Listeria were collected, spiked to 0.1% peptone and tested as the chemotactic effectors. It was discovered that the Euglena cells responded quickly to Listeria VOCs including decanal, 3,5-dimethylbenzaldehyde, ethyl acetate, indicating bacterial VOCs were used by Euglena to track the location of bacteria.	[Gaines, Anna; Ludovice, Miranda; Xu, Jie; Zanghi, Marc; Daley, Wayne; Britton, Doug] Georgia Inst Technol, Georgia Tech Res Inst, Aerosp Transportat & Adv Syst Lab, Atlanta, GA 30332 USA; [Meinersmann, Richard J.; Berrang, Mark] ARS, Richard B Russell Res Ctr, USDA, Athens, GA USA	University System of Georgia; Georgia Institute of Technology; United States Department of Agriculture (USDA)	Xu, J (corresponding author), Georgia Inst Technol, Georgia Tech Res Inst, Aerosp Transportat & Adv Syst Lab, Atlanta, GA 30332 USA.	jie.xu@gtri.gatech.edu		Xu, Jie/0000-0002-9155-4097; Ludovice, Miranda/0000-0001-6869-9151	Agricultural Research Service, United States Department of Agriculture [58-6040-5-010]	Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The submitted work was financially supported by Agricultural Research Service, United States Department of Agriculture under research agreement of 58-6040-5-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Alfonzo A, 2016, INT J FOOD MICROBIOL, V239, P65, DOI 10.1016/j.ijfoodmicro.2016.06.027; ANTIPA GA, 1983, J PROTOZOOL, V30, P55, DOI 10.1111/j.1550-7408.1983.tb01033.x; Arnold JW, 2016, CELL MICROBIOL, V18, P1459, DOI 10.1111/cmi.12591; Audrain B, 2015, FEMS MICROBIOL REV, V39, P222, DOI 10.1093/femsre/fuu013; Barry MT, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0791; BENTHAM C, 2019, NEURAL PLAST, V2019, DOI DOI 10.1101/667378; Bertram JH, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00018-17; Boenigk J, 2002, AQUAT MICROB ECOL, V27, P195, DOI 10.3354/ame027195; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Citron CA, 2012, J NAT PROD, V75, P1765, DOI 10.1021/np300468h; Cohen Michael F., 2006, Journal of Protozoology Research, V16, P16; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Denoncourt AM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00240; Diao JP, 2006, LAB CHIP, V6, P381, DOI 10.1039/b511958h; Dopheide A, 2011, APPL ENVIRON MICROB, V77, P4564, DOI 10.1128/AEM.02421-10; Fellous S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048436; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; Gao JP, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/2/027102; Ge ZF, 2016, LAB CHIP, V16, P480, DOI 10.1039/c5lc00978b; Giometto A, 2015, P NATL ACAD SCI USA, V112, P7045, DOI 10.1073/pnas.1422922112; Gissibl A, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00108; Gonsalves MJ, 2017, BRAZ J MICROBIOL, V48, P37, DOI 10.1016/j.bjm.2016.10.009; Gu YQ, 2007, SOIL BIOL BIOCHEM, V39, P2567, DOI 10.1016/j.soilbio.2007.05.011; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; HELLUNGLARSEN P, 1986, BIOL BULL, V170, P357, DOI 10.2307/1541847; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Lambrecht E, 2015, APPL ENVIRON MICROB, V81, P5604, DOI 10.1128/AEM.01031-15; Lazazzara V, 2017, MICROBIOL RES, V201, P52, DOI 10.1016/j.micres.2017.04.015; LEE JW, 1954, PHYSIOL ZOOL, V27, P275, DOI 10.1086/physzool.27.3.30152170; LEICK V, 1992, BIOESSAYS, V14, P61; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Mahdavifar A, 2014, J ELECTROCHEM SOC, V161, pB3064, DOI 10.1149/2.009402jes; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Menon P, 2003, WATER RES, V37, P4151, DOI 10.1016/S0043-1354(03)00349-X; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P83, DOI 10.3354/ame01229; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Ogawa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168114; Oguri S, 2015, J GEN APPL MICROBIOL, V61, P203, DOI 10.2323/jgam.61.203; Pachiadaki MG, 2016, DEEP-SEA RES PT II, V129, P223, DOI 10.1016/j.dsr2.2014.10.019; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pohnert G, TRENDS ECOL EVOL, V22, P198, DOI [10.1016/j.tree, DOI 10.1016/J.TREE]; Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126; Saleem M, 2013, ISME J, V7, P1912, DOI 10.1038/ismej.2013.95; Schmidt C, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0147270; Schulz-Bohm K, 2017, ISME J, V11, P817, DOI 10.1038/ismej.2016.144; Schulz-Bohm K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01212; Sharifi R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00196; SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812; Strom SL, 1998, J PLANKTON RES, V20, P831, DOI 10.1093/plankt/20.5.831; Tait E, 2014, J CHROMATOGR SCI, V52, P363, DOI 10.1093/chromsci/bmt042; Team S-l, SCIK LEARN MACH LEAR; Trigui H, 2016, APPL ENVIRON MICROB, V82, P2783, DOI 10.1128/AEM.03921-15; Vaerewijck MJM, 2014, COMPR REV FOOD SCI F, V13, P924, DOI 10.1111/1541-4337.12100; Velve-Casquillas G, 2010, NANO TODAY, V5, P28, DOI 10.1016/j.nantod.2009.12.001; Vigneau E, 2018, FOOD QUAL PREFER, V68, P135, DOI 10.1016/j.foodqual.2018.02.008; Wanjugi P, 2016, MICROB ECOL, V72, P526, DOI 10.1007/s00248-016-0825-6; Weise T, 2012, BEILSTEIN J ORG CHEM, V8, P579, DOI 10.3762/bjoc.8.65; Wolfram CJ, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4967777; Zubkov MV, 1996, FEMS MICROBIOL ECOL, V20, P137, DOI 10.1016/0168-6496(96)00018-9	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222484	10.1371/journal.pone.0222484	http://dx.doi.org/10.1371/journal.pone.0222484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596855	Green Published, gold			2022-12-26	WOS:000532444100011
J	Kornadt, AE; Siebert, JS; Wahl, HW				Kornadt, Anna E.; Siebert, Jelena S.; Wahl, Hans-Werner			The interplay of personality and attitudes toward own aging across two decades of later life	PLOS ONE			English	Article							FUTURE SELF-VIEWS; AGE STEREOTYPES; OLD-AGE; HEALTH; PERCEPTIONS; ADULTHOOD; CONSCIENTIOUSNESS; EXPECTATIONS; METAANALYSIS; TEMPERAMENT	Big Five personality traits are assumed to be linked with attitudes toward own aging. Since both constructs have central importance for the aging process, it is surprising that to our knowledge no study so far comprehensively addressed their mutual connection over time. We used data from the ILSE study, a longitudinal study capturing personality and attitudes toward own aging at four measurement occasions, spanning 20 years and including two participant cohorts in midlife (n = 501; born 1950-52) and later life (n = 500; born 1930-32). Dual latent change score models showed that personality was longitudinally related to change in attitudes toward own aging: Lower Neuroticism, higher Conscientiousness, and higher Openness predicted more positive attitudes, whereas the direction of the effect for Extraversion varied by time. Furthermore, the role of personality seems to be confined to certain sensitive periods in midlife and early old age. Contrary to our expectations, attitudes toward own aging had only marginal longitudinal impact on the Big Five. Our results shed light on the developmental co-dynamics of personality and subjective perceptions of aging across the second half of the lifespan.	[Kornadt, Anna E.] Bielefeld Univ, Dept Psychol, Bielefeld, Germany; [Siebert, Jelena S.; Wahl, Hans-Werner] Heidelberg Univ, Dept Psychol, Heidelberg, Germany	University of Bielefeld; Ruprecht Karls University Heidelberg	Kornadt, AE (corresponding author), Bielefeld Univ, Dept Psychol, Bielefeld, Germany.	anna.kornadt@uni-bielefeld.de	Kornadt, Anna/AAM-8763-2021	Kornadt, Anna/0000-0002-6634-0812	Dietmar Hopp Foundation; German Federal Ministry for Family, Senior Citizens, Women, and youth [314-1722102/16, 301-1720-295/2]	Dietmar Hopp Foundation; German Federal Ministry for Family, Senior Citizens, Women, and youth	This article reports data from the Interdisciplinary Longitudinal Study of Adult Development and Aging (ILSE). ILSE's fourth wave of data collection was supported by the Dietmar Hopp Foundation (https://dietmar-hopp-stiftung.de/die-stiftung/hopp-foundation). Financial support for the previous waves came from the German Federal Ministry for Family, Senior Citizens, Women, and youth (Grant numbers 314-1722102/16 and 301-1720-295/2) (https://www.bmfsfj.de/). Funding was received by HWW and others who are not authors on this paper. We are very thankful for this support.	Allen PM, 2015, PSYCHOL AGING, V30, P534, DOI 10.1037/pag0000039; Bellingtier JA, 2018, J GERONTOL B-PSYCHOL, V73, P1155, DOI 10.1093/geronb/gbw086; Brandtstadter J., 1998, HDB CHILD PSYCHOL, V1, P49; Bryant C, 2016, GERONTOLOGIST, V56, P256, DOI 10.1093/geront/gnu041; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; CASPI A, 1989, J PERS, V57, P375, DOI 10.1111/j.1467-6494.1989.tb00487.x; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Costa PT, 2000, ASSESSMENT, V7, P365, DOI 10.1177/107319110000700405; Denissen JJA, 2013, CHILD DEV PERSPECT, V7, P255, DOI 10.1111/cdep.12050; Diehl M, 2014, DEV REV, V34, P93, DOI 10.1016/j.dr.2014.01.001; Geiser C., 2012, DATA ANAL MPLUS; Greve W, 2010, CONSCIOUS COGN, V19, P721, DOI 10.1016/j.concog.2010.05.016; Hill PL, 2011, HEALTH PSYCHOL, V30, P536, DOI 10.1037/a0023859; Hudson NW, 2015, J PERS SOC PSYCHOL, V109, P490, DOI 10.1037/pspp0000021; Hudson NW, 2014, J RES PERS, V53, P68, DOI 10.1016/j.jrp.2014.08.008; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Jung S, 2018, J ADULT DEV, V25, P141, DOI 10.1007/s10804-018-9283-3; Kandler C, 2016, EUR J PERSONALITY, V30, P390, DOI 10.1002/per.2065; Kandler C, 2015, J PERS SOC PSYCHOL, V109, P175, DOI 10.1037/pspp0000028; Kandler C, 2014, EUR J PERSONALITY, V28, P231, DOI 10.1002/per.1952; Kandler C, 2013, DEV PSYCHOL, V49, P1739, DOI 10.1037/a0030744; Kandler C, 2012, BEHAV GENET, V42, P57, DOI 10.1007/s10519-011-9491-0; Kim KH, 2005, STRUCT EQU MODELING, V12, P368, DOI 10.1207/s15328007sem1203_2; Kleinspehn-Ammerlahn A, 2008, J GERONTOL B-PSYCHOL, V63, pP377, DOI 10.1093/geronb/63.6.P377; Kornadt AE, 2018, EUR J PERSONALITY, V32, P30, DOI 10.1002/per.2135; Kornadt AE, 2017, PSYCHOL AGING, V32, P388, DOI 10.1037/pag0000174; Kornadt AE, 2017, J GERONTOL B-PSYCHOL, V72, P582, DOI 10.1093/geronb/gbv099; Kornadt AE, 2016, J RES PERS, V60, P51, DOI 10.1016/j.jrp.2015.11.005; Kornadt AE, 2015, PSYCHOL AGING, V30, P967, DOI 10.1037/pag0000048; Kornadt AE, 2012, PSYCHOL AGING, V27, P164, DOI 10.1037/a0025110; Laidlaw K, 2007, INT J GERIATR PSYCH, V22, P367, DOI 10.1002/gps.1683; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2008, SOC BEHAV PERSONAL, V36, P559, DOI 10.2224/sbp.2008.36.4.559; Levy BR, 2005, PSYCHOL HEALTH, V20, P553, DOI 10.1080/14768320500066381; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; McAdams D., 2003, J GERONTOL B-PSYCHOL, V58, P296, DOI [10.1093/geronb/58.6.P296, DOI 10.1093/GERONB/58.6.P296]; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Miche M, 2014, PSYCHOL AGING, V29, P588, DOI 10.1037/a0037259; Moor C, 2006, INT J AGING HUM DEV, V63, P241, DOI 10.2190/AKRY-UM4K-PB1V-PBHF; Mueller S., 2017, PERSONALITY DEV LIFE, P69, DOI [10.1016/B978-0-12-804674-6.00006-5, DOI 10.1016/B978-0-12-804674-6.00006-5]; Mueller S, 2016, J RES PERS, V65, P94, DOI 10.1016/j.jrp.2016.08.007; Muthen B., 2010, MPLUS USERS GUIDE; Ostendorf F., 1993, NEO 5 FACTOR INVENTO; Roberts BW, 2005, REV GEN PSYCHOL, V9, P156, DOI 10.1037/1089-2680.9.2.156; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Roberts BW, 2006, HDB PERSONALITY DEV, P11, DOI DOI 10.4324/9781315805610.CH2; Rothermund K, 2003, INT J BEHAV DEV, V27, P549, DOI 10.1080/01650250344000208; Rupprecht FS, 2019, GEROPSYCH, V32, P57, DOI 10.1024/1662-9647/a000204; Sargent-Cox KA, 2014, J GERONTOL B-PSYCHOL, V69, P168, DOI 10.1093/geronb/gbt005; Sargent-Cox KA, 2012, HEALTH PSYCHOL, V31, P423, DOI 10.1037/a0027464; Sattler C., 2017, ENCY GEROPSYCHOLOGY, P1213, DOI [10.1007/978-981-287-082-7_238, DOI 10.1007/978-981-287-082-7_238]; Schelling HR, 2008, Z GERONTOL GERIATR, V41, P38, DOI 10.1007/s00391-007-0451-5; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schmitt M, 2008, INTERDISCIPLINARY LO; Schwaba T, 2018, J PERS SOC PSYCHOL, V115, P118, DOI 10.1037/pspp0000150; Shenkin SD, 2014, INT PSYCHOGERIATR, V26, P1417, DOI 10.1017/S1041610214000301; Siebert JS, 2018, PSYCHOL AGING, V33, P461, DOI 10.1037/pag0000252; Siebert JS, 2018, J GERONTOL B-PSYCHOL, V73, P836, DOI 10.1093/geronb/gbw050; Smith J, 1996, BERLINER ALTERSSTUDI, P498; Specht J., 2017, PERSONALITY DEV LIFE, DOI DOI 10.1016/B978-0-12-804674-6.00005-3; Stephan Y, 2015, J PERS, V83, P142, DOI 10.1111/jopy.12090; Steyer R., 1997, METHODS PSYCHOL RES, V2, P21, DOI DOI 10.1080/00273171.2020.1730739; Tewes U., 1994, HAMBURG WECHSLER INT; Wahl HW, 2013, Z ENTWICKL PADAGOGIS, V45, P66, DOI 10.1026/0049-8637/a000081; Westerhof GJ, 2014, PSYCHOL AGING, V29, P793, DOI 10.1037/a0038016; Wettstein M, 2017, PSYCHOL AGING, V32, P259, DOI 10.1037/pag0000166; Wettstein M, 2017, GEROPSYCH, V30, P5, DOI 10.1024/1662-9647/a000162; Wood D, 2006, PERS SOC PSYCHOL B, V32, P1482, DOI 10.1177/0146167206291008; Wrosch C., 2005, THINKING TIME MULTID, P110; Wrzus C, 2017, PERS SOC PSYCHOL REV, V21, P253, DOI 10.1177/1088868316652279; Wurm S, 2017, DEV REV, V46, P27, DOI 10.1016/j.dr.2017.08.002; Yu C.-Y., 2002, THESIS	74	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223622	10.1371/journal.pone.0223622	http://dx.doi.org/10.1371/journal.pone.0223622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596876	Green Published, gold			2022-12-26	WOS:000532444100050
J	Lopez, Y; Tato, M; Gargallo-Viola, D; Canton, R; Vila, J; Zsolt, I				Lopez, Y.; Tato, M.; Gargallo-Viola, D.; Canton, R.; Vila, J.; Zsolt, I			Mutant prevention concentration of ozenoxacin for quinolone-susceptible or - resistant Staphylococcus aureus and Staphylococcus epidermidis	PLOS ONE			English	Article							IN-VITRO; SELECTION WINDOW; INFECTIONS; MECHANISM; IMPETIGO; SKIN	Ozenoxacin (OZN) belongs to a new generation of non-fluorinated quinolones for the topical treatment of skin infections which has shown to be effective in the treatment of susceptible and resistant Gram-positive cocci. The mutant prevention concentration (MPC) of ozenoxacin, levofloxacin and ciprofloxacin was determined in quinolone-susceptible and -resistant strains including methicillin-susceptible S. aureus, methicillin-resistant S. aureus, methicillin-susceptible S. epidermidis and methicillin-resistant S. epidermidis with different profile of mutation in the quinolone resistance determining regions (QRDR). The MPC value of OZN for the methicillin-susceptible S. aureus strain susceptible to quinolones, without mutations in QRDR, was 0.05 mg/L, being 280-fold lower than that observed with ciprofloxacin and levofloxacin. In methicillin-susceptible and-resistant S. aureus strains with mutations in the gyrA or/and grlA genes the MPC of OZN went from 0.1 to 6 mg/L, whereas the MPC of levofloxacin and ciprofloxacin was > 50 mg/L for the same strains. For methicillin-susceptible and-resistant S. epidermidis the results were similar to those abovementioned for S. aureus. According to our results, the MPC of OZN was far below the quantity of ozenoxacin achieved in the epidermal layer, suggesting that the in vivo selection of mutants, if it occurs, will take place at low frequency. Ozenoxacin is an excellent candidate for the treatment of bacterial infections caused by susceptible and quinolone-resistant staphylococci isolated usually from skin infections.	[Lopez, Y.; Vila, J.] Inst Global Hlth Barcelona, Barcelona, Spain; [Tato, M.; Canton, R.] Hosp Univ Ramon y Cajal, Dept Clin Microbiol, Madrid, Spain; [Tato, M.; Canton, R.] Inst Ramon y Cajal Invest Sanit IRYCIS, Madrid, Spain; [Gargallo-Viola, D.] ABAC Therapeut, Barcelona, Spain; [Vila, J.] Univ Barcelona, Hosp Clin, Sch Med, Dept Clin Microbiol, Barcelona, Spain; [Zsolt, I] Ferrer Int, Med Dept, Barcelona, Spain	ISGlobal; Hospital Universitario Ramon y Cajal; University of Barcelona; Hospital Clinic de Barcelona	Vila, J (corresponding author), Inst Global Hlth Barcelona, Barcelona, Spain.; Vila, J (corresponding author), Univ Barcelona, Hosp Clin, Sch Med, Dept Clin Microbiol, Barcelona, Spain.	jvila@ub.edu	CANTON, RAFAEL/ABF-6353-2020; Cantón, Rafael/AAP-8669-2021	lopez, yuly/0000-0001-7491-740X; Zsolt, Ilonka/0000-0002-8900-722X; Canton, Rafael/0000-0003-1675-3173	Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0010]; European Development Regional Fund "A way to achieve Europe"; Agencia de Gestiod'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya [2017 SGR 0809]; Ferrer Internacional S.A	Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases; European Development Regional Fund "A way to achieve Europe"; Agencia de Gestiod'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya(Generalitat de Catalunya); Ferrer Internacional S.A	JV was supported by (REIPI RD16/0016/0010) Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases and was co-financed by European Development Regional Fund "A way to achieve Europe". JV was also supported by 2017 SGR 0809 from the Agencia de Gestiod'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya. "Ferrer Internacional S.A also provided funds to perform this study. In addition, this funder provided support in the form of salaries for author [IZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions' section.	Canton R, 2018, FUTURE MICROBIOL, V13, DOI 10.2217/fmb-2017-0289; Copin R, 2019, P NATL ACAD SCI USA, V116, P1745, DOI 10.1073/pnas.1814265116; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Fabrega A, 2009, MICROB BIOTECHNOL, V2, P40, DOI 10.1111/j.1751-7915.2008.00063.x; Gad GFM, 2010, BRAZ J MICROBIOL, V41, P333, DOI 10.1590/S1517-838220100002000012; Gebru E, 2011, J MED MICROBIOL, V60, P1512, DOI 10.1099/jmm.0.028654-0; Gropper Savion, 2014, Future Microbiol, V9, pS17, DOI 10.2217/fmb.14.83; Hebert AA, 2018, J DRUGS DERMATOL, V17, P1051; Hong YZ, 2019, P NATL ACAD SCI USA, V116, P10064, DOI 10.1073/pnas.1901730116; Hooper DC, 2015, ANN NY ACAD SCI, V1354, P12, DOI 10.1111/nyas.12830; Kanayama S, 2016, J INFECT CHEMOTHER, V22, P720, DOI 10.1016/j.jiac.2016.03.006; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; Liu LG, 2013, J ANTIBIOT, V66, P709, DOI 10.1038/ja.2013.87; Lopez Y, 2015, J ANTIMICROB CHEMOTH, V70, P57, DOI 10.1093/jac/dku375; Lopez Y, 2013, ANTIMICROB AGENTS CH, V57, P6389, DOI 10.1128/AAC.01509-13; Lopez Y, 2018, ENFERM INFEC MICR CL, V36, P146; Lopez Y., 2013, 53 INT C ANT AG CHEM; Maina EK, 2013, INT J INFECT DIS, V17, pE115, DOI 10.1016/j.ijid.2012.09.006; Marsilio F., 2018, PET TO MAN TRAVELLIN, P43; Metzler K, 2004, INT J ANTIMICROB AG, V24, P161, DOI 10.1016/j.ijantimicag.2004.02.021; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pereira LB, 2014, AN BRAS DERMATOL, V89, P293, DOI 10.1590/abd1806-4841.20142283; Remy JM, 2012, J ANTIMICROB CHEMOTH, V67, P2814, DOI 10.1093/jac/dks307; Sladden MJ, 2004, BMJ-BRIT MED J, V329, P95, DOI 10.1136/bmj.329.7457.95; Vila J, 2019, EXPERT REV ANTI-INFE, V17, P159, DOI 10.1080/14787210.2019.1573671; Yamakawa T, 2002, J ANTIMICROB CHEMOTH, V49, P455, DOI 10.1093/jac/49.3.455; Zhao XL, 2015, J ANTIMICROB CHEMOTH, V70, P639, DOI 10.1093/jac/dku463	29	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223326	10.1371/journal.pone.0223326	http://dx.doi.org/10.1371/journal.pone.0223326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596898	Green Published, gold			2022-12-26	WOS:000532444100029
J	Cao, XG; Deng, M; Song, F; Zhong, SH; Zhu, JH				Cao, Xiguang; Deng, Min; Song, Fei; Zhong, Shihu; Zhu, Junhao			Direct and moderating effects of environmental regulation intensity on enterprise technological innovation: The case of China	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; KUZNETS CURVE; PRODUCTIVITY; IMPACT; SUBSIDIES; COMPETITIVENESS; PERFORMANCE; INDUSTRY; GROWTH; INVESTMENT	There is few significant attempt to integrate environmental regulation, government financial support, and corporate technological innovation in a methodological framework. Employing the data of the industrial enterprises with an annual turnover of over 20 million yuan from 30 Chinese provinces or municipalities between 2008 and 2016, this paper applies the fixed effect regression model to reveal the relationships between environmental regulation, government financial support, and corporate technological innovation simultaneously. Results show that: (1) there exists a U-shaped relation between environmental regulation intensity and technological innovation of enterprises which declines first and then climbs up, and China is still at the stage of inhibition before the "inflection point". (2) government financial support does not significantly work on technological innovation directly, but environmental regulation drives this effect to be achieved; when the value of InER is higher than 3.69, government financial support can significantly facilitate corporate technological innovation. (3) the comparison between regional samples reveals that heterogeneity exists in the influence of environmental regulation intensity and government financial support on corporate technological innovation. The threshold value of enabling effects of environmental regulation in eastern region is higher than that of the central and western region. These results remain consistent after we experiment several robustness checks. Theory and policy implications of our work are discussed.	[Cao, Xiguang; Deng, Min; Zhu, Junhao] Shanghai Univ Finance & Econ, Sch Urban & Reg Sci, Inst Finance & Econ Res, Shanghai, Peoples R China; [Song, Fei] Jiangsu Open Univ, Sch Informat Engn, Nanjing, Peoples R China; [Zhong, Shihu] Shanghai Univ Finance & Econ, Sch Publ Econ & Adm, Dept Investment, Shanghai, Peoples R China	Shanghai University of Finance & Economics; Jiangsu Open University; Shanghai University of Finance & Economics	Zhong, SH (corresponding author), Shanghai Univ Finance & Econ, Sch Publ Econ & Adm, Dept Investment, Shanghai, Peoples R China.	zhongshihu@163.sufe.edu.cn	Cao, Xiguang/AAL-8844-2021	Zhong, Shihu/0000-0001-6100-1750; Deng, Min/0000-0001-5931-3739				Acemoglu D, 2012, AM ECON REV, V102, P131, DOI 10.1257/aer.102.1.131; Aghion P, 2016, J POLIT ECON, V124, P1; [Anonymous], 1997, OECD EC STUD; BARBERA AJ, 1990, J ENVIRON ECON MANAG, V18, P50, DOI 10.1016/0095-0696(90)90051-Y; Berman E, 2001, REV ECON STAT, V83, P498, DOI 10.1162/00346530152480144; Brannlund R., 1995, Environmental and Resource Economics, V6, P23, DOI 10.1007/BF00691409; Broekel T, 2017, INT REGIONAL SCI REV, V40, P297, DOI 10.1177/0160017615589007; Bronzini R, 2016, RES POLICY, V45, P442, DOI 10.1016/j.respol.2015.10.008; Chen BZ, 2000, CHINA ECON REV, V11, P1, DOI 10.1016/S1043-951X(99)00014-0; Clausen Tommy H., 2009, Structural Change and Economic Dynamics, V20, P239, DOI 10.1016/j.strueco.2009.09.004; Czarnitzki D, 2014, IND INNOV, V21, P380, DOI 10.1080/13662716.2014.973246; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Doloreux D., 2002, TECHNOL SOC, V24, P243, DOI [10.1016/S0160-791X(02)00007-6, DOI 10.1016/S0160-791X(02)00007-6, https://doi.org/10.1016/S0160-791X(02)00007-6]; Feres J, 2012, ENVIRON RESOUR ECON, V52, P65, DOI 10.1007/s10640-011-9520-8; Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8; GEMUNDEN HG, 1992, R&D MANAGE, V22, P359, DOI 10.1111/j.1467-9310.1992.tb01206.x; GOLLOP FM, 1983, J POLIT ECON, V91, P654, DOI 10.1086/261170; Gorg H, 2007, ECONOMICA, V74, P215, DOI 10.1111/j.1468-0335.2006.00547.x; GRAY WB, 1987, AM ECON REV, V77, P998; Greve HR, 2003, ACAD MANAGE J, V46, P685, DOI 10.2307/30040661; Guo D, 2016, RES POLICY, V45, P1129, DOI 10.1016/j.respol.2016.03.002; Guo J., 2019, FINANC TRADE EC, V40, P147, DOI DOI 10.16528/J.CNKI.22-1054/F.202205021; Guo LL, 2017, J CLEAN PROD, V162, P894, DOI 10.1016/j.jclepro.2017.05.210; Hamamoto M, 2006, RESOUR ENERGY ECON, V28, P299, DOI 10.1016/j.reseneeco.2005.11.001; JAFFE AB, 1995, J ECON LIT, V33, P132; Jaffe AB, 1997, REV ECON STAT, V79, P610, DOI 10.1162/003465397557196; Jia PR, 2018, J ENVIRON MANAGE, V206, P1308, DOI 10.1016/j.jenvman.2017.08.052; Jones CI, 2003, FINANCE, RESEARCH, EDUCATION AND GROWTH, P51; JORGENSON DW, 1990, RAND J ECON, V21, P314, DOI 10.2307/2555426; Levinson A, 1996, J PUBLIC ECON, V62, P5, DOI 10.1016/0047-2727(96)01572-1; Li W, 2020, ENVIRON TECHNOL, V41, P691, DOI 10.1080/09593330.2018.1509137; MAGAT WA, 1978, J ENVIRON ECON MANAG, V5, P1, DOI 10.1016/0095-0696(78)90002-5; Malesky EJ, 2008, J POLIT, V70, P97, DOI 10.1017/S0022381607080085; PALMER K, 1995, J ECON PERSPECT, V9, P119, DOI 10.1257/jep.9.4.119; Peng BH, 2018, J ENVIRON MANAGE, V218, P181, DOI 10.1016/j.jenvman.2018.04.068; PORTER ME, 1995, J ECON PERSPECT, V9, P97, DOI 10.1257/jep.9.4.97; PORTER ME, 1991, SCI AM, V264, P168, DOI 10.1038/scientificamerican0491-168; Triebswetter U, 2005, J CLEAN PROD, V13, P733, DOI 10.1016/j.jclepro.2004.01.009; Tsai WH, 2012, ENERGY, V39, P218, DOI 10.1016/j.energy.2012.01.027; Tsai WH, 2011, ENERGY, V36, P3022, DOI 10.1016/j.energy.2011.02.046; Van Rooij B, 2013, REGUL GOV, V7, P321, DOI 10.1111/rego.12001; Wallsten SJ, 2000, RAND J ECON, V31, P82, DOI 10.2307/2601030; Wang H, 2002, ECOL ECON, V41, P85, DOI 10.1016/S0921-8009(02)00016-2; Xiang, 2019, INT REGIONAL SCI REV; [阳立高 Yang Ligao], 2018, [中国软科学, China Soft Science], P138; Yang W, 2019, OBES SURG, V29, P168; Yin JH, 2015, ENERG POLICY, V77, P97, DOI 10.1016/j.enpol.2014.11.008; Yong JY, 2020, BUS STRATEG ENVIRON, V29, P212, DOI 10.1002/bse.2359; Yong JY, 2019, J CLEAN PROD, V215, P364, DOI 10.1016/j.jclepro.2018.12.306; Yu FF, 2016, ENERG POLICY, V89, P106, DOI 10.1016/j.enpol.2015.11.009; Zhao X, 2016, J CLEAN PROD, V112, P1528, DOI 10.1016/j.jclepro.2015.05.029; Zhou Y, 2017, HABITAT INT, V60, P10, DOI 10.1016/j.habitatint.2016.12.002	52	13	13	10	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223175	10.1371/journal.pone.0223175	http://dx.doi.org/10.1371/journal.pone.0223175			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7KN	31589643	gold, Green Published			2022-12-26	WOS:000532427300012
J	Kanamaru, T; Aihara, K				Kanamaru, Takashi; Aihara, Kazuyuki			Acetylcholine-mediated top-down attention improves the response to bottom-up inputs by deformation of the attractor landscape	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; NORMALIZATION MODEL; NEURAL EXCITABILITY; SPATIAL ATTENTION; GABA RELEASE; MODULATION; NEUROMODULATION; MECHANISMS; RECEPTORS; SYNAPSES	To understand the effect of attention on neuronal dynamics, we propose a multi-module network, with each module consisting of fully interconnected groups of excitatory and inhibitory neurons. This network shows transitive dynamics among quasi-attractors as its typical dynamics. When the release of acetylcholine onto the network is simulated by attention, the transitive dynamics change into stable dynamics in which the system converges to an attractor. We found that this network can reproduce three experimentally observed properties of attention-dependent response modulation, namely an increase in the firing rate, a decrease in the Fano factor of the firing rate, and a decrease in the correlation coefficients between the firing rates of pairs of neurons. Moreover, we also showed theoretically that the release of acetylcholine increases the sensitivity to bottom-up inputs by changing the response function.	[Kanamaru, Takashi] Kogakuin Univ, Dept Mech Sci & Engn, Tokyo, Japan; [Aihara, Kazuyuki] Univ Tokyo, Int Res Ctr Neurointelligence WPI & RCN, UTIAS, Bunkyo Ku, Tokyo, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan	Kogakuin University; University of Tokyo; University of Tokyo	Kanamaru, T (corresponding author), Kogakuin Univ, Dept Mech Sci & Engn, Tokyo, Japan.	kanamaru@cc.kogakuin.ac.jp		Kanamaru, Takashi/0000-0001-5018-0570	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study, JSPS KAKENHI [15H05707]; AMED [JP19dm0307009]; JST CREST, Japan [JPMJCR14D2]	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study, JSPS KAKENHI; AMED; JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST))	This research was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study, JSPS KAKENHI Grant No. 15H05707, AMED under Grant Number JP19dm0307009, and JST CREST, Grant No. JPMJCR14D2, Japan.	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buno W, 2006, J MOL NEUROSCI, V30, P161, DOI 10.1385/JMN:30:1:161; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Deco G, 2005, J NEUROPHYSIOL, V94, P295, DOI 10.1152/jn.01095.2004; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Deco G, 2011, EUR J NEUROSCI, V34, P146, DOI 10.1111/j.1460-9568.2011.07749.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Izhikevich EM, 1999, IEEE T NEURAL NETWOR, V10, P499, DOI 10.1109/72.761707; Kanamaru T, 2005, NEURAL COMPUT, V17, P1315, DOI 10.1162/0899766053630387; Kanamaru T, 2007, NEURAL NETWORKS, V20, P781, DOI 10.1016/j.neunet.2007.06.002; Kanamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053854; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuczewski N, 2005, J PHYSIOL-LONDON, V566, P907, DOI 10.1113/jphysiol.2005.089987; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Linster C, 2001, CHEM SENSES, V26, P585, DOI 10.1093/chemse/26.5.585; MILNOR J, 1985, COMMUN MATH PHYS, V99, P177, DOI 10.1007/BF01212280; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PERRY EK, 1995, BRAIN COGNITION, V28, P240, DOI 10.1006/brcg.1995.1255; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rodriguez A, 2004, J COGNITIVE NEUROSCI, V16, P856, DOI 10.1162/089892904970690; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Thiele A, 2018, NEURON, V97, P769, DOI 10.1016/j.neuron.2018.01.008; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223592	10.1371/journal.pone.0223592	http://dx.doi.org/10.1371/journal.pone.0223592			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589648	Green Published, gold			2022-12-26	WOS:000532427300031
J	Kundu, I; Martinez-Donate, A; Karkada, N; Roth, A; Felsher, M; Sandling, M; Szep, Z				Kundu, Iman; Martinez-Donate, Ana; Karkada, Navya; Roth, Alexis; Felsher, Marisa; Sandling, Marcus; Szep, Zsofia			Attitudes and referral practices for pre-exposure prophylaxis (PrEP) among HIV rapid testers and case managers in Philadelphia: A mixed methods study	PLOS ONE			English	Article							PLANNED BEHAVIOR; ANTIRETROVIRAL PROPHYLAXIS; PROVIDERS KNOWLEDGE; UNITED-STATES; RISK; MEN; PREVENTION; UNDERSTAND	Objective Adoption of pre-exposure prophylaxis (PrEP) to prevent HIV infection has been slow. The purpose of this study was to evaluate knowledge, attitudes and referral practices for PrEP among non-prescribing providers, who may play key role. Methods We performed a cross-sectional survey on PrEP knowledge, attitudes, and referral practices among 66 non-prescribing HIV prevention providers (1st August to 31st December, 2016), in Philadelphia, followed by qualitative interviews with 12 of them (5th April to 10th May, 2017). Results Participants had a mean age of 36 years, with 62% females. Majority were HIV case managers and rapid testers. For half of the respondents, PrEP eligibility screening was part of rapid HIV testing at their organization, 40% never had PrEP training and only 27% indicated personally screening clients for eligibility. Qualitative data revealed that participants held positive attitudes about PrEP and perceived organizational support, but had concerns about potential negative impacts and barriers to routine HIV screening. Conclusion Results highlight the importance of training non-prescribing HIV prevention providers about PrEP, addressing their concerns, and incorporating PrEP screening and referral into routine HIV testing.	[Kundu, Iman] Drexel Univ, Dept Environm & Occupat Hlth, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Martinez-Donate, Ana; Karkada, Navya; Roth, Alexis; Felsher, Marisa] Drexel Univ, Dept Community Hlth & Prevent, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Sandling, Marcus; Szep, Zsofia] Drexel Univ, Dept Med, Coll Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	Kundu, I (corresponding author), Drexel Univ, Dept Environm & Occupat Hlth, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA.	imankundu2007@gmail.com		Kundu, Iman/0000-0003-0611-9945				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BLUE CL, 1995, RES NURS HEALTH, V18, P105, DOI 10.1002/nur.4770180205; Calabrese SK, 2018, AIDS BEHAV, V22, P1122, DOI 10.1007/s10461-017-1979-z; Calabrese SK, 2017, AIDS PATIENT CARE ST, V31, P196, DOI 10.1089/apc.2017.0002; Centers for Disease Control and Prevention, 2017, HIV AIDS; Centers for Disease Control and Prevention, 2018, HIV SURV REP, V29; Centers for Disease Control and Prevention (CDC), 2017, HIV SURV REP, V28; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Desai M, 2016, HIV MED, V17, P133, DOI 10.1111/hiv.12285; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Galang RR, 2009, HIV PREEXPOSURE PROP, V8; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Highleyman L., 2016, PREP USE EXCEEDS 79; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Lapkin S, 2015, NURS EDUC TODAY, V35, P935, DOI 10.1016/j.nedt.2015.03.018; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mera R, 2012, FTC TDF TRUVADA HIV; Mimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nnumolu C, 2017, PHILADELPHIA DEP PUB; Parsons JT, 2017, JAIDS-J ACQ IMM DEF, V74, P285, DOI 10.1097/QAI.0000000000001251; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Riebl SK, 2015, EAT BEHAV, V18, P160, DOI 10.1016/j.eatbeh.2015.05.016; Roncancio AM, 2015, HEALTH EDUC BEHAV, V42, P621, DOI 10.1177/1090198115571364; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Seidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018; Senn H, 2013, AIDS RES HUM RETROV, V29, P1183, DOI [10.1089/aid.2013.0090, 10.1089/AID.2013.0090]; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Smith DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156592; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tariq Shema, 2013, JRSM Short Rep, V4, p2042533313479197, DOI 10.1177/2042533313479197; Tyson M, 2014, HEALTH PSYCHOL, V33, P1454, DOI 10.1037/hea0000047; US Public Health Service, 2014, PREEXP PROPH PREV HI	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223486	10.1371/journal.pone.0223486	http://dx.doi.org/10.1371/journal.pone.0223486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7KN	31589632	gold, Green Published			2022-12-26	WOS:000532427300024
J	Kim, RY; Kwon, S; Ra, H				Kim, Rae Young; Kwon, Soonil; Ra, Ho			Gravity influences bevacizumab distribution in an undisturbed balanced salt solution in vitro	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB; VITRECTOMY; PHARMACOKINETICS	Purpose The effects of gravity on bevacizumab or the recommended head position after intraocular bevacizumab injection have not been reported. To evaluate the effect of gravity on bevacizumab in vitro, we added bevacizumab to the upper part of a test tube filled with balanced salt solution (BSS) and examined its distribution over time. Materials and methods Sixty-four test tubes were divided equally into two groups; group 1 (32, collected from upper part of the tube) and group 2 (32, collected from lower part of the tube). Each test tube was filled with 5 mL BSS before bevacizumab (1.25 mg/0.05 mL) was added, and then stored at 36 degrees C. Bevacizumab concentration in 8 test tubes from each group was measured at 12, 24, 48, and 168 h using an enzyme-linked immunosorbent analysis (ELISA) kit. Mann-Whitney and Jonckheere-Terpstra tests were used for statistical analysis. Results Bevacizumab concentration was significantly higher in Group 2 than in Group 1 at 12, 24, 48, and 168 h (12, 24, 48, and 168 h; P < 0.01 each; Mann-Whitney test). The mean change in bevacizumab concentration over time tended to increase in Group 1 (P < 0.01; Jonckheere-Terpstra test), but tended to decrease in Group 2 (P < 0.01; Jonckheere-Terpstra test). Conclusions The significant differences in concentration between the upper and lower parts even after a considerable amount of storage time showed that bevacizumab did not dissolve immediately and diffused evenly throughout the solution. It appeared that more bevacizumab settled in the lower part of the tube than in the upper part because of gravitational force. However, the concentration difference between the upper and lower parts decreased as bevacizumab gradually diffused over time, indicating that the difference in concentration due to gravity was more significant at the beginning of bevacizumab injection.	[Kim, Rae Young; Ra, Ho] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kwon, Soonil] Hallym Univ, Dept Ophthalmol, Sacred Heart Hosp, Anyang, South Korea	Catholic University of Korea; Hallym University	Ra, H (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.; Kwon, S (corresponding author), Hallym Univ, Dept Ophthalmol, Sacred Heart Hosp, Anyang, South Korea.	magicham@hallym.or.kr; raho@catholic.ac.kr		Ra, Ho/0000-0001-9671-2210; Kwon, Soonil/0000-0003-1543-981X				Ahn J, 2013, J OCUL PHARMACOL TH, V29, P612, DOI 10.1089/jop.2013.0009; Cheema RA, 2010, RETINA-J RET VIT DIS, V30, P1646, DOI 10.1097/IAE.0b013e3181d6def0; Christoforidis JB, 2013, RETINA-J RET VIT DIS, V33, P946, DOI 10.1097/IAE.0b013e3182753b12; Ferenchak K, 2014, RETINA-J RET VIT DIS, V34, P1177, DOI 10.1097/IAE.0000000000000058; Jaissle GB, 2007, OPHTHAL SURG LAS IM, V38, P238, DOI 10.3928/15428877-20070501-10; Jooybar E, 2014, MATH BIOSCI, V255, P11, DOI 10.1016/j.mbs.2014.06.008; LIM JI, 1994, ARCH OPHTHALMOL-CHIC, V112, P1363, DOI 10.1001/archopht.1994.01090220113032; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Smiddy WE, 1999, SURV OPHTHALMOL, V43, P491, DOI 10.1016/S0039-6257(99)00036-3; Xu Y, 2012, INVEST OPHTH VIS SCI, V53, P5221, DOI 10.1167/iovs.12-9702	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223418	10.1371/journal.pone.0223418	http://dx.doi.org/10.1371/journal.pone.0223418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584989	Green Published, gold			2022-12-26	WOS:000532407600031
J	Silverman, RA; John-Stewart, GC; Beck, IA; Milne, R; Kiptinness, C; McGrath, CJ; Richardson, BA; Chohan, B; Sakr, SR; Frenkel, LM; Chung, MH				Silverman, Rachel A.; John-Stewart, Grace C.; Beck, Ingrid A.; Milne, Ross; Kiptinness, Catherine; McGrath, Christine J.; Richardson, Barbra A.; Chohan, Bhavna; Sakr, Samah R.; Frenkel, Lisa M.; Chung, Michael H.			Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study	PLOS ONE			English	Article							CD4 CELL COUNT; OLIGONUCLEOTIDE LIGATION ASSAY; DISEASE PROGRESSION; HIV-INFECTION; VIROLOGICAL FAILURE; NUTRITIONAL-STATUS; CLINICAL-OUTCOMES; WEIGHT-GAIN; FOLLOW-UP; RESISTANCE	Introduction Despite increased treatment availability, HIV-infected individuals continue to start anti-retroviral therapy (ART) late in disease progression, increasing early mortality risk. Materials and methods Nested prospective cohort study within a randomized clinical trial of adult patients initiating ART at clinics in urban Nairobi and rural Maseno, Kenya, between 2013-2014. We estimated mortality incidence rates following ART initiation and used Cox proportional hazards regression to identify predictors of mortality within 12 months of ART initiation. Analyses were stratified by clinic site to examine differences in mortality correlates and risk by location. Results Among 811 participants initiated on ART, the mortality incidence rate within a year of initiating ART was 7.44 per 100 person-years (95% CI 5.71, 9.69). Among 207 Maseno and 612 Nairobi participants initiated on ART, the mortality incidence rates (per 100 person-years) were 12.78 (95% CI 8.49, 19.23) and 5.72 (95% CI 4.05, 8.09). Maseno had a 2.20-fold greater risk of mortality than Nairobi (95% CI 1.29, 3.76; P = 0.004). This association remained [adjusted hazard ratio (HR) = 2.09 (95% CI 1.17, 3.74); P = 0.013] when adjusting for age, gender, education, pre-treatment drug resistance (PDR), and CD4 count, but not when adjusting for BMI. In unadjusted analyses, other predictors (P<0.05) of mortality included male gender (HR = 1.74), age (HR = 1.04 for 1-year increase), fewer years of education (HR = 0.92 for 1-year increase), unemployment (HR = 1.89), low body mass index (BMI<18.5 m/kg(2); HR = 4.99), CD4 count <100 (HR = 11.67) and 100-199 (HR = 3.40) vs. 200-350 cells/mu L, and pre-treatment drug resistance (PDR; HR = 2.49). The increased mortality risk associated with older age, males, and greater education remained when adjusted for location, age, education and PDR, but not when adjusted for BMI and CD4 count. PDR remained associated with increased mortality risk when adjusted for location, age, gender, education, and BMI, but not when adjusted for CD4 count. CD4 and BMI associations with increased mortality risk persisted in multivariable analyses. Despite similar baseline CD4 counts across locations, mortality risk associated with low CD4 count, low BMI, and PDR was greater in Maseno than Nairobi in stratified analyses. Conclusions High short-term post-ART mortality was observed, partially due to low CD4 count and BMI at presentation, especially in the rural setting. Male gender, older age, and markers of lower socioeconomic status were also associated with greater mortality risk. Engaging patients earlier in HIV infection remains critical. PDR may influence short-term mortality and further studies to optimize management will be important in settings with increasing PDR.	[Silverman, Rachel A.; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Silverman, Rachel A.; John-Stewart, Grace C.; Kiptinness, Catherine; McGrath, Christine J.; Richardson, Barbra A.; Chohan, Bhavna; Frenkel, Lisa M.; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Silverman, Rachel A.] Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA; [John-Stewart, Grace C.; Frenkel, Lisa M.; Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Frenkel, Lisa M.] Univ Washington, Pediat, Seattle, WA 98195 USA; [Beck, Ingrid A.; Milne, Ross; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chohan, Bhavna] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Sakr, Samah R.] Copt Hosp, Nairobi, Kenya; [Frenkel, Lisa M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Virginia Polytechnic Institute & State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle	Silverman, RA (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Silverman, RA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Silverman, RA (corresponding author), Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA.	rsilverman@vt.edu	Fazli, Ghazal/AAE-8320-2022		National Institutes of Health [R01-AI058723, R01-AI100037]; American Recovery and Reinvestment Act supplement [R01-AI058723]; University of Washington Center for AIDS Research [P30AI027757]; President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention [U62/CCU024512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act supplement; University of Washington Center for AIDS Research; President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health [R01-AI058723 and R01-AI100037] (LMF), including an American Recovery and Reinvestment Act supplement [R01-AI058723] (LMF). Support of the study was provided by the University of Washington Center for AIDS Research [P30AI027757]. The Coptic Hope Center for Infectious Diseases is supported by the President's Emergency Plan for AIDS Relief through a cooperative agreement [U62/CCU024512] from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck IA, 2014, J CLIN MICROBIOL, V52, P2320, DOI 10.1128/JCM.00306-14; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Blanco JR, 2010, AIDS REV, V12, P218; Boender TS, 2015, CLIN INFECT DIS, V61, P1749, DOI 10.1093/cid/civ656; Brown ER, 2009, J INFECT DIS, V199, P1292, DOI 10.1086/597617; Cawley C, 2017, HEALTH POLICY PLANN, V32, P1316, DOI 10.1093/heapol/czx091; Chalamilla Guerino, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P296, DOI 10.1177/1545109711406733; Chung MH, 2016, INCREASING HIV 1 PRE; Chung MH, 2014, JAIDS-J ACQ IMM DEF, V67, P246, DOI 10.1097/QAI.0000000000000312; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Chung MH, 2009, CURR HIV RES, V7, P441, DOI 10.2174/157016209788680552; Damtew B, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.138.4352; Evans D, 2012, OR SURG OR MED OR PA, V113, P362, DOI 10.1016/j.oooo.2011.09.004; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Filteau S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0253-8; Flynn AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189055; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Girardi E, 2001, AIDS, V15, P2201, DOI 10.1097/00002030-200111090-00021; Gordon CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125248; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Grobler L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub3; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Gupta RK, 2017, LANCET INFECT DIS; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Hassan AS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1814-2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ilovi C S, 2011, East Afr Med J, V88, P65; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kenya National Bureau of Statistics Ministry of Health/Kenya National AIDS Control Council/Kenya Kenya Medical Research Institute Population NCf Development/Kenya, 2015, KEN DEM HLTH SURV 20; Koethe JR, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-10; Koethe JR, 2010, JAIDS-J ACQ IMM DEF, V53, P507, DOI 10.1097/QAI.0b013e3181b32baf; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; Masiira B, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.21843; May MT, 2016, CLIN INFECT DIS, V62, P1571, DOI 10.1093/cid/ciw183; Mberu BU, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.33163; Mee P, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24826; Ministry of Health, 2016, GUIDELINES USE ANTIR; Mwangi J, 2012, PAN AFR MED J, V12; Nagata JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091403; NASCOP, 2011, GUID ANT DRUG THER K; NASCOP, 2014, GUID ANT DRUG THER K; National AIDS Control Council, 2016, KEN AIDS RESP PROGR; O'Brien D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20665; Olsen MF, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3187; Pavlinac PB, 2014, AM J TROP MED HYG, V91, P273, DOI 10.4269/ajtmh.13-0552; Pinoges L, 2015, JAIDS-J ACQ IMM DEF, V68, P527, DOI 10.1097/QAI.0000000000000513; Rawat R, 2014, JAIDS-J ACQ IMM DEF, V66, pE15, DOI 10.1097/QAI.0000000000000079; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Siika A M, 2010, East Afr Med J, V87, P443; Silverman RA, 2017, J INFECT DIS; Tesfamariam Kokeb, 2016, BMC Res Notes, V9, P512, DOI 10.1186/s13104-016-2313-y; Verani JR, 2015, CLIN INFECT DIS, V61, pS302, DOI 10.1093/cid/civ728; Walson JL, 2013, AIDS, V27, P1493, DOI 10.1097/QAD.0b013e32835ecba9; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weinberg MA, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00090; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, CONS GUID US ANT DRU; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658; Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x	69	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223411	10.1371/journal.pone.0223411	http://dx.doi.org/10.1371/journal.pone.0223411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584992	gold, Green Published			2022-12-26	WOS:000532407600028
J	Yang, GM; Yu, X; Xu, LW; Xin, Y; Fang, XJ				Yang, Gaoming; Yu, Xu; Xu, Lingwei; Xin, Yu; Fang, Xianjin			An intrusion detection algorithm for sensor network based on normalized cut spectral clustering	PLOS ONE			English	Article							MODEL; USER	Sensor network intrusion detection has attracted extensive attention. However, previous intrusion detection methods face the highly imbalanced attack class distribution problem, and they may not achieve a satisfactory performance. To solve this problem, we propose a new intrusion detection algorithm based on normalized cut spectral clustering for sensor network in this paper. The main aim is to reduce the imbalance degree among classes in an intrusion detection system. First, we design a normalized cut spectral clustering to reduce the imbalance degree between every two classes in the intrusion detection data set. Second, we train a network intrusion detection classifier on the new data set. Finally, we do extensive experiments and analyze the experimental results in detail. Simulation experiments show that our algorithm can reduce the imbalance degree among classes and reserves the distribution of the original data on the one hand, and improve effectively the detection performance on the other hand.	[Yang, Gaoming; Fang, Xianjin] Anhui Univ Sci & Technol, Sch Comp Sci & Engn, Huainan, Anhui, Peoples R China; [Yu, Xu; Xu, Lingwei] Qingdao Univ Sci & Technol, Dept Informat Sci & Technol, Qingdao, Shandong, Peoples R China; [Xin, Yu] Ningbo Univ, Fac Elect Engn & Comp Sci, Ningbo, Zhejiang, Peoples R China	Anhui University of Science & Technology; Qingdao University of Science & Technology; Ningbo University	Yu, X (corresponding author), Qingdao Univ Sci & Technol, Dept Informat Sci & Technol, Qingdao, Shandong, Peoples R China.	yuxu0532@163.com		Yang, Gaoming/0000-0002-7666-1038	National Natural Science Foundation of China [61402246, 61602133, 61572034]; Shandong Province Natural Science Foundation [ZR2019MF014, ZR2017BF023]; Major Science and Technology Projects in Anhui Province [18030901025]; Natural Science Research Project of Universities in Anhui Province [KJ2019A0109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Major Science and Technology Projects in Anhui Province; Natural Science Research Project of Universities in Anhui Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61402246 to XY, 61602133 to YX, 61572034 to XF), the Shandong Province Natural Science Foundation (Grant Nos. ZR2019MF014 to XY, ZR2017BF023 to LX), Major Science and Technology Projects in Anhui Province (grant number 18030901025 to XF), and the Natural Science Research Project of Universities in Anhui Province (Grant No. KJ2019A0109 to GY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburomman AA, 2016, APPL SOFT COMPUT, V38, P360, DOI 10.1016/j.asoc.2015.10.011; Ahmad I, 2018, IEEE ACCESS, V6, P33789, DOI 10.1109/ACCESS.2018.2841987; Bai F, 2019, P 2019 INT C EMB WIR, P373; Bin G, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Deng L, 2018, CLUSTER COMPUT, P1, DOI DOI 10.1007/S10586-017-0882-8; Han LS, 2019, INFORM SCIENCES, V476, P491, DOI 10.1016/j.ins.2018.06.017; Kumar N, 2018, 2018 8 INT S EMB COM; Li Kun-Lunn, 2005, Chinese Journal of Computers, V28, P274; Povey D, 2011, COMPUT SPEECH LANG, V25, P404, DOI 10.1016/j.csl.2010.06.003; Ring M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204507; Shams EA, 2018, WIREL NETW, V24, P1821, DOI 10.1007/s11276-016-1439-0; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Sun XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139513; Tayal A, 2015, IEEE T KNOWL DATA EN, V27, P3347, DOI 10.1109/TKDE.2015.2453171; Umer MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0180945; WU Z, 1993, IEEE T PATTERN ANAL, V15, P1101, DOI 10.1109/34.244673; Xu LW, 2017, MULTIMED TOOLS APPL, V76, P23891, DOI 10.1007/s11042-016-4138-z; Yang J, 2011, KNOWL-BASED SYST, V24, P740, DOI 10.1016/j.knosys.2010.12.010; Yu X, 2019, PATTERN RECOGN, V94, P96, DOI 10.1016/j.patcog.2019.05.030; Yu X, 2018, KNOWL-BASED SYST, V141, P80, DOI 10.1016/j.knosys.2017.11.010; Zhang B, 2018, SECUR COMMUN NETW, DOI 10.1155/2018/1914980	23	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0221920	10.1371/journal.pone.0221920	http://dx.doi.org/10.1371/journal.pone.0221920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP8QL	31584950	Green Published, gold			2022-12-26	WOS:000498523600001
J	Bansiddhi, P; Browni, JL; Khonmee, J; Norkaew, T; Nganvongpanit, K; Punyapornwithaya, V; Angkawanish, T; Somgird, C; Thitaram, C				Bansiddhi, Pakkanut; Browni, Janine L.; Khonmee, Jaruwan; Norkaew, Treepradab; Nganvongpanit, Korakot; Punyapornwithaya, Veerasak; Angkawanish, Taweepoke; Somgird, Chaleamchat; Thitaram, Chatchote			Management factors affecting adrenal glucocorticoid activity of tourist camp elephants in Thailand and implications for elephant welfare	PLOS ONE			English	Article							CAPTIVE ASIAN ELEPHANTS; RANGING AFRICAN ELEPHANTS; LOXODONTA-AFRICANA; NONINVASIVE ASSESSMENT; ENZYME-IMMUNOASSAY; STRESS; METABOLITES; MAXIMUS; SERUM; CORTISOL	Elephant camps are among the most popular destinations in Thailand for tourists from many countries. A wide range of management strategies are used by these camps, which can have varied impacts on health and welfare of elephants. The objectives of this study were to examine relationships between FGM (fecal glucocorticoid metabolite) concentrations and camp management factors (work routine, walking, restraint, rest area, foraging), and to other welfare indicators (stereotypic behaviors, body condition, foot health, and skin wounds). Data were obtained on 84 elephants (18 males and 66 females) from 15 elephant camps over a 1-year period. Elephants were examined every 3 months and assigned a body condition score, foot score, and wound score. Fecal samples were collected twice monthly for FGM analysis. Contrary to some beliefs, elephants in the observation only program where mahouts did not carry an ankus for protection had higher FGM concentrations compared to those at camps that offered riding with a saddle and shows. Elephants that were tethered in the forest at night had lower FGM concentrations compared to elephants that were kept in open areas inside the camps. There was an inverse relationship between FGM concentrations and occurrence of stereotypy, which was not anticipated. Thus, assessing adrenal activity via monitoring of FGM concentrations can provide important information on factors affecting the well-being of elephants. Results suggest that more naturalistic housing conditions and providing opportunities to exercise may be good for elephants under human care in Thailand, and that a no riding, no hook policy does not necessarily guarantee good welfare.	[Bansiddhi, Pakkanut; Browni, Janine L.; Khonmee, Jaruwan; Norkaew, Treepradab; Nganvongpanit, Korakot; Somgird, Chaleamchat; Thitaram, Chatchote] Chiang Mai Univ, Ctr Elephant & Wildlife Res, Chiang Mai, Thailand; [Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote] Chiang Mai Univ, Dept Compan Anim & Wildlife Clin, Fac Vet Med, Chiang Mai, Thailand; [Browni, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Khonmee, Jaruwan; Nganvongpanit, Korakot] Chiang Mai Univ, Dept Vet Biosci & Vet Publ Hlth, Fac Vet Med, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Dept Food Anim Clin, Fac Vet Med, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Excellent Ctr Vet Publ Hlth, Chiang Mai, Thailand; [Angkawanish, Taweepoke] Natl Elephant Inst, Lampang, Thailand	Chiang Mai University; Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Chiang Mai University; Chiang Mai University; Chiang Mai University	Thitaram, C (corresponding author), Chiang Mai Univ, Ctr Elephant & Wildlife Res, Chiang Mai, Thailand.; Thitaram, C (corresponding author), Chiang Mai Univ, Dept Compan Anim & Wildlife Clin, Fac Vet Med, Chiang Mai, Thailand.	chatchote.thitaram@cmu.ac.th	Thitaram, Chatchote/AHD-1584-2022; Punyapornwithaya, Veerasak/ABE-5119-2020; Punyapornwithaya, Verasak/V-9323-2019	Punyapornwithaya, Verasak/0000-0001-9870-7773; Khonmee, Jaruwan/0000-0002-3806-9746; Brown, Janine/0000-0003-3898-7755; Bansiddhi, Pakkanut/0000-0001-6699-4819; Thitaram, Chatchote/0000-0001-9319-5596	National Research Council of Thailand (NRCT) [170183]; Royal Golden Jubilee Ph.D. program, Thailand Research Fund (TRF) [PHD/0187/2558]; Chiang Mai University	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Royal Golden Jubilee Ph.D. program, Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Chiang Mai University	This work was supported by the National Research Council of Thailand (NRCT) (grant number 170183) http://www.trf.or.th/for CT, the Royal Golden Jubilee Ph.D. program, Thailand Research Fund (TRF) (grant number PHD/0187/2558) for KN and PB http://rgj.trf.or.th/main/home/, and Chiang Mai University http://www.cmu.ac.th for CT for a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala I, 2012, RES VET SCI, V93, P103, DOI 10.1016/j.rvsc.2011.05.013; Bansiddhi P, 2019, PEERJ, V7, DOI 10.7717/peerj.6756; Bansiddhi P, 2020, J APPL ANIM WELF SCI, V23, P164, DOI 10.1080/10888705.2019.1569522; Bansiddhi P, 2018, PEERJ, V6, DOI 10.7717/peerj.5996; BARNES RFW, 1983, AFR J ECOL, V21, P185, DOI 10.1111/j.1365-2028.1983.tb01180.x; Bergeron H, STEREOTYPIC ANIMAL B; Boyle SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141009; Brown J, 2019, BIORXIV, DOI [10.1101/634691, DOI 10.1101/634691]; Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Brown JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145673; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 1995, ZOO BIOL, V14, P555, DOI 10.1002/zoo.1430140608; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Bryant J.L., 2018, INT J AVIAN WILDLIFE, V3, P94; Burn CC, 2017, ANIM BEHAV, V130, P141, DOI 10.1016/j.anbehav.2017.06.006; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; Carlstead K, 2019, APPL ANIM BEHAV SCI, V211, P103, DOI 10.1016/j.applanim.2018.11.003; Carlstead Kathy, 1998, P172; Chatkupt Thomas T., 1999, Journal of Applied Animal Welfare Science, V2, P187, DOI 10.1207/s15327604jaws0203_2; DATHE HH, 1992, ZOO BIOL, V11, P285, DOI 10.1002/zoo.1430110408; de Silva S, 2017, BEHAV ECOL, V28, P243, DOI 10.1093/beheco/arw153; Fanson KV, 2013, EUR J WILDLIFE RES, V59, P655, DOI 10.1007/s10344-013-0718-7; Freymond SB, 2015, PHYSIOL BEHAV, V151, P121, DOI 10.1016/j.physbeh.2015.07.015; Friend TH, 1999, APPL ANIM BEHAV SCI, V64, P213, DOI 10.1016/S0168-1591(99)00039-8; Ganswindt A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P505, DOI 10.1086/430237; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Ganswindt A, 2010, WILDLIFE BIOL, V16, P323, DOI 10.2981/09-081; Greco BJ, 2017, APPL ANIM BEHAV SCI, V194, P104, DOI 10.1016/j.applanim.2017.05.003; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144276; Harris M., 2008, WC05007 DEFR; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150331; Ice GH, 2007, MEASURING STRESS HUM; Kajaysri J, 2014, J VET MED SCI, V76, P363, DOI 10.1292/jvms.13-0103; Kumar V, 2014, GEN COMP ENDOCR, V201, P37, DOI 10.1016/j.ygcen.2014.03.024; Kurt F, 2001, STER CAPT AS EL A S; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Menargues A, 2008, ANIM WELFARE, V17, P305; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Morfeld KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188701; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Mumby HS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov030; Mumby HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13946; Mumtaz F, 2018, BIOMED PHARMACOTHER, V105, P1205, DOI 10.1016/j.biopha.2018.05.086; Noppe G, 2016, INT J OBESITY, V40, P1503, DOI 10.1038/ijo.2016.113; Norkaew T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210537; Norkaew T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204965; North American Veterinary Technician Association, 1995, VET TECHN; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Payne E, 2015, PSYCHOL RES BEHAV MA, V8, P71, DOI 10.2147/PRBM.S74972; Pokharel SS, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox039; Pomerantz O, 2012, BEHAV BRAIN RES, V230, P274, DOI 10.1016/j.bbr.2012.02.019; Poole Joyce H., 2011, P109; R Core Team, 2018, R LANG ENV STAT COMP; Ralph CR, 2016, J ANIM SCI, V94, P457, DOI 10.2527/jas.2015-9645; Ramanathan A, 2008, J ZOO WILDLIFE MED, V39, P148, DOI 10.1638/2007-0008R1.1; Reul JMHM, 2015, NEUROBIOL STRESS, V1, P44, DOI 10.1016/j.ynstr.2014.10.001; Rossman ZT, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00060; Schein M, 2013, SCHEINS COMMON SENSE; Schmidt-Burbach J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139092; SCHOBER P, 2018, ANESTH ANALG, V126; Seesupa S, 2017, THAI J VET MED, V47, P501; Solowiej K, 2009, J Wound Care, V18, P357; Stan, 2012, INT J COMP PSYCHOL, V25, P60; Stead SK, 2000, J S AFR VET ASSOC, V71, P192; Tilbrook AJ, 2018, ANIM PROD SCI, V58, P408, DOI 10.1071/AN16808; Tingvold HG, 2013, AFR J ECOL, V51, P580, DOI 10.1111/aje.12069; Todd H., 2015, COMP FOOT LOCOMOTORY; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Vanitha V, 2011, J APPL ANIM WELF SCI, V14, P42, DOI 10.1080/10888705.2011.527603; Viljoen Jozua J., 2008, Koedoe, V50, P18; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Watson R, 2013, GEN COMP ENDOCR, V186, P16, DOI 10.1016/j.ygcen.2013.02.001; WIEPKEMA PR, 1987, APPL ANIM BEHAV SCI, V18, P257, DOI 10.1016/0168-1591(87)90221-8; Wong Ee Phin, 2018, Gajah, V48, P4; Woolley LA, 2009, J WILDLIFE MANAGE, V73, P827, DOI 10.2193/2008-412	84	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0221537	10.1371/journal.pone.0221537	http://dx.doi.org/10.1371/journal.pone.0221537			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB3DU	31574099	Green Published, gold			2022-12-26	WOS:000524518900001
J	Faheem, M; Saeed, S; Sajjad, A; Wang, S; Ali, A				Faheem, Muhammad; Saeed, Shafqat; Sajjad, Asif; Wang, Su; Ali, Abid			Spatio-temporal variations in wheat aphid populations and their natural enemies in four agro-ecological zones of Pakistan	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; SPATIAL VARIATION; SITOBION-AVENAE; CEREAL APHIDS; COTTON APHID; BT COTTON; PREDATORS; HOMOPTERA; SUBLETHAL; NITROGEN	Aphids are major pests of wheat crop in Pakistan inflicting considerable economic losses. A better knowledge of landscape scale spatial distribution of aphids and their natural enemies could be used to improve integrated pest management programs. Therefore, the present study aimed to document spatio-temporal variations in populations of wheat aphids and their natural enemies in Pakistan. The 2-year survey study was carried out at ten experimental farms located in five districts of four contrasted agro-ecological zones of eastern Pakistan (Punjab area) i.e. District Chakwal in arid zone, Gujranwala in rice-cropped zone, Faisalabad in central mixed-cropped zone, and Khanewal and Multan in cotton-cropped zone. The dominant aphid species i.e. Schizaphis graminum, Rhopalosiphum padi, R. maidis and Sitobion avenae varied significantly among the five districts surveyed. The population of S. graminum was observed more abundant in arid, R. padi in rice, S. avenae in aird and rice, and R. maidis in cotton-I zones. Aphids ended their population dynamics on 25th March in central mixed-cropped zone and 12th April in other three zones. Various species of natural enemies, mainly Coccinella septumpunctata, C. undecimpunctata, Menochilus sexmaculata, Chrysoperla carnea, Syrphidae and parasitoid mummies were inconsistently observed in four agroecological zones. The population of C. septumpunctata, was observed more abundant in rice zone, C. undecimpunctata and C. carnea in cotton-I and arid zones, M. sexmaculata in cotton-I and II zones, Syrphidae in cotton-I zone and parasitoid mummies in rice and arid zones. There were no clear relationships between aphid and the natural enemy populations. The present study may serve as a baseline regarding distribution of wheat aphids and their natural enemies and the results provided insights for further studies on the potential top-down (natural enemies) versus bottom-up (fertilization and irrigation regimes) forces in management of wheat aphids in eastern Pakistan.	[Faheem, Muhammad] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan, Pakistan; [Faheem, Muhammad] MARDI, CABI South East Asia, Serdang, Selangor, Malaysia; [Saeed, Shafqat] Muhammad Nawaz Shareef Univ Agr, Fac Agr & Environm Sci, Dept Entomol, Multan, Pakistan; [Sajjad, Asif] Islamia Univ Bahawalpur, Univ Coll Agr & Environm Sci, Dept Entomol, Bahawalpur, Pakistan; [Wang, Su] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Ali, Abid] Univ Agr Faisalabad, Fac Agr, Dept Entomol, Faisalabad, Pakistan	Bahauddin Zakariya University; Institute Penyelidikan Dan Kemajuan Pertanian; Islamia University of Bahawalpur; Beijing Academy of Agriculture & Forestry; University of Agriculture Faisalabad	Saeed, S (corresponding author), Muhammad Nawaz Shareef Univ Agr, Fac Agr & Environm Sci, Dept Entomol, Multan, Pakistan.; Wang, S (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	shafqat.saeed@mnsuam.edu.pk; wangsu@ipepbaafs.cn	Sajjad, Asif/AFQ-0406-2022; Ali, Abid/S-7218-2019; Ali, Abid/AAJ-5282-2020	Ali, Abid/0000-0003-3674-7811; Faheem, Muhammad/0000-0002-4668-5506	Punjab Agricultural Research Board (PARB) Lahore, Pakistan [13]	Punjab Agricultural Research Board (PARB) Lahore, Pakistan	This work was supported by the Punjab Agricultural Research Board (PARB) Lahore, Pakistan funded Project No. 13 was awarded to Mr. Muhammad Fahim (CABI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheer G. M., 2008, Journal of Agricultural Research (Lahore), V46, P367; AHEER GM, 1993, J AGR RES, V31, P75; Ali A, 2018, AGR ECOSYST ENVIRON, V266, P1, DOI 10.1016/j.agee.2018.07.012; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Amiri-Jami AR, 2014, J ASIA-PAC ENTOMOL, V17, P207, DOI 10.1016/j.aspen.2014.01.007; [Anonymous], 2017, PAKISSAN; Aslam Muhammad, 2005, Pakistan Entomologist, V27, P79; Aslam Muhammad, 2004, International Journal of Agriculture and Biology, V6, P974; Asmat R., 2018, PK1823 USDA GLOB AGR; BAANGOOD SA, 1980, CAN ENTOMOL, V112, P681, DOI 10.4039/Ent112681-7; Begon MC, 2006, ECOLOGY INDIVIDUALS, P281; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Brewer MJ, 2004, ANNU REV ENTOMOL, V49, P219, DOI 10.1146/annurev.ento.49.061802.123149; Damgaard C, 2018, EFFECT SPATIAL VARIA, DOI [10.1101/367953, DOI 10.1101/367953]; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2006, J PEST SCI, V79, P95, DOI 10.1007/s10340-006-0121-1; Desneux N, 2004, ENTOMOL EXP APPL, V112, P227, DOI 10.1111/j.0013-8703.2004.00198.x; Desneux N, 2004, PEST MANAG SCI, V60, P381, DOI 10.1002/ps.822; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Elliott NC, 2000, POPUL ECOL, V42, P81, DOI 10.1007/s101440050012; *FAO, 2004, FERT US CROP PAK; Fiebig M., 1998, IOBC-WPRS Bulletin, V21, P51; Frampton GK, 2000, J APPL ECOL, V37, P865, DOI 10.1046/j.1365-2664.2000.00541.x; Gair R, 1983, CEREAL PESTS DIS, P54; Gao GZ, 2018, ENTOMOL GEN, V37, P103, DOI 10.1127/entomologia/2018/0514; Genung MA, 2012, OECOLOGIA, V168, P167, DOI 10.1007/s00442-011-2080-3; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Han P, 2015, J PEST SCI, V88, P685, DOI 10.1007/s10340-015-0662-2; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Horgan FG, 2018, ENTOMOL GEN, V37, P19, DOI 10.1127/entomologia/2017/0468; Hulle M, 2020, ENTOMOL GEN, V40, P97, DOI 10.1127/entomologia/2019/0867; Inayat TP, 2011, INT J AGRIC BIOL, V13, P427; Jam NA, 2018, ENTOMOL GEN, V38, P173, DOI 10.1127/entomologia/2018/0734; Jankovic M, 2017, J PEST SCI, V90, P261, DOI 10.1007/s10340-016-0744-9; Jaworski CC, 2019, J APPL ECOL, V56, P1176, DOI 10.1111/1365-2664.13353; Jaworski CC, 2015, J PEST SCI, V88, P793, DOI 10.1007/s10340-015-0698-3; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Kafle K., 2015, INT J APP SCI BIOTEC, V3, P537; Khan A. M., 2012, JBIOFERTIL BIOPESTIC, V3, DOI [DOI 10.4172/2155-6202.1000122, 10.4172/2155-6202.1000122]; Khan SA, 2005, THESIS, P179; Khan SM, 2002, ASIAN J PLANT SCI, V1, P205; Khanal S. K., 2010, Bioenergy and biofuel from biowastes and biomass, P1, DOI 10.1145/1926180.1926195; Khattak MK, 2007, PAK J ZOOL, V39, P109; Kibe AM, 2006, AGR WATER MANAGE, V84, P221, DOI 10.1016/j.agwat.2006.02.010; Klueken AM, 2008, J PLANT DIS PROTECT, V115, P279, DOI 10.1007/BF03356277; Krebs C.J., 2009, ECOLOGY EXPT ANAL DI, P655; Nguyen LTH, 2018, ENTOMOL GEN, V38, P15, DOI 10.1127/entomologia/2018/0575; Liang P, 2012, ECOTOXICOLOGY, V21, P1889, DOI 10.1007/s10646-012-0922-3; Liu XL, 2017, ENTOMOL GEN, V36, P285, DOI 10.1127/entomologia/2017/0480; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mahmood R., 2002, Pakistan Journal of Biological Sciences, V5, P47, DOI 10.3923/pjbs.2002.47.50; MANN JA, 1995, ANN APPL BIOL, V126, P417, DOI 10.1111/j.1744-7348.1995.tb05376.x; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Memon RA, 2013, PAK J BOT, V45, P39; Merrill SC, 2009, J ECON ENTOMOL, V102, P533, DOI 10.1603/029.102.0210; Mohammed AAH, 2018, ENTOMOL GEN, V37, P47, DOI 10.1127/entomologia/2017/0471; Muhlenberg E, 2005, AGR FOREST ENTOMOL, V7, P133, DOI 10.1111/j.1461-9555.2005.00253.x; Murdoch WW, 1996, ECOLOGY, V77, P2001, DOI 10.2307/2265696; Ostman O, 2003, ECOL ECON, V45, P149, DOI 10.1016/S0921-8009(03)00007-7; Ovadia O, 2004, OECOLOGIA, V140, P398, DOI 10.1007/s00442-004-1604-5; PARC, 1980, AGR ZON PAK; Qamar Zeb, 2011, Sarhad Journal of Agriculture, V27, P443; Ray C, 1996, J ANIM ECOL, V65, P556, DOI 10.2307/5736; Saleem S, 2009, PAK J ZOOL, V41, P505; Stoltz RL, 1999, IDENTIFICATION KEYS; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; WEISZ R, 1995, J ECON ENTOMOL, V88, P1069, DOI 10.1093/jee/88.5.1069; Winder L, 1999, ENTOMOL EXP APPL, V93, P277, DOI 10.1023/A:1003982111689; Yang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04029-5; Young Cheryl L., 2005, Proceedings of the Hawaiian Entomological Society, V37, P73; ZHOU XL, 1995, GLOB CHANGE BIOL, V1, P303, DOI 10.1111/j.1365-2486.1995.tb00029.x	75	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222635	10.1371/journal.pone.0222635	http://dx.doi.org/10.1371/journal.pone.0222635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JL7LG	31568475	gold, Green Published			2022-12-26	WOS:000495709300001
J	Limpanuparb, T; Lorpaiboon, W; Chinsukserm, K				Limpanuparb, Taweetham; Lorpaiboon, Wanutcha; Chinsukserm, Kridtin			An in silico investigation of menthol metabolism	PLOS ONE			English	Article							FREE-ENERGIES; TOXICITY	Prevalence of mentholated products for consumption has brought great importance to studies on menthol's metabolic pathways to ensure safety, design more potent derivatives, and identify therapeutic benefits. Proposed pathways of (-)-menthol metabolism based on metabolites found experimentally in previous works by Yamaguchi, Caldwell & Farmer, Madyastha & Srivatsan and Hiki et al. were not in agreement. This in silico approach is based on the three in vivo studies and aims to resolve the discrepancies. Reactions in the pathways are conjugation with glucuronic acid/sulfate, oxidation to alcohol, aldehyde & carboxylic acid, and formation of a four-membered/five-membered ring. Gas-phase structures, standard Gibbs energies and SMD solvation energies at B3LYP/6-311++G(d,p) level were obtained for 102 compounds in the pathways. This study provides a more complete picture of menthol metabolism by combining information from three experimental studies and filling missing links in previously published pathways.	[Limpanuparb, Taweetham; Lorpaiboon, Wanutcha; Chinsukserm, Kridtin] Mahidol Univ, Int Coll, Sci Div, Salaya, Nakhon Pathom, Thailand	Mahidol University	Limpanuparb, T (corresponding author), Mahidol Univ, Int Coll, Sci Div, Salaya, Nakhon Pathom, Thailand.	taweetham.lim@mahidol.edu	Limpanuparb, Taweetham/A-6295-2011	Limpanuparb, Taweetham/0000-0002-8558-6199; Lorpaiboon, Wanutcha/0000-0002-7616-244X; Chinsukserm, Kridtin/0000-0002-8078-6888	Institute for the Promotion of Teaching Science and Technology [08/2557]	Institute for the Promotion of Teaching Science and Technology	T.L. received research funding from the Institute for the Promotion of Teaching Science and Technology (www.ipst.ac.th contract no. 08/2557). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijevych K, 2004, NICOTINE TOB RES, V6, pS17, DOI 10.1080/14622200310001649469; BERNSON VSM, 1983, CHEM-BIOL INTERACT, V46, P233, DOI 10.1016/0009-2797(83)90031-5; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Bryantsev VS, 2008, J PHYS CHEM B, V112, P9709, DOI 10.1021/jp802665d; Camaioni DM, 2005, J PHYS CHEM A, V109, P10795, DOI 10.1021/jp054088k; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; Galeotti N, 2002, NEUROSCI LETT, V322, P145, DOI 10.1016/S0304-3940(01)02527-7; Gelal A, 1999, CLIN PHARMACOL THER, V66, P128, DOI 10.1053/cp.1999.v66.100455001; Giovino GA, 2004, NICOTINE TOB RES, V6, pS67, DOI 10.1080/14622203710001649696; Hartner J, 2008, J MOL STRUCT, V872, P145, DOI 10.1016/j.molstruc.2007.02.029; Hiki N, 2011, CLIN PHARMACOL THER, V90, P221, DOI 10.1038/clpt.2011.110; Ho JM, 2016, J PHYS CHEM B, V120, P1319, DOI 10.1021/acs.jpcb.6b00164; Ho JM, 2010, THEOR CHEM ACC, V125, P3, DOI 10.1007/s00214-009-0667-0; Joint FAO/WHO Expert Committee on Food Additives (World Health Organization & Food and Agriculture Organization of the United Nations), EV CERT FOOD ADD 20; Limpanuparb T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4461-3; Limpanuparb T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170708; MADYASTHA KM, 1988, DRUG METAB DISPOS, V16, P765; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Miyazawa M, 2011, J OLEO SCI, V60, P127, DOI 10.5650/jos.60.127; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; RAKIETEN N, 1954, J AM PHARM ASSOC SCI, V43, P390, DOI 10.1002/jps.3030430703; Shao YH, 2015, MOL PHYS, V113, P184, DOI 10.1080/00268976.2014.952696; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Statistica, 2019, PROD VOL MENTH IND F; SWANDULLA D, 1987, PFLUG ARCH EUR J PHY, V409, P52, DOI 10.1007/BF00584749; SWANDULLA D, 1986, NEUROSCI LETT, V68, P23, DOI 10.1016/0304-3940(86)90223-5; THORUP I, 1983, TOXICOL LETT, V19, P207, DOI 10.1016/0378-4274(83)90120-0; Watson H, 1978, J SOC COSMET CHEM, V29, P200; Wiberg KB, 2004, J COMPUT CHEM, V25, P1342, DOI 10.1002/jcc.20058; Wolfram Research Inc, 2019, MATH VERS 12 1; YAMAGUCHI T, 1994, DRUG METAB DISPOS, V22, P616	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0216577	10.1371/journal.pone.0216577	http://dx.doi.org/10.1371/journal.pone.0216577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31561248	Green Published, Green Submitted, gold			2022-12-26	WOS:000532353700002
J	Delgado, R; Tibau, XA				Delgado, Rosario; Tibau, Xavier-Andoni			Why Cohen's Kappa should be avoided as performance measure in classification	PLOS ONE			English	Article							INTEROBSERVER AGREEMENT; RELIABILITY; ASSOCIATION; MODELS; COEFFICIENT; PREVALENCE	We show that Cohen's Kappa and Matthews Correlation Coefficient (MCC), both extended and contrasted measures of performance in multi-class classification, are correlated in most situations, albeit can differ in others. Indeed, although in the symmetric case both match, we consider different unbalanced situations in which Kappa exhibits an undesired behaviour, i.e. a worse classifier gets higher Kappa score, differing qualitatively from that of MCC. The debate about the incoherence in the behaviour of Kappa revolves around the convenience, or not, of using a relative metric, which makes the interpretation of its values difficult. We extend these concerns by showing that its pitfalls can go even further. Through experimentation, we present a novel approach to this topic. We carry on a comprehensive study that identifies an scenario in which the contradictory behaviour among MCC and Kappa emerges. Specifically, we find out that when there is a decrease to zero of the entropy of the elements out of the diagonal of the confusion matrix associated to a classifier, the discrepancy between Kappa and MCC rise, pointing to an anomalous performance of the former. We believe that this finding disables Kappa to be used in general as a performance measure to compare classifiers.	[Delgado, Rosario] Univ Autonoma Barcelona, Dept Math, Campus UAB, Cerdanyola Del Valles, Spain; [Tibau, Xavier-Andoni] Univ Autonoma Barcelona, Adv Stochast Modelling Res Grp, Campus UAB, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Delgado, R (corresponding author), Univ Autonoma Barcelona, Dept Math, Campus UAB, Cerdanyola Del Valles, Spain.	delgado@mat.uab.cat		Tibau Alberdi, Xavier-Andoni/0000-0002-7239-1421; Delgado, Rosario/0000-0003-1208-9236	Ministerio de Ciencia, Innovacion y Universidades del Gobierno de Espana [PGC2018 097848-B-I0]	Ministerio de Ciencia, Innovacion y Universidades del Gobierno de Espana(Spanish Government)	The authors are supported by Ministerio de Ciencia, Innovacion y Universidades del Gobierno de Espana, project ref. PGC2018 097848-B-I0.	Albatineh AN, 2006, J CLASSIF, V23, P301, DOI 10.1007/s00357-006-0017-z; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Andres AM, 2004, BRIT J MATH STAT PSY, V57, P1, DOI 10.1348/000711004849268; Bexkens Rens, 2018, Shoulder Elbow, V10, P308, DOI 10.1177/1758573218791813; BLAIR E, 1985, DEV MED CHILD NEUROL, V27, P615; BRENNAN RL, 1974, BRIT J MATH STAT PSY, V27, P154, DOI 10.1111/j.2044-8317.1974.tb00535.x; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cameron ML, 2003, AM J SPORT MED, V31, P83, DOI 10.1177/03635465030310012601; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Claessen FMAP, 2015, J SHOULDER ELB SURG, V24, P1613, DOI 10.1016/j.jse.2015.03.029; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DONKER DK, 1993, INT J BIOMED COMPUT, V33, P55, DOI 10.1016/0020-7101(93)90059-F; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Ferri C, 2009, PATTERN RECOGN LETT, V30, P27, DOI 10.1016/j.patrec.2008.08.010; FORBES AD, 1995, J CLIN MONITOR, V11, P189, DOI 10.1007/BF01617722; GOODMAN LA, 1963, J AM STAT ASSOC, V58, P310, DOI 10.2307/2283271; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Jeni LA, 2013, INT CONF AFFECT, P245, DOI 10.1109/ACII.2013.47; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; KRIPPENDORFF K, 1987, QUAL QUANT, V21, P109; Krippendorff K., 1980, CONTENT ANAL INTRO I; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; MAK TK, 1988, J R STAT SOC C-APPL, V37, P344, DOI 10.2307/2347309; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Passos AN, 2014, BRAZ J MICROBIOL, V45, P1357, DOI 10.1590/S1517-83822014000400028; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Powers D. M., 2012, EACL 2012 13 C EUROP, P345; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Stokic D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-253; Supper J, 2007, LECT NOTES COMPUT SC, V4447, P270; Tian Y, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00068; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140; Viera AJ, 2005, FAM MED, V37, P360; Warrens M. J., 2013, J MODERN MATH FRONTI, V2, P111, DOI DOI 10.14355/jmmf.2013.0204.01; Warrens MJ, 2008, PSYCHOMETRIKA, V73, P487, DOI 10.1007/s11336-008-9059-y; Warrens MJ, 2010, J CLASSIF, V27, P322, DOI 10.1007/s00357-010-9060-x; Witten IH, 2011, MOR KAUF D, P1; Zhao X., 2013, ANN INT COMMUN ASS, V36, P419, DOI [10.1080/23808985.2013.11679142, DOI 10.1080/23808985.2013.11679142]	48	83	83	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222916	10.1371/journal.pone.0222916	http://dx.doi.org/10.1371/journal.pone.0222916			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557204	Green Published, gold			2022-12-26	WOS:000532345500046
J	Li, B; Chen, YY; Wang, F; Guo, J; Fu, W; Li, M; Zheng, QC; Liu, Y; Fan, LL; Li, L; Xu, CR				Li, Bin; Chen, Yuyuan; Wang, Fei; Guo, Jun; Fu, Wen; Li, Min; Zheng, Qichang; Liu, Yong; Fan, Lingling; Li, Lei; Xu, Chuanrui			Bmi1 drives hepatocarcinogenesis by repressing the TGF beta 2/SMAD signalling axis	ONCOGENE			English	Article							CELL SELF-RENEWAL; TGF-BETA; C-MYC; IN-VIVO; H-RAS; GROWTH; RECEPTOR; PROTEIN; TUMORIGENESIS; ONCOPROTEIN	Bmi1 is overexpressed in one-third of hepatocellular carcinoma (HCC) patients and acts as an oncogene in hepatocarcinogenesis. However, the underlying mechanism is unclear. The role of TGF beta signalling in HCC is not well defined as well. Here, we report that TGF beta 2 is a target of Bmi1 in HCC and has a tumour-suppressing role. In Bmi1-knockout mouse livers and HCC cell lines, TGF beta 2/SMAD cascade proteins were upregulated. TGF beta 2 expression was inversely correlated with Bmi1 expression in human and mouse HCC tissues. In vitro, Bmi1 knockdown activated TGF beta 2/SMAD signalling and led to cell apoptosis via upregulation of p15 and p21. TGF beta 2 inhibition rescued the inhibitory effect of Bmi1 knockdown on HCC cell survival, proliferation, and cell-cycle progression. In vivo, restoration of TGF beta 2 expression blocked Bmi1/Ras-driven hepatocarcinogenesis in mice. Chromatin immunoprecipitation and luciferase reporter assays revealed that Bmi1 repressed TGF beta 2 expression by binding to its promoter as a co-factor of polycomb repressor complex 1. Our findings elucidate the molecular mechanism underlying hepatic Bmi1-driven carcinogenesis and highlight the importance of TGF beta 2 as a tumour suppressor in HCC development.	[Li, Bin; Chen, Yuyuan; Guo, Jun; Fu, Wen; Liu, Yong; Li, Lei; Xu, Chuanrui] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Peoples R China; [Wang, Fei] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan 430030, Peoples R China; [Li, Min; Zheng, Qichang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hepatobiliary Surg, Wuhan 430022, Peoples R China; [Fan, Lingling] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Stem Cell Ctr, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xu, CR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Peoples R China.	xcr@hust.edu.cn			National Science Foundation of China [81572723, 81872253]; Innovation Foundation of Higher Education of China [2016JCTD109]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Foundation of Higher Education of China	This study was supported by the National Science Foundation of China (81572723 and 81872253) and the Innovation Foundation of Higher Education of China (2016JCTD109).	Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; del Re E, 2004, J BIOL CHEM, V279, P22765, DOI 10.1074/jbc.M401350200; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dropmann A, 2016, ONCOTARGET, V7, P19499, DOI 10.18632/oncotarget.6967; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Goel HL, 2012, CANCER DISCOV, V2, P906, DOI 10.1158/2159-8290.CD-12-0085; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Jiang Y, 2015, ONCOGENE, V34, P6079, DOI 10.1038/onc.2015.53; Karla N, 2004, J BIOL CHEM, V279, P25313, DOI 10.1074/jbc.M400932200; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Levy L, 2002, ANN NY ACAD SCI, V963, P21; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; MITCHELL EJ, 1992, MOL BIOL CELL, V3, P1295, DOI 10.1091/mbc.3.11.1295; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Noma T, 1991, GROWTH FACTORS, V4, P247, DOI 10.3109/08977199109043910; Oh S, 2013, CANCER GENE THER, V20, P94, DOI 10.1038/cgt.2012.90; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Qi SB, 2014, INT J MOL SCI, V15, P20004, DOI 10.3390/ijms151120004; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; RODRIGUEZ C, 1995, J BIOL CHEM, V270, P15919, DOI 10.1074/jbc.270.27.15919; Rotzer D, 2001, EMBO J, V20, P480, DOI 10.1093/emboj/20.3.480; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shi Y, 2012, CARCINOGENESIS, V33, P1468, DOI 10.1093/carcin/bgs171; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yang T, 2014, THERANOSTICS, V4, P1096, DOI 10.7150/thno.9423	56	13	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					1063	1079		10.1038/s41388-019-1043-8	http://dx.doi.org/10.1038/s41388-019-1043-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31591477				2022-12-26	WOS:000511209700009
J	Ha, SD; Cho, W; DeKoter, RP; Kim, SO				Ha, Soon-Duck; Cho, Woohyun; DeKoter, Rodney P.; Kim, Sung Ouk			The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1 beta eRNA and mRNA transcription in mouse melanoma and macrophage cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; interleukin 1 (IL-1); transcription factor; chromatin modification; gene expression; melanoma; enhancer; eRNA; PU1; IL-1beta; enhancer; DNA looping; histone acetylation; melanoma cells	LONG NONCODING RNAS; KAPPA-B ACTIVATION; GENE-EXPRESSION; C/EBP-ALPHA; BINDING; INTERLEUKIN-1-BETA; DISTINCT; BIOLOGY; SITE; HEMATOPOIESIS	The DNA-binding protein PU.1 is a myeloid lineage-determining and pioneering transcription factor due to its ability to bind "closed" genomic sites and maintain "open" chromatin state for myeloid lineage-specific genes. The precise mechanism of PU.1 in cell type-specific programming is yet to be elucidated. The melanoma cell line B16BL6, although it is nonmyeloid lineage, expressed Toll-like receptors and activated the transcription factor NF-kappa B upon stimulation by the bacterial cell wall component lipopolysaccharide. However, it did not produce cytokines, such as IL-1 beta mRNA. Ectopic PU.1 expression induced remodeling of a novel distal enhancer (located similar to 10 kbp upstream of the IL-1 beta transcription start site), marked by nucleosome depletion, enhancer-promoter looping, and histone H3 lysine 27 acetylation (H3K27ac). PU.1 induced enhancer-promoter looping and H3K27ac through two distinct PU.1 regions. These PU.1-dependent events were independently required for subsequent signal-dependent and co-dependent events: NF-kappa B recruitment and further H3K27ac, both of which were required for enhancer RNA (eRNA) transcription. In murine macrophage RAW264.7 cells, these PU.1-dependent events were constitutively established and readily expressed eRNA and subsequently IL-1 beta mRNA by lipopolysaccharide stimulation. In summary, this study showed a sequence of epigenetic events in programming IL-1 beta transcription by the distal enhancer priming and eRNA production mediated by PU.1 and the signal-dependent transcription factor NF-kappa B.	[Ha, Soon-Duck; Cho, Woohyun; DeKoter, Rodney P.; Kim, Sung Ouk] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada; [Ha, Soon-Duck; Cho, Woohyun; DeKoter, Rodney P.; Kim, Sung Ouk] Univ Western Ontario, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6G 2V4, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada.	skim283@uwo.ca	Kim, Sung Ouk/AAO-1795-2020; KIM, Sung Ouk/A-1309-2008	Kim, Sung Ouk/0000-0002-0282-6661; DeKoter, Rodney/0000-0002-9201-1983	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-05514]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2018-05514 (to S. O. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamik J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070622; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Bose DA, 2017, CELL, V168, P135, DOI 10.1016/j.cell.2016.12.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; Gasque P, 2015, J INFECTION, V71, P413, DOI 10.1016/j.jinf.2015.06.006; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; GODAMBE SA, 1994, J IMMUNOL, V153, P143; GODAMBE SA, 1994, DNA CELL BIOL, V13, P561, DOI 10.1089/dna.1994.13.561; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Gutierrez-Aguirre I, 2015, METHODS MOL BIOL, V1302, P331, DOI 10.1007/978-1-4939-2620-6_24; Ha SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29463-x; Ha SD, 2016, J BIOL CHEM, V291, P8745, DOI 10.1074/jbc.M115.695809; Ha SD, 2014, J IMMUNOL, V193, P1333, DOI 10.4049/jimmunol.1400420; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ivashkiv LB, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0010-2015; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kastner P, 2008, INT J BIOCHEM CELL B, V40, P22, DOI 10.1016/j.biocel.2007.01.026; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Listman JA, 2005, J BIOL CHEM, V280, P41421, DOI 10.1074/jbc.M509143200; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; MATTEI S, 1994, INT J CANCER, V56, P853, DOI 10.1002/ijc.2910560617; Mayran A, 2018, J BIOL CHEM, V293, P13795, DOI 10.1074/jbc.R117.001232; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meng H, 2018, J BIOL CHEM, V293, P13786, DOI 10.1074/jbc.R117.813485; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; Ogata K, 2003, CURR OPIN STRUC BIOL, V13, P40, DOI 10.1016/S0959-440X(03)00012-5; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; PIERCE JW, 1988, P NATL ACAD SCI USA, V85, P1482, DOI 10.1073/pnas.85.5.1482; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; Pulugulla SH, 2018, J BIOL CHEM, V293, P19942, DOI 10.1074/jbc.RA118.005627; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; SWOPE VB, 1994, J INVEST DERMATOL, V102, P749, DOI 10.1111/1523-1747.ep12376970; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007; van Riel B, 2014, BIOL CHEM, V395, P1265, DOI 10.1515/hsz-2014-0195; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004426	88	10	10	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17487	17500		10.1074/jbc.RA119.010149	http://dx.doi.org/10.1074/jbc.RA119.010149			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31586032	hybrid, Green Published			2022-12-26	WOS:000503173500026
J	Schattauer, SS; Bedini, A; Summers, F; Reilly-Treat, A; Andrews, MM; Land, BB; Chavkin, C				Schattauer, Selena S.; Bedini, Andrea; Summers, Floyd; Reilly-Treat, Aiden; Andrews, Mackenzie M.; Land, Benjamin B.; Chavkin, Charles			Reactive oxygen species (ROS) generation is stimulated by ? opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); opiate opioid; G protein-coupled receptor (GPCR); G protein; cell signaling; MAPK; opioid; p38; peroxiredoxin; reactive oxygen	OXIDATIVE STRESS; NADPH-OXIDASE; SPINAL-CORD; KAPPA; DYNORPHIN; ANTAGONISTS; AGONIST; LIGAND; PHOSPHOLIPASE-A2; DESENSITIZATION	Activation of the mitogen-activated protein kinase (MAPK) c-Jun N-terminal kinase (JNK) by the G(i/o) protein?coupled ? opioid receptor (KOR), ? opioid, and D2 dopamine receptors stimulates peroxiredoxin 6 (PRDX6)-mediated production of reactive oxygen species (ROS). ROS production by KOR-inactivating antagonists norbinaltorphimine (norBNI) and JDTic blocks G?(i) protein activation, but the signaling mechanisms and consequences of JNK activation by KOR agonists remain uncharacterized. Binding of arrestins to KOR causes desensitization of G protein signaling and acts as a scaffold to initiate MAPK activation. Here, we found that the KOR agonists U50,488 and dynorphin B stimulated biphasic JNK activation with an early arrestin-independent phase, requiring the small G protein RAC family small GTPase 1 (RAC1) and protein kinase C (PKC), and a later arrestin-scaffolded phase, requiring RAC1 and Ras homolog family member (RHO) kinase. JNK activation by U50,488 and dynorphin B also stimulated PRDX6-dependent ROS production but with an inverted U-shaped dose-response relationship. KOR agonist-induced ROS generation resulted from the early arrestin-independent phase of JNK activation, and this ROS response was suppressed by arrestin-dependent activation of the MAPK p38. The apparent balance between p38 MAPK and JNK/ROS signaling has important physiological implications for understanding of dynorphin activities during the stress response. To visualize these activities, we monitored KOR agonist?mediated activation of ROS in transfected live cells by two fluorescent sensors, CellROX Green and HyPerRed. These findings establish an important aspect of opioid receptor signaling and suggest that ROS induction may be part of the physiological response to KOR activation.	[Schattauer, Selena S.; Summers, Floyd; Reilly-Treat, Aiden; Andrews, Mackenzie M.; Land, Benjamin B.; Chavkin, Charles] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Bedini, Andrea] Univ Bologna, Dept Pharm & Biotechnol FaBiT, I-4840126 Bologna, Italy; [Andrews, Mackenzie M.] Univ Washington, Dept Bioengn, Coll Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Bologna; University of Washington; University of Washington Seattle	Chavkin, C (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	cchavkin@uw.edu	Bedini, Andrea/GOE-5419-2022		NIH (Office of the Director, National Institutes of Health) [S10 OD016240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030074, P01DA035764] Funding Source: NIH RePORTER	NIH (Office of the Director, National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge support from the NIH (Office of the Director, National Institutes of Health) (Grant S10 OD016240) to the W. M. Keck Center for Advanced Studies in Neural Signaling and the assistance of Keck Center manager Dr. Nathaniel Peters.	Abraham AD, 2018, J NEUROSCI, V38, P8031, DOI 10.1523/JNEUROSCI.0653-18.2018; Appleyard SM, 1999, J BIOL CHEM, V274, P23802, DOI 10.1074/jbc.274.34.23802; BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; Bian JS, 2000, J PHARMACOL EXP THER, V292, P1065; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Brust TF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aai8441; Cao CM, 2005, BRIT J PHARMACOL, V145, P984, DOI 10.1038/sj.bjp.0706268; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Carroll FI, 2013, J MED CHEM, V56, P2178, DOI 10.1021/jm301783x; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chavkin C, 2016, NEUROPSYCHOPHARMACOL, V41, P373, DOI 10.1038/npp.2015.258; Chavkin C, 2015, NEUROPSYCHOPHARMACOL, V40, P2057, DOI 10.1038/npp.2015.74; Chen K, 2009, ANTIOXID REDOX SIGN, V11, P2467, DOI [10.1089/ars.2009.2594, 10.1089/ARS.2009.2594]; Costa-Neto CM, 2016, MOL PHARMACOL, V90, P587, DOI 10.1124/mol.116.105940; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Doyle T, 2013, NEUROSCIENCE, V241, P1, DOI 10.1016/j.neuroscience.2013.02.042; Doyle T, 2010, NEUROSCI LETT, V483, P85, DOI 10.1016/j.neulet.2010.07.013; Drake CT, 1996, J COMP NEUROL, V370, P377; Ehrich JM, 2015, J NEUROSCI, V35, P12917, DOI 10.1523/JNEUROSCI.2444-15.2015; Eichel K, 2018, TRENDS PHARMACOL SCI, V39, P200, DOI 10.1016/j.tips.2017.11.009; Ermakova YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6222; FISHER AB, 1992, BIOCHEM J, V288, P407, DOI 10.1042/bj2880407; Halls ML, 2018, TRENDS PHARMACOL SCI, V39, P148, DOI 10.1016/j.tips.2017.09.005; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Ibi M, 2011, J NEUROSCI, V31, P18094, DOI 10.1523/JNEUROSCI.4136-11.2011; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P10256, DOI 10.1021/bi00106a025; Kam AYF, 2004, J NEUROCHEM, V89, P391, DOI 10.1111/j.1471-4159.2004.02338.x; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Kuhar JR, 2015, CELL SIGNAL, V27, P1799, DOI 10.1016/j.cellsig.2015.05.019; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Liu JJ, 2018, SCIENCE, V360, P1314, DOI 10.1126/science.aao4927; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Munanairi A, 2018, CELL REP, V23, P866, DOI 10.1016/j.celrep.2018.03.087; Munro Thomas A., 2012, BMC Pharmacology, V12, P5, DOI 10.1186/1471-2210-12-5; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Schattauer SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00791-2; Schattauer SS, 2017, CELL SIGNAL, V32, P59, DOI 10.1016/j.cellsig.2017.01.016; Schattauer SS, 2012, J BIOL CHEM, V287, P41595, DOI 10.1074/jbc.M112.381368; Schiavone S, 2013, ANTIOXID REDOX SIGN, V18, P1475, DOI 10.1089/ars.2012.4720; Schindler AG, 2012, J NEUROSCI, V32, P17582, DOI 10.1523/JNEUROSCI.3220-12.2012; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shippenberg T S, 1986, NIDA Res Monogr, V75, P563; Stefanoska K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32592-y; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; SUDA M, 1983, LIFE SCI, V33, P275, DOI 10.1016/0024-3205(83)90496-4; Tejeda HA, 2012, CELL MOL LIFE SCI, V69, P857, DOI 10.1007/s00018-011-0844-x; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; WANG R, 1994, BIOCHEM J, V304, P131, DOI 10.1042/bj3040131; Wilson C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00381; Xu M, 2004, J NEUROSCI, V24, P4576, DOI 10.1523/JNEUROSCI.5552-03.2004; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhou JJ, 2002, BRIT J PHARMACOL, V135, P1675, DOI 10.1038/sj.bjp.0704640	70	26	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16884	16896		10.1074/jbc.RA119.009592	http://dx.doi.org/10.1074/jbc.RA119.009592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31575661	hybrid, Green Published			2022-12-26	WOS:000501801900033
J	Sen, S; Udgaonkar, JB				Sen, Sreemantee; Udgaonkar, Jayant B.			Binding-induced folding under unfolding conditions: Switching between induced fit and conformational selection mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src homology 3 domain (SH3 domain); protein folding; intrinsically disordered protein; ligand-binding protein; peptides; conformational selection; induced fit; reaction flux	SIDE-CHAIN INTERACTIONS; SH3 DOMAIN; TRANSITION-STATE; LIGAND CONCENTRATION; PROTEIN; DYNAMICS; SUBUNIT; FORMS; INTERMEDIATE; DENATURATION	The chemistry of protein?ligand binding is the basis of virtually every biological process. Ligand binding can be essential for a protein to function in the cell by stabilizing or altering the conformation of a protein, particularly for partially or completely unstructured proteins. However, the mechanisms by which ligand binding impacts disordered proteins or influences the role of disorder in protein folding is not clear. To gain insight into this question, the mechanism of folding induced by the binding of a Pro-rich peptide ligand to the SH3 domain of phosphatidylinositol 3-kinase unfolded in the presence of urea has been studied using kinetic methods. Under strongly denaturing conditions, folding was found to follow a conformational selection (CS) mechanism. However, under mildly denaturing conditions, a ligand concentration?dependent switch in the mechanism was observed. The folding mechanism switched from being predominantly a CS mechanism at low ligand concentrations to being predominantly an induced fit (IF) mechanism at high ligand concentrations. The switch in the mechanism manifests itself as an increase in the reaction flux along the IF pathway at high ligand concentrations. The results indicate that, in the case of intrinsically disordered proteins too, the folding mechanism is determined by the concentration of the ligand that induces structure formation.	[Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India; Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Science Education & Research (IISER) Pune	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	jayant@iiserpune.ac.in			Tata Institute of Fundamental Research; Indian Institute of Science Education and Research; Department of Science and Technology, Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Indian Institute of Science Education and Research; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by the Tata Institute of Fundamental Research, the Indian Institute of Science Education and Research, and the Department of Science and Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Bachmann A, 2011, P NATL ACAD SCI USA, V108, P3952, DOI 10.1073/pnas.1012668108; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Baliga C, 2019, BIOPHYS J, V116, P807, DOI 10.1016/j.bpj.2019.01.026; Batra-Safferling R, 2010, BIOL CHEM, V391, P33, DOI 10.1515/BC.2010.003; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dahal L, 2018, J MOL BIOL, V430, P2468, DOI 10.1016/j.jmb.2018.04.004; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Daniels KG, 2014, J AM CHEM SOC, V136, P822, DOI 10.1021/ja4086726; Dasgupta A, 2010, J MOL BIOL, V403, P430, DOI 10.1016/j.jmb.2010.08.046; Dasgupta A, 2012, BIOCHEMISTRY-US, V51, P8226, DOI 10.1021/bi3008627; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Galburt EA, 2016, BIOCHEMISTRY-US, V55, P7014, DOI 10.1021/acs.biochem.6b00914; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Greives N, 2014, P NATL ACAD SCI USA, V111, P10197, DOI 10.1073/pnas.1407545111; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; HERSKOVITS TT, 1975, BIOCHEMISTRY-US, V14, P4964, DOI 10.1021/bi00693a027; HERSKOVITS TT, 1969, SCIENCE, V163, P282, DOI 10.1126/science.163.3864.282; Hill SA, 2014, J MOL BIOL, V426, P21, DOI 10.1016/j.jmb.2013.08.027; Hsieh MC, 2017, J AM CHEM SOC, V139, P17007, DOI 10.1021/jacs.7b09362; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Kloks CPAM, 2004, BIOCHEMISTRY-US, V43, P10237, DOI 10.1021/bi049524s; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lou SC, 2016, J MOL BIOL, V428, P2507, DOI 10.1016/j.jmb.2016.04.002; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moulick R, 2015, J BIOL CHEM, V290, P25227, DOI 10.1074/jbc.M115.677575; Narayanan R, 2008, J AM CHEM SOC, V130, P11477, DOI 10.1021/ja803221c; Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041; Paul F, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005067; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; SANZ JM, 1994, FEBS LETT, V344, P216, DOI 10.1016/0014-5793(94)00384-X; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky Vladimir N., 2009, V7, P21, DOI 10.1007/978-1-4020-9434-7_2; Wani AH, 2009, J MOL BIOL, V387, P348, DOI 10.1016/j.jmb.2009.01.060; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	56	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16942	16952		10.1074/jbc.RA119.009742	http://dx.doi.org/10.1074/jbc.RA119.009742			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31582563	hybrid, Green Published			2022-12-26	WOS:000501801900038
J	Antunes, ACL; Jensen, VF; Jensen, D				Antunes, Ana Carolina Lopes; Jensen, Vibeke Frokjaer; Jensen, Dan			Unweaving tangled mortality and antibiotic consumption data to detect disease outbreaks - Peaks, growths, and foresight in swine production	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BIG DATA; SURVEILLANCE; MODEL; ANTIBODIES	As our capacity to collect and store health data is increasing, a new challenge of transforming data into meaningful information for disease monitoring and surveillance has arisen. The aim of this study was to explore the potential of using livestock mortality and antibiotic consumption data as a proxy for detecting disease outbreaks at herd level. Changes in the monthly records of mortality and antibiotic consumption were monitored in Danish swine herds that became positive for porcine reproductive and respiratory syndrome (PRRS) and porcine pleuropneumonia. Laboratory serological results were used to identify herds that changed from a negative to a positive status for the diseases. A dynamic linear model with a linear growth component was used to model the data. Alarms about state changes were raised based on forecast errors, changes in the growth component, and the values of the retrospectively smoothed values of the growth component. In all cases, the alarms were defined based on credible intervals and assessed prior and after herds got a positive disease status. The number of herds with alarms based on mortality increased by 3% in the 3 months prior to laboratory confirmation of PRRS-positive herds (Se = 0.47). A 22% rise in the number of weaner herds with alarms based on the consumption of antibiotics for respiratory diseases was found 1 month prior to these herds becoming PRRS-positive (Se = 0.22). For porcine pleuropneumonia-positive herds, a 10% increase in antibiotic consumption for respiratory diseases in sow herds was seen 1 month prior to a positive result (Se = 0.5). Monitoring changes in mortality data and antibiotic consumption showed changes at herd level prior to and in the same month as confirmation from diagnostic tests. These results also show a potential value for using these data streams as part of surveillance strategies.	[Antunes, Ana Carolina Lopes; Jensen, Vibeke Frokjaer] Tech Univ Denmark, Natl Vet Inst, Ctr Diagnost, Div Diagnost & Sci Advice Epidemiol, Lyngby, Denmark; [Jensen, Dan] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark	Technical University of Denmark; University of Copenhagen	Antunes, ACL (corresponding author), Tech Univ Denmark, Natl Vet Inst, Ctr Diagnost, Div Diagnost & Sci Advice Epidemiol, Lyngby, Denmark.	aclan@vet.dtu.dk	Jensen, Dan/M-1714-2019	Jensen, Dan/0000-0002-9437-0605; Lopes-Antunes, Ana-Carolina/0000-0001-8142-8241	Danish Food and Veterinary Administration	Danish Food and Veterinary Administration	The study was carried out as part of a research project at the Technical University of Denmark, funded by the Danish Food and Veterinary Administration (2011-2019). The aim of the project is to improve and explore the possibilities of using data from current databases in the surveillance of animal health and detection of disease out breaks. ACLA and VFJ received the salary based on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antunes ACL, 2017, PLOS ONE, P12; ANTUNES AK, 2017, PREV VET MED, V145, DOI [10.1016/j.prevetmed.2017.06.013, DOI 10.1016/J.PREVETMED.2017.06.013]; Antunes ACL, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00041; Antunes ACL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173099; Antunes ACL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0617-0; Backer JA, 2011, PREV VET MED, V99, P38, DOI 10.1016/j.prevetmed.2010.10.008; Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400; Berger SS, 2017, J VET DIAGN INVEST, V29, P797, DOI 10.1177/1040638717719481; Birkegard AC, 2018, ZOONOSES PUBLIC HLTH, V65, P936, DOI 10.1111/zph.12513; BOTNER A, 1994, VET MICROBIOL, V40, P351, DOI 10.1016/0378-1135(94)90122-8; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Dominiak KN, 2017, COMPUT ELECTRON AGR, V133, P46, DOI 10.1016/j.compag.2016.12.008; Food and Agriculture Organization of the United Nations, 2016, DRIV DYN EP ANT RES; Gates MC, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00074; Hogeveen H, 2010, SENSORS-BASEL, V10, P7991, DOI 10.3390/s100907991; Houe H, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-S1-S7; IDEXX, IDEXX PRRS X3 AB TES; Jensen DB, 2018, J DAIRY SCI, V101, P10428, DOI 10.3168/jds.2017-14134; Jensen DB, 2016, J DAIRY SCI, V99, P7344, DOI 10.3168/jds.2015-10060; Jensen DB, 2017, COMPUT ELECTRON AGR, V135, P51, DOI 10.1016/j.compag.2016.12.018; Jensen DB, 2017, COMPUT ELECT AGR; Jensen DB, 2015, PRE LIV FARM 2015 7; Jensen VF, 2014, PREV VET MED, V117, P554, DOI 10.1016/j.prevetmed.2014.08.006; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jensen VF, 2010, PREV VET MED, V95, P239, DOI 10.1016/j.prevetmed.2010.04.001; Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709; Klausen J, 2002, VET MICROBIOL, V88, P223, DOI 10.1016/S0378-1135(02)00111-6; Klausen J, 2007, J VET DIAGN INVEST, V19, P244, DOI 10.1177/104063870701900303; Lopes Antunes AC, 2016, PREV VET MED, P127, DOI [10.1016/j.prevetmed.2016.07.015, DOI 10.1016/J.PREVETMED.2016.07.015]; Martin LJ, 2016, EPIDEMIOL INFECT, V144, P325, DOI 10.1017/S0950268815001478; Montgomery D. C., 2012, INTRO STAT QUALITY C; NIELSEN R, 1991, J CLIN MICROBIOL, V29, P794, DOI 10.1128/JCM.29.4.794-797.1991; Ostersen T, 2010, COMPUT ELECTRON AGR, V74, P51, DOI 10.1016/j.compag.2010.06.003; Radostits OM, 2000, TXB DIS CATTLE SHEEP, V9th; Salman M.D., 2003, ANIMAL DIS SURVEILLA, V1st; Sorensen KJ, 1997, VET MICROBIOL, V56, P1, DOI 10.1016/S0378-1135(96)01345-4; Stege H, 2003, PREV VET MED, V57, P105, DOI 10.1016/S0167-5877(02)00233-7; Stevens KB, 2015, SPAT SPATIO-TEMPORAL, V13, P15, DOI 10.1016/j.sste.2015.04.003; VanderWaal K, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00110; Vigre H, 2010, PREV VET MED, V93, P98, DOI 10.1016/j.prevetmed.2009.10.010; West M., 2006, BAYESIAN FORECASTING; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223250	10.1371/journal.pone.0223250	http://dx.doi.org/10.1371/journal.pone.0223250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596880	Green Published, gold, Green Submitted			2022-12-26	WOS:000532444100027
J	Ghergherehchi, CL; Hibbard, EA; Mikesh, M; Bittner, GD; Sengelaub, DR				Ghergherehchi, Cameron L.; Hibbard, Emily A.; Mikesh, Michelle; Bittner, George D.; Sengelaub, Dale R.			Behavioral recovery and spinal motoneuron remodeling after polyethylene glycol fusion repair of singly cut and ablated sciatic nerves	PLOS ONE			English	Article							DENDRITIC ARBORIZATION PATTERNS; PHRENIC MOTONEURONS; MOTOR-NEURONS; DORSAL HORN; ADULT CAT; RAT; CORD; ORGANIZATION; MORPHOLOGY; INJURY	Polyethylene glycol repair (PEG-fusion) of severed sciatic axons restores their axoplasmic and membrane continuity, prevents Wallerian degeneration, maintains muscle fiber innervation, and greatly improves recovery of voluntary behaviors. We examined alterations in spinal connectivity and motoneuron dendritic morphology as one potential mechanism for improved behavioral function after PEG-fusion. At 2-112 days after a single-cut or allograft PEG-fusion repair of transected or ablated sciatic nerves, the number, size, location, and morphology of motoneurons projecting to the tibialis anterior muscle were assessed by retrograde labeling. For both lesion types, labeled motoneurons were found in the appropriate original spinal segment, but also in inappropriate segments, indicating mis-pairings of proximal-distal segments of PEG-fused motor axons. Although the number and somal size of motoneurons was unaffected, dendritic distributions were altered, indicating that PEG-fusion preserves spinal motoneurons but reorganizes their connectivity. This spinal reorganization may contribute to the remarkable behavioral recovery seen after PEG-fusion repair.	[Ghergherehchi, Cameron L.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Hibbard, Emily A.; Sengelaub, Dale R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Mikesh, Michelle; Bittner, George D.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Austin	Sengelaub, DR (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	sengelau@indiana.edu			Lone Star Paralysis Foundation; NIH [R01 NS081063]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081063] Funding Source: NIH RePORTER	Lone Star Paralysis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Lone Star Paralysis Foundation to GDB, NIH grant R01 NS081063 to GDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2002, EXP NEUROL, V178, P139, DOI 10.1006/exnr.2002.8031; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Badia J, 2010, MUSCLE NERVE, V42, P192, DOI 10.1002/mus.21652; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; BOWE CM, 1992, J COMP NEUROL, V321, P576, DOI 10.1002/cne.903210406; BRANNSTROM T, 1992, J COMP NEUROL, V318, P439, DOI 10.1002/cne.903180408; BRANNSTROM T, 1992, J COMP NEUROL, V318, P452, DOI 10.1002/cne.903180409; Britt JM, 2010, J NEUROPHYSIOL, V104, P695, DOI 10.1152/jn.01051.2009; BROWN PB, 1979, EXP NEUROL, V64, P453, DOI 10.1016/0014-4886(79)90224-3; Brushart T., 2011, NERVE REPAIR; BRUSHART TME, 1988, J NEUROSCI, V8, P1026; Burke RE, 1990, SYNAPTIC ORG BRAIN, P88; Byers JS, 2012, J COMP NEUROL, V520, P2683, DOI 10.1002/cne.23066; CAMERON WE, 1985, J COMP NEUROL, V231, P91, DOI 10.1002/cne.902310108; Carlton JM, 1986, SURG FORUM, V37, P611; CHEN XY, 1994, J COMP NEUROL, V343, P143, DOI 10.1002/cne.903430111; CULLHEIM S, 1987, J COMP NEUROL, V255, P82, DOI 10.1002/cne.902550107; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; de Ruiter GCW, 2008, EXP NEUROL, V211, P339, DOI 10.1016/j.expneurol.2007.12.023; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; FURICCHIA JV, 1987, EXP NEUROL, V96, P621, DOI 10.1016/0014-4886(87)90224-X; Ghergherehchi CL, 2019, J NEUROSCI METH, V314, P1, DOI 10.1016/j.jneumeth.2018.12.015; Ghergherehchi CL, 2016, J NEUROSCI RES, V94, P231, DOI 10.1002/jnr.23704; GOLDSTEIN LA, 1993, DEV BRAIN RES, V73, P151, DOI 10.1016/0165-3806(93)90133-U; Grafstein B, 1978, NEURONAL PLASTICITY, P155; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Hebbeler SL, 2003, J COMP NEUROL, V467, P80, DOI 10.1002/cne.10911; Helmbrecht MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123643; Kang H, 2007, J NEUROSCI, V27, P5948, DOI 10.1523/JNEUROSCI.0621-07.2007; KURZ EM, 1986, SCIENCE, V232, P395, DOI 10.1126/science.3961488; KURZ EM, 1991, J NEUROBIOL, V22, P976, DOI 10.1002/neu.480220909; Lappi DA, 2014, RIBOSOME-INACTIVATING PROTEINS: RICIN AND RELATED PROTEINS, P253; Little CM, 2009, J COMP NEUROL, V512, P359, DOI 10.1002/cne.21885; Lore AB, 1999, J NEUROSCI, V19, P2442; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; Mikesh M, 2018, J NEUROSCI RES, V96, P1243, DOI 10.1002/jnr.24227; Mikesh M, 2018, J NEUROSCI RES, V96, P1223, DOI 10.1002/jnr.24225; MINER N, 1956, J COMP NEUROL, V105, P161, DOI 10.1002/cne.901050109; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; O'Daly A, 2016, EUR J NEUROSCI, V43, P443, DOI 10.1111/ejn.13058; OHANLON GM, 1995, EXP BRAIN RES, V103, P243; PEYRONNARD JM, 1982, MUSCLE NERVE, V5, P654, DOI 10.1002/mus.880050811; Riley DC, 2015, J NEUROSCI RES, V93, P572, DOI 10.1002/jnr.23514; RITZ LA, 1992, J COMP NEUROL, V318, P209, DOI 10.1002/cne.903180206; Rose PK, 1998, J COMP NEUROL, V390, P392, DOI 10.1002/(SICI)1096-9861(19980119)390:3<392::AID-CNE7>3.0.CO;2-X; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; Rupp A, 2007, J NEUROSCI METH, V166, P266, DOI 10.1016/j.jneumeth.2007.07.015; SCHOENEN J, 1982, J COMP NEUROL, V211, P226, DOI 10.1002/cne.902110303; SCHRODER HD, 1980, J COMP NEUROL, V192, P567, DOI 10.1002/cne.901920313; Socolovsky M, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16431; STANDLER NA, 1982, EXP NEUROL, V75, P600, DOI 10.1016/0014-4886(82)90028-0; SUMNER BEH, 1971, NATURE, V233, P273, DOI 10.1038/233273a0; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; TITMUS MJ, 1990, PROG NEUROBIOL, V35, P1, DOI 10.1016/0301-0082(90)90039-J; Tung TH, 2010, J HAND SURG-AM, V35A, P332, DOI 10.1016/j.jhsa.2009.12.002; VANDENNOVEN S, 1993, EXP NEUROL, V123, P147; Wiberg R, 2017, J NEUROTRAUM, V34, P652, DOI 10.1089/neu.2015.4378; Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7; Yang LY, 2004, ENDOCRINOLOGY, V145, P161, DOI 10.1210/en.2003-0853	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223443	10.1371/journal.pone.0223443	http://dx.doi.org/10.1371/journal.pone.0223443			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584985	gold, Green Published			2022-12-26	WOS:000532407600035
J	Kaihan, AB; Hishida, M; Imaizumi, T; Okazaki, M; Kaihan, AN; Katsuno, T; Taguchi, A; Yasuda, Y; Tsuboi, N; Kosugi, T; Maruyama, S				Kaihan, Ahmad Baseer; Hishida, Manabu; Imaizumi, Takahiro; Okazaki, Masaki; Kaihan, Ahmad Naseer; Katsuno, Takayuki; Taguchi, Akihiko; Yasuda, Yoshinari; Tsuboi, Naotake; Kosugi, Tomoki; Maruyama, Shoichi			Circulating levels of CD34(+) cells predict longterm cardiovascular outcomes in patients on maintenance hemodialysis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CORONARY-ARTERY-DISEASE; RISK-FACTORS; THERAPY; REENDOTHELIALIZATION; MOBILIZATION; EVENTS	CD34(+) cells maintain vascular homeostasis and predict cardiovascular outcomes. We previously evaluated the association of CD34(+) cells with cardiovascular disease (CVD) events over 23 months, but long-term CVD outcomes in relation to levels of CD34(+) cells in patients on maintenance hemodialysis are unclear. Herein, we analyzed the long-term predictive potential levels of CD34(+) cells for CVD outcomes and all-cause mortality. Between March 2005 and May 2005, we enrolled 215 patients on maintenance hemodialysis at Nagoya Kyoritsu Hospital and followed them up to 12.8 years. According to the CD34(+) cell counts, patients were classified into the lowest, medium, and highest tertiles. Levels of CD34(+) cells were analyzed in association with four-point major adverse CV events (MACEs), CVD death, and all-cause mortality. In univariate analysis age, smoking habit, lower geriatric nutrition risk index, lower calcium x phosphate product, and lower intact parathyroid hormone were significantly associated with the lowest tertile. Whereas, in multivariate analysis, age and smoking habit were significantly associated with the lowest tertile. Among 139 (64.7%) patients who died during a mean follow-up period of 8.0 years, 39 (28.1%) patients died from CVD. Patients in the lowest tertile had a significantly lower survival rate than those in the medium and highest tertiles (p<0.001). Using multivariable analyses, the lowest tertile was significantly associated with four-point MACEs (hazard ratio 1.80, p = 0.023) and CVD death (hazard ratio 2.50, p = 0.011). In conclusion, our long-term observational study revealed that a low level of CD34(+) cells in the circulation predicts CVD outcomes among patients on maintenance hemodialysis.	[Kaihan, Ahmad Baseer; Hishida, Manabu; Imaizumi, Takahiro; Okazaki, Masaki; Yasuda, Yoshinari; Tsuboi, Naotake; Kosugi, Tomoki; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Kaihan, Ahmad Baseer; Kaihan, Ahmad Naseer] Balkh Univ, Fac Med, Mazar I Sharif, Afghanistan; [Hishida, Manabu] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Katsuno, Takayuki] Aichi Med Univ, Grad Sch Med, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan; [Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan; [Tsuboi, Naotake] Fujita Hlth Univ, Dept Nephrol, Grad Sch Med, Toyoake, Aichi, Japan	Nagoya University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aichi Medical University; Institute for Biomedical Research & Innovation (IBRI); Fujita Health University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan.	marus@med.nagoya-u.ac.jp	Okazaki, Masaki/GWZ-4494-2022		JSPS KAKENHI Grant [15H05291]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The current study was supported by JSPS KAKENHI Grant (15H05291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona CO, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8043792; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Cozzolino M, 2018, NEPHROL DIAL TRANSPL, V33, P28, DOI 10.1093/ndt/gfy174; Di Stefano R, 2010, CURR PHARM DES, DOI [10.2174/, DOI 10.2174/]; Dimmeler S, 2003, J AM COLL CARDIOL, V42, P2081, DOI 10.1016/j.jacc.2003.09.016; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2017, DIABETES CARE, V40, P125, DOI 10.2337/dc16-1755; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Henry TD, 2016, CELL TRANSPLANT, V25, P1701, DOI 10.3727/096368916X691484; Hill JM, 2004, OBSTET GYNECOL SURV, DOI [10.1097/01.ogx.0000074096.62998.d71093/eurheartj/ehw246, DOI 10.1097/01.OGX.0000074096.62998.D71093/EURHEARTJ/EHW246]; Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Lee HJ, 2015, NEPHRON, V130, P151, DOI 10.1159/000430471; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Makino H, 2015, J DIABETES INVEST, V6, P473, DOI 10.1111/jdi.12310; Mandraffino G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173030; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; Moeslinger T, 2001, KIDNEY INT, V59, pS2, DOI 10.1046/j.1523-1755.2001.59780002.x; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; van der Valk FM, 2017, EUR HEART J, V38, P425, DOI 10.1093/eurheartj/ehw246; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yasuda K, 2006, J AM SOC NEPHROL, V17, P2322, DOI 10.1681/ASN.2005090958; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	35	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223390	10.1371/journal.pone.0223390	http://dx.doi.org/10.1371/journal.pone.0223390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584974	gold, Green Published			2022-12-26	WOS:000532407600026
J	Udagawa, C; Horinouchi, H; Shiraishi, K; Kohno, T; Okusaka, T; Ueno, H; Tamura, K; Ohe, Y; Zembutsu, H				Udagawa, Chihiro; Horinouchi, Hidehito; Shiraishi, Kouya; Kohno, Takashi; Okusaka, Takuji; Ueno, Hideki; Tamura, Kenji; Ohe, Yuichiro; Zembutsu, Hitoshi			Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; SURFACTANT PROTEIN-A; INDUCED LIVER-INJURY; JAPANESE PATIENTS; GEMCITABINE; ERLOTINIB; SURVEILLANCE; ASSOCIATION; SAFETY; GLI1	Drug-induced interstitial lung disease (DIILD) is a serious side effect of chemotherapy in cancer patients with an extremely high mortality rate. In this study, to identify genetic variants with greater risk of DIILD, we carried out whole genome sequencing (WGS) of germline DNA samples from 26 patients who developed DIILD, and conducted a case-control association study between these 26 cases and general Japanese population controls registered in the integrative Japanese Genome Variation Database (iJGVD) as a screening study. The associations of 42 single nucleotide variants (SNVs) showing P < 0.0001 were further validated using an independent cohort of 18 DIILD cases as a replication study. A further combined analysis of the screening and replication studies showed a possible association of two SNVs, rs35198919 in intron 1 of the chromosome 22 open reading frame 34 (C22orf34) and rs12625311 in intron 1 of the teashirt zinc finger homeobox 2 (TSHZ2), with DIILD (P-combined = 1.87 x 10(-5) and 5.16 x 10(-5), respectively). Furthermore, in a subgroup analysis of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)-induced interstitial lung disease (ILD), we observed seven candidate SNVs that were possibly associated with ILD (P < 0.00001). This is the first study to identify genetic markers for the risk of DIILD using WGS. Collectively, our novel findings indicate that these SNVs may be applicable for predicting the risk of DIILD in patients receiving chemotherapy.	[Udagawa, Chihiro; Zembutsu, Hitoshi] Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan; [Horinouchi, Hidehito; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Shiraishi, Kouya; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Res Inst, Tokyo, Japan; [Okusaka, Takuji; Ueno, Hideki] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan; [Zembutsu, Hitoshi] Japanese Fdn Canc Res, Res Inst, Project Dev Liquid Biopsy Diag, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Japanese Foundation for Cancer Research	Zembutsu, H (corresponding author), Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan.; Zembutsu, H (corresponding author), Japanese Fdn Canc Res, Res Inst, Project Dev Liquid Biopsy Diag, Tokyo, Japan.	hitoshi.zembutsu@jfcr.or.jp		Horinouchi, Hidehito/0000-0001-9090-801X	AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca (HZ), https://www.astrazeneca.com/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ballester B, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA4798; Behr ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078511; BELLAMY EA, 1985, RADIOLOGY, V156, P155, DOI 10.1148/radiology.156.1.2408293; Brehmer D, 2005, CANCER RES, V65, P379; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Fernandez AB, 2008, CHEST, V134, P824, DOI 10.1378/chest.08-0943; Furukawa H, 2015, CLIN MED INSIGHTS-CI, V9, P1, DOI [10.4137/CCRPM.S23283, 10.4137/CCRPRPM.S23283]; Furukawa H, 2013, ANN RHEUM DIS, V72, P153, DOI 10.1136/annrheumdis-2012-201944; Gemma A, 2014, CANCER SCI, V105, P1584, DOI 10.1111/cas.12550; Gurjal A, 1999, LUNG CANCER-J IASLC, V26, P109, DOI 10.1016/S0169-5002(99)00081-1; Hamada T, 2016, RESPIROLOGY, V21, P338, DOI 10.1111/resp.12665; Inaguma S, 2015, ONCOTARGET, V6, P33648, DOI 10.18632/oncotarget.5203; Ishikawa N, 2008, INT J CANCER, V122, P2612, DOI 10.1002/ijc.23411; Johkoh T, 2014, CLIN LUNG CANCER, V15, P448, DOI 10.1016/j.cllc.2014.06.003; Juge PA, 2018, NEW ENGL J MED, V379, P2209, DOI 10.1056/NEJMoa1801562; KAMATA T, 1994, INTERNAL MED, V33, P252, DOI 10.2169/internalmedicine.33.252; Kang IS, 2014, KOREAN J INTERN MED, V29, P746, DOI 10.3904/kjim.2014.29.6.746; Koike T, 2014, MOD RHEUMATOL, V24, P390, DOI 10.3109/14397595.2013.843760; Lee T, 2010, ACTA DERM-VENEREOL, V90, P625, DOI 10.2340/00015555-0977; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Minami-Shimmyo Y, 2012, J THORAC ONCOL, V7, P177, DOI 10.1097/JTO.0b013e31823c4c07; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nakamura K, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3285-6; Nicoletti P, 2017, GASTROENTEROLOGY, V152, P1078, DOI 10.1053/j.gastro.2016.12.016; Nishimura M, 2016, CANCER CHEMOTH PHARM, V77, P1165, DOI 10.1007/s00280-016-3026-6; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; Osawa M, 2015, INT J CLIN ONCOL, V20, P1063, DOI 10.1007/s10147-015-0834-3; Perez-Alvarez R, 2011, SEMIN ARTHRITIS RHEU, V41, P256, DOI 10.1016/j.semarthrit.2010.11.002; Qin H, PULMONOLOGY; Riku M, 2016, ONCOTARGET, V7, P5690, DOI 10.18632/oncotarget.6788; Ripley B, 2016, DECIPHERING DRUG IND; Sawada T, 2009, RHEUMATOLOGY, V48, P1069, DOI 10.1093/rheumatology/kep052; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Skeoch S, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100356; Tabara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026034; Tamura M, 2013, ONCOLOGIST, V18, P454, DOI 10.1634/theoncologist.2012-0248; Udagawa C, 2018, CANCER SCI, V109, P446, DOI 10.1111/cas.13471; Ueta Mayumi, 2016, Taiwan J Ophthalmol, V6, P108, DOI 10.1016/j.tjo.2016.06.001; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Yague Xavier Hernandez, 2005, Clin Transl Oncol, V7, P515, DOI 10.1007/BF02717006; Yamasaki K, 2013, RESP MED, V107, P2088, DOI 10.1016/j.rmed.2013.09.023; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	49	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223371	10.1371/journal.pone.0223371	http://dx.doi.org/10.1371/journal.pone.0223371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584970	Green Published, gold			2022-12-26	WOS:000532407600023
J	Algotsson, J; Jonsson, P; Forsman, J; Topgaard, D; Soderman, O				Algotsson, Jenny; Jonsson, Peter; Forsman, Jan; Topgaard, Daniel; Soderman, Olle			Intermolecular interactions play a role in the distribution and transport of charged contrast agents in a cartilage model	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; DONNAN EQUILIBRIUM; MONTE-CARLO; GD-DTPA(2-); DIFFUSION; MRI; GLYCOSAMINOGLYCANS	The transport and distribution of charged molecules in polyelectrolyte solutions are of both fundamental and practical importance. A practical example, which is the specific subject addressed in the present paper, is the transport and distribution of charged species into cartilage. The charged species could be a contrast agent or a drug molecule involved in diagnosis or treatment of the widespread degenerative disease osteoarthritis, which leads to degradation of articular cartilage. Associated scientific issues include the rate of transport and the equilibrium concentrations of the charged species in the cartilage and the synovial fluid. To address these questions, we present results from magnetic resonance micro-imaging experiments on a model system of articular cartilage. The experiments yield temporally and spatially resolved data on the transport of a negatively charged contrast agent (charge = -2), used in medical examinations of cartilage, into a polyelectrolyte solution, which is designed to capture the electrostatic interactions in cartilage. Also presented is a theoretical analysis of the transport where the relevant differential equations are solved using finite element techniques as well as treated with approximate analytical expressions. In the analysis, non-ideal effects are included in the treatment of the mobile species in the system. This is made possible by using results from previous Monte Carlo simulations. The results demonstrate the importance of taking non-idealities into account when data from measurements of transport of charged solutes in a system with fixed charges from biological polyelectrolytes are analyzed.	[Algotsson, Jenny; Jonsson, Peter; Topgaard, Daniel; Soderman, Olle] Lund Univ, Div Phys Chem, Lund, Sweden; [Forsman, Jan] Lund Univ, Div Theoret Chem, Lund, Sweden	Lund University; Lund University	Soderman, O (corresponding author), Lund Univ, Div Phys Chem, Lund, Sweden.	olle.soderman@fkem1.lu.se	Jönsson, Peter/C-3351-2009	Jönsson, Peter/0000-0003-2994-8017; Soderman, Olle/0000-0002-6360-0789; Topgaard, Daniel/0000-0001-9373-6348	Swedish Research Council (VR) through the Linnaeus grant Organizing Molecular Matter (OMM) center of excellence; Swedish Research Council [621-2014-3907]; Swedish Research Council (VR) through the Linnaeus grant for the Organizing Molecular Matter (OMM) center of excellence	Swedish Research Council (VR) through the Linnaeus grant Organizing Molecular Matter (OMM) center of excellence(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (VR) through the Linnaeus grant for the Organizing Molecular Matter (OMM) center of excellence(Swedish Research Council)	This work was financially supported by the Swedish Research Council (VR) through the Linnaeus grant Organizing Molecular Matter (OMM) center of excellence. PJ was supported by a grant from the Swedish Research Council (621-2014-3907).; Financial support by the Swedish Research Council (VR) through the Linnaeus grant for the Organizing Molecular Matter (OMM) center of excellence is gratefully acknowledged. PJ was supported by a grant from the Swedish Research Council (number: 621-2014-3907).	Algotsson J, 2016, MAGN RESON MED, V76, P500, DOI 10.1002/mrm.25889; Algotsson J, 2012, MAGN RESON MED, V68, P1298, DOI 10.1002/mrm.24409; ALPER JS, 1990, J PHYS CHEM-US, V94, P4747, DOI 10.1021/j100374a068; Arbabi V, 2016, J BIOMECH, V49, P1510, DOI 10.1016/j.jbiomech.2016.03.024; Bansal PN, 2011, OSTEOARTHR CARTILAGE, V19, P970, DOI 10.1016/j.joca.2011.04.004; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; Bashir A, 1996, MAGNET RESON MED, V36, P665, DOI 10.1002/mrm.1910360504; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Cussler E.L., 1997, DIFFUSION MASS TRANS; Dai HL, 1996, J CHEM ENG DATA, V41, P970, DOI 10.1021/je9600257; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Kulmala KAM, 2013, MED ENG PHYS, V35, P1415, DOI 10.1016/j.medengphy.2013.03.010; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Nieminen MT, 2004, J BIOMECH, V37, P321, DOI 10.1016/S0021-9290(03)00291-4; OHSHIMA H, 1994, COLLOID POLYM SCI, V272, P803, DOI 10.1007/BF00652421; Ohshima H, 2008, J COLLOID INTERF SCI, V323, P313, DOI 10.1016/j.jcis.2008.04.027; Salo EN, 2012, OSTEOARTHR CARTILAGE, V20, P117, DOI 10.1016/j.joca.2011.11.016; Sigurdsson U, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-226; Soderman O, 2017, NEW DEV NMR, V8, P176; STELL G, 1986, BIOPHYS J, V50, P855, DOI 10.1016/S0006-3495(86)83526-3; Trattnig S, 1999, MAGN RESON IMAGING, V17, P577, DOI 10.1016/S0730-725X(98)00215-X; Vander Elst L, 2005, HELV CHIM ACTA, V88, P574, DOI 10.1002/hlca.200590040; Wang N, 2013, PHYS MED BIOL, V58, P4535, DOI 10.1088/0031-9155/58/13/4535; Williams R.J., 2007, CARTILAGE REPAIR STR, P1, DOI DOI 10.1007/978-1-59745-343-1_1	26	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0215047	10.1371/journal.pone.0215047	http://dx.doi.org/10.1371/journal.pone.0215047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581235	gold, Green Published, Green Submitted			2022-12-26	WOS:000532398600001
J	Lopes, LD; Weisberg, AJ; Davis, EW; Varize, CD; Silva, MDPE; Chang, JH; Loper, JE; Andreote, FD				Lopes, Lucas Dantas; Weisberg, Alexandra J.; Davis, Edward W., II; Varize, Camila de S.; Pereira e Silva, Michele de C.; Chang, Jeff H.; Loper, Joyce E.; Andreote, Fernando D.			Genomic and metabolic differences between Pseudomonas putida populations inhabiting sugarcane rhizosphere or bulk soil	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PLANT; MICROBIOME; BIOSYNTHESIS; DETERMINANTS; PANGENOME; DIVERSITY; BIOFILMS; BACTERIA; REVEALS	Pseudomonas putida is one of 13 major groups of Pseudomonas spp. and contains numerous species occupying diverse niches and performing many functions such as plant growth promotion and bioremediation. Here we compared a set of 19 P. putida isolates obtained from sugarcane rhizosphere or bulk soil using a population genomics approach aiming to assess genomic and metabolic differences between populations from these habitats. Phylogenomics placed rhizosphere versus bulk soil strains in separate clades clustering with different type strains of the P. putida group. Multivariate analyses indicated that the rhizosphere and bulk soil isolates form distinct populations. Comparative genomics identified several genetic functions (GO-terms) significantly different between populations, including some exclusively present in the rhizosphere or bulk soil strains, such as D-galactonic acid catabolism and cellulose biosynthesis, respectively. The metabolic profiles of rhizosphere and bulk soil populations analyzed by Biolog Ecoplates also differ significantly, most notably by the higher oxidation of D-galactonic/D-galacturonic acid by the rhizosphere population. Accordingly, D-galactonate catabolism operon (dgo) was present in all rhizosphere isolates and absent in the bulk soil population. This study showed that sugarcane rhizosphere and bulk soil harbor different populations of P. putida and identified genes and functions potentially associated with their soil niches.	[Lopes, Lucas Dantas; Varize, Camila de S.; Pereira e Silva, Michele de C.; Andreote, Fernando D.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil; [Lopes, Lucas Dantas; Weisberg, Alexandra J.; Davis, Edward W., II; Chang, Jeff H.; Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lopes, Lucas Dantas; Varize, Camila de S.] Univ Fed Sergipe, Dept Morphol, Sao Cristovao, SE, Brazil	Universidade de Sao Paulo; Oregon State University; Universidade Federal de Sergipe	Lopes, LD; Andreote, FD (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil.; Lopes, LD (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.; Lopes, LD (corresponding author), Univ Fed Sergipe, Dept Morphol, Sao Cristovao, SE, Brazil.	lucasdlopes2@hotmail.com; fdandreo@gmail.com	Andreote, Fernando Dini/B-8499-2012; de Cassia Pereira e Silva, Michele/D-3918-2016; Lopes, Lucas Dantas/AAC-4149-2019	Andreote, Fernando Dini/0000-0002-9883-9968; de Cassia Pereira e Silva, Michele/0000-0002-6426-8474; Davis, Edward/0000-0003-1229-4272	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/50353-7]; Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq) [302168/2014-1]; National Institute of Food and Agriculture (NIFA), US Department of Agriculture [2014-51181-22384, 201167019-30192]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Food and Agriculture (NIFA), US Department of Agriculture; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) project 2013/50353-7 to FDA; Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq) grant 302168/2014-1 to FDA; the National Institute of Food and Agriculture (NIFA), US Department of Agriculture award 2014-51181-22384 to JC; and the National Institute of Food and Agriculture (NIFA), US Department of Agriculture award 201167019-30192 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshalchi SA, 2015, ARCH MICROBIOL, V197, P135, DOI 10.1007/s00203-014-1030-y; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Berg G, 2006, FEMS MICROBIOL ECOL, V56, P250, DOI 10.1111/j.1574-6941.2005.00025.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blagodatskaya E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093282; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Bringhurst RM, 2001, P NATL ACAD SCI USA, V98, P4540, DOI 10.1073/pnas.071375898; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1242, DOI 10.1046/j.1462-2920.2003.00463.x; Carminati A, 2010, PLANT SOIL, V332, P163, DOI 10.1007/s11104-010-0283-8; Cherubin MR, 2016, GEODERMA, V265, P27, DOI 10.1016/j.geoderma.2015.11.017; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Cotrufo MF, 2015, NAT GEOSCI, V8, P776, DOI [10.1038/ngeo2520, 10.1038/NGEO2520]; Davis EW, 2016, PEERJ, V4, DOI 10.7717/peerj.2222; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Garrido-Sanz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150183; Gorley C.K., 2006, GETTING STARTED PRIM; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henz SR, 2004, BIOINFORMATICS, V21, P2319; Hesse C, 2018, ENVIRON MICROBIOL, V20, P2142, DOI 10.1111/1462-2920.14130; Hodcroft E., 2018, TREECOLLAPSERCL4; Hu XJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00596-14; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Knee EM, 2001, MOL PLANT MICROBE IN, V14, P775, DOI 10.1094/MPMI.2001.14.6.775; Lescat M, 2017, MOL ECOL, V26, P1802, DOI 10.1111/mec.13851; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LJUNGGREN H, 1961, J GEN MICROBIOL, V26, P521; Lopes LD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01341; Lopes LD, 2018, ENVIRON MICROBIOL, V20, P4401, DOI 10.1111/1462-2920.14363; Lopes LD, 2018, ENVIRON MICROBIOL, V20, P62, DOI 10.1111/1462-2920.13957; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Meziane H, 2005, MOL PLANT PATHOL, V6, P177, DOI 10.1111/j.1364-3703.2005.00276.x; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; Rogers JS, 2001, SYST BIOL, V50, P713, DOI 10.1080/106351501753328839; Russo DM, 2015, APPL ENVIRON MICROB, V81, P1013, DOI 10.1128/AEM.03175-14; Schlatter D, 2017, PHYTOPATHOLOGY, V107, P1284, DOI 10.1094/PHYTO-03-17-0111-RVW; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinberg N, 2015, J BACTERIOL, V197, P2092, DOI 10.1128/JB.02516-14; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Tay M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01161-13; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Udaondo Z, 2016, ENVIRON MICROBIOL, V18, P3268, DOI 10.1111/1462-2920.13015; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Venturi V, 2016, TRENDS PLANT SCI, V21, P187, DOI 10.1016/j.tplants.2016.01.005; Vurukonda Sai Shiva Krishna Prasad, 2016, Rhizosphere, V1, P4, DOI 10.1016/j.rhisph.2016.07.005; Wang SJ, 2001, BIODEGRADATION, V12, P189, DOI 10.1023/A:1013170322269; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yonezuka K, 2017, J GEN APPL MICROBIOL, V63, P1, DOI [10.2323/jgam.2016.06.003, 10.2323/j.gam.2016.06.003]; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	72	5	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223269	10.1371/journal.pone.0223269	http://dx.doi.org/10.1371/journal.pone.0223269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581220	Green Published, Green Submitted, gold			2022-12-26	WOS:000532398600044
J	Spilling, CA; Jones, PW; Dodd, JW; Barrick, TR				Spilling, Catherine A.; Jones, Paul W.; Dodd, James W.; Barrick, Thomas R.			Disruption of white matter connectivity in chronic obstructive pulmonary disease	PLOS ONE			English	Article							SMALL VESSEL DISEASE; STRUCTURAL NETWORK CONNECTIVITY; COGNITIVE IMPAIRMENT; BRAIN NETWORKS; DIFFUSION TRACTOGRAPHY; PREDICTS DEMENTIA; RISK-FACTORS; MRI; INTEGRITY; VOLUME	Background Mild cognitive impairment is a common systemic manifestation of chronic obstructive pulmonary disease (COPD). However, its pathophysiological origins are not understood. Since, cognitive function relies on efficient communication between distributed cortical and subcortical regions, we investigated whether people with COPD have disruption in white matter connectivity. Methods Structural networks were constructed for 30 COPD patients (aged 54-84 years, 57% male, FEV1 52.5% pred.) and 23 controls (aged 51-81 years, 48% Male). Networks comprised 90 grey matter regions (nodes) interconnected by white mater fibre tracts traced using deterministic tractography (edges). Edges were weighted by the number of streamlines adjusted for a) streamline length and b) end-node volume. White matter connectivity was quantified using global and nodal graph metrics which characterised the networks connection density, connection strength, segregation, integration, nodal influence and small-worldness. Between-group differences in white matter connectivity and within-group associations with cognitive function and disease severity were tested. Results COPD patients' brain networks had significantly lower global connection strength (p = 0.03) and connection density (p = 0.04). There was a trend towards COPD patients having a reduction in nodal connection density and connection strength across the majority of network nodes but this only reached significance for connection density in the right superior temporal gyrus (p = 0.02) and did not survive correction for end-node volume. There were no other significant global or nodal network differences or within-group associations with disease severity or cognitive function. Conclusion COPD brain networks show evidence of damage compared to controls with a reduced number and strength of connections. This loss of connectivity was not sufficient to disrupt the overall efficiency of network organisation, suggesting that it has redundant capacity that makes it resilient to damage, which may explain why cognitive dysfunction is not severe. This might also explain why no direct relationships could be found with cognitive measures. Smoking and hypertension are known to have deleterious effects on the brain. These confounding effects could not be excluded.	[Spilling, Catherine A.; Barrick, Thomas R.] St Georges Univ London, Neurosci Res Ctr, Mol & Clin Sci Res Inst, London, England; [Jones, Paul W.] St Georges Univ London, Inst Infect & Immun, London, England; [Dodd, James W.] Univ Bristol, Southmead Hosp, Acad Resp Unit, Learning & Res, Second Floor, Bristol, Avon, England	St Georges University London; University of London; King's College London; St Georges University London; Southmead Hospital; University of Bristol	Barrick, TR (corresponding author), St Georges Univ London, Neurosci Res Ctr, Mol & Clin Sci Res Inst, London, England.	tbarrick@sgul.ac.uk		Barrick, Thomas/0000-0003-1783-3650; Spilling, Catherine/0000-0002-6908-5079; Dodd, James/0000-0003-4805-5759	St George's, University of London	St George's, University of London	The research was funded by St George's, University of London research funds, https://www.sgul.ac.uk/.PWJ received this funding. Since this was internal funding there is no grant number associated with this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Aras YG, 2017, COGN NEURODYNAMICS, V11, P565, DOI 10.1007/s11571-017-9449-x; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berger I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0745-9; Berlot R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00292; Berlot R, 2014, NEUROIMAGE, V92, P27, DOI 10.1016/j.neuroimage.2014.01.031; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chang SS, 2012, J AM GERIATR SOC, V60, P1839, DOI 10.1111/j.1532-5415.2012.04171.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; Dag E, 2016, RESP CARE, V61, P1044, DOI 10.4187/respcare.04403; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Dodd JW, 2012, AM J RESP CRIT CARE, V186, P240, DOI 10.1164/rccm.201202-0355OC; Drakesmith M, 2015, NEUROIMAGE, V118, P313, DOI 10.1016/j.neuroimage.2015.05.011; Drakesmith M, 2015, HUM BRAIN MAPP, V36, P2629, DOI 10.1002/hbm.22796; Du J, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101712; Eijlers AJC, 2018, BRAIN, V141, P2605, DOI 10.1093/brain/awy202; Emery CF, 2003, HEALTH PSYCHOL, V22, P598, DOI 10.1037/0278-6133.22.6.598; Esser RW, 2016, CHEST, V149, P426, DOI 10.1378/chest.15-0027; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Garrison KA, 2015, NEUROIMAGE, V118, P651, DOI 10.1016/j.neuroimage.2015.05.046; Ginestet CE, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00051; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Heinen R, 2018, NEUROIMAGE-CLIN, V19, P963, DOI 10.1016/j.nicl.2018.06.025; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Incalzi RA, 1997, CHEST, V112, P1506, DOI 10.1378/chest.112.6.1506; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Lahousse L, 2015, RESP MED, V109, P1371, DOI 10.1016/j.rmed.2015.07.014; Lahousse L, 2013, AM J RESP CRIT CARE, V188, P783, DOI 10.1164/rccm.201303-0455OC; Lambert C, 2015, NEUROIMAGE-CLIN, V9, P194, DOI 10.1016/j.nicl.2015.07.002; Lawrence AJ, 2018, NEUROLOGY, V90, pE1898, DOI 10.1212/WNL.0000000000005551; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Lezak M D., 2004, NEUROPSYCHOLOGICAL A, P1185, DOI [10.1016/j.neuroimage.2004.07.037, DOI 10.1016/J.NEUROIMAGE.2004.07.037]; Li JY, 2013, J ZHEJIANG UNIV-SC A, V14, P1, DOI 10.1631/jzus.A1200274; Liao D, 1999, CHEST, V116, P150, DOI 10.1378/chest.116.1.150; Lin FC, 2013, DRUG ALCOHOL DEPEN, V129, P82, DOI 10.1016/j.drugalcdep.2012.09.013; Lin L, 2015, J MOL NEUROSCI, V56, P363, DOI 10.1007/s12031-015-0550-5; Lucas P, 2012, INT J CHRONIC OBSTR, P679, DOI [10.2147/COPD.S36222, DOI 10.2147/COPD.S36222]; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsuda-Abedini M, 2018, PEDIATR RES, V84, P387, DOI 10.1038/s41390-018-0037-5; Meade T, 2018, ARTHRIT CARE RES, V70, P39, DOI 10.1002/acr.23243; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Nitkunan A, 2008, MAGN RESON MED, V59, P528, DOI 10.1002/mrm.21461; Omachi TA, 2012, SLEEP MED, V13, P476, DOI 10.1016/j.sleep.2011.12.007; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ryu CW, 2013, COPD, V10, P357, DOI 10.3109/15412555.2012.752808; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P300, DOI 10.1159/000091438; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spilling CA, 2017, BMC PULM MED, V17, P1, DOI 10.1186/s12890-017-0435-1; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taki Y, 2013, NEURORADIOLOGY, V55, P689, DOI 10.1007/s00234-013-1157-6; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuladhar AM, 2016, HUM BRAIN MAPP, V37, P300, DOI 10.1002/hbm.23032; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Dijk EJ, 2004, J NEUROL NEUROSUR PS, V75, P733, DOI 10.1136/jnnp.2003.022012; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; van Duinkerken E, 2012, DIABETOLOGIA, V55, P1218, DOI 10.1007/s00125-012-2488-2; Vemuri P, 2017, J ALZHEIMERS DIS, V55, P1069, DOI 10.3233/JAD-160834; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1111/resp.13012, 10.1164/rccm.201701-0218PP]; Wang CR, 2017, NEUROTOX RES, V31, P453, DOI 10.1007/s12640-016-9690-9; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wei RZ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00076; Wolf H, 2004, INT J GERIATR PSYCH, V19, P995, DOI 10.1002/gps.1205; Xie XF, 2017, J AFFECT DISORDERS, V220, P8, DOI 10.1016/j.jad.2017.05.039; Zeestraten EA, 2017, NEUROLOGY, V89, P1869, DOI 10.1212/WNL.0000000000004594; Zhang H, 2013, AM J NEURORADIOL, V34, P334, DOI 10.3174/ajnr.A3235; Zhang HY, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000844; Zhang JY, 2014, DIABETES, V63, P3596, DOI 10.2337/db14-0342; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223297	10.1371/journal.pone.0223297	http://dx.doi.org/10.1371/journal.pone.0223297			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581226	Green Published, gold, Green Accepted			2022-12-26	WOS:000532398600048
J	Wedage, O; Picin, A; Blinkhorn, J; Douka, K; Deraniyagala, S; Kourampas, N; Perera, N; Simpson, I; Boivin, N; Petraglia, M; Roberts, P				Wedage, Oshan; Picin, Andrea; Blinkhorn, James; Douka, Katerina; Deraniyagala, Siran; Kourampas, Nikos; Perera, Nimal; Simpson, Ian; Boivin, Nicole; Petraglia, Michael; Roberts, Patrick			Microliths in the South Asian rainforest similar to 45-4 ka: New insights from Fa-Hien Lena Cave, Sri Lanka	PLOS ONE			English	Article							MODERN HUMAN OCCUPATION; LATER STONE-AGE; LATE PLEISTOCENE; HUMAN-EVOLUTION; ROCKSHELTER; AFRICA; EAST; TECHNOLOGY; MIDDLE; PERSPECTIVES	Microliths-small, retouched, often-backed stone tools-are often interpreted to be the product of composite tools, including projectile weapons, and efficient hunting strategies by modern humans. In Europe and Africa these lithic toolkits are linked to hunting of medium- and large-sized game found in grassland or woodland settings, or as adaptations to risky environments during periods of climatic change. Here, we report on a recently excavated lithic assemblage from the Late Pleistocene cave site of Fa-Hien Lena in the tropical evergreen rainforest of Sri Lanka. Our analyses demonstrate that Fa-Hien Lena represents the earliest microlith assemblage in South Asia (c. 48,000-45,000 cal. years BP) in firm association with evidence for the procurement of small to medium size arboreal prey and rainforest plants. Moreover, our data highlight that the lithic technology of Fa-Hien Lena changed little over the long span of human occupation (c. 48,000-45,000 cal. years BP to c. 4,000 cal. years BP) indicating a successful, stable technological adaptation to the tropics. We argue that microlith assemblages were an important part of the environmental plasticity that enabled Homo sapiens to colonise and specialise in a diversity of ecological settings during its expansion within and beyond Africa. The proliferation of diverse microlithic technologies across Eurasia c. 48-45 ka was part of a flexible human 'toolkit' that assisted our species' spread into all of the world's environments, and the development of specialised technological and cultural approaches to novel ecological situations.	[Wedage, Oshan; Picin, Andrea; Blinkhorn, James; Douka, Katerina; Boivin, Nicole; Petraglia, Michael; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Wedage, Oshan] Univ Sri Jayewardenepura, Dept Hist & Archaeol, Nugegoda, Sri Lanka; [Blinkhorn, James] Univ London, Royal Holloway, Dept Geog, London, England; [Douka, Katerina] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Deraniyagala, Siran; Perera, Nimal] Govt Sri Lanka, Dept Archaeol, Colombo, Sri Lanka; [Kourampas, Nikos; Simpson, Ian] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Kourampas, Nikos] Univ Edinburgh, Ctr Open Learning, Edinburgh, Midlothian, Scotland; [Boivin, Nicole; Petraglia, Michael; Roberts, Patrick] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Boivin, Nicole] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Boivin, Nicole; Petraglia, Michael] Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA	University Sri Jayewardenepura; University of London; Royal Holloway University London; University of Oxford; University of Stirling; University of Edinburgh; University of Queensland; University of Calgary; Smithsonian Institution; Smithsonian National Museum of Natural History	Wedage, O; Picin, A; Petraglia, M; Roberts, P (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany.; Wedage, O (corresponding author), Univ Sri Jayewardenepura, Dept Hist & Archaeol, Nugegoda, Sri Lanka.; Petraglia, M; Roberts, P (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.; Petraglia, M (corresponding author), Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA.	wedage@shh.mpg.de; picin@shh.mpg.de; petraglia@shh.mpg.de; roberts@shh.mpg.de	Picin, Andrea/R-1288-2016; Petraglia, Michael/ABA-9748-2021; Douka, Katerina/L-3287-2014	Picin, Andrea/0000-0002-8831-8325; Roberts, Patrick/0000-0002-4403-7548; Douka, Katerina/0000-0002-0558-0011; Simpson, Ian/0000-0003-2447-7877; BOIVIN, NICOLE/0000-0002-7783-4199; Blinkhorn, James/0000-0002-9399-5515; Petraglia, Michael/0000-0003-2522-5727	research council of the University of Sri Jayewardenepura (RC-USJ); NERC Grant for Radiocarbon Dating at the University of Oxford; Max Planck Society (Max Planck Gesellschaft)	research council of the University of Sri Jayewardenepura (RC-USJ); NERC Grant for Radiocarbon Dating at the University of Oxford; Max Planck Society (Max Planck Gesellschaft)(Max Planck Society)	OW is supported by the research council of the University of Sri Jayewardenepura (RC-USJ). KD was funded by a NERC Grant for Radiocarbon Dating at the University of Oxford. OW, PR, AP, NB, MDP, and PR were funded by the Max Planck Society (Max Planck Gesellschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; [Anonymous], 2010, UNDERSTANDING QUARTZ; [Anonymous], 1981, REPLICATIVE SYSTEMS; [Anonymous], J ARCHAEOLOGICAL MET, DOI DOI 10.1007/BF02229424; [Anonymous], 1998, ARCHAEOLOGY OCEANIA, DOI [DOI 10.1002/J.1834-4453.1998.TB00404.X, DOI 10.1002/j.1834-4453.1998.tb00404.x]; Bae CJ, 2017, SCIENCE, V358, DOI 10.1126/science.aai9067; Bae CJ, 2017, CURR ANTHROPOL, V58, pS514, DOI 10.1086/694078; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Barham L, 2001, HUMAN ROOTS AFRICA A, P65; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Barker G, 2013, J ARCHAEOL METHOD TH, V20, P256, DOI 10.1007/s10816-012-9150-7; Basak B, 2017, ASIAN PERSPECT, V56, P237, DOI 10.1353/asi.2017.0009; Basak B, 2014, CURR SCI INDIA, V107, P1167; Bergman C., 2017, QUATERNARY LEVANT, P267, DOI DOI 10.1017/9781316106754.030; Blinkhorn J, 2018, J ARCHAEOL SCI-REP, V20, P168, DOI 10.1016/j.jasrep.2018.04.020; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Brandt SA, 2012, QUATERN INT, V274, P38, DOI 10.1016/j.quaint.2012.03.047; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Burdukiewicz J.M., 2005, J ISRAEL PREHISTORIC, V35, P337; Callahan E, 1990, BASICS BIFACE KNAPPI; Campbell J.B., 1982, AUST ARCHAEOL, V14, P62; Clark G., 1969, WORLD PREHISTORY NEW, DOI DOI 10.1016/j.jhevol.2018.01.003; Clark JD, 2012, RECENT ADV INDO PACI; Clarkson C., 2018, LITHIC TECHNOLOGICAL, P37, DOI [10.1007/978-3-319-64407-3_3, DOI 10.1007/978-3-319-64407-3_3]; Clarkson C, 2018, VIENNA SER THEOR BIO, P175; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Clarkson C, 2009, ANTIQUITY, V83, P326, DOI 10.1017/S0003598X0009846X; Cooray P. G., 1984, INTRO GEOLOGY SRI LA, V38; Deraniyagala S. U., 1992, PREHISTORY SRI LANKA, V2nd; Diez-Martin F, 2009, J AFR ARCHAEOL, V7, P147, DOI 10.3213/1612-1651-10136; Douka K, 2019, NATURE, V565, P640, DOI 10.1038/s41586-018-0870-z; Elston RG, 2002, ARCHAEOLOGICAL PAPER, V12, P1; Forestier H, 2013, CR PALEVOL, V12, P45, DOI 10.1016/j.crpv.2012.09.003; Gamble C., 1993, TIMEWALKERS PREHISTO; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Groucutt HS, 2015, QUATERN INT, V382, P8, DOI 10.1016/j.quaint.2015.01.039; HARPER DAT, 2001, PALAEONTOLOGIA ELECT, V4; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Henshilwood C.S., 2011, HOMOSYMBOLICUS DAWN; Hiscock P, 2015, WORLD ARCHAEOL, V47, P158, DOI 10.1080/00438243.2014.991808; Hoabinhian Moser J., 2001, HOABINHIAN GEOGRAPHI; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Huysecom ?., 2003, J AFR ARCHAEOL, V1, P151, DOI DOI 10.3213/1612-1651-10007; Inizian M.-L., 1992, TECHNOLOGY KNAPPED S; Jacobs BW, 2008, CAMBRIDGE TEXTBOOK OF EFFECTIVE TREATMENTS IN PSYCHIATRY, P733, DOI 10.1017/CBO9780511544392.050; Ji XP, 2016, QUATERN INT, V400, P166, DOI 10.1016/j.quaint.2015.09.080; Kennedy K. A. R., 2000, GOD APES FOSSIL MEN; Knutsson K., 1988, PALEO REV ARCHEOLOGI, P95; Kolobova K, 2019, ARCHAEOL ANTHROP SCI, V11, P1407, DOI 10.1007/s12520-018-0613-y; Kourampas N, 2009, GEOARCHAEOLOGY, V24, P677, DOI 10.1002/gea.20287; Kuhn SL, 2014, QUATERN INT, V347, P29, DOI 10.1016/j.quaint.2014.05.040; Leplongeon A, 2014, QUATERN INT, V343, P100, DOI 10.1016/j.quaint.2013.12.002; Lewis L., 2017, EARLY MICROLITHIC TE; Lewis L, 2014, QUATERN INT, V350, P7, DOI 10.1016/j.quaint.2014.09.013; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Marean CW, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0239; Marwick B., 2018, LITHIC TECHNOLOGICAL, V9, P63; Marwick B, 2016, J HUM EVOL, V101, P45, DOI 10.1016/j.jhevol.2016.09.004; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2013, P NATL ACAD SCI; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mercader J, 2002, EVOL ANTHROPOL, V11, P117, DOI 10.1002/evan.10022; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069280; Misra VN, 2001, J BIOSCIENCES, V26, P491, DOI 10.1007/BF02704749; Moroni A, 2018, J ANTHROPOL SCI, V96, P1; Mourre V, 1996, PALEO, V8, P205, DOI DOI 10.3406/PAL.1996.1160; Pargeter J, 2019, EVOL ANTHROPOL, V28, P72, DOI 10.1002/evan.21775; Pargeter J, 2016, J ARCHAEOL SCI-REP, V10, P221, DOI 10.1016/j.jasrep.2016.09.019; Pelegrin J., 1988, JOURNEE DETUDES TECH, P55; Perera H.N., 2010, PREHISTORIC SRI LANK; Perera N, 2016, VERTEBR PALEOBIOL PA, P173, DOI 10.1007/978-94-024-0899-7_12; Perera N, 2011, J HUM EVOL, V61, P254, DOI 10.1016/j.jhevol.2011.04.001; Peresani M, 2019, ARCHAEOL ANTHROP SCI, V11, P3503, DOI 10.1007/s12520-018-0770-z; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Rabett RJ, 2012, HUMAN ADAPTATION IN THE ASIAN PALAEOLITHIC: HOMININ DISPERSAL AND BEHAVIOUR DURING THE LATE QUATERNARY, P1, DOI 10.1017/CBO9781139087582; Rabett RJ, 2012, CAMB ARCHAEOL J, V22, P37, DOI 10.1017/S0959774312000030; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts P, 2018, NAT HUM BEHAV, V2, P542, DOI 10.1038/s41562-018-0394-4; Roberts P, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0044; Roberts P, 2017, J HUM EVOL, V106, P102, DOI 10.1016/j.jhevol.2017.01.015; Roberts P, 2015, J WORLD PREHIST, V28, P69, DOI 10.1007/s10963-015-9085-5; Roberts P, 2015, SCIENCE, V347, P1246, DOI 10.1126/science.aaa1230; Roebroeks W., ANALECTA PRAEHISTORI, V21; Rose JI, 2004, CAMB ARCHAEOL J, V14, P205, DOI 10.1017/S0959774304000137; Sali S.A., 1989, UPPER PALAEOLITHIC M; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sankalia Hasmukh D., 1962, PREHISTORY PROTOHIST; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2011, CURR ANTHROPOL, V52, P583, DOI 10.1086/660847; Shipton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04057-3; Shott M, 2015, LITHIC TECHNOL, V40, P377, DOI 10.1179/2051618515Y.0000000017; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Shott MJ, 1999, N AM ARCHAEOL, V20, P217, DOI 10.2190/0VP5-TT1E-3WLC-9RCA; SINGHVI AK, 1986, EARTH PLANET SC LETT, V80, P139, DOI 10.1016/0012-821X(86)90027-0; Slack Michael J., 2004, Archaeology in Oceania, V39, P131; Sophady H, 2016, QUATERN INT, V416, P162, DOI 10.1016/j.quaint.2015.07.049; Summerhayes GR, 2017, QUATERN INT, V448, P14, DOI 10.1016/j.quaint.2016.04.023; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Tattersall I, 2014, LANG SCI, V46, P199, DOI 10.1016/j.langsci.2014.06.011; Villa P, 2012, P NATL ACAD SCI; Villa P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196786; Wang YP, 2017, CURR ANTHROPOL, V58, pS504, DOI 10.1086/693899; Wedage MCO, 2011, COMP STUDY STRATHIGR; Wedage O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08623-1; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; Wijeyapala W., 1997, NEW LIGHT PREHISTORY; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; Zeitoun V, 2012, CR PALEVOL, V11, P305, DOI 10.1016/j.crpv.2011.11.001	115	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222606	10.1371/journal.pone.0222606	http://dx.doi.org/10.1371/journal.pone.0222606			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8DK	31577796	Green Published, gold			2022-12-26	WOS:000515075000001
J	Iwata, TN; Sugihara, K; Wada, T; Agatsuma, T				Iwata, Tomomi Nakayama; Sugihara, Kiyoshi; Wada, Teiji; Agatsuma, Toshinori			[Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti-CTLA-4 antibody in a mouse model	PLOS ONE			English	Article							DRUG CONJUGATE; CANCER-THERAPY; EFFICACY; CHEMOTHERAPY; MECHANISMS; INHIBITOR; DS-8201A; TUMORS; CELLS	[Fam-] trastuzumab deruxtecan (DS-8201a) is a HER2 (ERBB2)-targeting antibody-drug conjugate, composed of a HER2-targeting antibody and a topoisomerase I inhibitor, exatecan derivative, that has antitumor effects in preclinical xenograft models and clinical trials. Recently, [fam-] trastuzumab deruxtecan was reported to enhance antitumor immunity and was beneficial in combination with an anti-PD-1 antibody in a mouse model. In this study, the antitumor effect of [fam-] trastuzumab deruxtecan in combination with an anti-CTLA-4 antibody was evaluated. [Fam-] trastuzumab deruxtecan monotherapy had antitumor activity in an immunocompetent mouse model with EMT6 human HER2-expressing mouse breast cancer cells (EMT6-hHER2). [Fam-] trastuzumab deruxtecan in combination with the anti-CTLA-4 antibody induced more potent antitumor activity than that by monotherapy with either agent. The combination therapy increased tumor-infiltrating CD4(+) and CD8(+) T cells in vivo. Mechanistically, cured mice with treatment of [fam-] trastuzumab deruxtecan and an anti-CTLA-4 antibody completely rejected EMT6-mock cells similar to EMT6-hHER2 cells, and splenocytes from the cured mice responded to both EMT6-hHER2 and EMT6-mock cells as measured by interferon-gamma release. Taken together, these results indicate that antitumor immunity is induced by [fam-] trastuzumab deruxtecan and is facilitated in combination with anti-CTLA-4 antibody.	[Iwata, Tomomi Nakayama; Sugihara, Kiyoshi; Wada, Teiji; Agatsuma, Toshinori] Daiichi Sankyo Co Ltd, R&D Div, Oncol Res Labs 1, Tokyo, Japan	Daiichi Sankyo Company Limited	Wada, T (corresponding author), Daiichi Sankyo Co Ltd, R&D Div, Oncol Res Labs 1, Tokyo, Japan.	wada.teiji.fv@daiichisankyo.co.jp			Daiichi Sankyo Co., Ltd, a global pharmaceutical company	Daiichi Sankyo Co., Ltd, a global pharmaceutical company(Daiichi Sankyo Company Limited)	Daiichi Sankyo Co., Ltd, a global pharmaceutical company, provided support for this study in the form of salaries to all the authors. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001; Bracci L, 2014, CELL DEATH DIFFER, V21, P15, DOI 10.1038/cdd.2013.67; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cook AM, 2016, CURR OPIN IMMUNOL, V39, P23, DOI 10.1016/j.coi.2015.12.003; Doi T, 2017, LANCET ONCOL, V18, P1512, DOI 10.1016/S1470-2045(17)30604-6; Gabrysiak M, 2016, ONCOL REP, V35, P3151, DOI 10.3892/or.2016.4723; Gerber HP, 2016, BIOCHEM PHARMACOL, V102, P1, DOI 10.1016/j.bcp.2015.12.008; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Iwata AJ, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e22065; Iwata TN, 2018, MOL CANCER THER, V17, P1494, DOI 10.1158/1535-7163.MCT-17-0749; Kitai Y, 2017, J IMMUNOL, V198, P1649, DOI 10.4049/jimmunol.1601694; Martin K, 2014, CANCER IMMUNOL IMMUN, V63, P925, DOI 10.1007/s00262-014-1565-4; McKenzie JA, 2018, JNCI-J NATL CANCER I, V110, P777, DOI 10.1093/jnci/djx257; Menon S, 2016, CANCERS, V8, DOI 10.3390/cancers8120106; Mok S, 2018, J IMMUNOL, V200; Nakada T, 2016, BIOORG MED CHEM LETT, V26, P1542, DOI 10.1016/j.bmcl.2016.02.020; Ogitani Y, 2016, CLIN CANCER RES, V22, P5097, DOI 10.1158/1078-0432.CCR-15-2822; Ogitani Y, 2016, CANCER SCI, V107, P1039, DOI 10.1111/cas.12966; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng J, 2015, CANCER RES, V75, P5034, DOI 10.1158/0008-5472.CAN-14-3098; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shitara K, 2019, LANCET ONCOL, V20, P827, DOI 10.1016/S1470-2045(19)30088-9; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Tamura K, 2019, LANCET ONCOL, V20, P816, DOI 10.1016/S1470-2045(19)30097-X; Wolchok JD, 2015, CELL, V162, P937, DOI 10.1016/j.cell.2015.07.045; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Zhao L, 2013, BLOOD, V122, P4230, DOI 10.1182/blood-2013-04-496554	30	13	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222280	10.1371/journal.pone.0222280	http://dx.doi.org/10.1371/journal.pone.0222280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574081	Green Published, Green Submitted			2022-12-26	WOS:000532376700006
J	Hashizume, N; Tanaka, Y; Fukahori, S; Ishii, S; Saikusa, N; Koga, Y; Higashidate, N; Masui, D; Sakamoto, S; Yagi, M				Hashizume, Naoki; Tanaka, Yoshiaki; Fukahori, Suguru; Ishii, Shinji; Saikusa, Nobuyuki; Koga, Yoshinori; Higashidate, Naruki; Masui, Daisuke; Sakamoto, Saki; Yagi, Minoru			Adherences to oral nutritional supplementation among hospital outpatients: An online cross-sectional survey in Japan	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTROLLED-TRIAL; IMPACT; COSTS; MALNUTRITION; METAANALYSIS; DISCHARGE; IMPROVES; CANCER; LENGTH	Oral nutritional supplements (ONS) are multi-nutrient products used to increase the energy and nutrient intakes of patients. The aim of this study was to examine whether or not the adherence of patients varies according to their receiving prescription or over-the-counter ONS. Data were obtained from an online cross-sectional survey conducted with patients in Japan. A total of 107 patients who matched the inclusion criteria for the prescription ONS group and 148 who matched the criteria for the over-the-counter ONS group were further analyzed. In the prescription and over-the-counter ONS groups, the main medical reason for ONS consumption were "malnutrition" (48 patients [44.9%] vs. 63 patients [42.6%] p = 0.798], "frailty" (29 patients [27.1%] vs. 36 patients [24.3%] p = 0.663) and "aging" (25 patients [23.4%] vs. 30 patients [20.3%] p = 0.644). The proportion of "No particular disease" for prescription ONS consumption was significantly lower than that for over-the-counter ONS (6 patients [5.6%] vs. 24 patients [16.2%] p = 0.001). The body mass index of the prescription ONS group was significantly higher than that of the over-the-counter ONS group (21.1 +/- 4.38 kg/m(2) vs. 19.9 +/- 3.75 kg/m(2), p = 0.0161). In the prescription ONS group, all patients were given medical advice by doctors or registered dietitians. In contrast, in the over-the-counter ONS group, only 46 patients (31.1%) were given advice by doctors or registered dietitians (p<0.001). In the prescription ONS group, ONS was taken significantly more times and for a longer duration than in the over-the-counter ONS group (p<0.0001). However, among patients given advice by doctors or registered dietitians, there were no significant differences between the groups. Greater support by the medical team is still needed in order to maximize adherence to supplementation, especially concerning the calories, timing and period, so that benefits can be achieved and sustained.	[Hashizume, Naoki; Tanaka, Yoshiaki; Fukahori, Suguru; Ishii, Shinji; Saikusa, Nobuyuki; Koga, Yoshinori; Higashidate, Naruki; Masui, Daisuke; Sakamoto, Saki; Yagi, Minoru] Kurume Univ, Dept Pediat Surg, Sch Med, Kurume, Fukuoka, Japan; [Tanaka, Yoshiaki] Kurume Univ Hosp, Div Med Safety Management, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Hashizume, N (corresponding author), Kurume Univ, Dept Pediat Surg, Sch Med, Kurume, Fukuoka, Japan.	n_hashidume@med.kurume-u.ac.jp		Hashizume, Naoki/0000-0001-9366-361X				Baldwin C, 2012, JNCI-J NATL CANCER I, V104, P371, DOI 10.1093/jnci/djr556; Baldwin C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002008.pub4; Bauer J, 2005, CLIN NUTR, V24, P998, DOI 10.1016/j.clnu.2005.07.002; Beattie AH, 2000, GUT, V46, P813, DOI 10.1136/gut.46.6.813; Cawood AL, 2012, AGEING RES REV, V11, P278, DOI 10.1016/j.arr.2011.12.008; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Ferreira IM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000998.pub3; Freijer K, 2013, CLIN NUTR, V32, P136, DOI 10.1016/j.clnu.2012.06.009; Gammack JK, 2015, CURR OPIN CLIN NUTR, V18, P32, DOI 10.1097/MCO.0000000000000125; Gariballa S, 2007, CLIN NUTR, V26, P545, DOI 10.1016/j.clnu.2007.06.007; Gariballa S, 2006, AM J MED, V119, P693, DOI 10.1016/j.amjmed.2005.12.006; Gomes F, 2018, CLIN NUTR, V37, P336, DOI 10.1016/j.clnu.2017.06.025; Gosney M, 2003, J ADV NURS, V43, P275, DOI 10.1046/j.1365-2648.2003.02710.x; Hubbard GP, 2012, CLIN NUTR, V31, P293, DOI 10.1016/j.clnu.2011.11.020; Jensen MB, 1997, NUTRITION, V13, P422, DOI 10.1016/S0899-9007(97)91280-6; Koretz RL, 2007, AM J GASTROENTEROL, V102, P412, DOI 10.1111/j.1572-0241.2006.01024.x; Lawson RM, 2003, CLIN NUTR, V22, P39, DOI 10.1054/clnu.2002.0588; Lee HO, 2016, ANN SURG TREAT RES, V90, P79, DOI 10.4174/astr.2016.90.2.79; Lis CG, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-27; McMurdo MET, 2009, J AM GERIATR SOC, V57, P2239, DOI 10.1111/j.1532-5415.2009.02568.x; Milne AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub3; Ministry of Health Labour and Welfare, 2 NDB OP DAT JAP 201; Ministry of Health Labour and Welfare, HLTH MED SERV; National Institute for Health and Care Excellence (NICE), 2006, NUTR SUPP AD OR NUTR; Nieuwenhuizen WF, 2010, CLIN NUTR, V29, P160, DOI 10.1016/j.clnu.2009.09.003; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Norman K, 2006, WORLD J GASTROENTERO, V12, P3380, DOI 10.3748/wjg.v12.i21.3385; Paccagnella A, 2011, CURR OPIN ONCOL, V23, P322, DOI 10.1097/CCO.0b013e3283479c66; Somanchi M, 2011, JPEN-PARENTER ENTER, V35, P209, DOI 10.1177/0148607110392234; Stratton RJ, 2013, AGEING RES REV, V12, P884, DOI 10.1016/j.arr.2013.07.002; Stratton RJ, 2010, P NUTR SOC, V69, P477, DOI 10.1017/S0029665110001977; Stratton RJ, 2003, DIS RELATED MALNUTRI; van den Berg GH, 2015, CLIN NUTR, V34, P15, DOI 10.1016/j.clnu.2014.04.011	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222972	10.1371/journal.pone.0222972	http://dx.doi.org/10.1371/journal.pone.0222972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557201	Green Published, gold			2022-12-26	WOS:000532345500051
J	Lear, TB; Lockwood, KC; Ouyang, YR; Evankovich, JW; Larsen, MB; Lin, B; Liu, Y; Chen, BB				Lear, Travis B.; Lockwood, Karina C.; Ouyang, Yurong; Evankovich, John W.; Larsen, Mads B.; Lin, Bo; Liu, Yuan; Chen, Bill B.			The RING-type E3 ligase RNF186 ubiquitinates Sestrin-2 and thereby controls nutrient sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; autophagy; high-throughput screening (HTS); ubiquitylation (ubiquitination); mechanistic target of rapamycin (mTOR); nutrient sensing; ring finger protein 186 (RNF186); SESN2	METABOLISM; MTOR; ACTIVATION; INHIBITOR; GROWTH; AGE	Nutrient sensing is a critical cellular process controlling metabolism and signaling. mTOR complex 1 (mTORC1) is the primary signaling hub for nutrient sensing and, when activated, stimulates anabolic processes while decreasing autophagic flux. mTORC1 receives nutrient status signals from intracellular amino acid sensors. One of these sensors, Sestrin-2, functions as an intracellular sensor of cytosolic leucine and inhibitor of mTORC1 activity. Genetic studies of Sestrin-2 have confirmed its critical role in regulating mTORC1 activity, especially in the case of leucine starvation. Sestrin-2 is known to be transcriptionally controlled by several mechanisms; however, the post-translational proteolytic regulation of Sestrin-2 remains unclear. Here, we explored how Sestrin-2 is regulated through the ubiquitin proteasome system. Using an unbiased screening approach of an siRNA library targeting ubiquitin E3 ligases, we identified a RING-type E3 ligase, ring finger protein 186 (RNF186), that critically mediates the Sestrin-2 ubiquitination and degradation. We observed that RNF186 and Sestrin-2 bind each other through distinct C-terminal motifs and that Lys-13 in Sestrin-2 is a putative ubiquitin acceptor site. RNF186 knockdown increased Sestrin-2 protein levels and decreased mTORC1 activation. These results reveal a new mechanism of E3 ligase control of mTORC1 activity through the RNF186-Sestrin-2 axis, suggesting that RNF186 inhibition may be a potential strategy to increase levels of the mTORC1 inhibitor Sestrin-2.	[Lear, Travis B.] Univ Pittsburgh, Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Lear, Travis B.; Lockwood, Karina C.; Ouyang, Yurong; Evankovich, John W.; Larsen, Mads B.; Lin, Bo; Liu, Yuan; Chen, Bill B.] Univ Pittsburgh, Sch Med, Aging Inst, Dept Med, Pittsburgh, PA 15213 USA; [Evankovich, John W.; Liu, Yuan; Chen, Bill B.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Div Pulm Allergy & Crit Care Med, Dept Med,Sch Med, Pittsburgh, PA 15213 USA; [Chen, Bill B.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Dept Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, Y; Chen, BB (corresponding author), 2, Bridgeside Point 1,100 Technol Dr, Pittsburgh, PA 15219 USA.	liuy13@upmc.edu; chenb@upmc.edu		Evankovich, John/0000-0003-2070-0883; , Karina/0000-0001-5001-7351; Lear, Travis/0000-0001-9156-0844	University of Pittsburgh Aging Institute seed fund; NIDDK, National Institutes of Health (NIH) [1R01DK119627]; NHLBI, NIH [5F31HL143843-02, 1K08HL144820, 5R01HL14277702, 5R35HL139860-02, 5R01HL133184]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL142777, F31HL143843, K08HL144820, R01HL133184, R35HL139860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119627] Funding Source: NIH RePORTER	University of Pittsburgh Aging Institute seed fund; NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the University of Pittsburgh Aging Institute seed fund (to B. B. C and Y. L.) as well as NIDDK, National Institutes of Health (NIH), Grant 1R01DK119627 (to Y. L.) and NHLBI, NIH, Grants 5F31HL143843-02 (to T. B. L.), 1K08HL144820 (to J. W. E.), 5R01HL14277702 (to Y. L.), and 5R35HL139860-02 and 5R01HL133184 (to B. B. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen J, 2018, NATURE, V557, P585, DOI 10.1038/s41586-018-0128-9; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding BX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22538; Fujimoto K, 2017, MUCOSAL IMMUNOL, V10, P446, DOI 10.1038/mi.2016.58; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Hu Y, 2016, AUTOPHAGY, V12, P2286, DOI 10.1080/15548627.2016.1230584; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Jiang Y, 2019, ONCOGENE, V38, P3989, DOI 10.1038/s41388-019-0713-x; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar A, 2018, MOL CELL BIOCHEM, V446, P1, DOI 10.1007/s11010-017-3267-7; Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19102-2; Lear T, 2016, J EXP MED, V213, P1029, DOI 10.1084/jem.20151229; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Liang YG, 2016, AUTOPHAGY, V12, P1229, DOI 10.1080/15548627.2016.1179403; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Romero Y, 2016, AGING CELL, V15, P1103, DOI 10.1111/acel.12514; Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Wang P, 2013, CELL SIGNAL, V25, P2320, DOI 10.1016/j.cellsig.2013.07.016; Wempe F, 2010, DIS MODEL MECH, V3, P246, DOI 10.1242/dmm.004234; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	39	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16527	16534		10.1074/jbc.AC119.010671	http://dx.doi.org/10.1074/jbc.AC119.010671			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31586034	Green Published, hybrid			2022-12-26	WOS:000501801900006
J	Mahumud, RA; Alam, K; Dunn, J; Gow, J				Mahumud, Rashidul Alam; Alam, Khorshed; Dunn, Jeff; Gow, Jeff			The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia	PLOS ONE			English	Article							HPV VACCINATION; UNITED-STATES; COVERAGE; IMPACT; TRANSMISSION; MONEY	Introduction Cervical cancer imposes a substantial health burden worldwide including in Australia and is caused by persistent infection with one of 13 sexually transmitted high-risk human papillomavirus (HPV) types. The objective of this study was to assess the cost-effectiveness of adding a nonavalent new Gardasil-9 (R) (9vHPV) vaccine to the national immunisation schedule in Australia across three different delivery strategies. Materials and methods The Papillomavirus Rapid Interface for Modelling and Economics (PRIME) model was used to examine the cost-effectiveness of 9vHPV vaccine introduction to prevent HPV infection. Academic literature and anecdotal evidence were included on the demographic variables, cervical cancer incidence and mortality, treatment costs, and vaccine delivery costs. The incremental cost-effectiveness ratios (ICERs) were measured per disability-adjusted life years (DALYs) averted, using the heuristic cost-effectiveness threshold defined by the World Health Organisation (WHO). Analyses and data from international agencies were used in scenario analysis from the health system and societal perspectives. Results The 9vHPV vaccination was estimated to prevent 113 new cases of cervical cancer (discounted) during a 20-year period. From the health system and societal perspectives, the 9vHPV vaccination was very cost-effective in comparison with the status quo, with an ICER of A$47,008 and A$44,678 per DALY averted, respectively, using the heuristic cost-effectiveness threshold level. Considering delivery strategies, the ICERs per DALY averted were A$47,605, A$46,682, and A$46,738 for school, health facilities, and outreach-based vaccination programs from the health system perspective, wherein, from the societal perspective, the ICERs per DALY averted were A$46,378, A$43,729, A$43,930, respectively. All estimates of ICERs fell below the threshold level (A$73,267). Conclusions This cost-effectiveness evaluation suggests that the routine two-dose 9vHPV vaccination strategy of preadolescent girls against HPV is very cost-effective in Australia from both the health system and societal perspectives. If equally priced, the 9vHPV option is the most economically viable vaccine. Overall, this analysis seeks to contribute to an evidence-based recommendation about the new 9vHPV vaccination in the national immunisation program in Australia.	[Mahumud, Rashidul Alam; Alam, Khorshed; Dunn, Jeff; Gow, Jeff] Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Hlth Econ & Policy Res, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam; Alam, Khorshed; Gow, Jeff] Univ Southern Queensland, Sch Commerce, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam] Bangladesh Icddr B, Hlth Econ Res Hlth Syst & Populat Studies Div, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Mahumud, Rashidul Alam] Univ Rajshahi, Dept Stat, Hlth & Epidemiol Res, Rajshahi, Bangladesh; [Dunn, Jeff] Canc Council Queensland, Canc Res Ctr, Fortitude Valley, Qld, Australia; [Dunn, Jeff] Prostate Canc Fdn Australia, St Leonards, NSW, Australia; [Gow, Jeff] Univ KwaZulu Natal, Sch Accounting Econ & Finance, Durban, South Africa	University of Southern Queensland; University of Southern Queensland; International Centre for Diarrhoeal Disease Research (ICDDR); University of Rajshahi; Cancer Council Queensland; University of Kwazulu Natal	Mahumud, RA (corresponding author), Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Hlth Econ & Policy Res, Toowoomba, Qld, Australia.; Mahumud, RA (corresponding author), Univ Southern Queensland, Sch Commerce, Toowoomba, Qld, Australia.; Mahumud, RA (corresponding author), Bangladesh Icddr B, Hlth Econ Res Hlth Syst & Populat Studies Div, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.; Mahumud, RA (corresponding author), Univ Rajshahi, Dept Stat, Hlth & Epidemiol Res, Rajshahi, Bangladesh.	rashed.mahumud@usq.edu.au	Mahumud, Rashidul Alam/O-2477-2018; Gow, Jeff/L-9647-2017	Mahumud, Rashidul Alam/0000-0001-9788-1868; Dunn, Jeff/0000-0002-1180-3381; Gow, Jeff/0000-0002-5726-298X; Alam, Khorshed/0000-0003-2232-0745	University of Southern Queensland, Australia	University of Southern Queensland, Australia	The study is part of the first author's PhD research works. The PhD program was funded by the University of Southern Queensland, Australia. We would also like to thank the Australian Institute of Health and Welfare, Central Cancer Registry, Australian Bureau of Statistics, and Australian Burden of Disease Study. We would like to gratefully acknowledge the reviewers and editors of our manuscript. Special thanks also to my PhD fellow colleague (Syed Afroz Keramat) for his cordial support during data collection and model selection.	[Anonymous], GEN HPV INF FACT SHE; [Anonymous], BMC HLTH SERVICES RE; [Anonymous], WHO CERV CANC PREV C; Australian Bureau of Statistics, 2019, CONS PRIC IND; Australian Institute of Health and Welfare, 2018, CERV CANC AUSTR CERV; Australian Technical Advisory Group on Immunisation (ATAGI), 2018, CLIN ADV FACT SHEET; Boiron L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1483-5; Botwright S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182663; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brisson M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv282; Brotherton JML, 2018, AUST J GEN PRACT, V47, P417, DOI 10.31128/AJGP-01-18-4462; Brotherton JML, 2017, INT J CANCER, V141, P1576, DOI 10.1002/ijc.30871; Brotherton JML, 2017, MED J AUSTRALIA, V206, P262, DOI 10.5694/mja16.00958; Brotherton JML, 2013, MED J AUSTRALIA, V199, P614, DOI 10.5694/mja13.10272; Chesson HW, 2018, VACCINE, V36, P4362, DOI 10.1016/j.vaccine.2018.04.071; Chesson HW, 2016, HUM VACC IMMUNOTHER, V12, P1363, DOI 10.1080/21645515.2016.1140288; Chesson HW, 2016, J INFECT DIS, V213, P1694, DOI 10.1093/infdis/jiw046; De La Fuente J, 2019, HUM VACC IMMUNOTHER, V15, P1949, DOI 10.1080/21645515.2018.1560770; Department of Health and Ageing, IMM AUSTR PROGR HUM; Donovan B, 2018, EUROSURVEILLANCE, P23, DOI [10.2807/1560-7917.es.2018.23.41, DOI 10.2807/1560-7917.ES.2018.23.41]; Drolet M, 2014, INT J CANCER, V134, P2264, DOI 10.1002/ijc.28541; Dubas-Jakobczyk K, 2016, MED PR, V67, P289, DOI 10.13075/mp.5893.00378; Durham DP, 2016, P NATL ACAD SCI USA, V113, P5107, DOI 10.1073/pnas.1515528113; Edejer T, 2003, MAKING CHOICES HLTH; Explore Community Development Council, 2019, IMM SERV IMM PRIC LI; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Georgousakis M, 2012, LANCET INFECT DIS, V12, P627, DOI 10.1016/S1473-3099(12)70031-2; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Henry DA, 2005, JAMA-J AM MED ASSOC, V294, P2630, DOI 10.1001/jama.294.20.2630; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kiatpongsan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106836; Laprise JF, 2016, J INFECT DIS, V214, P685, DOI 10.1093/infdis/jiw227; Largeron N, 2017, EXPERT REV PHARM OUT, V17, P85, DOI 10.1080/14737167.2016.1208087; Lerner D, 2010, J OCCUP ENVIRON MED, V52, P926, DOI 10.1097/JOM.0b013e3181f12fb0; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lowe A, 2013, NEW THERAPIES ADV CA; Mennini FS, 2017, COST EFFECT RESOUR A, V15, DOI 10.1186/s12962-017-0073-8; Office of the Prime Minister of Australia, 2017, NEW VACC STRENGTH HL; Patel C, 2018, EUROSURVEILLANCE, V23, P30, DOI 10.2807/1560-7917.ES.2018.23.41.1700737; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Roche Products Pty Ltd, 2013, ROCH RESP MED AUSTR; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Simms KT, 2016, LANCET PUBLIC HEALTH, V1, pE66, DOI 10.1016/S2468-2667(16)30019-6; Smith MA, 2017, PAPILLOMAVIRUS RES, V3, P134, DOI 10.1016/j.pvr.2017.04.003; Tan N, 2018, VACCINE, V36, P4830, DOI 10.1016/j.vaccine.2018.02.023; Van Minh H, 2017, BMC HEALTH SERV RES, V17, P1, DOI [10.1186/s12913-016-1943-z, DOI 10.1186/S12913-016-1943-Z]; Ward K, 2013, COMMUN DIS INTELL, V37, pE156; WHO, 2019, NAT CANC CONTR PROGR; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Zhang ZG, 2017, HUM VACC IMMUNOTHER, V13, P2280, DOI [10.1080/21645515.2017.1346755, 10.1080/21645515.2017.1353852]	54	4	4	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223658	10.1371/journal.pone.0223658	http://dx.doi.org/10.1371/journal.pone.0223658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596899	gold, Green Accepted, Green Published			2022-12-26	WOS:000532444100055
J	Putz, EJ; Putz, AM; Boettcher, A; Charley, S; Sauer, M; Palmer, M; Phillips, R; Hostetter, J; Loving, CL; Cunnick, JE; Tuggle, CK				Putz, E. J.; Putz, A. M.; Boettcher, A.; Charley, S.; Sauer, M.; Palmer, M.; Phillips, R.; Hostetter, J.; Loving, C. L.; Cunnick, J. E.; Tuggle, C. K.			Successful development of methodology for detection of hapten-specific contact hypersensitivity (CHS) memory in swine	PLOS ONE			English	Article							INTERFERON-GAMMA; ALPHA-BETA; T-CELLS; DERMATITIS; IMMUNITY; DELTA; MODEL; PIGS	Hapten contact hypersensitivity (CHS) elicits a well-documented inflammation response that can be used to illustrate training of immune cells through hapten-specific CHS memory. The education of hapten-specific memory T cells has been well-established, recent research in mice has expanded the "adaptive" characteristic of a memory response from solely a function of the adaptive immune system, to innate cells as well. To test whether similar responses are seen in a non-rodent model, we used hapten-specific CHS to measure the ear inflammation response of outbred pigs to dinitrofluorobenzene (DNFB), oxazolone (OXA), or vehicle controls. We adapted mouse innate memory literature protocols to the domestic pig model. Animals were challenged up to 32 days post initial sensitization exposure to the hapten, and specific ear swelling responses to this challenge were significant for 7, 21, and 32 days post-sensitization. We established hapten-specific CHS memory exists in a non-rodent model. We also developed a successful protocol for demonstrating these CHS responses in a porcine system.	[Putz, E. J.; Putz, A. M.; Boettcher, A.; Charley, S.; Sauer, M.; Cunnick, J. E.; Tuggle, C. K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Phillips, R.; Hostetter, J.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol Sci, Ames, IA USA; [Palmer, M.] USDA ARS, Natl Anim Dis Ctr, Infect Bacterial Dis Livestock Res Unit, POB 70, Ames, IA 50010 USA; [Loving, C. L.] USDA ARS, Natl Anim Dis Ctr, Food Safety & Enter Pathogens Res Unit, POB 70, Ames, IA 50010 USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Tuggle, CK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	cktuggle@iastate.edu		Putz, Ellie/0000-0001-7510-5710; Cunnick, Joan/0000-0002-8579-027X; Hostetter, Jesse/0000-0002-5555-5121	National Institutes of Health Office of the Director USA [5R24OD019813-04]; Higher Education Program, USDA HEP National Needs Fellowship [2012-3842019286]; USDA National Needs Fellowship Grant [2012-38420-19286]; Iowa State University Office of Vice President for Research; NIH [5R24OD019813-04]; Iowa State University Office of the Vice President; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD019813] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director USA; Higher Education Program, USDA HEP National Needs Fellowship; USDA National Needs Fellowship Grant(United States Department of Agriculture (USDA)); Iowa State University Office of Vice President for Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Office of the Vice President; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by CKT 5R24OD019813-04 National Institutes of Health Office of the Director USA. CKT Iowa State University Office of the Vice President for Research Bailey Career Development Award. EJP-Higher Education Program, USDA HEP National Needs Fellowship 2012-3842019286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EJP appreciates funding from a USDA National Needs Fellowship Grant (2012-38420-19286). We thank Trey Faaborg and the Swine Nutrition Farm and Lauren Christen Breeding Farm staff for assistance with all the animal work, and Warren Franke, Department of Kinesiology, ISU, for the use of a Harpenden skinfold caliper. We extend additional appreciation to Zahra Bond, and the USDA microscopy service team for the histology expertise. This research was partially funded by Iowa State University Office of Vice President for Research, and NIH grant 5R24OD019813-04.	[Anonymous], 2021, LANG ENV STAT COMP; Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Erkes DA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/175265; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Kimber I, 2002, CONTACT DERMATITIS, V46, P1, DOI 10.1034/j.1600-0536.2002.460101.x; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; Majewska-Szczepanik M, 2012, IMMUNOL CELL BIOL, V90, P784, DOI 10.1038/icb.2012.1; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Nuhaily S, 2009, TOXINS, V1, P25, DOI 10.3390/toxins1010025; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Powell EJ, 2018, LAB ANIM-UK, V52, P402, DOI 10.1177/0023677217750691; Powell Ellis J, 2017, J Rare Dis Res Treat, V2, P1; Rajao DS, 2017, J INNATE IMMUN, V9, P193, DOI 10.1159/000451007; Szczepanik M, 1996, J EXP MED, V184, P2129, DOI 10.1084/jem.184.6.2129; Vana G, 2000, VET PATHOL, V37, P565, DOI 10.1354/vp.37-6-565; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223483	10.1371/journal.pone.0223483	http://dx.doi.org/10.1371/journal.pone.0223483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596901	gold, Green Published			2022-12-26	WOS:000532444100037
J	Horii, T; Momo, K; Yasu, T; Kabeya, Y; Atsuda, K				Horii, Takeshi; Momo, Kenji; Yasu, Takeo; Kabeya, Yusuke; Atsuda, Koichiro			Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan	PLOS ONE			English	Article							HEALTH-INSURANCE; CARE; NONADHERENCE; THERAPY; TRIAL; PREDICTORS; IMPACT	Background The extent of medication adherence in patients with type 2 diabetes mellitus (T2DM) several years after starting treatment with hypoglycemic agents remains unknown. Most previous work on medication adherence targeting this group of patients has been undertaken across a single year or is questionnaire based. This study aimed to determine medication adherence status and factors affecting adherence 3 years after initiation of hypoglycemic agents, using a nationwide medical claim-based database in Japan. Methods This retrospective study was conducted on data from 884 subjects with T2DM to better understand medication adherence, the effects of polypharmacy, and other factors. We also investigated the effects of medication nonadherence on hemoglobin A1c levels. Proportion of days covered was defined as the number of days for which a hypoglycemic agent was prescribed and in the patient's possession to the number of days in the observation period. A proportion of days covered >= 0.8 were considered adherent, and those with a value < 0.8 as nonadherence. Polypharmacy was defined as taking >= 5 medications. Results Of the 884 patients investigated, 440 were considered adherent during the study period. Significant factors related to adherence included number of medications (3 or 4, or >= 5), male sex, age 50-<60 years, and total number of visits >= 17. Medication adherence was also a factor related to patients with hemoglobin A1c values < 7.0% at the end of the observation period. Conclusions We surveyed medication adherence for 3 years with post medication initiation, and found that subjects aged 50-<60 years, those with >= 3 concomitant medications, and those with a total number of visits >= 17 were more likely to be adherent and persistent, and more likely to continue their hypoglycemic agents. A high degree of medication adherence was found to have a positive influence on hemoglobin A1c levels.	[Horii, Takeshi; Atsuda, Koichiro] Kitasato Univ, Res & Educ Ctr Clin Pharm, Div Clin Pharm, Lab Pharm Practice & Sci 1,Sch Pharm, Sagamihara, Kanagawa, Japan; [Momo, Kenji] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Pharm, Tokyo, Japan; [Momo, Kenji] Showa Univ, Dept Hosp Pharmaceut, Sch Pharm, Tokyo, Japan; [Yasu, Takeo] Meiji Pharmaceut Univ, Pharmaceut Educ & Res Ctr, Dept Med Therapy Res, Tokyo, Japan; [Kabeya, Yusuke] Sowa Hosp, Dept Home Care Med, Sagamihara, Kanagawa, Japan	Kitasato University; University of Tokyo; Showa University; Meiji Pharmaceutical University	Horii, T (corresponding author), Kitasato Univ, Res & Educ Ctr Clin Pharm, Div Clin Pharm, Lab Pharm Practice & Sci 1,Sch Pharm, Sagamihara, Kanagawa, Japan.	horiit@pharm.kitasato-u.ac.jp	Horii, Takeshi/HHN-2404-2022	Momo, Kenji/0000-0001-9856-0097; Horii, Takeshi/0000-0002-5465-4531; Yasu, Takeo/0000-0003-0587-0091	Japan Diabetes Society Medical Staff Training and Research Fund [2017-17]	Japan Diabetes Society Medical Staff Training and Research Fund	This work was supported by the Japan Diabetes Society Medical Staff Training and Research Fund to TH; grant number 2017-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2008, DIABETES CARE, V31, P916, DOI 10.2337/dc07-1924; Ahmad NS, 2013, PATIENT PREFER ADHER, V7, P525, DOI 10.2147/PPA.S44698; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Cramer J, 2003, VALUE HEALTH, V6, P566, DOI 10.1046/j.1524-4733.2003.65269.x; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Curkendall SM, 2013, CURR MED RES OPIN, V29, P1275, DOI 10.1185/03007995.2013.821056; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Fujihara K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006122; Fukuda H, 2017, DIABETES RES CLIN PR, V123, P55, DOI 10.1016/j.diabres.2016.11.007; Gibson TB, 2010, AM J MANAG CARE, V16, P589; Hayashino Y, 2016, DIABETIC MED, V33, P599, DOI 10.1111/dme.12949; Hayashino Y, 2011, EXP CLIN ENDOCR DIAB, V119, P276, DOI 10.1055/s-0030-1265213; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Horii T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49424-2; Jamous RM, 2011, INT J CLIN PHARM-NET, V33, P942, DOI 10.1007/s11096-011-9561-7; Juarez DT, 2013, J PHARM HEALTH SERV, V4, P89, DOI 10.1111/jphs.12016; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P428, DOI 10.1093/schbul/sbn106; Kurtyka K, 2016, J DIABETES INVEST, V7, P737, DOI 10.1111/jdi.12474; Lawton J, 2008, DIABETIC MED, V25, P491, DOI 10.1111/j.1464-5491.2008.02400.x; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; Nagasawa M, 1990, Diabetes Educ, V16, P192, DOI 10.1177/014572179001600309; Nakaoka S, 2011, INTERNAL MED, V50, P687, DOI 10.2169/internalmedicine.50.4344; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Raum E, 2012, DIABETES RES CLIN PR, V97, P377, DOI 10.1016/j.diabres.2012.05.026; Sapkota S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128581, 10.1371/journal.pone.0118296]; Tiv M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032412, DOI 10.1371/J0URNAL.P0NE.0032412]; Trinacty CM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-24; Tunceli K, 2015, PATIENT PREFER ADHER, V9, P191, DOI 10.2147/PPA.S71346; Waeber B, 1999, J HYPERTENS, V17, P1041, DOI 10.1097/00004872-199917070-00022; WHO, 2003, ADH LONG TERM THER T, P221	37	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0223431	10.1371/journal.pone.0223431	http://dx.doi.org/10.1371/journal.pone.0223431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593574	gold, Green Published			2022-12-26	WOS:000532431700006
J	Podushkina, D; West, NW; Golenberg, EM				Podushkina, Diona; West, Nick W.; Golenberg, Edward M.			Utilizing multiplex fluor LAMPs to illuminate multiple gene expressions in situ	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; SPINACIA-OLERACEA; DNA; HYBRIDIZATION; PCR	In situ gene expression detection is the best way to determine temporal and spatial differences in gene expression. However, in situ hybridization procedures are inherently difficult to execute and typically suffer from degradation of sample tissues, limited sensitivity to genes with low expression, high background, and limitation to single gene detections. We propose to utilize an isothermal gene amplification technique, LAMP (Loop-Mediated Isothermal Amplification), to solve these problems in a novel way. LAMP greatly amplifies the signal of expressed genes and can use multiple sets of primers and different fluorescent-labeled probes to produce multiplex gene detection. LAMP is a rapid, isothermal reaction that reduces the handling and degradation of tissue by cutting down on the washing steps required by other methods. Using this technique, we have successfully amplified 3 target genes, have produced positive fluorescent in situ results simultaneously for two genes. We have also demonstrated that LAMP can be used to exploit standard NBT/BCIP (nitro-blue tetrazolium chloride/5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt) detection of single expression. In situ LAMP is a robust and applicable method that can be exploited for detection of gene expression in plant species, as well as in animals and bacteria.	[Podushkina, Diona; West, Nick W.; Golenberg, Edward M.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Golenberg, EM (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	Golenberg@wayne.edu	Golenberg, Edward/AAE-2441-2020	Golenberg, Edward/0000-0002-0048-4776	Wayne State University [062018]; NSF Directorate for Biological Sciences [1838291]	Wayne State University; NSF Directorate for Biological Sciences	This work was supported by a Wayne State University Undergraduate Research Opportunity Award 062018 to D.P. and E.M.G. The work was partially supported by NSF Directorate for Biological Sciences grant 1838291 to E.M.G. (Co-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395; Deng MH, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0530-z; Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166; Fernandez-Soto P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003126; Ganguli A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02623-9; Huber D, 2018, MICRO NANO ENG, V1, P15, DOI 10.1016/j.mne.2018.10.006; Jensen E, 2014, ANAT REC, V297, P1349, DOI 10.1002/ar.22944; Koch J., 2003, MOL CYTOGENETICS PRO, P77; Liu NW, 2017, SCI REP-UK, V7, DOI 10.1038/srep45601; Maruyama F, 2003, APPL ENVIRON MICROB, V69, P5023, DOI 10.1128/AEM.69.8.5023-5028.2003; Meng QL, 2013, CHIN J OCEANOL LIMN, V31, P128, DOI 10.1007/s00343-013-2070-x; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nagamine K, 2001, CLIN CHEM, V47, P1742; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nuovo GJ, 2001, J HISTOCHEM CYTOCHEM, V49, P1329, DOI 10.1177/002215540104901101; Park K, 2003, MODERN PATHOL, V16, P937, DOI 10.1097/01.MP.0000086487.78558.7D; Pfent C, 2005, DEV GENES EVOL, V215, P132, DOI 10.1007/s00427-004-0459-4; Sather DN, 2005, PLANTA, V222, P284, DOI 10.1007/s00425-005-1544-2; Stewart N T, 2000, Methods Cell Sci, V22, P67, DOI 10.1023/A:1009839501174; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; TECOTT LH, 1988, SCIENCE, V240, P1661, DOI 10.1126/science.2454508; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tucker JD, 2015, MUTAT RES-REV MUTAT, V763, P2, DOI 10.1016/j.mrrev.2014.11.006; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Yoshida A, 2005, J CLIN MICROBIOL, V43, P2418, DOI 10.1128/JCM.43.5.2418-2424.2005	27	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223333	10.1371/journal.pone.0223333	http://dx.doi.org/10.1371/journal.pone.0223333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584968	Green Published, gold			2022-12-26	WOS:000532407600021
J	Tsang, AR; Rajakumar, N; Jog, MS				Tsang, Adrianna R.; Rajakumar, Nagalingam; Jog, Mandar S.			Botulinum toxin A injection into the entopeduncular nucleus improves dynamic locomotory parameters in hemiparkinsonian rats	PLOS ONE			English	Article							QUANTITATIVE GAIT ANALYSIS; DEEP BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; TETANUS TOXIN; MODEL; NEUROTOXIN; GLUTAMATE; RELEASE; SPEED	Parkinson's disease is associated with hyperactivity of the subthalamic nucleus (STN), contributing to motor and gait disturbances. Although deep brain stimulation of the STN alleviates certain motor dysfunction, its specific effect on gait abnormalities remains controversial. This study investigated the long-term changes in locomotion following direct infusions of botulinum toxin-A into the globus pallidus internal segment (GPi) to suppress the flow of information from the STN to the GPi in a hemiparkinsonian rat model. Static and dynamic gait parameters were quantified using a CatWalk apparatus. Interestingly, botulinum toxin-A at 0.5 ng significantly reduced only the dynamic gait parameters of hemiparkinsonian rats at 1 week and 1 month post-infusion, while static gait parameters did not change. This study offers new insights into the complexity of basal ganglia in locomotor control and shows the potential of central infusion of botulinum toxin-A as a novel intervention in the study of experimental hemiparkinson's disease.	[Tsang, Adrianna R.; Jog, Mandar S.] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Rajakumar, Nagalingam] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Jog, Mandar S.] London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre	Jog, MS (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.; Jog, MS (corresponding author), London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada.	mandar.jog@lhsc.on.ca			Merz Pharmaceuticals	Merz Pharmaceuticals	This study was partially funded by an unrestricted grant from Merz Pharmaceuticals. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Antipova V, 2013, J NEUROSCI RES, V91, P838, DOI 10.1002/jnr.23210; Antipova VA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00119; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; BIGALKE H, 1981, N-S ARCH PHARMACOL, V316, P244, DOI 10.1007/BF00505657; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; BLIN O, 1991, J NEUROL SCI, V103, P51, DOI 10.1016/0022-510X(91)90283-D; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; Cantiniaux S, 2010, J NEUROL NEUROSUR PS, V81, P177, DOI 10.1136/jnnp.2009.174375; Chuang CS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-9; Cossu G, 2017, GAIT POSTURE, V52, P205, DOI 10.1016/j.gaitpost.2016.11.039; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Dibble LE, 2004, GAIT POSTURE, V19, P215, DOI 10.1016/S0966-6362(03)00065-1; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hawlitschka A, 2017, BRAIN RES, V1676, P46, DOI 10.1016/j.brainres.2017.09.016; Hawlitschka A, 2013, CURR PHARM BIOTECHNO, V14, P124; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Kelly Valerie E, 2006, J Neurol Phys Ther, V30, P184; Kelly VE, 2010, DISABIL REHABIL, V32, P929, DOI 10.3109/09638280903374139; Kim SD, 2014, MOVEMENT DISORD, V29, P835, DOI 10.1002/mds.25739; Kordys E, 2017, EJNMMI RES, V7, P1, DOI 10.1186/s13550-017-0317-9; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Krystkowiak P, 2003, ARCH NEUROL-CHICAGO, V60, P80, DOI 10.1001/archneur.60.1.80; Lau B, 2015, BRAIN, V138, P1284, DOI 10.1093/brain/awv047; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; OLSSON M, 1995, J NEUROSCI, V15, P3863; Rodriguez MC, 1991, ANN NEUROL, V44, pS1; Samotus O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153739; SANCHEZPRIETO J, 1987, EUR J BIOCHEM, V165, P675, DOI 10.1111/j.1432-1033.1987.tb11494.x; Schallert T, 2000, CONT NEUROS, P131; Shi LH, 2006, SYNAPSE, V59, P445, DOI 10.1002/syn.20261; Sofuwa O, 2005, ARCH PHYS MED REHAB, V86, P1007, DOI 10.1016/j.apmr.2004.08.012; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Tewari A, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00017; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tsang AR, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13230; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Wedekind F, 2018, J NEUROSCI RES, V96, P75, DOI 10.1002/jnr.24110; Westin JE, 2012, BEHAV BRAIN RES, V226, P519, DOI 10.1016/j.bbr.2011.10.006; Williams DR, 2006, J NEUROL NEUROSUR PS, V77, P468, DOI 10.1136/jnnp.2005.074070; Wree A, 2011, NEUROBIOL DIS, V41, P291, DOI 10.1016/j.nbd.2010.09.017; Zakin E, 2017, TOXINS, V9, DOI 10.3390/toxins9110365; Zhou M, 2015, NEUROSCI LETT, V584, P184, DOI 10.1016/j.neulet.2014.10.032; Zibetti M, 2011, MOVEMENT DISORD, V26, P2327, DOI 10.1002/mds.23903	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223450	10.1371/journal.pone.0223450	http://dx.doi.org/10.1371/journal.pone.0223450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584986	Green Published, gold			2022-12-26	WOS:000532407600036
J	Deuring, JJ; Li, M; Cao, WL; Chen, SR; Wang, WS; de Haar, C; van der Woude, CJ; Peppelenbosch, M				Deuring, J. Jasper; Li, Meng; Cao, Wanlu; Chen, Sunrui; Wang, Wenshi; de Haar, Colin; van der Woude, C. Janneke; Peppelenbosch, Maikel			Pregnane X receptor activation constrains mucosal NF-kappa B activity in active inflammatory bowel disease	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; INTESTINAL EPITHELIUM; EXPRESSION; PXR; SUSCEPTIBILITY; METABOLISM; THERAPY; ROLES; IBD	Background The Pregnane X Receptor (PXR) is a principal signal transducer in mucosal responses to xenobiotic stress. It is well-recognized that inflammatory bowel disease is accompanied by xenobiotic stress, but the importance of the PXR in limiting inflammatory responses in inflammatory bowel disease remains obscure at best. Methods We stimulate a total of 106 colonic biopsies from 19 Crohn's disease patients with active disease, 36 colonic biopsies from 8 control patients, colonic organoids and various cell culture models (either proficient or genetically deficient with respect to PXR) in vitro with the PXR ligand rifampicin or vehicle. Effects on NF-kappa B activity are assessed by measuring interleukin-8 (IL-8) and interleukin-1 beta (IL-1 beta) mRNA levels by qPCR and in cell culture models by NF-kappa B reporter-driven luciferase activity and Western blot for signal transduction elements. Results We observe a strict inverse correlation between colonic epithelial PXR levels and NF-kappa B target gene expression in colonic biopsies from Crohn's disease patients. PXR, activated by rifampicin, is rate-limiting for mucosal NF-kappa B activation in IBD. The correlation between colonic epithelial PXR levels and NF-kappa B target gene expression was also observed in intestinal organoids system. Furthermore, in preclinical in vitro models of intestinal inflammation, including intestinal organoids, genetic inactivation of PXR unleashes NF-kappa B-dependent signal transduction whereas conversely NF-kappa B signaling reduces levels of PXR expression. Conclusions Our data indicate that the PXR is a major and clinically relevant antagonist of NF-kappa B activity in the intestinal epithelial compartment during inflammatory bowel disease.	[Deuring, J. Jasper; Li, Meng; Cao, Wanlu; Chen, Sunrui; Wang, Wenshi; de Haar, Colin; van der Woude, C. Janneke; Peppelenbosch, Maikel] Erasmus MC, Dept Gastroenterol & Hepatol, Univ Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Peppelenbosch, M (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Univ Med Ctr, Rotterdam, Netherlands.	m.peppelenbosch@erasmusmc.nl		de Haar, Colin/0000-0003-4358-2410	China Scholarship Council [201506100033, 201606760056]; Dutch Society for the Replacement of Animal Testing; ZONMW [2016/22827/ZONMW]	China Scholarship Council(China Scholarship Council); Dutch Society for the Replacement of Animal Testing; ZONMW(Netherlands Organization for Health Research and Development)	M.L. [201506100033] and S.C. [201606760056] are supported by a China Scholarship Council stipend (https://www.chinesescholarshipcouncil.com/), M.P. receives funding from the Dutch Society for the Replacement of Animal Testing and ZONMW (2016/22827/ZONMW) for the financial support of this work (www.zonmw.nl).The sponsors were not involved study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO;2-X; Cao W, 2017, IMMUNITY, V47, P1182, DOI 10.1016/j.immuni.2017.11.012; De Sousa RRR, 2007, J ENZYM INHIB MED CH, V22, P439, DOI 10.1080/14756360601162063; Deuring JJ, 2013, INT J BIOCHEM CELL B, V45, P798, DOI 10.1016/j.biocel.2012.12.020; Deuring JJ, 2012, BIOCHEM J, V441, P87, DOI 10.1042/BJ20111281; Dou W, 2014, J NUTR BIOCHEM, V25, P923, DOI 10.1016/j.jnutbio.2014.04.006; Dring MM, 2006, GASTROENTEROLOGY, V130, P341, DOI 10.1053/j.gastro.2005.12.008; Glas J, 2011, INFLAMM BOWEL DIS, V17, P1917, DOI 10.1002/ibd.21562; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Hakim MS, 2018, VIRUS RES, V253, P28, DOI 10.1016/j.virusres.2018.05.022; Hyams JS, 2019, LANCET, V393, P1708, DOI 10.1016/S0140-6736(18)32592-3; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Krajcovicova A, 2014, J CROHNS COLITIS, V8, P1693, DOI 10.1016/j.crohns.2014.08.004; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Liu MJ, 2018, BRIT J PHARMACOL, V175, P3563, DOI 10.1111/bph.14424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDaniel DK, 2016, INFLAMM BOWEL DIS, V22, P2265, DOI 10.1097/MIB.0000000000000858; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mondanelli G, 2017, IMMUNITY, V46, P233, DOI 10.1016/j.immuni.2017.01.005; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Shi HY, 2018, J GASTROENTEROL, V53, P989, DOI 10.1007/s00535-018-1479-6; Sivaprakasam S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080856; Terc J, 2014, EUR J PHARM SCI, V55, P12, DOI 10.1016/j.ejps.2014.01.007; Uehara D, 2019, DIGEST LIVER DIS, V51, P226, DOI 10.1016/j.dld.2018.10.008; van den Brink GR, 2000, J IMMUNOL, V164, P3353, DOI 10.4049/jimmunol.164.6.3353; Voorneveld PW, 2014, GASTROENTEROLOGY, V147, P196, DOI 10.1053/j.gastro.2014.03.052; Wang WH, 2016, NEOPLASIA, V18, P711, DOI 10.1016/j.neo.2016.10.004; Wang WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25482; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yang J, 2018, PROTEIN CELL, V9, P474, DOI 10.1007/s13238-018-0543-6; Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010; Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117; Zhang J, 2015, DRUG METAB DISPOS, V43, P1181, DOI 10.1124/dmd.115.063800; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhang XX, 2015, DRUG DES DEV THER, V9, P6343, DOI 10.2147/DDDT.S79388; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	44	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0221924	10.1371/journal.pone.0221924	http://dx.doi.org/10.1371/journal.pone.0221924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581194	Green Published, gold			2022-12-26	WOS:000532398600007
J	Hughes, S; Egger, S; Carle, C; Smith, DP; Chambers, S; Kahn, C; Caperchione, CM; Moxey, A; O'Connell, DL				Hughes, Suzanne; Egger, Sam; Carle, Chelsea; Smith, David P.; Chambers, Suzanne; Kahn, Clare; Caperchione, Cristina M.; Moxey, Annette; O'Connell, Dianne L.			Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANDROGEN DEPRIVATION THERAPY; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; DOUBLE-BLIND; MEN; DIAGNOSIS; COMPLEMENTARY; PROGRESSION; PREVALENCE	Objective To assess the use of diet and the use of exercise for prostate cancer (and/or its treatments' side effects) by long-term survivors and whether such use is associated with selected socio-demographic, clinical, health-related quality-of-life (HRQOL) and psychological factors. Design, setting and participants Population-based cohort study in New South Wales, Australia of prostate cancer survivors aged <70 years at diagnosis and who returned a 10-year follow-up questionnaire. Methods Validated instruments assessed patient's HRQOL and psychological well-being. Poisson regression was used to estimate adjusted relative proportions (RRs) of prostate cancer survivor groups who were currently eating differently ('using diet') or exercise differently ('using exercise') to help with their prostate cancer. Results 996 (61.0% of 1634) participants completed the 10-year questionnaire of whom 118 (11.8%; 95%C1[9.8-13.9]) were using diet and 78 (7.8%; 95%C1[6.2-9.5]) were using exercise to help with their prostate cancer. Men were more likely to use diet or use exercise for prostate cancer if they were younger (p-trend = 0.020 for diet, p-trend = 0.045 for exercise), more educated (p-trend<0.001, p -trend = 0.011), support group participants (p-nominal<0.001, p-nominal = 0.005), had higher Gleason score at diagnosis (p-trend<0.001, p-trend = 0.002) and had knowledge of cancer spread (p-nominal = 0.002, p-nominal = 0.001). Use of diet was also associated with receipt of androgen deprivation therapy (RR = 1.59; 95%Cl[1.04-2.45]), a greater fear of cancer recurrence (p-trend = 0.010), cognitive avoidance (p-trend = 0.025) and greater perceived control of cancer course (p-trend = 0.014). Use of exercise was also associated with receipt of prostatectomy (RR = 2.02; 95%Cl[1.12-3.63]), receipt of androgen deprivation therapy (RR = 2.20; 95%C1[1.34-3.61]) and less satisfaction with medical treatments (p-trend = 0.044). Conclusions Few long-term prostate cancer survivors use diet or exercise to help with their prostate cancer. Survivors may benefit from counselling on the scientific evidence supporting healthy eating and regular exercise for improving quality-of-life and cancer-related outcomes.	[Hughes, Suzanne; Egger, Sam; Carle, Chelsea; Smith, David P.; Kahn, Clare; O'Connell, Dianne L.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Smith, David P.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Smith, David P.; O'Connell, Dianne L.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.; Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst, Gold Coast, Qld, Australia; [Chambers, Suzanne] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia; [Caperchione, Cristina M.] Univ Technol Sydney, Fac Hlth, Human Performance Res Ctr, Sydney, NSW, Australia; [Moxey, Annette; O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia	Cancer Council New South Wales; Monash University; University of Sydney; Griffith University; Menzies Health Institute Queensland; University of Technology Sydney; University of Technology Sydney; University of Newcastle	Egger, S (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.	same@nswcc.org.au		Egger, Sam/0000-0003-1808-6909	Prostate Cancer Foundation of Australia [PG40]; Cancer Institute NSW [15/CDF/1-10]	Prostate Cancer Foundation of Australia; Cancer Institute NSW	This work was supported by the Prostate Cancer Foundation of Australia (PG40) (to DLO'C). DPS was supported by a Career Development Fellowship from the Cancer Institute NSW (#15/CDF/1-10).	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; American Cancer Society, 2002, CANC PREV EARL DET C; [Anonymous], 2001, CENS POP HOUS SOC IN; Avery KNL, 2013, CANCER CAUSE CONTROL, V24, P1119, DOI 10.1007/s10552-013-0189-x; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Blanchard CM, 2004, PSYCHOL HEALTH, V19, P1, DOI 10.1080/08870440310001606507; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dahn JR, 2005, UROLOGY, V65, P953, DOI 10.1016/j.urology.2004.11.029; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Demark-Wahnefried W, 2008, CANCER EPIDEM BIOMAR, V17, P3577, DOI 10.1158/1055-9965.EPI-08-0008; Demark-Wahnefried Wendy, 2004, Int J Behav Nutr Phys Act, V1, P16, DOI 10.1186/1479-5868-1-16; Egger S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193686; Glover J, 2002, REMOTE AREAS STAT GE; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Greenberg DB, 1997, CANCER-AM CANCER SOC, V80, P1936, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1936::AID-CNCR10>3.0.CO;2-Z; Hackshaw-McGeagh LE, 2015, CANCER CAUSE CONTROL, V26, P1521, DOI 10.1007/s10552-015-0659-4; Hackshaw-McGeagh LE, 2015, INT J CANCER, V137, P1509, DOI 10.1002/ijc.29514; Hall JD, 2003, BJU INT, V91, P603, DOI 10.1046/j.1464-410X.2003.04181.x; Henderson JW, 2003, PSYCHO-ONCOL, V12, P59, DOI 10.1002/pon.636; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lin PH, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0234-y; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Menichetti J, 2016, CRIT REV ONCOL HEMAT, V108, P13, DOI 10.1016/j.critrevonc.2016.10.007; Nilsen TS, 2015, ACTA ONCOL, V54, P1805, DOI 10.3109/0284186X.2015.1037008; Patterson RE, 2003, J AM DIET ASSOC, V103, P323, DOI 10.1053/jada.2003.50045; Porter M, 2008, COMPLEMENT THER MED, V16, P318, DOI 10.1016/j.ctim.2008.04.001; Richman EL, 2011, CANCER RES, V71, P3889, DOI 10.1158/0008-5472.CAN-10-3932; Schroder FH, 2005, EUR UROL, V48, P922, DOI 10.1016/j.eururo.2005.08.005; Skolarus TA, 2014, CA-CANCER J CLIN, V64, P226, DOI 10.3322/caac.21234; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Taaffe DR, 2017, EUR UROL, V72, P293, DOI 10.1016/j.eururo.2017.02.019; Teleni L, 2016, ENDOCR-RELAT CANCER, V23, P101, DOI 10.1530/ERC-15-0456; Thomas R, 2014, PROSTATE CANCER P D, V17, P180, DOI 10.1038/pcan.2014.6; Thorsen L, 2008, SUPPORT CARE CANCER, V16, P987, DOI 10.1007/s00520-008-0411-7; Van Blarigan EL, 2015, CANCER PREV RES, V8, P962, DOI 10.1158/1940-6207.CAPR-15-0132; Vijayvergia N, 2015, J PERS MED, V5, P243, DOI 10.3390/jpm5030243; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilkinson S, 2008, EUR J CANCER CARE, V17, P492, DOI 10.1111/j.1365-2354.2007.00904.x; World Cancer Research Fund / American Institute for Cancer Research, 2018, DIET NUTR PHYS ACT C; World Health Organization, 2007, PREV CARD DIS GUID A; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P29, DOI 10.1016/j.canep.2014.11.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zopf EM, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12575; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	53	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223407	10.1371/journal.pone.0223407	http://dx.doi.org/10.1371/journal.pone.0223407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581210	Green Published, gold			2022-12-26	WOS:000532398600065
J	Azad, F; Rifat, MA; Manir, MZ; Biva, NA				Azad, Faria; Rifat, M. A.; Manir, Mohammad Zahidul; Biva, Nushrat Alam			Breastfeeding support through wet nursing during nutritional emergency: A cross sectional study from Rohingya refugee camps in Bangladesh	PLOS ONE			English	Article							INFANT; HEALTH; BEHAVIORS; MYANMAR; HISTORY; RIGHTS	Background/Objectives This study examined the best practices with regard to infant and young child feeding in emergency (IYCF-E) program. This was done by observing a breastfeeding support scenario through wet nursing in Rohingya refugee camps in Cox's Bazar, Bangladesh. Methods Information on demographics, IYCF-E knowledge, wet nursing support, type of constraints faced, and possible ways to overcome such constraints was collected through face-to-face interviews with 24 conveniently selected wet nurses. Linear regression was used to analyze the associations. Results Mean age of wet nurses was 21.6 years; 16.67% had adequate knowledge about IYCF-E; and 29.17% had prior knowledge about wet nursing. Mean age of supported infants was 1.29 months, and 58.33% had a familial relationship with the wet nurses. Duration of breastfeeding support was significantly associated with the wet nurse's age, age of the wet nurses' youngest children, familial relationship with infants, knowledge about IYCF-E, and followups from community nutrition workers (Ps < 0.05). The status of facing problems (58.33%) was negatively correlated with duration of wet nursing, although this association was not statistically significant. The most extensively reported problems were as follows: misunderstandings with the infant's family (85.71%), family workload and time limitations (21.43%), household distance (42.86%), and family members' poor compliance (21.43%). Counseling from community nutrition workers (64.29%) and mediation by community leaders (57.14%) played key roles in mitigating such problems. Self-satisfaction (37.50%), counseling 62.50%), and religious inspiration (58.33%) were key motivators behind dedicated breast-feeding support. Conclusion Wet nursing in the Rohingya refugee camps in Cox's Bazaar, Bangladesh, was associated with several factors involving both supply and demand. The present findings may help design better IYCF-E programs in similar context.	[Azad, Faria] World Food Programme United Nations, Coxs Bazar, Chittagong, Bangladesh; [Rifat, M. A.; Manir, Mohammad Zahidul] United Nations Childrens Fund, Coxs Bazar, Chittagong, Bangladesh; [Biva, Nushrat Alam] Univ Dhaka, Inst Nutr & Food Sci, Dhaka, Bangladesh	University of Dhaka	Rifat, MA (corresponding author), United Nations Childrens Fund, Coxs Bazar, Chittagong, Bangladesh.	rifatahmed011@gmail.com	Rifat, M A/J-2640-2019; Azad, Faria/AAM-6086-2021	Rifat, M A/0000-0003-0562-9791; Azad, Faria/0000-0002-4636-5035				Angood C., 2017, OPERATIONAL GUIDANCE; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beyrer C, 2017, LANCET, V390, P1570, DOI 10.1016/S0140-6736(17)32519-9; Binns CW, 2012, ASIA-PAC J PUBLIC HE, V24, P672, DOI 10.1177/1010539512453253; Borrel A, 2001, DISASTERS, V25, P149, DOI 10.1111/1467-7717.00167; Cook V, 2010, BR J MIDWIFERY, V18, P32; Dillaway HE, 2004, CLIN PEDIATR, V43, P417, DOI 10.1177/000992280404300502; Efird JT, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010131; Ergin A, 2018, MATERN CHILD HLTH J, V22, P454, DOI 10.1007/s10995-018-2433-1; Farzana KF., 2017, MEMORIES BURMESE ROH, P1, DOI [10.1057/978-1-137-58360-4, DOI 10.1057/978-1-137-58360-4]; Frimpong-Nnuroh D., 2004, I AFRICAN STUDIES RE, P85; Gribble K, 2018, J HUM LACT, V34, P40, DOI 10.1177/0890334417741469; Gribble KD, 2011, DISASTERS, V35, P720, DOI [10.1111/j.1467-7717.2010.01239.x, 10.1111/j.1467-7717.2011.01239.x]; Holland P, 2017, MEDIA PRACT, P10; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kent G., 2018, WORLD NUTR, V9, P314, DOI [10.26596/wn.201893314-323, DOI 10.26596/WN.201893314-323]; Khadivzadeh T, 2002, East Mediterr Health J, V8, P612; Kingston LN, 2015, INT J HUM RIGHTS, V19, P1163, DOI 10.1080/13642987.2015.1082831; Kumar S, 2018, GUARDIAN; Leidman E, 2018, JAMA-J AM MED ASSOC, V319, P1505, DOI 10.1001/jama.2018.2405; Mahmood SS, 2017, LANCET, V389, P1841, DOI 10.1016/S0140-6736(16)00646-2; Palmer V, 2011, DEV PRACT, V21, P96, DOI 10.1080/09614524.2011.530226; Palmquist AEL, 2018, INT HANDB POPUL, V8, P341, DOI 10.1007/978-94-024-1290-1_23; Riley A, 2017, TRANSCULT PSYCHIATRY, V54, P304, DOI 10.1177/1363461517705571; Shaker-Berbari L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12576; Stevens EE, 2009, J PERINAT EDUC, V18, P32, DOI 10.1624/105812409X426314; Summers A, 2018, MMWR-MORBID MORTAL W, V67, P533, DOI 10.15585/mmwr.mm6718a6; Thorley V., 2008, BREASTFEEDING REV, V16, P9; UNHCR & Save the Children, 2017, INF YOUNG CHILD FEED; White K, 2017, LANCET, V390, P1947, DOI 10.1016/S0140-6736(17)32677-6; Winterburn S, 2003, J COMMUNITY NURSING, V17, P4; World Health Organisation Staff World Health Organization & UNICEF, 2003, GLOB STRAT INF YOUNG; Wray J. D., 1978, Nutrition and human reproduction., P197; Zarni M., 2014, PACIFIC RIM LAW POLI, V23, P683	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222980	10.1371/journal.pone.0222980	http://dx.doi.org/10.1371/journal.pone.0222980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577816	Green Published, Green Submitted, gold			2022-12-26	WOS:000532388000019
J	Crona, B; Kall, S; Van Holt, T				Crona, Beatrice; Kall, Sofia; Van Holt, Tracy			Fishery Improvement Projects as a governance tool for fisheries sustainability: A global comparative analysis	PLOS ONE			English	Article							VALUE CHAINS; BIODIVERSITY CONSERVATION; SOCIAL LICENSE; SEAFOOD; CERTIFICATION; STEWARDSHIP; STANDARDS; BARRIERS; SCALE; TRACEABILITY	Fishery Improvement Projects (FIPs) are a form of private governance using seafood supply chains to reduce environmental impacts of fishing in some of the most challenged fisheries. Some FIPs are industry-led, others are championed by NGOs. They range across many different fishery types, in both high- and low-income settings. Their diversity is notable, and their proliferation remarkable. This rapid growth suggests FIPs are becoming a key feature of the fisheries governance landscape globally. Based on a global sample of 107 FIPs, we systematically examined their reported actions, the actors involved, and their achievements in terms of policy and practice outputs. The most common actions were dialogues with policy stakeholders, data collection, and educational efforts directed at fishers. Common policy outputs included development of management plans and/or a management body, and rules for limiting entry and increasing compliance. Practice related outputs were dominated by gear changes, and observer and traceability programs. Only crab and lobster FIPs engaged in sustained policy conversations as one of the most common actions. Shrimp and tuna fisheries report more engagement in testing and implementing changes to fishery practices. While supply chain actors are involved in all FIPs, retailers and 1st tier suppliers are relatively absent from FIP activities, and are primarily involved in rallying financial support or some policy engagement. Based on our analysis we discuss the opportunities and challenges FIPs will likely need to engage with to contribute to a global transition to more socially and environmentally sustainable fisheries. We outline key areas where further work is needed to understand how FIPs can improve their contribution to global fisheries governance in the future.	[Crona, Beatrice; Kall, Sofia; Van Holt, Tracy] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden; [Crona, Beatrice; Kall, Sofia] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Van Holt, Tracy] NYU, NYU Stern Ctr Sustainable Business, New York, NY USA	Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Stockholm University; New York University	Crona, B; Kall, S (corresponding author), Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden.; Crona, B; Kall, S (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.	beatrice.crona@kva.se; sofia.kall@kva.se	Crona, Beatrice/HHZ-3183-2022	Crona, Beatrice/0000-0003-1617-4067; Van Holt, Tracy/0000-0003-2842-6719; Kall, Sofia/0000-0001-8021-7346	Swedish Research Council Formas [2016-00375]; Swedish Research Council MISTRA; Global Economic Dynamics and the Biosphere Program of the Royal Swedish Academy of Sciences - Family Erling-Persson Foundation; NYU Stern Center for Sustainable Business	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council MISTRA; Global Economic Dynamics and the Biosphere Program of the Royal Swedish Academy of Sciences - Family Erling-Persson Foundation; NYU Stern Center for Sustainable Business	Support for this work was provided by the Swedish Research Council Formas through project 2016-00375, the Swedish Research Council MISTRA (through a core grant to the Stockholm Resilience Centre), and the Global Economic Dynamics and the Biosphere Program of the Royal Swedish Academy of Sciences, funded by the Family Erling-Persson Foundation. In the final stages of the writing TVH was also supported through NYU Stern Center for Sustainable Business. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf S, 2016, FISH RES, V182, P79, DOI 10.1016/j.fishres.2015.11.020; [Anonymous], 2007, REV EUR COMP INT ENV, DOI DOI 10.1111/J.1467-9388.2007.00560.X; Auld G, 2014, REGUL GOV, V8, P126, DOI 10.1111/rego.12034; Bailey M, 2016, CURR OPIN ENV SUST, V18, P25, DOI 10.1016/j.cosust.2015.06.004; Bansal P, 2000, ACAD MANAGE J, V43, P717, DOI 10.2307/1556363; Bene C., 2005, Development Policy Review, V23, P585, DOI 10.1111/j.1467-7679.2005.00304.x; Brander K, 2010, CURR OPIN ENV SUST, V2, P416, DOI 10.1016/j.cosust.2010.09.003; Brown RR, 2013, GLOBAL ENVIRON CHANG, V23, P701, DOI 10.1016/j.gloenvcha.2013.02.013; Bush SR, 2017, MAR POLICY, V77, P130, DOI 10.1016/j.marpol.2016.12.019; California environmental associates, 2017, PROGR SUST SEAF NUMB; California Environmental Associates, 2015, SUMM FIND GLOB LANDS; Cannon J, 2018, MAR POLICY, V97, P179, DOI 10.1016/j.marpol.2018.06.007; Coffey C, 2005, REV M T FIS, V4, P27; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; Deighan LK, 2015, MAR POLICY, V51, P476, DOI 10.1016/j.marpol.2014.10.009; Duggan DE, 2016, MAR POLICY, V67, P30, DOI 10.1016/j.marpol.2016.01.008; Falkner R., 2003, GLOBAL ENV POLIT, V3, P72, DOI DOI 10.1162/152638003322068227; Foley P, 2014, ECOL SOC, V19, DOI 10.5751/ES-06459-190228; Foley P, 2012, J AGRAR CHANGE, V12, P436, DOI 10.1111/j.1471-0366.2011.00344.x; Fransen LW, 2007, ORGANIZATION, V14, P667, DOI 10.1177/1350508407080305; Garcia SM, 2010, HDB FISHERIES CONSER, P139; Gibbon P, 2008, ECON SOC, V37, P315, DOI 10.1080/03085140802172656; Gifford R, 2014, ANNU REV PSYCHOL, V65, P541, DOI 10.1146/annurev-psych-010213-115048; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Glasbergen P., 2008, PARTNERSHIPS GOV SUS, P1, DOI [10.1007/s12043-009-0037-4, DOI 10.1007/S12043-009-0037-4]; Grafton Q. R., 2010, HDB MARINE FISHERIES; Grafton RQ, 2005, OCEAN COAST MANAGE, V48, P753, DOI 10.1016/j.ocecoaman.2005.08.003; Groeneveld R., 2017, HDB EC MANAGEMENT SU, P416, DOI [10.4337/9781786430724.00031, DOI 10.4337/9781786430724.00031]; Gulbrandsen L., 2010, TRANSLATIONAL ENV GO, DOI [10.4337/9781849806756, DOI 10.4337/9781849806756]; Gulbrandsen LH, 2014, REGUL GOV, V8, P74, DOI 10.1111/rego.12005; Gulbrandsen LH, 2009, MAR POLICY, V33, P654, DOI 10.1016/j.marpol.2009.01.002; Hardt MJ, 2017, J FOOD SCI, V82, pA3, DOI 10.1111/1750-3841.13796; Iles A., 2004, SCI PUBL POLICY, V31, P127, DOI DOI 10.3152/147154304781780127; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Kelly R, 2017, MAR POLICY, V81, P21, DOI 10.1016/j.marpol.2017.03.005; Konefal J, 2013, ORGAN ENVIRON, V26, P336, DOI 10.1177/1086026612467982; Kooiman J, 2005, FISH FOR LIFE, DOI 10.5117/9789053566862; Krippendorff K., 2013, CONTENT ANAL INTRO I; Leith P, 2014, SOC EPISTEMOL, V28, P277, DOI 10.1080/02691728.2014.922641; Marine Stewardship Council, 2014, GUID US MSC BENCHM T; Moore M., 2015, J CORPORATE CITIZENS, V58, P67, DOI [10.9774/GLEAF.4700.2015.ju.00009, DOI 10.9774/GLEAF.4700.2015.JU.00009]; Nyborg K, 2016, SCIENCE, V354, P42, DOI 10.1126/science.aaf8317; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Partelow S, 2019, INT J COMMONS, V13, P747, DOI 10.18352/ijc.938; Pattberg P, 2006, THIRD WORLD Q, V27, P579, DOI 10.1080/01436590600720769; Anh PT, 2011, J ENVIRON POL PLAN, V13, P373, DOI 10.1080/1523908X.2011.633701; Ponte S, 2005, ECON SOC, V34, P1, DOI 10.1080/0308514042000329315; Ponte S, 2012, J AGRAR CHANGE, V12, P300, DOI 10.1111/j.1471-0366.2011.00345.x; Pramod G, 2014, MAR POLICY, V48, P102, DOI 10.1016/j.marpol.2014.03.019; Rice J., 2010, HDB MARINE FISHERIES, P139; Ridgeway L., 2010, HDB MARINE FISHERIES, P485; Sampson GS, 2015, SCIENCE, V348, P504, DOI 10.1126/science.aaa4639; Schultz PW, 2014, EUR PSYCHOL, V19, P107, DOI 10.1027/1016-9040/a000163; Smith H, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00236; Sustainable Fisheries Partnership, 2015, SFP FISH IMPR PROJ T; Sutton M., 2008, SEAFOOD ECOLABELLING, P403, DOI DOI 10.1002/9781444301380.CH20; Symes D, 2006, FISH RES, V81, P113, DOI 10.1016/j.fishres.2006.06.015; Tekwa EW, 2019, P NATL ACAD SCI USA, V116, P689, DOI 10.1073/pnas.1806852116; Telesetsky A., 2017, ENVIRON LAW, V47, P765, DOI [10.2307/44371403, DOI 10.2307/44371403]; The Conservation Alliance for Seafood Solution, 2015, GUID SUPP FISH IMPR; Thompson TS, 2019, FOOD ADDIT CONTAM A, V36, P434, DOI 10.1080/19440049.2019.1577993; Thyresson M, 2013, MAR POLICY, V38, P246, DOI 10.1016/j.marpol.2012.05.041; Tolentino-Zondervan F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163537; Tolentino-Zondervan F, 2016, WORLD DEV, V83, P264, DOI 10.1016/j.worlddev.2016.01.011; Van Holt T, 2018, ANN NY ACAD SCI, V1421, P46, DOI 10.1111/nyas.13613; Van Holt T, 2017, SCI TOTAL ENVIRON, V579, P930, DOI 10.1016/j.scitotenv.2016.10.052; Van Holt T, 2016, CURR OPIN ENV SUST, V20, P61, DOI 10.1016/j.cosust.2016.06.003; Van Holt T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080667; Vellema S, 2015, J CLEAN PROD, V107, P105, DOI 10.1016/j.jclepro.2014.03.090; Ward TJ, 2008, FISH FISH, V9, P169, DOI 10.1111/j.1467-2979.2008.00277.x; WWF, 2013, FIP HDB GUID DEV FIS	72	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223054	10.1371/journal.pone.0223054	http://dx.doi.org/10.1371/journal.pone.0223054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574120	Green Published, Green Submitted, gold			2022-12-26	WOS:000532376700027
J	Nakatsu, D; Kano, F; Shinozaki-Narikawa, N; Murata, M				Nakatsu, Daiki; Kano, Fumi; Shinozaki-Narikawa, Naeko; Murata, Masayuki			Pyk2-dependent phosphorylation of LSR enhances localization of LSR and tricellulin at tricellular tight junctions	PLOS ONE			English	Article							LIPOLYSIS-STIMULATED RECEPTOR; PYK2 ACTIVATION; ADHESION KINASE; BARRIER; PROTEIN; OCCLUDIN; CLAUDINS; INHIBITORS; MECHANISM; CONTACTS	Tight junctions (TJs) are cellular junctions within the mammalian epithelial cell sheet that function as a physical barrier to molecular transport within the intercellular space. Dysregulation of TJs leads to various diseases. Tricellular TJs (tTJs), specialized structural variants of TJs, are formed by multiple transmembrane proteins (e.g., lipolysis-stimulated lipoprotein receptor [LSR] and tricellulin) within tricellular contacts in the mammalian epithelial cell sheet. However, the mechanism for recruiting LSR and tricellulin to tTJs is largely unknown. Previous studies have identified that tyrphostin 9, the dual inhibitor of Pyk2 (a nonreceptor tyrosine kinase) and receptor tyrosine kinase platelet-derived growth factor receptor (PDGFR), suppresses LSR and tricellulin recruitment to tTJs in EpH4 (a mouse mammary epithelial cell line) cells. In this study, we investigated the effect of Pyk2 inhibition on LSR and tricellulin localization to tTJs. Pyk2 inactivation by its specific inhibitor or repression by RNAi inhibited the localization of LSR and downstream tricellulin to tTJs without changing their expression level in EpH4 cells. Pyk2-dependent changes in subcellular LSR and tricellulin localization were independent of c-Jun N-terminal kinase (JNK) activation and expression. Additionally, Pyk2-dependent LSR phosphorylation at Tyr-237 was required for LSR and tricellulin localization to tTJs and decreased epithelial barrier function. Our findings indicated a novel mechanism by which Pyk2 regulates tTJ assembly and epithelial barrier function in the mammalian epithelial cell sheet.	[Nakatsu, Daiki; Kano, Fumi; Shinozaki-Narikawa, Naeko; Murata, Masayuki] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Ctr, Midori Ku, Yokohama, Kanagawa, Japan; [Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan	Tokyo Institute of Technology; University of Tokyo	Murata, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Cell Biol Ctr, Midori Ku, Yokohama, Kanagawa, Japan.; Murata, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	mmurata@bio.c.u-tokyo.ac.jp			JSPS KAKENHI [17K07379, 17H05870]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) (17K07379) to F.K. and JSPS KAKENHI Grant-inAid for Scientific Research on Innovative Areas (17H05870) to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2012, FRONT BIOSCI-LANDMRK, V17, P784, DOI 10.2741/3957; Block ER, 2010, J BIOL CHEM, V285, P13372, DOI 10.1074/jbc.M109.083089; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chang B, 2019, EUR J CELL BIOL, V98, P1, DOI 10.1016/j.ejcb.2018.11.003; Chauhan D, 2000, J BIOL CHEM, V275, P27845; Cording J, 2013, J CELL SCI, V126, P554, DOI 10.1242/jcs.114306; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Ganju RK, 2000, J BIOL CHEM, V275, P17263, DOI 10.1074/jbc.M000689200; Getsios S, 2015, CELL TISSUE RES, V360, P435, DOI 10.1007/s00441-015-2171-2; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Jia W, 2014, MOL MED REP, V9, P779, DOI 10.3892/mmr.2013.1875; Khan N, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00438; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Kumar S, 1999, J BIOL CHEM, V274, P30657, DOI 10.1074/jbc.274.43.30657; Li SY, 2004, J CLIN INVEST, V114, P1782, DOI 10.1172/JCI200418046; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; MANN CJ, 1995, BIOCHEMISTRY-US, V34, P10421, DOI 10.1021/bi00033a014; Markov AG, 2015, IUBMB LIFE, V67, P29, DOI 10.1002/iub.1347; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Miller CJ, 2017, BIOCHEM PHARMACOL, V142, P39, DOI 10.1016/j.bcp.2017.06.127; Mills RD, 2015, J BIOL CHEM, V290, P8677, DOI 10.1074/jbc.M114.633107; Nakatsu D, 2015, P NATL ACAD SCI USA, V112, pE1067, DOI 10.1073/pnas.1417197112; Nakatsu D, 2014, GENES CELLS, V19, P565, DOI 10.1111/gtc.12158; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Naydenov NG, 2014, J BIOL CHEM, V289, P2424, DOI 10.1074/jbc.M113.498691; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Samarasekera GDNG, 2018, MOL BIOL CELL, V29, P123, DOI 10.1091/mbc.E17-04-0251; Saso W, 2018, BIOCHEM BIOPH RES CO, V501, P374, DOI 10.1016/j.bbrc.2018.04.187; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Sonoki H, 2015, NUTRIENTS, V7, P4578, DOI 10.3390/nu7064578; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; The CUCKOO Workgroup, VERS 3 0 GROUP BAS P; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; Ying WZ, 2008, AM J PHYSIOL-RENAL, V295, pF406, DOI 10.1152/ajprenal.90294.2008; Zheng MH, 2014, J MOL NEUROSCI, V54, P282, DOI 10.1007/s12031-014-0291-x	50	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223300	10.1371/journal.pone.0223300	http://dx.doi.org/10.1371/journal.pone.0223300			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574128	Green Published, gold			2022-12-26	WOS:000532376700042
J	Soldi, GDR; Ribeiro, IC; Ahagon, CM; Coelho, LPO; Cabral, GB; Lopes, GISL; Ferreira, JLD; Brigido, LFD; Matsuda, EM; Campos, NC; Proenca, C; Ferrari, AMD; Campeas, AE; da Eira, M; Queiroz, S; Morejon, KML; Moraes, MJ				Romero Soldi, Giselle de Faria; Ribeiro, Isadora Coutinho; Ahagon, Cintia Mayumi; Ozorio Coelho, Luana Portes; Cabral, Gabriela Bastos; Silva Lopez Lopes, Giselle Ibette; de Paula Ferreira, Joao Leandro; de Macedo Brigido, Luis Fernando; Matsuda, Elaine Monteiro; Campos, Norberto Camilo; Proenca, Cilene; de Paula Ferrari, Angela Maria; Campeas, Alexandre Ely; da Eira, Margareth; Queiroz, Simone; Loro Morejon, Karen Mirna; de Moraes, Monica Jacques		Salvage Therapy Working Grp	Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in Sao Paulo State, Brazil	PLOS ONE			English	Article							NAIVE HIV-1-INFECTED PATIENTS; SUBTYPE; LOPINAVIR/RITONAVIR; EXPANSION; EFFICACY; SAFETY	Background Protease inhibitors (PI) are especially important in salvage therapy. Previous treatment failure with a PI containing regimen may elicit resistance mutations, reducing PI susceptibility and limiting treatment options. The aim of this study was to describe major PI mutations among patients exposed to at least one PI to evaluate predictors of mutation emergence and the impact of subtypes on resistance. Methodology Partial HIV-1 pol sequences (Sanger Sequencing) from patients exposed to PI with virological failure were genotyped from January 2014 to December 2017. Drug resistance mutations (DRM), antiretroviral susceptibility (GSS) and subtypes, along clinical and laboratory parameters, were evaluated using logistic regression to access the predictors of mutation emergence. Results In 27.5% (466/1696) of the cases at least one major PI mutations was identified, most commonly M46 (14.7%), V82 (13.8%) and I54 (13.3%). Mutations to NRTI and NNRTI were observed in 69.6% and 59.9%, respectively, of the 1696 sequences. Full activity to darunavir was predicted in 88% (1496/1696), but was only 57% among those with at least one PI-DRM. Subtype C sequences had less major PI-DRMs (10%, 9/87) compared to B (28%, 338/1216) or F (35%, 58/168) (p<0.001) but adjusted analysis suggested that this association is not independent from a shorter treatment time and fewer regimens (OR 0.59, Confidence Interval 95: 0.2-2.5, p = 0.48). Subtype F, together with NRTI mutations and longer time on treatment was associated to presence of PI-DRM, to a lower darunavir GSS and to mutations at codon I50. Conclusions Among patients with PI-DRM, full activity to darunavir was compromised in almost half of the cases and efforts to detect failure at earlier time are warranted, particularly for HIV-1 subtype F that showed association to the emergence of resistance, with potential impact in protease inhibitors sequencing. Furthermore, NRTI mutations may serve as an indicative of sufficient adherence to allow PI-DRM emergence.	[Romero Soldi, Giselle de Faria; Ribeiro, Isadora Coutinho; Ahagon, Cintia Mayumi; Ozorio Coelho, Luana Portes; Cabral, Gabriela Bastos; Silva Lopez Lopes, Giselle Ibette; de Paula Ferreira, Joao Leandro; de Macedo Brigido, Luis Fernando; Matsuda, Elaine Monteiro; Campos, Norberto Camilo; Proenca, Cilene; de Paula Ferrari, Angela Maria; Campeas, Alexandre Ely; da Eira, Margareth; Queiroz, Simone; Loro Morejon, Karen Mirna; de Moraes, Monica Jacques; Salvage Therapy Working Grp] Adolfo Lutz Inst, Ctr Virol, Lab Retrovirus, Nucl Doencas Vinculacao Sanguinea Sexual, Sao Paulo, Brazil	Instituto Adolfo Lutz	Brigido, LFD (corresponding author), Adolfo Lutz Inst, Ctr Virol, Lab Retrovirus, Nucl Doencas Vinculacao Sanguinea Sexual, Sao Paulo, Brazil.	lubrigido@gmail.com	Brigido, Luis F M/C-2155-2011; MATSUDA, ELAINE M/J-3951-2016	Brigido, Luis F M/0000-0002-1022-7837; 	Sao Paulo Research Foundation [2013/194417]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	LFMB was supported by grant number 2013/194417 from the Sao Paulo Research Foundation (http://www.fapesp.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A THOMPSON Jennifer, 2018, CLIN INFECT DIS, V68, P1184, DOI 10.1093/cid/ciy589; [Anonymous], 2004, AIDS LONDON, V18, P909, DOI [10.1097/00002030-200404090-00008, DOI 10.1097/00002030-200404090-00008]; Boyd MA, 2015, LANCET HIV, V2, pE42, DOI 10.1016/S2352-3018(14)00061-7; Brigido LFM, 2011, AIDS RES HUM RETROV, V27, P339, DOI 10.1089/aid.2010.0157; Cid-Silva P, 2018, AIDS, V32, P121, DOI [10.1097/QAD.0000000000001679, 10.1097/qad.0000000000001679]; Clutter DS, 2016, INFECT GENET EVOL, V46, P292, DOI 10.1016/j.meegid.2016.08.031; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Guimaraes PMD, 2015, AIDS RES HUM RETROV, V31, P1219, DOI [10.1089/aid.2014.0354, 10.1089/AID.2014.0354]; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; Fily F, 2018, TROP MED INT HEALTH, V23, P1075, DOI 10.1111/tmi.13131; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Lopez-Cortes LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148924; Matsuda EM, 2018, AIDS RES HUM RETROV, V34, P156, DOI [10.1089/aid.2017.0052, 10.1089/AID.2017.0052]; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Coelho LPO, 2019, ARCH VIROL, V164, P699, DOI 10.1007/s00705-018-04122-8; Palma AC, 2012, J ANTIMICROB CHEMOTH, V67, P1075, DOI 10.1093/jac/dks010; Paraskevis D, 2015, INFECT GENET EVOL, V30, P96, DOI 10.1016/j.meegid.2014.12.012; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Ryom L, 2018, HIV MED, V19, P309, DOI 10.1111/hiv.12600; Shafer RW, 2017, J INFECT DIS, V216, pS843, DOI 10.1093/infdis/jix398; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; UNAIDS, 2017, INF BRAS; UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2018, GUID US ANT AG AD AD	25	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223210	10.1371/journal.pone.0223210	http://dx.doi.org/10.1371/journal.pone.0223210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JF2SE	31574109	gold, Green Published			2022-12-26	WOS:000491235000001
J	Halasz, LM; Patel, SA; McDougall, JA; Fedorenko, C; Sun, Q; Goulart, BHL; Roth, JA				Halasz, Lia M.; Patel, Shilpen A.; McDougall, Jean A.; Fedorenko, Catherine; Sun, Qin; Goulart, Bernardo H. L.; Roth, Joshua A.			Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries	PLOS ONE			English	Article							COMORBIDITY INDEX; HEART-DISEASE; RADIOTHERAPY; RISK; ADOPTION; POPULATION; MELANOMA; SURVIVAL; OUTCOMES; TRIAL	Purpose In 2013, the American Society for Radiation Oncology (ASTRO) issued a Choosing Wisely recommendation against the routine use of intensity modulated radiotherapy (IMRT) for whole breast irradiation. We evaluated IMRT use and subsequent impact on Medicare expenditure in the period immediately preceding this recommendation to provide a baseline measure of IMRT use and associated cost consequences. Methods and materials SEER records for women >= 66 years with first primary diagnosis of Stage I/II breast cancer (2008-2011) were linked with Medicare claims (2007-2012). Eligibility criteria included lumpectomy within 6 months of diagnosis and radiotherapy within 6 months of lumpectomy. We evaluated IMRT versus conventional radiotherapy (cRT) use overall and by SEER registry (12 sites). We used generalized estimating equations logit models to explore adjusted odds ratios (OR) for associations between clinical, sociodemographic, and health services characteristics and IMRT use. Mean costs were calculated from Medicare allowable costs in the year after diagnosis. Results Among 13,037 women, mean age was 74.4, 50.5% had left-sided breast cancer, and 19.8% received IMRT. IMRT use varied from 0% to 52% across SEER registries. In multivariable analysis, left-sided breast cancer (OR 1.75), living in a big metropolitan area (OR 2.39), living in a census tract with.$90,000 median income (OR 1.75), neutral or favorable local coverage determination (OR 3.86, 1.72, respectively), and free-standing treatment facility (OR 3.49) were associated with receipt of IMRT (p<0.001). Mean expenditure in the year after diagnosis was $8,499 greater (p<0.001) among women receiving IMRT versus cRT. Conclusion We found highly variable use of IMRT and higher expenditure in the year after diagnosis among women treated with IMRT (vs. cRT) with early-stage breast cancer and Medicare insurance. Our findings suggest a considerable opportunity to reduce treatment variation and cost of care while improving alignment between practice and clinical guidelines.	[Halasz, Lia M.; Patel, Shilpen A.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Patel, Shilpen A.; Goulart, Bernardo H. L.; Roth, Joshua A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [McDougall, Jean A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Fedorenko, Catherine; Sun, Qin; Goulart, Bernardo H. L.; Roth, Joshua A.] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA; [Goulart, Bernardo H. L.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA; [Patel, Shilpen A.] Grail Inc, Menlo Pk, CA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Roth, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Roth, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA.	jroth@fredhutch.org		Roth, Joshua/0000-0001-6621-8342	National Cancer Institute [5P30 CA015704-40]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the National Cancer Institute (5P30 CA015704-40, Study PI: Roth JA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett GC, 2009, RADIOTHER ONCOL, V92, P34, DOI 10.1016/j.radonc.2009.03.003; Boekel NB, 2016, INT J RADIAT ONCOL, V94, P1061, DOI 10.1016/j.ijrobp.2015.11.040; Boero IJ, 2016, INT J RADIAT ONCOL, V94, P700, DOI 10.1016/j.ijrobp.2015.12.018; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donovan E, 2007, RADIOTHER ONCOL, V82, P254, DOI 10.1016/j.radonc.2006.12.008; Etzioni R, 2002, MED CARE, V40, P63; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hattangadi JA, 2012, JNCI-J NATL CANCER I, V104, P29, DOI 10.1093/jnci/djr495; Jagsi R, 2018, INT J RADIAT ONCOL, V101, P1149, DOI 10.1016/j.ijrobp.2018.04.075; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Mukesh MB, 2013, J CLIN ONCOL, V31, P4488, DOI 10.1200/JCO.2013.49.7842; Pignol JP, 2016, RADIOTHER ONCOL, V121, P414, DOI 10.1016/j.radonc.2016.08.021; Pinsky PF, 2014, ANN INTERNAL MED; POTOSKY AL, 1993, MED CARE, V31, P732; Ramsey SD, 2016, J CLIN ONCOL, V34, P980, DOI 10.1200/JCO.2015.64.6620; Roberts KB, 2013, INT J RADIAT ONCOL, V85, P1186, DOI 10.1016/j.ijrobp.2012.10.009; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Shah C, 2017, EXPERT REV ANTICANC, V17, P187, DOI 10.1080/14737140.2017.1285231; Smith BD, 2011, JNCI-J NATL CANCER I, V103, P798, DOI 10.1093/jnci/djr100; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; van den Bogaard VAB, 2017, J CLIN ONCOL, V35, P1171, DOI 10.1200/JCO.2016.69.8480; Waddle MR, 2017, INT J RADIAT ONCOL, V99, P1078, DOI 10.1016/j.ijrobp.2017.07.042; Wang EH, 2015, INT J RADIAT ONCOL, V91, P303, DOI 10.1016/j.ijrobp.2014.09.011; Zagar TM, 2013, NAT REV CLIN ONCOL, V10, P310, DOI 10.1038/nrclinonc.2013.59; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222904	10.1371/journal.pone.0222904	http://dx.doi.org/10.1371/journal.pone.0222904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568536	Green Published, gold			2022-12-26	WOS:000532364900014
J	Kim, DS; Kim, SB; Fennimore, SA				Kim, Dong Sub; Kim, Steven B.; Fennimore, Steven A.			Incorporating statistical strategy into image analysis to estimate effects of steam and allyl isocyanate on weed control	PLOS ONE			English	Article							METHYL-BROMIDE; COLOR INDEXES	Weeds are the major limitation to efficient crop production, and effective weed management is necessary to prevent yield losses due to crop-weed competition. Assessments of the relative efficacy of weed control treatments by traditional counting methods is labor intensive and expensive. More efficient methods are needed for weed control assessments. There is extensive literature on advanced techniques of image analysis for weed recognition, identification, classification, and leaf area, but there is limited information on statistical methods for hypothesis testing when data are obtained by image analysis (RGB decimal code). A traditional multiple comparison test, such as the Dunnett-Tukey-Kramer (DTK) test, is not an optimal statistical strategy for the image analysis because it does not fully utilize information contained in RGB decimal code. In this article, a bootstrap method and a Poisson model are considered to incorporate RGB decimal codes and pixels for comparing multiple treatments on weed control. These statistical methods can also estimate interpretable parameters such as the relative proportion of weed coverage and weed densities. The simulation studies showed that the bootstrap method and the Poisson model are more powerful than the DTK test for a fixed significance level. Using these statistical methods, three soil disinfestation treatments, steam, allyl-isothiocyanate (AITC), and control, were compared. Steam was found to be significantly more effective than AITC, a difference which could not be detected by the DTK test. Our study demonstrates that an appropriate statistical method can leverage statistical power even with a simple RGB index.	[Kim, Dong Sub; Fennimore, Steven A.] Univ Calif Davis, Dept Plant Sci, Salinas, CA USA; [Kim, Steven B.] Calif State Univ Monterey Bay, Math & Stat Dept, Seaside, CA 93955 USA	University of California System; University of California Davis; California State University System; California State University Monterey Bay	Kim, SB (corresponding author), Calif State Univ Monterey Bay, Math & Stat Dept, Seaside, CA 93955 USA.	stkim@csumb.edu		Kim, Steven/0000-0002-1845-8410	National Institute of Food and Agriculture USDA-NIFA Methyl Bromide Transitions Program [2015-07297, 2017-04265]	National Institute of Food and Agriculture USDA-NIFA Methyl Bromide Transitions Program	This work was supported by the National Institute of Food and Agriculture USDA-NIFA Methyl Bromide Transitions Program 2015-07297 and 2017-04265 to DSK and SAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of Food and Agriculture USDA-NIFA Methyl Bromide Transitions Program 2015-07297 and 2017-04265 to DSK and SAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bangarwa SK, 2012, WEED TECHNOL, V26, P449, DOI 10.1614/WT-D-11-00152.1; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Canty A., 2021, R PACKAGE VERSION 1; Downie HF, 2015, PLANT CELL ENVIRON, V38, P1213, DOI 10.1111/pce.12448; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; EBEL RL, 1951, PSYCHOMETRIKA, V16, P407; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Golzarian MR, 2012, T ASABE, V55, P261; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Hollander M., 1973, NONPARAMETRIC STAT M; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kutner M., 2004, APPL LINEAR STAT MOD; Longchamps L, 2012, WEED TECHNOL, V26, P649, DOI 10.1614/WT-D-12-00030.1; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Meyer GE, 1998, T ASAE, V41, P1189, DOI 10.13031/2013.17244; PENA JM, 2015, T ASAE, V15, P5609, DOI DOI 10.3390/S150305609; Samtani JB, 2011, CROP PROT, V30, P45, DOI 10.1016/j.cropro.2010.08.023; Sen F, 2010, J STORED PROD RES, V46, P28, DOI 10.1016/j.jspr.2009.07.005; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Van Hecke T, 2012, J STAT MANAG SYST, V15, P241, DOI 10.1080/09720510.2012.10701623; Wenzhu Y., 2015, INF PROCESS AGR, V2, P149, DOI [10.1016/j.inpa.2015.07.003, DOI 10.1016/J.INPA.2015.07.003]; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Wyatt A., 2016, TIPS NET        0319	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222695	10.1371/journal.pone.0222695	http://dx.doi.org/10.1371/journal.pone.0222695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568510	Green Published, gold			2022-12-26	WOS:000532364900008
J	Chang, ML; Moussette, S; Gamero-Estevez, E; Galvez, JH; Chiwara, V; Gupta, IR; Ryan, AK; Naumova, AK				Chang, Matthew L.; Moussette, Sanny; Gamero-Estevez, Enrique; Galvez, Jose Hector; Chiwara, Victoria; Gupta, Indra R.; Ryan, Aimee K.; Naumova, Anna K.			Regulatory interaction between the ZPBP2-ORMDL3/Zpbp2-Ormdl3 region and the circadian clock	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ORMDL3 EXPRESSION; AIRWAY RESPONSIVENESS; DNA METHYLATION; RISK; PATTERNS; ARCHITECTURE; METABOLISM; 17Q12-Q21; IMMUNITY	Genome-wide association study (GWAS) loci for several immunity-mediated diseases (early onset asthma, inflammatory bowel disease (IBD), primary biliary cholangitis, and rheumatoid arthritis) map to chromosomal region 17q12-q21. The predominant view is that association between 17q12-q21 alleles and increased risk of developing asthma or IBD is due to regulatory variants. ORM sphingolipid biosynthesis regulator (ORMDL3) residing in this region is the most promising gene candidate for explaining association with disease. However, the relationship between 17q12-q21 alleles and disease is complex suggesting contributions from other factors, such as trans-acting genetic and environmental modifiers or circadian rhythms. Circadian rhythms regulate expression levels of thousands of genes and their dysregulation is implicated in the etiology of several common chronic inflammatory diseases. However, their role in the regulation of the 17q12-q21 genes has not been investigated. Moreover, the core clock gene nuclear receptor subfamily 1, group D, member 1 (NR1D1) resides about 200 kb distal to the GWAS region. We hypothesized that circadian rhythms influenced gene expression levels in 17q12-q21 region and conversely, regulatory elements in this region influenced transcription of the core clock gene NR1D1 in cis. To test these hypotheses, we examined the diurnal expression profiles of zona pellucida binding protein 2 (ZPBP2/Zpbp2), gasdermin B (GSDMB), and ORMDL3/Ormdl3 in human and mouse tissues and analyzed the impact of genetic variation in the ZPBP2/Zpbp2 region on NR1D1/Nr1d1 expression. We found that Ormdl3 and Zpbp2 were controlled by the circadian clock in a tissue-specific fashion. We also report that deletion of the Zpbp2 region altered the expression profile of Nr1d1 in lungs and ileum in a time-dependent manner. In liver, the deletion was associated with enhanced expression of Ormdl3. We provide the first evidence that disease-associated genes Zpbp2 and Ormdl3 are regulated by circadian rhythms and the Zpbp2 region influences expression of the core clock gene Nr1d1.	[Chang, Matthew L.; Moussette, Sanny; Gupta, Indra R.; Ryan, Aimee K.; Naumova, Anna K.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Gamero-Estevez, Enrique; Chiwara, Victoria; Gupta, Indra R.; Ryan, Aimee K.; Naumova, Anna K.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Galvez, Jose Hector] Canadian Ctr Computat Genom, Montreal, PQ, Canada; [Gupta, Indra R.; Ryan, Aimee K.] McGill Univ, Dept Paediat, Montreal, PQ, Canada; [Naumova, Anna K.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Naumova, AK (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada.; Naumova, AK (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Naumova, AK (corresponding author), McGill Univ, Dept Obstet & Gynecol, Montreal, PQ, Canada.	anna.naoumova@mcgill.ca		Chang, Matthew Lok-Man/0000-0003-3184-3388; Naumova, Anna K./0000-0001-8481-5765	Bridge fund from the RI MUHC; CIHR; Natural Sciences and Engineering Research Council of Canada (CA) [RGPIN-201904433]; Research Institute of the MUHC; Department of Human Genetics, McGill University	Bridge fund from the RI MUHC; CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (CA)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Research Institute of the MUHC; Department of Human Genetics, McGill University	This work was supported by AKN, Bridge fund from the RI MUHC; AKN, Operating grant from CIHR; AKN, Natural Sciences and Engineering Research Council of Canada (CA), RGPIN-201904433; AKN, The Research Institute of the MUHC; VC, Department of Human Genetics, McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tuwaijri A, 2016, J MED GENET, V53, P232, DOI 10.1136/jmedgenet-2015-103313; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berlivet S, 2012, HUM GENET, V131, P1161, DOI 10.1007/s00439-012-1142-x; Bourgey M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz037; Christou S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39668-3; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Debeuf N, 2019, J ALLERGY CLIN IMMUN; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Espaillat Mel Pilar, 2017, Advances in Biological Regulation, V63, P140, DOI 10.1016/j.jbior.2016.11.001; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; He B, 2014, P NATL ACAD SCI USA, V111, pE2191, DOI 10.1073/pnas.1320308111; Hoogerwerf WA, 2008, GASTROENTEROLOGY, V135, P2019, DOI 10.1053/j.gastro.2008.08.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanagaratham C, 2018, MAMM GENOME, V29, P281, DOI 10.1007/s00335-018-9743-x; Kelly RS, 2018, CHEST, V154, P335, DOI 10.1016/j.chest.2018.05.038; Kervezee L, 2018, P NATL ACAD SCI USA, V115, P5540, DOI 10.1073/pnas.1720719115; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; Laufer VA, 2019, HUM MOL GENET, V28, P858, DOI 10.1093/hmg/ddy395; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Loser S, 2017, J ALLERGY CLIN IMMUN, V139, P1496, DOI 10.1016/j.jaci.2016.07.033; Miller M, 2017, J IMMUNOL, V198, P3017, DOI 10.4049/jimmunol.1601848; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moussette S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172707; Naumova AK, 2013, HUM GENET, V132, P811, DOI 10.1007/s00439-013-1298-z; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qiu F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14828; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Siow D, 2015, J LIPID RES, V56, P898, DOI 10.1194/jlr.M057539; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Sundar IK, 2015, AM J RESP CELL MOL, V53, P285, DOI 10.1165/rcmb.2014-0476TR; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06568-5; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; Wu G, 2018, P NATL ACAD SCI USA, V115, P12313, DOI 10.1073/pnas.1809442115; Xu YC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005992; Zhakupova A, 2016, FASEB J, V30, P4289, DOI 10.1096/fj.201600639R; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	54	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223212	10.1371/journal.pone.0223212	http://dx.doi.org/10.1371/journal.pone.0223212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560728	gold, Green Published			2022-12-26	WOS:000532353700040
J	Huang, H; Lennikov, A; Saddala, MS; Gozal, D; Grab, DJ; Khalyfa, A; Fan, LJ				Huang, Hu; Lennikov, Anton; Saddala, Madhu Sudhana; Gozal, David; Grab, Dennis J.; Khalyfa, Abdelnaby; Fan, Lijuan			Placental growth factor negatively regulates retinal endothelial cell barrier function through suppression of glucose-6-phosphate dehydrogenase and antioxidant defense systems	FASEB JOURNAL			English	Article						diabetic retinopathy; G6PD; P1GF; retina; EC	VASCULAR-PERMEABILITY; DIABETIC-RETINOPATHY; PATHWAY; ANGIOGENESIS; BEVACIZUMAB; INHIBITION; ANTIBODIES; DELETION; ASSAY; VEGF	We report that placental growth factor (PlGF) negatively affects the endothelial cell (EC) barrier function through a novel regulatory mechanism. The PlGF mAb promotes (but recombinant protein disrupts) EC barrier function, thus affecting the barrier-forming protein levels, membrane distribution, and EC monolayer impedance by the electrical cell-impedance sensing system, Western blot, and immunofluorescence staining. RNA sequencing-based transcriptome analysis identified the up-regulation of the pentose phosphate pathway (PPP) and the antioxidant defense protein by PlGF blockade. The PlGF and PlGF/VEGF dimers (but not VEGF-A) down-regulated the protein expression of glucose-6-phosphate dehydrogenase (G6PD) and peroxiredoxin (PRDX). G6PD inhibition and gene silencing (small interfering RNA) abolished the beneficial effects of PlGF inhibition on EC barrier function and PRDX3/6 protein expression. VEGF receptor (VEGFR)1 or VEGFR2 blockade prevented the inhibitory effect of PlGF on G6PD protein expression and EC barrier function. The PRDX6 played dual roles in EC barrier function through glutathione peroxidase and phospholipase A2 activity. In sum, PlGF negatively regulates EC barrier function through the activation of VEGFR1 and VEGFR2 and the suppression of the G6PD/PPP and the antioxidant pathways.	[Huang, Hu; Lennikov, Anton; Saddala, Madhu Sudhana; Fan, Lijuan] Univ Missouri, Dept Ophthalmol, 1 Hosp Dr, Columbia, MO 65212 USA; [Gozal, David; Khalyfa, Abdelnaby] Univ Missouri, Child Hlth Res Inst, Columbia, MO USA; [Grab, Dennis J.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Grab, Dennis J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Johns Hopkins University; Uniformed Services University of the Health Sciences - USA	Huang, H (corresponding author), Univ Missouri, Dept Ophthalmol, 1 Hosp Dr, Columbia, MO 65212 USA.	huangh1@missouri.edu	Gozal, David/ABH-3805-2020; Saddala, Madhu Sudhana/C-6147-2018	Saddala, Madhu Sudhana/0000-0002-6373-7080; behar cohen, francine/0000-0001-8571-9513	U.S. National Institutes of Health, National Eye Institute [R01 EY027824]; Missouri University Start-Up Fund; NATIONAL EYE INSTITUTE [R01EY027824] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Missouri University Start-Up Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dmitry Rumyancev (Belgorod, Russia) for graphical abstract artwork assets design. This work was supported by the U.S. National Institutes of Health, National Eye Institute (Grant R01 EY027824 to H.H.), and the Missouri University Start-Up Fund (to H.H.). The authors declare no conflicts of interest.	Al Kahtani E, 2017, EYE, V31, P529, DOI 10.1038/eye.2016.246; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arjunan P, 2018, P NATL ACAD SCI USA, V115, P10351, DOI 10.1073/pnas.1801379115; Bierhansl L, 2017, PHYSIOLOGY, V32, P126, DOI 10.1152/physiol.00031.2016; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Cappai G, 2011, DIABETOLOGIA, V54, P1539, DOI 10.1007/s00125-011-2099-3; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Deissler HL, 2013, EXP EYE RES, V115, P162, DOI 10.1016/j.exer.2013.07.018; Fisher AB, 2018, J LIPID RES, V59, P1132, DOI 10.1194/jlr.R082578; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; Huang H, 2015, DIABETES, V64, P200, DOI 10.2337/db14-0016; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P7565, DOI 10.1167/iovs.11-8002; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; Nguyen QD, 2018, ACTA OPHTHALMOL, V96, pE1, DOI 10.1111/aos.13325; Rupprecht KR, 2010, ANAL BIOCHEM, V407, P160, DOI 10.1016/j.ab.2010.08.003; Saddala MS, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0199-1; Saddala MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34955-x; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; STERNBERG J, 1983, J IMMUNOL METHODS, V64, P39, DOI 10.1016/0022-1759(83)90382-4; Van Bergen T, 2019, PROG RETIN EYE RES, V69, P116, DOI 10.1016/j.preteyeres.2018.10.006; Van Bergen T, 2017, EXP EYE RES, V165, P136, DOI 10.1016/j.exer.2017.09.012; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	44	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13695	13709		10.1096/fj.201901353R	http://dx.doi.org/10.1096/fj.201901353R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585507	Green Published			2022-12-26	WOS:000507466100051
J	Moyet, L; Salvi, D; Bouchnak, I; Miras, S; Perrot, L; Seigneurin-Berny, D; Kuntz, M; Rolland, N				Moyet, Lucas; Salvi, Daniel; Bouchnak, Imen; Miras, Stephane; Perrot, Laura; Seigneurin-Berny, Daphne; Kuntz, Marcel; Rolland, Norbert			Calmodulin is involved in the dual subcellular location of two chloroplast proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; subcellular fractionation; subcellular organelle; calmodulin (CaM); plant molecular biology; plant biochemistry; Chloroplast envelope; Subcellular location	QUINONE OXIDOREDUCTASE; INNER ENVELOPE; BINDING; INITIATION; IMPORT	yyy Cell compartmentalization is an essential process by which eukaryotic cells separate and control biological processes. Although calmodulins are well-known to regulate catalytic properties of their targets, we show here their involvement in the subcellular location of two plant proteins. Both proteins exhibit a dual location, namely in the cytosol in addition to their association to plastids (where they are known to fulfil their role). One of these proteins, ceQORH, a long-chain fatty acid reductase, was analyzed in more detail, and its calmodulin-binding site was identified by specific mutations. Such a mutated form is predominantly targeted to plastids at the expense of its cytosolic location. The second protein, TIC32, was also shown to be dependent on its calmodulin-binding site for retention in the cytosol. Complementary approaches (bimolecular fluorescence complementation and reverse genetics) demonstrated that the calmodulin isoform CAM5 is specifically involved in the retention of ceQORH in the cytosol. This study identifies a new role for calmodulin and sheds new light on the intriguing CaM-binding properties of hundreds of plastid proteins, despite the fact that no CaM or CaM-like proteins were identified in plastids.	[Moyet, Lucas; Salvi, Daniel; Bouchnak, Imen; Miras, Stephane; Perrot, Laura; Seigneurin-Berny, Daphne; Kuntz, Marcel; Rolland, Norbert] Univ Grenoble Alpes, CNRS, INRA, CEA,IRIG,LPCV, 17 Rue Martyrs, F-38000 Grenoble, France; [Bouchnak, Imen] Cornell Univ, Ithaca, NY 14853 USA; [Miras, Stephane] Kelly Sci, CH-1204 Geneva, Switzerland; [Perrot, Laura] INRA, Genet & Ameliorat Fruits & Legumes, F-84140 Montfavet, France; [Seigneurin-Berny, Daphne] Univ Grenoble Alpes, CNRS, INSERM, Inst Avancee Biosci, La Tronche, France	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Cornell University; INRAE; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rolland, N (corresponding author), Univ Grenoble Alpes, CNRS, INRA, CEA,IRIG,LPCV, 17 Rue Martyrs, F-38000 Grenoble, France.	norbert.rolland@cea.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885; PERROT, Laura/0000-0003-1149-4504	French National Research Agency [ANR-10-LABX-49-01]; ANR Genomique Vegetale-Genoplante 2010 Glyco-chloroplast [ANR-06-GPLA-0003]; ANR Blanc Chloro-Pro [ANR-2010-BLAN-1610-01]; Labex GRAL from the French National Research Agency [ANR-10-LABX-49-01]; INRA Plant Biology and Breeding Division [ANR-10-LABX-49-01]; CEA; ANR [ANR-15-IDEX-02]; ANR Labex GRAL; CNRS; INRA	French National Research Agency(French National Research Agency (ANR)); ANR Genomique Vegetale-Genoplante 2010 Glyco-chloroplast(French National Research Agency (ANR)); ANR Blanc Chloro-Pro(French National Research Agency (ANR)); Labex GRAL from the French National Research Agency(French National Research Agency (ANR)); INRA Plant Biology and Breeding Division; CEA(French Atomic Energy Commission); ANR(French National Research Agency (ANR)); ANR Labex GRAL(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INRA	This work was supported by the French National Research Agency. This work was supported in part by Fellowships ANR-06-GPLA-0003, ANR Genomique Vegetale-Genoplante 2010 Glyco-chloroplast; ANR-2010-BLAN-1610-01, ANR Blanc Chloro-Pro; and ANR-10-LABX-49-01, Labex GRAL from the French National Research Agency (to L.M.). This work was also supported in part by Ph.D. Fellowship ANR-10-LABX-49-01 (Labex GRAL) from the INRA Plant Biology and Breeding Division and from the French National Research Agency (to I.B.) and by a Ph.D. fellowship from the CEA (to S.M.). We also acknowledge ANR Project Grant ANR-15-IDEX-02. Additional support was provided by specific ANR Labex GRAL, CNRS, and INRA funding and by access to the local IRIG-CEA facilities for confocal microscopy. The authors declare that they have no conflicts of interest with the contents of this article.	AL-Quraan NA, 2010, PLANT PHYSIOL BIOCH, V48, P697, DOI 10.1016/j.plaphy.2010.04.011; Armbruster U, 2009, MOL PLANT, V2, P1325, DOI 10.1093/mp/ssp082; Bandaranayake PCG, 2010, PLANT CELL, V22, P1404, DOI 10.1105/tpc.110.074831; Bouchnak I, 2019, MOL CELL PROTEOMICS, V18, P1285, DOI 10.1074/mcp.RA118.000988; Bouchnak I, 2018, JOVE-J VIS EXP, DOI 10.3791/58581; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrie C, 2013, BBA-MOL CELL RES, V1833, P253, DOI 10.1016/j.bbamcr.2012.05.029; Chang WL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00239; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curien G, 2016, PHYTOCHEMISTRY, V122, P45, DOI 10.1016/j.phytochem.2015.11.015; Daras G, 2014, MOL PLANT, V7, P989, DOI 10.1093/mp/ssu030; Dell'Aglio E, 2013, MOL BIOSYST, V9, P1234, DOI 10.1039/c3mb00004d; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Jokipii-Lukkari S, 2016, PLANT SCI, V247, P138, DOI 10.1016/j.plantsci.2016.03.013; La Verde V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051331; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Lee DW, 2017, CURR OPIN PLANT BIOL, V40, P1, DOI [10.1016/j.pbI.2017.06.011, 10.1016/j.pbi.2017.06.011]; Mas SMY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00329; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Nada A, 2004, J CELL SCI, V117, P3975, DOI 10.1242/jcs.01265; Nevarez PA, 2017, PLANT PHYSIOL, V173, P1953, DOI 10.1104/pp.16.00116; Puyaubert J, 2008, PLANT PHYSIOL, V146, P478, DOI 10.1104/pp.107.111534; Rodriguez-Concepcion M, 1999, EMBO J, V18, P1996, DOI 10.1093/emboj/18.7.1996; Sharma M, 2018, PHOTOSYNTH RES, V138, P335, DOI 10.1007/s11120-018-0543-7; Sjuts I, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00168; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Tsitsekian D, 2019, J EXP BOT, V70, P2185, DOI 10.1093/jxb/ery440; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	38	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17543	17554		10.1074/jbc.RA119.010846	http://dx.doi.org/10.1074/jbc.RA119.010846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31578278	Green Published, hybrid			2022-12-26	WOS:000503173500030
J	Binda, C; Genier, S; Degrandmaison, J; Picard, S; Frechette, L; Jean, S; Marsault, E; Parent, JL				Binda, Chantal; Genier, Samuel; Degrandmaison, Jade; Picard, Samuel; Frechette, Louis; Jean, Steve; Marsault, Eric; Parent, Jean-Luc			L-type prostaglandin D synthase regulates the trafficking of the PGD(2) DP1 receptor by interacting with the GTPase Rab4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); Rab; receptor recycling; protein complex; L-type prostaglandin D synthase (L-PGDS); prostaglandin D2 synthase (PTGDS); DP1; prostaglandin D2; PGD2; inflammation; cell signaling	PROTEIN-COUPLED RECEPTOR; HUMAN PROSTACYCLIN RECEPTOR; LIPOCALIN-TYPE; BETA-TRACE; BETA(2)-ADRENERGIC RECEPTOR; INTRACELLULAR TRAFFICKING; ACTIVATION; EXPRESSION; CELLS; GEFS	Accumulating evidence indicates that G protein?coupled receptors (GPCRs) interact with Rab GTPases during their intracellular trafficking. How GPCRs recruit and activate the Rabs is unclear. Here, we report that depletion of endogenous L-type prostaglandin D synthase (L-PGDS) in HeLa cells inhibited recycling of the prostaglandin D-2 (PGD(2)) DP1 receptor (DP1) to the cell surface after agonist-induced internalization and that L-PGDS overexpression had the opposite effect. Depletion of endogenous Rab4 prevented l-PGDS?mediated recycling of DP1, and l-PGDS depletion inhibited Rab4-dependent recycling of DP1, indicating that both proteins are mutually involved in this pathway. DP1 stimulation promoted its interaction through its intracellular C terminus with Rab4, which was increased by l-PGDS. Confocal microscopy revealed that DP1 activation induces l-PGDS/Rab4 co-localization. l-PGDS/Rab4 and DP1/Rab4 co-immunoprecipitation levels were increased by DP1 agonist treatment. Pulldown assays with purified GST-l-PGDS and His(6)-Rab4 indicated that both proteins interact directly. l-PGDS interacted preferentially with the inactive, GDP-locked Rab4S22N variant rather than with WT Rab4 or with constitutively active Rab4Q67L proteins. Overexpression and depletion experiments disclosed that l-PGDS partakes in Rab4 activation following DP1 stimulation. Experiments with deletion mutants and synthetic peptides revealed that amino acids 85?92 in l-PGDS are involved in its interaction with Rab4 and in its effect on DP1 recycling. Of note, GTP?S loading and time-resolved FRET assays with purified proteins suggested that l-PGDS enhances GDP-GTP exchange on Rab4. Our results reveal how l-PGDS, which produces the agonist for DP1, regulates DP1 recycling by participating in Rab4 recruitment and activation.	[Binda, Chantal; Genier, Samuel; Degrandmaison, Jade; Picard, Samuel; Frechette, Louis; Parent, Jean-Luc] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada; [Binda, Chantal; Genier, Samuel; Degrandmaison, Jade; Picard, Samuel; Frechette, Louis; Marsault, Eric; Parent, Jean-Luc] Univ Sherbrooke, Fac Med & Sci Sante, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Jean, Steve] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada; [Picard, Samuel; Marsault, Eric] Univ Sherbrooke, Fac Med & Sci Sante, Dept Pharmacol Physiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Parent, JL (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	jean-luc.parent@usherbrooke.ca	Degrandmaison, Jade/AAZ-5191-2021	Degrandmaison, Jade/0000-0002-9492-2537; Jean, Steve/0000-0001-6881-5781; Genier, Samuel/0000-0002-5957-4012	Canadian Institutes of Health Research; Fonds de Recherche Quebec-Sante (FRQS)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec-Sante (FRQS)	This work was supported by a grant from the Canadian Institutes of Health Research (to J. L. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Doctoral salary award from the Fonds de Recherche Quebec-Sante (FRQS).	Arsenault D, 2012, J CELL PHYSIOL, V227, P789, DOI 10.1002/jcp.22792; Barbarin A, 2011, BIOCHEM J, V437, P97, DOI 10.1042/BJ20110361; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Binda C, 2014, J CELL BIOL, V204, P377, DOI 10.1083/jcb.201304015; Blodorn B, 1996, NEUROSCI LETT, V209, P117, DOI 10.1016/0304-3940(96)12614-8; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Caza TN, 2014, ANN RHEUM DIS, V73, P1888, DOI 10.1136/annrheumdis-2013-203794; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Costanzi S, 2009, J COMPUT AID MOL DES, V23, P747, DOI 10.1007/s10822-008-9218-3; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; Dateyama I, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224428; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Do MT, 2017, ONCOGENE, V36, P5757, DOI 10.1038/onc.2017.183; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Esseltine JL, 2012, J NEUROSCI, V32, P16933, DOI 10.1523/JNEUROSCI.0625-12.2012; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Ferrandiz-Huertas C, 2011, INT J CANCER, V128, P192, DOI 10.1002/ijc.25310; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Fujimori K, 2000, J BIOL CHEM, V275, P40511, DOI 10.1074/jbc.M007688200; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2007, EUR J PHARMACOL, V557, P115, DOI 10.1016/j.ejphar.2006.11.058; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Genier S, 2016, MOL BIOL CELL, V27, P3800, DOI 10.1091/mbc.E16-04-0224; Gerena RL, 2000, J ANDROL, V21, P848; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Gulbranson DR, 2017, P NATL ACAD SCI USA, V114, pE8224, DOI 10.1073/pnas.1712176114; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hu CT, 2013, CELL SIGNAL, V25, P1539, DOI 10.1016/j.cellsig.2013.03.022; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; Jean S, 2012, MOL BIOL CELL, V23, P2723, DOI 10.1091/mbc.E12-05-0375; Kanie T, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2795; Koch Daniel, 2016, Small GTPases, V7, P93, DOI 10.1080/21541248.2016.1156803; Lachance V, 2014, J CELL SCI, V127, P111, DOI 10.1242/jcs.132944; Lachance V, 2011, J BIOL CHEM, V286, P40802, DOI 10.1074/jbc.M111.267815; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Lebon G, 2012, M S-MED SCI, V28, P876, DOI 10.1051/medsci/20122810017; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Mathurin K, 2011, J BIOL CHEM, V286, P2696, DOI 10.1074/jbc.M110.178277; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Muller Matthias P, 2018, Small GTPases, V9, P5, DOI 10.1080/21541248.2016.1276999; Mulvaney EP, 2017, BBA-MOL CELL RES, V1864, P1819, DOI 10.1016/j.bbamcr.2017.07.010; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; Parent A, 2010, J BIOL CHEM, V285, P40838, DOI 10.1074/jbc.M110.142257; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Reichman M, 2015, J BIOMOL SCREEN, V20, P1294, DOI 10.1177/1087057115596326; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Roy SJ, 2013, MOL ENDOCRINOL, V27, P1245, DOI 10.1210/me.2013-1091; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Segev N, 2001, Sci STKE, V2001, pre11, DOI 10.1126/stke.2001.100.re11; Smythe E, 2002, MOL CELL, V9, P205, DOI 10.1016/S1097-2765(02)00462-8; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; UENO R, 1983, P NATL ACAD SCI-BIOL, V80, P1735, DOI 10.1073/pnas.80.6.1735; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1990, J BIOL CHEM, V265, P371; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	89	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16865	16883		10.1074/jbc.RA119.008233	http://dx.doi.org/10.1074/jbc.RA119.008233			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31575663	hybrid, Green Published			2022-12-26	WOS:000501801900032
J	Ridley, C; Lockhart-Cairns, MP; Collins, RF; Jowitt, TA; Subramani, DB; Kesimer, M; Baldock, C; Thornton, DJ				Ridley, Caroline; Lockhart-Cairns, Michael P.; Collins, Richard F.; Jowitt, Thomas A.; Subramani, Durai B.; Kesimer, Mehmet; Baldock, Clair; Thornton, David J.			The C-terminal dimerization domain of the respiratory mucin MUC5B functions in mucin stability and intracellular packaging before secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; mucus; von Willebrand factor; lung; cryo-electron microscopy; small-angle X-ray scattering (SAXS); Mucus obstruction	PORCINE SUBMAXILLARY MUCIN; GEL-FORMING MUCIN; CYSTIC-FIBROSIS; GENOMIC ORGANIZATION; MUCUS GLYCOPROTEINS; INTESTINAL MUCIN; PROTEIN; CDNA; IDENTIFICATION; SEQUENCE	Mucin 5B (MUC5B) has an essential role in mucociliary clearance that protects the pulmonary airways. Accordingly, knowledge of MUC5B structure and its interactions with itself and other proteins is critical to better understand airway mucus biology and improve the management of lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The role of an N-terminal multimerization domain in the supramolecular organization of MUC5B has been previously described, but less is known about its C-terminal dimerization domain. Here, using cryogenic electron microscopy (cryo-EM) and small-angle X-ray scattering (SAXS) analyses of recombinant disulfide-linked dimeric MUC5B dimerization domain we identified an asymmetric, elongated twisted structure, with a double globular base. We found that the dimerization domain is more resistant to disruption than the multimerization domain suggesting the twisted structure of the dimerization domain confers additional stability to MUC5B polymers. Size-exclusion chromatography-multiangle light scattering (SEC-MALS), SPR-based biophysical analyses and microscale thermophoresis of the dimerization domain disclosed no further assembly, but did reveal reversible, calcium-dependent interactions between the dimerization and multimerization domains that were most active at acidic pH, suggesting that these domains have a role in MUC5B intragranular organization. In summary, our results suggest a role for the C-terminal dimerization domain of MUC5B in compaction of mucin chains during granular packaging via interactions with the N-terminal multimerization domain. Our findings further suggest that the less stable multimerization domain provides a potential target for mucin depolymerization to remove mucus plugs in COPD and other lung pathologies.	[Ridley, Caroline; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; Baldock, Clair; Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England; [Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat, Oxford Rd, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Infect Immun & Resp Med, Oxford Rd, Manchester M13 9PT, Lancs, England; [Lockhart-Cairns, Michael P.; Baldock, Clair] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cell Matrix Biol & Regenerat Med, Oxford Rd, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Lockhart-Cairns, Michael P.; Collins, Richard F.; Jowitt, Thomas A.; Baldock, Clair; Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Subramani, Durai B.; Kesimer, Mehmet] Univ N Carolina, Sch Med, Cyst Fibrosis Res Ctr, Marsico Lung Inst, Chapel Hill, NC 27599 USA	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldock, C (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Oxford Rd, Manchester M13 9PT, Lancs, England.; Thornton, DJ (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Oxford Rd, Manchester M13 9PT, Lancs, England.	clair.baldock@manchester.ac.uk; dave.thornton@manchester.ac.uk	, Mehmet Kesimer/AHB-9223-2022; Lockhart-Cairns, Michael/AAJ-3888-2021; Subramani, Durai/N-1448-2013	Lockhart-Cairns, Michael/0000-0003-2289-1281; Jowitt, Thomas/0000-0002-4045-0933; Ridley, Caroline/0000-0002-5483-0320; Subramani, Durai/0000-0002-2256-3096; Thornton, David/0000-0001-7148-1970; Baldock, Clair/0000-0003-3497-1959	MRC [EM16619]; BBSRC [EM16619]; Wellcome Trust [EM16619, 203128/Z/16/Z]; MRC [MR/R002800/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Professor Tim Hardingham (University of Manchester) for critical reading of the manuscript. We acknowledge support from the Electron Microscopy, Biomolecular Analysis and Biological Mass Spectrometry core facilities at the University of Manchester. We acknowledge Diamond for access and support of the Cryo-EM facilities at theUKnational electron bio-imaging center (eBIC), proposal EM16619 (3 sessions), funded by the Wellcome Trust, MRC, and BBSRC. We also thank Diamond for access to SAXS beamline B21, proposal mx17773-50. The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust Grant 203128/Z/16/Z.	Abdullah LH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89752; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonser LR, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120112; Button B, 2016, ANN AM THORAC SOC, V13, pS156, DOI 10.1513/AnnalsATS.201507-455KV; Chang TH, 2015, ELIFE, V4, DOI 10.7554/eLife.06554; Danev R, 2017, ELIFE, V6, DOI 10.7554/eLife.23006; Davies HS, 2016, ANAL CHEM, V88, P11609, DOI 10.1021/acs.analchem.6b03095; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; Desseyn JL, 1997, J BIOL CHEM, V272, P16873, DOI 10.1074/jbc.272.27.16873; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; Ehre C, 2019, AM J RESP CRIT CARE, V199, P171, DOI 10.1164/rccm.201802-0245OC; Ermund A, 2017, BIOCHEM BIOPH RES CO, V492, P331, DOI 10.1016/j.bbrc.2017.08.113; Ermund A, 2017, CLIN EXP PHARMACOL P, V44, P639, DOI 10.1111/1440-1681.12744; Esther CR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3488; Fernandez-Petty CM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125954; Grubb BR, 2016, AM J PHYSIOL-LUNG C, V310, pL860, DOI 10.1152/ajplung.00015.2016; GUM JR, 1992, J BIOL CHEM, V267, P21375; GUM JR, 1994, J BIOL CHEM, V269, P2440; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hill DB, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01297-2018; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13665, DOI 10.1074/jbc.270.23.13665; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; MEERZAMAN D, 1994, J BIOL CHEM, V269, P12932; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Perez-Vilar J, 1998, J BIOL CHEM, V273, P6982, DOI 10.1074/jbc.273.12.6982; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, IEEE T PATTERN ANAL, V39, P706, DOI 10.1109/TPAMI.2016.2627573; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ridley C, 2018, BIOCHEM SOC T, V46, P1099, DOI 10.1042/BST20170402; Ridley C, 2016, AM J PHYSIOL-LUNG C, V310, pL993, DOI 10.1152/ajplung.00046.2016; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; Shiltagh N, 2014, BLOOD, V123, P4143, DOI 10.1182/blood-2013-07-517086; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Symmes BA, 2018, BIOCHEM SOC T, V46, P707, DOI 10.1042/BST20170455; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tarrant BJ, 2017, RESPIROLOGY, V22, P1084, DOI 10.1111/resp.13047; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Thornton DJ, 1996, BIOCHEM J, V316, P967, DOI 10.1042/bj3160967; THORNTON DJ, 1989, ANAL BIOCHEM, V182, P160, DOI 10.1016/0003-2697(89)90735-5; Trillo-Muyo S, 2018, J BIOL CHEM, V293, P5746, DOI 10.1074/jbc.RA117.001014; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; WAGNER DD, 1983, J BIOL CHEM, V258, P2065; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Xu ER, 2019, BLOOD, V133, P366, DOI 10.1182/blood-2018-04-843615; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	66	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17105	17116		10.1074/jbc.RA119.010771	http://dx.doi.org/10.1074/jbc.RA119.010771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31570524	hybrid, Green Published			2022-12-26	WOS:000501801900050
J	Sakuma, K; Ishida, R; Kodama, T; Takada, Y				Sakuma, Kay; Ishida, Risa; Kodama, Taketoshi; Takada, Yoshitake			Reconstructing the population history of the sandy beach amphipod Haustorioides japonicus using the calibration of demographic transition (CDT) approach	PLOS ONE			English	Article							SEA DEMERSAL FISH; MOLECULAR CLOCKS; JAPAN; PACIFIC; RATES; PHYLOGEOGRAPHY; DIVERGENCE; NEUTRALITY; DYNAMICS; TESTS	Calibration of the molecular rate is one of the major challenges in marine population genetics. Although the use of an appropriate evolutionary rate is crucial in exploring population histories, calibration of the rate is always difficult because fossil records and geological events are rarely applicable for rate calibration. The acceleration of the evolutionary rate for recent coalescent events (or more simply, the time dependency of the molecular clock) is also a problem that can lead to overestimation of population parameters. Calibration of demographic transition (CDT) is a rate calibration technique that assumes a post-glacial demographic expansion, representing one of the most promising approaches for dealing with these potential problems in the rate calibration. Here, we demonstrate the importance of using an appropriate evolutionary rate, and the power of CDT, by using populations of the sandy beach amphipod Haustorioides japonicus along the Japanese coast of the northwestern Pacific Ocean. Analysis of mitochondrial sequences found that the most peripheral population in the Pacific coast of northeastern Honshu Island (Tohoku region) is genetically distinct from the other northwestern Pacific populations. By using the two-epoch demographic model and rate of temperature change, the evolutionary rate was modeled as a log-normal distribution with a median rate of 2.2%/My. The split-time of the Tohoku population was subsequently estimated to be during the previous interglacial period by using the rate distribution, which enables us to infer potential causes of the divergence between local populations along the continuous Pacific coast of Japan.	[Sakuma, Kay; Ishida, Risa; Kodama, Taketoshi; Takada, Yoshitake] Fisheries Res & Educ Agcy, Japan Sea Natl Fisheries Res Inst, Niigata, Japan	Japan Fisheries Research & Education Agency (FRA)	Sakuma, K (corresponding author), Fisheries Res & Educ Agcy, Japan Sea Natl Fisheries Res Inst, Niigata, Japan.	keisakuma@affrc.go.jp	; Takada, Yoshitake/B-5288-2008; Kodama, Taketoshi/D-4305-2018	Sakuma, Kay/0000-0003-1995-9740; Takada, Yoshitake/0000-0001-9782-1195; Kodama, Taketoshi/0000-0001-8031-7881; Sakuma, Kay/0000-0002-0124-1063	Ministry of Agriculture, Forestry and Fisheries; Ministry of Education, Culture, Sports, Science and Technology, Japan [25340114, 15H02265]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by "A project for development of assessment methods for the coastal environment" funded by the Ministry of Agriculture, Forestry and Fisheries, and Grants-inAid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25340114 and 15H02265). There was no additional external funding received for this study.	Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; Audzijonyte A, 2006, MOL ECOL, V15, P3287, DOI 10.1111/j.1365-294X.2006.02998.x; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Copilas-Ciocianu D, 2019, ORG DIVERS EVOL, V19, P191, DOI 10.1007/s13127-019-00401-7; Crandall ED, 2012, MOL BIOL EVOL, V29, P707, DOI 10.1093/molbev/msr227; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Goto R, 2017, J OCEANOGR, V73, P103, DOI 10.1007/s10872-016-0380-2; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Harada N, 2012, DEEP-SEA RES PT II, V61-64, P93, DOI 10.1016/j.dsr2.2011.12.007; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hirase S, 2016, GENOME BIOL EVOL, V8, P1267, DOI 10.1093/gbe/evw063; Ho SYW, 2014, MOL ECOL, V23, P5947, DOI 10.1111/mec.12953; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoareau TB, 2016, SYST BIOL, V65, P449, DOI 10.1093/sysbio/syv120; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kamihira Y, 2000, REV HAKODATE U, V31, P91; Kamihira Y, 1992, REV HAKODATE U SPEC, V1, P1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Koizumi I, 2006, PALAEOGEOGR PALAEOCL, V232, P36, DOI 10.1016/j.palaeo.2005.09.003; Kojima S, 2001, MAR ECOL PROG SER, V217, P135, DOI 10.3354/meps217135; Kokita T, 2011, MOL ECOL, V20, P143, DOI 10.1111/j.1365-294X.2010.04920.x; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; R Core Team, 2018, R LANG ENV STAT COMP; Rambaut A, 2013, TRACER V1 6; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sakanishi Y, 2018, PHYCOL RES, V66, P253, DOI 10.1111/pre.12331; Sakuma K, 2015, ICHTHYOL RES, V62, P363, DOI 10.1007/s10228-014-0441-8; Sakuma K, 2014, ZOOL SCI, V31, P375, DOI 10.2108/zs130271; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Seike K, 2016, J OCEANOGR, V72, P141, DOI 10.1007/s10872-015-0297-1; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Suzuki Y, 2013, POPUL ECOL, V55, P107, DOI 10.1007/s10144-012-0358-x; TAJIMA F, 1989, GENETICS, V123, P585; Takada Y, 2018, ESTUAR COAST SHELF S, V200, P19, DOI 10.1016/j.ecss.2017.10.012; Takada Y, 2015, ECOL RES, V30, P101, DOI 10.1007/s11284-014-1215-5; Venables WN., 2002, MODERN APPL STAT S 4; YANG ZB, 1994, J MOL EVOL, V39, P105	51	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223624	10.1371/journal.pone.0223624	http://dx.doi.org/10.1371/journal.pone.0223624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596891	Green Submitted, Green Published, gold			2022-12-26	WOS:000532444100051
J	Urban, T; Waldauf, P; Krajcova, A; Jiroutkova, K; Halacova, M; Dzupa, V; Janousek, L; Pokorna, E; Duska, F				Urban, Tomas; Waldauf, Petr; Krajcova, Adela; Jiroutkova, Katerina; Halacova, Milada; Dzupa, Valer; Janousek, Libor; Pokorna, Eva; Duska, Frantisek			Kinetic characteristics of propofol-induced inhibition of electron-transfer chain and fatty acid oxidation in human and rodent skeletal and cardiac muscles	PLOS ONE			English	Article							ANESTHETIC 2,6-DIISOPROPYLPHENOL; INFUSION SYNDROME; MITOCHONDRIA; RESPIRATION	Introduction Propofol causes a profound inhibition of fatty acid oxidation and reduces spare electron transfer chain capacity in a range of human and rodent cells and tissues-a feature that might be related to the pathogenesis of Propofol Infusion Syndrome. We aimed to explore the mechanism of propofol-induced alteration of bioenergetic pathways by describing its kinetic characteristics. Methods We obtained samples of skeletal and cardiac muscle from Wistar rat (n = 3) and human subjects: vastus lateralis from hip surgery patients (n = 11) and myocardium from brain-dead organ donors (n = 10). We assessed mitochondrial functional indices using standard SUIT protocol and high resolution respirometry in fresh tissue homogenates with or without short-term exposure to a range of propofol concentration (2.5-100 mu g/ml). After finding concentrations of propofol causing partial inhibition of a particular pathways, we used that concentration to construct kinetic curves by plotting oxygen flux against substrate concentration during its stepwise titration in the presence or absence of propofol. By spectrophotometry we also measured the influence of the same propofol concentrations on the activity of isolated respiratory complexes. Results We found that human muscle and cardiac tissues are more sensitive to propofol-mediated inhibition of bioenergetic pathways than rat's tissue. In human homogenates, palmitoyl carnitine-driven respiration was inhibited at much lower concentrations of propofol than that required for a reduction of electron transfer chain capacity, suggesting FAO inhibition mechanism different from downstream limitation or carnitine-palmitoyl transferase-1 inhibition. Inhibition of Complex I was characterised by more marked reduction of Vmax, in keeping with non-competitive nature of the inhibition and the pattern was similar to the inhibition of Complex II or electron transfer chain capacity. There was neither inhibition of Complex IV nor increased leak through inner mitochondrial membrane with up to 100 mu g/ml of propofol. If measured in isolation by spectrophotometry, propofol 10 mu g/ml did not affect the activity of any respiratory complexes. Conclusion In human skeletal and heart muscle homogenates, propofol in concentrations that are achieved in propofol-anaesthetized patients, causes a direct inhibition of fatty acid oxidation, in addition to inhibiting flux of electrons through inner mitochondrial membrane. The inhibition is more marked in human as compared to rodent tissues.	[Urban, Tomas; Waldauf, Petr; Krajcova, Adela; Jiroutkova, Katerina; Halacova, Milada; Duska, Frantisek] Charles Univ Prague, OXYLAB Mitochondrial Physiol Lab, Fac Med 3, Prague, Czech Republic; [Urban, Tomas; Waldauf, Petr; Krajcova, Adela; Jiroutkova, Katerina; Halacova, Milada; Dzupa, Valer; Duska, Frantisek] FNKV Univ Hosp, Prague, Czech Republic; [Dzupa, Valer] Charles Univ Prague, Dept Orthopaed & Traumatol, Fac Med 3, Prague, Czech Republic; [Janousek, Libor] Inst Clin & Expt Med, Dept Transplantat Surg, Prague, Czech Republic; [Pokorna, Eva] Inst Clin & Expt Med, Dept Organ Recovery & Transplantat Databases, Prague, Czech Republic	Charles University Prague; University Hospital Vinohrady; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Duska, F (corresponding author), Charles Univ Prague, OXYLAB Mitochondrial Physiol Lab, Fac Med 3, Prague, Czech Republic.; Duska, F (corresponding author), FNKV Univ Hosp, Prague, Czech Republic.	frantisek.duska@lf3.cuni.cz	Jiroutková, Kateřina/AAN-8434-2021; Jiroutková, Kateřina/AAU-7859-2020; Waldauf, Petr/K-6785-2017; Krajčová, Adéla/AAM-6645-2020; Dzupa, Valer/D-1423-2018	Jiroutková, Kateřina/0000-0003-4102-9769; Waldauf, Petr/0000-0003-4668-5837; Dzupa, Valer/0000-0002-0291-6456; Urban, Tomas/0000-0001-5061-0585; Duska, Frantisek/0000-0003-1559-4078	Agentura pro zdravotnicky vyzkum (abbreviated AZV, translated as Grant agency for Healthcare Research) [16-28663A]	Agentura pro zdravotnicky vyzkum (abbreviated AZV, translated as Grant agency for Healthcare Research)	The study was supported by Agentura pro zdravotnicky vyzkum (abbreviated AZV, translated as Grant agency for Healthcare Research), grant No 16-28663A.	BRANCA D, 1991, ARCH BIOCHEM BIOPHYS, V290, P517, DOI 10.1016/0003-9861(91)90575-4; BRANCA D, 1991, BIOCHEM PHARMACOL, V42, P87, DOI 10.1016/0006-2952(91)90684-W; BRANCA D, 1995, COMP BIOCHEM PHYS C, V110, P41, DOI 10.1016/0742-8413(94)00078-O; Campos S, 2013, EUR J ANAESTH, V30, P154, DOI [10.1097/00003643-201306001-00479, DOI 10.1097/00003643-201306001-00479]; Casati A, 1999, CAN J ANAESTH, V46, P235, DOI 10.1007/BF03012602; Diedrich Daniel A, 2011, J Intensive Care Med, V26, P59, DOI 10.1177/0885066610384195; Dykens JA, 2008, DRUG INDUCED MITOCHO, DOI [10.1002/9780470372531, DOI 10.1002/9780470372531]; Fontana-Ayoub M, 2016, MITOCHONDRIAL PHYSL, P1; Gnaiger E., 2010, MITOCHONDR PHYSL NET, V2, P1; HERREGODS L, 1987, ANAESTHESIA, V42, P360, DOI 10.1111/j.1365-2044.1987.tb03975.x; Krajcova A, 2018, CIRC RES; Krajcova A, 2018, CRIT CARE MED, V46, pe206, DOI 10.1097/CCM.0000000000002875; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Rigoulet M, 1996, EUR J BIOCHEM, V241, P280; Schenkman KA, 2000, CRIT CARE MED, V28, P172, DOI 10.1097/00003246-200001000-00028; Sharline Madera, 2013, J CHEM INF MODEL, V53, P1689; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sumi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27220-8; Sumi C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192796; Tong Xian-xiang, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P1021; Vanlander AV, 2015, ANESTHESIOLOGY, V122, P343, DOI 10.1097/ALN.0000000000000484; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Vollmer JP, 2018, CRIT CARE MED, V46, pE91, DOI 10.1097/CCM.0000000000002802; Withington DE, 2004, PEDIATR ANESTH, V14, P505, DOI 10.1111/j.1460-9592.2004.01299.x; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2; Wolf AR, 2004, PEDIATR ANESTH, V14, P435, DOI 10.1111/j.1460-9592.2004.01332.x; Wong JM, 2010, AM J THER, V17, P487, DOI 10.1097/MJT.0b013e3181ed837a; Ziak J, 2015, MITOCHONDRION, V21, P106, DOI 10.1016/j.mito.2015.02.002	29	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0217254	10.1371/journal.pone.0217254	http://dx.doi.org/10.1371/journal.pone.0217254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE4QL	31584947	Green Published, gold, Green Submitted			2022-12-26	WOS:000526704200001
J	Zuo, Y; Whitbeck, JC; Haila, GJ; Hakim, AA; Rothlauf, PW; Eisenberg, RJ; Cohen, GH; Krummenacher, C				Zuo, Yi; Whitbeck, J. Charles; Haila, Gabriel J.; Hakim, Abraham A.; Rothlauf, Paul W.; Eisenberg, Roselyn J.; Cohen, Gary H.; Krummenacher, Claude			Saliva enhances infection of gingival fibroblasts by herpes simplex virus 1	PLOS ONE			English	Article							ENTRY MEDIATOR; GLYCOPROTEIN-D; NECTIN-1 EXPRESSION; PSEUDORABIES VIRUS; TYPE-1 INFECTION; KAPPA-B; HERPESVIRUSES; RECEPTOR; CELLS; DEFENSE	Oral herpes is a highly prevalent infection caused by herpes simplex virus 1 (HSV-1). After an initial infection of the oral cavity, HSV-1 remains latent in sensory neurons of the trigeminal ganglia. Episodic reactivation of the virus leads to the formation of mucocutaneous lesions (cold sores), but asymptomatic reactivation accompanied by viral shedding is more frequent and allows virus spread to new hosts. HSV-1 DNA has been detected in many oral tissues. In particular, HSV-1 can be found in periodontal lesions and several studies associated its presence with more severe periodontitis pathologies. Since gingival fibroblasts may become exposed to salivary components in periodontitis lesions, we analyzed the effect of saliva on HSV-1 and-2 infection of these cells. We observed that human gingival fibroblasts can be infected by HSV-1. However, pre-treatment of these cells with saliva extracts from some but not all individuals led to an increased susceptibility to infection. Furthermore, the active saliva could expand HSV-1 tropism to cells that are normally resistant to infection due to the absence of HSV entry receptors. The active factor in saliva was partially purified and comprised high molecular weight complexes of glycoproteins that included secretory Immunoglobulin A. Interestingly, we observed a broad variation in the activity of saliva between donors suggesting that this activity is selectively present in the population. The active saliva factor, has not been isolated, but may lead to the identification of a relevant biomarker for susceptibility to oral herpes. The presence of a salivary factor that enhances HSV-1 infection may influence the risk of oral herpes and/or the severity of associated oral pathologies.	[Zuo, Yi; Whitbeck, J. Charles; Cohen, Gary H.] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Haila, Gabriel J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ USA; [Hakim, Abraham A.; Rothlauf, Paul W.; Krummenacher, Claude] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Eisenberg, Roselyn J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Krummenacher, Claude] Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA	University of Pennsylvania; Rowan University; Rowan University; University of Pennsylvania; Rowan University	Krummenacher, C (corresponding author), Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA.; Krummenacher, C (corresponding author), Rowan Univ, Dept Mol & Cellular Biosci, Glassboro, NJ 08028 USA.	Krummenacher@rowan.edu		Krummenacher, Claude/0000-0002-3492-4987	Public Health Service grant from the National Institute of Dental and Craniofacial Research [DE022137]; College of Science and Mathematics at Rowan University	Public Health Service grant from the National Institute of Dental and Craniofacial Research; College of Science and Mathematics at Rowan University	This study was supported by Public Health Service grant DE022137 from the National Institute of Dental and Craniofacial Research (to C. K.) (https://www.nidcr.nih.gov/) and the College of Science and Mathematics at Rowan University (https://www.rowan.edu/home/sciencemathematics).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x; Bilichodmath Shivaprasad, 2009, J Oral Sci, V51, P79; Brandtzaeg P, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20401; COHEN GH, 1986, J VIROL, V60, P157, DOI 10.1128/JVI.60.1.157-166.1986; Dawes C, 2015, ARCH ORAL BIOL, V60, P863, DOI 10.1016/j.archoralbio.2015.03.004; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fabian TK, 2012, INT J MOL SCI, V13, P4295, DOI 10.3390/ijms13044295; Ghiasi H, 2000, VIRUS RES, V68, P137, DOI 10.1016/S0168-1702(00)00165-9; Gilbert SC, 2006, J ORAL PATHOL MED, V35, P548, DOI 10.1111/j.1600-0714.2006.00461.x; Gnann JW, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0568-7; Grenier G, 2009, ORAL MICROBIOL IMMUN, V24, P506, DOI 10.1111/j.1399-302X.2009.00542.x; GU M, 1995, ORAL MICROBIOL IMMUN, V10, P54, DOI 10.1111/j.1399-302X.1995.tb00118.x; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Handler CG, 1996, J VIROL, V70, P6076, DOI 10.1128/JVI.70.9.6076-6082.1996; HEINEMAN HS, 1980, ARCH ORAL BIOL, V25, P257, DOI 10.1016/0003-9969(80)90031-X; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2009, STRUCTURE, V17, P147, DOI 10.1016/j.str.2009.01.003; Huang YY, 2007, J CLIN ENDOCR METAB, V92, P1965, DOI 10.1210/jc.2007-0040; Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087; Hung SL, 2012, J PERIODONTAL RES, V47, P635, DOI 10.1111/j.1600-0765.2012.01476.x; Hung SL, 2002, VIRUS RES, V86, P59, DOI 10.1016/S0168-1702(02)00055-2; Hung SL, 2002, ORAL MICROBIOL IMMUN, V17, P215, DOI 10.1034/j.1399-302X.2002.170403.x; Kamma JJ, 2001, J CLIN PERIODONTOL, V28, P879, DOI 10.1034/j.1600-051x.2001.028009879.x; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 1999, J VIROL, V73, P8127, DOI 10.1128/JVI.73.10.8127-8137.1999; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; Ling LJ, 2004, J PERIODONTOL, V75, P1479, DOI 10.1902/jop.2004.75.11.1479; Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Martinez WM, 2002, J VIROL, V76, P7255, DOI 10.1128/JVI.76.14.7255-7262.2002; McQuillan Geraldine, 2018, NCHS Data Brief, P1; Miller CG, 2001, MOL THER, V3, P160, DOI 10.1006/mthe.2000.0240; Miller CS, 2008, ORAL SURG ORAL MED O, V105, P43, DOI 10.1016/j.tripleo.2007.06.011; Mizutani K, 2016, BIOCHEM J, V473, P2691, DOI 10.1042/BCJ20160235; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Muller HD, 2017, CLIN ORAL INVEST, V21, P2445, DOI 10.1007/s00784-016-2041-7; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Nagashunmugam T, 1998, J INFECT DIS, V178, P1635, DOI 10.1086/314511; PEI XY, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0101326; Petermann P, 2015, J VIROL, V89, P262, DOI 10.1128/JVI.02917-14; Pourgonabadi S, 2017, ARCH ORAL BIOL, V73, P295, DOI 10.1016/j.archoralbio.2016.10.012; Rahn E, 2017, J INVEST DERMATOL, V137, P884, DOI 10.1016/j.jid.2016.11.027; Ramchandani M, 2016, SEX TRANSM DIS, V43, P756, DOI 10.1097/OLQ.0000000000000522; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; ROIZMAN B, 2007, FIELDS VIROLOGY, P2502; Saygun I, 2004, J PERIODONTAL RES, V39, P207, DOI 10.1111/j.1600-0765.2004.00728.x; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shukla SY, 2009, INVEST OPHTH VIS SCI, V50, P2878, DOI 10.1167/iovs.08-2981; Slots J, 2003, ORAL SURG ORAL MED O, V96, P327, DOI 10.1016/S1079-2104(03)00352-4; Slots J, 2000, PERIODONTOL, V2015, P28; Sondej Melissa, 2009, Clin Proteomics, V5, P52, DOI 10.1007/s12014-008-9021-0; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Tabak LA, 2006, PEDIATR DENT, V28, P110; Tabak LA, 2006, PEDIAT DENT, V28, P92; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Terry-Allison T, 1998, J VIROL, V72, P5802, DOI 10.1128/JVI.72.7.5802-5810.1998; Thier K, 2017, J VIROL, V91, DOI 10.1128/JVI.01295-17; Ting M, 2000, J PERIODONTAL RES, V35, P17, DOI 10.1034/j.1600-0765.2000.035001017.x; Valimaa H, 2002, J DENT RES, V81, P416, DOI 10.1177/154405910208100612; Wald A, 2004, SEX TRANSM INFECT, V80, P272, DOI 10.1136/sti.2003.007823; Wald A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P656; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Yu Z, 2007, CANCER GENE THER, V14, P738, DOI 10.1038/sj.cgt.7701062; Yu ZK, 2007, MOL THER, V15, P103, DOI 10.1038/sj.mt.6300009; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhang SY, 2015, J EXP MED, V212, P1342, DOI 10.1084/jem.2129insight4	77	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223299	10.1371/journal.pone.0223299	http://dx.doi.org/10.1371/journal.pone.0223299			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581238	Green Published, gold			2022-12-26	WOS:000532398600049
J	Bin Naser, I; Hoque, MM; Faruque, SN; Kamruzzaman, M; Yamasaki, S; Faruque, SM				Bin Naser, Iftekhar; Hoque, M. Mozammel; Faruque, Shah Nayeem; Kamruzzaman, M.; Yamasaki, Shinji; Faruque, Shah M.			Vibrio cholerae strains with inactivated cqsS gene overproduce autoinducer-2 which enhances resuscitation of dormant environmental V. cholerae	PLOS ONE			English	Article							BIOFILMS ENHANCE; VIRULENCE; WATER	Background Toxigenic Vibrio cholerae resides in aquatic reservoirs of cholera-endemic areas mostly in a dormant form known as conditionally viable environmental cells (CVEC) in which the bacteria remain embedded in an exopolysaccharide matrix, and fail to grow in routine bacteriological culture. The CVEC can be resuscitated by supplementing culture media with either of two autoinducers CAI-1 and Al-2, which are signal molecules controlling quorum sensing, a regulatory network of bacterial gene expression dependent on cell density. This study investigated possible existence of variant strains that overproduce Als, sufficient to resuscitate CVEC in environmental waters. Methods Environmental V. cholerae isolates and Tn insertion mutants of a V. cholerae strain C6706 were screened for production of Als using bioluminescent reporter strains. Relevant mutations in environmental strains which overproduced Al-2 were characterized by nucleotide sequencing and genetic complementation studies. Effect of Als produced in culture supernatants of relevant strains on reactivation of CVEC in water was determined by resuscitation assays. Results Two of 54 environmental V. cholerae isolates were found to overproduce Al-2. Screening of a Tn-insertion library of V. cholerae strain C6706, identified a mutant which overproduced Al-2, and carried Tn insertion in the cqsS gene. Nucleotide sequencing also revealed mutations inactivating the cqsS gene in environmental isolates which overproduced Al-2, and this property was reversed when complemented with a wild type cqsS gene. Culture of river water samples supplemented with spent medium of these mutants resuscitated dormant V. cholerae cells in water. Significance V. cholerae strains with inactivated cqsS gene may offer a convenient source of Al-2 in enhanced assays for monitoring bacteriological quality of water. The results also suggest a potential role of naturally occurring cqsS mutants in the environmental biology of V. cholerae. Furthermore, similar phenomenon may have relevance in the ecology of other water-borne bacterial pathogens beyond V. cholerae.	[Bin Naser, Iftekhar; Faruque, Shah M.] Independent Univ Bangladesh, Sch Life Sci, Dhaka, Bangladesh; [Bin Naser, Iftekhar; Faruque, Shah M.] BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh; [Bin Naser, Iftekhar; Hoque, M. Mozammel; Kamruzzaman, M.; Faruque, Shah M.] Int Ctr Diarrhoea Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh; [Faruque, Shah Nayeem] North South Univ, Dept Biochem & Microbiol, Dhaka, Bangladesh; [Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka, Japan	Independent University Bangladesh (IUB); Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); North South University (NSU); Osaka Metropolitan University	Faruque, SM (corresponding author), Independent Univ Bangladesh, Sch Life Sci, Dhaka, Bangladesh.; Faruque, SM (corresponding author), BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh.; Faruque, SM (corresponding author), Int Ctr Diarrhoea Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh.	shah.faruque@iub.edu.bd	Kamruzzaman, Muhammad/S-2756-2019	Kamruzzaman, Muhammad/0000-0003-2005-9846; Hoque, Md Mozammel/0000-0002-6014-6955; Faruque, Shah/0000-0002-7006-622X				Bari SMN, 2013, P NATL ACAD SCI USA, V110, P9926, DOI 10.1073/pnas.1307697110; BRAYTON PR, 1987, J MICROBIOL METH, V6, P309, DOI 10.1016/0167-7012(87)90015-7; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Colwell Rita R., 1994, P117; Colwell RR, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P1; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2006, J INFECT DIS, V193, P1029, DOI 10.1086/500953; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; KHAN MU, 1984, TROP GEOGR MED, V36, P335; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; MONSUR K. A., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P440, DOI 10.1016/0035-9203(61)90090-6; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P277; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8	24	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223226	10.1371/journal.pone.0223226	http://dx.doi.org/10.1371/journal.pone.0223226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574121	gold, Green Published			2022-12-26	WOS:000532376700037
J	Bracke, MBM; Koene, P; Estevez, I; Butterworth, A; de Jong, IC				Bracke, Marc B. M.; Koene, Paul; Estevez, Inma; Butterworth, Andy; de Jong, Ingrid C.			Broiler welfare trade-off: A semi-quantitative welfare assessment for optimised welfare improvement based on an expert survey	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEM; CAGED ATLANTIC SALMON; MODEL SWIM 1.0; SEMANTIC MODEL; ENRICHMENT MATERIALS; FOOTPAD DERMATITIS; ANIMAL-WELFARE; PIGS; INDICATORS; RICHPIG	In order to support decision making on how to most effectively improve broiler welfare an innovative expert survey was conducted based on principles derived from semantic modelling. Twenty-seven experts, mainly broiler welfare scientists (n = 20; and 7 veterinarians), responded (response rate 38%) by giving welfare scores (GWS, scale 0-10) to 14 bench marking housing systems (HSs), and explaining these overall scores by selecting, weighing and scoring main welfare parameters, including both input and output measures. Data exploration followed by REML (Linear Mixed Model) and ALM (Automatic Linear Modelling) analyses revealed 6 clusters of HSs, sorted from high to low welfare, i.e. mean GWS (with superscripts indicating significant differences): 1. (semi-natural backyard) Flock (8.8(a)); 2. Nature (7.7(ab)), Label Rouge II (7.4(ab)), Free range EU (7.2(ab)), Better Life (7.2(ab)); 3. Organic EU (7.0(bc)), Freedom Food (6.2(bc)); 4. Organic US (5.8(bcd)) Concepts NL (5.6(abcdef)), GAP 2 (4.9(bcd)) 5. Conventional EU (3.7(de)), Conventional US (2.9(ef)), Modern cage (2.9(abcdef)); 6. Battery cage (1.3(f)). Mean weighting factors (WF, scale 0-10) of frequently (n> = 15) scored parameters were: Lameness (8.8), Health status (8.6), Litter (8.3), Density (8.2), Air quality (8.1), Breed (8.0), Enrichment (7.0) and Outdoor (6.6). These did not differ significantly, and did not have much added value in explaining GWS. Effects of Role (Scientist/Vet), Gender (M/F) and Region (EU/non-EU) did not significantly affect GWS or WF, except that women provided higher WF than men (7.2 vs 6.4, p<0.001). The contribution of welfare components to overall welfare has been quantified in two ways: a) using the beta-coefficients of statistical regression (ALM) analyses, and b) using a semantic-modelling type (weighted average) calculation of overall scores (CalcWS) from parameter level scores (PLS) and WF. GWS and CalcWS were highly correlated (R =similar to 0.85). CalcWS identified Lameness, Health status, Density, Breed, Air quality and Litter as main parameters contributing to welfare. ALM showed that the main parameters which significantly explained the variance in GWS based on all PLS, were the output parameter Health status (with a beta-coefficient of 0.38), and the input parameters (stocking) Density (0.42), Litter (0.14) and Enrichment (0.27). The beta coefficients indicated how much GWS would improve from 1 unit improvement in PLS for each parameter, thus the potential impact on GWS ranged from 1.4 welfare points for Litter to 4.2 points for Density. When all parameters were included, 81% of the variance in GWS was explained (77% for inputs alone; 39% for outputs alone). From this, it appears that experts use both input and output parameters to explain overall welfare, and that both are important. The major conventional systems and modern cages for broilers received low welfare scores (2.9-3.7), well below scores that may be considered acceptable (5.5). Also, several alternatives like GAP 2 (4.9), Concepts NL (5.6), Organic US (5.8) and Freedom Food (6.2) are unacceptable, or at risk of being unacceptable due to individual variation between experts and farms. Thus, this expert survey provides a preliminary semi-quantified decision support tool to help determine how to most effectively improve broiler welfare in a wide range of HSs.	[Bracke, Marc B. M.; Koene, Paul; de Jong, Ingrid C.] Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands; [Estevez, Inma] Neiker Tecnalia Basque Inst Agr Res & Dev, Vitoria, Spain; [Estevez, Inma] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Butterworth, Andy] Univ Bristol, Sch Vet Sci, Bristol, Avon, England	Wageningen University & Research; Basque Foundation for Science; University of Bristol	Bracke, MBM (corresponding author), Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands.	marc.bracke@wur.nl		de Jong, Ingrid/0000-0003-1811-499X	Open Philanthropy Project	Open Philanthropy Project	This work was made possible by a grant from the Open Philanthropy Project (https://www.openphilanthropy.org/) to Wageningen Livestock Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the funder preferred open-access publication and, through asking clarifying questions, helped identify an omission in the abstract which has been rectified.	[Anonymous], 2001, Journal of Applied Animal Welfare Science, V4, P3, DOI 10.1207/S15327604JAWS0401_2; [Anonymous], 2018, EFFECTIVE ALTRUISM; [Anonymous], 2013, IBM SPSS STAT 210 WI; Bilgili SF, 2009, J APPL POULTRY RES, V18, P583, DOI 10.3382/japr.2009-00023; Blokhuis HJ, 2010, ACTA AGR SCAND A-AN, V60, P129, DOI 10.1080/09064702.2010.523480; Bollard, 2016, INITIAL GRANTS SUPPO; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1666; Bracke MBM, 2008, ANIM WELFARE, V17, P289; Bracke MBM, 2007, ANIM WELFARE, V16, P229; Bracke MBM, 2007, APPL ANIM BEHAV SCI, V104, P14, DOI 10.1016/j.applanim.2006.05.006; Bracke MBM, 2007, APPL ANIM BEHAV SCI, V104, P1, DOI 10.1016/j.applanim.2006.05.005; Bracke MBM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212610; Bracke MBM, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-29; Bracke MBM, 1999, NETH J AGR SCI, V47, P279; Bracke MBM, 2004, APPL ANIM BEHAV SCI, V87, P45, DOI [10.1016/j.aplanim.2003.12.006, 10.1016/j.applanim.2003.12.006]; Bracke MBM, 2004, APPL ANIM BEHAV SCI, V87, P31, DOI 10.1016/j.applanim.2003.12.005; Bracke MBM, 2002, J ANIM SCI, V80, P1819; Bracke MBM, 2002, J ANIM SCI, V80, P1835; Bracke MBM, THESIS; Buijs S, 2017, ANIMAL, V11, P244, DOI 10.1017/S1751731116001476; Collins Lisa M, 2013, Animals (Basel), V3, P416, DOI 10.3390/ani3020416; Cotra A., 2017, WILL HEN WELFARE BE; de Jong IC, 2014, J APPL POULTRY RES, V23, P51, DOI 10.3382/japr.2013-00803; De Mol RM, 2006, NJAS-WAGEN J LIFE SC, V54, P157, DOI 10.1016/S1573-5214(06)80019-9; EA, 2016, INTR EFF ALTR; Ellen H, 2012, 619 WAG LIV RES; Federici J, 2015, BRAZ J POULTRY SCI, V18; Folkedal O, 2016, ANIM WELFARE, V25, P135, DOI 10.7120/09627286.25.1.135; Gocsik E, 2016, AGR SYST, V146, P55, DOI 10.1016/j.agsy.2016.04.001; JPE, BROMAXX BROIL HOUS S; Koene P., 2014, 771 WAG LIV RES; Koene P, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00035; NCC, 2017, AN WELF GUID AUT CHE; Nunnally CJJ, 1970, INTRO PSYCHOL MEASUR; Opengart K, 2018, J APPL POULTRY RES, V27, P424, DOI 10.3382/japr/pfy002; Pettersen JM, 2014, REV AQUACULT, V6, P162, DOI 10.1111/raq.12039; SCAHAW, 2000, WELF CHICK KEPT MEAT; Smithers R., 2018, GUARDIAN; Souza APO, 2015, ANIM WELFARE, V24, P45, DOI 10.7120/09627286.24.1.045; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; Tuyttens FAM, 2015, POULTRY SCI, V94, P1758, DOI 10.3382/ps/pev167; Ursinus WW, 2009, ANIM WELFARE, V18, P545; Van Emous R., SMP18004; Vasdal G, 2018, ANIMAL, V12, P334, DOI 10.1017/S1751731117001434; Vissers LSM, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9070473; Widowski TM, 2000, APPL ANIM BEHAV SCI, V68, P39, DOI 10.1016/S0168-1591(00)00088-5; Yeates J, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8040053	47	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222955	10.1371/journal.pone.0222955	http://dx.doi.org/10.1371/journal.pone.0222955			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574105	Green Published, gold			2022-12-26	WOS:000532376700019
J	Jeon, D; Chang, EG; McGing, M; Hartman-Filson, M; Sommers, M; Lewis, E; Balmes, JR; Moisi, D; Lederman, MM; Madsen, KA; Woodruff, PG; Hunt, PW; Huang, L				Jeon, Diane; Chang, Emily G.; McGing, Maggie; Hartman-Filson, Marlene; Sommers, Mathew; Lewis, Eula; Balmes, John R.; Moisi, Daniela; Lederman, Michael M.; Madsen, Kristine A.; Woodruff, Prescott G.; Hunt, Peter W.; Huang, Laurence		Inflammation Aging Microbes Obstru	Pneumoproteins are associated with pulmonary function in HIV-infected persons	PLOS ONE			English	Article							CLARA CELL PROTEIN; SOLUBLE RECEPTOR; LUNG-FUNCTION; DISEASE; SERUM; COPD; INFLAMMATION; ACTIVATION; BIOMARKER; RISK	Background COPD is a common HIV comorbidity, and HIV-infected individuals have a higher incidence and earlier onset of COPD compared to HIV-uninfected individuals. While the pathogenesis of HIV-associated COPD is largely unknown, chronic inflammation may contribute. Four pneumoproteins known to be markers of lung injury and inflammation have been associated with COPD in HIV-uninfected individuals: PARC/CCL-18, SP-D, CC-16, and sRAGE. Objective To determine whether these pneumoproteins are also associated with pulmonary function and COPD Assessment Test (CAT) scores in HIV-infected individuals. Methods Associations between plasma pneumoprotein levels and pulmonary function were determined in a cross-sectional study of otherwise healthy HIV-infected individuals enrolled between September 2016 and June 2017. Covariates included HIV-associated (antiretroviral therapy, CD4 count, and viral load) and COPD-associated (smoking and BMI) covariates. Results Among 65 participants, 78.5% were male, 50.8% had undetectable viral load, and 76.9% were ever-smokers. Mean post-bronchodilator FEVi/FVC was 0.71, and mean DLco%predicted was 61%. Higher PARC/CCL-18 was associated with lower DLco%predicted and higher CAT score. Higher CC-16 was associated with lower DLco%predicted and lower FVC%predicted. Conclusions This exploratory analysis is the first to characterize associations between these four pneu-moproteins and pulmonary function in an HIV-infected cohort. Our findings suggest the pathogenesis of HIV-associated COPD may differ from that of non-HIV-associated COPD due to HIV-specific inflammatory changes affecting DLco. PARC/CCL-18 is associated with structural and functional pulmonary abnormalities and may be an important COPD biomarker candidate in HIV infection. Our study is a preliminary step toward finding clinically relevant COPD biomarkers in high-risk populations.	[Jeon, Diane; Balmes, John R.] Univ Calif Berkeley Univ Calif San Francisco Join, Berkeley, CA 94720 USA; [Chang, Emily G.; McGing, Maggie; Hartman-Filson, Marlene; Sommers, Mathew; Huang, Laurence] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, HIV ID & Global Med Div, San Francisco, CA 94143 USA; [Chang, Emily G.; McGing, Maggie; Hartman-Filson, Marlene; Sommers, Mathew; Lewis, Eula; Balmes, John R.; Huang, Laurence] Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA; [Lewis, Eula] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Balmes, John R.; Madsen, Kristine A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Balmes, John R.; Huang, Laurence] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Moisi, Daniela; Lederman, Michael M.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Hunt, Peter W.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Chang, Emily G.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [McGing, Maggie] Univ Colorado, Dept Med, Denver, CO USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Case Western Reserve University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Jeon, D (corresponding author), Univ Calif Berkeley Univ Calif San Francisco Join, Berkeley, CA 94720 USA.	diane.jeon@ucsf.edu	Hunt, Peter W./P-2976-2017; Huang, Laurence/AAZ-7120-2021	Hunt, Peter W./0000-0002-4571-4870; Huang, Laurence/0000-0003-3888-2195	NIH [R01 HL128156, K24 HL087713]; UC Berkeley-UCSF; UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128156, K24HL087713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley-UCSF; UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grants R01 HL128156 and K24 HL087713 (LH). This study was also supported by UC Berkeley-UCSF grants, Schoeneman Summer Stipend and Thesis Grant, and UCSF grants, Pathways Explore Summer Fellowship and Travel Grant (DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the authors of the Inflammation, Aging, Microbes and Obstructive Lung Disease (I AM OLD Study). The lead author is Laurence Huang(laurence.huang@ucsf.edu).The other authors of this group include Peter W. Hunt (Department of Medicine, University of California San Francisco, San Francisco, California, United States of America), Prescott G. Woodruff (Department of Medicine, University of California San Francisco, San Francisco, California, United States of America), Michael M. Lederman (Department of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America), Daniela Moisi (Department of Medicine, Case Western Reserve University, Cleveland, Ohio, United State of America), Jue Lin (Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, United States of America), Eula Lewis (Department of Anesthesia and Perioperative Care, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America), Emily G. Chang (Department of Statistics, University of California Davis, Davis, California, United States of America), Maggie McGing (Department of Medicine, University of Colorado, Denver, Denver, Colorado, United State of America), Marlena HartmanFilson (Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America), and Mathew Sommers (Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America).	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Arjomandi M, 2018, AM J RESP CRIT CARE, V197, P1319, DOI 10.1164/rccm.201708-1613OC; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Broeckaert F, 2000, ENVIRON HEALTH PERSP, V108, P533, DOI 10.2307/3454615; Brune KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149679; Buendia-Roldan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168552; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2013, JAIDS-J ACQ IMM DEF, V64, P271, DOI 10.1097/QAI.0b013e3182a9215a; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Decramer M, 2016, GOLD, P1; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dilektasli AG, 2017, INT J CHRONIC OBSTR, V12, P199, DOI 10.2147/COPD.S118424; Doney B, 2014, J OCCUP ENVIRON MED, V56, P1088, DOI 10.1097/JOM.0000000000000232; Drummond MB, 2016, SEMIN RESP CRIT CARE, V37, P277, DOI 10.1055/s-0036-1578801; Drummond MB, 2015, AIDS, V29, P1691, DOI 10.1097/QAD.0000000000000750; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; Faner R, 2014, THORAX, V69, P666, DOI 10.1136/thoraxjnl-2013-204778; Fitzpatrick M, 2013, CLIN CHEST MED, V34, P325, DOI 10.1016/j.ccm.2013.01.010; Fitzpatrick ME, 2016, AIDS, V30, P1327, DOI 10.1097/QAD.0000000000001092; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Fitzpatrick ME, 2013, JAIDS-J ACQ IMM DEF, V64, P284, DOI 10.1097/QAI.0b013e3182a9213a; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo MR, 2018, ANN AM THORAC SOC, V15, P192, DOI 10.1513/AnnalsATS.201606-492OC; Gingo MR, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-75; Gingo MR, 2013, CLIN CHEST MED, V34, P273, DOI 10.1016/j.ccm.2013.02.002; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hasegawa M, 2011, J RHEUMATOL, V38, P877, DOI 10.3899/jrheum.100591; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jones PW, 2011, EUR RESPIR J, V38, P29, DOI 10.1183/09031936.00177210; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones PA, 2009, COLORADO WATER LAW FOR NON-LAWYERS, P1; JORENS PG, 1995, EUR RESPIR J, V8, P1647, DOI 10.1183/09031936.95.08101647; Liu JCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124426; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Morris A, 2009, J CLIN MICROBIOL, V47, P3773, DOI 10.1128/JCM.01712-09; Pardo A, 2001, J LEUKOCYTE BIOL, V70, P610; Park HY, 2013, AM J RESP CRIT CARE, V188, P1413, DOI 10.1164/rccm.201305-0892OC; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; US Dept of Health and Human Services, TOB SMOK CAUS DIS BI; Van Miert E, 2005, TOXICOL LETT, V159, P115, DOI 10.1016/j.toxlet.2005.05.007; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vos T, 2014, YEARS LIVED DISABILI, P2163; Wheaton AG, 2015, MMWR-MORBID MORTAL W, V64, P289; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP; Zemans RL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0597-7	72	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223263	10.1371/journal.pone.0223263	http://dx.doi.org/10.1371/journal.pone.0223263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574118	Green Published, gold			2022-12-26	WOS:000532376700040
J	Pendola, M; Jain, G; Evans, JS				Pendola, Martin; Jain, Gaurav; Evans, John Spencer			Skeletal development in the sea urchin relies upon protein families that contain intrinsic disorder, aggregation-prone, and conserved globular interactive domains	PLOS ONE			English	Article							SPICULE MATRIX PROTEIN; INTRACRYSTALLINE BIOMINERALIZATION PROTEIN; SEQUENCE REPEATS; MODEL PEPTIDE; PREDICTION; ORGANIZES; REGIONS; CALCITE; SERVER	The formation of the sea urchin spicule skeleton requires the participation of hydrogel-forming protein families that regulate mineral nucleation and nanoparticle assembly processes that give rise to the spicule. However, the structure and molecular behavior of these proteins is not well established, and thus our ability to understand this process is hampered. We embarked on a study of sea urchin spicule proteins using a combination of biophysical and bioinformatics techniques. Our biophysical findings indicate that recombinant variants of the two most studied spicule matrix proteins, SpSM50 and SpSM30B/C (S. purpuratus) have a conformational landscape that include a C-terminal random coil/intrinsically disordered MAPQG sequence coupled to a conserved, folded N-terminal C-type lectin-like (CTLL) domain, with SpSM50 > SpSM30B/C with regard to intrinsic disorder. Both proteins possess solvent-accessible unfolded MAQPG sequence regions where Asn, Gln, and Arg residues may be accessible for protein hydrogel interactions with water molecules. Our bioinformatics study included seven other spicule matrix proteins where we note similarities between these proteins and rare, unusual proteins that possess folded and unfolded traits. Moreover, spicule matrix proteins possess three types of sequences: intrinsically disordered, amyloid-like, and folded protein-protein interactive. Collectively these reactive domains would be capable of driving protein assembly and hydrogel formation. Interestingly, three types of global conformations are predicted for the nine member protein set, wherein we note variations in the arrangement of intrinsically disordered and interactive globular domains. These variations may reflect species-specific requirements for spiculogenesis. We conclude that the molecular landscape of spicule matrix protein families enables them to function as hydrogelators, nucleators, and assemblers of mineral nanoparticles.	[Pendola, Martin; Jain, Gaurav; Evans, John Spencer] NYU, Lab Chem Phys, Ctr Skeletal & Craniofacial Biol, New York, NY 10003 USA	New York University	Evans, JS (corresponding author), NYU, Lab Chem Phys, Ctr Skeletal & Craniofacial Biol, New York, NY 10003 USA.	jse1@nyu.edu	Evans, John Spencer/AAD-2396-2019; Jain, Gaurav/AAY-7376-2021	Jain, Gaurav/0000-0002-0148-249X; Pendola, Martin/0000-0003-1453-695X	U.S. Army Research Office	U.S. Army Research Office	The sole funder for this work is the U.S. Army Research Office. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors Pendola, Jain, and Evans received partial salary from this funder.	Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; Cameron RA, 2009, NUCL ACIDS RES; Chang EP, 2015, BIOCHEMISTRY-US, V54, P5348, DOI 10.1021/acs.biochem.5b00842; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Elsharkawy S, 2018, NATURE COMMUN; Evans JS, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900036; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; HARKEY MA, 1995, DEV BIOL, V168, P549, DOI 10.1006/dbio.1995.1101; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Jain G, 2006, BIOCHEMISTRY-US, V55, P4410; Jain G, 2018, BIOCHEMISTRY-US, V57, P3032, DOI 10.1021/acs.biochem.8b00207; Jain G, 2017, BIOCHEMISTRY-US, V56, P2663, DOI 10.1021/acs.biochem.7b00083; KATOHFUKUI Y, 1992, INT J DEV BIOL, V36, P353; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; LOWENSTAM H. A., 1989, BIOMINERALISATION, P1; Mann K, 2010, PROTEOME SCI, V8, P1, DOI DOI 10.1186/1477-5956-8-1; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Mann S., 2001, BIOMINERALIZATION PR, P6; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; McGuffin LJ, 2017, PROTEIN-STRUCT FUNCT, V86, P335; Olson IC, 2012, J AM CHEM SOC, V134, P7351, DOI 10.1021/ja210808s; Peled-Kamar M, 2002, EXP CELL RES, V272, P56, DOI 10.1006/excr.2001.5398; Pendola M, 2018, ACS OMEGA, V3, P11823, DOI 10.1021/acsomega.8b01697; Pendola M, 2017, ACS OMEGA, V2, P6151, DOI 10.1021/acsomega.7b00719; Perovic I, 2014, BIOCHEMISTRY-US, V53, P3669; Perovic I, 2014, BIOCHEMISTRY-US, V53, P7259, DOI 10.1021/bi5008854; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peysselon F, 2011, MOL BIOSYST, V7, P3353, DOI 10.1039/c1mb05316g; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Smithers B, 2016, PROTEIN SCI, V25, P1030, DOI 10.1002/pro.2913; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Urry LA, 2000, DEV BIOL, V225, P201, DOI 10.1006/dbio.2000.9828; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wilt F, 2008, INVERTEBR BIOL, V127, P452, DOI 10.1111/j.1744-7410.2008.00147.x; Wustman B, 2002, BIOPOLYMERS, V65, P1305; Xu GZ, 1999, BIOPOLYMERS, V49, P303; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Zhang B, 2000, BIOPOLYMERS, V54, P464, DOI 10.1002/1097-0282(200011)54:6<464::AID-BIP90>3.0.CO;2-N	49	3	3	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222068	10.1371/journal.pone.0222068	http://dx.doi.org/10.1371/journal.pone.0222068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574084	Green Published, gold			2022-12-26	WOS:000532376700005
J	Hayashi, N; Yamaguchi, S; Rodenburg, F; Wong, SY; Ujimoto, K; Miki, T; Iba, T				Hayashi, Nobuhiro; Yamaguchi, Syunta; Rodenburg, Frans; Wong, Sing Ying; Ujimoto, Kei; Miki, Takahiro; Iba, Toshiaki			Multiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; C-REACTIVE PROTEIN; PROCALCITONIN; MARKER; ADAMTS13	Serum components of sepsis patients vary with the severity of infection, the resulting inflammatory response, per individual, and even over time. Tracking these changes is crucial in properly treating sepsis. Hence, several blood-derived biomarkers have been studied for their potential in assessing sepsis severity. However, the classical approach of selecting individual biomarkers is problematic in terms of accuracy and efficiency. We therefore present a novel approach for detecting biomarkers using longitudinal proteomics data. This does not require a predetermined set of proteins and can therefore reveal previously unknown related proteins. Our approach involves examining changes over time of both protein abundance and post-translational modifications in serum, using two-dimensional gel electrophoresis (2D-PAGE). 2D-PAGE was conducted using serum from n = 20 patients, collected at five time points, starting from the onset of sepsis. Changes in protein spots were examined using 49 spots for which the signal intensity changed by at least two-fold over time. These were then screened for significant spikes or dips in intensity that occurred exclusively in patients with adverse outcome. Individual level variation was handled by a mixed effects model. Finally, for each time transition, partial correlations between spots were estimated through a Gaussian graphical model (GGM) based on the ridge penalty. Identifications of spots of interest by tandem mass spectrometry revealed that many were either known biomarkers for inflammation (complement components), or had previously been suggested as biomarkers for kidney failure (haptoglobin) or liver failure (ceruloplasmin). The latter two are common complications in severe sepsis. In the GGM, many of the tightly connected spots shared known biological functions or even belonged to the same protein; including hemoglobin chains and acute phase proteins. Altogether, these results suggest that our screening method can successfully identify biomarkers for disease states and cluster biologically related proteins using longitudinal proteomics data derived from 2D-PAGE.	[Hayashi, Nobuhiro; Yamaguchi, Syunta; Rodenburg, Frans; Wong, Sing Ying] Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan; [Hayashi, Nobuhiro; Ujimoto, Kei] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo, Japan; [Miki, Takahiro] Nihon Univ, Surugadai Hosp, Chiyoda Ku, Tokyo, Japan; [Iba, Toshiaki] Juntendo Univ, Dept Emergency & Disaster Med, Bunkyo Ku, Tokyo, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Nihon University; Juntendo University	Hayashi, N (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan.; Hayashi, N (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo, Japan.	nhayashi@bio.titech.ac.jp	Iba, Toshiaki/AAP-7141-2021; Hayashi, Nobuhiro/F-6088-2011	Iba, Toshiaki/0000-0002-0255-4088; Hayashi, Nobuhiro/0000-0002-9950-094X; Wong, Sing Ying/0000-0002-6211-6557	Ministry of Education, Science, Sports and Culture of Japan [16K11421]; NIMS Nanofabrication Platform in Nanotechnology Platform Project - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Otsuka Toshimi Scholarship Foundation;  [25462831]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIMS Nanofabrication Platform in Nanotechnology Platform Project - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical); 	This work was supported in part by Grants-in-Aid for Scientific Research C 25462831, the Otsuka Toshimi Scholarship Foundation, and 16K11421 from the Ministry of Education, Science, Sports and Culture of Japan. A part of this study was supported by NIMS Nanofabrication Platform in Nanotechnology Platform Project sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abe R, 2010, CRIT CARE, V14, DOI 10.1186/cc8898; Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Depret F, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1837-4; Fukushima H, 2013, SHOCK, V39, P409, DOI 10.1097/SHK.0b013e3182908ea7; Habe K, 2012, THROMB RES, V129, P598, DOI 10.1016/j.thromres.2011.10.011; Hausfater P, 2008, INTENS CARE MED, V34, P1377, DOI 10.1007/s00134-008-1083-y; Hayashi N., 2011, EXPECTED MAT FUTURE, V11, P42; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; Janz DR, 2013, CRIT CARE, V17, DOI 10.1186/cc13108; Kiehntopf M, 2011, SHOCK, V36, P560, DOI 10.1097/SHK.0b013e318237ea7c; Kurosawa G, 2009, J IMMUNOL METHODS, V351, P1, DOI 10.1016/j.jim.2009.09.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Lv M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058735; Maier M, 2009, J TRAUMA, V66, P243, DOI 10.1097/TA.0b013e31817c966f; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Morath C, 2007, NEPHROL DIAL TRANSPL, V22, P2701, DOI 10.1093/ndt/gfm353; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Pandey NR, 2014, WORLD J EMERG MED, V5, P42, DOI [10.5847/wjem.j.1920-8642.2014.01.007, 10.5847/wjem.j.issn.1920-8642.2014.01.007]; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rodriguez-Caballero E, 2018, NAT GEOSCI, V11, P185, DOI 10.1038/s41561-018-0072-1; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-1; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Skibsted S, 2013, CRIT CARE, V17, DOI 10.1186/cc12693; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; van Wieringen WN, 2016, COMPUT STAT DATA AN, V103, P284, DOI 10.1016/j.csda.2016.05.012; van Wieringen WN, 2015, LECT N BIOINFORMAT, V8623, P170, DOI 10.1007/978-3-319-24462-4_15; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yang H, 2017, J INTERN MED, V282, P76, DOI 10.1111/joim.12619	39	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0222403	10.1371/journal.pone.0222403	http://dx.doi.org/10.1371/journal.pone.0222403			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568522	gold, Green Published			2022-12-26	WOS:000532364900003
J	Gebresenbet, RF; Aliyu, AD				Gebresenbet, Rediet Fikru; Aliyu, Anteneh Dirar			Injury severity level and associated factors among road traffic accident victims attending emergency department of Tirunesh Beijing Hospital, Addis Ababa, Ethiopia: A cross sectional hospital-based study	PLOS ONE			English	Article								Background Road Traffic Accidents have become an enormous global public health problem killing approximately 1.25 million people and injuring 20 to 50 million others yearly. It is the 10th leading cause of death universally and the number one cause of mortality of the young population between the ages of 5 and 29. Only few studies have been conducted on the severity of road traffic injuries in Ethiopia hence the need for the study. Objective To assess injury severity level and associated factors among road traffic accident victims. Methods A cross-sectional study of patients involved in road traffic accident and attended Tirunesh Beijing hospital, Addis Ababa, Ethiopia. Victims were consecutively recruited until sample size (164) attained during the study period. Data collectors administered a structured questionnaire. The collected data was then entered and cleaned using Epi info and exported to IBM SPSS for statistical analysis. Independent factors associated with injury severity were assessed using bivariate and multivariate logistic regression. Results A total of 164 road traffic injury victims were included to the study. Prevalence of severe injury accounted for 36.6% of cases. "can read and write" educational status OR 35.194 (95% CI; 3.325-372.539), sustaining multiple injury OR 18.400(95% CI; 5.402-62.671), sustaining multiple injury type OR 6.955(95% CI; 1.716-28.185) and being transported by ambulance from the scene of accident OR 13.800(95% CI; 1.481-128.635) were the explanatory variables found to have a statistically significant association with severe injury. Conclusion This study showed road traffic accident is predominantly affecting the economically active, male young population. Not a single victim received pre-hospital care, majority were extracted by bystanders and most used commercial vehicle to be transported to a health institution reflecting the need for improvements in pre-hospital emergency services and socio-economic related infrastructures.	[Gebresenbet, Rediet Fikru] Armauer Hansen Res Inst, Dept Clin Trial, Addis Ababa, Ethiopia; [Aliyu, Anteneh Dirar] Jimma Univ, Dept Publ Hlth, Coll Publ Hlth, Jimma, Ethiopia	Jimma University	Gebresenbet, RF (corresponding author), Armauer Hansen Res Inst, Dept Clin Trial, Addis Ababa, Ethiopia.	redietbibo@gmail.com		Gebresenbet, Rediet/0000-0002-5057-3988				Abegaz T, 2014, ACCIDENT ANAL PREV, P18; African Development Bank Organisation for Economic Co-operation and Development, 2017, PROGRAMMEAFRICAN EC; Al-Mugahed L., 2008, KHAT CHEWING YEMEN T; [Anonymous], HLTH SECT TRANSF PLA; Asefa F, 2014, BIOMEDCENTRAL, P2; Baru A, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-018-0206-1; Boniface R, 2016, PAN AFRICAN MED J, P2; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Deloitte, 2018, EST MACR IMP SECT EO; Eckersley W, 2010, B WORLD HEALTH ORGAN, V88, P235, DOI 10.2471/BLT.09.067512; Federal Democratic Republic of Ethiopia Population Census Commission, 2008, 3 FED DEM REP ETH PO; Guo Y, 2018, ACCIDENT ANAL PREVEN, V113; Guo YY, 2018, TRANSPORT RES F-TRAF, V59, P212, DOI 10.1016/j.trf.2018.09.008; Guo YY, 2018, ACCIDENT ANAL PREV, V115, P118, DOI 10.1016/j.aap.2018.03.006; Hailemichael F, 2015, BMC RES NOTES, P2; Hamilton DL, 2011, SOCIAL COGNITION, SOCIAL IDENTITY, AND INTERGROUP RELATIONS: A FESTSCHRIFT IN HONOR OF MARILYNN B. BREWER, P27; Hassen A, 2011, NO ETHIOPIA BIOMEDCE, P3; International Traffic Safety Data and Analysis Group, REP SER ROAD TRAFF C; Marquez PV, 2013, CHALLENGE NONCOMMUNI; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; Mekonnen FH, 2014, ETHIOP J HEALTH DEV, P4; Milton JC, 2008, ACCIDENT ANAL PREV, P265; Misker D, 2017, 2017 INT J PUBLIC HL, V2, P3; Mogaka EO, 2011, PAN AFRICAN MED J, P2; Mohamed N, ALCOHOL DRUG USE FAT; Mutooro SM, COMP KAMPALA TRAUMA; Nantulya VM, 2012, ROAD TRAFFIC INJURIE; OECD, 2017, OECD UPD 2017; Racioppi F., 2004, PREVENTING ROAD TRAF; Sami A, 2011, CHINESE J TRAUMATOLO, P281; Seid M, 2015, BIOMEDCENTRAL, P5; Seid M, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0035-4; Tiruneh BT, 2014, INCIDENCE ROAD TRAFF, P1; Tulu GS, 2015, TRANSPORT RES REC, P1, DOI 10.3141/2512-01; Tulu GS, 2013, CHARACTERISTICS POLI, P3; Tulu GS, 2016, J TRANSP SAF SECUR, P8, DOI [10.4271/2016-01-1439, DOI 10.4271/2016-01-1439]; WHO, 2015, GLOB STAT REP ROAD S, P130; WHO, 2001, INJ SURV GUID WHO CO; WHO, 2018, TOP 10 CAUS DEATH; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2004, WORLD HEAL J, V1, P11, DOI DOI 10.1089/ACM.2009.0657; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization, 2004, WHO GLOB ACT PLAN LA, V2nd; Zewude BT, 2016, ETHIOPIA J CIVIL ENV, V8, P38; 2009, GLOB STAT REP ROAD S, P1	46	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222793	10.1371/journal.pone.0222793	http://dx.doi.org/10.1371/journal.pone.0222793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557216	Green Published, gold			2022-12-26	WOS:000532345500035
J	Montalbano, A; Mlinar, B; Bonfiglio, F; Polenzani, L; Magnani, M; Corradetti, R				Montalbano, Alberto; Mlinar, Boris; Bonfiglio, Francesco; Polenzani, Lorenzo; Magnani, Maurizio; Corradetti, Renato			Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and alpha(1)-adrenoceptor antagonism	PLOS ONE			English	Article							UNIT-ACTIVITY; BINDING; SLEEP; ANTIDEPRESSANTS; AUTOINHIBITION; AUTORECEPTORS; DEPRESSION; AFFERENTS; MECHANISM; CATS	Trazodone is an antidepressant drug with considerable affinity for 5-HT1A receptors and a alpha(1)-adrenoceptors for which the drug is competitive agonist and antagonist, respectively. In this study, we used cell-attached or whole-cell patch-clamp recordings to characterize the effects of trazodone at somatodendritic 5-HT1A receptors (5-HT(1A)ARs) and alpha(1)-adrenoceptors of serotonergic neurons in rodent dorsal raphe slices. To reveal the effects of trazodone at alpha(1)-adrenoceptors, the baseline firing of 5-HT neurons was facilitated by applying the selective alpha(1)-adrenoceptor agonist phenylephrine at various concentrations. In the absence of phenylephrine, trazodone (1-10 mu M) concentration-dependently silenced neurons through activation of 5-HT1AARs. The effect was fully antagonized by the selective 5-HT1A receptor antagonist Way-100635. With 5-HT1A receptors blocked by Way-100635, trazodone (1-10 mu M) concentration-dependently inhibited neuron firing facilitated by 1 mu M phenylephrine. Parallel rightward shift of dose-response curves for trazodone recorded in higher phenylephrine concentrations (10-100 mu M) indicated competitive antagonism at alpha(1)-adrenoceptors. Both effects of trazodone were also observed in slices from Tph2(-/-) mice that lack synthesis of brain serotonin, showing that the activation of 5-HT(1A)ARs was not mediated by endogenous serotonin. In whole-cell recordings, trazodone activated 5-HT(1A)AR-coupled G protein-activated inwardly-rectifying (GIRK) channel conductance with weak partial agonist efficacy (similar to 35%) compared to that of the full agonist 5-CT. Collectively our data show that trazodone, at concentrations relevant to its clinical effects, exerts weak partial agonism at 5-HT(1A)ARs and disfacilitation of firing through alpha(1)-adrenoceptor antagonism. These two actions converge in inhibiting dorsal raphe serotonergic neuron activity, albeit with varying contribution depending on the intensity of alpha(1)-adrenoceptor stimulation.	[Montalbano, Alberto; Mlinar, Boris; Bonfiglio, Francesco; Corradetti, Renato] Univ Firenze, NEUROFARBA, Dipartimento Neurosci Psicol, Area Farmaco & Salute Bambino, Florence, Italy; [Polenzani, Lorenzo; Magnani, Maurizio] Angelini SpA, Angelini RR&D Res Regulatory & Dev, Rome, Italy	University of Florence	Corradetti, R (corresponding author), Univ Firenze, NEUROFARBA, Dipartimento Neurosci Psicol, Area Farmaco & Salute Bambino, Florence, Italy.	renato.corradetti@unifi.it	Mlinar, Boris/A-7034-2008	Mlinar, Boris/0000-0001-9082-0827	Angelini S.p.A. [039RD15382]	Angelini S.p.A.	This study was funded by Angelini S.p.A., by grant number 039RD15382 awarded to Prof. Renato Corradetti. The funder provided support in the form of salaries for authors L.P and M.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andrade R, 2015, ACS CHEM NEUROSCI, V6, P1110, DOI 10.1021/acschemneuro.5b00034; Araragi N, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00097; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Artigas F, 2018, EUR NEUROPSYCHOPHARM, V28, P445, DOI 10.1016/j.euroneuro.2017.10.032; BARABAN JM, 1981, BRAIN RES, V204, P1, DOI 10.1016/0006-8993(81)90646-6; BARABAN JM, 1980, NEUROPHARMACOLOGY, V19, P355, DOI 10.1016/0028-3908(80)90187-2; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; BLIER P, 1987, SYNAPSE, V1, P470, DOI 10.1002/syn.890010511; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; BOESS FG, 1994, NEUROPHARMACOLOGY, V33, P275, DOI 10.1016/0028-3908(94)90059-0; Cespuglio R, 2018, SLEEP MED, V49, P31, DOI 10.1016/j.sleep.2018.05.034; Chazalon M, 2018, NEUROPHARMACOLOGY, V138, P315, DOI 10.1016/j.neuropharm.2018.06.014; Commons KG, 2019, ACS CHEM NEUROSCI, V10, P3048, DOI 10.1021/acschemneuro.8b00698; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; CRESPI F, 1988, NEUROSCIENCE, V27, P885, DOI 10.1016/0306-4522(88)90191-1; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; Fagiolini A, 2012, CNS DRUGS, V26, P1033, DOI 10.1007/s40263-012-0010-5; Feige B, 2013, INT J PSYCHOPHYSIOL, V89, P171, DOI 10.1016/j.ijpsycho.2013.04.002; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Fornal CA, 1996, J PHARMACOL EXP THER, V278, P752; Ghanbari R, 2010, J PSYCHOPHARMACOL, V24, P39, DOI 10.1177/0269881108095714; Ghanbari R, 2012, EUR NEUROPSYCHOPHARM, V22, P518, DOI 10.1016/j.euroneuro.2011.11.005; Ghanbari R, 2010, J PHARMACOL EXP THER, V335, P197, DOI 10.1124/jpet.110.169417; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hervas I, 2001, NEUROPSYCHOPHARMACOL, V24, P11, DOI 10.1016/S0893-133X(00)00175-5; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; Karhu D, 2010, J CLIN PHARMACOL, V50, P1438, DOI 10.1177/0091270009360979; Kenakin T, 2014, BIOCHEM PHARMACOL, V87, P40, DOI 10.1016/j.bcp.2013.07.033; Lesch KP, 2012, PHILOS T R SOC B, V367, P2426, DOI 10.1098/rstb.2012.0039; LEVINE ES, 1992, J NEUROSCI, V12, P4037; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Mlinar B, 2005, NEUROREPORT, V16, P1351, DOI 10.1097/01.wnr.0000175249.25535.bf; Mlinar B, 2017, EUR NEUROPSYCHOPHARM, V27, P1258, DOI 10.1016/j.euroneuro.2017.10.033; Mlinar B, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00195; Mlinar B, 2015, J GEN PHYSIOL, V145, P225, DOI 10.1085/jgp.201411330; Montalbano A, 2015, EUR NEUROPSYCHOPHARM, V25, P2022, DOI 10.1016/j.euroneuro.2015.08.021; Montalbano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140369; Odagaki Y, 2005, J PSYCHOPHARMACOL, V19, P235, DOI 10.1177/0269881105051526; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Pazzagli M, 1999, EUR J PHARMACOL, V383, P249, DOI 10.1016/S0014-2999(99)00644-5; Peyron C, 1996, J COMP NEUROL, V364, P402; Pineyro G, 1999, PHARMACOL REV, V51, P533; Portella MJ, 2011, J CLIN PSYCHIAT, V72, P962, DOI 10.4088/JCP.09m05827blu; Sakai K, 2000, NEUROREPORT, V11, P3237, DOI 10.1097/00001756-200009280-00037; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; SCUVEEMOREAU J, 1982, ARCH INT PHARMACOD T, V260, P299; Settimo L, 2018, J PSYCHOPHARMACOL, V32, P96, DOI 10.1177/0269881117742101; Sheehan David V, 2009, Psychiatry (Edgmont), V6, P20; Stahl SM, 2009, CNS SPECTRUMS, V14, P536, DOI 10.1017/S1092852900024020; SUNDARAM H, 1993, BIOCHEM PHARMACOL, V45, P1003, DOI 10.1016/0006-2952(93)90243-P; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; WAEBER C, 1995, EUR J PHARMACOL, V283, P31, DOI 10.1016/0014-2999(95)00275-P	54	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222855	10.1371/journal.pone.0222855	http://dx.doi.org/10.1371/journal.pone.0222855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557210	gold, Green Published			2022-12-26	WOS:000532345500042
J	Movsisyan, NK; Petrosyan, V; Abelyan, G; Sochor, O; Baghdasaryan, S; Etter, JF				Movsisyan, Narine K.; Petrosyan, Varduhi; Abelyan, Gohar; Sochor, Ondrej; Baghdasaryan, Satenik; Etter, Jean-Francois			Learning to assist smokers through encounters with standardized patients: An innovative training for physicians in an Eastern European country	PLOS ONE			English	Article							SMOKING-CESSATION; TOBACCO	Objectives A lack of physician training is a major obstacle for effective tobacco dependence treatment. This study assessed the feasibility of an active learning training program and its effects on smoking cessation counselling skills of medical residents in Armenia, an Eastern European country with high smoking prevalence. Study design The study used a pre-post assessment of smoking cessation counselling activities and a course evaluation survey to assess the feasibility of the intervention in a different environment. Methods We adapted an active learning training model developed in Switzerland. Residents were trained in Yerevan, Armenia, using video-taped counselling sessions, role plays, standardized patients (actors), group discussions and immediate feedback. The training evaluation was done using a semi-structured anonymous questionnaire. The study assessed the physicians' self-reported smoking cessation counselling activities before and 6 months after the training. A non-parametric Mann-Whitney test was used to assess pre-post differences in physicians' counselling skills measured on ordinal scale. Results Of the 37 residents trained, 75% were female, 89% aged 20-29 years and 83% were never-smokers. Twenty-eight trainees (76%) returned the course evaluation survey and 32 (86%) answered a questionnaire on skills self-assessment at 6 months follow-up. The majority agreed the course was successful in achieving its learning objectives (64%-96%) and increased their confidence in assisting their patients to quit (74%). After 6 months, the physicians were more likely than at baseline to adhere to evidence-based counselling strategies, including assessing the smoking status and dependence and matching the advice to the patient motivation. The training did not, however, improve the prescription of tobacco dependence medications. Conclusions Six months after the training, several self-reported smoking cessation counselling activities had significantly improved compared to baseline. This training model is acceptable for medical residents in Yerevan, Armenia and offers a promising approach in addressing the lack of physician counselling skills in similar settings and populations.	[Movsisyan, Narine K.; Petrosyan, Varduhi; Abelyan, Gohar] Amer Univ Armenia, Gerald & Patricia Turpanjian Sch Publ Hlth, Yerevan, Armenia; [Movsisyan, Narine K.; Sochor, Ondrej] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Baghdasaryan, Satenik] Yerevan State Med Univ, Dept Postgrad & Continuing Med Educ, Yerevan, Armenia; [Etter, Jean-Francois] Univ Geneva, Fac Med, Inst Global Hlth, Campus Biotech, Geneva, Switzerland	American University of Armenia; St Anne's University Hospital Brno (FNUSA-ICRC); Yerevan State Medical University; University of Geneva	Movsisyan, NK (corresponding author), Amer Univ Armenia, Gerald & Patricia Turpanjian Sch Publ Hlth, Yerevan, Armenia.; Movsisyan, NK (corresponding author), St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.	narinekm@gmail.com	Petrosyan, Varduhi/ABG-2964-2020		Swiss National Science Foundation (SNSF); Swiss Agency for Development and Cooperation (SDC), within the SCOPES 2013-2016 Project, SNSF grant [IZ73Z0_152616]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC), within the SCOPES 2013-2016 Project, SNSF grant	The work of all authors except SB was supported by the Swiss National Science Foundation (SNSF) and the Swiss Agency for Development and Cooperation (SDC), within the SCOPES 2013-2016 Project, SNSF grant IZ73Z0_152616. The SNSF and SDC had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	[Anonymous], 2015, WHO REP GLOB TOB EP; Carson KV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000214.pub2; Cornuz J, 2002, ANN INTERN MED, V136, P429, DOI 10.7326/0003-4819-136-6-200203190-00006; Fiore MC, 2008, TREATING TOBACCO USE; Geller AC, 2005, AM J PUBLIC HEALTH, V95, P950, DOI 10.2105/AJPH.2004.057331; Humair JP, 2003, J GEN INTERN MED, V18, P1023, DOI 10.1111/j.1525-1497.2003.20732.x; Kralikova E, 2009, DRUG ALCOHOL REV, V28, P474, DOI 10.1111/j.1465-3362.2009.00104.x; Ockene JK, 2016, J GEN INTERN MED, V31, P172, DOI 10.1007/s11606-015-3508-y; Reile R, 2018, PUBLIC HEALTH, V161, P1, DOI 10.1016/j.puhe.2018.02.009; Rigotti NA, 2009, ADDICTION, V104, P288, DOI 10.1111/j.1360-0443.2008.02442.x; Steinberg MB, 2007, J GEN INTERN MED, V22, P1459, DOI 10.1007/s11606-007-0282-5; Warren CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-72	12	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222813	10.1371/journal.pone.0222813	http://dx.doi.org/10.1371/journal.pone.0222813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557211	Green Published, gold			2022-12-26	WOS:000532345500036
J	Pinto, I; Duque, M; Goncalves, J; Akkapeddi, P; Oliveira, ML; Cabrita, R; Yunes, JA; Durum, SK; Barata, JT; Fragoso, R				Pinto, Ines; Duque, Mafalda; Goncalves, Joana; Akkapeddi, Padma; Oliveira, Mariana L.; Cabrita, Rita; Yunes, J. Andres; Durum, Scott K.; Barata, Joao T.; Fragoso, Rita			NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling	ONCOGENE			English	Article							ANKYRIN-REPEAT PROTEIN; ENHANCER FACTOR-I; ACTIVATING MUTATIONS; DIFFERENTIATION; NOTCH1/NICD; INHIBITOR; ISOFORM; ENCODES; LEF1	T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with a dismal prognosis in patients with resistant or relapsed disease. Although NOTCH is a known driver in T-ALL, its clinical inhibition has significant limitations. Our previous studies suggested that NRARP, a negative regulator of Notch signaling, could have a suppressive role in T-ALL. Here, we report that NRARP levels are significantly increased in primary T-ALL cells suggesting that NRARP is not sufficient to block NOTCH oncogenic signals. Interestingly, although NRARP overexpression blocks NOTCH1 signaling and delays the proliferation of T-ALL cells that display high levels of Notch1 signaling, it promotes the expansion of T-ALL cells with lower levels of Notch1 activity. We found that NRARP interacts with lymphoid enhancer-binding factor 1 (LEF1) and potentiates Wnt signaling in T-ALL cells with low levels of Notch. Together these results indicate that NRARP plays a dual role in T-ALL pathogenesis, regulating both Notch and Wnt pathways, with opposite functional effects depending on Notch activity. Consistent with this hypothesis, mice transplanted with T-cells co-expressing NOTCH1 and NRARP develop leukemia later than mice transplanted with T-NOTCH1 cells. Importantly, mice transplanted with T-cells overexpressing NRARP alone developed leukemia with similar kinetics to those transplanted with T-NOTCH1 cells. Our findings uncover a role for NRARP in T-ALL pathogenesis and indicate that Notch inhibition may be detrimental for patients with low levels of Notch signaling, which would likely benefit from the use of Wnt signaling inhibitors. Importantly, our findings may extend to other cancers where Notch and Wnt play a role.	[Pinto, Ines; Duque, Mafalda; Goncalves, Joana; Akkapeddi, Padma; Oliveira, Mariana L.; Cabrita, Rita; Barata, Joao T.; Fragoso, Rita] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Yunes, J. Andres] Ctr Infantil Boldrini, Campinas, SP, Brazil; [Yunes, J. Andres] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, Campinas, SP, Brazil; [Durum, Scott K.] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA	Universidade de Lisboa; Universidade Estadual de Campinas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fragoso, R (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal.	arfragoso@medicina.ulisboa.pt	Pinto, Inês/GVT-4690-2022; Fragoso, Rita/ABH-3528-2020; Akkapeddi, Ph.D., Padma/AAX-9406-2021; Fragoso, Rita/O-7164-2019; Gonçalves, Joana/AAL-5516-2020; Barata, Joao/D-9181-2015	Fragoso, Rita/0000-0002-9206-1964; durum, scott/0000-0003-1307-9582; Goncalves, Joana/0000-0003-1997-9514; dos Santos Dias Duque, Mafalda/0000-0002-1459-161X; Oliveira, Mariana/0000-0001-8669-7627; Barata, Joao/0000-0002-4826-8976; Yunes, Jose Andres/0000-0002-1316-3525	Fundacao para a Ciencia e a Tecnologia (FCT) [IF/00788/2013]; European Research Council [ERC CoG-648455]; Marie Curie Protein Conjugates ITN; FCT [PD/BD/114102/2015]; Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado [UID/BIM/50005/2019]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Marie Curie Protein Conjugates ITN; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado	The authors thank the members of the JBarata laboratory for comments and discussions, and Sergio Almeida e Joao Sabino for the valuable help with PLA assays. The authors especially thank the generosity of patients and their families for providing primary samples, and the health care professionals (Service directors, physicians, and nurses) from IPO Lisboa and Centro Infantil Boldrini involved in the collection of those samples. This work was supported by the grant IF/00788/2013 from Fundacao para a Ciencia e a Tecnologia (FCT) awarded to RF and by the consolidator grant ERC CoG-648455 from the European Research Council awarded to JTB. PA is a Marie Curie ITN PhD student, supported by Marie Curie Protein Conjugates ITNand. MLO is a LisbonBioMed student supported by an FCT PhD fellowship (PD/BD/114102/2015). RF and JTB are FCT starting and consolidator investigators, respectively. Publication costs of this work were supported by UID/BIM/50005/2019, project funded by Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado.	Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Arensman MD, 2014, MOL CANCER THER, V13, P2303, DOI 10.1158/1535-7163.MCT-13-1005; Bernasconi-Elias P, 2016, ONCOGENE, V35, P6077, DOI 10.1038/onc.2016.133; Correia NC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31894; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Fullmer Amber, 2009, Curr Hematol Malig Rep, V4, P148, DOI 10.1007/s11899-009-0021-6; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125429; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Jin YH, 2009, MOL CELLS, V27, P15, DOI 10.1007/s10059-009-0001-7; Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002; Kobielak A, 2001, ACTA BIOCHIM POL, V48, P221; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Lahaye K, 2002, MECH DEVELOP, V110, P113, DOI 10.1016/S0925-4773(01)00570-6; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Papayannidis C, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.80; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Roti G, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00170; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Smith Malcolm A, 2009, Curr Hematol Malig Rep, V4, P175, DOI 10.1007/s11899-009-0024-3; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; Squiban B, 2017, LEUKEMIA LYMPHOMA, V58, P2728, DOI 10.1080/10428194.2017.1300896; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Wang WB, 2005, ACTA BIOCH BIOPH SIN, V37, P173, DOI 10.1111/j.1745-7270.2005.00023.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924	35	6	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	5					975	986		10.1038/s41388-019-1042-9	http://dx.doi.org/10.1038/s41388-019-1042-9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KI2VY	31586130	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000511209700002
J	Ferousi, C; Lindhoud, S; Baymann, F; Hester, ER; Reimann, J; Kartal, B				Ferousi, Christina; Lindhoud, Simon; Baymann, Frauke; Hester, Eric R.; Reimann, Joachim; Kartal, Boran			Discovery of a functional, contracted heme-binding motif within a multiheme cytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitrogen metabolism; heme; cytochrome; cytochrome c; electron paramagnetic resonance (EPR); anaerobic ammonium oxidation (anammox); heme proteins; hydrazine synthase (HZS); nitric oxide (NO); nitrogen cycle	NO REDUCTASE-ACTIVITY; NITROSOMONAS-EUROPAEA; ANAEROBIC OXIDATION; STRUCTURAL BASIS; PROTEINS; POTENTIALS; RESOLUTION; LIGATION; AMMONIA; C(554)	Anaerobic ammonium-oxidizing (anammox) bacteria convert nitrite and ammonium via nitric oxide (NO) and hydrazine into dinitrogen gas by using a diverse array of proteins, including numerous c-type cytochromes. Many new catalytic and spectroscopic properties of c-type cytochromes have been unraveled by studies on the biochemical pathways underlying the anammox process. The unique anammox intermediate hydrazine is produced by a multiheme cytochrome c protein, hydrazine synthase, through the comproportionation of ammonium and NO and the input of three electrons. It is unclear how these electrons are delivered to hydrazine synthase. Here, we report the discovery of a functional tetraheme c-type cytochrome from the anammox bacterium Kuenenia stuttgartiensis with a naturally-occurring contracted Cys?Lys?Cys?His (CKCH) heme-binding motif, which is encoded in the hydrazine synthase gene cluster. The purified tetraheme protein (named KsTH) exchanged electrons with hydrazine synthase. Complementary spectroscopic techniques revealed that this protein harbors four low-spin hexa-coordinated hemes with His/Lys (heme 1), His/Cys (heme 2), and two His/His ligations (hemes 3 and 4). A genomic database search revealed that c-type cytochromes with a contracted CXCH heme-binding motif are present throughout the bacterial and archaeal domains in the tree of life, suggesting that this heme recognition site may be employed by many different groups of microorganisms.	[Ferousi, Christina; Lindhoud, Simon; Hester, Eric R.; Reimann, Joachim] Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 AL Nijmegen, Netherlands; [Baymann, Frauke] AMU, UMR 7281, CNRS, Lab Bioenerget & Ingn Prot, Marseille 09, France; [Kartal, Boran] Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Celciusstr 1, D-28359 Bremen, Germany; [Lindhoud, Simon] Wageningen Univ, Lab Biochem, NL-6708 WE Wageningen, Netherlands; [Ferousi, Christina] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Wageningen University & Research; Cornell University	Reimann, J (corresponding author), Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 AL Nijmegen, Netherlands.; Baymann, F (corresponding author), AMU, UMR 7281, CNRS, Lab Bioenerget & Ingn Prot, Marseille 09, France.; Kartal, B (corresponding author), Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Celciusstr 1, D-28359 Bremen, Germany.	baymann@imm.cnrs.fr; jokelreimann@gmail.com; bkartal@mpi-bremen.de	Kartal, Boran/ABD-5400-2021	Ferousi, Christina/0000-0001-6400-7373; Hester, Eric/0000-0002-5232-5574; Kartal, Boran/0000-0003-4199-952X	CNRS [TGE RPE FR3443]	CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank Wolfgang Nitschke for insightful discussions. Guylaine Nuijten is acknowledged for maintenance of the K. stuttgartiensis culture. We thank M. S. M. Jetten for discussions and support. We acknowledge Hans Wessels for carrying out the MS/MS analysis. EPR work was supported by TGE RPE FR3443 from CNRS and the EPR facilities of Aix-Marseille University.	Akram M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4310; Amacher JF, 2015, J AM CHEM SOC, V137, P8435, DOI 10.1021/jacs.5b01493; ANDERSSON KK, 1986, J BIOL CHEM, V261, P1126; Aragao D, 2003, ACTA CRYSTALLOGR D, V59, P644, DOI 10.1107/S090744490300194X; ARCIERO DM, 1991, BIOCHEMISTRY-US, V30, P11459, DOI 10.1021/bi00112a013; Arp DJ, 2007, ANNU REV MICROBIOL, V61, P503, DOI 10.1146/annurev.micro.61.080706.093449; BAYMANN F, 1991, ANAL BIOCHEM, V199, P269, DOI 10.1016/0003-2697(91)90100-8; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan L, 2001, J MOL BIOL, V308, P353, DOI 10.1006/jmbi.2001.4600; BUTT WD, 1962, PROC R SOC SER B-BIO, V156, P429, DOI 10.1098/rspb.1962.0049; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; de Almeida NM, 2016, BBA-BIOENERGETICS, V1857, P1694, DOI 10.1016/j.bbabio.2016.07.006; Dietl A, 2015, NATURE, V527, P404, DOI 10.1038/nature15517; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ettwig KF, 2016, P NATL ACAD SCI USA, V113, P12792, DOI 10.1073/pnas.1609534113; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Frank J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23053-7; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Hu Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09268-w; Ishida M, 2004, BIOCHEMISTRY-US, V43, P9823, DOI 10.1021/bi049546e; Iverson TM, 2001, J BIOL INORG CHEM, V6, P390, DOI 10.1007/s007750100213; Kartal B, 2016, TRENDS BIOCHEM SCI, V41, P998, DOI 10.1016/j.tibs.2016.08.015; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Khmelenina V. N., 2018, AEROBIC UTILIZATION, P1; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Kleingardner JG, 2011, METALLOMICS, V3, P396, DOI 10.1039/c0mt00086h; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liu J, 2014, CHEM REV, V114, P4366, DOI 10.1021/cr400479b; Maalcke WJ, 2016, J BIOL CHEM, V291, P17077, DOI 10.1074/jbc.M116.735530; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; McGarry JM, 2018, J BIOL INORG CHEM, V23, P861, DOI 10.1007/s00775-018-1582-4; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Motomura T, 2017, J BIOL CHEM, V292, P9599, DOI 10.1074/jbc.M116.746263; Na SI, 2018, J MICROBIOL, V56, P280, DOI 10.1007/s12275-018-8014-6; PALMER G, 1985, BIOCHEM SOC T, V13, P548, DOI 10.1042/bst0130548; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; UBBINK M, 1994, BIOCHEMISTRY-US, V33, P10051, DOI 10.1021/bi00199a032; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; Upadhyay AK, 2003, J AM CHEM SOC, V125, P1738, DOI 10.1021/ja020922x; Upadhyay AK, 2006, J AM CHEM SOC, V128, P4330, DOI 10.1021/ja055183+; YAMANAKA T, 1974, J BIOCHEM-TOKYO, V75, P1265, DOI 10.1093/oxfordjournals.jbchem.a130510; Zhong FF, 2018, INORG CHEM, V57, P5754, DOI 10.1021/acs.inorgchem.8b00010; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	53	11	12	11	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16953	16965		10.1074/jbc.RA119.010568	http://dx.doi.org/10.1074/jbc.RA119.010568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31582564	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000501801900039
J	Musilova, J; Mulcahy, ME; Kuijk, MM; McLoughlin, RM; Bowie, AG				Musilova, Jana; Mulcahy, Michelle E.; Kuijk, Marieke M.; McLoughlin, Rachel M.; Bowie, Andrew G.			Toll-like receptor 2?dependent endosomal signaling by Staphylococcus aureus in monocytes induces type I interferon and promotes intracellular survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; host-pathogen interaction; Toll-like receptor (TLR); Staphylococcus aureus (S; aureus); monocyte; interferon; infectious disease; immune evasion; nonprofessional phagocyte	IFN-BETA PRODUCTION; MYD88 ADAPTER-LIKE; DENDRITIC CELLS; TLR2; TRAM; MANIPULATION; CONTRIBUTES; MACROPHAGES; INFECTIONS; ACTIVATION	Pathogen activation of innate immune pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) stimulates cellular signaling pathways. This often leads to outcomes that contribute to pathogen clearance. Alternatively, activation of specific PRR pathways can aid pathogen survival. The human pathogen Staphylococcus aureus is a case in point, employing strategies to escape innate immune recognition and killing by the host. As for other bacteria, PRR-stimulated type I interferon (IFN-I) induction has been proposed as one such immune escape pathway that may favor S. aureus. Cell wall components of S. aureus elicit TLR2-dependent cellular responses, but the exact signaling pathways activated by S. aureus?TLR2 engagement and the consequences of their activation for the host and bacterium are not fully known. We previously showed that TLR2 activates both a cytoplasmic and an endosome-dependent signaling pathway, the latter leading to IFN-I production. Here, we demonstrate that S. aureus infection of human monocytes activates a TLR2-dependent endosomal signaling pathway, leading to IFN-I induction. We mapped the signaling components of this pathway and identified roles in IFN-I stimulation for the Toll-interleukin-1 receptor (TIR) adaptor Myd88 adaptor-like (Mal), TNF receptor-associated factor 6 (TRAF6), and I?B kinase (IKK)-related kinases, but not for TRIF-related adaptor molecule (TRAM) and TRAF3. Importantly, monocyte TLR2-dependent endosomal signaling enabled immune escape for S. aureus, because this pathway, but not IFN-I per se, contributed to intracellular bacterial survival. These results reveal a TLR2-dependent mechanism in human monocytes whereby S. aureus manipulates innate immune signaling for its survival in cells.	[Musilova, Jana; Mulcahy, Michelle E.; Kuijk, Marieke M.; McLoughlin, Rachel M.; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	agbowie@tcd.ie		McLoughlin, Rachel/0000-0003-4553-018X; Kuijk, Marieke/0000-0001-8763-2702; Musilova, Jana/0000-0003-2238-0668; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [15/IA/3041, 11/PI/1056, 16/IA/4376]; Wellcome Investigator Award [202846/Z/16/Z]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Investigator Award	This work was supported by Science Foundation Ireland Grants 15/IA/3041 (to R. M. M.) and 11/PI/1056 and 16/IA/4376 (to A. G. B.) and Wellcome Investigator Award (202846/Z/16/Z) (to R. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Bravo-Santano N, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00374-18; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Gries CM, 2016, INFECT IMMUN, V84, P3564, DOI 10.1128/IAI.00447-16; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Israel L, 2017, CELL, V168, P789, DOI 10.1016/j.cell.2017.01.039; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaplan A, 2012, J IMMUNOL, V189, P4537, DOI 10.4049/jimmunol.1201111; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Melzer M, 2013, J HOSP INFECT, V84, P143, DOI 10.1016/j.jhin.2012.12.013; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Neumann Y, 2016, AUTOPHAGY, V12, P2069, DOI 10.1080/15548627.2016.1226732; Nilsen NJ, 2015, J BIOL CHEM, V290, P3209, DOI 10.1074/jbc.M114.593426; O'Keeffe KM, 2015, INFECT IMMUN, V83, P3445, DOI 10.1128/IAI.00358-15; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Olivier AC, 2009, J INFECT DIS, V200, P1367, DOI 10.1086/606012; Parker D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003951; Parker D, 2012, J IMMUNOL, V189, P4040, DOI 10.4049/jimmunol.1201055; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pietrocola G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00166; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Scumpia PO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006496; Stack J, 2014, J IMMUNOL, V193, P6090, DOI 10.4049/jimmunol.1401605; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	50	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17031	17042		10.1074/jbc.RA119.009302	http://dx.doi.org/10.1074/jbc.RA119.009302			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31558608	Green Published, hybrid			2022-12-26	WOS:000501801900045
J	Hansson, E; Skioldebrand, E				Hansson, Elisabeth; Skioldebrand, Eva			Anti-inflammatory effects induced by ultralow concentrations of bupivacaine in combination with ultralow concentrations of sildenafil (Viagra) and vitamin D3 on inflammatory reactive brain astrocytes	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IN-VITRO; PAIN; CYTOSKELETON; MECHANISM; RESPONSES; NALOXONE; GLIA; CGMP; CA2+	Network coupled cells, such as astrocytes, regulate their cellular homeostasis via Ca2+ signals spread between the cells through gap junctions. Intracellular Ca2+ release is controlled by different signaling pathways that can be stimulated by ATP, glutamate and serotonin (5-HT). Based on our findings, all these pathways are influenced by inflammatory agents and must be restored to fully recover the Ca2+ signaling network. An ultralow concentration of the local anesthetic agent bupivacaine reduced 5-HT-evoked intracellular Ca2+ release, and an ultralow concentration of the phosphodiesterase-5 inhibitor sildenafil in combination with vitamin D3 reduced ATP-evoked intracellular Ca2+ release. Combinations of these three substances downregulated 5-HT-, glutamate- and ATP-evoked intracellular Ca2+ release to a more normal Ca2+ signaling state. Furthermore, inflammatory Toll-like receptor 4 expression decreased with a combination of these three substances. Substance P receptor neurokinin (NK)-1 expression was reduced by ultralow concentrations of bupivacaine. Here, bupivacaine and sildenafil (at extremely low concentrations) combined with vitamin D3 have potential anti-inflammatory properties. According to the present study, drug combinations at the right concentrations, especially extremely low concentrations of bupivacaine and sildenafil, affect different cellular biochemical mechanisms and represent a potential solution for downregulating inflammatory parameters, thereby restoring cells or networks to normal physiological homeostasis.	[Hansson, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Skioldebrand, Eva] Swedish Univ Agr Sci, Inst Biomed Sci & Vet Publ Hlth, Dept Pathol, Uppsala, Sweden; [Skioldebrand, Eva] Gothenburg Univ, Sahlgrenska Univ Hosp, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden	University of Gothenburg; Swedish University of Agricultural Sciences; Sahlgrenska University Hospital; University of Gothenburg	Hansson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	elisabeth.hansson@neuro.gu.se		Skioldebrand, Eva/0000-0002-1572-9932; Hansson, Elisabeth/0000-0003-0610-9114	Edit Jacobsson's Foundation, Gothenburg, Sweden; AFA Insurance, Stockholm, Sweden	Edit Jacobsson's Foundation, Gothenburg, Sweden; AFA Insurance, Stockholm, Sweden	Edit Jacobsson's Foundation, Gothenburg, Sweden, EH, and AFA Insurance, Stockholm, Sweden, EH.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adamczak DM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112252; Beamer E, 2017, BRAIN RES BULL, V135, P129, DOI 10.1016/j.brainresbull.2017.10.006; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Block L, 2013, NEUROSCIENCE, V250, P536, DOI 10.1016/j.neuroscience.2013.07.033; Block L, 2015, CLIN J PAIN, V31, P968, DOI 10.1097/AJP.0000000000000200; Block L, 2013, EUR J NEUROSCI, V38, P3669, DOI 10.1111/ejn.12364; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Chatton JY, 2016, GLIA, V64, P1667, DOI 10.1002/glia.22971; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Nunes AKD, 2016, NEUROSCI LETT, V630, P59, DOI 10.1016/j.neulet.2016.07.029; DeLuca GC, 2013, NEUROPATH APPL NEURO, V39, P458, DOI 10.1111/nan.12020; Enkhjargal B, 2017, J CEREBR BLOOD F MET, V37, P2555, DOI 10.1177/0271678X16671147; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Giaume C, 2012, J PHYSIOL-PARIS, V106, P34, DOI 10.1016/j.jphysparis.2011.09.001; Hansson E, 2008, NEUROSCIENCE, V155, P1237, DOI 10.1016/j.neuroscience.2008.04.027; Hansson E, 2006, ACTA PHYSIOL, V187, P321, DOI 10.1111/j.1748-1716.2006.01568.x; Hansson E, 2019, SCAND J PAIN; Hansson E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1361-8; Hansson E, 2016, IBRO REP, V1, P1, DOI 10.1016/j.ibror.2016.06.001; Hansson E, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0091-2; Hansson E, 2010, SCAND J PAIN, V1, P67, DOI 10.1016/j.sjpain.2010.01.002; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hildebrand KR, 2001, CLIN J PAIN, V17, P239, DOI 10.1097/00002508-200109000-00009; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Jiao KP, 2017, NEUROREPORT, V28, P492, DOI 10.1097/WNR.0000000000000782; Jo WK, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00268, 10.3382/fncel.2015.00268]; Lacagnina MJ, 2018, PHARMACOL THERAPEUT, V184, P145, DOI 10.1016/j.pharmthera.2017.10.006; Li F, 2015, INT J MOL MED, V36, P967, DOI 10.3892/ijmm.2015.2318; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Peixoto CA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/940207; Peixoto CA, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0099-7; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Raposo C, 2014, BRAIN RES BULL, V104, P60, DOI 10.1016/j.brainresbull.2014.04.002; Ronnback C, 2017, INT J OPEN ACCESS OP, V2, P7, DOI [10.15226/2474-9249/2/1/00117, DOI 10.15226/2474-9249/2/1/00117]; Ronnback C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00533; Rotter Sopasakis V, 2018, CARTILAGE, P1, DOI 10.1177/|9476035|8770256; Nunes AKS, 2015, BRAIN RES, V1627, P119, DOI 10.1016/j.brainres.2015.09.008; Shim S, 2016, SCHIZOPHR RES, V170, P226, DOI 10.1016/j.schres.2015.11.015; Thakur KK, 2017, PHARMACOL RES, V115, P224, DOI 10.1016/j.phrs.2016.11.019; TODA S, 2011, MOL PAIN, V7, DOI DOI 10.1186/1744-8069-7-1; Vardjan N, 2015, NEUROCHEM RES, V40, P2414, DOI 10.1007/s11064-015-1545-x; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Zhang JL, 2017, EXP THER MED, V13, P1074, DOI 10.3892/etm.2017.4058	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223648	10.1371/journal.pone.0223648	http://dx.doi.org/10.1371/journal.pone.0223648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596904	Green Published, gold			2022-12-26	WOS:000532444100054
J	Sekizuka, T; Iguchi, S; Umeyama, T; Inamine, Y; Makimura, K; Kuroda, M; Miyazaki, Y; Kikuchi, K				Sekizuka, Tsuyoshi; Iguchi, Shigekazu; Umeyama, Takashi; Inamine, Yuba; Makimura, Koichi; Kuroda, Makoto; Miyazaki, Yoshitsugu; Kikuchi, Ken			Clade II Candida auris possess genomic structural variations related to an ancestral strain	PLOS ONE			English	Article							ALS GENE FAMILY; CLONAL STRAIN; RESISTANCE; EMERGENCE; SUSCEPTIBILITY; HAEMULONII; MECHANISMS; AGENTS	Candida auris is an invasive and multidrug-resistant ascomycetous yeast that is under global surveillance. All clinical cases of C. auris infection diagnosed from 1997 to 2019 in Japan were non-invasive and sporadic otitis media cases. In the present study, we performed whole-genome sequencing of seven C. auris strains isolated from patients with otitis media in Japan, all of which belonged to clade II. Comparative genome analysis using the high-quality draft genome sequences JCM 15448(T) revealed that single nucleotide variations (SNVs), clade-specific accessory genes, and copy number variations (CNVs) were identified in each C. auris clade. A total of 61 genes involved in cell wall and stress response-related functions was absent in clade II, and the pattern of conserved CNVs in each clade was more stable in clade II than in other clades. Our data suggest that the genomic structural diversity is stable in C. auris isolated from each biogeographic location, and Japanese strains isolated from patients with otitis media might belong to an ancestral type of C. auris. One Japanese strain, TWCC 58362, with reduced susceptibility to fluconazole, exhibited no mutation in ergosterol biosynthesis-related genes (ERG). However, TWCC 58362-specific variations, including SNVs, indels, and CNVs were detected, suggesting that gene duplication events in C. auris might contribute to antifungal drug resistance. Taken together, we demonstrated that genomic structural variations in C. auris could correlate to geographical dissemination, epidemiology, lesions in the host, and antifungal resistance.	[Sekizuka, Tsuyoshi; Inamine, Yuba; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Iguchi, Shigekazu; Kikuchi, Ken] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Umeyama, Takashi; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Makimura, Koichi] Teikyo Univ, Grad Sch Med, Dept Med Mycol, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Tokyo Women's Medical University; National Institute of Infectious Diseases (NIID); Teikyo University	Sekizuka, T (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.; Kikuchi, K (corresponding author), Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan.	sekizuka@niid.go.jp; kikuchi.ken@twmu.ac.jp		Kikuchi, Ken/0000-0002-3165-8206; Sekizuka, Tsuyoshi/0000-0002-1302-5472; miyazaki, yoshitsugu/0000-0001-8942-0869; Umeyama, Takashi/0000-0002-6635-4288	Japan Agency for Medical Research and Development, AMED [JP19fk0108048, JP19fk0108103, JP18fk0108045]	Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Japan Agency for Medical Research and Development, AMED (JP19fk0108048 and JP19fk0108103 to MK, and JP18fk0108045 to YM and KK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Borman AM, 2017, MED MYCOL, V55, P563, DOI 10.1093/mmy/myw147; Borman AM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00189-16; Calvo B, 2016, J INFECTION, V73, P369, DOI 10.1016/j.jinf.2016.07.008; Chatterjee S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1863-z; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Dominguez EG, 2019, MSPHERE, V4, DOI 10.1128/mSphereDirect.00680-18; Dwivedi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016218; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escandon P, 2019, CLIN INFECT DIS, V68, P15, DOI 10.1093/cid/ciy411; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Iguchi S, 2019, J INFECT CHEMOTHER, V25, P743, DOI 10.1016/j.jiac.2019.05.034; Iguchi S, 2018, JPN J INFECT DIS, V71, P174, DOI [10.7883/yoken.jjid.2017.466, 10.7883/yoken.JJID.2017.466]; Ishikane M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165346; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katchman E, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.11.009; Kato Kengo, 2017, Journal of Biological Methods, V4, pe79, DOI 10.14440/jbm.2017.169; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kolondra A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2078-z; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Koskiniemi S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002787; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwon YJ, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01624-18; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee WG, 2011, J CLIN MICROBIOL, V49, P3139, DOI 10.1128/JCM.00319-11; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Luo GPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025909; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Magobo RE, 2014, EMERG INFECT DIS, V20, P1250, DOI 10.3201/eid2007.131765; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Morales-Lopez SE, 2017, EMERG INFECT DIS, V23, P162, DOI 10.3201/eid2301.161497; Munoz JF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07779-6; Murciano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033362; Oh BJ, 2011, MED MYCOL, V49, P98, DOI 10.3109/13693786.2010.493563; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Rhodes J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0045-x; Saris K, 2018, CURR OPIN INFECT DIS, V31, P334, DOI 10.1097/QCO.0000000000000469; Sarma S, 2013, INDIAN J MED MICROBI, V31, P90, DOI 10.4103/0255-0857.108746; Sarma S, 2017, INFECT DRUG RESIST, V10, P155, DOI 10.2147/IDR.S116229; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Schelenz S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0132-5; Sharma C, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00722-15; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vallabhaneni S, 2017, AM J TRANSPLANT, V17, P296, DOI 10.1111/ajt.14121; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Won EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118770; YAMAGUCHI H., 2012, MED MYCOL RES, V3, P17; Yang F, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00071-17; Yang F, 2013, ANTIMICROB AGENTS CH, V57, P5026, DOI 10.1128/AAC.00516-13	71	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223433	10.1371/journal.pone.0223433	http://dx.doi.org/10.1371/journal.pone.0223433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596885	Green Published, gold			2022-12-26	WOS:000532444100032
J	Tey, SL; Chew, STH; How, CH; Yalawar, M; Baggs, G; Chow, WL; Cheong, M; San Ong, RH; Husain, FS; Kwan, SC; Tan, CYL; Low, YL; Tan, NC; Huynh, DTT				Tey, Siew Ling; Chew, Samuel Teong Huang; How, Choon How; Yalawar, Menaka; Baggs, Geraldine; Chow, Wai Leng; Cheong, Magdalin; San Ong, Rebecca Hui; Husain, Farah Safdar; Kwan, Shuyi Charmaine; Tan, Cynthia Yan Ling; Low, Yen Ling; Ngiap Chuan Tan; Dieu Thi Thu Huynh			Factors associated with muscle mass in community-dwelling older people in Singapore: Findings from the SHIELD study	PLOS ONE			English	Article							KOREA NATIONAL-HEALTH; HYDROXY-BETA-METHYLBUTYRATE; SERUM 25-HYDROXYVITAMIN D; PHYSICAL-ACTIVITY SCALE; ASIAN WORKING GROUP; VITAMIN-D; REFERENCE VALUES; ELDERLY PASE; RISK-FACTORS; CHINESE MEN	Objectives Aging is associated with low muscle mass and has been linked to adverse health outcomes. The objectives of this cross-sectional study were: (1) to describe anthropometry, body composition, appendicular skeletal muscle mass index (ASMI; appendicular skeletal muscle mass/height(2)), and prevalence of low ASMI in older people with normal nutritional status (Malnutrition Universal Screening Tool score = 0); (2) to determine factors associated with ASMI, and odds ratios of having low ASMI. Methods SHIELD is a study of community-dwelling older people aged 65 years and above in Singapore. ASMI was determined using bioelectrical impedance analysis and low ASMI was defined as < 7.0 kg/m(2) for males and < 5.7 kg/m(2) for females (Asian Working Group for Sarcopenia, 2014). Results A total of 400 older people (183 males and 217 females) took part in this study. The overall prevalence of low ASMI was 20.6% (15.5% in males and 24.9% in females). Females had significantly lower ASMI than males (P < 0.0001), age was inversely associated with ASMI (P = 0.0024) while BMI and calf circumference were positively associated with ASMI (both P < 0.0001) in the total cohort. In addition, ASMI was positively associated with bone mass in both genders (both P < 0.0001). After adjusting for covariates, the odds ratios of having low ASMI with every 1 year and 10 years increase in age were 1.13 (95% CI: 1.06, 1.20) and 3.36 (95% CI: 1.82, 6.21) respectively. Conclusions The high prevalence of low ASMI in community-dwelling older people with normal nutritional status highlights the need for early screening. There was a strong inverse association between age and ASMI while BMI, calf circumference and bone mass were positively associated with ASMI. These findings will give further weight to the importance and development of public health strategies in maintaining and improving muscle health in this population group.	[Tey, Siew Ling; Low, Yen Ling; Dieu Thi Thu Huynh] Asia Pacific Ctr, Abbott Nutr Res & Dev, Singapore, Singapore; [Chew, Samuel Teong Huang] Changi Gen Hosp, Dept Geriatr Med, Singapore, Singapore; [How, Choon How] Changi Gen Hosp, Care & Hlth Integrat, Singapore, Singapore; [How, Choon How; Ngiap Chuan Tan] SingHlth Duke NUS Family Med Acad Clin Program, Singapore, Singapore; [Yalawar, Menaka] Cognizant Technol Solut Pvt Ltd, Stat Serv, Bangalore, Karnataka, India; [Baggs, Geraldine] Abbott Nutr Res & Dev, Columbus, OH USA; [Chow, Wai Leng; San Ong, Rebecca Hui] Changi Gen Hosp, Hlth Serv Res, Singapore, Singapore; [Cheong, Magdalin] Changi Gen Hosp, Dept Dietet & Food Serv, Singapore, Singapore; [Husain, Farah Safdar; Kwan, Shuyi Charmaine; Tan, Cynthia Yan Ling; Ngiap Chuan Tan] SingHlth Polyclin, Singapore, Singapore	Changi General Hospital; Changi General Hospital; Changi General Hospital; Changi General Hospital	Tey, SL (corresponding author), Asia Pacific Ctr, Abbott Nutr Res & Dev, Singapore, Singapore.	siewling.tey@abbott.com	Chew, Samuel TH/AAC-9562-2021; Tey, Siew Ling/AAV-8115-2021; Chew, Samuel/AAD-6831-2022	Chew, Samuel TH/0000-0003-2810-1332; Chew, Samuel/0000-0003-2810-1332; Tey, Siew Ling/0000-0002-5064-5283; Ong Hui Shan, Rebecca/0000-0001-8978-0557	Economic Development Board of Singapore; Abbott Nutrition Research and Development, and Changi General Hospital	Economic Development Board of Singapore(Singapore Economic Development Board); Abbott Nutrition Research and Development, and Changi General Hospital	This study was supported by the Economic Development Board of Singapore, Abbott Nutrition Research and Development, and Changi General Hospital. Abbott Nutrition Research and Development provided support in the form of salaries for authors [SLT, GB, YLL, and DTTH]. Abbott Nutrition Research and Development and Changi General Hospital were involved in the study design, data collection and analysis, or preparation of the manuscript. Cognizant Technologies Solution Pvt. Ltd. is not one of the funders and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cognizant Technologies Solution Pvt. Ltd. is a Contract Research Organization, which provides statistical services to Abbott Nutrition. Cognizant Technologies Solution Pvt. Ltd. provided support in the form of salaries for author [YM]. The specific roles of these authors are articulated in the `author contributions' section.	Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; [Anonymous], 2018, CLIN NUTR; Auyeung TW, 2014, GERIATR GERONTOL INT, V14, P76, DOI 10.1111/ggi.12213; Batsis JA, 2014, J NUTR HEALTH AGING, V18, P123, DOI 10.1007/s12603-013-0366-3; Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Bear DE, 2019, AM J CLIN NUTR, V109, P1119, DOI 10.1093/ajcn/nqy373; Beaudart C, 2017, OSTEOPOROSIS INT, V28, P1817, DOI 10.1007/s00198-017-3980-9; Benedetti MG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4840531; Biben V., 2017, Asian Journal of Epidemiology, V10, P63, DOI 10.3923/aje.2017.63.69; Bloom I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030308; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268; Carlson BW, 2019, ENCY BRITTANICA; Cereda E, 2016, CLIN NUTR, V35, P1282, DOI 10.1016/j.clnu.2016.03.008; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2017, NUTR J, V16, DOI 10.1186/s12937-016-0224-3; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chen LK, 2016, J AM MED DIR ASSOC, V17, P5; Cheng Q, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0632-z; Cheng Q, 2014, J BONE MINER METAB, V32, P78, DOI 10.1007/s00774-013-0468-3; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9; Deutz NEP, 2019, J AM MED DIR ASSOC, V20, P22, DOI 10.1016/j.jamda.2018.11.021; Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007; Dewansingh P, 2018, NUTR RES, V49, P1, DOI 10.1016/j.nutres.2017.08.004; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Foong YC, 2016, J CACHEXIA SARCOPENI, V7, P275, DOI 10.1002/jcsm.12065; Han PP, 2016, J GERONTOL A-BIOL, V71, P529, DOI 10.1093/gerona/glv108; Hanach NI, 2019, ADV NUTR, V10, P59, DOI 10.1093/advances/nmy065; Hayashida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111810; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hong Sangmo, 2016, Osteoporos Sarcopenia, V2, P103, DOI 10.1016/j.afos.2016.04.002; Huang C., 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.; Huh JH, 2014, OSTEOPOROSIS INT, V25, P1053, DOI 10.1007/s00198-013-2531-2; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Ismail N, 2015, ASIA-PAC J PUBLIC HE, V27, p62S, DOI 10.1177/1010539515590179; Jang IY, 2018, CLIN INTERV AGING, V13, P91, DOI 10.2147/CIA.S155619; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kanehisa H, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-4; Kawakami R, 2015, GERIATR GERONTOL INT, V15, P969, DOI 10.1111/ggi.12377; Kim MK, 2011, J CLIN ENDOCR METAB, V96, P3250, DOI 10.1210/jc.2011-1602; Kim S, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e151; Kim S, 2014, J KOREAN MED SCI, V29, P995, DOI 10.3346/jkms.2014.29.7.995; Ko MJ, 2015, BRIT J NUTR, V114, P1838, DOI 10.1017/S0007114515003633; Komar B, 2015, J NUTR HEALTH AGING, V19, P437, DOI 10.1007/s12603-014-0559-4; Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213; Lee SY, 2018, J AM MED DIR ASSOC, V19, P378, DOI 10.1016/j.jamda.2018.02.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu G, 2014, J ACAD NUTR DIET, V114, P1544, DOI 10.1016/j.jand.2014.05.012; Liu LK, 2013, GERIATR GERONTOL INT, V13, P964, DOI 10.1111/ggi.12040; Maeda K, 2017, ANN NUTR METAB, V71, P10, DOI 10.1159/000478707; Makizako H, 2017, J CACHEXIA SARCOPENI, V8, P607, DOI 10.1002/jcsm.12197; MAUREL DB, 2017, BIOMEDICINES, V5, DOI DOI 10.1016/J.52452; Meng LP, 2017, ASIA PAC J CLIN NUTR, V26, P849, DOI 10.6133/apjcn.072016.13; Moon SS, 2014, ENDOCR J, V61, P61, DOI 10.1507/endoc; Morley JE, 2017, CURR OPIN CLIN NUTR, V20, P1, DOI 10.1097/MCO.0000000000000330; Novotny SA, 2015, PHYSIOLOGY, V30, P8, DOI 10.1152/physiol.00033.2014; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; Pongchaiyakul C, 2013, J BONE MINER METAB, V31, P346, DOI 10.1007/s00774-013-0422-4; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Ryu M, 2013, AGE AGEING, V42, P734, DOI 10.1093/ageing/aft063; Sampaio RAC, 2014, GERIATR GERONTOL INT, V14, P109, DOI 10.1111/ggi.12206; Sanz-Paris A, 2018, J NUTR HEALTH AGING, V22, P664, DOI 10.1007/s12603-018-0995-7; Seino S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131975; Sergi G, 2017, AGING CLIN EXP RES, V29, P591, DOI 10.1007/s40520-016-0622-6; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shams-White MM, 2017, AM J CLIN NUTR, V105, P1528, DOI 10.3945/ajcn.116.145110; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Shimokata H, 2014, GERIATR GERONTOL INT, V14, P85, DOI 10.1111/ggi.12219; Singapore Department of Statistics, 2018, BAYESASS3 SNPS; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Tai V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4183; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Volkert D, 2019, CLIN NUTR, V38, P10, DOI 10.1016/j.clnu.2018.05.024; Wang H, 2019, J NUTR HEALTH AGING, V23, P14, DOI 10.1007/s12603-018-1088-3; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WHO, 2011, GLOBAL HLTH AGING; Woo J, 2018, CURR OPIN CLIN NUTR, V21, P19, DOI 10.1097/MCO.0000000000000432; World Health Organization, 2017, INT CAR OLD PEOPL GU; Wu HM, 2015, ARCH GERONTOL GERIAT, V61, P168, DOI 10.1016/j.archger.2015.06.020; Xu HQ, 2018, ARCH OSTEOPOROS, V14, DOI 10.1007/s11657-018-0545-2; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Yamada Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070809; Yap K. B., 2007, SMJ Singapore Medical Journal, V48, P911; Yoo JI, 2018, ASIA PAC J CLIN NUTR, V27, P527, DOI 10.6133/apjcn.082017.02; Zeng P, 2015, ARCH GERONTOL GERIAT, V60, P118, DOI 10.1016/j.archger.2014.08.010; Zou L, 2017, INT J ENV RES PUB HE, P14	93	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223222	10.1371/journal.pone.0223222	http://dx.doi.org/10.1371/journal.pone.0223222			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596873	Green Published, gold			2022-12-26	WOS:000532444100023
J	Brucher, VC; Storp, JJ; Kerschke, L; Nelis, P; Eter, N; Alnawaiseh, M				Bruecher, Viktoria C.; Storp, Jens J.; Kerschke, Laura; Nelis, Pieter; Eter, Nicole; Alnawaiseh, Maged			Influence of mydriasis on optical coherence tomography angiography imaging in patients with age-related macular degeneration	PLOS ONE			English	Article							NERVE-FIBER LAYER; THICKNESS MEASUREMENTS; PUPIL-DILATION; VASCULAR DENSITY; CHORIOCAPILLARIS; REPEATABILITY; DOMAIN; REPRODUCIBILITY; ARTIFACTS; CATARACT	Purpose To evaluate the effect of topical mydriatic eye drops on optical coherence tomography angiography (OCTA) parameters in patients with age-related macular degeneration (AMD). Methods 27 eyes of 27 patients suffering from AMD were included in this cross-sectional study. Patients with >=-4.5 diopters spherical equivalent, corneal opacities or dense cataract preventing high-quality imaging were excluded. Whole-en-face scans of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in the central 3x3mm foveal region as well as whole-en-face and peripapillary scans of the radial peripapillary capillaries (RPC) were generated using OCTA (AngioVue (R), Optovue). Imaging was first conducted with patients' eyes in miosis, then in mydriasis after instillation of a dilating eye drop (0.5% tropicamide, 2.5% phenylephrine-HCl). Main outcome measures were flow density (FD), foveal avascular zone (FAZ), signal strength index (SSI) and motion artifact score (MAS). Results Our results reveal that in AMD patients there is no significant difference between FD measurements taken in miosis and those taken in mydriasis around the SCP (p = 0.198), DCP (p = 0.458), RPC whole-en-face (p = 0.275) and RPC peripapillary (p = 0.503). Measurements taken in these two states appear to be equivalent for assessment of FD (90%CI within +/- 0.05). No significant difference was found either in the area of the FAZ (p = 0.338) or in the SSI (p = 0.371) before and after the instillation of tropicamide/phenylephrine. MAS was significantly lower after the application of mydriatic eye drops (p = 0.003). Conclusions Our findings reveal that neither measurements of FD nor measurements of the FAZ area changed significantly in AMD patients after the application of tropicamide/phenylephrine. Since MAS improved significantly in dilation, mydriatic examination is recommended. Nevertheless, a comparison of OCTA metrics from images taken with different pupil states (miosis versus mydriasis) is valid for clinical trials.	[Bruecher, Viktoria C.; Storp, Jens J.; Nelis, Pieter; Eter, Nicole; Alnawaiseh, Maged] Univ Munster, Dept Ophthalmol, Med Ctr, Munster, North Rhine Wes, Germany; [Kerschke, Laura] Univ Munster, Dept Biometry & Clin Res, Med Ctr, Munster, North Rhine Wes, Germany	University of Munster; University of Munster	Brucher, VC (corresponding author), Univ Munster, Dept Ophthalmol, Med Ctr, Munster, North Rhine Wes, Germany.	viktoria.bruecher@ukmuenter.de	Kerschke, Laura/S-5289-2016	Kerschke, Laura/0000-0002-1195-7399				Al-Sheikh Mayss, 2017, Int J Retina Vitreous, V3, P13, DOI 10.1186/s40942-017-0068-9; Al-Sheikh M, 2017, BRIT J OPHTHALMOL, V101, P449, DOI 10.1136/bjophthalmol-2016-308764; Alnawaiseh M, 2018, OPHTHALMOLOGE, V115, P659, DOI 10.1007/s00347-017-0539-2; Alnawaiseh M, 2019, RETINA-J RET VIT DIS, V39, P210, DOI 10.1097/IAE.000000000000190; Alnawaiseh M, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2056-3; Alnawaiseh M, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0789-z; Alnawaiseh M, 2017, RETINA-J RET VIT DIS, V37, P1642, DOI 10.1097/IAE.0000000000001419; Alten F, 2016, GRAEF ARCH CLIN EXP, V254, P2165, DOI 10.1007/s00417-016-3375-1; Borrelli E, 2018, AM J OPHTHALMOL, V196, P34, DOI 10.1016/j.ajo.2018.08.014; Camino A, 2016, BIOMED OPT EXPRESS, V7, P3905, DOI 10.1364/BOE.7.003905; Cheng CSM, 2011, CLIN EXP OPHTHALMOL, V39, P215, DOI 10.1111/j.1442-9071.2010.02460.x; Cheng JY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00996; Chua J, 2019, J HYPERTENS, V37, P572, DOI 10.1097/HJH.0000000000001916; Falavarjani KG, 2017, BRIT J OPHTHALMOL, V101, P989, DOI 10.1136/bjophthalmol-2016-309678; Falavarjani KG, 2017, BRIT J OPHTHALMOL, V101, P564, DOI 10.1136/bjophthalmol-2016-309104; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Hollo G, 2018, J GLAUCOMA, V27, pE133, DOI 10.1097/IJG.0000000000000983; Hsu SY, 2008, J GLAUCOMA, V17, P30, DOI 10.1097/IJG.0b013e31811243b4; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658; Iafe NA, 2016, INVEST OPHTH VIS SCI, V57, P5780, DOI 10.1167/iovs.16-20045; Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Lauermann JL, 2018, GRAEF ARCH CLIN EXP, V256, P1807, DOI 10.1007/s00417-018-4053-2; Lauermann JL, 2017, GRAEF ARCH CLIN EXP, V255, P1535, DOI 10.1007/s00417-017-3684-z; LEE CH, 2018, BR J OPHTHALMOL, DOI DOI 10.1136/BJOPHTHALMOL-2018-312516; Lee MW, 2019, BRIT J OPHTHALMOL, V103, P704, DOI 10.1136/bjophthalmol-2018-312516; Lei JQ, 2017, JAMA OPHTHALMOL, V135, P1092, DOI 10.1001/jamaophthalmol.2017.3431; Ma J, 2017, OPHTHALMOL EYE DIS, V9, DOI 10.1177/1179172116686075; Manalastas PIC, 2017, J GLAUCOMA, V26, P851, DOI 10.1097/IJG.0000000000000768; Mansouri K, 2018, J GLAUCOMA, V27, P336, DOI 10.1097/IJG.0000000000000914; Massa GC, 2010, EYE, V24, P1498, DOI 10.1038/eye.2010.72; Milani P, 2018, GRAEF ARCH CLIN EXP, V256, P1419, DOI 10.1007/s00417-018-4012-y; Mwanza JC, 2013, INT OPHTHALMOL, V33, P335, DOI 10.1007/s10792-012-9689-z; Nassisi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212563; Nassisi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207638; Nassisi M, 2019, BRIT J OPHTHALMOL, V103, P911, DOI 10.1136/bjophthalmol-2018-312643; Perrott-Reynolds R, 2019, EYE, V33, P274, DOI 10.1038/s41433-018-0229-6; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Roemer S, 2019, RETINA-J RET VIT DIS, V39, P2384, DOI 10.1097/IAE.0000000000002321; Rosen RB, 2019, AM J OPHTHALMOL; Rotsos T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008110; Sacconi R, 2019, BRIT J OPHTHALMOL, V103, P1320, DOI 10.1136/bjophthalmol-2018-313004; Savini G, 2010, EYE, V24, P1503, DOI 10.1038/eye.2010.66; Savini G, 2006, J GLAUCOMA, V15, P336, DOI 10.1097/01.ijg.0000212244.64584.c2; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Smith M, 2007, BRIT J OPHTHALMOL, V91, P1686, DOI 10.1136/bjo.2006.113134; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Sung MS, 2018, AM J OPHTHALMOL, V192, P157, DOI 10.1016/j.ajo.2018.05.022; Tanga L, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0168-y; Wang Q, 2016, AM J OPHTHALMOL, V168, P95, DOI 10.1016/j.ajo.2016.05.005; Wang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159911; Yang Y, 2016, INVEST OPHTH VIS SCI, V57, P6020, DOI 10.1167/iovs.16-19542; Yanik Odabas O, 2018, RETINA-J RET VIT DIS, V38, P1238, DOI 10.1097/IAE.0000000000001671; Zafar S, 2004, J GLAUCOMA, V13, P34, DOI 10.1097/00061198-200402000-00007; 2001, AM J OPHTHALMOL, V132, P668, DOI DOI 10.1016/S0002-9394(01)01218-1	57	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223452	10.1371/journal.pone.0223452	http://dx.doi.org/10.1371/journal.pone.0223452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584983	Green Published, gold			2022-12-26	WOS:000532407600037
J	Stracci, F; Gili, A; Naldini, G; Gianfredi, V; Malaspina, M; Passamonti, B; Bianconi, F				Stracci, Fabrizio; Gili, Alessio; Naldini, Giulia; Gianfredi, Vincenza; Malaspina, Morena; Passamonti, Basilio; Bianconi, Fortunato			Geospatial analysis of the influence of family doctor on colorectal cancer screening adherence	PLOS ONE			English	Article							MULTILEVEL LOGISTIC-REGRESSION; PARTICIPATION; PROGRAM; IMPACT; INEQUALITIES; COLONOSCOPY; MORTALITY; BARRIERS; SYSTEM; CARE	Background Despite the well-recognised relevance of screening in colorectal cancer (CRC) control, adherence to screening is often suboptimal. Improving adherence represents an important public health strategy. We investigated the influence of family doctors (FDs) as determinant of CRC screening adherence by comparing each FDs practice participation probability to that of the residents in the same geographic areas using the whole population geocoded. Methods We used multilevel logistic regression model to investigate factors associated with CRC screening adherence, among 333,843 people at their first screening invitation. Standardized Adherence Rates (SAR) by age, gender, and socioeconomic status were calculated comparing FDs practices to the residents in the same geographic areas using geocoded target population. Results Screening adherence increased from 41.0% (95% CI, 40.8-41.2) in 2006-2008 to 44.7% (95% CI, 44.5-44.9) in 2011-2012. Males, the most deprived and foreign-born people showed low adherence. FD practices and the percentage of foreign-born people in a practice were significant clustering factors. SAR for 145 (21.4%) FDs practices differed significantly from people living in the same areas. Predicted probabilities of adherence were 31.7% and 49.0% for FDs with low and high adherence, respectively. Discussion FDs showed a direct and independent effect to the CRC screening adherence of the people living in their practice. FDs with significantly high adherence level could be the key to adherence improvement. Impact Most deprived individuals and foreigners represent relevant targets for interventions in public health aimed to improve CRC screening adherence.	[Stracci, Fabrizio] Univ Perugia, Dept Expt Med, Publ Hlth Sect, Perugia, Italy; [Stracci, Fabrizio; Gili, Alessio; Bianconi, Fortunato] Umbria Canc Registry, Perugia, Italy; [Naldini, Giulia; Gianfredi, Vincenza] Univ Perugia, Sch Specializat Hyg & Prevent Med, Perugia, Italy; [Malaspina, Morena; Passamonti, Basilio] Azienda USL Umbria 1, Lab Unico Screening, Perugia, Italy	University of Perugia; University of Perugia	Stracci, F (corresponding author), Univ Perugia, Dept Expt Med, Publ Hlth Sect, Perugia, Italy.; Stracci, F (corresponding author), Umbria Canc Registry, Perugia, Italy.	fabrizio.stracci@unipg.it	Gianfredi, Vincenza/W-1408-2017; Bianconi, Fortunato/L-7359-2019; Gili, Alessio/AAO-6078-2021	Gianfredi, Vincenza/0000-0003-3848-981X; Bianconi, Fortunato/0000-0002-3132-0061; Gili, Alessio/0000-0002-4359-5193	Department of Health, Regional Government of Umbria	Department of Health, Regional Government of Umbria	This work was supported by the Department of Health, Regional Government of Umbria.	[Anonymous], 2015, STAT STAT SOFTW REL; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Benton SC, 2017, BRIT J CANCER, V116, P1551, DOI 10.1038/bjc.2017.129; Bianconi F, 2012, IEEE T SYST MAN CY A, V42, P1410, DOI 10.1109/TSMCA.2012.2210209; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brown Tiffany, 2015, Prev Med Rep, V2, P886, DOI 10.1016/j.pmedr.2015.09.003; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Caranci N, 2010, EPIDEMIOL PREV, V34, P167; Fang CY, 2018, CANCER-AM CANCER SOC, V124, P1877, DOI 10.1002/cncr.31177; Ferlay J, 2015, GLOBOCAN 2012 V1 0 C; Ferroni E, 2012, PREV MED, V55, P587, DOI 10.1016/j.ypmed.2012.10.007; Fidler MM, 2017, INT J CANCER, V140, P2709, DOI 10.1002/ijc.30686; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gupta S, 2013, JAMA INTERN MED, V173, P1725, DOI 10.1001/jamainternmed.2013.9294; Halloran SP, 2012, ENDOSCOPY, V44, pSE65, DOI 10.1055/s-0032-1309791; Honein-AbouHaidar GN, 2016, CANCER EPIDEM BIOMAR, V25, P907, DOI 10.1158/1055-9965.EPI-15-0990; Hudson SV, 2007, CANCER DETECT PREV, V31, P417, DOI 10.1016/j.cdp.2007.08.004; Hughes AG, 2015, J COMMUN HEALTH, V40, P1065, DOI 10.1007/s10900-015-0032-2; Janz NK, 2003, PREV MED, V37, P627, DOI 10.1016/j.ypmed.2003.09.016; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lopez-Torres-Hidalgo J, REV ESP ENFERM DIG, V105, P272; McGregor SE, 2005, CAN J GASTROENTEROL, V19, P343, DOI 10.1155/2005/359243; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Meyskens FL, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv309; Naishadham D, 2011, CANCER EPIDEM BIOMAR, V20, P1296, DOI 10.1158/1055-9965.EPI-11-0250; Neath AA, 2012, WIRES COMPUT STAT, V4, P199, DOI 10.1002/wics.199; Pornet C, 2010, J EPIDEMIOL COMMUN H, V64, P318, DOI 10.1136/jech.2008.081117; Power E, 2009, FUTURE ONCOL, V5, P1371, DOI 10.2217/fon.09.134; Raine R, 2016, BRIT J CANCER, V114, P321, DOI 10.1038/bjc.2015.413; Rat C, 2018, EUR J CANCER PREV, V27, P227, DOI 10.1097/CEJ.0000000000000344; Rossi PG, 2018, J MED SCREEN, V25, P17, DOI 10.1177/0969141317704476; Rossi PG, 2015, AM J GASTROENTEROL, V110, P1359, DOI 10.1038/ajg.2015.240; Salas D, 2014, CANCER CAUSE CONTROL, V25, P985, DOI 10.1007/s10552-014-0398-y; Senore C, 2015, GUT, V64, P1158, DOI 10.1136/gutjnl-2014-308081; Shin HY, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3881-5; Smith SG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3512-1; Stracci F, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00210; Stronks K, 2009, J PUBLIC HEALTH-UK, V31, P324, DOI 10.1093/pubmed/fdp070; Swan J, 2010, CANCER-AM CANCER SOC, V116, P4872, DOI 10.1002/cncr.25215; Van Gennep A., 1904, TABOU TOTEMISME MADA; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Weiss JM, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/1619747; Wools A, 2016, EUR J PUBLIC HEALTH, V26, P158, DOI 10.1093/eurpub/ckv148; Zorzi M, 2015, GUT, V64, P784, DOI 10.1136/gutjnl-2014-307508	47	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0222396	10.1371/journal.pone.0222396	http://dx.doi.org/10.1371/journal.pone.0222396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584952	Green Published, gold			2022-12-26	WOS:000532407600007
J	Maffei, A; Angrilli, A				Maffei, Antonio; Angrilli, Alessandro			E-MOVIE - Experimental MOVies for Induction of Emotions in neuroscience: An innovative film database with normative data and sex differences	PLOS ONE			English	Article							RESTORATION; ELICITATION; ENVIRONMENT; RESPONSES; STIMULI; STATES	The need for a validated set of emotional clips to elicit emotions in more ecological experiments is increasing. Here we present the validation of a new database of emotional films, named E-MOVIE, which includes, in this first validation phase, 39 excerpts arranged in six categories, three negative (Fear, Sadness and Compassion), two positive (Erotic and Scenery) and a Neutral category. Notably, Compassion and Scenery are new in the field as they were not included in other databases. The clips in E-MOVIE are characterized by homogenous durations of approximately two minutes, which make them suitable for psychophysiological research. In order to study the affective profile prompted by each category 174 participants (112 women) rated the movies on multiple dimensions, namely valence and arousal, intensity and discreteness of the induction of one of the six basic emotions and, finally, intensity of the experience of the emotional states defined by a series of emotional adjectives. Erotic clips were effective in the elicitation of a positive emotional state, characterized by high levels of arousal and excitement. On the other hand, Fear clips (selected without blood to avoid disgust reaction) prompted an affect characterized by high arousal, low valence and high levels of reported fear and anxiety. Women reported greater unpleasantness, distress, anxiety and jittery than men to the three negative categories. Compassion clips, characterized by the depiction of crying characters, were able to induce an affective state dominated by sadness and feeling touched, consistent with an empathic reaction to emotional sufferance. Sadness clips, instead, elicited an affective state characterized by sadness together with distress and angst. We also demonstrated that clips depicting natural environments (i.e. Scenery) prompted in the viewer a surprised, inspired affective state, characterized by high valence and arousal (especially in males), a result which suggests that their past categorization as neutral stimuli was inaccurate and problematic.	[Maffei, Antonio; Angrilli, Alessandro] Univ Padua, Dept Gen Psychol, Padua, Italy; [Angrilli, Alessandro] CNR Neurosci Inst, Sect Padova, Padua, Italy; [Angrilli, Alessandro] Univ Padua, PNC Padova Neurosci Ctr, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Angrilli, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.; Angrilli, A (corresponding author), CNR Neurosci Inst, Sect Padova, Padua, Italy.; Angrilli, A (corresponding author), Univ Padua, PNC Padova Neurosci Ctr, Padua, Italy.	alessandro.angrilli@unipd.it	Maffei, Antonio/AAB-5793-2021	Maffei, Antonio/0000-0003-4470-6243; Angrilli, Alessandro/0000-0002-5571-7637	Ministry of Research MIUR [262]	Ministry of Research MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partially funded by a grant from Ministry of Research MIUR (Dipartimenti di Eccellenza DM 11/05/2017 n.262) to the Department of General Psychology, University of Padova. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beute F, 2014, APPL PSYCHOL-HLTH WE, V6, P67, DOI 10.1111/aphw.12019; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Bradley M.M., 2007, INT AFFECTIVE DIGITI, V2nd; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Cisler JM, 2009, COGNITION EMOTION, V23, P675, DOI 10.1080/02699930802051599; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Costa M, 2001, J NONVERBAL BEHAV, V25, P225, DOI 10.1023/A:1012544204986; De Cesarei A, 2017, NEUROSCI BIOBEHAV R, V74, P44, DOI 10.1016/j.neubiorev.2017.01.012; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1976, PICTURES FACIAL AFFE; Felnhofer A, 2015, INT J HUM-COMPUT ST, V82, P48, DOI 10.1016/j.ijhcs.2015.05.004; FRIJDA NH, 1989, AM PSYCHOL, V44, P1546; Gabert-Quillen CA, 2015, BEHAV RES METHODS, V47, P773, DOI 10.3758/s13428-014-0500-0; Gilman TL, 2017, BEHAV RES METHODS, P1, DOI [10.3758/s13428-015-0685-x, DOI 10.3758/S13428-015-0685-X]; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Golland Y, 2018, BIOL PSYCHOL, V139, P47, DOI 10.1016/j.biopsycho.2018.10.003; Golland Y, 2014, PSYCHOPHYSIOLOGY, V51, P1101, DOI 10.1111/psyp.12261; GROSS JJ, 1994, PSYCHOPHYSIOLOGY, V31, P460, DOI 10.1111/j.1469-8986.1994.tb01049.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hendriks MCP, 2008, J SOC PSYCHOL, V148, P22, DOI 10.3200/SOCP.148.1.22-42; Hendriks MCP, 2006, COGNITION EMOTION, V20, P878, DOI 10.1080/02699930500450218; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Jenkins LM, 2012, BRAIN IMPAIR, V13, P212, DOI 10.1017/BrImp.2012.18; Johnsen SAK, 2013, EUR J PSYCHOL, V9, P798, DOI 10.5964/ejop.v9i4.633; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Karama S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022343; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Lang P. J., 1999, A2 U FLOR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maffei A, 2019, PHYSIOL BEHAV, V204, P256, DOI 10.1016/j.physbeh.2019.02.037; Maffei A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145562; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; Menninghaus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128451; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Samson AC, 2016, COGNITION EMOTION, V30, P827, DOI 10.1080/02699931.2015.1031089; Sarlo M, 2005, NEUROSCI LETT, V382, P291, DOI 10.1016/j.neulet.2005.03.037; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Singer T, 2014, CURR BIOL, V24, pR875, DOI 10.1016/j.cub.2014.06.054; STERNBACH RA, 1962, J PSYCHOSOM RES, V6, P87, DOI 10.1016/0022-3999(62)90059-4; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; von Leupoldt A, 2007, BEHAV RES METHODS, V39, P606, DOI 10.3758/BF03193032; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Wierzba M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01336; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	54	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223124	10.1371/journal.pone.0223124	http://dx.doi.org/10.1371/journal.pone.0223124			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581254	Green Published, gold			2022-12-26	WOS:000532398600032
J	Rai, A; Maharjan, MR; Fry, HAH; Chhetri, PK; Wasti, PC; Saville, NM				Rai, Anjana; Maharjan, Macha Raja; Fry, Helen A. Harris; Chhetri, Parbati K.; Wasti, Purna Chandra; Saville, Naomi M.			Consumption of rice, acceptability and sensory qualities of fortified rice amongst consumers of social safety net rice in Nepal	PLOS ONE			English	Article							DIETARY DIVERSITY; CHILD UNDERNUTRITION; DOUBLE-BLIND; WOMEN; SCHOOLCHILDREN; FORTIFICATION; DEFICIENCY; ADEQUACY; EFFICACY; ANEMIA	Introduction Micronutrient deficiencies are prevalent in Nepal where starchy foods constitute a large proportion of diets and consumption of micronutrient-rich foods is inadequate. We conducted a study to determine whether rice would be an appropriate vehicle for micronutrient fortification in Nepal. Materials and methods In Bajura in remote rural Nepal, we conducted a household survey to characterize rice intakes in 195 households, and a double-blinded acceptability test with 177 social safety net rice consumers >18 years of age. Of these, 168 tasted fortified and unfortified rice to assess whether respondents could differentiate between fortified and non-fortified rice and their sensory properties. Rice was fortified by blending hot extruded kernels containing 6 micro nutrients together with non-fortified rice at a 1:99 ratio. We used binomial tests to assess whether participants could correctly differentiate fortified rice, from non-fortified rice and paired t-tests to compare scores for sensory qualities of cooked fortified and non-fortified rice. We used multiple regression to test associations between per capita consumption and age, gender, wealth and food security. Results Per capita consumption of rice (median 216g/day, IQR 144.0, 288.0) did not vary by wealth but was +52.08g, (95% CI 10.43, 93.72) higher amongst moderately to severely food insecure households compared with food secure / mildly food insecure. Most respondents could not differentiate fortified rice from non-fortified rice: 37.5% identified uncooked fortified rice and 39.3% cooked rice, which was not different from the 33% expected by chance (p = 0.22 and p = 0.09 respectively). The sensory qualities of fortified rice were acceptable (scoring 3.9 out of 5) and did not differ from non-fortified rice (p>0.05). Conclusion A rice fortification programme implemented through the Nepal Food Corporation's social safety nets has potential because purchase and consumption of rice is high and fortified rice is acceptable among consumers in remote food insecure areas of Nepal.	[Rai, Anjana; Maharjan, Macha Raja; Chhetri, Parbati K.; Saville, Naomi M.] UN World Food Programme Nepal, Nutr Sect, Kathmandu, Nepal; [Fry, Helen A. Harris] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Wasti, Purna Chandra] Minist Agr & Livestock Dev, Dept Food Technol & Qual Control, Kathmandu, Nepal; [Saville, Naomi M.] UCL, Inst Global Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Rai, A (corresponding author), UN World Food Programme Nepal, Nutr Sect, Kathmandu, Nepal.	anjirai@hotmail.co.uk	Rai, Anjana/AAF-6321-2021; Saville, Naomi/J-7244-2015	Rai, Anjana/0000-0001-7430-3424; Saville, Naomi/0000-0002-1735-3684; Harris-Fry, Helen/0000-0003-2367-908X	United Nations World Food Programme, Nepal	United Nations World Food Programme, Nepal	This study was funded by United Nations World Food Programme, Nepal (https://www1.wfp.org/countries/nepal).The funders provided financial and technical support in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Alavi S., 2008, RICE FORTIFICATION D; Angeles-Agdeppa I, 2005, NUTR REV, V63, pS116, DOI 10.1301/nr.2005.dec.S116-S125; Angeles-Agdeppa I, 2008, INT J VITAM NUTR RES, V78, P74, DOI 10.1024/0300-9831.78.2.74; Ara G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210501; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Beinner MA, 2010, J NUTR, V140, P49, DOI 10.3945/jn.109.112623; Beinner MA, 2010, CIENCIA TECNOL ALIME, V30, P516, DOI 10.1590/S0101-20612010000200034; Bilinsky P., 2007, MONTHS ADEQUATE HOUS; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bowman SA, 2011, METHODOLOGY USER GUI; Busert LK, 2016, J NUTR, V146, P1387, DOI 10.3945/jn.115.220137; Campbell RK, 2014, J HEALTH POPUL NUTR, V32, P198; Central Bureau of Statistics, 2001, POP CENS 2001 NEP; Central Bureau of Statistics, 2016, ANN HOUS SURV 2014 1; Chakraborty B, 2014, ACCEPTABILITY FORTIF; Coates J., 2007, HOUSEHOLD FOOD INSEC, V34; de Pee S, 2017, SCALING RICE FORTIFI; Della Lucia CM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050296; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Fiorentino M, 2015, EUROPEAN J NUTR FOOD, P769; Harris-Fry H, 2016, PUBLIC HEALTH NUTR, V19, P2495, DOI 10.1017/S1368980016000537; Harris-Fry HA, 2018, EUR J CLIN NUTR, V72, P1524, DOI 10.1038/s41430-017-0063-0; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Hotz C, 2008, FOOD NUTR BULL, V29, P140, DOI 10.1177/156482650802900208; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050538; MOH Nepal New Era ICF, 2017, NEP DEM HLTH SURV 20; Montgomery S, 2015, THESIS, P57; Moretti D, 2005, J FOOD SCI, V70, pS330, DOI 10.1111/j.1365-2621.2005.tb09987.x; Moretti D, 2006, AM J CLIN NUTR, V84, P822, DOI 10.1093/ajcn/84.4.822; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Muthayya S, 2012, FOOD NUTR BULL, V33, P296, DOI 10.1177/156482651203300410; Parajuli RP, 2012, J BIOSOC SCI, V44, P401, DOI 10.1017/S0021932012000065; Perignon M, 2015, EUROPEAN J NUTR FOOD, V5, P832; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Piccoli NB, 2012, FOOD NUTR BULL, V33, pS360, DOI 10.1177/15648265120334S312; Radhika MS, 2011, AM J CLIN NUTR, V94, P1202, DOI 10.3945/ajcn.110.007179; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Saville NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194064; Saville NM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1102-x; Sudo N, 2006, EUR J CLIN NUTR, V60, P469, DOI 10.1038/sj.ejcn.1602339; Swindale A., 2006, FHI 360FANTA; Tacsan L, 2015, RICE FORTIFICATION C; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Van TK, 2014, ANN NY ACAD SCI, V1324, P48, DOI 10.1111/nyas.12506; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Watts B.M, 1989, BASIC SENSORY METHOD; WFP Gov of Nepal, 2018, LANDSC AN RIC FORT N; WFP Nepal, 2010, FOOD SEC ATL NEP; Wiesmann D, 2009, INT FOOD POLICY RES; WORLD FOOD PROGRAMME [WFP], 2009, EM FOOD SEC ASS HDB; Yusufali R, 2014, SCALING RICE FORTIFI, P43; Zerfu TA, 2016, AM J CLIN NUTR, V103, P1482, DOI 10.3945/ajcn.115.116798	53	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222903	10.1371/journal.pone.0222903	http://dx.doi.org/10.1371/journal.pone.0222903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581257	Green Published, Green Accepted, gold			2022-12-26	WOS:000532398600021
J	Gulzari, UA; Khan, S; Sajid, M; Anjum, S; Torres, FS; Sarjoughian, H; Gani, A				Gulzari, Usman Ali; Khan, Sarzamin; Sajid, Muhammad; Anjum, Sheraz; Torres, Frank Sill; Sarjoughian, Hessam; Gani, Abdullah			A low latency and low power indirect topology for on-chip communication	PLOS ONE			English	Article							NETWORK; ALGORITHM	This paper presents the Hybrid Scalable-Minimized-Butterfly-Fat-Tree (H-SMBFT) topology for on-chip communication. Main aspects of this work are the description of the architectural design and the characteristics as well as a comparative analysis against two established indirect topologies namely Butterfly-Fat-Tree (BFT) and Scalable-Minimized-Butterfly-Fat-Tree (SMBFT). Simulation results demonstrate that the proposed topology outperforms its predecessors in terms of performance, area and power dissipation. Specifically, it improves the link interconnectivity between routing levels, such that the number of required links isreduced. This results into reduced router complexity and shortened routing paths between any pair of communicating nodes in the network. Moreover, simulation results under synthetic as well as real-world embedded applications workloads reveal that H-SMBFT can reduce the average latency by up-to35.63% and 17.36% compared to BFT and SMBFT, respectively. In addition, the power dissipation of the network can be reduced by up-to33.82% and 19.45%, while energy consumption can be improved by up-to32.91% and 16.83% compared to BFT and SMBFT, respectively.	[Gulzari, Usman Ali] Univ Lahore, Dept Elect Engn, Islamabad, Pakistan; [Khan, Sarzamin] COMSATS Univ Islamabad, Dept Elect Engn, Wah Campus, Wah Cantt, Pakistan; [Sajid, Muhammad] Univ Western Ontario, Dept Elect & Comp Engn, London, ON, Canada; [Anjum, Sheraz] COMSATS Univ, Dept Comp Sci, Wah Campus, Wah Cantt, Pakistan; [Torres, Frank Sill] Inst Protect Maritime Infrastruct, German Aerosp Ctr, Bremerhaven, Germany; [Sarjoughian, Hessam] Arizona State Univ, Arizona Ctr Integrat Modeling & Simulat, Tempe, AZ USA; [Gani, Abdullah] Univ Malaysia Sabah, Fac Comp & Informat, Int Campus Labuan, Wp Labuan, Malaysia	COMSATS University Islamabad (CUI); Western University (University of Western Ontario); COMSATS University Islamabad (CUI); Helmholtz Association; German Aerospace Centre (DLR); Arizona State University; Arizona State University-Tempe; Universiti Malaysia Sabah	Gulzari, UA (corresponding author), Univ Lahore, Dept Elect Engn, Islamabad, Pakistan.	usmangulzari2000@yahoo.com	Gani, Abdullah/C-2888-2009	Gani, Abdullah/0000-0002-4388-020X; Sill Torres, Frank/0000-0002-4028-455X	Fakulti Komputer dan Informatik Universiti Malaysia Sabah Kampus Antarabangsa Labuan Jalan Sungai Pagar W. P Labuan	Fakulti Komputer dan Informatik Universiti Malaysia Sabah Kampus Antarabangsa Labuan Jalan Sungai Pagar W. P Labuan	This work was supported by the Fakulti Komputer dan Informatik Universiti Malaysia Sabah Kampus Antarabangsa Labuan Jalan Sungai Pagar 87000 W. P Labuan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Anjum Sheraz, 2009, Journal of Electronic Science and Technology of China, V7, P104; Anjum S., 2012, RES J APPL SCI ENG T, V4, P1997; Chen Chia-Hsin Owen, 2010, 2010 ACM/IEEE International Symposium on Networks-on-Chip (NOCS), P173, DOI 10.1109/NOCS.2010.26; Chen X, 2011, IEEE INT C BIOINFORM, P3, DOI 10.1109/BIBM.2011.12; Elmiligi H, 2009, MICROPROCESS MICROSY, V33, P343, DOI 10.1016/j.micpro.2009.03.002; Flich Jose, 2008, IEEE Computer Architecture Letters, V7, P13, DOI 10.1109/L-CA.2007.16; Grot B, 2009, 2009 IEEE 15 INT S H; Gulzari UA, 2017, IET COMPUT DIGIT TEC, V11, P140, DOI 10.1049/iet-cdt.2016.0184; Gulzari UA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167590; Gulzari UA, 2015, 2015 IEEE 9TH INTERNATIONAL SYMPOSIUM ON EMBEDDED MULTICORE/MANYCORE SYSTEMS-ON-CHIP (MCSOC), P267, DOI 10.1109/MCSoC.2015.51; Hossain Hemayet, 2007, Proceedings of the International Conference on Information and Communication Technology, ICICT 2007, P254; Hossain H, 2005, IEEE PACIF, P613; Ju XG, 2012, MICROPROCESS MICROSY, V36, P505, DOI 10.1016/j.micpro.2012.04.006; Kahng AB, 2015, IEEE EMBED SYST LETT, V7, P41, DOI 10.1109/LES.2015.2402197; Khan S, 2018, IEEE ACCESS, V6, P11242, DOI 10.1109/ACCESS.2017.2778340; Khan S, 2018, IET COMPUT DIGIT TEC, V12, P30, DOI 10.1049/iet-cdt.2017.0068; Khan Z, INT J ELECT COMPUTER, V7, P2757; Khawaja SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125230; Kim J, 2007, INT SYMP MICROARCH, P172, DOI 10.1109/MICRO.2007.29; Kumar S, inventors; NetSpeed Systems, assignee. Systems and methods for selecting a router to connect a bridge in the network on chip (NoC). United States patent, Patent No. [US 9,762,474, 9762474]; Manoj PDS, 2017, IEEE T CIRCUITS-I, V64, P1432, DOI 10.1109/TCSI.2016.2647322; Morgan AA, THESIS; Muhammad ST, 2015, COMPUTATIONAL INTELL, P191; Ngo VD, 2005, LECT NOTES COMPUT SC, V3824, P300; Pande PP, 2005, IEEE T COMPUT, V54, P1025, DOI 10.1109/TC.2005.134; Qasem MFA, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, COMMUNICATIONS AND COMPUTING (ICSPCC), P715, DOI 10.1109/ICSPCC.2014.6986289; Raju TNK, 2005, PEDIATRICS, V116, P732, DOI 10.1542/peds.2005-1134; Sahu PK, 2014, J SYST ARCHITECT, V60, P562, DOI 10.1016/j.sysarc.2014.04.004; Sahu PK, 2012, 2012 INTERNATIONAL SYMPOSIUM ON ELECTRONIC SYSTEM DESIGN (ISED 2012), P172, DOI 10.1109/ISED.2012.17; Tran A. T., 2012, ECEVCL20122 VLSI COM	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222759	10.1371/journal.pone.0222759	http://dx.doi.org/10.1371/journal.pone.0222759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577809	Green Published, gold			2022-12-26	WOS:000532388000012
J	Labastida-Estrada, E; Machkour-M'Rabet, S; Carrillo, L; Henaut, Y; Castelblanco-Martinez, DN				Labastida-Estrada, Elizabeth; Machkour-M'Rabet, Salima; Carrillo, Laura; Henaut, Yann; Nataly Castelblanco-Martinez, Delma			Genetic structure of Mexican lionfish populations in the southwest Gulf of Mexico and the Caribbean Sea	PLOS ONE			English	Article							PTEROIS-VOLITANS LINNAEUS; SIMPLE SEQUENCE REPEATS; INVASIVE LIONFISH; YUCATAN PENINSULA; MITOCHONDRIAL-DNA; GENOTYPING ERRORS; REEF; CONNECTIVITY; DISPERSAL; PATHWAYS	The recent expansion of the invasive lionfish throughout the Western Hemisphere is one of the most extensively studied aquatic invasions. Molecular studies have improved our understanding of larval dispersal, connectivity, and biogeographical barriers among lionfish populations, but none have included Mexican localities, an important area for the larval dispersal of Pterois volitans through the Western Caribbean and the Gulf of Mexico. Here, we present a genetic analysis of lionfishes collected along Mexican coasts, examining their connectivity with other Caribbean localities (Belize, Cuba, Puerto Rico) and the role of ocean currents on population structure. We collected 213 lionfish samples from seven locations comprising four countries. To evaluate genetic structure, mitochondrial control region and nuclear inter-simple sequence repeat markers were used. We found that lionfish collected along Mexican coasts show a similar haplotype composition (H02 followed by H01 and H04) to other Caribbean locations, and the H03 rare haplotype was not found. Haplotype composition in the southwest Gulf of Mexico suggests a discontinuity between the southern and northern areas of the Gulf of Mexico. The southern area clustered more strongly to the Caribbean region, and this is supported by the complexity of water circulation in the semi-enclosed region of the Gulf of Mexico. Mitochondrial genetic diversity parameters show small values, whereas nuclear markers produce medium to high values. Only nuclear markers highlighted significant genetic differentiation between the southwest Gulf of Mexico and Caribbean region, confirming a phylogeographic break between both regions. Separate analysis of Caribbean locations indicates restricted larval exchange between southern and northern regions of the Mesoamerican Barrier Reef System, potentially in response to regional oceanographic circulation.	[Labastida-Estrada, Elizabeth; Machkour-M'Rabet, Salima] Colegio Frontera Sur, Lab Ecol Mol & Conservac, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Carrillo, Laura] Colegio Frontera Sur, Dept Sistemat & Ecol Acuat, Chetmal, Quintana Roo, Mexico; [Henaut, Yann] Colegio Frontera Sur, Lab Conducta Anim, Chetmal, Quintana Roo, Mexico; [Nataly Castelblanco-Martinez, Delma] Univ Quintana Roo, Consejo Nacl Ciencia & Tecnol, Chetmal, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); Universidad de Quintana Roo	Machkour-M'Rabet, S (corresponding author), Colegio Frontera Sur, Lab Ecol Mol & Conservac, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	smachkou@ecosur.mx	Castelblanco-Martínez, Delma Nataly/AAQ-3666-2021; Castelblanco-Martínez, Nataly/T-5997-2018; Carrillo, Laura/AAC-5556-2022	Castelblanco-Martínez, Delma Nataly/0000-0003-3229-8406; Castelblanco-Martínez, Nataly/0000-0003-3229-8406; Carrillo, Laura/0000-0001-8296-007X; Machkour-M'Rabet, Salima/0000-0002-9505-3900; Labastida-Estrada, Elizabeth/0000-0002-3237-5566; Henaut, Yann/0000-0002-8805-1739	Consejo Nacional de Ciencia y Tecnologi [288387]	Consejo Nacional de Ciencia y Tecnologi	The scholarship No 288387 from the Consejo Nacional de Ciencia y Tecnologi ' a (CONACyT) was attributed to ELE to realize this research.	Aguilar-Perera A, 2010, AQUAT INVASIONS, V5, pS9, DOI 10.3391/ai.2010.5.S1.003; Badan A, 2005, GEOPH MONOG SERIES, V161, P57; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Briones-Fourzan P, 2008, LIMNOL OCEANOGR, V53, P970, DOI 10.4319/lo.2008.53.3.0970; Butterfield JSS, 2015, MAR BIOL, V162, P773, DOI 10.1007/s00227-015-2623-y; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Carrillo L, 2016, CONT SHELF RES, V120, P41, DOI 10.1016/j.csr.2016.03.014; Carrillo L, 2015, CONT SHELF RES, V109, P164, DOI 10.1016/j.csr.2015.09.014; Carrillo L, 2007, CORAL REEFS SO GULF, P34; Casu M, 2011, GENETICA, V139, P1293, DOI 10.1007/s10709-012-9631-3; Casu M, 2009, J EXP MAR BIOL ECOL, V368, P147, DOI 10.1016/j.jembe.2008.09.021; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cossu P, 2015, HYDROBIOLOGIA, V755, P39, DOI 10.1007/s10750-015-2216-2; Cote IM, 2018, J FISH BIOL, V92, P660, DOI 10.1111/jfb.13544; Cowen RK, 2001, CORAL REEF FISHES, P149; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de la Cerda AMV, 2005, GEOPH MONOG SERIES, V161, P279; Garcia-Rivas MD, 2018, ENVIRON BIOL FISH, V101, P563, DOI 10.1007/s10641-018-0718-2; Garcia-Rivas MD, 2017, MAR BIOL RES, V13, P899, DOI 10.1080/17451000.2017.1314496; Del Rio-Portilla MA, 2016, MITOCHONDRIAL DNA A, V27, P1423, DOI 10.3109/19401736.2014.953075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fogg A. Q., 2016, GULF CARIBB RES, V27, pSC1, DOI DOI 10.18785/GCR.2701.07; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Freshwater DW, 2009, MAR BIOL, V156, P1213, DOI 10.1007/s00227-009-1163-8; Gasmi S, 2014, ESTUAR COAST SHELF S, V145, P22, DOI 10.1016/j.ecss.2014.04.005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Mendez IAG, 2017, CONSERV GENET RESOUR, V9, P493, DOI 10.1007/s12686-017-0700-x; Harms-Tuohy CA, 2016, MAR ECOL PROG SER, V558, P181, DOI 10.3354/meps11738; Havel JE, 2015, HYDROBIOLOGIA, V750, P147, DOI 10.1007/s10750-014-2166-0; Hixon MA, 2016, MAR ECOL PROG SER, V558, P161, DOI 10.3354/meps11909; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Johnson J, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2981-0; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Kitchens LL, 2017, BIOL INVASIONS, V19, P1971, DOI 10.1007/s10530-017-1417-1; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Labastida E, 2015, LAT AM J AQUAT RES, V43, P1011, DOI 10.3856/vol43-issue5-fulltext-21; Labastida-Estrada E, 2019, AQUAT CONSERV, V29, P211, DOI 10.1002/aqc.2999; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luque C, 2002, HEREDITAS, V136, P251, DOI 10.1034/j.1601-5223.2002.1360312.x; Machkour-M'Rabet S, 2017, CORAL REEFS, V36, P535, DOI 10.1007/s00338-017-1551-3; Machkour-M'Rabet S, 2017, BIOCHEM SYST ECOL, V70, P260, DOI 10.1016/j.bse.2016.12.013; Machkour-M'Rabet S, 2012, J INSECT CONSERV, V16, P479, DOI 10.1007/s10841-011-9434-3; Malpica-Cruz L, 2016, MAR POLICY, V74, P158, DOI 10.1016/j.marpol.2016.09.027; Maltagliati F, 2006, BIOCHEM SYST ECOL, V34, P626, DOI 10.1016/j.bse.2006.02.003; Martinez S, 2019, ECOL INDIC, V102, P10, DOI 10.1016/j.ecolind.2019.02.027; Ng W.L., 2015, ASM SCI J, V9, P30; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Portela R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23339-w; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salas-Monreal D, 2018, J MARINE SYST, V179, P88, DOI 10.1016/j.jmarsys.2017.12.001; Santander-Monsalvo J, 2012, BIOINVASIONS REC, V1, P121, DOI 10.3391/bir.2012.1.2.07; Sanvicente-Anorve L, 2014, MAR ECOL PROG SER, V498, P27, DOI 10.3354/meps10631; Schmitz WJ, 2005, GEOPH MONOG SERIES, V161, P11; Schultz TF, 2013, CONSERV GENET RESOUR, V5, P599, DOI 10.1007/s12686-013-9860-5; Sellers AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131075; Shanks AL, 2009, BIOL BULL-US, V216, P373; Sheinbaum J, 2016, DYNAM ATMOS OCEANS, V76, P217, DOI 10.1016/j.dynatmoce.2016.08.001; Sturges W, 2005, GEOPHYS MONOGR SER, V161; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toledo-Hernandez C, 2014, AQUAT INVASIONS, V9, P227, DOI 10.3391/ai.2014.9.2.12; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zavala-Hidalgo J, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001879	73	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222997	10.1371/journal.pone.0222997	http://dx.doi.org/10.1371/journal.pone.0222997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574129	gold, Green Published			2022-12-26	WOS:000532376700022
J	Pineda-Pena, AC; Pingarilho, M; Li, GD; Vrancken, B; Libin, P; Gomes, P; Camacho, RJ; Theys, K; Abecasis, AB				Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Li, Guangdi; Vrancken, Bram; Libin, Pieter; Gomes, Perpetua; Camacho, Ricardo Jorge; Theys, Kristof; Abecasis, Ana Barroso		Portuguese HIV-1 Resistance Study	Drivers of HIV-1 transmission: The Portuguese case	PLOS ONE			English	Article							DRUG-RESISTANCE; MOLECULAR EPIDEMIOLOGY; SURVEILLANCE; RECOMBINANT; PREVALENCE; MUTATIONS	Background Portugal has one of the most severe HIV-1 epidemics in Western Europe. Two subtypes circulate in parallel since the beginning of the epidemic. Comparing their transmission patterns and its association with transmitted drug resistance (TDR) is important to pinpoint transmission hotspots and to develop evidence-based treatment guidelines. Methods Demographic, clinical and genomic data were collected from 3599 HIV-1 naive patients between 2001 and 2014. Sequences obtained from drug resistance testing were used for subtyping, TDR determination and transmission clusters (TC) analyses. Results In Portugal, transmission of subtype B was significantly associated with young males, while transmission of subtype G was associated with older heterosexuals. In Portuguese originated people, there was a decreasing trend both for prevalence of subtype G and for number of TCs in this subtype. The active TCs that were identified (i.e. clusters originated after 2008) were associated with subtype B-infected males residing in Lisbon. TDR was significantly different when comparing subtypes B (10.8% [9.5-12.2]) and G (7.6% [6.4-9.0]) (p = 0.001). Discussion TC analyses shows that, in Portugal, the subtype B epidemic is active and fueled by young male patients residing in Lisbon, while transmission of subtype G is decreasing. Despite similar treatment rates for both subtypes in Portugal, TDR is significantly different between subtypes.	[Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Abecasis, Ana Barroso] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Basic Sci Dept, Bogota, Colombia; [Li, Guangdi] Cent South Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Natl Clin Res Ctr Metab Dis,Dept Metab & Endocrin, Changsha, Hunan, Peoples R China; [Vrancken, Bram; Libin, Pieter; Camacho, Ricardo Jorge; Theys, Kristof] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Clin & Epidemiol Virol, Leuven, Belgium; [Libin, Pieter] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium; [Gomes, Perpetua] CHLO HEM, Lab Biol Mol, SPC, LMCBM, Lisbon, Portugal; [Gomes, Perpetua] Inst Univ Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Caparica, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidad del Rosario; Universidad del Rosario; Central South University; KU Leuven; Vrije Universiteit Brussel; Instituto Superior de Ciencias da Saude Egas Moniz	Abecasis, AB (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.	ana.abecasis@ihmt.unl.pt	Abecasis, Ana/ABF-6657-2020; Abecasis, Ana/B-6295-2009; Li, Guangdi/AAU-6951-2020; Vrancken, Bram/AAF-7901-2019; Pineda-Pena, Andrea-Clemencia/N-9809-2015; Gomes, Perpetua/I-5652-2012	Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Vrancken, Bram/0000-0001-6547-5283; Pineda-Pena, Andrea-Clemencia/0000-0003-1937-0506; Gomes, Perpetua/0000-0003-3271-8255; Li, Guangdi/0000-0001-8852-034X; Libin, Pieter/0000-0003-3906-758X	European Funds through grant 'Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe - BEST HOPE - (HIVERA: Harmonizing Integrating Vitalizing European Research [249697]; L''Oreal Portugal Medals of Honor for Women in Science 2012 (L''Oreal Portugal); FCT [GHTM-UID/Multi/04413/2013]; Gilead Genese HIVLatePresenters; National Nature Science Foundation of China [31571368]; Innovation-driven Project of Central South University [2016CX031]; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) [G.0692.14, G.0611.09N]; VIROGENESIS project from the European Union's Horizon 2020 research and innovation programme [634650]; Flemish Government - department EWI-FWO Krediet aan Navorsers (Theys) [KAN2012 1.5.249.12]; FWO; FWO (Fonds Wetenschappelijk Onderzoek Vlaanderen); MigrantHIV project [FCT: PTDC/DTP-EPI/7066/2014]; L''Oreal Portugal Medals of Honor for Women in Science 2012 (Comissao Nacional da Unesco); L''Oreal Portugal Medals of Honor for Women in Science 2012 (Fundacao para a Ciencia e Tecnologia (FCT))	European Funds through grant 'Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe - BEST HOPE - (HIVERA: Harmonizing Integrating Vitalizing European Research; L''Oreal Portugal Medals of Honor for Women in Science 2012 (L''Oreal Portugal); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Gilead Genese HIVLatePresenters; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-driven Project of Central South University; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO)(FWO); VIROGENESIS project from the European Union's Horizon 2020 research and innovation programme; Flemish Government - department EWI-FWO Krediet aan Navorsers (Theys); FWO(FWO); FWO (Fonds Wetenschappelijk Onderzoek Vlaanderen)(FWO); MigrantHIV project; L''Oreal Portugal Medals of Honor for Women in Science 2012 (Comissao Nacional da Unesco); L''Oreal Portugal Medals of Honor for Women in Science 2012 (Fundacao para a Ciencia e Tecnologia (FCT))	This study was supported by European Funds through grant 'Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe - BEST HOPE - (project funded through HIVERA: Harmonizing Integrating Vitalizing European Research on HIV/Aids, grant 249697)' to ABA; by L''Oreal Portugal Medals of Honor for Women in Science 2012 (financed through L''Oreal Portugal, Comissao Nacional da Unesco and Fundacao para a Ciencia e Tecnologia (FCT - http://www.fct.pt)) to ABA; by FCT for funds to GHTM-UID/Multi/04413/2013; by the MigrantHIV project (financed by FCT: PTDC/DTP-EPI/7066/2014 to ABA; by Gilead Genese HIVLatePresenters to ABA; by the National Nature Science Foundation of China (31571368) to GL; by the Innovation-driven Project of Central South University (2016CX031) to GL; by the Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) grant G.0692.14, and G.0611.09N to KT; by the VIROGENESIS project that receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 634650 to KT. The computational resources and services used in this work were provided by the Hercules Foundation and the Flemish Government - department EWI-FWO Krediet aan Navorsers (Theys, KAN2012 1.5.249.12.) to KT. KT is supported by a postdoctoral grant from FWO. BV is supported by a postdoctoral grant of the FWO (Fonds Wetenschappelijk Onderzoek Vlaanderen). L''Oreal Portugal, Comissao Nacional da Unesco and Gilead Ge ' nese HIVLatePresenters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Conselho Cientifico do Programa Nacional para a Infec ao VIH/SIDA, 2016, REC PORT TRAT INF VI; Cortes Martins H, 2018, 149 I NAC SAUD DOUT; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; European AIDS clinical society (EACS), 2018, EUR GUID TREATM HIV; European Centre for Disease Prevention and Control World Health Organization. Regional Office for Europe, 2017, HIV AIDS SURV EUR; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162; Libin PJK, 2019, BIOINFORMATICS, V35, P1763, DOI 10.1093/bioinformatics/bty851; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Pineda-Pena AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19080-5; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pingarilho M, 2016, 11 C NAC VIH SIDA 13; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Ragonnet-Cronin ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep32251; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ssemwanga D, 2015, AIDS REV, V17, P3; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; UNAIDS, 2018, GLOB AIDS UPD 2018 M; Wertheim JO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006000; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006	32	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0218226	10.1371/journal.pone.0218226	http://dx.doi.org/10.1371/journal.pone.0218226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568476	Green Published, gold, Green Submitted			2022-12-26	WOS:000532364900001
J	Anriquez, G; Toledo, G				Anriquez, Gustavo; Toledo, Gabriela			De-climatizing food security: Lessons from climate change micro-simulations in Peru	PLOS ONE			English	Article							AGRICULTURE; IMPACT; ADAPTATION	This paper brings advances in weather data collection and modeling, and developments in socioeconomic climate microsimulations to bear on the analysis of the implications of climate change (CC) in the design of public policies to combat food insecurity. It uses new downscaled predictions of future climate in 2050, derived from three Earth System Models calibrated with a new historical weather station dataset for Peru. This climate data is used in a three-stage socioeconomic microsimulation model that includes climate risk, and deals with the endogeneity of incomes and simultaneity of expected food consumption and its variability. We estimate the impact of CC on agricultural yields, and find results consistent and fully bounded within what the global simulations literature has found, with yields falling up to 13% in some regions. However, we show that these drops (and increases) in yields translate to much smaller changes in food consumption, and also surprisingly, to very minor impacts on vulnerability to food insecurity. The document explores what explains this surprising result, showing that in addition to characteristics that are specific to Peru, there are household and market mediating mechanisms that are available in all countries, which explain how changes in yields, and corresponding farm incomes have a reduced impact in vulnerability to food insecurity. Finally, in light of these findings, we explore which policies might have greater impact in reducing food insecurity in contexts of hunger prevalence.	[Anriquez, Gustavo; Toledo, Gabriela] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Econ Agr, Santiago, Chile; [Anriquez, Gustavo; Toledo, Gabriela] Ctr Socioecon Impact Environm Policies, Santiago, Chile	Pontificia Universidad Catolica de Chile	Anriquez, G (corresponding author), Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Econ Agr, Santiago, Chile.; Anriquez, G (corresponding author), Ctr Socioecon Impact Environm Policies, Santiago, Chile.	Gustavo.Anriquez@uc.cl	Anriquez, Gustavo/AGF-2067-2022; Segura, Renato/AAV-8757-2020	Anriquez, Gustavo/0000-0003-2968-8286	FAO AMICAF project; CONICYT; Economics Ministry of Chile	FAO AMICAF project; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Economics Ministry of Chile	The authors are grateful for the financial support that made this study possible, in particular from the FAO AMICAF project, CONICYT and Economics Ministry of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anriquez G, 2008, ESTIMATING NUTR IMPA; Anriquez G, 2013, FOOD POLICY, V38, P190, DOI 10.1016/j.foodpol.2012.02.010; Arslan A, 2015, J AGR ECON, V66, P753, DOI 10.1111/1477-9552.12107; Asfaw S, 2015, WELFARE IMPACTS CLIM; Biewald A, 2015, IMPACT CLIMATE CHANG; Christiaensen LucJ., 2000, MEASURING HOUSEHOLD; Conforti P. F, 2011, LOOKING AHEAD WORLD; Davis B, 2010, WORLD DEV, V38, P48, DOI 10.1016/j.worlddev.2009.01.003; De Pinto A, 2017, THRIVING AGR SECTOR, DOI [10.2499/9780896292949, DOI 10.2499/9780896292949]; Devereux S, 2004, IDS BULL-I DEV STUD, V35, P22, DOI 10.1111/j.1759-5436.2004.tb00130.x; Di Falco S, 2011, AM J AGR ECON, V93, P825, DOI 10.1093/ajae/aar006; Diewert W.E., 1976, J ECONOMETRICS, V4, P114, DOI [DOI 10.1016/0304-4076(76)90009-9, 10.1016/0304-4076(76)90009-9]; Fischer G, 2002, CLIMATE CHANGE AGR V, P152; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Food and Agriculture Organization, 2020, The state of food and agriculture 2020: overcoming water challenges in agriculture, DOI 10.4060/cb1447en; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; JUST RE, 1979, AM J AGR ECON, V61, P276, DOI 10.2307/1239732; Karfakis P., 2011, ESA FAO WP SERI, P11, DOI [10.22004/ag.econ.289003, DOI 10.22004/AG.ECON.289003]; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Naiken L., 2014, METHODOLOGICAL ISSUE; Nelson G.C, 2010, FOOD SECURITY FARMIN; Nelson Gerald C, 2014, Proc Natl Acad Sci U S A, V111, P3274, DOI 10.1073/pnas.1222465110; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parry M, 2005, PHILOS T R SOC B, V360, P2125, DOI 10.1098/rstb.2005.1751; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Reyes Garcia M, 2009, TABLAS PERUANAS COMP; Saha A, 1997, APPL ECON, V29, P459, DOI 10.1080/000368497326958; SEN Amartya Kumar., 1962, Economic Weekly, V14, P243; SENAMHI FAO, 2014, FAO STAT DOWNS CLIM; Seo SN, 2015, MICROBEHAVIOUR EC GL; Skoufias E, 2013, POPUL ENVIRON, V34, P370, DOI 10.1007/s11111-012-0167-3; Van Wart J, 2013, GLOBAL CHANGE BIOL, V19, P3822, DOI 10.1111/gcb.12302; Walsh R. P. D., 1981, Weather, V36, P201, DOI 10.1002/j.1477-8696.1981.tb05400.x; WHO / FAO, 2004, HUM EN REQ, P107; Wiebe K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085010	37	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222483	10.1371/journal.pone.0222483	http://dx.doi.org/10.1371/journal.pone.0222483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6IT	31560703	Green Published, gold			2022-12-26	WOS:000532353700011
J	Kolecka, M; Farke, D; Failling, K; Kramer, M; Schmidt, MJ				Kolecka, Malgorzata; Farke, Daniela; Failling, Klaus; Kramer, Martin; Schmidt, Martin J.			Intraoperative measurement of intraventricular pressure in dogs with communicating internal hydrocephalus	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; INTRACRANIAL-PRESSURE; BRAIN; SHUNTS; MODEL; COMPLICATIONS; SEVOFLURANE; PULSATIONS; ISOFLURANE; VENTRICLE	Collapse of the lateral cerebral ventricles after ventriculo-peritoneal drainage is a fatal complication in dogs with internal hydrocephalus. It occurs due to excessive outflow of cerebrospinal fluid into the peritoneal cavity (overshunting). In most shunt systems, one-way valves with different pressure settings regulate flow into the distal catheter to avoid overshunting. The rationale for the choice of an appropriate opening pressure is a setting at the upper limit of normal intracranial pressure in dogs. However, physiological intraventricular pressure in normal dogs vary between 5 and 12 mm Hg. Furthermore, we hypothesise that intraventricular pressure in hydrocephalic dogs might differ from pressure in normal dogs and we also consider that normotensive hydrocephalus exists in dogs, as in humans. In order to evaluate intraventricular pressure in hydrocephalic dogs, twenty-three client owned dogs with newly diagnosed communicating internal hydrocephalus were examined before implantation of a ventriculo-peritoneal shunt using a single use piezo-resistive strain-gauge sensor (Micro-Sensor ICP probe). Ventricular volume and brain volume were measured before surgery, based on magnetic resonance images. Total ventricular volume was calculated and expressed in relation to the total volume of the brain, including the cerebrum, cerebellum, and brainstem (ventricle-brain index). Multiple logistic regression analysis was performed to assess the influence of the covariates "age", "gender", "duration of clinical signs", "body weight", and "ventricle-brain index" on intraventricular pressure. The mean cerebrospinal fluid pressure in the hydrocephalic dogs was 8.8 mm Hg (standard deviation 4.22), ranging from 3-18 mm Hg. The covariates "age", (P = 0.782), "gender" (P = 0.162), "body weight", (P = 0.065), or ventricle-brain index (P = 0.27)" were not correlated with intraventricular pressure. The duration of clinical signs before surgery, however, was correlated with intraventricular pressure (P< 0.0001). Dogs with internal hydrocephalus do not necessarily have increased intraventricular pressure. Normotensive communicating hydrocephalus exists in dogs.	[Kolecka, Malgorzata; Farke, Daniela; Kramer, Martin; Schmidt, Martin J.] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany; [Failling, Klaus] Justus Liebig Univ Giessen, Fac Vet Med, Unit Biomath & Data Proc, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Schmidt, MJ (corresponding author), Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin Neurosurg Neuroradiol & Clin Neur, Giessen, Germany.	Martin.J.Schmidt@vetmed.uni-giessen.de						Akins PT, 2011, NEUROCRIT CARE, V15, P461, DOI 10.1007/s12028-011-9543-6; BAGLEY RS, 1995, AM J VET RES, V56, P1475; BERING EA, 1962, J NEUROSURG, V19, P405, DOI 10.3171/jns.1962.19.5.0405; Biel M, 2013, JAVMA-J AM VET MED A, V242, P948, DOI 10.2460/javma.242.7.948; Browd SR, 2006, PEDIATR NEUROL, V34, P171, DOI 10.1016/j.pediatrneurol.2005.05.021; Browd SR, 2006, PEDIATR NEUROL, V34, P83, DOI 10.1016/j.pediatrneurol.2005.05.020; Cedzich C, 2003, ZBL NEUROCHIR, V64, P51; CHADDUCK WM, 1992, NEUROSURGERY, V30, P867, DOI 10.1227/00006123-199206000-00008; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Coates JR, 2006, COMP CONT EDUC PRACT, V28, P136; CONZEMIUS MG, 1995, VET SURG, V24, P195, DOI 10.1111/j.1532-950X.1995.tb01318.x; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; de Stefani A, 2011, VET SURG, V40, P183, DOI 10.1111/j.1532-950X.2010.00764.x; DEONARINE V, 1994, INVEST RADIOL, V29, P287, DOI 10.1097/00004424-199403000-00006; Desai B, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16191; DIROCCO C, 1979, CHILD BRAIN, V5, P81; Drellich S, 2000, COMP CONT EDUC PRACT, V22, P764; Egnor M, 2002, PEDIATR NEUROSURG, V36, P281, DOI 10.1159/000063533; Elder BD, 2014, ADULT HYDROCEPHALUS, P175; Eymann R, 2007, J NEUROSURG, V106, P179, DOI 10.3171/ped.2007.106.3.179; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Gradner G, 2019, J VET INTERN MED, V12, P1; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; Hanak BW, 2017, PEDIATR NEUROSURG, V52, P381, DOI 10.1159/000452840; Harary M, 2018, SENSORS BASEL, V5, P18, DOI DOI 10.3390/21868778; Harrington ML, 1996, VET CLIN N AM-SMALL, V26, P843, DOI 10.1016/S0195-5616(96)50108-7; Kim H, 2015, J NEUROSURG, V122, P1330, DOI 10.3171/2014.12.JNS14516; Kitagawa M, 2005, VET REC, V156, P206, DOI 10.1136/vr.156.7.206; Kolecka M, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0137-8; Laubner S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0479-5; LEONARD JL, 1973, AM J VET RES, V34, P213; Levine DN, 2008, J NEUROL SCI, V269, P1, DOI 10.1016/j.jns.2007.12.022; Mc Gavin MD, 2007, PATHOLOGIC BASIS VET, P873; MCCORMICK JM, 1992, PEDIATR NEUROSURG, V18, P127, DOI 10.1159/000120650; Meling TR, 2005, PEDIATR NEUROSURG, V41, P8, DOI 10.1159/000084859; MENDELOW AD, 1983, J NEUROSURG, V58, P45, DOI 10.3171/jns.1983.58.1.0045; NOVAK G, 1974, Laboratory Animals (London), V8, P85, DOI 10.1258/002367774780943779; OI S, 1986, CHILD NERV SYST, V2, P179, DOI 10.1007/BF00706807; Oreskovic D, 2017, NEUROSCIENCE, V354, P69, DOI 10.1016/j.neuroscience.2017.04.025; Packer RA, 2011, AM J VET RES, V72, P103, DOI 10.2460/ajvr.72.1.103; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Penn RD, 2005, J NEUROSURG, V102, P1069, DOI 10.3171/jns.2005.102.6.1069; Ragland Jeremy, 2016, Journal of Neurocritical Care, V9, P105, DOI 10.18700/jnc.160101; Rigamonti D., 2012, OPERATIVE NEUROSURGI, P1127; SCHELLER MS, 1990, BRIT J ANAESTH, V65, P388, DOI 10.1093/bja/65.3.388; Schmidt MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124174; Schmidt MJ, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-30; Schmidt MJ, 2019, J VET INTERN MED; Scrivani PV, 2009, VET RADIOL ULTRASOUN, V50, P269, DOI 10.1111/j.1740-8261.2009.01532.x; SELBY LA, 1979, AM J VET RES, V40, P411; Shihab N, 2011, VET SURG, V40, P477, DOI 10.1111/j.1532-950X.2011.00832.x; SHORES A, 1985, VET SURG, V14, P257, DOI 10.1111/j.1532-950X.1985.tb00879.x; Shores A, 1991, P AM COLL VET INTERN, P831; SIMPSON ST, 1987, J AM ANIM HOSP ASSOC, V23, P629; Skjolding AD, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-20; Sturges BK, 2018, J VET INTERN MED; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; Takahashi Y, 2001, CHILD NERV SYST, V17, P472, DOI 10.1007/s003810000424; Thomas WB, 2010, VET CLIN N AM-SMALL, V40, P143, DOI 10.1016/j.cvsm.2009.09.008; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Vite CH, 2006, BRAUNDS CLIN NEUROLO, P7; Wagshul ME, 2006, J NEUROSURG, V104, P810, DOI 10.3171/jns.2006.104.5.810; Wunschmann A, 2001, VET PATHOL, V38, P67, DOI 10.1354/vp.38-1-67	63	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222725	10.1371/journal.pone.0222725	http://dx.doi.org/10.1371/journal.pone.0222725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560704	Green Published, gold			2022-12-26	WOS:000532353700020
J	Ishikawa, T; Sasaki, R; Nishimura, T; Aibe, Y; Saeki, I; Iwamoto, T; Hidaka, I; Takami, T; Sakaida, I				Ishikawa, Tsuyoshi; Sasaki, Ryo; Nishimura, Tatsuro; Aibe, Yuki; Saeki, Issei; Iwamoto, Takuya; Hidaka, Isao; Takami, Taro; Sakaida, Isao			A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification	PLOS ONE			English	Article							INSULIN-RESISTANCE; CONTROLLED-TRIAL; LIGATION; SCLEROTHERAPY; OBLITERATION; PREVENTION; CIRRHOSIS	Variceal hemorrhage may cause high rebleeding and mortality rates. Preventing the first episode of variceal bleeding is mandatory in patients with high-risk esophageal varices (EV). This study aimed to identify factors that predict the recurrence of EV after endoscopic treatment (ET), and to develop a reasonable therapeutic strategy for EV in cirrhosis. From January 2012 to December 2014, 45 patients with cirrhosis and high-risk EV underwent ET, including sclerotherapy and/or ligation. Statistical analyses identified factors associated with the recurrence of EV after ET, and the Kaplan-Meier method determined the cumulative variceal recurrence rates. The 1-, 2-, and 3-year cumulative posttreatment recurrence rates for EV were 13.3%, 29.5%, and 32.2%, respectively. No significant differences were evident between the patients with and without variceal recurrences at 1-year posttreatment. The multivariate regression analyses identified a history of partial splenic embolization (PSE) and the pretreatment Child-Pugh classification as independent predictors of variceal recurrences at 2 years (p < 0.05) and 3 years (p < 0.05) posttreatment. While EV did not recur after ET and splenic artery embolization in cases with Child-Pugh class A, the overall posttreatment variceal recurrence rates were 0% and 66.7% when PSE was performed before and after ET, respectively, in those with Child-Pugh class B or C. Splenic artery embolization significantly reduced the hepatic venous pressure gradient and markedly lowered the Child-Pugh score in 15 patients. Adjunctive PSE and pretreatment Child-Pugh class A could be independently associated with reduced cumulative recurrence rates of EV post-ET. From the perspectives of portal hemodynamics and hepatic function, splenic artery embolization before or after ET could prevent posttreatment variceal recurrence in patients with Child-Pugh class A, and PSE before ET could achieve the long-term eradication of EV following ET in those with Child-Pugh class B or C.	[Ishikawa, Tsuyoshi; Sasaki, Ryo; Nishimura, Tatsuro; Aibe, Yuki; Saeki, Issei; Iwamoto, Takuya; Hidaka, Isao; Takami, Taro; Sakaida, Isao] Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Ishikawa, T (corresponding author), Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Ube, Yamaguchi, Japan.	tsu0920@yamaguchi-u.ac.jp						Ali SM, 2017, J LAPAROENDOSC ADV S, V27, P333, DOI 10.1089/lap.2016.0436; Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; Bohnacker S, 2000, BEST PRACT RES CL GA, V14, P477, DOI 10.1053/bega.2000.0092; Chawla Y K, 1988, Indian J Gastroenterol, V7, P215; Chikamori F, 2007, HEPATO-GASTROENTEROL, V54, P1847; D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013; Dhiman RK, 2003, WORLD J GASTROENTERO, V9, P1090; Dhiman RK, 1996, GUT, V38, P759, DOI 10.1136/gut.38.5.759; Dhiman RK, 2000, GASTROINTEST ENDOSC, V51, P639, DOI 10.1016/S0016-5107(00)70319-1; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Ishikawa T, 2017, AM J ROENTGENOL, V209, pW169, DOI 10.2214/AJR.16.17307; Ishikawa T, 2014, J GASTROENTEROL, V49, P1333, DOI 10.1007/s00535-013-0893-z; Liver cancer study group of Japan, 2015, GEN RULES CLIN PATHO; Lo GH, 1999, GASTROINTEST ENDOSC, V49, P428, DOI 10.1016/S0016-5107(99)70038-6; Lo GH, 2018, HEPATOL INT, V12, pS91, DOI 10.1007/s12072-017-9828-8; Lo GH, 2010, HEPATOLOGY, V52, P230, DOI 10.1002/hep.23617; Madoff DC, 2005, RADIOGRAPHICS, V25, pS191, DOI 10.1148/rg.25si055504; Miyaaki H, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.05.02; MUKAIYA M, 1994, CANCER CHEMOTH PHARM, V33, pS37, DOI 10.1007/BF00686666; Ohmoto K, 2006, DIGEST DIS SCI, V51, P352, DOI 10.1007/s10620-006-3137-8; Palsson B, 2005, EUR J GASTROEN HEPAT, V17, P1153, DOI 10.1097/00042737-200511000-00001; Sarin SK, 2005, AM J GASTROENTEROL, V100, P797, DOI 10.1111/j.1572-0241.2005.40468.x; Seno H, 2006, J GASTROEN HEPATOL, V21, P227, DOI 10.1111/j.1440-1746.2006.04129.x; Shimizu H, 2009, INTERNAL MED, V48, P747, DOI 10.2169/internalmedicine.48.1649; SPIGOS DG, 1979, AM J ROENTGENOL, V132, P777, DOI 10.2214/ajr.132.5.777; Svoboda P, 1999, SURG ENDOSC-ULTRAS, V13, P580, DOI 10.1007/s004649901045; Taniai N, 2002, HEPATO-GASTROENTEROL, V49, P984; Taniai N, 1999, HEPATO-GASTROENTEROL, V46, P2849; The Japan Society for Portal Hypertension, 2013, GEN RULES STUDY PORT; Xu RY, 2004, WORLD J GASTROENTERO, V10, P1072	30	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223153	10.1371/journal.pone.0223153	http://dx.doi.org/10.1371/journal.pone.0223153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557230	Green Published, gold			2022-12-26	WOS:000532345500083
J	Yan, ZM; Zhang, JQ; Long, H; Sun, XM; Li, DJ; Tang, T; Li, XA; Hui, W				Yan, Zhumin; Zhang, Jingqiao; Long, Hai; Sun, Xueming; Li, Dingjie; Tang, Tian; Li, X. Allen; Hui, Wu			Correlation of CT texture changes with treatment response during radiation therapy for esophageal cancer: An exploratory study	PLOS ONE			English	Article							NECK-CANCER; RADIOTHERAPY; HEAD; IMAGES	Purpose To analyze the change of CT texture features of esophageal squamous cell carcinoma (ESC) during RT delivery and to correlate these changes with the RT responses and survival. Methods A total of 61 ESC patients received radical RT were screened. Weekly CTs (4-6 sets for each patient) were acquired during RT. The tumors, normal esophageal mucosa tissue (NEC) of 5 cm and the spinal cord in the relevant area were delineated. CT texture features were extracted with a home-made tool. The changes of these features were analyzed by t-test. The correlations of the changes of features with RT responses and with patient survival were investigated by Pearson analysis. Results The average changes were increased by 0.00072 +/- 0.00197 for coarseness, by 0.14 +/- 0.40 for entropy, and by 2.34 +/- 3.56 for strength. In addition, the average changes were reduced by 8.88 +/- 15.71cc for volume and by 0.07 +/- 0.11 for busyness. The changes of the coarseness, strength, STD and entropy in ESC were different for the good and poor response groups. The survival rate of the patients was significantly correlated with the change of coarseness and strength (P = 0.0027 and P = 0.0001). Conclusions During RT, changes of CT texture features of ESC, e.g., coarseness, strength, STD, entropy and volume are correlated with radiation response and survival rate. With more clinical data and robust research, CT features, e.g., coarseness and strength, can be selected as outstanding imaging biomarkers for prediction of RT prognosis of ESC.	[Yan, Zhumin; Long, Hai; Sun, Xueming; Li, Dingjie; Tang, Tian; Hui, Wu] Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Zhang, Jingqiao] New York Proton Ctr, Dept Radiat Oncol, New York, NY USA; [Li, X. Allen] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA	Zhengzhou University; Medical College of Wisconsin	Hui, W (corresponding author), Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China.	wuhui7008@126.com						Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Chen XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178961; Chia-Chin L, 2018, MEDICINE, V97, DOI [10.1097/MD, DOI 10.1097/MD]; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Diot Q, 2012, INT J RADIAT ONCOL, V84, P1024, DOI 10.1016/j.ijrobp.2011.11.080; Feng M, 2015, INT J RADIAT ONCOL, V91, P1041, DOI 10.1016/j.ijrobp.2014.12.057; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2018, ACTA ONCOL, V57, P1475, DOI 10.1080/0284186X.2018.1486039; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Mayer R, 2015, RADIAT ONCOL INVEST, V6, P281, DOI [10.1002/(SICI)1520-6823(1998)6, DOI 10.1002/(SICI)1520-6823(1998)6]; MIRA JG, 1982, INT J RADIAT ONCOL, V8, P1625, DOI 10.1016/0360-3016(82)90627-7; Paul J, 2017, INT J RADIAT ONCOL, V98, P463, DOI 10.1016/j.ijrobp.2017.02.032; Qiu GQ, 2012, SURG LAPARO ENDO PER, V22, P424, DOI 10.1097/SLE.0b013e31825d393d; Ren W, 2017, ONCOTARGE, V8, DOI [10.18632/oncotarget.22304, DOI 10.18632/ONCOTARGET.22304]; Si Y, 2018, AM J ROENTGENOL, V211, P358, DOI 10.2214/AJR.17.18934; Sylvester R., 1979, WHO HDB REP RES CANC; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vosmik M, 2010, WORLD J GASTROENTERO, V16, P5555, DOI 10.3748/wjg.v16.i44.5555; Yu H, 2009, IEEE T MED IMAGING, V28, P374, DOI 10.1109/TMI.2008.2004425	22	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223140	10.1371/journal.pone.0223140	http://dx.doi.org/10.1371/journal.pone.0223140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557242	Green Published, gold			2022-12-26	WOS:000532345500080
J	Zhang, JP; Ying, Y; Yao, XH				Zhang, Jinping; Ying, Yue; Yao, Xiaohua			Effects of turning frequency on the nutrients of Camellia oleifera shell co-compost with goat dung and evaluation of co-compost maturity	PLOS ONE			English	Article							SPENT MUSHROOM SUBSTRATE; PIG MANURE; SAWDUST; CARBON; C/N	Composting is an important treatment method for Camellia oleifera shell and goat dung, which is crucial for the development of tea oil industry and goat breeding industry. Ventilation is the important regulatory factor in composting process, and high degree of maturity is the principal requirement for safe application of composting product. In the study, four treatments were designed as every 5 days turning (A1), every 7 days turning (A2), every 10 days turning(A3), and every 15 days turning (A4) for evaluating the maturity of Camellia oleifera shell co-composted with goat dung and optimizing turning frequency. During composting, TN, NO3--N, GI, Solvita maturity index was increased along with composting process, while NH4+-N, C/N shown an opposite trend. For all treatments, the longest thermophilic period (over 50 degrees C), highest total nutrient and lowest C/N ratio were observed in A2. A turning frequency of every 7 days for co-compost of Camellia oleifera shell and goat dung could enhance the composting product quality. According to the analysis of spearman correlation, TN, C/N ratio, and GI could be used to comprehensively evaluate the compost maturity.	[Zhang, Jinping; Ying, Yue; Yao, Xiaohua] Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhang, JP (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China.	jinpingzhang@126.com		zhang, jinping/0000-0002-1496-659X	Provincial Department of Science and Technology of Zhejiang, China [2017C02022]	Provincial Department of Science and Technology of Zhejiang, China	This work was financially supported by the Provincial Department of Science and Technology of Zhejiang, China, Grant NO. 2017C02022. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2007, J ENG SCI TECHNOL, V2, P81; [Anonymous], REP MARK DEM INV STR; ARJA HV, 1997, AGR ECOSYST ENVIRON, V66, P19; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; [曹云 Cao Yun], 2015, [农业环境科学学报, Journal of Agro-Environment Science], V34, P2198; [王引权 Wang Yinquan], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P247; Getahun T, 2012, RESOUR CONSERV RECY, V65, P79, DOI 10.1016/j.resconrec.2012.05.007; Gomez-Brandon M, 2008, CHEMOSPHERE, V70, P436, DOI 10.1016/j.chemosphere.2007.06.065; Grube M, 2006, GEODERMA, V130, P324, DOI 10.1016/j.geoderma.2005.02.005; Haney RL, 2008, RENEW AGR FOOD SYST, V23, P171, DOI 10.1017/S174217050800224X; Himanen M, 2011, BIORESOURCE TECHNOL, V102, P2842, DOI 10.1016/j.biortech.2010.10.059; Huang GF, 2004, WASTE MANAGE, V24, P805, DOI 10.1016/j.wasman.2004.03.011; Itavaara M, 1997, COMPOST SCI UTIL, V5, P84; Jiang Z, 2018, J HAINAN NORMAL U NA, V31; Kalemelawa F, 2012, BIORESOURCE TECHNOL, V126, P375, DOI 10.1016/j.biortech.2012.04.030; Khan N, 2014, BIORESOURCE TECHNOL, V168, P245, DOI 10.1016/j.biortech.2014.02.123; Ko HJ, 2008, WASTE MANAGE, V28, P813, DOI 10.1016/j.wasman.2007.05.010; Li Z., 2006, THESIS; Lin H, 2012, FOOD FERMENT IND, V38, P199; [刘雪梅 Liu Xuemei], 2018, [应用化工, Applied Chemical Industry], V47, P190; Meng XY, 2019, BIORESOURCE TECHNOL, V276, P281, DOI [10.1016/j.bio, 10.1016/j.biortech.2018.12.097]; Meng XY, 2018, J ENVIRON MANAGE, V216, P62, DOI 10.1016/j.jenvman.2017.09.056; Meng XY, 2018, BIORESOURCE TECHNOL, V251, P22, DOI 10.1016/j.biortech.2017.09.077; National Standards of the People's Republic of China, 2009, 19332009 GBT, P1; Nolan T, 2011, BIORESOURCE TECHNOL, V102, P7131, DOI 10.1016/j.biortech.2011.04.066; Ogunwande GA, 2008, BIORESOURCE TECHNOL, V99, P7495, DOI 10.1016/j.biortech.2008.02.020; Qian XY, 2014, WASTE MANAGE, V34, P530, DOI 10.1016/j.wasman.2013.10.007; Ramaswamy J, 2010, BIORESOURCE TECHNOL, V101, P2294, DOI 10.1016/j.biortech.2009.10.089; Rashad FM, 2010, BIORESOURCE TECHNOL, V101, P5952, DOI 10.1016/j.biortech.2010.02.103; Sykes P, 2007, RESOUR CONSERV RECY, V52, P410, DOI 10.1016/j.resconrec.2007.05.005; Troy SM, 2012, J ENVIRON MANAGE, V111, P70, DOI 10.1016/j.jenvman.2012.06.035; Wang Y. C., 2016, THESIS; Xiao B, 2017, ANHUI AGR SCI B, V23; Xie YZ, 2018, SAUDI J BIOL SCI, V25, P234, DOI 10.1016/j.sjbs.2017.08.006; Zhang JP, 2018, BIORESOURCES, V13, P7508, DOI 10.15376/biores.13.4.7508-7518; Zhao HY, 2013, J INTEGR AGR, V12, P1087, DOI 10.1016/S2095-3119(13)60488-8; Zhu JJ, 2013, CARBOHYD RES, V382, P52, DOI 10.1016/j.carres.2013.10.007	38	7	9	15	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222841	10.1371/journal.pone.0222841	http://dx.doi.org/10.1371/journal.pone.0222841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557206	Green Published, gold			2022-12-26	WOS:000532345500039
J	Hsu, YL; Huang, MS; Hung, JY; Chang, WA; Tsai, YM; Pan, YC; Lin, YS; Tsai, HP; Kuo, PL				Hsu, Ya-Ling; Huang, Ming-Shyan; Hung, Jen-Yu; Chang, Wei-An; Tsai, Ying-Ming; Pan, Yi-Chung; Lin, Yi-Shiuan; Tsai, Hung-Pei; Kuo, Po-Lin			Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer	ONCOGENE			English	Article							BREAST-CANCER; LIVER METASTASIS; STELLATE CELLS; MICROENVIRONMENT; HEMATOPOIESIS; ACTIVATION; EXPRESSION; FIBROSIS; INITIATE	Metastatic tumors have been shown to establish a supportive pre-metastatic niche (PMN) in distant organs, which in turn determines disseminated tumor cells' targeting of such organs. PMN is formed through the recruitment of bone-marrow-derived cells (BMDCs); however, the role of BMDCs in PMN formation is not fully understood. On the basis of RNA-seq data and bioinformatic analysis, secretion of extracellular vesicle (EV) miR-92a by BMDCs of lung cancer-bearing mice contributes to the establishment of liver PMN. Both BMDC-derived EVs and miR-92a mimics potentiate the activation of hepatic stellate cells (HSCs), subsequently increasing extracellular matrix (ECM) deposition in mice. Consequently, remodeling of the liver microenvironment enhanced immunosuppressive cell accumulation and cancer cell attachment. EVs miR-92a directly suppressed its target SMAD7, leading to the enhancement of transforming growth factor-beta signaling in HSC. Elevated levels of circulating miR-92a are found in the sera of lung cancer patients, and EVs isolated from these patients have a similar ability to increase HSCs activation and ECM protein expression. Our study reveals the sequential steps of liver PMN formation in lung cancer, providing critical mediators that prepare PMN in the liver, and identifies new targets that offer valuable options for diagnosis and therapeutic intervention.	[Hsu, Ya-Ling; Tsai, Ying-Ming] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Huang, Ming-Shyan] E DA Canc Hosp, Dept Internal Med, Kaohsiung 840, Taiwan; [Huang, Ming-Shyan] I Shou Univ, Sch Med, Kaohsiung 840, Taiwan; [Hung, Jen-Yu; Chang, Wei-An; Tsai, Ying-Ming] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung 807, Taiwan; [Hung, Jen-Yu; Chang, Wei-An; Tsai, Ying-Ming] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung 807, Taiwan; [Chang, Wei-An; Pan, Yi-Chung; Lin, Yi-Shiuan; Kuo, Po-Lin] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan; [Tsai, Hung-Pei] Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung 807, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung 807, Taiwan; [Kuo, Po-Lin] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University	Kuo, PL (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan.; Kuo, PL (corresponding author), Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung 807, Taiwan.; Kuo, PL (corresponding author), Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan.	kuopolin@seed.net.tw			Ministry of Science and Technology [MOST 107-2320-B-037-011-MY3, MOST 104-2314-B-037-053-MY4]; Kaohsiung Medical University Hospital [KMUHS10701, KMUHS10712]; Kaohsiung Medical University [KMU-DK108003, KMU-DK108008, KMU-TC108A04]; E-DA Cancer Hospital Research Foundation [EDCHI107001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Hospital; Kaohsiung Medical University; E-DA Cancer Hospital Research Foundation	The authors gratefully acknowledge the support of research grants from the Ministry of Science and Technology (MOST 107-2320-B-037-011-MY3; MOST 104-2314-B-037-053-MY4), the Kaohsiung Medical University Hospital (KMUHS10701; KMUHS10712), the Kaohsiung Medical University (KMU-DK108003; KMU-DK108008; KMU-TC108A04), and the E-DA Cancer Hospital Research Foundation (EDCHI107001). The authors thank the Center for Research Resources and Development of Kaohsiung Medical University.	Adler BJ, 2014, NAT REV ENDOCRINOL, V10, P737, DOI 10.1038/nrendo.2014.169; Barbazan J, 2017, CANCER RES, V77, P3431, DOI 10.1158/0008-5472.CAN-16-1917; Bian EB, 2014, TOXICOL LETT, V224, P175, DOI 10.1016/j.toxlet.2013.10.038; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brodt P, 2016, CLIN CANCER RES, V22, P5971, DOI 10.1158/1078-0432.CCR-16-0460; Burnier JV, 2011, ONCOGENE, V30, P3766, DOI 10.1038/onc.2011.89; Chang YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178676; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Deng Z, 2017, ONCOGENE, V36, P639, DOI 10.1038/onc.2016.229; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hara T, 2017, BIOCHEM BIOPH RES CO, V490, P688, DOI 10.1016/j.bbrc.2017.06.102; Hashimoto M, 2016, INT J CANCER, V139, P812, DOI 10.1002/ijc.30118; Houg DS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0842-9; Huang AL, 2014, ASIAN PAC J CANCER P, V15, P8143, DOI 10.7314/APJCP.2014.15.19.8143; Jiang T, 2017, CLIN LUNG CANCER, V18, P631, DOI 10.1016/j.cllc.2017.04.015; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim KW, 2017, CANCER RES TREAT, V49, P1, DOI 10.4143/crt.2016.606; Lin LY, 2016, ONCOGENE, V35, P6038, DOI 10.1038/onc.2016.131; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Ren YJ, 2016, ONCOTARGET, V7, P53245, DOI 10.18632/oncotarget.10644; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Taylor D, 2011, J IMMUNOL, V186, P5956, DOI 10.4049/jimmunol.1003558; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsao AS, 2016, J THORAC ONCOL, V11, P613, DOI 10.1016/j.jtho.2016.03.012; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Xu WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14399; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	39	22	23	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					739	753		10.1038/s41388-019-1024-y	http://dx.doi.org/10.1038/s41388-019-1024-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KQ3JF	31558801				2022-12-26	WOS:000516822100001
J	Nicolai, S; Mahen, R; Raschella, G; Marini, A; Pieraccioli, M; Malewicz, M; Venkitaraman, AR; Melino, G				Nicolai, Sara; Mahen, Robert; Raschella, Giuseppe; Marini, Alberto; Pieraccioli, Marco; Malewicz, Michal; Venkitaraman, Ashok R.; Melino, Gerry			ZNF281 is recruited on DNA breaks to facilitate DNA repair by non-homologous end joining	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; DAMAGE RESPONSE; HOMOLOGOUS-RECOMBINATION; ATM; PLURIPOTENCY; KU	Efficient repair of DNA double-strand breaks (DSBs) is of critical importance for cell survival. Although non-homologous end joining (NHEJ) is the most used DSBs repair pathway in the cells, how NHEJ factors are sequentially recruited to damaged chromatin remains unclear. Here, we identify a novel role for the zinc-finger protein ZNF281 in participating in the ordered recruitment of the NHEJ repair factor XRCC4 at damage sites. ZNF281 is recruited to DNA lesions within seconds after DNA damage through a mechanism dependent on its DNA binding domain and, at least in part, on poly-ADP ribose polymerase (PARP) activity. ZNF281 binds XRCC4 through its zinc-finger domain and facilitates its recruitment to damaged sites. Consequently, depletion of ZNF281 impairs the efficiency of the NHEJ repair pathway and decreases cell viability upon DNA damage. Survival analyses from datasets of commonly occurring human cancers show that higher levels of ZNF281 correlate with poor prognosis of patients treated with DNA-damaging therapies. Thus, our results define a late ZNF281-dependent regulatory step of NHEJ complex assembly at DNA lesions and suggest additional possibilities for cancer patients' stratification and for the development of personalised therapeutic strategies.	[Nicolai, Sara; Marini, Alberto; Malewicz, Michal; Melino, Gerry] Univ Cambridge, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Mahen, Robert; Venkitaraman, Ashok R.] Univ Cambridge, MRC, Canc Unit, Cambridge CB2 0XZ, England; [Raschella, Giuseppe] ENEA, Lab Biosafety & Risk Assessment, I-00123 Rome, Italy; [Pieraccioli, Marco; Melino, Gerry] Univ Roma Tor Vergata, Dept Expt Med, I-00133 Rome, Italy	University of Cambridge; University of Leicester; University of Cambridge; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Rome Tor Vergata	Melino, G (corresponding author), Univ Cambridge, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.	gm614@mrc-tox.cam.ac.uk	Pieraccioli, Marco/K-4294-2018; Marini, Alberto/AIA-5808-2022; Marini, Alberto/AAA-7802-2022	Pieraccioli, Marco/0000-0003-3995-535X; Marini, Alberto/0000-0001-7222-9056; MELINO, GERRY/0000-0001-9428-5972; Nicolai, Sara/0000-0001-8776-1440; Mahen, Robert/0000-0002-4748-3690	Medical Research Council, UK; Associazione Italiana per la Ricerca contro il Cancro (AIRC) [20473]; EMBO Fellowship [ASTF 572-2015]; Wellcome Trust Henry Wellcome Fellowship [100090/12/Z]; MRC [MC_UU_00025/2, MC_UU_12022/1, MC_U132670600] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); EMBO Fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Henry Wellcome Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank D.J. Read for his expert assistance in confocal microscopy and G. Legube and M. Bushell for providing the DIvA and the NHEJ and HR reporter cell lines, respectively. This work was supported by the Medical Research Council, UK; grants from Associazione Italiana per la Ricerca contro il Cancro (AIRC) to GM IG#20473 (2018-2022). SN was supported by an EMBO Fellowship (ASTF 572-2015). RM was supported by a Wellcome Trust Henry Wellcome Fellowship (grant number 100090/12/Z).	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen G, 2018, NUCLEIC ACIDS RES, V46, P1266, DOI 10.1093/nar/gkx1258; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02894-w; Craxton A, 2015, CELL DEATH DIFFER, V22, P890, DOI 10.1038/cdd.2015.22; Fidalgo M, 2016, CELL STEM CELL, V19, P355, DOI 10.1016/j.stem.2016.05.025; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Fidalgo M, 2011, STEM CELLS, V29, P1705, DOI 10.1002/stem.736; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Goldstein M, 2013, P NATL ACAD SCI USA, V110, P16874, DOI 10.1073/pnas.1306160110; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Izhar L, 2015, CELL REP, V11, P1486, DOI 10.1016/j.celrep.2015.04.053; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Law DJ, 1999, BIOCHEM BIOPH RES CO, V262, P113, DOI 10.1006/bbrc.1999.1180; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Nowsheen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05161-0; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Pieraccioli M, 2016, ONCOGENE, V35, P2592, DOI 10.1038/onc.2015.320; Pieraccioli M, 2018, P NATL ACAD SCI USA, V115, P7356, DOI 10.1073/pnas.1801435115; Raschell G, 2017, ONCOGENE, V36, P4673, DOI 10.1038/onc.2017.60; Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wei HT, 2016, GENOM PROTEOM BIOINF, V14, P131, DOI 10.1016/j.gpb.2016.05.001; Xiao X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06771-4; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	38	16	16	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					754	766		10.1038/s41388-019-1028-7	http://dx.doi.org/10.1038/s41388-019-1028-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31570788	hybrid, Green Published			2022-12-26	WOS:000509197200002
J	Gemperline, DC; Marshall, RS; Lee, KH; Zhao, QZ; Hu, WM; McLoughlin, F; Scalf, M; Smith, LM; Vierstra, RD				Gemperline, David C.; Marshall, Richard S.; Lee, Kwang-Hee; Zhao, Qingzhen; Hu, Weiming; McLoughlin, Fionn; Scalf, Mark; Smith, Lloyd M.; Vierstra, Richard D.			Proteomic analysis of affinity-purified 26S proteasomes identifies a suite of assembly chaperones in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; chaperone; mass spectrometry (MS); proteasome; protein assembly; protein degradation; proteomics; ubiquitin; core protease; regulatory particle	20S PROTEASOME; UBIQUITIN RECOGNITION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; PROTEIN; SUBUNIT; COMPLEX; PURIFICATION; SUBSTRATE; PARTICLE	The 26S proteasome is an essential protease that selectively eliminates dysfunctional and short-lived regulatory proteins in eukaryotes. To define the composition of this proteolytic machine in plants, we tagged either the core protease (CP) or the regulatory particle (RP) sub-complexes in Arabidopsis to enable rapid affinity purification followed by mass spectrometric analysis. Studies on proteasomes enriched from whole seedlings, with or without ATP needed to maintain the holo-proteasome complex, identified all known proteasome subunits but failed to detect isoform preferences, suggesting that Arabidopsis does not construct distinct proteasome sub-types. We also detected a suite of proteasome-interacting proteins, including likely orthologs of the yeast and mammalian chaperones Pba1, Pba2, Pba3, and Pba4 that assist in CP assembly; Ump1 that helps connect CP half-barrels; Nas2, Nas6, and Hsm3 that assist in RP assembly; and Ecm29 that promotes CP?RP association. Proteasomes from seedlings exposed to the proteasome inhibitor MG132 accumulated assembly intermediates, reflecting partially built proteasome sub-complexes associated with assembly chaperones, and the CP capped with the PA200/Blm10 regulator. Genetic analyses of Arabidopsis UMP1 revealed that, unlike in yeast, this chaperone is essential, with mutants lacking the major UMP1a and UMP1b isoforms displaying a strong gametophytic defect. Single ump1 mutants were hypersensitive to conditions that induce proteotoxic, salt and osmotic stress, and also accumulated several proteasome assembly intermediates, consistent with its importance for CP construction. Insights into the chaperones reported here should enable study of the assembly events that generate the 26S holo-proteasome in Arabidopsis from the collection of 64 or more subunits.	[Gemperline, David C.; Marshall, Richard S.; Lee, Kwang-Hee; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Scalf, Mark; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Marshall, Richard S.; Zhao, Qingzhen; Hu, Weiming; McLoughlin, Fionn; Vierstra, Richard D.] Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA; [Zhao, Qingzhen] Liaocheng Univ, Sch Life Sci, 1 Hunan Rd, Liaocheng 252059, Shandong, Peoples R China; [Hu, Weiming] South China Agr Univ, Sch Life Sci, 483 Wushan Rd, Guangzhou 510640, Guangdong, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); Liaocheng University; South China Agricultural University	Vierstra, RD (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	rdvierstra@wustl.edu		Hu, Weiming/0000-0002-0151-886X	National Institutes of Health NIGMS [R01-GM124452, R01-GM114292, R35-GM126914]; National Science Foundation; Plant Genome Research Program [IOS-1339325]; University of Wisconsin Genetics Training Program - National Institutes of Health; National Science Foundation of China [CNSF-3120097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114292, R01GM124452, R35GM126914] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Wisconsin Genetics Training Program - National Institutes of Health; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grants R01-GM124452 (to R. D. V.), R01-GM114292 and R35-GM126914 (to M. S. and L. M. S.), the National Science Foundation, Plant Genome Research Program Grant IOS-1339325 (to R. D. V.), and a graduate fellowship from the University of Wisconsin Genetics Training Program sponsored by the National Institutes of Health (to D. C. G.). Q. Z. was supported by a fellowship from the National Science Foundation of China (CNSF-3120097). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Hernandez V, 2017, MOL PLANT, V10, P846, DOI 10.1016/j.molp.2017.04.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Book AJ, 2010, J BIOL CHEM, V285, P25554, DOI 10.1074/jbc.M110.136622; Brachmann CB, 1998, YEAST, V14, P115; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de la Pena AH, 2018, SCIENCE, V362, P1018, DOI 10.1126/science.aav0725; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Finley D, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033985; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Fu HY, 1998, GENETICS, V149, P677; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gemperline DC, 2016, PROTEOMICS, V16, P920, DOI 10.1002/pmic.201500420; Gladman NP, 2016, PLANT CELL, V28, P1279, DOI 10.1105/tpc.15.01022; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Han JJ, 2019, NEW PHYTOL, V221, P1359, DOI 10.1111/nph.15471; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Howell Lauren A, 2017, [Frontiers in Biology, 生物学前沿], V12, P19; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim DY, 2013, PLANT CELL, V25, P1523, DOI 10.1105/tpc.112.108613; Klepikova AV, 2016, PLANT J, V88, P1058, DOI 10.1111/tpj.13312; Kovacs J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00107; Kurimoto E, 2017, PROTEIN SCI, V26, P1080, DOI 10.1002/pro.3153; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Larkin RM, 2016, P NATL ACAD SCI USA, V113, pE1116, DOI 10.1073/pnas.1515741113; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Lee KH, 2011, PLANT CELL, V23, P4298, DOI 10.1105/tpc.111.089482; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Lin YL, 2011, PLANT CELL, V23, P2754, DOI 10.1105/tpc.111.086702; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Marshall RS, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00040; Marshall RS, 2018, ELIFE, V7, DOI [10.7554/eLife.34532, 10.7554/elife.34532]; Marshall RS, 2017, METHODS MOL BIOL, V1511, P301, DOI 10.1007/978-1-4939-6533-5_24; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Murata S, 2018, NAT IMMUNOL, V19, P923, DOI 10.1038/s41590-018-0186-z; Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Saeki Y, 2017, J BIOCHEM, V161, P113, DOI 10.1093/jb/mvw091; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Satoh T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092231; Saveliev SV, 2013, ANAL CHEM, V85, P907, DOI 10.1021/ac302423t; Shibahara T, 2002, EUR J BIOCHEM, V269, P1474, DOI 10.1046/j.1432-1033.2002.02792.x; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Suty L, 2003, INT J BIOCHEM CELL B, V35, P637, DOI 10.1016/S1357-2725(02)00386-2; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; Wang GF, 2019, PLANT PHYSIOL, V180, P2120, DOI 10.1104/pp.18.01419; Wenger CD, 2013, J PROTEOME RES, V12, P1377, DOI 10.1021/pr301024c; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Yang BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11388; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	74	10	11	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17570	17592		10.1074/jbc.RA119.010219	http://dx.doi.org/10.1074/jbc.RA119.010219			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31562246	hybrid, Green Published			2022-12-26	WOS:000503173500032
J	Zhao, HY; Datta, SAK; Kim, SH; To, SC; Chaturvedi, SK; Rein, A; Schuck, P				Zhao, Huaying; Datta, Siddhartha A. K.; Kim, Sung H.; To, Samuel C.; Chaturvedi, Sumit K.; Rein, Alan; Schuck, Peter			Nucleic acid?induced dimerization of HIV-1 Gag protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); virus assembly; protein-nucleic acid interaction; analytical ultracentrifugation; fluorescence; fluorescence-detected sedimentation velocity; Gag multimerization; protein oligomerization; virus-like particle (VLP)	NUCLEOCAPSID PROTEIN; SEDIMENTATION-VELOCITY; REVEALS STRUCTURES; CRYSTAL-STRUCTURES; COMPLEX-SYSTEMS; MATRIX PROTEIN; BINDING; RNA; CONFORMATION; DOMAIN	HIV-1 Gag is a highly flexible multidomain protein that forms the protein lattice of the immature HIV-1 virion. In vitro, it reversibly dimerizes, but in the presence of nucleic acids (NAs), it spontaneously assembles into virus-like particles (VLPs). High-resolution structures have revealed intricate details of the interactions of the capsid (CA) domain of Gag and the flanking spacer peptide SP1 that stabilize VLPs, but much less is known about the assembly pathway and the interactions of the highly flexible NA-binding nucleocapsid (NC) domain. Here, using a novel hybrid fluorescence proximity/sedimentation velocity method in combination with calorimetric analyses, we studied initial binding events by monitoring the sizes and conformations of complexes of Gag with very short oligonucleotides. We observed that high-affinity binding of oligonucleotides induces conformational changes in Gag accompanied by the formation of complexes with a 2:1 Gag/NA stoichiometry. This NA-liganded dimerization mode is distinct from the widely studied dimer interface in the CA domain and from protein interactions arising in the SP1 region and may be mediated by protein-protein interactions localized in the NC domain. The formation of the liganded dimer is strongly enthalpically driven, resulting in higher dimerization affinity than the CA-domain dimer. Both detailed energetic and conformational analyses of different Gag constructs revealed modulatory contributions to NA-induced dimerization from both matrix and CA domains. We hypothesize that allosterically controlled self-association represents the first step of VLP assembly and, in concert with scaffolding along the NA, can seed the formation of two-dimensional arrays near the NA.	[Zhao, Huaying; Kim, Sung H.; To, Samuel C.; Chaturvedi, Sumit K.; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Datta, Siddhartha A. K.; Rein, Alan] NCI, HIV Dynam & Replicat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schuck, P (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA.	peter.schuck@nih.gov	Chaturvedi, Sumit K/P-5052-2014	Chaturvedi, Sumit K/0000-0003-3600-8883; Schuck, Peter/0000-0002-8859-6966; Rein, Alan/0000-0002-8273-546X; To, Samuel/0000-0001-9186-4987	National Institute of Biomedical Imaging and Bioengineering; NCI, Center for Cancer Research; Intramural AIDS Targeted Antiviral Program of the National Institutes of Health	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering and NCI, Center for Cancer Research, and by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Bloomfield VA, 1998, METHOD ENZYMOL, V295, P364; Bombarda E, 2007, BIOPHYS J, V93, P208, DOI 10.1529/biophysj.106.101378; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Chaturvedi SK, 2017, NAT PROTOC, V12, P1777, DOI 10.1038/nprot.2017.064; Chaturvedi SK, 2017, BIOPHYS J, V112, P1374, DOI 10.1016/j.bpj.2017.02.020; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Comas-Garcia M, 2018, ELIFE, V7, DOI 10.7554/eLife.38438; Comas-Garcia M, 2017, ELIFE, V6, DOI 10.7554/eLife.27055; Crist RM, 2009, J VIROL, V83, P2216, DOI 10.1128/JVI.02031-08; Datta SAK, 2007, J MOL BIOL, V365, P812, DOI 10.1016/j.jmb.2006.10.073; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; Datta SAK, 2016, J VIROL, V90, P1773, DOI 10.1128/JVI.02061-15; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; Datta SAK, 2011, J MOL BIOL, V406, P205, DOI 10.1016/j.jmb.2010.11.051; Datta Siddhartha A. K., 2009, V485, P197, DOI 10.1007/978-1-59745-170-3_14; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Deshmukh L, 2015, P NATL ACAD SCI USA, V112, P3374, DOI 10.1073/pnas.1501985112; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; Dubois N, 2018, RNA BIOL, V15, P923, DOI 10.1080/15476286.2018.1481696; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Fujita H., 1975, FDN ULTRACENTRIFUGAL; Gaines CR, 2018, J MOL BIOL, V430, P2113, DOI 10.1016/j.jmb.2018.04.042; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; JOHNSON ML, 1992, ANAL BIOCHEM, V206, P215, DOI 10.1016/0003-2697(92)90356-C; KARPEL RL, 1987, J BIOL CHEM, V262, P4961; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mallery DL, 2018, ELIFE, V7, DOI 10.7554/eLife.35335; Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; Newman JL, 2004, PROTEIN SCI, V13, P2101, DOI 10.1110/ps.04614804; Olson ED, 2019, SEMIN CELL DEV BIOL, V86, P129, DOI 10.1016/j.semcdb.2018.03.015; Perez-Caballero D, 2004, J VIROL, V78, P9560, DOI 10.1128/JVI.78.17.9560-9563.2004; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2016, SEDIMENTATION VELOCI; Schuck P., 2017, SEDIMENTATION VELOCI; Schuck P., 2015, BASIC PRINCIPLES ANA; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tanwar HS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006221; Wagner JM, 2016, ELIFE, V5, DOI 10.7554/eLife.17063; Wang MZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01856-y; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.17812; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083439; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhao HY, 2012, ANAL CHEM, V84, P9513, DOI 10.1021/ac302357w; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010	77	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16480	16493		10.1074/jbc.RA119.010580	http://dx.doi.org/10.1074/jbc.RA119.010580			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31570521	Green Published, hybrid			2022-12-26	WOS:000501801900001
J	Early, JV; Mullen, S; Parish, T				Early, Julie, V; Mullen, Steven; Parish, Tanya			A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis	PLOS ONE			English	Article							IN-VITRO; MODEL; PERSISTENCE; DORMANT; DRUGS	There is an urgent need for new anti-tubercular agents which can lead to a shortened treatment time by targeting persistent or non-replicating bacilli. In order to assess compound activity against non-replicating Mycobacterium tuberculosis, we developed a method to detect the bactericidal activity of novel compounds within 7 days. Our method uses incubation at low pH in order to induce a non-replicating state. We used a strain of M. tuberculosis expressing luciferase; we first confirmed the linear relationship between luminescence and viable bacteria (determined by colony forming units) under our assay conditions. We optimized the assay parameters in 96-well plates in order to achieve a reproducible assay. Our final assay used M. tuberculosis in phosphate-citrate buffer, pH 4.5 exposed to compounds for 7 days; viable bacteria were determined by luminescence. We recorded the minimum bactericidal concentration at pH 4.5 (MBC4.5) representing >2 logs of kill. We confirmed the utility of the assay with control compounds. The ionophores monensin, niclosamide, and carbonyl cyanide 3-chlorophenylhydrazone and the anti-tubercular drugs pretomanid and rifampicin were active, while several other drugs such as isoniazid, ethambutol, and linezolid were not.	[Early, Julie, V; Mullen, Steven; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Washington, DC 98195 USA		Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Washington, DC 98195 USA.	tanya.parish@idri.org	Parish, Tanya/A-8912-2014	Parish, Tanya/0000-0001-7507-0423	Eli Lilly and Company; Bill and Melinda Gates Foundation [OPP1024038]	Eli Lilly and Company(Eli Lilly); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative awarded to TP (https://www.lilly.com/) and by the Bill and Melinda Gates Foundation under grant OPP1024038 awarded to TP (https://www.gatesfoundation.org/). The sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2012, J ANTIMICROB CHEMOTH, V67, P404, DOI 10.1093/jac/dkr472; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Carroll Paul, 2018, BMC Res Notes, V11, P685, DOI 10.1186/s13104-018-3798-3; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Clinical and Laboratory Standards Institute (CLSI), 1999, M26A CLSI; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Early J, 2019, ACS INFECT DIS, V5, P272, DOI 10.1021/acsinfecdis.8b00256; Early Julie, 2015, Methods Mol Biol, V1285, P269, DOI 10.1007/978-1-4939-2450-9_16; Gold Ben, 2015, Methods Mol Biol, V1285, P293, DOI 10.1007/978-1-4939-2450-9_18; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gordon SV, 2018, MICROBIOL-SGM, V164, P437, DOI 10.1099/mic.0.000601; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Iacobino A, 2017, INT J MYCOBACT, V6, P213, DOI 10.4103/ijmy.ijmy_85_17; Iversen PW, 2004, ASSAY GUIDANCE MANUA; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; Piccaro G, 2015, J ANTIBIOT, V68, P711, DOI 10.1038/ja.2015.52; SALFINGER M, 1988, ANTIMICROB AGENTS CH, V32, P1002, DOI 10.1128/AAC.32.7.1002; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2010, GUID TREATM TUB 2010; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang M, 2012, ANTIMICROB AGENTS CH, V56, P5782, DOI 10.1128/AAC.01125-12	25	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0222970	10.1371/journal.pone.0222970	http://dx.doi.org/10.1371/journal.pone.0222970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589621	Green Submitted, Green Published, gold			2022-12-26	WOS:000532427300008
J	Dassah, ET; Kusi-Mensah, E; Morhe, ESK; Odoi, AT				Dassah, Edward T.; Kusi-Mensah, Eunice; Morhe, Emmanuel S. K.; Odoi, Alexander T.			Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana	PLOS ONE			English	Article							PREECLAMPSIA; MORTALITY; ECLAMPSIA	Background Data pertaining to maternal and perinatal outcomes associated with the complete spectrum of hypertensive disorders in pregnancy (HDPs) is sparse in low resource settings. This study aimed to determine adverse maternal and perinatal outcomes among women admitted with HDPs in a tertiary hospital in Ghana, and directly compare these outcomes among women with pre-eclampsia/eclampsia and those with chronic/gestational hypertension. Methods An analytical cross-sectional study was conducted among women who were admitted with HDPs to Komfo Anokye Teaching Hospital from July 1, 2014 to September 30, 2014. Data was collected on their socio-demographic and reproductive characteristics using a pretested structured questionnaire and review of their antenatal records. Crude and adjusted relative risks (RRs), with 95% confidence intervals (CIs), associated with adverse maternal and perinatal outcomes were compared using multivariable binomial regression. P <= 0.05 was considered statistically significant. Results A total of 451 women with HDPs were studied: 5.3%, 32.4%, 48.8% and 13.5% had chronic hypertension, gestational hypertension, pre-eclampsia and eclampsia respectively. Over 80% were either referrals or "self-referred" from other facilities. Overall, 87% had adverse maternal or perinatal outcomes. Women with pre-eclampsia/eclampsia were at increased risks of caesarean section (adjusted RR, 1.37; 95% CI, 1.01-1.87), preterm delivery at <34 weeks' gestation (adjusted RR, 2.74; 95% CI, 1.40-5.36) and preterm delivery at <37 weeks' gestation (adjusted RR, 1.89; 95% CI, 1.25-2.85), compared to women with chronic/gestational hypertension. Conclusion Women with pre-eclampsia/eclampsia were at higher risk of adverse pregnancy outcome compared to those with chronic/gestational hypertension. Strategies for prevention and management of pre-eclampsia/eclampsia to improve pregnancy outcomes are required in this major maternity care centre.	[Dassah, Edward T.] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Dassah, Edward T.; Odoi, Alexander T.] Komfo Anokye Teaching Hosp, Dept Obstet & Gynaecol, Kumasi, Ghana; [Kusi-Mensah, Eunice] Komfo Anokye Teaching Hosp, Transfus Med Unit, Kumasi, Ghana; [Morhe, Emmanuel S. K.] Univ Hlth & Allied Sci, Sch Med, Ho, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Dassah, ET (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana.; Dassah, ET (corresponding author), Komfo Anokye Teaching Hosp, Dept Obstet & Gynaecol, Kumasi, Ghana.	edidassah@yahoo.com	Morhe, Emmanuel S.K./AAL-3923-2020	Morhe, Emmanuel S.K./0000-0003-1696-1132; Dassah, Edward/0000-0002-9533-7831				Addo J, 2012, Ghana Med J, V46, P4; Adu-Bonsaffoh K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1575-2; Adu-Bonsaffoh K, 2014, INT J GYNECOL OBSTET, V127, P238, DOI 10.1016/j.ijgo.2014.06.010; Adu-Bonsaffoh K, 2013, INT J GYNECOL OBSTET, V123, P110, DOI 10.1016/j.ijgo.2013.05.017; Biostatistics Unit Department of Obstetrics and Gynaecology, 2016, ANNUAL INPATIENT REC; Browne JL, 2015, TROP MED INT HEALTH, V20, P1778, DOI 10.1111/tmi.12606; Browne JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125749; Crentsil EE, 2012, THESIS; Danso KA, 2010, INT J GYNECOL OBSTET, V110, P78, DOI 10.1016/j.ijgo.2010.01.026; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ekele BA, 2007, INT J GYNECOL OBSTET, V96, P62, DOI 10.1016/j.ijgo.2006.09.027; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Goldenberg RL, 2011, INT J GYNECOL OBSTET, V113, P91, DOI 10.1016/j.ijgo.2011.01.002; Kwawununu FK, 2012, INT J GYNECOL OBSTET, V117, P183, DOI 10.1016/j.ijgo.2011.12.008; Lee QY, 2012, ACTA OBSTET GYN SCAN, V91, P87, DOI 10.1111/j.1600-0412.2011.01249.x; Nathan HL, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020401; Ngwenya S, 2017, INT J WOMENS HEALTH, V9, P353, DOI 10.2147/IJWH.S131934; Olusanya BO, 2012, HYPERTENS PREGNANCY, V31, P120, DOI 10.3109/10641955.2010.525280; Ray JG, 2001, EARLY HUM DEV, V64, P129, DOI 10.1016/S0378-3782(01)00181-5; Roberts CL, 2005, MED J AUSTRALIA, V182, P332, DOI 10.5694/j.1326-5377.2005.tb06730.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P58, DOI 10.1016/j.ijgo.2013.06.003; Tuuli MG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.065; WHO, 2019, INT STAT CLASS DIS R, V10th	25	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223478	10.1371/journal.pone.0223478	http://dx.doi.org/10.1371/journal.pone.0223478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JH7WH	31584982	Green Published, gold			2022-12-26	WOS:000492979100001
J	Berni, ER; Jones, BI; Berni, TR; Whitehouse, J; Hudson, M; Orr, J; Conway, P; Amlani, B; Currie, CJ				Berni, Ellen R.; Jones, Bethan, I; Berni, Thomas R.; Whitehouse, James; Hudson, Mark; Orr, James; Conway, Pete; Amlani, Bharat; Currie, Craig J.			The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; LIVER-DISEASE; POPULATION; CANCER	The purpose of this study was to produce two statistical survival models in those with cirrhosis utilising only routine parameters, including non-liver-related clinical factors that influence survival. The first model identified and utilised factors impacting short-term survival to 90-days post incident diagnosis, and a further model characterised factors that impacted survival following this acute phase. Data were from the Clinical Practice Research Datalink linked with Hospital Episode Statistics. Incident cases in patients >= 18 years were identified between 1998 and 2014. Patients that had prior history of cancer or had received liver transplants prior were excluded. Model-1 used a logistic regression model to predict mortality. Model-2 used data from those patients who survived 90 days, and used an extension of the Cox regression model, adjusting for time-dependent covariables. At 90 days, 23% of patients had died. Overall median survival was 3.7 years. Model-1: numerous predictors, prior comorbidities and decompensating events were incorporated. All comorbidities contributed to increased odds of death, with renal disease having the largest adjusted odds ratio (OR = 3.35, 95`)/X12.97-3.77). Model-2: covariables included cumulative admissions for liver disease-related events and admissions for infections. Significant covariates were renal disease (adjusted hazard ratio (HR = 2.89, 2.47-3.38)), elevated bilirubin levels (aHR = 1.38, 1.26-1.51) and low sodium levels (aHR = 2.26, 1.84-2.78). An internal validation demonstrated reliability of both models. In conclusion: two survival models that included parameters commonly recorded in routine clinical practice were generated that reliably forecast the risk of death in patients with cirrhosis: in the acute, post diagnosis phase, and following this critical, 90 day phase. This has implications for practice and helps better forecast the risk of mortality from cirrhosis using routinely recorded parameters without inputs from specialists.	[Berni, Ellen R.; Jones, Bethan, I; Berni, Thomas R.; Conway, Pete; Currie, Craig J.] Pharmatelligence, Global Epidemiol, Cardiff, Wales; [Whitehouse, James; Amlani, Bharat] Norgine Pharmaceut Ltd, Uxbridge, Middx, England; [Hudson, Mark; Orr, James] Freeman Rd Hosp, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Hudson, Mark; Orr, James] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Currie, Craig J.] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, Wales	Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Cardiff University	Currie, CJ (corresponding author), Pharmatelligence, Global Epidemiol, Cardiff, Wales.; Currie, CJ (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, Wales.	currie@cardiff.ac.uk		Jones, Bethan/0000-0003-1954-9362	Norgine Pharmaceuticals Limited	Norgine Pharmaceuticals Limited	CJC is a director of and ERB, BIJ and TRB are employees of Pharmatelligence, a research consultancy that received funding from Norgine Pharmaceuticals Limited (https://eur03.safelinks.protection.outlook.com/?url=https%3 A%2F%2Fwww.norgine.com&data=01%7C01% 7Ccurrie%40cardiff.ac.uk%7Cf79daa6c11034 16ddf3c08d73d27b5b4%7Cbdb74b30956848 56bdbf06759778fcbc%7C1&sdata=%2FN0DSf KrwJscGgVf5t8ODYQ%2Fp0xKoE%2F5jJWWd Vm33jI%3D&reserved=0) for this work. MH has contributed to advisory boards for Norgine Pharmaceuticals Limited. PC, JW and BA on behalf of the funders played a role in the design of the study, the decision to publish, and the reviewing of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; *BRIT LIV TRUST, FACTS LIV DIS; Degre D, 2004, TRANSPL INT, V17, P31, DOI 10.1007/s00147-003-0655-6; Fleming KM, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02517.x; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Hall Philip, 2012, Ulster Med J, V81, P30; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kartoun U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186301; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Mindikoglu AL, 2013, AM J NEPHROL, V38, P345, DOI 10.1159/000355540; Neff Guy W, 2011, Gastroenterol Hepatol (N Y), V7, P661; Ng Charles K F, 2007, Clin Biochem Rev, V28, P11; Orrego H, 1987, GASTROENTEROLOGY, V92, P208, DOI 10.1016/0016-5085(87)90861-4; Peng Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002877; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Qin G, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0302-7; Song X, 2008, STAT SINICA, V18, P947; Veldt BJ, 2002, J HEPATOL, V36, P93, DOI 10.1016/S0168-8278(01)00228-8; Vinholt PJ, 2016, THROMB RES, V148, P136, DOI 10.1016/j.thromres.2016.08.012; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223253	10.1371/journal.pone.0223253	http://dx.doi.org/10.1371/journal.pone.0223253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581237	Green Published, Green Accepted, gold			2022-12-26	WOS:000532398600043
J	Chung, SY; Han, JW; Kim, DS; Yoon, HI; Suh, CO				Chung, Seung Yeun; Han, Jung Woo; Kim, Dong-Seok; Yoon, Hong In; Suh, Chang-Ok			Treatment outcomes based on radiation therapy fields for bifocal germinoma: Synchronous or disseminated disease?	PLOS ONE			English	Article							GERM-CELL TUMORS; INTRACRANIAL GERMINOMA; BASAL GANGLIA; RADIOTHERAPY; CHILDREN; IRRADIATION; EXPERIENCE; SURVIVORS	Intracranial germinoma sometimes present as bifocal germinoma, and whether bifocal germinoma should be treated as a synchronous or disseminated disease remains unclear. This study aimed to determine the optimal treatment modality for bifocal germinoma. Patients with bifocal germinoma who received radiotherapy (RT) from March 1990 to August 2017 were included for analysis. A total of 21 patients were included. The median follow-up period was 76.2 months (range, 6.2-305.4 months). There were 17 patients who received craniospinal irradiation (CSI) with local RT; 3, whole ventricular RT (WVRT) with local RT; and 1, local RT only. Three recurrences occurred (1 patient each among those who underwent CSI, WVRT, and local RT). Recurrence in the patient who received CSI and who received WVRT occurred in the right thalamus and right frontal convexity, respectively. Meanwhile, the patient who received local RT showed not only a recurred lesion in the hypothalamus, but also cerebrospinal fluid seeding. For this patient, salvage CSI was performed and complete response was achieved after treatment. However, after 9 years and 6 months, he was diagnosed with glioblastoma and expired. As for toxicity, although 17 patients showed decrease in complete blood count levels during treatment, all patients recovered soon after treatment completion. Our findings suggest that bifocal germinoma may be considered as a disseminated disease when considering the patterns of failure according to RT fields. In addition, patients who received CSI showed low acute toxicity rates. However, further studies are necessary to confirm these findings.	[Chung, Seung Yeun; Yoon, Hong In] Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Han, Jung Woo] Yonsei Univ, Severance Hosp, Dept Pediat, Coll Med, Seoul, South Korea; [Kim, Dong-Seok] Yonsei Univ, Severance Hosp, Dept Pediat Neurosurg, Coll Med, Seoul, South Korea; [Suh, Chang-Ok] CHA Univ, CHA Bundang Med Ctr, Dept Radiat Oncol, Seongnam Si, Gyeonggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Yoon, HI (corresponding author), Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	YHI0225@yuhs.ac		Chung, Seung Yeun/0000-0002-3877-6950; Yoon, Hong In/0000-0002-2106-6856	Ministry of Science, Korea, through the research and development program of the National Research Foundation of Korea [NRF-2017R1C1B2010379]	Ministry of Science, Korea, through the research and development program of the National Research Foundation of Korea	This work was supported by the Ministry of Science, Korea, through the research and development program of the National Research Foundation of Korea (NRF-2017R1C1B2010379) to Hong In Yoon. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahfoudh R, 2014, CHILD NERV SYST, V30, P625, DOI 10.1007/s00381-013-2287-1; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Bamberg M, 1999, J CLIN ONCOL, V17, P2585, DOI 10.1200/JCO.1999.17.8.2585; Boukobza Monique, 2019, eNeurologicalSci, V15, P100187, DOI 10.1016/j.ensci.2019.100187; Buglione M, 2015, REP PRACT ONCOL RADI, V20, P284, DOI 10.1016/j.rpor.2015.03.003; Calaminus G, 2013, NEURO-ONCOLOGY, V15, P788, DOI 10.1093/neuonc/not019; Cho J, 2009, RADIOTHER ONCOL, V91, P75, DOI 10.1016/j.radonc.2008.10.012; Dorr W, 2002, NORMAL TISSUE REACTI; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Haas-Kogan DA, 2003, INT J RADIAT ONCOL, V56, P511, DOI 10.1016/S0360-3016(02)04611-4; Huang PI, 2008, CHILD NERV SYST, V24, P1315, DOI 10.1007/s00381-008-0648-y; HUH SJ, 1992, RADIOTHER ONCOL, V25, P213, DOI 10.1016/0167-8140(92)90271-U; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Joo JH, 2014, ANTICANCER RES, V34, P5715; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; Lafay-Cousin L, 2006, INT J RADIAT ONCOL, V65, P486, DOI 10.1016/j.ijrobp.2005.12.011; Lakhdar F, 2008, J NEURORADIOLOGY, V35, P177, DOI 10.1016/j.neurad.2007.07.004; Lian X, 2019, J CANCER RES CLIN, V145, P709, DOI 10.1007/s00432-018-2743-0; Maity A, 2004, INT J RADIAT ONCOL, V58, P1165, DOI 10.1016/j.ijrobp.2003.08.028; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Merchant TE, 2000, INT J RADIAT ONCOL, V46, P1171, DOI 10.1016/S0360-3016(99)00375-2; Noorda EM, 2001, EUR J CANCER, V37, P605, DOI 10.1016/S0959-8049(00)00438-X; Ogawa K, 2004, INT J RADIAT ONCOL, V58, P705, DOI 10.1016/j.ijrobp.2003.07.001; Ogawa K, 2008, INT J RADIAT ONCOL, V72, P1347, DOI 10.1016/j.ijrobp.2008.03.055; Packer R J, 2000, Oncologist, V5, P312; Phi JH, 2013, J NEUROSURG-PEDIATR, V11, P107, DOI 10.3171/2012.10.PEDS11487; Phi JH, 2010, J NEURO-ONCOL, V99, P227, DOI 10.1007/s11060-010-0119-7; Rogers SJ, 2005, LANCET ONCOL, V6, P509, DOI 10.1016/S1470-2045(05)70245-X; Schoenfeld GO, 2006, INT J RADIAT ONCOL, V65, P481, DOI 10.1016/j.ijrobp.2005.12.012; Sonoda Y, 2008, J NEUROSURG-PEDIATR, V2, P118, DOI 10.3171/PED/2008/2/8/118; St Clair WH, 2004, INT J RADIAT ONCOL, V58, P727, DOI 10.1016/S0360-3016(03)01574-8; Sutton LN, 1999, NEUROSURGERY, V45, P1292, DOI 10.1097/00006123-199912000-00002; Thakkar JP, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0496-9; Ventura M, 2019, ENDOCRINOL DIAB META, DOI 10.1530/EDM-18-0149; Weksberg DC, 2012, INT J RADIAT ONCOL, V82, P1341, DOI 10.1016/j.ijrobp.2011.04.033	35	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223481	10.1371/journal.pone.0223481	http://dx.doi.org/10.1371/journal.pone.0223481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581215	Green Published, gold			2022-12-26	WOS:000532398600069
J	Hally, KE; Bird, GK; La Flamme, AC; Harding, SA; Larsen, PD				Hally, Kathryn E.; Bird, Georgina K.; La Flamme, Anne C.; Harding, Scott A.; Larsen, Peter D.			Platelets modulate multiple markers of neutrophil function in response to in vitro Toll-like receptor stimulation	PLOS ONE			English	Article							EXTRACELLULAR TRAPS; EXPRESSION; SECRETION; ACTIVATION; ELASTASE; REVEALS; ACID; PERIODONTOPATHOGENS; LIPOPOLYSACCHARIDE; PHAGOCYTOSIS	Introduction In addition to their role in facilitating leukocyte-mediated inflammation, platelets can dampen leukocyte pro-inflammatory responses in some contexts. Consequently, platelets are increasingly appreciated as regulators of inflammation. Together, platelets and neutrophils play a role in inflammation through Toll-like receptor (TLR) expression, although we do not fully understand how platelets shape neutrophil responses to TLR stimulation. Here, we aimed to determine the extent to which platelets can modulate neutrophil function in response to in vitro stimulation with TLR4, TLR2/1, and TLR2/6 agonists. Methods Neutrophils from 10 healthy individuals were cultured alone or with autologous platelets. Neutrophils platelets were left unstimulated or were stimulated with 1 or 100 ng/mL lipopolysaccharide (LPS; a TLR4 agonist), Pam3CSK4 (a TLR2/1 agonist) and fibroblast-stimulating lipopeptide (FSL)-1 (a TLR2/6 agonist). Neutrophil activation and phagocytic activity were assessed by flow cytometry, and elastase and interleukin-8 secretion were assessed by ELISA. Results The addition of platelets attenuated neutrophil CD66b and CD11b expression in response to various doses of Pam3CSK4 and FSL-1. Furthermore, platelet co-culture was associated with higher CD62L expression (indicating reduced CD62L shedding) in response to these TLR agonists. Platelets also reduced elastase secretion in unstimulated cultures and in response to low-dose TLR stimulation. Conversely, platelet co-culture increased neutrophil phagocytosis in unstimulated cultures and in response to low-dose Pam3CSK4 and FSL-1. Platelets also increased IL-8 secretion in response to low-dose LPS. Conclusion Platelets are complex immunomodulators that can attenuate some, and simultaneously augment other, neutrophil functions. This modulation can occur both in the absence and presence of TLR stimulation.	[Hally, Kathryn E.; Larsen, Peter D.] Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand; [Hally, Kathryn E.; Bird, Georgina K.; La Flamme, Anne C.; Harding, Scott A.; Larsen, Peter D.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Hally, Kathryn E.; Bird, Georgina K.; La Flamme, Anne C.; Harding, Scott A.; Larsen, Peter D.] Wellington Cardiovasc Res Grp, Wellington, New Zealand; [Harding, Scott A.] Wellington Hosp, Dept Cardiol, Wellington, New Zealand	University of Otago; Victoria University Wellington	Hally, KE (corresponding author), Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand.; Hally, KE (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.; Hally, KE (corresponding author), Wellington Cardiovasc Res Grp, Wellington, New Zealand.	kathryn.hally@otago.ac.nz		Hally, Kathryn/0000-0003-3608-3795	Victoria University of Wellington, New Zealand; Heart Foundation, New Zealand; Victoria University of Wellington; Wellington Medical Research Foundation, Research For Life [2016/279]	Victoria University of Wellington, New Zealand; Heart Foundation, New Zealand; Victoria University of Wellington; Wellington Medical Research Foundation, Research For Life	K.E.H. was supported by a Doctoral Scholarship from Victoria University of Wellington, New Zealand (www.victoria.ac.nz) and is currently supported by a Postdoctoral Fellowship from the Heart Foundation, New Zealand (www.heartfoundation.org.nz).G.K.B.is currently supported by a Doctoral Scholarship from Victoria University of Wellington. This study was funded by the Wellington Medical Research Foundation, Research For Life (2016/279; www.researchforlife.org.nz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Assinger A, 2011, J THROMB HAEMOST, V9, P799, DOI 10.1111/j.1538-7836.2011.04193.x; Assinger A, 2012, THROMB RES, V130, pE73, DOI 10.1016/j.thromres.2012.04.017; Bain W, 2019, BLOOD ADV, V3, P432, DOI 10.1182/bloodadvances.2018026286; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Corken A, 2014, ARTERIOSCL THROM VAS, V34, P996, DOI 10.1161/ATVBAHA.113.303113; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; DELPRINCIPE D, 1990, J LEUKOCYTE BIOL, V48, P7, DOI 10.1002/jlb.48.1.7; Deree J, 2006, J SURG RES, V133, P22, DOI 10.1016/j.jss.2006.02.031; Diacovo TG, 1996, BLOOD, V88, P146; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Engstrom KK, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4901135; Falker K, 2014, CELL SIGNAL, V26, P279, DOI 10.1016/j.cellsig.2013.11.011; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gros A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00678; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hally KE, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1036; Hally KE, 2017, THROMB RES, V158, P8, DOI 10.1016/j.thromres.2017.07.031; Hally KE, 2018, PLATELETS, P1; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hargrave Barbara, 2012, J Extra Corpor Technol, V44, P198; Hechler B, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.2537.2537; Herbertsson H, 2001, SCAND J CLIN LAB INV, V61, P641, DOI 10.1080/003655101753268008; Jancinova V, 2003, THROMB RES, V109, P293, DOI 10.1016/S0049-3848(03)00239-1; Jancinova V, 2004, Bratisl Lek Listy, V105, P250; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Lee K. H., 1993, Singapore Medical Journal, V34, P245; Lefer AM, 1998, CIRCULATION, V98, P1322, DOI 10.1161/01.CIR.98.13.1322; Linke B, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1463216; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Losche W, 1996, BLOOD COAGUL FIBRIN, V7, P210; Luo SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42080; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; Middleton EA, 2018, AM J RESP CELL MOL, V59, P18, DOI 10.1165/rcmb.2017-0420TR; Milioli M, 2015, J PROTEOMICS, V121, P56, DOI 10.1016/j.jprot.2015.03.013; Nami N, 2016, PLATELETS, V27, P143, DOI 10.3109/09537104.2015.1048216; Pokrovskaya ID, 2016, J THROMB HAEMOST, V14, P572, DOI 10.1111/jth.13225; Reinisch CM, 2001, FREE RADICAL RES, V34, P461, DOI 10.1080/10715760100300401; Rivadeneyra L, 2014, THROMB RES, V133, P235, DOI 10.1016/j.thromres.2013.11.028; Sadallah S, 2011, J IMMUNOL, V186, P6543, DOI 10.4049/jimmunol.1002788; Sahoo M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004327; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stocker TJ, 2017, THROMB HAEMOSTASIS, V117, P651, DOI 10.1160/TH16-12-0921; Stokes KY, 2012, J PHYSIOL-LONDON, V590, P1023, DOI 10.1113/jphysiol.2011.225417; van Oostrom AJ, 2004, NETH J MED, V62, P320; Velez P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08198; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Walsh TG, 2018, AM J PHYSIOL-HEART C, V314, pH1043, DOI 10.1152/ajpheart.00134.2018; Wuescher LM, 2015, J THROMB HAEMOST, V13, P303, DOI 10.1111/jth.12795; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Ziegler M, 2019, CARDIOVASC RES, V115, P1178, DOI 10.1093/cvr/cvz070	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223444	10.1371/journal.pone.0223444	http://dx.doi.org/10.1371/journal.pone.0223444			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581214	Green Published, gold			2022-12-26	WOS:000532398600068
J	Lutz, SM; Thwing, A; Fingerlin, T				Lutz, Sharon Marie; Thwing, Annie; Fingerlin, Tasha			eQTL mapping of rare variant associations using RNA-seq data: An evaluation of approaches	PLOS ONE			English	Article								Expression quantitative trait loci (eQTL) provide insight on transcription regulation and illuminate the molecular basis of phenotypic outcomes. High-throughput RNA sequencing (RNA-seq) is becoming a popular technique to measure gene expression abundance. Traditional eQTL mapping methods for microarray expression data often assume the expression data follow a normal distribution. As a result, for RNA-seq data, total read count measurements can be normalized by normal quantile transformation in order to fit the data using a linear regression. Other approaches model the total read counts using a negative binomial regression. While these methods work well for common variants (minor allele frequencies > 5% or 1%), an extension of existing methodology is needed to accommodate a collection of rare variants in RNA-seq data. Here, we examine 2 approaches that are direct applications of existing methodology and apply these approaches to RNAseq studies: 1) collapsing the rare variants in the region and using either negative binomial regression or Poisson regression and 2) using the normalized read counts with the Sequence Kernel Association Test (SKAT), the burden test for SKAT (SKAT-Burden), or an optimal combination of these two tests (SKAT-0). We evaluated these approaches via simulation studies under numerous scenarios and applied these approaches to the 1,000 Genomes Project.	[Lutz, Sharon Marie] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Lutz, Sharon Marie] Harvard Pilgr Hlth Care, Boston, MA 02215 USA; [Lutz, Sharon Marie] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Thwing, Annie; Fingerlin, Tasha] Univ Colorado, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA; [Fingerlin, Tasha] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Lutz, SM (corresponding author), Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA.; Lutz, SM (corresponding author), Harvard Pilgr Hlth Care, Boston, MA 02215 USA.; Lutz, SM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	smlutz@hsph.harvard.edu			National Heart, Lung, and Blood Institute [K01HL125858]; NHLBI [R21HL113543]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125858] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SML was supported by National Heart, Lung, and Blood Institute K01HL125858. TEF was supported by NHLBI R21HL113543.	Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; DEAN CB, 1992, J AM STAT ASSOC, V87, P451, DOI 10.2307/2290276; Hu YJ, 2015, J AM STAT ASSOC, V110, P962, DOI 10.1080/01621459.2015.1038449; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sun W, 2013, STAT BIOSCI, V5, P198, DOI 10.1007/s12561-012-9068-3; Sun W, 2012, BIOMETRICS, V68, P1, DOI 10.1111/j.1541-0420.2011.01654.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223273	10.1371/journal.pone.0223273	http://dx.doi.org/10.1371/journal.pone.0223273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581212	gold, Green Published, Green Submitted			2022-12-26	WOS:000532398600045
J	Vijayvargiya, P; Jeraldo, PR; Thoendel, MJ; Greenwood-Quaintance, KE; Garrigos, ZE; Sohail, MR; Chia, N; Pritt, BS; Patel, R				Vijayvargiya, Prakhar; Jeraldo, Patricio R.; Thoendel, Matthew J.; Greenwood-Quaintance, Kerryl E.; Garrigos, Zerelda Esquer; Sohail, M. Rizwan; Chia, Nicholas; Pritt, Bobbi S.; Patel, Robin			Application of metagenomic shotgun sequencing to detect vector-borne pathogens in clinical blood samples	PLOS ONE			English	Article							TOOLS	Background Vector-borne pathogens are a significant public health concern worldwide. Infections with these pathogens, some of which are emerging, are likely under-recognized due to the lack of widely-available laboratory tests. There is an urgent need for further advancement in diagnostic modalities to detect new and known vector-borne pathogens. We evaluated the utility of metagenomic shotgun sequencing (MGS) as a pathogen agnostic approach for detecting vector-borne pathogens from human blood samples. Methods Residual whole blood samples from patients with known infection with Babesia microti, Borrelia hermsii, Plasmodium falciparum, Mansonella perstans, Anaplasma phagocytophilum or Ehrlichia chaffeensis were studied. Samples underwent DNA extraction, removal of human DNA, whole genome amplification, and paired-end library preparation, followed by sequencing on Illumina HiSeq 2500. Bioinformatic analysis was performed using the Liver-more Metagenomics Analysis Toolkit (LMAT), Metagenomic Phylogenetic Analysis (MetaPhlAn2), Genomic Origin Through Taxonomic CHAllenge (GOTTCHA) and Kraken 2. Results Eight samples were included in the study (2 samples each for P. falciparum and A. phagocytophilum). An average of 27.5 million read pairs was generated per sample (range, 18.3-38.8 million) prior to removal of human reads. At least one of the analytic tools was able to detect four of six organisms at the genus level, and the organism present in five of eight specimens at the species level. Mansonella and Ehrlichia species were not detected by any of the tools; however, mitochondrial cytochrome c oxidase subunit I amino acid sequence analysis suggested the presence of M. perstans genetic material. Conclusions MGS is a promising tool with the potential to evolve as a non-hypothesis driven diagnostic test to detect vector-borne pathogens, including protozoa and helminths.	[Vijayvargiya, Prakhar; Thoendel, Matthew J.; Garrigos, Zerelda Esquer; Sohail, M. Rizwan; Patel, Robin] Mayo Clin, Div Infect Dis, Rochester, MN 55902 USA; [Jeraldo, Patricio R.; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, MN USA; [Jeraldo, Patricio R.; Chia, Nicholas] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Greenwood-Quaintance, Kerryl E.; Pritt, Bobbi S.; Patel, Robin] Mayo Clin, Div Clin Microbiol, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55902 USA.; Patel, R (corresponding author), Mayo Clin, Div Clin Microbiol, Rochester, MN 55902 USA.	patel.robin@mayo.edu	Sohail, Muhammad/K-1803-2016	Sohail, Muhammad/0000-0001-6355-0526; Jeraldo, Patricio/0000-0003-0282-4217				Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; [Anonymous], 2017, VECTOR BORNE DIS 201; Babady NE, 2009, AM J TROP MED HYG, V81, P516, DOI 10.4269/ajtmh.2009.81.516; Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6; Breitwieser FP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1568-0; Breitwieser FP, 2019, BRIEF BIOINFORM, V20, P1125, DOI 10.1093/bib/bbx120; Breitwieser FP, 2016, BIORXIV, DOI DOI 10.1101/084715; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Didion JP, 2017, PEERJ, V5, DOI 10.7717/peerj.3720; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Gehringer C, 2014, J INFECT DIS, V210, P1633, DOI 10.1093/infdis/jiu320; GOULD FK, 1988, LANCET, V2, P461; Gyarmati P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23532; Hardwick SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05555-0; Hornung BVH, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz045; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; Ivy MI, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00402-18, 10.1128/jcm.00402-18]; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Parize P, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.006; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022; Thoendel MJ, 2018, CLIN INFECT DIS, V67, P1333, DOI 10.1093/cid/ciy303; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	28	17	17	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222915	10.1371/journal.pone.0222915	http://dx.doi.org/10.1371/journal.pone.0222915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577814	Green Published, gold			2022-12-26	WOS:000532388000017
J	Bai, YF; Wang, SW; Xu, WK; Weng, YY; Zhu, SM; Sheng, H; Zhu, J; Zhang, F				Bai, Yongfeng; Wang, Siwei; Xu, Wenkai; Weng, Yuanyuan; Zhu, Shengmei; Sheng, Hao; Zhu, Jin; Zhang, Feng			Cinobufacini ameliorates experimental colitis via modulating the composition of gut microbiota	PLOS ONE			English	Article							IBD	Background Cinobufacini, the sterilized hot water extraction of dried toad skin, has been widely used in the treatment of inflammation and cancers. Recently we found cinobufacini could ameliorate dextran sulfate sodium (DSS)-induced colitis in mice, but the underlying mechanism was not fully understood. In current study, we explored the effect of cinobufacini on gut microbiota in DSS-induced acute colitic mouse model by pyrosequencing of colonic contents. Methods C57BL/6 mice were supplied with normal or 3.0% DSS containing drinking water. DSS-treat mice were gavaged daily either with vehicle (water) or cinobufacini (10.0 or 30.0 mg/kg) for 7 days. The composition of the gut microbiota was assessed by analyzing 16S rRNA gene sequences. Results Our data indicated that cinobufacini reversed DSS-induced gut dysbiosis and enhanced intestinal barrier integrity. Moreover, changing of some specific microbial groups such as Proteobacteria and Bacteroides was closely correlated with the re-establishment of intestinal equilibrium and the recovery of intestinal function. Conclusion Cinobufacini prevents colitis in mice by modifying the composition and function of gut microbiota. The current study provides additional mechanistic insight in the therapeutic effect of cinobufacini treatment and may pave the way for clinical application of cinobufacini in colitis therapy.	[Bai, Yongfeng; Weng, Yuanyuan; Zhu, Jin; Zhang, Feng] Quzhou Peoples Hosp, Dept Clin Lab, Quzhou, Zhejiang, Peoples R China; [Wang, Siwei; Zhang, Feng] Quzhou Peoples Hosp, Dept Core Facil, Quzhou, Zhejiang, Peoples R China; [Xu, Wenkai; Zhu, Shengmei] Quzhou Peoples Hosp, Dept Med Informat & Technol, Quzhou, Zhejiang, Peoples R China; [Sheng, Hao; Zhang, Feng] Zhejiang Univ, Med Sch, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhu, J; Zhang, F (corresponding author), Quzhou Peoples Hosp, Dept Clin Lab, Quzhou, Zhejiang, Peoples R China.; Zhang, F (corresponding author), Quzhou Peoples Hosp, Dept Core Facil, Quzhou, Zhejiang, Peoples R China.; Zhang, F (corresponding author), Zhejiang Univ, Med Sch, Hangzhou, Zhejiang, Peoples R China.	qzhosp@163.com; feng.zhang@zcmu.edu.cn		Wang, Siwei/0000-0001-8813-6647	Suitable Technology Promotion Center New Technology and Product Research and Development Projects [2019PY089]; Science and Technology Projects of Quzhou [2018K20, 2016J016]; Chinese Medicine Science Foundation of Zhejiang Province [2018ZB134]	Suitable Technology Promotion Center New Technology and Product Research and Development Projects; Science and Technology Projects of Quzhou; Chinese Medicine Science Foundation of Zhejiang Province	This work was supported by Suitable Technology Promotion Center New Technology and Product Research and Development Projects (F.Z., 2019PY089), Science and Technology Projects of Quzhou (F.Z., 2018K20; S.W.W., 2016J016) and the Chinese Medicine Science Foundation of Zhejiang Province (S.W.W., 2018ZB134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Cao GT, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03260; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cui HT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00571; Delday M, 2019, INFLAMM BOWEL DIS, V25, P85, DOI 10.1093/ibd/izy281; Filho GAC, 2005, TOXICON, V45, P777, DOI 10.1016/j.toxicon.2005.01.017; Gamallat Y, 2016, BIOMED PHARMACOTHER, V83, P536, DOI 10.1016/j.biopha.2016.07.001; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Mattos-Graner RO, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1400858; McFadden RMT, 2015, INFLAMM BOWEL DIS, V21, P2483, DOI 10.1097/MIB.0000000000000522; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Nishida A, 2018, CLIN J GASTROENTEROL, V11, P1, DOI 10.1007/s12328-017-0813-5; Qi J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/312684; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Wang SW, 2019, J PHARMACOL EXP THER, V368, P391, DOI 10.1124/jpet.118.254516; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01274; Zambetti LP, 2014, J PATHOL, V233, P321, DOI 10.1002/path.4357; Zheng HH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01703; Zhou Y, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/7467498; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	31	3	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223231	10.1371/journal.pone.0223231	http://dx.doi.org/10.1371/journal.pone.0223231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568499	gold, Green Published			2022-12-26	WOS:000532364900031
J	Smilnak, GJ; Deans, JR; Doraiswamy, PM; Stinnett, S; Whitson, HE; Lad, EM				Smilnak, Gordon J.; Deans, John R.; Doraiswamy, P. Murali; Stinnett, Sandra; Whitson, Heather E.; Lad, Eleonora M.			Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; DIABETES-MELLITUS; BRAIN; GLAUCOMA; MACULOPATHY; VISION; RISK; EPIDEMIOLOGY	Introduction Previous studies evaluating the association between clinically diagnosed Alzheimer's disease (AD) and age-related macular degeneration (AMD) have generated conflicting results. This study is the first to assess whether AMD prevalence is higher in AD patients than non-AD controls by using histopathology to definitively diagnose AD. Methods This was a retrospective case-control study utilizing diagnostic information extracted from autopsy reports of patients age 75 and above, including 115 with a neuropathological diagnosis of AD and 57 age-matched normal controls. Results The rate of AMD was not significantly higher in AD cases (53.0%) than in controls (59.6%) (z = 0.820, p = 0.794). AMD severity as determined by Sarks score was similar between AD patients and controls (chi(2) = 2.96, p = 0.706). There was also no significant association between Braak stage of AD severity and AMD (chi(2) = 4.55, p = 0.602). Discussion No significant effect of AD diagnosis or pathologic severity on AMD comorbidity was found, suggesting that any shared mechanisms between AMD and AD may be nondeterministic.	[Smilnak, Gordon J.; Deans, John R.; Stinnett, Sandra; Lad, Eleonora M.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Doraiswamy, P. Murali] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Whitson, Heather E.] Duke Univ, Med Ctr, Dept Internal Med, Div Geriatr, Durham, NC 27710 USA; [Deans, John R.] Univ N Carolina, Dept Ophthalmol, Kittner Eye Ctr, Chapel Hill, NC 27515 USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Lad, EM (corresponding author), Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA.	nora.lad@duke.edu		Whitson, Heather/0000-0002-8417-4846; Stinnett, Sandra/0000-0001-7192-0195	National Institutes of Health [K23EY026988]; NATIONAL EYE INSTITUTE [K23EY026988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grant number K23EY026988 EML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MKM, 2012, AM J EPIDEMIOL, V175, P511, DOI 10.1093/aje/kwr329; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Curtis LH, 2012, AM J OPHTHALMOL, V153, P1116, DOI 10.1016/j.ajo.2011.11.032; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; GEN, 2019, GENETIC ENG BIOTECHN; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jindal V, 2015, MOL NEUROBIOL, V51, P878, DOI 10.1007/s12035-014-8732-7; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Keenan TDL, 2014, JAMA OPHTHALMOL, V132, P63, DOI 10.1001/jamaophthalmol.2013.5696; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Lad EM, 2015, GRAEF ARCH CLIN EXP, V253, P1941, DOI 10.1007/s00417-015-3094-z; Le Fur I, 2010, NEUROBIOL AGING, V31, P165, DOI 10.1016/j.neurobiolaging.2008.03.003; Logue MW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.007; Malek G, 2014, CELL MOL LIFE SCI, V71, P4617, DOI 10.1007/s00018-014-1709-x; Marcus C, 2014, CLIN NUCL MED, V39, pE413, DOI 10.1097/RLU.0000000000000547; MARGETA MA, 2018, OPHTHALMOLOGIE, V256, P2449, DOI DOI 10.1007/S00417-018-4081-Y; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mott RT, 2005, NEUROIMAG CLIN N AM, V15, P755, DOI 10.1016/j.nic.2005.09.003; Ong SS, 2019, J NEUROL, V266, P1566, DOI 10.1007/s00415-018-9028-z; Ong SS, 2018, JAMA NEUROL, V75, P650, DOI 10.1001/jamaneurol.2018.0602; Pham TQ, 2006, GERONTOLOGY, V52, P353, DOI 10.1159/000094984; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rogers MAM, 2010, AM J EPIDEMIOL, V171, P728, DOI 10.1093/aje/kwp453; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Servick K., 2019, SCI MAGAZINE; Sivak JM, 2013, INVEST OPHTH VIS SCI, V54, P871, DOI 10.1167/iovs.12-10827; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Thorpe CT, 2012, J AM GERIATR SOC, V60, P644, DOI 10.1111/j.1532-5415.2012.03907.x; Turunen M, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.08.010; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Walker J, 2019, WALL STREET J; Whitson HE, 2011, AGING CLIN EXP RES, V23, P343, DOI 10.1007/BF03325233; Williams MA, 2015, AM J GERIAT PSYCHIAT, V23, P1290, DOI 10.1016/j.jagp.2015.06.005; Williams MA, 2014, J ALZHEIMERS DIS, V42, P909, DOI 10.3233/JAD-140243; Wong TY, 2002, AM J OPHTHALMOL, V134, P828; Woo SJ, 2012, OPHTHALMOLOGY, V119, P2094, DOI 10.1016/j.ophtha.2012.04.026; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1	52	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223199	10.1371/journal.pone.0223199	http://dx.doi.org/10.1371/journal.pone.0223199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568508	gold, Green Published			2022-12-26	WOS:000532364900027
J	Cotrim, MF; da Silva, JB; Lourenco, FMD; Teixeira, AV; Gava, R; Alves, CZ; Candido, ACD; Campos, CNS; Pereira, MD; Torres, SB; Bacchetta, G; Teodoro, PE				Cotrim, Mayara Favero; da Silva, Josue Bispo; dos Santos Lourenco, Flavia Mendes; Teixeira, Anielli Verzotto; Gava, Ricardo; Alves, Charline Zaratin; da Silva Candido, Ana Carina; Silva Campos, Cid Naudi; Pereira, Marcio Dias; Torres, Salvador Barros; Bacchetta, Gianluigi; Teodoro, Paulo Eduardo			Studying the link between physiological performance of Crotalaria ochroleuca and the distribution of Ca, P, K and S in seeds with Xray fluorescence	PLOS ONE			English	Article							POST-PHLOEM TRANSPORT; SULFUR METABOLISM; COAT COLOR; RESPONSES; PHOSPHATE; CALCIUM	This study describes the use of X-ray fluorescence spectroscopy in Crotalaria ochroleuca seed technology. This work evaluated X-ray fluorescence techniques to estimate the physiological performance of different C. ochroleuca seed coat colours based on the concentration and distribution of Ca, P, K, and S in seed structures. The treatments consisted of seeds separated by coat colours (yellow, green, and red) and a control treatment (colour mix according to their natural occurrence in commercial lots), and was carried out in a completely randomized design, with four replications. The physiological performance was evaluated by analyzing the water content, germination, first germination count, germination speed index, electrical conductivity, seedling emergence, and seedling length and dry mass. X-ray fluorescence spectroscopy techniques were carried out with quantitative analyses (Ca, P, K, and S concentration in the seed coat and the whole seed) and qualitative analyses (macronutrient mapping). The EDXRF and mu-XRF techniques are efficient and promising to differentiate the physiological performance of C. ochroleuca seeds, based on the concentration and distribution of Ca, P, K, and S in different structures. Ca is predominant in the seed coat, and K, S, and P are found throughout the embryonic axis. Seeds of yellow and green coats have higher nutrients concentration and distribution in the embryonic axis, revealing high germinative capacity and physiological performance. Seeds of red coat have higher nutrients concentration in the seed coat and lower assimilation, showing less vigour, which interferes directly in the quality of commercial lots.	[Cotrim, Mayara Favero; Teixeira, Anielli Verzotto; Gava, Ricardo; Alves, Charline Zaratin; da Silva Candido, Ana Carina; Silva Campos, Cid Naudi; Teodoro, Paulo Eduardo] Fed Univ Mato Grosso do Sul UFMS, Chapadao Do Sul, MS, Brazil; [da Silva, Josue Bispo] Fed Univ Mato Grosso do Sul UFMS, Tres Lagoas, MS, Brazil; [dos Santos Lourenco, Flavia Mendes] State Univ Sao Paulo UNESP, Ilha Solteira, SP, Brazil; [Pereira, Marcio Dias] Fed Univ Rio Grande do Norte UFRN, Natal, RN, Brazil; [Torres, Salvador Barros] Fed Univ Semiarid UFERSA, Mossoro, RN, Brazil; [Bacchetta, Gianluigi] Univ Cagliari, Cagliari, CA, Italy	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Norte; Universidade Federal Rural do Semi-Arido (UFERSA); University of Cagliari	Teodoro, PE (corresponding author), Fed Univ Mato Grosso do Sul UFMS, Chapadao Do Sul, MS, Brazil.	eduteodoro@hotmail.com	Gava, Ricardo/AAH-3920-2019; Cotrim, Mayara/AAG-9962-2020; Campos, Cid Naudi Silva/I-7063-2015	Gava, Ricardo/0000-0001-6268-5728; Cotrim, Mayara/0000-0003-0878-4922; Campos, Cid Naudi Silva/0000-0001-6810-885X; TEODORO, PAULO/0000-0002-8236-542X	Higher Education Personnel Improvement Coordination Brazil (CAPES) [001]; FAPESP [2015/19121-8]; Federal University of Mato Grosso do Sul	Higher Education Personnel Improvement Coordination Brazil (CAPES); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Federal University of Mato Grosso do Sul	This study was funded in part by Federal University of Mato Grosso do Sul and Higher Education Personnel Improvement Coordination Brazil (CAPES) - Finance Code 001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to the CENA-USP for the use of the mu-XRF system granted by FAPESP process 2015/19121-8.	[Anonymous], 2009, SEED VIGOUR TESTING; Bevilaqua GAP, 2002, RURAL, V32, P31; Bewley J. D, 2013, SPRINGER NAT, V3, P392, DOI DOI 10.1007/978-1-4614-4693-4; Bhering LL, 2017, CROP BREED APPL BIOT, V17, P187, DOI 10.1590/1984-70332017v17n2s29; Borji M., 2007, Asian Journal of Plant Sciences, V6, P781; BRASIL. Ministerio da Agricultura Pecuaria e Abastecimento, 2009, REGR AN SEM MIN AGR; Capaldi FR, 2015, TROP PLANT BIOL, V8, P60, DOI 10.1007/s12042-015-9152-1; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Debiasi H, 2016, PESQUI AGROPECU BRAS, V51, P1720, DOI [10.1590/S0100-204X2016001000003, 10.1590/s0100-204x2016001000003]; Ertekin M, 2010, AFR J AGR RES, V5, P2434; Gotor C, 2015, AMINO ACIDS, V47, P2155, DOI 10.1007/s00726-014-1786-z; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kopittke PM, 2018, PLANT PHYSIOL, V178, P507, DOI 10.1104/pp.18.00759; Lee J, 2017, FOOD CHEM, V214, P248, DOI 10.1016/j.foodchem.2016.07.066; Lu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057360; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Malavolta E, 2008, FUTURO NUTRICAO PLAN; MARCOS-FILHO J., 2015, FISIOLOGIA SEMENTES, V2; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Matthews S., 2006, Seed Testing International, P32; MINGOTI A. S., 2005, ANALISE DADOS ATRAVE; Ministerio da Agricultura Pecuaria e de Abastecimento, NORMAS E PARA PRODUC; Moraghan JT, 2006, FOOD CHEM, V95, P554, DOI 10.1016/j.foodchem.2004.10.060; Murphy A., 2017, FISIOLOGIA DESENVOLV; Nadeem M, 2011, PLANT SOIL, V346, P231, DOI 10.1007/s11104-011-0814-y; Nakagawa J, 1999, VIGOUR SEMENTES CONC, V2, P24; Nieves-Cordones M, 2016, METAL IONS LIFE SCI, V16, P291, DOI 10.1007/978-3-319-21756-7_9; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Radchuk V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00510; Ramos I, 2016, SPECTROCHIM ACTA B, V120, P30, DOI 10.1016/j.sab.2016.03.014; Rodrigues ES, 2018, FRONT PLANT SCI, V9, P1; Sikuku P. A., 2013, Journal of Biodiversity and Environmental Sciences (JBES), V3, P245; Singh KL, 2014, WILCZEK SEEDS PLANT; Stadler R, 2005, PLANT PHYSIOL, V139, P701, DOI 10.1104/pp.105.065607; Steinbrecher T, 2017, J EXP BOT, V68, P765, DOI 10.1093/jxb/erw428; Stulen I, 2012, PR INT PLANT SULFUR, P1, DOI 10.1007/978-94-007-4450-9_1; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Tillmann MAA, 2012, SEMENTES FUNDAMENTOS, V3, P161; USDA. United States Department of Agriculture, 2018, TROP SUN SUNN HEMP C; Van Dongen JT, 2003, ANN BOT-LONDON, V91, P729, DOI 10.1093/aob/mcg066; Vogiatzaki E, 2017, CURR BIOL, V27, P2893, DOI 10.1016/j.cub.2017.08.026; Wang QG, 2009, AGRON J, V101, P345, DOI 10.2134/agronj2008.0103; White PJ, 2012, PLANT SOIL, V357, P1, DOI 10.1007/s11104-012-1128-4; Yan DW, 2014, PLANT CELL PHYSIOL, V55, P1521, DOI 10.1093/pcp/pcu089	47	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222987	10.1371/journal.pone.0222987	http://dx.doi.org/10.1371/journal.pone.0222987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557223	Green Published, gold			2022-12-26	WOS:000532345500055
J	dos Santos, A; do Amaral, AT; Fritsche-Neto, R; Kamphorst, SH; Ferreira, FRA; do Amaral, JFT; Vivas, JMS; Santos, PHAD; de Lima, VJ; Khan, S; Schmitt, KFM; Leite, JT; dos Santos, DR; Bispo, RB; Santos, TD; de Oliveira, UA; Guimaraes, LJM; Rodriguez, O				dos Santos, Adriano; do Amaral Junior, Antonio Teixeira; Fritsche-Neto, Roberto; Kamphorst, Samuel Henrique; Alves Ferreira, Fernando Rafael; Teixeira do Amaral, Jose Francisco; Silva Vivas, Janieli Maganha; Araujo Diniz Santos, Pedro Henrique; de Lima, Valter Jario; Khan, Shahid; Medeiros Schmitt, Katia Fabiane; Leite, Jhean Torres; dos Santos Junior, Divino Rosa; Bispo, Rosimeire Barboza; Santos, Talles de Oliveira; de Oliveira, Ueliton Alves; Moreira Guimaraes, Lauro Jose; Rodriguez, Oscar			Relative importance of gene effects for nitrogen-use efficiency in popcorn	PLOS ONE			English	Article							GRAIN-YIELD; MAIZE; TRAITS; LINES; EAR	The objective of this study was to evaluate the effects of additive and non-additive genes on the efficiency of nitrogen (N) use and N responsiveness in inbred popcorn lines. The parents, hybrids and reciprocal crosses were evaluated in a 10x10 triple lattice design at two sites and two levels of N availability. To establish different N levels in the two experiments, fertilization was carried out at sowing, according to soil analysis reports. However, for the experiments with ideal nitrogen availability, N was sidedressed according to the crop requirement, whereas for the N-poor experiments sidedressing consisted of 30% of that applied in the N-rich environment. Two indices were evaluated, the Harmonic Mean of the Relative Performance (HMRP) and Agronomic Efficiency under Low Nitrogen Availability (AELN), both based on grain yield at both N levels. Both additive and non-additive gene effects were important for selection for N-use efficiency. Moreover, there was allelic complementarity between the lines and a reciprocal effect for N-use efficiency, indicating the importance of the choice of the parents used as male or female. The best hybrids were obtained from inbred popcorn lines with contrasting N-use efficiency and N responsiveness.	[dos Santos, Adriano; do Amaral Junior, Antonio Teixeira; Kamphorst, Samuel Henrique; Alves Ferreira, Fernando Rafael; Silva Vivas, Janieli Maganha; Araujo Diniz Santos, Pedro Henrique; de Lima, Valter Jario; Khan, Shahid; Medeiros Schmitt, Katia Fabiane; Leite, Jhean Torres; dos Santos Junior, Divino Rosa; Bispo, Rosimeire Barboza; Santos, Talles de Oliveira; de Oliveira, Ueliton Alves] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Ctr Ciencias & Tecnol Agr, Lab Melhoramento Genet Vegetal, Campos Dos Goytacazes, RJ, Brazil; [Fritsche-Neto, Roberto] Escola Super Agr Luiz de Queiroz ESALQ, Dept Genet, Piracicaba, SP, Brazil; [Teixeira do Amaral, Jose Francisco] Univ Fed Espirito Santo UFES, Ctr Ciencias Agr & Engn, Dept Engn Rural, Alegre, ES, Brazil; [Moreira Guimaraes, Lauro Jose] Ctr Nacl Pesquisa Milho & Sorgo, Empresa Brasileira Pesquisa Agr EMBRAPA, Sete Lagoas, MG, Brazil; [Rodriguez, Oscar] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA	Universidade Estadual do Norte Fluminense; Universidade Federal do Espirito Santo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Nebraska System; University of Nebraska Lincoln	do Amaral, AT (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Ctr Ciencias & Tecnol Agr, Lab Melhoramento Genet Vegetal, Campos Dos Goytacazes, RJ, Brazil.	amaraljr@uenf.br	Katia, Schmitt/AAE-4170-2019; de Lima, Valter Jário/AAM-2489-2020; Leite, Jhean Torres/GPG-3933-2022; Kamphorst, Samuel Henrique/AAJ-3687-2020; Santos, Talles De Oliveira/Q-7503-2018; dos Santos, Adriano/U-3735-2017; KHAN, SHAHID/ABE-8815-2020; do Amaral, Antônio Teixeira/AAD-6291-2021; Ferreira, Fernando Rafael Alves/S-8595-2019; Fritsche-Neto, Roberto/B-2256-2013	Katia, Schmitt/0000-0002-7914-5303; de Lima, Valter Jário/0000-0002-2982-085X; Leite, Jhean Torres/0000-0001-5148-3020; Kamphorst, Samuel Henrique/0000-0001-9727-3539; Santos, Talles De Oliveira/0000-0003-0473-4282; dos Santos, Adriano/0000-0003-4892-4723; KHAN, SHAHID/0000-0002-0853-5080; do Amaral, Antônio Teixeira/0000-0003-4831-7878; Ferreira, Fernando Rafael Alves/0000-0002-8180-5649; Fritsche-Neto, Roberto/0000-0003-4310-0047; Maganha Silva Vivas, janieli/0000-0002-4768-2091; Santos, PedroHenrique Araujo Diniz/0000-0002-7781-215X; Rosa dos Santos junior, Divino/0000-0002-8104-558X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Rio de Janeiro State Research Support Foundation (FAPERJ) [E26/200.486/2018]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro State Research Support Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and Rio de Janeiro State Research Support Foundation (FAPERJ), with the project E26/200.486/2018.	Abdel-Moneam M. A., 2014, Asian Journal of Crop Science, V6, P142, DOI 10.3923/ajcs.2014.142.149; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; Canas RA, 2012, NEW PHYTOL, V194, P440, DOI 10.1111/j.1469-8137.2012.04067.x; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Coque M, 2008, THEOR APPL GENET, V117, P729, DOI 10.1007/s00122-008-0815-2; Cruz CD, 2012, MODELOS BIOMETRICOS; de Souza LV, 2008, PESQUI AGROPECU BRAS, V43, P1517, DOI 10.1590/S0100-204X2008001100010; Derera J, 2015, EUPHYTICA, V205, P121, DOI 10.1007/s10681-015-1410-7; dos Santos A, 2017, CIENC AGROTEC, V41, P22, DOI 10.1590/1413-70542017411030816; DoVale JC, 2012, PESQUI AGROPECU BRAS, V47, P385, DOI 10.1590/S0100-204X2012000300010; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Gowda R. K., 2013, Molecular Plant Breeding, V2013, P116; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Liu RX, 2012, PLANT MOL BIOL REP, V30, P297, DOI 10.1007/s11105-011-0346-x; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Mukanga M, 2010, EUPHYTICA, V174, P293, DOI 10.1007/s10681-010-0178-z; Paponov IA, 2005, PLANT SOIL, V272, P111, DOI 10.1007/s11104-004-4211-7; Silva VMPE, 2013, SCI AGR, V70, P167, DOI 10.1590/S0103-90162013000300005; Ramalho MAP, 2012, APLICAC GENETICA QUA; Resende MDV, 2007, MATEMATICA ESTATISTI; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Uribelarrea M, 2007, FIELD CROP RES, V100, P82, DOI 10.1016/j.fcr.2006.05.008; Worku M, 2008, MAYDICA, V53, P279; Wu YS, 2011, EUPHYTICA, V180, P281, DOI 10.1007/s10681-011-0409-y; Zhang YD, 2005, AGRON J, V97, P1097, DOI 10.2134/agronj2004.0260; [郑祖平 ZHENG Zuping], 2007, [玉米科学, Maize Science], V15, P14	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222726	10.1371/journal.pone.0222726	http://dx.doi.org/10.1371/journal.pone.0222726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557221	Green Published, gold			2022-12-26	WOS:000532345500033
J	Fang, Y; Gao, J; Huang, C; Peng, H; Wu, RP				Fang, Yong; Gao, Jian; Huang, Cheng; Peng, Hua; Wu, Runpu			Self Multi-Head Attention-based Convolutional Neural Networks for fake news detection	PLOS ONE			English	Article								With the rapid development of the internet, social media has become an essential tool for getting information, and attracted a large number of people join the social media platforms because of its low cost, accessibility and amazing content. It greatly enriches our life. However, its rapid development and widespread also have provided an excellent convenience for the range of fake news, people are constantly exposed to fake news and suffer from it all the time. Fake news usually uses hyperbole to catch people's eyes with dishonest intention. More importantly, it often misleads the reader and causes people to have wrong perceptions of society. It has the potential for negative impacts on society and individuals. Therefore, it is significative research on detecting fake news. In the paper, we built a model named SMHA-CNN (Self Multi-Head Attention-based Convolutional Neural Networks) that can judge the authenticity of news with high accuracy based only on content by using convolutional neural networks and self multi-head attention mechanism. In order to prove its validity, we conducted experiments on a public dataset and achieved a precision rate of 95.5% with a recall rate of 95.6% under the 5-fold cross-validation. Our experimental result indicates that the model is more effective at detecting fake news.	[Fang, Yong; Gao, Jian; Huang, Cheng] Sichuan Univ, Coll Cybersecur, Chengdu, Sichuan, Peoples R China; [Peng, Hua] Sichuan Univ, Coll Elect & Informat Engn, Chengdu, Sichuan, Peoples R China; [Wu, Runpu] China Informat Technol Secur Evaluat Ctr, Beijing 100085, Peoples R China	Sichuan University; Sichuan University	Huang, C (corresponding author), Sichuan Univ, Coll Cybersecur, Chengdu, Sichuan, Peoples R China.	opcodesec@gmail.com		Huang, Cheng/0000-0002-5871-946X	Key Research and Development Plan Project of Sichuan Province [2019YFG0407]; Fundamental Research Funds for the Central Universities [20826041B4249, 20826041B4252]	Key Research and Development Plan Project of Sichuan Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported in part by Key Research and Development Plan Project of Sichuan Province (No.2019YFG0407), and the Fundamental Research Funds for the Central Universities under Grant 20826041B4249 and Grant 20826041B4252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2012, P IEEE S SECUR PRIV, P461, DOI 10.1109/SP.2012.34; Bastos MT, 2019, SOC SCI COMPUT REV, V37, P38, DOI 10.1177/0894439317734157; Chung J., 2020, ARXIV; De Sarkar Sohan, 2018, P INT C COMPUTATIONA, P3371; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Feng S., 2012, P 50 ANN M ASS COMP, V2, P171, DOI DOI 10.5555/2390665.2390708; Girgis S, 2018, PROCEEDINGS OF 2018 13TH INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING AND SYSTEMS (ICCES), P93, DOI 10.1109/ICCES.2018.8639198; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Gupta A, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P729; Jablonska, 2016, EUROPEAN J ED SOCIAL, V1, P66; Jin ZW, 2016, AAAI CONF ARTIF INTE, P2972; Jin ZW, 2017, IEEE T MULTIMEDIA, V19, P598, DOI 10.1109/TMM.2016.2617078; Karimi Hamid, 2018, P INT C COMPUTATIONA, P1546; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Lin Z., 2017, PROC 5 INT C LEARN R, P1; Mohammad SM, 2017, ACM T INTERNET TECHN, V17, DOI 10.1145/3003433; OBRIEN N., 2018, LANGUAGE FAKE NEWS O; Perez-Rosas Veronica, 2017, ARXIV170807104; Potthast M, 2017, ARXIV; Qian F, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3834; Ruchansky N, 2017, CIKM'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P797, DOI 10.1145/3132847.3132877; Shu K., 2017, ACM SIGKDD EXPLOR NE, V19, P22, DOI [DOI 10.1145/3137597.3137600, 10.1145/3137597.3137600]; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Xu Chang, 2018, ARXIV180506593; Yang F., 2017, ARXIV170901189; Yang Y., 2018, ARXIV180600749; Yin W., 2016, T ASS COMPUT LINGUIS, V4, P259, DOI [10.1162/tacl_a_00097, DOI 10.1162/TACL_A_00097]; Zhao ZW, 2016, INTERSPEECH, P705, DOI 10.21437/Interspeech.2016-354; Zhou P, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P207, DOI 10.18653/v1/p16-2034; Zhou XY, 2019, PROCEEDINGS OF THE TWELFTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'19), P836, DOI 10.1145/3289600.3291382	35	13	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222713	10.1371/journal.pone.0222713	http://dx.doi.org/10.1371/journal.pone.0222713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LK5JG	31557213	gold, Green Published			2022-12-26	WOS:000530901600001
J	Vazquez-Marrufo, M; Garcia-Valdecasas, M; Caballero-Diaz, R; Martin-Clemente, R; Galvao-Carmona, A				Vazquez-Marrufo, Manuel; Garcia-Valdecasas, Macarena; Caballero-Diaz, Rocio; Martin-Clemente, Ruben; Galvao-Carmona, Alejandro			Multiple evoked and induced alpha modulations in a visual attention task: Latency, amplitude and topographical profiles	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; TIME-FREQUENCY ANALYSIS; BAND POWER CHANGES; HUMAN EEG; OSCILLATIONS; POTENTIALS; RESPONSES; SYNCHRONIZATION; VARIABILITY; MECHANISMS	Alpha event-related desynchronization (ERD) has been widely applied to understand the psychophysiological role of this band in cognition. In particular, a considerable number of publications have described spectral alterations in several pathologies using this time-frequency approach. However, ERD is not capable of specifically showing nonphase (induced) activity related to the presentation of stimuli. Recent studies have described an evoked and induced activity in the early phases (first 200 ms) of stimulus processing. However, scarce studies have analyzed induced and evoked modulations in longer latencies (>200 ms) and their potential roles in cognitive processing. The main goal of the present study was to analyze diverse evoked and induced modulations in response to visual stimuli. Thus, 58-channel electroencephalogram (EEG) was recorded in 21 healthy subjects during the performance of a visual attention task, and analyses were performed for both target and standard stimuli. The initial result showed that phase-locked and nonphase locked activities coexist in the early processing of target and standard stimuli as has been reported by previous studies. However, more modulations were evident in longer latencies in both evoked and induced activities. Correlation analyses suggest that similar maps were present for evoked and induced activities at different timepoints. In the discussion section, diverse proposals will be stated to define the potential roles of these modulations in the information processing for this cognitive task. As a general conclusion, induced activity enables the observation of cognitive mechanisms that are not visible by ERD or ERP modulations.	[Vazquez-Marrufo, Manuel; Garcia-Valdecasas, Macarena; Caballero-Diaz, Rocio] Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain; [Martin-Clemente, Ruben] Univ Seville, Higher Tech Sch Engn, Signal Proc & Commun Dept, Seville, Spain; [Galvao-Carmona, Alejandro] Loyola Andalucia Univ, Dept Psychol, Seville, Spain	University of Sevilla; University of Sevilla; Universidad Loyola Andalucia	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain.	marrufo@us.es	Marrufo, Manuel Vazquez/Y-8460-2019; Galvao-Carmona, Alejandro/A-1725-2015; Martin-Clemente, Ruben/E-8977-2012	Marrufo, Manuel Vazquez/0000-0002-0456-7165; Galvao-Carmona, Alejandro/0000-0002-5126-1273; Martin-Clemente, Ruben/0000-0002-5905-7189	Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain) [PSI2016-78133-P]	Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain)	This study was supported by Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain, PSI2016-78133-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MS, 2017, BEHAV BRAIN RES, V317, P179, DOI 10.1016/j.bbr.2016.09.037; Alegre M, 2006, CLIN NEUROPHYSIOL, V117, P16, DOI 10.1016/j.clinph.2005.08.030; Bareither I, 2014, J NEUROPHYSIOL, V112, P1082, DOI 10.1152/jn.00550.2013; Basar E, 2014, COGN NEURODYNAMICS, V8, P437, DOI 10.1007/s11571-014-9301-5; Brismar T, 2007, PHYSIOL BEHAV, V92, P141, DOI 10.1016/j.physbeh.2007.05.047; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Digiacomo MR, 2008, BRAIN RES, V1234, P94, DOI 10.1016/j.brainres.2008.07.072; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Ergen M, 2014, INT J PSYCHOPHYSIOL, V94, P463, DOI 10.1016/j.ijpsycho.2014.08.177; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Herrmann CS, 2014, BRAIN TOPOGR, V27, P438, DOI 10.1007/s10548-013-0327-5; Jones LA, 2016, BRAIN COGNITION, V102, P33, DOI 10.1016/j.bandc.2015.12.005; Karrasch M, 2006, INT J PSYCHOPHYSIOL, V59, P168, DOI 10.1016/j.ijpsycho.2005.04.006; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Klimesch W, 1997, COGNITIVE BRAIN RES, V6, P83, DOI 10.1016/S0926-6410(97)00018-9; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1186, DOI 10.1016/S1388-2457(01)00543-0; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Mu Y, 2010, NEUROIMAGE, V53, P757, DOI 10.1016/j.neuroimage.2010.07.008; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V43, P757, DOI 10.1016/0013-4694(77)90092-X; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V47, P21, DOI 10.1016/0013-4694(79)90029-4; Sabate M, 2011, NEUROSCIENCE, V189, P236, DOI 10.1016/j.neuroscience.2011.05.011; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; Vazquez-Marrufo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187244; Vazquez-Marrufo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062523; Woertz M, 2004, COGNITIVE BRAIN RES, V20, P256, DOI 10.1016/j.cogbrainres.2004.03.014; Worden MS, 2000, J NEUROSCI, V20	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223055	10.1371/journal.pone.0223055	http://dx.doi.org/10.1371/journal.pone.0223055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557253	Green Published, gold			2022-12-26	WOS:000532345500061
J	Shah, D; Torres, C; Bhandari, V				Shah, Dilip; Torres, Claudio; Bhandari, Vineet			Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activation and pulmonary vascular injury	FASEB JOURNAL			English	Article						PGC-1 alpha mitochondria biogenesis; endothelial dysfunction; acute lung injury; adipokine	ACUTE LUNG INJURY; PYRROLOQUINOLINE QUINONE PQQ; OXIDATIVE STRESS; INFLAMMATION; BIOGENESIS; PROTEIN; SYSTEM; DNA	Adiponectin (APN), an adipocyte-derived adipokine, has been shown to limit lung injury originating from endothelial cell (EC) damage. Previously we reported that obese mice with low circulatory APN levels exhibited pulmonary vascular endothelial dysfunction. This study was designed to investigate the cellular and molecular mechanisms underlying the pulmonary endothelium-dependent protective effects of APN. Our results demonstrated that in APN(-/-) mice, there was an inherent state of endothelium mitochondrial dysfunction that could contribute to endothelial activation and increased susceptibility to LPS-induced acute lung injury (ALI). We noted that APN(-/-) mice showed decreased expression of mitochondrial biogenesis regulatory protein peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and its downstream proteins nuclear respiratory factor 1, transcription factor A, mitochondrial, and Sirtuin (Sirt)3 and Sirt1 expression in whole lungs and in freshly isolated lung ECs from these mice at baseline and subjected to LPS-induced ALI. We further showed that treating APN(-/-) mice with PGC-1 alpha activator pyrroloquinoline quinone enhances mitochondrial biogenesis and function in lung endothelium and attenuation of ALI. These results suggest that the pulmonary endothelium-protective properties of APN are mediated, at least in part, by an enhancement of mitochondrial biogenesis through a mechanism involving PGC-1 alpha activation.	[Shah, Dilip; Bhandari, Vineet] Drexel Univ, Coll Med, Dept Pediat, New Coll Bldg,Suite 7408,245 N Broad St, Philadelphia, PA 19104 USA; [Torres, Claudio] Drexel Univ, Coll Med, Dept Neurobiol & Anat Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Shah, D (corresponding author), Drexel Univ, Coll Med, Dept Pediat, New Coll Bldg,Suite 7408,245 N Broad St, Philadelphia, PA 19104 USA.	dks74@drexel.edu	Bhandari, Vineet/AAS-3365-2020	Shah, Dilip/0000-0002-4248-5611	Departmental of Pediatrics; Drexel University Fund [282656]; U.S. National Institutes of Health, National Institute on Aging [1R56AG056696-01]; Commonwealth Universal Research Enhancement Program (CURE) [450095-5626]; NATIONAL INSTITUTE ON AGING [R56AG056696] Funding Source: NIH RePORTER	Departmental of Pediatrics; Drexel University Fund; U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Commonwealth Universal Research Enhancement Program (CURE); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Departmental of Pediatrics and Drexel University Fund (282656 to D.S. and V.B.), U.S. National Institutes of Health, National Institute on Aging 1R56AG056696-01 (to C.T.), and the Commonwealth Universal Research Enhancement Program (CURE; 450095-5626 to D.S., C.T., and V.B.). The authors declare no conflicts of interest.	Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Cherry AD, 2014, J BIOL CHEM, V289, P41, DOI 10.1074/jbc.M113.512483; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113; Eising JB, 2014, EUR RESPIR J, V43, P1189, DOI 10.1183/09031936.00149613; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Henderson WR, 2017, AM J RESP CRIT CARE, V196, P822, DOI 10.1164/rccm.201612-2495CI; Hough RF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124329; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Johansson PI, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2275-7; Kang NY, 2018, ADV EXP MED BIOL, V1071, P151, DOI 10.1007/978-3-319-91137-3_19; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; Kumar N, 2015, CAN J PHYSIOL PHARM, V93, P71, DOI 10.1139/cjpp-2014-0270; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Kurundkar D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.120722; Lee Seung Jae, 2017, Biomed Hub, V2, P1, DOI 10.1159/000460813; Lee YL, 2017, SHOCK, V48, P54, DOI 10.1097/SHK.0000000000000838; Liu QY, 2018, MOL IMMUNOL, V103, P115, DOI 10.1016/j.molimm.2018.09.010; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Piao LM, 2018, INT J CARDIOL, V267, P150, DOI 10.1016/j.ijcard.2018.05.089; Ponnalagu D, 2016, MITOCHONDRION, V27, P6, DOI 10.1016/j.mito.2016.01.001; Qiao LP, 2012, DIABETES, V61, P1463, DOI 10.2337/db11-1475; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Rocco PRM, 2003, EUR RESPIR J, V22, P20, DOI 10.1183/09031936.03.00108603; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rub C, 2017, CELL TISSUE RES, V367, P111, DOI 10.1007/s00441-016-2485-8; SHAH D, 2016, AM J RESP CRIT CARE, V193; Shah D, 2019, AM J RESP CELL MOL, V60, P465, DOI 10.1165/rcmb.2018-0194OC; Shah D, 2015, J BIOL CHEM, V290, P29642, DOI 10.1074/jbc.M115.690784; Shah D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11362; Sliman SM, 2013, CELL BIOCHEM BIOPHYS, V67, P399, DOI 10.1007/s12013-011-9330-1; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e; Xu B, 2016, J BIOL CHEM, V291, P19274, DOI 10.1074/jbc.M116.740324; Xu L, 2013, J SURG RES, V183, P752, DOI 10.1016/j.jss.2013.01.055; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	48	13	13	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13617	13631		10.1096/fj.201901123R	http://dx.doi.org/10.1096/fj.201901123R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585050	Bronze, Green Published			2022-12-26	WOS:000507466100045
J	Kirmiz, M; Gillies, TE; Dickson, EJ; Trimmer, JS				Kirmiz, Michael; Gillies, Taryn E.; Dickson, Eamonn J.; Trimmer, James S.			Neuronal ER?plasma membrane junctions organized by Kv2?VAP pairing recruit Nir proteins and affect phosphoinositide homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol signaling; plasma membrane; potassium channel; membrane protein; organelle; endoplasmic reticulum (ER); brain; neuron; lipids; membrane contact site (MCS); membrane-associated phosphatidylinositol transfer proteins; plasma membrane; plasma membrane junction	KV2.1 K+ CHANNEL; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; POTASSIUM CHANNELS; EXPRESSION PATTERNS; SUBSURFACE CISTERNS; MAMMALIAN HOMOLOGS; MOLECULAR-CLONING; CRAC CHANNELS; ER	The association of plasma membrane (PM)-localized voltage-gated potassium (Kv2) channels with endoplasmic reticulum (ER)-localized vesicle-associated membrane protein-associated proteins VAPA and VAPB defines ER?PM junctions in mammalian brain neurons. Here, we used proteomics to identify proteins associated with Kv2/VAP-containing ER?PM junctions. We found that the VAP-interacting membrane-associated phosphatidylinositol (PtdIns) transfer proteins PYK2 N-terminal domain-interacting receptor 2 (Nir2) and Nir3 specifically associate with Kv2.1 complexes. When coexpressed with Kv2.1 and VAPA in HEK293T cells, Nir2 colocalized with cell-surface?conducting and -nonconducting Kv2.1 isoforms. This was enhanced by muscarinic-mediated PtdIns(4,5)P-2 hydrolysis, leading to dynamic recruitment of Nir2 to Kv2.1 clusters. In cultured rat hippocampal neurons, exogenously expressed Nir2 did not strongly colocalize with Kv2.1, unless exogenous VAPA was also expressed, supporting the notion that VAPA mediates the spatial association of Kv2.1 and Nir2. Immunolabeling signals of endogenous Kv2.1, Nir2, and VAP puncta were spatially correlated in cultured neurons. Fluorescence-recovery-after-photobleaching experiments revealed that Kv2.1, VAPA, and Nir2 have comparable turnover rates at ER?PM junctions, suggesting that they form complexes at these sites. Exogenous Kv2.1 expression in HEK293T cells resulted in significant differences in the kinetics of PtdIns(4,5)P-2 recovery following repetitive muscarinic stimulation, with no apparent impact on resting PtdIns(4,5)P-2 or PtdIns(4)P levels. Finally, the brains of Kv2.1-knockout mice had altered composition of PtdIns lipids, suggesting a crucial role for native Kv2.1-containing ER?PM junctions in regulating PtdIns lipid metabolism in brain neurons. These results suggest that ER?PM junctions formed by Kv2 channel?VAP pairing regulate PtdIns lipid homeostasis via VAP-associated PtdIns transfer proteins.	[Kirmiz, Michael; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Gillies, Taryn E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dickson, Eamonn J.; Trimmer, James S.] Univ Calif Davis, Davis Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Stanford University; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Davis Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	; Dickson, Eamonn/C-2276-2017	Gillies, Taryn/0000-0001-6223-9357; Trimmer, James/0000-0002-6117-3912; Dickson, Eamonn/0000-0001-8619-7630; Kirmiz, Michael/0000-0001-9316-0182	National Institutes of Health Research [R01 HL144071, R21 NS101648, R01 GM127513, T32 GM007377]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL144071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377, R01GM127513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS101648] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Research Grants R01 HL144071 and R21 NS101648 (to J. S. T.), Grant R01 GM127513 (to E. J. D.), and Grant T32 GM007377 (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa Y, 1997, BIOCHEM BIOPH RES CO, V236, P559, DOI 10.1006/bbrc.1997.7009; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Besprozvannaya M, 2018, ELIFE, V7, DOI 10.7554/eLife.31019; Bishop HI, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00001; Bishop HI, 2015, J NEUROSCI, V35, P14922, DOI 10.1523/JNEUROSCI.1897-15.2015; Calderon Juan C, 2014, Biophys Rev, V6, P133, DOI 10.1007/s12551-013-0135-x; Chang CL, 2015, J BIOL CHEM, V290, P14289, DOI 10.1074/jbc.M114.621375; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Chang JHT, 1997, J NEUROSCI, V17, P5881; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Kovel CGF, 2017, JAMA NEUROL, V74, P1228, DOI 10.1001/jamaneurol.2017.1714; Dickson EJ, 2019, BIOCHEM J, V476, P1, DOI 10.1042/BCJ20180022; Dickson EJ, 2017, ADV EXP MED BIOL, V997, P95, DOI 10.1007/978-981-10-4567-7_7; Dickson EJ, 2016, J CELL BIOL, V213, P33, DOI 10.1083/jcb.201508106; DREWE JA, 1992, J NEUROSCI, V12, P538; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Gallo A, 2016, ANNU REV CELL DEV BI, V32, P279, DOI 10.1146/annurev-cellbio-111315-125024; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Helmuth JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-372; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Honigsperger C, 2017, J PHYSIOL-LONDON, V595, P739, DOI 10.1113/JP273024; Hsieh TS, 2017, MOL BIOL CELL, V28, P3171, DOI 10.1091/mbc.E17-06-0377; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Johnson B, 2018, P NATL ACAD SCI USA, V115, pE7331, DOI 10.1073/pnas.1805757115; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Kim YJ, 2016, BIOCHEM SOC T, V44, P197, DOI 10.1042/BST20150187; Kim YJ, 2015, DEV CELL, V33, P549, DOI 10.1016/j.devcel.2015.04.028; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Kirmiz M, 2018, MOL BIOL CELL, V29, P2410, DOI 10.1091/mbc.E18-05-0337; Kirmiz M, 2018, J NEUROSCI, V38, P7562, DOI 10.1523/JNEUROSCI.0893-18.2018; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Kruse M, 2016, J NEUROSCI, V36, P1386, DOI 10.1523/JNEUROSCI.3535-15.2016; Lavancier F, 2020, BIOMETRICS, V76, P36, DOI 10.1111/biom.13115; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Lev S, 1999, MOL CELL BIOL, V19, P2278; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Liu PW, 2014, J NEUROSCI, V34, P4991, DOI 10.1523/JNEUROSCI.1925-13.2014; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; Lu CW, 1999, J NEUROSCI, V19, P7317, DOI 10.1523/JNEUROSCI.19-17-07317.1999; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; McKenzie AT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27293-5; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Palacio S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0267-17.2017; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peltola MA, 2011, EMBO REP, V12, P1293, DOI 10.1038/embor.2011.204; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shivanandan A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-349; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sun EW, 2019, P NATL ACAD SCI USA, V116, P5775, DOI 10.1073/pnas.1820156116; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tao-Cheng JH, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0387-2; Tao-Cheng JH, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0366-7; Thiffault I, 2015, J GEN PHYSIOL, V146, P399, DOI 10.1085/jgp.201511444; Tilley DC, 2014, P NATL ACAD SCI USA, V111, pE4789, DOI 10.1073/pnas.1406876111; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Traynor-Kaplan A, 2017, BBA-MOL CELL BIOL L, V1862, P513, DOI 10.1016/j.bbalip.2017.02.002; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Wu YM, 2017, P NATL ACAD SCI USA, V114, pE4859, DOI 10.1073/pnas.1701078114; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3	96	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17735	17757		10.1074/jbc.RA119.007635	http://dx.doi.org/10.1074/jbc.RA119.007635			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31594866	Green Published, hybrid			2022-12-26	WOS:000504206800004
J	Holck, J; Fredslund, F; Moller, MS; Brask, J; Krogh, KBRM; Lange, L; Welner, DH; Svensson, B; Meyer, AS; Wilkens, C				Holck, Jesper; Fredslund, Folmer; Moller, Marie S.; Brask, Jesper; Krogh, Kristian B. R. M.; Lange, Lene; Welner, Ditte H.; Svensson, Birte; Meyer, Anne S.; Wilkens, Casper			A carbohydrate-binding family 48 module enables feruloyl esterase action on polymeric arabinoxylan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; enzyme mechanism; structure?function; molecular docking; molecular dynamics; arabinoxylan; carbohydrate-binding module; carbohydrate esterase family 1; ferulic acid esterase	SUBSTRATE-SPECIFICITY; STRUCTURE REFINEMENT; MOLECULAR-BASIS; STARCH; RECOGNITION; GENERATION; HYDROLYSIS; FEATURES; REVEALS; DOMAIN	Feruloyl esterases (EC 3.1.1.73), belonging to carbohydrate esterase family 1 (CE1), hydrolyze ester bonds between ferulic acid (FA) and arabinose moieties in arabinoxylans. Recently, some CE1 enzymes identified in metagenomics studies have been predicted to contain a family 48 carbohydrate-binding module (CBM48), a CBM family associated with starch binding. Two of these CE1s, wastewater treatment sludge (wts) Fae1A and wtsFae1B isolated from wastewater treatment surplus sludge, have a cognate CBM48 domain and are feruloyl esterases, and wtsFae1A binds arabinoxylan. Here, we show that wtsFae1B also binds to arabinoxylan and that neither binds starch. Surface plasmon resonance analysis revealed that wtsFae1B's K-d for xylohexaose is 14.8 mu m and that it does not bind to starch mimics, beta-cyclodextrin, or maltohexaose. Interestingly, in the absence of CBM48 domains, the CE1 regions from wtsFae1A and wtsFae1B did not bind arabinoxylan and were also unable to catalyze FA release from arabinoxylan. Pretreatment with a beta-D-1,4-xylanase did enable CE1 domain-mediated FA release from arabinoxylan in the absence of CBM48, indicating that CBM48 is essential for the CE1 activity on the polysaccharide. Crystal structures of wtsFae1A (at 1.63 angstrom resolution) and wtsFae1B (1.98 angstrom) revealed that both are folded proteins comprising structurally-conserved hydrogen bonds that lock the CBM48 position relative to that of the CE1 domain. wtsFae1A docking indicated that both enzymes accommodate the arabinoxylan backbone in a cleft at the CE1-CBM48 domain interface. Binding at this cleft appears to enable CE1 activities on polymeric arabinoxylan, illustrating an unexpected and crucial role of CBM48 domains for accommodating arabinoxylan.	[Holck, Jesper; Moller, Marie S.; Svensson, Birte; Meyer, Anne S.; Wilkens, Casper] Tech Univ Denmark, Dept Biotechnol & Biomed, Sect Prot Chem & Enzyme Technol, Bldg 224, DK-2800 Lyngby, Denmark; [Fredslund, Folmer; Welner, Ditte H.] Tech Univ Denmark, Enzyme Engn & Struct Biol, Novo Nordisk Fdn Ctr Biosustainabil, Bldg 220, DK-2800 Lyngby, Denmark; [Brask, Jesper; Krogh, Kristian B. R. M.] Novozymes AS, Biologiens Vej 2, DK-2800 Lyngby, Denmark; [Lange, Lene] LLa Bioecon Res & Advisory, Karensgade 5, DK-2500 Valby, Denmark	Technical University of Denmark; Technical University of Denmark; Novozymes	Wilkens, C (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Sect Prot Chem & Enzyme Technol, Bldg 224, DK-2800 Lyngby, Denmark.	cwil@dtu.dk	Wilkens, Casper/AAP-4214-2021; Fredslund, Folmer/ABH-5821-2020; Wilkens, Casper/GRR-1975-2022; Meyer, Anne S/AAN-2157-2020; Møller, Marie Sofie/AAH-2568-2021; Holck, Jesper/Q-4399-2016; Møller, Marie Sofie/GRE-9135-2022; Brask, Jesper/AAM-5107-2020; Wilkens, Casper/R-1070-2016	Fredslund, Folmer/0000-0003-0881-1927; Meyer, Anne S/0000-0001-8910-9931; Møller, Marie Sofie/0000-0001-9017-3367; Holck, Jesper/0000-0002-8072-1101; Brask, Jesper/0000-0002-0425-9875; Svensson, Birte/0000-0002-2993-8196; Wilkens, Casper/0000-0001-7692-067X; Welner, Ditte Hededam/0000-0001-9297-4133	Independent Research Fund Denmark, Natural Sciences [272-06-0050]	Independent Research Fund Denmark, Natural Sciences	We thank the beamline staff at ID30-A3 and ID23-2 for assistance, and the ESRF for synchrotron beamtime. S. tefan Janec.ek is gratefully acknowledged for invaluable input about carbohydrate-binding modules CBM20, -48, and -69. The Independent Research Fund Denmark, Natural Sciences, supported the purchase of the Biacore T100 instrument through Grant 272-06-0050.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartolome B, 1997, APPL ENVIRON MICROB, V63, P208; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biely P, 2016, BIOTECHNOL ADV, V34, P1260, DOI 10.1016/j.biotechadv.2016.09.001; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Bunzel M, 2010, PHYTOCHEM REV, V9, P47, DOI 10.1007/s11101-009-9139-3; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cockburn D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160112; DARVILL JE, 1980, PLANT PHYSIOL, V66, P1135, DOI 10.1104/pp.66.6.1135; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faulds CB, 2005, FEBS J, V272, P4362, DOI 10.1111/j.1742-4658.2005.04849.x; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujimoto Z, 2013, J BIOL CHEM, V288, P12376, DOI 10.1074/jbc.M113.460097; Garg S, 2016, CURR METABOL, V4, P23, DOI 10.2174/2213235X03666150915211224; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gonzalez-Garcia S, 2018, IND CROP PROD, V123, P331, DOI 10.1016/j.indcrop.2018.07.003; Gruninger RJ, 2016, BIOCHEM J, V473, P839, DOI 10.1042/BJ20151153; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Helbert W, 2019, P NATL ACAD SCI USA, V116, P10184, DOI 10.1073/pnas.1906635116; Hermoso JA, 2004, J MOL BIOL, V338, P495, DOI 10.1016/j.jmb.2004.03.003; Holck J, 2019, ENZYME MICROB TECH, V129, DOI 10.1016/j.enzmictec.2019.05.010; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Miller M.A., 2010, P GAT COMP ENV WORKS; Monaco S, 2013, J APPL CRYSTALLOGR, V46, P804, DOI 10.1107/S0021889813006195; Naidu DS, 2018, CARBOHYD POLYM, V179, P28, DOI 10.1016/j.carbpol.2017.09.064; Nakamura A.M., 2017, BIOTECHNOL RES INNOV, V1, P35, DOI DOI 10.1016/J.BIORI.2017.02.001; Naran R, 2008, PLANT PHYSIOL, V148, P132, DOI 10.1104/pp.108.123513; Oliveira DM, 2019, BIORESOURCE TECHNOL, V278, P408, DOI 10.1016/j.biortech.2019.01.064; Peng H, 2014, FEBS LETT, V588, P1161, DOI 10.1016/j.febslet.2014.02.050; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schubot FD, 2001, BIOCHEMISTRY-US, V40, P12524, DOI 10.1021/bi011391c; Simmons TJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13902; Sorensen HR, 2007, ENZYME MICROB TECH, V41, P103, DOI 10.1016/j.enzmictec.2006.12.009; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wefers D, 2017, J MOL BIOL, V429, P2509, DOI 10.1016/j.jmb.2017.06.017; Wilkens C, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0840-y; Wong MT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02504; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	58	15	15	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17339	17353		10.1074/jbc.RA119.009523	http://dx.doi.org/10.1074/jbc.RA119.009523			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31558605	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000503173500015
J	Roy, NS; Jian, XY; Soubias, O; Zhai, P; Hall, JR; Dagher, JN; Coussens, NP; Jenkins, LM; Luo, RB; Akpan, IO; Hall, MD; Byrd, RA; Yohe, ME; Randazzo, PA				Roy, Neeladri Sekhar; Jian, Xiaoying; Soubias, Olivier; Zhai, Peng; Hall, Jessica R.; Dagher, Jessica N.; Coussens, Nathan P.; Jenkins, Lisa M.; Luo, Ruibai; Akpan, Itoro O.; Hall, Matthew D.; Byrd, R. Andrew; Yohe, Marielle E.; Randazzo, Paul A.			Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); allosteric regulation; GTPase-activating protein (GAP); cell signaling; protein?protein interaction; actin remodeling; ArfGAP with SH3 domain; ankyrin repeat and PH domain 1 (ASAP1); integrin adhesion; phosphatidylinositol 4; 5-bisphosphate (PIP2); pleckstrin homology domain	PLECKSTRIN HOMOLOGY DOMAIN; STRUCTURAL BASIS; AMINO-TERMINUS; FACTOR-I; ARF GAP; ALLOSTERIC ACTIVATION; CRYSTAL-STRUCTURES; KINETIC-ANALYSIS; MOLECULAR-BASIS; MEMBRANE	Arf GAP with Src homology 3 domain, ankyrin repeat, and pleckstrin homology (PH) domain 1 (ASAP1) is a multidomain GTPase-activating protein (GAP) for ADP-ribosylation factor (ARF)-type GTPases. ASAP1 affects integrin adhesions, the actin cytoskeleton, and invasion and metastasis of cancer cells. ASAP1's cellular function depends on its highly-regulated and robust ARF GAP activity, requiring both the PH and the ARF GAP domains of ASAP1, and is modulated by phosphatidylinositol 4,5-bisphosphate (PIP2). The mechanistic basis of PIP2-stimulated GAP activity is incompletely understood. Here, we investigated whether PIP2 controls binding of the N-terminal extension of ARF1 to ASAP1's PH domain and thereby regulates its GAP activity. Using [Delta 17]ARF1, lacking the N terminus, we found that PIP2 has little effect on ASAP1's activity. A soluble PIP2 analog, dioctanoyl-PIP2 (diC8PIP(2)), stimulated GAP activity on an N terminus-containing variant, [L8K]ARF1, but only marginally affected activity on [Delta 17]ARF1. A peptide comprising residues 2-17 of ARF1 ([2-17]ARF1) inhibited GAP activity, and PIP2-dependently bound to a protein containing the PH domain and a 17-amino acid-long interdomain linker immediately N-terminal to the first beta-strand of the PH domain. Point mutations in either the linker or the C-terminal alpha-helix of the PH domain decreased [2-17]ARF1 binding and GAP activity. Mutations that reduced ARF1 N-terminal binding to the PH domain also reduced the effect of ASAP1 on cellular actin remodeling. Mutations in the ARF N terminus that reduced binding also reduced GAP activity. We conclude that PIP2 regulates binding of ASAP1's PH domain to the ARF1 N terminus, which may partially regulate GAP activity.	[Roy, Neeladri Sekhar; Jian, Xiaoying; Zhai, Peng; Luo, Ruibai; Akpan, Itoro O.; Yohe, Marielle E.; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Jenkins, Lisa M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Soubias, Olivier; Byrd, R. Andrew] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Hall, Jessica R.; Dagher, Jessica N.; Coussens, Nathan P.; Hall, Matthew D.] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Yohe, Marielle E.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhai, Peng] Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Hall, Jessica R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Dagher, Jessica N.] Novo Nordisk, Beijing 100020, Peoples R China; [Yohe, Marielle E.] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Frederick, MD 21702 USA.; Yohe, ME (corresponding author), NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.	Marielle.Yohe@nih.gov; randazzp@mail.nih.gov	ROY, NEELADRI SEKHAR/AHC-8075-2022; Jenkins, Lisa/AAI-2490-2021; Byrd, R. Andrew/F-8042-2015	Byrd, R. Andrew/0000-0003-3625-4232; Coussens, Nathan/0000-0002-3896-7909; Hatton, Jessica/0000-0003-2104-171X	National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kate Hebron for insightful discussions, Douglas Lowy for Clone 7 NIH 3T3 fibroblasts, and Valerie Barr for help with microscopy. Molecular graphics were performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from National Institutes of Health Grant P41-GM103311.	Abankwa D, 2008, CELL CYCLE, V7, P2667, DOI 10.4161/cc.7.17.6596; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Aguiar J, 2003, J COLLOID INTERF SCI, V258, P116, DOI 10.1016/S0021-9797(02)00082-6; Aizel K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001652; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Brodie NI, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700479; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Buffart TE, 2005, CELL ONCOL, V27, P57; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Chen Pei-Wen, 2012, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1713s55; Chen Z, 2018, DATA BRIEF, V17, P356, DOI 10.1016/j.dib.2018.01.024; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cote M, 2015, J CELL SCI, V128, P4341, DOI 10.1242/jcs.172742; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hall MD, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/2/022001; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; He XJ, 2013, STRUCTURE, V21, P355, DOI 10.1016/j.str.2013.01.001; Hou T, 2014, INT J CLIN EXP PATHO, V7, P280; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2012, J BIOL CHEM, V287, P24273, DOI 10.1074/jbc.M112.368084; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Lakowicz JR, 2006, PRINCIPLES FLUORESCE, Vthird, P361; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li YF, 2019, BIOCHEMISTRY-US, V58, P1423, DOI 10.1021/acs.biochem.8b01323; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Liu YZ, 2014, STRUCTURE, V22, P421, DOI 10.1016/j.str.2013.12.011; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2008, J BIOL CHEM, V283, P21965, DOI 10.1074/jbc.M802268200; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo R, 2009, CELL SIGNAL, V21, P1169, DOI 10.1016/j.cellsig.2009.03.006; Malaby AW, 2018, STRUCTURE, V26, P106, DOI 10.1016/j.str.2017.11.019; Malaby AW, 2013, P NATL ACAD SCI USA, V110, P14213, DOI 10.1073/pnas.1301883110; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Northup John K, 2012, Cell Logist, V2, P140; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randazzo P. A., 2013, CELLULAR LOGISTICS, V3, pe27609, DOI [10.4161/cl.27609, DOI 10.4161/CL.27609]; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Roy N.S., 2016, CELL LOGIST, V6, pe1181700, DOI [10.1080/21592799.2016.1181700, DOI 10.1080/21592799.2016.1181700]; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Seidel RD, 2004, BIOCHEMISTRY-US, V43, P15393, DOI 10.1021/bi0490385; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; TERUI T, 1994, J BIOL CHEM, V269, P28130; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014	90	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17354	17370		10.1074/jbc.RA119.009269	http://dx.doi.org/10.1074/jbc.RA119.009269			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31591270	Green Published, hybrid			2022-12-26	WOS:000503173500016
J	Jenoh, EM; de Villiers, EP; de Villiers, SM; Okoth, S; Jefwa, J; Kioko, E; Kaimenyi, D; Hendrickx, M; Dahdouh-Guebas, F; Koedam, N				Jenoh, Elisha Mrabu; de Villiers, Etienne P.; de Villiers, Santie M.; Okoth, Sheila; Jefwa, Joyce; Kioko, Esther; Kaimenyi, Davies; Hendrickx, Marijke; Dahdouh-Guebas, Farid; Koedam, Nico			Infestation mechanisms of two woodborer species in the mangrove Sonneratia alba J. Smith in Kenya and co-occurring endophytic fungi	PLOS ONE			English	Article							CELLULOSE DIGESTION; GAZI BAY; BARK; DEFOLIATION; INSECTS; SYSTEMS; TRAITS	Insect damage on trees can severely affect the quality of timber, reduce the fecundity of the host and render it susceptible to fungal infestation and disease. Such pathology weakens or eventually kills the host. Infestation by two insect woodborer species (a moth and a beetle) is causing mortality of Sonneratia alba, a wide-ranging pioneer mangrove species of the Indo-Pacific. Establishing the infestation mechanism of the two insect woodborer species is an initial and essential step towards understanding their ecological role in the mangroves and in determining sustainable management priorities and options. Our main objectives were to investigate the infestation mechanism employed by the two insect woodborers which infest S. alba trees, to establish the occurrence of secondary infestation by endophytic fungi in the infested S. alba branches, and to explore a control management option to the woodborer infestation. We conducted an external inspection of infested branches in two large embayments in Kenya, Gazi Bay and Mida Creek, and by splitting infested branches we determined the respective internal infestation mechanisms. Infested wood samples from Gazi Bay and Mida Creek were incubated at 28 +/- 1 degrees C for 3-5 days to establish the presence of fungi. A survey was conducted in both Gazi Bay and Mida Creek to ascertain the presence of ants on S. alba. The infestation characteristics of the two insect woodborer species were different. It took 6-8 months for the beetle to kill a branch of 150 cm-200 cm long. For the moth to kill a branch, it depended upon several factors including the contribution by multiple species, other than the moth infestation alone. A total of 15 endophytic fungal species were identified. Two ant species Oecophylla longipoda and a Pheidole sp. inhabited 62% and 69% respectively of sampled S. alba trees in Gazi Bay whereas only Pheidole sp. inhabited 17% of the sampled S. alba trees in Mida Creek. In summary, we have documented the time it takes each woodborer species to kill a branch, the infestation mechanism of the two insect woodborers, and we hypothesized on the role of two ant species. The presence of several different fungal species was ascertained, and we discussed their possible role in the infested wood. Our results cannot unambiguously associate the woodborers and identified fungi. We recommend further studies to investigate the presence or absence, and if present, the nature of fungi in the gut of the woodborers.	[Jenoh, Elisha Mrabu] Kenya Marine & Fisheries Res Inst KMFRI, Mombasa, Kenya; [Jenoh, Elisha Mrabu; Dahdouh-Guebas, Farid] Univ Libre Bruxelles ULB, Dept Biol Organismes, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Jenoh, Elisha Mrabu; Koedam, Nico] Vrije Univ Brussel, Lab Plant Biol & Nat Management APNA, Ecol & Biodivers, Brussels, Belgium; [de Villiers, Etienne P.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [de Villiers, Santie M.; Kaimenyi, Davies] Pwani Univ, Dept Biochem & Biotechnol, Kilifi, Kenya; [Okoth, Sheila] Univ Nairobi UoN, Ctr Biotechnol & Bioinformat CEBIB, Nairobi, Kenya; [Jefwa, Joyce; Kioko, Esther] Natl Museums Kenya NMK, Nairobi, Kenya; [Hendrickx, Marijke] BCCM IHEM Sci Inst Publ Hlth Mycol & Aerobiol Sec, Rue Juliette Wytsmanstr, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Pwani University; University of Nairobi	Jenoh, EM (corresponding author), Kenya Marine & Fisheries Res Inst KMFRI, Mombasa, Kenya.; Jenoh, EM (corresponding author), Univ Libre Bruxelles ULB, Dept Biol Organismes, Lab Syst Ecol & Resource Management, Brussels, Belgium.; Jenoh, EM (corresponding author), Vrije Univ Brussel, Lab Plant Biol & Nat Management APNA, Ecol & Biodivers, Brussels, Belgium.	elishamrabu@gmail.com		de Villiers, Etienne/0000-0001-9878-1009; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Jenoh, Elisha/0000-0001-6855-1704; Kaimenyi, Davies/0000-0002-6320-3740	Flemish Interuniversity Council-University Development Cooperation (VLIR-UOS); VLIR PhD Scholarship	Flemish Interuniversity Council-University Development Cooperation (VLIR-UOS); VLIR PhD Scholarship	This research was funded by the Flemish Interuniversity Council-University Development Cooperation (VLIR-UOS; http://www.vliruos.be/).EMJ had a VLIR PhD Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuodha PAW, 2001, HYDROBIOLOGIA, V458, P255, DOI 10.1023/A:1013130916811; ANDERSON C, 1995, BIOTROPICA, V27, P218, DOI 10.2307/2388997; Arunpanichlert J, 2010, CHEM PHARM BULL, V58, P1033, DOI 10.1248/cpb.58.1033; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Barnett HL, 2003, ILLUSTRATED GENERA I, P15; Becker PT, 2014, MED MYCOL, V52, P826, DOI 10.1093/mmy/myu064; Bosire JO, 2014, BIOGEOSCIENCES, V11, P2623, DOI 10.5194/bg-11-2623-2014; Brakel WH, 1979, MARINE PARKS RECREAT, P409; Brokaw N, 2000, FOREST ECOL MANAG, V129, P89, DOI 10.1016/S0378-1127(99)00141-3; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; Brune A, 2007, NATURE, V450, P487, DOI 10.1038/450487a; Bumrungsri Sara, 2008, Songklanakarin Journal of Science and Technology, V30, P579; Burrows D.W., 2003, THESIS J COOK U; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; Dahdouh-Guebas F., 2002, Wetlands Ecology and Management, V10, P179, DOI 10.1023/A:1020133110407; Dahdouh-Guebas F, 2000, ECON BOT, V54, P513, DOI 10.1007/BF02866549; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; Di Nitto D, 2014, BIOGEOSCIENCES, V11, P857, DOI 10.5194/bg-11-857-2014; Dibong S.D., 2008, AFR J ENV SCI TECHNO, V2, P371; Doute RN, 1981, SERIES, V30; Edburg SL, 2012, FRONT ECOL ENVIRON, V10, P416, DOI 10.1890/110173; Geib MS, 2008, PNAS, V105, P35; Gordon I., 2003, DIE BACK SONNERATIA, P281; Jenoh EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154849; Kairo JG, 2001, S AFR J BOT, V67, P383, DOI 10.1016/S0254-6299(15)31153-4; KUKOR JJ, 1988, PHYSIOL ZOOL, V61, P364, DOI 10.1086/physzool.61.4.30161254; KUKOR JJ, 1986, J CHEM ECOL, V12, P1057, DOI 10.1007/BF01638996; LEE BKH, 1973, MYCOLOGIA, V65, P894, DOI 10.2307/3758522; Loganathachetti DS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09281-3; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Martin M. M., 1987, INVERTEBRATE MICROBI; MATTSON WJ, 1975, SCIENCE, V190, P515, DOI 10.1126/science.190.4214.515; Moraa CB, 2013, BIODEGRADING ENZYMES; Mwangi JG., 2002, NEW PEST CAUSING DEC; Neukermans G, 2008, J SPAT SCI, V53, P75, DOI 10.1080/14498596.2008.9635137; Nickrent DL, 2004, PLANT HLTH INSTRUCTO, DOI [10.1094/PH-I-2004-0330-01, DOI 10.1094/PH-I-2004-0330-01]; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Okello JA, 2014, ECOL EVOL, V4, P3187, DOI 10.1002/ece3.1154; Rajput KS, 2007, MICROBIOL RES, V162, P229, DOI 10.1016/j.micres.2004.07.003; Saenger P, 2013, MANGROVE ECOLOGY SIL; Salle A, 2014, FOREST ECOL MANAG, V328, P79, DOI 10.1016/j.foreco.2014.05.027; Sauvard D, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P63; Schowalter TD, 1993, NATURE; Scott JG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0011; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Spalding M., 2010, WORLD MANGROVE ATLAS; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tomlinson C.B., 1986, CAMBRIDGE TROPICAL B; Tong YF, 2003, J TROP ECOL, V19, P397, DOI 10.1017/S0266467403003444; Wang'ondu VW, 2013, FLORA, V208, P522, DOI 10.1016/j.flora.2013.08.004; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhou SL, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3658-3; [No title captured]	55	1	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0221285	10.1371/journal.pone.0221285	http://dx.doi.org/10.1371/journal.pone.0221285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31585459	Green Published, gold			2022-12-26	WOS:000532407600004
J	O'Neill, HC; Lim, HK; Periasamy, P; Kumarappan, L; Tan, JKH; O'Neill, TJ				O'Neill, Helen C.; Lim, Hong K.; Periasamy, Pravin; Kumarappan, Lavanya; Tan, Jonathan K. H.; O'Neill, Terence J.			Transplanted spleen stromal cells with osteogenic potential support ectopic myelopoiesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ANTIGEN-PRESENTING CELLS; DENDRITIC-LIKE CELLS; HEMATOPOIETIC STEM; BONE-MARROW; PROGENITOR CELLS; PERIVASCULAR CELLS; MURINE SPLEEN; PRECURSORS; NICHES	Spleen stromal lines which support in vitro hematopoiesis are investigated for their lineage origin and hematopoietic support function in vivo. Marker expression and gene profiling identify a lineage relationship with mesenchymal stem cells and perivascular reticular cells described recently in bone marrow. Stromal lines commonly express Cxcl12, Pdgfra and Pdgfr typical of bone marrow derived perivascular reticular cells but reflect a unique cell type in terms of other gene and marker expression. Their classification as osteoprogenitors is confirmed through ability to undergo osteogenic, but not adipogenic or chondrogenic differentiation. Some stromal lines were shown to form ectopic niches for HSCs following engraftment under the kidney capsule of NOD/SCID mice. The presence of myeloid cells and a higher representation of a specific dendritic-like cell type over other myeloid cells within grafts was consistent with previous in vitro evidence of hematopoietic support capacity. These studies reinforce the role of perivascular/perisinusoidal reticular cells in hematopoiesis and implicate such cells as niches for hematopoiesis in spleen.	[O'Neill, Helen C.; Lim, Hong K.; Tan, Jonathan K. H.] Bond Univ, Clem Jones Res Ctr Regenerat Med, Gold Coast, Qld, Australia; [Periasamy, Pravin; Kumarappan, Lavanya] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Periasamy, Pravin] Natl Univ Singapore, Yoo Long Sch Med, Dept Microbiol, Singapore, Singapore; [O'Neill, Terence J.] Bond Univ, Big Data Ctr, Bond Business Sch, Gold Coast, Qld, Australia	Bond University; Australian National University; National University of Singapore; Bond University	O'Neill, HC (corresponding author), Bond Univ, Clem Jones Res Ctr Regenerat Med, Gold Coast, Qld, Australia.	honeill@bond.edu.au	O'NEILL, Helen/AAW-8921-2021	O'NEILL, Helen/0000-0002-9506-284X; Tan, Jonathan/0000-0002-0911-1925; O'Neill, Terence/0000-0001-6485-6965	Australian Research Council [DP130101703]; National Health and Medical Research Council of Australia [585443]; CJ Martin Fellowship from the National Health and Medical Research Council of Australia; Australian National University Postgraduate Scholarships	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian National University Postgraduate Scholarships	This work was supported by project grants to HO from the Australian Research Council (#DP130101703) and the National Health and Medical Research Council of Australia (#585443). JT was supported by a CJ Martin Fellowship from the National Health and Medical Research Council of Australia. PP and HL were supported by Australian National University Postgraduate Scholarships.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Asada N, 2017, INT J HEMATOL, V106, P45, DOI 10.1007/s12185-017-2262-9; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Bouamar H, 2009, BLOOD, V114; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Corselli M, 2013, BLOOD, V121, P2891, DOI 10.1182/blood-2012-08-451864; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Despars G, 2008, STEM CELLS DEV, V17, P917, DOI 10.1089/scd.2007.0170; Despars G, 2006, IN VITRO CELL DEV-AN, V42, P208; Despars G, 2006, STEM CELLS, V24, P1496, DOI 10.1634/stemcells.2005-0530; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dor FJMF, 2006, EXP HEMATOL, V34, P1573, DOI 10.1016/j.exphem.2006.06.016; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; Farnsworth RH, 2006, PULM PHARMACOL THER, V19, P51, DOI 10.1016/j.pupt.2005.02.003; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hey YY, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0186-4; Hey YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162358; Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652; Hinton RA, 2012, J LEUKOCYTE BIOL, V91, P341, DOI 10.1189/jlb.0611302; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Meirelles LD, 2015, STEM CELLS DEV, V24, P2822, DOI 10.1089/scd.2015.0153; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morita Y, 2011, EXP HEMATOL, V39, P351, DOI 10.1016/j.exphem.2010.12.008; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Ni KP, 1999, BRIT J HAEMATOL, V105, P58, DOI 10.1046/j.1365-2141.1999.01294.x; O'Neill HC, 2004, STEM CELLS, V22, P475, DOI 10.1634/stemcells.22-4-475; O'Neill HC, 2014, CURR STEM CELL RES T, V9, P354, DOI 10.2174/1574888X09666140421115836; O'Neill HC, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/954275; Oda A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26693-x; Oh IH, 2010, STEM CELLS, V28, P1243, DOI 10.1002/stem.453; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Periasamy P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00073; Periasamy P, 2013, EXP HEMATOL, V41, P281, DOI 10.1016/j.exphem.2012.11.003; Periasamy P, 2013, J LEUKOCYTE BIOL, V93, P63, DOI 10.1189/jlb.0512260; Periasamy P, 2009, EXP HEMATOL, V37, P1060, DOI 10.1016/j.exphem.2009.06.001; Petvises S, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0255-y; Petvises S, 2016, CELL MOL IMMUNOL, V13, P443, DOI 10.1038/cmi.2015.16; Petvises S, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00501; Petvises S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088311; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tan JKH, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0039-2; Tan JKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40401; Tan JKH, 2014, J IMMUNOL, V193, P1194, DOI 10.4049/jimmunol.1302115; Tan JKH, 2011, J CELL MOL MED, V15, P1189, DOI 10.1111/j.1582-4934.2010.01089.x; Tan JKH, 2010, BLOOD, V115, P3678, DOI 10.1182/blood-2009-06-227108; Tasev D, 2016, ANGIOGENESIS, V19, P325, DOI 10.1007/s10456-016-9506-9; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Wanjare Maureen, 2014, Stem Cell Reports, V2, P746, DOI 10.1016/j.stemcr.2014.04.012; Wilson HL, 2000, P NATL ACAD SCI USA, V97, P4784, DOI 10.1073/pnas.080278897; Wilson HL, 2003, BLOOD, V102, P1661, DOI 10.1182/blood-2002-08-2426; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0	80	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223416	10.1371/journal.pone.0223416	http://dx.doi.org/10.1371/journal.pone.0223416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584977	Green Published, Green Submitted, gold			2022-12-26	WOS:000532407600030
J	Garud, A; Carrillo, AJ; Collier, LA; Ghosh, A; Kim, JD; Lopez-Lopez, B; Ouyang, S; Borkovich, KA				Garud, Amruta; Carrillo, Alexander J.; Collier, Logan A.; Ghosh, Arit; Kim, James D.; Lopez-Lopez, Berenise; Ouyang, Shouqiang; Borkovich, Katherine A.			Genetic relationships between the RACK1 homolog cpc-2 and heterotrimeric G protein subunit genes in Neurospora crassa	PLOS ONE			English	Article							AMINO-ACID CONTROL; BETA-GAMMA DIMER; G-ALPHA SUBUNITS; MATING-TYPE; GLOBAL ANALYSIS; SEXUAL DEVELOPMENT; ADENYLYL-CYCLASE; FEMALE FERTILITY; RECEPTOR; CONIDIATION	Receptor for Activated C Kinase-1 (RACK1) is a multifunctional eukaryotic scaffolding protein with a seven WD repeat structure. Among their many cellular roles, RACK1 homologs have been shown to serve as alternative G beta subunits during heterotrimeric G protein signaling in many systems. We investigated genetic interactions between the RACK1 homolog cpc-2, the previously characterized G beta subunit gnb-1 and other G protein signaling components in the multicellular filamentous fungus Neurospora crassa. Results from cell fractionation studies and from fluorescent microscopy of a strain expressing a CPC-2-GFP fusion protein revealed that CPC-2 is a cytoplasmic protein. Genetic epistasis experiments between cpc-2, the three G alpha genes (gna-1, gna-2 and gna-3) and gnb-1 demonstrated that cpc-2 is epistatic to gna-2 with regards to basal hyphae growth rate and aerial hyphae height, while deletion of cpc-2 mitigates the increased macroconidiation on solid medium observed in Delta gnb-1 mutants. Delta cpc-2 mutants inappropriately produce conidiophores during growth in submerged culture and mutational activation of gna-3 alleviates this defect. Delta cpc-2 mutants are female-sterile and fertility could not be restored by mutational activation of any of the three G alpha genes. With the exception of macroconidiation on solid medium, double mutants lacking cpc-2 and gnb-1 exhibited more severe defects for all phenotypic traits, supporting a largely synergistic relationship between GNB-1 and CPC-2 in N. crassa.	[Garud, Amruta; Carrillo, Alexander J.; Collier, Logan A.; Ghosh, Arit; Kim, James D.; Lopez-Lopez, Berenise; Ouyang, Shouqiang; Borkovich, Katherine A.] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA; [Ghosh, Arit] Univ Delaware, Dept Biol Sci, Delaware, OH USA; [Ouyang, Shouqiang] Yangzhou Univ, Coll Hort & Plant Protect, Key Lab Plant Funct Genom, Minist Educ, Yangzhou, Jiangsu, Peoples R China	University of California System; University of California Riverside; University of Delaware; Yangzhou University	Borkovich, KA (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	katherine.borkovich@ucr.edu		Ghosh, Arit/0000-0002-6582-8146; Borkovich, Katherine/0000-0002-1112-6034	NIH [GM086565, GM068087]; University of California Agriculture and Natural Resources Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM062756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Agriculture and Natural Resources Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by NIH grants GM086565 and GM068087 (to KAB) and University of California Agriculture and Natural Resources Agricultural Experiment Station mission funding (to KAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kenneth Allen and Clifford Slayman for the gift of PMA-1 antibody and Jason Stajich for advice on phylogenetic analysis. We acknowledge the Fungal Genetics Stock Center for supplying strains. We thank Gloria Turner and members of the Borkovich laboratory for many helpful discussions.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; [Anonymous], 1990, FUNGAL GENET NEWSL, DOI [DOI 10.4148/1941-4765.1472, 10.4148/1941-4765.1472]; AVALOS J, 1989, CURR GENET, V16, P369, DOI 10.1007/BF00340716; Baasiri RA, 1997, GENETICS, V147, P137; BARTHELMESS IB, 1990, GENET RES, V55, P7, DOI 10.1017/S0016672300025131; Bock A, 2014, TRENDS PHARMACOL SCI, V35, P630, DOI 10.1016/j.tips.2014.10.002; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BORKOVICH KA, 1987, J BIOL CHEM, V262, P7081; Cabrera IE, 2015, G3-GENES GENOM GENET, V5, P2729, DOI 10.1534/g3.115.020974; Cai ZD, 2015, FUNGAL GENET BIOL, V81, P120, DOI 10.1016/j.fgb.2015.04.007; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chini B, 2013, BIOCHEM SOC T, V41, P135, DOI 10.1042/BST20120344; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corrochano LM, 2016, CURR BIOL, V26, P1577, DOI 10.1016/j.cub.2016.04.038; CORTAT M, 1974, ARCH MICROBIOL, V95, P305, DOI 10.1007/BF02451771; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Eaton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048026; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Ghosh A, 2014, G3-GENES GENOM GENET, V4, P349, DOI 10.1534/g3.113.008813; GUIGNARD R, 1984, CAN J MICROBIOL, V30, P1210, DOI 10.1139/m84-192; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Ivey FD, 1996, MOL BIOL CELL, V7, P1283, DOI 10.1091/mbc.7.8.1283; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Kim H, 2012, GENETICS, V190, P1389, DOI 10.1534/genetics.111.136358; KRUGER D, 1990, CURR GENET, V18, P211, DOI 10.1007/BF00318383; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Krystofova S, 2006, EUKARYOT CELL, V5, P1503, DOI 10.1128/EC.00124-06; Kuck U., 2006, FUNGAL GENET NEWSL, V53, P9, DOI [10.4148/1941-4765.1106, DOI 10.4148/1941-4765.1106]; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li GT, 2017, ENVIRON MICROBIOL, V19, P1959, DOI 10.1111/1462-2920.13710; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li LD, 2006, EUKARYOT CELL, V5, P1287, DOI 10.1128/EC.00109-06; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Madi L, 1997, GENETICS, V146, P499; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; MULLER F, 1995, MOL GEN GENET, V248, P162, DOI 10.1007/BF02190797; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Ouyang SQ, 2015, G3-GENES GENOM GENET, V5, P1899, DOI 10.1534/g3.115.020073; Pall M. L., 1993, FUNGAL GENET NEWSL, V40, P57; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; PALUH JL, 1988, P NATL ACAD SCI USA, V85, P3728, DOI 10.1073/pnas.85.11.3728; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park G, 2011, METHODS MOL BIOL, V722, P179, DOI 10.1007/978-1-61779-040-9_13; Perkins D., 1985, NEUROSPORA NEWSL, V31, P41; PLESOFSKYVIG N, 1983, EXP MYCOL, V7, P283, DOI 10.1016/0147-5975(83)90049-X; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5; RANDALL TA, 1995, GENETICS, V141, P119; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sattlegger E, 1998, J BIOL CHEM, V273, P20404, DOI 10.1074/jbc.273.32.20404; Schauber C, 1998, GENES CELLS, V3, P307, DOI 10.1046/j.1365-2443.1998.00192.x; Selker EU, 2011, CURR BIOL, V21, pR139, DOI 10.1016/j.cub.2011.01.006; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Spatafora JW, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0053-2016; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; Stajich JE, 2012, NUCLEIC ACIDS RES, V40, pD675, DOI 10.1093/nar/gkr918; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; TONTHAT TC, 1978, ARCH MICROBIOL, V116, P279, DOI 10.1007/BF00417852; TURNER GE, 1993, J BIOL CHEM, V268, P14805; Turner GE, 2011, METHODS MOL BIOL, V722, P191, DOI 10.1007/978-1-61779-040-9_14; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wang L, 2011, MOL MICROBIOL, V81, P1484, DOI 10.1111/j.1365-2958.2011.07783.x; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Won S, 2012, EUKARYOT CELL, V11, P1239, DOI 10.1128/EC.00151-12; Wright SJ, 2011, GENETICS, V189, P165, DOI 10.1534/genetics.111.129270; Xu BE, 1997, MOL BIOL CELL, V8, P1649, DOI 10.1091/mbc.8.9.1649; Yang Q, 2002, EUKARYOT CELL, V1, P378, DOI 10.1128/EC.1.3.378-390.2002; Yin ZY, 2018, ENVIRON MICROBIOL, V20, P3168, DOI 10.1111/1462-2920.14102; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	79	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223334	10.1371/journal.pone.0223334	http://dx.doi.org/10.1371/journal.pone.0223334			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581262	Green Published, gold			2022-12-26	WOS:000532398600055
J	Price, JT; Vwalika, B; Hobbs, M; Nelson, JAE; Stringer, EM; Zou, F; Rittenhouse, KJ; Azcarate-Peril, A; Kasaro, MP; Stringer, JSA				Price, Joan T.; Vwalika, Bellington; Hobbs, Marcia; Nelson, Julie A. E.; Stringer, Elizabeth M.; Zou, Fei; Rittenhouse, Katelyn J.; Azcarate-Peril, Andrea; Kasaro, Margaret P.; Stringer, Jeffrey S. A.			Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in Zambia	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; AFRICAN WOMEN; PRETERM BIRTH; ASSOCIATION; FLORA; RISK; PREEXPOSURE; ACQUISITION; OUTCOMES	Vaginal dysbiosis has been shown to increase the risk of some adverse birth outcomes. HIV infection may be associated with shifts in the vaginal microbiome. We characterized microbial communities in vaginal swabs collected between 16-20 gestational weeks in the Zambian Preterm Birth Prevention Study to investigate whether HIV and its treatment alter the microbiome in pregnancy. We quantified relative abundance and diversity of bacterial taxa by whole-genome shotgun sequencing and identified community state types (CST) by hierarchical clustering. Associations between exposures-HIV serostatus (HIV+ vs HIV-) and preconceptional ART (ART+ vs ART-)-and microbiome characteristics were tested with rank-sum, and by linear and logistic regression, accounting for sampling by inverse-probability weighting. Of 261 vaginal swabs, 256 (98%) had evaluable sequences; 98 (38%) were from HIV+ participants, 55 (56%) of whom had preconceptional ART exposure. Major CSTs were dominated by: L. crispatus (CST 1; 17%), L.] iners (CST 3; 32%), Gardnerella vaginalis (CST 4-I; 37%), G. vaginalis & Atopobium vaginae (CST 4-II; 5%), and other mixed anaerobes (CST 4-III; 9%). G. vaginalis was present in 95%; mean relative abundance was higher in HIV+ (0.46 +/- 0.29) compared to HIV- participants (0.35 +/- 0.33; rank-sum p = .01). Shannon diversity was higher in HIV+/ART+ (coeff 0.17; 95%CI (0.01,0.33), p = .04) and HIV+/ART- (coeff 0.37; 95%CI (0.19,0.55), p < .001) participants compared to HIV-. Anaerobe-dominant CSTs were more prevalent in HIV+/ART+ (63%, AOR 3.11; 95%CI: 1.48,6.55, p = .003) and HIV+/ART- (85%, AOR 7.59; 95%CI (2.80,20.6), p < .001) compared to HIV- (45%). Restricting the comparison to 111 women in either CST 3 (L. iners dominance) or CST 1 (L. crispatus dominance), CST 3 frequency was similar in HIV- (63%) and HIV+/ART- participants (67%, AOR 1.31; 95%CI: (0.25,6.90), p = .7), but higher in HIV+/ART+ (89%, AOR 6.44; 95%CI: (1.12,37.0), p = .04). Pregnant women in Zambia, particularly those with HIV, had diverse anaerobe-dominant vaginal microbiota.	[Price, Joan T.; Stringer, Elizabeth M.; Rittenhouse, Katelyn J.; Stringer, Jeffrey S. A.] Univ N Carolina, Sch Med, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Price, Joan T.; Vwalika, Bellington] Univ Zambia, Dept Obstet & Gynecol, Sch Med, Lusaka, Zambia; [Price, Joan T.; Kasaro, Margaret P.] UNC Global Projects Zambia, Lusaka, Zambia; [Hobbs, Marcia] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Nelson, Julie A. E.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Zou, Fei] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Azcarate-Peril, Andrea] Univ N Carolina, Microbiome Core Facil, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Price, JT (corresponding author), Univ N Carolina, Sch Med, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA.; Price, JT (corresponding author), Univ Zambia, Dept Obstet & Gynecol, Sch Med, Lusaka, Zambia.; Price, JT (corresponding author), UNC Global Projects Zambia, Lusaka, Zambia.	joan_price@med.unc.edu	Nelson, Julie/ABE-7315-2021; Azcarate-Peril, M. Andrea/AAA-9056-2022; Laboratory Core, HIV STD/AGD-7085-2022; Stringer, Jeffrey S. A./AAU-2342-2021; Azcarate-Peril, M. Andrea/AFO-7157-2022; Rittenhouse, Katelyn/G-2446-2017	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Rittenhouse, Katelyn/0000-0002-5571-0793; Stringer, Jeffrey/0000-0002-9590-7216	Global Alliance to Prevent Prematurity and Stillbirth (Seattle Children's Hospital) [GAPPS 13008]; Center for AIDS Research [CFAR P30-050410]; National Institutes of Health [T32 HD075731, K01 TW010857, D43 TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075731] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009340, K01TW010857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Global Alliance to Prevent Prematurity and Stillbirth (Seattle Children's Hospital); Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study presented in this manuscript is partially funded by the Global Alliance to Prevent Prematurity and Stillbirth (Seattle Children's Hospital/GAPPS 13008; https://www.gapps.org/) and the Center for AIDS Research (CFAR P30-050410; https://unccfar.org/). Trainee support has been provided for JTP (T32 HD075731; K01 TW010857) and KJR (D43 TW009340) through the National Institutes of Health (https://www.nih.gov/). The conclusions and opinions expressed in this article are those of the authors and do not necessarily reflect those of the sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Bisanz JE, 2015, APPL ENVIRON MICROB, V81, P4965, DOI 10.1128/AEM.00780-15; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114; Castillo Marcela C, 2018, Gates Open Res, V2, P25, DOI 10.12688/gatesopenres.12820.2; Chaim W, 1997, ARCH GYNECOL OBSTET, V259, P51, DOI 10.1007/BF02505309; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Doyle R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02150-17; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Dumond JB, 2015, ANTIMICROB AGENTS CH, V59, P6395, DOI 10.1128/AAC.01148-15; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Judkins DR., 1990, J OFF STAT, V6, P223, DOI DOI 10.1016/J.AMJMED.2017.09.025.(ADVANCE; Kharsany ABM, 2015, JAIDS-J ACQ IMM DEF, V70, P289, DOI 10.1097/QAI.0000000000000761; Kimberlin DF, 1998, SEMIN PERINATOL, V22, P242, DOI 10.1016/S0146-0005(98)80012-8; Kindinger LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0223-9; Lahti Leo, TOOLS MICROBIOME ANA; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Parnell LA, 2017, SEMIN PERINATOL, V41, P392, DOI 10.1053/j.semperi.2017.07.010; Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083; Ravel J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0291-2; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Short CS, 2018, C RETR OPP INF 4 7 M; Srinivasan S, 2018, C RETR OPP INF 4 7 M; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; van Oostrum N, 2013, HUM REPROD, V28, P1809, DOI 10.1093/humrep/det096; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wedi COO, 2016, LANCET HIV, V3, pE33, DOI 10.1016/S2352-3018(15)00207-6; Zevin AS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005889	43	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223128	10.1371/journal.pone.0223128	http://dx.doi.org/10.1371/journal.pone.0223128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JF4OD	31577818	gold, Green Published			2022-12-26	WOS:000491366300001
J	Dey, P; Ramanujam, R; Venkatesan, G; Nagarathnam, R				Dey, Priya; Ramanujam, Ramani; Venkatesan, Ganesan; Nagarathnam, Radhakrishnan			Sodium alginate potentiates antioxidant defense and PR proteins against early blight disease caused by Alternaria solani in Solanum lycopersicum Linn	PLOS ONE			English	Article							OXIDATIVE STRESS; SPECTROPHOTOMETRIC DETERMINATION; SUPEROXIDE-DISMUTASE; PROTEASE INHIBITOR; HYDROGEN-PEROXIDE; RESISTANCE; RESPONSES; INFECTION; CATALASE; POLYSACCHARIDE	The use of biopolymers as elicitors in controlling plant diseases is gaining momentum worldwide due to their eco-friendly and non-toxic nature. In the present study, we have used an algal biopolymer (sodium alginate) and tested its applicability as an elicitor in inducing resistance factors against Alternaria solani, which causes early blight disease in Solanum lycopersicum (tomato plant). We have pre-treated tomato plants with different concentrations of sodium alginate (0.2%, 0.4%, and 0.6%) before A. solani infection. We found that sodium alginate has effectively controlled the growth of A. solani. In addition, a significant increase in the expression levels of SOD was observed in response to pathogen infection. The increased protease inhibitors activity further suggest that sodium alginate restrict the development of A. solani infection symptoms in tomato leaves. This corroborates well with the cell death analysis wherein increased sodium alginate pre-treatment results in decreased cell death. Also, the expression profile analyses reveal the induction of genes only in sodium alginate-pretreated tomato leaves, which are implicated in plant defense mechanism. Taken together, our results suggest that sodium alginate can be used as an elicitor to induce resistance against A. solani in tomato plants.	[Dey, Priya; Ramanujam, Ramani; Nagarathnam, Radhakrishnan] Univ Madras, Ctr Adv Studies Bot, Unit Plant Pathol, Guindy Campus, Chennai, Tamil Nadu, India; [Venkatesan, Ganesan] Acme Progen Biotech India Pvt Ltd, Salem, Tamil Nadu, India	University of Madras	Nagarathnam, R (corresponding author), Univ Madras, Ctr Adv Studies Bot, Unit Plant Pathol, Guindy Campus, Chennai, Tamil Nadu, India.	nradhakrishnan@unom.ac.in		Nagarathnam, Dr. Radhakrishnan/0000-0003-2771-0195	Acme Progen Biotech (India) Pvt. Ltd	Acme Progen Biotech (India) Pvt. Ltd	Acme Progen Biotech (India) Pvt. Ltd has provided support in the form of RT-PCR study design, data collection and analysis.	Adhikari P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102019; Aftab T, 2011, RADIAT PHYS CHEM, V80, P833, DOI 10.1016/j.radphyschem.2011.03.004; Ali A, 2014, CARBOHYD POLYM, V112, P134, DOI 10.1016/j.carbpol.2014.05.070; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Barone Amalia, 2008, Int J Plant Genomics, V2008, P820274, DOI 10.1155/2008/820274; Battacharyya D, 2015, SCI HORTIC-AMSTERDAM, V196, P39, DOI 10.1016/j.scienta.2015.09.012; Baysal Omur, 2005, Journal of General Plant Pathology, V71, P204, DOI 10.1007/s10327-005-0194-3; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bela K, 2015, J PLANT PHYSIOL, V176, P192, DOI 10.1016/j.jplph.2014.12.014; Blackman LM, 2008, MOL PLANT PATHOL, V9, P495, DOI 10.1111/J.1364-3703.2008.00478.X; BOWLER C, 1994, CRIT REV PLANT SCI, V13, P199, DOI 10.1080/713608062; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chavan V, 2013, PHYSIOL MOL PLANT P, V83, P35, DOI 10.1016/j.pmpp.2013.03.002; Conrath U, 2006, PLANT SIGNAL BEHAV, V1, P179, DOI 10.4161/psb.1.4.3221; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Daudi A., 2012, BIOPROTOCOL, V2, pe263, DOI DOI 10.1016/j.envexpbot.2012.08.003; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Davis BJ, 2006, DISC ELECTROPHORESIS, V121, P404, DOI [10.1111/j.1749-6632.1964.tb14213.x, DOI 10.1111/J.1749-6632.1964.TB14213.X]; Desalegn Regassa, 2016, Journal of Plant Breeding and Crop Science, V8, P206; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Dugyala S, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0096-0; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fries LLM, 1996, SOIL BIOL BIOCHEM, V28, P981, DOI 10.1016/0038-0717(96)00115-0; Han C, 2009, PLANT GROWTH REGUL, V58, P153, DOI 10.1007/s10725-009-9363-2; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu XK, 2004, J APPL PHYCOL, V16, P73, DOI 10.1023/B:JAPH.0000019139.35046.0c; Idrees M, 2015, IND CROP PROD, V63, P269, DOI 10.1016/j.indcrop.2014.09.037; Idrees M, 2011, AGR SCI CHINA, V10, P1213, DOI 10.1016/S1671-2927(11)60112-0; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kupper FC, 2013, J EXP BOT, V64, P2653, DOI 10.1093/jxb/ert110; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lambais MR, 2003, NEW PHYTOL, V160, P421, DOI 10.1046/j.1469-8137.2003.00881.x; Lawrence CB, 2000, PHYSIOL MOL PLANT P, V57, P211, DOI 10.1006/pmpp.2000.0298; Le Quang L, 2009, RADIAT PHYS CHEM, V78, P796, DOI 10.1016/j.radphyschem.2009.05.001; Lehmann S, 2015, PHYTOCHEMISTRY, V112, P54, DOI 10.1016/j.phytochem.2014.08.027; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Liu PP, 2011, PLANT PHYSIOL, V157, P2216, DOI 10.1104/pp.111.187773; Mani SD, 2018, ALGAL RES, V32, P121, DOI 10.1016/j.algal.2018.02.025; Mercier L, 2001, NEW PHYTOL, V149, P43, DOI 10.1046/j.1469-8137.2001.00011.x; Mishra S, 2011, PROTOPLASMA, V248, P565, DOI 10.1007/s00709-010-0210-0; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Radhakrishnan N, 2011, CROP PROT, V30, P24, DOI 10.1016/j.cropro.2010.08.020; Radhakrishnan N, 2009, CROP PROT, V28, P974, DOI 10.1016/j.cropro.2009.07.010; Sano Y, 1999, CARBOHYD POLYM, V38, P183, DOI 10.1016/S0144-8617(98)00119-2; Sarin NB., 2014, BIO-PROTOCOL, V4, DOI [10.21769/BioProtoc.1108, DOI 10.21769/BIOPROTOC.1108]; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; SELLERS RM, 1980, ANALYST, V105, P950, DOI 10.1039/an9800500950; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; SPANU P, 1988, NEW PHYTOL, V109, P119, DOI 10.1111/j.1469-8137.1988.tb00226.x; Spricigo DA, 2014, INT MICROBIOL, V17, P159, DOI 10.2436/20.1501.01.218; Tayefi-Nasrabadi H, 2011, AFR J BIOTECHNOL, V10, P751; Thakur Meenakshi, 2013, ISRN Biochem, V2013, P762412, DOI 10.1155/2013/762412; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Trouvelot S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00592; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VENEGAS M, 1993, BOT MAR, V36, P47, DOI 10.1515/botm.1993.36.1.47; VOLK S, 1989, PLANT CELL ENVIRON, V12, P701, DOI 10.1111/j.1365-3040.1989.tb01630.x; Wang SY, 2006, PEPTIDES, V27, P3129, DOI 10.1016/j.peptides.2006.07.013; Wiesel L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00655; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022; Yi SY, 2003, MOL CELLS, V15, P364; Zhao Z, 2016, IEEE ICC, DOI [10.1109/ICC.2016.7511413, 10.1109/iNIS.2016.013, 10.1109/iNIS.2016.60]	66	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223216	10.1371/journal.pone.0223216	http://dx.doi.org/10.1371/journal.pone.0223216			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568481	Green Submitted, Green Published, gold			2022-12-26	WOS:000532364900029
J	Ullah, S; Ai, C; Huang, SH; Zhang, JJ; Jia, LL; Jia, JC; Zhou, W; He, P				Ullah, Sami; Ai, Chao; Huang, Shaohui; Zhang, Jiajia; Jia, Liangliang; Jia, Jinchuan; Zhou, Wei; He, Ping			The responses of extracellular enzyme activities and microbial community composition under nitrogen addition in an upland soil	PLOS ONE			English	Article							FUNGAL COMMUNITIES; GLOBAL PERSPECTIVE; ORGANIC-MATTER; BIOMASS; CARBON; FERTILIZATION; BACTERIAL; FOREST; MAIZE; LIMITATION	Tremendous amounts of nitrogen (N) fertilizer have been added to arable lands, often resulting in substantial effects on terrestrial ecosystems, including soil acidification, altered enzyme activities and changes in microbial community composition. Soil microbes are the major drivers of soil carbon (C) and N cycling; therefore, understanding the response of microbial communities to elevated N inputs is of significant importance. This study was carried out to investigate the influences of different N fertilization rates (0, 182, and 225 kg ha(-1) representing control, low, and high N supply for each crop season for summer maize and winter wheat) on soil biochemical attributes, extracellular enzyme activities, and the microbial community composition in a winter wheat-summer maize rotation cropping system in north-central China. The results showed that N addition significantly decreased the soil pH in both the wheat and maize seasons. Microbial biomass N (MBN) decreased following N fertilization in the wheat season, while the opposite trend in MBN was observed in the maize season. Response ratio analysis showed that the activities of enzymes involved in C, N, and phosphorus cycling were significantly enhanced under N enrichment in both the wheat and maize seasons, and higher enzyme activities were noted in the high N addition treatment than in the low N addition treatment. A linear increase in fungal abundance with the N addition gradient was observed in the wheat season, whereas the fungal abundance increased and then decreased in the maize season. The bacterial abundance showed an increased and then decreased trend in response to the N addition gradient in both the wheat and maize crop seasons. Moreover, the partial least squares path model (PLS-PM) analysis showed that soil pH and soil organic carbon (SOC) were the most important soil variables, causing shifts in the soil bacteria. Furthermore, compared with the N-cycling enzymes, the C-cycling enzymes were significantly affected by the soil pH and SOC. Taken together, these results suggest that the effect of N addition on enzyme activities was consistent in both crop seasons, while the effects on MBN and microbial community composition to N addition were highly variable in the two crop seasons. Moreover, N fertilization-induced changes in the soil chemical properties such as soil acidity and SOC played a substantial role in shaping the microbial community.	[Ullah, Sami; Ai, Chao; Huang, Shaohui; Zhang, Jiajia; Jia, Jinchuan; Zhou, Wei; He, Ping] Chinese Acad Agr Sci CAAS, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China; [Jia, Liangliang] Hebei Acad Agr & Forestry Sci, Shijiazhuang, Hebei, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hebei Academy of Agricultural & Forestry Sciences	He, P (corresponding author), Chinese Acad Agr Sci CAAS, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.	heping02@caas.cn	He, Ping/HGD-5389-2022; Jia, Liangliang/ABD-5715-2021; Ullah, Sami/ABF-6810-2021; Ai, Chao/AAZ-2856-2020	Ullah, Sami/0000-0001-6525-1386; He, Ping/0000-0003-1786-6858; Ai, Chao/0000-0002-0707-1018	National Key Research and Development program of China [2016YFD0200101]; International Plant Nutrition Institute (IPNI); CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research - Fundamental Research Funds for Central Non-profit Scientific Institution [1610132019047]	National Key Research and Development program of China; International Plant Nutrition Institute (IPNI); CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research - Fundamental Research Funds for Central Non-profit Scientific Institution	This research was supported by the National Key Research and Development program of China (No. 2016YFD0200101), the International Plant Nutrition Institute (IPNI) and CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research supported by Fundamental Research Funds for Central Non-profit Scientific Institution (No.1610132019047).	Ai C, 2018, GEODERMA, V319, P156, DOI 10.1016/j.geoderma.2018.01.010; Ai C, 2013, SOIL BIOL BIOCHEM, V57, P30, DOI 10.1016/j.soilbio.2012.08.003; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bell CW, 2013, JOVE-J VIS EXP, DOI 10.3791/50961; Benitez E, 2005, BIORESOURCE TECHNOL, V96, P785, DOI 10.1016/j.biortech.2004.08.010; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Boxman AW, 1998, FOREST ECOL MANAG, V101, P65, DOI 10.1016/S0378-1127(97)00126-6; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Calderon FJ, 2001, SOIL SCI SOC AM J, V65, P118, DOI 10.2136/sssaj2001.651118x; China Agriculture Press, 2016, CHIN AGR YB; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cusack DF, 2016, REV GEOPHYS, V54, P523, DOI 10.1002/2015RG000510; Dai XL, 2019, GEODERMA, V337, P1116, DOI 10.1016/j.geoderma.2018.11.023; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P1347, DOI 10.1016/0038-0717(94)90216-X; Farrer EC, 2016, ECOL LETT, V19, P1287, DOI 10.1111/ele.12665; Fisk MC, 1996, SOIL BIOL BIOCHEM, V28, P751, DOI 10.1016/0038-0717(96)00007-7; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Francioli D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01446; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; Gu YF, 2009, EUR J SOIL BIOL, V45, P239, DOI 10.1016/j.ejsobi.2009.02.005; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Jian SY, 2016, SOIL BIOL BIOCHEM, V101, P32, DOI 10.1016/j.soilbio.2016.07.003; Jin ShuQin, 2018, Journal of Resources and Ecology, V9, P50; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Kara O, 2008, BIOL FERT SOILS, V45, P193, DOI 10.1007/s00374-008-0327-x; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; Leprince F, 1996, EUR J SOIL SCI, V47, P511, DOI 10.1111/j.1365-2389.1996.tb01851.x; LILJEROTH E, 1994, PLANT SOIL, V161, P233, DOI 10.1007/BF00046394; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Ma J, 2007, PLANT NUTR FERTILIZE, V2; PETERSEN SO, 1994, APPL ENVIRON MICROB, V60, P2421, DOI 10.1128/AEM.60.7.2421-2430.1994; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Pierre WH, 1928, J AM SOC AGRONOMY, V20; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Springob G, 2003, SOIL BIOL BIOCHEM, V35, P629, DOI 10.1016/S0038-0717(03)00052-X; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thirukkumaran CM, 2000, SOIL BIOL BIOCHEM, V32, P59, DOI 10.1016/S0038-0717(99)00129-7; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; TUNLID A, 1992, SOIL BIOCH, V7, P229; Turlapati SA, 2013, FEMS MICROBIOL ECOL, V83, P478, DOI 10.1111/1574-6941.12009; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang C, 2018, SOIL BIOL BIOCHEM, V121, P103, DOI 10.1016/j.soilbio.2018.03.009; Wang FH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02424; Wang XL, 2009, GEODERMA, V153, P285, DOI 10.1016/j.geoderma.2009.08.020; Wang XB, 2015, APPL SOIL ECOL, V96, P265, DOI 10.1016/j.apsoil.2015.08.018; Willers C, 2015, J APPL MICROBIOL, V119, P1207, DOI 10.1111/jam.12902; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Yang S, 2006, J NANJING U SCI TECH, V1; Zhang C, 2022, SPORT BIOMECH, V21, P142, DOI 10.1080/14763141.2019.1646796; Zhang J, 2018, AGRONOMY J; Zhang JJ, 2017, AGRON J, V109, P1082, DOI 10.2134/agronj2016.08.0477; Zhang XY, 2018, ECOL INDIC, V93, P164, DOI 10.1016/j.ecolind.2018.04.078; Zhao SC, 2014, AGR ECOSYST ENVIRON, V194, P29, DOI 10.1016/j.agee.2014.05.006	71	24	25	9	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223026	10.1371/journal.pone.0223026	http://dx.doi.org/10.1371/journal.pone.0223026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568535	Green Published, gold			2022-12-26	WOS:000532364900020
J	Aponte, PM; Gutierrez-Reinoso, MA; Sanchez-Cepeda, EG; Garcia-Herreros, M				Aponte, Pedro M.; Gutierrez-Reinoso, Miguel A.; Sanchez-Cepeda, Edison G.; Garcia-Herreros, Manuel			Differential role of r-met-hu G-CSF on male reproductive function and development in prepubertal domestic mammals	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MALE GERM-CELLS; FACTOR RHG-CSF; FACTOR CROSSES; RAM LAMBS; FILGRASTIM; SPERMATOGENESIS; EXPRESSION; GROWTH; MACROPHAGES	The understanding of mammalian spermatogenesis niche factors active during sexual development may be leveraged to impact reproduction in farm animals. The aim of this study was to evaluate the effects of r-met-hu/G-CSF (filgrastim) on prepubertal sexual development of guinea pigs (Cavia porcellus) and ram lambs (Ovis aries). Individuals of both species were administered r-met-hu/G-CSF daily for 4 days. During and after administration protocols, testicular function and development were assessed through hematological responses, hormonal profiles (gonadotropins, testosterone and cortisol) testicular morphometry and germ cell kinetics. As expected, r-met-hu/G-CSF acutely mobilized white-lineage blood cells in both species. LH was increased by r-met-hu/G-CSF in guinea pigs (P<0.01) but T remained unchanged. In ram lambs gonadotropins and T increased in dose-response fashion (P<0.01) while cortisol values were stable and similar in treated and control animals (P>0.05). In guinea pigs there were no differences in testicular weights and volumes 2-mo after r-met-hu/G-CSF application (P>0.05). However, ram lambs showed a dose-response effect regarding testis weight (P<0.05). 66.66% of ram lambs had initial testes not yet in meiosis or starting the first spermatogenic wave. After 60-days only 25% of control animals were pubertal while all treated animals (1140-mu g) had reached puberty. We propose an integrated hypothesis that G-CSF can stimulate spermatogenesis through two possible ways. 1) r-met-hu/G-CSF may go through the brain blood barrier and once there it can stimulate GnRH-neurons to release GnRH with the subsequent release of gonadotrophins. 2) a local testicular effect through stimulation of steroidogenesis that enhances spermiogenesis via testosterone production and a direct stimulation over spermatogonial stem cells self-renewal. In conclusion, this study shows that r-met-hu/G-CSF differentially affects prepubertal sexual development in hystricomorpha and ovine species, a relevant fact to consider when designing methods to hasten sexual developmental in mammalian species.	[Aponte, Pedro M.] Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Campus Cumbaya, Quito, Ecuador; [Aponte, Pedro M.] Univ San Francisco Quito USFQ, Colegio Ciencias Salud, Escuela Med Vet, Campus Cumbaya, Quito, Ecuador; [Aponte, Pedro M.] Univ San Francisco Quito USFQ, Inst Invest Biomed One Hlth, Campus Cumbaya, Quito, Ecuador; [Gutierrez-Reinoso, Miguel A.] Univ Tecn Cotopaxi UTC, Fac Ciencias Agr & Recursos Nat, Carrera Med Vet, Latacunga, Ecuador; [Sanchez-Cepeda, Edison G.] AGROCALIDAD, Ambato, Ecuador; [Garcia-Herreros, Manuel] Natl Secretariat Higher Educ Sci Technol & Innova, Quito, Ecuador; [Garcia-Herreros, Manuel] Inst Nacl Invest Agr & Vet IP INIAV IP, Polo Santarem, Santarem, Portugal		Aponte, PM (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Campus Cumbaya, Quito, Ecuador.; Aponte, PM (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias Salud, Escuela Med Vet, Campus Cumbaya, Quito, Ecuador.; Aponte, PM (corresponding author), Univ San Francisco Quito USFQ, Inst Invest Biomed One Hlth, Campus Cumbaya, Quito, Ecuador.; Garcia-Herreros, M (corresponding author), Natl Secretariat Higher Educ Sci Technol & Innova, Quito, Ecuador.; Garcia-Herreros, M (corresponding author), Inst Nacl Invest Agr & Vet IP INIAV IP, Polo Santarem, Santarem, Portugal.	pmaponte@usfq.edu.ec; herrerosgm@gmail.com	Aponte, Pedro/AAM-2670-2021	Garcia-Herreros, Manuel/0000-0002-0911-6689; Aponte, Pedro/0000-0001-6905-1672	National Secretariat of Higher Education, Science, Technology, and Innovation, SENESCYT - Project Prometeo, Ecuador; National Secretariat of Higher Education, Science, Technology, and Innovation, SENESCYT - Project AGROCALIDAD, Ecuador; Universidad San Francisco de Quito USFQ, COCIBA, Ecuador [12249]	National Secretariat of Higher Education, Science, Technology, and Innovation, SENESCYT - Project Prometeo, Ecuador; National Secretariat of Higher Education, Science, Technology, and Innovation, SENESCYT - Project AGROCALIDAD, Ecuador; Universidad San Francisco de Quito USFQ, COCIBA, Ecuador	This work was supported by the partnership (individual grant, 2014) National Secretariat of Higher Education, Science, Technology, and Innovation, SENESCYT - Project Prometeo and AGROCALIDAD, Ecuador, (https://www.educacionsuperior.gob.ec/) to MGH and PMA received support through a research grant (Projectgrant 12249) from Universidad San Francisco de Quito USFQ, COCIBA, Ecuador https://www.usfq.edu.ec/Paginas/Inicio.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 2002, DRUGS, V62, P79, DOI 10.2165/00003495-200262001-00006; Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Aponte PM, 2018, ANIMAL, V12, P784, DOI 10.1017/S1751731117002129; Aponte PM, 2005, THERIOGENOLOGY, V64, P1440, DOI 10.1016/j.theriogenology.2005.03.016; Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; BANKS WA, 1992, J ANDROL, V13, P254; Barreca T, 1997, CURR THER RES CLIN E, V58, P88, DOI 10.1016/S0011-393X(97)80117-8; Belibasaki S, 2000, SMALL RUMINANT RES, V37, P109, DOI 10.1016/S0921-4488(99)00131-5; Benavides-Garcia R, 2015, FERTIL STERIL, V103, P270, DOI 10.1016/j.fertnstert.2014.09.023; Bielli A, 2000, ANIM REPROD SCI, V58, P73, DOI 10.1016/S0378-4320(99)00076-7; BILASPURI GS, 1986, THERIOGENOLOGY, V25, P485, DOI 10.1016/0093-691X(86)90133-0; Bollwein H, 2016, DOMEST ANIM ENDOCRIN, V56, pS180, DOI 10.1016/j.domaniend.2016.02.006; Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943; Cohen PE, 1997, MOL ENDOCRINOL, V11, P1636, DOI 10.1210/me.11.11.1636; Cohen PE, 2002, ENDOCRINOLOGY, V143, P1413, DOI 10.1210/en.143.4.1413; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Dale DC, 2018, SUPPORT CARE CANCER, V26, P7, DOI 10.1007/s00520-017-3854-x; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Eftekhar M, 2018, J RES MED SCI, V23, DOI 10.4103/jrms.JRMS_628_17; Endo Y, 2015, J VET MED SCI, V77, P507, DOI 10.1292/jvms.14-0586; Engelhardt B., 2007, BLOOD BRAIN BARRIERS, P9; Engelken TJ, 2008, THERIOGENOLOGY, V70, P573, DOI 10.1016/j.theriogenology.2008.05.038; Farese AM, 2015, DRUG TODAY, V51, P537, DOI 10.1358/dot.2015.51.9.2386730; Fuller MT, 2016, CURR TOP DEV BIOL, V116, P375, DOI 10.1016/bs.ctdb.2015.11.041; Gaytan F, 1996, J ENDOCRINOL, V150, P57, DOI 10.1677/joe.0.1500057; Geuna S, 2015, CELL TISSUE RES, V360, P5, DOI 10.1007/s00441-015-2143-6; Hashimoto S, 2002, THER APHER, V6, P431, DOI 10.1046/j.1526-0968.2002.00467.x; Hoglund M, 1998, MED ONCOL, V15, P229, DOI 10.1007/BF02787205; Khanlarkhani N, 2016, J MOL HISTOL, V47, P59, DOI 10.1007/s10735-015-9647-y; Kim J, 2011, ANDROLOGIA, V43, P87, DOI 10.1111/j.1439-0272.2009.01023.x; Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809; Koruji M, 2009, IN VITRO CELL DEV-AN, V45, P281, DOI 10.1007/s11626-008-9169-y; Koskenniemi JJ, 2017, CURR OPIN ENDOCRINOL, V24, P215, DOI 10.1097/MED.0000000000000339; KOTZUR T, 2017, REPROD BIOL ENDOCRIN, V15, DOI DOI 10.1186/S12958-017-0236-7; Kwan EM, 2018, CLIN GENITOURIN CANC, V16, pE193, DOI 10.1016/j.clgc.2017.08.012; Licollari A, 2017, J PHARM SCI-US, V106, P1475, DOI 10.1016/j.xphs.2017.02.009; LUNSTRA DD, 1988, THERIOGENOLOGY, V29, P803, DOI 10.1016/0093-691X(88)90217-8; McLay RN, 1997, BIOL REPROD, V57, P822, DOI 10.1095/biolreprod57.4.822; McLay RN, 1997, BRAIN, V120, P2083, DOI 10.1093/brain/120.11.2083; Miyamoto M, 2001, INT J PHARM, V226, P127, DOI 10.1016/S0378-5173(01)00797-9; NIVEN RW, 1993, PHARMACEUT RES, V10, P1604, DOI 10.1023/A:1018920619424; NOLLER DW, 1977, BIOL REPROD, V17, P532, DOI 10.1095/biolreprod17.4.532; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; PERRY V, 1990, AUST VET J, V67, P13, DOI 10.1111/j.1751-0813.1990.tb07383.x; Quirion E, 2009, CLIN J ONCOL NURS, V13, P324, DOI 10.1188/09.CJON.324-328; Rodriguez-Gil JE, 2007, THERIOGENOLOGY, V67, P1359, DOI 10.1016/j.theriogenology.2007.02.008; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Salhab SA, 2001, SMALL RUMINANT RES, V40, P187, DOI 10.1016/S0921-4488(00)00224-8; Salmassi A, 2004, FERTIL STERIL, V81, P786, DOI 10.1016/j.fertnstert.2003.09.039; Sanzari JK, 2015, LIFE SCI SPACE RES, V5, P13, DOI 10.1016/j.lssr.2015.03.002; Satyamitra M, 2017, RADIAT RES, V187, P659, DOI 10.1667/RR14555.1; Scaramuzzi RJ, 2008, REPROD DOMEST ANIM, V43, P129, DOI 10.1111/j.1439-0531.2008.01152.x; Shibata M, 2007, J NEUROENDOCRINOL, V19, P432, DOI 10.1111/j.1365-2826.2007.01549.x; SKINNER JD, 1968, J REPROD FERTIL, V16, P463; Syrstad O, 1998, TROP ANIM HEALTH PRO, V30, P257, DOI 10.1023/A:1005083430140; Thundathil JC, 2016, THERIOGENOLOGY, V86, P397, DOI 10.1016/j.theriogenology.2016.04.054; Valasi I, 2012, ANIM REPROD SCI, V130, P126, DOI 10.1016/j.anireprosci.2012.01.005; Vilanova LT, 2003, THERIOGENOLOGY, V60, P1083, DOI 10.1016/S0093-691X(03)00106-7; Welte K, 2014, EXPERT OPIN BIOL TH, V14, P983, DOI 10.1517/14712598.2014.905537; YARNEY TA, 1993, THERIOGENOLOGY, V40, P735, DOI 10.1016/0093-691X(93)90209-N; Zambrano A, 2001, J CELL BIOCHEM, V80, P625, DOI 10.1002/1097-4644(20010315)80:4<625::AID-JCB1017>3.0.CO;2-9; Zylinska K, 1999, Pituitary, V2, P211, DOI 10.1023/A:1009905427902	65	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222871	10.1371/journal.pone.0222871	http://dx.doi.org/10.1371/journal.pone.0222871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557198	Green Submitted, gold, Green Published			2022-12-26	WOS:000532345500045
J	Dhaliwal, DS; Ii, MMW				Dhaliwal, Daljeet S.; Ii, Martin M. Williams			Optimum plant density for crowding stress tolerant processing sweet corn	PLOS ONE			English	Article							MAIZE HYBRIDS; PHYSIOLOGICAL-BASIS; POPULATION-DENSITY; TEMPERATE MAIZE; YIELD; IMPROVEMENT; TRAITS	Globally, gains in sweet corn [Zea mays L.var. rugosa (or saccharata)] are a fraction of the yield advances made in field corn (Zea mays L.) in the last half-century. Grain yield improvement of field corn is associated with increased tolerance to higher plant densities (i.e., crowding stress). Processing sweet corn hybrids that tolerate crowding stress have been identified; however, such hybrids appear to be under-planted in the processing sweet corn. Using crowding stress tolerant (CST) hybrids, the objectives of this study were to: (1) identify optimum plant densities for a range of growing conditions; (2) quantify gaps in production between current and optimum plant densities; and (3) enumerate changes in yield and ear traits when shifting from current to optimum plant densities. Using a CST shrunken-2 (sh2) processing sweet corn hybrid, on-farm plant density trials were conducted in thirty fields across the states of Illinois, Minnesota and Wisconsin, from 2013 to 2017 in order to capture a wide variety of growing conditions. Linear mixed-effects models were used to identify the optimum plant density corresponding to maximum ear mass (Mt ha(-1)), case production (cases ha(-1)), and profitability to the processor ($ ha(-1)). Kernel moisture, indicative of plant development, was unaffected by plant density. Ear traits, such as ear number and ear mass per plant, average ear length, and filled ear length declined linearly with increasing plant density. Nonetheless, there was a large economic benefit to the grower and processor by shifting to higher plant densities in most environments. This research shows that increasing plant densities of CST hybrids from current (58,475 plants ha(-1)) to optimum (73,075 plants ha(-1)) could improve processing sweet corn green ear yield and processor profitability on average of 1.13 Mt ha(-1) and $525 ha(-1), respectively.	[Dhaliwal, Daljeet S.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Ii, Martin M. Williams] USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Ii, MMW (corresponding author), USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA.	martin.williams@ars.usda.gov		Williams, Martin/0000-0002-6302-7724; Dhaliwal, Daljeet/0000-0001-8116-4012				[Anonymous], NLME LINEAR NONLINEA; Boerboom C, 1999, CROP PROFILE CORN SW; BRADLEY J P, 1988, Journal of Production Agriculture, V1, P34; Choe E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147418; Duvick D. N., 2004, Plant Breeding Reviews, V24, P109; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Francis CA, 1995, S ALT APPR ON FARM R; Lee EA, 2007, CROP SCI, V47, pS202, DOI 10.2135/cropsci2007.04.0010IPBS; Lertrat K., 2007, INT J PLANT BREEDING, V1, P27, DOI DOI 10.1016/S0140-6736(02)11602-3; MACK HJ, 1972, J AM SOC HORTIC SCI, V97, P757; Mansfield BD, 2014, CROP SCI, V54, P157, DOI 10.2135/cropsci2013.04.0252; Morris T. F., 2000, HortTechnology, V10, P331; MOSS JD, 1979, HORTSCIENCE, V14, P176; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pataky JK, 2011, PLANT DIS, V95, P1492, DOI 10.1094/PDIS-03-11-0236; Rangarajan A, 2002, HORTTECHNOLOGY, V12, P410, DOI 10.21273/HORTTECH.12.3.410; Rosen C, 1987, VEGETABLE CROPS RES, P134; Sangoi L, 2002, FIELD CROP RES, V79, P39, DOI 10.1016/S0378-4290(02)00124-7; Shelton AC, 2013, SUSTAINABILITY-BASEL, V5, P2442, DOI 10.3390/su5062442; Szymanek M., 2012, TRENDS VITAL FOOD CO; Team R, 2016, RSTUDIO INT DEV R; Tokatlidis IS, 2004, FIELD CROP RES, V88, P103, DOI 10.1016/j.fcr.2003.11.013; Tollenaar M., 1994, Genetic improvement of field crops., P183; TOLLENAAR M, 1991, CROP SCI, V31, P119, DOI 10.2135/cropsci1991.0011183X003100010029x; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Tracy F.W, 2001, SPECIALTY CORNS, P155; Williams MM, 2016, FIELD CROP RES, V185, P45, DOI 10.1016/j.fcr.2015.10.022; Williams MM, 2015, AGRON J, V107, P1782, DOI 10.2134/agronj15.0011; Williams MM, 2014, FIELD CROP RES, V157, P20, DOI 10.1016/j.fcr.2013.12.003; Williams MM, 2012, FIELD CROP RES, V128, P55, DOI 10.1016/j.fcr.2011.12.007	31	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223107	10.1371/journal.pone.0223107	http://dx.doi.org/10.1371/journal.pone.0223107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557241	Green Published, Green Submitted, gold			2022-12-26	WOS:000532345500070
J	Gebremedhn, H; Amssalu, B; De Smet, L; de Graaf, DC				Gebremedhn, Haftom; Amssalu, Bezabeh; De Smet, Lina; de Graaf, Dirk C.			Factors restraining the population growth of Varroa destructor in Ethiopian honey bees (Apis mellifera simensis)	PLOS ONE			English	Article							BROOD-CELL-SIZE; HYGIENIC BEHAVIOR; SCIENTIFIC NOTE; COLONY LOSSES; DRONE BROOD; RESISTANCE; INFESTATION; WORKER; SURVIVAL; REPRODUCTION	Worldwide, the ecto-parasitic mite Varroa destructor has been assigned as an important driver of honey bee (Apis mellifera) colony losses. Unlike the subspecies of European origin, the honey bees in some African countries such as Uganda and Ethiopia may not be as threatened or suffer less from mite-infestations. However, only little is known about the factors or traits that enable them to co-exist with the mite without beekeepers' intervention. Hence, this study was designed to investigate these factors or traits that limit the Varroa mite population in Ethiopian honey bees (Apis mellifera simensis). The study was conducted in the primary honey producing region of Ethiopia, i.e. Tigray. Mite infestation levels were shown to be lower in traditional hives (when compared to framed hives) and when colonies were started up from swarm catching (when compared to colony splitting). However, the influence of the comb cell size on mite infestation was not observed. With respect to the bee biology, the hygienic behavior was shown to be high (pin-test: 92.2% removal in 24 hours) and was negatively correlated with phoretic mite counts (Pearson; r = -0.79; P < 0.01) and mite infestation levels in brood (Pearson; r = -0.46; P < 0.001). Efforts to estimate the Varroa mite reproductive capacity were seriously hampered by an extremely low brood infestation level. From the 133 founder mites found (in 6727 capped brood cells) only 18.80% were capable of producing a reproductive progeny. Failure to produce adult male progeny was unexpectedly high (79.70%). We have suggested a few adaptations to the test protocols allowing to estimate the protective traits of honey bee colonies under very low Varroa pressure. Apart from that, this study demonstrates that the honey bees from Ethiopia are suitable targets to further decipher the genetic predisposition of resistance against V. destructor. It is still unclear to what extent simensis differs from the more common scutellata subspecies.	[Gebremedhn, Haftom; De Smet, Lina; de Graaf, Dirk C.] Univ Ghent, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Gebremedhn, Haftom] Tigray Agr Res Inst, Mekelle, Ethiopia; [Amssalu, Bezabeh] Holeta Bee Res Ctr, Holeta, Ethiopia	Ghent University	Gebremedhn, H (corresponding author), Univ Ghent, Lab Mol Entomol & Bee Pathol, Ghent, Belgium.; Gebremedhn, H (corresponding author), Tigray Agr Res Inst, Mekelle, Ethiopia.	haftush@yahoo.com	de Graaf, Dirk C./HGD-4017-2022	de Graaf, Dirk/0000-0001-8817-0781	BOF (Bijzonder Onderzoeksfonds) scholarship under Ghent University in Belgium [001W14316]; Tigray Agricultural Research Institute [33-13-17]; Ethiopian Agricultural Research Institute in Ethiopia [33-13-17]; International Foundation for Science (IFS) [1-1-B-6119-1]; Belgian Science policy office (BelSpo) [1-1-B-6119-1]; Ethiopian Agricultural Research Institute; Ghent University, Bijzonder Onderzoeksfonds	BOF (Bijzonder Onderzoeksfonds) scholarship under Ghent University in Belgium; Tigray Agricultural Research Institute; Ethiopian Agricultural Research Institute in Ethiopia; International Foundation for Science (IFS)(International Foundation for Science); Belgian Science policy office (BelSpo)(Belgian Federal Science Policy Office); Ethiopian Agricultural Research Institute; Ghent University, Bijzonder Onderzoeksfonds	The study was funded by the BOF (Bijzonder Onderzoeksfonds) scholarship under Ghent University in Belgium (Award Number: 001W14316 | Recipient: Gebremedhn Haftom), Tigray Agricultural Research Institute and Ethiopian Agricultural Research Institute in Ethiopia (Award Number: 33-13-17 | Recipient: Gebremedhn Haftom) and International Foundation for Science (IFS) and Belgian Science policy office (BelSpo) (Award Number: 1-1-B-6119-1 | Recipient: Gebremedhn Haftom) and we greatly appreciated the funding organizations for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the beekeepers, bee technicians, bee experts and researchers in the Tigray National, Regional State for their cooperation and technical support during the study. We thank also the Tigray Agricultural Research Institute, Ethiopian Agricultural Research Institute, International Foundation for Science (IFS) and Belgian Science policy office (BelSpo) and Ghent University, Bijzonder Onderzoeksfonds for their financial support.	Abazinab M., 2016, EUROPEAN J BIOLOGICA, V8, P45; Abejew T. A., 2017, Advances in Agriculture, V2017, P6354250, DOI 10.1155/2017/6354250; Akinwande KL, 2012, J APICULT RES, V51, P369, DOI 10.3896/IBRA.1.51.4.15; Allsopp M., 2006, ANAL VARROA DESTRUCT; Arathi HS, 2000, ETHOLOGY, V106, P365, DOI 10.1046/j.1439-0310.2000.00556.x; Archer CR, 2014, OIKOS, V123, P401, DOI 10.1111/j.1600-0706.2013.00949.x; Ardestani MM, 2016, J APICULT RES, V54, P335, DOI 10.1080/00218839.2016.1159788; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Begna D., 2014, J FISHERIES LIVESTOC, V2; BOECKING O, 1992, EXP APPL ACAROL, V16, P321, DOI 10.1007/BF01218574; Broeckx BJG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44254-8; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Calderon RA, 2012, EXP APPL ACAROL, V56, P297, DOI 10.1007/s10493-012-9518-0; Calderon RA, 2007, EXP APPL ACAROL, V43, P25, DOI 10.1007/s10493-007-9102-1; Chemurot M., 2017, DISTRIBUTION INFESTA; Chemurot M, 2016, EXP APPL ACAROL, V68, P497, DOI 10.1007/s10493-016-0013-x; Coffey MF, 2010, APIDOLOGIE, V41, P522, DOI 10.1051/apido/2010003; Correa-Marques Maria H., 2003, Genetics and Molecular Research, V2, P1; Correa-Marques MH, 2000, AM BEE J, V140, P820; CSA, 2017, REP LIV LIV CHAR PRI; De Guzman LI, 2002, AM BEE J, V142, P58; Dessalegn B., 2016, INT J TOXICOLOGY ENV, V1, P4, DOI [10.15226/2572-3162/2/1/00102, DOI 10.15226/2572-3162/2/1/00102]; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Dietemann V, 2009, APIDOLOGIE, V40, P285, DOI 10.1051/apido/2009013; Dong Y, 2016, FINAL REPORT WEEMA I; Erickson EH, 1990, SIZE CELLS SPECULATI, P98; Factbook CIAW, 2012, WORLD FACTB CENTR IN; Fazier M, 2010, APIDOLOGIE, V41, P463, DOI 10.1051/apido/2009073; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garrido C, 2004, CHEMOECOLOGY, V14, P193, DOI 10.1007/s00049-004-0278-0; Gebremedhn H, 2013, SEASONAL HONEYBEE FO; Gebretsadik T, 2016, INT J RES GRANTHAALA, V4; Godifey G., 2015, EPIDEMIOLOGY HONEY B; Guerra JCV, 2000, GENET MOL BIOL, V23, P89, DOI 10.1590/S1415-47572000000100016; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hepbum HR, 1998, HONEYBEES AFRICA; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Judd TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116199; Kamel SM, 2003, APIDOLOGIE, V34, P189, DOI 10.1051/apido:2003014; Kebede A., 2011, HONEY BEE PRODUCTION; Khalenkow M., 2018, TEST PROTOCOLS; Kurze C, 2016, ZOOLOGY, V119, P290, DOI 10.1016/j.zool.2016.03.007; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Martin SJ, 2002, APIDOLOGIE, V33, P51, DOI 10.1051/apido:2001007; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Mezgabu E, 2016, J VET SCI TECHNOLOGY, V7, DOI [10.4172/2157-7579, DOI 10.4172/2157-7579]; Mohammed N.A., 2002, GEOGRAPHICAL RACES H; MORITZ RFA, 1985, J HERED, V76, P267, DOI 10.1093/oxfordjournals.jhered.a110090; Muli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094459; Mumoki FN, 2014, AFR ENTOMOL, V22, P473, DOI 10.4001/003.022.0313; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nganso BT, 2018, PARASITOLOGY, V145, P1633, DOI [10.1017/S0031182018000616, 10.1017/s0031182018000616]; Nganso BT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179329; Nuru A, 2002, J APICULT RES, V41, P35, DOI 10.1080/00218839.2002.11101066; Oddie MAY, 2017, PEERJ, V5, DOI 10.7717/peerj.3956; Panziera D, 2017, J APICULT RES, V56, P635, DOI 10.1080/00218839.2017.1351860; Pereira Rogerio A., 2013, Insects, V4, P521, DOI 10.3390/insects4040521; Piccirillo GA, 2004, APIDOLOGIE, V35, P359, DOI 10.1051/apido:2004022; Piccirillo Giancarlo A., 2003, Genetics and Molecular Research, V2, pUnpaginated; Pirk CWW, 2016, APIDOLOGIE, V47, P276, DOI 10.1007/s13592-015-0406-6; Rinkevich FD, 2017, INSECTS, V8, DOI 10.3390/insects8010009; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Saucy F, 2014, J APICULT RES, V53, P327, DOI 10.3896/IBRA.1.53.3.01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 1998, APIDOLOGIE, V29, P291, DOI 10.1051/apido:19980308; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; Stanimirovic Z, 2002, ACTA VET-BEOGRAD, V52, P169, DOI 10.2298/AVB0203169S; Strauss U, 2016, PARASITOLOGY, V143, P374, DOI 10.1017/S0031182015001754; Strauss U, 2015, EXP APPL ACAROL, V65, P89, DOI 10.1007/s10493-014-9842-7; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Tadele Alemu, 2014, International Journal of Innovation and Applied Studies, V9, P1987; Tantillo G, 2015, ITAL J FOOD SAF, V4, P157, DOI 10.4081/ijfs.2015.5364; Taylor MA, 2008, J APICULT RES, V47, P239, DOI 10.3896/IBRA.1.47.4.01; Tilahun M, 2016, LIVESTOCK RES RURAL, V28, P5; Unicef, 2016, ETH COUNTR PROF UN; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Yalcinkaya Aygun, 2010, Mellifera, V10, P24	83	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223236	10.1371/journal.pone.0223236	http://dx.doi.org/10.1371/journal.pone.0223236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557264	Green Published, gold			2022-12-26	WOS:000532345500092
J	Umata, K; Sakai, Y; Ikeda, S; Tsuji, S; Kawasaki, H; Ohama, T; Sato, K				Umata, Koji; Sakai, Yusuke; Ikeda, Shunta; Tsuji, Shunya; Kawasaki, Hideyoshi; Ohama, Takashi; Sato, Koichi			Distribution of SET/I2PP2A protein in gastrointestinal tissues	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PP2A; ACTIVATING FACTOR-I; PHOSPHATASE 2A; SET ONCOPROTEIN; INHIBITORS; OVEREXPRESSION; TRANSCRIPTION; REPLICATION; ACETYLATION; ONCOGENE	SET (also called I2PP2A and TIF-1) is a multi-functional protein that regulates a variety of cell signaling including nucleosome assembly, histone binding, and tumorigenesis. Elevated SET protein levels are observed in various human tumors, and are correlated with poor prognosis and drug-resistance. We recently reported that SET protein levels in cancer cells were positively correlated with poor prognosis of gastric cancer patients. Using immunohistochemistry, SET protein was observed not only in cancer cells, but also in some interstitial cells. However, the tissue distribution of SET has not been investigated. Here we performed co-immunofluorescent staining to characterize SET protein distribution in gastrointestinal tissues. We found that even though the positive rate is much lower than epithelial cells, SET protein is also expressed in non-epithelial cells, such as monocytes/macrophages, neural cells, myofibroblasts, and smooth muscle cells. Our results indicate an extensive role of SET in a variety of cell types.	[Umata, Koji; Sakai, Yusuke; Ikeda, Shunta; Tsuji, Shunya; Kawasaki, Hideyoshi; Ohama, Takashi; Sato, Koichi] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi, Japan	Yamaguchi University	Ohama, T (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi, Japan.	t.ohama@yamaguchi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [17H03915, 18K05994]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI, Grant Number 17H03915 and 18K05994). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Bhutia YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053436; Christensen DJ, 2011, BLOOD, V118, P4150, DOI 10.1182/blood-2011-04-351072; Cristobal I, 2015, CLIN CANCER RES, V21, P347, DOI 10.1158/1078-0432.CCR-14-0724; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; Enjoji S, 2018, MOL CANCER RES, V16, P554, DOI 10.1158/1541-7786.MCR-17-0393; Enjoji S, 2015, J VET MED SCI, V77, P1451, DOI 10.1292/jvms.15-0193; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Farrell AS, 2014, MOL CANCER RES, V12, P924, DOI 10.1158/1541-7786.MCR-13-0542; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu H, 2015, ONCOTARGET, V6, P14913, DOI 10.18632/oncotarget.3818; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Trakhtenberg EF, 2014, J NEUROSCI, V34, P7361, DOI 10.1523/JNEUROSCI.3658-13.2014; Trotta R, 2011, BLOOD, V117, P2378, DOI 10.1182/blood-2010-05-285130; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang DL, 2016, NATURE, V538, P118, DOI 10.1038/nature19759; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222845	10.1371/journal.pone.0222845	http://dx.doi.org/10.1371/journal.pone.0222845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557212	Green Published, gold			2022-12-26	WOS:000532345500040
J	Wang, LQ; Wang, Y; Chen, A; Teli, M; Kondo, R; Jalali, A; Fan, Y; Liu, SZ; Zhao, XY; Siegel, A; Minami, K; Agarwal, M; Li, BY; Yokota, H				Wang, Luqi; Wang, Yue; Chen, Andy; Teli, Meghana; Kondo, Rika; Jalali, Aydin; Fan, Yao; Liu, Shengzhi; Zhao, Xinyu; Siegel, Amanda; Minami, Kazumasa; Agarwal, Mangilal; Li, Bai-Yan; Yokota, Hiroki			Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway	FASEB JOURNAL			English	Article						breast cancer; VOC; osteoclasts; bone metastasis	PROLIFERATOR-ACTIVATED RECEPTOR; BREAST-CANCER; CELL-LINES; IN-VITRO; STATINS; OSTEOCLASTOGENESIS; BISPHOSPHONATES; SUPPRESSION; MECHANISM; SNAIL	Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. Currently, no drug is able to cure breast cancer associated bone metastasis. In this study, we focused on statins that are known to inhibit cholesterol production and act as antitumor agents. After an initial potency screening of 7 U.S. Food and Drug Administration approved statins, we examined pitavastatin as a drug candidate for inhibiting tumor and tumor-induced bone loss. In vitro analysis revealed that pitavastatin acted as an inhibitor of tumor progression by altering stress to the endoplasmic reticulum, down-regulating peroxisome proliferator-activated receptor gamma, and reducing Snail and matrix metalloproteinase 9. In bone homeostasis, it blocked osteoclast development by suppressing transcription factors c-Fos and JunB, but stimulated osteoblast mineralization by regulating bone morphogenetic protein 2 and p53. In a mouse model, pitavastatin presented a dual role in tumor inhibition in the mammary fat pad, as well as in bone protection in the osteolytic tibia. In mass spectrometry based analysis, volatile organic compounds (VOCs) that were linked to lipid metabolism and cholesterol synthesis were elevated in mice from the tumor-grown placebo group. Notably, pitavastatin-treated mice reduced specific VOCs that are linked to lipid metabolites in the mevalonate pathway. Collectively, the results lay a foundation for further investigation of pitavastatin's therapeutic efficacy in tumor-induced bone loss, as well as VOC-based diagnosis of tumor progression and treatment efficacy.	[Wang, Luqi; Wang, Yue; Fan, Yao; Li, Bai-Yan; Yokota, Hiroki] Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China; [Wang, Luqi; Wang, Yue; Chen, Andy; Teli, Meghana; Kondo, Rika; Jalali, Aydin; Fan, Yao; Liu, Shengzhi; Zhao, Xinyu; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, 723 West Michigan St,SL220, Indianapolis, IN 46202 USA; [Siegel, Amanda; Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Integrated Nanosyst Dev Inst, Indianapolis, IN 46202 USA; [Siegel, Amanda] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Mech Engn, Indianapolis, IN 46202 USA; [Kondo, Rika; Minami, Kazumasa] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Zhao, Xinyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Yokota, Hiroki] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Yokota, Hiroki] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Harbin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Osaka University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Li, BY (corresponding author), Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China.; Yokota, H (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, 723 West Michigan St,SL220, Indianapolis, IN 46202 USA.	liby@ems.hrbmu.edu.cn; hyokota@iupui.edu	Siegel, Amanda/AAR-7871-2020	Siegel, Amanda/0000-0003-4112-0212	100 Voices of Hope; U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR052144]; NIH/National Cancer Institute [R03CA238555]; NATIONAL CANCER INSTITUTE [R03CA238555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	100 Voices of Hope; U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Ali Daneshkhah, Paul Grocki, and Mark Woollam (all from Indiana University-Purdue University Indianapolis) for technical support, and Hisako Masuda (Indiana University, Kokomo, IN, USA) for data analysis. This study was supported, in part, by funds from 100 Voices of Hope (to H.Y.) and the U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052144) and NIH/National Cancer Institute (R03CA238555 to H.Y.). The authors declare no conflicts of interest.	Ahern TP, 2014, LANCET ONCOL, V15, pE461, DOI 10.1016/S1470-2045(14)70119-6; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Brook N, 2018, INT J BIOCHEM CELL B, V96, P63, DOI 10.1016/j.biocel.2018.01.003; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Catapano AL, 2012, CLIN LIPIDOL, V7, P3, DOI 10.2217/CLP.12.21; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chimento A, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00807; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Coleman R E, 2000, Breast Cancer, V7, P361, DOI 10.1007/BF02966406; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Davies Jonathan T, 2016, Lipid Insights, V9, P13; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Dunford JE, 2010, CURR PHARM DESIGN, V16, P2961; Fan M, 2016, CELL PHYSIOL BIOCHEM, V38, P1319, DOI 10.1159/000443076; Gago-Dominguez M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1628; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Gobel A, 2015, BREAST CANCER RES TR, V154, P623, DOI 10.1007/s10549-015-3624-8; Hamamura K, 2015, CELL SIGNAL, V27, P353, DOI 10.1016/j.cellsig.2014.11.020; Hamamura K, 2013, J BONE MINER METAB, V31, P618, DOI 10.1007/s00774-013-0450-0; Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0019; Iannelli F, 2018, RECENT PAT ANTI-CANC, V13, P184, DOI 10.2174/1574892812666171129141211; Iarrobino N. A., 2018, AM J CLIN ONCOL; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Kamiya Nobuhiro, 2012, Curr Mol Pharmacol, V5, P153; Khalid T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143283; Kobayashi Y, 2017, ONCOTARGET, V8, P72147, DOI 10.18632/oncotarget.20046; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; Kotta-Loizou I, 2012, ANTI-CANCER AGENT ME, V12, P1025, DOI 10.2174/187152012803529664; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Lan CH, 2014, ENVIRON POLLUT, V193, P156, DOI 10.1016/j.envpol.2014.06.014; Lavra L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13246; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu SZ, 2018, CANCER RES, V78, P3865, DOI 10.1158/0008-5472.CAN-18-0056; Liu YL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-276; Minami K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45686; Miyazaki T, 2011, ANAL BIOCHEM, V410, P7, DOI 10.1016/j.ab.2010.11.014; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nomura S, 2006, J EXP CLIN CANC RES, V25, P443; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rogers MJ, 2000, NAT MED, V6, P21, DOI 10.1038/71484; Siegel AP, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa6ac6; Sopkova J, 2017, GEN PHYSIOL BIOPHYS, V36, P501, DOI 10.4149/gpb_2017045; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Wang CS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05383; Wang HN, 2017, ONCOTARGET, V8, P88122, DOI 10.18632/oncotarget.21490; Wang LQ, 2018, INT J ONCOL, V53, P1001, DOI 10.3892/ijo.2018.4481; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wieczorek E, 2015, TUMOR BIOL, V36, P163, DOI 10.1007/s13277-014-2747-6; Woollam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38920-0; Xu WX, 2015, CELL SIGNAL, V27, P2332, DOI 10.1016/j.cellsig.2015.08.014; Zhang W, 2018, ONCOTARGET, V9, P3690, DOI [10.18632/oncotarget.23196, 10.18632/oncotarget.24286]	56	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13710	13721		10.1096/fj.201901388R	http://dx.doi.org/10.1096/fj.201901388R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585508	Green Published, Bronze			2022-12-26	WOS:000507466100052
J	Dupont, C; Chen, YS; Xu, ZJ; Roquet-Baneres, F; Blaise, M; Witt, AK; Dubar, F; Biot, C; Guerardel, Y; Maurer, FP; Chng, SS; Kremer, L				Dupont, Christian; Chen, Yushu; Xu, Zhujun; Roquet-Baneres, Francoise; Blaise, Mickael; Witt, Anne-Kathrin; Dubar, Faustine; Biot, Christophe; Guerardel, Yann; Maurer, Florian P.; Chng, Shu-Sin; Kremer, Laurent			A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; drug action; drug resistance; inhibitor; cell wall; antibiotic action; Flippase; MmpL3; PIPD1; therapeutic activity; Trehalose Monomycolate	CELL-WALL; TREHALOSE MONOMYCOLATE; MEMBRANE TRANSPORTER; DRUG DISCOVERY; ANTIGEN 85C; TARGET; INSIGHTS; DOCKING; FAMILY; MUTANT	Mycobacterium tuberculosis, the causative agent of tuberculosis, remains a major human pathogen, and current treatment options to combat this disease are under threat because of the emergence of multidrug-resistant and extensively drug-resistant tuberculosis. High-throughput whole-cell screening of an extensive compound library has recently identified a piperidinol-containing molecule, PIPD1, as a potent lead compound against M. tuberculosis. Herein, we show that PIPD1 and related analogs exert in vitro bactericidal activity against the M. tuberculosis strain mc(2)6230 and also against a panel of multidrug-resistant and extensively drug-resistant clinical isolates of M. tuberculosis, suggesting that PIPD1's mode of action differs from those of most first- and second-line anti-tubercular drugs. Selection and DNA sequencing of PIPD1-resistant mycobacterial mutants revealed the presence of single-nucleotide polymorphisms in mmpL3, encoding an inner membrane-associated mycolic acid flippase in M. tuberculosis. Results from functional assays with spheroplasts derived from a M. smegmatis strain lacking the endogenous mmpL3 gene but harboring the M. tuberculosis mmpL3 homolog indicated that PIPD1 inhibits the MmpL3-driven translocation of trehalose monomycolate across the inner membrane without altering the proton motive force. Using a predictive structural model of MmpL3 from M. tuberculosis, docking studies revealed a PIPD1-binding cavity recently found to accommodate different inhibitors in M. smegmatis MmpL3. In conclusion, our findings have uncovered bactericidal activity of a new chemical scaffold. Its anti-tubercular activity is mediated by direct inhibition of the flippase activity of MmpL3 rather than by inhibition of the inner membrane proton motive force, significantly advancing our understanding of MmpL3-targeted inhibition in mycobacteria.	[Dupont, Christian; Roquet-Baneres, Francoise; Blaise, Mickael; Kremer, Laurent] Univ Montpellier, Inst Rech Infectiol Montpellier, CNRS, UMR9004, F-34293 Montpellier, France; [Kremer, Laurent] INSERM, Inst Rech Infectiol Montpellier, F-34293 Montpellier, France; [Chen, Yushu; Xu, Zhujun; Chng, Shu-Sin] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Witt, Anne-Kathrin; Maurer, Florian P.] Leibniz Lung Ctr, Res Ctr Borstel, Natl Reference Ctr Mycobacteria, D-23845 Borstel, Germany; [Dubar, Faustine; Biot, Christophe; Guerardel, Yann] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; National University of Singapore; Forschungszentrum Borstel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kremer, L (corresponding author), Univ Montpellier, Inst Rech Infectiol Montpellier, CNRS, UMR9004, F-34293 Montpellier, France.; Kremer, L (corresponding author), INSERM, Inst Rech Infectiol Montpellier, F-34293 Montpellier, France.; Chng, SS (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.	chmchngs@nus.edu.sg; laurent.kremer@irim.cnrs.fr	Biot, Christophe/ABG-3796-2020; Kremer, Laurent/M-4935-2017; Maurer, Florian/ABA-1918-2020; Chng, Shu Sin/B-1759-2018	Biot, Christophe/0000-0002-7396-1959; Kremer, Laurent/0000-0002-6604-4458; Maurer, Florian/0000-0001-8353-5964; Chen, Yushu/0000-0002-9085-6341; Dubar, Faustine/0000-0002-0233-7067; Chng, Shu Sin/0000-0001-5466-7183; Blaise, Mickael/0000-0002-7860-3464; Guerardel, Yann/0000-0003-4967-9512	Fondation pour la Recherche Medicale Grant [DEQ20150331719]; French National Research Agency MyCat Grant [ANR-15-CE18-0007-02]; Joachim Herz Foundation; Singapore Ministry of Education Tier 1 grant (National University of Singapore-CNRS Collaborative Track); French National Research Agency MyTraM Grant [ANR-17-CE11-0008-01]	Fondation pour la Recherche Medicale Grant(Fondation pour la Recherche Medicale); French National Research Agency MyCat Grant(French National Research Agency (ANR)); Joachim Herz Foundation; Singapore Ministry of Education Tier 1 grant (National University of Singapore-CNRS Collaborative Track); French National Research Agency MyTraM Grant(French National Research Agency (ANR))	This work was supported by Fondation pour la Recherche Medicale Grant DEQ20150331719 (to L.K.), French National Research Agency MyCat Grant ANR-15-CE18-0007-02 (to L.K. and Y.G.) and MyTraM Grant ANR-17-CE11-0008-01 (to M.B.), funds from the Joachim Herz Foundation (to F.P.M.), and a Singapore Ministry of Education Tier 1 grant (National University of Singapore-CNRS Collaborative Track; to S.S.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bailo R, 2015, BIOCHEM PHARMACOL, V96, P159, DOI 10.1016/j.bcp.2015.05.001; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bernut A, 2016, MOL MICROBIOL, V99, P866, DOI 10.1111/mmi.13283; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cox JAG, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.6, 10.1038/nmicrobiol.2015.6]; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Degiacomi G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43495; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Dupont C, 2016, MOL MICROBIOL, V101, P515, DOI 10.1111/mmi.13406; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Feng XX, 2015, P NATL ACAD SCI USA, V112, pE7073, DOI 10.1073/pnas.1521988112; Foss MH, 2016, ACS INFECT DIS, V2, P500, DOI 10.1021/acsinfecdis.6b00052; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kozikowski AP, 2017, J MED CHEM, V60, P5876, DOI 10.1021/acs.jmedchem.7b00582; Kumar V, 2018, MED RES REV, V38, P684, DOI 10.1002/med.21454; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Li K, 2014, J MED CHEM, V57, P3126, DOI 10.1021/jm500131s; Li W, 2019, ACS INFECT DIS, V5, P1001, DOI 10.1021/acsinfecdis.9b00048; Li W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01547; Li W, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02399-16, 10.1128/aac.02399-16]; Li W, 2016, ANTIMICROB AGENTS CH, V60, P5198, DOI 10.1128/AAC.00826-16; Li W, 2014, ANTIMICROB AGENTS CH, V58, P6413, DOI 10.1128/AAC.03229-14; Lun SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3907; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Melly G, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030070; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Nataraj V, 2015, MOL MICROBIOL, V98, P7, DOI 10.1111/mmi.13101; Ozkan P, 2002, BBA-GEN SUBJECTS, V1572, P143, DOI 10.1016/S0304-4165(02)00303-3; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Poce G, 2016, MINI-REV MED CHEM, V16, P1274, DOI 10.2174/1389557516666160118105319; Rao SPS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007355; Remuinan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060933; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Shetty A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02960; Su CC, 2019, P NATL ACAD SCI USA, V116, P11241, DOI 10.1073/pnas.1901346116; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Viljoen A, 2018, J BIOL CHEM, V293, P2755, DOI 10.1074/jbc.RA117.000760; Viljoen A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00388; Viljoen A, 2017, MOL MICROBIOL, V104, P889, DOI 10.1111/mmi.13675; Xu ZJ, 2017, P NATL ACAD SCI USA, V114, P7993, DOI 10.1073/pnas.1700062114; Zhang B, 2019, CELL, V176, P636, DOI 10.1016/j.cell.2019.01.003; Zheng HQ, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02459-17, 10.1128/aac.02459-17]	51	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17512	17523		10.1074/jbc.RA119.010135	http://dx.doi.org/10.1074/jbc.RA119.010135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31562241	Green Published, hybrid			2022-12-26	WOS:000503173500028
J	Anagnostou, P; Dominici, V; Battaggia, C; Lisi, A; Sarno, S; Boattini, A; Calo, C; Francalacci, P; Vona, G; Tofanelli, S; Vilar, MG; Colonna, V; Pagani, L; Bisol, GD				Anagnostou, Paolo; Dominici, Valentina; Battaggia, Cinzia; Lisi, Alessandro; Sarno, Stefania; Boattini, Alessio; Calo, Carla; Francalacci, Paolo; Vona, Giuseppe; Tofanelli, Sergio; Vilar, Miguel G.; Colonna, Vincenza; Pagani, Luca; Bisol, Giovanni Destro			Inter-individual genomic heterogeneity within European population isolates	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC-CHARACTERIZATION; PATTERNS; FINLAND; SIZE; TOOL	A number of studies carried out since the early '70s has investigated the effects of isolation on genetic variation within and among human populations in diverse geographical contexts. However, no extensive analysis has been carried out on the heterogeneity among genomes within isolated populations. This issue is worth exploring since events of recent admixture and/or subdivision could potentially disrupt the genetic homogeneity which is to be expected when isolation is prolonged and constant over time. Here, we analyze literature data relative to 87,815 autosomal single-nucleotide polymorphisms, which were obtained from a total of 28 European populations. Our results challenge the traditional paradigm of population isolates as structured as genetically (and genomically) uniform entities. In fact, focusing on the distribution of variance of intra-population diversity measures across individuals, we show that the inter-individual heterogeneity of isolated populations is at least comparable to the open ones. More in particular, three small and highly inbred isolates (Sappada, Sauris and Timau in Northeastern Italy) were found to be characterized by levels of inter-individual heterogeneity largely exceeding that of all other populations, possibly due to relatively recent events of genetic introgression. Finally, we propose a way to monitor the effects of inter-individual heterogeneity in disease-gene association studies.	[Anagnostou, Paolo; Dominici, Valentina; Battaggia, Cinzia; Lisi, Alessandro; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Anagnostou, Paolo; Bisol, Giovanni Destro] Ist Italiano Antropol, Rome, Italy; [Sarno, Stefania; Boattini, Alessio] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy; [Calo, Carla; Francalacci, Paolo; Vona, Giuseppe] Univ Cagliari, Dipartimento Sci Vitae & Ambiente, Cagliari, Italy; [Tofanelli, Sergio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Vilar, Miguel G.] Natl Geog Soc, Washington, DC USA; [Colonna, Vincenza] Natl Res Council CNR, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Pagani, Luca] Univ Padua, Dept Biol, APE Lab, Padua, Italy; [Pagani, Luca] Univ Tartu, Estonian Bioctr, Inst Genom, Tartu, Estonia	Sapienza University Rome; University of Bologna; University of Cagliari; University of Pisa; National Geographic Society; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Padua; Estonian Biocentre; University of Tartu	Anagnostou, P; Bisol, GD (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.; Anagnostou, P; Bisol, GD (corresponding author), Ist Italiano Antropol, Rome, Italy.	paolo.anagnostou@uniroma1.it; giovanni.destrobisol@uniroma1.it	Pagani, Luca/G-8511-2017	Pagani, Luca/0000-0002-6639-524X; Anagnostou, Paolo/0000-0003-0768-4612	Universita di Roma "La Sapienza" [C26A13HSHB]; Istituto Italiano di Antropologia (Atlante bio-culturale Italiano); European Research Council [ERC-2011-AdG 295733]; National Geographic Society Genographic 2.0 grant	Universita di Roma "La Sapienza"; Istituto Italiano di Antropologia (Atlante bio-culturale Italiano); European Research Council(European Research Council (ERC)European Commission); National Geographic Society Genographic 2.0 grant(National Geographic Society)	The study was supported by the Universita di Roma "La Sapienza" (ref. C26A13HSHB), the Istituto Italiano di Antropologia (Atlante bio-culturale Italiano), the European Research Council ERC-2011-AdG 295733 grant (Langelin) and National Geographic Society Genographic 2.0 grant to ST (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou P, 2017, SCI REP-UK, V7, DOI 10.1038/srep41614; Anagnostou P, 2017, ANN HUM BIOL, V44, P140, DOI 10.1080/03014460.2016.1181784; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bittles Alan H, 2005, J Mol Genet Med, V1, P43; Capocasa M, 2014, J ANTHROPOL SCI, V92, P201, DOI 10.4436/JASS.92001; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Colonna V, 2013, EUR J HUM GENET, V21, P89, DOI 10.1038/ejhg.2012.113; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Elhaik E, 2013, GENOME BIOL EVOL, V5, P1021, DOI 10.1093/gbe/evt066; Esko T, 2013, EUR J HUM GENET, V21, P659, DOI 10.1038/ejhg.2012.229; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hatzikotoulas K, 2014, BRIEF FUNCT GENOMICS, V13, P371, DOI 10.1093/bfgp/elu022; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Human Genome Diversity Project (HGDP), 2008, ENC GEN GEN PROT INF, P923; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Karafet TM, 2015, EUR J HUM GENET, V23, P1405, DOI 10.1038/ejhg.2014.299; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Palin K, 2011, GENET EPIDEMIOL, V35, P853, DOI 10.1002/gepi.20635; Panoutsopoulou K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6345; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sarno S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01802-4; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Viazzo PP, 2007, HIST ALPES, V12, P13; Vogel F., 1992, ISOLATION MIGRATION, P41, DOI DOI 10.1017/CBO9780511983634.006; WARD RH, 1970, AM J HUM GENET, V22, P538; Xue YL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15927; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0214564	10.1371/journal.pone.0214564	http://dx.doi.org/10.1371/journal.pone.0214564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596857	Green Published, Green Submitted, gold			2022-12-26	WOS:000532444100002
J	Lee, KJ; Piett, CG; Andrews, JF; Mann, E; Nagel, ZD; Gassman, NR				Lee, Kevin J.; Piett, Cortt G.; Andrews, Joel F.; Mann, Elise; Nagel, Zachary D.; Gassman, Natalie R.			Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer	PLOS ONE			English	Article							POLYMERASE-BETA; LIGASE-III; CELL-LINES; POLY(ADP-RIBOSE) POLYMERASE; GENE-EXPRESSION; MUTANT P53; XRCC1; TUMOR; POLYMORPHISMS; SURVIVAL	DNA repair defects have been increasingly focused on as therapeutic targets. In hormone-positive breast cancer, XRCC1-deficient tumors have been identified and proposed as targets for combination therapies that damage DNA and inhibit DNA repair pathways. XRCC1 is a scaffold protein that functions in base excision repair (BER) by mediating essential interactions between DNA glycosylases, AP endonuclease, poly(ADP-ribose) polymerase 1, DNA polymerase beta (POL beta), and DNA ligases. Loss of XRCC1 confers BER defects and hypersensitivity to DNA damaging agents. BER defects have not been evaluated in triple negative breast cancers (TNBC), for which new therapeutic targets and therapies are needed. To evaluate the potential of XRCC1 as an indicator of BER defects in TNBC, we examined XRCC1 expression in the TCGA database and its expression and localization in TNBC cell lines. The TCGA database revealed high XRCC1 expression in TNBC tumors and TNBC cell lines show variable, but mostly high expression of XRCC1. XRCC1 localized outside of the nucleus in some TNBC cell lines, altering their ability to repair base lesions and single-strand breaks. Subcellular localization of POL beta also varied and did not correlate with XRCC1 localization. Basal levels of DNA damage correlated with observed changes in XRCC1 expression, localization, and measure repair capacity. The results confirmed that XRCC1 expression changes indicate DNA repair capacity changes but emphasize that basal DNA damage levels along with protein localization are better indicators of DNA repair defects. Given the observed over-expression of XRCC1 in TNBC preclinical models and tumors, XRCC1 expression levels should be assessed when evaluating treatment responses of TNBC preclinical model cells.	[Lee, Kevin J.; Andrews, Joel F.; Gassman, Natalie R.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Lee, Kevin J.; Andrews, Joel F.; Mann, Elise; Gassman, Natalie R.] Univ S Alabama, Coll Med, Mobile, AL 36688 USA; [Piett, Cortt G.; Nagel, Zachary D.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	University of South Alabama; University of South Alabama; Harvard University; Harvard T.H. Chan School of Public Health	Gassman, NR (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA.; Gassman, NR (corresponding author), Univ S Alabama, Coll Med, Mobile, AL 36688 USA.	nrgassman@health.southalabama.edu	Classen, Scott/AAY-8176-2020	Gassman, Natalie/0000-0002-8488-2332	National Institutes of Health, National Institute of Environmental Health Sciences [R21ES028015]; National Institutes of Health, National Cancer Institute [P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES028015] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R21ES028015 [NRG] from National Institutes of Health, National Institute of Environmental Health Sciences and P01CA092584 [ZDN] National Institutes of Health, National Cancer Institute. The authors declare there are not conflicts of interest. Editorial support was provided by the Dean's Office, University of South Alabama College of Medicine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P520, DOI 10.1016/j.molonc.2014.01.001; Albarakati N, 2015, MOL ONCOL, V9, P204, DOI 10.1016/j.molonc.2014.08.001; Ali R, 2018, CANCER RES, V78, P6818, DOI 10.1158/0008-5472.CAN-18-0633; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Boichuk S, 2017, ONCOL LETT, V14, P5039, DOI 10.3892/ol.2017.6795; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Caldecott KW, 2014, EXP CELL RES, V329, P2, DOI 10.1016/j.yexcr.2014.08.027; Camirand A, 2013, AM J CANCER RES, V3, P500; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chaim IA, 2017, P NATL ACAD SCI USA, V114, pE10379, DOI 10.1073/pnas.1712032114; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; De Summa S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.30; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gassman NR, 2015, DNA REPAIR, V31, P52, DOI 10.1016/j.dnarep.2015.05.001; Gassman NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118819; Gassman NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049301; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Holton NW, 2018, DNA REPAIR, V66-67, P42, DOI 10.1016/j.dnarep.2018.04.007; Holton NW, 2017, JOVE-J VIS EXP, DOI 10.3791/56265; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Horton JK, 2014, MOL CANCER RES, V12, P1128, DOI 10.1158/1541-7786.MCR-13-0502; Horton JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00257; Horton JK, 2013, DNA REPAIR, V12, P774, DOI 10.1016/j.dnarep.2013.06.004; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Kang YJ, 2018, DNA REPAIR, V68, P34, DOI 10.1016/j.dnarep.2018.06.001; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kirby TW, 2017, NUCLEIC ACIDS RES, V45, P1958, DOI 10.1093/nar/gkw1257; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Kiriyama T, 2008, BIOCHEM BIOPH RES CO, V374, P631, DOI 10.1016/j.bbrc.2008.07.088; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li SX, 2010, ENVIRON MOL MUTAGEN, V51, P897, DOI 10.1002/em.20606; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OConnor PM, 1997, CANCER RES, V57, P4285; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Patrono C, 2014, WORLD J CLIN ONCOL, V5, P874, DOI 10.5306/wjco.v5.i5.874; Polo LM, 2019, CELL REP, V26, P573, DOI 10.1016/j.celrep.2018.12.082; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Prasad R, 2019, DNA REPAIR, V73, P71, DOI 10.1016/j.dnarep.2018.11.004; Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011; Sawant A, 2017, DNA REPAIR, V51, P46, DOI 10.1016/j.dnarep.2017.01.002; Slyskova J, 2018, NUCLEIC ACIDS RES, V46, P9537, DOI 10.1093/nar/gky764; Sonavane M, 2018, CHEM RES TOXICOL, V31, P510, DOI 10.1021/acs.chemrestox.8b00050; Sultana R, 2013, CANCER RES, V73, P1621, DOI 10.1158/0008-5472.CAN-12-2929; Sykora P, 2013, NEUROBIOL AGING, V34, P1717, DOI 10.1016/j.neurobiolaging.2012.12.016; Takanami T, 2005, MUTAT RES-GEN TOX EN, V582, P135, DOI 10.1016/j.mrgentox.2005.01.007; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Whitaker AM, 2017, FRONT BIOSCI-LANDMRK, V22, P1493, DOI 10.2741/4555; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wolf DM, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0025-7; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	66	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223725	10.1371/journal.pone.0223725	http://dx.doi.org/10.1371/journal.pone.0223725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596905	Green Published, Green Submitted, gold			2022-12-26	WOS:000532444100057
J	Wilhelm, JA; Qiu, M; Paina, L; Colantuoni, E; Mukuru, M; Ssengooba, F; Bennett, S				Wilhelm, Jess Alan; Qiu, Mary; Paina, Ligia; Colantuoni, Elizabeth; Mukuru, Moses; Ssengooba, Freddie; Bennett, Sara			The impact of PEPFAR transition on HIV service delivery at health facilities in Uganda	PLOS ONE			English	Article							MANAGEMENT-INFORMATION-SYSTEM; PROGRAMS; SUSTAINABILITY; CARE	Background Since 2004, the President's Emergency Plan for AIDS Relief (PEPFAR) has played a large role in Uganda's HIV/AIDS response. To better target resources to high burden regions and facilities, PEPFAR planned to withdraw from 29% of previously-supported health facilities in Uganda between 2015 and 2017. Methods We conducted a cross-sectional survey of 226 PEPFAR-supported health facilities in Uganda in mid-2017. The survey gathered information on availability, perceived quality, and access to HIV services before and after transition. We compare responses for facilities transitioned to those maintained on PEPFAR, accounting for survey design. We also extracted data from DHIS2 for the period October 2013-December 2017 on the number of HIV tests and counseling (HTC), number of patients on antiretroviral therapy (Current on ART), and retention on first-line ART (Retention) at 12 months. Using mixed effect models, we compare trends in service volume around the transition period. Results There were 206 facilities that reported transition and 20 that reported maintenance on PEPFAR. Some facilities reporting transition may have been in a gap between implementing partners. The median transition date was September 2016, nine months prior to the survey. Transition facilities were more likely to discontinue HIV outreach following transition (51.6% vs. 1.4%, p<0.001) and to report declines in HIV care access (43.5% vs. 3.1%, p<0.001) and quality (35.6% vs. 0%, p<0.001). However, transition facilities did not differ in their trends in HIV service volume relative to maintenance facilities. Conclusions Transition from PEPFAR resulted in facilities reporting worsening patient access and service quality for HIV care, but there is insufficient evidence to suggest negative impacts on volume of HIV services. Facility respondents' perceptions about access and quality may be overly pessimistic, or they may signal forthcoming impacts. Unrelated to transition, declining retention on ART in Uganda is a cause for concern.	[Wilhelm, Jess Alan; Qiu, Mary; Paina, Ligia; Bennett, Sara] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Colantuoni, Elizabeth] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Mukuru, Moses; Ssengooba, Freddie] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University	Wilhelm, JA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	jw176503@ohio.edu	Mukuru, Moses/AAP-3260-2021	Mukuru, Moses/0000-0002-2139-6679; Paina, Ligia/0000-0002-8403-7825; Qiu, Mary/0000-0003-4814-4591	Project SOAR [AID-OAA-140060]; United States Agency for International Development (USAID); United States President's Emergency Plan for AIDS Relief (PEPFAR)	Project SOAR; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by Project SOAR (http://www.projsoar.org/) through Cooperative agreement AID-OAA-140060, made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR) and United States Agency for International Development (USAID). Sara Bennett is the principal recipient of the sub-agreement funding the activity on which this manuscript is based. Both Project SOAR and USAID were permitted to review and comment on the manuscript prior to submission but do not have control over the content or the decision to publish. The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.	amfAR, 2018, ZIMB DAT PEPFAR MON; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bean MC, 2017, AIDS PATIENT CARE ST, V31, P222, DOI 10.1089/apc.2016.0318; Bennett S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136177; Bennett S, 2015, EVAL PROGRAM PLANN, V52, P148, DOI 10.1016/j.evalprogplan.2015.05.003; Binagwaho A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002075; Boeke CE, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3735-0; Boeke CE, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3042-8; Burrows D., 2016, TRANSITIONS DONOR FU; Chaulagai CN, 2005, HEALTH POLICY PLANN, V20, P375, DOI 10.1093/heapol/czi044; Cloete C, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu058; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Freeman A, 2014, AIDS BEHAV, V18, P2135, DOI 10.1007/s10461-014-0761-8; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Kates J, 2017, FINANCING RESPONSE H; Katz IT, 2015, AIDS CARE, V27, P1298, DOI 10.1080/09540121.2015.1051502; Kiberu VM, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-40; Kruk ME, 2015, AM J PUBLIC HEALTH, V105, pS207, DOI 10.2105/AJPH.2014.302511; Kruk ME, 2012, HEALTH AFFAIR, V31, P1478, DOI 10.1377/hlthaff.2012.0197; Lohman N, 2017, INT J HEALTH POLICY, V6, P83, DOI 10.15171/ijhpm.2016.98; Luboga SA, 2016, HEALTH POLICY PLANN, V31, P897, DOI 10.1093/heapol/czw009; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; Matsubayashi T, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S9; McCreesh N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2420-y; Ministry of Health of Uganda, 2018, NAT HLTH FAC MAST; Ministy of Health, 2018, NAT HLTH EXP UG 2017; Mpimbaza A, 2015, AM J TROP MED HYG, V92, P18, DOI 10.4269/ajtmh.14-0284; Oberth G, 2016, AJAR-AFR J AIDS RES, V15, P35, DOI 10.2989/16085906.2016.1138976; Patcharanarumol W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1008; PEPFAR, 2015, 2015 STRAT DIR SUMM; PEPFAR, 2015, COUNTR REG OP PLAN C; Rodriguez DC, 2017, B WORLD HEALTH ORGAN, V95, P121, DOI 10.2471/BLT.16.179861; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Silverman R., 2018, PROJECTED HLTH FINAN; StataCorp, 2017, STATA STAT SOFTWARE; Staveteig S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186316; UNAIDS, 2014, 90 90 90 AMB TREATM; van der Kop ML, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25196; Vogus A, 2015, GLOB HEALTH-SCI PRAC, V3, P274, DOI 10.9745/GHSP-D-14-00227; Wollum A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2512-9	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223426	10.1371/journal.pone.0223426	http://dx.doi.org/10.1371/journal.pone.0223426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7QS	31596884	Green Published, gold			2022-12-26	WOS:000532444100031
J	Tanaka, M; Hasegawa, S; Nakao, S; Shimada, K; Mukai, R; Matsumoto, K; Nakamura, M				Tanaka, Mizuki; Hasegawa, Shiori; Nakao, Satoshi; Shimada, Kazuyo; Mukai, Ririka; Matsumoto, Kiyoka; Nakamura, Mitsuhiro			Analysis of drug-induced hearing loss by using a spontaneous reporting system database	PLOS ONE			English	Article							RISK-FACTORS; INDUCED OTOTOXICITY; THERAPY; DISPROPORTIONALITY; ASSOCIATION; PREVALENCE; VANCOMYCIN; MECHANISMS; INHIBITORS; SURVIVORS	Many drugs can cause hearing loss, leading to sensorineural deafness. The aim of this study was to evaluate the risk of drug-induced hearing loss (DIHL) by using the Japanese Adverse Drug Event Report (JADER) database and to obtain profiles of DIHL onset in clinical settings. We relied on the Medical Dictionary for Regulatory Activities preferred terms and standardized queries, and calculated the reporting odds ratios (RORs). Furthermore, we applied multivariate logistic regression analysis, association rule mining, and time-to-onset analysis using Weibull proportional hazard models. Of 534688 reports recorded in the JADER database from April 2004 to June 2018, adverse event signals were detected for platinum compounds, sulfonamides (plain) (loop diuretics), interferons, ribavirin, other aminoglycosides, papillomavirus vaccines, drugs used in erectile dysfunction, vancomycin, erythromycin, and pancuronium by determining RORs. The RORs of other aminoglycosides, other quaternary ammonium compounds, drugs used in erectile dysfunction, and sulfonamides (plain) were 29.4 (22.4-38.6), 18.5 (11.2-30.6), 15.4 (10.6-22.5), and 12.6 (10.0-16.0), respectively. High lift score was observed for patients with congenital diaphragmatic hernia treated with pancuronium using association rule mining. The median durations (interquartile range) for DIHL due to platinum compounds, sulfonamides (plain), interferons, antivirals for treatment of hepatitis C virus (HCV) infections, other aminoglycosides, carboxamide derivatives, macrolides, and pneumococcal vaccines were 25.5 (7.5-111.3), 80.5 (4.5-143.0), 64.0 (14.0-132.0), 53.0 (9.0-121.0), 11.0 (3.0-26.8), 1.5 (0.3-11.5), 3.5 (1.3-6.8), and 2.0 (1.0-4.5), respectively. Our results demonstrated potential risks associated with several drugs based on their RORs. We recommend to closely monitor patients treated with aminoglycosides for DIHL for at least two weeks. Moreover, individuals receiving platinum compounds, sulfonamides (plain), interferons, and antivirals for HCV infection therapy should be carefully observed for DIHL for at least several months.	[Tanaka, Mizuki; Hasegawa, Shiori; Nakao, Satoshi; Shimada, Kazuyo; Mukai, Ririka; Matsumoto, Kiyoka; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan	Gifu Pharmaceutical University	Nakamura, M (corresponding author), Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan.	mnakamura@gifu-pu.ac.jp		Hasegawa, Shiori/0000-0003-0444-7945; Nakao, Satoshi/0000-0001-7413-2637; Nakamura, Mitsuhiro/0000-0002-5062-5522	Japan Society for the Promotion of Science KAKENHI [17K08452]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Japan Society for the Promotion of Science KAKENHI grant number, 17K08452. There was no additional external funding received for this study.	Abe J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190102; Abe J, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0048-5; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Au A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079226; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; BRUMMETT RE, 1989, ANTIMICROB AGENTS CH, V33, P791, DOI 10.1128/AAC.33.6.791; Bruniera FR, 2015, EUR REV MED PHARMACO, V19, P694; Castiglione A, 2016, AUDIOL NEURO-OTOL, V21, P21, DOI 10.1159/000448350; Cheung PY, 1999, J PEDIATR-US, V135, P233, DOI 10.1016/S0022-3476(99)70027-2; Cianfrone G, 2011, EUR REV MED PHARMACO, V15, P601; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Egberts ACG, 2002, DRUG SAFETY, V25, P453, DOI 10.2165/00002018-200225060-00010; Elloumi H, 2007, WORLD J GASTROENTERO, V13, P5411, DOI 10.3748/wjg.v13.i40.5411; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Formann E, 2004, AM J GASTROENTEROL, V99, P873, DOI 10.1111/j.1572-0241.2004.30372.x; GATELL JM, 1987, ANTIMICROB AGENTS CH, V31, P1383, DOI 10.1128/AAC.31.9.1383; Hahsler M, 2005, J STAT SOFTW, V14; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Hatahira H, 2017, J PHARM HEALTH CARE, V3, DOI 10.1186/s40780-017-0088-5; Ikeda K, 1997, HEARING RES, V107, P1, DOI 10.1016/S0378-5955(97)00009-9; Jiang MY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00308; KANDA Y, 1994, LANCET, V343, P1134, DOI 10.1016/S0140-6736(94)90237-2; Khan AS, 2011, LARYNGOSCOPE, V121, P1049, DOI 10.1002/lary.21450; Kobel M, 2017, HEARING RES, V349, P148, DOI 10.1016/j.heares.2016.12.008; Lanvers-Kaminsky C, 2017, CLIN PHARMACOL THER, V101, P491, DOI 10.1002/cpt.603; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Masumoto K, 2007, EUR J PEDIATR, V166, P607, DOI 10.1007/s00431-006-0300-3; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Morini F, 2008, J PEDIATR SURG, V43, P380, DOI 10.1016/j.jpedsurg.2007.10.048; Nakamura M, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0035-2; Nakao S, 2017, BIOL PHARM BULL, V40, P2158, DOI 10.1248/bpb.b17-00561; Noren GN, 2007, DATA MIN KNOWL DISC, V14, P305, DOI 10.1007/s10618-006-0052-8; Ozawa K, 2017, DRUG SAFETY, V40, P1219, DOI 10.1007/s40264-017-0574-6; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Robertson CMT, 2006, ACTA PAEDIATR, V95, P214, DOI 10.1080/08035250500294098; Sasaoka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164309; Sauzet O, 2013, DRUG SAFETY, V36, P995, DOI 10.1007/s40264-013-0061-7; Sheth S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00338; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Takeyama M, 2017, BIOL PHARM BULL, V40, P1447, DOI 10.1248/bpb.b17-00266; Tunca Ayse, 2004, Turk J Gastroenterol, V15, P97; Umetsu R, 2015, BIOL PHARM BULL, V38, P1689, DOI 10.1248/bpb.b15-00243; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; van Puijenbroek EP, 2000, EUR J CLIN PHARMACOL, V56, P733, DOI 10.1007/s002280000215; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Yildirim P, 2015, APPL CLIN INFORM, V6, P728, DOI 10.4338/ACI-2015-06-RA-0076; Zhu Ai -Ling, 2003, AMIA Annu Symp Proc, P758	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2019	14	10							e0217951	10.1371/journal.pone.0217951	http://dx.doi.org/10.1371/journal.pone.0217951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7MD	31593579	Green Published, gold			2022-12-26	WOS:000532431700001
J	Khattak, MI; Csikar, J; Vinall, K; Douglas, G				Khattak, Maria Ishaq; Csikar, Julia; Vinall, Karen; Douglas, Gail			The views and experiences of general dental practitioners (GDP's) in West Yorkshire who used the International Caries Detection and Assessment System (ICDAS) in research	PLOS ONE			English	Article							MANAGEMENT; DENTISTS; HEALTH; PREVENTION	Objective To explore, through face to face interviews with a selection of General Dental Practitioners (GDPs), their views and experiences of having used the International Caries Detection and Assessment System (ICDAS) within primary care research studies for recording caries. Methods This qualitative study involved one on one interviews with eight GDP's who had previously used ICDAS on patients in their dental practices as part of a research study. The participants were selected from among those who had taken part in two clinical studies in the UK using convenient, but purposive sampling. The interviews were tape-recorded and transcribed; the data analysis was conducted by thematic analysis. Results GDP's indicated their beliefs that ICDAS had an important role in caries prevention but reported four main barriers while using the full (6 caries stages) ICDAS coding system in their practices: lack of simplicity of coding, financial implications and time consumption (in both training and use of ICDAS) and inadequate undergraduate training. An overarching theme identified from the GDPS was the willingness to offer potential solutions to their barriers which might improve the utilisation of the system in primary care. Conclusion The GDPs experienced common obstacles in using ICDAS in the primary care setting, many of which have relatively straight-forward solutions which they put forward themselves such as: incentivisation, undergraduate-level training in ICDAS for both dentists and nurses and computerized data entry. Further qualitative and quantitative research is needed on how to facilitate the utilisation of the system in dental practice. It is also recommended to explore the influences of wider agencies on influencing primary dental care professionals' caries management, including appropriate recording of diagnosis and risk assessment.	[Khattak, Maria Ishaq; Csikar, Julia; Vinall, Karen; Douglas, Gail] Univ Leeds, Sch Dent, Leeds, W Yorkshire, England; [Khattak, Maria Ishaq] Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Pakistan	University of Leeds; Khyber Medical University	Khattak, MI (corresponding author), Univ Leeds, Sch Dent, Leeds, W Yorkshire, England.; Khattak, MI (corresponding author), Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Pakistan.	Mariakhankhattak@yahoo.com	Csikar, Julia/T-7646-2019	Csikar, Julia/0000-0002-6943-9762; Khattak, Maria Ishaq/0000-0003-4502-6805				Almerich-Silla J, 2010, MED ORAL PATOL ORAL, pe574, DOI [10.4317/medoral.19890, DOI 10.4317/MEDORAL.19890]; Anderson P, 2011, EUR J DENT EDUC, V15, P18, DOI 10.1111/j.1600-0579.2011.00709.x; ARTA G, 2015, FAPUNI FESP SCIELO, V29, DOI [10.1590/1807-3107bor-2015.vol29.0126, DOI 10.1590/1807-3107BOR-2015.VOL29.0126]; BADER JD, 1995, J PUBLIC HEALTH DENT, V55, P181, DOI 10.1111/j.1752-7325.1995.tb02364.x; Bader JD, 2001, COMMUNITY DENT ORAL, V29, P399, DOI 10.1034/j.1600-0528.2001.290601.x; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Braga MM, 2009, CARIES RES, V43, P245, DOI 10.1159/000217855; Braga Mariana M, 2010, Dent Clin North Am, V54, P479, DOI 10.1016/j.cden.2010.03.006; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; de Amorim RG, 2011, SPRINGER NATURE, V16, P513, DOI [10.1007/s00784-011-0528-9, DOI 10.1007/S00784-011-0528-9]; Deery C, 2013, BRIT DENT J, V214, P551, DOI 10.1038/sj.bdj.2013.525; Dikmen B, 2015, J ISTANB UNIV FAC DE, V49, P63, DOI 10.17096/jiufd.38691; El-Damanhoury Hatem M, 2014, Eur J Dent, V8, P493, DOI 10.4103/1305-7456.143631; Featherstone JDB, 1999, COMMUNITY DENT ORAL, V27, P31, DOI 10.1111/j.1600-0528.1999.tb01989.x; Fitzgerald L, 2002, HUM RELAT, V55, P1429, DOI 10.1177/001872602128782213; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Gomez J, 2014, COMMUNITY DENT HLTH, V31, P91, DOI 10.1922/CDH_3341Gomez08; Honkala E, 2011, INT J DENT, V2011, DOI 10.1155/2011/150424; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Ismail A I, 2004, J Dent Res, V83 Spec No C, pC56; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kuhnisch J, 2008, COMMUNITY DENT ORAL, V36, P475, DOI 10.1111/j.1600-0528.2008.00436.x; Leung Lawrence, 2015, J Family Med Prim Care, V4, P324, DOI 10.4103/2249-4863.161306; Locock L, 2001, SOC SCI MED, V53, P745, DOI 10.1016/S0277-9536(00)00387-7; Luz PB, 2015, EUR J DENT EDUC, V19, P235, DOI 10.1111/eje.12131; Mehta A., 2012, COMPREHENSIVE REV CA; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Norlyk A, 2010, QUAL HEALTH RES, V20, P420, DOI 10.1177/1049732309357435; Nunn J, 2000, BRIT DENT J, V189, P639, DOI 10.1038/sj.bdj.4800853a; Pitts NB, 2013, COMMUNITY DENT ORAL, V41, pe41, DOI 10.1111/cdoe.12025; Pitts NB, 2009, MONOGR ORAL SCI, V21, P128, DOI 10.1159/000224217; Rogers Everett M., 2015, INT ENCY SOCIAL BEHA, V2nd, P378; SHEIHAM A, 1984, INT J EPIDEMIOL, V13, P142, DOI 10.1093/ije/13.2.142; Shivakumar Km, 2009, J Conserv Dent, V12, P10, DOI 10.4103/0972-0707.53335; Topping GVA, 2009, MONOGR ORAL SCI, V21, P15, DOI 10.1159/000224210	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223376	10.1371/journal.pone.0223376	http://dx.doi.org/10.1371/journal.pone.0223376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM7CZ	31584966	Green Published, gold			2022-12-26	WOS:000532407600024
J	Williams, K; Hughson, AG; Chesebro, B; Race, B				Williams, Katie; Hughson, Andrew G.; Chesebro, Bruce; Race, Brent			Inactivation of chronic wasting disease prions using sodium hypochlorite	PLOS ONE			English	Article							CREUTZFELDT-JAKOB; SCRAPIE; DISINFECTION; INFECTIVITY; DECONTAMINATION; ENCEPHALOPATHY; VARIANT; AGENTS; STRAIN; DEER	Chronic wasting disease (CWD) is a fatal prion disease that can infect deer, elk and moose. CWD has now been detected in 26 states of the USA, 3 Canadian provinces, South Korea, Norway, Sweden and Finland. CWD continues to spread from endemic areas, and new foci of infections are frequently detected. As increasing numbers of cervids become infected, the likelihood for human exposure increases. To date, no cases of CWD infection in humans have been confirmed, but experience with the BSE zoonosis in the United Kingdom suggests exposure to CWD should be minimized. Specifically, hunters, meat processors and others in contact with tissues from potentially CWD-infected cervids need a practical method to decontaminate knives, saws and other equipment. Prions are notoriously difficult to inactivate, and most effective methods require chemicals or sterilization processes that are either dangerous, caustic, expensive or not readily available. Although corrosive, sodium hypochlorite (bleach) is widely available and affordable and has been shown to inactivate prion agents including those that cause scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. In the current study, we confirm that bleach is an effective disinfectant for CWD prions and establish minimum times and bleach concentrations to eliminate prion seeding activity from stainless steel and infected brain homogenate solutions. We found that a five-minute treatment with a 40% dilution of household bleach was effective at inactivating CWD seeding activity from stainless-steel wires and CWD-infected brain homogenates. However, bleach was not able to inactivate CWD seeding activity from solid tissues in our studies.	[Williams, Katie; Hughson, Andrew G.; Chesebro, Bruce; Race, Brent] NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Race, B (corresponding author), NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	raceb@nih.gov			Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases.; We thank Byron Caughey, Kim Hasenkrug, and Jay Carroll for critical review of the manuscript; Mike Miller, Terry Kreeger, and Jean Jewell for CWD-positive cervid tissues. This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases.	Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; BROWN P, 1982, J INFECT DIS, V145, P683, DOI 10.1093/infdis/145.2.683; BROWN P, 1986, J INFECT DIS, V153, P1145, DOI 10.1093/infdis/153.6.1145; BROWN P, 1982, NEW ENGL J MED, V306, P1279, DOI 10.1056/NEJM198205273062107; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Fukuzaki Satoshi, 2006, Biocontrol Science, V11, P147; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; HARTLEY EG, 1967, NATURE, V213, P1135, DOI 10.1038/2131135a0; Henderson DM, 2015, J GEN VIROL, V96, P210, DOI 10.1099/vir.0.069906-0; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hughson AG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005914; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; KIMBERLIN RH, 1983, J NEUROL SCI, V59, P355, DOI 10.1016/0022-510X(83)90021-7; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Mori T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24993; Nakano Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156058; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; Race B, 2019, VET RES, V50, DOI 10.1186/s13567-019-0626-2; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; WALKER AS, 1983, AM J PUBLIC HEALTH, V73, P661, DOI 10.2105/AJPH.73.6.661; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	33	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223659	10.1371/journal.pone.0223659	http://dx.doi.org/10.1371/journal.pone.0223659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584997	gold, Green Published			2022-12-26	WOS:000532407600048
J	Fang, Y; Wang, HY; Liu, X; Xin, DD; Rao, YC; Zhu, B				Fang, Yuan; Wang, Haoye; Liu, Xia; Xin, Dedong; Rao, Yuchun; Zhu, Bo			Transcriptome analysis of Xanthomonas oryzae pv. oryzicola exposed to H2O2 reveals horizontal gene transfer contributes to its oxidative stress response	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PERFORMANCE; EXPRESSION; RESISTANCE; VIRULENCE; PACKAGE; REGULON; SIGNAL; BURST	Xanthomonas oryzae pv. oryzicola (Xoc), the causal agent of bacterial leaf streak, is one of the most severe seed-borne bacterial diseases of rice. However, the molecular mechanisms underlying Xoc in response to oxidative stress are still unknown. In this study, we performed a time-course RNA-seq analysis on the Xoc in response to H2O2, aiming to reveal its oxidative response network. Overall, our RNA sequence analysis of Xoc revealed a significant global gene expression profile when it was exposed to H2O2. There were 7, 177, and 246 genes that were differentially regulated at the early, middle, and late stages after exposure, respectively. Three genes (xoc_1643, xoc_1946, xoc_3249) showing significantly different expression levels had proven relationships with oxidative stress response and pathogenesis. Moreover, a hypothetical protein (XOC_2868) showed significantly differential expression, and the xoc_2868 mutants clearly displayed a greater H2O2 sensitivity and decreased pathogenicity than those of the wild-type. Gene localization and phylogeny analysis strongly suggests that this gene may have been horizontally transferred from a Burkholderiaceae ancestor. Our study not only provides a first glance of Xoc's global response against oxidative stress, but also reveals the impact of horizontal gene transfer in the evolutionary history of Xoc.	[Fang, Yuan; Wang, Haoye; Liu, Xia; Xin, Dedong; Rao, Yuchun] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Zhejiang, Peoples R China; [Zhu, Bo] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban Agr, Minist Agr China, Shanghai, Peoples R China	Zhejiang Normal University; Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Rao, YC (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Zhejiang, Peoples R China.; Zhu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban Agr, Minist Agr China, Shanghai, Peoples R China.	ryc@zjnu.cn; bzhu1981@sjtu.edu.cn			Zhejiang National Natural Science Foundation of China [LY18C140003, 31200003]	Zhejiang National Natural Science Foundation of China	This work was supported by Zhejiang National Natural Science Foundation of China (LY18C140003), http://www.zjnsf.gov.cn/, to YF; National Natural Science Foundation of China (31200003), http://www.nsfc.gov.cn/, to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Berghoff BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003576; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doke N, 1996, GENE, V179, P45, DOI 10.1016/S0378-1119(96)00423-4; Duwat P, 1999, MOL MICROBIOL, V31, P845, DOI 10.1046/j.1365-2958.1999.01222.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo W, 2012, APPL ENVIRON MICROB, V78, P5672, DOI 10.1128/AEM.07997-11; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jo K, 2014, METHODS, V67, P364, DOI 10.1016/j.ymeth.2014.02.001; Jozefczuk J, 2011, METHOD ENZYMOL, V500, P99, DOI 10.1016/B978-0-12-385118-5.00006-2; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang XY, 2016, PEST MANAG SCI, V72, P997, DOI 10.1002/ps.4080; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Maza E, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00164; Mongkolsuk S, 2000, J BACTERIOL, V182, P6845, DOI 10.1128/JB.182.23.6845-6849.2000; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nobre LS, 2013, APPL MICROBIOL BIOT, V97, P2563, DOI 10.1007/s00253-013-4730-3; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Qian GL, 2013, MOL PLANT PATHOL, V14, P145, DOI 10.1111/j.1364-3703.2012.00838.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Shimizu R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-169; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; Zhu ML, 2019, NUCLEIC ACIDS RES, V47, P7592, DOI 10.1093/nar/gkz467	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0218844	10.1371/journal.pone.0218844	http://dx.doi.org/10.1371/journal.pone.0218844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581193	gold, Green Submitted, Green Published			2022-12-26	WOS:000532398600003
J	van IJzendoorn, M; van den Born, J; Hijmans, R; Bodde, R; Buter, H; Dam, W; Kingma, P; Maes, G; van der Veen, T; Zijlstra, W; Dijkstra, B; Navis, G; Boerma, C				van IJzendoorn, Marjolein; van den Born, Jacob; Hijmans, Ryanne; Bodde, Rianne; Buter, Hanneke; Dam, Wendy; Kingma, Peter; Maes, Gwendolyn; van der Veen, Tsjitske; Zijlstra, Wierd; Dijkstra, Baukje; Navis, Gerjan; Boerma, Christiaan			An observational study on intracutaneous sodium storage in intensive care patients and controls	PLOS ONE			English	Article							OSMOTICALLY INACTIVE NA+; MONOCYTE CHEMOATTRACTANT; TISSUE SODIUM; SKIN; MOBILIZATION; DEFINITIONS; MACROPHAGES; BALANCE; SEPSIS; GROWTH	The development of ICU-acquired sodium disturbances is not fully understood. Alterations in non-osmotic skin sodium storage, hypothetically inflammation-driven, could play a role. To investigate this in critically ill patients we conducted a patient-control study with skin punch biopsies in patients with sepsis (n = 15), after coronary artery bypass grafting (CABG, n = 15) and undergoing total hip arthroplasty (THA-controls, n = 15) respectively, together representing a range in severity of systemic inflammation. Biopsies were taken within 24 hours (sepsis) and within 2 hours (CABG) after ICU-admission, and prior to arthroplasty. Biopsies were analysed for sodium content. In addition immunostainings and quantitative real time PCR were performed. The primary aim of this study was to detect possible differences in amounts of cutaneous sodium. The secondary aims were to quantify inflammation and lymphangiogenesis with concomitant markers. The highest amounts of both water and sodium were found in patients with sepsis, with slightly lower values after CABG and the lowest amounts in THA-controls. Correlation between water and sodium was 0.5 (p<0.01). In skin biopsies in all groups comparable amounts of macrophages, T-cells and lymph vessels were found. In all groups comparable expression of inflammation markers were found. However, higher mRNA transcript expression levels of markers of lymphangiogenesis were found in patients with sepsis and after CABG. The conjoint accumulation of water and sodium points towards oedema formation. However, the correlation coefficient of 0.5 leaves room for alternative explanations, including non-osmotic sodium storage. No signs of dermal inflammation were found, but upregulation of markers of lymphangiogenesis could indicate future lymphangiogenesis.	[van IJzendoorn, Marjolein; Buter, Hanneke; Kingma, Peter; Maes, Gwendolyn; van der Veen, Tsjitske; Boerma, Christiaan] Med Ctr Leeuwarden, Intens Care, Friesland, Netherlands; [van IJzendoorn, Marjolein; van den Born, Jacob; Hijmans, Ryanne; Bodde, Rianne; Dam, Wendy; Navis, Gerjan] Univ Med Ctr Groningen, Dept Internal Med Nephrol, Groningen, Netherlands; [Zijlstra, Wierd; Dijkstra, Baukje] Med Ctr Leeuwarden, Dept Orthopaed Surg, Friesland, Netherlands	Medical Center Leeuwarden; University of Groningen; Medical Center Leeuwarden	van IJzendoorn, M (corresponding author), Med Ctr Leeuwarden, Intens Care, Friesland, Netherlands.; van IJzendoorn, M (corresponding author), Univ Med Ctr Groningen, Dept Internal Med Nephrol, Groningen, Netherlands.	vanijzendoorn@kpnmail.nl	Zijlstra, Wierd/ABB-9018-2020; Zijlstra, Wierd/AFM-2737-2022		Stichting Intensive Care Onderzoek Friesland	Stichting Intensive Care Onderzoek Friesland	Funding for laboratory fees concerning analysis of the biopsies (measurements of sodium and nitrogen, immunostainings and qRT-PCR) was provided by a local hospital fund (Stichting Intensive Care Onderzoek Friesland). Funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript and in this way no conflict of interest applies.	Bihari S, 2013, CRIT CARE RESUSC, V15, P294; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Crescenzi R, 2018, OBESITY, V26, P310, DOI 10.1002/oby.22090; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; GARNETT ES, 1968, CLIN SCI, V35, P93; Hijmans RS, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1815-5; Hijmans RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178940; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Lindner G, 2013, J CRIT CARE, V28, P214, DOI 10.1016/j.jcrc.2012.11.017; Linz P, 2015, NMR BIOMED, V28, P54, DOI 10.1002/nbm.3224; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mouta Carla, 2003, Lymphat Res Biol, V1, P201, DOI 10.1089/153968503768330247; Padtberg JH, 1910, ARCH EXP PATHOL PHAR, V63, P60, DOI 10.1007/BF01840852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Schafflhuber M, 2007, AM J PHYSIOL-RENAL, V292, pF1490, DOI 10.1152/ajprenal.00300.2006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Titze J, 2005, AM J PHYSIOL-RENAL, V289, pF793, DOI 10.1152/ajprenal.00096.2005; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2002, AM J KIDNEY DIS, V40, P508, DOI 10.1053/ajkd.2002.34908; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Titze J, 2009, SEMIN DIALYSIS, V22, P253, DOI 10.1111/j.1525-139X.2009.00569.x; van IJzendoorn MCO, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/9571583; Wahlgren V, 1909, ARCH EXP PATHOL PHAR, V61, P97, DOI 10.1007/BF01841955	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223100	10.1371/journal.pone.0223100	http://dx.doi.org/10.1371/journal.pone.0223100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581250	Green Published, gold			2022-12-26	WOS:000532398600029
J	Jeon, SM; Park, S; Rhie, SJ; Kwon, JW				Jeon, Soo-Min; Park, Susan; Rhie, Sandy Jeong; Kwon, Jin-Won			Prescribing patterns of polypharmacy in Korean pediatric patients	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; ACUTE GASTROENTERITIS; CHILDREN; PREVALENCE; ASSOCIATION; MANAGEMENT; EVENTS; TRENDS; RISK	Background Several studies have examined the risk and health outcomes related to polypharmacy among the elderly. However, information regarding polypharmacy among pediatric patients is lacking. Objective The aim of this study was to investigate the prevalence of polypharmacy and its related factors among the pediatric population of South Korea. Methods We used national claim data from the Health Insurance Review and Assessment Service-Pediatric Patients Sample (HIRA-PPS) in Korea originating from 2012 through 2016. Polypharmacy was defined as a daily average of two or more drugs used yearly. Complex chronic conditions (CCCs) were examined to evaluate concomitant chronic diseases in pediatric patients. Age-specific contraindications and potential drug-drug interactions were assessed according to criteria established by the Korea Institute of Drug Safety & Risk Management (KIDS). Descriptive statistics and logistic regression were conducted to analyze the status of polypharmacy and its associated risk factors in pediatric patients. Results The 5-year prevalence of pediatric polypharmacy in pediatric patients was 3.7%. The prevalence of polypharmacy was much higher in younger pediatric patients: 9.5% for patients between the ages of 1-7 years, 0.9% for ages 6-11 years, and 1.1% for ages 12-19 years. Pediatric patients with CCCs, Medical Aid benefits, or a hospital admission history had a significantly higher prevalence of polypharmacy when compared to their counterparts without those conditions. The most commonly prescribed drugs were respiratory agents (29%) followed by anti-allergic drugs (18.7%), central nervous system agents (15.9%), antibiotics (10.1%), and gastrointestinal drugs (7.7%). There was a positive correlation between the daily average number of inappropriate prescriptions and the degree of polypharmacy, especially in pediatric patients between the ages of 1-7 years. Contraindications and potential drug-drug interactions occurred in 11.0% and 10.1% of patients exposed to polypharmacy, respectively. Conclusions One in ten pediatric patients under the age of 7 years was prescribed two or more concurrent drugs on average per day. Furthermore, pediatric patients exposed to polypharmacy showed an increased risk of inappropriate drug use. The implementation of a medication review system that considers pediatric patient polypharmacy exposure would reduce inappropriate drug use and prevent unwanted adverse outcomes.	[Jeon, Soo-Min; Park, Susan; Kwon, Jin-Won] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Jeon, Soo-Min; Park, Susan; Kwon, Jin-Won] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea; [Rhie, Sandy Jeong] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Rhie, Sandy Jeong] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Ewha Womans University; Ewha Womans University	Kwon, JW (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Kwon, JW (corresponding author), Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea.	jwkwon@knu.ac.kr		Park, Susan/0000-0002-7082-8554; Rhie, Jeong Yeon/0000-0003-2554-3370	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2018R1D1A1B07043416]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2018R1D1A1B07043416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakaki PM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208047; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Burns KH, 2010, PEDIATRICS, V126, P638, DOI 10.1542/peds.2009-1658; Burt J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1078-7; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Comer JS, 2010, J AM ACAD CHILD PSY, V49, P1001, DOI 10.1016/j.jaac.2010.07.007; Cox ER, 2008, PEDIATRICS, V122, pE1053, DOI 10.1542/peds.2008-0214; Diaz-Caneja CM, 2014, INT J NEUROPSYCHOPH, V17, P1063, DOI 10.1017/S1461145712001265; Doan J, 2013, ANN PHARMACOTHER, V47, P324, DOI 10.1345/aph.1R621; Feinstein JA, 2015, PHARMACOEPIDEM DR S, V24, P1049, DOI 10.1002/pds.3843; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Feudtner C, 2012, ARCH PEDIAT ADOL MED, V166, P9, DOI 10.1001/archpediatrics.2011.161; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gu Qiuping, 2010, NCHS Data Brief, P1; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, P619, DOI 10.1097/MPG.0b013e31816e219e; Hilt RJ, 2014, J CHILD ADOL PSYCHOP, V24, P83, DOI 10.1089/cap.2013.0036; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Lai SW, 2012, GERIATR GERONTOL INT, V12, P491, DOI 10.1111/j.1447-0594.2011.00800.x; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; Morden NE, 2012, ARCH PEDIAT ADOL MED, V166, P91, DOI 10.1001/archpediatrics.2011.162; Nazarian LF, 1996, PEDIATRICS, V97, P424; OECD, 2017, HLTH GLANC 2017 OECD; Park HY, 2017, DRUG SAFETY, V40, P1109, DOI 10.1007/s40264-017-0559-5; Park HY, 2016, INT J CLIN PHARM TH, V54, P369, DOI 10.5414/CP202484; Principi N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1772-z; Rui P., 2016, NATL AMBULATORY MED; Sharma S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1512-4; Tamma PD, 2017, JAMA INTERN MED, V177, P1308, DOI 10.1001/jamainternmed.2017.1938; Tchoe B, 2010, INT J ENV RES PUB HE, V7, P3235, DOI 10.3390/ijerph7083235; Toteja N, 2014, INT J NEUROPSYCHOPH, V17, P1095, DOI 10.1017/S1461145712001320	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222781	10.1371/journal.pone.0222781	http://dx.doi.org/10.1371/journal.pone.0222781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KL8VK	31574095	gold, Green Submitted, Green Published			2022-12-26	WOS:000513696100001
J	O'Connor, SM; Mixson-Hayden, T; Ganova-Raeva, L; Djibo, DA; Brown, M; Xia, GL; Kamili, S; Jacobs, M; Dong, MX; Thomas, AG; Bulterys, M; Hale, B				O'Connor, Siobhan M.; Mixson-Hayden, Tonya; Ganova-Raeva, Lilia; Djibo, Djeneba Audrey; Brown, Matthew; Xia, Guo-Liang; Kamili, Saleem; Jacobs, Marni; Dong, Maxia; Thomas, Anne G.; Bulterys, Marc; Hale, Braden			Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country	PLOS ONE			English	Article							C VIRUS; SEXUAL RISK; COINFECTION; MORTALITY; INFECTIONS; ERA	Background Guyana expanded its HIV response in 2005 but the epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections has not been characterized. Methods The 2011 Seroprevalence and Behavioral Epidemiology Risk Survey for HIV and STIs collected biologic specimens with demographic and behavioral data from a representative sample of Guyana military personnel. Diagnostics included commercial serum: HIV antibody; total antibody to hepatitis B core (anti-HBc); IgM anti-HBc; hepatitis B surface antigen (HBsAg); anti-HBs; antibody to HCV with confirmatory testing; and HBV DNA sequencing with S gene fragment phylogenetic analysis. Chi-square, p-values and prevalence ratios Results Among 480 participants providing serologic specimens, 176 (36.7%) tested anti-HBc-positive. Overall, 19 (4.0%) participants tested HBsAg-positive; 17 (89.5%) of the HBsAg-positive participants also had detectable anti-HBc, including 1 (5.3%) IgM anti-HBc-positive male. Four (6.8%) females with available HBV testing were HBsAg-positive, all aged 23-29 years. Sixteen (16, 84.2%) HBsAg-positive participants had sufficient specimen for DNA testing. All 16 had detectable HBV DNA, 4 with viral load >2x10(4)IU/ml. Sequencing found: 12 genotype (gt) A1 with 99.9% genetic identity between 1 IgM anti-HBc-positive and 1 anti-HBc-negative; 2 gtD1; and 2 with insufficient specimen. No statistically significant associations between risk factors and HBV infection were identified. Conclusions Integrated HIV surveillance identified likely recent adult HBV transmission, current HBV infection among females of reproductive age, moderate HBV infection prevalence (all gtA1 and D1), no HCV infections and low HIV frequency among Guyana military personnel. Integrated HIV surveillance helped characterize HBV and HCV epidemiology, including probable recent transmission, prompting targeted responses to control ongoing HBV transmission and examination of hepatitis B vaccine policies.	[O'Connor, Siobhan M.; Mixson-Hayden, Tonya; Ganova-Raeva, Lilia; Xia, Guo-Liang; Kamili, Saleem] US Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Djibo, Djeneba Audrey; Jacobs, Marni; Thomas, Anne G.; Bulterys, Marc; Hale, Braden] US Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA USA; [Brown, Matthew; Dong, Maxia] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA; [Dong, Maxia] CDC Guyana, US Ctr Dis Control & Prevent, Div Global HIV & TB, Georgetown, Guyana; [O'Connor, Siobhan M.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Djibo, Djeneba Audrey] Albert Einstein Healthcare Network, Dept Med, Philadelphia, PA USA; [Brown, Matthew] US Natl Inst Hlth, Ctr Global Hlth, Natl Canc Inst, China Off, Beijing, Peoples R China; [Jacobs, Marni] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Bulterys, Marc] US Ctr Dis Control & Prevent, Ctr Global Hlth, CDC Kenya, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Yeshiva University; Children's National Health System	O'Connor, SM (corresponding author), US Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.; O'Connor, SM (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	sbo5@cdc.gov		Brown, Matthew/0000-0001-6535-4940; O'Connor, Siobhan/0000-0001-7218-3270	United States President's Emergency Plan for AIDS Relief through the Department of Defense HIV/AIDS Prevention Program, Naval Health Research Center (US Government Work) [105]; United States Centers for Disease Control and Prevention/Division of Viral Hepatitis, Guyana Defence Force and Guyana National Public Health Laboratory	United States President's Emergency Plan for AIDS Relief through the Department of Defense HIV/AIDS Prevention Program, Naval Health Research Center (US Government Work); United States Centers for Disease Control and Prevention/Division of Viral Hepatitis, Guyana Defence Force and Guyana National Public Health Laboratory	This work was supported by the United States President's Emergency Plan for AIDS Relief through the Department of Defense HIV/AIDS Prevention Program, Naval Health Research Center (US Government Work [17 USC 105]) and by the United States Centers for Disease Control and Prevention/Division of Viral Hepatitis, Guyana Defence Force and Guyana National Public Health Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2015, INT J PUBLIC HEALTH, V60, P789, DOI 10.1007/s00038-015-0708-5; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P429, DOI 10.3851/IMP2595; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Anastario M, 2011, INT J STD AIDS, V22, P73, DOI 10.1258/ijsa.2010.010274; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P369; [Anonymous], UN GEN ASS SPEC ASS; Berenguer J, 2012, AIDS, V26, P2241, DOI 10.1097/QAD.0b013e3283574e94; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Couto CA, 2013, J CLIN GASTROENTEROL, V47, P83, DOI 10.1097/MCG.0b013e318268003b; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Guyana Ministry of Health National AIDS Programme, 2009, GUYAN BEH SURV SURV; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Lloyd J, 2014, SEX TRANSM INFECT, V90, P382, DOI 10.1136/sextrans-2013-051463; Lock G, 2006, J VIRAL HEPATITIS, V13, P571, DOI 10.1111/j.1365-2893.2006.00735.x; Macera CA, 2017, CURR HIV RES, V15, P82, DOI [10.2174/1570162X15666170516164521, 10.2174/1570162x15666170516164521]; Ministry of Health Guyana, GUYAN NAT HIV AIDS S; Ministry of Health Guyana, NAT GUID MAN HIV INF; Ministry of Health Guyana, BEH SURV SURV EX SUM; Ministry of Health (MOH) Bureau of Statistics (BOS) and ICF Macro, 2010, GUYAN DEM HLTH SURV; Organization WH, 2015, GUID PREV CAR TREATM; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Qureshi Huma, 2009, BMC Res Notes, V2, P212, DOI 10.1186/1756-0500-2-212; Ramachandran S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025232; Republic of Guyana, 2015, GUYAN AIDS RESP PROG; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Stahlman S, 2014, SEX TRANSM DIS, V41, P359, DOI 10.1097/OLQ.0000000000000133; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953; Thio CL, 2013, AIDS, V27, P191, DOI 10.1097/QAD.0b013e32835a9984; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; UNAIDS, WHO EP FACT SHEET 20; UNAIDS, UNAIDS REP GLOB HIV; World Health Organization, IMM VACC BIOL	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0222835	10.1371/journal.pone.0222835	http://dx.doi.org/10.1371/journal.pone.0222835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574098	gold, Green Published			2022-12-26	WOS:000532376700015
J	Faist, B; Schlott, F; Stemberger, C; Dennehy, KM; Krackhardt, A; Verbeek, M; Grigoleit, GU; Schiemann, M; Hoffmann, D; Dick, A; Martin, K; Hildebrandt, M; Busch, DH; Neuenhahn, M				Faist, Benjamin; Schlott, Fabian; Stemberger, Christian; Dennehy, Kevin M.; Krackhardt, Angela; Verbeek, Mareike; Grigoleit, Goetz U.; Schiemann, Matthias; Hoffmann, Dieter; Dick, Andrea; Martin, Klaus; Hildebrandt, Martin; Busch, Dirk H.; Neuenhahn, Michael			Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy	PLOS ONE			English	Article							ALLOGENEIC BONE-MARROW; ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; STEM-CELL; CYTOMEGALOVIRUS DISEASE; ADOPTIVE TRANSFER; TRANSPLANT; RECIPIENTS; GANCICLOVIR; LYMPHOCYTES	Adoptive T cell therapy (ACT) has become a treatment option for viral reactivations in patients undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). Animal models have shown that pathogen-specific central memory T cells (T-CM) are protective even at low numbers and show long-term survival, extensive proliferation and high plasticity after adoptive transfer. Concomitantly, our own recent clinical data demonstrate that minimal doses of purified (not in-vitro-expanded) human CMV epitope-specific T cells can be sufficient to clear viremia. However, it remains to be determined if human virus-specific T-CM show the same promising features for ACT as their murine counterparts. Using a peptide specific proliferation assay (PSPA) we studied the human Adenovirus- (AdV), Cytomegalo-virus- (CMV) and Epstein-Barr virus- (EBV) specific T-CM repertoires and determined their functional and proliferative capacities in vitro. T-CM products were generated from buffy coats, as well as from non-mobilized and mobilized apheresis products either by flow cytometry-based cell sorting or magnetic cell enrichment using reversible Fab-Streptamers. Adjusted to virus serology and human leukocyte antigen (HLA)-typing, donor samples were analyzed with MHC multimer- and intracellular cytokine staining (ICS) before and after PSPA. T-CM cultures showed strong proliferation of a plethora of functional virus-specific T cells. Using PSPA, we could unveil tiniest virus epitope-specific T-CM populations, which had remained undetectable in conventional ex-vivo-staining. Furthermore, we could confirm these characteristics for mobilized apheresis- and GMP-grade Fab-Streptamer-purified T-CM products. Consequently, we conclude that T-CM bare high potential for prophylactic low-dose ACT. In addition, use of Fab-Streptamer-purified T-CM allows circumventing regulatory restrictions typically found in conventional ACT product generation. These GMP-compatible T-CM can now be used as a broad-spectrum antiviral T cell prophylaxis in alloHSCT patients and PSPA is going to be an indispensable tool for advanced T-CM characterization during concomitant immune monitoring.	[Faist, Benjamin; Schlott, Fabian; Schiemann, Matthias; Busch, Dirk H.; Neuenhahn, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Faist, Benjamin; Schlott, Fabian; Hoffmann, Dieter; Busch, Dirk H.; Neuenhahn, Michael] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Stemberger, Christian] Juno Therapeut, Munich, Germany; [Dennehy, Kevin M.] German Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany; [Dennehy, Kevin M.] Univ Hosp Tubingen, Inst Med Virol, Tubingen, Germany; [Krackhardt, Angela; Verbeek, Mareike] Tech Univ Munich, Dept Med 3, Klinikum Rechts Isar, Munich, Germany; [Grigoleit, Goetz U.] Univ Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Hoffmann, Dieter] Tech Univ Munich, Inst Virol, Munich, Germany; [Dick, Andrea] Ludwig Maximilians Univ Munchen, Dept Transfus Med & Haemostaseol, Munich, Germany; [Martin, Klaus] Klin Techn Univ Munchen, Deutsch Herzzentrum Munchen, Inst Anaesthesiol, Munich, Germany; [Hildebrandt, Martin; Neuenhahn, Michael] TUM Cells Interdisciplinary Ctr Cellular Therapie, Munich, Germany	Technical University of Munich; German Center for Infection Research; German Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; University of Wurzburg; Technical University of Munich; University of Munich; German Heart Centre Munich; Technical University of Munich	Neuenhahn, M (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Neuenhahn, M (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.; Neuenhahn, M (corresponding author), TUM Cells Interdisciplinary Ctr Cellular Therapie, Munich, Germany.	michael.neuenhahn@tum.de			German Center for Infection Research (DZIF) [TTU 07.801, TTU 07.902]; Deutsche Forschungsgemeinschaft (DFG) [TR36-A10]	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Center for Infection Research (DZIF, TTU 07.801 and 07.902) (B.F., F.S.,K.M.D., D.H.B., M.N.), and the Deutsche Forschungsgemeinschaft (DFG) through collaborative center TR36-A10 (M.N. and D.H.B.). C.S. is an employee of Juno Therapeutics GmbH, CellGene. Juno Therapeutics GmbH, CellGene provided support in the form of salaries for authors [CS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of CS is articulated in the 'author contributions' section.	Ameres S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003383; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barrett AJ, 2006, LEUKEMIA, V20, P1661, DOI 10.1038/sj.leu.2404334; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bettinotti MP, 2003, INT J CANCER, V105, P210, DOI 10.1002/ijc.11045; Bleakley M, 2015, J CLIN INVEST, V125, P2677, DOI 10.1172/JCI81229; Bleakley M, 2014, BIOL BLOOD MARROW TR, V20, P705, DOI 10.1016/j.bbmt.2014.01.032; Bleakley M, 2010, BLOOD, V115, P4923, DOI 10.1182/blood-2009-12-260539; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Bowman LJ, 2017, EXPERT OPIN INV DRUG, V26, P235, DOI 10.1080/13543784.2017.1274733; Bunse CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077925; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Cherrier L, 2018, AM J TRANSPLANT, V18, P3060, DOI 10.1111/ajt.15135; Cho C, 2019, ANNU REV MED, V70, P381, DOI 10.1146/annurev-med-120617-041210; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dossinger G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061384; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; El Chaer F, 2016, BLOOD, V128, P2624, DOI 10.1182/blood-2016-06-688432; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Gonzalez-Vicent M, 2019, EUR J HAEMATOL, V102, P210, DOI 10.1111/ejh.13194; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Gupta V, 2011, BLOOD, V117, P2307, DOI 10.1182/blood-2010-10-265603; Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Heslop HE, 2012, BLOOD, V119, P2436, DOI 10.1182/blood-2012-01-397828; Keib A, 2019, J IMMUNOL, V202, P618, DOI 10.4049/jimmunol.1801003; Keib A, 2017, VIRAL IMMUNOL, V30, P149, DOI 10.1089/vim.2016.0145; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Lazarus HM, 2006, LEUKEMIA, V20, P1673, DOI 10.1038/sj.leu.2404328; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Macesic N, 2015, AM J TRANSPLANT, V15, P827, DOI 10.1111/ajt.13023; Mann TH, 2019, NAT IMMUNOL, V20, P1092, DOI 10.1038/s41590-019-0478-y; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Marty FM, 2017, NEW ENGL J MED, V377, P2433, DOI 10.1056/NEJMoa1706640; Marty FM, 2019, BIOL BLOOD MARROW TR, V25, P369, DOI 10.1016/j.bbmt.2018.09.038; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Neuenhahn M, 2017, LEUKEMIA, V31, P2161, DOI 10.1038/leu.2017.16; O'Reilly RJ, 2015, BONE MARROW TRANSPL, V50, pS43, DOI 10.1038/bmt.2015.95; Odendahl M, 2014, CYTOTHERAPY, V16, P1245, DOI 10.1016/j.jcyt.2014.05.023; Oliveira G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8265; Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825; Passweg JR, 2017, BONE MARROW TRANSPL, V52, P811, DOI 10.1038/bmt.2017.34; Passweg JR, 2019, BONE MARROW TRANSPL, V54, P1575, DOI 10.1038/s41409-019-0465-9; Rafailidis PI, 2010, J CLIN VIROL, V49, P151, DOI 10.1016/j.jcv.2010.07.008; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Schlott F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193554; Schlott F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171035; SCHMIDT GM, 1991, NEW ENGL J MED, V324, P1005, DOI 10.1056/NEJM199104113241501; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Stemberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035798; van den Berg SPH, 2019, MED MICROBIOL IMMUN, V208, P365, DOI 10.1007/s00430-019-00608-7; Wall SA, 2017, BLOOD REV, V31, P362, DOI 10.1016/j.blre.2017.07.002; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Xia AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01719; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749; Zheng H, 2009, J IMMUNOL, V182, P5938, DOI 10.4049/jimmunol.0802212	69	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223258	10.1371/journal.pone.0223258	http://dx.doi.org/10.1371/journal.pone.0223258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568490	Green Published, Green Submitted, gold			2022-12-26	WOS:000532364900034
J	Hagstrom, H; Widman, L; von Seth, E				Hagstrom, Hannes; Widman, Linnea; von Seth, Erik			Association between temperature, sunlight hours and alcohol consumption	PLOS ONE			English	Article								Background Alcohol is a major risk factor for liver cirrhosis. Recently, it was proposed that colder climate might causally lead to increased consumption of alcohol. Methods We performed an ecologic study, using monthly updated data on mean temperature, sunlight hours and alcohol consumption from ten regions in Sweden, using publicly available data. A generalised additive model, adjusted for region, was applied to examine the association between mean temperature and mean sunlight hours with mean alcohol consumption. Results We found a non-linear inverse association between mean monthly temperature and mean alcohol consumption, suggesting that warmer temperature was associated with increased alcohol consumption and colder temperature with a decreased consumption. We found no association between mean sunlight hours and alcohol consumption. Consumption was highest during public holidays. Conclusions We found no association between a colder climate and increased alcohol consumption. Socio-economic factors are likely to explain the suggested association.	[Hagstrom, Hannes; von Seth, Erik] Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, Stockholm, Sweden; [Hagstrom, Hannes] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Widman, Linnea] Karolinska Inst, Dept Environm Med, Unit Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Hagstrom, H (corresponding author), Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, Stockholm, Sweden.; Hagstrom, H (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.	hannes.hagstrom@ki.se	Hagström, Hannes/I-2036-2019	Hagström, Hannes/0000-0002-8474-1759				[Anonymous], 2018, GLOB STAT REP ALC HL; Jepsen P, 2019, HEPATOLOGY, V69, P1852, DOI 10.1002/hep.30547; Ventura-Cots M, 2019, HEPATOLOGY, V69, P1916, DOI 10.1002/hep.30315; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	4	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2019	14	9							e0223312	10.1371/journal.pone.0223312	http://dx.doi.org/10.1371/journal.pone.0223312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6MW	31568515	Green Published, gold			2022-12-26	WOS:000532364900037
J	Klotz, L; Wendler, O; Frischknecht, R; Shigemoto, R; Schulze, H; Enz, R				Klotz, Lisa; Wendler, Olaf; Frischknecht, Renato; Shigemoto, Ryuichi; Schulze, Holger; Enz, Ralf			Localization of group II and III metabotropic glutamate receptors at pre- and postsynaptic sites of inner hair cell ribbon synapses	FASEB JOURNAL			English	Article						cochlea; mGluR; IHC; mGlu receptor	MAMMALIAN COCHLEA; SYNAPTIC VESICLE; MICE LACKING; RAT RETINA; EXPRESSION; CHANNELS; MGLUR3; IDENTIFICATION; MECHANISMS; PLASTICITY	Glutamate is the major excitatory neurotransmitter in the CNS binding to a variety of glutamate receptors. Metabotropic glutamate receptors (mGluR1 to mGluR8) can act excitatory or inhibitory, depending on associated signal cascades. Expression and localization of inhibitory acting mGluRs at inner hair cells (IHCs) in the cochlea are largely unknown. Here, we analyzed expression of mGluR2, mGluR3, mGluR4, mGluR6, mGluR7, and mGluR8 and investigated their localization with respect to the presynaptic ribbon of IHC synapses. We detected transcripts for mGluR2, mGluR3, and mGluR4 as well as for mGluR7a, mGluR7b, mGluR8a, and mGluR8b splice variants. Using receptor-specific antibodies in cochlear wholemounts, we found expression of mGluR2, mGluR4, and mGluR8b close to presynaptic ribbons. Super resolution and confocal microscopy in combination with 3-dimensional reconstructions indicated a postsynaptic localization of mGluR2 that overlaps with postsynaptic density protein 95 on dendrites of afferent type I spiral ganglion neurons. In contrast, mGluR4 and mGluR8b were expressed at the presynapse close to IHC ribbons. In summary, we localized in detail 3 mGluR types at IHC ribbon synapses, providing a fundament for new therapeutical strategies that could protect the cochlea against noxious stimuli and excitotoxicity.	[Klotz, Lisa; Enz, Ralf] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany; [Wendler, Olaf] Friedrich Alexander Univ Erlangen Nurnberg, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol Head & Neck Surg, Erlangen, Germany; [Frischknecht, Renato] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Erlangen, Germany; [Schulze, Holger] Friedrich Alexander Univ Erlangen Nurnberg, Dept Otorhinolaryngol Head & Neck Surg, Expt Otolaryngol, Erlangen, Germany; [Shigemoto, Ryuichi] IST Austria, Klosterneuburg, Austria	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institute of Science & Technology - Austria	Enz, R (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	ralf.enz@fau.de	Klotz-Weigand, Lisa Janina/AGG-1603-2022; Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444; Klotz-Weigand, Lisa Janina/0000-0001-9378-5684	Deutsche Forschungsgemeinschaft (DFG); Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg	The authors thank Jean-Philippe Pin (Institut de Genomique Fonctionnelle, Montpellier, France) for providing expression constructs encoding for mGluR2 or mGluR3, Francesco Ferraguti (Innsbruck Medical University, Innsbruck, Austria) for mGluR4 antibodies, and the Optical Imaging Center Erlangen (OICE) for excellent scientific and technical support. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg. The authors declare no conflicts of interest.	Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Delgado DM, 2017, ELIFE, V6, DOI 10.7554/eLife.25233; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Doleviczenyi Z, 2005, NEUROSCI LETT, V385, P93, DOI 10.1016/j.neulet.2005.05.017; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Dutting E, 2011, BIOCHEM J, V435, P365, DOI 10.1042/BJ20101854; Duvoisin RM, 2005, EUR J NEUROSCI, V22, P425, DOI 10.1111/j.1460-9568.2005.04210.x; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; Frank MM, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.324; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Fujikawa T, 2014, HEARING RES, V314, P20, DOI 10.1016/j.heares.2014.05.001; Girotto G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085352; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goutman JD, 2015, FEBS LETT, V589, P3354, DOI 10.1016/j.febslet.2015.08.030; HARTVEIT E, 1995, EUR J NEUROSCI, V7, P1472, DOI 10.1111/j.1460-9568.1995.tb01142.x; Hu SSJ, 2010, J COMP NEUROL, V518, P3848, DOI 10.1002/cne.22429; Jean P, 2019, P NATL ACAD SCI USA, V116, P9084, DOI 10.1073/pnas.1818358116; Jin LE, 2018, CEREB CORTEX, V28, P974, DOI 10.1093/cercor/bhx005; Johnson KA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00264; Jung SY, 2015, P NATL ACAD SCI USA, V112, pE3141, DOI 10.1073/pnas.1417207112; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Koga K, 2010, J NEUROSCI RES, V88, P2252, DOI 10.1002/jnr.22382; Koulen P, 2005, INVEST OPHTH VIS SCI, V46, P287, DOI 10.1167/iovs.04-0963; Koulen P, 1996, EUR J NEUROSCI, V8, P2177, DOI 10.1111/j.1460-9568.1996.tb00739.x; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Liberman MC, 2016, ADV EXP MED BIOL, V875, P1, DOI 10.1007/978-1-4939-2981-8_1; Linden AM, 2009, NEUROPHARMACOLOGY, V57, P172, DOI 10.1016/j.neuropharm.2009.05.002; Long LL, 2018, INDIAN J OTOLARYNGOL, V70, P425, DOI 10.1007/s12070-018-1448-7; Lu Y, 2014, NEUROSCIENCE, V274, P429, DOI 10.1016/j.neuroscience.2014.05.057; Martemyanov KA, 2014, INVEST OPHTH VIS SCI, V55, P8201, DOI 10.1167/iovs.14-15928; Martinez-Monedero R, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0078-16.2016; Mascia F, 2017, J NEUROCHEM, V141, P577, DOI 10.1111/jnc.14021; Masilamoni GJ, 2018, CURR OPIN PHARMACOL, V38, P72, DOI 10.1016/j.coph.2018.03.004; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moller Thor C, 2017, Biophys Rep, V3, P57, DOI 10.1007/s41048-017-0036-9; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Neef J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02612-y; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Nouvian R, 2015, CELL TISSUE RES, V361, P301, DOI 10.1007/s00441-015-2158-z; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Okumura K, 2010, BRAIN RES, V1307, P53, DOI 10.1016/j.brainres.2009.10.039; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Petralia RS, 1996, J COMP NEUROL, V372, P356; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Pootanakit K, 1999, VISUAL NEUROSCI, V16, P221, DOI 10.1017/S0952523899162035; Pujol R, 1999, ANN NY ACAD SCI, V884, P249, DOI 10.1111/j.1749-6632.1999.tb08646.x; Quraishi S, 2007, J COMP NEUROL, V501, P931, DOI 10.1002/cne.21274; Reiner A, 2018, NEURON, V98, P1080, DOI 10.1016/j.neuron.2018.05.018; Rose M, 2008, J NEUROCHEM, V105, P2375, DOI 10.1111/j.1471-4159.2008.05331.x; Roux I, 2016, J NEUROPHYSIOL, V116, P479, DOI 10.1152/jn.01038.2015; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Suzuki S, 2017, PEPTIDES, V89, P42, DOI 10.1016/j.peptides.2017.01.007; Takago H, 2018, HEARING RES, V362, P1, DOI 10.1016/j.heares.2018.02.007; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; Tong MJ, 2013, JARO-J ASSOC RES OTO, V14, P321, DOI 10.1007/s10162-013-0374-3; Valenzuela JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0606; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Vogl C, 2015, J CELL SCI, V128, P638, DOI 10.1242/jcs.162099; Wan GQ, 2015, HEARING RES, V329, P1, DOI 10.1016/j.heares.2015.04.008; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Yin S, 2014, J NEUROSCI, V34, P79, DOI 10.1523/JNEUROSCI.1129-13.2014; Yu PP, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0515-3	77	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13734	13746		10.1096/fj.201901543R	http://dx.doi.org/10.1096/fj.201901543R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585509	Bronze			2022-12-26	WOS:000507466100054
J	Yang, SD; Deng, QF; Sun, LQ; Dong, KD; Li, YY; Wu, SY; Huang, R				Yang, Sidi; Deng, Qifeng; Sun, Lanqing; Dong, Kedi; Li, Yuanyuan; Wu, Shuyan; Huang, Rui			Salmonella effector SpvB interferes with intracellular iron homeostasis via regulation of transcription factor NRF2	FASEB JOURNAL			English	Article						salmonellosis; pSLT plasmid; macrophage; hypoferremia; ferroportin	TYPHIMURIUM INFECTION; FPN1 TRANSCRIPTION; CELL-DEATH; FERROPORTIN; VIRULENCE; PROTEIN; IDENTIFICATION; MACROPHAGES; DEFICIENCY; EXPRESSION	Iron is a necessary nutrient for humans and nearly all bacterial species. During Salmonella infection, macrophages limit the availability of iron to intracellular pathogens in one of the central components of nutritional immunity. However, Salmonella also have mechanisms to interfere with the antimicrobial effect of host iron withdrawal and meet their own nutrient requirements by scavenging iron from the host. Here, we provide what is, to our knowledge, the first report that SpvB, a pSLT-encoded cytotoxic protein whose function is associated with the intracellular stage of salmonellosis, perturbs macrophage iron metabolism, thereby facilitating Salmonella survival and intracellular replication. In investigating the underlying mechanism, we observed that the Salmonella effector SpvB down-regulated nuclear factor erythroid-derived 2 related factor 2 (NRF2), and its C-terminal domain was necessary and sufficient for NRF2 degradation via the proteasome pathway. Decreased NRF2 expression in the nucleus resulted in a decrease in its transcriptional target ferroportin, encoding the sole macrophage iron exporter, thus ultimately decreasing iron efflux and increasing the intracellular iron content. Additionally, SpvB contributes to the pathogenesis of Salmonella including severe serum hypoferremia, increased splenic and hepatic bacterial burden, and inflammatory injury in vivo. Together, our observations uncovered a novel contribution of SpvB to Salmonella pathology via interference with host intracellular iron metabolism.	[Yang, Sidi; Deng, Qifeng; Sun, Lanqing; Dong, Kedi; Li, Yuanyuan; Wu, Shuyan; Huang, Rui] Soochow Univ, Coll Med, Dept Med Microbiol, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Wu, SY; Huang, R (corresponding author), Soochow Univ, Coll Med, Dept Med Microbiol, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.	wushuyan@suda.edu.cn; hruisdm@163.com			Natural Science Foundation of China [81671976, 31670140]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX18_2522, KYCX19_1976]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Practice Innovation Program of Jiangsu Province; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors thank Ying Xu, Chao Li, Ying Ye, and Kai Huang (Cambridge Suda Genome Resource Center, Soochow University) for excellent technical support and for fruitful discussions. This work was supported by the Natural Science Foundation of China (81671976 and 31670140), the Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX18_2522 and KYCX19_1976), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Besser JM, 2018, FOOD MICROBIOL, V71, P55, DOI 10.1016/j.fm.2017.08.018; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Brown DE, 2015, INFECT IMMUN, V83, P2290, DOI 10.1128/IAI.02863-14; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Chu YY, 2016, ONCOTARGET, V7, P8295, DOI 10.18632/oncotarget.6989; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Gotoh H, 2003, MICROB PATHOGENESIS, V34, P227, DOI 10.1016/S0882-4010(03)00034-2; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kim KH, 2017, FREE RADICAL BIO MED, V113, P48, DOI 10.1016/j.freeradbiomed.2017.09.011; Kurita A, 2003, MICROB PATHOGENESIS, V35, P43, DOI 10.1016/S0882-4010(03)00066-4; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Mambu J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00500; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2015, CELL HOST MICROBE, V18, P254, DOI 10.1016/j.chom.2015.06.017; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nunez G, 2018, J IMMUNOL, V201, P11, DOI 10.4049/jimmunol.1800325; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Passaris I, 2018, GENETICS, V210, P621, DOI 10.1534/genetics.118.300822; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Sabelli M, 2017, HEPATOLOGY, V65, P1512, DOI 10.1002/hep.29007; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614; Wang CY, 2019, BLOOD, V133, P18, DOI 10.1182/blood-2018-06-815894; Willemetz A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00498	38	10	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13450	13464		10.1096/fj.201900883RR	http://dx.doi.org/10.1096/fj.201900883RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31569998	Bronze			2022-12-26	WOS:000507466100033
J	Bhaduri, S; Zhang, HM; Erramilli, S; Cramer, WA				Bhaduri, Satarupa; Zhang, Huamin; Erramilli, Satchal; Cramer, William A.			Structural and functional contributions of lipids to the stability and activity of the photosynthetic cytochrome b(6)f lipoprotein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein; phospholipid; glycolipid; protein stability; membrane protein; cytochrome b6f; lipid; thermal stability	EVOLVING PHOTOSYSTEM-II; MEMBRANE-PROTEIN; SULFOQUINOVOSYL DIACYLGLYCEROL; DIELECTRIC HETEROGENEITY; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; BC(1) COMPLEX; BC COMPLEXES; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPIDS	The photosynthetic cytochrome b(6)f complex, a homodimer containing eight distinct subunits and 26 transmembrane helices per monomer, catalyzes proton-coupled electron transfer across the thylakoid membrane. The 2.5-?-resolution structure of the complex from the cyanobacterium Nostoc sp. revealed the presence of 23 lipid-binding sites per monomer. Although the crystal structure of the cytochrome b(6)f from a plant source has not yet been solved, the identities of the lipids present in a plant b(6)f complex have previously been determined, indicating that the predominant lipid species are monogalactosyldiacylglycerol (MGDG), digalactosyldiacylglycerol (DGDG), phosphatidylglycerol (PG), and sulfoquinovosyldiacylglycerol (SQDG). Despite the extensive structural analyses of b(6)f?lipid interactions, the basis of the stabilization by lipids remains poorly understood. In the present study, we report on the effect of individual lipids on the structural and functional integrity of the b(6)f complex, purified from Spinacea oleracea. It was found that (i) galactolipids (MGDG, DGDG, and SQDG) and phospholipids dilinolenoyl-phosphatidylglycerol (DLPG), 1,2-dioleoylphosphatidylglycerol (DOPG), and 1,2-dioleoyl-sn-glycerol-3-phosphatidylcholine (DOPC) structurally stabilize the complex to varying degrees; (ii) SQDG has a major role in stabilizing the dimeric complex; (iii) the b(6)f complex is stabilized by incorporation into nanodiscs or bicelles; (iv) removal of bound phospholipid by phospholipase A(2) inactivates the cytochrome complex; and (v) activity can be restored significantly by the addition of the anionic lipid PG, which is attributed to stabilization of the quinone portal and the hinge region of the iron?sulfur protein.	[Bhaduri, Satarupa; Cramer, William A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47906 USA; [Zhang, Huamin] SSCI, W Lafayette, IN 47906 USA; [Erramilli, Satchal] Univ Chicago, Dept Biochem & Mol Biophys, Chicago, IL 60637 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Chicago	Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47906 USA.	waclab@purdue.edu		Erramilli, Satchal/0000-0001-8694-7681; Bhaduri, Satarupa/0000-0001-8432-2194	United States Department of Energy Grant [DOE DE-SC0018238]; National Institutes of Health [GMS-117372]	United States Department of Energy Grant(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States Department of Energy Grant DOE DE-SC0018238 (to W. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Supported by National Institutes of Health Grant GMS-117372 (to A. Kossiakoff, University of Chicago).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agarwal R, 2015, BIOCHEMISTRY-US, V54, P3151, DOI 10.1021/acs.biochem.5b00279; Aoki M, 2004, EUR J BIOCHEM, V271, P685, DOI 10.1111/j.1432-1033.2003.03970.x; Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Baniulis D, 2011, METHODS MOL BIOL, V684, P65, DOI [10.1007/978.1.60761.925.3_7, 10.1007/978-1-60761-925-3_7]; Bhaduri S, 2017, J PHYS CHEM B, V121, P975, DOI 10.1021/acs.jpcb.6b11709; Bolla JR, 2019, ANNU REV BIOCHEM, V88, P85, DOI 10.1146/annurev-biochem-013118-111508; Bolla JR, 2018, NAT CHEM, V10, P363, DOI [10.1038/NCHEM.2919, 10.1038/nchem.2919]; Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Cramer WA, 2016, ADV PHOTOSYNTH RESP, V41, P177, DOI 10.1007/978-94-017-7481-9_9; de Vitry C, 2004, J BIOL CHEM, V279, P44621, DOI 10.1074/jbc.M406955200; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Droppa M, 1995, PHOTOSYNTH RES, V46, P287, DOI 10.1007/BF00020442; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grinkova YV, 2010, PROTEIN ENG DES SEL, V23, P843, DOI 10.1093/protein/gzq060; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Hasan SS, 2014, STRUCTURE, V22, P1008, DOI 10.1016/j.str.2014.05.004; Hasan SS, 2014, J PHYS CHEM B, V118, P6614, DOI 10.1021/jp501165k; Hasan SS, 2013, BIOCHEMISTRY-US, V52, P2649, DOI 10.1021/bi301638h; Hasan SS, 2012, PHILOS T R SOC B, V367, P3406, DOI 10.1098/rstb.2012.0058; Hasan SS, 2012, PHYS CHEM CHEM PHYS, V14, P13853, DOI 10.1039/c2cp41386h; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; Holzl G, 2009, PLANT PHYSIOL, V150, P1147, DOI 10.1104/pp.109.139758; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; JORDAN BR, 1983, BIOCHIM BIOPHYS ACTA, V725, P77, DOI 10.1016/0005-2728(83)90226-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jussupow A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1850; Kobayashi K, 2016, J PLANT RES, V129, P565, DOI 10.1007/s10265-016-0827-y; Kobayashi K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00336; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Liko I, 2018, P NATL ACAD SCI USA, V115, P6691, DOI 10.1073/pnas.1721152115; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McKibbin C, 2007, J MOL BIOL, V374, P1319, DOI 10.1016/j.jmb.2007.10.018; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Minoda A, 2003, FEBS LETT, V553, P109, DOI 10.1016/S0014-5793(03)00981-5; Minoda A, 2002, EUR J BIOCHEM, V269, P2353, DOI 10.1046/j.1432-1033.2002.02896.x; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Sakurai I, 2003, PLANT PHYSIOL, V133, P1376, DOI 10.1104/pp.103.026955; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; Sato N, 2000, P NATL ACAD SCI USA, V97, P10655, DOI 10.1073/pnas.97.19.10655; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sedlak E, 2014, BIOPHYS J, V107, P2932, DOI 10.1016/j.bpj.2014.10.055; Siegenthaler P-A., 1998, LIPIDS PHOTOSYNTHESI; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Eerden FJ, 2015, BBA-BIOMEMBRANES, V1848, P1319, DOI 10.1016/j.bbamem.2015.02.025; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Yen HY, 2018, NATURE, V559, P424, DOI 10.1038/s41586-018-0325-6; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	58	3	4	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17758	17767		10.1074/jbc.RA119.009331	http://dx.doi.org/10.1074/jbc.RA119.009331			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31597701	hybrid, Green Published			2022-12-26	WOS:000504206800005
J	Theodorou, I; Courtin, P; Palussiere, S; Kulakauskas, S; Bidnenko, E; Pechoux, C; Fenaille, F; Penno, C; Mahony, J; van Sinderen, D; Chapot-Chartier, MP				Theodorou, Ilias; Courtin, Pascal; Palussiere, Simon; Kulakauskas, Saulius; Bidnenko, Elena; Pechoux, Christine; Fenaille, Francois; Penno, Christophe; Mahony, Jennifer; van Sinderen, Douwe; Chapot-Chartier, Marie-Pierre			A dual-chain assembly pathway generates the high structural diversity of cell-wall polysaccharides in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-positive bacteria; polysaccharide; cell wall; biosynthesis; bacteriophage; glycopolymer; glycosyltransferase; lactic acid bacteria; rhamnan; rhamnose	STREPTOCOCCUS; HOST; BIOSYNTHESIS; RECOGNITION; SURFACE; IDENTIFICATION; CARBOHYDRATE; DETERMINANT; EXPRESSION; MECHANISM	In Lactococcus lactis, cell-wall polysaccharides (CWPSs) act as receptors for many bacteriophages, and their structural diversity among strains explains, at least partially, the narrow host range of these viral predators. Previous studies have reported that lactococcal CWPS consists of two distinct components, a variable chain exposed at the bacterial surface, named polysaccharide pellicle (PSP), and a more conserved rhamnan chain anchored to, and embedded inside, peptidoglycan. These two chains appear to be covalently linked to form a large heteropolysaccharide. The molecular machinery for biosynthesis of both components is encoded by a large gene cluster, named cwps. In this study, using a CRISPR/Cas-based method, we performed a mutational analysis of the cwps genes. MALDI-TOF MS-based structural analysis of the mutant CWPS combined with sequence homology, transmission EM, and phage sensitivity analyses enabled us to infer a role for each protein encoded by the cwps cluster. We propose a comprehensive CWPS biosynthesis scheme in which the rhamnan and PSP chains are independently synthesized from two distinct lipid-sugar precursors and are joined at the extracellular side of the cytoplasmic membrane by a mechanism involving a membrane-embedded glycosyltransferase with a GT-C fold. The proposed scheme encompasses a system that allows extracytoplasmic modification of rhamnan by complex substituting oligo-/polysaccharides. It accounts for the extensive diversity of CWPS structures observed among lactococci and may also have relevance to the biosynthesis of complex rhamnose-containing CWPSs in other Gram-positive bacteria.	[Theodorou, Ilias; Penno, Christophe; Mahony, Jennifer; van Sinderen, Douwe] Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland; [Theodorou, Ilias; Penno, Christophe; Mahony, Jennifer; van Sinderen, Douwe] Univ Coll Cork, APC Microbiome Ireland, Western Rd, Cork, Ireland; [Courtin, Pascal; Palussiere, Simon; Kulakauskas, Saulius; Bidnenko, Elena; Chapot-Chartier, Marie-Pierre] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Pechoux, Christine] INRA, UMR 1313, GABI, Plateforme MIMA2, F-78350 Jouy En Josas, France; [Fenaille, Francois] Univ Paris Saclay, CEA, Inst Joliot,MetaboHUB Paris, Serv Pharmacol & Immunoanal,UMR 0496,Lab Etud Met, F-91191 Gif Sur Yvette, France	University College Cork; University College Cork; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Chapot-Chartier, MP (corresponding author), INRA, Micalis Inst, F-78350 Jouy En Josas, France.	d.vansinderen@ucc.ie; Marie-Pierre.Chapot-Chartier@inra.fr	mahony, jennifer/AAG-8357-2020; Van Sinderen, Douwe/A-6778-2015	mahony, jennifer/0000-0001-5846-6303; Van Sinderen, Douwe/0000-0003-1823-7957; Fenaille, Francois/0000-0001-6787-4149; Theodorou, Ilias/0000-0001-8508-9558; Bidnenko, Elena/0000-0002-9945-0946; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	INRA	INRA	The work of the M.-P. C.-C. team was supported by INRA. The authors declare that they have no conflict of interest with the contents of this article.	Ainsworth S, 2014, MBIO, V5, DOI 10.1128/mBio.00880-14; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Breum SO, 2007, FEMS MICROBIOL LETT, V276, P156, DOI 10.1111/j.1574-6968.2007.00928.x; Caliot E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002756; Cavanagh D, 2015, FOOD MICROBIOL, V47, P45, DOI 10.1016/j.fm.2014.11.001; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Farenc C, 2014, J VIROL, V88, P7005, DOI 10.1128/JVI.00739-14; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; Lavelle K, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100577; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Lugli GA, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw049; Lukose V, 2017, GLYCOBIOLOGY, V27, P820, DOI 10.1093/glycob/cwx064; Mahony J, 2008, APPL ENVIRON MICROB, V74, P6206, DOI 10.1128/AEM.01053-08; Mahony J, 2017, FEMS MICROBIOL REV, V41, pS16, DOI 10.1093/femsre/fux019; Mahony J, 2013, APPL ENVIRON MICROB, V79, P4385, DOI 10.1128/AEM.00653-13; Mann E, 2016, CAN J CHEM, V94, P883, DOI 10.1139/cjc-2015-0594; McCabe O, 2015, MOL MICROBIOL, V96, P875, DOI 10.1111/mmi.12978; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mistou MY, 2016, FEMS MICROBIOL REV, V40, P464, DOI 10.1093/femsre/fuw006; Mostowy RJ, 2018, TRENDS MICROBIOL, V26, P1008, DOI 10.1016/j.tim.2018.06.006; O'Driscoll J, 2004, APPL ENVIRON MICROB, V70, P5546, DOI 10.1128/AEM.70.9.5546-5556.2004; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Rigottier-Gois L, 2015, J INFECT DIS, V211, P62, DOI 10.1093/infdis/jiu402; Rush JS, 2017, J BIOL CHEM, V292, P19441, DOI 10.1074/jbc.M117.815910; Sadovskaya I, 2017, MBIO, V8, DOI 10.1128/mBio.01303-17; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Tytgat HLP, 2014, MICROBIOL MOL BIOL R, V78, P372, DOI 10.1128/MMBR.00007-14; van der Meulen SB, 2016, RNA BIOL, V13, P353, DOI 10.1080/15476286.2016.1146855; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Ventura M, 2005, APPL ENVIRON MICROB, V71, P487, DOI 10.1128/AEM.71.1.487-500.2005; Vinogradov E, 2018, CARBOHYD RES, V462, P39, DOI 10.1016/j.carres.2018.04.002; Vinogradov E, 2018, CARBOHYD RES, V461, P25, DOI 10.1016/j.carres.2018.03.011; Woodward L, 2016, CURR OPIN STRUC BIOL, V40, P81, DOI 10.1016/j.sbi.2016.07.016; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	47	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17612	17625		10.1074/jbc.RA119.009957	http://dx.doi.org/10.1074/jbc.RA119.009957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31582566	hybrid, Green Published			2022-12-26	WOS:000503173500035
J	Moglia, A; Gianoglio, S; Acquadro, A; Valentino, D; Milani, AM; Lanteri, S; Comino, C				Moglia, Andrea; Gianoglio, Silvia; Acquadro, Alberto; Valentino, Danila; Milani, Anna Maria; Lanteri, Sergio; Comino, Cinzia			Identification of DNA methyltransferases and demethylases in Solanum melongena L., and their transcription dynamics during fruit development and after salt and drought stresses	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; EXPRESSION ANALYSIS; METHYLATION PATTERNS; DUPLICATED GENES; REVEALS; EVOLUTION; EPIGENOME; FAMILY; PLANTS; ROLES	DNA methylation through the activity of cytosine-5-methyltransferases (C5-MTases) and DNA demethylases plays important roles in genome protection as well as in regulating gene expression during plant development and plant response to environmental stresses. In this study, we report on a genome-wide identification of six C5-MTases (Sme/MET1, Sme/CMT2, Sme/CMT3a, Sme/CMT3b, Sme/DRM2, Sme/DRM3) and five demethylases (Sme/Demethylase_1, Sme/Demethylase_2, Sme/Demethylase_3, Sme/Demethylase_4, Sme/Demethylase_5) in eggplant. Gene structural characteristics, chromosomal localization and phylogenetic analyses are also described. The transcript profiling of both C5-MTases and demethylases was assessed at three stages of fruit development in three eggplant commercial F1 hybrids: i.e. 'Clara', 'Nite Lady' and 'Bella Roma', representative of the eggplant berry phenotypic variation. The trend of activation of C5-MTases and demethylase genes varied in function of the stage of fruit development and was genotype dependent. The transcription pattern of C5MTAses and demethylases was also assessed in leaves of the F1 hybrid 'Nite Lady' subjected to salt and drought stresses. A marked up-regulation and downregulation of some C5-MTases and demethylases was detected, while others did not vary in their expression profile. Our results suggest a role for both C5-MTases and demethylases during fruit development, as well as in response to abiotic stresses in eggplant, and provide a starting framework for supporting future epigenetic studies in the species.	[Moglia, Andrea; Gianoglio, Silvia; Acquadro, Alberto; Valentino, Danila; Milani, Anna Maria; Lanteri, Sergio; Comino, Cinzia] Univ Torino, Dept Agr Forest & Food Sci Plant Genet & Breeding, Grugliasco, Italy	University of Turin	Comino, C (corresponding author), Univ Torino, Dept Agr Forest & Food Sci Plant Genet & Breeding, Grugliasco, Italy.	cinzia.comino@unito.it	; Lanteri, Sergio/P-4902-2015	COMINO, CINZIA/0000-0002-1503-505X; MOGLIA, Andrea/0000-0001-7431-844X; ACQUADRO, Alberto/0000-0002-5322-9701; Lanteri, Sergio/0000-0003-3012-8710				Ahmad F, 2014, GENET MOL RES, V13, P5159, DOI 10.4238/2014.July.7.9; Al-Lawati A, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018299; Ashapkin VV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P141, DOI 10.1134/S0006297916020085; Barchi L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47985-w; Bernacchia G, 1998, PLANT J, V13, P317, DOI 10.1046/j.1365-313X.1998.00034.x; Candaele J, 2014, PLANT PHYSIOL, V164, P1350, DOI 10.1104/pp.113.233312; Cao DY, 2014, GENE, V550, P230, DOI 10.1016/j.gene.2014.08.034; Cerruti E., 2018, 62 SIGA ANN C VER VE; Cheng JF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1587-x; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi J, 2019, BIORXIV, DOI DOI 10.1101/527523V1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Conde D, 2017, PLANT CELL ENVIRON, V40, P2806, DOI 10.1111/pce.13056; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Dai Y, 2005, BBA-GENE STRUCT EXPR, V1729, P118, DOI 10.1016/j.bbaexp.2005.04.001; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; El-Sharkawy I, 2015, J EXP BOT, V66, P7359, DOI 10.1093/jxb/erv433; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Gallusci P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00807; Garg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088947; Giannino D, 2003, J EXP BOT, V54, P2623, DOI 10.1093/jxb/erg292; Gianoglio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181669; Gu TT, 2016, MOL GENET GENOMICS, V291, P1333, DOI 10.1007/s00438-016-1187-y; Henikoff S, 1998, GENETICS, V149, P307; Kawanabe T, 2016, P NATL ACAD SCI USA, V113, pE6704, DOI 10.1073/pnas.1613372113; Kumar R, 2016, FUNCT INTEGR GENOMIC, V16, P513, DOI 10.1007/s10142-016-0502-3; Lang ZB, 2017, P NATL ACAD SCI USA, V114, pE4511, DOI 10.1073/pnas.1705233114; Lauss K, 2018, PLANT PHYSIOL, V176, P1627, DOI 10.1104/pp.17.01054; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li Y, 2018, PLANT CELL REP, V37, P77, DOI 10.1007/s00299-017-2215-z; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu CX, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080398; Liu RE, 2015, P NATL ACAD SCI USA, V112, P10804, DOI 10.1073/pnas.1503362112; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Qian YX, 2014, PLANT CELL REP, V33, P1661, DOI 10.1007/s00299-014-1645-0; Rival A, 2008, J EXP BOT, V59, P3271, DOI 10.1093/jxb/ern178; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Shaik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049331; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Sudan J, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1202-6; Takuno S, 2013, P NATL ACAD SCI USA, V110, P1797, DOI 10.1073/pnas.1215380110; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Uthup TK, 2011, MOL PLANT, V4, P996, DOI 10.1093/mp/ssr039; Victoria D, 2018, PLANT GROWTH REGUL, V84, P81, DOI 10.1007/s10725-017-0323-y; Wang BH, 2015, GENES GENOM, V37, P713, DOI 10.1007/s13258-015-0301-6; Wang HF, 2015, P NATL ACAD SCI USA, V112, P13729, DOI 10.1073/pnas.1519067112; Wang L, 2019, PLANT BIOTECHNOL J, V17, P826, DOI 10.1111/pbi.13018; Wang L, 2018, PLANT J, V93, P460, DOI 10.1111/tpj.13790; Wang PF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00007; Wang WS, 2015, BIOCHEM BIOPH RES CO, V465, P790, DOI 10.1016/j.bbrc.2015.08.089; Wibowo A, 2016, ELIFE, V5, DOI 10.7554/eLife.13546; Xing MQ, 2015, PLANT PHYSIOL, V168, P1417, DOI 10.1104/pp.15.00414; Xu JD, 2015, PLANT MOL BIOL REP, V33, P1, DOI 10.1007/s11105-014-0732-2; Yaari R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09496-0; Zhang HM, 2018, NAT REV MOL CELL BIO, V19, P489, DOI 10.1038/s41580-018-0016-z; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhou XH, 2014, SCI HORTIC-AMSTERDAM, V176, P200, DOI 10.1016/j.scienta.2014.07.010	60	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223581	10.1371/journal.pone.0223581	http://dx.doi.org/10.1371/journal.pone.0223581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596886	Green Published, gold			2022-12-26	WOS:000532444100046
J	Moffett, SX; Klein, EA; Brannigan, G; Martin, JV				Moffett, Steven X.; Klein, Eric A.; Brannigan, Grace; Martin, Joseph, V			L-3,3 ',5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors	PLOS ONE			English	Article							GABA-A-RECEPTOR; ADULT MALE RATS; AMINOBUTYRIC ACID(A) RECEPTOR; THYROID-HORMONE; ACUTE MICROINJECTIONS; L-TRIIODOTHYRONINE; PREOPTIC REGION; PROTEIN-PHOSPHORYLATION; SLEEP; NEUROSTEROIDS	The nicotinic acetylcholine receptor (nAChR) is an excitatory pentameric ligand-gated ion channel (pLGIC), homologous to the inhibitory gamma-aminobutyric acid (GABA) type A receptor targeted by pharmaceuticals and endogenous sedatives. Activation of the GABA(A) receptor by the neurosteroid allopregnanolone can be inhibited competitively by thyroid hormone (L-3,3',5-triiodothyronine, or T3), but modulation of nAChR by T3 or neurosteroids has not been investigated. Here we show that allopregnanolone inhibits the nAChR from Torpedo californica at micromolar concentrations, as do T3 and the anionic neurosteroid pregnenolone sulfate (PS). We test for the role of protein and ligand charge in mediated receptor inhibition by varying pH in a narrow range around physiological pH. We find that both T3 and PS become less potent with increasing pH, with remarkably similar trends in IC50 when T3 is neutral at pH < 7.3. After deprotonation of T3 (but no additional deprotonation of PS) at pH 7.3, T3 loses potency more slowly with increasing pH than PS. We interpret this result as indicating the negative charge is not required for inhibition but does increase activity. Finally, we show that both T3 and PS affect nAChR channel desensitization, which may implicate a binding site homologous to one that was recently indicated for accelerated desensitization of the GABA(A) receptor by PS.	[Moffett, Steven X.; Klein, Eric A.; Brannigan, Grace; Martin, Joseph, V] Rutgers Univ Camden, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Klein, Eric A.; Martin, Joseph, V] Rutgers Univ Camden, Dept Biol, Camden, NJ 08102 USA; [Brannigan, Grace] Rutgers Univ Camden, Dept Phys, Camden, NJ USA	Rutgers State University Camden; Rutgers State University Camden; Rutgers State University Camden	Martin, JV (corresponding author), Rutgers Univ Camden, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA.; Martin, JV (corresponding author), Rutgers Univ Camden, Dept Biol, Camden, NJ 08102 USA.	joe.martin@rutgers.edu	Brannigan, Grace/ABA-2750-2021	Brannigan, Grace/0000-0001-8949-2694; Martin, Joseph/0000-0003-3757-3091; Klein, Eric/0000-0003-3941-6233	National Science Foundation [MCB1330728]	National Science Foundation(National Science Foundation (NSF))	Grant number MCB1330728 was awarded to GB and JVM from the National Science Foundation (https://www.nsf.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri N, 2018, BRIT J ANAESTH, V120, P768, DOI 10.1016/j.bja.2017.12.039; Baenziger JE, 2017, CURR TOP MEMBR, V80, P95, DOI 10.1016/bs.ctm.2017.05.002; Barrantes FJ, 2000, KIDNEY INT, V57, P1382, DOI 10.1046/j.1523-1755.2000.00979.x; Bauer Whybrow, 2005, BEHAV PSYCHIAT ASPEC; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Belelli D, 1999, NEUROCHEM INT, V34, P447, DOI 10.1016/S0197-0186(99)00037-6; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chapell R, 1998, EUR J PHARMACOL, V349, P115, DOI 10.1016/S0014-2999(98)00182-4; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Covey DF, 2001, BRAIN RES REV, V37, P91, DOI 10.1016/S0165-0173(01)00126-6; Covey DF, 2000, J PHARMACOL EXP THER, V293, P1009; Covey DF, 2000, J MED CHEM, V43, P3201, DOI 10.1021/jm0002477; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Damianisch K, 2001, NEUROPSYCHOPHARMACOL, V25, P576, DOI 10.1016/S0893-133X(01)00242-1; Darnaudery M, 1999, NEUROSCIENCE, V92, P583, DOI 10.1016/S0306-4522(99)00019-6; Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; Dratman MB, 1996, THYROID, V6, P639, DOI 10.1089/thy.1996.6.639; DRATMAN MB, 1978, AM J PHYSIOL, V235, pE638, DOI 10.1152/ajpendo.1978.235.6.E638; DRATMAN MB, 1982, SCIENCE, V215, P309, DOI 10.1126/science.7053582; DRATMAN MB, 1976, P NATL ACAD SCI USA, V73, P941, DOI 10.1073/pnas.73.3.941; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gulinello M, 2003, J PHARMACOL EXP THER, V305, P541, DOI 10.1124/jpet.102.045120; Gunnarsson T, 2001, NEUROPSYCHOBIOLOGY, V43, P70, DOI 10.1159/000054869; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hosie AM, 2009, NEUROPHARMACOLOGY, V56, P149, DOI 10.1016/j.neuropharm.2008.07.050; HUCHO F, 1986, EUR J BIOCHEM, V158, P211, DOI 10.1111/j.1432-1033.1986.tb09740.x; James TD, 2013, HORM BEHAV, V64, P81, DOI 10.1016/j.yhbeh.2013.05.004; Joksimovic SL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01127; Ke L, 1996, J NEUROCHEM, V67, P1100; Kudo K, 2002, EUR J PHARMACOL, V456, P19, DOI 10.1016/S0014-2999(02)02623-7; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; li L, 1991, CELLULAR MOL BIOL, V12, P83; Longone P, 2008, NEUROCHEM INT, V52, P596, DOI 10.1016/j.neuint.2007.10.001; Lynagh T, 2014, J NEUROSCI, V34, P2155, DOI 10.1523/JNEUROSCI.4307-13.2014; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Martin JV, 2013, BRAIN RES, V1516, P45, DOI 10.1016/j.brainres.2013.01.032; Martin JV, 1996, NEUROSCIENCE, V73, P705, DOI 10.1016/0306-4522(96)00052-8; Martin JV, 2004, BRAIN RES, V1004, P98, DOI 10.1016/j.brainres.2003.12.043; MASON GA, 1993, NEUROPSYCHOPHARMACOL, V8, P253, DOI 10.1038/npp.1993.28; McGrath M, 2018, ANESTHESIOLOGY, V129, P959, DOI 10.1097/ALN.0000000000002356; MIENVILLE JM, 1989, BRAIN RES, V489, P190, DOI 10.1016/0006-8993(89)90024-3; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Moffett SX, 2013, BRAIN RES, V1516, P55, DOI 10.1016/j.brainres.2013.04.017; OCHOA ELM, 1983, BIOCHIM BIOPHYS ACTA, V727, P151, DOI 10.1016/0005-2736(83)90379-6; PALMA A, 1991, J MEMBRANE BIOL, V120, P67, DOI 10.1007/BF01868592; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Puia G, 2011, NEUROPHARMACOLOGY, V60, P1254, DOI 10.1016/j.neuropharm.2010.12.013; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Sarkar PK, 2006, NEUROSCIENCE, V137, P125, DOI 10.1016/j.neuroscience.2005.10.002; Sarkar PK, 1998, NEUROREPORT, V9, P1149, DOI 10.1097/00001756-199804200-00035; SARKAR PK, 1994, NEUROPSYCHOPHARMACOL, V11, P151, DOI 10.1038/sj.npp.1380101; Sarkar PK, 2011, INDIAN J EXP BIOL, V49, P169; Seljeset S, 2018, NEUROPHARMACOLOGY, V136, P23, DOI 10.1016/j.neuropharm.2018.02.008; Sharp L, 2019, BIOCH BIOPHYSICA ACT; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sooksawate T, 2001, NEUROPHARMACOLOGY, V40, P178, DOI 10.1016/S0028-3908(00)00159-3; Sridhar GR, 1996, J SLEEP RES, V5, P198; STEIGER A, 1993, BRAIN RES, V615, P267, DOI 10.1016/0006-8993(93)90037-N; Steinlein OK, 2010, PFLUG ARCH EUR J PHY, V460, P495, DOI 10.1007/s00424-009-0766-8; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Uki M, 1999, J NEUROCHEM, V72, P808, DOI 10.1046/j.1471-4159.1999.0720808.x; Wang Mingde, 2011, Front Endocrinol (Lausanne), V2, P44, DOI 10.3389/fendo.2011.00044; Westergard T, 2015, PLOS ONE, V10, P1; Zhang M, 2017, J NEUROCHEM, V141, P137, DOI 10.1111/jnc.13965	78	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0223272	10.1371/journal.pone.0223272	http://dx.doi.org/10.1371/journal.pone.0223272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584962	Green Published, gold			2022-12-26	WOS:000532407600016
J	Yang, WG; Zhang, XC; Gong, W; Ye, YY; Yang, YS				Yang, Weige; Zhang, Xiaocun; Gong, Wei; Ye, Yuanyuan; Yang, Yongsheng			Soil erosion and corn yield in a cultivated catchment of the Chinese Mollisol region	PLOS ONE			English	Article							BLACK SOIL; SPATIAL-DISTRIBUTION; NORTHEAST CHINA; ORGANIC-CARBON; AGRICULTURAL CATCHMENT; DEPOSITION RATES; CS-137 TECHNIQUE; LOESS PLATEAU; PRODUCTIVITY; REDISTRIBUTION	Evaluation of soil redistribution rates and influence on crop yield in agricultural catchments is very important information, which can provide a scientific basis for arrangement of soil and water conservation measures and sustainable crop production. In recent decades, the soil erosion has greatly aggravated in the Mollisol region of Northeast China due to unreasonable land management, which in turn has reduced crop yield. The objectives of this study were to investigate the spatial distribution of soil redistribution and the relationship between crop yield and soil redistribute at a catchment of the Chinese Mollisol region. A total of 176 soil samples were collected based on a 200 m by 200 m grid and 4 yr of corn (Zea mays L.) yields were measured. The Cs-137 trace technique and Zhang Xinbao's mass balance model indicated that the soil redistribution rates ranged from -7122.25 to 5471.70 t km(-2) yr(-1) and averaged -830.10 t km(-2) yr(-1). Soil erosion dominated in the research area. The corn yields for four years ranged from 43.24 to 136.19 kg km(-2) and averaged 90.42 kg km(-2). The spatial distribution of soil redistribution rates and corn yield showed a similar ribbon and plaque characteristics at the catchment. An equation between corn yield and soil redistribution rates was fitted and showed that there was a significant negative correlation between corn yield and soil erosion rates, while there was no relationship between the corn yield and soil deposition rates. Therefore, effective soil and water conservation measures are urgently needed to increase crop yield and realize sustainable land-use management.	[Yang, Weige; Zhang, Xiaocun; Gong, Wei] Shangluo Univ, Coll Rural Planning & Architectural Engn, Shangluo, Shaanxi, Peoples R China; [Gong, Wei; Ye, Yuanyuan] Shangluo Univ, Coll Chem Engn & Modern Mat, Shangluo, Shaanxi, Peoples R China; [Yang, Yongsheng] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Qinghai, Peoples R China	Shangluo University; Shangluo University; Chinese Academy of Sciences	Yang, WG (corresponding author), Shangluo Univ, Coll Rural Planning & Architectural Engn, Shangluo, Shaanxi, Peoples R China.	yangweige121@163.com	Lang, Ming/HIK-0758-2022		National Natural Science Foundation of China [41571299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the projects of National Natural Science Foundation of China (Grand No. 41571299).; This study was financially supported by the projects of the National Natural Science Foundation of China (Grand No. 41571299). The authors thank Mr. Junying Yang and Yafeng Wang for their hard work in the field and laboratory analyses. The authors are grateful to the anonymous reviewers and editors for their constructive comments and valuable suggestions.	An J, 2014, CATENA, V123, P243, DOI 10.1016/j.catena.2014.08.009; [Anonymous], 2008, SL1902007; Bakker MM, 2004, CATENA, V57, P55, DOI 10.1016/j.catena.2003.07.002; Benmansour M, 2013, J ENVIRON RADIOACTIV, V115, P97, DOI 10.1016/j.jenvrad.2012.07.013; CARTER DL, 1985, SOIL SCI SOC AM J, V49, P207, DOI 10.2136/sssaj1985.03615995004900010041x; Chappell A, 2003, CATENA, V52, P209, DOI 10.1016/S0341-8162(03)00015-8; Chen ZC, 2006, SOILS, V36, P584, DOI [10.3321/j.issn:0253-9829.2004.06.002, DOI 10.3321/J.ISSN:0253-9829.2004.06.002]; Collins AL, 2001, GEODERMA, V104, P299, DOI 10.1016/S0016-7061(01)00087-8; Damnati B, 2013, J AFR EARTH SCI, V79, P50, DOI 10.1016/j.jafrearsci.2012.10.006; de la Rosa D, 2000, AGR ECOSYST ENVIRON, V81, P179, DOI 10.1016/S0167-8809(00)00161-4; den Biggelaar C, 2001, ADV AGRON, V72, P1, DOI 10.1016/S0065-2113(01)72010-X; Dong YF, 2013, INT J SEDIMENT RES, V28, P111, DOI 10.1016/S1001-6279(13)60023-2; Du P, 2011, APPL RADIAT ISOTOPES, V69, P717, DOI 10.1016/j.apradiso.2011.01.022; Duan XW, 2012, J GEOGR SCI, V22, P737, DOI 10.1007/s11442-012-0959-5; Duan XW, 2011, CATENA, V87, P268, DOI 10.1016/j.catena.2011.06.012; ELLIOTT WJ, 1990, CIRCULATION, V81, P970, DOI 10.1161/01.CIR.81.3.970; ESRI, 2017, PRINC GEOST AN; [范昊明 Fan Haoming], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P66; Fang HY, 2017, SOIL TILL RES, V165, P23, DOI 10.1016/j.still.2016.07.015; Fang HY, 2012, GEOMORPHOLOGY, V169, P142, DOI 10.1016/j.geomorph.2012.04.019; Fang HY, 2012, J ENVIRON RADIOACTIV, V112, P125, DOI 10.1016/j.jenvrad.2012.05.018; Fang HJ, 2006, LAND DEGRAD DEV, V17, P89, DOI 10.1002/ldr.697; Gao XF, 2015, SOIL TILL RES, V145, P126, DOI 10.1016/j.still.2014.09.004; Gaspar L, 2013, CATENA, V102, P46, DOI 10.1016/j.catena.2011.01.004; Gharibreza M, 2013, SOIL TILL RES, V131, P1, DOI 10.1016/j.still.2013.02.010; GOVERS G, 1993, FARM LAND ER TEMP, P285; He C.G., 2001, J SOIL WATER CONSERV, V15, P110; Hillel D., 1980, APPL SOIL PHYS, P70; Hurni H, 1987, SOIL CONSERVATION PR, P654; Lar R., 1981, GEODERMA, V25, P215, DOI [10.1016/0016-7061(81)90037-9, DOI 10.1016/0016-7061(81)90037-9]; Li FC, 2013, J PLANT NUTR SOIL SC, V176, P647, DOI 10.1002/jpln.201200341; [李光录 LI Guanglu], 2007, [干旱地区农业研究, Agricultural Research in the Arid Areas], V25, P42; Liu B., 2008, SCI SOIL WATER CONSE, V6, P1; Liu XB, 2011, SOIL TILL RES, V117, P44, DOI 10.1016/j.still.2011.08.005; Nie XJ, 2009, 2009 INTERNATIONAL CONFERENCE ON ENVIRONMENTAL SCIENCE AND INFORMATION APPLICATION TECHNOLOGY,VOL I, PROCEEDINGS, P635, DOI 10.1109/ESIAT.2009.65; Petrovic J, 2013, ENVIRON SCI-PROC IMP, V15, P1279, DOI 10.1039/c3em00084b; Porto P, 2001, J HYDROL, V248, P93, DOI 10.1016/S0022-1694(01)00389-4; Soil Survey Office of China, 1992, CHIN SOIL SURV TECHN; [张兴义 Zhang Xingyi], 2006, [大豆科学, Soybean Science], V25, P123; Sui YY, 2009, FIELD CROP RES, V111, P276, DOI 10.1016/j.fcr.2009.01.005; SUTHERLAND R A, 1991, Soil Technology, V4, P33, DOI 10.1016/0933-3630(91)90038-O; Teramage MT, 2013, GEODERMA, V192, P59, DOI 10.1016/j.geoderma.2012.08.030; VERITY GE, 1990, CAN J SOIL SCI, V70, P471, DOI 10.4141/cjss90-046; Wallbrink PJ, 2002, CATENA, V47, P179, DOI 10.1016/S0341-8162(01)00185-0; [王禹 Wang Yu], 2010, [核农学报, Acta Agriculturae Nucleatae Sinica], V24, P790; Wang ZQ, 2009, SCI CHINA SER D, V52, P1005, DOI 10.1007/s11430-009-0093-0; Wu LP, 2003, CHINA WATER RESOURCE; Xu XZ, 2010, ENVIRON SCI POLICY, V13, P793, DOI 10.1016/j.envsci.2010.07.004; [阎百兴 Yan Moxin], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P33; Yang MY, 2006, SOIL TILL RES, V87, P186, DOI 10.1016/j.still.2005.03.010; Yang YH, 2011, PEDOSPHERE, V21, P706, DOI 10.1016/S1002-0160(11)60173-2; ZHANG XB, 1990, HYDROLOG SCI J, V35, P243, DOI 10.1080/02626669009492427; Zhao L, 2012, J MT SCI-ENGL, V9, P96, DOI 10.1007/s11629-012-2241-9; Zhou KQ, 2015, FIELD CROP RES, V171, P138, DOI 10.1016/j.fcr.2014.10.017	54	8	8	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0221553	10.1371/journal.pone.0221553	http://dx.doi.org/10.1371/journal.pone.0221553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581190	gold, Green Published			2022-12-26	WOS:000532398600004
J	Oliver, GR; Tang, XJ; Schultz-Rogers, LE; Vidal-Folch, N; Jenkinson, WG; Schwab, TL; Gaonkar, K; Cousin, MA; Nair, A; Basu, S; Chanana, P; Oglesbee, D; Klee, EW				Oliver, Gavin R.; Tang, Xiaojia; Schultz-Rogers, Laura E.; Vidal-Folch, Noemi; Jenkinson, W. Garrett; Schwab, Tanya L.; Gaonkar, Krutika; Cousin, Margot A.; Nair, Asha; Basu, Shubham; Chanana, Pritha; Oglesbee, Devin; Klee, Eric W.			A tailored approach to fusion transcript identification increases diagnosis of rare inherited disease	PLOS ONE			English	Article							BALANCED TRANSLOCATION; INTELLECTUAL DISABILITY; GENE FUSION; PATIENT; RETARDATION; ASSOCIATION; SEQUENCE; DELETION; FEMALE; EXT1	Background RNA sequencing has been proposed as a means of increasing diagnostic rates in studies of undiagnosed rare inherited disease. Recent studies have reported diagnostic improvements in the range of 7.5-35% by profiling splicing, gene expression quantification and allele specific expression. To-date however, no study has systematically assessed the presence of gene-fusion transcripts in cases of germline disease. Fusion transcripts are routinely identified in cancer studies and are increasingly recognized as having diagnostic, prognostic or therapeutic relevance. Isolated reports exist of fusion transcripts being detected in cases of developmental and neurological phenotypes, and thus, systematic application of fusion detection to germline conditions may further increase diagnostic rates. However, current fusion detection methods are unsuited to the investigation of germline disease due to performance biases arising from their development using tumor, cell-line or in-silico data. Methods We describe a tailored approach to fusion candidate identification and prioritization in a cohort of 47 undiagnosed, suspected inherited disease patients. We modify an existing fusion transcript detection algorithm by eliminating its cell line-derived filtering steps, and instead, prioritize candidates using a custom workflow that integrates genomic and transcriptomic sequence alignment, biological and technical annotations, customized categorization logic, and phenotypic prioritization. Results We demonstrate that our approach to fusion transcript identification and prioritization detects genuine fusion events excluded by standard analyses and efficiently removes phenotypically unimportant candidates and false positive events, resulting in a reduced candidate list enriched for events with potential phenotypic relevance. We describe the successful genetic resolution of two previously undiagnosed disease cases through the detection of pathogenic fusion transcripts. Furthermore, we report the experimental validation of five additional cases of fusion transcripts with potential phenotypic relevance. Conclusions The approach we describe can be implemented to enable the detection of phenotypically relevant fusion transcripts in studies of rare inherited disease. Fusion transcript detection has the potential to increase diagnostic rates in rare inherited disease and should be included in RNA-based analytical pipelines aimed at genetic diagnosis.	[Oliver, Gavin R.; Tang, Xiaojia; Schultz-Rogers, Laura E.; Jenkinson, W. Garrett; Gaonkar, Krutika; Cousin, Margot A.; Nair, Asha; Basu, Shubham; Chanana, Pritha; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA; [Oliver, Gavin R.; Tang, Xiaojia; Schultz-Rogers, Laura E.; Jenkinson, W. Garrett; Gaonkar, Krutika; Cousin, Margot A.; Nair, Asha; Basu, Shubham; Chanana, Pritha; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55902 USA; [Vidal-Folch, Noemi; Oglesbee, Devin; Klee, Eric W.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55902 USA; [Schwab, Tanya L.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Oglesbee, Devin] Mayo Clin, Dept Med Genet, Rochester, MN USA; [Klee, Eric W.] Mayo Clin, Dept Clin Genom, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Klee, EW (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA.; Klee, EW (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MN 55902 USA.; Klee, EW (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55902 USA.; Klee, EW (corresponding author), Mayo Clin, Dept Clin Genom, Rochester, MN 55902 USA.	klee.eric@mayo.edu	Oglesbee, Devin/AAU-5420-2021	Oliver, Gavin/0000-0002-9948-3799; Oglesbee, Devin/0000-0002-7147-5527	Mayo Clinic Center for Individualized Medicine; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS	Mayo Clinic Center for Individualized Medicine; Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Mayo Clinic Center for Individualized Medicine. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	Aigner J, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-61; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babiceanu M, 2016, NUCLEIC ACIDS RES, V44, P2859, DOI 10.1093/nar/gkw032; Backx L, 2011, CHROMOSOME RES, V19, pS59; Bertelsen B, 2015, PSYCHIAT RES, V225, P268, DOI 10.1016/j.psychres.2014.12.028; Boczek NJ, 2018, EUR J HUM GENET, V26, P1797, DOI 10.1038/s41431-018-0222-3; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Borsani G, 2008, EUR J MED GENET, V51, P292, DOI 10.1016/j.ejmg.2008.02.006; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Ceroni F, 2014, AUTISM RES, V7, P254, DOI 10.1002/aur.1365; Chase J, 2009, HAEMATOL-HEMATOL J, V94, P218; Cousin MA, 2018, J CLIN IMMUNOL, V38, P307, DOI 10.1007/s10875-018-0499-6; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Dai XF, 2018, BBA-REV CANCER, V1869, P149, DOI 10.1016/j.bbcan.2017.12.003; Di Gregorio E, 2013, J MED GENET, V50, P543, DOI 10.1136/jmedgenet-2013-101542; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8; Godard P, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1401-2; Hackmann K, 2013, EUR J HUM GENET, V21, P112, DOI 10.1038/ejhg.2012.97; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; He Y, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010040; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kremer LS, 2018, J INHERIT METAB DIS, V41, P525, DOI 10.1007/s10545-017-0133-4; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; KUMAR S, 2016, SCI REP UK, V6; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Mansouri MR, 2006, HUM GENET, V119, P162, DOI 10.1007/s00439-005-0122-9; Mayo S, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/4798474; Moyses-Oliveira M, 2015, AM J MED GENET B, V168, P669, DOI 10.1002/ajmg.b.32355; Nothwang HG, 2001, HUM MOL GENET, V10, P797, DOI 10.1093/hmg/10.8.797; Oliver GR, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.560; Peng ZY, 2015, J CANCER, V6, P555, DOI 10.7150/jca.11997; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Ramocki MB, 2003, EUR J HUM GENET, V11, P527, DOI 10.1038/sj.ejhg.5200995; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; Sarrion P, 2013, SCI REP-UK, P3; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szuhai K, 2011, HUM MUTAT, V32, pE2036, DOI 10.1002/humu.21423; van Heesch S, 2014, CELL REP, V9, P2001, DOI 10.1016/j.celrep.2014.11.022; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yuan CF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040714; Yuan HL, 2013, CANCER DISCOV, V3, P1394, DOI 10.1158/2159-8290.CD-13-0186; Yue Y, 2005, HUM GENET, V117, P1, DOI 10.1007/s00439-005-1273-4; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhou X, 2010, MOL PSYCHIATR, V15, P670, DOI 10.1038/mp.2009.127	53	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0223337	10.1371/journal.pone.0223337	http://dx.doi.org/10.1371/journal.pone.0223337			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577830	gold, Green Published			2022-12-26	WOS:000532388000031
J	Abiola, SE; Mello, MM				Abiola, Sara E.; Mello, Michelle M.			Multilevel legal approaches to obesity prevention: A conceptual and methodological toolkit	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL MODEL; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; UNITED-STATES; WEIGHT STATUS; HEALTH; CHILDREN; POLICY; FOOD; LAW	Introduction State lawmakers have explored numerous policy alternatives to reduce overweight and obesity. Evaluating effects of these laws is important but presents substantial methodological challenges. We present a conceptual framework that allows for classification of obesity prevention laws based on ecological level of influence and the underlying legal mechanism involved to guide analysis of the relationship between a substantial range of obesity prevention laws and BMI. Methods Obesity prevention laws (OPLs) for all 50 states and DC were obtained via primary legal research using the LexisNexis Advanced Legislative Services (ALS) database. For legal provisions that met inclusion criteria, reviewers abstracted information on bill state, citation, passage and effective dates, target population, and obesity prevention mechanism. Laws were categorized by ecological level of influence on weight-related behaviors and the legal mechanism utilized to change behavioral determinants of BMI. Results Laws designed to increase community-level opportunities for physical activity were the most frequently enacted OPL while laws designed to alter nutrition standards for school meals or competitive foods were comparatively less common, appearing in only 16% and 34% of states, respectively. Conclusion Prior studies of obesity policies have focused on specific interventions. We identified and categorized state-level laws that operate at all ecological levels and found that laws passed during the initial burst of lawmaking were largely confined to measures aimed at increasing opportunities for physical activity. Creating public spaces for recreation is an important step to promoting healthier lifestyles to reduce obesity risk; more comprehensive, multilevel legal approaches should also be pursued.	[Abiola, Sara E.] Columbia Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10032 USA; [Mello, Michelle M.] Stanford Law Sch, Stanford Sch Med, Dept Hlth Res & Policy, Palo Alto, CA USA	Stanford University	Abiola, SE (corresponding author), Columbia Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10032 USA.	sabiola@columbia.edu		Mello, Michelle/0000-0003-2877-4270; Abiola, Sara/0000-0001-6687-258X	Robert Wood Johnson Foundation's Public Health Law Research Program, "An Empirical Evaluation of Public Health Law Approaches to Obesity Prevention" [65795, 66156]; Robert Wood Johnson Foundation's Public Health Law Research Program	Robert Wood Johnson Foundation's Public Health Law Research Program, "An Empirical Evaluation of Public Health Law Approaches to Obesity Prevention"; Robert Wood Johnson Foundation's Public Health Law Research Program(Robert Wood Johnson Foundation (RWJF))	This work was supported by the Robert Wood Johnson Foundation's Public Health Law Research Program, "An Empirical Evaluation of Public Health Law Approaches to Obesity Prevention", https://www.rwjf.org/, RWJF Grant #: 65795, 66156 awarded to M.M.M. The corresponding author takes responsibility for all design decisions and errors herein. The study sponsor did not have any role in study design, collection, analysis, or interpretation of data; writing the report or the decision to submit the report for publication.; This work was supported by the Robert Wood Johnson Foundation's Public Health Law Research Program. Members of that program's Methods Core provided valuable comments on an earlier version of this article. We would like to thank Jamie Chriqui, Amy Eyler, Jennifer Pomeranz, Serena Vinter, Amy Winterfield, Jess Alderman, Ellen Jones, and Marlene Schwartz for expert input into the study design as members of the project's Obesity Policy Advisory Group. We are grateful to Marie Burks and Ilina Chaudhuri for excellent research assistance and Paragon Corporation for database development work. We also gratefully acknowledge the work of the National Cancer Institute and MayaTech Corporation in constructing the School Nutrition and Education State Policy Classification System and the Physical Education and Recess State Policy Classification System and assisting us in replicating their coding methodology. The corresponding author takes responsibility for all design decisions and errors herein.	Abiola S, OBESITY PREVENTION P; Andreyeva T, 2014, J OCCUP ENVIRON MED, V56, P1120, DOI 10.1097/JOM.0000000000000298; [Anonymous], CLASS LAWS ASS SCH S; Auld MC, 2009, ECONOMICA, V76, P719, DOI 10.1111/j.1468-0335.2008.00709.x; Boehmer T, PREVENTING CHRONIC D, V4, P56; Boehmer TK, 2008, AM J PREV MED, V34, P333, DOI 10.1016/j.amepre.2008.01.003; Booth ML, 2001, AUST NZ J PUBL HEAL, V25, P162, DOI 10.1111/j.1753-6405.2001.tb01840.x; Burris S, 2012, MILBANK Q, V90, P375, DOI 10.1111/j.1468-0009.2012.00667.x; Burris S, 2010, MILBANK Q, V88, P169, DOI 10.1111/j.1468-0009.2010.00595.x; Cawley J, 2008, OBESITY, V16, P162, DOI 10.1038/oby.2007.3; Centers for Disease Control and Prevention, DIV NUTR PHYS ACT OB; Choo EK, 2014, J ADOLESCENT HEALTH, V55, P160, DOI 10.1016/j.jadohealth.2014.02.018; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; Dietz W H, 1993, Pediatr Rev, V14, P337, DOI 10.1542/pir.14-9-337; Dodson EA, 2009, J PUBLIC HEALTH POL, V30, pS161, DOI 10.1057/jphp.2008.57; Economos CD, 2007, J LAW MED ETHICS, V35, P131, DOI 10.1111/j.1748-720X.2007.00117.x; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Egger G, 2003, Obes Rev, V4, P115, DOI 10.1046/j.1467-789X.2003.00100.x; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Eyler AA, 2012, AM J PUBLIC HEALTH, V102, P2294, DOI 10.2105/AJPH.2012.300763; Fletcher JM, 2015, HEALTH ECON, V24, P566, DOI 10.1002/hec.3045; Fleury J, 2006, AM J COMMUN PSYCHOL, V37, P129, DOI 10.1007/s10464-005-9002-7; Gostin L., 2008, PUBLIC HLTH LAW POWE; Graff SK, 2012, ANNU REV PUBL HEALTH, V33, P307, DOI 10.1146/annurev-publhealth-031811-124608; Gregson J, 2001, J NUTR EDUC, V33, pS4, DOI 10.1016/S1499-4046(06)60065-1; Harper S, 2014, J POLICY ANAL MANAG, V33, P141, DOI 10.1002/pam.21735; Hey DW, 2004, KINESIOLOGY, P1; Institute of Medicine, 2005, PREVENTING CHILDHOOD; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Krieger N, 2014, EPIDEMIOLOGY, V25, P494, DOI 10.1097/EDE.0000000000000104; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Lukachko A, 2014, SOC SCI MED, V103, P42, DOI 10.1016/j.socscimed.2013.07.021; Macinko J, 2012, AM J PUBLIC HEALTH, V102, P1697, DOI 10.2105/AJPH.2012.300716; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; National Association of State Boards of Education, STATE SCH HLTH POLIC; National Conference of State Legislatures, CHRON DIS PREV HLTH; Nicklas TA, 1995, AM J MED SCI, V310, pS101, DOI 10.1097/00000441-199512000-00018; Nieman P, 2012, PAED CHILD HEALT-CAN, V17, P205, DOI 10.1093/pch/17.4.205; Nix S, 1999, J AM DIET ASSOC, V99, pA55; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Pomeranz JL, 2015, AM J PREV MED, V49, P428, DOI 10.1016/j.amepre.2015.02.027; Quinn LA, 2005, JOGNN-J OBST GYN NEO, V34, P672, DOI 10.1177/0884217505281877; Sallis JF, 2006, FUTURE CHILD, V16, P89, DOI 10.1353/foc.2006.0009; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; SCHLICKER SA, 1994, NUTR REV, V52, P11, DOI 10.1111/j.1753-4887.1994.tb01348.x; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Taber DR, 2013, PREV MED, V57, P629, DOI 10.1016/j.ypmed.2013.08.018; Taber DR, 2013, JAMA PEDIATR, V167, P513, DOI 10.1001/jamapediatrics.2013.399; Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353; Taber DR, 2011, AM J PUBLIC HEALTH, V101, P1769, DOI 10.2105/AJPH.2011.300221; Thomson H, 2004, BMJ-BRIT MED J, V328, P282, DOI 10.1136/bmj.328.7434.282; Tremper C, 2010, EVALUATION REV, V34, P242, DOI 10.1177/0193841X10370018; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Wagenaar A, 2013, PUBLIC HLTH LAW RES; Wagenaar A, 2015, AM J PUBLIC HEALTH, pe1; Wallander JL, 2013, INT J OBESITY, V37, P920, DOI 10.1038/ijo.2013.31; Weintraub DL, 2008, ARCH PEDIAT ADOL MED, V162, P232, DOI 10.1001/archpediatrics.2007.43	61	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0220971	10.1371/journal.pone.0220971	http://dx.doi.org/10.1371/journal.pone.0220971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574096	Green Published, gold			2022-12-26	WOS:000532376700003
J	Dhital, R; Shibanuma, A; Miyaguchi, M; Kiriya, J; Jimba, M				Dhital, Rolina; Shibanuma, Akira; Miyaguchi, Moe; Kiriya, Junko; Jimba, Masamine			Effect of psycho-social support by teachers on improving mental health and hope of adolescents in an earthquake-affected district in Nepal: A cluster randomized controlled trial	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATURAL DISASTERS; DEPRESSION; INTERVENTION; SYMPTOMS; CHILDREN; CHILDHOOD; SURVIVORS; SCALE	Introduction Adolescents can be prone to mental health problems such as post-traumatic stress disorder (PTSD) and depression following disasters. School teachers can provide timely psychosocial support that could instill hope and improve mental health among adolescents in a post-earthquake situation in a low-resource setting. This study examined the effect of training for school teachers on psycho-social support on adolescents' mental health and hope in an earthquake affected district in Nepal. Methods This cluster randomized controlled trial was conducted in 15 schools in Dhading, a severely affected district by the 2015 earthquake in Nepal. The schools were randomized, as a result, 8 were in the intervention group and 7 in the control group. A total of 1,220 adolescents were recruited at baseline of which 605 adolescents belonged to intervention group and 615 to control group. The follow-up rate at 6 months was 83%. This trial was registered with Clinicaltrials.gov with registration number NCT03387007. Results The intervention did not show significant effects for PTSD symptoms (Intervention*time, beta = 0.33, p = 0.536), depression symptoms (Intervention*time, beta = 0.30, p = 0.249), and hope (Intervention*time, beta = -0.23, p = 0.588), among the adolescents at 6 months follow-up. Conclusion The intervention did not improve mental health symptoms and hope among adolescents at 6 months follow-up. More focused and longer training could be necessary to address mental health among adolescents affected by earthquake. Additionally, longer follow-up could be necessary to assess the changes taking place over time.	[Dhital, Rolina; Shibanuma, Akira; Miyaguchi, Moe; Kiriya, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan	University of Tokyo	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	dhital, rolina/AGW-9575-2022; Shibanuma, Akira/C-7652-2016	Shibanuma, Akira/0000-0003-2058-1722; Dhital, Rolina/0000-0002-9491-2881	Ministry of Education, Culture, Sports, Science and Technology; National Center for Global Health and Medicines; Association of Medical Doctors of Asia in Tokyo, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicines; Association of Medical Doctors of Asia in Tokyo, Japan	This work was supported by the Grant-in-Aid for Challenging Exploratory Research from Ministry of Education, Culture, Sports, Science and Technology, and National Center for Global Health and Medicines, and Post-Disaster Health Promotion Project in Dhading from The Association of Medical Doctors of Asia in Tokyo, Japan. The funding sources had no role in the study design, implementation of the intervention, data collection and analysis and interpretation of data; in the writing of the report or in the decision to submit the article for publication.	Berger R, 2009, PSYCHOTHER PSYCHOSOM, V78, P364, DOI 10.1159/000235976; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Brown RC, 2017, PSYCHOL MED, V47, P1893, DOI 10.1017/S0033291717000496; Caldas DE Almeida Jose Miguel, 2002, World Psychiatry, V1, P155; Dhand NK, 2014, SAMPLE SIZE CALCULAT; Farooqui M, 2017, TRENDS PSYCHIATR PSY, V39, P135, DOI 10.1590/2237-6089-2016-0029; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Fu C, 2015, J CHILD ADOLESC MENT, V27, P161, DOI 10.2989/17280583.2015.1117978; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001632; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Guo J, 2015, J NERV MENT DIS, V203, P469, DOI 10.1097/NMD.0000000000000310; HANCHATE AD, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.H440; Horn SR, 2016, EXP NEUROL, V284, P119, DOI 10.1016/j.expneurol.2016.07.002; Huff Charlotte, 2018, Manag Care, V27, P20; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Jacobs MB, 2015, CHILD YOUTH CARE FOR, V44, P511, DOI 10.1007/s10566-015-9311-4; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Kar Nilamadhab, 2006, Clin Pract Epidemiol Ment Health, V2, P17, DOI 10.1186/1745-0179-2-17; Kessler RC, 2005, ARCH GEN PSYCHIAT, P62; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kohrt BA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-127; Lamichhane J, 2015, LANCET, V386, P2251, DOI 10.1016/S0140-6736(15)01132-0; Luitel NP, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-014-0030-5; MoHA, 2015, NEP EARTHQ 2072 SIT; National Planning Commission, 2015, NEP EARTHQ 2015 POST; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; OSOCC UNOCHA ACAPS, 2015, NEP EARTHQ DISTR PRO; Schmid KL, 2011, ADV CHILD DEV BEHAV, V41, P69; Shorey HS, 2002, APA ED DIRECTORIATE, P12; Snyder CR, 1997, J PEDIATR PSYCHOL, V22, P399, DOI 10.1093/jpepsy/22.3.399; Stoddard SA, 2015, AM J COMMUN PSYCHOL, V56, P332, DOI 10.1007/s10464-015-9754-7; UNDP, 2009, ISDR GLOB ASS REP PO; United Nations, 2017, WORLD POPULATION PRO; UNOSSC, 2017, S S ACT CIT FRIENDL; UNRWA (United Nations Relief and Works Agency for Palestine Refugees in the Near East), 2013, PSYCH SUPP ED EM TRA; Vloet A, 2014, J TRAUMA STRESS, V27, P622, DOI 10.1002/jts.21955; Weare K, 2011, HEALTH PROMOT INT, V26, pI29, DOI 10.1093/heapro/dar075; WELLS VE, 1985, PSYCHIAT DEV, V3, P83; Wolmer L, 2005, J CHILD PSYCHOL PSYC, V46, P1161, DOI 10.1111/j.1469-7610.2005.00416.x; Wolmer L, 2003, CHILD ADOL PSYCH CL, V12, P363, DOI 10.1016/S1056-4993(02)00104-9; Zhu ZH, 2014, NEUROPSYCH DIS TREAT, V10, P977, DOI 10.2147/NDT.S55016	44	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223046	10.1371/journal.pone.0223046	http://dx.doi.org/10.1371/journal.pone.0223046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6RH	31574127	Green Published, gold			2022-12-26	WOS:000532376700026
J	Shelton, M; Ritso, M; Liu, J; O'Neil, D; Kocharyan, A; Rudnicki, MA; Stanford, WL; Skerjanc, IS; Blais, A				Shelton, Michael; Ritso, Morten; Liu, Jun; O'Neil, Daniel; Kocharyan, Avetik; Rudnicki, Michael A.; Stanford, William L.; Skerjanc, Ilona S.; Blais, Alexandre			Gene expression profiling of skeletal myogenesis in human embryonic stem cells reveals a potential cascade of transcription factors regulating stages of myogenesis, including quiescent/activated satellite cell-like gene expression	PLOS ONE			English	Article							EFFICIENT DERIVATION; TARGETED DISRUPTION; MOLECULAR SIGNATURE; MUSCLE PROGENITORS; COMMON TARGET; IN-VITRO; MESODERM; QUIESCENT; DIFFERENTIATION; LINEAGE	Human embryonic stem cell (hESC)-derived skeletal muscle progenitors (SMP)-defined as PAX7-expressing cells with myogenic potential-can provide an abundant source of donor material for muscle stem cell therapy. As in vitro myogenesis is decoupled from in vivo timing and 3D-embryo structure, it is important to characterize what stage or type of muscle is modeled in culture. Here, gene expression profiling is analyzed in hESCs over a 50 day skeletal myogenesis protocol and compared to datasets of other hESC-derived skeletal muscle and adult murine satellite cells. Furthermore, day 2 cultures differentiated with high or lower concentrations of CHIR99021, a GSK3A/GSK3B inhibitor, were contrasted. Expression profiling of the 50 day time course identified successively expressed gene subsets involved in mesoderm/paraxial mesoderm induction, somitogenesis, and skeletal muscle commitment/formation which could be regulated by a putative cascade of transcription factors. Initiating differentiation with higher CHIR99021 concentrations significantly increased expression of MSGN1 and TGFB-superfamily genes, notably NODAL, resulting in enhanced paraxial mesoderm and reduced ectoderm/neuronal gene expression. Comparison to adult satellite cells revealed that genes expressed in 50-day cultures correlated better with those expressed by quiescent or early activated satellite cells, which have the greatest therapeutic potential. Day 50 cultures were similar to other hESC-derived skeletal muscle and both expressed known and novel SMP surface proteins. Overall, a putative cascade of transcription factors has been identified which regulates four stages of myogenesis. Subsets of these factors were upregulated by high CHIR99021 or their binding sites were significantly over-represented during SMP activation, ranging from quiescent to late-activated stages. This analysis serves as a resource to further study the progression of in vitro skeletal myogenesis and could be mined to identify novel markers of pluripotent-derived SMPs or regulatory transcription/growth factors. Finally, 50-day hESC-derived SMPs appear similar to quiescent/early activated satellite cells, suggesting they possess therapeutic potential.	[Shelton, Michael; Liu, Jun; O'Neil, Daniel; Kocharyan, Avetik; Stanford, William L.; Skerjanc, Ilona S.; Blais, Alexandre] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ritso, Morten; Rudnicki, Michael A.; Stanford, William L.] Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Ritso, Morten; Rudnicki, Michael A.; Stanford, William L.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [O'Neil, Daniel; Stanford, William L.; Blais, Alexandre] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Rudnicki, Michael A.] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Skerjanc, IS; Blais, A (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Blais, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.	iskerjan@uottawa.ca; alexandre.blais@uottawa.ca		Stanford, William/0000-0002-5813-8016; Blais, Alexandre/0000-0003-2446-1883; Ritso, Morten/0000-0003-4266-0149	Muscular Dystrophy Association [218371]; Canadian Institutes of Health Research [MOP-119458, FDN-148387]; Queen Elizabeth II Graduate Scholarship in Science and Technology; University of Ottawa Brain and Mind Research Institute's Centre for Neuromuscular Disease Scholarship in Translational Research; Canada Research Chair in Molecular Genetics; US National Institutes for Health [R01AR044031]; Ontario Institute for Regenerative Medicine; Stem Cell Network; Tier 1 Canada Research Chair Program in Integrative Stem Cell Biology; Natural Sciences and Engineering Research Council of Canada grant [2016-06081]; University of Ottawa, Ottawa, Canada; Canada Foundation for Innovation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship in Science and Technology; University of Ottawa Brain and Mind Research Institute's Centre for Neuromuscular Disease Scholarship in Translational Research; Canada Research Chair in Molecular Genetics; US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Institute for Regenerative Medicine; Stem Cell Network; Tier 1 Canada Research Chair Program in Integrative Stem Cell Biology; Natural Sciences and Engineering Research Council of Canada grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Ottawa, Ottawa, Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by an award from the Muscular Dystrophy Association to Ilona S. Skerjanc (218371). Alexandre Blais was funded by a grant from the Canadian Institutes of Health Research (MOP-119458). Michael Shelton was supported in part by the Queen Elizabeth II Graduate Scholarship in Science and Technology. Morten Ritso was supported by the University of Ottawa Brain and Mind Research Institute's Centre for Neuromuscular Disease Scholarship in Translational Research. Michael A. Rudnicki holds the Canada Research Chair in Molecular Genetics. These studies were carried out with support of grants to M.A.R. from the US National Institutes for Health (R01AR044031), the Canadian Institutes of Health Research (FDN-148387), the Ontario Institute for Regenerative Medicine, and the Stem Cell Network. Willian L. Stanford was supported by the Tier 1 Canada Research Chair Program in Integrative Stem Cell Biology, with hESC SMP research sponsored by a Natural Sciences and Engineering Research Council of Canada grant (2016-06081). The authors acknowledge the Cell Biology and Image Acquisition Core funded by the University of Ottawa, Ottawa, Canada and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012; Alexander MS, 2016, CELL STEM CELL, V19, P800, DOI 10.1016/j.stem.2016.08.006; Alli NS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.221; An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Andreucci JJ, 2002, J BIOL CHEM, V277, P16426, DOI 10.1074/jbc.M110891200; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.3.CO;2-W; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007; Borue X, 2004, DEVELOPMENT, V131, P3967, DOI 10.1242/dev.01276; Bothe I, 2006, DEV DYNAM, V235, P2845, DOI 10.1002/dvdy.20903; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Cao N, 2013, CELL RES, V23, P1119, DOI 10.1038/cr.2013.102; Caron L, 2016, STEM CELL TRANSL MED, V5, P1145, DOI 10.5966/sctm.2015-0224; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297; Chalamalasetty RB, 2014, DEVELOPMENT, V141, P4285, DOI 10.1242/dev.110908; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Choi IY, 2016, CELL REP, V15, P2301, DOI 10.1016/j.celrep.2016.05.016; Daily K, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.30; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Dearth CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058486; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Dias AS, 2014, SCIENCE, V343, P791, DOI 10.1126/science.1247575; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Ducceschi M, 2014, J MOL HISTOL, V45, P329, DOI 10.1007/s10735-014-9567-2; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Edom-Vovard F, 1999, J CELL SCI, V112, P191; Fomenou MD, 2005, DEV DYNAM, V233, P1386, DOI 10.1002/dvdy.20464; Fujimaki S, 2018, STEM CELLS, V36, P278, DOI 10.1002/stem.2743; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Gopinath SD, 2014, STEM CELL REP, V2, P414, DOI 10.1016/j.stemcr.2014.02.002; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Hicks MR, 2018, NAT CELL BIOL, V20, P46, DOI 10.1038/s41556-017-0010-2; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hu J, 2015, BIOMATERIALS, V73, P51, DOI 10.1016/j.biomaterials.2015.09.008; Hwang PM, 2015, NAT REV DRUG DISCOV, V14, P313, DOI 10.1038/nrd4554; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Katoh M, 2006, INT J MOL MED, V17, P795; Kempf H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13602; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lagha M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-696; Lapan AD, 2012, HUM MOL GENET, V21, P3668, DOI 10.1093/hmg/dds196; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Leroy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071770; Lilja KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176190; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Lu MF, 1999, DEV BIOL, V205, P145, DOI 10.1006/dbio.1998.9116; Machado L, 2017, CELL REP, V21, P1982, DOI 10.1016/j.celrep.2017.10.080; Magli A, 2017, CELL REP, V19, P2867, DOI 10.1016/j.celrep.2017.06.005; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Naujok O, 2014, STEM CELL REV REP, V10, P480, DOI 10.1007/s12015-014-9509-0; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; PEDROSADOMELLOF F, 1992, EXPERIENTIA, V48, P491, DOI 10.1007/BF01928171; Peng M, 1997, DOMEST ANIM ENDOCRIN, V14, P286, DOI 10.1016/S0739-7240(97)00025-8; Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6; Rao LJ, 2012, STEM CELL REV REP, V8, P1109, DOI 10.1007/s12015-012-9413-4; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rescan PY, 2010, INT J DEV BIOL, V54, P913, DOI 10.1387/ijdb.092893pr; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Shamblott MJ, 2002, DEV DYNAM, V224, P373, DOI 10.1002/dvdy.10116; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shelton M, 2016, METHODS, V101, P73, DOI 10.1016/j.ymeth.2015.09.019; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Shi XZ, 2012, J CELL SCI, V125, P5329, DOI 10.1242/jcs.105239; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tan JY, 2013, STEM CELLS DEV, V22, P1893, DOI 10.1089/scd.2012.0590; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; van Velthoven CTJ, 2017, CELL REP, V21, P1994, DOI 10.1016/j.celrep.2017.10.037; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wang YX, 2019, CELL STEM CELL, V24, P419, DOI 10.1016/j.stem.2019.01.002; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Wu JB, 2018, CELL REP, V25, P1966, DOI 10.1016/j.celrep.2018.10.067; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xi HB, 2017, CELL REP, V18, P1573, DOI 10.1016/j.celrep.2017.01.040; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717; Zakariyah Abeer, 2019, Curr Protoc Stem Cell Biol, V48, pe75, DOI 10.1002/cpsc.75; Zalc A, 2014, DEVELOPMENT, V141, P2780, DOI 10.1242/dev.110155; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	132	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222946	10.1371/journal.pone.0222946	http://dx.doi.org/10.1371/journal.pone.0222946			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560727	Green Published, gold			2022-12-26	WOS:000532353700026
J	Yu, L; Shen, Z; Liu, Q; Zhan, XY; Luo, XY; An, XM; Sun, YL; Li, MX; Wang, S; Nie, Z; Ao, YSQ; Zhao, YN; Peng, GQ; Ben Mamoun, C; He, L; Zhao, JL				Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; Ben Mamoun, Choukri; He, Lan; Zhao, Junlong			Crystal structures of Babesia microti lactate dehydrogenase BmLDH reveal a critical role for Arg99 in catalysis	FASEB JOURNAL			English	Article						LDH; growth inhibitor; catalytic mechanism; babesiosis	PLASMODIUM-FALCIPARUM; AZITHROMYCIN; ATOVAQUONE; INHIBITORS; GENOME; SITE; IDENTIFICATION; RESISTANCE; EFFICACY; SEQUENCE	The tick- and transfusion-transmitted human pathogen Babesia microti infects host erythrocytes to cause the pathologic symptoms associated with human babesiosis, an emerging disease with worldwide distribution and potentially fatal clinical outcome. Drugs currently recommended for the treatment of babesiosis are associated with a high failure rate and significant adverse events, highlighting the urgent need for more-effective and safer babesiosis therapies. Unlike other apicomplexan parasites, B. microti lacks a canonical lactate dehydrogenase (LDH) but instead expresses a unique enzyme, B. microti LDH (BmLDH), acquired through evolution by horizontal transfer from a mammalian host. Here, we report the crystal structures of BmLDH in apo state and ternary complex (enzyme-NADH-oxamate) solved at 2.79 and 1.89 angstrom. Analysis of these structures reveals that upon binding to the coenzyme and substrate, the active pocket of BmLDH undergoes a major conformational change from an opened and disordered to a closed and stabilized state. Biochemical assays using wild-type and mutant B. microti and human LDHs identified Arg99 as a critical residue for the catalytic activity of BmLDH but not its human counterpart. Interestingly, mutation of Arg99 to Ala had no impact on the overall structure and affinity of BmLDH to NADH but dramatically altered the closure of the enzyme's active pocket. Together, these structural and biochemical data highlight significant differences between B. microti and human LDH enzymes and suggest that BmLDH could be a suitable target for the development of selective antibabesial inhibitors.	[Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; He, Lan; Zhao, Junlong] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [He, Lan; Zhao, Junlong] Huazhong Agr Univ, Minist Agr, Key Lab Anim Epidem Dis & Infect Zoonoses, Wuhan, Peoples R China; [Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; He, Lan; Zhao, Junlong] Key Lab Prevent Vet Med, Wuhan, Peoples R China; [Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Yale University	He, L (corresponding author), Huazhong Agr Univ, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	helan@mail.hzau.edu.cn	He, Lan/AFU-5817-2022	Shen, Zhou/0000-0001-8772-2978	National Key Research and Development Program of China [2017YFD0501201]; National Key Basic Research Program (973 Program) of China [2015CB150302]; National Natural Science Foundation of China [31772729]; Natural Science Foundation of Hubei Province [2017CFA020]	National Key Research and Development Program of China; National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank the staff from BL17U/BL19U1/Beamline of the National Centre for Protein Sciences Shanghai (NCPSS), Shanghai Synchrotron Radiation Facility (Pudong, China) for assistance during data collection, and Dr. Deling Zhang (Center for Protein Research, Huazhong Agricultural University), for technical support. This study was supported by the National Key Research and Development Program of China (2017YFD0501201), the National Key Basic Research Program (973 Program) of China (2015CB150302), the National Natural Science Foundation of China (31772729), and the Natural Science Foundation of Hubei Province (2017CFA020). The authors declare no conflicts of interest.	Abraham A, 2018, J BIOL CHEM, V293, P19974, DOI 10.1074/jbc.AC118.005771; Al-Anouti F, 2004, J BIOL CHEM, V279, P52300, DOI 10.1074/jbc.M409175200; Bork S, 2004, MOL BIOCHEM PARASIT, V136, P165, DOI 10.1016/j.molbiopara.2004.03.009; Boucher JI, 2014, ELIFE, V3, DOI 10.7554/eLife.02304; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Cameron A, 2004, J BIOL CHEM, V279, P31429, DOI 10.1074/jbc.M402433200; Chaikuad A, 2005, BIOCHEMISTRY-US, V44, P16221, DOI 10.1021/bi051416y; Choi SR, 2007, J COMB CHEM, V9, P292, DOI 10.1021/cc060110n; Conners R, 2005, MOL BIOCHEM PARASIT, V142, P137, DOI 10.1016/j.molbiopara.2005.03.015; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; Dunn CR, 1996, NAT STRUCT BIOL, V3, P912, DOI 10.1038/nsb1196-912; Gomez MS, 1997, MOL BIOCHEM PARASIT, V90, P235, DOI 10.1016/S0166-6851(97)00140-0; Gray J, 2010, TICKS TICK-BORNE DIS, V1, P3, DOI 10.1016/j.ttbdis.2009.11.003; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Holmes RS, 2009, COMPUT BIOL CHEM, V33, P379, DOI 10.1016/j.compbiolchem.2009.07.006; Hwang SJ, 2010, J VET MED SCI, V72, P765, DOI 10.1292/jvms.09-0535; Iguchi A, 2014, J VET MED SCI, V76, P1291, DOI 10.1292/jvms.14-0139; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kavanagh KL, 2004, BIOCHEMISTRY-US, V43, P879, DOI 10.1021/bi035108g; Kirk SK, 2017, J VET INTERN MED, V31, P1108, DOI 10.1111/jvim.14777; Kletsova EA, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0198-9; Kolappan S, 2015, ACTA CRYSTALLOGR D, V71, P185, DOI 10.1107/S1399004714024791; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Lawres LA, 2016, J EXP MED, V213, P1307, DOI 10.1084/jem.20151519; Madern D, 2004, MOL BIOL EVOL, V21, P489, DOI 10.1093/molbev/msh042; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Mamoun C. B., 2018, ELS, DOI [10.1002/9780470015902.a0001945, DOI 10.1002/9780470015902.A0001945]; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; Raju M, 2007, PEDIATR INFECT DIS J, V26, P181, DOI 10.1097/01.inf.0000250622.11505.8f; Razakantoanina V, 2000, PARASITOL RES, V86, P665, DOI 10.1007/PL00008549; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; Shoemark DK, 2007, FEBS J, V274, P2738, DOI 10.1111/j.1742-4658.2007.05808.x; Silva JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35284; Simon MS, 2017, CLIN INFECT DIS, V65, P1222, DOI 10.1093/cid/cix477; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Vivas L, 2005, EXP PARASITOL, V111, P105, DOI 10.1016/j.exppara.2005.06.007; Vudriko P, 2014, DRUG TARGET INSIGHT, V8, P31, DOI 10.4137/DTI.S16504; Wormser GP, 2010, CLIN INFECT DIS, V50, P381, DOI 10.1086/649859; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Zhang HL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005250	44	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13669	13682		10.1096/fj.201901259R	http://dx.doi.org/10.1096/fj.201901259R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585506				2022-12-26	WOS:000507466100049
J	Allegrini, M; Gomez, ED; Smalla, K; Zabaloy, MC				Allegrini, Marco; Gomez, Elena del, V; Smalla, Kornelia; Celina Zabaloy, Maria			Suppression treatment differentially influences the microbial community and the occurrence of broad host range plasmids in the rhizosphere of the model cover crop Avena sativa L.	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; ROOT EXUDATION; SOIL; GLYPHOSATE; DIVERSITY; ARCHAEA; CARBON; NITRIFICATION; COLONIZATION; PREVALENCE	Cover crop suppression with glyphosate-based herbicides (GBHs) represents a common agricultural practice. The objective of this study was to compare rhizospheric microbial communities of A. sativa plants treated with a GBH relative to the mechanical suppression (mowing) in order to assess their differences and the potential implications for soil processes. Samples were obtained at 4, 10, 17 and 26 days post-suppression. Soil catabolic profiling and DNA-based methods were applied. At 26 days, higher respiration responses and functional diversity indices (Shannon index and catabolic evenness) were observed under glyphosate suppression and a neat separation of catabolic profiles was detected in multivariate analysis. Sarcosine and Tween 20 showed the highest contribution to this separation. Metabarcoding revealed a non-significant effect of suppression method on either alpha-diversity metrics or beta-diversity. Conversely, differences were detected in the relative abundance of specific bacterial taxa. Mesorhizobium sequences were detected in higher relative abundance in glyphosate-treated plants at the end of the experiment while the opposite trend was observed for Gaiella. Quantitative PCR of amoA gene from ammonia-oxidizing archaea showed a lower abundance under GBH suppression again at 26 days, while ammonia-oxidizing bacteria remained lower at all sampling times. Broad host range plasmids IncP-1 beta and IncP-1 epsilon were exclusively detected in the rhizosphere of glyphosate-treated plants at 10 days and at 26 days, respectively. Overall, our study demonstrates differential effects of suppression methods on the abundance of specific bacterial taxa, on the physiology and mobile genetic elements of microbial communities while no differences were detected in taxonomic diversity.	[Allegrini, Marco; Gomez, Elena del, V] Univ Nacl Rosario, IICAR, Lab Biodiversidad Vegetal & Microbiana, Campo Expt J Villarino,CONICET, Zavalla, Argentina; [Smalla, Kornelia] Julius Kuhn Inst, Inst Epidemiol & Pathogen Diagnost, Fed Res Ctr Cultivated Plants JKI, Braunschweig, Germany; [Celina Zabaloy, Maria] UNS, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, CONICET, Bahia Blanca, Buenos Aires, Argentina; [Celina Zabaloy, Maria] Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Julius Kuhn-Institut; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Allegrini, M (corresponding author), Univ Nacl Rosario, IICAR, Lab Biodiversidad Vegetal & Microbiana, Campo Expt J Villarino,CONICET, Zavalla, Argentina.; Zabaloy, MC (corresponding author), UNS, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, CONICET, Bahia Blanca, Buenos Aires, Argentina.; Zabaloy, MC (corresponding author), Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina.	marcalleg88@hotmail.com; mzabaloy@uns.edu.ar	Allegrini, Marco/AAB-8484-2022	Allegrini, Marco/0000-0002-3597-0387	Argentinean National Agency for Scientific and Technological Promotion (ANPCyT) [PICT 2012-0122, PICT 2015-1556]; National Scientific and Technical Research Council (CONICET) [PUE 22920160100043CO]; German Academic Exchange Service (DAAD); Ministry of Education, Culture, Science and Technology of Argentina (MECCyT) [57265911]; CONICET Doctoral and Post-doctoral fellowships	Argentinean National Agency for Scientific and Technological Promotion (ANPCyT); National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Education, Culture, Science and Technology of Argentina (MECCyT); CONICET Doctoral and Post-doctoral fellowships	This study was supported mainly by Argentinean National Agency for Scientific and Technological Promotion (ANPCyT) through projects PICT 2012-0122 and PICT 2015-1556 awarded to MCZ and EdVG, respectively, and partially by the project PUE 22920160100043CO of the National Scientific and Technical Research Council (CONICET). The authors acknowledge the German Academic Exchange Service (DAAD) and the Ministry of Education, Culture, Science and Technology of Argentina (MECCyT) for ALEARG short-term scholarship 2016 (57265911) awarded to MA, and CONICET Doctoral and Post-doctoral fellowships to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini M, 2017, SOIL BIOL BIOCHEM, V105, P206, DOI 10.1016/j.soilbio.2016.11.024; Anderson MJ, 2001, AUSTRAL ECOL; [Anonymous], 2009, PLASMID, V62, P134, DOI [10.1016/j.plasmid.2009.05.004, DOI 10.1016/J.PLASMID.2009.05.004]; Arango L, 2014, EUR J SOIL BIOL, V63, P41, DOI 10.1016/j.ejsobi.2014.05.005; Barriuso J, 2010, ENVIRON MICROBIOL, V12, P1021, DOI 10.1111/j.1462-2920.2009.02146.x; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Blau K, 2018, MBIO, V9, DOI 10.1128/mBio.01300-18; BOYLE TP, 1990, RES J WATER POLLUT C, V62, P749; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carey CJ, 2016, SOIL BIOL BIOCHEM, V99, P158, DOI 10.1016/j.soilbio.2016.05.014; Carfagno P, 2012, CONTRIBUCION CULTIVO, P36; Chavarria DN, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016142-8395; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Clayton SJ, 2005, BIOL FERT SOILS, V41, P109, DOI 10.1007/s00374-004-0811-x; COUPLAND D, 1979, NEW PHYTOL, V83, P17, DOI 10.1111/j.1469-8137.1979.tb00721.x; Dealtry S, 2014, APPL ENVIRON MICROB, V80, P4012, DOI 10.1128/AEM.04016-13; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Degens BP, 2001, SOIL BIOL BIOCHEM, V33, P1143, DOI 10.1016/S0038-0717(01)00018-9; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Druille M, 2013, APPL SOIL ECOL, V64, P99, DOI 10.1016/j.apsoil.2012.10.007; Dunon V, 2013, FEMS MICROBIOL ECOL, V86, P415, DOI 10.1111/1574-6941.12173; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egle K, 2003, AGRONOMIE, V23, P511, DOI 10.1051/agro:2003025; Feld L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126080; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Hermans SM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02826-16; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Heuer H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00002; Horwath W.R., 1996, METHODS SOIL ANAL PA, P753; Hoshino YT, 2011, MICROBES ENVIRON, V26, P307, DOI 10.1264/jsme2.ME11131; Huang JL, 2005, J MOL EVOL, V61, P682, DOI 10.1007/s00239-004-0349-4; Imparato V, 2016, APPL SOIL ECOL, V98, P47, DOI 10.1016/j.apsoil.2015.09.007; Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1410, DOI 10.1128/AEM.03728-12; Jenkins M, 2017, SOIL SCI SOC AM J, V81, P1371, DOI 10.2136/sssaj2017.02.0063; Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176; Kassambara A, 2017, FACTOEXTRA EXTRACT V, V5, P1; Kremer RJ, 2005, INT J ENVIRON AN CH, V85, P1165, DOI 10.1080/03067310500273146; Krogh KA, 2003, CHEMOSPHERE, V50, P871, DOI 10.1016/S0045-6535(02)00648-3; Laitinen P, 2007, PLANT SOIL, V300, P51, DOI 10.1007/s11104-007-9387-1; Lancaster SH, 2010, PEST MANAG SCI, V66, P59, DOI 10.1002/ps.1831; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Littell RC, 2002, WILEY SERIES PROBABI, P87; Liu L, 1997, PHYSIOL MOL PLANT P, V51, P111, DOI 10.1006/pmpp.1997.0113; Lu YC, FOOD REV; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Martino DL, 1995, UNIDAD DIFUSION INFO, P8; Mijangos I, 2009, SOIL BIOL BIOCHEM, V41, P505, DOI 10.1016/j.soilbio.2008.12.009; Molbak L, 2007, FEMS MICROBIOL ECOL, V59, P167, DOI 10.1111/j.1574-6941.2006.00229.x; Newman MM, 2016, SCI TOTAL ENVIRON, V543, P155, DOI 10.1016/j.scitotenv.2015.11.008; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ouyang Y, 2016, SOIL BIOL BIOCHEM, V96, P4, DOI 10.1016/j.soilbio.2016.01.012; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pfeiffer S, 2014, ENVIRON MICROBIOL, V16, P2389, DOI 10.1111/1462-2920.12350; R Core Team, 2021, R LANGUAGE ENV STAT; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Raymann K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00026-17; RODRIGUES JJV, 1982, WEED SCI, V30, P316, DOI 10.1017/S0043174500040601; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scott MJ, 2000, BBA-BIOMEMBRANES, V1508, P235, DOI 10.1016/S0304-4157(00)00013-7; Senechkin IV, 2010, MICROB ECOL, V60, P829, DOI 10.1007/s00248-010-9670-1; Sihtmae M, 2013, APPL SOIL ECOL, V72, P215, DOI 10.1016/j.apsoil.2013.07.005; Subbarao GV, 2015, PLANT SCI, V233, P155, DOI 10.1016/j.plantsci.2015.01.012; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tesfamariam T, 2009, EUR J AGRON, V31, P126, DOI 10.1016/j.eja.2009.03.007; TOP EM, 1995, APPL ENVIRON MICROB, V61, P1691, DOI 10.1128/AEM.61.5.1691-1698.1995; van Elsas JD, 2003, NEW PHYTOL, V157, P525, DOI 10.1046/j.1469-8137.2003.00697.x; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wodnicka M, 2000, J BIOMOL SCREEN, V5, P141, DOI 10.1177/108705710000500306; Yanai RD, 2003, PLANT SOIL, V257, P133, DOI 10.1023/A:1026257508033; Zabaloy MC, 2012, APPL SOIL ECOL, V61, P333, DOI 10.1016/j.apsoil.2011.12.004; Zabaloy MC, 2010, APPL SOIL ECOL, V46, P240, DOI 10.1016/j.apsoil.2010.08.006; Zabaloy MC, 2017, APPL SOIL ECOL; Zhang MY, 2018, BIOL FERT SOILS, V54, P697, DOI 10.1007/s00374-018-1293-6; Zobiole LHS, 2011, J APPL MICROBIOL, V110, P118, DOI 10.1111/j.1365-2672.2010.04864.x	84	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0223600	10.1371/journal.pone.0223600	http://dx.doi.org/10.1371/journal.pone.0223600			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596877	gold, Green Published, Green Submitted			2022-12-26	WOS:000532444100047
J	Chokchaloemwong, D; Hattori, S; Cuesta, E; Jintasakul, P; Shibata, M; Azuma, Y				Chokchaloemwong, Duangsuda; Hattori, Soki; Cuesta, Elena; Jintasakul, Pratueng; Shibata, Masateru; Azuma, Yoichi			A new carcharodontosaurian theropod (Dinosauria: Saurischia) from the Lower Cretaceous of Thailand	PLOS ONE			English	Article							CONCAVENATOR-CORCOVATUS THEROPODA; KHOK KRUAT FORMATION; IGUANODONTIAN DINOSAUR; CARNOSAUR DINOSAURIA; EVOLUTION; OSTEOLOGY; PNEUMATICITY; PHYLOGENY; RECONSTRUCTION; SPECIMEN	The isolated fossil remains of an allosauroid theropod from the Lower Cretaceous Khok Kruat Formation of Khorat, Thailand, are described in this study. Detailed observations support the establishment of a new allosauroid, Siamraptor suwati gen. et sp. nov. This new taxon is based on a composite cranial and postcranial skeleton comprising premaxilla, maxilla, jugal, surangular, prearticular, articular, vertebrae, manual ungual, ischium, tibia, and pedal phalanx. It is distinguished from other allosauroids by characters such as a jugal with straight ventral margin and dorsoventrally deep anterior process below the orbit, a surangular with a deep oval concavity at the posterior end of the lateral shelf and four posterior surangular foramina, a long and narrow groove along the suture between the surangular and the prearticular, an articular with a foramen at the notch of the suture with the prearticular, an anterior cervical vertebra with a pneumatic foramen (so-called 'pleurocoel') excavating parapophysis, and cervical and posterior dorsal vertebrae penetrated by a pair of small foramina bilaterally at the base of the neural spine. The presence of a huge number of camerae and pneumatopores in cranial and axial elements reveals a remarkable skeletal pneumatic system in this new taxon. Moreover, the phylogenetic analyses revealed that Siamraptor is a basal taxon of Carcharodontosauria, involving a new sight of the paleobiogeographical context of this group. Siamraptor is the best preserved carcharodontosaurian theropod in Southeast Asia, and it sheds new light on the early evolutionary history of Carcharodontosauria.	[Chokchaloemwong, Duangsuda; Jintasakul, Pratueng] Nakhon Ratchasima Rajabhat Univ, Northeastern Res Inst Petrified Wood & Mineral Re, Nakhon Ratchasima Dist, Nakhon Ratchasi, Thailand; [Hattori, Soki; Cuesta, Elena; Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Univ, Inst Dinosaur Res, Eiheiji Cho, Fukui, Japan; [Hattori, Soki; Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Dinosaur Museum, Katsuyama, Fukui, Japan	Nakhon Ratchasima Rajabhat University; Fukui Prefectural University	Hattori, S (corresponding author), Fukui Prefectural Univ, Inst Dinosaur Res, Eiheiji Cho, Fukui, Japan.; Hattori, S (corresponding author), Fukui Prefectural Dinosaur Museum, Katsuyama, Fukui, Japan.	s-hattori@fpu.ac.jp	Cuesta, Elena/AAA-3526-2020	Cuesta, Elena/0000-0002-4409-8420; Hattori, Soki/0000-0002-7598-1638	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand; Japan Society of Promotion of Science (JSPS) [PE18034]	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand; Japan Society of Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Fukui Prefectural Government, Japan, and Nakhon Ratchasima Rajabhat University, Thailand. EC research was financed by a Postdoctoral Fellowship program of the Japan Society of Promotion of Science (JSPS) (Ref. PE18034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2015, J ASIAN EARTH SCI, V98, P358, DOI 10.1016/j.jseaes.2014.11.032; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Britt BB, 1993, PNEUM POSTCR BON DIN; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, ZOOTAXA, P1; Brusatte SL, 2012, ACTA PALAEONTOL POL, V57, P65, DOI 10.4202/app.2010.0125; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; BUFFETAUT E, 1992, PALAEONTOLOGY, V35, P801; Buffetaut E, 1996, NATURE, V381, P689, DOI 10.1038/381689a0; Buffetaut E, 2012, 10 ANN M EUR ASS VER, P27; Buffetaut E, 2005, INT C GEOL GEOT MIN, P28; Buffetaut E, 2007, B SOC GEOL FR, V178, P497, DOI 10.2113/gssgfbull.178.6.497; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Calvo JO, 2004, AMEGHINIANA, V41, P565; Cappetta H., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1990, P659; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Cau A, 2018, PEERJ, V6, DOI 10.7717/peerj.4868; Chanthasit P., 2015, 2 INT S AS DIN 2015, P23; CHURE DJ, 2000, NEW SPECIES ALLOSAUR; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157973; Cuesta E, 2018, J VERTEBR PALEONTOL, V38, DOI 10.1080/02724634.2018.1485153; Cuesta E, 2019, CRETACEOUS RES, V95, P106, DOI 10.1016/j.cretres.2018.10.026; Cuesta E, 2018, CRETACEOUS RES, V91, P176, DOI 10.1016/j.cretres.2018.06.007; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dong Z-M, 1978, KEXUE TONGBAO, V23, P302; Dunhill AM, 2016, J BIOGEOGR, V43, P1691, DOI 10.1111/jbi.12766; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Filla J., 1992, HUNTERIA, V2, P1; Gao Yuhui, 1993, Vertebrata Palasiatica, V31, P308; Gao Yuhui, 1992, Vertebrata Palasiatica, V30, P313; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gold MEL, 2013, AM MUS NOVIT, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Harris J.D., 1998, B NEW MEXICO MUSEUM, V13, P1; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P5; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hu S. y., 1964, Vertebrata Palasiatica, V8, P42; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; HUTT S, 1996, NEUES JB GEOLOGIE PA, P635; Canale JI, 2015, HIST BIOL, V27, P1, DOI 10.1080/08912963.2013.861830; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Maddison WP, 2011, MESQUITE MODULAR SYS; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Malafaia E, 2019, J PALEONTOL, V93, P157, DOI 10.1017/jpa.2018.47; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Marsh OC, 1881, AM J SCI, V16, P417; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Meesook A, 2011, GEOLOGY OF THAILAND, P169; Mo JY, 2014, ACTA GEOL SIN-ENGL, V88, P1051, DOI 10.1111/1755-6724.12272; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; Rauhut OWM, 2016, PALAEONTOL ELECTRON, V19; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut Oliver W.M., 1995, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V16, P357; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rowe T., 1990, P151; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Shibata M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145904; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E., 1931, MATH ABTEILUNG NEUE, V9, P6; Suteethorn Varavudh, 1995, P133; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; von Huene F, 1923, BULL GEOL SOC AM, V34, P449; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Ward DE, 1964, DEP MINERAL RESOURCE, V6, P1; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Wu XC, 2009, ACTA GEOL SIN-ENGL, V83, P9, DOI 10.1111/j.1755-6724.2009.00002.x; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Yukawa H, 2014, PROGR 2 INT S AS DIN, P109; Z-M Dong, 1973, MEM I VERTEBR PALEON, P11; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; ZHAO XJ, 1993, CAN J EARTH SCI, V30, P2027, DOI 10.1139/e93-178; Zurriaguz VL, 2017, CRETACEOUS RES, V73, P14, DOI 10.1016/j.cretres.2017.01.001	110	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0222489	10.1371/journal.pone.0222489	http://dx.doi.org/10.1371/journal.pone.0222489			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596853	Green Published, gold			2022-12-26	WOS:000532444100012
J	Payelleville, A; Blackburn, D; Lanois, A; Pages, S; Cambon, MC; Ginibre, N; Clarke, DJ; Givaudan, A; Brillard, J				Payelleville, Amaury; Blackburn, Dana; Lanois, Anne; Pages, Sylvie; Cambon, Marine C.; Ginibre, Nadege; Clarke, David J.; Givaudan, Alain; Brillard, Julien			Role of the Photorhabdus Dam methyltransferase during interactions with its invertebrate hosts	PLOS ONE			English	Article							DNA ADENINE METHYLATION; HETERORHABDITIS-BACTERIOPHORA; FULL VIRULENCE; LUMINESCENS; GENE; SYMBIOSIS; PATHOGENICITY; XENORHABDUS; MECHANISMS; EXPRESSION	Photorhabdus luminescens is an entomopathogenic bacterium found in symbiosis with the nematode Heterorhabditis. Dam DNA methylation is involved in the pathogenicity of many bacteria, including P. luminescens, whereas studies about the role of bacterial DNA methylation during symbiosis are scarce. The aim of this study was to determine the role of Dam DNA methylation in P. luminescens during the whole bacterial life cycle including during symbiosis with H. bacteriophora. We constructed a strain overexpressing dam by inserting an additional copy of the dam gene under the control of a constitutive promoter in the chromosome of P. luminescens and then achieved association between this recombinant strain and nematodes. The dam overexpressing strain was able to feed the nematode in vitro and in vivo similarly as a control strain, and to re-associate with Infective Juvenile (IJ) stages in the insect. No difference in the amount of emerging IJs from the cadaver was observed between the two strains. Compared to the nematode in symbiosis with the control strain, a significant increase in LT50 was observed during insect infestation with the nematode associated with the dam overexpressing strain. These results suggest that during the life cycle of P. luminescens, Dam is not involved the bacterial symbiosis with the nematode H. bacteriophora, but it contributes to the pathogenicity of the nemato-bacterial complex.	[Payelleville, Amaury; Lanois, Anne; Pages, Sylvie; Cambon, Marine C.; Ginibre, Nadege; Givaudan, Alain; Brillard, Julien] Univ Montpellier, INRA, DGIMI, Montpellier, France; [Blackburn, Dana; Clarke, David J.] Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Cambon, Marine C.] UPS Univ Paul Sabatier, CNRS, Evolut & Diversite Biol, Toulouse, France; [Payelleville, Amaury] Univ Libre Bruxelles ULB, Van Melderen Lab, Cellular & Mol Microbiol, Brussels, Belgium	INRAE; Universite de Montpellier; University College Cork; Centre National de la Recherche Scientifique (CNRS); Universite Libre de Bruxelles	Payelleville, A; Brillard, J (corresponding author), Univ Montpellier, INRA, DGIMI, Montpellier, France.; Payelleville, A (corresponding author), Univ Libre Bruxelles ULB, Van Melderen Lab, Cellular & Mol Microbiol, Brussels, Belgium.	Amaury.Payelleville@ulb.ac.be; julien.brillard@umontpellier.fr	Clarke, David J/I-7859-2014; Payelleville, Amaury/GLQ-9880-2022; Payelleville, Amaury/AAZ-4518-2020	Payelleville, Amaury/0000-0002-0584-9017; Payelleville, Amaury/0000-0002-0584-9017; Cambon, Marine/0000-0001-5234-4196; Clarke, David/0000-0001-9082-0501	GAIA doctoral school [584]; Academie d'Agriculture de France; INRA Plant Health and Environment (SPE) division [SPE-IB17-DiscriMet]; French ministry MEAE; French ministry MESRI; French National Research Agency (EPI-PATH project) [ANR-17-CE20-0005]	GAIA doctoral school; Academie d'Agriculture de France; INRA Plant Health and Environment (SPE) division; French ministry MEAE; French ministry MESRI; French National Research Agency (EPI-PATH project)(French National Research Agency (ANR))	AP received funding from GAIA doctoral school #584 and from Academie d'Agriculture de France for a Dufrenoy grant. JB received funding from INRA Plant Health and Environment (SPE) division for financial support (SPE-IB17-DiscriMet) and from the French ministries MEAE and MESRI for a PHC ULYSSES 2018 grant, and from the French National Research Agency (EPI-PATH project, ANR-17-CE20-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDING RA, 1982, NEMATOLOGICA, V28, P354, DOI 10.1163/187529282X00402; Bintrim SB, 1998, J BACTERIOL, V180, P1261, DOI 10.1128/JB.180.5.1261-1269.1998; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Bowen DJ, 2001, APPL ENVIRON MICROB, V67, P4834, DOI 10.1128/AEM.67.10.4834-4841.2001; Brillard J, 2002, J BACTERIOL, V184, P3871, DOI 10.1128/JB.184.14.3871-3878.2002; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Clarke DJ, 2017, CURR TOP MICROBIOL, V402, P81, DOI 10.1007/82_2016_21; Clarke DJ, 2014, ADV APPL MICROBIOL, V88, P1, DOI 10.1016/B978-0-12-800260-5.00001-2; CLARKE DJ, 1995, J INVERTEBR PATHOL, V66, P149, DOI 10.1006/jipa.1995.1078; Davis-Richardson, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00518, DOI 10.3389/FMICB.2016.00518]; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; Erova TE, 2006, INFECT IMMUN, V74, P5763, DOI 10.1128/IAI.00994-06; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Glaeser A, 2015, BIOTECHNIQUES, V59, P74, DOI 10.2144/000114317; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hu Patrick J, 2007, WormBook, P1; Ichida H, 2007, FEBS J, V274, P951, DOI 10.1111/j.1742-4658.2007.05643.x; Ichida H, 2009, BIOCHEM BIOPH RES CO, V389, P301, DOI 10.1016/j.bbrc.2009.08.137; Jubelin G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003915; Julio SM, 2002, INFECT IMMUN, V70, P1006, DOI 10.1128/IAI.70.2.1006-1009.2002; Kohler S, 1999, INFECT IMMUN, V67, P6695; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumar N, 2012, J BACTERIOL, V194, P5963, DOI 10.1128/JB.01371-12; Kumar S, 2018, NUCLEIC ACIDS RES, V46, P3429, DOI 10.1093/nar/gky126; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; LobnerOlesen A, 1996, EMBO J, V15, P5999; Mouammine A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43670; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Payelleville A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30620-5; Payelleville A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01671; POITOUT S, 1970, Annales de Zoologie Ecologie Animale, V2, P79; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Robinson VL, 2005, FEMS MICROBIOL LETT, V252, P251, DOI 10.1016/j.femsle.2005.09.001; Rousset F, 2014, ECOGRAPHY, V37, P781, DOI 10.1111/ecog.00566; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Somvanshi VS, 2010, MOL MICROBIOL, V77, P1021, DOI 10.1111/j.1365-2958.2010.07270.x; Watson RJ, 2005, MOL MICROBIOL, V56, P763, DOI 10.1111/j.1365-2958.2005.04574.x; Zamora-Lagos MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5121-z	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2019	14	10							e0212655	10.1371/journal.pone.0212655	http://dx.doi.org/10.1371/journal.pone.0212655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7QS	31596856	Green Submitted, Green Published, gold			2022-12-26	WOS:000532444100001
J	Tejera, E; Carrera, I; Jimenes-Vargas, K; Armijos-Jaramillo, V; Sanchez-Rodriguez, A; Cruz-Monteagudo, M; Perez-Castillo, Y				Tejera, E.; Carrera, I; Jimenes-Vargas, Karina; Armijos-Jaramillo, V; Sanchez-Rodriguez, A.; Cruz-Monteagudo, M.; Perez-Castillo, Y.			Cell fishing: A similarity based approach and machine learning strategy for multiple cell lines-compound sensitivity prediction	PLOS ONE			English	Article							CONNECTIVITY MAP; QSAR	The prediction of cell-lines sensitivity to a given set of compounds is a very important factor in the optimization of in-vitro assays. To date, the most common prediction strategies are based upon machine learning or other quantitative structure-activity relationships (QSAR) based approaches. In the present research, we propose and discuss a straightforward strategy not based on any learning modelling but exclusively relying upon the chemical similarity of a query compound to reference compounds with annotated activity against cell lines. We also compare the performance of the proposed method to machine learning predictions on the same problem. A curated database of compounds-cell lines associations derived from ChemBL version 22 was created for algorithm construction and cross-validation. Validation was done using 10-fold cross-validation and testing the models on new data obtained from ChemBL version 25. In terms of accuracy, both methods perform similarly with values around 0.65 across 750 cell lines in 10-fold cross-validation experiments. By combining both methods it is possible to achieve 66% of correct classification rate in more than 26000 newly reported interactions comprising 11000 new compounds. A Web Service implementing the described approaches (both similarity and machine learning based models) is freely available at: http://bioquirnio.udla.edu.ec/cellfishing.	[Tejera, E.; Jimenes-Vargas, Karina; Armijos-Jaramillo, V] Univ Las Amer, Fac Ingn & Ciencias Aplicadas, Ingn Biotecnol, Quito, Ecuador; [Tejera, E.; Armijos-Jaramillo, V; Sanchez-Rodriguez, A.; Perez-Castillo, Y.] Univ Las Amer, Grp Bioquimioinformat, Quito, Ecuador; [Carrera, I] Escuela Politec Nacl, Dept Informat & Ciencias Comp, Quito, Ecuador; [Carrera, I] Univ Porto, Fac Ciencias, Dept Ciencias Comp, Porto, Portugal; [Sanchez-Rodriguez, A.] Univ Tecn Particular Loja, Loja, Ecuador; [Cruz-Monteagudo, M.] Univ Miami UM, Ctr Computat Sci CCS, Miami, FL USA; [Cruz-Monteagudo, M.] West Coast Univ, Miami, FL USA; [Perez-Castillo, Y.] Univ Las Amer, Escuela Ciencias Fis & Matemat, Quito, Ecuador	Universidad de Las Americas - Ecuador; Universidad de Las Americas - Ecuador; Escuela Politecnica Nacional Ecuador; Universidade do Porto; Universidad Tecnica Particular de Loja; Universidad de Las Americas - Ecuador	Tejera, E (corresponding author), Univ Las Amer, Fac Ingn & Ciencias Aplicadas, Ingn Biotecnol, Quito, Ecuador.; Tejera, E (corresponding author), Univ Las Amer, Grp Bioquimioinformat, Quito, Ecuador.	edutp00@gmail.com	Perez-Castillo, Yunierkis/AAY-1756-2020	Perez-Castillo, Yunierkis/0000-0002-3710-0035; Armijos-Jaramillo, Vinicio Danilo/0000-0003-2965-2515; Carrera, Ivan/0000-0003-4337-7433; Tejera, Eduardo/0000-0002-1377-0413	Universidad de las Americas, Quito, Ecuador [BIO.ETP.18.01]	Universidad de las Americas, Quito, Ecuador	This work was funded by Universidad de las Americas, Quito, Ecuador. (BIO.ETP.18.01). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amnnad-ud-din M, 2014, J CHEM INF MODEL, V54, P2347, DOI 10.1021/ci500152b; Bajorath J, 2009, DRUG DISCOV TODAY, V14, P698, DOI 10.1016/j.drudis.2009.04.003; Bender A, 2006, ANN REP COMP CHEM, V2, P141, DOI 10.1016/S1574-1400(06)02009-3; Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006; Cheng J, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0095-1; Cortes-Ciriano I., 2015, BIOINFORMATICS, V32, DOI [10.1093/bioinformatics/btv529, DOI 10.1093/BIOINFORMATICS/BTV529]; Cortes-Ciriano I, 2017, BIORXIV, DOI [10.1101/105478, DOI 10.1101/105478]; Cruz-Monteagudo M, 2017, DRUG DISCOV TODAY, V22, P994, DOI 10.1016/j.drudis.2017.02.004; Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382; Ding P, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax095; Duan QN, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.15; Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074; Guha R, 2008, J CHEM INF MODEL, V48, P1716, DOI 10.1021/ci8001414; Jenkins JL, SILICO TARGET FISHIN, DOI [10.1016/j.ddtec.2006.12.008, DOI 10.1016/J.DDTEC.2006.12.008]; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Lagunin AA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191838; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Liu X, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-33; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Peon A., 2017, PREDICTING RELIABILI; Peon A, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00015; RDKit, 2018, OP SOURC CHEM; Stumpfe D, 2012, J MED CHEM, V55, P2932, DOI 10.1021/jm201706b; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Wang KJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003315; ZHANG J, 2018, MOLECULES, V23, DOI DOI 10.3390/MOLECULES23092208; Zhang NQ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004498	27	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2019	14	10							e0223276	10.1371/journal.pone.0223276	http://dx.doi.org/10.1371/journal.pone.0223276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7KN	31589649	Green Published, gold			2022-12-26	WOS:000532427300015
J	Ma, TL; Hu, TH; Hung, CH; Wang, JH; Lu, SN; Chen, CH				Ma, Te-Ling; Hu, Tsung-Hui; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Chen, Chien-Hung			Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment	PLOS ONE			English	Article							SURFACE-ANTIGEN; GUIDELINES; THERAPY	Background This study investigated the incidence and predictors of retreatment after discontinuation of either entecavir (ETV) or tenofovir disoproxil fumarate (TDF) treatment in Taiwan. Methods A total of 535 non-cirrhotic chronic hepatitis B (CHB) patients undergoing either ETV (n = 358) or TDF (n = 177) treatment were enrolled. Patients were followed for at least 12 months after stopping ETV or TDF treatment. Most patients (86.3%) fulfilled the retreatment criteria of Taiwan's National Health Plan. Results The 5-year cumulative rates of clinical relapse and retreatment were 52.1% and 47%, respectively, in 160 hepatitis B e antigen (HBeAg)-positive patients, and were 62% and 54.8%, respectively, in 375 HBeAg-negative patients. The median duration from the end of treatment until clinical relapse and retreatment was 40 and 57 weeks, respectively, for all patients. Multivariate Cox regression analysis revealed that discontinuing TDF treatment, old age, male gender, and higher baseline HBsAg levels were independent factors of retreatment in HBeAg-positive patients; old age, HBV genotype B, and higher baseline and end-of-treatment HBsAg levels were independent factors in HBeAg-negative patients. A total of 18.8% of retreated patients satisfied the retreatment criteria of hepatic decompensation according to Taiwan's National Health Plan. Of the 64 patients who had clinical relapse without retreatment, 17 achieved sustained virological remission and 26 did not experience clinical relapse until their last visit after clinical relapse. Four patients developed HBsAg loss. Conclusions The 5-year retreatment rate was about 50% in HBeAg-positive and HBeAg-negative patients. Discontinuing TDF treatment was an independent factor of retreatment in HBeAg-positive patients.	[Ma, Te-Ling; Hu, Tsung-Hui; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Chen, Chien-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Ma, Te-Ling; Hu, Tsung-Hui; Hung, Chao-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Chen, Chien-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	e580306@ms31.hinet.net			Ministry of Science and Technology [NMRPG8G6102]; Chang Gung Memorial Hospital, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was financially supported by grants NMRPG8G6102 from the Ministry of Science and Technology and CMRPG8F from the Chang Gung Memorial Hospital, Taiwan.	Chen CH, 2018, CLIN MICROBIOL INFEC, V24, P997, DOI 10.1016/j.cmi.2017.12.013; Chen CH, 2018, J VIRAL HEPATITIS, V25, P590, DOI 10.1111/jvh.12851; Chen CH, 2015, CLIN GASTROENTEROL H, V13, P1984, DOI 10.1016/j.cgh.2015.06.002; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Jeng WJ, 2018, HEPATOLOGY, V68, P425, DOI 10.1002/hep.29640; Jeng WJ, 2016, CLIN GASTROENTEROL H, V14, P1813, DOI 10.1016/j.cgh.2016.07.002; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Kuo MT, 2019, ALIMENT PHARM THER, V49, P218, DOI 10.1111/apt.15053; Lee CM, 2003, SCAND J GASTROENTERO, V38, P95, DOI 10.1080/00365520310000500; Liaw YF, 2018, GASTROENTEROLOGY, V154, P2280, DOI 10.1053/j.gastro.2018.03.066; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Papatheodoridis GV, 2018, ANTIVIR THER, V23, P677, DOI 10.3851/IMP3256; Papatheodoridis GV, 2018, HEPATOLOGY, V68, P415, DOI 10.1002/hep.29497; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Su TH, 2018, J INFECT DIS, V217, P1193, DOI 10.1093/infdis/jix690; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Xu WX, 2018, CAN J GASTROENTEROL, V2019, DOI 10.1155/2018/1817680	20	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2019	14	10							e0222221	10.1371/journal.pone.0222221	http://dx.doi.org/10.1371/journal.pone.0222221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7CZ	31584951	gold, Green Published			2022-12-26	WOS:000532407600006
J	Aoki, M; Murase, T				Aoki, Masafumi; Murase, Takatoshi			Obesity-associated insulin resistance adversely affects skin function	PLOS ONE			English	Article							OXIDATIVE STRESS; BARRIER FUNCTION; RECEPTOR SUBSTRATE-1; DOWN-REGULATION; DIFFERENTIATION; INFLAMMATION; MICE; MECHANISMS; FILAGGRIN; FRAGILITY	The aim of this study was to identify changes in skin function associated with obesity and the mechanisms underlying these changes. Functional changes and gene expression in skin were investigated in C57BLI6J mice fed either a control or high -fat diet (HFD). The insulin responsiveness of the skin and skeletal muscle was also evaluated. The effects of inhibiting insulin signaling and altered glucose concentration on skin function-associated molecules and barrier function were analyzed in keratinocytes. HFD-fed mice were not only severely obese, but also exhibited impaired skin barrier function and diminished levels of glycerol transporter aquaporin-3, keratins, and desmosomal proteins involved in maintaining skin structure. Moreover, the expression of cell cycle regulatory molecules was altered. Insulin signaling was attenuated in the skin and skeletal muscle of HFD-fed mice. In keratinocytes, inhibition of insulin signaling leads to decreased keratin expression and diminished barrier function, and higher glucose concentrations increased the expression of CDK inhibitor 1A and 1C, which are associated with cell-cycle arrest. Obesity-associated impairment of skin function can be attributed to structural fragility, abnormal glycerol transport, and dys-regulated proliferation of epidermal cells. These alterations are at least partly due to cutaneous insulin resistance and hyperglycemia.	[Aoki, Masafumi; Murase, Takatoshi] Kao Corp, Biol Sci Labs, Ichikai, Tochigi, Japan	KAO Corporation	Murase, T (corresponding author), Kao Corp, Biol Sci Labs, Ichikai, Tochigi, Japan.	murase.takatoshi@kao.com		Murase, Takatoshi/0000-0002-5496-0133	Kao Corporation	Kao Corporation	This study was fully funded by Kao Corporation and all authors were permanent employees of Kao Corporation. Kao Corporation provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Boden G, 2013, CURR PHARM DESIGN, V19, P5678, DOI 10.2174/1381612811319320003; Boer M, 2016, POSTEP DERM ALERGOL, V33, P1, DOI 10.5114/pdia.2015.48037; Boric M, 2013, J CHEM NEUROANAT, V53, P33, DOI 10.1016/j.jchemneu.2013.10.001; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brown Jenny, 2004, Nurs Stand, V18, P38; Calleja-Agius J, 2007, Menopause Int, V13, P60, DOI 10.1258/175404507780796325; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Chiricozzi A, 2016, EXPERT REV CLIN IMMU, V12, P1299, DOI 10.1080/1744666X.2016.1201423; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hara M, 2003, P NATL ACAD SCI USA, V100, P7360, DOI 10.1073/pnas.1230416100; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Ibuki A, 2012, EXP DERMATOL, V21, P178, DOI 10.1111/j.1600-0625.2011.01409.x; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jensen JM, 2000, J INVEST DERMATOL, V115, P708, DOI 10.1046/j.1523-1747.2000.00103.x; Jiang N, 2015, TOHOKU J EXP MED, V236, P71, DOI 10.1620/tjem.236.71; Jin T, 2017, ANN DERMATOL, V29, P407, DOI 10.5021/ad.2017.29.4.407; Johnson JL, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015297; Jungersted JM, 2010, ACTA DERM-VENEREOL, V90, P350, DOI 10.2340/00015555-0894; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim MY, 2011, ANN DERMATOL, V23, P439, DOI 10.5021/ad.2011.23.4.439; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Lee SH, 2006, YONSEI MED J, V47, P293, DOI 10.3349/ymj.2006.47.3.293; Li CL, 2017, ADV EXP MED BIOL, V969, P1, DOI 10.1007/978-94-024-1057-0_1; Ling-juan Z., 2018, KERATINS SKIN EPIDER, DOI [10.5772/intechopen.79050, DOI 10.5772/INTECHOPEN.79050]; Loffler H, 2002, SKIN RES TECHNOL, V8, P19; Matsumoto M, 2014, INT J COSMETIC SCI, V36, P477, DOI 10.1111/ics.12145; McLean W H Irwin, 2007, Ulster Med J, V76, P72; Menon GK, 2012, INT J PHARMACEUT, V435, P3, DOI 10.1016/j.ijpharm.2012.06.005; Mori S, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0632-1; Nino M, 2012, PEDIATR DERMATOL, V29, P567, DOI 10.1111/j.1525-1470.2012.01738.x; Okano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166215; Pendaries V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.29; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qin HX, 2011, ARCH BIOCHEM BIOPHYS, V508, P138, DOI 10.1016/j.abb.2011.01.014; Quondamatteo F, 2014, CELL TISSUE RES, V355, P1, DOI 10.1007/s00441-013-1751-2; Re RN, 2009, OCHSNER J, V9, P133; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Sakai S, 2003, J INVEST DERMATOL, V120, P79, DOI 10.1046/j.1523-1747.2003.12006.x; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627; Swann G, 2010, J VIS COMMUN MED, V33, P148, DOI 10.3109/17453054.2010.525439; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Tellechea A, 2013, INT J LOW EXTR WOUND, V12, P4, DOI 10.1177/1534734612474303; Terashi Hiroto, 2005, Int Wound J, V2, P298, DOI 10.1111/j.1742-4801.2005.00148.x; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Wertheimer E, 2000, J INVEST DERMATOL, V115, P24, DOI 10.1046/j.1523-1747.2000.00008.x; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wikramanayake TC, 2014, ADV WOUND CARE, V3, P272, DOI 10.1089/wound.2013.0503; Zong HH, 2009, J BIOL CHEM, V284, P4679, DOI 10.1074/jbc.M807408200	55	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223528	10.1371/journal.pone.0223528	http://dx.doi.org/10.1371/journal.pone.0223528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6ZN	31581253	gold, Green Published			2022-12-26	WOS:000532398600071
J	Gilligan, TM; Sibilia, F; Farrell, D; Lyons, D; Kennelly, SP; Bokde, ALW				Gilligan, Therese M.; Sibilia, Francesca; Farrell, Dervla; Lyons, Declan; Kennelly, Sean P.; Bokde, Arun L. W.			No relationship between fornix and cingulum degradation and within-network decreases in functional connectivity in prodromal Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER DEGENERATION; POSTERIOR CINGULATE; STRUCTURAL CONNECTIVITY; EPISODIC MEMORY; WHOLE-BRAIN; STATE; DEMENTIA; MRI; ABNORMALITIES	Introduction The earliest changes in the brain due to Alzheimer's disease are associated with the neural networks related to memory function. We investigated changes in functional and structural connectivity among regions that support memory function in prodromal Alzheimer's disease, i.e., during the mild cognitive impairment (MCI) stage. Methods Twenty-three older healthy controls and 25 adults with MCI underwent multimodal MRI scanning. Limbic white matter tracts the fornix, parahippocampal cingulum, retrosplenial cingulum, subgenual cingulum and uncinate fasciculus were reconstructed in ExploreDTl using constrained spherical deconvolution-based tractography. Using a network-of-interest approach, resting-state functional connectivity time-series correlations among sub-parcellations of the default mode and limbic networks, the hippocampus and the thalamus were calculated in Conn. Analysis Controlling for age, education, and gender between group linear regressions of five diffusion-weighted measures and of resting state connectivity measures were performed per hemisphere. FDR-corrections were performed within each class of measures. Correlations of within-network Fisher Z-transformed correlation coefficients and the mean diffusivity per tract were performed. Whole-brain graph theory measures of cluster coefficient and average path length were inspecting using the resting state data. Results & conclusion MCI-related changes in white matter structure were found in the fornix, left parahippocampal cingulum, left retrosplenial cingulum and left subgenual cingulum. Functional connectivity decreases were observed in the MCI group within the DMN-a sub-network, between the hippocampus and sub-areas-a and -c of the DMN, between DMN-c and DMN-a, and, in the right hemisphere only between DMN-c and both the thalamus and limbic-a. No relationships between white matter tract 'integrity' (mean diffusivity) and within sub-network functional connectivity were found. Graph theory revealed that changes in the MCI group was mostly restricted to diminished between-neighbour connections of the hippocampi and of nodes within DMN-a and DMN-b.	[Gilligan, Therese M.; Sibilia, Francesca; Farrell, Dervla; Bokde, Arun L. W.] Trinity Coll Dublin, Sch Med, Discipline Psychiat, Dublin, Ireland; [Gilligan, Therese M.; Sibilia, Francesca; Farrell, Dervla; Kennelly, Sean P.; Bokde, Arun L. W.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Lyons, Declan] St Patricks Univ Hosp, Dublin, Ireland; [Kennelly, Sean P.] Trinity Coll Dublin, Sch Med, Discipline Med Gerontol, Dublin, Ireland; [Kennelly, Sean P.] Tallaght Univ Hosp, Dept Age Related Healthcare, Memory Assessment & Support Serv, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Gilligan, TM (corresponding author), Trinity Coll Dublin, Sch Med, Discipline Psychiat, Dublin, Ireland.; Gilligan, TM (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland.	therese_gilligan@yahoo.co.uk		Bokde, Arun/0000-0003-0114-4914; Gilligan, Therese/0000-0002-3589-701X; Kennelly, Sean/0000-0002-3721-0197	Meath Foundation; Science Foundation Ireland [11/RFP.1/NES/3194]; European Regional Development Fund via the Interregional 4A Ireland Wales Programme 2007-2013; Science Foundation Ireland	Meath Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Regional Development Fund via the Interregional 4A Ireland Wales Programme 2007-2013; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This research was supported by a grant from The Meath Foundation that was awarded to A. L.W.B and S.P.K. A.L.W.B. was funded in part by the Science Foundation Ireland (grant number 11/RFP.1/NES/3194, http://www.sfi.ie/funding/researcher-database/), and (together with P.G. Mullins and J.P. McNulty) from the European Regional Development Fund via the Interregional 4A Ireland Wales Programme 2007-2013 http://www.irelandwales.ie//projects/priority_1_theme_2/neuroskill.The MRI data were accessed from the Lonsdale cluster maintained by the Trinity Centre for High Performance Computing. This cluster was funded through grants from Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Adluru N, 2014, NEUROIMAGE-CLIN, V4, P730, DOI 10.1016/j.nicl.2014.04.008; Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Alderson T, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00370; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Badhwar AmanPreet, 2017, Alzheimers Dement (Amst), V8, P73, DOI 10.1016/j.dadm.2017.03.007; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2007, ALZHEIMERS DEMENT, V3, P122, DOI 10.1016/j.jalz.2007.01.019; Berg AI, 2013, AGING MENT HEALTH, V17, P293, DOI 10.1080/13607863.2012.751582; Bijsterbosch J., 2017, INTRO RESTING STATE; Bokde ALW, 2009, PROG NEUROBIOL, V89, P125, DOI 10.1016/j.pneurobio.2009.06.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Bruscoli M, 2004, INT PSYCHOGERIATR, V16, P129, DOI 10.1017/S1041610204000092; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Contreras JA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101687; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dai ZJ, 2014, NEUROSCI BULL, V30, P217, DOI 10.1007/s12264-013-1421-0; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Dong HS, 2016, INT PSYCHOGERIATR, V28, P1; Ekstrom C., 2020, PWR BASIC FUNCTIONS; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; Ewers M, 2011, PROG NEUROBIOL, V95, P535, DOI 10.1016/j.pneurobio.2011.06.004; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Field AP, 2017, BEHAV RES THER, V98, P19, DOI 10.1016/j.brat.2017.05.013; Fischer FU, 2015, NEUROIMAGE-CLIN, V8, P660, DOI 10.1016/j.nicl.2015.06.007; Fletcher E, 2013, JAMA NEUROL, V70, P1389, DOI 10.1001/jamaneurol.2013.3263; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frantzidis CA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00224; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jovicich J, 2019, J ALZHEIMERS DIS, V69, P15, DOI 10.3233/JAD-180158; Kavcic V, 2008, ALZHEIMERS DEMENT, V4, P381, DOI 10.1016/j.jalz.2008.07.001; KEHOE EG, 2015, FRONT AGING NEUROSCI, V7, DOI DOI 10.3389/FNAGI.2015.00001; Kitamura S, 2013, BRAIN RES, V1515, P12, DOI 10.1016/j.brainres.2013.03.052; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Konukoglu E, 2016, NEUROIMAGE, V134, P573, DOI 10.1016/j.neuroimage.2016.04.038; Lancaster MA, 2016, J INT NEUROPSYCH SOC, V22, P1005, DOI 10.1017/S1355617716000904; Lau WKW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.55; LEBLEBICI SY, 2016, NEURAL PLAST, V1, DOI DOI 10.1038/NENERGY.2016.93; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; Liang P, 2011, PLOS ONE, V6, P1; Liao WQ, 2014, ACAD RADIOL, V21, P597, DOI 10.1016/j.acra.2013.12.001; LIN Q, 2018, FRONT AGING NEUROSCI, V10, DOI DOI 10.3389/FNAGI.2018.00001; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Liu Y, 2014, CEREB CORTEX, V24, P1422, DOI 10.1093/cercor/bhs410; Mahjoub I, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Mair P, 2018, WRS2 COLLECTION ROBU; Metzler-Baddeley C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059849; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mourao RJ, 2016, INT J GERIATR PSYCH, V31, P905, DOI 10.1002/gps.4406; Nestor PJ, 2004, NAT REV NEUROSCI, V7, pS34; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Nowrangi MA, 2013, ALZHEIMERS DEMENT, V9, P519, DOI 10.1016/j.jalz.2012.05.2186; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Penny W, 2006, STAT PARAMETRIC MAPP; Pereira JB, 2016, CEREB CORTEX, V26, P3476, DOI 10.1093/cercor/bhw128; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Phillips DJ, 2015, NEUROIMAGE-CLIN, V7, P377, DOI 10.1016/j.nicl.2015.01.007; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Pini L, 2016, AGEING RES REV, V30, P25, DOI 10.1016/j.arr.2016.01.002; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Radanovic M, 2013, EXPERT REV NEUROTHER, V13, P483, DOI [10.1586/ERN.13.45, 10.1586/ern.13.45]; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; RCore Team, 2020, R LANG ENV STAT COMP; Reginold W, 2016, DEMENT GER COGN D EX, V6, P233, DOI 10.1159/000446770; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Reijmer YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044074; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Sibilia F, 2017, BRAIN CONNECT, V7, P366, DOI 10.1089/brain.2017.0493; Smith AD, 2002, P NATL ACAD SCI USA, V99, P4135, DOI 10.1073/pnas.082107399; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; Van der Mussele S, 2014, J ALZHEIMERS DIS, V42, P1239, DOI 10.3233/JAD-140405; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vecchio F, 2015, J ALZHEIMERS DIS, V45, P745, DOI 10.3233/JAD-142484; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Wang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036961; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wickham H, 2019, DYPLR GRAMMAR DATA M; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wickham H., 2019, STRINGR SIMPLE CONSI; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yu JH, 2017, NEUROSCI BIOBEHAV R, V83, P405, DOI 10.1016/j.neubiorev.2017.10.026; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299; Zheng D, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0140-x; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; Zhuang L, 2013, PLOS ONE, V8, P1	119	5	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0222977	10.1371/journal.pone.0222977	http://dx.doi.org/10.1371/journal.pone.0222977			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	31581245	Green Published, gold			2022-12-26	WOS:000532398600025
J	Gruendner, J; Schwachhofer, T; Sippl, P; Wolf, N; Erpenbeck, M; Gulden, C; Kapsner, LA; Zierk, J; Mate, S; Sturzl, M; Croner, R; Prokosch, HU; Toddenroth, D				Gruendner, Julian; Schwachhofer, Thorsten; Sippl, Phillip; Wolf, Nicolas; Erpenbeck, Marcel; Gulden, Christian; Kapsner, Lorenz A.; Zierk, Jakob; Mate, Sebastian; Stuerzl, Michael; Croner, Roland; Prokosch, Hans-Ulrich; Toddenroth, Dennis			KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services	PLOS ONE			English	Article							MEDICAL INFORMATICS; DATA INTEGRATION; CARE; SMART	Background and objective To take full advantage of decision support, machine learning, and patient-level prediction models, it is important that models are not only created, but also deployed in a clinical setting. The KETOS platform demonstrated in this work implements a tool for researchers allowing them to perform statistical analyses and deploy resulting models in a secure environment. Methods The proposed system uses Docker virtualization to provide researchers with reproducible data analysis and development environments, accessible via Jupyter Notebook, to perform statistical analysis and develop, train and deploy models based on standardized input data. The platform is built in a modular fashion and interfaces with web services using the Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) standard to access patient data. In our prototypical implementation we use an OMOP common data model (OMOP-CDM) database. The architecture supports the entire research lifecycle from creating a data analysis environment, retrieving data, and training to final deployment in a hospital setting. Results We evaluated the platform by establishing and deploying an analysis and end user application for hemoglobin reference intervals within the University Hospital Erlangen. To demonstrate the potential of the system to deploy arbitrary models, we loaded a colorectal cancer dataset into an OMOP database and built machine learning models to predict patient outcomes and made them available via a web service. We demonstrated both the integration with FHIR as well as an example end user application. Finally, we integrated the platform with the open source DataSHIELD architecture to allow for distributed privacy preserving data analysis and training across networks of hospitals. Conclusion The KETOS platform takes a novel approach to data analysis, training and deploying decision support models in a hospital or healthcare setting. It does so in a secure and privacy-preserving manner, combining the flexibility of Docker virtualization with the advantages of standardized vocabularies, a widely applied database schema (OMOP-CDM), and a standardized way to exchange medical data (FHIR).	[Gruendner, Julian; Schwachhofer, Thorsten; Sippl, Phillip; Wolf, Nicolas; Erpenbeck, Marcel; Gulden, Christian; Prokosch, Hans-Ulrich; Toddenroth, Dennis] Friedrich Alexander Univ Erlangen Nurnberg FAU, Chair Med Informat, Erlangen, Germany; [Kapsner, Lorenz A.; Zierk, Jakob; Mate, Sebastian; Prokosch, Hans-Ulrich] Univ Klinikum Erlangen, Med Ctr Informat & Commun Technol, Erlangen, Germany; [Zierk, Jakob] Univ Klinikum Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany; [Stuerzl, Michael] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Surg, Div Mol & Expt Surg, Erlangen, Germany; [Croner, Roland] Univ Hosp, Dept Gen Visceral Vasc & Graft Surg, Magdeburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University Hospital Magdeburg	Gruendner, J (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Chair Med Informat, Erlangen, Germany.	julian.gruendner@fau.de	Stürzl, Michael/B-3019-2015	Stürzl, Michael/0000-0002-9276-2824; Mate, Sebastian/0000-0002-1389-3384; Gruendner, Julian/0000-0001-7204-5329; Kapsner, Lorenz A./0000-0003-1866-860X	MIRACUM project; German Ministry for Education and Research (BMBF) [FKZ: 01ZZ1801A]	MIRACUM project; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from MIRACUM project. This research has been conducted within the MIRACUM consortium. MIRACUM is funded by the German Ministry for Education and Research (BMBF) under the Funding Numbers FKZ: 01ZZ1801A.; This work was supported by grants from MIRACUM project. This research has been conducted within the MIRACUM consortium. MIRACUM is funded by the German Ministry for Education and Research (BMBF) under the Funding Numbers FKZ: 01ZZ1801A.	[Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; [Anonymous], 2018, ATLAS; [Anonymous], 2018, GT FHIR OMOP ON FHIR; Apple, 2019, ACC HLTH REC; Arzideh F, REFERENCE LIMIT ESTI; Baldow C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005898; Barker W., 2018, HEAT WAVE US IS POIS; Dua D, 2019, MACHINE LEARNING REP; Fortier I, 2010, INT J EPIDEMIOL, V39, P1383, DOI 10.1093/ije/dyq139; Gaye A, 2014, INT J EPIDEMIOL, V43, P1929, DOI 10.1093/ije/dyu188; Gibson E, 2018, COMPUT METH PROG BIO, V158, P113, DOI 10.1016/j.cmpb.2018.01.025; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Google, 2019, CLOUD HEALTHC API; Gruendner J, 2019, STUD HEALTH TECHNOL, V258, P115, DOI 10.3233/978-1-61499-959-1-115; Grundner J, 2018, STUD HEALTH TECHNOL, V247, P101, DOI 10.3233/978-1-61499-852-5-101; Haarbrandt B, 2018, METHOD INFORM MED, V57, pE66, DOI 10.3414/ME18-02-0002; hl7, HL7 FHIR; HL7, 2018, HL7 FHIR VERS HIST; Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Hughes N, 2019, LIBERATING EVIDENCE; Khalilia Mohammed, 2015, AMIA Annu Symp Proc, V2015, P717; Kuhn M., THE CARET PACKAGE; LAURSEN S O, 1981, Ugeskrift for Laeger, V143, P1081; Leisch F, 2012, MLBENCH MACHINE LEAR; Logemann T, GEN DATA PROTECTION; Maier C, 2018, APPL CLIN INFORM, V9, P54, DOI 10.1055/s-0037-1617452; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; Medizininformatik-Initiative, 2019, MED IN BESCHL VERW F; Microsoft, 2019, AZ API FHIR; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Prasser F, 2018, METHOD INFORM MED, V57, pE57, DOI 10.3414/ME17-02-0022; Prokosch HU, 2018, METHOD INFORM MED, V57, pE82, DOI 10.3414/ME17-02-0025; Saripalle RK, 2019, INT J E-HEALTH MED C, V10, DOI 10.4018/IJEHMC.2019010105; Semler SC, 2018, METHOD INFORM MED, V57, pE50, DOI 10.3414/ME18-03-0003; Soto GES J. A., 2007, COMPUT CARDIOL, DOI [10.1109/CIC.2007.4745457:4, DOI 10.1109/CIC.2007.4745457:4]; Velickovski F, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-S2-S9; Vreeman Daniel J., 2010, International Journal of Functional Informatics and Personalised Medicine, V3, P273; Wehling M, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-31; Winter A, 2018, METHOD INFORM MED, V57, pE92, DOI 10.3414/ME18-02-0004; Zierk J, 2018, CLIN CHEM LAB MED, DOI [10.1515/cclm-2018-0771 30367783, DOI 10.1515/CCLM-2018-077130367783]	41	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223010	10.1371/journal.pone.0223010	http://dx.doi.org/10.1371/journal.pone.0223010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JF4OF	31581246	Green Published, gold			2022-12-26	WOS:000491366500001
J	Cisneros-Mata, MA; Mangin, T; Bone, J; Rodriguez, L; Smith, SL; Gaines, SD				Angel Cisneros-Mata, Miguel; Mangin, Tracey; Bone, Jennifer; Rodriguez, Laura; Smith, Sarah Lindley; Gaines, Steven D.			Fisheries governance in the face of climate change: Assessment of policy reform implications for Mexican fisheries	PLOS ONE			English	Article							MARINE FISHERIES; CHANGE IMPACTS; VULNERABILITY; FISH	Climate change is driving shifts in the abundance and distribution of marine fish and invertebrates and is having direct and indirect impacts on seafood catches and fishing communities, exacerbating the already negative effects of unsustainably high fishing pressure that exist for some stocks. Although the majority of fisheries in the world are managed at the national or local scale, most existing approaches to assessing climate impacts on fisheries have been developed on a global scale. It is often difficult to translate from the global to regional and local settings because of limited relevant data. To address the need for fisheries management entities to identify those fisheries with the greatest potential for climate change impacts, we present an approach for estimating expected climate change-driven impacts on the productivity and spatial range of fisheries at the regional scale in a data-poor context. We use a set of representative Mexican fisheries as test cases. To assess the implications of climate impacts, we compare biomass, harvest, and profit outcomes from a bio-economic model under contrasting management policies and with and without climate change. Overall results show that climate change is estimated to negatively affect nearly every fishery in our study. However, the results indicate that overfishing is a greater threat than climate change for these fisheries, hence fixing current management challenges has a greater upside than the projected future costs of moderate levels of climate change. Additionally, this study provides meaningful first approximations of potential effects of both climate change and management reform in Mexican fisheries. Using the climate impact estimations and model outputs, we identify high priority stocks, fleets, and regions for policy reform in Mexico in the face of climate change. This approach can be applied in other data-poor circumstances to focus future research and policy reform efforts on stocks now subject to additional stress due to climate change. Considering their growing relevance as a critical source of protein and micronutrients to nourish our growing population, it is urgent for regions to develop sound fishery management policies in the short-term as they are the most important intervention to mitigate the adverse effects of climate change on marine fisheries.	[Angel Cisneros-Mata, Miguel] Inst Nacl Pesca & Acuacultura, Guaymas, Sonora, Mexico; [Mangin, Tracey; Bone, Jennifer; Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Mangin, Tracey; Bone, Jennifer; Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Sustainable Fisheries Grp, Santa Barbara, CA 93106 USA; [Rodriguez, Laura] Environm Def Fund Mexico AC, La Paz, Bcs, Mexico; [Smith, Sarah Lindley] Environm Def Fund, Boston, MA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Environmental Defense Fund	Mangin, T (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; Mangin, T (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Sustainable Fisheries Grp, Santa Barbara, CA 93106 USA.	tmangin@ucsb.edu		Smith, Sarah/0000-0002-6905-2429	Leona M. and Harry B. Helmsley Charitable Trust; Walton Family Foundation; Alianza WWF-Fundacion Carlos Slim; David and Lucile Packard Foundation	Leona M. and Harry B. Helmsley Charitable Trust; Walton Family Foundation; Alianza WWF-Fundacion Carlos Slim; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We gratefully acknowledge and thank The Leona M. and Harry B. Helmsley Charitable Trust, which provided support in the form of salaries for authors [TM, JB, SLS, SDG], The Walton Family Foundation, which provided support in the form of meeting costs, salaries for authors [LR], and funding for expert support [MAC], the Alianza WWF-Fundacion Carlos Slim, which provided support in the form of meeting costs, and the David and Lucile Packard Foundation, which provide support in the form of salaries for authors [TM, JB], for their financial support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Bakun A, 2015, CURR CLIM CHANGE REP, V1, P85, DOI 10.1007/s40641-015-0008-4; Barange M., 2018, IMPACTS CLIMATE CHAN, P627; Barange M., 2009, CLIMATE CHANGE IMPLI, P7; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Booth DJ., 2018, CLIMATE CHANGE IMPAC, P875, DOI [10.1002/9781119154051.ch26, DOI 10.1002/9781119154051.CH26]; Brander KM, GLOBAL FISH PRODUCTI; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cisneros-Mata MA, 2016, SOME GUIDELINES REFO, V15; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Daw T, CLIMATE CHANGE CAPTU, V44; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Easterling W, FOOD FIBRE FOREST PR, V42; FAO, 2018, STAT WORLD FISH AQ; Free CM, 2019, SCIENCE, V363, P979, DOI 10.1126/science.aau1758; Gaines SD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1378; Ganster P, 2012, CABOS PROSPECTIVA PA; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holbrook NJ, 2014, CLIMATIC CHANGE, V124, P703, DOI 10.1007/s10584-014-1110-7; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Kritzer JP, 2019, ICES J MAR SCI, DOI [10.1093/icesjms/fsz038/5425355, DOI 10.1093/ICESJMS/FSZ038/5425355]; Lenton A, EFFECTS CLIMATE CHAN, V12; Litz MNC, 2011, SEASONAL OCCURRENCES, V52, P12; Arroyo AM, 2011, ATMOSFERA, V24, P103; McIlgorm A, 2010, MAR POLICY, V34, P170, DOI 10.1016/j.marpol.2009.06.004; Mollmann C, 2012, ADV ECOL RES, V47, P303, DOI 10.1016/B978-0-12-398315-2.00004-1; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Oceana, 2019, AUD PESQ PESC CIEG; Payne MR, 2016, ICES J MAR SCI, V73, P1272, DOI 10.1093/icesjms/fsv231; Pella J. J., 1969, Bulletin Inter-American Tropical Tuna Commission, V13, P421; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Ricel JC, 2011, ICES J MAR SCI, V68, P1343, DOI 10.1093/icesjms/fsr041; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Robinson CJ, 2016, FISH RES, V173, P128, DOI 10.1016/j.fishres.2015.08.014; Rose GA, 2005, ICES J MAR SCI, V62, P1360, DOI 10.1016/j.icesjms.2005.05.007; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; Saldivar-Lucio R, REV BIOL MAR OCEANOG; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Tzanatos E, 2014, CLIMATIC CHANGE, V122, P41, DOI 10.1007/s10584-013-0972-4; WEATHERDON LV, 2016, FRONT MAR SCI, V3, DOI DOI 10.3389/FMARS.2016.00048/FULL; YOSHIMOTO SS, 1993, CAN J FISH AQUAT SCI, V50, P181, DOI 10.1139/f93-020	46	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2019	14	10							e0222317	10.1371/journal.pone.0222317	http://dx.doi.org/10.1371/journal.pone.0222317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6VM	31577835	gold, Green Published			2022-12-26	WOS:000532388000009
J	Wentzel-Larsen, T; Anhoj, J				Wentzel-Larsen, Tore; Anhoj, Jacob			Joint distribution for number of crossings and longest run in independent Bernoulli observations. The R package crossrun	PLOS ONE			English	Article								The R package crossrun computes the joint distribution of the number of crossings and the longest run in a sequence of independent Bernoulli observations. The main intended application is statistical process control where the joint distribution may be used for systematic investigation, and possibly refinement, of existing rules for distinguishing between signal and noise. While the crossrun vignette is written to assist in practical use, this article gives a hands-on explanation of why the procedures works. The article also includes a discussion of limitations of the present version of crossrun together with an outline of ongoing work to meet these limitations. There is more to come, and it is necessary to grasp the basic ideas behind the procedure implemented both to understand these planned extensions, and how presently implemented rules in statistical process control, based on the number of crossings and the longest run, may be refined.	[Wentzel-Larsen, Tore] Eastern & Southern Norway, Ctr Child & Adolescent Mental Hlth, Oslo, Norway; [Wentzel-Larsen, Tore] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway; [Anhoj, Jacob] Univ Copenhagen, Rigshosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Wentzel-Larsen, T (corresponding author), Eastern & Southern Norway, Ctr Child & Adolescent Mental Hlth, Oslo, Norway.; Wentzel-Larsen, T (corresponding author), Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.	tore.wentzellarsen@gmail.com		Wentzel-Larsen, Tore/0000-0002-0318-4162; Anhoj, Jacob/0000-0002-7701-1774				Anhoj J, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0564-0; Anhoj J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121349; Anhoj J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113825; [Anonymous], 2014, R LANG ENV STAT COMP; Fazekas I, 2010, MATHEMATICA, V2, P215; Hanrot G, 2019, MPFR LIB VERSION 4 0; Schilling MF, 2012, MATH MAG, V85, P141, DOI DOI 10.4169/MATH.MAG.85.2.141	7	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2019	14	10							e0223233	10.1371/journal.pone.0223233	http://dx.doi.org/10.1371/journal.pone.0223233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6RH	31574115	Green Published, gold			2022-12-26	WOS:000532376700038
J	Bajaj, JS; Fan, S; Thacker, LR; Fagan, A; Gavis, E; White, MB; Heuman, DM; Fuchs, M; Fiehn, O				Bajaj, Jasmohan S.; Fan, Sili; Thacker, Leroy R.; Fagan, Andrew; Gavis, Edith; White, Melanie B.; Heuman, Douglas M.; Fuchs, Michael; Fiehn, Oliver			Serum and urinary metabolomics and outcomes in cirrhosis	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; GUT MICROBIOTA; SURVIVAL; SPECTROSCOPY; READMISSIONS	Background Cirrhosis can alter several metabolic pathways. Metabolomics could prognosticate outcomes like hepatic encephalopathy (HE), transplant, hospitalization and death. Aim Determine changes in serum and urine metabolomics in cirrhotics who develop outcomes. Methods Cirrhotic outpatients underwent data, serum/urine collection and were followed for 90 days. Demographics, cirrhosis details and medications were collected. Metabolomics was performed on urine/serum using GC/MS with subsequent bioinformatics analyses (ChemRICH, MetaMAPP and PLS-DA). Logistic regression adjusting for covariates (demographics, alcohol etiology, prior HE, PPI, SBP prophylaxis, rifaximin/lactulose) were performed and ROC curves comparing MELD to adjusted serum & urine metabolites were created. Results 211 patients gave serum, of which 64 were hospitalized, 19 developed HE, 13 were transplanted and 11 died. 164 patients gave urine of which 56 were hospitalized, 18 developed HE, 12 were transplanted and 11 died. Metabolomics: Saturated fatty acids, amino acids and bioenergetics-related metabolites differentiated patients with/without outcomes. After regression, 232, 228, 284 and 229 serum metabolites were significant for hospitalization, HE, death and transplant. In urine 290, 284, 227 & 285 metabolites were significant for hospitalization, HE, death and transplant respectively. AUC was higher for serum metabolites vs MELD for HE (0.85 vs.0.76), death (0.99 vs.0.88), transplant (0.975 vs.0.94) and hospitalizations (0.84 vs.0.83). Similarly, urinary metabolite AUC was also higher than MELD for HE (0.87 vs.0.72), death (0.92 vs 0.86), transplant (0.99 vs.0.90) and hospitalizations (0.89 vs.0.84). Conclusions In this exploratory study, serum and metabolites focused on lipid, bioenergetics and amino acid metabolism are altered in cirrhotics who develop negative outcomes.	[Bajaj, Jasmohan S.; Fagan, Andrew; Gavis, Edith; White, Melanie B.; Heuman, Douglas M.; Fuchs, Michael] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA; [Bajaj, Jasmohan S.; Fagan, Andrew; Gavis, Edith; White, Melanie B.; Heuman, Douglas M.; Fuchs, Michael] McGuire VA Med Ctr, Richmond, VA 23249 USA; [Fan, Sili; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; University of California System; University of California Davis; Virginia Commonwealth University	Bajaj, JS (corresponding author), Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA.; Bajaj, JS (corresponding author), McGuire VA Med Ctr, Richmond, VA 23249 USA.	Jasmohan.bajaj@vcuhealth.org	Fan, Sili/ABA-8666-2020	Thacker, Leroy/0000-0001-9805-3909	NIH NCATS [R21TR002024]; VA merit review [2I0CX00176]; NIH [U2C ES030158]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [R21TR002024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U2CES030158] Funding Source: NIH RePORTER	NIH NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VA merit review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by NIH NCATS R21TR002024 Jasmohan Bajaj, VA merit review 2I0CX00176 Jasmohan Bajaj. NIH U2C ES030158 Oliver Fiehn.	Bajaj JS, 2019, HEPATOLOGY, V70, P450, DOI 10.1002/hep.30589; Bajaj JS, 2019, CLIN GASTROENTEROL H, V17, P756, DOI 10.1016/j.cgh.2018.07.022; Bajaj JS, 2018, HEPATOLOGY, V68, P1621, DOI 10.1002/hep.30056; Bajaj JS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98019; Bajaj JS, 2016, HEPATOLOGY, V64, P200, DOI 10.1002/hep.28414; Bajaj JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep18559; Bajaj JS, 2015, HEPATOLOGY, V62, P1260, DOI 10.1002/hep.27819; Bajaj JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060042; Bajaj JS, 2012, METAB BRAIN DIS, V27, P205, DOI 10.1007/s11011-012-9303-0; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Claria J, 2016, HEPATOLOGY, V64, P1249, DOI 10.1002/hep.28740; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Dam G, 2015, SCAND J CLIN LAB INV, V75, P674, DOI 10.3109/00365513.2015.1074276; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Gluud LL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001939.pub4; Jimenez B, 2010, J PROTEOME RES, V9, P5180, DOI 10.1021/pr100486e; Juanola O, 2019, FASEB J, V33, P11595, DOI 10.1096/fj.201901327R; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Khan V, 2018, METABOLITES, V8, DOI 10.3390/metabo8040067; Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001; Lai JC, 2019, GASTROENTEROLOGY, V156, P1675, DOI 10.1053/j.gastro.2019.01.028; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; McPhail MJW, 2017, METAB BRAIN DIS, V32, P331, DOI 10.1007/s11011-016-9904-0; McPhail MJW, 2016, J HEPATOL, V64, P1058, DOI 10.1016/j.jhep.2016.01.003; Mindikoglu AL, 2018, TRANSL RES, V195, P25, DOI 10.1016/j.trsl.2017.12.002; Ney M, 2018, AM J GASTROENTEROL, V113, P1506, DOI 10.1038/s41395-018-0243-0; Patidar KR, 2014, AM J GASTROENTEROL, V109, P1757, DOI 10.1038/ajg.2014.264; Riggio O, 2010, AM J GASTROENTEROL, V105, P1374, DOI 10.1038/ajg.2009.738; Sarma MK, 2011, METAB BRAIN DIS, V26, P173, DOI 10.1007/s11011-011-9250-1; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shawcross DL, 2011, J HEPATOL, V54, P640, DOI 10.1016/j.jhep.2010.07.045; Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P1181, DOI 10.1016/j.cgh.2016.04.009; Tapper EB, 2016, HEPATOLOGY, V64, P26, DOI 10.1002/hep.28471; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Wanichthanarak K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171046; Williams HRT, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-108	38	12	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223061	10.1371/journal.pone.0223061	http://dx.doi.org/10.1371/journal.pone.0223061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6IT	31560724	gold, Green Published			2022-12-26	WOS:000532353700032
J	Fuente-Soro, L; Iniesta, C; Lopez-Varela, E; Cuna, M; Guilaze, R; Maixenchs, M; Bernardo, EL; Augusto, O; Gonzalez, R; Couto, A; Munguambe, K; Naniche, D				Fuente-Soro, Laura; Iniesta, Carlos; Lopez-Varela, Elisa; Cuna, Mauro; Guilaze, Rui; Maixenchs, Maria; Luis Bernardo, Edson; Augusto, Orvalho; Gonzalez, Raquel; Couto, Aleny; Munguambe, Khatia; Naniche, Denise			Tipping the balance towards long-term retention in the HIV care cascade: A mixed methods study in southern Mozambique	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; BARRIERS; FACILITATORS; LINKAGE; PATIENT; INITIATION; CONTINUUM; TANZANIA; SERVICES	Background The implementation of quality HIV control programs is crucial for the achievement of the UNAIDS 90-90-90 targets and to motivate people living with HIV (PLWHIV) to link and remain in HIV-care. The aim of this mixed method cross-sectional study was to estimate the linkage and long-term retention in care of PLWHIV and to identify factors potentially interfering along the HIV-care continuum in southern Mozambique. Methods A home-based semi-structured interview was conducted in 2015 to explore barriers and facilitators to the HIV-care cascade among individuals that had been newly HIV-diagnosed in community testing campaigns in 2010 or 2012. Linkage and long-term retention were estimated retrospectively through client self-reports and clinical records. Cohen's Kappa coefficient was calculated to measure the agreement between participant self-reported and documented cascade outcomes. Results Among the 112 interviewed participants, 24 (21.4%) did not disclose their HIV-positive serostatus to the interviewer. While 84 (75.0%) self-reported having enrolled in care, only 69 (61.6%) reported still being in-care 3-5 years after diagnosis of which 17.4% reported having disengaged and re-engaged. An important factor affecting optimal continuum in HIV-care was the impact of the fear-based authoritarian relationship between the health system and the patient that could act as both driver and barrier. Conclusion Special attention should be given to quantify and understand repeated cycles of patient disengagement and re-engagement in HIV-care. Strategies to improve the relationship between the health system and patients are still needed in order to optimally engage PLWHIV for long-term periods.	[Fuente-Soro, Laura; Lopez-Varela, Elisa; Cuna, Mauro; Guilaze, Rui; Maixenchs, Maria; Luis Bernardo, Edson; Augusto, Orvalho; Munguambe, Khatia; Naniche, Denise] CISM, Maputo, Mozambique; [Fuente-Soro, Laura; Lopez-Varela, Elisa; Maixenchs, Maria; Gonzalez, Raquel; Naniche, Denise] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain; [Iniesta, Carlos] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Luis Bernardo, Edson] Direccao Dist SaUde, Manhica, Maputo, Mozambique; [Couto, Aleny] Minist Hlth, Natl STI HIV AIDS Program, Maputo, Mozambique; [Munguambe, Khatia] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Eduardo Mondlane University	Fuente-Soro, L (corresponding author), CISM, Maputo, Mozambique.; Fuente-Soro, L (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.	laura.delafuente@isglobal.org	Augusto, Orvalho/J-8767-2019; varela, elisa lopez/ABE-4092-2020; Gonzalez, Raquel/J-3604-2017; Naniche, Denise/S-1814-2018	Augusto, Orvalho/0000-0002-0005-3968; varela, elisa lopez/0000-0002-6725-5687; Gonzalez, Raquel/0000-0001-5487-801X; Iniesta, Carlos/0000-0002-0928-2679; Fuente-Soro, Laura/0000-0002-8580-5857; Naniche, Denise/0000-0002-4495-6325; Maixenchs, Maria/0000-0002-5782-8197	Government of Mozambique; Spanish Agency for International Development (AECID)	Government of Mozambique; Spanish Agency for International Development (AECID)	The authors gratefully acknowledge the Ministry of Health of Mozambique, our research team, collaborators, Fundacao Ariel Glaser, and especially all communities and participants involved. Also, we want acknowledge Elisabeth Salvo and Clara Pons for their contributions and the study interviewers Vitorina Felipe Cossa, Ines Lui ' s Macamo and Lui ' sa Antonieta Macumbe. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID).	Abdalla SM, 2019, NURS ETHICS, V26, P2239, DOI 10.1177/0969733018787224; Agaba Patricia A, 2018, J AIDS Clin Res, V9, DOI 10.4172/2155-6113.1000756; [Anonymous], 2016, REP MOC CONS NAC COM; Arnold EM, 2008, AIDS CARE, V20, P80, DOI 10.1080/09540120701449138; Ayieko J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202990; Bassett IV, 2017, JAIDS-J ACQ IMM DEF, V74, P432, DOI [10.1097/QAI.0000000000001277, 10.1097/qai.0000000000001277]; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bogart LM, 2013, AIDS CARE, V25, P843, DOI 10.1080/09540121.2012.729808; Boulle A, 2016, HIV CASE BASED SURVE; Camlin CS, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25023; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; De Schacht C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1240; Decroo T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016800; Eshun-Wilson I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210408; Fuente-Soro L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25095; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gonzalez R., HIGH HIV PREVALENCE, DOI [10.1111/j.1468-1293.2012.01018.x, DOI 10.1111/J.1468-1293.2012.01018.X]; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartung C., 2010, OPEN DATA KIT TOOLS; HIarlaithe MO, 2014, AIDS BEHAV, V18, pS516, DOI 10.1007/s10461-014-0756-5; Hladik W, 2016, INT J STD AIDS, V27, P5, DOI 10.1177/0956462415581728; Holtzman CW, 2015, AIDS CARE, V27, P817, DOI 10.1080/09540121.2015.1009362; Inguane CA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20846; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kabudula CW, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0023-z; Kagoya HR, 2013, AFR J PRIM HEALTH CA, V5, DOI 10.4102/phcfm.v5i1.491; Kiwanuka G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3450-9; Knight LC, 2015, AIDS CARE, V27, P1162, DOI 10.1080/09540121.2015.1035633; Kruk ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160764; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Lopez-Varela E, 2018, JAIDS-J ACQ IMM DEF, V78, P527, DOI [10.1097/QAI.0000000000001720, 10.1097/qai.0000000000001720]; Maixenchs M, 2015, POST ART SYMPTOMS WE, DOI [10.1371/journal.pone.0137336, DOI 10.1371/JOURNAL.PONE.0137336]; Marty L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25100; Masa R, 2017, AJAR-AFR J AIDS RES, V16, P91, DOI 10.2989/16085906.2017.1308386; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Nhassengo P, 2018, BARRIERS FACILITATOR, DOI [10.1371/journal.pone.0205919, DOI 10.1371/JOURNAL.PONE.0205919]; Pecoraro A, 2014, AIDS CARE, V26, P1249, DOI 10.1080/09540121.2014.897910; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Pons-Duran C, 2016, TROP MED INT HEALTH, V21, P1513, DOI 10.1111/tmi.12789; Sacoor C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0184249; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Sando D, 2014, JAIDS-J ACQ IMM DEF, V67, pS228, DOI 10.1097/QAI.0000000000000378; SEEMAN M, 1964, AM SOCIOL REV, V29, P770, DOI 10.2307/2091442; Shabalala FS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25120; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Tomori C, 2014, AIDS CARE, V26, P907, DOI 10.1080/09540121.2013.861574; Topp SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193641; UNAIDS, 2018, MILES GO CLOS GAPS B; UNAIDS, 2014, 90 90 90 AMB TREATM; Zanolini A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002636	57	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222028	10.1371/journal.pone.0222028	http://dx.doi.org/10.1371/journal.pone.0222028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6IT	31560689	Green Published, gold			2022-12-26	WOS:000532353700006
J	Marzouk, M; Kelley, M; Fadhil, I; Slama, S; Longuere, KS; Ariana, P; Carson, G; Marsh, V				Marzouk, Manar; Kelley, Maureen; Fadhil, Ibtihal; Slama, Slim; Longuere, Kajsa-Stina; Ariana, Proochista; Carson, Gail; Marsh, Vicki			"If I have a cancer, it is not my fault I am a refugee": A qualitative study with expert stakeholders on cancer care management for Syrian refugees in Jordan	PLOS ONE			English	Article							HEALTH	` Background Noncommunicable diseases including cancer are widespread amongst the 5.6 million Syrian refugees currently hosted in the Middle East. Given its prevalence as the third leading cause of death in Syria, cancer is likely to be an important health burden among Syrian refugees. Against this background, our aim was to describe the clinical, ethical and policy decision-making experiences of health actors working within the current refugee cancer care system; the impact of refugee cancer care health policies on health care providers and policy makers in this context; and provide suggestions for the way delivery of care should be optimised in a sustained emergency situation. Methods From April-July 2016, we conducted in-depth interviews with 12 purposively sampled health officials and health care workers from the Jordanian Ministry of Health, multilateral donors and international non-governmental organisations. Data were analysed using a framework analysis approach to identify systemic, practical and ethical challenges to optimising care for refugees, through author agreement on issues emerging from the data and those linked more directly to areas of questioning. Results As has been previously reported, central challenges for policy makers and health providers were the lack of quality cancer prevalence data to inform programming and care delivery for this refugee population, and insufficient health resource allocation to support services. In addition, limited access to international funding for the host country, the absence of long-term funding schemes, and barriers to coordination between institutions and frontline clinicians were seen as key barriers. In this context where economic priorities inevitably drive decision-making on public health policy and individual care provision, frontline healthcare workers and policy makers experienced significant moral distress where duties of care and humanitarian values were often impossible to uphold. Conclusions Our findings confirm and expand understanding of the challenges involved in resource allocation decisions for cancer care in refugee populations, and highlight these for the particular situation of long term Syrian refugees in Jordan. The insights offered by frontline clinicians and policy makers in this context reveal the unintended personal and moral impact of resource allocation decisions. With many countries facing similar challenges in the provision of cancer care for refugees, the lessons learned from Jordan suggest key areas for policy revision and international investment in developing cancer care policies for refugees internationally.	[Marzouk, Manar; Longuere, Kajsa-Stina; Ariana, Proochista; Carson, Gail; Marsh, Vicki] Univ Oxford, Nuffield Dept Med, Oxford, England; [Kelley, Maureen] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Kelley, Maureen] Univ Oxford, Wellcome Ctr Eth & Humanities, Nuffield Dept Populat Hlth, Oxford, England; [Fadhil, Ibtihal; Slama, Slim] WHO Reg Off Eastern Mediterranean, Cairo, Egypt; [Marsh, Vicki] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Marzouk, Manar] Reset Refugees & Communities Char, London, England; [Longuere, Kajsa-Stina] Imperial Coll London, UK Energy Res Ctr, London, England	University of Oxford; University of Oxford; University of Oxford; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Imperial College London	Marzouk, M (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Marzouk, M (corresponding author), Reset Refugees & Communities Char, London, England.	manar@validinternational.org	Fadhil, Ibtihal/AAF-4123-2021	Kelley, Maureen/0000-0001-8230-5315; Carson, Gail/0000-0001-8439-9933	Eve Jones Memorial Scholarship from Brasenose college at the University of Oxford; Brasenose Graduate Studentship from Brasenose college at the University of Oxford; Wellcome Trust Strategic Award [096527]; Wellcome Trust [200344/Z/15/Z]; MRC Newton Fund Collaborative Award [200344/Z/15/Z]; International Health and Tropical Medicine Masters' Programme at the University of Oxford	Eve Jones Memorial Scholarship from Brasenose college at the University of Oxford; Brasenose Graduate Studentship from Brasenose college at the University of Oxford; Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Newton Fund Collaborative Award; International Health and Tropical Medicine Masters' Programme at the University of Oxford	MM received funding from the Eve Jones Memorial Scholarship and Brasenose Graduate Studentship from Brasenose college at the University of Oxford to support this research project and writing. The efforts of MK and VM were supported by funding from Wellcome Trust Strategic Award (grant 096527) and Wellcome Trust and MRC Newton Fund Collaborative Award (grant 200344/Z/15/Z). The results and interpretation presented here do not necessarily reflect the views of the study funders.; The authors wish to sincerely thank all participants for their valuable insights about the subject matter, for giving context to the findings, and for assistance with the relevant literature. MMis grateful to the International Health and Tropical Medicine Masters' Programme at the University of Oxford for the academic and research support, WHO-EMRO for an internship placement that facilitated the conduct of this research, MMthanks Stuart Golodetz for proofreading this paper.	Abdel-Razeq Hikmat, 2015, Hematol Oncol Stem Cell Ther, V8, P64, DOI 10.1016/j.hemonc.2015.02.001; Achilli L., 2015, SYRIAN REFUGEES JORD, DOI DOI 10.2870/821248; Amnesty International, 2017, JORD 2016 2017; Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; [Anonymous], 2019, OP PORT REF SIT; [Anonymous], 2018, SYR REG REF RESP; [Anonymous], 2015, SIL CRIS TREAT NONC; Ben Morrison T, 2013, HEALTH CARE WOMEN IN, V34, P980, DOI 10.1080/07399332.2013.770002; Crisp J., 2015, SYRIANS REFUGEES GLO; Doocy S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2429-3; Green J, 2009, QUALITATIVE METHODS; Greene M.J., 2014, QUAL REP, V19, P1, DOI https://doi.org/10.46743/2160-3715/2014.1106; International Labour Organisation, REF RIGHT WORK JORD; Jameton A, 1993, AWHONNS Clin Issues Perinat Womens Health Nurs, V4, P542; Kerasidou A, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0407-8; King Hussein Cancer Center, FREQ ASK QUEST; Kvale S, 2009, LEARNING CRAFT QUAIT; Leaning Jennifer, 2011, Confl Health, V5, P6, DOI 10.1186/1752-1505-5-6; Mason M., 2010, FORUM QUAL SOC RES, V11; Medecins Sans Frontieres, 2016, JORD MSF OP NEW CLIN; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Norwegian Refugee Council (NRC) and International Human Rights Clinic (IHRC), 2016, SEC STAT SYR REF DOC, P32; Pappaioanou M, 2003, SOC SCI MED, V57, P1925, DOI 10.1016/S0277-9536(03)00058-3; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rachiotis G, 2014, INT J MED SCI, V11, P442, DOI 10.7150/ijms.7933; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Spiegel P, LANCET ONCOLOGY; Trends G., 2016, GLOB TRENDS FORC DIS; UNHCR, 1967, 1951 CONV ITS 1967 P; UNHCR, 2017, HLTH ACC UT SURV; UNHCR, GUID UNHCR SUPP HLTH; UNHCR, 2015, UNHCR PROJ GLOB RES; UNHCR & JHAS, 2016, JORD MED REF GLANC Y; UNOCHA, 2017, CRIS; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; WHO (World Health Organization), 2015, REG SIT REP JAN 2015; WHO (World Health Organization), 2014, SYR AR REP CANC COUN; World Bank, 2018, WORLD BANK COUNTR LE; World Health Organisation, 2018, DEFF REG GROUP; World Health Organisation, 2016, JORD STAT; World Health Organization, 2015, SYR AR REP WHO STAT	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0222496	10.1371/journal.pone.0222496	http://dx.doi.org/10.1371/journal.pone.0222496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6IT	31560701	Green Published, gold, Green Submitted			2022-12-26	WOS:000532353700013
J	Peng, C; Wu, GL; Liao, TW; Wang, HD				Peng, Chong; Wu, Guanglin; Liao, T. Warren; Wang, Hedong			Research on multi-agent genetic algorithm based on tabu search for the job shop scheduling problem	PLOS ONE			English	Article							NEIGHBORHOOD-STRUCTURE; SHIFTING BOTTLENECK; LOCAL SEARCH	The solution to the job shop scheduling problem (JSSP) is of great significance for improving resource utilization and production efficiency of enterprises. In this paper, in view of its non-deterministic polynomial properties, a multi-agent genetic algorithm based on tabu search (MAGATS) is proposed to solve JSSPs under makespan constraints. Firstly, a multi-agent genetic algorithm (MAGA) is proposed. During the process, a multi-agent grid environment is constructed based on characteristics of multi-agent systems and genetic algorithm (GA), and a corresponding neighbor interaction operator, a mutation operator based on neighborhood structure and a self-learning operator are designed. Then, combining tabu search algorithm with a MAGA, the algorithm MAGATS are presented. Finally, 43 benchmark instances are tested with the new algorithm. Compared with four other algorithms, the optimization performance of it is analyzed based on obtained test results. Effectiveness of the new algorithm is verified by analysis results.	[Peng, Chong; Wu, Guanglin; Wang, Hedong] Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China; [Liao, T. Warren] Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA	Beihang University; Louisiana State University System; Louisiana State University	Peng, C (corresponding author), Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China.	pch@buaa.edu.cn		Liao, Thunshun/0000-0001-5018-8898	National Natural Science Foundation of China [51875029]; National Science and Technology Major Project "HighGrade CNC Machine Tools and Basic Manufacturing Equipments" [2016ZX04004006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "HighGrade CNC Machine Tools and Basic Manufacturing Equipments"	The research was supported by National Natural Science Foundation of China (Grant No. 51875029) and was supported by the National Science and Technology Major Project "HighGrade CNC Machine Tools and Basic Manufacturing Equipments" (Grant No. 2016ZX04004006) to CP.	Asadzadeh L, 2015, COMPUT IND ENG, V85, P376, DOI 10.1016/j.cie.2015.04.006; Balas E, 1998, MANAGE SCI, V44, P262, DOI 10.1287/mnsc.44.2.262; BALAS E, 1969, OPER RES, V17, P941, DOI 10.1287/opre.17.6.941; Bean JC, 2017, ORSA J COMPUT, V6, P154; Calis B, 2015, J INTELL MANUF, V26, P961, DOI 10.1007/s10845-013-0837-8; Chang HC, 2015, J ASIAN PAC COMMUN, V25, P1, DOI 10.1075/japc.25.1.01cha; Chen DW, 2017, IEEE T IND INFORM, V13, P2000, DOI 10.1109/TII.2017.2682855; Chen WC, 2017, INT J ADV MANUF TECH, V93, P225, DOI 10.1007/s00170-016-8859-y; Cheng L, 2016, INT J ADV MANUF TECH, V84, P405, DOI 10.1007/s00170-015-8023-0; Cheng RW, 1996, COMPUT IND ENG, V30, P983, DOI 10.1016/0360-8352(96)00047-2; Dell'Amico M., 1993, Annals of Operations Research, V41, P231, DOI 10.1007/BF02023076; Engin O, 2018, APPL SOFT COMPUT, V72, P166, DOI 10.1016/j.asoc.2018.08.002; Gao L, 2015, COMPUT IND ENG, V88, P417, DOI 10.1016/j.cie.2015.08.002; Garey M. R., 1976, Mathematics of Operations Research, V1, P117, DOI 10.1287/moor.1.2.117; HOLLAND JH, 1975, ADOPTION NATURAL ART; Knopp S, 2017, EUR J OPER RES, V263, P50, DOI 10.1016/j.ejor.2017.04.050; Kuhpfahl J, 2016, COMPUT OPER RES, V66, P44, DOI 10.1016/j.cor.2015.07.011; Kurdi M, 2016, COMPUT OPER RES, V67, P132, DOI 10.1016/j.cor.2015.10.005; Lawrence S., 1984, RESOURCE CONSTRAIN S, V4, P4411; Liu JM, 2002, ARTIF INTELL, V136, P101, DOI 10.1016/S0004-3702(01)00174-6; Liu Y, 2019, TRANSPORT RES C-EMER, V101, P18, DOI 10.1016/j.trc.2019.01.027; Manne A., 1959, COWLES FDN DISCUSSIO, P8; Matsuo H., 1988, CONTROLLED SEARCH SI; Nowicki E, 1996, MANAGE SCI, V42, P797, DOI 10.1287/mnsc.42.6.797; Pezzella F, 2000, EUR J OPER RES, V120, P297, DOI 10.1016/S0377-2217(99)00158-7; Rey GZ, 2015, INT J ADV MANUF TECH, V81, P1871, DOI 10.1007/s00170-015-7347-0; Sels V, 2011, EUR J OPER RES, V215, P512, DOI 10.1016/j.ejor.2011.06.031; VANLAARHOVEN PJM, 1992, OPER RES, V40, P113, DOI 10.1287/opre.40.1.113; Xu XD, 2007, INT J ADV MANUF TECH, V34, P783, DOI 10.1007/s00170-006-0652-x; Zhang CY, 2008, INT J ADV MANUF TECH, V39, P965, DOI 10.1007/s00170-007-1354-8; Zhang CY, 2007, COMPUT OPER RES, V34, P3229, DOI 10.1016/j.cor.2005.12.002	32	7	7	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2019	14	9							e0223182	10.1371/journal.pone.0223182	http://dx.doi.org/10.1371/journal.pone.0223182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN4ZE	31560722	Green Published, gold			2022-12-26	WOS:000514846300001
J	Mo, SS; Urdahl, AM; Nesse, LL; Slettemeas, JS; Ramstad, SN; Torp, M; Norstrom, M				Mo, Solveig Solverod; Urdahl, Anne Margrete; Nesse, Live Lingaas; Slettemeas, Jannice Schau; Ramstad, Silje Nostvedt; Torp, Mona; Norstrom, Madelaine			Occurrence of and risk factors for extended-spectrum cephalosporin-resistant Enterobacteriaceae determined by sampling of all Norwegian broiler flocks during a six month period	PLOS ONE			English	Article							BETA-LACTAMASE GENES; ESCHERICHIA-COLI; CAMPYLOBACTER COLONIZATION; COMPANION ANIMALS; RETAIL MEAT; PREVALENCE; SALMONELLA; PLASMIDS; POULTRY	All broiler flocks reared and slaughtered in Norway from May-October 2016 (n = 2110) were screened for the presence of extended-spectrum cephalosporin (ESC) -resistant Enterobacteriaceae. Furthermore, we investigated possible risk factors for occurrence of such bacteria in broiler flocks. The odds of a flock being positive for ESC-resistant Enterobacteriaceae increased if the previous flock in the same house was positive, and if the flock was reared during September-October. However, we cannot exclude seasonal fluctuations in occurrence of ESC-resistant Enterobacteriaceae during the months November to April. The overall occurrence of ESC-resistant Enterobacteriaceae was 10.4%, and primarily linked to the presence of blaCMY (82.6%) in positive isolates. We describe the first findings of Escherichia coli with bla(CTX-M-1), Klebsiella pneumoniae with both bla(CTX-M-15) and bla(SHV-12), and K. pneumoniae with bla(CMY) isolated from Norwegian broiler production. This study gives us a unique overview and estimate of the true occurrence of ESC-resistant Enterobacteriaceae in Norwegian broilers over a six-month period. To the best of our knowledge, this is the most comprehensive study performed on the occurrence of ESC-resistant Enterobacteriaceae in a broiler population.	[Mo, Solveig Solverod; Urdahl, Anne Margrete; Nesse, Live Lingaas; Slettemeas, Jannice Schau; Ramstad, Silje Nostvedt; Torp, Mona] Norwegian Vet Inst, Dept Anim Hlth Welf & Food Safety, Oslo, Norway; [Norstrom, Madelaine] Norwegian Vet Inst, Dept Anal & Diagnost, Oslo, Norway; [Ramstad, Silje Nostvedt] Oslo Univ Hosp, Dept Med Microbiol, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute; University of Oslo	Mo, SS (corresponding author), Norwegian Vet Inst, Dept Anim Hlth Welf & Food Safety, Oslo, Norway.	solveig.mo@vetinst.no		Urdahl, Anne Margrete/0000-0002-6149-2825; Slettemeas, Jannice Schau/0000-0003-2542-6991; Mo, Solveig Solverod/0000-0003-4532-9857	Norwegian Veterinary Institute; Norwegian Research Council [250212/E50]	Norwegian Veterinary Institute; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Veterinary Institute to LNN and the Norwegian Research Council (https://www.forskningsradet.no/, grant number 250212/E50), awarded to LNN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; Animalia, ACT PLAN NO DET ESBL; [Anonymous], 2017, STAT POULTR IND ACT; Borjesson S, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-3; Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Chowdhury S, 2012, POULTRY SCI, V91, P2701, DOI 10.3382/ps.2012-02412; DANMAP, 2014, US ANT AG OCC ANT RE; Day MJ, 2016, J ANTIMICROB CHEMOTH, V71, P1178, DOI 10.1093/jac/dkv485; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Egea P, 2012, INT J FOOD MICROBIOL, V159, P69, DOI 10.1016/j.ijfoodmicro.2012.08.002; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Heier BT, 2017, SURVEILLANCE PROGRAM; Hiroi M, 2012, J VET MED SCI, V74, P1635, DOI 10.1292/jvms.11-0479; Hiroi M, 2012, J VET MED SCI, V74, P189, DOI 10.1292/jvms.11-0372; Hofshagen M, 2008, SURVEILLANCE CONTROL; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Jonsson ME, 2012, PREV VET MED, V107, P95, DOI 10.1016/j.prevetmed.2012.05.002; KAPPERUD G, 1993, EPIDEMIOL INFECT, V111, P245, DOI 10.1017/S0950268800056958; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Lyngstad TM, 2008, POULTRY SCI, V87, P1987, DOI 10.3382/ps.2008-00132; Mo SS, 2016, PREV VET MED, V130, P112, DOI 10.1016/j.prevetmed.2016.06.011; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030; NORM/NORM-VET, 2017, US ANT AG OCC ANT RE; NORM/NORM-VET, 2006, US ANT AG OCC ANT RE; NORM/ NORM-VET, 2014, US ANT AG OCC ANT RE; NORM/NORM-VET, 2016, US ANT AG OCC ANT RE; NORM/NORM-VET. NORM/NORM-VET, 2012, US ANT AG OCC ANT R; NORM/NORM-VET. NORM/NORM-VET, 2011, US ANT AG OCC ANT RE; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Refsum T., ANTIMICROBIAL USE NO, DOI [10.1016/j.prevetmed.2016.06.011, DOI 10.1016/J.PREVETMED.2016.06.011]; Schmidt GV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131672; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Sunde M, 2009, J ANTIMICROB CHEMOTH, V63, P215, DOI 10.1093/jac/dkn445; SWEDRES/SVARM. SWEDRES/SVARM, 2015, CONS ANT OCC ANT RES; Torp M, 2016, SURVEILLANCE PROGRAM; Vogt D, 2014, MICROB DRUG RESIST, V20, P485, DOI 10.1089/mdr.2013.0210	44	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0223074	10.1371/journal.pone.0223074	http://dx.doi.org/10.1371/journal.pone.0223074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557254	gold, Green Published			2022-12-26	WOS:000532345500063
